PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sharma, R; Mahanti, GK; Panda, G; Rath, A; Dash, S; Mallik, S; Zhao, ZM				Sharma, Rohit; Mahanti, Gautam Kumar; Panda, Ganapati; Rath, Adyasha; Dash, Sujata; Mallik, Saurav; Zhao, Zhongming			Comparative performance analysis of binary variants of FOX optimization algorithm with half-quadratic ensemble ranking method for thyroid cancer detection	SCIENTIFIC REPORTS			English	Article							CLASSIFICATION; IMAGES; TOPSIS	Thyroid cancer is a life-threatening condition that arises from the cells of the thyroid gland located in the neck's frontal region just below the adam's apple. While it is not as prevalent as other types of cancer, it ranks prominently among the commonly observed cancers affecting the endocrine system. Machine learning has emerged as a valuable medical diagnostics tool specifically for detecting thyroid abnormalities. Feature selection is of vital importance in the field of machine learning as it serves to decrease the data dimensionality and concentrate on the most pertinent features. This process improves model performance, reduces training time, and enhances interpretability. This study examined binary variants of FOX-optimization algorithms for feature selection. The study employed eight transfer functions (S and V shape) to convert the FOX-optimization algorithms into their binary versions. The vision transformer-based pre-trained models (DeiT and Swin Transformer) are used for feature extraction. The extracted features are transformed using locally linear embedding, and binary FOX-optimization algorithms are applied for feature selection in conjunction with the Naive Bayes classifier. The study utilized two datasets (ultrasound and histopathological) related to thyroid cancer images. The benchmarking is performed using the half-quadratic theory-based ensemble ranking technique. Two TOPSIS-based methods (H-TOPSIS and A-TOPSIS) are employed for initial model ranking, followed by an ensemble technique for final ranking. The problem is treated as multi-objective optimization task with accuracy, F2-score, AUC-ROC and feature space size as optimization goals. The binary FOX-optimization algorithm based on the V1 transfer function achieved superior performance compared to other variants using both datasets as well as feature extraction techniques. The proposed framework comprised a Swin transformer to extract features, a Fox optimization algorithm with a V1 transfer function for feature selection, and a Naive Bayes classifier and obtained the best performance for both datasets. The best model achieved an accuracy of 94.75%, an AUC-ROC value of 0.9848, an F2-Score of 0.9365, an inference time of 0.0353 seconds, and selected 5 features for the ultrasound dataset. For the histopathological dataset, the diagnosis model achieved an overall accuracy of 89.71%, an AUC-ROC score of 0.9329, an F2-Score of 0.8760, an inference time of 0.05141 seconds, and selected 12 features. The proposed model achieved results comparable to existing research with small features space.	[Sharma, Rohit; Mahanti, Gautam Kumar] NIT, Dept Elect & Commun Engn, Durgapur 713209, India; [Panda, Ganapati] CV Raman Global Univ, Dept Elect & Commun Engn, Bhubaneswar 752054, India; [Rath, Adyasha] CV Raman Global Univ, Dept Comp Sci & Engn, Bhubaneswar 752054, India; [Dash, Sujata] Nagaland Univ, Dept Informat Technol, Dimapur, India; [Mallik, Saurav] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA	National Institute of Technology (NIT System); National Institute of Technology Durgapur; Nagaland University; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Health Science Center Houston	Mallik, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA.; Zhao, ZM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA.	sauravmtech2@gmail.com; Zhongming.Zhao@uth.tmc.edu	Mallik, Saurav/D-1608-2014; Mahanti, Kumar/AAI-6119-2020; Panda, Goutam/AAA-2846-2020	Sharma, Rohit/0000-0002-4489-1621	Precision Health Chair Professorship fund; National Institutes of Health grants	Precision Health Chair Professorship fund; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the Precision Health Chair Professorship fund and National Institutes of Health grants. The funders did not participate in the study design, data analysis, decision to publish, or preparation of the manuscript.	Rehman HAU, 2021, ARAB J SCI ENG, V46, P9437, DOI 10.1007/s13369-020-05206-x; Agrawal P, 2021, IEEE ACCESS, V9, P26766, DOI 10.1109/ACCESS.2021.3056407; [Anonymous], 2019, Annals of translational medicine; Böhland M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257635; Buddhavarapu VG, 2020, PATTERN RECOGN LETT, V140, P1, DOI 10.1016/j.patrec.2020.09.020; Cabanillas M. E., 2018, Am. Cancer Soc. Oncol. Pract. Clin. Manag., V521; Carrasco J, 2020, SWARM EVOL COMPUT, V54, DOI 10.1016/j.swevo.2020.100665; Chi JN, 2017, J DIGIT IMAGING, V30, P477, DOI 10.1007/s10278-017-9997-y; Nguyen DT, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20071822; Nguyen DT, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111976; Do T-H., 2022, 2022 INT C MULT AN P, P1; Dokeroglu T, 2022, NEUROCOMPUTING, V494, P269, DOI 10.1016/j.neucom.2022.04.083; Islam MJ, 2017, APPL SOFT COMPUT, V59, P182, DOI 10.1016/j.asoc.2017.04.050; Jia WK, 2022, COMPLEX INTELL SYST, V8, P2663, DOI 10.1007/s40747-021-00637-x; Jothi JAA, 2017, MULTIMED TOOLS APPL, V76, P18711, DOI 10.1007/s11042-017-4363-0; Kim J, 2020, NAT REV ENDOCRINOL, V16, P17, DOI 10.1038/s41574-019-0263-x; Krohling RA, 2015, PROCEDIA COMPUT SCI, V55, P308, DOI 10.1016/j.procs.2015.07.054; Liu Z, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P9992, DOI 10.1109/ICCV48922.2021.00986; Lourenzutti R, 2014, EXPERT SYST APPL, V41, P4414, DOI 10.1016/j.eswa.2014.01.015; Mirjalili S., 2011, INT C GEN EV METH, V1, P2; Mirjalili S, 2013, SWARM EVOL COMPUT, V9, P1, DOI 10.1016/j.swevo.2012.09.002; Mistry R, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7239; Mohammadi M, 2020, OMEGA-INT J MANAGE S, V96, DOI 10.1016/j.omega.2020.102254; Mohammed H, 2023, APPL INTELL, V53, P1030, DOI 10.1007/s10489-022-03533-0; Pedraza L, 2015, PROC SPIE, V9287, DOI 10.1117/12.2073532; Razia S., 2020, Modern Approaches in Machine Learning and Cognitive Science: A Walkthrough: Latest Trends in AI, P203; Sai Sundar K, 2018, INT C ISMAC COMPUTAT, P1635; Sawhney R, 2019, ADV INTELL SYST, V800, P27, DOI 10.1007/978-3-319-94649-8_4; Sharma R., 2023, Curr. Med. Imaging, V19, P1573; Sharma R, 2023, J IMAGING, V9, DOI 10.3390/jimaging9090173; Si T. etal, 2023, IEEE Access; Thompson LDR, 2018, ENDOCR PATHOL, V29, P242, DOI 10.1007/s12022-018-9520-0; Touvron H, 2021, PR MACH LEARN RES, V139, P7358; Verleysen M, 2005, LECT NOTES COMPUT SC, V3512, P758	34	1	1	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 10	2023	13	1							19598	10.1038/s41598-023-46865-8	http://dx.doi.org/10.1038/s41598-023-46865-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB6V2	37950041	gold, Green Published			2024-09-18	WOS:001136497000077
J	Manikis, GC; Simos, NJ; Kourou, K; Kondylakis, H; Poikonen-Saksela, P; Mazzocco, K; Pat-Horenczyk, R; Sousa, B; Oliveira-Maia, AJ; Mattson, J; Roziner, I; Marzorati, C; Marias, K; Nuutinen, M; Karademas, E; Fotiadis, D				Manikis, Georgios C.; Simos, Nicholas J.; Kourou, Konstantina; Kondylakis, Haridimos; Poikonen-Saksela, Paula; Mazzocco, Ketti; Pat-Horenczyk, Ruth; Sousa, Berta; Oliveira-Maia, Albino J.; Mattson, Johanna; Roziner, Ilan; Marzorati, Chiara; Marias, Kostas; Nuutinen, Mikko; Karademas, Evangelos; Fotiadis, Dimitrios			Personalized Risk Analysis to Improve the Psychological Resilience of Women Undergoing Treatment for Breast Cancer: Development of a Machine Learning-Driven Clinical Decision Support Tool	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						breast cancer; classification; machine mental health; interventions; risk assessment	QUALITY-OF-LIFE; VALIDATION; QUESTIONNAIRE; RECURRENCE; OUTCOMES; STRESS; MODEL	Background: Health professionals are often faced with the need to identify women at risk of manifesting poor psychological resilience following the diagnosis and treatment of breast cancer. Machine learning algorithms are increasingly used to support clinical decision support (CDS) tools in helping health professionals identify women who are at risk of adverse well-being outcomes and plan customized psychological interventions for women at risk. Clinical flexibility, cross-validated performance accuracy, and model explainability permitting person-specific identification of risk factors are highly desirable features of such tools. Objective: This study aimed to develop and cross-validate machine learning models designed to identify breast cancer survivors at risk of poor overall mental health and global quality of life and identify potential targets of personalized psychological interventions according to an extensive set of clinical recommendations. Methods: A set of 12 alternative models was developed to improve the clinical flexibility of the CDS tool. All models were validated using longitudinal data from a prospective, multicenter clinical pilot at 5 major oncology centers in 4 countries (Italy, project). A total of 706 patients with highly treatable breast cancer were enrolled shortly after diagnosis and before the onset of oncological treatments and were followed up for 18 months. An extensive set of demographic, lifestyle, clinical, psychological, and biological variables measured within 3 months after enrollment served as predictors. Rigorous feature selection isolated key psychological resilience outcomes that could be incorporated into future clinical practice. Results: Balanced random forest classifiers were successful at predicting well-being outcomes, with accuracies ranging between 78% and 82% (for 12-month end points after diagnosis) and between 74% and 83% (for 18-month end points after diagnosis). Explainability and interpretability analyses built on the best-performing models were used to identify potentially modifiable psychological and lifestyle characteristics that, if addressed systematically in the context of personalized psychological interventions, would be most likely to promote resilience for a given patient. Conclusions: Our results highlight the clinical utility of the BOUNCE modeling approach by focusing on resilience predictors that can be readily available to practicing clinicians at major oncology centers. The BOUNCE CDS tool paves the way for personalized risk assessment methods to identify patients at high risk of adverse well-being outcomes and direct valuable resources toward those most in need of specialized psychological interventions.	[Manikis, Georgios C.; Simos, Nicholas J.; Kondylakis, Haridimos; Marias, Kostas; Karademas, Evangelos] Fdn Res & Technol Hellas, Inst Comp Sci, Iraklion, Greece; [Kourou, Konstantina; Fotiadis, Dimitrios] Univ Ioannina, Dept Mat Sci & Engn, Ioannina, Greece; [Kourou, Konstantina; Fotiadis, Dimitrios] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Poikonen-Saksela, Paula; Mattson, Johanna] Univ Helsinki, Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland; [Mazzocco, Ketti; Marzorati, Chiara] European Inst Oncol Ist di Ricovero e Cura Caratte, Appl Res Div Cognit & Psychol Sci, Milan, Italy; [Mazzocco, Ketti] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Pat-Horenczyk, Ruth] Hebrew Univ Jerusalem, Sch Social Work & Social Welf, Jerusalem, Israel; [Sousa, Berta] Champalimaud Fdn, Champalimaud Res & Clin Ctr, Breast Unit, Lisbon, Portugal; [Oliveira-Maia, Albino J.] Champalimaud Fdn, Champalimaud Res & Clin Ctr, Lisbon, Portugal; [Roziner, Ilan] Tel Aviv Univ, Sackler Fac Med, Dept Commun Disorders, Tel Aviv, Israel; [Nuutinen, Mikko] Nord Healthcare Grp, Helsinkifin, Finland; [Fotiadis, Dimitrios] Fdn Res & Technol Hellas, Biomed Res Inst, Univ Campus Ioannina,Bldg E5, GR-45110 Ioannina, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); University of Helsinki; Helsinki University Central Hospital; University of Milan; Hebrew University of Jerusalem; Fundacao Champalimaud; Fundacao Champalimaud; Tel Aviv University; Foundation for Research & Technology - Hellas (FORTH)	Fotiadis, D (corresponding author), Fdn Res & Technol Hellas, Biomed Res Inst, Univ Campus Ioannina,Bldg E5, GR-45110 Ioannina, Greece.	fotiadis@uoi.gr	marzorati, chiara/AAA-9400-2019; Simos, Nicholas/HPF-7881-2023; Mazzocco, Ketti/AAP-4509-2020; Manikis, George/AAC-4867-2019; Karademas, Evangelos/V-1601-2019; Marias, Kostas/AAM-2330-2021; Oliveira-Maia, Albino Jorge/B-7976-2009; Pat-Horenczyk, Ruth/H-1886-2017	Kondylakis, Haridimos/0000-0002-9917-4486; Manikis, Georgios C./0000-0002-3396-0644; Marzorati, Chiara/0000-0001-7761-2804; Oliveira-Maia, Albino Jorge/0000-0001-5071-3007; Simos, Nicholas/0000-0002-2459-7572; Pat-Horenczyk, Ruth/0000-0002-5589-8837; Marias, Kostas/0000-0003-3783-5223; Mazzocco, Ketti/0000-0003-1382-6779; Sousa, Berta/0000-0003-2287-4799; Kourou, Konstantina/0000-0003-4310-2739	European Union Horizon 2020 research and innovation program [777167]	European Union Horizon 2020 research and innovation program(Horizon 2020)	This project received funding from the European Union Horizon 2020 research and innovation program under grant 777167.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Adadi A, 2018, IEEE ACCESS, V6, P52138, DOI 10.1109/ACCESS.2018.2870052; Ahmadi M, 2022, BMC MED INFORM DECIS, V22, DOI 10.1186/s12911-022-02044-9; Aizpurua-Perez I, 2020, EUR J ONCOL NURS, V49, DOI 10.1016/j.ejon.2020.101854; Apley DW, 2020, J ROY STAT SOC B, V82, P1059, DOI 10.1111/rssb.12377; Assessment list for trustworthy artificial intelligence (ALTAI), 2020, US; Ayer T, 2010, CANCER-AM CANCER SOC, V116, P3310, DOI 10.1002/cncr.25081; Baniecki H, 2021, J MACH LEARN RES, V22; Biecek P., 2018, J. Mach. Learn. Res, V19, P1, DOI [DOI 10.48550/ARXIV.1806.08915, DOI 10.1021/ACS.MOLPHARMACEUT.7B00346]; Bishop CM, 2006, PATTERN RECOGNITION, V1, DOI [DOI 10.1117/1, DOI 10.1117/1.2819119]; Bonanno GA, 2011, PSYCHOL TRAUMA-US, V3, P117, DOI 10.1037/a0020921; Borgi M, 2020, NEUROSCI BIOBEHAV R, V119, P406, DOI 10.1016/j.neubiorev.2020.10.011; BOUNCE project, About us; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Deshields TL, 2016, PSYCHO-ONCOLOGY, V25, P11, DOI 10.1002/pon.3800; Dosilovic FK, 2018, 2018 41ST INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P210, DOI 10.23919/MIPRO.2018.8400040; Eshlaghy AbbasToloie., 2013, Journal of Health and Medicine Information, V4, P124, DOI DOI 10.4172/2157-7420.1000124; Fisher A, 2019, J MACH LEARN RES, V20; Garnefski N, 2006, PERS INDIV DIFFER, V41, P1045, DOI 10.1016/j.paid.2006.04.010; Global Cancer Observatory, US; Greenwell BM, 2017, R J, V9, P421; Gunning D, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aay7120; Heitzmann CA, 2011, PSYCHO-ONCOLOGY, V20, P302, DOI 10.1002/pon.1735; Higgins O, 2023, INT J MENT HEALTH NU, V32, P966, DOI 10.1111/inm.13114; Johnston MC, 2015, PSYCHOSOMATICS, V56, P168, DOI 10.1016/j.psym.2014.10.005; Kelly CJ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1426-2; Kim W, 2012, J BREAST CANCER, V15, P230; Lazarus RS., 1984, Stress, appraisal, and coping; Lemaître G, 2017, J MACH LEARN RES, V18; Leventhal H., 2004, HDB HLTH PSYCHOL, P197; Liu XY, 2009, IEEE T SYST MAN CY B, V39, P539, DOI 10.1109/TSMCB.2008.2007853; Molnar C., 2019, Interpretable Machine Learning: A Guide for Making Black Box Models Explainable; Morrill EF, 2008, PSYCHO-ONCOLOGY, V17, P948, DOI 10.1002/pon.1313; Moser A, 2012, J CLIN EPIDEMIOL, V65, P1107, DOI 10.1016/j.jclinepi.2012.04.007; Muller, 2017, ARXIV170808296; Parvandeh S, 2020, BIOINFORMATICS, V36, P3093, DOI 10.1093/bioinformatics/btaa046; Pettini G, 2022, JMIR RES PROTOC, V11, DOI 10.2196/34564; Price WN, 2019, JAMA-J AM MED ASSOC, V322, P1765, DOI 10.1001/jama.2019.15064; Rocchi S, 2017, NEUROPSYCH DIS TREAT, V13, P2987, DOI 10.2147/NDT.S147315; Roine E, 2021, BREAST, V59, P110, DOI 10.1016/j.breast.2021.06.012; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Simard S, 2009, SUPPORT CARE CANCER, V17, P241, DOI 10.1007/s00520-008-0444-y; Simos NJ, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110777; Staniak M, 2018, R J, V10, P395; Tan PN., 2016, Introduction to data mining; Varoquaux G., 2011, JMLR, V12, P2825; Vodermaier A, 2011, SUPPORT CARE CANCER, V19, P1899, DOI 10.1007/s00520-011-1251-4; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON M, 1994, J PSYCHOSOC ONCOL, V12, P33, DOI 10.1300/J077V12N03_03; Wu Y, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n972; Zhong Y, 2023, COMMUN STAT-SIMUL C, V52, P110, DOI 10.1080/03610918.2020.1850790	53	4	4	3	5	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY East, Unit 1100, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	JUN 12	2023	25								e43838	10.2196/43838	http://dx.doi.org/10.2196/43838			17	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	L3PL9	37307043	Green Published, Green Submitted, gold			2024-09-18	WOS:001022412200003
J	Novielli, P; Romano, D; Magarelli, M; Di Bitonto, P; Diacono, D; Chiatante, A; Lopalco, G; Sabella, D; Venerito, V; Filannino, P; Bellotti, R; De Angelis, M; Iannone, F; Tangaro, S				Novielli, Pierfrancesco; Romano, Donato; Magarelli, Michele; Di Bitonto, Pierpaolo; Diacono, Domenico; Chiatante, Annalisa; Lopalco, Giuseppe; Sabella, Daniele; Venerito, Vincenzo; Filannino, Pasquale; Bellotti, Roberto; De Angelis, Maria; Iannone, Florenzo; Tangaro, Sabina			Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification	FRONTIERS IN MICROBIOLOGY			English	Article						machine learning; explainable artificial intelligence; colorectal cancer; microbiome; biomarker identification; microbiota; precision medicine	GUT MICROBIOTA; AI	Background Colorectal cancer (CRC) is a type of tumor caused by the uncontrolled growth of cells in the mucosa lining the last part of the intestine. Emerging evidence underscores an association between CRC and gut microbiome dysbiosis. The high mortality rate of this cancer has made it necessary to develop new early diagnostic methods. Machine learning (ML) techniques can represent a solution to evaluate the interaction between intestinal microbiota and host physiology. Through explained artificial intelligence (XAI) it is possible to evaluate the individual contributions of microbial taxonomic markers for each subject. Our work also implements the Shapley Method Additive Explanations (SHAP) algorithm to identify for each subject which parameters are important in the context of CRC.Results The proposed study aimed to implement an explainable artificial intelligence framework using both gut microbiota data and demographic information from subjects to classify a cohort of control subjects from those with CRC. Our analysis revealed an association between gut microbiota and this disease. We compared three machine learning algorithms, and the Random Forest (RF) algorithm emerged as the best classifier, with a precision of 0.729 +/- 0.038 and an area under the Precision-Recall curve of 0.668 +/- 0.016. Additionally, SHAP analysis highlighted the most crucial variables in the model's decision-making, facilitating the identification of specific bacteria linked to CRC. Our results confirmed the role of certain bacteria, such as Fusobacterium, Peptostreptococcus, and Parvimonas, whose abundance appears notably associated with the disease, as well as bacteria whose presence is linked to a non-diseased state.Discussion These findings emphasizes the potential of leveraging gut microbiota data within an explainable AI framework for CRC classification. The significant association observed aligns with existing knowledge. The precision exhibited by the RF algorithm reinforces its suitability for such classification tasks. The SHAP analysis not only enhanced interpretability but identified specific bacteria crucial in CRC determination. This approach opens avenues for targeted interventions based on microbial signatures. Further exploration is warranted to deepen our understanding of the intricate interplay between microbiota and health, providing insights for refined diagnostic and therapeutic strategies.	[Novielli, Pierfrancesco; Romano, Donato; Magarelli, Michele; Di Bitonto, Pierpaolo; Chiatante, Annalisa; Filannino, Pasquale; De Angelis, Maria; Tangaro, Sabina] Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy; [Novielli, Pierfrancesco; Romano, Donato; Diacono, Domenico; Bellotti, Roberto; Tangaro, Sabina] Ist Nazl Fis Nucl, Sez Bari, Bari, Italy; [Lopalco, Giuseppe; Sabella, Daniele; Venerito, Vincenzo; Iannone, Florenzo] Univ Bari Aldo Moro, Dipartimento Med Precis & Rigenerat & Area Jon, Bari, Italy; [Bellotti, Roberto] Univ Bari Aldo Moro, Dipartimento Interateneo Fis M Merlin, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Tangaro, S (corresponding author), Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy.; Tangaro, S (corresponding author), Ist Nazl Fis Nucl, Sez Bari, Bari, Italy.	sabina.tangaro@uniba.it	Lopalco, Giuseppe/K-6148-2016; Filannino, Pasquale/I-8065-2019; Bellotti, Roberto/HTM-5191-2023; Diacono, Domenico/HNR-1850-2023; Di Bitonto, Pierpaolo/HJH-5665-2023; Novielli, Pierfrancesco/KJC-3148-2024; De Angelis, Maria/AAA-9909-2019; Iannone, Florenzo/AIC-3027-2022; Tangaro, Sabina/AAN-6617-2020	Novielli, Pierfrancesco/0000-0001-8773-0636; Tangaro, Sabina/0000-0002-1372-3916; De Angelis, Maria/0000-0002-2010-884X	University of Bari [CUP H99J21017720005]; National Recovery and Resilience Plan [3138]; European Union [CN00000013, 1031]; University and Research [CUP H93C22000450007]; MIUR (Italian Ministry for Education, University and Research) in the "PON Ricerca e Competitivita [PONa3 00052]; Avviso 254/Ric, University of Bari	University of Bari; National Recovery and Resilience Plan; European Union(European Union (EU)); University and Research; MIUR (Italian Ministry for Education, University and Research) in the "PON Ricerca e Competitivita(Ministry of Education, Universities and Research (MIUR)); Avviso 254/Ric, University of Bari	The author(s) declare financial support was received for the research, authorship, and/or publication of this article.This research was funded by the University of Bari, PojectXAI4Microbiome -Intelligenza Artificiale eXplainable perl'identificazione di marker metabolici personalizzati nella malattiadi Behcet code S30-CUP H99J21017720005. The NationalRecovery and Resilience Plan (NRRP) Mission 4 Component2 Investment 1.4-Call for tender no. 3138 of 16 December2021 of Italian Ministry of University and Research funded by the European Union-NextGenerationEU. Award number: Project code: CN00000013, Concession decree no. 1031 of 17February 2022 adopted by the Italian Ministry of University and Research, CUP H93C22000450007, Project title "National Center for HPC, Big Data and Quantum Computing" support this project. Authors would like to thank the resources made available by ReCaS, a project funded by the MIUR (ItalianMinistry for Education, University and Research) in the "PONRicerca e Competitivita' 2007-2013-Azione I-Interventi di rafforzamento strutturale"PONa300052, Avviso 254/Ric,University of Bari.r The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the University of Bari, Poject XAI4Microbiome -Intelligenza Artificiale eXplainable per l'identificazione di marker metabolici personalizzati nella malattia di Behcet code S30-CUP H99J21017720005. The National Recovery and Resilience Plan (NRRP) Mission 4 Component 2 Investment 1.4-Call for tender no. 3138 of 16 December 2021 of Italian Ministry of University and Research funded by the European Union-NextGenerationEU. Award number: Project code: CN00000013, Concession decree no. 1031 of 17 February 2022 adopted by the Italian Ministry of University and Research, CUP H93C22000450007, Project title "National Center for HPC, Big Data and Quantum Computing" support this project. Authors would like to thank the resources made available by ReCaS, a project funded by the MIUR (Italian Ministry for Education, University and Research) in the "PON Ricerca e Competitivita' 2007-2013-Azione I-Interventi di rafforzamento strutturale" PONa3 00052, Avviso 254/Ric, University of Bari.	AITCHISON J, 1982, J ROY STAT SOC B, V44, P139; Amodeo I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259724; Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3; Bellando-Randone S, 2021, J PERS MED, V11, DOI 10.3390/jpm11070625; Bellantuono L, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-43856-7; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cao Q, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.607325; Chen H, 2022, GUT PATHOG, V14, DOI 10.1186/s13099-022-00527-8; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Elangovan A, 2021, DIGEST DIS SCI, V66, P3156, DOI 10.1007/s10620-020-06602-x; Golob JL, 2024, CELL REP MED, V5, DOI 10.1016/j.xcrm.2023.101350; Ibrahimi E, 2023, FRONT MICROBIOL, V14, DOI 10.3389/fmicb.2023.1250909; Janzing D, 2020, PR MACH LEARN RES, V108, P2907; Koliarakis I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174146; Löwenmark T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72132-1; Lombardi A, 2021, FRONT SYST NEUROSCI, V15, DOI 10.3389/fnsys.2021.766980; Lombardi A, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.674055; Lundberg SM, 2017, ADV NEUR IN, V30; Lundberg SM, 2020, NAT MACH INTELL, V2, P56, DOI 10.1038/s42256-019-0138-9; Marcos-Zambrano Laura Judith, 2022, Zenodo, DOI 10.5281/ZENODO.7382814; Montalban-Arques A, 2021, CELL HOST MICROBE, V29, P1573, DOI 10.1016/j.chom.2021.08.001; Morgan E, 2023, GUT, V72, P338, DOI 10.1136/gutjnl-2022-327736; Murphy G, 2011, INT J CANCER, V128, P1668, DOI 10.1002/ijc.25481; Novielli P., 2023, PREPRINT, DOI [10.21203/rs.3.rs-3519546/v1, DOI 10.21203/RS.3.RS-3519546/V1]; Ozenne B, 2015, J CLIN EPIDEMIOL, V68, P855, DOI 10.1016/j.jclinepi.2015.02.010; Papoutsoglou G, 2023, FRONT MICROBIOL, V14, DOI 10.3389/fmicb.2023.1261889; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rynazal R, 2023, GENOME BIOL, V24, DOI 10.1186/s13059-023-02858-4; SCHAFFER C, 1993, MACH LEARN, V13, P135, DOI 10.1023/A:1022639714137; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Venerito V, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.917939; Vijaymeena M., 2016, Machine Learning and Applications: An International Journal, V3, P19, DOI [DOI 10.5121/MLAIJ2016.3103, DOI 10.5121/MLAIJ.2016.3103]; Wang N, 2023, TRENDS MICROBIOL, V31, P159, DOI 10.1016/j.tim.2022.08.010; Wu YQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23265-y; Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7; Ye PF, 2020, CANCERS, V12, DOI 10.3390/cancers12061408; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang HX, 2023, CANCER IMMUNOL IMMUN, V72, P315, DOI 10.1007/s00262-022-03256-8; Zhang XS, 2023, CELL HOST MICROBE, V31, P418, DOI 10.1016/j.chom.2023.01.013; Zhou ZW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00371	44	3	3	17	17	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-302X		FRONT MICROBIOL	Front. Microbiol.	FEB 15	2024	15								1348974	10.3389/fmicb.2024.1348974	http://dx.doi.org/10.3389/fmicb.2024.1348974			11	Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology	JM7W3	38426064	gold			2024-09-18	WOS:001173660300001
J	Clarijs, ME; Thurell, J; Kühn, F; Uyl-de Groot, CA; Hedayati, E; Karsten, MM; Jager, A; Koppert, LB				Clarijs, Marloes E.; Thurell, Jacob; Kuehn, Friedrich; Uyl-de Groot, Carin A.; Hedayati, Elham; Karsten, Maria M.; Jager, Agnes; Koppert, Linetta B.			Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach	CANCERS			English	Review						metastatic breast cancer; quality of life; patient reported outcomes	EUROPEAN ORGANIZATION; CLINICAL-TRIALS; SYMPTOM BURDEN; EORTC QLQ-C30; SHORT-FORM; LONG-TERM; WOMEN; IMPACT; CHEMOTHERAPY; SURVIVAL	Simple Summary Metastatic breast cancer (MBC) remains incurable despite treatment improvements. The health-related quality of life is a multidimensional entity which covers physical, psychological and social dimensions. It is an important outcome particularly in patients with metastatic disease, as the primary goal of therapy is no longer curation, but to provide the best possible quality of life weighted against treatment risks and adverse symptoms. Patient-reported outcomes reflecting the quality of life are usually measured with validated questionnaires to evaluate treatment strategies based on symptom burden and to improve care delivery. This review shares insights into the role of patient-reported outcome measurements in MBC patients and describes the heterogeneity of current questionnaires. We conclude that an up-to-date and standardized outcome set is needed, containing relevant domains referring to individual needs to improve the quality of life assessment among MBC patients. This is a prerequisite to learn about how they could impact the clinical care pathway. Metastatic breast cancer (MBC) patients are almost always treated to minimize the symptom burden, and to prolong life without a curative intent. Although the prognosis of MBC patients has improved in recent years, the median survival after diagnosis is still only 3 years. Therefore, the health-related quality of life (HRQoL) should play a leading role in making treatment decisions. Heterogeneity in questionnaires used to evaluate the HRQoL in MBC patients complicates the interpretability and comparability of patient-reported outcomes (PROs) globally. In this review, we aimed to provide an overview of PRO instruments used in real-world MBC patients and to discuss important issues in measuring HRQoL. Routinely collecting symptom information using PROs could enhance treatment evaluation and shared decision-making. Standardizing these measures might help to improve the implementation of PROs, and facilitates collecting and sharing data to establish valid comparisons in research. This is a prerequisite to learn about how they could impact the clinical care pathway. In addition, the prognostic value of intensified PRO collection throughout therapy on survival and disease progression is promising. Future perspectives in the field of PROs and MBC are described.	[Clarijs, Marloes E.; Koppert, Linetta B.] Erasmus MC, Canc Inst, Dept Surg Oncol, Acad Breast Canc Ctr, NL-3015 GD Rotterdam, Netherlands; [Thurell, Jacob; Hedayati, Elham] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Thurell, Jacob; Hedayati, Elham] Karolinska Univ Hosp, S-17176 Stockholm, Sweden; [Kuehn, Friedrich; Karsten, Maria M.] Charite Univ Med Berlin, Dept Gynecol, Breast Ctr, D-10117 Berlin, Germany; [Kuehn, Friedrich; Karsten, Maria M.] Free Univ Berlin, D-10117 Berlin, Germany; [Kuehn, Friedrich; Karsten, Maria M.] Humboldt Univ, D-10117 Berlin, Germany; [Uyl-de Groot, Carin A.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Dept Hlth Technol Assessment, NL-3062 PA Rotterdam, Netherlands; [Jager, Agnes] Erasmus MC, Canc Inst, Dept Med Oncol, Acad Breast Canc Ctr, NL-3015 GD Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Erasmus University Rotterdam; Erasmus University Rotterdam - Excl Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Koppert, LB (corresponding author), Erasmus MC, Canc Inst, Dept Surg Oncol, Acad Breast Canc Ctr, NL-3015 GD Rotterdam, Netherlands.	m.clarijs@erasmusmc.nl; jacob.thurell@ki.se; friedrich.kuehn@charite.de; uyl@eshpm.eur.nl; elham.hedayati@ki.se; maria-margarete.karsten@charite.de; a.jager@erasmusmc.nl; l.koppert@erasmusmc.nl	Hedayati, Elham/AAK-6037-2021; jager, agnes/V-6381-2017	Hedayati, Elham/0000-0003-1352-4332; Karsten, Maria Margarete/0000-0001-7587-7550; koppert, linetta/0000-0003-1944-6777				Adamowicz K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01389-x; Adamowicz K, 2012, CANCER TREAT REV, V38, P554, DOI 10.1016/j.ctrv.2011.07.002; Amado Fernanda, 2006, Sao Paulo Med. J., V124, P203, DOI 10.1590/S1516-31802006000400006; [Anonymous], 2021, BREAST CANC ESTIMATE; Aranda S, 2005, EUR J CANCER CARE, V14, P211, DOI 10.1111/j.1365-2354.2005.00541.x; Badwe RA, 2014, J CLIN ONCOL, V32; Barnadas A, 2019, J PATIENT-REP OUTCOM, V3, DOI 10.1186/s41687-019-0161-y; Basch E, 2017, JAMA-J AM MED ASSOC, V318, P197, DOI 10.1001/jama.2017.7156; Basch E, 2016, J CLIN ONCOL, V34, P557, DOI 10.1200/JCO.2015.63.0830; Bjelic-Radisic V, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06894-2; Bottomley A, 2016, LANCET ONCOL, V17, pE510, DOI 10.1016/S1470-2045(16)30510-1; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; Brédart A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-15; Cardoso F, 2017, BREAST, V31, P244, DOI 10.1016/j.breast.2016.10.001; Cardoso F, 2010, ANN ONCOL, V21, pv15, DOI 10.1093/annonc/mdq160; Cardoso F, 2018, BREAST, V39, P131, DOI 10.1016/j.breast.2018.03.002; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2014, PSYCHOL ASSESSMENT, V26, P513, DOI 10.1037/a0035768; Claessens AKM, 2020, QUAL LIFE RES, V29, P3363, DOI 10.1007/s11136-020-02604-4; Cleeland CS, 2014, BREAST, V23, P763, DOI 10.1016/j.breast.2014.08.004; Costa WA, 2017, CLINICS, V72, P758, DOI 10.6061/clinics/2017(12)07; Danesh M, 2014, J CANCER EDUC, V29, P175, DOI 10.1007/s13187-013-0566-x; Davie A, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07294-2; DEHAES JCJM, 1990, BRIT J CANCER, V62, P1034, DOI 10.1038/bjc.1990.434; Denis F, 2019, JAMA-J AM MED ASSOC, V321, P306, DOI 10.1001/jama.2018.18085; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; DiBonaventura MD, 2014, AM HEALTH DRUG BENEF, V7, P386; Ecclestone C, 2016, SUPPORT CARE CANCER, V24, P4035, DOI 10.1007/s00520-016-3217-z; Efficace F, 2004, EUR J CANCER, V40, P1021, DOI 10.1016/j.ejca.2004.01.014; Fallowfield LJ, 1999, BREAST CANCER RES TR, V55, P189; Friedrich M, 2019, QUAL LIFE RES, V28, P1615, DOI 10.1007/s11136-019-02147-3; Gennari A, 2005, CANCER, V104, P1742, DOI 10.1002/cncr.21359; Ghislain I, 2016, LANCET ONCOL, V17, pE294, DOI 10.1016/S1470-2045(16)30099-7; Goodwin PJ, 2003, JNCI-J NATL CANCER I, V95, P263, DOI 10.1093/jnci/95.4.263; Karamouzis MV, 2007, EUR J CANCER CARE, V16, P433, DOI 10.1111/j.1365-2354.2006.00771.x; Kokkonen K, 2017, BREAST CANCER-TOKYO, V24, P128, DOI 10.1007/s12282-016-0687-2; Krohe M, 2016, BREAST CANCER-BASIC, V10, P93, DOI 10.4137/BCBCR.S39385; Lee CK, 2010, BRIT J CANCER, V102, P1341, DOI 10.1038/sj.bjc.6605649; Lima Eunice de Oliveira Lacerda, 2020, Rev. Gaúcha Enferm., V41, pe20190292; Love AW, 2004, AUST NZ J PSYCHIAT, V38, P526, DOI 10.1080/j.1440-1614.2004.01385.x; Marshall S, 2006, J EVAL CLIN PRACT, V12, P559, DOI 10.1111/j.1365-2753.2006.00650.x; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McLachlan SA, 1998, EUR J CANCER, V34, P510, DOI 10.1016/S0959-8049(97)10076-4; Meisel JL, 2012, CLIN BREAST CANCER, V12, P119, DOI 10.1016/j.clbc.2012.01.010; Mettlin C, 1999, CA-CANCER J CLIN, V49, P138, DOI 10.3322/canjclin.49.3.138; Michael YL, 2000, CANCER-AM CANCER SOC, V89, P2176, DOI 10.1002/1097-0142(20001201)89:11<2176::AID-CNCR5>3.0.CO;2-6; Mierzynska J, 2020, EUR J CANCER, V125, P69, DOI 10.1016/j.ejca.2019.10.031; Mougalian SS, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00107; Müller V, 2018, BREAST, V37, P154, DOI 10.1016/j.breast.2017.08.008; Musoro JZ, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz037; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Ong WL, 2017, JAMA ONCOL, V3, P677, DOI 10.1001/jamaoncol.2016.4851; Osoba D, 2002, J CLIN ONCOL, V20, P3106, DOI 10.1200/JCO.2002.03.090; Park EM, 2018, PSYCHOSOMATICS, V59, P251, DOI 10.1016/j.psym.2018.01.007; Pe M, 2018, LANCET ONCOL, V19, pE459, DOI 10.1016/S1470-2045(18)30418-2; Petersen MA, 2018, EUR J CANCER, V100, P8, DOI 10.1016/j.ejca.2018.04.016; Porter ME, 2016, NEW ENGL J MED, V374, P504, DOI 10.1056/NEJMp1511701; Pusic AL, 2009, PLAST RECONSTR SURG, V124, P345, DOI 10.1097/PRS.0b013e3181aee807; Reed E, 2012, EUR J CANCER CARE, V21, P565, DOI 10.1111/j.1365-2354.2012.01370.x; Reed E, 2012, J PAIN SYMPTOM MANAG, V43, P747, DOI 10.1016/j.jpainsymman.2011.05.005; Shin JA, 2016, J PALLIAT MED, V19, P863, DOI 10.1089/jpm.2016.0027; Slovacek L, 2010, MED ONCOL, V27, P958, DOI 10.1007/s12032-009-9316-7; Snyder CF, 2009, LANCET, V374, P369, DOI 10.1016/S0140-6736(09)61400-8; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Stein KD, 2008, CANCER-AM CANCER SOC, V112, P2577, DOI 10.1002/cncr.23448; Sundquist M, 2017, BREAST, V31, P46, DOI 10.1016/j.breast.2016.10.005; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; Tosello G, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011276.pub2; Turner J, 2005, PSYCHO-ONCOLOGY, V14, P396, DOI 10.1002/pon.856; Turner-Bowker DM, 2016, CURR MED RES OPIN, V32, P1709, DOI 10.1080/03007995.2016.1205005; Tyczynski JE, 2004, INT J CANCER, V112, P1056, DOI 10.1002/ijc.20514; van Egdom LSE, 2019, VALUE HEALTH, V22, P1197, DOI 10.1016/j.jval.2019.04.1927; Wallwiener M, 2016, GEBURTSH FRAUENHEILK, V76, P1065, DOI 10.1055/s-0042-113188; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	75	13	13	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	MAY	2021	13	10							2308	10.3390/cancers13102308	http://dx.doi.org/10.3390/cancers13102308			14	Oncology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology	SI2WE	34065805	Green Published, gold			2024-09-18	WOS:000654686200001
J	Alabi, RO; Youssef, O; Pirinen, M; Elmusrati, M; Makitie, AA; Leivo, I; Almangush, A				Alabi, Rasheed Omobolaji; Youssef, Omar; Pirinen, Matti; Elmusrati, Mohammed; Makitie, Antti A.; Leivo, Ilmo; Almangush, Alhadi			Machine learning in oral squamous cell carcinoma: Current status, clinical concerns and prospects for future-A systematic review	ARTIFICIAL INTELLIGENCE IN MEDICINE			English	Review						Machine learning; Oral squamous cell carcinoma; Systematic review; Explainable AI	ARTIFICIAL NEURAL-NETWORK; MULTIVARIABLE PREDICTION MODEL; INDIVIDUAL PROGNOSIS; CANCER-DIAGNOSIS; VECTOR MACHINE; INTELLIGENCE; CLASSIFICATION; PERFORMANCE; RISK; REGRESSION	Background: Oral cancer can show heterogenous patterns of behavior. For proper and effective management of oral cancer, early diagnosis and accurate prediction of prognosis are important. To achieve this, artificial intelligence (AI) or its subfield, machine learning, has been touted for its potential to revolutionize cancer management through improved diagnostic precision and prediction of outcomes. Yet, to date, it has made only few contributions to actual medical practice or patient care. Objectives: This study provides a systematic review of diagnostic and prognostic application of machine learning in oral squamous cell carcinoma (OSCC) and also highlights some of the limitations and concerns of clinicians towards the implementation of machine learning-based models for daily clinical practice. Data sources: We searched OvidMedline, PubMed, Scopus, Web of Science, and Institute of Electrical and Electronics Engineers (IEEE) databases from inception until February 2020 for articles that used machine learning for diagnostic or prognostic purposes of OSCC. Eligibility criteria: Only original studies that examined the application of machine learning models for prognostic and/or diagnostic purposes were considered. Data extraction: Independent extraction of articles was done by two researchers (A.R. & O.Y) using predefine study selection criteria. We used the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) in the searching and screening processes. We also used Prediction model Risk of Bias Assessment Tool (PROBAST) for assessing the risk of bias (ROB) and quality of included studies. Results: A total of 41 studies were published to have used machine learning to aid in the diagnosis/or prognosis of OSCC. The majority of these studies used the support vector machine (SVM) and artificial neural network (ANN) algorithms as machine learning techniques. Their specificity ranged from 0.57 to 1.00, sensitivity from 0.70 to 1.00, and accuracy from 63.4 % to 100.0 % in these studies. The main limitations and concerns can be grouped as either the challenges inherent to the science of machine learning or relating to the clinical implementations. Conclusion: Machine learning models have been reported to show promising performances for diagnostic and prognostic analyses in studies of oral cancer. These models should be developed to further enhance explainability, interpretability, and externally validated for generalizability in order to be safely integrated into daily clinical practices. Also, regulatory frameworks for the adoption of these models in clinical practices are necessary.	[Alabi, Rasheed Omobolaji; Elmusrati, Mohammed] Univ Vaasa, Dept Ind Digitalizat, Sch Technol & Innovat, Vaasa, Finland; [Youssef, Omar; Almangush, Alhadi] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Youssef, Omar; Makitie, Antti A.; Almangush, Alhadi] Univ Helsinki, Fac Med, Res Program Syst Oncol, Helsinki, Finland; [Pirinen, Matti] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Pirinen, Matti] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Pirinen, Matti] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Makitie, Antti A.] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland; [Makitie, Antti A.] Helsinki Univ Hosp, Helsinki, Finland; [Makitie, Antti A.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Ear Nose & Throat Dis, Stockholm, Sweden; [Makitie, Antti A.] Karolinska Univ Hosp, Stockholm, Sweden; [Leivo, Ilmo; Almangush, Alhadi] Univ Turku, Inst Biomed, Pathol, Turku, Finland; [Almangush, Alhadi] Misurata Univ, Fac Dent, Misurata, Libya	University of Vaasa; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Turku	Alabi, RO (corresponding author), Univ Vaasa, Dept Ind Digitalizat, Sch Technol & Innovat, Vaasa, Finland.	rasheed.alabi@student.uwasa.fi	Almangush, Alhadi/E-8307-2013; Youssef, Omar/AAC-8395-2020; Elmusrati, Mohammed/H-8442-2012	Pirinen, Matti/0000-0002-1664-1350; youssef, Omar/0000-0002-1827-9156; Elmusrati, Mohammed/0000-0001-9304-6590; Leivo, Ilmo/0000-0002-9609-1597	School of Technology and Innovations, University of Vaasa Scholarship Fund; Turku University Hospital Fund; Helsinki University Hospital Research Fund	School of Technology and Innovations, University of Vaasa Scholarship Fund; Turku University Hospital Fund; Helsinki University Hospital Research Fund	The School of Technology and Innovations, University of Vaasa Scholarship Fund. Turku University Hospital Fund, and Helsinki University Hospital Research Fund.	Al-Bahrani Reda, 2013, 2013 IEEE International Conference on Big Data, P9, DOI 10.1109/BigData.2013.6691752; Al-Ma'aitah M, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1052-0; Alabi RO, 2019, VIRCHOWS ARCH, V475, P489, DOI 10.1007/s00428-019-02642-5; Alabi RO, 2020, INT J MED INFORM, V136, DOI 10.1016/j.ijmedinf.2019.104068; Alabi RO, 2020, CEUR WORKSHOP PROC; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Anderson Jeffrey P, 2015, J Diabetes Sci Technol, V10, P6, DOI 10.1177/1932296815620200; Ariji Y, 2019, OR SURG OR MED OR PA, V127, P458, DOI 10.1016/j.oooo.2018.10.002; Aubreville M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12320-8; Bali J, 2019, INDIAN J OPHTHALMOL, V67, P3, DOI 10.4103/ijo.IJO_1292_18; Barocas S, 2016, CALIF LAW REV, V104, P671, DOI 10.15779/Z38BG31; Bernease Herman, 2017, PROMISE PERIL HUMAN; Brocklehurst P, 2017, LANCET, V389, P1719, DOI 10.1016/S0140-6736(17)30568-8; Bur AM, 2019, ORAL ONCOL, V92, P20, DOI 10.1016/j.oraloncology.2019.03.011; Castelvecchi D, 2016, NATURE, V538, P21, DOI [10.1038/nature.2016.20491, 10.1038/538020a]; Chan CH, 2019, IEEE T BIOMED CIRC S, V13, P766, DOI 10.1109/TBCAS.2019.2918244; Chang SW, 2014, SAINS MALAYS, V43, P567; Chang SW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-170; Chen DC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/632786; Chen Y I, 2018, 32 C NEURAL INFORM P; Cheng CS, 2018, J UNIVERS COMPUT SCI, V24, P742; Chien CW, 2008, HEPATO-GASTROENTEROL, V55, P1140; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; Collins GS, 2015, EUR UROL, V67, P1142, DOI 10.1016/j.eururo.2014.11.025; Crawford K, 2016, NATURE, V538, P311, DOI 10.1038/538311a; Das DK, 2018, TISSUE CELL, V53, P111, DOI 10.1016/j.tice.2018.06.004; Davis SE, 2019, J AM MED INFORM ASSN, V26, P1448, DOI 10.1093/jamia/ocz127; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Denkert C, 2018, LANCET ONCOL, V19, P40, DOI 10.1016/S1470-2045(17)30904-X; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; European Union, 2019, HIGH LEVEL EXPERT GR; Exarchos KP, 2012, IEEE T INF TECHNOL B, V16, P1127, DOI 10.1109/TITB.2011.2165076; Faradmal J, 2014, ASIAN PAC J CANCER P, V15, P5883, DOI 10.7314/APJCP.2014.15.14.5883; ( FDA) FaDA, 2019, PROP REG FRAM MOD AR; Fogel AL, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0012-2; Geis JR, 2019, RADIOLOGY, V293, P436, DOI 10.1148/radiol.2019191586; Gohari MR, 2011, ASIAN PAC J CANCER P, V12, P1469; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Haenssle HA, 2019, ANN ONCOL, V30, P854, DOI 10.1093/annonc/mdz015; Heinrichs B, 2020, HUM BRAIN MAPP, V41, P1435, DOI 10.1002/hbm.24886; Holzinger A., 2017, ARXIV171209923; Holzinger A, 2020, KUNSTL INTELL, V34, P193, DOI 10.1007/s13218-020-00636-z; Holzinger A, 2019, WIRES DATA MIN KNOWL, V9, DOI 10.1002/widm.1312; Huang SG, 2020, CANCER LETT, V471, P61, DOI 10.1016/j.canlet.2019.12.007; Jeyaraj PR, 2019, J CANCER RES CLIN, V145, P829, DOI 10.1007/s00432-018-02834-7; Kanda S., 2003, ORAL RADIOL, V19, P35, DOI [10.1007/BF02493239, DOI 10.1007/BF02493239]; Karadaghy OA, 2019, JAMA OTOLARYNGOL, V145, P1115, DOI 10.1001/jamaoto.2019.0981; Kawazu T, 2001, INT CONGR SER, V1230, P1187; Keane PA, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0048-y; Kelly CJ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1426-2; Kim DW, 2019, KOREAN J RADIOL, V20, DOI 10.3348/kjr.2019.0025; Kim KY, 2011, ORAL ONCOL, V47, P1069, DOI 10.1016/j.oraloncology.2011.07.017; Kononenko I, 2001, ARTIF INTELL MED, V23, P89, DOI 10.1016/S0933-3657(01)00077-X; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; LALITHMANI K, 2019, INT J REC TECH ENG, V7, P397; Lavanya L., 2019, Int. J. Eng. Res. Technol, V12, P596; Levitin G., 2007, COMPUTATIONAL INTELL, DOI [10.1007/978-3-540-37368-1, DOI 10.1007/978-3-540-37368-1]; Lu C, 2017, MODERN PATHOL, V30, P1655, DOI 10.1038/modpathol.2017.98; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Lynch CM, 2017, INT J MED INFORM, V108, P1, DOI 10.1016/j.ijmedinf.2017.09.013; Majumder SK, 2005, LASER SURG MED, V36, P323, DOI 10.1002/lsm.20160; Mandel JC, 2016, J AM MED INFORM ASSN, V23, P899, DOI 10.1093/jamia/ocv189; McRae MP, 2020, CANCER CYTOPATHOL, V128, P207, DOI 10.1002/cncy.22236; Mermod M, 2020, HEAD NECK-J SCI SPEC, V42, P1811, DOI 10.1002/hed.26105; Michie D., 1994, Neural and Statistical Classification; Mintz Y, 2019, MINIM INVASIV THER, V28, P73, DOI 10.1080/13645706.2019.1575882; Moher D., 2009, INDOOR SMOKE SOLID F, V6, DOI 10.1371/journal.pmed.1000097; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Nabi J, 2018, HASTINGS CENT REP, V48, P10, DOI 10.1002/hast.895; Nawandhar A, 2020, BIOMED SIGNAL PROCES, V55, DOI 10.1016/j.bspc.2019.101671; Nayak GS, 2006, BIOPOLYMERS, V82, P152, DOI 10.1002/bip.20473; Nestor B, 2018, ARXIV181112583; Ngiam KY, 2019, LANCET ONCOL, V20, pE262, DOI 10.1016/S1470-2045(19)30149-4; Patil S, 2019, J ORAL PATHOL MED, V48, P773, DOI 10.1111/jop.12854; Powles J, 2017, HEALTH TECHNOL-GER, V7, P351, DOI 10.1007/s12553-017-0179-1; Qian ZH, 2019, CANCER LETT, V451, P128, DOI 10.1016/j.canlet.2019.02.054; Romeo V, 2020, ANTICANCER RES, V40, P271, DOI 10.21873/anticanres.13949; Shaban-Nejad A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0058-9; Shah ND, 2018, JAMA-J AM MED ASSOC, V320, P27, DOI 10.1001/jama.2018.5602; Shams W, 2017, Intl Appl Eng Res, V12, P4893; Sharm N, 2015, NETW MODEL ANAL HLTH, V4, DOI 10.1007/s13721-015-0085-2; Sharma N, 2014, NETW MODEL ANAL HLTH, V3, DOI 10.1007/s13721-014-0058-x; Sharma N, 2013, NETW MODEL ANAL HLTH, V2, P285, DOI 10.1007/s13721-013-0045-7; Sharma Neha, 2015, ScientificWorldJournal, V2015, P234191, DOI 10.1155/2015/234191; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21590, 10.3322/caac.21601]; SPEIGHT PM, 1995, BRIT DENT J, V179, P382, DOI 10.1038/sj.bdj.4808932; Sunny S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224885; Tan AD, 2019, CANCER LETT, V458, P39, DOI 10.1016/j.canlet.2019.05.015; Tseng WT, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0241-3; Turki T, 2018, COMPUT BIOL MED, V101, P236, DOI 10.1016/j.compbiomed.2018.08.006; Uthoff RD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207493; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Wang CY, 2003, LASER SURG MED, V32, P318, DOI 10.1002/lsm.10153; Wang XJ, 2020, J ORAL PATHOL MED, V49, P417, DOI 10.1111/jop.12983; Willems SM, 2019, ORAL ONCOL, V98, P8, DOI 10.1016/j.oraloncology.2019.09.003; Xu SP, 2019, IEEE ACCESS, V7, P158603, DOI 10.1109/ACCESS.2019.2950286; Yan H, 2019, VIB SPECTROSC, V103, DOI 10.1016/j.vibspec.2019.102938; Yu MK, 2018, CELL, V173, P1562, DOI 10.1016/j.cell.2018.05.056; Yu MX, 2019, PHOTODIAGN PHOTODYN, V26, P430, DOI 10.1016/j.pdpdt.2019.05.008; Zachary L., 2017, DOCTOR JUST WONT ACC; Zheng BC, 2014, EXPERT SYST APPL, V41, P1476, DOI 10.1016/j.eswa.2013.08.044; Zhu LC, 2013, BIOMED REP, V1, P757, DOI 10.3892/br.2013.140; Zlotogorski-Hurvitz A, 2019, J CANCER RES CLIN, V145, P685, DOI 10.1007/s00432-018-02827-6; Zolbanin HM, 2015, DECIS SUPPORT SYST, V74, P150, DOI 10.1016/j.dss.2015.04.003	105	75	80	3	34	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0933-3657	1873-2860		ARTIF INTELL MED	Artif. Intell. Med.	MAY	2021	115								102060	10.1016/j.artmed.2021.102060	http://dx.doi.org/10.1016/j.artmed.2021.102060		APR 2021	14	Computer Science, Artificial Intelligence; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering; Medical Informatics	SU7IB	34001326				2024-09-18	WOS:000663305100007
J	Roseiro, M; Henriques, J; Paredes, S; Rocha, T; Sousa, J				Roseiro, M.; Henriques, J.; Paredes, S.; Rocha, T.; Sousa, J.			An interpretable machine learning approach to estimate the influence of inflammation biomarkers on cardiovascular risk assessment	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Inflammation biomarkers; GRACE; Data Fusion; Interpretability; Personalization	CANCER	Background and objective: Cardiovascular disease has a huge impact on health care services, originating unsustainable costs at clinical, social, and economic levels. In this context, patients' risk stratification tools are central to support clinical decisions contributing to the implementation of effective preventive health care. Although useful, these tools present some limitations, in particular, some lack of performance as well as the impossibility to consider new risk factors potentially important in the prognosis of severe car-diac events. Moreover, the actual use of these tools in the daily practice requires the physicians' trust. The main goal of this work addresses these two issues: (i) evaluate the importance of inflammation biomark-ers when combined with a risk assessment tool; (ii) incorporation of personalization and interpretability as key elements of that assessment.Methods: Firstly, machine learning based models were created to assess the potential of the inflam-mation biomarkers applied in secondary prevention, namely in the prediction of the six month risk of death/myocardial infarction. Then, an approach based on three main phases was created: (i) set of inter-pretable rules supported by clinical evidence; (ii) selection based on a machine learning classifier able to identify for a given patient the most suitable subset of rules; (iii) an ensemble scheme combining the previous subset of rules in the estimation of the patient cardiovascular risk. All the results were statis-tically validated ( t-test, Wilcoxon-signed rank test) according to a previous verification of data normality (Shapiro-Wilk).Results: The proposed methodology was applied to a real acute coronary syndrome patients dataset ( N = 1544) from the Cardiology Unit of Coimbra Hospital and Universitary centre. The first assessment was based on the GRACE tool and a Random Forest classifier, the incorporation of inflammation biomark-ers achieved SE = 0.83; SP = 0.84 whereas the original GRACE risk factors reached SE = 0.75; SP = 0.85. In the second phase, the proposed approach with inflammation biomarkers achieved SE = 0.763 and SP = 0.778. Conclusions: This approach confirms the potential of combining inflammation markers with the GRACE score, increasing SE and SP, when compared with the original GRACE. Additionally, it assures inter-pretability and personalization, which are critical issues to allow its application in the daily clinical prac-tice.(c) 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )	[Roseiro, M.; Henriques, J.; Paredes, S.; Rocha, T.] Univ Coimbra, Ctr Informat & Syst, CISUC, P-3030290 Coimbra, Portugal; [Paredes, S.; Rocha, T.] Polytech Inst Coimbra, Coimbra Inst Engn IPC ISEC, Rua Pedro Nunes, P-3030199 Coimbra, Portugal; [Sousa, J.] Ctr Hosp & Univ Coimbra, Cardiol Dept, Praceta Prof Mota Pinto, Coimbra, Portugal; [Paredes, S.] Coimbra Inst Engn, Informat & Syst Engn Dept, Rua Pedro Nunes Quinta Nora, P-3030199 Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Paredes, S (corresponding author), Coimbra Inst Engn, Informat & Syst Engn Dept, Rua Pedro Nunes Quinta Nora, P-3030199 Coimbra, Portugal.	sparedes@isec.pt	Henriques, Jorge/A-6015-2018	Rocha, Teresa/0000-0002-3497-7368; Paredes, Simao/0000-0002-1021-1173; Sousa, Jose/0000-0002-0449-0479	FCT-Foundation for Science and Technology, I.P./MCTES through national funds (PIDDAC) [UIDP/00326/2020]	FCT-Foundation for Science and Technology, I.P./MCTES through national funds (PIDDAC)	Acknowledgments This work is funded by the FCT-Foundation for Science and Technology, I.P./MCTES through national funds (PIDDAC) , within the scope of CISUC R&D Unit-UIDB/00326/2020 or project code UIDP/00326/2020.	Abreu D, 2020, REV PORT CARDIOL, V39, P27, DOI 10.1016/j.repc.2019.05.010; Angiolillo DJ, 2004, REV ESP CARDIOL, V57, P433, DOI 10.1016/S1885-5857(06)60174-6; Austin PC, 2021, CAN J CARDIOL, V37, P1322, DOI 10.1016/j.cjca.2020.11.010; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Danesh J, BMJ BR MED J; Durán JM, 2021, J MED ETHICS, V47, P329, DOI [10.1136/medethics-2021-107531, 10.1136/medethics-2020-106820]; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fioranelli M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02031; Gonçalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Linardatos P, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23010018; Ma X, 2020, COMPUT METH PROG BIO, V186, DOI 10.1016/j.cmpb.2019.105224; Markus AF, 2021, J BIOMED INFORM, V113, DOI 10.1016/j.jbi.2020.103655; Nayak BK, 2011, INDIAN J OPHTHALMOL, V59, P85, DOI 10.4103/0301-4738.77005; Odeberg J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009968; Somashekhar SP, 2018, ANN ONCOL, V29, P418, DOI 10.1093/annonc/mdx781; Timmis A, 2018, EUR HEART J, V39, P508, DOI 10.1093/eurheartj/ehx628; Tscherny K, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13444; Valente F, 2022, DATA MIN KNOWL DISC, V36, P1140, DOI 10.1007/s10618-022-00821-8; Ward IR, 2021, COMPUT METH PROG BIO, V212, DOI 10.1016/j.cmpb.2021.106415	19	9	9	2	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	MAR	2023	230								107347	10.1016/j.cmpb.2023.107347	http://dx.doi.org/10.1016/j.cmpb.2023.107347		JAN 2023	9	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	8F7PB	36645940	hybrid			2024-09-18	WOS:000919849700001
J	van der Kluit, MJ; Dijkstra, GJ; de Rooij, SE				van der Kluit, Maria Johanna; Dijkstra, Geke J.; de Rooij, Sophia E.			Reliability and validity of the Patient Benefit Assessment Scale for Hospitalised Older Patients (P-BAS HOP)	BMC GERIATRICS			English	Article						Older adults; Hospitalisation; Patient perspective; Goal setting; Patient-reported outcomes; Validity; Reliability; Responsiveness; Minimal important change (MIC); Value-based health care	QUALITY-OF-LIFE; HEALTH OUTCOMES; CANCER-PATIENTS; RESPONSE SHIFT; COMMUNITY; RISK	BackgroundThe Patient Benefit Assessment Scale for Hospitalised Older Patients (P-BAS HOP) is a tool which is capable of both identifying the priorities of the individual patient and measuring the outcomes relevant to him/her, resulting in a Patient Benefit Index (PBI) with range 0-3, indicating how much benefit the patient had experienced from the admission. The aim of this study was to evaluate the reliability, validity, responsiveness and interpretability of the P-BAS HOP.MethodsA longitudinal study among hospitalised older patients with a baseline interview during hospitalisation and a follow-up by telephone 3 months after discharge. Test-retest reliability of the baseline and follow-up questionnaire were tested. Percentage of agreement, Cohen's kappa with quadratic weighting and maximum attainable kappa were calculated per item. The PBI was calculated for both test and retest of baseline and follow-up and compared with Intraclass Correlation Coefficient (ICC). Construct validity was tested by evaluating pre-defined hypotheses comparing the priority of goals with experienced symptoms or limitations at admission and the achievement of goals with progression or deterioration of other constructs. Responsiveness was evaluated by correlating the PBI with the anchor question 'How much did you benefit from the admission?'. This question was also used to evaluate the interpretability of the PBI with the visual anchor-based minimal important change distribution method.ResultsReliability was tested with 53 participants at baseline and 72 at follow-up. Mean weighted kappa of the baseline items was 0.38. ICC between PBI of the test and retest was 0.77.Mean weighted kappa of the follow-up items was 0.51. ICC between PBI of the test and retest was 0.62.For the construct validity, tested in 451 participants, all baseline hypotheses were confirmed. From the follow-up hypotheses, tested in 344 participants, five of seven were confirmed.The Spearman's correlation coefficient between the PBI and the anchor question was 0.51.The optimal cut-off point was 0.7 for 'no important benefit' and 1.4 points for 'important benefit' on the PBI.ConclusionsAlthough the concept seems promising, the reliability and validity of the P-BAS HOP appeared to be not yet satisfactory. We therefore recommend adapting the P-BAS HOP.	[van der Kluit, Maria Johanna; de Rooij, Sophia E.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Dijkstra, Geke J.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Appl Hlth Res, Groningen, Netherlands; [Dijkstra, Geke J.] NHL Stenden Univ Appl Sci, Res Grp Living Wellbeing & Care Older People, Leeuwarden, Netherlands; [de Rooij, Sophia E.] Med Spectrum Twente, Med Sch Twente, Enschede, Netherlands	University of Groningen; University of Groningen; NHL Stenden University of Applied Sciences; Medical Spectrum Twente	van der Kluit, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	m.j.van.der.kluit@umcg.nl	van+der+KluitEmail, Maria/L-5369-2019	van der Kluit, Maria/0000-0001-8758-232X; Dijkstra, Geke/0000-0001-5622-4730	University of Groningen	University of Groningen	This study was funded by an unrestricted grant from the University of Groningen.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Aburub AS, 2017, QUAL LIFE RES, V26, P1091, DOI 10.1007/s11136-016-1458-4; Ahmed S, 2004, J CLIN EPIDEMIOL, V57, P561, DOI 10.1016/j.jclinepi.2003.11.003; Boyd C, 2019, J AM GERIATR SOC, V67, P665, DOI 10.1111/jgs.15809; Buurman BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026951; CICCHETTI DV, 1991, J CLIN EXP NEUROPSYC, V13, P328, DOI 10.1080/01688639108401047; Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences, V2nd ed, DOI https://doi.org/10.4324/9780203771587; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; de Vet H.C., 2011, TURK J VET ANIM SCI, DOI [10.1017/CBO9780511996214, DOI 10.1017/CBO9780511996214, DOI 10.3906/VET-1810-60]; de Vet HCW, 2007, QUAL LIFE RES, V16, P131, DOI 10.1007/s11136-006-9109-9; DEHAES JCJM, 1990, BRIT J CANCER, V62, P1034, DOI 10.1038/bjc.1990.434; Heim N, 2015, AGE AGEING, V44, P239, DOI 10.1093/ageing/afu187; Hinz A, 2011, EUR J CANCER CARE, V20, P601, DOI 10.1111/j.1365-2354.2011.01256.x; Laan W, 2014, J NUTR HEALTH AGING, V18, P848, DOI [10.1007/s12603-014-0479-3, 10.1007/s12603-014-0558-5]; Lafont C, 2011, J NUTR HEALTH AGING, V15, P645, DOI 10.1007/s12603-011-0335-7; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lowry R., 2021, VASSARSTATS WEBSITE; Mars GMJ, 2009, QUAL LIFE RES, V18, P1207, DOI 10.1007/s11136-009-9537-4; McPhail S, 2010, HEALTH QUAL LIFE OUT, V8, DOI [10.1186/1477-7525-8-146, 10.1186/1477-7525-8-65]; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; Sim J, 2005, PHYS THER, V85, P257; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tooth LR, 2004, ARCH PHYS MED REHAB, V85, P1371, DOI 10.1016/j.apmr.2003.12.002; van der Kluit MJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038203; van der Kluit MJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029993; Wettergren L, 2009, QUAL LIFE RES, V18, P737, DOI 10.1007/s11136-009-9490-2; Zisberg A, 2015, J AM GERIATR SOC, V63, P55, DOI 10.1111/jgs.13193	29	3	3	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2318		BMC GERIATR	BMC Geriatr.	MAR 1	2021	21	1							149	10.1186/s12877-021-02079-z	http://dx.doi.org/10.1186/s12877-021-02079-z			15	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	QR7JI	33648447	gold, Green Published			2024-09-18	WOS:000625390800002
J	Hatwell, J; Gaber, MM; Azad, RMA				Hatwell, Julian; Gaber, Mohamed Medhat; Atif Azad, R. Muhammad			Ada-WHIPS: explaining AdaBoost classification with applications in the health sciences	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Explainable AI; Computer aided diagnostics; AdaBoost; Black box problem; Interpretability	ARTIFICIAL-INTELLIGENCE; CLASSIFIERS; RULES; PREDICTION; CANCER; SYSTEM; MODEL	Background Computer Aided Diagnostics (CAD) can support medical practitioners to make critical decisions about their patients' disease conditions. Practitioners require access to the chain of reasoning behind CAD to build trust in the CAD advice and to supplement their own expertise. Yet, CAD systems might be based on black box machine learning models and high dimensional data sources such as electronic health records, magnetic resonance imaging scans, cardiotocograms, etc. These foundations make interpretation and explanation of the CAD advice very challenging. This challenge is recognised throughout the machine learning research community. eXplainable Artificial Intelligence (XAI) is emerging as one of the most important research areas of recent years because it addresses the interpretability and trust concerns of critical decision makers, including those in clinical and medical practice. Methods In this work, we focus on AdaBoost, a black box model that has been widely adopted in the CAD literature. We address the challenge - to explain AdaBoost classification - with a novel algorithm that extracts simple, logical rules from AdaBoost models. Our algorithm,Adaptive-Weighted High Importance Path Snippets(Ada-WHIPS), makes use of AdaBoost's adaptive classifier weights. Using a novel formulation, Ada-WHIPS uniquely redistributes the weights among individual decision nodes of the internal decision trees of the AdaBoost model. Then, a simple heuristic search of the weighted nodes finds a single rule that dominated the model's decision. We compare the explanations generated by our novel approach with the state of the art in an experimental study. We evaluate the derived explanations with simple statistical tests of well-known quality measures, precision and coverage, and a novel measurestabilitythat is better suited to the XAI setting. Results Experiments on 9 CAD-related data sets showed that Ada-WHIPS explanations consistently generalise better (mean coverage 15%-68%) than the state of the art while remaining competitive for specificity (mean precision 80%-99%). A very small trade-off in specificity is shown to guard against over-fitting which is a known problem in the state of the art methods. Conclusions The experimental results demonstrate the benefits of using our novel algorithm for explaining CAD AdaBoost classifiers widely found in the literature. Our tightly coupled, AdaBoost-specific approach outperforms model-agnostic explanation methods and should be considered by practitioners looking for an XAI solution for this class of models.	[Hatwell, Julian; Gaber, Mohamed Medhat; Atif Azad, R. Muhammad] Birmingham City Univ, Curzon St, Birmingham B5 5JU, W Midlands, England	Birmingham City University	Hatwell, J (corresponding author), Birmingham City Univ, Curzon St, Birmingham B5 5JU, W Midlands, England.	julian.hatwell@bcu.ac.uk		Hatwell, Julian/0000-0001-6589-5165				Acharya UR, 2015, KNOWL-BASED SYST, V81, P56, DOI 10.1016/j.knosys.2015.02.005; Adadi A, 2018, IEEE ACCESS, V6, P52138, DOI 10.1109/ACCESS.2018.2870052; Adnan MN, 2017, AUSTRALAS J INF SYST, V21; Al-Janabi S, 2019, INT J GRID UTIL COMP, V10, P512; Al-Janabi S, 2014, 2014 INTERNATIONAL CONGRESS ON TECHNOLOGY, COMMUNICATION AND KNOWLEDGE (ICTCK); Andrews R, 1995, KNOWL-BASED SYST, V8, P373, DOI 10.1016/0950-7051(96)81920-4; [Anonymous], 2019, UND SOC WAV 2 3 NURS, V7251; [Anonymous], 2006, SSRN ELECT J; [Anonymous], 2016, ARXIV160609066STAT; [Anonymous], 2019, ARXIV190412991; [Anonymous], 2013, P INT C APPL MATH TH; Appel R., 2013, JMLR Workshop and Conference Proceedings, P594; Aravindh K, 2018, INT J PURE APPL MATH, V119, P415; Asgari S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6048748; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; CLARK P, 1991, LECT NOTES ARTIF INT, V482, P151; Davillas A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148561; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng HT, 2019, INT J DATA SCI ANAL, V7, P277, DOI 10.1007/s41060-018-0144-8; Dhurandhar A, 2018, ARXIV180207623CS; Dolejsí M, 2008, I S BIOMED IMAGING, P656, DOI 10.1109/ISBI.2008.4541081; Dua Dheeru, 2017, UCI machine learning repository, DOI DOI 10.1016/J.DSS.2009.05.016; El-Sappagh S, 2018, IEEE ACCESS, V6, P37371, DOI 10.1109/ACCESS.2018.2852004; Freund Y., 1999, Proceedings of the Twelfth Annual Conference on Computational Learning Theory, P102, DOI 10.1145/307400.307419; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Guidotti R., 2018, CoRR abs/1805.10820; Jalali A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2647-9; Jaree T, 2008, P 2 AUSTR WORKSH HLT, V80; Jovanovic M, 2016, ARTIF INTELL MED, V72, P12, DOI 10.1016/j.artmed.2016.07.003; Kastner M, 2012, COMPUT INTELL; Kavakiotis I, 2017, COMPUT STRUCT BIOTEC, V15, P104, DOI 10.1016/j.csbj.2016.12.005; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kwon BC, 2019, IEEE T VIS COMPUT GR, V25, P299, DOI 10.1109/TVCG.2018.2865027; Lamy JB, 2019, ARTIF INTELL MED, V94, P42, DOI 10.1016/j.artmed.2019.01.001; Letham B, 2015, ANN APPL STAT, V9, P1350, DOI 10.1214/15-AOAS848; Lipton ZC, 2018, COMMUN ACM, V61, P36, DOI 10.1145/3233231; Lundberg SM, 2017, ADV NEUR IN, V30; Lundberg SM, 2017, ARXIV170606060CSSTAT; Mahdi MA, 2019, INT C BIG DAT NETW T; Mashayekhi M, 2015, LECT NOTES COMPUTER, V9091; Mencar C, 2013, FUZZ LOG APPL 10 INT; Michal F, 2019, INTERPRETABILITY BLA; Pande V, 2019, NY TIMES; Pazzani MJ, 2001, METHOD INFORM MED, V40, P380; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pedreschi D, 2018, ARXIV180609936CS; Quinlan J.R., 1987, Ijcai, P304; Ribeiro MT, 2018, AAAI CONF ARTIF INTE, P1527; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Sabaas A, 2014, INTERPRETING RANDOM; Shakeel PM, 2020, NEURAL COMPUT APPL, V32, P777, DOI 10.1007/s00521-018-03972-2; Subianto M, 2007, IEEE DATA MINING, P661, DOI 10.1109/ICDM.2007.40; Sun Sheng, 2013, International Journal of Functional Informatics and Personalised Medicine, V4, P167, DOI 10.1504/IJFIPM.2013.057406; Tjoa E, 2019, ARXIV PREPRINT ARXIV, P21; Turgeman L, 2016, ARTIF INTELL MED, V72, P72, DOI 10.1016/j.artmed.2016.08.005; Wachter S., 2017, Harv JL Technol, V31, P841; Waitman LR, 2006, J INTELL INF SYST, V27, P49, DOI 10.1007/s10844-006-1626-z; Walker KW, 2019, J ACAD LIBR, V45, P203, DOI 10.1016/j.acalib.2019.02.013; Yin ZJ, 2019, J AM MED INFORM ASSN, V26, P561, DOI 10.1093/jamia/ocz009; Yoo I, 2012, J MED SYST, V36, P2431, DOI 10.1007/s10916-011-9710-5; Zhu J, 2009, STAT INTERFACE, V2, P349	64	48	51	0	22	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	OCT 2	2020	20	1							250	10.1186/s12911-020-01201-2	http://dx.doi.org/10.1186/s12911-020-01201-2			25	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	NZ2WL	33008388	Green Accepted, Green Submitted, Green Published, gold			2024-09-18	WOS:000576958200001
J	Lococo, F; Ghaly, G; Chiappetta, M; Flamini, S; Evangelista, J; Bria, E; Stefani, A; Vita, E; Martino, A; Boldrini, L; Sassorossi, C; Campanella, A; Margaritora, S; Mohammed, A				Lococo, Filippo; Ghaly, Galal; Chiappetta, Marco; Flamini, Sara; Evangelista, Jessica; Bria, Emilio; Stefani, Alessio; Vita, Emanuele; Martino, Antonella; Boldrini, Luca; Sassorossi, Carolina; Campanella, Annalisa; Margaritora, Stefano; Mohammed, Abdelrahman			Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review	CANCERS			English	Review						NSCLC; artificial intelligence; machine learning; lung cancer surgery; prediction model radiomics	NSCLC PATIENTS; RADIOMICS; RADIOTHERAPY; DIAGNOSIS; OUTCOMES; BRIDGE; MODEL	Simple Summary Artificial intelligence (AI) has largely changed the overall management of non-small-cell lung cancer (NSCLC) by enhancing different aspects, including staging, prognosis assessment, treatment prediction, response evaluation, recurrence/prognosis prediction, and personalized prognostic assessment. In the present narrative review, we analyzed and discuss studies reporting on how AI algorithms could predict responses to various treatment modalities, such as surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy.Abstract Artificial Intelligence (AI) has revolutionized the management of non-small-cell lung cancer (NSCLC) by enhancing different aspects, including staging, prognosis assessment, treatment prediction, response evaluation, recurrence/prognosis prediction, and personalized prognostic assessment. AI algorithms may accurately classify NSCLC stages using machine learning techniques and deep imaging data analysis. This could potentially improve precision and efficiency in staging, facilitating personalized treatment decisions. Furthermore, there are data suggesting the potential application of AI-based models in predicting prognosis in terms of survival rates and disease progression by integrating clinical, imaging and molecular data. In the present narrative review, we will analyze the preliminary studies reporting on how AI algorithms could predict responses to various treatment modalities, such as surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy. There is robust evidence suggesting that AI also plays a crucial role in predicting the likelihood of tumor recurrence after surgery and the pattern of failure, which has significant implications for tailoring adjuvant treatments. The successful implementation of AI in personalized prognostic assessment requires the integration of different data sources, including clinical, molecular, and imaging data. Machine learning (ML) and deep learning (DL) techniques enable AI models to analyze these data and generate personalized prognostic predictions, allowing for a precise and individualized approach to patient care. However, challenges relating to data quality, interpretability, and the ability of AI models to generalize need to be addressed. Collaboration among clinicians, data scientists, and regulators is critical for the responsible implementation of AI and for maximizing its benefits in providing a more personalized prognostic assessment. Continued research, validation, and collaboration are essential to fully exploit the potential of AI in NSCLC management and improve patient outcomes. Herein, we have summarized the state of the art of applications of AI in lung cancer for predicting staging, prognosis, and pattern of recurrence after treatment in order to provide to the readers a large comprehensive overview of this challenging issue.	[Lococo, Filippo; Chiappetta, Marco; Evangelista, Jessica; Bria, Emilio; Stefani, Alessio; Vita, Emanuele; Martino, Antonella; Boldrini, Luca; Sassorossi, Carolina; Margaritora, Stefano] Univ Cattolica Sacro Cuore, Fac Med & Surg, I-00168 Rome, Italy; [Lococo, Filippo; Chiappetta, Marco; Flamini, Sara; Evangelista, Jessica; Sassorossi, Carolina; Campanella, Annalisa; Margaritora, Stefano] A Gemelli Univ Hosp Fdn IRCCS, Thorac Surg, I-00168 Rome, Italy; [Ghaly, Galal; Mohammed, Abdelrahman] Cairo Univ, Fac Med & Surg, Thorac Surg Unit, Giza 12613, Egypt; [Bria, Emilio; Stefani, Alessio; Vita, Emanuele] A Gemelli Univ Hosp Fdn IRCCS, Med Oncol, I-00168 Rome, Italy; [Martino, Antonella; Boldrini, Luca] A Gemelli Univ Hosp Fdn IRCCS, Radiotherapy Unit, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Egyptian Knowledge Bank (EKB); Cairo University	Lococo, F (corresponding author), Univ Cattolica Sacro Cuore, Fac Med & Surg, I-00168 Rome, Italy.; Lococo, F (corresponding author), A Gemelli Univ Hosp Fdn IRCCS, Thorac Surg, I-00168 Rome, Italy.	filippo.lococo@policlinicogemelli.it; galal.ghaly@nci.cu.edu.eg; marco.chiappetta@policlinicogemelli.it; sara.flamini@guest.policlinicogemelli.it; jessica.evangelista@policlinicogemelli.it; emilio.bria@policlinicogemelli.it; alessio.stefani@unicatt.it; emanuele.vita@guest.policlinicogemelli.it; antonella.martino@policlinicogemelli.it; luca.boldrini@policlinicogemelli.it; carolina.sassorossi01@unicatt.it; annalisa.campanella@guest.policlinicogemelli.it; stefano.margaritora@policlinicogemelli.it; filippomaria.lococo@unicatt.it	Boldrini, Luca/AAB-9976-2022; MArtino, Antonella/IQR-7798-2023; Chiappetta, Marco/AAC-2298-2022; Lococo, Filippo/AAB-3408-2021; Chiappetta, Marco/M-7818-2018	Lococo, Filippo/0000-0002-9383-5554; Ghaly, Galal/0000-0003-0734-110X; Martino, Antonella/0000-0002-7091-1542; Chiappetta, Marco/0000-0002-3807-6911; Boldrini, Luca/0000-0002-5631-1575	Ministry of Health under the frame of ERA PerMed	Ministry of Health under the frame of ERA PerMed	This project was supported by Ministry of Health under the frame of ERA PerMed.	Abels Esther, 2017, J Pathol Inform, V8, P23, DOI 10.4103/jpi.jpi_11_17; Aerts HJWL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33860; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Amisha, 2019, J FAM MED PRIM CARE, V8, P2328, DOI 10.4103/jfmpc.jfmpc_440_19; Asamura H, 2013, J THORAC CARDIOV SUR, V146, P24, DOI 10.1016/j.jtcvs.2012.12.047; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Beck KS, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.661244; Choi H, 2021, EUR RADIOL, V31, P2866, DOI 10.1007/s00330-020-07431-2; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; D'Antonoli TA, 2020, ACAD RADIOL, V27, P497, DOI 10.1016/j.acra.2019.05.019; Denton E, 2016, J MULTIDISCIP HEALTH, V9, DOI 10.2147/JMDH.S76762; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Fiste O, 2024, CANCERS, V16, DOI 10.3390/cancers16040831; Gao YA, 2020, J THORAC DIS, V12, P4531, DOI 10.21037/jtd-2019-itm-013; Hosny A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002711; Huang SG, 2019, CANCERS, V11, DOI 10.3390/cancers11081140; Huynh E, 2016, RADIOTHER ONCOL, V120, P258, DOI 10.1016/j.radonc.2016.05.024; Jochems A, 2017, INT J RADIAT ONCOL, V99, P344, DOI 10.1016/j.ijrobp.2017.04.021; Jochems A, 2016, RADIOTHER ONCOL, V121, P459, DOI 10.1016/j.radonc.2016.10.002; Khorrami M, 2019, RADIOL-ARTIF INTELL, V1, DOI 10.1148/ryai.2019180012; Kim JH, 2021, BMC MED INFORM DECIS, V21, DOI 10.1186/s12911-021-01679-4; Kim MS, 2020, TRANSL LUNG CANCER R, V9, P507, DOI 10.21037/tlcr.2020.04.11; Kirienko M, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/1382309; Kroschke J, 2022, ROFO-FORTSCHR RONTG, V194, P720, DOI 10.1055/a-1729-1516; Lagerwaard FJ, 2012, INT J RADIAT ONCOL, V83, P348, DOI 10.1016/j.ijrobp.2011.06.2003; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lee JH, 2022, TRANSL LUNG CANCER R, V11, P1217, DOI 10.21037/tlcr-21-1012; Lee JH, 2020, RADIOLOGY, V295, P448, DOI 10.1148/radiol.2020191921; Li JW, 2021, J THORAC DIS, V13, P7021, DOI 10.21037/jtd-21-864; Liu ZY, 2019, THERANOSTICS, V9, P1303, DOI 10.7150/thno.30309; Lococo F, 2023, BMC CANCER, V23, DOI 10.1186/s12885-023-10997-x; Lou B, 2019, LANCET DIGIT HEALTH, V1, pE136, DOI 10.1016/S2589-7500(19)30058-5; Mattonen SA, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041010; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Mu W, 2020, EUR J NUCL MED MOL I, V47, P1168, DOI 10.1007/s00259-019-04625-9; Nemoto T, 2022, JCO CLIN CANCER INFO, V6, DOI 10.1200/CCI.21.00176; Oikonomou A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22357-y; Qian ZH, 2019, CANCER LETT, V451, P128, DOI 10.1016/j.canlet.2019.02.054; Sim Y, 2020, RADIOLOGY, V294, P199, DOI 10.1148/radiol.2019182465; Song JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep38282; Tam MDBS, 2021, CLIN RADIOL, V76, P607, DOI 10.1016/j.crad.2021.03.021; Tau N, 2020, AM J ROENTGENOL, V215, P192, DOI 10.2214/AJR.19.22346; Giang TT, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01140-y; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Wang DD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02855; Wang L, 2020, THORAC CANCER, V11, P851, DOI 10.1111/1759-7714.13298; Wang SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27707-4; Wang XX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13773-7; Weikert T, 2019, CONTRAST MEDIA MOL I, DOI 10.1155/2019/1545747; Wichmann JL, 2020, INVEST RADIOL, V55, P619, DOI 10.1097/RLI.0000000000000673; Wissel D, 2021, bioRxiv, DOI [10.1101/2021.09.16.460589, 10.1101/2021.09.16.460589, DOI 10.1101/2021.09.16.460589]; Wu YJ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00743; Yoon HJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001753; Yoshiyasu N, 2021, J THORAC CARDIOV SUR, V162, P477, DOI 10.1016/j.jtcvs.2020.05.009; You HS, 2020, CANCER MANAG RES, V12, P1947, DOI 10.2147/CMAR.S244932; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593; Zhao W, 2018, CANCER RES, V78, P6881, DOI 10.1158/0008-5472.CAN-18-0696; Zhong YF, 2022, RADIOLOGY, V302, P200, DOI 10.1148/radiol.2021210902	58	1	1	7	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	MAY	2024	16	10							1832	10.3390/cancers16101832	http://dx.doi.org/10.3390/cancers16101832			18	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	SJ7F3	38791910	Green Published, gold			2024-09-18	WOS:001234144600001
J	Wang, QB; Chen, KY; Dou, WR; Ma, YT				Wang, Qingbin; Chen, Kaiyi; Dou, Wanrong; Ma, Yutao			Cross-Attention Based Multi-Resolution Feature Fusion Model for Self-Supervised Cervical OCT Image Classification	IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS			English	Article						Cervical cancer; cross-attention; optical coherence tomography; self-supervised learning; vision transformer	CANCER	Cervical cancer seriously endangers the health of the female reproductive system and even risks women's life in severe cases. Optical coherence tomography (OCT) is a non-invasive, real-time, high-resolution imaging technology for cervical tissues. However, since the interpretation of cervical OCT images is a knowledge-intensive, time-consuming task, it is tough to acquire a large number of high-quality labeled images quickly, which is a big challenge for supervised learning. In this study, we introduce the vision Transformer (ViT) architecture, which has recently achieved impressive results in natural image analysis, into the classification task of cervical OCT images. Our work aims to develop a computer-aided diagnosis (CADx) approach based on a self-supervised ViT-based model to classify cervical OCT images effectively. We leverage masked autoencoders (MAE) to perform self-supervised pre-training on cervical OCT images, so the proposed classification model has a better transfer learning ability. In the fine-tuning process, the ViT-based classification model extracts multi-scale features from OCT images of different resolutions and fuses them with the cross-attention module. The ten-fold cross-validation results on an OCT image dataset from a multi-center clinical study of 733 patients in China indicate that our model achieved an AUC value of 0.9963 +/- 0.0069 with a 95.89 +/- 3.30% sensitivity and 98.23 +/- 1.36 % specificity, outperforming some state-of-the-art classification models based on Transformers and convolutional neural networks (CNNs) in the binary classification task of detecting high-risk cervical diseases, including high-grade squamous intraepithelial lesion (HSIL) and cervical cancer. Furthermore, ourmodel with the cross-shaped voting strategy achieved a sensitivity of 92.06% and specificity of 95.56% on an external validation dataset containing 288 three-dimensional (3D) OCT volumes from118 Chinese patients in a different new hospital. This result met or exceeded the average of four medical expertswho have used OCT for over one year. In addition to promising classification performance, our model has a remarkable ability to detect and visualize local lesions using the attention map of the standard ViT model, providing good interpretability for gynecologists to locate and diagnose possible cervical diseases.	[Wang, Qingbin; Chen, Kaiyi; Dou, Wanrong] Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China; [Ma, Yutao] Cent China Normal Univ, Sch Comp Sci, Wuhan 430079, Peoples R China; [Ma, Yutao] Cent China Normal Univ, Hubei Prov Key Lab Artificial Intelligence & Smart, Wuhan 430079, Peoples R China	Wuhan University; Central China Normal University; Central China Normal University	Ma, YT (corresponding author), Cent China Normal Univ, Sch Comp Sci, Wuhan 430079, Peoples R China.; Ma, YT (corresponding author), Cent China Normal Univ, Hubei Prov Key Lab Artificial Intelligence & Smart, Wuhan 430079, Peoples R China.	qbwang@whu.edu.cn; chris@whu.edu.cn; wanrongdou@whu.edu.cn; ytma@ccnu.edu.cn	Ma, Yutao/AAR-5140-2020	Ma, Yutao/0000-0003-4239-2009	National Key Research and Development Program of China [2020AAA0107705]; Science and Technology Major Project of Hubei Province in China (Next-Generation AI Technologies) [2019AEA170]	National Key Research and Development Program of China(National Key Research & Development Program of China); Science and Technology Major Project of Hubei Province in China (Next-Generation AI Technologies)	This work was supported in part by the National Key Research and Development Program of China under Grant 2020AAA0107705 and in part by the Science and Technology Major Project of Hubei Province in China (Next-Generation AI Technologies) under Grant 2019AEA170.	Almubarak HA, 2017, PROCEDIA COMPUT SCI, V114, P281, DOI 10.1016/j.procs.2017.09.044; [Anonymous], 2020, ARXIV; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Bhargava A, 2018, ADV INTELL SYST, V624, P1491, DOI 10.1007/978-981-10-5903-2_155; Brisson M, 2020, LANCET, V395, P575, DOI 10.1016/S0140-6736(20)30068-4; Caron M, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P9630, DOI 10.1109/ICCV48922.2021.00951; Chen KY, 2022, MED PHYS, V49, P3638, DOI 10.1002/mp.15630; Chen L, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101539; Chen Ting, 2019, 25 AMERICAS C INFORM; Chen XL, 2021, PROC CVPR IEEE, P15745, DOI 10.1109/CVPR46437.2021.01549; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cubuk ED, 2020, IEEE COMPUT SOC CONF, P3008, DOI 10.1109/CVPRW50498.2020.00359; Fan HQ, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P6804, DOI 10.1109/ICCV48922.2021.00675; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Fu L, 2022, INT J MED INFORM, V159, DOI 10.1016/j.ijmedinf.2021.104675; Gallwas J, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.1.016013; Gao HH, 2024, IEEE T NEUR NET LEAR, V35, P4826, DOI 10.1109/TNNLS.2022.3155486; Gao HH, 2022, IEEE T COMPUT SOC SY, V9, P336, DOI 10.1109/TCSS.2021.3102591; Gao ZF, 2020, IEEE T MED IMAGING, V39, P1524, DOI 10.1109/TMI.2019.2952939; Hassan B, 2021, COMPUT BIOL MED, V136, DOI 10.1016/j.compbiomed.2021.104727; He K., 2022, arXiv, DOI DOI 10.48550/ARXIV.2202.12165; He KM, 2022, PROC CVPR IEEE, P15979, DOI 10.1109/CVPR52688.2022.01553; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jing LL, 2021, IEEE T PATTERN ANAL, V43, P4037, DOI 10.1109/TPAMI.2020.2992393; Kaiming He, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P9726, DOI 10.1109/CVPR42600.2020.00975; Lanchantin J, 2021, PROC CVPR IEEE, P16473, DOI 10.1109/CVPR46437.2021.01621; Li Y., 2022, P IEEE CVF C COMP VI, P4804; Li YX, 2021, MED IMAGE ANAL, V70, DOI 10.1016/j.media.2021.102006; Li YX, 2020, IEEE T MED IMAGING, V39, P3403, DOI 10.1109/TMI.2020.2994778; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu Y, 2017, CELL MOL BIOL, V63, P92, DOI 10.14715/cmb/2017.63.2.14; Liu Z, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P9992, DOI 10.1109/ICCV48922.2021.00986; Loshchilov I., 2017, P ICLR, P1; Loshchilov I., 2019, PROC 7 INT C LEARN R; Ma YT, 2019, IEEE T BIO-MED ENG, V66, P2447, DOI 10.1109/TBME.2018.2890167; Paczos T, 2021, J LOW GENIT TRACT DI, V25, P137, DOI 10.1097/LGT.0000000000000590; Pang YW, 2019, PROC CVPR IEEE, P7328, DOI 10.1109/CVPR.2019.00751; Ren CC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86711-3; Schiffman M, 2019, PAPILLOMAVIRUS RES, V7, P184, DOI 10.1016/j.pvr.2019.04.012; Shamshad F., 2022, arXiv; Simonyan K., 2015, International Conference on Learning Representations, P1; Singh VK, 2022, COMPUT BIOL MED, V140, DOI 10.1016/j.compbiomed.2021.105070; Touvron H, 2021, PR MACH LEARN RES, V139, P7358; Vaswani A, 2017, ADV NEUR IN, V30; World Health Organization, 2020, Global strategy to accelerate the elimination of cervical cancer as a public health problem; Zeng XX, 2018, THERANOSTICS, V8, P3099, DOI 10.7150/thno.24599; Zhang YH, 2021, NEUROCOMPUTING, V462, P491, DOI 10.1016/j.neucom.2021.08.051; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhou KC, 2019, NAT PHOTONICS, V13, P794, DOI 10.1038/s41566-019-0508-1	51	3	3	3	13	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1545-5963	1557-9964		IEEE ACM T COMPUT BI	IEEE-ACM Trans. Comput. Biol. Bioinform.	JUL-AUG	2023	20	4					2541	2554		10.1109/TCBB.2023.3246979	http://dx.doi.org/10.1109/TCBB.2023.3246979			14	Biochemical Research Methods; Computer Science, Interdisciplinary Applications; Mathematics, Interdisciplinary Applications; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Computer Science; Mathematics	O9TJ9	37027657				2024-09-18	WOS:001047167100017
J	Omar, M; Nuzzo, PV; Ravera, F; Bleve, S; Fanelli, GN; Zanettini, C; Valencia, I; Marchionni, L				Omar, Mohamed; Nuzzo, Pier Vitale; Ravera, Francesco; Bleve, Sara; Fanelli, Giuseppe Nicolo; Zanettini, Claudio; Valencia, Itzel; Marchionni, Luigi			Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						Triple negative breast cancer; Neoadjuvant chemotherapy; Gene signature; Notch signaling pathway; Prediction of therapeutic response	SELECTION; SURVIVAL; RECEPTOR; PATHWAY; MODELS; PAR1	BackgroundWhile the efficacy of neoadjuvant chemotherapy (NACT) in treating triple-negative breast cancer (TNBC) is generally accepted, not all patients derive benefit from this preoperative treatment. Presently, there are no validated biomarkers to predict the NACT response, and previous attempts to develop predictive classifiers based on gene expression data have not demonstrated clinical utility. However, predictive models incorporating biological constraints have shown increased robustness and improved performance compared to agnostic classifiers.MethodsWe used the preoperative transcriptomic profiles from 298 patients with TNBC to train and test a rank-based classifier, k-top scoring pairs, to predict whether the patient will have pathological complete response (pCR) or residual disease (RD) following NACT. To reduce overfitting and enhance the signature's interpretability, we constrained the training process to genes involved in the Notch signaling pathway. Subsequently, we evaluated the signature performance on two independent cohorts with 75 and 71 patients. Finally, we assessed the prognostic value of the signature by examining its association with relapse-free survival (RFS) using Kaplan-Meier (KM) survival estimates and a multivariate Cox proportional hazards model.ResultsThe final signature consists of five gene pairs, whose relative ordering can be predictive of the NACT response. The signature has a robust performance at predicting pCR in TNBC patients with an area under the ROC curve (AUC) of 0.76 and 0.85 in the first and second testing cohorts, respectively, outperforming other gene signatures developed for the same purpose. Additionally, the signature was significantly associated with RFS in an independent TNBC patient cohort even after adjusting for T stage, patient age at the time of diagnosis, type of breast surgery, and menopausal status.ConclusionWe introduce a robust gene signature to predict pathological complete response (pCR) in patients with TNBC. This signature applies easily interpretable, rank-based decision rules to genes regulated by the Notch signaling pathway, a known determinant in breast cancer chemoresistance. The robust predictive and prognostic performance of the signature make it a strong candidate for clinical implementation, aiding in the stratification of TNBC patients undergoing NACT.	[Omar, Mohamed; Nuzzo, Pier Vitale; Ravera, Francesco; Bleve, Sara; Fanelli, Giuseppe Nicolo; Zanettini, Claudio; Valencia, Itzel; Marchionni, Luigi] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Omar, Mohamed] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ravera, Francesco] Univ Genoa, Dept Internal Med, Genoa, Italy; [Bleve, Sara] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amador, Dept Med Oncol, Meldola, Italy; [Fanelli, Giuseppe Nicolo] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Div Pathol 1, I-56126 Pisa, Italy	Cornell University; Weill Cornell Medicine; Harvard University; Dana-Farber Cancer Institute; University of Genoa; University of Pisa	Omar, M; Marchionni, L (corresponding author), Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA.; Omar, M (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	mao4005@med.cornell.edu; lum4003@med.cornell.edu	Nuzzo, Pier Vitale/GRX-4635-2022; Fanelli, Giuseppe Nicolo/GVU-5406-2022; Omar, Mohamed/AAH-5967-2020	Fanelli, Giuseppe Nicolo/0000-0001-7069-7980; Omar, Mohamed/0000-0002-8068-1920	Not applicable.	Not applicable.	Not applicable.	Afsari B, 2015, BIOINFORMATICS, V31, P273, DOI 10.1093/bioinformatics/btu622; BeLow M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102204; Bertucci F, 2014, CANCER LETT, V355, P70, DOI 10.1016/j.canlet.2014.09.014; Bianchini G, 2022, NAT REV CLIN ONCOL, V19, P91, DOI 10.1038/s41571-021-00565-2; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; COX DR, 1972, J R STAT SOC B, V34, P187; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng HT, 2012, IEEE IJCNN; Deng HT, 2013, PATTERN RECOGN, V46, P3483, DOI 10.1016/j.patcog.2013.05.018; Feng ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026399; Gatza ML, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2899; GEMAN D, 2004, STAT APPL GENET MOL, V3, P1, DOI DOI 10.2202/1544-6115.1071; Ghantous Y, 2022, INT J CANCER, V150, P450, DOI 10.1002/ijc.33828; Giuli MV, 2019, J ONCOL, V2019, DOI 10.1155/2019/8707053; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hernández NA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-47; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kallarackal J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230313; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kassambara A., 2021, rstatix: pipe-friendly framework for basic statistical tests; Korde LA, 2021, J CLIN ONCOL, V39, P1485, DOI 10.1200/JCO.20.03399; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li X, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02415-8; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lidfeldt J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134932; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Madsen CD, 2015, NAT CELL BIOL, V17, P68, DOI 10.1038/ncb3083; Mazo C, 2020, CANCERS, V12, DOI 10.3390/cancers12051133; Nagata T, 2017, BREAST CANCER-TOKYO, V24, P326, DOI 10.1007/s12282-016-0708-1; Nagata T, 2014, BREAST CANCER-TOKYO, V21, P96, DOI 10.1007/s12282-012-0357-y; Omar M, 2023, ISCIENCE, V26, DOI 10.1016/j.isci.2023.106108; Pineda B, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0626-0; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Risi E, 2018, BREAST CANCER RES TR, V170, P329, DOI 10.1007/s10549-018-4766-2; Roberts MS, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01305-7; Saraiva DP, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2017-000208; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stine RA, 2001, SOCIOL METHOD RES, V30, P124, DOI 10.1177/0049124101030001011; Stover DG, 2016, CLIN CANCER RES, V22, P6039, DOI 10.1158/1078-0432.CCR-16-0471; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Therneau TM, 2000, Modeling survival data: Extending the Cox model. 1st2000; Therneau TM., 2020, R package version; Trivers KF, 2009, CANCER CAUSE CONTROL, V20, P1071, DOI 10.1007/s10552-009-9331-1; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Urfali-Mamatoglu C, 2018, BIOMED PHARMACOTHER, V101, P129, DOI 10.1016/j.biopha.2018.02.020; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Yang E, 2016, ONCOGENE, V35, P1529, DOI 10.1038/onc.2015.217; Zhao YD, 2020, CANCER MED-US, V9, P6281, DOI 10.1002/cam4.3284	53	1	2	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	NOV 15	2023	21	1							811	10.1186/s12967-023-04713-3	http://dx.doi.org/10.1186/s12967-023-04713-3			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	X9QY2	37964363	Green Published, gold			2024-09-18	WOS:001101725300001
J	Takasawa, K; Asada, K; Kaneko, S; Shiraishi, K; Machino, H; Takahashi, S; Shinkai, N; Kouno, N; Kobayashi, K; Komatsu, M; Mizuno, T; Okubo, Y; Mukai, M; Yoshida, T; Yoshida, Y; Horinouchi, H; Watanabe, SI; Ohe, Y; Yatabe, Y; Kohno, T; Hamamoto, R				Takasawa, Ken; Asada, Ken; Kaneko, Syuzo; Shiraishi, Kouya; Machino, Hidenori; Takahashi, Satoshi; Shinkai, Norio; Kouno, Nobuji; Kobayashi, Kazuma; Komatsu, Masaaki; Mizuno, Takaaki; Okubo, Yu; Mukai, Masami; Yoshida, Tatsuya; Yoshida, Yukihiro; Horinouchi, Hidehito; Watanabe, Shun-Ichi; Ohe, Yuichiro; Yatabe, Yasushi; Kohno, Takashi; Hamamoto, Ryuji			Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability	EXPERIMENTAL AND MOLECULAR MEDICINE			English	Article							GENE; TRANSCRIPTION; REVEALS; RUNX3	DNA methylation is an epigenetic modification that results in dynamic changes during ontogenesis and cell differentiation. DNA methylation patterns regulate gene expression and have been widely researched. While tools for DNA methylation analysis have been developed, most of them have focused on intergroup comparative analysis within a dataset; therefore, it is difficult to conduct cross-dataset studies, such as rare disease studies or cross-institutional studies. This study describes a novel method for DNA methylation analysis, namely, methPLIER, which enables interdataset comparative analyses. methPLIER combines Pathway Level Information Extractor (PLIER), which is a non-negative matrix factorization (NMF) method, with regularization by a knowledge matrix and transfer learning. methPLIER can be used to perform intersample and interdataset comparative analysis based on latent feature matrices, which are obtained via matrix factorization of large-scale data, and factor-loading matrices, which are obtained through matrix factorization of the data to be analyzed. We used methPLIER to analyze a lung cancer dataset and confirmed that the data decomposition reflected sample characteristics for recurrence-free survival. Moreover, methPLIER can analyze data obtained via different preprocessing methods, thereby reducing distributional bias among datasets due to preprocessing. Furthermore, methPLIER can be employed for comparative analyses of methylation data obtained from different platforms, thereby reducing bias in data distribution due to platform differences. methPLIER is expected to facilitate cross-sectional DNA methylation data analysis and enhance DNA methylation data resources. DNA methylation is significant in diseases like cancer. However, its full impact on gene activity is not completely understood. This research, led by Ken Takasawa and Ryuji Hamamoto, aimed to create a new method to examine DNA methylation data for better comprehension of its biological relevance. The team utilized a technique named "methPLIER," an analysis type that compares various DNA methylation data sets. They examined data from 9,756 cancer samples, focusing on how DNA methylation near gene beginnings might regulate gene activity. The scientists used a unique approach to condense the data and then applied methPLIER to discover patterns that could clarify biological processes. They concluded that this technique could aid in understanding the biological significance of DNA methylation patterns. Looking forward, methPLIER could be crucial for future disease research and might assist in developing new cancer diagnosis and treatment methods.This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.	[Takasawa, Ken; Asada, Ken; Kaneko, Syuzo; Machino, Hidenori; Takahashi, Satoshi; Shinkai, Norio; Kouno, Nobuji; Kobayashi, Kazuma; Komatsu, Masaaki; Hamamoto, Ryuji] Natl Canc Ctr, Res Inst, Div Med AI Res & Dev, Tokyo 1040045, Japan; [Takasawa, Ken; Asada, Ken; Kaneko, Syuzo; Machino, Hidenori; Takahashi, Satoshi; Shinkai, Norio; Kouno, Nobuji; Kobayashi, Kazuma; Komatsu, Masaaki; Hamamoto, Ryuji] RIKEN Ctr Adv Intelligence Project, Canc Translat Res Team, Tokyo 1030027, Japan; [Shiraishi, Kouya; Mizuno, Takaaki; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 1040045, Japan; [Mizuno, Takaaki; Yoshida, Tatsuya; Horinouchi, Hidehito; Ohe, Yuichiro] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan; [Mizuno, Takaaki] Natl Canc Ctr, Dept Expt Therapeut, Tokyo 1040045, Japan; [Okubo, Yu; Yoshida, Yukihiro; Watanabe, Shun-Ichi] Natl Canc Ctr, Dept Thorac Surg, Tokyo 1040045, Japan; [Mukai, Masami] Natl Canc Ctr, Div Med Informat, Tokyo 1040045, Japan; [Yatabe, Yasushi] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo 1040045, Japan	National Cancer Center - Japan; RIKEN; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Takasawa, K; Hamamoto, R (corresponding author), Natl Canc Ctr, Res Inst, Div Med AI Res & Dev, Tokyo 1040045, Japan.; Takasawa, K; Hamamoto, R (corresponding author), RIKEN Ctr Adv Intelligence Project, Canc Translat Res Team, Tokyo 1030027, Japan.	ktakazaw@ncc.go.jp; rhamamot@ncc.go.jp	Komatsu, Masaaki/ABC-7821-2020; Machino, Hidenori/KGK-4406-2024; Takasawa, Ken/AAY-6755-2020; Kobayashi, Hirokazu/HJI-5211-2023; Hamamoto, Ryuji/AAF-9600-2019; Asada, Ken/AAP-6668-2020; Kouno, Nobuji/IQW-9509-2023	Machino, Hidenori/0000-0001-6843-7696	Japan Agency for Medical Research and Development (AMED); Division of Medical AI Research and Development at the National Cancer Center Research Institute	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Division of Medical AI Research and Development at the National Cancer Center Research Institute	We thank Prof. Hiroyuki Mano and the members of the Division of Medical AI Research and Development at the National Cancer Center Research Institute for their technical support and helpful discussions.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Artacho-Cordón F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Cao YX, 2010, J BIOL CHEM, V285, P2152, DOI 10.1074/jbc.M109.039172; Collado-Torres L, 2017, NAT BIOTECHNOL, V35, P319, DOI 10.1038/nbt.3838; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/epi.11.105, 10.2217/EPI.11.105]; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fasanelli F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10192; Felling RJ, 2012, EPIGENOMICS-UK, V4, P125, DOI [10.2217/EPI.12.2, 10.2217/epi.12.2]; Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6; Gu Y., 2017, INT J BIOL SCI REP, V7, P142000; Hamamoto R, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac246; Hamamoto R, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010062; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Klajic J, 2014, CLIN CANCER RES, V20, P6357, DOI 10.1158/1078-0432.CCR-14-0297; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/B978-0-12-380866-0.60002-2, 10.1016/S0065-2660(10)70002-X]; Lee DD, 2019, J CLIN INVEST, V129, P223, DOI 10.1172/JCI121303; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Locke WJ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01150; Maeda Y, 2011, AM J RESP CRIT CARE, V184, P421, DOI 10.1164/rccm.201101-0106OC; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Mao WG, 2019, NAT METHODS, V16, P607, DOI 10.1038/s41592-019-0456-1; McEwen LM, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0556-2; McInnes L, 2020, Arxiv, DOI [arXiv:1802.03426, 10.21105/joss.00861, DOI 10.48550/ARXIV.1802.03426]; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Morris TJ, 2015, METHODS, V72, P3, DOI 10.1016/j.ymeth.2014.08.011; Müller F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1664-9; Naumov VA, 2013, EPIGENETICS-US, V8, P921, DOI 10.4161/epi.25577; Paparella A, 2022, J HUM GENET, V67, P547, DOI 10.1038/s10038-022-01043-y; Pereira IT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105806; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Plongthongkum N, 2014, NAT REV GENET, V15, P647, DOI 10.1038/nrg3772; Rauluseviciute I, 2020, BMC MED GENOMICS, V13, DOI 10.1186/s12920-020-0657-6; Renaud S, 2015, BRIT J CANCER, V113, P1206, DOI 10.1038/bjc.2015.327; Sadikovic B, 2021, GENET MED, V23, P1065, DOI 10.1038/s41436-020-01096-4; Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Sato K, 2006, ONCOL REP, V15, P129; Shiraishi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12451; Song J, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0341-7; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takasawa K, 2018, HUM CELL, V31, P78, DOI 10.1007/s13577-017-0190-x; Taroni JN, 2019, CELL SYST, V8, P380, DOI 10.1016/j.cels.2019.04.003; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Tian Y, 2017, BIOINFORMATICS, V33, P3982, DOI 10.1093/bioinformatics/btx513; Titus AJ, 2016, BIOINFORMATICS, V32, P2517, DOI 10.1093/bioinformatics/btw180; Vitos-Faleato J, 2020, P NATL ACAD SCI USA, V117, P2588, DOI 10.1073/pnas.1921404117; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112708; Wang ZH, 2020, NEOPLASIA, V22, P154, DOI 10.1016/j.neo.2020.01.001; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wei JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9699; Witte T, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0066-6; Wu YF, 2017, ONCOTARGETS THER, V10, P5827, DOI 10.2147/OTT.S151857; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhou WD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw967; Zuo QQ, 2014, INT J BIOL MARKER, V29, pE354, DOI 10.5301/jbm.5000107	66	1	1	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1226-3613	2092-6413		EXP MOL MED	Exp. Mol. Med.	MAR	2024	56	3					646	655		10.1038/s12276-024-01173-7	http://dx.doi.org/10.1038/s12276-024-01173-7		MAR 2024	10	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine	MR6O6	38433247	Green Published, gold			2024-09-18	WOS:001177708600001
J	Souza, PVD; Lughofer, E; Guimaraes, AJ				de Campos Souza, Paulo Vitor; Lughofer, Edwin; Guimaraes, Augusto Junio			An interpretable evolving fuzzy neural network based on self-organized direction-aware data partitioning and fuzzy logic neurons	APPLIED SOFT COMPUTING			English	Article						Evolving fuzzy neural network; Adaptation of neuron parameters; Interpretability of model components; Degree of changes of neurons; Pattern classification problems	EXTREME LEARNING-MACHINE; DYNAMIC-SYSTEMS; PREDICTION; NORMS	This paper proposes the definition of the architecture of an evolving fuzzy neural network based on self-organizing direction aware data partitioning through stochastic processes based on the dataset used in the model. The choice between four different types of logical neurons in the second layer and the six different types of neuron activation function that compose the artificial neural network of aggregation are defined in a procedure of generating random pairs of combinations between the two factors. The combination that obtains the maximization of training accuracy is chosen to compose the network and perform the composition of the model structure, whose components can be transferred to readable IF-THEN rules for interpretability purposes. Furthermore, the model is able to adapt its parameters and evolve its structure autonomously with new data samples through self-organized direction-aware data partitioning (SODA). In this context, we also propose a technique to measure the degree of changes of neurons (rules), which could be used for structural active learning purposes (e.g, to request user feedback in the case of significant changes). To compare the proposed approach, binary pattern classification tests were performed, and the results were compared with other models of fuzzy neural networks and neural networks, obtaining satisfactory results with the stochastic definition of elements that compose their architecture comparing the final accuracy of the model when classifying real datasets. The proposed model obtained the best result in 3 of the four synthetic bases evaluated, in addition to the best accuracy results in the classification of patterns in five of the nine evaluated real datasets. It highlights the accuracy in problems in patients who underwent breast cancer surgery (72.44%), diabetes evaluation (67.87%), Australian (72.27%) and German (80.51%) credit ratings evaluation, and finally in the classification of radar signals in the ionosphere (90.46%). It is also noteworthy to obtain fuzzy rules in evolution extracted from a real problem of the identification of respiratory diseases through the collection of saliva with 76.67% of accuracy. The results presented by the model were superior to traditional artificial intelligence models, while it was possible to extract knowledge in form of interpretable rules and to realize how these changed over time. (C) 2021 The Author(s). Published by Elsevier B.V.	[de Campos Souza, Paulo Vitor; Lughofer, Edwin] Johannes Kepler Univ Linz, JKU Dept Knowledge Based Math Syst, A-4203 Linz, Austria; [Guimaraes, Augusto Junio] Fac UNA Betim, Av Gov Valadares,640 Centro, BR-32510010 Betim, MG, Brazil	Johannes Kepler University Linz	Souza, PVD (corresponding author), Johannes Kepler Univ Linz, JKU Dept Knowledge Based Math Syst, A-4203 Linz, Austria.	paulo.de_campos_souza@jku.at; edwin.lughofer@jku.at; augustojunioguimaraes@gmail.com	; Campos Souza, Paulo Vitor/O-5816-2018	Guimaraes, Augusto/0000-0003-1314-3441; Campos Souza, Paulo Vitor/0000-0002-7343-5844	Austrian Science Fund (FWF) [P32272-N38]; LCM K2 Center for Symbiotic Mechatronics; Austrian Science Fund (FWF) [P32272] Funding Source: Austrian Science Fund (FWF)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); LCM K2 Center for Symbiotic Mechatronics; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The first author acknowledges the support by the Austrian Science Fund (FWF): contract number P32272-N38, acronym IL-EFS. The second author also acknowledges the support by the ''LCM K2 Center for Symbiotic Mechatronics'' within the framework of the Austrian COMET-K2 program.	Aguiar C., 2020, ARXIV PREPRINT ARXIV; Albert A., 1972, REGRESSION MOORE PEN; Angelov P., 2011, Proceedings 2011 IEEE Workshop on Evolving and Adaptive Intelligent Systems (EAIS 2011), P62, DOI 10.1109/EAIS.2011.5945926; Angelov P, 2017, INT J INTELL SYST, V32, P1261, DOI 10.1002/int.21899; Angelov P, 2012, INT J GEN SYST, V41, P163, DOI 10.1080/03081079.2011.634807; Angelov PP, 2018, IEEE T CYBERNETICS, V48, P2981, DOI 10.1109/TCYB.2017.2753880; [Anonymous], 2019, EVOL SYST; [Anonymous], 2010, FUZZY INFORM PROCESS; [Anonymous], 1999, System Indentification - Theory for the User; [Anonymous], 2011, INT J ARTIF INTELL E, DOI DOI 10.1088/1742-6596/1237/2/022030; [Anonymous], 1986, Parallel Distributed Processing: Explorations and the microsctructure of cognition; [Anonymous], 2014, 2014 IEEE C EV AD IN; Araujo VS, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0536-y; Asici E, 2020, INT J GEN SYST, V49, P143, DOI 10.1080/03081079.2019.1668385; Bermeo JP, 2019, IFMBE PROC, V68, P409, DOI 10.1007/978-981-10-9038-7_77; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Bezerra C.G., 2020, INFORM SCIENTIST; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Calvo T, 2001, FUZZY SET SYST, V120, P385, DOI 10.1016/S0165-0114(99)00125-6; Caminhas W.M., 1999, JACIII, V3, P151; Carreira-Perpinan M, 1997, CS9609 U SHEFF DEPT; Çayli GD, 2020, FUZZY SET SYST, V386, P105, DOI 10.1016/j.fss.2019.03.010; Chang PC, 2011, INT J ELEC POWER, V33, P17, DOI 10.1016/j.ijepes.2010.08.008; Clevert D.-A., 2016, 4 INT C LEARN REPR I; D'Angelo MFSV, 2014, APPL SOFT COMPUT, V21, P647, DOI 10.1016/j.asoc.2014.04.007; Dan YX, 2020, FUZZY SET SYST, V386, P77, DOI 10.1016/j.fss.2019.02.001; de Campos Souza P.V., 2018, 5 IEEE LATIN AM C CO, V5; Souza PVD, 2019, APPL INTELL, V49, P3221, DOI 10.1007/s10489-019-01449-w; Souza PVD, 2019, SOFT COMPUT, V23, P12475, DOI 10.1007/s00500-019-03792-z; Souza PVD, 2018, IEEE CONF EVOL ADAPT; Souza PVD, 2018, COMM COM INF SC, V831, P13, DOI 10.1007/978-3-319-95312-0_2; Souza PVD, 2018, J INTELL FUZZY SYST, V35, P2597, DOI 10.3233/JIFS-18426; Souza PVD, 2018, 2018 IEEE SYMPOSIUM ON COMPUTER APPLICATIONS & INDUSTRIAL ELECTRONICS (ISCAIE 2018), P25, DOI 10.1109/ISCAIE.2018.8405439; Deschrijver G, 2004, IEEE T FUZZY SYST, V12, P45, DOI 10.1109/TFUZZ.2003.822678; Doob J. L., 1953, Stochastic Processes, V7; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Efron B., 1993, INTRO BOOTSTRAP MONO; Efron Bradley., 1994, An introduction to the bootstrap, DOI 10.1007/978-1-4899-4541-9; Ferdaus MM, 2020, INFORM SCIENCES, V512, P481, DOI 10.1016/j.ins.2019.10.001; Sáez RG, 2019, IEEE T IND ELECTRON, V66, P3060, DOI 10.1109/TIE.2018.2842780; Gu XW, 2020, INT J INTELL SYST, V35, P923, DOI 10.1002/int.22230; Gu XW, 2018, INFORM SCIENCES, V423, P80, DOI 10.1016/j.ins.2017.09.025; GUIMARAES AJ, 2019, ARTIF INTELL, P401, DOI DOI 10.1007/978-3-030-19823-7_34; Guimaraes AJ, 2018, LECT NOTES ARTIF INT, V11238, P229, DOI 10.1007/978-3-030-03928-8_19; Hajek P., 1998, PERSPECTIVES LOGIC; Hanin B, 2019, MATHEMATICS-BASEL, V7, DOI 10.3390/math7100992; Hell M, 2007, NAFIPS 2007 - 2007 ANNUAL MEETING OF THE NORTH AMERICAN FUZZY INFORMATION PROCESSING SOCIETY, P331, DOI 10.1109/NAFIPS.2007.383860; HIROTA K, 1994, IEEE T FUZZY SYST, V2, P151, DOI 10.1109/91.277963; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Kasabov N, 2001, IEEE T SYST MAN CY B, V31, P902, DOI 10.1109/3477.969494; Kim KJ, 2000, EXPERT SYST APPL, V19, P125, DOI 10.1016/S0957-4174(00)00027-0; Klement EP, 2004, FUZZY SET SYST, V145, P439, DOI 10.1016/S0165-0114(03)00304-X; Lemos A. P., 2012, FUZZY INFORM PROCESS, P1; Li WH, 2020, FUZZY SET SYST, V386, P36, DOI 10.1016/j.fss.2019.03.007; Lichman M, 2013, UCI MACHINE LEARNING; Lin CT, 2021, IEEE T CYBERNETICS, V51, P4959, DOI 10.1109/TCYB.2020.3010805; Lin J.W., 2003, MANAG AUDIT J, V18, P657, DOI [10.1108/02686900310495151, DOI 10.1108/02686900310495151]; Lin YY, 2013, IEEE T NEUR NET LEAR, V24, P310, DOI 10.1109/TNNLS.2012.2231436; Liu SL, 2014, NEUROCOMPUTING, V144, P318, DOI 10.1016/j.neucom.2014.04.041; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Lughofer E, 2011, EVOL SYST-GER, V2, P165, DOI 10.1007/s12530-011-9032-3; Menezes MVF, 2019, PATTERN RECOGN LETT, V128, P1, DOI 10.1016/j.patrec.2019.08.001; Miche Y, 2010, IEEE T NEURAL NETWOR, V21, P158, DOI 10.1109/TNN.2009.2036259; Montgomery DC., 2017, DESIGN ANAL EXPT; Nair G., 2010, ICML, P807, DOI 10.1123/jab.2016-0355; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/502007; Okabe A., 2009, Spatial Tessellations: Concepts and Applications of Voronoi Diagrams, V501; PEDRYCZ W, 1993, FUZZY SET SYST, V56, P1, DOI 10.1016/0165-0114(93)90181-G; PEDRYCZ W, 1991, IEEE T PATTERN ANAL, V13, P289, DOI 10.1109/34.75517; Pedrycz W., 1998, An Introduction to Fuzzy Sets: Analysis and Design; Pedrycz W, 2006, IEEE T FUZZY SYST, V14, P860, DOI 10.1109/TFUZZ.2006.879977; Pinto D., 2015, PROCEEDINGS, P343; Ponce H, 2020, ENG APPL ARTIF INTEL, V89, DOI 10.1016/j.engappai.2019.103427; Quinlan J. R., 2014, C4.5: Programs for Machine Learning; Rezende, 2018, 15 ENC NAC INT ART E, P799; Rong HJ, 2008, NEUROCOMPUTING, V72, P359, DOI 10.1016/j.neucom.2008.01.005; Schalkoff RJ, 1997, Artificial neural network, V1; SHI Y, 2018, IOP C SER EARTH ENV, V128; Araújo VJS, 2019, MACH LEARN KNOW EXTR, V1, P466, DOI 10.3390/make1010028; Silva S, 2020, NEURAL COMPUT APPL, V32, P7597, DOI 10.1007/s00521-018-3789-2; Souza A. P., 2018, International Journal of Artificial Intelligence and Applications, V9, P13; Souza P.V.C., INTERPRETABLE MACHIN; Souza P.V.C., 2018, Int. J. Appl. Eng. Res., V13, P2985; Souza P, 2020, KNOWL-BASED SYST, V203, DOI 10.1016/j.knosys.2020.106099; Souza PVD, 2020, APPL SOFT COMPUT, V92, DOI 10.1016/j.asoc.2020.106275; Souza PVD, 2021, EVOL SYST-GER, V12, P899, DOI 10.1007/s12530-020-09336-3; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Yen VT, 2019, NEURAL COMPUT APPL, V31, P6945, DOI 10.1007/s00521-018-3520-3; Wang JZ, 2019, ENERG CONVERS MANAGE, V181, P425, DOI 10.1016/j.enconman.2018.12.020; WATSON DF, 1981, COMPUT J, V24, P167, DOI 10.1093/comjnl/24.2.167; Yager RR, 1996, FUZZY SET SYST, V80, P111, DOI 10.1016/0165-0114(95)00133-6; Yager RR, 2020, INFORM PROCESSING MA, P621, DOI 10.1007/978-3-030-50143-3_49; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091; Yu H, 2022, IEEE T FUZZY SYST, V30, P412, DOI 10.1109/TFUZZ.2020.3039681; ZADEH LA, 1976, INT J MAN MACH STUD, V8, P249, DOI 10.1016/S0020-7373(76)80001-6; Zarrin PS, 2019, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7010011; Zhang WW, 2022, ASIAN J CONTROL, V24, P227, DOI 10.1002/asjc.2485; Zhang Z, 2020, MECH ADV MATER STRUC, V27, P3, DOI 10.1080/15376494.2018.1444216; Zhou HB, 2020, APPL SOFT COMPUT, V95, DOI 10.1016/j.asoc.2020.106516	101	14	14	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1568-4946	1872-9681		APPL SOFT COMPUT	Appl. Soft. Comput.	NOV	2021	112								107829	10.1016/j.asoc.2021.107829	http://dx.doi.org/10.1016/j.asoc.2021.107829		SEP 2021	20	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	XG1VN		hybrid, Green Published			2024-09-18	WOS:000724547700004
J	Horiguchi, M; Hassett, MJ; Uno, H				Horiguchi, Miki; Hassett, Michael J.; Uno, Hajime			Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology	CLINICAL TRIALS			English	Article						Hazard ratio; log-rank test; restricted mean survival time; survival data analysis; weighted log-rank test	GOODNESS-OF-FIT; MEAN SURVIVAL-TIME; HAZARD RATIOS; MODEL	Background: More than 95% of recent cancer randomized controlled trials used the log-rank test to detect a treatment difference making it the predominant tool for comparing two survival functions. As with other tests, the log-rank test has both advantages and disadvantages. One advantage is that it offers the highest power against proportional hazards differences, which may be a major reason why alternative methods have rarely been employed in practice. The performance of statistical tests has traditionally been investigated both theoretically and numerically for several patterns of difference between two survival functions. However, to the best of our knowledge, there has been no attempt to compare the performance of various statistical tests using empirical data from past oncology randomized controlled trials. So, it is unknown whether the log-rank test offers a meaningful power advantage over alternative testing methods in contemporary cancer randomized controlled trials. Focusing on recently reported phase III cancer randomized controlled trials, we assessed whether the log-rank test gave meaningfully greater power when compared with five alternative testing methods: generalized Wilcoxon, test based on maximum of test statistics from multiple weighted log-rank tests, difference int-year event rate, and difference in restricted mean survival time with fixed and adaptive tau. Methods: Using manuscripts from cancer randomized controlled trials recently published in high-tier clinical journals, we reconstructed patient-level data for overall survival (69 trials) and progression-free survival (54 trials). For each trial endpoint, we estimated the empirical power of each test. Empirical power was measured as the proportion of trials for which a test would have identified a significant result (pvalue < .05). Results: For overall survival,t-year event rate offered the lowest (30.4%) empirical power and restricted mean survival time with fixed tau offered the highest (43.5%). The empirical power of the other types of tests was almost identical (36.2%-37.7%). For progression-free survival, the tests we investigated offered numerically equivalent empirical power (55.6%-61.1%). No single test consistently outperformed any other test. Conclusion: The empirical power assessment with the past cancer randomized controlled trials provided new insights on the performance of statistical tests. Although the log-rank test has been used in almost all trials, our study suggests that the log-rank test is not the only option from an empirical power perspective. Near universal use of the log-rank test is not supported by a meaningful difference in empirical power. Clinical trial investigators could consider alternative methods, beyond the log-rank test, for their primary analysis when designing a cancer randomized controlled trial. Factors other than power (e.g. interpretability of the estimated treatment effect) should garner greater consideration when selecting statistical tests for cancer randomized controlled trials.	[Horiguchi, Miki; Hassett, Michael J.; Uno, Hajime] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA; [Uno, Hajime] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Uno, H (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	huno@ds.dfci.harvard.edu	Horiguchi, Miki/AAJ-2677-2021; Uno, Hajime/W-4099-2019; Hassett, Michael/M-5032-2019	Uno, Hajime/0000-0003-0622-8471; Horiguchi, Miki/0000-0002-9800-1954	Dana-Farber Cancer Institute	Dana-Farber Cancer Institute	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work was partially supported by institutional funds of Dana-Farber Cancer Institute.	A'Hern RP, 2018, CLIN ONCOL-UK, V30, pE75, DOI 10.1016/j.clon.2018.04.011; A'Hern RP, 2016, J CLIN ONCOL, V34, P3474, DOI 10.1200/JCO.2016.67.8045; Anderson KM, 2018, ASA BIOPHARMACEUTICA; Chappell R, 2016, JAMA ONCOL, V2, P906, DOI 10.1001/jamaoncol.2016.0001; COX DR, 1972, J R STAT SOC B, V34, P187; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eaton A, 2020, CLIN TRIALS, V17, P285, DOI 10.1177/1740774520905563; Fleming TR., 2011, Counting processes and survival analysis, V169; Freidlin B, 2019, J CLIN ONCOL, V37, P3455, DOI 10.1200/JCO.19.01681; Gill R. D., 1980, MATH CTR TRACTS, V124, DOI [10.1111/j.1467-9574.1980.tb00692.x, DOI 10.1111/J.1467-9574.1980.TB00692.X]; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Hasegawa T, 2020, PHARM STAT, V19, P436, DOI 10.1002/pst.2004; Horiguchi M, 2019, ONCOLOGIST, V24, P867, DOI 10.1634/theoncologist.2018-0141; Horiguchi M, 2018, STAT MED, V37, P2307, DOI 10.1002/sim.7661; KALBFLEISCH JD, 1981, BIOMETRIKA, V68, P105, DOI 10.1093/biomet/68.1.105; Karrison TG, 2016, STATA J, V16, P678, DOI 10.1177/1536867X1601600308; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.1093/biomet/80.3.557; LIN DY, 1991, J AM STAT ASSOC, V86, P725, DOI 10.2307/2290404; Liu JP, 2002, STAT MED, V21, P231, DOI 10.1002/sim.1012; Marubini E., 1995, ANAL SURVIVAL DATA C; McCaw ZR, 2019, AM J MED, V132, P13, DOI 10.1016/j.amjmed.2018.07.026; Péron J, 2016, JAMA ONCOL, V2, P901, DOI 10.1001/jamaoncol.2015.6359; PRENTICE RL, 1978, BIOMETRIKA, V65, P167, DOI 10.2307/2335292; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; SASIENI P, 1993, J AM STAT ASSOC, V88, P144, DOI 10.2307/2290707; Schemper M, 2009, STAT MED, V28, P2473, DOI 10.1002/sim.3623; SCHOENFELD D, 1980, BIOMETRIKA, V67, P145; Tian L, 2020, BIOMETRICS, V76, P1157, DOI 10.1111/biom.13237; Tian L, 2018, BIOMETRICS, V74, P694, DOI 10.1111/biom.12770; Trinquart L, 2016, J CLIN ONCOL, V34, P1813, DOI 10.1200/JCO.2015.64.2488; Uno H, 2020, J CLIN ONCOL, V38, P2000, DOI 10.1200/JCO.19.03097; Uno H, 2020, ONCOLOGIST, V25, P91, DOI 10.1634/theoncologist.2019-0464; Uno H, 2015, ANN INTERN MED, V163, P127, DOI 10.7326/M14-1741; Uno H, 2014, J CLIN ONCOL, V32, P2380, DOI 10.1200/JCO.2014.55.2208; WEI LJ, 1984, J AM STAT ASSOC, V79, P649, DOI 10.2307/2288412; Weir IR, 2019, ANN ONCOL, V30, P96, DOI 10.1093/annonc/mdy462; Xu R, 2000, Biostatistics, V1, P423, DOI 10.1093/biostatistics/1.4.423	39	3	3	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1740-7745	1740-7753		CLIN TRIALS	Clin. Trials	DEC	2020	17	6					597	606	1740774520940256	10.1177/1740774520940256	http://dx.doi.org/10.1177/1740774520940256		SEP 2020	10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	OO1HG	32933339				2024-09-18	WOS:000570662100001
J	de Hond, AAH; Kant, IMJ; Honkoop, PJ; Smith, AD; Steyerberg, EW; Sont, JK				de Hond, Anne A. H.; Kant, Ilse M. J.; Honkoop, Persijn J.; Smith, Andrew D.; Steyerberg, Ewout W.; Sont, Jacob K.			Machine learning did not beat logistic regression in time series prediction for severe asthma exacerbations	SCIENTIFIC REPORTS			English	Article							TRADE-OFF; MODELS; INTERPRETABILITY; PROBABILITY; ACCURACY; CANCER	Early detection of severe asthma exacerbations through home monitoring data in patients with stable mild-to-moderate chronic asthma could help to timely adjust medication. We evaluated the potential of machine learning methods compared to a clinical rule and logistic regression to predict severe exacerbations. We used daily home monitoring data from two studies in asthma patients (development: n = 165 and validation: n = 101 patients). Two ML models (XGBoost, one class SVM) and a logistic regression model provided predictions based on peak expiratory flow and asthma symptoms. These models were compared with an asthma action plan rule. Severe exacerbations occurred in 0.2% of all daily measurements in the development (154/92,787 days) and validation cohorts (94/40,185 days). The AUC of the best performing XGBoost was 0.85 (0.82-0.87) and 0.88 (0.86-0.90) for logistic regression in the validation cohort. The XGBoost model provided overly extreme risk estimates, whereas the logistic regression underestimated predicted risks. Sensitivity and specificity were better overall for XGBoost and logistic regression compared to one class SVM and the clinical rule. We conclude that ML models did not beat logistic regression in predicting short-term severe asthma exacerbations based on home monitoring data. Clinical application remains challenging in settings with low event incidence and high false alarm rates with high sensitivity.	[de Hond, Anne A. H.; Kant, Ilse M. J.] Leiden Univ, Med Ctr, Dept Informat Technol & Digital Innovat, Albinusdreef 2, NL-2300 RC Leiden, Netherlands; [de Hond, Anne A. H.; Kant, Ilse M. J.; Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Clin AI Implementat & Res Lab, Albinusdreef 2, NL-2300 RC Leiden, Netherlands; [de Hond, Anne A. H.; Kant, Ilse M. J.; Honkoop, Persijn J.; Steyerberg, Ewout W.; Sont, Jacob K.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Albinusdreef 2, NL-2300 RC Leiden, Netherlands; [Smith, Andrew D.] Univ Hosp Wishaw, Dept Resp Med, 50 Netherton St, Wishaw ML2 0DP, Scotland	Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	de Hond, AAH (corresponding author), Leiden Univ, Med Ctr, Dept Informat Technol & Digital Innovat, Albinusdreef 2, NL-2300 RC Leiden, Netherlands.; de Hond, AAH (corresponding author), Leiden Univ, Med Ctr, Clin AI Implementat & Res Lab, Albinusdreef 2, NL-2300 RC Leiden, Netherlands.; de Hond, AAH (corresponding author), Leiden Univ, Med Ctr, Dept Biomed Data Sci, Albinusdreef 2, NL-2300 RC Leiden, Netherlands.	a.a.h.de_hond@lumc.nl	Sont, Jacob/J-8071-2015; Steyerberg, Ewout/C-1509-2018	Smith, Andrew/0000-0003-4648-4090				Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Cearns M, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0607-2; Chen PHC, 2019, NAT MATER, V18, P410, DOI 10.1038/s41563-019-0345-0; Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Finkelstein J, 2017, ANN NY ACAD SCI, V1387, P153, DOI 10.1111/nyas.13218; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Honkoop PJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013935; Honkoop PJ, 2013, EUR RESPIR J, V41, P53, DOI 10.1183/09031936.00205911; Johansson U, 2011, FUTURE MED CHEM, V3, P647, DOI [10.4155/fmc.11.23, 10.4155/FMC.11.23]; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Ma JS, 2003, IEEE IJCNN, P1741; Mak RH, 2019, JAMA ONCOL, V5, P654, DOI 10.1001/jamaoncol.2019.0159; Malasinghe LP, 2019, J AMB INTEL HUM COMP, V10, P57, DOI 10.1007/s12652-017-0598-x; Martin A, 2020, J ASTHMA, V57, P1339, DOI 10.1080/02770903.2019.1648505; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Mori T, 2019, EMPIR SOFTW ENG, V24, P779, DOI 10.1007/s10664-018-9638-1; Neuhaus AH, 2018, BIOL PSYCHIAT, V84, pE79, DOI 10.1016/j.biopsych.2017.09.032; Nusinovici S, 2020, J CLIN EPIDEMIOL, V122, P56, DOI 10.1016/j.jclinepi.2020.03.002; Obradovic D, 2016, CLIN RESPIR J, V10, P784, DOI 10.1111/crj.12291; Sanchez-Morillo D, 2016, CHRON RESP DIS, V13, P264, DOI 10.1177/1479972316642365; Sanders S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128233; Satici C, 2020, INT J INFECT DIS, V98, P84, DOI 10.1016/j.ijid.2020.06.038; Schober P, 2021, ANESTH ANALG, V132, P365, DOI 10.1213/ANE.0000000000005247; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Smith AE, 2003, ARTIF INTELL MED, V27, P1, DOI 10.1016/S0933-3657(02)00088-X; Steyerberg E.W., 2019, CLIN PREDICTION MODE; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; Tsang K. C. H., 2020 42 ANN INT C IE, P5673; van Calster B, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1466-7; Wallace BC, 2014, KNOWL INF SYST, V41, P33, DOI 10.1007/s10115-013-0670-6; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Winters BD, 2018, CRIT CARE MED, V46, P130, DOI 10.1097/CCM.0000000000002803; Wynants L, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3505	36	6	6	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 27	2022	12	1							20363	10.1038/s41598-022-24909-9	http://dx.doi.org/10.1038/s41598-022-24909-9			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6M9YM	36437306	gold, Green Published			2024-09-18	WOS:000889218700037
J	Wei, JY; Wang, X; Guo, HP; Zhang, L; Shi, Y; Wang, X				Wei, Jiayi; Wang, Xin; Guo, Hongping; Zhang, Ling; Shi, Yao; Wang, Xiao			Subclassification of lung adenocarcinoma through comprehensive multi-omics data to benefit survival outcomes	COMPUTATIONAL BIOLOGY AND CHEMISTRY			English	Article						Lung adenocarcinoma; Multi-omics data; Subtype classification; Feature selection; Survival analysis	FEATURE-SELECTION; TUMORS IMPACT; CELL-ADHESION; CANCER CELLS; CLASSIFICATION; EXPRESSION; SUBTYPES; CABYR; MICROENVIRONMENT	Objectives: Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer. Understanding the molecular mechanisms underlying tumor progression is of great clinical significance. This study aims to identify novel molecular markers associated with LUAD subtypes, with the goal of improving the precision of LUAD subtype classification. Additionally, optimization efforts are directed towards enhancing insights from the perspective of patient survival analysis. Materials and methods: We propose an innovative feature-selection approach that focuses on LUAD classification, which is comprehensive and robust. The proposed method integrates multi-omics data from The Cancer Genome Atlas (TCGA) and leverages a synergistic combination of max-relevance and min-redundancy, least absolute shrinkage and selection operator, and Boruta algorithms. These selected features were deployed in six machinelearning classifiers: logistic regression, random forest, support vector machine, naive Bayes, k-Nearest Neighbor, and XGBoost. Results: The proposed approach achieved an area under the receiver operating characteristic curve (AUC) of 0.9958 for LR. Notably, the accuracy and AUC of a composite model incorporating copy number, methylation, as well as RNA- sequencing data for expression of exons, genes, and miRNA mature strands surpassed the accuracy and AUC metrics of models with single-omics data or other multi-omics combinations. Survival analyses, revealed the SVM classifier to elicit optimal classification, outperforming that achieved by TCGA. To enhance model interpretability, SHapley Additive exPlanations (SHAP) values were utilized to elucidate the impact of each feature on the predictions. Gene Ontology (GO) enrichment analysis identified significant biological processes, molecular functions, and cellular components associated with LUAD subtypes. Conclusion: In summary, our feature selection process, based on TCGA multi-omics data and combined with multiple machine learning classifiers, proficiently identifies molecular subtypes of lung adenocarcinoma and their corresponding significant genes. Our method could enhance the early detection and diagnosis of LUAD, expedite the development of targeted therapies and, ultimately, lengthen patient survival.	[Wei, Jiayi; Wang, Xin; Shi, Yao; Wang, Xiao] Qingdao Univ, Qingdao, Peoples R China; [Guo, Hongping] Hubei Normal Univ, Huangshi, Peoples R China; [Zhang, Ling] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Qingdao University; Hubei Normal University; Salk Institute	Shi, Y; Wang, X (corresponding author), Qingdao Univ, Qingdao, Peoples R China.; Zhang, L (corresponding author), Salk Inst Biol Studies, La Jolla, CA 92037 USA.	linzhang@salk.edu; yshi@qdu.edu.cn; xwang1020@qdu.edu.cn	Wang, Xiao/LEM-6820-2024		National Natural Science Foundation of China [12101346]; Natural Science Foundation of Shandong Province [ZR2021QA044]; Natural Science Foundation of Hubei Province [2022CFB942]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	<B>Acknowledgement</B> #The authors wish it to be known that, in their opinion, they should be regarded as Joint First Authors. This research was funded by National Natural Science Foundation of China (12101346) , Natural Science Foundation of Shandong Province (ZR2021QA044) , and Natural Science Foundation of Hubei Province (2022CFB942)	Ali N.M., 2020, Indones. J. Electr. Eng. Comput. Sci., V20, P712, DOI [10.11591/ijeecs.v20.i2.pp712-719, DOI 10.11591/IJEECS.V20.I2.PP712-719]; [Anonymous], 2013, Autoimmunity: From Bench to Bedside; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai WJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4958-5; Cai ZH, 2015, MOL BIOSYST, V11, P791, DOI 10.1039/c4mb00659c; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen H, 2021, INT J GEN MED, V14, P5771, DOI 10.2147/IJGM.S327641; Chen JB, 2020, NAT GENET, V52, P177, DOI 10.1038/s41588-019-0569-6; Chen LY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.720110; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Choi J, 2022, EJNMMI RES, V12, DOI 10.1186/s13550-022-00908-9; Chu F, 2005, INT J NEURAL SYST, V15, P475, DOI 10.1142/S0129065705000396; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Dong YY, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9173589; Eriksson P, 2022, BIOINFORMATICS, V38, P1022, DOI 10.1093/bioinformatics/btab763; Ettinger DS, 2022, J NATL COMPR CANC NE, V20, P497, DOI 10.6004/jnccn.2022.0025; Faruki H, 2017, J THORAC ONCOL, V12, P943, DOI 10.1016/j.jtho.2017.03.010; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Fu LH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233283; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanley CJ, 2023, NAT COMMUN, V14, DOI 10.1038/s41467-023-35832-6; Harjunpää H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01078; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Huang F, 2018, ONCOL REP, V39, P809, DOI 10.3892/or.2017.6140; Inamura K, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00193; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kassambara A., 2021, rstatix: pipe-friendly framework for basic statistical tests; Keogh A, 2022, TRANSL LUNG CANCER R, DOI 10.21037/tlcr-22-230; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; de Sousa VML, 2018, PATHOBIOLOGY, V85, P96, DOI 10.1159/000487440; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P143, DOI 10.1093/abbs/gmq118; Liljedahl H, 2021, INT J CANCER, V148, P238, DOI 10.1002/ijc.33242; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu LB, 2021, TRANSL CANCER RES, V10, P2859, DOI 10.21037/tcr-20-2275; Luo CL, 2007, CLIN CANCER RES, V13, P1288, DOI 10.1158/1078-0432.CCR-06-1742; Menard S., 2001, APPL LOGISTIC REGRES; Menyhárt O, 2021, COMPUT STRUCT BIOTEC, V19, P949, DOI 10.1016/j.csbj.2021.01.009; Myers D.J., 2022, StatPearls Internet; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qian ZL, 2014, MOL CANCER RES, V12, P335, DOI 10.1158/1541-7786.MCR-13-0391; Rodriguez-Canales J, 2016, CANCER TREAT RES, V170, P25, DOI 10.1007/978-3-319-40389-2_2; Shen ZH, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.932973; Sherafatian M, 2019, ONCOL LETT, V18, P2125, DOI 10.3892/ol.2019.10462; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tang M, 2023, CANCER MED-US, V12, P5035, DOI 10.1002/cam4.5238; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Therneau TM., 2020, R package version; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Travis W.D., 1999, Histol. Typing Lung Pleural Tumours, P21, DOI [10.1007/978-3-642-60049-4, DOI 10.1007/978-3-642-60049-4]; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang HT, 2017, INT J CLIN EXP PATHO, V10, P11747; Wei JH, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20211494; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Xiao QQ, 2016, ONCOTARGET, V7, P9514, DOI 10.18632/oncotarget.7069; Yu QY, 2022, AGING-US, V14, P5537, DOI 10.18632/aging.204167; Zhang J, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-24183-9; Zhao Y, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-07888-4; Zhong LX, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04391-2; Zhu CN, 2024, MOL IMMUNOL, V171, P1, DOI 10.1016/j.molimm.2024.04.013; Zu LL, 2022, J CLIN MED, V11, DOI 10.3390/jcm11216421	66	0	0	4	4	ELSEVIER SCI LTD	London	125 London Wall, London, ENGLAND	1476-9271	1476-928X		COMPUT BIOL CHEM	Comput. Biol. Chem.	OCT	2024	112								108150	10.1016/j.compbiolchem.2024.108150	http://dx.doi.org/10.1016/j.compbiolchem.2024.108150		JUL 2024	14	Biology; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science	ZE1F4	39018587				2024-09-18	WOS:001273520900001
J	Park, JR; Bagatell, R; Cohn, SL; Pearson, AD; Villablanca, JG; Berthold, F; Burchill, S; Boubaker, A; McHugh, K; Nuchtern, JG; London, WB; Seibel, NL; Lindwasser, OW; Maris, JM; Brock, P; Schleiermacher, G; Ladenstein, R; Matthay, KK; Valteau-Couanet, D				Park, Julie R.; Bagatell, Rochelle; Cohn, Susan L.; Pearson, Andrew D.; Villablanca, Judith G.; Berthold, Frank; Burchill, Susan; Boubaker, Ariane; McHugh, Kieran; Nuchtern, Jed G.; London, Wendy B.; Seibel, Nita L.; Lindwasser, O. Wolf; Maris, John M.; Brock, Penelope; Schleiermacher, Gudrun; Ladenstein, Ruth; Matthay, Katherine K.; Valteau-Couanet, Dominique			Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting	JOURNAL OF CLINICAL ONCOLOGY			English	Article							HIGH-RISK NEUROBLASTOMA; MINIMAL RESIDUAL DISEASE; CHILDRENS ONCOLOGY GROUP; STAGE 4 NEUROBLASTOMA; STEM-CELL TRANSPLANTATION; INRG TASK-FORCE; BONE-MARROW; PHASE-I; INDUCTION CHEMOTHERAPY; METAIODOBENZYLGUANIDINE SCINTIGRAPHY	Purpose More than two decades ago, an international working group established the International Neuroblastoma Response Criteria (INRC) to assess treatment response in children with neuroblastoma. However, this system requires modification to incorporate modern imaging techniques and new methods for quantifying bone marrow disease that were not previously widely available. The National Cancer Institute sponsored a clinical trials planning meeting in 2012 to update and refine response criteria for patients with neuroblastoma. Methods Multidisciplinary investigators from 13 countries reviewed data from published trials performed through cooperative groups, consortia, and single institutions. Data from both prospective and retrospective trials were used to refine the INRC. Monthly international conference calls were held from 2011 to 2015, and consensus was reached through review by working group leadership and the National Cancer Institute Clinical Trials Planning Meeting leadership council. Results Overall response in the revised INRC will integrate tumor response in the primary tumor, soft tissue and bone metastases, and bone marrow. Primary and metastatic soft tissue sites will be assessed using Response Evaluation Criteria in Solid Tumors (RECIST) and iodine-123 (I-123)-metaiodobenzylguanidine (MIBG) scans or [F-18] fluorodeoxyglucose-positron emission tomography scans if the tumor is MIBG nonavid. I-123-MIBG scans, or [F-18] fluorodeoxyglucose-positron emission tomography scans for MIBG-nonavid disease, replace technetium-99m diphosphonate bone scintigraphy for osteomedullary metastasis assessment. Bone marrow will be assessed by histology or immunohistochemistry and cytology or immunocytology. Bone marrow with <= 5% tumor involvement will be classified as minimal disease. Urinary catecholamine levels will not be included in response assessment. Overall response will be defined as complete response, partial response, minor response, stable disease, or progressive disease. Conclusion These revised criteria will provide a uniform assessment of disease response, improve the interpretability of clinical trial results, and facilitate collaborative trial designs. (C) 2017 by American Society of Clinical Oncology	[Park, Julie R.] Seattle Childrens Hosp, 4800 Sandpoint Way NE, Seattle, WA 98105 USA; [Park, Julie R.] Univ Washington, Sch Med, Seattle, WA USA; [Bagatell, Rochelle; Maris, John M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bagatell, Rochelle; Maris, John M.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Cohn, Susan L.] Univ Chicago, Chicago, IL 60637 USA; [Pearson, Andrew D.] Inst Canc Res, Sutton, Surrey, England; [Pearson, Andrew D.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England; [Burchill, Susan] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [McHugh, Kieran; Brock, Penelope] NHS Trust, Great Ormond St Hosp Children, London, England; [Villablanca, Judith G.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Villablanca, Judith G.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Matthay, Katherine K.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Berthold, Frank] Childrens Hosp, Cologne, Germany; [Berthold, Frank] Univ Cologne, Cologne, Germany; [Boubaker, Ariane] Clin La Source, Inst Radiol, Lausanne, Switzerland; [Nuchtern, Jed G.] Texas Childrens Hosp, Houston, TX 77030 USA; [Nuchtern, Jed G.] Baylor Coll Med, Houston, TX 77030 USA; [London, Wendy B.] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA; [Seibel, Nita L.; Lindwasser, O. Wolf] NCI, Bethesda, MD 20892 USA; [Schleiermacher, Gudrun] Inst Curie, Paris, France; [Valteau-Couanet, Dominique] Gustave Roussy, Villejuif, France; [Ladenstein, Ruth] St Anna Childrens Hosp, Childrens Canc Res Inst, Vienna, Austria	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Chicago; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Saint James's University Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California San Francisco; University of Cologne; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UNICANCER; Universite PSL; Institut Curie; UNICANCER; Gustave Roussy; Saint Anna Children's Hospital; St. Anna Children's Cancer Research Institute (CCRI)	Park, JR (corresponding author), Seattle Childrens Hosp, 4800 Sandpoint Way NE, Seattle, WA 98105 USA.	julie.park@seattlechildrens.org	Schleiermacher, Gudrun/AAN-4711-2021; Berthold, Frank/HNC-2850-2023; London, Wendy/ABA-8948-2021; Cohn, Susan/AAB-6010-2021; Park, Julie/HGC-0199-2022	Cohn, Susan/0000-0001-5749-7650; Berthold, Frank/0000-0002-7613-1723	National Cancer Institute Pediatric and Adolescent Solid Tumor Steering Committee; Alex's Lemonade Stand Foundation; Ben Towne Foundation; EVAN Foundation; Cancer Research UK Institut of Cancer Research (ICR) Core Award [C347/A15403]; National Institute for Health Research Research Methods Programme/ICR Biomedical Research Centre	National Cancer Institute Pediatric and Adolescent Solid Tumor Steering Committee; Alex's Lemonade Stand Foundation; Ben Towne Foundation; EVAN Foundation; Cancer Research UK Institut of Cancer Research (ICR) Core Award; National Institute for Health Research Research Methods Programme/ICR Biomedical Research Centre	Supported by the National Cancer Institute Pediatric and Adolescent Solid Tumor Steering Committee, Alex's Lemonade Stand Foundation, the Ben Towne Foundation, the EVAN Foundation, Cancer Research UK Institut of Cancer Research (ICR) Core Award No. C347/A15403, and the National Institute for Health Research Research Methods Programme/ICR Biomedical Research Centre.	ADY N, 1995, EUR J CANCER, V31A, P256, DOI 10.1016/0959-8049(94)00509-4; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Bagatell R, 2016, J CLIN ONCOL, V34, P740, DOI 10.1200/JCO.2015.63.2042; Bagatell R, 2011, J CLIN ONCOL, V29, P208, DOI 10.1200/JCO.2010.31.7107; Baker DL, 2010, NEW ENGL J MED, V363, P1313, DOI 10.1056/NEJMoa1001527; Beiske K, 2009, BRIT J CANCER, V100, P1627, DOI 10.1038/sj.bjc.6605029; Berthold F, 2005, LANCET ONCOL, V6, P649, DOI 10.1016/S1470-2045(05)70291-6; Boubaker A, 2008, Q J NUCL MED MOL IM, V52, P388; Brisse HJ, 2011, RADIOLOGY, V261, P243, DOI 10.1148/radiol.11101352; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Burchill SA, 2004, J CLIN PATHOL, V57, P14, DOI 10.1136/jcp.57.1.14; Burchill SA, CANCER; Cai JY, 2012, AM J CLIN ONCOL-CANC, V35, P275, DOI 10.1097/COC.0b013e318210f51b; Cheung IY, 2003, J CLIN ONCOL, V21, P3853, DOI 10.1200/JCO.2003.11.077; Cheung NKV, 1997, J CLIN ONCOL, V15, P2807, DOI 10.1200/JCO.1997.15.8.2807; Choi YB, 2015, J KOREAN MED SCI, V30, P1062, DOI 10.3346/jkms.2015.30.8.1062; Cistaro A, 2015, NUCL MED REV, V18, P102, DOI 10.5603/NMR.2015.0024; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; De Bernardi B, 2008, BRIT J CANCER, V99, P1027, DOI 10.1038/sj.bjc.6604640; De Bernardi B, 2009, J CLIN ONCOL, V27, P1034, DOI 10.1200/JCO.2008.17.5877; Decarolis B, 2013, J CLIN ONCOL, V31, P944, DOI 10.1200/JCO.2012.45.8794; Di Giannatale A, 2014, EUR J CANCER, V50, P170, DOI 10.1016/j.ejca.2013.08.012; DuBois SG, 2015, BRIT J CANCER, V112, P644, DOI 10.1038/bjc.2015.12; DuBois SG, 2016, J CLIN ONCOL, V34, P1368, DOI 10.1200/JCO.2015.65.4889; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gains JE, 2011, J NUCL MED, V52, P1041, DOI 10.2967/jnumed.110.085100; Irwin MS, 2015, PEDIATR CLIN N AM, V62, P225, DOI 10.1016/j.pcl.2014.09.015; Kiratli PÖ, 2016, SEMIN NUCL MED, V46, P308, DOI 10.1053/j.semnuclmed.2016.01.004; Kreissman SG, 2013, LANCET ONCOL, V14, P999, DOI 10.1016/S1470-2045(13)70309-7; Kushner BH, 2003, J CLIN ONCOL, V21, P1082, DOI 10.1200/JCO.2003.07.142; Kushner BH, 2009, J CLIN ONCOL, V27, P1041, DOI 10.1200/JCO.2008.17.6107; Ladenstein R, 2010, J CLIN ONCOL, V28, P3516, DOI 10.1200/JCO.2009.27.3524; London WB, 2011, J CLIN ONCOL, V29, P3286, DOI 10.1200/JCO.2010.34.3392; Marachelian A, 2012, PEDIATR BLOOD CANCER, V58, P675, DOI 10.1002/pbc.23250; Matthay KK, 2010, BRIT J CANCER, V102, P1319, DOI 10.1038/sj.bjc.6605621; Matthay KK, 2009, J CLIN ONCOL, V27, P1020, DOI 10.1200/JCO.2007.15.7628; MATTHAY KK, 1993, J CLIN ONCOL, V11, P2226, DOI 10.1200/JCO.1993.11.11.2226; Matthay KK, 2003, J CLIN ONCOL, V21, P2486, DOI 10.1200/JCO.2003.09.122; Maurer BJ, 2013, PEDIATR BLOOD CANCER, V60, P1801, DOI 10.1002/pbc.24643; Méhes G, 2003, AM J PATHOL, V163, P393, DOI 10.1016/S0002-9440(10)63669-3; Melzer HI, 2011, EUR J NUCL MED MOL I, V38, P1648, DOI 10.1007/s00259-011-1843-8; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; Papathanasiou ND, 2011, J NUCL MED, V52, P519, DOI 10.2967/jnumed.110.083303; Pearson ADJ, 2008, LANCET ONCOL, V9, P247, DOI 10.1016/S1470-2045(08)70069-X; Piccardo A, 2012, EUR J NUCL MED MOL I, V39, P57, DOI 10.1007/s00259-011-1938-2; Pinto NR, 2015, J CLIN ONCOL, V33, P3008, DOI 10.1200/JCO.2014.59.4648; Schmidt M, 2008, EUR J CANCER, V44, P1552, DOI 10.1016/j.ejca.2008.03.013; Schwartz LH, 2009, EUR J CANCER, V45, P261, DOI 10.1016/j.ejca.2008.10.028; Sharp SE, 2009, J NUCL MED, V50, P1237, DOI 10.2967/jnumed.108.060467; Shulkin BL, 1998, J NUCL MED, V39, P679; Shusterman S, 2010, J CLIN ONCOL, V28, P4969, DOI 10.1200/JCO.2009.27.8861; Simon T, 2008, PEDIATR BLOOD CANCER, V50, P965, DOI 10.1002/pbc.21343; Simon T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-21; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Sisson JC, 1999, Q J NUCL MED, V43, P217; Strother DR, 2012, J CLIN ONCOL, V30, P1842, DOI 10.1200/JCO.2011.37.9990; Stutterheim J, 2012, CLIN CANCER RES, V18, P808, DOI 10.1158/1078-0432.CCR-11-0849; Suc A, 1996, CANCER, V77, P805, DOI 10.1002/(SICI)1097-0142(19960215)77:4<805::AID-CNCR29>3.0.CO;2-3; SUNDELL IB, 1989, ANN NUTR METAB, V33, P333, DOI 10.1159/000177555; Taggart DR, 2009, J CLIN ONCOL, V27, P5343, DOI 10.1200/JCO.2008.20.5732; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; van Wezel EM, 2015, PEDIATR BLOOD CANCER, V62, P1368, DOI 10.1002/pbc.25507; Villablanca JG, 2016, PEDIATR BLOOD CANCER, V63, P1349, DOI 10.1002/pbc.25994; Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995; Viprey VF, 2014, J CLIN ONCOL, V32, P1074, DOI 10.1200/JCO.2013.53.3604; WEETMAN RM, 1976, J PEDIATR-US, V88, P46, DOI 10.1016/S0022-3476(76)80725-1; Yanik GA, 2015, BIOL BLOOD MARROW TR, V21, P673, DOI 10.1016/j.bbmt.2014.12.008; Yanik GA, 2013, J NUCL MED, V54, P541, DOI 10.2967/jnumed.112.112334	69	214	232	0	14	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	AUG 1	2017	35	22					2580	+		10.1200/JCO.2016.72.0177	http://dx.doi.org/10.1200/JCO.2016.72.0177			13	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	FB9QL	28471719	Green Published			2024-09-18	WOS:000406473900020
J	Izetta, J; Verdes, PF; Granitto, PM				Izetta, Javier; Verdes, Pablo F.; Granitto, Pablo M.			Improved multiclass feature selection via list combination	EXPERT SYSTEMS WITH APPLICATIONS			English	Article						Feature selection; Multiclass problems; Support vector machine	SAMPLE-FEATURE MACHINE; CLASS DISCOVERY; GENE SELECTION; CANCER; CLASSIFICATION; PREDICTION; PROFILE; MS	Feature selection is a crucial machine learning technique aimed at reducing the dimensionality of the input space. By discarding useless or redundant variables, not only it improves model performance but also facilitates its interpretability. The well-known Support Vector Machines-Recursive Feature Elimination (SVM-RFE) algorithm provides good performance with moderate computational efforts, in particular for wide datasets. When using SVM-RFE on a multiclass classification problem, the usual strategy is to decompose it into a series of binary ones, and to generate an importance statistics for each feature on each binary problem. These importances are then averaged over the set of binary problems to synthesize a single value for feature ranking. In some cases, however, this procedure can lead to poor selection. In this paper we discuss six new strategies, based on list combination, designed to yield improved selections starting from the importances given by the binary problems. We evaluate them on artificial and real-world datasets, using both One-Vs-One (OVO) and One-Vs-All (OVA) strategies. Our results suggest that the OVO decomposition is most effective for feature selection on multiclass problems. We also find that in most situations the new K-First strategy can find better subsets of features than the traditional weight average approach. (C) 2017 Elsevier Ltd. All rights reserved.	[Izetta, Javier; Verdes, Pablo F.; Granitto, Pablo M.] UNR CONICET, French Argentine Int Ctr Informat & Syst Sci, CIFASIS, Bv 27 Febrero 210 Bis, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Granitto, PM (corresponding author), UNR CONICET, French Argentine Int Ctr Informat & Syst Sci, CIFASIS, Bv 27 Febrero 210 Bis, RA-2000 Rosario, Santa Fe, Argentina.	izetta@cifasis-conicet.gov.ar; verdes@cifasis-conicet.gov.ar; granitto@cifasis-conicet.gov.ar	Granitto, Pablo/A-3645-2013	Granitto, Pablo/0000-0002-2473-8769				Allwein E. L., 2001, Journal of Machine Learning Research, V1, P113, DOI 10.1162/15324430152733133; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cappellin L, 2012, METABOLOMICS, V8, P761, DOI 10.1007/s11306-012-0405-9; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; Dittman D. J., 2013, FLAIRS C; Duan KB, 2007, LECT NOTES COMPUT SC, V4447, P47; Fabris A, 2010, J MASS SPECTROM, V45, P1065, DOI 10.1002/jms.1797; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Granitto PM, 2006, CHEMOMETR INTELL LAB, V83, P83, DOI 10.1016/j.chemolab.2006.01.007; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; HO TK, 1994, IEEE T PATTERN ANAL, V16, P66, DOI 10.1109/34.273716; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hua JP, 2009, PATTERN RECOGN, V42, P409, DOI 10.1016/j.patcog.2008.08.001; Jurman G, 2008, BIOINFORMATICS, V24, P258, DOI 10.1093/bioinformatics/btm550; Kanth N.R., 2015, 2015 IEEE INT C COMP, P1, DOI DOI 10.1109/ICCIC.2015.7435793; KIRA K, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P129; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lichman M, 2013, UCI MACHINE LEARNING; Liu H, 2005, IEEE INTELL SYST, V20, P64, DOI 10.1109/MIS.2005.105; Mohsenzadeh Y, 2016, PATTERN RECOGN, V60, P835, DOI 10.1016/j.patcog.2016.06.028; Mohsenzadeh Y, 2013, IEEE T CYBERNETICS, V43, P2241, DOI 10.1109/TCYB.2013.2260736; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Neumayer R, 2011, LECT NOTES COMPUT SC, V6611, P763, DOI 10.1007/978-3-642-20161-5_89; Nguyen MH, 2010, PATTERN RECOGN, V43, P584, DOI 10.1016/j.patcog.2009.09.003; Nuray R, 2006, INFORM PROCESS MANAG, V42, P595, DOI 10.1016/j.ipm.2005.03.023; Raies AB, 2016, WIRES COMPUT MOL SCI, V6, P147, DOI 10.1002/wcms.1240; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Saari D.G., 2001, Chaotic Elections! A Mathematician Looks at Voting; del Pulgar JS, 2013, MEAT SCI, V93, P420, DOI 10.1016/j.meatsci.2012.10.003; Schulze M, 2011, SOC CHOICE WELFARE, V36, P267, DOI 10.1007/s00355-010-0475-4; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Uysal AK, 2016, EXPERT SYST APPL, V43, P82, DOI 10.1016/j.eswa.2015.08.050; Vapnik V., 1999, NATURE STAT LEARNING; Weston J., 1999, 7th European Symposium on Artificial Neural Networks. ESANN'99. Proceedings, P219; Weston J., 2000, P 13 INT C NEUR INF, P647; You WJ, 2014, EXPERT SYST APPL, V41, P1463, DOI 10.1016/j.eswa.2013.08.043; YOUNG HP, 1988, AM POLIT SCI REV, V82, P1231, DOI 10.2307/1961757; Zhou NN, 2016, SMART INNOV SYST TEC, V54, P303, DOI 10.1007/978-3-319-33747-0_30; Zhou WG, 2014, COMPUT BIOL MED, V47, P66, DOI 10.1016/j.compbiomed.2014.01.014; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	44	8	8	0	35	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0957-4174	1873-6793		EXPERT SYST APPL	Expert Syst. Appl.	DEC 1	2017	88						205	216		10.1016/j.eswa.2017.06.043	http://dx.doi.org/10.1016/j.eswa.2017.06.043			12	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Operations Research & Management Science	FF3IS		Green Published			2024-09-18	WOS:000408789300015
J	Li, XY; Xiang, J; Wu, FX; Li, M				Li, Xingyi; Xiang, Ju; Wu, Fang-Xiang; Li, Min			A Dual Ranking Algorithm Based on the Multiplex Network for Heterogeneous Complex Disease Analysis	IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS			English	Article						Diseases; Biomarkers; Prognostics and health management; Multiplexing; Gene expression; Proteins; Biology; Heterogeneous complex diseases; biomarker; network propagation; multiplex network; dual ranking	MOLECULAR INTERACTION DATABASE; PROTEOME-SCALE MAP; GENE-EXPRESSION; ENVIRONMENTAL-FACTORS; CANCER; INTERACTOME; BIOMARKER; SIGNATURES; RESOURCE	Identifying biomarkers of heterogeneous complex diseases has always been one of the focuses in medical research. In previous studies, the powerful network propagation methods have been applied to finding marker genes related to specific diseases, but existing methods are mostly based on a single network, which may be greatly affected by the incompleteness of the network and the ignorance of a large amount of information about physical and functional interactions between biological components. Other methods that directly integrate multiple types of interactions into an aggregate network have the risks that different types of data may conflict with each other and the characteristics and topologies of each individual network are lost. Meanwhile, biomarkers used in clinical trials should have the characteristics of small quantity and strong discriminate ability. In this study, we developed a multiplex network-based dual ranking framework (DualRank) for heterogeneous complex disease analysis. We applied the proposed method to heterogeneous complex diseases for diagnosis, prognosis, and classification. The results showed that DualRank outperformed competing methods and could identify biomarkers with the small quantity, great prediction performance (average AUC = 0.818) and biological interpretability.	[Li, Xingyi; Xiang, Ju; Li, Min] Cent South Univ, Sch Comp Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Li, Xingyi; Xiang, Ju; Li, Min] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53726 USA; [Xiang, Ju] Changsha Med Univ, Neurosci Res Ctr, Changsha 410219, Hunan, Peoples R China; [Xiang, Ju] Changsha Med Univ, Dept Basic Med Sci, Changsha 410219, Hunan, Peoples R China; [Wu, Fang-Xiang] Univ Saskatchewan, Div Biomed Engn, Saskatoon, SK S7N 5A9, Canada; [Wu, Fang-Xiang] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada	Central South University; University of Wisconsin System; University of Wisconsin Madison; Changsha Medical University; Changsha Medical University; University of Saskatchewan; University of Saskatchewan	Li, M (corresponding author), Cent South Univ, Sch Comp Sci & Engn, Changsha 410083, Hunan, Peoples R China.	xingyili@csu.edu.cn; xiangju@csu.edu.cn; faw341@mail.usask.ca; limin@mail.csu.edu.cn	Li, XingYi/R-3466-2016; Li, Min/U-3131-2018; Xiang, Ju/Q-2118-2016	Li, Min/0000-0002-0188-1394; Wu, Fang-Xiang/0000-0002-4593-9332; Xiang, Ju/0000-0002-3045-5706	National Key Research and Development Project of China [2019YFA0706202]; Hunan Provincial Science and Technology Program [2019CB1007]; Degree & Postgraduate Education Reform Project of Hunan Province [2019JGYB051]; Training Program for Excellent Young Innovators of Changsha [kq2009093]; Hunan Provincial Innovation Foundation For Postgraduate [CX20190123]	National Key Research and Development Project of China(National Key Research & Development Program of China); Hunan Provincial Science and Technology Program; Degree & Postgraduate Education Reform Project of Hunan Province; Training Program for Excellent Young Innovators of Changsha; Hunan Provincial Innovation Foundation For Postgraduate	This work was supported in part by the National Key Research and Development Project of China under Grant 2019YFA0706202, the Hunan Provincial Science and Technology Program (No. 2019CB1007), the Degree & Postgraduate Education Reform Project of Hunan Province (No. 2019JGYB051), the Training Program for Excellent Young Innovators of Changsha (No. kq2009093), and the Hunan Provincial Innovation Foundation For Postgraduate (No. CX20190123). Parts of this paper appeared at the 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM2019) [60].	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; [Anonymous], 2004, FINITE MIXTURE MODEL; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Borrebaeck CAK, 2017, NAT REV CANCER, V17, P199, DOI 10.1038/nrc.2016.153; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Chen X, 2019, TSINGHUA SCI TECHNOL, V24, P446, DOI 10.26599/TST.2018.9010097; Choi J, 2017, BIOINFORMATICS, V33, P3619, DOI 10.1093/bioinformatics/btx487; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrenberger T, 2015, METHODS MOL BIOL, V1278, P57, DOI 10.1007/978-1-4939-2425-7_4; Gómez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Huang J, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2016.00084, 10.3389/fgene.2017.00084]; Kaizer EC, 2007, J CLIN ENDOCR METAB, V92, P3705, DOI 10.1210/jc.2007-0979; Kaprio J, 2002, TWIN RES, V5, P358, DOI 10.1375/twin.5.5.358; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Köhler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lesterhuis WJ, 2017, NAT REV DRUG DISCOV, V16, P264, DOI 10.1038/nrd.2016.233; Leung A, 2014, BIOINFORMATICS, V30, P2230, DOI 10.1093/bioinformatics/btu172; Levy H, 2012, GENES IMMUN, V13, P593, DOI 10.1038/gene.2012.41; Li M, 2019, IEEE ACM T COMPUT BI, V16, P417, DOI 10.1109/TCBB.2017.2705143; Li M, 2020, IEEE ACM T COMPUT BI, V17, P817, DOI 10.1109/TCBB.2017.2749571; Li XY, 2021, IEEE ACM T COMPUT BI, V18, P2483, DOI 10.1109/TCBB.2020.2973148; Li XY, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01401; Li XY, 2019, IEEE INT C BIOINFORM, P812, DOI 10.1109/BIBM47256.2019.8983050; Li XY, 2020, BRIEF BIOINFORM, V21, P566, DOI 10.1093/bib/bbz017; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lim S, 2020, BRIEF BIOINFORM, V21, P36, DOI 10.1093/bib/bby097; Liu R, 2014, MED RES REV, V34, P455, DOI 10.1002/med.21293; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Montero-Meléndez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076235; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Page L., 1999, PAGERANK CITATION RA; Piñero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ringnér M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun DC, 2019, BRIEF BIOINFORM, V20, P89, DOI 10.1093/bib/bbx090; Valdeolivas A, 2019, BIOINFORMATICS, V35, P497, DOI 10.1093/bioinformatics/bty637; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Volanisa D, 2010, TOXICOL LETT, V193, P131, DOI 10.1016/j.toxlet.2009.12.018; Winter C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002511; Yang BW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03024-2; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zheng RQ, 2021, IEEE ACM T COMPUT BI, V18, P347, DOI 10.1109/TCBB.2019.2900614; Zou M, 2015, BIOINFORMATICS, V31, P3330, DOI 10.1093/bioinformatics/btv374	60	4	4	1	7	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1545-5963	1557-9964		IEEE ACM T COMPUT BI	IEEE-ACM Trans. Comput. Biol. Bioinform.	JUL-AUG	2022	19	4					1993	2002		10.1109/TCBB.2021.3059046	http://dx.doi.org/10.1109/TCBB.2021.3059046			10	Biochemical Research Methods; Computer Science, Interdisciplinary Applications; Mathematics, Interdisciplinary Applications; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Computer Science; Mathematics	3T9GF	33577455				2024-09-18	WOS:000840575900008
J	Badre, A; Pan, CL				Badre, Adrien; Pan, Chongle			LINA: A Linearizing Neural Network Architecture for Accurate First-Order and Second-Order Interpretations	IEEE ACCESS			English	Article						Predictive models; Neural networks; Computational modeling; Bioinformatics; Genomics; Prediction algorithms; Machine learning algorithms; Interpretable machine learning; predictive genomics; bioinformatics; deep neural networks	BREAST-CANCER; EPISTASIS; ASSOCIATION	While neural networks can provide high predictive performance, it was a challenge to identify the salient features and important feature interactions used for their predictions. This represented a key hurdle for deploying neural networks in many biomedical applications that require interpretability, including predictive genomics. In this paper, linearizing neural network architecture (LINA) was developed here to provide both the first-order and the second-order interpretations on both the instance-wise and the model-wise levels. LINA combines the representational capacity of a deep inner attention neural network with a linearized intermediate representation for model interpretation. In comparison with DeepLIFT, LIME, Grad*Input and L2X, the first-order interpretation of LINA had better Spearman correlation with the ground-truth importance rankings of features in synthetic datasets. In comparison with NID and GEH, the second-order interpretation results from LINA achieved better precision for identification of the ground-truth feature interactions in synthetic datasets. These algorithms were further benchmarked using predictive genomics as a real-world application. LINA identified larger numbers of important single nucleotide polymorphisms (SNPs) and salient SNP interactions than the other algorithms at given false discovery rates. The results showed accurate and versatile model interpretation using LINA.	[Badre, Adrien; Pan, Chongle] Univ Oklahoma, Sch Comp Sci, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Pan, CL (corresponding author), Univ Oklahoma, Sch Comp Sci, Norman, OK 73019 USA.	cpan@ou.edu			National Center for Complementary & Integrative Health; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [R01AT011618]; University of Oklahoma	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Oklahoma	This work was supported in part by the National Center for Complementary & Integrative Health, in part by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) under Award R01AT011618, in part by the Startup Fund to Chongle Pan in The University of Oklahoma.	Amos CI, 2017, CANCER EPIDEM BIOMAR, V26, P126, DOI 10.1158/1055-9965.EPI-16-0106; Badré A, 2021, J HUM GENET, V66, P359, DOI 10.1038/s10038-020-00832-7; Baltres A, 2020, BREAST CANCER-TOKYO, V27, P1007, DOI 10.1007/s12282-020-01100-4; Bermeitinger B, 2019, KDIR: PROCEEDINGS OF THE 11TH INTERNATIONAL JOINT CONFERENCE ON KNOWLEDGE DISCOVERY, KNOWLEDGE ENGINEERING AND KNOWLEDGE MANAGEMENT - VOL 1: KDIR, P532, DOI 10.5220/0008364305320538; Cardoso SR, 2022, BRIT J CANCER, V126, P981, DOI 10.1038/s41416-021-01612-6; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Chen Jianbo, 2018, P MACHINE LEARNING R, V80; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cui TY, 2020, FRONT ARTIF INTEL AP, V325, P1087, DOI 10.3233/FAIA200205; Dandl Susanne, 2020, Parallel Problem Solving from Nature - PPSN XVI. 16th International Conference, PPSN 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12269), P448, DOI 10.1007/978-3-030-58112-1_31; Do DT, 2020, GENOMICS, V112, P2445, DOI 10.1016/j.ygeno.2020.01.017; Fergus P, 2020, IEEE ACM T COMPUT BI, V17, P668, DOI 10.1109/TCBB.2018.2868667; Gao M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020154; Gonçalves E, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20199405; Lam LHT, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9100325; Lundberg SM, 2017, ADV NEUR IN, V30; Molnar C., 2019, INTERPRETABLE MACHIN; Pace RK, 1997, STAT PROBABIL LETT, V33, P291, DOI 10.1016/s0167-7152(96)00140-x; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Rivandi M, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00280; Shaker OG, 2019, CLIN BREAST CANCER, V19, pE220, DOI 10.1016/j.clbc.2018.09.004; Shrikumar A, 2017, PR MACH LEARN RES, V70; Sorokina D, 2007, LECT NOTES ARTIF INT, V4701, P323; Tsang M, 2018, P INT C LEARN REPR I; van de Haar J, 2019, CELL, V177, P1375, DOI 10.1016/j.cell.2019.05.005; Velasco-Ruiz A, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13111942; Wang LW, 2018, CLIN PHARMACOL THER, V103, P243, DOI 10.1002/cpt.915; Wu LN, 2016, ONCOTARGET, V7, P5042, DOI 10.18632/oncotarget.5837; Zhao XY, 2021, CANCER RES, V81, P6090, DOI 10.1158/0008-5472.CAN-21-2555	31	4	4	1	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2022	10						36166	36176		10.1109/ACCESS.2022.3163257	http://dx.doi.org/10.1109/ACCESS.2022.3163257			11	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	0O4TZ	35462722	Green Accepted, gold			2024-09-18	WOS:000783521600001
J	Schenk, A; Berger, M; Schmid, M				Schenk, Alina; Berger, Moritz; Schmid, Matthias			Pseudo-value regression trees	LIFETIME DATA ANALYSIS			English	Article						Gradient boosting; Interactions; Model trees; Pseudo-values; Survival probabilities	INTERNATIONAL EXPERT CONSENSUS; COMPETING RISKS; PRIMARY THERAPY; MODELS; PREDICTION	This paper presents a semi-parametric modeling technique for estimating the survival function from a set of right-censored time-to-event data. Our method, named pseudo-value regression trees (PRT), is based on the pseudo-value regression framework, modeling individual-specific survival probabilities by computing pseudo-values and relating them to a set of covariates. The standard approach to pseudo-value regression is to fit a main-effects model using generalized estimating equations (GEE). PRT extend this approach by building a multivariate regression tree with pseudo-value outcome and by successively fitting a set of regularized additive models to the data in the nodes of the tree. Due to the combination of tree learning and additive modeling, PRT are able to perform variable selection and to identify relevant interactions between the covariates, thereby addressing several limitations of the standard GEE approach. In addition, PRT include time-dependent effects in the node-wise models. Interpretability of the PRT fits is ensured by controlling the tree depth. Based on the results of two simulation studies, we investigate the properties of the PRT method and compare it to several alternative modeling techniques. Furthermore, we illustrate PRT by analyzing survival in 3,652 patients enrolled for a randomized study on primary invasive breast cancer.	[Schenk, Alina; Berger, Moritz; Schmid, Matthias] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Med Fac, Bonn, Germany	University of Bonn	Schenk, A (corresponding author), Univ Bonn, Inst Med Biometry Informat & Epidemiol, Med Fac, Bonn, Germany.	schenk@imbie.uni-bonn.de	Schenk, Alina/JTU-4161-2023	Schenk, Alina/0000-0003-1998-2625; Schmid, Matthias/0000-0002-0788-0317	Projekt DEAL	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Andersen PK, 2010, STAT METHODS MED RES, V19, P71, DOI 10.1177/0962280209105020; Andersen PK, 2003, BIOMETRIKA, V90, P15, DOI 10.1093/biomet/90.1.15; Bacchetti P, 1995, Lifetime Data Anal, V1, P35, DOI 10.1007/BF00985256; Binder N, 2014, LIFETIME DATA ANAL, V20, P303, DOI 10.1007/s10985-013-9247-7; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bühlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Bühlmann P, 2003, J AM STAT ASSOC, V98, P324, DOI 10.1198/016214503000125; Chen HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165409; CIAMPI A, 1995, J CLIN EPIDEMIOL, V48, P675, DOI 10.1016/0895-4356(94)00164-L; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; COX DR, 1972, J R STAT SOC B, V34, P187; de Gregorio A, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01348-w; Demirtas H., 2004, Journal of Modern Applied Statistical Methods, V3, P485, DOI DOI 10.22237/jmasm/1099268340; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Garcia TP, 2019, BIOSTATISTICS, V20, P129, DOI 10.1093/biostatistics/kxx065; Gerds TA, 2013, STAT MED, V32, P2173, DOI 10.1002/sim.5681; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Grand MK, 2019, BIOMETRICAL J, V61, P290, DOI 10.1002/bimj.201700274; Graw F, 2009, LIFETIME DATA ANAL, V15, P241, DOI 10.1007/s10985-008-9107-z; Greenwell B., 2022, TREE BASED METHODS S; Gron R, 2014, CH CRC HANDB MOD STA, P221; Hofner B, 2014, COMPUTATION STAT, V29, P3, DOI 10.1007/s00180-012-0382-5; Hofner B, 2011, ECOLOGY, V92, P1895, DOI 10.1890/10-2276.1; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2019, BIOSTATISTICS, V20, P546, DOI 10.1093/biostatistics/kxy079; Hothorn T, 2018, SCAND J STAT, V45, P110, DOI 10.1111/sjos.12291; Hothorn T, 2014, J ROY STAT SOC B, V76, P3, DOI 10.1111/rssb.12017; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Jia BL, 2022, LIFETIME DATA ANAL, V28, P356, DOI 10.1007/s10985-022-09552-w; Kalbfleisch J, 2002, STAT ANAL FAILURE TI; Klein JP, 2005, BIOMETRICS, V61, P223, DOI 10.1111/j.0006-341X.2005.031209.x; Kvamme H, 2023, J MACH LEARN RES, V24; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; LEBLANC M, 1992, BIOMETRICS, V48, P411, DOI 10.2307/2532300; Lee C, 2018, AAAI CONF ARTIF INTE, P2314; Loh WY, 2019, STAT MED, V38, P545, DOI 10.1002/sim.7677; Lu B, 2007, BIOMETRICS, V63, P935, DOI 10.1111/j.1541-0420.2007.00764.x; Mogensen UB, 2013, STAT MED, V32, P3102, DOI 10.1002/sim.5775; Molinaro AM, 2004, J MULTIVARIATE ANAL, V90, P154, DOI 10.1016/j.jmva.2004.02.003; Overgaard M, 2017, ANN STAT, V45, P1988, DOI 10.1214/16-AOS1516; Pournelle G. H., 1953, Journal of Mammalogy, V34, P133, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Puth MT, 2020, LIFETIME DATA ANAL, V26, P545, DOI 10.1007/s10985-019-09489-7; Quinlan JR, 1992, P 5 AUSTR JOINT C AR, P343, DOI DOI 10.1142/9789814536271; Rahman MM, 2021, AAAI CONF ARTIF INTE, V35, P479; Scheike TH, 2008, BIOMETRIKA, V95, P205, DOI 10.1093/biomet/asm096; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Stensrud MJ, 2020, JAMA-J AM MED ASSOC, V323, P1401, DOI 10.1001/jama.2020.1267; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Van der Laan Mark J, 2003, SPR S STAT; van der Ploeg T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100234; Vatcheva K P, 2015, Epidemiology (Sunnyvale), V6; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Zeileis A, 2007, STAT NEERL, V61, P488, DOI 10.1111/j.1467-9574.2007.00371.x; Zelleis A, 2008, J COMPUT GRAPH STAT, V17, P492, DOI 10.1198/106186008X319331; Zhao LL, 2020, IEEE J BIOMED HEALTH, V24, P3308, DOI 10.1109/JBHI.2020.2980204; Zhao LL, 2020, STAT MED, V39, P3685, DOI 10.1002/sim.8687	57	0	0	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1380-7870	1572-9249		LIFETIME DATA ANAL	Lifetime Data Anal.	APR	2024	30	2					439	471		10.1007/s10985-024-09618-x	http://dx.doi.org/10.1007/s10985-024-09618-x		FEB 2024	33	Mathematics, Interdisciplinary Applications; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	LZ0I2	38403840	hybrid			2024-09-18	WOS:001170274000001
J	Chappel, JR; King, ME; Fleming, J; Eberlin, LS; Reif, DM; Baker, ES				Chappel, Jessie R.; King, Mary E.; Fleming, Jonathon; Eberlin, Livia S.; Reif, David M.; Baker, Erin S.			Aggregated Molecular Phenotype Scores: Enhancing Assessment and Visualization of Mass Spectrometry Imaging Data for Tissue-Based Diagnostics	ANALYTICAL CHEMISTRY			English	Article; Early Access							BREAST-CANCER; IDENTIFICATION; TECHNOLOGIES; REGRESSION; PROTEOMICS; MARGINS; PACKAGE; TOF	Mass spectrometry imaging (MSI) has gained increasingpopularityfor tissue-based diagnostics due to its ability to identify and visualizemolecular characteristics unique to different phenotypes within heterogeneoussamples. Data from MSI experiments are often assessed and visualizedusing various supervised and unsupervised statistical approaches.However, these approaches tend to fall short in identifying and conciselyvisualizing subtle, phenotype-relevant molecular changes. To addressthese shortcomings, we developed aggregated molecular phenotype (AMP)scores. AMP scores are generated using an ensemble machine learningapproach to first select features differentiating phenotypes, weightthe features using logistic regression, and combine the weights andfeature abundances. AMP scores are then scaled between 0 and 1, withlower values generally corresponding to class 1 phenotypes (typicallycontrol) and higher scores relating to class 2 phenotypes. AMP scores,therefore, allow the evaluation of multiple features simultaneouslyand showcase the degree to which these features correlate with variousphenotypes. Due to the ensembled approach, AMP scores are able toovercome limitations associated with individual models, leading tohigh diagnostic accuracy and interpretability. Here, AMP score performancewas evaluated using metabolomic data collected from desorption electrosprayionization MSI. Initial comparisons of cancerous human tissues totheir normal or benign counterparts illustrated that AMP scores distinguishedphenotypes with high accuracy, sensitivity, and specificity. Furthermore,when combined with spatial coordinates, AMP scores allow visualizationof tissue sections in one map with distinguished phenotypic borders,highlighting their diagnostic utility.	[Chappel, Jessie R.; Fleming, Jonathon] North Carolina State Univ, Bioinformat Res Ctr, Dept Biol Sci, Raleigh, NC 27606 USA; [King, Mary E.; Eberlin, Livia S.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Reif, David M.] NIEHS, Predict Toxicol Branch, Div Translat Toxicol, Durham, NC 27709 USA; [Baker, Erin S.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27514 USA	North Carolina State University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill	Eberlin, LS (corresponding author), Baylor Coll Med, Dept Surg, Houston, TX 77030 USA.; Reif, DM (corresponding author), NIEHS, Predict Toxicol Branch, Div Translat Toxicol, Durham, NC 27709 USA.; Baker, ES (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27514 USA.	eberlin@IDCm.edu; david.reif@nih.gov; erinmsb@unc.edu	Baker, Erin/AAS-4038-2021; Baker, Erin/K-3979-2017	Fleming, Jonathon/0000-0003-2447-3139; Reif, David/0000-0001-7815-6767; Baker, Erin/0000-0001-5246-2213; Chappel, Jessie/0009-0005-1492-118X	National Institute of Environmental Health Sciences [P42 ES027704, P42 ES031009]; National Institute of General Medical Sciences [R01 GM141277]; National Institute of Health National Cancer Institute [R33 CA229068]; Welch Foundation [Q-1895-20220331, STAR RD 84003201]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation)	This work was funded by grants from the National Institute of Environmental Health Sciences (P42 ES027704 and P42 ES031009), the National Institute of General Medical Sciences (R01 GM141277), the National Institute of Health National Cancer Institute (R33 CA229068), the Welch Foundation (Q-1895-20220331), and a cooperative agreement with the Environmental Protection Agency (STAR RD 84003201). The views expressed in this manuscript do not reflect those of the funding agencies. We also would like to thank Marta Sans, Kyana Y. Garza, and Rachel J. DeHoog for their hard work collecting the data analyzed in this manuscript.	Abdelmoula WM, 2016, P NATL ACAD SCI USA, V113, P12244, DOI 10.1073/pnas.1510227113; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Bemis KD, 2015, BIOINFORMATICS, V31, P2418, DOI 10.1093/bioinformatics/btv146; Berghmans E, 2020, J PERS MED, V10, DOI 10.3390/jpm10020054; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cao X, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-12199-0; DeHoog RJ, 2019, P NATL ACAD SCI USA, V116, P21401, DOI 10.1073/pnas.1911333116; Deininger SÖ, 2008, J PROTEOME RES, V7, P5230, DOI 10.1021/pr8005777; Dill AL, 2010, ANAL BIOANAL CHEM, V398, P2969, DOI 10.1007/s00216-010-4259-6; Eberlin LS, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002108; Eberlin LS, 2014, P NATL ACAD SCI USA, V111, P2436, DOI 10.1073/pnas.1400274111; Eberlin LS, 2012, CANCER RES, V72, P645, DOI 10.1158/0008-5472.CAN-11-2465; Eberlin LS, 2010, ANAL CHEM, V82, P3430, DOI 10.1021/ac9029482; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gu J, 2014, APPL IMMUNOHISTO M M, V22, P1, DOI 10.1097/PAI.0000000000000022; Guenther S, 2015, CANCER RES, V75, P1828, DOI 10.1158/0008-5472.CAN-14-2258; Ifa DR, 2016, CLIN CHEM, V62, P111, DOI 10.1373/clinchem.2014.237172; Igbokwe A, 2011, ARCH PATHOL LAB MED, V135, P67, DOI 10.1043/2010-0413-RAR.1; Inglese P, 2017, CHEM SCI, V8, P3500, DOI 10.1039/c6sc03738k; Lee AHS, 2007, J CLIN PATHOL, V60, P1333, DOI 10.1136/jcp.2006.046078; Lee JW, 2007, ADV CANCER RES, V96, P269, DOI 10.1016/S0065-230X(06)96010-2; Liaw A., 2002, R NEWS, V2, P18; Pagni F, 2016, PROTEOMICS, V16, P1775, DOI 10.1002/pmic.201500448; Paine MRL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154837; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pell R, 2019, J PATHOL CLIN RES, V5, P81, DOI 10.1002/cjp2.127; Pes B, 2020, NEURAL COMPUT APPL, V32, P5951, DOI 10.1007/s00521-019-04082-3; Porcari AM, 2018, ANAL CHEM, V90, P11324, DOI 10.1021/acs.analchem.8b01961; Prasad M, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-19365-4; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Sans M, 2017, CANCER RES, V77, P2903, DOI 10.1158/0008-5472.CAN-16-3044; Sarkari S., 2014, 2014 36 ANN INT C IE; Spraggins JM, 2016, PROTEOMICS, V16, P1678, DOI 10.1002/pmic.201600003; Thiele C, 2021, J STAT SOFTW, V98, DOI 10.18637/jss.v098.i11; Tian H, 2017, ANAL CHEM, V89, P4611, DOI 10.1021/acs.analchem.7b00164; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trede D, 2012, ANAL CHEM, V84, P6079, DOI 10.1021/ac300673y; Trindade GF, 2018, ANAL CHEM, V90, P3936, DOI 10.1021/acs.analchem.7b04877; Ucal Y, 2017, BBA-PROTEINS PROTEOM, V1865, P795, DOI 10.1016/j.bbapap.2017.01.005; Vaysse PM, 2017, ANALYST, V142, P2690, DOI 10.1039/c7an00565b; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Vijayalakshmi K, 2020, INT J CANCER, V147, P256, DOI 10.1002/ijc.32843; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Woolman M, 2021, ANAL CHEM, V93, P4408, DOI 10.1021/acs.analchem.0c04129; Wu CP, 2013, MASS SPECTROM REV, V32, P218, DOI 10.1002/mas.21360; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	49	3	3	1	15	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	2023 AUG 14	2023										10.1021/acs.analchem.3c02389	http://dx.doi.org/10.1021/acs.analchem.3c02389		AUG 2023	10	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	P0SV6	37579019	Green Accepted			2024-09-18	WOS:001047833700001
C	Sadaei, HJ; Loguercio, S; Neyestanak, MS; Torkamani, A; Prilutsky, D		Hunter, L; Altman, RB; Ritchie, MD; Murray, T; Klein, TE		Sadaei, Hossein Javedani; Loguercio, Salvatore; Neyestanak, Mahdi Shafiei; Torkamani, Ali; Prilutsky, Daria			Zoish: A Novel Feature Selection Approach Leveraging Shapley Additive Values for Machine Learning Applications in Healthcare	BIOCOMPUTING 2024, PSB 2024	Biocomputing-Pacific Symposium on Biocomputing		English	Proceedings Paper	29th Pacific Symposium on Biocomputing (PSB)	JAN 03-07, 2024	Kohala Coast, HI			Feature Selectors; Zoish; SHapley Additive exPlanations		In the intricate landscape of healthcare analytics, effective feature selection is a prerequisite for generating robust predictive models, especially given the common challenges of sample sizes and potential biases. Zoish uniquely addresses these issues by employing Shapley additive values-an idea rooted in cooperative game theory-to enable both transparent and automated feature selection. Unlike existing tools, Zoish is versatile, designed to seamlessly integrate with an array of machine learning libraries including scikit-learn, XGBoost, CatBoost, and imbalanced-learn. The distinct advantage of Zoish lies in its dual algorithmic approach for calculating Shapley values, allowing it to efficiently manage both large and small datasets. This adaptability renders it exceptionally suitable for a wide spectrum of healthcare-related tasks. The tool also places a strong emphasis on interpretability, providing comprehensive visualizations for analyzed features. Its customizable settings offer users fine-grained control over feature selection, thus optimizing for specific predictive objectives. This manuscript elucidates the mathematical framework underpinning Zoish and how it uniquely combines local and global feature selection into a single, streamlined process. To validate Zoish's efficiency and adaptability, we present case studies in breast cancer prediction and Montreal Cognitive Assessment (MoCA) prediction in Parkinson's disease, along with evaluations on 300 synthetic datasets. These applications underscore Zoish's unparalleled performance in diverse healthcare contexts and against its counterparts.	[Sadaei, Hossein Javedani; Loguercio, Salvatore; Neyestanak, Mahdi Shafiei; Torkamani, Ali] Scripps Res, Scripps Res Translat Inst, La Jolla, CA 92037 USA; [Sadaei, Hossein Javedani; Loguercio, Salvatore; Neyestanak, Mahdi Shafiei; Torkamani, Ali] Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Prilutsky, Daria] Amer Inc, Takeda Dev Ctr, Cambridge, MA 02139 USA	Scripps Research Institute; Scripps Research Institute; Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.	Sadaei, HJ (corresponding author), Scripps Res, Scripps Res Translat Inst, La Jolla, CA 92037 USA.; Sadaei, HJ (corresponding author), Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	hjavedani@scripps.edu; loguerci@scripps.edu; mshafiei@scripps.edu; atorkama@scripps.edu; daria.prilutsky@takeda.com			 [UL1RR025774];  [R01HG010881]	; 	This work is supported by UL1RR025774 and R01HG010881. Also We would like to express our gratitude to Dua, D. and Graff, C.<SUP>21</SUP> for generously providing us with the Breast Cancer Data used in this study. Without their contribution, this research would not have been possible.	Alickovic E, 2017, NEURAL COMPUT APPL, V28, P753, DOI 10.1007/s00521-015-2103-9; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Dua Dheeru, 2017, UCI machine learning repository, DOI DOI 10.1016/J.DSS.2009.05.016; Fryer D, 2021, IEEE ACCESS, V9, P144352, DOI 10.1109/ACCESS.2021.3119110; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Javedani Sadaei H., 2023, Zoish: Automated feature selectoion tools; Javedani Sadaei H., 2023, Lohrasb: A scalable estimator optimization tool compatible with scikit-learn APIs; Johnstone IM, 2009, Statistical challenges of high-dimensional data; Karczmarz A, 2021, Arxiv, DOI arXiv:2108.04126; Liaw R., 2020, arXiv; Liaw R, 2018, Arxiv, DOI arXiv:1807.05118; Lundberg S., 2023, SHAP (SHapley Additive exPlanations); Lundberg SM, 2017, ADV NEUR IN, V30; Michalak TP, 2013, J ARTIF INTELL RES, V46, P607, DOI 10.1613/jair.3806; Molnar C, 2020, COMM COM INF SC, V1323, P417, DOI 10.1007/978-3-030-65965-3_28; Muja M, 2014, IEEE T PATTERN ANAL, V36, P2227, DOI 10.1109/TPAMI.2014.2321376; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Saarela M, 2021, SN APPL SCI, V3, DOI 10.1007/s42452-021-04148-9; Sadaei HJ, 2022, NPJ PARKINSONS DIS, V8, DOI 10.1038/s41531-022-00412-w; Shapley L.S., 2016, Contribution to the Theory of Games, DOI 10.1515/9781400881970-018; Tang Jiliang, 2014, Data Classif. Algorithms Appl., V37, DOI DOI 10.1201/B17320; Varma S., 2012, XGBoost: A Scalable Tree Boosting System, V12, P48; Verdinelli I, 2023, Arxiv, DOI arXiv:2303.05981; WOLBERG WH, 1994, CANCER LETT, V77, P163, DOI 10.1016/0304-3835(94)90099-X; Yang JL, 2022, Arxiv, DOI arXiv:2109.09847	26	1	1	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE	2335-6936		978-981-12-8642-1	BIOCOMPUT-PAC SYM			2024							81	95						15	Computer Science, Artificial Intelligence; Engineering, Biomedical; Mathematical & Computational Biology	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science; Engineering; Mathematical & Computational Biology	BX2DV	38160271				2024-09-18	WOS:001258333100007
J	Fan, Y; Wang, YH; Wang, FZ; Huang, L; Yang, YN; Wong, KC; Li, XT				Fan, Yi; Wang, Yunhe; Wang, Fuzhou; Huang, Lei; Yang, Yuning; Wong, Ka-c.; Li, Xiangtao			Reliable Identification and Interpretation of Single-Cell Molecular Heterogeneity and Transcriptional Regulation using Dynamic Ensemble Pruning	ADVANCED SCIENCE			English	Article						dynamic ensemble pruning; optimization direction; single-cell RNA sequencing; unsupervised clustering	RNA-SEQ DATA; GENE-EXPRESSION; DIVERSITY; CANCER; STATES; ATLAS	Unsupervised clustering is an essential step in identifying cell types from single-cell RNA sequencing (scRNA-seq) data. However, a common issue with unsupervised clustering models is that the optimization direction of the objective function and the final generated clustering labels in the absence of supervised information may be inconsistent or even arbitrary. To address this challenge, a dynamic ensemble pruning framework (DEPF) is proposed to identify and interpret single-cell molecular heterogeneity. In particular, a silhouette coefficient-based indicator is developed to determine the optimization direction of the bi-objective function. In addition, a hierarchical autoencoder is employed to project the high-dimensional data onto multiple low-dimensional latent space sets, and then a clustering ensemble is produced in the latent space by the basic clustering algorithm. Following that, a bi-objective fruit fly optimization algorithm is designed to prune dynamically the low-quality basic clustering in the ensemble. Multiple experiments are conducted on 28 real scRNA-seq datasets and one large real scRNA-seq dataset from diverse platforms and species to validate the effectiveness of the DEPF. In addition, biological interpretability and transcriptional and post-transcriptional regulatory are conducted to explore biological patterns from the cell types identified, which could provide novel insights into characterizing the mechanisms.	[Fan, Yi; Li, Xiangtao] Jilin Univ, Sch Artificial Intelligence, Jilin, Peoples R China; [Wang, Yunhe] Hebei Univ Technol, Sch Artificial Intelligence, Tianjin, Peoples R China; [Yang, Yuning] City Univ Hong Kong, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China; [Wang, Fuzhou; Huang, Lei; Wong, Ka-c.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	Jilin University; Hebei University of Technology; City University of Hong Kong; University of Toronto	Li, XT (corresponding author), Jilin Univ, Sch Artificial Intelligence, Jilin, Peoples R China.	lixt314@jlu.edu.cn	Wang, Fuzhou/N-5170-2019; Li, Xiangtao/A-4804-2019; Wong, Ka-Chun/L-7160-2019	WANG, Fuzhou/0000-0002-9028-5382; Li, Xiangtao/0000-0002-8716-9823; Huang, Lei/0000-0003-2458-5149; yi, fan/0000-0001-8620-2735	National Natural Science Foundation of China [62076109, 62206086]; Fundamental Research Funds for the Central Universities [419080520657]; Jilin Province Outstanding Young Scientific and Technological Talents Project [20230508098RC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jilin Province Outstanding Young Scientific and Technological Talents Project	The work described in this paper was substantially supported by the National Natural Science Foundation of China under grant nos. 62076109, 62206086, and also funded by "the Fundamental Research Funds for the Central Universities (grant nos. 419080520657)". The work described in this paper was substantially supported by the grant from Jilin Province Outstanding Young Scientific and Technological Talents Project (grant nos. 20230508098RC).	[Anonymous], 2002, Journal of Machine Learning Research; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Burnett LC, 2017, J CLIN INVEST, V127, P293, DOI 10.1172/JCI88648; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Chen L, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa039; Cover T. M., 2006, Elements of Information Theory, V2nd; Cui SN, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105973; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eraslan G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07931-2; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Goolam M, 2016, CELL, V165, P61, DOI 10.1016/j.cell.2016.01.047; Guo MZ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004575; Haydont V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020368; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Huang D., 2018, IEEE Trans Syst Man Cybern Syst, V51, P508; Huang D, 2020, IEEE T KNOWL DATA EN, V32, P1212, DOI 10.1109/TKDE.2019.2903410; Huang D, 2018, IEEE T CYBERNETICS, V48, P1460, DOI 10.1109/TCYB.2017.2702343; Huang D, 2016, IEEE T KNOWL DATA EN, V28, P1312, DOI 10.1109/TKDE.2015.2503753; Huang HY, 2020, NUCLEIC ACIDS RES, V48, pD148, DOI 10.1093/nar/gkz896; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Huh R, 2020, NUCLEIC ACIDS RES, V48, P86, DOI 10.1093/nar/gkz959; [Anonymous], 2020, Nat Rev Dis Primers, V6, P93, DOI [10.1038/s41572-020-00224-3, 10.1038/s41572-020-00233-2]; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Karagiannis TT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16159-y; Kiselev VY, 2019, NAT REV GENET, V20, P273, DOI 10.1038/s41576-018-0088-9; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lancet JE, 2021, LANCET HAEMATOL, V8, pE481, DOI 10.1016/S2352-3026(21)00134-4; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI [DOI 10.1103/PHYSREVE.80.056117, 10.1103/PhysRevE.80.056117]; Lee HO, 2020, NAT GENET, V52, P594, DOI 10.1038/s41588-020-0636-z; Lin PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1188-0; Liu HF, 2017, BIOINFORMATICS, V33, P2691, DOI 10.1093/bioinformatics/btx167; Liu HF, 2017, IEEE T KNOWL DATA EN, V29, P1129, DOI 10.1109/TKDE.2017.2650229; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Luo ZX, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99003-7; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Miyashita N, 2020, AM J RESP CELL MOL, V63, P831, DOI 10.1165/rcmb.2019-0396OC; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Mudd TW, 2021, CELL IMMUNOL, V360, DOI 10.1016/j.cellimm.2020.104260; Mukhopadhyay A, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2742642; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Nguyen N, 2007, IEEE DATA MINING, P607, DOI 10.1109/ICDM.2007.73; Orozco LD, 2020, CELL REP, V30, P1246, DOI 10.1016/j.celrep.2019.12.082; Oshi M, 2022, NPJ BREAST CANCER, V8, DOI 10.1038/s41523-022-00466-2; Pan WT, 2012, KNOWL-BASED SYST, V26, P69, DOI 10.1016/j.knosys.2011.07.001; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Piñero J, 2021, COMPUT STRUCT BIOTEC, V19, P2960, DOI 10.1016/j.csbj.2021.05.015; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qiu P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14976-9; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Romanov RA, 2017, NAT NEUROSCI, V20, P176, DOI 10.1038/nn.4462; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Segerstolpe Å, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Syed V, 2016, J CELL BIOCHEM, V117, P1279, DOI 10.1002/jcb.25496; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI [10.1093/nar/gky1131, 10.1093/nar/gkac1000]; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tian T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22008-3; Titus AS, 2020, AM J PHYSIOL-HEART C, V318, pH1538, DOI 10.1152/ajpheart.00740.2019; Tran D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21312-2; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wan S, 2020, GENOME RES, V30, P205, DOI 10.1101/gr.254557.119; Wang B, 2017, NAT METHODS, V14, P414, DOI 10.1038/nmeth.4207; Wang YJ, 2016, DIABETES, V65, P3028, DOI 10.2337/db16-0405; Wawruszak A, 2021, CANCERS, V13, DOI 10.3390/cancers13184700; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wu JJ, 2015, IEEE T KNOWL DATA EN, V27, P155, DOI 10.1109/TKDE.2014.2316512; Xie JY, 2016, PR MACH LEARN RES, V48; Xin YR, 2016, CELL METAB, V24, P608, DOI 10.1016/j.cmet.2016.08.018; Xu YQ, 2022, CELL REP, V40, DOI 10.1016/j.celrep.2022.111295; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang YC, 2019, BIOINFORMATICS, V35, P1269, DOI 10.1093/bioinformatics/bty793; Yoo M, 2015, BIOINFORMATICS, V31, P3069, DOI 10.1093/bioinformatics/btv313; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng YAS, 2020, IEEE INT C BIOINFORM, P519, DOI 10.1109/BIBM49941.2020.9313569; Zhang SW, 2021, ADV CLIN EXP MED, V30, P263, DOI 10.17219/acem/131753; Zhang XX, 2019, NUCLEIC ACIDS RES, V47, pD721, DOI 10.1093/nar/gky900; Zhao J, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00550-9; Zheng XL, 2018, IEEE T SYST MAN CY-S, V48, P790, DOI 10.1109/TSMC.2016.2616347; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	90	1	1	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2198-3844		ADV SCI	Adv. Sci.	AUG	2023	10	22								10.1002/advs.202205442	http://dx.doi.org/10.1002/advs.202205442		JUN 2023	27	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	O0AC8	37290050	gold			2024-09-18	WOS:001003338300001
J	Zhou, SK; Greenspan, H; Davatzikos, C; Duncan, JS; Van Ginneken, B; Madabhushi, A; Prince, JL; Rueckert, D; Summers, RM				Zhou, S. Kevin; Greenspan, Hayit; Davatzikos, Christos; Duncan, James S.; Van Ginneken, Bram; Madabhushi, Anant; Prince, Jerry L.; Rueckert, Daniel; Summers, Ronald M.			A Review of Deep Learning in Medical Imaging: Imaging Traits, Technology Trends, Case Studies With Progress Highlights, and Future Promises	PROCEEDINGS OF THE IEEE			English	Review						Imaging; Medical diagnostic imaging; Image segmentation; Diseases; Task analysis; Medical services; Computed tomography; Deep learning (DL); medical imaging; survey	CONVOLUTIONAL NEURAL-NETWORK; PROSTATE-CANCER; RISK CATEGORIES; BRAIN AGE; SEGMENTATION; CNN; VALIDATION; EXTRACTION; DIAGNOSIS; BIOPSIES	Since its renaissance, deep learning (DL) has been widely used in various medical imaging tasks and has achieved remarkable success in many medical imaging applications, thereby propelling us into the so-called artificial intelligence (AI) era. It is known that the success of AI is mostly attributed to the availability of big data with annotations for a single task and the advances in high-performance computing. However, medical imaging presents unique challenges that confront DL approaches. In this survey article, we first present traits of medical imaging, highlight both clinical needs and technical challenges in medical imaging, and describe how emerging trends in DL are addressing these issues. We cover the topics of network architecture, sparse and noisy labels, federating learning, interpretability, uncertainty quantification, and so on. Then, we present several case studies that are commonly found in clinical practice, including digital pathology and chest, brain, cardiovascular, and abdominal imaging. Rather than presenting an exhaustive literature survey, we instead describe some prominent research highlights related to these case study applications. We conclude with a discussion and presentation of promising future directions.	[Zhou, S. Kevin] Univ Sci & Technol China, Sch Biomed Engn, Hefei 230052, Peoples R China; [Zhou, S. Kevin] Chinese Acad Sci, Inst Comp Technol, Beijing 100190, Peoples R China; [Greenspan, Hayit] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel; [Davatzikos, Christos] Univ Penn, Radiol Dept, Philadelphia, PA 19104 USA; [Davatzikos, Christos] Univ Penn, Elect & Syst Engn Dept, Philadelphia, PA 19104 USA; [Duncan, James S.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Duncan, James S.] Yale Univ, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA; [Van Ginneken, Bram] Radboud Univ Nijmegen Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Madabhushi, Anant] Louis Stokes Cleveland Vet Adm Med Ctr, Cleveland, OH 44106 USA; [Prince, Jerry L.] Johns Hopkins Univ, Elect & Comp Engn Dept, Baltimore, MD 21218 USA; [Rueckert, Daniel] Tech Univ Munich TU Munich, Klinikum Rechts Isar, D-81675 Munich, Germany; [Rueckert, Daniel] Imperial Coll London, Dept Comp, London SW7 2AZ, England; [Summers, Ronald M.] NIH, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Computing Technology, CAS; Tel Aviv University; University of Pennsylvania; University of Pennsylvania; Yale University; Yale University; Radboud University Nijmegen; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Louis Stokes Cleveland Veterans Affairs Medical Center; Johns Hopkins University; Technical University of Munich; Imperial College London; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Zhou, SK (corresponding author), Univ Sci & Technol China, Sch Biomed Engn, Hefei 230052, Peoples R China.	zhoushaohua@ict.ac.cn	Davatzikos, Christos/ABE-2057-2021; Summers, Ronald/AAX-6290-2021; Madabhushi, Anant/AAG-2908-2019; Prince, Jerry/A-3281-2010; Rueckert, Daniel/C-4393-2008; Razzak, Imran/AEW-5139-2022	Duncan, James/0000-0002-5167-9856; Madabhushi, Anant/0000-0002-5741-0399; Rueckert, Daniel/0000-0002-5683-5889; Razzak, Imran/0000-0002-3930-6600	National Institutes of Health [1U24CA199374-01, R01CA202752-01A1, R01CA208236-01A1, R01CA216579-01A1, R01CA220581-01A1, 1U01CA239055-01, 1U54CA254566-01, 1U01CA248226-01, 1R43EB028736-01]; VA Merit Review Award from the Biomedical Laboratory Research and Development Service of the United States Department of Veterans Affairs [IBX004121A]; Israeli Science Foundation (ISF); Ministry of Science Technology; National Institutes of Health Clinical Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Award from the Biomedical Laboratory Research and Development Service of the United States Department of Veterans Affairs(US Department of Veterans Affairs); Israeli Science Foundation (ISF)(Israel Science Foundation); Ministry of Science Technology; National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work of Anant Madabhushi was supported in part by the National Institutes of Health under Award 1U24CA199374-01, Award R01CA202752-01A1, Award R01CA208236-01A1, Award R01CA216579-01A1, Award R01CA220581-01A1, Award 1U01CA239055-01, Award 1U54CA254566-01, Award 1U01CA248226-01, and Award 1R43EB028736-01 and in part by the VA Merit Review Award IBX004121A from the Biomedical Laboratory Research and Development Service of the United States Department of Veterans Affairs. The work of Hayit Greenspan was supported in part by the Israeli Science Foundation (ISF) and in part by the Ministry of Science & Technology. The work of Ronald M. Summers was supported by the National Institutes of Health Clinical Center.	[Anonymous], 2013, MIT TECHNOLOGY REV 2; Ardila D, 2019, NAT MED, V25, P954, DOI 10.1038/s41591-019-0447-x; Armato SG, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.4.044501; Awate SP, 2019, MED IMAGE ANAL, V55, P181, DOI 10.1016/j.media.2019.04.014; BABAIAN RJ, 1985, UROLOGY, V25, P564, DOI 10.1016/0090-4295(85)90280-8; Bagdasaryan E, 2020, PR MACH LEARN RES, V108, P2938; Bai WJ, 2018, LECT NOTES COMPUT SC, V11073, P586, DOI 10.1007/978-3-030-00937-3_67; Bai WJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0471-x; Bakas S., 2018, Identifying the best machine learning algorithms for Brain Tumor Segmentation. Progression Assessment, and Overall Survival Prediction in the BRATS Challenge; Balakrishnan G, 2019, IEEE T MED IMAGING, V38, P1788, DOI 10.1109/TMI.2019.2897538; Bankman IN, 2009, HANDBOOK OF MEDICAL IMAGE PROCESSING AND ANALYSIS, 2ND EDITION, P1; Bar Y, 2015, I S BIOMED IMAGING, P294, DOI 10.1109/ISBI.2015.7163871; Bashyam VM, 2020, BRAIN, V143, P2312, DOI 10.1093/brain/awaa160; Baumgartner CF, 2019, LECT NOTES COMPUT SC, V11765, P119, DOI 10.1007/978-3-030-32245-8_14; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Bello GA, 2019, NAT MACH INTELL, V1, P95, DOI 10.1038/s42256-019-0019-2; Ben-Cohen A, 2019, IEEE ENG MED BIO, P886, DOI [10.1109/embc.2019.8857465, 10.1109/EMBC.2019.8857465]; Bera K, 2019, NAT REV CLIN ONCOL, V16, P703, DOI 10.1038/s41571-019-0252-y; Beutel J., 2000, HDB MED IMAGING IMAG, V2; Bhagwat N, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006376; Biffi C, 2018, LECT NOTES COMPUT SC, V11071, P464, DOI 10.1007/978-3-030-00934-2_52; Brown M, 2019, ACAD RADIOL, V26, P626, DOI 10.1016/j.acra.2018.07.006; Budovec JJ, 2014, RADIOGRAPHICS, V34, P254, DOI 10.1148/rg.341135036; Bulten W, 2020, LANCET ONCOL, V21, P233, DOI 10.1016/S1470-2045(19)30739-9; Bustin A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00017; Bustos A, 2020, MED IMAGE ANAL, V66, DOI 10.1016/j.media.2020.101797; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Carass A, 2018, NEUROIMAGE, V183, P150, DOI 10.1016/j.neuroimage.2018.08.003; Carreira J, 2017, PROC CVPR IEEE, P4724, DOI 10.1109/CVPR.2017.502; Chan R. K., MED PHYS, V47; Chartsias A, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101535; Chen H, 2018, NEUROIMAGE, V170, P446, DOI 10.1016/j.neuroimage.2017.04.041; Chen KT, 2019, RADIOLOGY, V290, P649, DOI 10.1148/radiol.2018180940; Chen Qin, 2018, Medical Image Computing and Computer Assisted Intervention - MICCAI 2018. 21st International Conference. Proceedings: Lecture Notes in Computer Science (LNCS 11071), P472, DOI 10.1007/978-3-030-00934-2_53; Chen Sihong, 2019, MED3D TRANSFER LEARN; Cheng PM, 2018, ABDOM RADIOL, V43, P1120, DOI 10.1007/s00261-017-1294-1; Cheng RD, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.2.024007; Cheplygina V, 2019, MED IMAGE ANAL, V54, P280, DOI 10.1016/j.media.2019.03.009; Chu LC, 2019, J AM COLL RADIOL, V16, P1338, DOI 10.1016/j.jacr.2019.05.034; Ciompi F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46479; Clough JR, 2019, LECT NOTES COMPUT SC, V11767, P656, DOI 10.1007/978-3-030-32251-9_72; Cole JH, 2017, NEUROIMAGE, V163, P115, DOI 10.1016/j.neuroimage.2017.07.059; Corredor G, 2019, CLIN CANCER RES, V25, P1526, DOI 10.1158/1078-0432.CCR-18-2013; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Courtiol P, 2019, NAT MED, V25, P1519, DOI 10.1038/s41591-019-0583-3; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; Cruz-Roa A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196828; de Marvao A, 2020, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00195; Dewey BE, 2019, MAGN RESON IMAGING, V64, P160, DOI 10.1016/j.mri.2019.05.041; Dolz J, 2018, NEUROIMAGE, V170, P456, DOI 10.1016/j.neuroimage.2017.04.039; Dong Yang, 2017, Medical Image Computing and Computer Assisted Intervention  MICCAI 2017. 20th International Conference. Proceedings: LNCS 10435, P507, DOI 10.1007/978-3-319-66179-7_58; Dou Q, 2018, PROCEEDINGS OF THE TWENTY-SEVENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P691; Dreizin D, 2020, J DIGIT IMAGING, V33, P243, DOI 10.1007/s10278-019-00207-1; Duncan JS, 2020, P IEEE, V108, P3, DOI 10.1109/JPROC.2019.2956422; Elsken T., 2018, The Journal of Machine Learning Research; Ferdian E, 2020, RADIOL-CARDIOTHORAC, V2, DOI 10.1148/ryct.2020190032; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frid-Adar M, 2018, NEUROCOMPUTING, V321, P321, DOI 10.1016/j.neucom.2018.09.013; Fu YB, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/ab843e; Gaillochet M., 2020, Lecture Notes in Computer Science, P44, DOI [DOI 10.1007/978-3-030-59713-9_5, 10.1007/978-3-030-59713-9_5]; GAL Y, 2016, INT C MACH LEARN, P1050, DOI DOI 10.5555/3045390.3045502; Gerard SE, 2019, I S BIOMED IMAGING, P1207, DOI [10.1109/ISBI.2019.8759212, 10.1109/isbi.2019.8759212]; Gerard SE, 2019, IEEE T MED IMAGING, V38, P156, DOI 10.1109/TMI.2018.2858202; Ghesu FC, 2019, LECT NOTES COMPUT SC, V11769, P676, DOI 10.1007/978-3-030-32226-7_75; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672; Gozes O., 2020, ARXIV PREPRINT ARXIV; Green- baum Nathaniel R, 2019, Mimic-cxr-jpg, a large publicly available database of labeled chest radiographs; Greenspan H, 2020, MED IMAGE ANAL, V66, DOI 10.1016/j.media.2020.101800; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Han Li, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12264), P417, DOI 10.1007/978-3-030-59719-1_41; Han S, 2020, NEUROIMAGE, V218, DOI 10.1016/j.neuroimage.2020.116819; Haskins G, 2020, MACH VISION APPL, V31, DOI 10.1007/s00138-020-01060-x; Havaei M, 2017, MED IMAGE ANAL, V35, P18, DOI 10.1016/j.media.2016.05.004; He S. Kevin, 2020, ARXIV201209501; Heindl A, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx137; Hesamian MH, 2019, J DIGIT IMAGING, V32, P582, DOI 10.1007/s10278-019-00227-x; Nguyen HV, 2015, LECT NOTES COMPUT SC, V9349, P677, DOI 10.1007/978-3-319-24553-9_83; Howard A, 2017, ARXIV, P1; Huang C, 2019, LECT NOTES COMPUT SC, V11765, P291, DOI 10.1007/978-3-030-32245-8_33; Huang G., 2017, ARXIV160806993V5, P4700, DOI [DOI 10.1109/CVPR.2017.243, 10.1109/CVPR.2017.243]; Huang Xiaojie, 2014, Med Image Anal, V18, P253, DOI 10.1016/j.media.2013.10.012; Humpire-Mamani GE, 2020, RADIOL-ARTIF INTELL, V2, DOI 10.1148/ryai.2020190102; Huo YK, 2019, NEUROIMAGE, V194, P105, DOI 10.1016/j.neuroimage.2019.03.041; Irvin Jeremy, 2019, Proceedings of the AAAI Conference on Artificial Intelligence, DOI 10.1609/aaai.v33i01.3301590; Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z; Isensee F, 2018, LECT NOTES COMPUT SC, V10663, P120, DOI 10.1007/978-3-319-75541-0_13; Islam Jyoti, 2018, Brain Inform, V5, P2, DOI 10.1186/s40708-018-0080-3; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Jing BY, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2577; Jingchun Cheng, 2017, 2017 IEEE International Conference on Computer Vision (ICCV), P686, DOI 10.1109/ICCV.2017.81; Jonsson BA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13163-9; Jungo A, 2019, LECT NOTES COMPUT SC, V11765, P48, DOI 10.1007/978-3-030-32245-8_6; Kamnitsas K, 2017, LECT NOTES COMPUT SC, V10265, P597, DOI 10.1007/978-3-319-59050-9_47; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kaplan S, 2019, J DIGIT IMAGING, V32, P773, DOI 10.1007/s10278-018-0150-3; Kather JN, 2019, NAT MED, V25, P1054, DOI 10.1038/s41591-019-0462-y; Kazemifar S, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aad100; Kazerooni AF, 2020, J MAGN RESON IMAGING, V52, P54, DOI 10.1002/jmri.26907; Ker J, 2018, IEEE ACCESS, V6, P9375, DOI 10.1109/ACCESS.2017.2788044; Kervadec H, 2019, MED IMAGE ANAL, V54, P88, DOI 10.1016/j.media.2019.02.009; Kleesiek J, 2016, NEUROIMAGE, V129, P460, DOI 10.1016/j.neuroimage.2016.01.024; Konecny J., 2016, ARXIV; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kuo CC, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0104-2; Lee CY, 2015, JMLR WORKSH CONF PRO, V38, P562; Li H., 2017, Visualizing the loss landscape of neural nets; Li WQ, 2019, LECT NOTES COMPUT SC, V11861, P133, DOI 10.1007/978-3-030-32692-0_16; Li XL, 2020, IEEE WIREL COMMUN, V27, P116, DOI 10.1109/MWC.001.2000076; Li XX, 2019, LECT NOTES COMPUT SC, V11768, P485, DOI 10.1007/978-3-030-32254-0_54; Li XX, 2018, LECT NOTES COMPUT SC, V11072, P206, DOI 10.1007/978-3-030-00931-1_24; Li ZJ, 2019, LECT NOTES COMPUT SC, V11769, P275, DOI 10.1007/978-3-030-32226-7_31; Liao HF, 2019, LECT NOTES COMPUT SC, V11769, P203, DOI 10.1007/978-3-030-32226-7_23; Lin WA, 2019, PROC CVPR IEEE, P10504, DOI 10.1109/CVPR.2019.01076; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu B, 2020, J CANCER RES CLIN, V146, P153, DOI 10.1007/s00432-019-03098-5; Liu D, 2010, PROC CVPR IEEE, P2831, DOI 10.1109/CVPR.2010.5540016; Liu JM, 2017, MED PHYS, V44, P4630, DOI 10.1002/mp.12399; Liu MX, 2018, MED IMAGE ANAL, V43, P157, DOI 10.1016/j.media.2017.10.005; Liu SQ, 2018, LECT NOTES COMPUT SC, V11071, P851, DOI 10.1007/978-3-030-00934-2_94; Liu SQ, 2014, I S BIOMED IMAGING, P1015, DOI 10.1109/ISBI.2014.6868045; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lu DC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22000-w; Lung-RADS Assessment Categories, 2019, LUNG CT SCREEN REP D; Madabhushi A, 2020, LANCET ONCOL, V21, P187, DOI 10.1016/S1470-2045(19)30793-4; Mateos-Pérez JM, 2018, NEUROIMAGE-CLIN, V20, P506, DOI 10.1016/j.nicl.2018.08.019; Miao S, 2016, IEEE T MED IMAGING, V35, P1352, DOI 10.1109/TMI.2016.2521800; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Moeskops Pim, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P478, DOI 10.1007/978-3-319-46723-8_55; Mou X., 2019, Machine Learning for Tomographic Imaging.; MURDOCH WJ, 2019, ARXIV190104592, V1, P147, DOI DOI 10.1073/PNAS.1900654116; Murphy K, 2020, RADIOLOGY, V296, pE166, DOI 10.1148/radiol.2020201874; Murphy K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62148-y; Nair T, 2020, MED IMAGE ANAL, V59, DOI 10.1016/j.media.2019.101557; Natterer F., COMPUTATIONAL RADIOL, V110; Nie D, 2018, LECT NOTES COMPUT SC, V11073, P370, DOI 10.1007/978-3-030-00937-3_43; Nielsen AN, 2020, BIOL PSYCHIAT-COGN N, V5, P791, DOI 10.1016/j.bpsc.2019.11.007; Oktay O., 2018, Medical Imaging with Deep Learning, DOI DOI 10.48550/ARXIV; Oktay O, 2018, IEEE T MED IMAGING, V37, P384, DOI 10.1109/TMI.2017.2743464; Onishi U., 2018, P ICMRM SCI M KSMRM; Parajuli N, 2019, MED IMAGE ANAL, V55, P116, DOI 10.1016/j.media.2019.04.007; Pereira S, 2018, MED IMAGE ANAL, V44, P228, DOI 10.1016/j.media.2017.12.009; Pham CH, 2017, I S BIOMED IMAGING, P197, DOI 10.1109/ISBI.2017.7950500; Pickhardt PJ, 2020, LANCET DIGIT HEALTH, V2, pE192, DOI 10.1016/S2589-7500(20)30025-X; Prince J. L., 2015, MED IMAGING SIGNALS; Prokop M, 2020, RADIOLOGY, V296, pE97, DOI 10.1148/radiol.2020201473; Qin C, 2019, LECT NOTES COMPUT SC, V11492, P249, DOI 10.1007/978-3-030-20351-1_19; Raghu M, 2019, ADV NEUR IN, V32; Rathore S, 2017, NEUROIMAGE, V155, P530, DOI 10.1016/j.neuroimage.2017.03.057; Recht MP, 2020, EUR RADIOL, V30, P3576, DOI 10.1007/s00330-020-06672-5; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Romo-Bucheli D, 2017, CYTOM PART A, V91A, P566, DOI 10.1002/cyto.a.23065; Romo-Bucheli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32706; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roth HR, 2018, COMPUT MED IMAG GRAP, V66, P90, DOI 10.1016/j.compmedimag.2018.03.001; Roth HR, 2016, IEEE T MED IMAGING, V35, P1170, DOI 10.1109/TMI.2015.2482920; Roth HR, 2015, CANC IMAG ARCH; Roth HR, 2019, MED, V47, P541; Rubin DL, 2011, RADIOGRAPHICS, V31, P1511, DOI 10.1148/rg.316105207; Rueckert D, 2020, P IEEE, V108, P110, DOI 10.1109/JPROC.2019.2943836; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Saillard C, 2020, J HEPATOL, V73, pS381; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Schlegl T, 2019, MED IMAGE ANAL, V54, P30, DOI 10.1016/j.media.2019.01.010; Sheller MJ, 2019, LECT NOTES COMPUT SC, V11383, P92, DOI 10.1007/978-3-030-11723-8_9; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI [10.1146/annurev-bioeng-071516044442, 10.1146/annurev-bioeng-071516-044442]; Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975; Shi Gonglei, 2020, ARXIV200703868; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Shin Seung Yeon, 2020, Med Image Comput Comput Assist Interv, V12264, P207, DOI 10.1007/978-3-030-59719-1_21; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Skrede OJ, 2020, LANCET, V395, P350, DOI 10.1016/S0140-6736(19)32998-8; Strom P, 2020, LANCET ONCOL, V21, P222, DOI 10.1016/S1470-2045(19)30738-7; Szegedy C, 2014, Arxiv, DOI [arXiv:1312.6199, DOI 10.1109/CVPR.2015.7298594]; Tachibana R, 2018, RADIOGRAPHICS, V38, P2034, DOI 10.1148/rg.2018170173; Tajbakhsh N, 2020, MED IMAGE ANAL, V63, DOI 10.1016/j.media.2020.101693; Tomita N, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14645; Tran P.V., 2016, ARXIV160400494; Tran W. T., 2020, CAN ASSOC RADIOL J, V72; Wachinger C, 2018, NEUROIMAGE, V170, P434, DOI 10.1016/j.neuroimage.2017.02.035; Wang S, 2019, RADIOTHER ONCOL, V132, P171, DOI 10.1016/j.radonc.2018.10.019; Wang X., 2017, 2017 IEEE C COMP VIS, DOI [DOI 10.1109/CVPR.2017.369, 10.1109/CVPR.2017.369]; Wang XL, 2019, COMPUT BIOL MED, V107, P39, DOI 10.1016/j.compbiomed.2019.02.002; Wenjia Bai, 2017, Medical Image Computing and Computer-Assisted Intervention, MICCAI 2017. 20th International Conference. Proceedings: LNCS 10434, P253, DOI 10.1007/978-3-319-66185-8_29; Wickstrom K, 2020, MED IMAGE ANAL, V60, DOI 10.1016/j.media.2019.101619; Wolterink Jelmer M., 2017, Simulation and Synthesis in Medical Imaging. Second International Workshop, SASHIMI 2017. Held in Conjunction with MICCAI 2017. Proceedings: LNCS 10557, P14, DOI 10.1007/978-3-319-68127-6_2; Wolterink JM, 2019, MED IMAGE ANAL, V51, P46, DOI 10.1016/j.media.2018.10.005; Xie WY, 2020, IEEE T MED IMAGING, V39, P2664, DOI 10.1109/TMI.2020.2995108; Xiong ZH, 2019, IEEE T MED IMAGING, V38, P515, DOI 10.1109/TMI.2018.2866845; Xu J., 2017, ARXIV171204119; Xu J, 2016, IEEE T MED IMAGING, V35, P119, DOI 10.1109/TMI.2015.2458702; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Xu Y, 2014, MED IMAGE ANAL, V18, P591, DOI 10.1016/j.media.2014.01.010; Xu ZB, 2018, LECT NOTES COMPUT SC, V11071, P711, DOI 10.1007/978-3-030-00934-2_79; Yan K, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.3.036501; Yan WZ, 2019, EBIOMEDICINE, V47, P543, DOI 10.1016/j.ebiom.2019.08.023; Yang JL, 2019, LECT NOTES COMPUT SC, V11765, P255, DOI 10.1007/978-3-030-32245-8_29; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Yang X, 2017, NEUROIMAGE, V158, P378, DOI 10.1016/j.neuroimage.2017.07.008; Ye CQ, 2019, IEEE ACCESS, V7, P23421, DOI 10.1109/ACCESS.2019.2899635; Yi X, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101552; Youbao Tang, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12264), P573, DOI 10.1007/978-3-030-59719-1_56; Zeng LL, 2018, EBIOMEDICINE, V30, P74, DOI 10.1016/j.ebiom.2018.03.017; Zhang H., 2019, P INT C MACH LEARN, P7354, DOI DOI 10.48550/ARXIV.1805.08318; Zhang L, 2019, INT J POLYM SCI, V2019, DOI 10.1155/2019/9058161; Zhang ZZ, 2018, PROC CVPR IEEE, P9242, DOI 10.1109/CVPR.2018.00963; Zhao C, 2018, LECT NOTES COMPUT SC, V11070, P100, DOI 10.1007/978-3-030-00928-1_12; Zhao Y., 2018, ARXIV; Zheng Q, 2019, MED IMAGE ANAL, V56, P80, DOI 10.1016/j.media.2019.06.001; Zhou S. K., 2019, Handbook of Medical Image Computing and Computer Assisted Intervention; Zhou ZW, 2019, LECT NOTES COMPUT SC, V11767, P384, DOI 10.1007/978-3-030-32251-9_42; Zhu JW, 2020, MED IMAGE ANAL, V64, DOI 10.1016/j.media.2020.101746; Zhu ZT, 2019, INT CONF 3D VISION, P240, DOI 10.1109/3DV.2019.00035; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; 2018, P IEEE C COMP VIS PA, P7132	215	318	336	39	383	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9219	1558-2256		P IEEE	Proc. IEEE	MAY	2021	109	5					820	838		10.1109/JPROC.2021.3054390	http://dx.doi.org/10.1109/JPROC.2021.3054390			19	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	RV5UD	37786449	Green Submitted, Green Accepted	Y	N	2024-09-18	WOS:000645896700010
J	Li, LY; Liu, ZP				Li, Lingyu; Liu, Zhi-Ping			A connected network-regularized logistic regression model for feature selection	APPLIED INTELLIGENCE			English	Article						Regularized logistic regression; Feature selection; Network-based sparse penalty; Network connectivity; Biomarker discovery	VARIABLE SELECTION; CONSTRAINED REGULARIZATION; EXPRESSION DATA; PREDICTION; FRAMEWORK; LASSO	Feature selection on a network structure can not only discover interesting variables but also mine out their intricate interactions. Regularization is often employed to ensure the sparsity and smoothness of the coefficients in logistic regression. However, currently available methods fail to embed the network connectivity in regularized penalty functions. In this paper, a connected network-regularized logistic regression (CNet-RLR) model for feature selection considering the structural connectivity in a network was proposed. Mathematically, it was a convex optimization problem constrained by inequalities reflecting network connectivity. Considering the non-differentiability of Lasso penalty, we constructed an equivalent formulation of CNet-RLR by employing auxiliary variables. An interior-point algorithm was designed to efficiently achieve the solutions. Theoretically, we proved their grouping effect and oracle property and guaranteed algorithmic convergence. In both synthetic simulation data and real-world uterine corpus endometrial carcinoma (UCEC) cancer genomics data, we validated the CNet-RLR model is efficient to identify the connected-network-structured features that can serve as diagnostic biomarkers. In the comparison study, we also proved the proposed CNet-RLR model results in better classification performance and feature interpretability than the other regularized logistic regression (RLR) alternatives and another graph embedded feature selection model.	[Li, Lingyu; Liu, Zhi-Ping] Shandong Univ, Sch Control Sci & Engn, Jinan 250061, Shandong, Peoples R China	Shandong University	Liu, ZP (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan 250061, Shandong, Peoples R China.	lingyuli@mail.sdu.edu.cn; zpliu@sdu.edu.cn	Li, Lingyu/KCL-1214-2024; Liu, Zhi-Ping/C-9846-2010	Li, Lingyu/0000-0002-4559-2711; Liu, Zhi-Ping/0000-0001-7742-9161	National Key Research and Development Program of China [2020YFA0712402]; National Natural Science Foundation of China (NSFC) [61973190, 61572287]; Shandong Provincial Key Research and Development Program (Major Scientific and Technological Innovation Project) [2019JZZY010423]; Innovation Method Fund of China (Ministry of Science and Technology of China) [2018IM020200]; Program of Qilu Young Scholars of Shandong University	National Key Research and Development Program of China(National Key Research & Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shandong Provincial Key Research and Development Program (Major Scientific and Technological Innovation Project); Innovation Method Fund of China (Ministry of Science and Technology of China); Program of Qilu Young Scholars of Shandong University	This work was partially supported by the National Key Research and Development Program of China under grant number 2020YFA0712402; National Natural Science Foundation of China (NSFC) under grant numbers 61973190 and 61572287; Shandong Provincial Key Research and Development Program (Major Scientific and Technological Innovation Project) under grant number 2019JZZY010423; the Innovation Method Fund of China (Ministry of Science and Technology of China) under grant number 2018IM020200; the Program of Qilu Young Scholars of Shandong University.	Althaus E, 2014, LECT NOTES COMPUT SC, V8881, P268, DOI 10.1007/978-3-319-12691-3_21; Alvarez-Miranda E, 2017, COMPUT OPER RES, V87, P63, DOI 10.1016/j.cor.2017.05.015; [Anonymous], 2014, J APPL MATH, DOI DOI 10.1007/S12035-014-9049-2; Bapat R.B., 2010, Graphs and Matrices, V27; Binder H, 2008, BIOINFORMATICS, V24, P2566, DOI 10.1093/bioinformatics/btn412; Bommert A, 2020, COMPUT STAT DATA AN, V143, DOI 10.1016/j.csda.2019.106839; Bougleux S, 2009, INT J COMPUT VISION, V84, P220, DOI 10.1007/s11263-008-0159-z; Boyd, 2021, ARXIV210203304; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; Brito-Pacheco C, 2020, J ALGORITHMS COMPUT, V14, DOI 10.1177/1748302620971535; BROSAMLER GA, 1988, MATH PROC CAMBRIDGE, V104, P561, DOI 10.1017/S0305004100065750; Carbon S, 2021, NUCLEIC ACIDS RES, V49, pD325, DOI 10.1093/nar/gkaa1113; Carvajal R, 2013, OPER RES, V61, P824, DOI 10.1287/opre.2013.1183; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chen L, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-161; Cheng W, 2014, BIOINFORMATICS, V30, P139, DOI 10.1093/bioinformatics/btu293; Chung F. R., 1997, SPECTRAL GRAPH THEOR, V92, DOI DOI 10.1090/CBMS/092; Cui XS, 2022, APPL ECON LETT, V29, P540, DOI 10.1080/13504851.2021.1875115; DEJONG P, 1987, PROBAB THEORY REL, V75, P261, DOI 10.1007/BF00354037; Delbaen F., 1998, SEMIN PROBABILITY, P313; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fathi-Hafshejani S, 2020, OPTIM ENG, V21, P1019, DOI 10.1007/s11081-020-09514-x; Franklin J.N., 2012, Matrix Theory; Goldman M, 2015, NUCLEIC ACIDS RES, V43, pD812, DOI 10.1093/nar/gku1073; Golub G. H., 2013, MATRIX COMPUTATIONS, Vfourth, DOI DOI 10.56021/9781421407944; GROTSCHEL M, 1990, SIAM J DISCRETE MATH, V3, P502; Guyon I., 2003, J MACH LEARN RES, V3, P1157; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hans R, 2020, INT J INTERACT MULTI, V6, P91, DOI 10.9781/ijimai.2019.07.004; Hastie T., 2015, Statistical Learning with Sparsity: The Lasso and Generalizations, DOI [10.1201/b18401, DOI 10.1201/B18401]; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; HSU PL, 1947, P NATL ACAD SCI USA, V33, P25, DOI 10.1073/pnas.33.2.25; Jamal F, 2019, J STAT MANAG SYST, DOI 10.1080/09720510.2019.1668159; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; JUDD KL, 1985, J ECON THEORY, V35, P19, DOI 10.1016/0022-0531(85)90059-6; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karlos S, 2020, ALGORITHMS, V13, DOI 10.3390/a13010026; Knight K, 2000, ANN STAT, V28, P1356; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Kong YC, 2018, BIOINFORMATICS, V34, P3727, DOI 10.1093/bioinformatics/bty429; Kumar P, 2021, INT J INTERACT MULTI, V6, P95, DOI 10.9781/ijimai.2020.10.001; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Li CY, 2010, ANN APPL STAT, V4, P1498, DOI 10.1214/10-AOAS332; Li LY, 2020, COMPUT STRUCT BIOTEC, V18, P3434, DOI 10.1016/j.csbj.2020.10.028; Li Q, 2018, DNA CELL BIOL, V37, P473, DOI 10.1089/dna.2017.4062; Li QH, 2016, STRUCT MULTIDISCIP O, V54, P971, DOI 10.1007/s00158-016-1459-5; Li XX, 2020, J MACH LEARN RES, V21; Liang SW, 2021, COM APPL MATH COMPUT, V3, P293, DOI 10.1007/s42967-020-00085-3; Liang XY, 2020, STRUCT EQU MODELING, V27, P722, DOI 10.1080/10705511.2019.1693273; Liu C, 2019, IEEE ACM T COMPUT BI, V16, P312, DOI 10.1109/TCBB.2017.2767589; Liu ZQ, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0159-z; Liu ZP, 2016, BIOMARK MED, V10, P633, DOI 10.2217/bmm-2015-0035; Liu ZP, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav095; Mei Q., 2008, Proceedings of the 17th international conference on World Wide Web, P101; Mello AC, 2020, BIOMED RES INT-UK, V2020, DOI 10.1155/2020/3968279; Min WW, 2018, IEEE ACM T COMPUT BI, V15, P944, DOI 10.1109/TCBB.2016.2640303; Mockus Jonas, 2012, Bayesian approach to global optimization: theory and applications, V37; Mohanty, FISHERIES BIOL NEW A, P251; Moncada R, 2020, NAT BIOTECHNOL, V38, P333, DOI 10.1038/s41587-019-0392-8; Newman M, 2010, NETWORKS INTRO, DOI [10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Ng B., 2012, 2012 2nd International Workshop on Pattern Recognition in NeuroImaging (PRNI), P101, DOI 10.1109/PRNI.2012.11; Pappa KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142229; Provan JS, 1996, ALGORITHMICA, V15, P351; Qiao XY, 2014, WIRES COMPUT STAT, V6, P177, DOI 10.1002/wics.1299; Rao M, 2018, Measure Theory and Integration; RESSEL P, 1982, P AM MATH SOC, V85, P272, DOI 10.2307/2044295; Saleem N, 2020, INT J INTERACT MULTI, V6, P84, DOI 10.9781/ijimai.2019.06.001; Sun H, 2014, STAT SINICA, V24, P1433, DOI 10.5705/ss.2012.317; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tikhonov A. N., 1977, Solutions of Ill-Posed Prob-lems; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wang JG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr251; Wang XR, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11661; Wang YM, 2017, MATH PROGRAM, V166, P241, DOI 10.1007/s10107-017-1117-8; West D.B., 2001, Introduction to Graph Theory, V2; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu MY, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0951-7; Wu Y, 2020, INT J INTERACT MULTI, V6, P51, DOI 10.9781/ijimai.2020.02.005; Xu ZB, 2010, SCI CHINA INFORM SCI, V53, P1159, DOI 10.1007/s11432-010-0090-0; Ya Arsenin, 2020, ILL POSED PROBLEMS N, P1; Yang LM, 2016, APPL INTELL, V45, P241, DOI 10.1007/s10489-016-0758-2; Yang QX, 2020, BRIEF BIOINFORM, V21, P1058, DOI 10.1093/bib/bbz049; Yao L, 2017, J COMPUT SCI TECH-CH, V32, P68, DOI 10.1007/s11390-017-1706-2; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhang L, 2019, GENE, V707, P216, DOI 10.1016/j.gene.2019.05.028; Zhou, 2006, DISCRETE REGULARIZAT; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhou J., 2011, Malsar: Multi-task learning via structural regularization, V21; Zhou Yi-fei, 2019, Nature Communications, V10, DOI [10.1038/s41467-019-13698-x, 10.1038/s41467-019-12821-2]; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	92	7	7	3	37	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0924-669X	1573-7497		APPL INTELL	Appl. Intell.	AUG	2022	52	10					11672	11702		10.1007/s10489-021-02877-3	http://dx.doi.org/10.1007/s10489-021-02877-3		JAN 2022	31	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	2Q2EN					2024-09-18	WOS:000749244500001
J	Bologna, G; Hayashi, Y				Bologna, Guido; Hayashi, Yoichi			CHARACTERIZATION OF SYMBOLIC RULES EMBEDDED IN DEEP DIMLP NETWORKS: A CHALLENGE TO TRANSPARENCY OF DEEP LEARNING	JOURNAL OF ARTIFICIAL INTELLIGENCE AND SOFT COMPUTING RESEARCH			English	Article						ensembles; Deep Learning; rule extraction; feature detectors	EXTRACTION	Rule extraction from neural networks is a fervent research topic. In the last 20 years many authors presented a number of techniques showing how to extract symbolic rules from Multi Layer Perceptrons (MLPs). Nevertheless, very few were related to ensembles of neural networks and even less for networks trained by deep learning. On several datasets we performed rule extraction from ensembles of Discretized Interpretable Multi Layer Perceptrons (DIMLP), and DIMLPs trained by deep learning. The results obtained on the Thyroid dataset and the Wisconsin Breast Cancer dataset show that the predictive accuracy of the extracted rules compare very favorably with respect to state of the art results. Finally, in the last classification problem on digit recognition, generated rules from the MNIST dataset can be viewed as discriminatory features in particular digit areas. Qualitatively, with respect to rule complexity in terms of number of generated rules and number of antecedents per rule, deep DIMLPs and DIMLPs trained by arcing give similar results on a binary classification problem involving digits 5 and 8. On the whole MNIST problem we showed that it is possible to determine the feature detectors created by neural networks and also that the complexity of the extracted rulesets can be well balanced between accuracy and interpretability.	[Bologna, Guido] Univ Appl Sci Western Switzerland, Dept Comp Sci, Rue Prairie 4, CH-1202 Geneva, Switzerland; [Hayashi, Yoichi] Meiji Univ, Dept Comp Sci, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	University of Applied Sciences & Arts Western Switzerland; Meiji University	Bologna, G (corresponding author), Univ Appl Sci Western Switzerland, Dept Comp Sci, Rue Prairie 4, CH-1202 Geneva, Switzerland.		Hayashi, Yoichi/JGM-9831-2023					Abe S, 1999, IEEE T SYST MAN CY C, V29, P140, DOI 10.1109/5326.740676; Andrews R, 1995, KNOWL-BASED SYST, V8, P373, DOI 10.1016/0950-7051(96)81920-4; [Anonymous], 2013, IJCAI 2013 WORKSH NE; [Anonymous], 2012, The MNIST database of hand- written digits; [Anonymous], 2015, THESIS; Bologna G, 2001, Int J Neural Syst, V11, P247, DOI 10.1016/S0129-0657(01)00068-0; Bologna G, 2000, LECT NOTES ARTIF INT, V1778, P240; Bologna G, 1998, IEEE WORLD CONGRESS ON COMPUTATIONAL INTELLIGENCE, P146, DOI 10.1109/IJCNN.1998.682252; Bologna G., 2004, J. Appl. Log., V3, P325, DOI [10.1016/j.jal.2004.03.004, DOI 10.1016/J.JAL.2004.03.004]; Bologna G, 2015, LECT NOTES COMPUT SC, V9095, P276, DOI 10.1007/978-3-319-19222-2_23; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breman L., 460 U CAL STAT DEP; Cherkassky Vladimir., 2015, MEASURES COMPLEXITY, P267, DOI [DOI 10.1007/978-3-319-21852-6_19, DOI 10.1007/978-3-319-21852-619, 10.1007/978-3-319-21852-619]; Chorowski J, 2015, IEEE T NEUR NET LEAR, V26, P62, DOI 10.1109/TNNLS.2014.2310059; Diederich J, 2008, STUD COMPUT INTELL, V80, P1, DOI 10.1007/978-3-540-75390-2; Duch W, 2001, IEEE T NEURAL NETWOR, V12, P277, DOI 10.1109/72.914524; Freitas A.A., 2014, ACM SIGKDD EXPLORATI, V15, P1, DOI [10.1145/2594473.2594475, DOI 10.1145/2594473.2594475]; GALLANT SI, 1988, COMMUN ACM, V31, P152, DOI 10.1145/42372.42377; Hailesilassie T., 2016, INFORM SECURITY IJCS, V14, P376; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Hara A., 2012, 2012 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2012.6252446; Hayashi Yoichi, 2015, Informatics in Medicine Unlocked, V1, P9, DOI 10.1016/j.imu.2015.12.002; Hayashi Yoichi, 2015, Informatics in Medicine Unlocked, V1, P1, DOI 10.1016/j.imu.2015.12.003; Hayashi Y., 2013, 2013 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2013.6706823; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huysmans J, 2008, IEEE T SYST MAN CY B, V38, P299, DOI 10.1109/TSMCB.2007.912079; Odajima K, 2008, NEURAL NETWORKS, V21, P1020, DOI 10.1016/j.neunet.2008.01.003; Quinlan J., 1994, The Morgan Kaufmann Series in Machine Learning, V16, P235; Setiono R, 2000, APPL INTELL, V12, P15, DOI 10.1023/A:1008307919726; Setiono R, 2008, IEEE T NEURAL NETWOR, V19, P299, DOI 10.1109/TNN.2007.908641; Vahed A., 1996, Proceedings of the Rule Extraction from Trained Artificial Neural Networks Workshop, Society for the Study of Artificial Intelligence and Simulation of Behavior Workshop Series (AISB 96), University of Sussex, Brighton, UK, P51; Verbeke W, 2011, EXPERT SYST APPL, V38, P2354, DOI 10.1016/j.eswa.2010.08.023; Vincent P., 2008, P INT C MACH LEARN, P1096, DOI 10.1145/1390156.1390294; Zhou ZH, 2003, AI COMMUN, V16, P3	34	64	70	0	16	SCIENDO	WARSAW	BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND	2083-2567	2449-6499		J ARTIF INTELL SOFT	J. Artif. Intell. Soft Comput. Res.	OCT	2017	7	4					265	286		10.1515/jaiscr-2017-0019	http://dx.doi.org/10.1515/jaiscr-2017-0019			22	Computer Science, Artificial Intelligence	Emerging Sources Citation Index (ESCI)	Computer Science	FF4BM		gold, Green Submitted			2024-09-18	WOS:000408871900004
C	Katole, SN; Karmore, SP		Karthigaikumar, P; Arulmurugan, C; Manojkumar, T		Katole, Shubhangi N.; Karmore, Swapnili P.			A New Approach of Microarray Data Dimension Reduction for Medical Applications	2015 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS AND COMMUNICATION SYSTEMS (ICECS)			English	Proceedings Paper	2nd International Conference on Electronics and Communication Systems (ICECS)	FEB 26-27, 2015	Coimbatore, INDIA	Dept Elect Telecommunicat Engn, IEEE, Univ Auckland, Kyungpook Natl Univ, Inst Electron & Telecommunicat Engineers, Electron Devices Soc		microarray data; dimension reduction; redundancy; MINE; relevancy; recognition; medical applications	SUPPORT VECTOR MACHINES; CLASSIFICATION; SELECTION	To employ and develop the performance of the dimensionality reduction for microarray data there is need of good dimension reduction technique. High-dimensional data bring great challenges in terms of computational complexity and classification performance. Therefore, it is necessary to effectively compress in a low-dimensional feature space from high dimensional feature space to design a learner with good performance. Feature extraction has a stronger ability to extract structure information in variables. Feature selection preserves the original features so that obtained feature subset has better explanatory ability. Therefore, dimension reduction is essential to study and understand the mechanism of practical problems of the microarray data. Dimension reduction is the important term which is majorly used in the big areas of genetics, medical and bioinformatics field. In medical applications for high dimensional cancer microarray data the dimension reduction is the important step. In this paper, a new Maximal Information-based Nonparametric Exploration method is proposed for the dimension reduction of the microarray data. In MINE method the MIC ( Maximal Information Coefficient) plays the important role to show the relation between the data. The paper focused on improving the performance in terms of recognition accuracy, relevance, interpretability and redundancy, after comparing the performance of MINE method and Total PLS algorithm on data.	[Katole, Shubhangi N.; Karmore, Swapnili P.] GH Raisoni Coll Engn, Dept Comp Sci & Engn, Nagpur, Maharashtra, India	GH Raisoni College of Engineering (GHRCE), Nagpur	Katole, SN (corresponding author), GH Raisoni Coll Engn, Dept Comp Sci & Engn, Nagpur, Maharashtra, India.	snkatole1990@gmail.com; Swapnali.karmore@raisoni.net	Karmore, Swapnili/C-6563-2019	Karmore, Swapnili/0000-0003-2068-4043				Anaissi A., FRAMEWORK HIGH DIMEN; Araujo D., 2011, P INT JOINT C NEUR N; Dai JJ, 2006, STAT APPL GENET MOL, V5; Deegalla S., 2009, 12 INT C INF FUS SEA; Fan JQ, 2008, ANN STAT, V36, P2605, DOI 10.1214/07-AOS504; Gheyas IA, 2010, PATTERN RECOGN, V43, P5, DOI 10.1016/j.patcog.2009.06.009; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hua JP, 2009, PATTERN RECOGN, V42, P409, DOI 10.1016/j.patcog.2008.08.001; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Yan J, 2006, IEEE T KNOWL DATA EN, V18, P320, DOI 10.1109/TKDE.2006.45; Yang WH, 2008, IEEE T KNOWL DATA EN, V20, P601, DOI 10.1109/TKDE.2007.190720; You W., 2014, IEEE T HUMAN MACHINE, V44	14	2	2	0	4	IEEE	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017 USA			978-1-4799-7225-8				2015							409	412						4	Engineering, Electrical & Electronic; Telecommunications	Conference Proceedings Citation Index - Science (CPCI-S)	Engineering; Telecommunications	BF4DE					2024-09-18	WOS:000380619600080
J	Akhter, Y; Singh, R; Vatsa, M				Akhter, Yasmeena; Singh, Richa; Vatsa, Mayank			AI-based radiodiagnosis using chest X-rays: A review	FRONTIERS IN BIG DATA			English	Review						chest X-ray; trusted AI; interpretable deep learning; Pneumoconiosis; tuberculosis; pneumonia; COVID-19	INTERSTITIAL LUNG-DISEASE; COMPUTER-AIDED DIAGNOSIS; HISTOGRAM EQUALIZATION; NEURAL-NETWORK; COVID-19; TUBERCULOSIS; RADIOGRAPHS; CLASSIFICATION; SEGMENTATION; PNEUMOCONIOSIS	Chest Radiograph or Chest X-ray (CXR) is a common, fast, non-invasive, relatively cheap radiological examination method in medical sciences. CXRs can aid in diagnosing many lung ailments such as Pneumonia, Tuberculosis, Pneumoconiosis, COVID-19, and lung cancer. Apart from other radiological examinations, every year, 2 billion CXRs are performed worldwide. However, the availability of the workforce to handle this amount of workload in hospitals is cumbersome, particularly in developing and low-income nations. Recent advances in AI, particularly in computer vision, have drawn attention to solving challenging medical image analysis problems. Healthcare is one of the areas where AI/ML-based assistive screening/diagnostic aid can play a crucial part in social welfare. However, it faces multiple challenges, such as small sample space, data privacy, poor quality samples, adversarial attacks and most importantly, the model interpretability for reliability on machine intelligence. This paper provides a structured review of the CXR-based analysis for different tasks, lung diseases and, in particular, the challenges faced by AI/ML-based systems for diagnosis. Further, we provide an overview of existing datasets, evaluation metrics for different[][15mm][0mm]Q5 tasks and patents issued. We also present key challenges and open problems in this research domain.	[Akhter, Yasmeena; Singh, Richa; Vatsa, Mayank] Indian Inst Technol Jodhpur, Jodhpur, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur	Vatsa, M (corresponding author), Indian Inst Technol Jodhpur, Jodhpur, India.	mvasta@iitj.ac.in	SINGH, RICHA/JSL-6421-2023; Vatsa, Mayank/AAR-7199-2020		MIETY, the Government of India; Swarnajayanti Fellowship	MIETY, the Government of India; Swarnajayanti Fellowship	This research was supported by a grant from MIETY, the Government of India. MV is partially supported through the Swarnajayanti Fellowship.	Abbas A, 2021, APPL INTELL, V51, P854, DOI 10.1007/s10489-020-01829-7; Abdullah-Al-Wadud M, 2007, IEEE T CONSUM ELECTR, V53, P593, DOI 10.1109/TCE.2007.381734; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Abin Deepa, 2022, 2022 International Conference on Electronics and Renewable Systems (ICEARS), P981, DOI 10.1109/ICEARS53579.2022.9752286; Ahmed Faisal, 2013, Chinese Journal of Engineering, DOI 10.1155/2013/831747; Al-Rakhami M. S., 2021, DIAGNOSIS COVID 19 X, DOI DOI 10.1101/2020.08.24.20181339; Alfadhli FHO, 2017, 2017 INTERNATIONAL CONFERENCE ON ROBOTICS, AUTOMATION AND SCIENCES (ICORAS); Anderson P, 2016, LECT NOTES COMPUT SC, V9909, P382, DOI 10.1007/978-3-319-46454-1_24; Annangi P, 2010, I S BIOMED IMAGING, P892, DOI 10.1109/ISBI.2010.5490130; [Anonymous], 2008, COMPUT VIS IMAGE UND, DOI DOI 10.1016/j.cviu.2007.09.014; Anuar Aimoldin, 2019, SIIM-ACR Pneumothorax Segmentation; Aoyama M, 2002, MED PHYS, V29, P701, DOI 10.1118/1.1469630; Ashizawa K, 1999, AM J ROENTGENOL, V172, P1311, DOI 10.2214/ajr.172.5.10227508; Ayaz M, 2021, PHYS ENG SCI MED, V44, P183, DOI 10.1007/s13246-020-00966-0; Azad R, 2019, IEEE INT CONF COMP V, P406, DOI 10.1109/ICCVW.2019.00052; Banerjee Satanjeev, 2005, P ACL WORKSHOP IEEMM; Berk R, 2021, SOCIOL METHOD RES, V50, P3, DOI 10.1177/0049124118782533; Blain M, 2021, DIAGN INTERV RADIOL, V27, P20, DOI 10.5152/dir.2020.20205; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Bustos A, 2020, MED IMAGE ANAL, V66, DOI 10.1016/j.media.2020.101797; Candemir S, 2014, IEEE T MED IMAGING, V33, P577, DOI 10.1109/TMI.2013.2290491; Cao FD, 2021, SYMMETRY-BASEL, V13, DOI 10.3390/sym13050814; Chandalia A., 2022, CHANDALIA A; Chandra TB, 2020, EXPERT SYST APPL, V158, DOI 10.1016/j.eswa.2020.113514; Chang-soo P., 2021, CHANGSOO P; Chattopadhay A, 2018, IEEE WINT CONF APPL, P839, DOI 10.1109/WACV.2018.00097; Chen LC, 2017, Arxiv, DOI arXiv:1706.05587; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen SD, 2003, IEEE T CONSUM ELECTR, V49, P1301, DOI 10.1109/TCE.2003.1261233; Cho Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74626-4; Chouldechova A, 2017, BIG DATA-US, V5, P153, DOI 10.1089/big.2016.0047; Chowdhury MEH, 2020, IEEE ACCESS, V8, P132665, DOI 10.1109/ACCESS.2020.3010287; Clarke L. P., 2022, IEEE ENG MED BIOL; COOTES TF, 1994, IMAGE VISION COMPUT, V12, P355, DOI 10.1016/0262-8856(94)90060-4; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Das D, 2021, INT C PATT RECOG, P3612, DOI 10.1109/ICPR48806.2021.9412748; Dasanayaka C, 2021, COMP M BIO BIO E-IV, V9, P39, DOI 10.1080/21681163.2020.1808532; Demner-Fushman Dina, 2012, Journal of Computing Science and Engineering, V6, P168, DOI 10.5626/JCSE.2012.6.2.168; Demner-Fushman D, 2016, J AM MED INFORM ASSN, V23, P304, DOI 10.1093/jamia/ocv080; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Devnath L, 2021, COMPUT BIOL MED, V129, DOI 10.1016/j.compbiomed.2020.104125; Dosovitskiy A, 2021, Arxiv, DOI arXiv:2010.11929; Duong LT, 2021, EXPERT SYST APPL, V184, DOI 10.1016/j.eswa.2021.115519; Duran-Lopez L, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10165683; Dwork C., 2012, P 3 INN THEOR COMP S, DOI [DOI 10.1145/2090236.2090255, 10.1145/2090236.2090255]; E LJ, 2019, PEDIATR PULM, V54, P1617, DOI 10.1002/ppul.24431; El Gannour O., 2020, 2020 IEEE 2nd international conference on electronics, control, optimization and computer science (ICECOCS), P1; Elshennawy NM, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10090649; Eslami M, 2020, IEEE T MED IMAGING, V39, P2553, DOI 10.1109/TMI.2020.2974159; Ferreira JR, 2020, IEEE ENG MED BIO, P1238, DOI 10.1109/EMBC44109.2020.9176517; Fischer AM, 2020, J THORAC IMAG, V35, pS28, DOI 10.1097/RTI.0000000000000500; Gabor D., 1946, J. Inst. Electr. Eng. Part I Gen, V93, P429, DOI [10.1049/ji-3-2.1946.0074, DOI 10.1049/JI-1.1947.0015, 10.1049/ji-3-2.1946.0076, DOI 10.1049/JI-3-2.1946.0074]; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Gongye C, 2020, ICCAD-IEEE ACM INT, DOI 10.1145/3400302.3418782; Gour M, 2020, Arxiv, DOI arXiv:2006.13817; Govindarajan S, 2021, COMPUT METH PROG BIO, V204, DOI 10.1016/j.cmpb.2021.106058; Gozes O, 2019, IEEE ENG MED BIO, P4076, DOI [10.1109/EMBC.2019.8856729, 10.1109/embc.2019.8856729]; Guendel S, 2019, Arxiv, DOI arXiv:1905.06362; Gupta A, 2021, APPL SOFT COMPUT, V99, DOI 10.1016/j.asoc.2020.106859; HALL EL, 1975, IEEE T BIO-MED ENG, V22, P518, DOI 10.1109/TBME.1975.324475; Hao CF, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18179091; Harding D. S., 2015, HARDING DS; Hardt M, 2016, ADV NEUR IN, V29; HASEGAWA A, 1994, PROC SPIE, V2167, P654; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hirano H, 2021, BMC MED IMAGING, V21, DOI 10.1186/s12880-020-00530-y; Homayounieh F, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.41096; Hong L., 2008, HONG L; Hong L., 2009, HONG L; Hospitales H., 2020, Covid Data Save Lives; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Huo Z., 2014, HUO Z; Hurt B, 2020, J THORAC IMAG, V35, P285, DOI 10.1097/RTI.0000000000000505; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; Hwang EJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.1095; Hwang S, 2017, LECT NOTES COMPUT SC, V10553, P92, DOI 10.1007/978-3-319-67558-9_11; Hwang S, 2015, PROC SPIE, V9785, DOI 10.1117/12.2216198; IDC, 2014, DIG UN DRINK DAT GRO; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Islam Md Zabirul, 2020, Inform Med Unlocked, V20, P100412, DOI 10.1016/j.imu.2020.100412; ISMIR, 2020, IT SOC MED INT RAD R; Jaeger S, 2014, QUANT IMAG MED SURG, V4, P475, DOI 10.3978/j.issn.2223-4292.2014.11.20; Jain R, 2021, APPL INTELL, V51, P1690, DOI 10.1007/s10489-020-01902-1; Jang R, 2020, JMIR MED INF, V8, DOI 10.2196/18089; Jégou S, 2017, IEEE COMPUT SOC CONF, P1175, DOI 10.1109/CVPRW.2017.156; Jiezhi Z., 2018, JIEZHI Z; Jin WQ, 2021, COMPUT BIOL MED, V131, DOI 10.1016/j.compbiomed.2021.104252; Jinpeng L., 2020, JINPENG L; Johnson AEW, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0322-0; Kai K., 2019, KAI K; Kaijin X., 2019, KAIJIN X; Kang Z., 2019, DEEP LEARNING BASED; KATSURAGAWA S, 1988, MED PHYS, V15, P311, DOI 10.1118/1.596224; Kaviani S, 2022, EXPERT SYST APPL, V198, DOI 10.1016/j.eswa.2022.116815; Kermany Daniel, 2018, Mendeley Data, V2; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Khan AI, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105581; Khasawneh N, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21175940; Kim JR, 2017, AM J ROENTGENOL, V209, P1374, DOI 10.2214/AJR.17.18224; Kim YG, 2020, EUR RADIOL, V30, P4943, DOI 10.1007/s00330-020-06892-9; Kim YG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55373-7; Kusakunniran W, 2021, J MED IMAGING, V8, DOI 10.1117/1.JMI.8.S1.014001; LEDLEY R S, 1975, Computers in Biology and Medicine, V5, P53, DOI 10.1016/0010-4825(75)90018-9; Lei R., 2021, LEI R; Lenga M, 2020, PR MACH LEARN RES, V121, P413; Li BC, 2019, IEEE ENG MED BIO, P4851, DOI [10.1109/embc.2019.8857277, 10.1109/EMBC.2019.8857277]; Li D, 2022, EMERG RADIOL, V29, P365, DOI 10.1007/s10140-022-02019-3; Li LH, 2001, ACAD RADIOL, V8, P629, DOI 10.1016/S1076-6332(03)80688-8; Li X, 2020, Arxiv, DOI arXiv:1906.05190; Li X, 2020, Arxiv, DOI [arXiv:2004.03042, 10.48550/arXiv.2004.03042]; Li X, 2021, I S BIOMED IMAGING, P1677, DOI 10.1109/ISBI48211.2021.9433761; Li X, 2020, I S BIOMED IMAGING, P1154, DOI [10.1109/ISBI45749.2020.9098628, 10.1109/isbi45749.2020.9098628]; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Lin C.-Y., 2003, HUMAN LANGUAGE TECHN; Little KJ, 2017, J AM COLL RADIOL, V14, P208, DOI 10.1016/j.jacr.2016.07.011; Liu L, 2017, PATTERN RECOGN, V62, P135, DOI 10.1016/j.patcog.2016.08.032; Liu L, 2016, IEEE T IMAGE PROCESS, V25, P1368, DOI 10.1109/TIP.2016.2522378; Longjiang E, 2021, PEDIATR PULM, V56, P1036, DOI 10.1002/ppul.25229; Lu MT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7416; Luojie L., 2018, LUOJIE L; Lyman K., 2019, LYMAN K; Ma XJ, 2021, PATTERN RECOGN, V110, DOI 10.1016/j.patcog.2020.107332; Madani A, 2018, I S BIOMED IMAGING, P1038, DOI 10.1109/ISBI.2018.8363749; Mahmud T, 2020, COMPUT BIOL MED, V122, DOI 10.1016/j.compbiomed.2020.103869; Majkowska A, 2020, RADIOLOGY, V294, P421, DOI 10.1148/radiol.2019191293; Malhotra A, 2022, PATTERN RECOGN, V122, DOI 10.1016/j.patcog.2021.108243; McDonald CJ, 2005, HEALTH AFFAIR, V24, P1214, DOI 10.1377/hlthaff.24.5.1214; Minhwa L., 2017, MINHWA L; Mitchell C., 2012, WORLD RADIOGRAPHY DA; Mittal A, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20041068; Mittal S, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0271931; Mooney P., 2018, Chest X-Ray Images (Pneumonia); Msonda P, 2020, TRAIT SIGNAL, V37, P1075, DOI 10.18280/ts.370620; Munadi K, 2020, IEEE ACCESS, V8, P217897, DOI 10.1109/ACCESS.2020.3041867; Murphy K., 2019, The Global Innovation Index 2019, P129; Murphy K, 2020, RADIOLOGY, V296, pE166, DOI 10.1148/radiol.2020201874; Murray V, 2009, IEEE IMAGE PROC, P4201, DOI 10.1109/ICIP.2009.5414522; Narayanan BN, 2020, PROC SPIE, V11318, DOI 10.1117/12.2547635; Nguyen H, 2022, Arxiv, DOI arXiv:2012.15029; Oh Y, 2020, IEEE T MED IMAGING, V39, P2688, DOI 10.1109/TMI.2020.2993291; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Okumura E, 2011, J DIGIT IMAGING, V24, P1126, DOI 10.1007/s10278-010-9357-7; Oloko-Oba Mustapha, 2020, Computer Vision and Graphics. International Conference, ICCVG 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12334), P121, DOI 10.1007/978-3-030-59006-2_11; Opelt Andreas., 2006, IEEE COMPUTER SOC C, V1, P3; Owais M, 2020, JMIR MED INF, V8, DOI 10.2196/21790; Panwar H, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110190; Panwar H, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109944; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Pasa F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42557-4; Cohen JP, 2020, Arxiv, DOI arXiv:2006.11988; Pereira RM, 2020, COMPUT METH PROG BIO, V194, DOI 10.1016/j.cmpb.2020.105532; Pham TD, 2021, HEALTH INF SCI SYST, V9, DOI 10.1007/s13755-020-00135-3; Punn NS, 2021, APPL INTELL, V51, P2689, DOI 10.1007/s10489-020-01900-3; Putha P., 2022, PUTHA P; Putha P., 2021, PUTHA P; Qiang D., 2020, QIAND D; Radford A, 2016, Arxiv, DOI [arXiv:1511.06434, DOI 10.48550/ARXIV.1511.06434]; Rahman M, 2021, COMPUT ELECTR ENG, V93, DOI 10.1016/j.compeleceng.2021.107252; Rahman T., 2020, COVID-19 radiography dataset; Rahman T, 2021, COMPUT BIOL MED, V132, DOI 10.1016/j.compbiomed.2021.104319; Rahman T, 2020, IEEE ACCESS, V8, P191586, DOI 10.1109/ACCESS.2020.3031384; Rajaraman S, 2020, IEEE ACCESS, V8, P27318, DOI [10.1109/ACCESS.2020.2971257, 10.1109/access.2020.2971257]; Rajaraman S, 2019, PROC SPIE, V10950, DOI 10.1117/12.2512752; Rajpurkar P, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00322-2; Rajpurkar P, 2017, Arxiv, DOI arXiv:1711.05225; Redmon J, 2017, PROC CVPR IEEE, P6517, DOI 10.1109/CVPR.2017.690; Reis E. P., 2022, BRAX BRAZILIAN LABEL; Rajagopal R, 2021, PATTERN RECOGN IMAGE, V31, P313; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rosenthal A, 2017, J CLIN MICROBIOL, V55, P3267, DOI 10.1128/JCM.01013-17; Russell C., 2017, Advances in neural information processing systems; Ryoo Sungweon, 2014, Osong Public Health Res Perspect, V5, pS43, DOI 10.1016/j.phrp.2014.10.007; Sabour S., 2017, ADV NEURAL INFORM PR, P3856; Saha Prottoy, 2021, Inform Med Unlocked, V22, P100505, DOI 10.1016/j.imu.2020.100505; Sahadevan V., 2002, SAHADEVAN V; Sahlol AT, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12071146; Santosh KC, 2016, INT J COMPUT ASS RAD, V11, P1637, DOI 10.1007/s11548-016-1359-6; Schultheiss M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69789-z; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Settles M., 2005, An Introduction to Particle Swarm Optimization; Seyyed-Kalantari L, 2021, PACIFIC SYMPOSIUM ON BICOMPUTING 2021, P232; Shankar S., 2022, SHANKAR S; Shaoliang P., 2020, SHAOLIANG P; SHERRIER RH, 1987, IEEE T MED IMAGING, V6, P1, DOI 10.1109/TMI.1987.4307791; Shi WQ, 2021, IEEE J BIOMED HEALTH, V25, P2376, DOI 10.1109/JBHI.2021.3074893; Shiraishi J, 2000, AM J ROENTGENOL, V174, P71, DOI 10.2214/ajr.174.1.1740071; Sim Y, 2020, RADIOLOGY, V294, P199, DOI 10.1148/radiol.2019182465; Singh A, 2021, BIOMED SIGNAL PROCES, V68, DOI 10.1016/j.bspc.2021.102666; Singh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204155; Smilkov D, 2017, Arxiv, DOI [arXiv:1706.03825, DOI 10.48550/ARXIV.1706.03825]; Soleymanpour Elaheh, 2011, J Med Signals Sens, V1, P191; Sousa RT, 2014, COMP MED SY, P477, DOI 10.1109/CBMS.2014.98; Stein A, 2018, RSNA Pneumonia Detection Challenge; Subramanian V, 2019, LECT NOTES COMPUT SC, V11769, P522, DOI 10.1007/978-3-030-32226-7_58; Sundaram S, 2021, arXiv; Syeda-Mahmood Tanveer, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12262), P561, DOI 10.1007/978-3-030-59713-9_54; Tabik S, 2020, IEEE J BIOMED HEALTH, V24, P3595, DOI 10.1109/JBHI.2020.3037127; Takemiya R, 2019, PROC SPIE, V11050, DOI 10.1117/12.2521652; Tan MX, 2020, Arxiv, DOI [arXiv:1905.11946, DOI 10.48550/ARXIV.1905.11946]; Tang YB, 2019, PR MACH LEARN RES, V102, P457; Tang YX, 2019, LECT NOTES COMPUT SC, V11769, P431, DOI 10.1007/978-3-030-32226-7_48; Thian YL, 2021, RADIOL-ARTIF INTELL, V3, DOI 10.1148/ryai.2021200190; Ting H., 2021, TING H; Ucar F, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109761; Ul Abideen Z, 2020, IEEE ACCESS, V8, P22812, DOI 10.1109/ACCESS.2020.2970023; van Ginneken B, 2006, MED IMAGE ANAL, V10, P19, DOI 10.1016/j.media.2005.02.002; Vaya MD, 2020, Arxiv, DOI [arXiv:2006.01174, 10.48550/arXiv.2006.01174]; Vedantam R, 2015, PROC CVPR IEEE, P4566, DOI 10.1109/CVPR.2015.7299087; Venkata Hari G. P., 2022, HARI GPV; Wang CM, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0496-2; Wang DD, 2020, 2020 DIGITAL IMAGE COMPUTING: TECHNIQUES AND APPLICATIONS (DICTA), DOI 10.1109/DICTA51227.2020.9363416; Wang HJ, 2020, Cambria Sinophone Wo, P111, DOI 10.1109/CVPRW50498.2020.00020; Wang L., 2020, ACTUALMED COVID 19 C; Wang NW, 2020, IEEE INT CONF ELECTR, P281, DOI 10.1109/iceiec49280.2020.9152329; Wang XH, 2020, OCCUP ENVIRON MED, V77, P597, DOI 10.1136/oemed-2019-106386; Wang XS, 2017, PROC CVPR IEEE, P3462, DOI 10.1109/CVPR.2017.369; Wang ZD, 2020, RNA BIOL, V17, P1576, DOI 10.1080/15476286.2019.1709296; Wanli J., 2021, DEEP LEARNING BASED; Wessel J, 2019, Arxiv, DOI [arXiv:1908.08329, DOI 10.48550/ARXIV.1908.08329]; WHO, 2021, M REP WHO EXP CONS D, P27; World Health Organization, 2018, WORLD HLTH STAT 2018; World Health Organization, 2013, WHO/HTM/TB/2013.11; Xu Horace, 2010, P 3 INT WORKSH PULM, P129; Xue Y, 2018, LECT NOTES COMPUT SC, V11070, P457, DOI 10.1007/978-3-030-00928-1_52; Yang F, 2021, BMC MED IMAGING, V21, DOI 10.1186/s12880-021-00723-z; Yao ZJ, 2016, INT SYM COMPUT INTEL, P447, DOI [10.1109/ISCID.2016.109, 10.1109/ISCID.2016.1110]; Yu DD, 2020, COMPUT METH PROG BIO, V197, DOI 10.1016/j.cmpb.2020.105674; Yu PC, 2011, J DIGIT IMAGING, V24, P382, DOI 10.1007/s10278-010-9276-7; Yue ZJ, 2020, COMPUT INTEL NEUROSC, V2020, DOI 10.1155/2020/8876798; Zadbuke AS, 2012, INT J SCI ENG RES, V3, P1; Zafar MB, 2017, PR MACH LEARN RES, V54, P962; Zech JR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002683; Zhang DJ, 2021, ELECTRONICS-SWITZ, V10, DOI 10.3390/electronics10131512; Zhang JP, 2021, IEEE T MED IMAGING, V40, P879, DOI 10.1109/TMI.2020.3040950; Zhang LZ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-77924-z; Zhang R, 2020, IEEE ENG MED BIO, P1552, DOI [10.1109/EMBC44109.2020.9175919, 10.1109/embc44109.2020.9175919]; Zhang W, 2019, LECT NOTES COMPUT SC, V11769, P594, DOI 10.1007/978-3-030-32226-7_66; Zhao WG, 2020, NEURAL COMPUT APPL, V32, P9383, DOI 10.1007/s00521-019-04452-x; Zhu JY, 2017, IEEE I CONF COMP VIS, P2242, DOI 10.1109/ICCV.2017.244	241	8	8	2	27	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-909X		FRONT BIG DATA	Front. Big Data	APR 6	2023	6								1120989	10.3389/fdata.2023.1120989	http://dx.doi.org/10.3389/fdata.2023.1120989			27	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Computer Science; Science & Technology - Other Topics	E0EU3	37091458	Green Published, gold			2024-09-18	WOS:000972378100001
J	Galiana, L; Rudilla, D; Oliver, A; Barreto, P				Galiana, Laura; Rudilla, David; Oliver, Amparo; Barreto, Pilar			The Short Demoralization Scale (SDS): A new tool to appraise demoralization in palliative care patients	PALLIATIVE & SUPPORTIVE CARE			English	Article						Demoralization; Symptom assessment; Palliative care; Psychometric testing; End of life	OUTCOME MEASURES; CANCER-PATIENTS; DEPRESSION; VALIDATION; QUALITY; VERSION; REVALIDATION; REFINEMENT; DISTRESS; CRITERIA	Objective:The Demoralization Scale (DS) is the most widely used measure for assessing demoralization. Following the recent clamor for brief assessment tools, and taking into account that demoralization has proved to be a symptom that needs to be controlled and treated in the palliative care setting, a shorter scale is needed. The aim of the present research is to introduce and evaluate the Short Demoralization Scale (SDS). Method:We employed a cross-sectional design that included a survey of 226 Spanish palliative care patients from the Hospital General Universitario de Valencia. We employed the SDS, the DS, and the Hospital Anxiety and Depression Scale (HADS). Results:The confirmatory factor analysis supported the one-factor structure of the SDS (chi(2)(5) = 12.915; p = 0.024; CFI = 0.999; RMSEA = 0.084; CI95% = [0.028, 0.141]). The reliability was found to be appropriate, with a value of Cronbach's alpha (alpha) equal to 0.920. A cutoff criterion of 10 was established, which favored the interpretability of the instrument. Significance of results:The SDS corrects previous limitations, has a simple scoring system, is cost-effective, and is widely and fully available. In addition, our findings demonstrate that the SDS can be employed effectively in the clinical context.	[Galiana, Laura; Oliver, Amparo] Univ Valencia, Dept Methodol Behav Sci, Ave Blasco Ibanez 21, Valencia 46010, Spain; [Rudilla, David] Hosp Gen Univ Valencia, Home Care Unit, Valencia, Spain; [Barreto, Pilar] Univ Valencia, Dept Assessment Treatments & Personal, Valencia, Spain	University of Valencia; University of Valencia	Galiana, L (corresponding author), Univ Valencia, Dept Methodol Behav Sci, Ave Blasco Ibanez 21, Valencia 46010, Spain.	Laura.Galiana@uv.es	Galiana, Laura/I-1158-2012; Oliver, Amparo/K-9894-2017	Galiana, Laura/0000-0002-5342-5251; Oliver, Amparo/0000-0002-1207-4088				Akizuki N, 2005, J PAIN SYMPTOM MANAG, V29, P91, DOI 10.1016/j.jpainsymman.2004.04.016; Antunes B, 2014, PALLIATIVE MED, V28, P158, DOI 10.1177/0269216313491619; Bausewein C., 2011, Outcome measurement in palliative care: The essentials; Benito E, 2014, J PAIN SYMPTOM MANAG, V47, P1008, DOI 10.1016/j.jpainsymman.2013.06.018; Bjordal K, 2000, EUR J CANCER, V36, P1796, DOI 10.1016/S0959-8049(00)00186-6; Bossola M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-43; Butcher J.N., 1990, Development and use of the MMPI-2 Content Scales; Chochinov HM, 1997, AM J PSYCHIAT, V154, P674; Cicchetti DV., 1994, Psychol Assess, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences, V2nd ed, DOI https://doi.org/10.4324/9780203771587; Cormier JN, 2011, SURG ONCOL CLIN N AM, V20, P201, DOI 10.1016/j.soc.2010.09.002; Costantini A, 2013, RIV PSICHIATR, V48, P234, DOI 10.1708/1292.14291; Dalal DK, 2015, MORE STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS, P112; Daveson BA, 2012, PALLIATIVE MED, V26, P242, DOI 10.1177/0269216311409614; Dawson J., 2010, BMJ, V340, P464, DOI DOI 10.1136/BMJ.C464; de Jong CAJ., 2008, Open Addict J, V1, P7, DOI DOI 10.2174/1874941000801010007; DOHRENWEND BP, 1980, ARCH GEN PSYCHIAT, V37, P1229; Hadnagy Zsolt, 2012, Orvosi Hetilap, V153, P737, DOI 10.1556/OH.2012.29346; Harding R, 2011, J PAIN SYMPTOM MANAG, V42, P493, DOI 10.1016/j.jpainsymman.2011.06.008; Hearn J, 1997, J PUBLIC HEALTH MED, V19, P193, DOI 10.1093/oxfordjournals.pubmed.a024608; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hung H.C., 2010, Journal of Internal Medicine of Taiwan, V21, P427, DOI [10.6314/JIMT.2010.21(6).06, DOI 10.6314/JIMT.2010.21(6).06]; JuliAo M., 2015, PALLIAT SUPPORT CARE, V14, P138; Juliao M, 2016, PALLIAT SUPPORT CARE, V14, P468, DOI 10.1017/S1478951515001364; Kissane DW, 2004, J PALLIATIVE CARE, V20, P269, DOI 10.1177/082585970402000402; Mehnert A, 2011, J PAIN SYMPTOM MANAG, V42, P768, DOI 10.1016/j.jpainsymman.2011.02.013; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Morita T, 2001, PALLIATIVE MED, V15, P419, DOI 10.1191/026921601680419474; Mularski RA, 2007, J PAIN SYMPTOM MANAG, V34, pS7, DOI 10.1016/j.jpainsymman.2007.04.004; Mullane Mary, 2009, Palliat Support Care, V7, P323, DOI 10.1017/S1478951509990253; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Robinson S, 2016, CANCER-AM CANCER SOC, V122, P2251, DOI 10.1002/cncr.30015; Robinson S, 2016, CANCER-AM CANCER SOC, V122, P2260, DOI 10.1002/cncr.30012; Rose M, 2009, QUAL LIFE RES, V18, P125, DOI 10.1007/s11136-008-9436-0; Rudilla D, 2016, PALLIAT SUPPORT CARE, V14, P321, DOI 10.1017/S1478951515001182; Rudilla D, 2016, J PAIN SYMPTOM MANAG, V51, P769, DOI 10.1016/j.jpainsymman.2015.11.019; Rudilla D, 2016, PALLIAT SUPPORT CARE, V14, P99, DOI 10.1017/S1478951515000747; Sloan JA, 2007, VALUE HEALTH, V10, pS59, DOI 10.1111/j.1524-4733.2007.00267.x; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann C, 2004, PALLIATIVE MED, V18, P121, DOI 10.1191/0269216304pm858oa	43	14	14	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1478-9515	1478-9523		PALLIAT SUPPORT CARE	Palliat. Support Care	OCT	2017	15	5					516	523		10.1017/S1478951516000973	http://dx.doi.org/10.1017/S1478951516000973			8	Health Policy & Services	Social Science Citation Index (SSCI)	Health Care Sciences & Services	FH1YY	28065203				2024-09-18	WOS:000410936900003
J	Li, YP; Ammari, S; Lawrance, L; Quillent, A; Assi, T; Lassau, N; Chouzenoux, E				Li, Yingping; Ammari, Samy; Lawrance, Littisha; Quillent, Arnaud; Assi, Tarek; Lassau, Nathalie; Chouzenoux, Emilie			Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion	CANCERS			English	Article						radiomics; gliomas; glioblastomas; tumor grade; IDH mutation; 1p; 19q codeletion	SURVIVAL; FEATURES; SYSTEM; SMOTE	Simple Summary In 2016, the World Health Organization (WHO) recommended the incorporation of molecular parameters, in addition to histology, for an optimal definition of the central nervous system (CNS) tumors. Gliomas, being among the most common types of CNS tumors, have distinct clinical outcomes and treatment strategies based on different tumor grades, isocitrate dehydrogenase (IDH) mutation, and 1p/19q codeletion statuses. This paper uses radiomics models to noninvasively predict the glioma subtype with clinical Magnetic Resonance Imaging (MRI) images. Different settings in the radiomics pipeline were investigated to achieve optimal performance, together with a better understanding of the exact role of each setting in the model performance. The characteristics of the radiomic features that best distinguish the glioma subtypes were also analyzed. This paper not only provides a radiomics pipeline which works well for predicting the glioma subtype, but it also contributes to the radiomics model development and interpretability. Gliomas are among the most common types of central nervous system (CNS) tumors. A prompt diagnosis of the glioma subtype is crucial to estimate the prognosis and personalize the treatment strategy. The objective of this study was to develop a radiomics pipeline based on the clinical Magnetic Resonance Imaging (MRI) scans to noninvasively predict the glioma subtype, as defined based on the tumor grade, isocitrate dehydrogenase (IDH) mutation status, and 1p/19q codeletion status. A total of 212 patients from the public retrospective The Cancer Genome Atlas Low Grade Glioma (TCGA-LGG) and The Cancer Genome Atlas Glioblastoma Multiforme (TCGA-GBM) datasets were used for the experiments and analyses. Different settings in the radiomics pipeline were investigated to improve the classification, including the Z-score normalization, the feature extraction strategy, the image filter applied to the MRI images, the introduction of clinical information, ComBat harmonization, the classifier chain strategy, etc. Based on numerous experiments, we finally reached an optimal pipeline for classifying the glioma tumors. We then tested this final radiomics pipeline on the hold-out test data with 51 randomly sampled random seeds for reliable and robust conclusions. The results showed that, after tuning the radiomics pipeline, the mean AUC improved from 0.8935 (+/- 0.0351) to 0.9319 (+/- 0.0386), from 0.8676 (+/- 0.0421) to 0.9283 (+/- 0.0333), and from 0.6473 (+/- 0.1074) to 0.8196 (+/- 0.0702) in the test data for predicting the tumor grade, IDH mutation, and 1p/19q codeletion status, respectively. The mean accuracy for predicting the five glioma subtypes also improved from 0.5772 (+/- 0.0816) to 0.6716 (+/- 0.0655). Finally, we analyzed the characteristics of the radiomic features that best distinguished the glioma grade, the IDH mutation, and the 1p/19q codeletion status, respectively. Apart from the promising prediction of the glioma subtype, this study also provides a better understanding of the radiomics model development and interpretability. The results in this paper are replicable with our python codes publicly available in github.	[Li, Yingping; Ammari, Samy; Lawrance, Littisha; Lassau, Nathalie] Univ Paris Saclay, Lab Imagerie Biomed Multimodale Paris Saclay, CNRS, CEA,BIOMAPS,UMR1281 Inserm, F-94805 Villejuif, France; [Li, Yingping; Quillent, Arnaud; Chouzenoux, Emilie] Univ Paris Saclay, Ctr Vis Numer, Inst Natl Rech Informat & Automat INRIA, F-91190 Gif Sur Yvette, France; [Ammari, Samy; Lawrance, Littisha; Lassau, Nathalie] Univ Paris Saclay, Dept Imagerie Med, Gustave Roussy Canc Campus Grand Paris, F-94805 Villejuif, France; [Assi, Tarek] Univ Paris Saclay, Dept Med Oncol, Gustave Roussy Canc Campus Grand Paris, F-94805 Villejuif, France	Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; CEA; Universite Paris Saclay; Universite Paris Cite; Universite Paris Saclay; Universite Paris Cite; UNICANCER; Gustave Roussy; Universite Paris Cite; UNICANCER; Gustave Roussy; Universite Paris Saclay	Li, YP (corresponding author), Univ Paris Saclay, Lab Imagerie Biomed Multimodale Paris Saclay, CNRS, CEA,BIOMAPS,UMR1281 Inserm, F-94805 Villejuif, France.; Li, YP (corresponding author), Univ Paris Saclay, Ctr Vis Numer, Inst Natl Rech Informat & Automat INRIA, F-91190 Gif Sur Yvette, France.	yingping.li@universite-paris-saclay.fr; samy.ammari@gustaveroussy.fr; littisha.lawrance@gustaveroussy.fr; arnaud.quillent@inria.fr; tarek.assi@gustaveroussy.fr; nathalie.lassau@gustaveroussy.fr; emilie.chouzenoux@centralesupelec.fr	Lawrance, Littisha/KCZ-1998-2024; Assi, Tarek/AAQ-2907-2021	AMMARI, SAMY/0000-0002-1506-0714; Chouzenoux, Emilie/0000-0003-3631-6093; Quillent, Arnaud/0000-0001-6358-1293; LI, Yingping/0000-0003-4145-8395; Lawrance, Littisha/0000-0002-0838-2053; Lassau, Nathalie/0000-0001-8068-6513	China Scholarship Council (CSC) [201801810027]	China Scholarship Council (CSC)(China Scholarship Council)	Y.L.'s PhD thesis is funded by the China Scholarship Council (CSC), grant number 201801810027.	Arita H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30273-4; Baid U., 2021, arXiv preprint arXiv:2107.02314; Bakas S., 2017, CANC IMAGING ARCH, V4; Bakas S., 2017, The Cancer Imaging Archive, P286, DOI DOI 10.7937/K9/TCIA.2017.KLXWJJ1Q; Bakas S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.117; Bakas Spyridon, 2016, Brainlesion, V9556, P144, DOI [10.1007/978-3-319-30858-6_1, 10.1007/978-3-319-30858-6_13]; Chai RC, 2021, CANCER BIOL MED, V18, P271, DOI 10.20892/j.issn.2095-3941.2020.0179; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen W, 2018, INT J BIOMED IMAGING, V2018, DOI [10.1155/2018/2512037, 10.1109/TSC.2018.2803826]; Cho HH, 2018, PEERJ, V6, DOI 10.7717/peerj.5982; Choi YS, 2021, NEURO-ONCOLOGY, V23, P304, DOI 10.1093/neuonc/noaa177; Cinarer G., 2020, NEW TRENDS ISSUES PR, V12, P80, DOI [10.18844/gjpaas.v0i12.4989, DOI 10.18844/GJPAAS.V0I12.4989]; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Delev D, 2019, J NEURO-ONCOL, V141, P223, DOI 10.1007/s11060-018-03030-w; Ditmer A, 2018, J NEURO-ONCOL, V140, P583, DOI 10.1007/s11060-018-2984-4; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gore S, 2020, LECT NOTES COMPUT SC, V12449, P240, DOI 10.1007/978-3-030-66843-3_23; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; Ingalhalikar M., 2019, INT WORKSHOP RADIOMI, P53; Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim M, 2020, EUR RADIOL, V30, P2142, DOI 10.1007/s00330-019-06548-3; Kocak B, 2020, EUR RADIOL, V30, P877, DOI 10.1007/s00330-019-06492-2; Kong ZR, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.551771; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Li YP, 2021, CANCERS, V13, DOI 10.3390/cancers13123000; Li ZC, 2018, CANCER MED-US, V7, P5999, DOI 10.1002/cam4.1863; Liu X, 2019, AGING-US, V11, P673, DOI 10.18632/aging.101769; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu CF, 2018, CLIN CANCER RES, V24, P4429, DOI 10.1158/1078-0432.CCR-17-3445; Orlhac F, 2022, J NUCL MED, V63, P172, DOI 10.2967/jnumed.121.262464; Park YW, 2019, KOREAN J RADIOL, V20, P1381, DOI 10.3348/kjr.2018.0814; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qi ST, 2012, CANCER SCI, V103, P269, DOI 10.1111/j.1349-7006.2011.02134.x; Qin JB, 2017, MED SCI MONITOR, V23, P2168, DOI 10.12659/MSM.901270; Read J, 2011, MACH LEARN, V85, P333, DOI 10.1007/s10994-011-5256-5; Rohlfing T, 2010, HUM BRAIN MAPP, V31, P798, DOI 10.1002/hbm.20906; Shofty B, 2018, INT J COMPUT ASS RAD, V13, P563, DOI 10.1007/s11548-017-1691-5; Sun P, 2019, IEEE ACCESS, V7, P102010, DOI 10.1109/ACCESS.2019.2928975; Tan Y, 2019, EUR RADIOL, V29, P3325, DOI 10.1007/s00330-019-06056-4; Tandel GS, 2019, CANCERS, V11, DOI 10.3390/cancers11010111; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; Tian Q, 2018, J MAGN RESON IMAGING, V48, P1518, DOI 10.1002/jmri.26010; van der Voort SR, 2019, CLIN CANCER RES, V25, P7455, DOI 10.1158/1078-0432.CCR-19-1127; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Walker C, 2011, BRIT J RADIOL, V84, pS90, DOI 10.1259/bjr/23430927; Wu S, 2019, J CANCER RES CLIN, V145, P543, DOI 10.1007/s00432-018-2787-1; Xiao TH, 2019, THIRD INTERNATIONAL SYMPOSIUM ON IMAGE COMPUTING AND DIGITAL MEDICINE (ISICDM 2019), P208, DOI 10.1145/3364836.3364877; Yu JH, 2017, EUR RADIOL, V27, P3509, DOI 10.1007/s00330-016-4653-3; Zhang X, 2018, J MAGN RESON IMAGING, V48, P916, DOI 10.1002/jmri.25960; Zhou H, 2017, NEURO-ONCOLOGY, V19, P862, DOI 10.1093/neuonc/now256	52	27	33	1	21	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	APR	2022	14	7							1778	10.3390/cancers14071778	http://dx.doi.org/10.3390/cancers14071778			26	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	0L4MQ	35406550	Green Published, gold			2024-09-18	WOS:000781450100001
J	Zhou, YZ; Xu, PR; Hooker, G				Zhou, Yunzhe; Xu, Peiru; Hooker, Giles			A generic approach for reproducible model distillation	MACHINE LEARNING			English	Article; Early Access						Interpretability; Model distillation; Multiple testing; Reproducibility; Explainable artificial intelligence		Model distillation has been a popular method for producing interpretable machine learning. It uses an interpretable "student" model to mimic the predictions made by the black box "teacher" model. However, when the student model is sensitive to the variability of the data sets used for training even when keeping the teacher fixed, the corresponded interpretation is not reliable. Existing strategies stabilize model distillation by checking whether a large enough sample of pseudo-data is generated to reliably reproduce student models, but methods to do so have so far been developed separately for each specific class of student model. In this paper, we develop a generic approach for stable model distillation based on central limit theorem for the estimated fidelity of the student to the teacher. We start with a collection of candidate student models and search for candidates that reasonably agree with the teacher. Then we construct a multiple testing framework to select a sample size such that the consistent student model would be selected under different pseudo samples. We demonstrate the application of our proposed approach on three commonly used intelligible models: decision trees, falling rule lists and symbolic regression. Finally, we conduct simulation experiments on Mammographic Mass and Breast Cancer datasets and illustrate the testing procedure throughout a theoretical analysis with Markov process. The code is publicly available at https://github.com/yunzhe-zhou/GenericDistillation.	[Zhou, Yunzhe] Univ Calif Berkeley, Dept Psychol, 2121 Berkeley Way, Berkeley, CA 94720 USA; [Xu, Peiru] Univ Calif Berkeley, Dept Math, Evans Hall, Berkeley, CA 94720 USA; [Hooker, Giles] Univ Penn, Dept Stat & Data Sci, Acad Res Bldg, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Pennsylvania	Zhou, YZ (corresponding author), Univ Calif Berkeley, Dept Psychol, 2121 Berkeley Way, Berkeley, CA 94720 USA.	ztzyz615@berkeley.edu; xpr2019@berkeley.edu; ghooker@wharton.upenn.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	No Statement Available	Affenzeller M, 2014, GENETIC PROGRAMMING, P175, DOI [DOI 10.1007/978-1-4939-0375-7_10, 10.1007/978-1-4939-0375-7_10]; Augusto DA, 2000, SIXTH BRAZILIAN SYMPOSIUM ON NEURAL NETWORKS, VOL 1, PROCEEDINGS, P173, DOI 10.1109/SBRN.2000.889734; Bishop C. M., 1994, Technical Report No. NCRG/94/004.; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE, DOI [10.1201/9781315139470/CLASSIFICATION-REGRESSION-TREES-LEO-BREIMAN, DOI 10.1201/9781315139470, 10.1201/9781315139470]; Breiman L., 2002, MANUAL SETTING USING, V1; Creswell A, 2018, IEEE SIGNAL PROC MAG, V35, P53, DOI 10.1109/MSP.2017.2765202; Donsker M. D., 1951, An invariance principle for certain probability limit theorems; Doob J.L., 1949, CALCUL PROBABILITES, P23; Doshi-Velez F, 2017, Arxiv, DOI arXiv:1702.08608; Du MN, 2020, COMMUN ACM, V63, P68, DOI 10.1145/3359786; Duembgen L, 2010, Arxiv, DOI arXiv:1012.2063; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elter M, 2007, MED PHYS, V34, P4164, DOI 10.1118/1.2786864; Ferreira Leonardo Augusto, 2020, 2020 IEEE Congress on Evolutionary Computation (CEC), DOI 10.1109/CEC48606.2020.9185620; Ghosal I, 2022, Arxiv, DOI arXiv:2209.00147; Gibbons RD, 2013, J CLIN PSYCHIAT, V74, P669, DOI 10.4088/JCP.12m08338; Hinton G., 2015, DISTILLING KNOWLEDGE, V2; Aldeia GSI, 2022, GENET PROGRAM EVOL M, V23, P309, DOI 10.1007/s10710-022-09435-x; Johansson U, 2011, IEEE C EVOL COMPUTAT, P1444; Kleber A, 2013, DEVEL SEDIM, V66, P1, DOI 10.1016/B978-0-444-53118-6.00001-5; KOZA JR, 1994, STAT COMPUT, V4, P87, DOI 10.1007/BF00175355; Kuncheva LI, 2014, COMBINING PATTERN CLASSIFIERS: METHODS AND ALGORITHMS, 2ND EDITION, P1; Loh WY, 2011, WIRES DATA MIN KNOWL, V1, P14, DOI 10.1002/widm.8; Lundberg SM, 2017, ADV NEUR IN, V30; MANGASARIAN OL, 1995, OPER RES, V43, P570, DOI 10.1287/opre.43.4.570; Meurer A, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.103; Moro S, 2014, DECIS SUPPORT SYST, V62, P22, DOI 10.1016/j.dss.2014.03.001; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; National Academies of Sciences Engineering and Medicine., 2019, Reproducibility and replicability in science; Kingma DP, 2014, Arxiv, DOI [arXiv:1312.6114, 10.48550/arXiv.1312.6114]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quinlan J. R., 2014, C4.5: Programs for Machine Learning; Quinlan J.R., 1987, Ijcai, P304; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Ruiqurm, 2018, Kaggle; Tan S, 2018, PROCEEDINGS OF THE 2018 AAAI/ACM CONFERENCE ON AI, ETHICS, AND SOCIETY (AIES'18), P303, DOI 10.1145/3278721.3278725; van de Schoot R, 2021, NAT REV METHOD PRIME, V1, DOI [10.1038/s43586-020-00001-2, 10.1038/s43586-021-00017-2]; Van Rossum G., 2009, Python 3 Reference Manual; Wand M.P., 1994, Kernel smoothing, DOI DOI 10.1201/B14876; Wang F, 2015, JMLR WORKSH CONF PRO, V38, P1013; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Zhou YC, 2018, Arxiv, DOI arXiv:1808.07573; Zhou ZZ, 2021, KDD '21: PROCEEDINGS OF THE 27TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P2429, DOI 10.1145/3447548.3467274	46	0	0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0885-6125	1573-0565		MACH LEARN	Mach. Learn.	2024 AUG 5	2024										10.1007/s10994-024-06597-w	http://dx.doi.org/10.1007/s10994-024-06597-w		AUG 2024	44	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	A6U0Z		hybrid			2024-09-18	WOS:001283857800001
J	Wang, HM; Yin, YD; Zhu, ZJ				Wang, Hongmiao; Yin, Yandong; Zhu, Zheng-Jiang			Encoding LC-MS-Based Untargeted Metabolomics Data into Images toward AI-Based Clinical Diagnosis	ANALYTICAL CHEMISTRY			English	Article							ENDOSCOPIC MANAGEMENT; CANCER	Liquid chromatography-mass spectrometry (LC-MS)-based untargeted metabolomics provides comprehensive and quantitative profiling of metabolites in clinical investigations. The use of whole metabolome profiles is a promising strategy for disease diagnosis but technically challenging. Here, we developed an approach, namely MetImage, to encode LC-MS-based untargeted metabolomics data into multi-channel digital images. Then, the images that represent the comprehensive metabolome profiles can be employed for developing deep learning-based AI models toward clinical diagnosis. In this work, we demonstrated the application of MetImage for clinical screening of esophageal squamous cell carcinoma (ESCC) in a clinical cohort with 1104 participants. A convolutional neuronal network-based AI model was trained to distinguish ESCC screening positive and negative subjects using their serum metabolomics data. Superior performances such as sensitivity (85%), specificity (92%), and area under curve (0.95) were validated in an independent testing cohort (N = 442). Importantly, we demonstrated that our AI-based ESCC screening model is not a "black box". The encoded images reserved the characteristics of mass spectra from the raw LC-MS data; therefore, metabolite identifications in key image features were readily achieved. Altogether, MetImage is a unique approach that encodes raw LC-MS-based untargeted metabolomics data into images and facilitates the utilization of whole metabolome profiles for AI-based clinical applications with improved interpretability.	[Wang, Hongmiao; Yin, Yandong; Zhu, Zheng-Jiang] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 200032, Peoples R China; [Wang, Hongmiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Zheng-Jiang] Shanghai Key Lab Aging Studies, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, ZJ (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 200032, Peoples R China.; Zhu, ZJ (corresponding author), Shanghai Key Lab Aging Studies, Shanghai 201210, Peoples R China.	jiangzhu@sioc.ac.cn	zhu, zheng jiang/C-5306-2011	zhu, zheng jiang/0000-0002-3272-3567	National Natural Science Foundation of China [22022411]; National Key R&D Program of China [2022YFC3400702]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]; Shanghai Key Laboratory of Aging Studies [19DZ2260400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Shanghai Municipal Science and Technology Major Project; Shanghai Key Laboratory of Aging Studies	ACKNOWLEDGMENTS The work was supported by the National Natural Science Foundation of China (22022411) , National Key R&D Program of China (2022YFC3400702) , Shanghai Municipal Science and Technology Major Project (2019SHZDZX02) , and Shanghai Key Laboratory of Aging Studies (19DZ2260400) .	Alseekh S, 2021, NAT METHODS, V18, P747, DOI 10.1038/s41592-021-01197-1; Alzubaidi L, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00444-8; Bianco S, 2018, NAT GENET, V50, P662, DOI 10.1038/s41588-018-0098-8; Buergel T, 2022, NAT MED, V28, P2309, DOI 10.1038/s41591-022-01980-3; Cadow J, 2021, BIOINFORMATICS, V37, pI245, DOI 10.1093/bioinformatics/btab311; Codipilly DC, 2018, GASTROINTEST ENDOSC, V88, P413, DOI 10.1016/j.gie.2018.04.2352; DeBerardinis RJ, 2022, CELL, V185, P2678, DOI 10.1016/j.cell.2022.06.029; di Pietro M, 2018, GASTROENTEROLOGY, V154, P421, DOI 10.1053/j.gastro.2017.07.041; Dinges SS, 2019, NAT REV UROL, V16, P339, DOI 10.1038/s41585-019-0185-3; Gilpin LH, 2018, PR INT CONF DATA SC, P80, DOI 10.1109/DSAA.2018.00018; He K., 2016, PROC IEEE C COMPUTER, DOI [DOI 10.1109/CVPR.2016.90, 10.1109/CVPR.2016.90]; Hilvo M, 2020, EUR HEART J, V41, P371, DOI 10.1093/eurheartj/ehz387; Hilvo M, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.570628; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Kachroo P, 2022, NAT MED, V28, P814, DOI 10.1038/s41591-022-01714-5; Kang M, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab454; Karlstaedt A, 2022, NAT REV CARDIOL, V19, P414, DOI 10.1038/s41569-022-00698-6; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim JA, 2017, CHIN CLIN ONCOL, V6, DOI 10.21037/cco.2017.09.05; Lao-Sirieix P, 2012, NAT REV CLIN ONCOL, V9, P278, DOI 10.1038/nrclinonc.2012.35; Levitsky LI, 2019, J PROTEOME RES, V18, P709, DOI 10.1021/acs.jproteome.8b00717; Li X, 2021, J CANCER, V12, P3190, DOI 10.7150/jca.54429; Lin D, 2021, LANCET DIGIT HEALTH, V3, P486; López-López A, 2018, EXPERT REV MOL DIAGN, V18, P557, DOI 10.1080/14737159.2018.1481391; Lv JL, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.419; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Nemet I, 2020, CELL, V180, P862, DOI 10.1016/j.cell.2020.02.016; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Shen X., 2022, CHEM ENG J, V23; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56; Vaughan TL, 2015, NAT REV GASTRO HEPAT, V12, P243, DOI 10.1038/nrgastro.2015.24; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang FF, 2020, J AM SOC MASS SPECTR, V31, P2296, DOI 10.1021/jasms.0c00254	36	5	5	15	49	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	APR 12	2023	95	16					6533	6541		10.1021/acs.analchem.2c05079	http://dx.doi.org/10.1021/acs.analchem.2c05079		APR 2023	9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	E5TI0	37042095				2024-09-18	WOS:000970550700001
J	Amorim, JP; Abreu, PH; Santos, J; Cortes, M; Vila, V				Amorim, Jose P.; Abreu, Pedro H.; Santos, Joao; Cortes, Marc; Vila, Victor			Evaluating the faithfulness of saliency maps in explaining deep learning models using realistic perturbations	INFORMATION PROCESSING & MANAGEMENT			English	Article						Deep learning; Interpretability; Saliency map; Convolutional neural network	NEURAL-NETWORK	Deep Learning has reached human-level performance in several medical tasks including clas-sification of histopathological images. Continuous effort has been made at finding effective strategies to interpret these types of models, among them saliency maps, which depict the weights of the pixels on the classification as an heatmap of intensity values, have been by far the most used for image classification. However, there is a lack of tools for the systematic evaluation of saliency maps, and existing works introduce non-natural noise such as random or uniform values. To address this issue, we propose an approach to evaluate the faithfulness of the saliency maps by introducing natural perturbations in the image, based on oppose-class substitution, and studying their impact on evaluation metrics adapted from saliency models. We validate the proposed approach on a breast cancer metastases detection dataset PatchCamelyon with 327,680 patches of histopathological images of sentinel lymph node sections. Results show that GradCAM, Guided-GradCAM and gradient-based saliency map methods are sensitive to natural perturbations and correlate to the presence of tumor evidence in the image. Overall, this approach proves to be a solution for the validation of saliency map methods without introducing confounding variables and shows potential for application on other medical imaging tasks.	[Amorim, Jose P.; Abreu, Pedro H.] Univ Coimbra, CISUC, Dept Informat Engn, Coimbra, Portugal; [Amorim, Jose P.; Santos, Joao] IPO Porto Res Ctr, Porto, Portugal; [Cortes, Marc; Vila, Victor] Leitat Technol Ctr, Barcelona, Spain	Universidade de Coimbra	Amorim, JP (corresponding author), IPO Porto Res Ctr, Porto, Portugal.	jpamorim@dei.uc.pt; pha@dei.uc.pt; joao.santos@ipoporto.min-saude.pt; mcortes@leitat.org; vjvila@leitat.org	Santos, João/E-4373-2018; Abreu, Pedro/ABE-1698-2020	CORTES, Marc/0000-0003-0198-7372; Miranda dos Santos, Joao Antonio/0000-0003-2465-5143; Henriques Abreu, Pedro/0000-0002-9278-8194; Amorim, Jose/0000-0002-9477-0078				Adebayo J, 2018, ADV NEUR IN, V31; Alqaraawi A, 2020, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON INTELLIGENT USER INTERFACES, IUI 2020, P275, DOI 10.1145/3377325.3377519; Alvarez-Melis D., 2017, P 2017 C EMP METH NA, P412, DOI DOI 10.18653/V1/D17-1042; Amorim JP, 2023, IEEE REV BIOMED ENG, V16, P192, DOI 10.1109/RBME.2021.3131358; Amorim JP, 2020, IEEE IJCNN, DOI 10.1109/ijcnn48605.2020.9206800; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bándi P, 2019, IEEE T MED IMAGING, V38, P550, DOI 10.1109/TMI.2018.2867350; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Brinker TJ, 2019, EUR J CANCER, V111, P148, DOI 10.1016/j.ejca.2019.02.005; Bylinskii Z, 2019, IEEE T PATTERN ANAL, V41, P740, DOI 10.1109/TPAMI.2018.2815601; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dhurandhar A, 2018, ADV NEUR IN, V31; Graziani M, 2023, ARTIF INTELL REV, V56, P3473, DOI 10.1007/s10462-022-10256-8; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hooker S, 2019, ADV NEUR IN, V32; Liu P, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2019.102099; Meudec Raphael, 2021, Zenodo; Molnar C., 2019, INTERPRETABLE MACHIN, P247; Nemirovsky Daniel, 2022, Uncertainty in Artificial Intelligence, P1488; Ong MLH, 2016, WORLD J GASTRO SURG, V8, P179, DOI 10.4240/wjgs.v8.i3.179; Panigutti C, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2021.102657; Poyiadzi R., 2020, FACE: Feasible and actionable counterfactual explanations, P344; Riche N, 2013, IEEE I CONF COMP VIS, P1153, DOI 10.1109/ICCV.2013.147; Samek W, 2017, IEEE T NEUR NET LEAR, V28, P2660, DOI 10.1109/TNNLS.2016.2599820; Selbst AD, 2017, INT DATA PRIV LAW, V7, P233, DOI 10.1093/idpl/ipx022; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Simonyan K, 2014, INT C LEARN REPR ICL; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Smilkov D, 2017, ICML WORKSH VIS DEEP, V2017, P1, DOI [DOI 10.48550/ARXIV.1706.03825, 10.48550/arXiv.1706.03825]; Sundararajan M, 2017, PR MACH LEARN RES, V70; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tjoa E, 2021, IEEE T NEUR NET LEAR, V32, P4793, DOI 10.1109/TNNLS.2020.3027314; Tomsett R, 2020, AAAI CONF ARTIF INTE, V34, P6021; van Diest Paul J, 2010, Breast Dis, V31, P65, DOI 10.3233/BD-2010-0298; Veeling BS, 2018, LECT NOTES COMPUT SC, V11071, P210, DOI 10.1007/978-3-030-00934-2_24; Vilone G, 2021, INFORM FUSION, V76, P89, DOI 10.1016/j.inffus.2021.05.009; Yona G, 2021, P WORKSHOP EXPLAINAB, DOI DOI 10.48550/ARXIV.2110.14297; Zeiler M. D., 2013, ECCV; Zhang ZJ, 2022, INFORM PROCESS MANAG, V59, DOI 10.1016/j.ipm.2022.102988	40	12	13	4	11	ELSEVIER SCI LTD	London	125 London Wall, London, ENGLAND	0306-4573	1873-5371		INFORM PROCESS MANAG	Inf. Process. Manage.	MAR	2023	60	2							103225	10.1016/j.ipm.2022.103225	http://dx.doi.org/10.1016/j.ipm.2022.103225		DEC 2022	14	Computer Science, Information Systems; Information Science & Library Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Information Science & Library Science	7S9AA					2024-09-18	WOS:000911042300001
J	Liang, YL; Gharipour, A; Kelemen, E; Kelemen, A				Liang, Yulan; Gharipour, Amin; Kelemen, Erik; Kelemen, Arpad			Homogeneous Ensemble Feature Selection for Mass Spectrometry Data Prediction in Cancer Studies	MATHEMATICS			English	Article						ensemble feature selection; machine learning; mass spectrometry proteomics; ovarian cancer; prediction	CLINICAL PROTEOMICS; VARIABLE SELECTION; OVARIAN; BIOMARKERS; DISEASE; KRAS	The identification of important proteins is critical for the medical diagnosis and prognosis of common diseases. Diverse sets of computational tools have been developed for omics data reduction and protein selection. However, standard statistical models with single-feature selection involve the multi-testing burden of low power with limited available samples. Furthermore, high correlations among proteins with high redundancy and moderate effects often lead to unstable selections and cause reproducibility issues. Ensemble feature selection in machine learning (ML) may identify a stable set of disease biomarkers that could improve the prediction performance of subsequent classification models and thereby simplify their interpretability. In this study, we developed a three-stage homogeneous ensemble feature selection (HEFS) approach for both identifying proteins and improving prediction accuracy. This approach was implemented and applied to ovarian cancer proteogenomics datasets comprising (1) binary putative homologous recombination deficiency (HRD)- positive or -negative samples; (2) multiple mRNA classes (differentiated, proliferative, immunoreactive, mesenchymal, and unknown samples). We conducted and compared various ML methods with HEFS including random forest (RF), support vector machine (SVM), and neural network (NN) for predicting both binary and multiple-class outcomes. The results indicated that the prediction accuracies varied for both binary and multiple-class classifications using various ML approaches with the proposed HEFS method. RF and NN provided better prediction accuracies than simple Naive Bayes or logistic models. For binary outcomes, with a sample size of 122 and nine selected prediction proteins using our proposed three-stage HEFS approach, the best ensemble ML (Treebag) achieved 83% accuracy, 85% sensitivity, and 81% specificity. For multiple (five)-class outcomes, the proposed HEFS-selected proteins combined with Principal Component Analysis (PCA) in NN resulted in prediction accuracies for multiple-class classifications ranging from 75% to 96% for each of the five classes. Despite the different prediction accuracies of the various models, HEFS identified consistent sets of proteins linked to the binary and multiple-class outcomes.	[Liang, Yulan] Univ Maryland Baltimore, Dept Family & Community Hlth, Baltimore, MD 21201 USA; [Gharipour, Amin] Griffith Univ, Sch Informat & Commun Technol, Gold Coast Campus, Brisbane, Qld 4222, Australia; [Kelemen, Erik] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Kelemen, Arpad] Univ Maryland Baltimore, Dept Org Syst & Adult Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Griffith University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Liang, YL (corresponding author), Univ Maryland Baltimore, Dept Family & Community Hlth, Baltimore, MD 21201 USA.	liang@umaryland.edu; amin.gharipour@griffithuni.edu.au; kelemen.erik@gmail.com; kelemen@umaryland.edu					We thank Johns Hopkins University for providing the data.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Baggerly KA, 2005, JNCI-J NATL CANCER I, V97, P307, DOI 10.1093/jnci/dji008; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Bannach-Brown A, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-0942-7; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bin Goh WW, 2019, BRIEF BIOINFORM, V20, P347, DOI 10.1093/bib/bbx128; Bin Goh WW, 2016, J PROTEOME RES, V15, P3167, DOI 10.1021/acs.jproteome.6b00402; Boja ES, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-22; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Brenner DE, 2007, CANCER EPIDEM BIOMAR, V16, P1918, DOI 10.1158/1055-9965.EPI-07-2619; Budhraja S, 2023, BRIEF BIOINFORM, V24, DOI 10.1093/bib/bbad382; Capriotti E, 2011, GENOMICS, V98, P310, DOI 10.1016/j.ygeno.2011.06.010; Cavalcante MD, 2016, BIOMARK RES, V4, DOI 10.1186/s40364-016-0055-6; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng LH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92864-y; Choi J, 2017, STAT BIOSCI, V9, P1, DOI 10.1007/s12561-016-9144-1; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; Crutchfield CA, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-015-9102-9; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Friedman JH, 2009, The Elements of Statistical Learning - Data Mining, Inference and Prediction, V2, P1, DOI DOI 10.1007/B94608; Goh WWB, 2016, J BIOINF COMPUT BIOL, V14, DOI 10.1142/S0219720016500293; Hathout Y, 2015, EXPERT REV PROTEOMIC, V12, P329, DOI 10.1586/14789450.2015.1064771; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Kuhn M., 2019, Applied Predictive Modeling; Liang YL, 2007, STAT METHODS MED RES, V16, P139, DOI 10.1177/0962280206071927; Liang YL, 2019, STAT APPL GENET MOL, V18, DOI 10.1515/sagmb-2018-0039; Liang YL, 2018, BRIEF BIOINFORM, V19, P1051, DOI 10.1093/bib/bbx036; Liang YL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-354; Liang Yulan, 2005, Int J Bioinform Res Appl, V1, P399, DOI 10.1504/IJBRA.2005.008443; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; McShane LM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-220; Neumann U, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0142-8; Neumann U, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0114-4; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Ruggles KV, 2017, MOL CELL PROTEOMICS, V16, P959, DOI 10.1074/mcp.MR117.000024; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Simon R, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv153; Tewari D, 2015, J CLIN ONCOL, V33, P1460, DOI 10.1200/JCO.2014.55.9898; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tucker SL, 2014, CLIN CANCER RES, V20, P3280, DOI 10.1158/1078-0432.CCR-14-0445; Walsh CS, 2015, GYNECOL ONCOL, V137, P343, DOI 10.1016/j.ygyno.2015.02.017; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Wang J, 2017, MOL CELL PROTEOMICS, V16, P121, DOI 10.1074/mcp.M116.060301; Wang W, 2017, DRUG DISCOV TODAY, V22, P912, DOI 10.1016/j.drudis.2016.12.006; Wen HJ, 2018, NATL SCI REV, V5, P619, DOI 10.1093/nsr/nwy021; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069	52	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-7390		MATHEMATICS-BASEL	Mathematics	JUL	2024	12	13							2085	10.3390/math12132085	http://dx.doi.org/10.3390/math12132085			15	Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	YJ2F4		gold			2024-09-18	WOS:001268050300001
J	Chen, KL; Cao, JS; Zhang, X; Wang, X; Zhao, XY; Li, QC; Chen, S; Wang, P; Liu, TL; Du, J; Liu, SY; Zhang, LC				Chen, Kaili; Cao, Jiashi; Zhang, Xin; Wang, Xiang; Zhao, Xiangyu; Li, Qingchu; Chen, Song; Wang, Peng; Liu, Tielong; Du, Juan; Liu, Shiyuan; Zhang, Lichi			Differentiation between spinal multiple myeloma and metastases originated from lung using multi-view attention-guided network	FRONTIERS IN ONCOLOGY			English	Article						multiple myeloma (MM); spinal metastases; lung cancer; deep learning; attention guidance strategy; radiomics	BONE METASTASES; UNKNOWN ORIGIN; MANAGEMENT; DIAGNOSIS	PurposeMultiple myeloma (MM) and metastasis originated are the two common malignancy diseases in the spine. They usually show similar imaging patterns and are highly demanded to differentiate for precision diagnosis and treatment planning. The objective of this study is therefore to construct a novel deep-learning-based method for effective differentiation of two diseases, with the comparative study of traditional radiomics analysis. MethodsWe retrospectively enrolled a total of 217 patients with 269 lesions, who were diagnosed with spinal MM (79 cases, 81 lesions) or spinal metastases originated from lung cancer (138 cases, 188 lesions) confirmed by postoperative pathology. Magnetic resonance imaging (MRI) sequences of all patients were collected and reviewed. A novel deep learning model of the Multi-view Attention-Guided Network (MAGN) was constructed based on contrast-enhanced T1WI (CET1) sequences. The constructed model extracts features from three views (sagittal, coronal and axial) and fused them for a more comprehensive differentiation analysis, and the attention guidance strategy is adopted for improving the classification performance, and increasing the interpretability of the method. The diagnostic efficiency among MAGN, radiomics model and the radiologist assessment were compared by the area under the receiver operating characteristic curve (AUC). ResultsAblation studies were conducted to demonstrate the validity of multi-view fusion and attention guidance strategies: It has shown that the diagnostic model using multi-view fusion achieved higher diagnostic performance [ACC (0.79), AUC (0.77) and F1-score (0.67)] than those using single-view (sagittal, axial and coronal) images. Besides, MAGN incorporating attention guidance strategy further boosted performance as the ACC, AUC and F1-scores reached 0.81, 0.78 and 0.71, respectively. In addition, the MAGN outperforms the radiomics methods and radiologist assessment. The highest ACC, AUC and F1-score for the latter two methods were 0.71, 0.76 & 0.54, and 0.69, 0.71, & 0.65, respectively. ConclusionsThe proposed MAGN can achieve satisfactory performance in differentiating spinal MM between metastases originating from lung cancer, which also outperforms the radiomics method and radiologist assessment.	[Chen, Kaili; Du, Juan] Naval Med Univ, Shanghai Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol,Changzheng Hosp, Huangpu, Peoples R China; [Cao, Jiashi] Navy Med Univ, Hosp Chinese Peoples Liberat Army 455, Shanghai Hosp 455, Dept Orthoped, Shanghai, Peoples R China; [Cao, Jiashi; Liu, Tielong] Navy Med Univ, Shanghai Changzheng Hosp, Spine Tumor Ctr, Dept Orthopaed Oncol,Changzheng Hosp, Huangpu, Peoples R China; [Zhang, Xin; Zhao, Xiangyu; Zhang, Lichi] Shanghai Jiao Tong Univ, Inst Med Image Technol, Sch Biomed Engn, Shanghai, Peoples R China; [Wang, Xiang; Li, Qingchu; Chen, Song; Wang, Peng; Liu, Shiyuan] Navy Med Univ, Changzheng Hosp, Shanghai Changzheng Hosp, Dept Radiol, Huangpu, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Naval Medical University	Du, J (corresponding author), Naval Med Univ, Shanghai Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol,Changzheng Hosp, Huangpu, Peoples R China.; Zhang, LC (corresponding author), Shanghai Jiao Tong Univ, Inst Med Image Technol, Sch Biomed Engn, Shanghai, Peoples R China.; Liu, SY (corresponding author), Navy Med Univ, Changzheng Hosp, Shanghai Changzheng Hosp, Dept Radiol, Huangpu, Peoples R China.	juan_du@live.com; cjr.liushiyuan@vip.163.com; lichizhang@sjtu.edu.cn	xin, baoquan/ISB-5957-2023; wang, liangyu/KHD-1769-2024; Li, Qingchu/AAE-5217-2022; PENG, CHENG/KCL-2506-2024		National Natural Science Foundation of China [82001812, 62001292]; Pyramid Talent Project of Shanghai Changzheng Hospital; key project of the National Natural Science Foundation of China [81930049]; Shanghai Science and Technology Commission [19411951300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pyramid Talent Project of Shanghai Changzheng Hospital; key project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This study was funded by the National Natural Science Foundation of China (Grant number 82001812; 62001292), Pyramid Talent Project of Shanghai Changzheng Hospital, The key project of the National Natural Science Foundation of China (grant number 81930049); Shanghai Science and Technology Commission (grant number 19411951300).	Bollen L, 2018, EUR J CANCER, V104, P81, DOI 10.1016/j.ejca.2018.08.028; Brigle K, 2017, SEMIN ONCOL NURS, V33, P225, DOI 10.1016/j.soncn.2017.05.012; Castillo TJMM, 2022, CANCERS, V14, DOI 10.3390/cancers14010012; Chee CG, 2021, EUR RADIOL, V31, P6825, DOI 10.1007/s00330-021-07832-x; Cowan AJ, 2022, JAMA-J AM MED ASSOC, V327, P464, DOI 10.1001/jama.2022.0003; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gui CC, 2022, J NEUROSURG-SPINE, V36, P294, DOI 10.3171/2021.3.SPINE201534; Hwang H, 2021, DIAGN INTERV IMAG, V102, P611, DOI 10.1016/j.diii.2021.05.009; Jiang XR, 2021, J MAGN RESON IMAGING, V54, P497, DOI 10.1002/jmri.27579; Jin ZC, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.874847; Lang N, 2019, MAGN RESON IMAGING, V64, P4, DOI 10.1016/j.mri.2019.02.013; Lang N, 2013, MAGN RESON IMAGING, V31, P1285, DOI 10.1016/j.mri.2012.10.006; Li KP, 2018, PROC CVPR IEEE, P9215, DOI 10.1109/CVPR.2018.00960; Liu JF, 2022, EUR RADIOL, V32, P572, DOI 10.1007/s00330-021-08150-y; Pare GE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208860; Pearce T, 2012, BRIT J RADIOL, V85, P1102, DOI 10.1259/bjr/30649204; Piccioli A, 2015, J ORTHOP TRAUMATOL, V16, P81, DOI 10.1007/s10195-015-0344-0; Ren MH, 2021, MED PHYS, V48, P5142, DOI 10.1002/mp.15137; ROUGRAFF BT, 1993, J BONE JOINT SURG AM, V75A, P1276, DOI 10.2106/00004623-199309000-00003; Sahgal A, 2021, LANCET ONCOL, V22, P1023, DOI 10.1016/S1470-2045(21)00196-0; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shigematsu Y, 2014, AM J NEURORADIOL, V35, P2013, DOI 10.3174/ajnr.A4012; Tang HS, 2018, MAGN RESON IMAGING C, V26, P559, DOI 10.1016/j.mric.2018.06.010; van de Donk NWCJ, 2021, LANCET, V397, P410, DOI 10.1016/S0140-6736(21)00135-5; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Wakabayashi K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92363-0; Wang QZ, 2021, J BONE ONCOL, V27, DOI 10.1016/j.jbo.2021.100354; Wang X, 2019, EUR RADIOL, V29, P6049, DOI 10.1007/s00330-019-06084-0; Xing XY, 2020, BRIT J RADIOL, V93, DOI 10.1259/bjr.20190891; Xiong X, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.601699; Yin P, 2019, J MAGN RESON IMAGING, V49, P752, DOI 10.1002/jmri.26238; Zhang JH, 2020, EUR SPINE J, V29, P1061, DOI 10.1007/s00586-019-06213-9; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319	33	5	5	1	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2234-943X			FRONT ONCOL	Front. Oncol.	SEP 8	2022	12								981769	10.3389/fonc.2022.981769	http://dx.doi.org/10.3389/fonc.2022.981769			12	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	4Y5OK	36158659	Green Published, gold			2024-09-18	WOS:000861577000001
J	Deng, QR; Wang, Z; Xiang, ST; Wang, QH; Liu, YF; Hou, TJ; Sun, HY				Deng, Qirui; Wang, Zhe; Xiang, Sutong; Wang, Qinghua; Liu, Yifei; Hou, Tingjun; Sun, Huiyong			RLpMIEC: High-Affinity Peptide Generation Targeting Major Histocompatibility Complex-I Guided and Interpreted by Interaction Spectrum-Navigated Reinforcement Learning	JOURNAL OF CHEMICAL INFORMATION AND MODELING			English	Article							MHC CLASS-I; ANTIGEN PRESENTATION; INTERACTION INTERFACE; NEOANTIGEN VACCINE; BINDING; PREDICTION; CANCER; RESPONSES; BLOCKADE; DYNAMICS	Major histocompatibility complex (MHC) plays a vital role in presenting epitopes (short peptides from pathogenic proteins) to T-cell receptors (TCRs) to trigger the subsequent immune responses. Vaccine design targeting MHC generally aims to find epitopes with a high binding affinity for MHC presentation. Nevertheless, to find novel epitopes usually requires high-throughput screening of bulk peptide database, which is time-consuming, labor-intensive, more unaffordable, and very expensive. Excitingly, the past several years have witnessed the great success of artificial intelligence (AI) in various fields, such as natural language processing (NLP, e.g., GPT-4), protein structure prediction and engineering (e.g., AlphaFold2), and so on. Therefore, herein, we propose a deep reinforcement-learning (RL)-based generative algorithm, RLpMIEC, to quantitatively design peptide targeting MHC-I systems. Specifically, RLpMIEC combines the energetic spectrum (namely, the molecular interaction energy component, MIEC) based on the peptide-MHC interaction and the sequence information to generate peptides with strong binding affinity and precise MIEC spectra to accelerate the discovery of candidate peptide vaccines. RLpMIEC performs well in all the generative capability evaluations and can generate peptides with strong binding affinities and precise MIECs and, moreover, with high interpretability, demonstrating its powerful capability in participation for accelerating peptide-based vaccine development.	[Deng, Qirui; Xiang, Sutong; Wang, Qinghua; Sun, Huiyong] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Zhe; Liu, Yifei; Hou, Tingjun] Zhejiang Univ, Innovat Inst Artificial Intelligence Med, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China; [Wang, Zhe] Hangzhou Normal Univ, Sch Pharm, Hangzhou 311121, Peoples R China	China Pharmaceutical University; Zhejiang University; Hangzhou Normal University	Sun, HY (corresponding author), China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China.; Hou, TJ (corresponding author), Zhejiang Univ, Innovat Inst Artificial Intelligence Med, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China.	tingjunhou@zju.edu.cn; huiyongsun@cpu.edu.cn	Wang, Qinghua/GVT-3252-2022; Hou, Tingjun/C-7492-2011; Sun, Huiyong/N-4102-2013	Hou, Tingjun/0000-0001-7227-2580; Sun, Huiyong/0000-0002-7107-7481	National Natural Science Foundation of China [22220102001, 22303082, 81603031]; Young Elite Scientists Sponsorship Program by CPU [1131810011, 1132010013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Elite Scientists Sponsorship Program by CPU	This work was supported the National Natural Science Foundation of China (22220102001, 22303082, and 81603031) and the Young Elite Scientists Sponsorship Program by CPU (1131810011 and 1132010013).	Albert BA, 2023, NAT MACH INTELL, V5, P861, DOI 10.1038/s42256-023-00694-6; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Augusto DG, 2023, NATURE, V620, P128, DOI 10.1038/s41586-023-06331-x; Bell DR, 2021, J CHEM THEORY COMPUT, V17, P7962, DOI 10.1021/acs.jctc.1c00870; Berkers CR, 2015, J IMMUNOL, V195, P4085, DOI 10.4049/jimmunol.1402455; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blaschke T, 2020, J CHEM INF MODEL, V60, P5918, DOI 10.1021/acs.jcim.0c00915; Bonsack M, 2019, CANCER IMMUNOL RES, V7, P719, DOI 10.1158/2326-6066.CIR-18-0584; Bravi B, 2021, CELL SYST, V12, P195, DOI 10.1016/j.cels.2020.11.005; Brown T., 2020, P ADV NEURAL INFORM, VVolume 33, P1877; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Chen ZQ, 2023, BIOINFORMATICS, V39, DOI 10.1093/bioinformatics/btad055; Chu YY, 2022, NAT MACH INTELL, V4, P300, DOI 10.1038/s42256-022-00459-7; Culshaw A, 2017, NAT IMMUNOL, V18, P1228, DOI 10.1038/ni.3850; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Devlin JR, 2020, NAT CHEM BIOL, V16, P1269, DOI 10.1038/s41589-020-0610-1; Ding B, 2013, J CHEM INF MODEL, V53, P1213, DOI 10.1021/ci400011c; Driller R, 2019, J BIOL CHEM, V294, P13269, DOI 10.1074/jbc.RA119.008937; Duperret EK, 2019, CANCER IMMUNOL RES, V7, P174, DOI 10.1158/2326-6066.CIR-18-0283; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fang YM, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac378; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gao YC, 2023, NAT MACH INTELL, V5, P236, DOI 10.1038/s42256-023-00619-3; Ge JX, 2024, CELL REP PHYS SCI, V5, DOI 10.1016/j.xcrp.2024.101980; Gfeller D, 2023, CELL SYST, V14, P72, DOI 10.1016/j.cels.2022.12.002; Grant EJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07815-5; Grazioli F, 2023, BIOINFORMATICS, V39, DOI 10.1093/bioinformatics/btac820; Gu Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08790-1; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2012, J PROTEOME RES, V11, P2982, DOI 10.1021/pr3000688; Illing PT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07109-w; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Khan AR, 2023, BIOINFORMATICS, V39, DOI 10.1093/bioinformatics/btad632; Kim Y, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-241; Kim Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-394; Li GY, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab160; Lineburg KE, 2021, IMMUNITY, V54, P1055, DOI 10.1016/j.immuni.2021.04.006; Liu JX, 2011, EUR J IMMUNOL, V41, P2097, DOI 10.1002/eji.201041370; Lu TS, 2021, NAT MACH INTELL, V3, P864, DOI 10.1038/s42256-021-00383-2; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Marijt KA, 2019, MOL IMMUNOL, V113, P43, DOI 10.1016/j.molimm.2018.03.029; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mavridis G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95786-x; Mei ST, 2020, BRIEF BIOINFORM, V21, P1119, DOI 10.1093/bib/bbz051; Miller MS, 2019, J BIOL CHEM, V294, P19322, DOI 10.1074/jbc.RA119.010251; Mishto M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02572; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Neefjes J, 2013, NAT CHEM BIOL, V9, P769, DOI [10.1038/nchembio.1391, 10.1038/NCHEMBIO.1391]; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nguyen AT, 2021, BIOPHYSICA-BASEL, V1, P194, DOI 10.3390/biophysica1020015; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; O'Donnell TJ, 2020, CELL SYST, V11, P418, DOI 10.1016/j.cels.2020.09.001; O'Donnell TJ, 2018, CELL SYST, V7, P129, DOI 10.1016/j.cels.2018.05.014; OpenAI, 2023, GPT 4 TECHN REP, DOI DOI 10.48550/ARXIV.2303.08774; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pei BK, 2020, IMMUNOGENETICS, V72, P295, DOI 10.1007/s00251-020-01163-9; Peng XA, 2023, NAT MACH INTELL, V5, P395, DOI 10.1038/s42256-023-00634-4; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Polykovskiy D, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.565644; Radford A., Improving Language Understanding by Generative Pre-Training; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rock KL, 2016, TRENDS IMMUNOL, V37, P724, DOI 10.1016/j.it.2016.08.010; Schrodinger L. L. C., 2017, THEPYMOL MOL GRAPHIC; Schutte RJ, 2018, CLIN LAB MED, V38, P669, DOI 10.1016/j.cll.2018.08.002; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Song Y, 2023, P NATL ACAD SCI USA, V120, DOI 10.1073/pnas.2214430120; Sun HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24817; Tian C, 2020, J CHEM THEORY COMPUT, V16, P528, DOI 10.1021/acs.jctc.9b00591; Trolle T, 2015, BIOINFORMATICS, V31, P2174, DOI 10.1093/bioinformatics/btv123; Trowsdale J, 2005, CURR OPIN IMMUNOL, V17, P498, DOI 10.1016/j.coi.2005.07.015; Vaswani A, 2017, ADV NEUR IN, V30; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Wang FX, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab595; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang QH, 2023, CELL REP PHYS SCI, V4, DOI 10.1016/j.xcrp.2023.101466; Wang QH, 2022, J CHEM INF MODEL, V62, P3993, DOI 10.1021/acs.jcim.2c00851; Wang XY, 2024, ACTA PHARMACOL SIN, V45, P1978, DOI 10.1038/s41401-024-01284-x; Wu JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02559; Yerly D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071464; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zhao Y, 2023, SCI ADV, V9, DOI 10.1126/sciadv.abo5128	92	0	0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9596	1549-960X		J CHEM INF MODEL	J. Chem Inf. Model.	AUG 9	2024	64	16					6432	6449		10.1021/acs.jcim.4c01153	http://dx.doi.org/10.1021/acs.jcim.4c01153		AUG 2024	18	Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science, Information Systems; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry; Computer Science	D7U8V	39118363				2024-09-18	WOS:001289119100001
J	Sadeghi, Z; Alizadehsani, R; Cifci, MA; Kausar, S; Rehman, R; Mahanta, P; Bora, PK; Almasri, A; Alkhawaldeh, RS; Hussain, S; Alatas, B; Shoeibi, A; Moosaei, H; Hladík, M; Nahavandi, S; Pardalos, PM				Sadeghi, Zahra; Alizadehsani, Roohallah; Cifci, Mehmet Akif; Kausar, Samina; Rehman, Rizwan; Mahanta, Priyakshi; Bora, Pranjal Kumar; Almasri, Ammar; Alkhawaldeh, Rami S.; Hussain, Sadiq; Alatas, Bilal; Shoeibi, Afshin; Moosaei, Hossein; Hladik, Milan; Nahavandi, Saeid; Pardalos, Panos M.			A review of Explainable Artificial Intelligence in healthcare	COMPUTERS & ELECTRICAL ENGINEERING			English	Review						Explainable AI; Transparent AI; Interpretability; Healthcare	TICK-BORNE ENCEPHALITIS; AI; IMMUNIZATION; FRAMEWORK; CANCER	Explainable Artificial Intelligence (XAI) encompasses the strategies and methodologies used in constructing AI systems that enable end -users to comprehend and interpret the outputs and predictions made by AI models. The increasing deployment of opaque AI applications in highstakes fields, particularly healthcare, has amplified the need for clarity and explainability. This stems from the potential high -impact consequences of erroneous AI predictions in such critical sectors. The effective integration of AI models in healthcare hinges on the capacity of these models to be both explainable and interpretable. Gaining the trust of healthcare professionals necessitates AI applications to be transparent about their decision -making processes and underlying logic. Our paper conducts a systematic review of the various facets and challenges of XAI within the healthcare realm. It aims to dissect a range of XAI methodologies and their applications in healthcare, categorizing them into six distinct groups: feature -oriented methods, global methods, concept models, surrogate models, local pixel -based methods, and human -centric approaches. Specifically, this study focuses on the significance of XAI in addressing healthcarerelated challenges, underscoring its vital role in safety -critical scenarios. Our objective is to provide an exhaustive exploration of XAI's applications in healthcare, alongside an analysis of relevant experimental outcomes, thereby fostering a holistic understanding of XAI's role and potential in this critical domain.	[Sadeghi, Zahra] Dalhousie Univ, Inst Big Data Analyt, Fac Comp Sci, Halifax, NS, Canada; [Alizadehsani, Roohallah] Deakin Univ, Inst Intelligent Syst Res & Innovat IISRI, Geelong, Australia; [Cifci, Mehmet Akif] Tu Wien Univ, Inst Comp Technol, A-1040 Vienna, Austria; [Cifci, Mehmet Akif] Bandirma Onyedi Eylul Univ, Dept Comp Engn, TR-10200 Balikesir, Turkiye; [Cifci, Mehmet Akif] Klaipedos Valstybine Kolegija Higher Educ Inst, Engn & Informat Dept, LT-92294 Klaipeda, Lithuania; [Kausar, Samina] Univ Kotli Azad Jammu & Kashmir, Kotli Azad Kashmir, Pakistan; [Rehman, Rizwan; Mahanta, Priyakshi; Bora, Pranjal Kumar] Dibrugarh Univ, Ctr Comp Sci & Applicat, Dibrugarh, Assam, India; [Almasri, Ammar] Al Balqa Appl Univ, Dept Management Informat Sys, Salt 19117, Jordan; [Alkhawaldeh, Rami S.] Univ Jordan, Dept Comp Informat Syst, Aqaba 77110, Jordan; [Hussain, Sadiq] Dibrugarh Univ, Examinat Branch, Dibrugarh, Assam, India; [Alatas, Bilal] Firat Univ, Dept Software Engn, TR-23100 Elazig, Turkiye; [Shoeibi, Afshin] Univ Granada, Data Sci & Computat Intelligence Inst, Granada, Spain; [Moosaei, Hossein] Jan Evangelista Purkyne Univ Usti nad Labem, Fac Sci, Dept Informat, Usti Nad Labem, Czech Republic; [Moosaei, Hossein] Prague Univ Econ & Business, Fac Informat & Stat, Dept Econometr, Prague, Czech Republic; [Hladik, Milan] Charles Univ Prague, Fac Math & Phys, Sch CS, Dept Appl Math, Prague, Czech Republic; [Nahavandi, Saeid] Swinburne Univ Technol, Hawthorn, Australia; [Pardalos, Panos M.] Univ Florida, Dept Ind & Syst Engn, Ctr Appl Optimizat, Gainesville, FL 32611 USA; [Pardalos, Panos M.] HSE Univ, Lab LATNA, Rodionova St 136, Nizhnii Novgorod, Russia	Dalhousie University; Deakin University; Technische Universitat Wien; Balikesir University; Bandirma Onyedi Eylul University; Dibrugarh University; Al-Balqa Applied University; University of Jordan; Dibrugarh University; Firat University; University of Granada; University of Jan Evangelista Purkyne; Prague University of Economics & Business; Charles University Prague; Swinburne University of Technology; State University System of Florida; University of Florida	Alizadehsani, R (corresponding author), Deakin Univ, Inst Intelligent Syst Res & Innovat IISRI, Geelong, Australia.	r.alizadehsani@deakin.edu.au	Rehman, Rizwan/KEH-0399-2024; Nahavandi, Saeid/AAE-5536-2022; Alkhawaldeh, Rami/O-2950-2018; cifci, Mehmet/V-2885-2018; Alatas, Bilal/W-4747-2018; Almasri, Ammar/ABI-8115-2020; Hussain, Sadiq/ABA-9849-2020; Alizadehsani, Roohallah/ABA-6810-2022; Shoeibi, Afshin/AAT-3624-2020; Moosaei, Hossein/AAG-2289-2021	Alizadehsani, Roohallah/0000-0003-0898-5054; Moosaei, Hossein/0000-0002-0640-2161	Czech Science Foundation [22-11117S, 22-19353S]	Czech Science Foundation(Grant Agency of the Czech Republic)	The work of H. Moosaei was supported by the Czech Science Foundation Grant 22-19353S. Milan Hladik was supported by the Czech Science Foundation Grant 22-11117S. The work of P.M. Pardalos PM was conducted within the framework of the Basic Research Program at the National Research University Higher School of Economics (HSE) .	Adadi A, 2018, IEEE ACCESS, V6, P52138, DOI 10.1109/ACCESS.2018.2870052; Agarwal N, 2023, COMPUT APPL ENG EDUC, V31, P728, DOI 10.1002/cae.22602; Agarwal N, 2022, MULTIMED TOOLS APPL, V81, P34129, DOI 10.1007/s11042-022-13180-9; Ahmad I, 2024, J INF SECUR APPL, V80, DOI 10.1016/j.jisa.2023.103654; Al-Shedivat M, 2020, J MACH LEARN RES, V21; Alamatsaz N, 2024, BIOMED SIGNAL PROCES, V90, DOI 10.1016/j.bspc.2023.105884; Albahri A.S., 2023, Information Fusion; Ali S, 2023, COMPUT BIOL MED, V166, DOI 10.1016/j.compbiomed.2023.107555; Alicioglu G, 2022, COMPUT GRAPH-UK, V102, P502, DOI 10.1016/j.cag.2021.09.002; Alizadehsani R., 2024, IEEE Access; Allgaier J, 2023, ARTIF INTELL MED, V143, DOI 10.1016/j.artmed.2023.102616; Alsubai S, 2024, PEERJ COMPUT SCI, V10, DOI 10.7717/peerj-cs.1996; Alvarez-Melis D, 2018, ADV NEUR IN, V31; Amini M., 2024, A hybrid ai framework to address the issue of frequent missing values with application in ehr systems: the case of parkinson's disease; Angelov PP, 2021, WIRES DATA MIN KNOWL, V11, DOI 10.1002/widm.1424; [Anonymous], 2015, Inceptionism: Going deeper into neural networks; Arik SO, 2021, AAAI CONF ARTIF INTE, V35, P6679; Arras L, 2017, Arxiv, DOI arXiv:1706.07206; Arun N, 2021, RADIOL-ARTIF INTELL, V3, DOI 10.1148/ryai.2021200267; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baio G, 2020, J STAT SOFTW, V95, P1, DOI 10.18637/jss.v095.i14; Band S.S., 2023, Informatics in Medicine Unlocked; Arrieta AB, 2020, INFORM FUSION, V58, P82, DOI 10.1016/j.inffus.2019.12.012; Behrad F, 2022, EXPERT SYST APPL, V200, DOI 10.1016/j.eswa.2022.117006; Bélanger S, 2023, J IMMUNOL, V210, P1752, DOI 10.4049/jimmunol.2200927; Bethge M, 2019, Arxiv, DOI arXiv:1904.00760; Bharati S., 2023, IEEE Transactions on Artificial Intelligence. Explainable artificial intelligence for education and training; Bharati S, 2023, Interpretable Cognitive Internet of Things for Healthcare, P1; Biffi C, 2020, IEEE T MED IMAGING, V39, P2088, DOI 10.1109/TMI.2020.2964499; Biswas M, 2021, BRAIN INFORM, V14; Bocheva G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22169097; Borys K, 2023, EUR J RADIOL, V162, DOI 10.1016/j.ejrad.2023.110786; Bosede Enitan Comfort, 2021, Int J Med Sci Health Res; Carcagnì P, 2023, SENSORS-BASEL, V23, DOI 10.3390/s23031694; Carrieri AP, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83922-6; Carson DL, 2000, CROP SCI, V40, P1769, DOI 10.2135/cropsci2000.4061769x; Chaddad A, 2023, SENSORS-BASEL, V23, DOI 10.3390/s23020634; Chakraborty D, 2021, CANCERS, V13, DOI 10.3390/cancers13143450; Chattopadhay A, 2018, IEEE WINT CONF APPL, P839, DOI 10.1109/WACV.2018.00097; Chen X, 2019, RELIAB ENG SYST SAFE, V181, P97, DOI 10.1016/j.ress.2018.06.016; Chittajallu DR, 2019, I S BIOMED IMAGING, P66, DOI [10.1109/isbi.2019.8759428, 10.1109/ISBI.2019.8759428]; Cho J, 2019, 2019 IEEE INT C BIG; Chou YL, 2022, INFORM FUSION, V81, P59, DOI 10.1016/j.inffus.2021.11.003; Cirqueira D, 2020, MACHINE LEARNING KNO, V4; Dave D, 2020, Arxiv, DOI arXiv:2011.03195; de Vries BM, 2023, FRONT MED-LAUSANNE, V10, DOI 10.3389/fmed.2023.1180773; Dehnoei S, 2020, Doctoral dissertation; Deperlioglu O, 2022, FUTURE GENER COMP SY, V129, P152, DOI 10.1016/j.future.2021.11.018; Eck A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1843-1; El-Sappagh S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82098-3; Ferrari D, 2020, MOL BIOTECHNOL, V62, P43, DOI 10.1007/s12033-019-00224-z; Fontes M, 2024, IEEE ACCESS, V12, P26419, DOI 10.1109/ACCESS.2024.3367606; Gauch JM, 1999, IEEE T IMAGE PROCESS, V8, P69, DOI 10.1109/83.736688; Goel Tripti, 2023, IEEE J Biomed Health Inform, VPP, DOI 10.1109/JBHI.2023.3242354; Gupta J, 2024, Arch Comput Meth Eng, P1; Hao J, 2020, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2020, P355; Hassan MR, 2022, FUTURE GENER COMP SY, V127, P462, DOI 10.1016/j.future.2021.09.030; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hendrickson R., 1984, A Survey of Sensitivity Analysis Methodology; Hier DB, 2023, 2023 IEEE C COMP INT, P1; Hinz Steffen, 2021, Tailor-made Antibodies by Multidimensional Functional Screening.; Hinz SC, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00688; Horácek J, 2018, COMPUT BIOL MED, V101, P1, DOI 10.1016/j.compbiomed.2018.07.017; Hosny KM, 2024, APPL SOFT COMPUT, V159, DOI 10.1016/j.asoc.2024.111624; Hossain MS, 2020, IEEE NETWORK, V34, P126, DOI 10.1109/MNET.011.2000458; Incerti D, 2021, Arxiv, DOI arXiv:2102.09437; Iooss B., 2015, Uncertainty Management in Simulation-Optimization of Complex Systems, P101, DOI [10.1007/978-1-4899-7547-85, DOI 10.1007/978-1-4899-7547-85, DOI 10.1007/978-1-4899-7547-8_5]; Izadyyazdanabadi M, 2018, MED IM COMP COMP A 2; Jagatheesaperumal SK, 2022, IEEE OPEN J COMM SOC, V3, P2106, DOI 10.1109/OJCOMS.2022.3215676; Jameel T., 2020, 2020 3 INT C COMP MA, P1; Jerby-Arnon L, 2022, NAT BIOTECHNOL, V40, P1467, DOI 10.1038/s41587-022-01288-0; Jung J, 2023, Heliyon; Kamal MS, 2021, IEEE T INSTRUM MEAS, V70, DOI 10.1109/TIM.2021.3107056; KAMBOMBO M, 2022, Doctoral dissertation; Kaplan A, 2019, BUS HORIZONS, V62, P15, DOI 10.1016/j.bushor.2018.08.004; Karimi M, 2019, BIOINFORMATICS, V35, P3329, DOI 10.1093/bioinformatics/btz111; Karthik Raja S, 2020, Int J Res Dermatol; Kavya R, 2021, BIOMED SIGNAL PROCES, V69, DOI 10.1016/j.bspc.2021.102681; Kim B, 2018, PR MACH LEARN RES, V80; Kinimi E, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11082206; Kleiter I, 2007, INFECTION, V35, P26, DOI 10.1007/s15010-006-6614-2; Kletz S, 2019, HEALTHC TECHNOL LETT, V6, P197, DOI 10.1049/htl.2019.0077; Komatsu M, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11010371; Kucherenko S, 2016, Derivative-based global sensitivity measures and their link with sobol'sensitivity indices. monte carlo and quasi-monte carlo methods; Kumeda B, 2019, I C COMM SOFTW NET, P682, DOI [10.1109/ICCSN.2019.8905362, 10.1109/iccsn.2019.8905362]; Lamy JB, 2019, ARTIF INTELL MED, V94, P42, DOI 10.1016/j.artmed.2019.01.001; Lauritsen SM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17431-x; Li BX, 2022, NANOSCALE, V14, P7110, DOI 10.1039/d2nr00306f; Li Xue-Peng, 2020, Comp Biochem Physiol Toxicol; Loh HW, 2022, COMPUT METH PROG BIO, V226, DOI 10.1016/j.cmpb.2022.107161; Longo L, 2020, MACHINE LEARNING KNO; Lundberg SM, 2017, ADV NEUR IN, V30; Magesh PR, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104041; Mahendran A, 2015, PROC CVPR IEEE, P5188, DOI 10.1109/CVPR.2015.7299155; Mahmoudi MR, 2021, ARTIF INTELL REV, V54, P639, DOI 10.1007/s10462-020-09862-1; Marta Hrenczuk, 2021, Transplant Proc; Meldo A, 2020, ARTIF INTELL MED, V108, DOI 10.1016/j.artmed.2020.101952; Mishra R.K., 2023, Int. J. Inf. Manag. Data Insights, V3, P100145, DOI 10.1016/j.jjimei.2022.100145; Mishra RK, 2022, LECT NOTES ELECTR EN, V929, P27, DOI 10.1007/978-981-19-5550-1_3; Mishra RK, 2022, IMAGE VISION COMPUT, V128, DOI 10.1016/j.imavis.2022.104573; Moreno Escobar J.S., 2021, Aplicacion de registro y reporte automatico de parametros fisiologicos para la trazabilidad psicofisiologica en personas post COVID-19; Muddamsetty SM, 2021, PATT REC ICPR INT WO; Musa IH, 2022, CANCER CONTROL, V29, DOI 10.1177/10732748221095946; Musa TH, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5737893; Mutanu L., 2017, A self-learning framework for validation of runtime adaptation in service-oriented systems; Nahavandi S, 2024, INFORM FUSION, V105, DOI 10.1016/j.inffus.2023.102221; Nahavandi S, 2022, Arxiv, DOI arXiv:2212.12808; Nasarian E, 2024, INFORM FUSION, V108, DOI 10.1016/j.inffus.2024.102412; Odusami M, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22030740; Oestreich MA, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0275866; Pappalardo M, 2021, J PERS MED, V11, DOI 10.3390/jpm11050402; Peng JF, 2021, J MED SYST, V45, DOI 10.1007/s10916-021-01736-5; Pietila E, 2023, MED C MED BIOL ENG C, P573; Plischke E, 2013, EUR J OPER RES, V226, P536, DOI 10.1016/j.ejor.2012.11.047; Porumb M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56927-5; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Rucco M, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8050770; Sabol P, 2020, J BIOMED INFORM, V109, DOI 10.1016/j.jbi.2020.103523; Sadeghi Z, 2019, MACHINE LEARNING OPT, V5; Saeed W, 2023, KNOWL-BASED SYST, V263, DOI 10.1016/j.knosys.2023.110273; Samek W, 2017, Arxiv, DOI arXiv:1708.08296; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Shahroudnejad A, 2021, Arxiv, DOI arXiv:2102.01792; Sheu RK, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22208068; Shin Hak Sup Park., 2019, Prep Biochem Biotechnol, P3; Shrikumar A, 2017, PR MACH LEARN RES, V70; Sigut J, 2024, SENSORS-BASEL, V24, DOI 10.3390/s24010239; Simonyan K, 2014, Arxiv, DOI [arXiv:1312.6034, DOI 10.48550/ARXIV.1312.6034]; Sudar K. Muthamil, 2022, 2022 INT C SUST COMP; Suh J, 2020, BJU INT, V126, P694, DOI 10.1111/bju.15122; Sup Shin Hak, 2019, Prep Biochem Biotechnol; Tjoa E, 2021, IEEE T NEUR NET LEAR, V32, P4793, DOI 10.1109/TNNLS.2020.3027314; van Stein B, 2022, IEEE ACCESS, V10, P103364, DOI 10.1109/ACCESS.2022.3210175; Varnaite R, 2020, J IMMUNOL, V204, P914, DOI [10.4049/jimmunol.1901115, 10.4049/jimmunol.190111]; Varzandian A, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.673120; Vieth B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12266-7; Wani NA, 2024, COMPUT METH PROG BIO, V243, DOI 10.1016/j.cmpb.2023.107879; Warman A., 2020, medRxiv; Xiang A, 2019, AMIA ANN S P; Xie F, 2020, JMIR MED INF, V8, DOI 10.2196/21798; Yang MC, 2020, CRIT CARE MED, V48, pE1091, DOI 10.1097/CCM.0000000000004550; Ye QH, 2021, COMP MED SY, P521, DOI 10.1109/CBMS52027.2021.00103; Yeboah D, 2020, IEEE ACCESS, V8, P180690, DOI 10.1109/ACCESS.2020.3027453; Yoo TK, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.2.8; Yuan H, 2023, IEEE T PATTERN ANAL, V45, P5782, DOI 10.1109/TPAMI.2022.3204236; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zent O, 2003, VACCINE, V21, P4655, DOI 10.1016/j.vaccine.2003.08.005; Zhang JD, 2023, ACS CENTRAL SCI, V9, P1035, DOI 10.1021/acscentsci.2c01468; Zhang Y, 2021, IEEE T EM TOP COMP I, V5, P726, DOI 10.1109/TETCI.2021.3100641; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhu SW, 2023, ANN OPER RES, V321, P717, DOI 10.1007/s10479-022-05094-4	151	4	4	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-7906	1879-0755		COMPUT ELECTR ENG	Comput. Electr. Eng.	AUG	2024	118		A						109370	10.1016/j.compeleceng.2024.109370	http://dx.doi.org/10.1016/j.compeleceng.2024.109370		JUN 2024	20	Computer Science, Hardware & Architecture; Computer Science, Interdisciplinary Applications; Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	WA3Q7		hybrid			2024-09-18	WOS:001252113300001
J	Wiberg, H; Yu, P; Montanaro, P; Mather, J; Birz, S; Schneider, M; Bertsimas, D				Wiberg, Holly; Yu, Peter; Montanaro, Pat; Mather, Jeff; Birz, Suzi; Schneider, Michelle; Bertsimas, Dimitris			Prediction of Neutropenic Events in Chemotherapy Patients: A Machine Learning Approach	JCO CLINICAL CANCER INFORMATICS			English	Article							FEBRILE NEUTROPENIA; CLINICAL ONCOLOGY; AMERICAN SOCIETY; RISK	PURPOSE Severe and febrile neutropenia present serious hazards to patients with cancer undergoing chemotherapy. We seek to develop a machine learning-based neutropenia prediction model that can be used to assess risk at the initiation of a chemotherapy cycle. MATERIALS AND METHODS We leverage rich electronic medical records (EMRs) data from a large health care system and apply machine learning methods to predict severe and febrile neutropenic events. We outline the data curation process and challenges posed by EMRs data. We explore a range of algorithms with an emphasis on model interpretability and ease of use in a clinical setting. RESULTS Our final proposed model demonstrates an out-of-sample area under the receiver operating characteristic curve of 0.865 (95% CI, 0.830 to 0.891) in the prediction of neutropenic events on the basis of only 20 clinical features. The model validates known risk factors and offers insight into potential novel clinical indicators and treatment characteristics that elevate risk. It relies on factors that are directly extractable from EMRs, provided a tool can be easily integrated into existing workflows. A cost-based analysis provides insight into optimal risk thresholds and offers a framework for tailoring algorithms to individual hospital needs. CONCLUSION A better understanding of neutropenic risk on an individual level enables a more informed approach to patient monitoring and treatment decisions.	[Wiberg, Holly; Bertsimas, Dimitris] MIT, Operat Res Ctr, Cambridge, MA 02142 USA; [Yu, Peter; Montanaro, Pat; Mather, Jeff; Birz, Suzi; Schneider, Michelle] Hartford HealthCare, Hartford, CT USA; [Bertsimas, Dimitris] MIT, Sloan Sch Management, 100 Main St,Bldg E62-560, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bertsimas, D (corresponding author), MIT, Sloan Sch Management, 100 Main St,Bldg E62-560, Cambridge, MA 02142 USA.	dbertsim@mit.edu	Wiberg, Holly/ACW-2759-2022	Birz, Suzi/0000-0002-9512-799X; Mather, Jeffrey/0000-0002-4824-2928	Hartford HealthCare; National Science Foundation [174530]	Hartford HealthCare; National Science Foundation(National Science Foundation (NSF))	Supported by a grant from Hartford HealthCare. H.W. is also supported by the National Science Foundation Graduate Research Fellowship under Grant No. 174530.	[Anonymous], 2018, NAT BIOMED ENG, V2, P709, DOI 10.1038/s41551-018-0315-x; Becker PS, 2020, J NATL COMPR CANC NE, V18, P13, DOI 10.6004/jnccn.2020.0002; Bertsimas D., 2020, SPARSE CLASSIFICATIO; Bertsimas D, 2018, Machine Learning Under a Modern Optimization Lens; Bertsimas D, 2021, MACH LEARN, V110, P185, DOI 10.1007/s10994-020-05923-2; Bertsimas D, 2017, MACH LEARN, V106, P1039, DOI 10.1007/s10994-017-5633-9; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L. I., 1984, CLASSIFICATION REGRE, V40, P358, DOI DOI 10.1002/WIDM.8; Chen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096413; Chen T., 2018, ARXIV ABS180607366; Cho BJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71927-6; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Holborow A., 2019, CLIN MED, V19, P89; Hosmer W, 2011, SUPPORT CARE CANCER, V19, P333, DOI 10.1007/s00520-010-0821-1; Kim HS, 2016, ONCOLOGY-BASEL, V91, P274, DOI 10.1159/000449226; Li E, 2021, JCO ONCOL PRACT, V17, P511, DOI 10.1200/OP.20.01047; Lyman GH, 2011, CANCER-AM CANCER SOC, V117, P1917, DOI 10.1002/cncr.25691; Pawloski PA, 2017, J AM MED INFORM ASSN, V24, pE129, DOI 10.1093/jamia/ocw131; Sendelbach S, 2013, AACN ADV CRIT CARE, V24, P378, DOI 10.1097/NCI.0b013e3182a903f9; Smith TJ, 2015, J CLIN ONCOL, V33, P3199, DOI 10.1200/JCO.2015.62.3488; Taplitz RA, 2018, J CLIN ONCOL, V36, P1443, DOI 10.1200/JCO.2017.77.6211; Trevor Hastie R.T.J.F., 2009, The elements of statistical learning: data mining, inference, and prediction, V2	22	6	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2473-4276			JCO CLIN CANCER INFO	JCO Clin. Cancer Info.	AUG	2021	5						904	911		10.1200/CCI.21.00046	http://dx.doi.org/10.1200/CCI.21.00046			8	Oncology	Emerging Sources Citation Index (ESCI)	Oncology	XC1XL	34464160	Bronze			2024-09-18	WOS:000721814300013
J	Lim, YW; Adler, AS; Johnson, DS				Lim, Yoong Wearn; Adler, Adam S.; Johnson, David S.			Predicting antibody binders and generating synthetic antibodies using deep learning	MABS			English	Article						Antibody repertoires; deep learning; machine learning; deep sequencing; convolutional neural networks; generative adversarial networks	IMMUNOGLOBULIN	The antibody drug field has continually sought improvements to methods for candidate discovery and engineering. Historically, most such methods have been laboratory-based, but informatics methods have recently started to make an impact. Deep learning, a subfield of machine learning, is rapidly gaining prominence in the biomedical research. Recent advances in microfluidics technologies and next-generation sequencing have not only revolutionized therapeutic antibody discovery, but also contributed to a vast amount of antibody repertoire sequencing data, providing opportunities for deep learning-based applications. Previously, we used microfluidics, yeast display, and deep sequencing to generate a panel of binder and non-binder antibody sequences to the cancer immunotherapy targets PD-1 and CTLA-4. Here we encoded the antibody light and heavy chain complementarity-determining regions (CDR3s) into antibody images, then built and trained convolutional neural network models to classify binders and non-binders. To improve model interpretability, we performed in silico mutagenesis to identify CDR3 residues that were important for binder classification. We further built generative deep learning models using generative adversarial network models to produce synthetic antibodies against PD-1 and CTLA-4. Our models generated variable length CDR3 sequences that resemble real sequences. Overall, our study demonstrates that deep learning methods can be leveraged to mine and learn patterns in antibody sequences, offering insights into antibody engineering, optimization, and discovery.	[Lim, Yoong Wearn; Adler, Adam S.; Johnson, David S.] GigaGen Inc A Grifols Co, 1 Tower Pl,Ste 750, San Francisco, CA 94080 USA		Johnson, DS (corresponding author), GigaGen Inc A Grifols Co, 1 Tower Pl,Ste 750, San Francisco, CA 94080 USA.	seasquirtdoctor@gmail.com		Adler, Adam/0000-0001-9301-0037; Lim, Yoong Wearn/0000-0002-8568-4901				Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Akbar R., 2021, IN SILICO PROOF PRIN; Akbar R, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108856; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Asensio MA, 2019, MABS-AUSTIN, V11, P870, DOI 10.1080/19420862.2019.1583995; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Bujotzek A, 2015, PROTEINS, V83, P681, DOI 10.1002/prot.24756; Chen X., 2020, PREDICTING ANTIBODY, P159798; Chollet Franc<comma>ois, 2017, R interface to keras; Csardi G., 2006, INTERJOURNAL 2006, V1695; Dunbar J, 2016, BIOINFORMATICS, V32, P298, DOI 10.1093/bioinformatics/btv552; Dunbar J, 2014, NUCLEIC ACIDS RES, V42, pD1140, DOI 10.1093/nar/gkt1043; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Honegger A, 2001, J MOL BIOL, V309, P657, DOI 10.1006/jmbi.2001.4662; Horst A, 2021, FRONT ARTIF INTELL, V4, DOI 10.3389/frai.2021.715462; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Jain T, 2017, BIOINFORMATICS, V33, P3758, DOI 10.1093/bioinformatics/btx519; Jespersen MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00298; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kleftogiannis D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1058; Konishi H, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2853-y; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liberis E, 2018, BIOINFORMATICS, V34, P2944, DOI 10.1093/bioinformatics/bty305; Liu F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28517; Liu G, 2020, BIOINFORMATICS, V36, P2126, DOI 10.1093/bioinformatics/btz895; Magar R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84637-4; Marks C, 2021, BIOINFORMATICS, V37, P4041, DOI 10.1093/bioinformatics/btab434; Mason DM, 2021, NAT BIOMED ENG, V5, P600, DOI 10.1038/s41551-021-00699-9; Min X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1878-3; Olimpieri PP, 2013, BIOINFORMATICS, V29, P2285, DOI 10.1093/bioinformatics/btt369; Robert PA., 2021, 1000000000 SYNTHETIC; Ruffolo JA, 2022, PATTERNS, V3, DOI 10.1016/j.patter.2021.100406; Ruffolo JA, 2020, BIOINFORMATICS, V36, P268, DOI 10.1093/bioinformatics/btaa457; Saka K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85274-7; Schneider C, 2022, BIOINFORMATICS, V38, P377, DOI 10.1093/bioinformatics/btab660; Shin JE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22732-w; Sidhom JW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21879-w; Taft JM., 2021, PREDICTIVE PROFILING; Wagih O, 2017, BIOINFORMATICS, V33, P3645, DOI 10.1093/bioinformatics/btx469; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI DOI 10.1007/978-3-319-24277-4; Zeng HY, 2016, BIOINFORMATICS, V32, P121, DOI 10.1093/bioinformatics/btw255	44	20	21	9	68	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1942-0862	1942-0870		MABS-AUSTIN	mAbs	DEC 31	2022	14	1							e2069075	10.1080/19420862.2022.2069075	http://dx.doi.org/10.1080/19420862.2022.2069075			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	0V4XR	35482911	Green Published, gold			2024-09-18	WOS:000788348200001
C	Shankar, V; Yang, XL; Krishna, V; Tan, B; Silva, O; Rojansky, R; Ng, A; Valvert, F; Briercheck, E; Weinstock, D; Natkunam, Y; Fernandez-Pol, S; Rajpurkar, P		Hegselmann, S; Parziale, A; Shanmugam, D; Tang, S; Asiedu, MN; Chang, S; Hartvigsen, T; Singh, H		Shankar, Vivek; Yang, Xiaoli; Krishna, Vrishab; Tan, Brent; Silva, Oscar; Rojansky, Rebecca; Ng, Andrew; Valvert, Fabiola; Briercheck, Edward; Weinstock, David; Natkunam, Yasodha; Fernandez-Pol, Sebastian; Rajpurkar, Pranav			LymphoML: An interpretable artificial intelligence-based method identifies morphologic features that correlate with lymphoma subtype	MACHINE LEARNING FOR HEALTH, ML4H, VOL 225	Proceedings of Machine Learning Research		English	Proceedings Paper	3rd Machine Learning for Health Symposium	DEC 10-10, 2023	New Orleans, LA			model interpretability; nuclear morphology; segmentation; SHAP analysis; deep learning; digital pathology; DLBCL; Hodgkin lymphoma; Non-Hodgkin lymphoma; B-cell lymphoma; T-cell lymphoma	CLASSIFICATION	The accurate classification of lymphoma subtypes using hematoxylin and eosin (H&E)stained tissue is complicated by the wide range of morphological features these cancers can exhibit. We present LymphoML - an interpretable machine learning method that identifies morphologic features that correlate with lymphoma subtypes. Our method applies steps to process H&E-stained tissue microarray cores, segment nuclei and cells, compute features encompassing morphology, texture, and architecture, and train gradient-boosted models to make diagnostic predictions. LymphoML's interpretable models, developed on a limited volume of H&E-stained tissue, achieve non-inferior diagnostic accuracy to pathologists using whole-slide images and outperform black box deep-learning on a dataset of 670 cases from Guatemala spanning 8 lymphoma subtypes. Using SHapley Additive exPlanation (SHAP) analysis, we assess the impact of each feature on model prediction and find that nuclear shape features are most discriminative for DLBCL (F1-score: 78.7%) and classical Hodgkin lymphoma (F1-score: 74.5%). Finally, we provide the first demonstration that a model combining features from H&E-stained tissue with features from a standardized panel of 6 immunostains results in a similar diagnostic accuracy (85.3%) to a 46-stain panel (86.1%).	[Shankar, Vivek; Krishna, Vrishab; Ng, Andrew] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Yang, Xiaoli] Stanford Univ, Dept Stat, Stanford, CA USA; [Tan, Brent; Silva, Oscar; Rojansky, Rebecca; Natkunam, Yasodha; Fernandez-Pol, Sebastian] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA USA; [Rajpurkar, Pranav] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Valvert, Fabiola] La Liga Nacl Canc Guatemala INCAN, Guatemala City, Guatemala; [Briercheck, Edward] Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Weinstock, David] Dana Farber Canc Inst, Boston, MA USA; [Weinstock, David] Harvard Med Sch, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Shankar, V (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	vivek96@stanford.edu; xiaoliy2@stanford.edu; vrishab@stanford.edu; sfernand@stanford.edu	Natkunam, Yasodha/L-5454-2015	Fernandez-Pol, Sebastian/0000-0002-0428-0199				Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Brancati N, 2019, IEEE ACCESS, V7, P44709, DOI 10.1109/ACCESS.2019.2908724; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; El Achi H, 2019, ANN CLIN LAB SCI, V49, P153; Eniu Alexandru E, 2017, Am Soc Clin Oncol Educ Book, V37, P409, DOI 10.14694/EDBK_175251; Evans T, 2022, FUTURE GENER COMP SY, V133, P281, DOI 10.1016/j.future.2022.03.009; Graham S, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101563; Gupta S, 2010, DIAGN CYTOPATHOL, V38, P94, DOI 10.1002/dc.21154; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Jamil Ayesha, 2021, StatPearls; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Ke GL, 2017, ADV NEUR IN, V30; Kingma Diederik P, 2014, Adam: A method 537 for stochastic optimization; LESTY C, 1986, CYTOMETRY, V7, P117, DOI 10.1002/cyto.990070202; Li DG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19817-3; Lin Tsung-Yi, 2020, IEEE Trans Pattern Anal Mach Intell, V42, P318, DOI 10.1109/TPAMI.2018.2858826; Lundberg SM, 2017, ADV NEUR IN, V30; Metter DM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4337; Miyoshi H, 2020, LAB INVEST, V100, P1300, DOI 10.1038/s41374-020-0442-3; Mohlman JS, 2020, AM J CLIN PATHOL, V153, P743, DOI [10.1093/AJCP/AQAA001, 10.1093/ajcp/aqaa001]; Schmidt U, 2018, LECT NOTES COMPUT SC, V11071, P265, DOI 10.1007/978-3-030-00934-2_30; Srinidhi CL, 2022, MED IMAGE ANAL, V75, DOI 10.1016/j.media.2021.102256; Steinbuss G, 2021, CANCERS, V13, DOI 10.3390/cancers13102419; Stirling DR, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04344-9; Subramanian V, 2018, LECT NOTES COMPUT SC, V11071, P245, DOI 10.1007/978-3-030-00934-2_28; Sun RF, 2016, MODERN PATHOL, V29, P1118, DOI 10.1038/modpathol.2016.92; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Valvert F, 2021, BLOOD ADV, V5, P2447, DOI 10.1182/bloodadvances.2021004347; Vrabac D, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00915-w; Nowakowski GS, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0208-6; Wang HY, 2017, ARCH PATHOL LAB MED, V141, P1236, DOI 10.5858/arpa.2016-0521-RA; Yu WH, 2021, CANCERS, V13, DOI 10.3390/cancers13215463; Zhang JF, 2020, MED PHYS, V47, P4241, DOI 10.1002/mp.14357; Zhu ML, 2022, LAB INVEST, V102, P1058	35	0	0	0	0	JMLR-JOURNAL MACHINE LEARNING RESEARCH	SAN DIEGO	1269 LAW ST, SAN DIEGO, CA, UNITED STATES	2640-3498			PR MACH LEARN RES			2023	225						528	558						31	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods; Engineering, Biomedical	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science; Engineering	BW9SX					2024-09-18	WOS:001221195600031
J	Wu, XL; Wu, H; Miao, SL; Cao, GQ; Su, H; Pan, J; Xu, YL				Wu, Xiaoli; Wu, Hao; Miao, Shouliang; Cao, Guoquan; Su, Huang; Pan, Jie; Xu, Yilun			Deep learning prediction of esophageal squamous cell carcinoma invasion depth from arterial phase enhanced CT images: a binary classification approach	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Esophageal squamous cell carcinoma; Deep learning; Computed tomography	CANCER; TOMOGRAPHY; SURVIVAL	BackgroundPrecise prediction of esophageal squamous cell carcinoma (ESCC) invasion depth is crucial not only for optimizing treatment plans but also for reducing the need for invasive procedures, consequently lowering complications and costs. Despite this, current techniques, which can be invasive and costly, struggle with achieving the necessary precision, highlighting a pressing need for more effective, non-invasive alternatives.MethodWe developed ResoLSTM-Depth, a deep learning model to distinguish ESCC stages T1-T2 from T3-T4. It integrates ResNet-18 and Long Short-Term Memory (LSTM) networks, leveraging their strengths in spatial and sequential data processing. This method uses arterial phase CT scans from ESCC patients. The dataset was meticulously segmented by an experienced radiologist for effective training and validation.ResultsUpon performing five-fold cross-validation, the ResoLSTM-Depth model exhibited commendable performance with an accuracy of 0.857, an AUC of 0.901, a sensitivity of 0.884, and a specificity of 0.828. These results were superior to the ResNet-18 model alone, where the average accuracy is 0.824 and the AUC is 0.879. Attention maps further highlighted influential features for depth prediction, enhancing model interpretability.ConclusionResoLSTM-Depth is a promising tool for ESCC invasion depth prediction. It offers potential for improvement in the staging and therapeutic planning of ESCC.	[Wu, Xiaoli; Wu, Hao; Xu, Yilun] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; [Miao, Shouliang; Cao, Guoquan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China; [Su, Huang; Pan, Jie] Wenzhou Cent Hosp, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Xu, YL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China.	xuyilun@wzhospital.cn			Wenzhou Municipal Science and Technology Commission Major Projects Funds	Wenzhou Municipal Science and Technology Commission Major Projects Funds	No Statement Available	Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Ba-Ssalamah A, 2011, EUR RADIOL, V21, P2326, DOI 10.1007/s00330-011-2187-2; Choi J, 2010, SURG ENDOSC, V24, P1380, DOI 10.1007/s00464-009-0783-x; Choi KJ, 2018, RADIOLOGY, V289, P688, DOI 10.1148/radiol.2018180763; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Fan YX, 2023, BMC BIOINFORMATICS, V24, DOI 10.1186/s12859-023-05378-x; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI [10.1162/neco.1997.9.8.1735, 10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Jin EH, 2020, GASTROENTEROLOGY, V158, P2169, DOI [10.1053/j.gastro.2020.02.036, 10.1053/j.gastro.2020.02.03]; Karmazanovsky GG, 2015, WORLD J GASTROENTERO, V21, P8878, DOI 10.3748/wjg.v21.i29.8878; Luo HY, 2019, LANCET ONCOL, V20, P1645, DOI 10.1016/S1470-2045(19)30637-0; Mansfield SA, 2017, SURG ENDOSC, V31, P3227, DOI 10.1007/s00464-016-5351-6; Mayerhoefer ME, 2020, J NUCL MED, V61, P488, DOI 10.2967/jnumed.118.222893; Moon JY, 2014, SCAND J GASTROENTERO, V49, P589, DOI 10.3109/00365521.2013.838604; Morgan E, 2022, GASTROENTEROLOGY, V163, P649, DOI 10.1053/j.gastro.2022.05.054; Rajpurkar P, 2023, NEW ENGL J MED, V388, P1981, DOI 10.1056/NEJMra2301725; Rice TW, 2017, J THORAC ONCOL, V12, P36, DOI 10.1016/j.jtho.2016.10.016; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Shapiro J, 2015, LANCET ONCOL, V16, P1090, DOI 10.1016/S1470-2045(15)00040-6; Smyth EC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.48; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Suzuki K, 2017, RADIOL PHYS TECHNOL, V10, P257, DOI 10.1007/s12194-017-0406-5; van Westreenen HL, 2004, J CLIN ONCOL, V22, P3805, DOI 10.1200/JCO.2004.01.083; Wang S, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00986-2018; Wang S, 2019, RADIOTHER ONCOL, V132, P171, DOI 10.1016/j.radonc.2018.10.019; Wang WY, 2023, FRONT ONCOL, V13, DOI 10.3389/fonc.2023.1132423; Wang Y, 2022, ESOPHAGUS-TOKYO, V19, P269, DOI 10.1007/s10388-021-00886-2; Waters JK, 2022, CURR ONCOL REP, V24, P375, DOI 10.1007/s11912-021-01153-4; Winiker M, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/dox113; Wu L, 2018, CHINESE J CANCER RES, V30, P396, DOI 10.21147/j.issn.1000-9604.2018.04.02; Yang MW, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.722961; Yu YK, 2023, THORAC CANCER, V14, P127, DOI 10.1111/1759-7714.14722; Zhang FG, 2017, TRANSL ONCOL, V10, P324, DOI 10.1016/j.tranon.2017.02.006	34	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	JAN 2	2024	24	1							3	10.1186/s12911-023-02386-y	http://dx.doi.org/10.1186/s12911-023-02386-y			9	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	DX4B9	38167058	gold, Green Published			2024-09-18	WOS:001135359400003
J	Karabacak, M; Jagtiani, P; Carrasquilla, A; Germano, IM; Margetis, K				Karabacak, Mert; Jagtiani, Pemla; Carrasquilla, Alejandro; Germano, Isabelle M.; Margetis, Konstantinos			Prognosis Individualized: Survival predictions for WHO grade II and III gliomas with a machine learning-based web application	NPJ DIGITAL MEDICINE			English	Article							CLASSIFICATION; DIAGNOSIS; MODEL	WHO grade II and III gliomas demonstrate diverse biological behaviors resulting in variable survival outcomes. In the context of glioma prognosis, machine learning (ML) approaches could facilitate the navigation through the maze of factors influencing survival, aiding clinicians in generating more precise and personalized survival predictions. Here we report the utilization of ML models in predicting survival at 12, 24, 36, and 60 months following grade II and III glioma diagnosis. From the National Cancer Database, we analyze 10,001 WHO grade II and 11,456 grade III cranial gliomas. Using the area under the receiver operating characteristic (AUROC) values, we deploy the top-performing models in a web application for individualized predictions. SHapley Additive exPlanations (SHAP) enhance the interpretability of the models. Top-performing predictive models are the ones built with LightGBM and Random Forest algorithms. For grade II gliomas, the models yield AUROC values ranging from 0.813 to 0.896 for predicting mortality across different timeframes, and for grade III gliomas, the models yield AUROCs ranging from 0.855 to 0.878. ML models provide individualized survival forecasts for grade II and III glioma patients across multiple clinically relevant time points. The user-friendly web application represents a pioneering digital tool to potentially integrate predictive analytics into neuro-oncology clinical practice, to empower prognostication and personalize clinical decision-making.	[Karabacak, Mert; Carrasquilla, Alejandro; Germano, Isabelle M.; Margetis, Konstantinos] Mt Sinai Hlth Syst, Dept Neurosurg, New York, NY 10029 USA; [Jagtiani, Pemla] SUNY Downstate Hlth Sci Univ, Dept Med, New York, NY 11203 USA	Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; SUNY Downstate Health Sciences University	Margetis, K (corresponding author), Mt Sinai Hlth Syst, Dept Neurosurg, New York, NY 10029 USA.	Konstantinos.Margetis@mountsinai.org	Karabacak, Mert/HMW-1735-2023; germano, isabelle/J-8327-2017	Jagtiani, Pemla/0000-0002-6075-0255; Margetis, Konstantinos/0000-0002-3715-8093	The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors provide the following disclaimer for use of the web application: "The web tool should not be used to guide any clinical decisio	The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors provide the following disclaimer for use of the web application: "The web tool should not be used to guide any clinical decisio	The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors provide the following disclaimer for use of the web application: "The web tool should not be used to guide any clinical decisions, including but not limited to diagnosis and treatment. The authors make no warranties or representations, express or implied, regarding the accuracy, timeliness, relevance, or utility of the information contained in this tool. The information in the tool is subject to change and can be affected by various confounders, therefore it may be outdated, incomplete, or incorrect. The authors do not record any specific user information or initiate contact with users."	Akiba T, 2019, Arxiv, DOI [arXiv:1907.10902, DOI 10.48550/ARXIV.1907.10902]; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai YN, 2023, J CANCER RES CLIN, V149, P13575, DOI 10.1007/s00432-023-05155-6; Capelle L, 2013, J NEUROSURG, V118, P1157, DOI 10.3171/2013.1.JNS121; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.7326/M14-0698, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1038/bjc.2014.639, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1016/j.jclinepi.2014.11.010, 10.1016/j.eururo.2014.11.025]; Corell A, 2018, ACTA NEUROL SCAND, V138, P359, DOI 10.1111/ane.12973; Cruz JA, 2006, CANCER INFORM, V2, P59; Delgado-López PD, 2017, CLIN TRANSL ONCOL, V19, P931, DOI 10.1007/s12094-017-1631-4; Fernández-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Fu XF, 2022, INT J GEN MED, V15, P1517, DOI 10.2147/IJGM.S335571; Gatsonis CA, 2009, RADIOLOGY, V253, P593, DOI 10.1148/radiol.2533091633; Gittleman H, 2020, NEURO-ONCOLOGY, V22, P665, DOI 10.1093/neuonc/noz191; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; Guo XP, 2023, FRONT ONCOL, V13, DOI 10.3389/fonc.2023.1131642; Hollmann N, 2023, Arxiv, DOI [arXiv:2207.01848, DOI 10.48550/ARXIV.2207.01848]; Jacobs CD, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00118; Jakola AS, 2022, J NEUROSURG, V137, P1321, DOI 10.3171/2022.1.JNS212514; Jia ZT, 2022, BMC NEUROL, V22, DOI 10.1186/s12883-022-02879-9; Jin K, 2021, INT J GEN MED, V14, P9523, DOI 10.2147/IJGM.S337227; Karabacak M, 2023, CANCERS, V15, DOI 10.3390/cancers15030812; Karabacak M, 2023, ACTA RADIOL, V64, P1994, DOI 10.1177/02841851221143496; Ke G., 2017, Advances in Neural Information Processing Systems; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Li GZ, 2022, BRAIN, V145, P1151, DOI 10.1093/brain/awab340; Lundberg SM, 2017, ADV NEUR IN, V30; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Niculescu-Mizil A., 2005, ICML, DOI 10.1145/1102351.1102430; Arik SO, 2020, Arxiv, DOI [arXiv:1908.07442, DOI 10.1609/AAAI.V35I8.16826, 10.1609/aaai.v35i8.16826]; Ostrom QT, 2023, NEURO-ONCOLOGY, V25, P799, DOI 10.1093/neuonc/noac198; Ostrom QT, 2019, NEURO-ONCOLOGY, V21, pV1, DOI 10.1093/neuonc/noz150; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Sharma M, 2023, J NEURO-ONCOL, V162, P199, DOI 10.1007/s11060-023-04286-7; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Sun LW, 2022, INT J GEN MED, V15, P4697, DOI 10.2147/IJGM.S352773; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; van Calster B, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1466-7; Xu CN, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.969907; Yang DX, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1793; Yousefi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11817-6; Zhang C, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-38629-1; Zhang YF, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.957059; Zhao R, 2022, HEALTH INFORM J, V28, DOI 10.1177/14604582221135427	48	6	6	3	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2398-6352			NPJ DIGIT MED	npj Digit. Med.	OCT 26	2023	6	1							200	10.1038/s41746-023-00948-y	http://dx.doi.org/10.1038/s41746-023-00948-y			10	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	U9PI3	37884599	Green Published, gold			2024-09-18	WOS:001088049700002
J	Tiwari, PC; Pal, R; Chaudhary, MJ; Nath, R				Tiwari, Prafulla C.; Pal, Rishi; Chaudhary, Manju J.; Nath, Rajendra			Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges	DRUG DEVELOPMENT RESEARCH			English	Review						artificial intelligence; drug discovery; drug repurposing	DISCOVERY; PERFORMANCE; CANCER; MODEL; QSAR	By harnessing artificial intelligence (AI) algorithms and machine learning techniques, the entire drug discovery process stands to undergo a profound transformation, offering a myriad of advantages. Foremost among these is the ability of AI to conduct swift and efficient screenings of expansive compound libraries, significantly augmenting the identification of potential drug candidates. Moreover, AI algorithms can prove instrumental in predicting the efficacy and safety profiles of candidate compounds, thus endowing invaluable insights and reducing reliance on extensive preclinical and clinical testing. This predictive capacity of AI has the potential to streamline the drug development pipeline and enhance the success rate of clinical trials, ultimately resulting in the emergence of more efficacious and safer therapeutic agents. However, the deployment of AI in drug discovery introduces certain challenges that warrant attention. A primary hurdle entails the imperative acquisition of high-quality and diverse data. Furthermore, ensuring the interpretability of AI models assumes critical importance in securing regulatory endorsement and cultivating trust within scientific and medical communities. Addressing ethical considerations, including data privacy and mitigating bias, represents an additional momentous challenge, requiring assiduous navigation. In this review, we provide an intricate and comprehensive overview of the multifaceted challenges intrinsic to conventional drug development paradigms, while simultaneously interrogating the efficacy of AI in effectively surmounting these formidable obstacles.	[Tiwari, Prafulla C.; Pal, Rishi; Nath, Rajendra] King Georges Med Univ, Dept Pharmacol & Therapeut, Lucknow 226003, Uttar Pradesh, India; [Chaudhary, Manju J.] Govt Med Coll, Dept Physiol, Kannauj, Uttar Pradesh, India	King George's Medical University	Pal, R (corresponding author), King Georges Med Univ, Dept Pharmacol & Therapeut, Lucknow 226003, Uttar Pradesh, India.	rishipal@kgmcindia.edu	Pal, Rishi/AAX-9512-2021; Tiwari, Prafulla Chandra/I-1320-2014	Pal, Rishi/0000-0001-9813-6990; Chaudhary, Manju J/0000-0002-4661-2243; Tiwari, Prafulla Chandra/0000-0001-7913-5386				Adam G, 2020, NPJ PRECIS ONCOL, V4, DOI 10.1038/s41698-020-0122-1; Adir O, 2020, ADV MATER, V32, DOI 10.1002/adma.201901989; Ahmed Z, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa010; Aliper A, 2016, MOL PHARMACEUT, V13, P2524, DOI 10.1021/acs.molpharmaceut.6b00248; Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1043, DOI 10.1001/jama.2020.1039; Bai QF, 2022, WIRES COMPUT MOL SCI, V12, DOI 10.1002/wcms.1581; Baptista D, 2021, BRIEF BIOINFORM, V22, P360, DOI 10.1093/bib/bbz171; Basile AO, 2019, TRENDS PHARMACOL SCI, V40, P624, DOI 10.1016/j.tips.2019.07.005; Bender A, 2020, DRUG DISCOV TODAY, V26, P511, DOI 10.1016/j.drudis.2020.12.009; Bittner MI, 2022, PATTERNS, V3, DOI 10.1016/j.patter.2022.100529; Braga RC, 2013, CURR TOP MED CHEM, V13, P1127, DOI 10.2174/1568026611313090010; Caporuscio F, 2011, CURR MED CHEM, V18, P2543, DOI 10.2174/092986711795933669; Chan HCS, 2019, TRENDS PHARMACOL SCI, V40, P592, DOI 10.1016/j.tips.2019.06.004; Chen HM, 2018, DRUG DISCOV TODAY, V23, P1241, DOI 10.1016/j.drudis.2018.01.039; Chen RL, 2018, MOLECULES, V23, DOI 10.3390/molecules23092208; Chen W, 2023, MOL THER NUCL ACIDS, V31, P691, DOI 10.1016/j.omtn.2023.02.019; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Diaconu A., 2022, IOP Conference Series: Materials Science and Engineering, DOI 10.1088/1757-899X/1254/1/012036; Dlamini Z, 2020, COMPUT STRUCT BIOTEC, V18, P2300, DOI 10.1016/j.csbj.2020.08.019; Fountzilas E, 2022, GENOME MED, V14, DOI 10.1186/s13073-022-01102-1; Gawehn E, 2016, MOL INFORM, V35, P3, DOI 10.1002/minf.201501008; Gorgulla C, 2022, CURR OPIN CHEM BIOL, V69, DOI 10.1016/j.cbpa.2022.102156; Gupta R, 2021, MOL DIVERS, V25, P1315, DOI 10.1007/s11030-021-10217-3; He B, 2016, J CELL MOL MED, V20, P2231, DOI 10.1111/jcmm.12930; Honek J, 2017, MED WRITING, V26, P5; Issa NT, 2021, SEMIN CANCER BIOL, V68, P132, DOI 10.1016/j.semcancer.2019.12.011; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Jiménez-Luna J, 2021, EXPERT OPIN DRUG DIS, V16, P949, DOI 10.1080/17460441.2021.1909567; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Klepeis JL, 2003, J AM CHEM SOC, V125, P8422, DOI 10.1021/ja034846p; Kolluri S, 2022, AAPS J, V24, DOI 10.1208/s12248-021-00644-3; Kuenzi BM, 2020, CANCER CELL, V38, P672, DOI 10.1016/j.ccell.2020.09.014; Langer T, 2006, EXPERT OPIN DRUG DIS, V1, P261, DOI 10.1517/17460441.1.3.261; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; Leach A.R., 2007, An Introduction to Chemoinformatics, DOI [10.1007/978-1-4020-6291-9, DOI 10.1007/978-1-4020-6291-9]; Leach AR, 2010, J MED CHEM, V53, P539, DOI 10.1021/jm900817u; Lim JJ, 2020, ADV THER-GERMANY, V3, DOI 10.1002/adtp.201900122; Liu XX, 2020, LANCET DIGIT HEALTH, V2, pE537, DOI [10.1136/bmj.m3164, 10.1016/S2589-7500(20)30218-1, 10.1016/S2589-7500(20)30219-3]; Liu XW, 2018, EXPERT OPIN DRUG DIS, V13, P23, DOI 10.1080/17460441.2018.1403419; Mak KK, 2019, DRUG DISCOV TODAY, V24, P773, DOI 10.1016/j.drudis.2018.11.014; McNair D, 2023, ANNU REV PHARMACOL, V63, P77, DOI 10.1146/annurev-pharmtox-051921-023255; Meenakshi D.U., 2022, Deep Learning and Site-Specific Drug Delivery, P1, DOI DOI 10.1002/9781119857983.CH1; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; Murugan NA, 2022, DRUG DISCOV TODAY, V27, P1913, DOI 10.1016/j.drudis.2022.05.013; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Park SH, 2018, RADIOLOGY, V286, P800, DOI 10.1148/radiol.2017171920; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Santín EP, 2021, WIRES COMPUT MOL SCI, V11, DOI 10.1002/wcms.1516; Pu LM, 2019, BMC PHARMACOL TOXICO, V20, DOI 10.1186/s40360-018-0282-6; Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI [10.1038/nnano.2011.10, 10.1038/NNANO.2011.10]; Reddy AS, 2007, CURR PROTEIN PEPT SC, V8, P329; Rodgers T.-H., 2023, AIML DRUG DISCOVERY; Salo-Ahen OMH, 2021, PROCESSES, V9, DOI 10.3390/pr9010071; Schneider P, 2020, NAT REV DRUG DISCOV, V19, P353, DOI 10.1038/s41573-019-0050-3; Shah P, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0148-3; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Stokes JM, 2020, CELL, V180, P688, DOI 10.1016/j.cell.2020.01.021; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Tsigelny IF, 2019, BRIEF BIOINFORM, V20, P1434, DOI 10.1093/bib/bby004; Vamathevan J, 2019, NAT REV DRUG DISCOV, V18, P463, DOI 10.1038/s41573-019-0024-5; Vijayan RSK, 2022, DRUG DISCOV TODAY, V27, P967, DOI 10.1016/j.drudis.2021.11.023; Vogt M, 2018, J MED CHEM, V61, P10895, DOI 10.1021/acs.jmedchem.8b01626; Weissler EH, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05489-x; Zhong FS, 2018, SCI CHINA LIFE SCI, V61, P1191, DOI 10.1007/s11427-018-9342-2	64	8	8	13	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4391	1098-2299		DRUG DEVELOP RES	Drug Dev. Res.	DEC	2023	84	8					1652	1663		10.1002/ddr.22115	http://dx.doi.org/10.1002/ddr.22115		SEP 2023	12	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CF0P2	37712494				2024-09-18	WOS:001066118900001
J	de Boer, ML; Slatman, J				de Boer, Marjolein Lotte; Slatman, Jenny			Producing ME/CFS in Dutch Newspapers. A Social-Discursive Analysis About Non/credibility	SOCIAL EPISTEMOLOGY			English	Article						ME/CFS; credibility deficits; epistemic injustice; discourse analysis	EPISTEMIC INJUSTICE; JUSTICE; CONSTRUCTION; STIGMA; CANCER; VIRTUE; MEDIA	Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) is a highly contested illness. This paper analyzes the discursive production of knowledge about, and recognition of ME/CFS. By mobilizing insights from social epistemology and epistemic injustice studies, this paper reveals how actors, through their social-discursive practices, attribute to establishing, sustaining, and disregarding their own and others' epistemological position. In focusing on the case of the Dutch newspaper reporting about ME/CFS, this paper shows that the debate about this condition predominantly revolves around the ways in which people who make truth claims are represented. In being portrayed as gendered, affectatious, formerly very able, fanatical, or benevolent, people with ME/CFS are constructed as non-/credible. In the debate about what causes ME/CFS, by contrast, the production of non-/credible knowledge focuses more on the content of epistemic positions. Actors in this debate argue that they know the (clear) causes for the illness, something which functions as a discursive strategy to establish and enhance their credibility. This paper contends, however, that since this discursive demarcation of causes is consistently infused with uncertainty - with multi-interpretability, with diffuse explanations, and absence of current knowledge - the credibility of these actors' epistemic position is undercut rather than established.	[de Boer, Marjolein Lotte; Slatman, Jenny] Tilburg Univ, Dept Culture Studies, Tilburg, Netherlands; [de Boer, Marjolein Lotte] Tilburg Univ, Dept Culture Studies, NL-5000 LE Tilburg, Netherlands	Tilburg University; Tilburg University	de Boer, ML (corresponding author), Tilburg Univ, Dept Culture Studies, NL-5000 LE Tilburg, Netherlands.	m.l.deboer@tilburguniversity.edu	Slatman, Jenny/AAQ-1021-2020	Slatman, Jenny/0000-0002-1451-9378	Dutch Scientific Research Council [277-20.008/2737]	Dutch Scientific Research Council	This work was supported by the Dutch Scientific Research Council under Grant number 277-20.008/2737 (PI: Jenny Slatman).	Anderson E, 2012, SOC EPISTEMOL, V26, P163, DOI 10.1080/02691728.2011.652211; Bianchi R, 2016, PSYCHIAT RES, V245, P91, DOI 10.1016/j.psychres.2016.08.025; Blease C, 2017, J MED ETHICS, V43, P549, DOI 10.1136/medethics-2016-103691; Boczkowski PJ, 2004, INSIDE TECHNOL, P1; Byrne EA, 2020, MED HEALTH CARE PHIL, V23, P371, DOI 10.1007/s11019-020-09945-4; Byrne P, 1997, J ROY SOC MED, V90, P618, DOI 10.1177/014107689709001107; Capurro G, 2018, CAN J SOCIOL, V43, P25, DOI 10.29173/cjs29301; Carel H, 2014, MED HEALTH CARE PHIL, V17, P529, DOI 10.1007/s11019-014-9560-2; Curran J, 2010, JOURNALISM STUD, V11, P464, DOI 10.1080/14616701003722444; de Boer M, 2014, WOMEN STUD INT FORUM, V44, P17, DOI 10.1016/j.wsif.2014.02.014; de Boer ML, 2021, SOCIOL HEALTH ILL, V43, P1335, DOI 10.1111/1467-9566.13301; Dotson K, 2012, FRONTIERS, V33, P24; Dotson K, 2011, HYPATIA, V26, P236, DOI 10.1111/j.1527-2001.2011.01177.x; Dumit J, 2006, SOC SCI MED, V62, P577, DOI 10.1016/j.socscimed.2005.06.018; Fricker M, 2008, THEORIA-SPAIN, V23, P69; Fricker M, 2017, ROUTL PHILOS COMPAN, P268; Greco J, 2012, PHILOS PHENOMEN RES, V85, P1, DOI 10.1111/j.1933-1592.2011.00567.x; Groenevelt I, 2022, HEALTH-LONDON, V26, P589, DOI 10.1177/13634593211017187; Hunt J, 2022, J HEALTH PSYCHOL, V27, P3106, DOI 10.1177/13591053221084494; Jang S, 2016, J MEDIA ECON, V29, P73, DOI 10.1080/08997764.2016.1170021; Johannisson K., 2001, GENDER INEQUALITIES, P99; Kidd IJ, 2017, J APPL PHILOS, V34, P172, DOI 10.1111/japp.12172; Kirmayer L.J., 1984, TRANSCULTURAL PSYCHI, V21, P159, DOI [DOI 10.1177/136346158402100301, 10.1177/136346158402100301]; Komaroff AL, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.606824; Lee ES, 2011, HYPATIA, V26, P258, DOI 10.1111/j.1527-2001.2011.01165.x; Lian OS, 2015, SOCIOL HEALTH ILL, V37, P920, DOI 10.1111/1467-9566.12249; Maitra Ishani., 2010, PHILOS BOOK, V51, P195, DOI [10.1111/j.1468-0149.2010.00511.x, DOI 10.1111/J.1468-0149.2010.00511.X]; Martinez-Avila D., 2013, Nasko, V4, P223, DOI DOI 10.7152/NASKO.V4I1.15163; Mason Rebecca, 2021, The Routledge Handbook of Social and Political Philosophy of Language, P247; Newbigging K, 2018, SOC SCI MED, V219, P36, DOI 10.1016/j.socscimed.2018.10.003; Parviainen J, 2021, SOC EPISTEMOL, V35, P232, DOI 10.1080/02691728.2021.1882610; Penson RT, 2004, ONCOLOGIST, V9, P708, DOI 10.1634/theoncologist.9-6-708; Porter Roy., 1987, Mind-Forg'd Manacles: A History of Madness in England from the Restoration to the Regency; Reyes A, 2011, DISCOURSE SOC, V22, P781, DOI 10.1177/0957926511419927; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Sharpe M, 2019, MED HUMANIT, V45, P183, DOI 10.1136/medhum-2018-011598; Sherman BR, 2016, SOC EPISTEMOL, V30, P229, DOI 10.1080/02691728.2015.1031852; Spencer L., 2021, Philosophy of Medicine, V2, P1, DOI [10.5195/pom.2021.19, DOI 10.5195/POM.2021.19]; Steers-McCrum AR, 2020, SOC EPISTEMOL, V34, P241, DOI 10.1080/02691728.2019.1682710; Toscano Alberto., 2017, Fanaticism: On the Uses of an Idea; Valdez AR, 2019, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00412; van Dijk T.A., 2001, METHODS CRITICAL DIS, P95, DOI [10.4135/9780857028020.d7, DOI 10.4135/9780857028020.D7]; Wardrope A, 2015, MED HEALTH CARE PHIL, V18, P341, DOI 10.1007/s11019-014-9608-3; WARE NC, 1992, MED ANTHROPOL Q, V6, P347, DOI 10.1525/maq.1992.6.4.02a00030; Warman J, 2023, EPISTEME-J INDIV SOC, V20, P107, DOI 10.1017/epi.2021.3; Werner A, 2003, SOC SCI MED, V57, P1409, DOI 10.1016/S0277-9536(02)00520-8; Wessely S., 1998, Chronic Fatigue and its Syndromes; Wodak R., 2009, METHODS CRITICAL DIS, V2, P1	48	0	0	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-1728	1464-5297		SOC EPISTEMOL	Soc. Epistemol.	SEP 20	2020	37	5					592	609		10.1080/02691728.2023.2171748	http://dx.doi.org/10.1080/02691728.2023.2171748		APR 2023	18	History & Philosophy Of Science; Philosophy; Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	History & Philosophy of Science; Philosophy; Social Sciences - Other Topics	IS4B1		hybrid			2024-09-18	WOS:000963967100001
J	Xu, JX; Wu, XY; Chen, JL; Cheng, Y; Zhang, X				Xu, Jiaxuan; Wu, Xiangyan; Chen, Junlin; Cheng, Yue; Zhang, Xin			A TP53-associated metabolic gene signature for the prediction of overall survival and therapeutic responses in hepatocellular carcinoma	JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES			English	Article						Hepatocellular carcinoma; TP53 mutation; Metabolic reprogramming; Immune heterogeneity; Gene signature	CANCER; INVASION; PACKAGE; TP53	Background: TP53 is one of the most prevalent mutated genes in hepatocellular carcinoma (HCC), while the role of TP53 mutations in HCC metabolic reprogramming remains unclear.Methods: The differential analysis of gene expression profile between HCC patients with wild-type and mutated TP53 was performed to identify TP53-associated metabolic genes (TMGs). The TMGs were utilized to construct and validate a TP53-associated metabolic gene signature (TMS). Comprehensive bioinformatics analyses were performed to explore clinical application value and biological interpretability of TMS.Results: We identified 86 TMGs based on the TP53 mutation status. TMS including CYP26B1, CYP2C9, G6PD, PYGM and TKTL1 was constructed and validated to identify the low-TMSscore group had a better prognosis than the high-TMSscore group. Tryptophan metabolism and fatty acid metabolism were significantly enriched in the low-TMSscore group. Moreover, it was characterized by a higher abundance of gamma delta T cell and natural killer cell than the high-TMSscore group. Compared to the high-TMSscore group, the low-TMSscore group was more likely to respond to immune checkpoint therapy.Conclusions: The TMS is a potential strategy for prognostic prediction and immune checkpoint therapy guidance for HCC patients. Our study provides new insights into the involvement of TP53 mutations in tumor metabolic reprogramming.	[Xu, Jiaxuan; Chen, Junlin] Zhejiang Chinese Med Univ, Sch Clin Med 2, Hangzhou, Peoples R China; [Wu, Xiangyan] Guangdong Univ Technol, Sch Electromech Engn, Guangzhou, Peoples R China; [Cheng, Yue] Tongde Hosp Zhejiang Prov, Hangzhou, Peoples R China; [Zhang, Xin] Zhejiang Chinese Med Univ, Sch Pharmaceut Sci, Hangzhou, Peoples R China	Zhejiang Chinese Medical University; Guangdong University of Technology; Zhejiang Chinese Medical University	Cheng, Y (corresponding author), Tongde Hosp Zhejiang Prov, Hangzhou, Peoples R China.; Zhang, X (corresponding author), Zhejiang Chinese Med Univ, Sch Pharmaceut Sci, Hangzhou, Peoples R China.	2804260692@qq.com; 1036797285@qq.com; 976949252@qq.com; chengyuelucky@126.com; drjanson@126.com						Allard D, 2019, IMMUNOL LETT, V205, P31, DOI 10.1016/j.imlet.2018.05.001; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Blagih J, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237453; Braun DA, 2020, NAT MED, V26, P909, DOI 10.1038/s41591-020-0839-y; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen L, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01412; Chen WBA, 2020, J TRANSL AUTOIMMUN, V3, DOI 10.1016/j.jtauto.2020.100067; Choi H, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0895-9; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Cui MQ, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00666-y; Finn RS, 2018, HEPATOLOGY, V67, P422, DOI 10.1002/hep.29486; Ghosh M, 2021, CANCER CELL, V39, P494, DOI 10.1016/j.ccell.2021.01.003; Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong JY, 2022, GENOME MED, V14, DOI 10.1186/s13073-021-00995-8; Icard P, 2018, DRUG RESIST UPDATE, V38, P1, DOI 10.1016/j.drup.2018.03.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.21254, 10.3322/caac.20073]; Jiang TT, 2021, HEPATOLOGY, V74, P233, DOI 10.1002/hep.31685; Jiang Y, 2019, NATURE, V567, P257, DOI 10.1038/s41586-019-0987-8; Kamp WM, 2016, CURR OPIN GENET DEV, V38, P16, DOI 10.1016/j.gde.2016.02.007; Li L, 2020, DNA REPAIR, V88, DOI 10.1016/j.dnarep.2020.102785; Lin AQ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1062-7; Link Tim, 2017, Hepatoma Res, V3, P95, DOI 10.20517/2394-5079.2017.07; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Liu J, 2019, J MOL CELL BIOL, V11, P284, DOI 10.1093/jmcb/mjy070; Liu WB, 2019, CLIN CANCER RES, V25, P5525, DOI 10.1158/1078-0432.CCR-18-3083; Loughran RM, 2022, ADV BIOL REGUL, V83, DOI 10.1016/j.jbior.2021.100839; Lu M, 2018, ACTA BIOCH BIOPH SIN, V50, P370, DOI 10.1093/abbs/gmy009; Mayakonda A, 2018, GENOME RES, V28, P1747, DOI 10.1101/gr.239244.118; Muriel P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136969; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pitolli C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246241; Rao CV, 2017, CARCINOGENESIS, V38, P2, DOI 10.1093/carcin/bgw118; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seo J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01367-5; Singal AG, 2022, CLIN GASTROENTEROL H, V20, P9, DOI 10.1016/j.cgh.2020.09.036; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung JY, 2022, CANCERS, V14, DOI 10.3390/cancers14061438; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang JY, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10020234; Wang MD, 2016, HEPAT ONCOL, V3, P241, DOI 10.2217/hep-2016-0012; Wang X, 2019, J CELL MOL MED, V23, P694, DOI 10.1111/jcmm.13977; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Yang C, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa164; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhu ZR, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04596-0	49	1	1	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1687-8507			J RADIAT RES APPL SC	J. Radiat. Res. Appl. Sci.	JUN	2023	16	2							100552	10.1016/j.jrras.2023.100552	http://dx.doi.org/10.1016/j.jrras.2023.100552		FEB 2023	13	Multidisciplinary Sciences; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Radiology, Nuclear Medicine & Medical Imaging	9X5QV		hybrid			2024-09-18	WOS:000949825200001
J	Farahani, FV; Fiok, K; Lahijanian, B; Karwowski, W; Douglas, PK				Farahani, Farzad V.; Fiok, Krzysztof; Lahijanian, Behshad; Karwowski, Waldemar; Douglas, Pamela K.			Explainable AI: A review of applications to neuroimaging data	FRONTIERS IN NEUROSCIENCE			English	Review						explainable AI; interpretability; artificial intelligence (AI); deep learning; neural networks; medical imaging; neuroimaging	SUPPORT VECTOR MACHINE; DEEP NEURAL-NETWORKS; ARTIFICIAL-INTELLIGENCE; FEATURE-SELECTION; CLASSIFICATION; DISEASES; MODELS; IMPACT; CANCER; IMAGES	Deep neural networks (DNNs) have transformed the field of computer vision and currently constitute some of the best models for representations learned via hierarchical processing in the human brain. In medical imaging, these models have shown human-level performance and even higher in the early diagnosis of a wide range of diseases. However, the goal is often not only to accurately predict group membership or diagnose but also to provide explanations that support the model decision in a context that a human can readily interpret. The limited transparency has hindered the adoption of DNN algorithms across many domains. Numerous explainable artificial intelligence (XAI) techniques have been developed to peer inside the "black box " and make sense of DNN models, taking somewhat divergent approaches. Here, we suggest that these methods may be considered in light of the interpretation goal, including functional or mechanistic interpretations, developing archetypal class instances, or assessing the relevance of certain features or mappings on a trained model in a post-hoc capacity. We then focus on reviewing recent applications of post-hoc relevance techniques as applied to neuroimaging data. Moreover, this article suggests a method for comparing the reliability of XAI methods, especially in deep neural networks, along with their advantages and pitfalls.	[Farahani, Farzad V.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21218 USA; [Farahani, Farzad V.; Fiok, Krzysztof; Karwowski, Waldemar] Univ Cent Florida, Dept Ind Engn & Management Syst, Orlando, FL 32816 USA; [Lahijanian, Behshad] Univ Florida, Dept Ind & Syst Engn, Gainesville, FL USA; [Lahijanian, Behshad] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA USA; [Douglas, Pamela K.] Univ Cent Florida, Sch Modeling Simulat & Training, Orlando, FL USA	Johns Hopkins University; State University System of Florida; University of Central Florida; State University System of Florida; University of Florida; University System of Georgia; Georgia Institute of Technology; State University System of Florida; University of Central Florida	Farahani, FV (corresponding author), Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21218 USA.; Farahani, FV (corresponding author), Univ Cent Florida, Dept Ind Engn & Management Syst, Orlando, FL 32816 USA.	ffaraha2@jhu.edu	Fiok, Krzysztof/E-6038-2015; Karwowski, Waldemar/B-2449-2012	Karwowski, Waldemar/0000-0002-9134-3441				Achtibat R, 2024, Arxiv, DOI [arXiv:2206.03208, DOI 10.48550/ARXIV.2206.03208, 10.48550/arXiv.2206.03208]; Adebayo J, 2018, ADV NEUR IN, V31; Alex V., 2017, PROCSPIE; Cruz-Roa AA, 2013, LECT NOTES COMPUT SC, V8150, P403, DOI 10.1007/978-3-642-40763-5_50; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Alvarez-Melis D, 2018, Arxiv, DOI arXiv:1806.08049; Ancona M, 2018, Arxiv, DOI arXiv:1711.06104; Anderson Ariana, 2012, Machine Learning and Interpretation in Neuroimaging. International Workshop (MLINI 2011). Held at NIPS 2011. Revised and Selected and Invited Contributions, P242, DOI 10.1007/978-3-642-34713-9_31; [Anonymous], 2016, P ADV NEURAL INFORM; Arras L, 2017, Arxiv, DOI arXiv:1706.07206; Arras L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181142; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baehrens D., 2009, arXiv, DOI [10.48550/arXiv.0912.1128, DOI 10.48550/ARXIV.0912.1128]; Arrieta AB, 2020, INFORM FUSION, V58, P82, DOI 10.1016/j.inffus.2019.12.012; Becker S, 2023, Arxiv, DOI arXiv:1807.03418; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Binder A, 2021, NAT MACH INTELL, V3, P355, DOI 10.1038/s42256-021-00303-4; Biran O., 2017, IJCAI Workshop on Explainable AI (XAI); Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Böhle M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00194; Bologna G, 2017, J ARTIF INTELL SOFT, V7, P265, DOI 10.1515/jaiscr-2017-0019; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Chen Jianbo, 2018, P MACHINE LEARNING R, V80; Cheng H.-T., 2016, P 1 WORKSH DEEP LEAR, P7; Chereda H, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00845-7; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Chu LY, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P1244, DOI 10.1145/3219819.3220063; Couture HD, 2018, LECT NOTES COMPUT SC, V11071, P254, DOI 10.1007/978-3-030-00934-2_29; Datta A, 2016, P IEEE S SECUR PRIV, P598, DOI 10.1109/SP.2016.42; de Sousa IP, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19132969; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Doshi-Velez F, 2017, Arxiv, DOI arXiv:1702.08608; Dosilovic FK, 2018, 2018 41ST INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P210, DOI 10.23919/MIPRO.2018.8400040; Dosovitskiy A, 2016, PROC CVPR IEEE, P4829, DOI 10.1109/CVPR.2016.522; Douglas PK, 2011, NEUROIMAGE, V56, P544, DOI 10.1016/j.neuroimage.2010.11.002; Eitel F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-03785-9; El-Sappagh S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82098-3; Erhan D., 2009, 1341 U MONTR DEP INF; Essemlali A., 2020, PROC MACH LEARN RES, P217; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Farahani FV, 2018, MATH COMPUT SIMULAT, V149, P48, DOI 10.1016/j.matcom.2018.02.001; Feiyu Xu, 2019, Natural Language Processing and Chinese Computing. 8th CCF International Conference, NLPCC 2019. Proceedings. Lecture Notes in Artificial Intelligence, Subseries of Lecture Notes in Computer Science (LNAI 11839), P563, DOI 10.1007/978-3-030-32236-6_51; Fiok K, 2022, J DEF MODEL SIMUL-AP, V19, P133, DOI 10.1177/15485129211028651; Gaonkar B, 2013, NEUROIMAGE, V78, P270, DOI 10.1016/j.neuroimage.2013.03.066; Ghorbani A, 2019, ADV NEUR IN, V32; Ghorbani A, 2019, AAAI CONF ARTIF INTE, P3681; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672; Grigorescu S, 2020, J FIELD ROBOT, V37, P362, DOI 10.1002/rob.21918; Guidotti R, 2018, Arxiv, DOI arXiv:1805.10820; Guidotti R, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3236009; Gunning D, 2019, AI MAG, V40, P44, DOI 10.1609/aimag.v40i2.2850; Guyon I., 2003, J MACH LEARN RES, V3, P1157; Hägele M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62724-2; Hall P., 2019, An introduction to machine learning interpretability; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Herent P., 2018, BIORXIV, DOI [10.1101/413302, DOI 10.1101/413302]; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Holldobler S., 2017, P 2 YOUNG SCI INT WO, P92; Holzinger Andreas, 2018, 2018 World Symposium on Digital Intelligence for Systems and Machines (DISA). Proceedings, P55, DOI 10.1109/DISA.2018.8490530; Holzinger A, 2014, IEEE Intelligent Informatics Bulletin, V15, P6; Holzinger A, 2021, Arxiv, DOI arXiv:2103.00519; Holzinger A, 2022, LECT NOTES ARTIF INT, V13200, P13, DOI 10.1007/978-3-031-04083-2_2; Holzinger A, 2022, LECT NOTES ARTIF INT, V13200, P3, DOI 10.1007/978-3-031-04083-2_1; Holzinger A, 2017, Arxiv, DOI arXiv:1712.09923; Holzinger A, 2019, WIRES DATA MIN KNOWL, V9, DOI 10.1002/widm.1312; Holzinger Andreas, 2016, Brain Inform, V3, P119, DOI 10.1007/s40708-016-0042-6; Holzinger A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S6-I1; Hosny A, 2018, NAT REV CANCER, V18, P500, DOI 10.1038/s41568-018-0016-5; Hryniewska W, 2021, PATTERN RECOGN, V118, DOI 10.1016/j.patcog.2021.108035; Hu SP, 2020, IEEE ACCESS, V8, P118869, DOI 10.1109/ACCESS.2020.3005510; Goodfellow IJ, 2015, Arxiv, DOI arXiv:1412.6572; Jiménez-Luna J, 2020, NAT MACH INTELL, V2, P573, DOI 10.1038/s42256-020-00236-4; Joshi G, 2021, IEEE ACCESS, V9, P59800, DOI 10.1109/ACCESS.2021.3070212; Douglas PK, 2020, Arxiv, DOI arXiv:2002.06816; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Kerr WT, 2014, NEUROIMAGE, V84, P1107, DOI 10.1016/j.neuroimage.2013.07.050; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim B, 2018, PR MACH LEARN RES, V80; Kindermans PJ, 2017, Arxiv, DOI arXiv:1705.05598; Kindermans Pieter-Jan, 2019, Lecture Notes in Computer Science, P267; Kohoutová L, 2020, NAT PROTOC, V15, P1399, DOI 10.1038/s41596-019-0289-5; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2019, CURR OPIN NEUROBIOL, V55, P167, DOI 10.1016/j.conb.2019.04.002; Kriegeskorte N, 2018, NAT NEUROSCI, V21, P1148, DOI 10.1038/s41593-018-0210-5; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Lake BM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16001837; Lamy JB, 2019, ARTIF INTELL MED, V94, P42, DOI 10.1016/j.artmed.2019.01.001; Landecker W, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P32, DOI 10.1109/CIDM.2013.6597214; Langlotz CP, 2019, RADIOLOGY, V291, P781, DOI 10.1148/radiol.2019190613; Lapuschkin S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08987-4; Lapuschkin S, 2016, PROC CVPR IEEE, P2912, DOI 10.1109/CVPR.2016.318; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee H, 2019, NAT BIOMED ENG, V3, P173, DOI 10.1038/s41551-018-0324-9; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li XX, 2018, LECT NOTES COMPUT SC, V11072, P206, DOI 10.1007/978-3-030-00931-1_24; Lipton ZC, 2018, COMMUN ACM, V61, P36, DOI 10.1145/3233231; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Lucieri A, 2021, Arxiv, DOI arXiv:2103.05112; Lundberg SM, 2017, ADV NEUR IN, V30; Lundervold AS, 2019, Z MED PHYS, V29, P102, DOI 10.1016/j.zemedi.2018.11.002; Zintgraf LM, 2017, Arxiv, DOI [arXiv:1702.04595, 10.48550/arXiv.1702.04595]; Ma SG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-60; Magister LC, 2021, Arxiv, DOI [arXiv:2107.11889, DOI 10.48550/ARXIV.2107.11889]; Mahendran A, 2015, PROC CVPR IEEE, P5188, DOI 10.1109/CVPR.2015.7299155; Mccarthy John W., 1960, Programs with common sense; Meske Christian, 2020, Artificial Intelligence in HCI. First International Conference, AI-HCI 2020 Held as Part of the 22nd HCI International Conference, HCII 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12217), P54, DOI 10.1007/978-3-030-50334-5_4; Miller T, 2019, ARTIF INTELL, V267, P1, DOI 10.1016/j.artint.2018.07.007; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Mirchi N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229596; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mohseni S, 2021, ACM T INTERACT INTEL, V11, DOI 10.1145/3387166; Molnar C., 2020, Lulu. com; Montavon G, 2018, DIGIT SIGNAL PROCESS, V73, P1, DOI 10.1016/j.dsp.2017.10.011; Montavon G, 2017, PATTERN RECOGN, V65, P211, DOI 10.1016/j.patcog.2016.11.008; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Nigri E, 2020, IEEE IJCNN, DOI 10.1109/IJCNN48605.2020.9206837; Osman A., 2020, GROUND TRUTH EVALUAT; Papanastasopoulos Z., 2020, PROCSPIE; Paschali M, 2018, LECT NOTES COMPUT SC, V11070, P493, DOI 10.1007/978-3-030-00928-1_56; Pennisi M, 2021, ARTIF INTELL MED, V118, DOI 10.1016/j.artmed.2021.102114; Pfeifer B., 2021, GRAPH GUIDED RANDOM; Puri N., 2017, ARXIV, VarXiv; Qin Y, 2018, LECT NOTES COMPUT SC, V11072, P603, DOI 10.1007/978-3-030-00931-1_69; Hoffman RR, 2019, Arxiv, DOI [arXiv:1812.04608, DOI 10.48550/ARXIV.1812.04608]; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Ribeiro M. T., 2016, NOTHING ELSE MATTERS; Richardson E, 2017, PROC CVPR IEEE, P5553, DOI 10.1109/CVPR.2017.589; Robnik-Sikonja M, 2008, IEEE T KNOWL DATA EN, V20, P589, DOI 10.1109/TKDE.2007.190734; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Morcos AS, 2018, Arxiv, DOI [arXiv:1803.06959, DOI 10.48550/ARXIV.1803.06959, 10.48550/arXiv.1803.06959]; Samek W, 2016, Arxiv, DOI arXiv:1611.08191; Samek W, 2017, Arxiv, DOI arXiv:1708.08296; Samek W, 2017, IEEE T NEUR NET LEAR, V28, P2660, DOI 10.1109/TNNLS.2016.2599820; Schirrmeister RT, 2017, HUM BRAIN MAPP, V38, P5391, DOI 10.1002/hbm.23730; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Scott A.C., 1977, AM J COMPUT LINGUIST; Segev E, 2020, SOCIOL COMPASS, V14, DOI 10.1111/soc4.12779; Selvaraju R. R., 2016, Grad-CAM: Why did you say that?; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI [10.1146/annurev-bioeng-071516044442, 10.1146/annurev-bioeng-071516-044442]; Shortliffe E.H., 1975, MATH BIOSCI, V23, P351, DOI 10.1016/0025-5564(75)90047-4; Shrikumar A, 2017, PR MACH LEARN RES, V70; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan K, 2014, Arxiv, DOI [arXiv:1312.6034, DOI 10.48550/ARXIV.1312.6034]; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Singh A, 2020, LECT NOTES COMPUT SC, V12069, P21, DOI 10.1007/978-3-030-63419-3_3; Ross AS, 2017, Arxiv, DOI arXiv:1703.03717; Smilkov D, 2017, Arxiv, DOI [arXiv:1706.03825, DOI 10.48550/ARXIV.1706.03825]; Srinivasan V, 2017, INT CONF ACOUST SPEE, P1692, DOI 10.1109/ICASSP.2017.7952445; Staniak M, 2018, Arxiv, DOI arXiv:1804.01955; Sturm I, 2016, J NEUROSCI METH, V274, P141, DOI 10.1016/j.jneumeth.2016.10.008; Sundararajan M, 2017, PR MACH LEARN RES, V70; SWARTOUT W, 1991, IEEE EXPERT, V6, P58, DOI 10.1109/64.87686; Tang ZQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10212-1; Thomas AW, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01321; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Tjoa E, 2021, IEEE T NEUR NET LEAR, V32, P4793, DOI 10.1109/TNNLS.2020.3027314; Springenberg JT, 2015, Arxiv, DOI [arXiv:1412.6806, 10.48550/arXiv.1412.6806, DOI 10.48550/ARXIV.1412.6806]; Tonekaboni S, 2019, PR MACH LEARN RES, V106; Ribeiro MT, 2016, Arxiv, DOI arXiv:1611.05817; Ustun B, 2016, MACH LEARN, V102, P349, DOI 10.1007/s10994-015-5528-6; van der Velden BHM, 2022, MED IMAGE ANAL, V79, DOI 10.1016/j.media.2022.102470; Vayena E, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002689; Wang CJ, 2019, EUR RADIOL, V29, P3348, DOI 10.1007/s00330-019-06214-8; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; Wilson B, 2019, Arxiv, DOI arXiv:1902.11097; Windisch P, 2020, NEURORADIOLOGY, V62, P1515, DOI 10.1007/s00234-020-02465-1; Xu Y, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1685-x; Yang Chengliang, 2018, AMIA Annu Symp Proc, V2018, P1571; Yasaka K, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002707; Yeom SK, 2021, PATTERN RECOGN, V115, DOI 10.1016/j.patcog.2021.107899; Yosinski J, 2015, Arxiv, DOI arXiv:1506.06579; Young T, 2018, IEEE COMPUT INTELL M, V13, P55, DOI 10.1109/MCI.2018.2840738; Zeiler M. D., 2013, ECCV; Zhang JM, 2018, INT J COMPUT VISION, V126, P1084, DOI 10.1007/s11263-017-1059-x; Zhang X, 2022, IEEE J BIOMED HEALTH, V26, P5289, DOI 10.1109/JBHI.2021.3066832; Zhao GN, 2018, LECT NOTES COMPUT SC, V11070, P485, DOI 10.1007/978-3-030-00928-1_55; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhu GM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00869	181	14	14	4	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 1	2022	16								906290	10.3389/fnins.2022.906290	http://dx.doi.org/10.3389/fnins.2022.906290			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	7J6TE	36583102	Green Published, gold			2024-09-18	WOS:000904713100001
J	Infante, G; Miceli, R; Ambrogi, F				Infante, Gabriele; Miceli, Rosalba; Ambrogi, Federico			Sample size and predictive performance of machine learning methods with survival data: A simulation study	STATISTICS IN MEDICINE			English	Article						machine learning; prediction; sample size; simulation; time-to-event	NEURAL-NETWORK MODELS; BREAST-CANCER; PROPORTIONAL-HAZARDS; ADJUVANT THERAPY; FLUOROURACIL; LEVAMISOLE; TRIAL	Prediction models are increasingly developed and used in diagnostic and prognostic studies, where the use of machine learning (ML) methods is becoming more and more popular over traditional regression techniques. For survival outcomes the Cox proportional hazards model is generally used and it has been proven to achieve good prediction performances with few strong covariates. The possibility to improve the model performance by including nonlinearities, covariate interactions and time-varying effects while controlling for overfitting must be carefully considered during the model building phase. On the other hand, ML techniques are able to learn complexities from data at the cost of hyper-parameter tuning and interpretability. One aspect of special interest is the sample size needed for developing a survival prediction model. While there is guidance when using traditional statistical models, the same does not apply when using ML techniques. This work develops a time-to-event simulation framework to evaluate performances of Cox regression compared, among others, to tuned random survival forest, gradient boosting, and neural networks at varying sample sizes. Simulations were based on replications of subjects from publicly available databases, where event times were simulated according to a Cox model with nonlinearities on continuous variables and time-varying effects and on the SEER registry data.	[Infante, Gabriele; Ambrogi, Federico] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Infante, Gabriele; Miceli, Rosalba] Fdn IRCCS Ist Nazl Tumori, Unit Biostat Clin Res, Milan, Italy; [Ambrogi, Federico] IRCCS Policlin San Donato, Sci Directorate, San Donato Milanese, Italy; [Ambrogi, Federico] Univ Milan, Dept Clin Sci & Community Hlth, Via Celoria 22, I-20133 Milan, Italy	University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Policlinico San Donato; University of Milan	Ambrogi, F (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Via Celoria 22, I-20133 Milan, Italy.	federico.ambrogi@unimi.it	Miceli, Rosalba/C-1215-2017; Ambrogi, Federico/D-4294-2015; Infante, Gabriele/AAB-8816-2019	Ambrogi, Federico/0000-0001-9358-011X; Infante, Gabriele/0000-0001-7505-5784	The work was partially supported by Italian Ministry of Education, University and Research project PRIN 2017, prot. 20178S4EK9_004, Innovative Statistical methods in biomedical research on biomarkers: from their identification to their use in clinical prac [20178S4EK9_004]; Italian Ministry of Education, University and Research project PRIN	The work was partially supported by Italian Ministry of Education, University and Research project PRIN 2017, prot. 20178S4EK9_004, Innovative Statistical methods in biomedical research on biomarkers: from their identification to their use in clinical prac; Italian Ministry of Education, University and Research project PRIN	The work was partially supported by Italian Ministry of Education, University and Research project PRIN 2017, prot. 20178S4EK9_004, Innovative Statistical methods in biomedical research on biomarkers: from their identification to their use in clinical practice.	Abadi Martin, 2016, arXiv; Ambrogi F, 2007, COMPUT STAT DATA AN, V52, P30, DOI 10.1016/j.csda.2007.05.001; [Anonymous], SEER STAT DAT INC SE; [Anonymous], Keras; 2015; Austin PC, 2021, STAT METHODS MED RES, V30, P1465, DOI 10.1177/09622802211002867; Balki I, 2019, CAN ASSOC RADIOL J, V70, P344, DOI 10.1016/j.carj.2019.06.002; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Biganzoli E, 1998, STAT MED, V17, P1169, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1169::AID-SIM796>3.3.CO;2-4; Biganzoli E, 2002, NEURAL NETWORKS, V15, P209, DOI 10.1016/S0893-6080(01)00131-9; Boulesteix AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061562; BRAND RJ, 1976, CIRCULATION, V53, P348, DOI 10.1161/01.CIR.53.2.348; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brilleman SL, 2021, J STAT SOFTW, V97, DOI 10.18637/jss.v097.i03; Bühlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Crowther MJ, 2013, STAT MED, V32, P4118, DOI 10.1002/sim.5823; Eng KH, 2017, J CLIN ONCOL, V35, P465, DOI 10.1200/JCO.2016.67.2279; Ensor J., PMSAMPSIZE CALCULATE; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Fornili M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2179-1; Friedman JH, 2009, The Elements of Statistical Learning - Data Mining, Inference and Prediction, V2, P1, DOI DOI 10.1007/B94608; Gensheimer MF, 2019, PEERJ, V7, DOI 10.7717/peerj.6257; Gerds TA., 2021, MED RISK PREDICTION; Gerds TA, 2007, BIOMETRICS, V63, P1283, DOI 10.1111/j.1541-0420.2007.00832.x; Hothorn T., MBOOST MODEL BASED B; Ishwaran H., 2021, FAST UNIFIED RANDOM; Ishwaran H., RANDOMFORESTSRC GETT; Ishwaran H., 2021, randomForestSRC: random survival forests vignette; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Kattan Michael W, 2018, Diagn Progn Res, V2, P7, DOI 10.1186/s41512-018-0029-2; Kvamme H, 2021, LIFETIME DATA ANAL, V27, P710, DOI 10.1007/s10985-021-09532-6; Lee C, 2020, IEEE T BIO-MED ENG, V67, P122, DOI 10.1109/TBME.2019.2909027; Li JCA, 2003, SOCIOL METHOD RES, V32, P117, DOI 10.1177/0049124103031004005; LIESTOL K, 1994, STAT MED, V13, P1189, DOI 10.1002/sim.4780131202; Lorenz E, 2017, AM J EPIDEMIOL, V185, P650, DOI 10.1093/aje/kww122; McCulloch WS, 2016, EMBODIMENTS OF MIND, P19; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Morris TP, 2019, STAT MED, V38, P2074, DOI 10.1002/sim.8086; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Rahnenführer J, 2023, BMC MED, V21, DOI 10.1186/s12916-023-02858-y; RAVDIN PM, 1992, BREAST CANCER RES TR, V22, P285, DOI 10.1007/BF01840841; Riley RD, 2022, STAT MED, V41, P1280, DOI 10.1002/sim.9275; Riley RD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m441; Riley RD, 2019, STAT MED, V38, P1276, DOI 10.1002/sim.7992; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Royston P, 2008, Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Schmid M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-269; Schmoor C, 2000, J CLIN ONCOL, V18, P1696, DOI 10.1200/JCO.2000.18.8.1696; SCHUMACHER M, 1994, J CLIN ONCOL, V12, P2086, DOI 10.1200/JCO.1994.12.10.2086; Smith H, 2022, DIAGN PROGN RES, V6, DOI 10.1186/s41512-022-00124-y; Sonabend R., NEURAL NETWORKS SURV; Sperr E., PUBMED YEAR; Surveillance Research Program, National Cancer Institute SEER*Stat software; van der Ploeg T, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-137; Wallisch C, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-021-01487-4; Zhao LL, 2020, IEEE J BIOMED HEALTH, V24, P3308, DOI 10.1109/JBHI.2020.2980204	58	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	DEC 30	2023	42	30					5657	5675		10.1002/sim.9931	http://dx.doi.org/10.1002/sim.9931		NOV 2023	19	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	AZ6D8	37947168	Green Published, hybrid			2024-09-18	WOS:001103134100001
J	Sheng, TH; Li, B; Solea, E				Sheng, Tianhong; Li, Bing; Solea, Eftychia			On skewed Gaussian graphical models	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Alternating direction method of multipliers; Gaussian graphical model; Lasso; Penalized likelihood; Skewed Gaussian distribution	TUNING PARAMETER SELECTION; LIKELIHOOD-ESTIMATION; REPRESENTATION; SHRINKAGE; NETWORKS; L(1)	We introduce a skewed Gaussian graphical model as an extension to the Gaussian graphical model. One of the appealing properties of the Gaussian distribution is that conditional independence can be fully characterized by the sparseness in the precision matrix. The skewed Gaussian distribution adds a shape parameter to the Gaussian distribution to take into account possible skewness in the data; thus it is more flexible than the Gaussian model. Nevertheless, the appealing property of the Gaussian distribution is retained to a large degree: the conditional independence is still characterized by the sparseness in the parameters, which now include a shape parameter in addition to the precision matrix. As a result, the skewed Gaussian graphical model can be efficiently estimated through a penalized likelihood method just as the Gaussian graphical model. We develop an algorithm to maximize the penalized likelihood based on the alternating direction method of multipliers, and establish the asymptotic normality and variable selection consistency for the new estimator. Through simulations, we demonstrate that our method performs better than the Gaussian and Gaussian copula methods when these distributional assumptions are not satisfied. The method is applied to a breast cancer MicroRNA dataset to construct a gene network, which shows better interpretability than the Gaussian graphical model.	[Sheng, Tianhong; Li, Bing] Penn State Univ, Dept Stat, 326 Thomas Bldg, University Pk, PA 16802 USA; [Solea, Eftychia] ENSAI, CREST, Campus Ker Lann,Rue Blaise Pascal,BP 37203, F-35172 Bruz, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Ecole Nationale de la Statistique et de l'Analyse de l'Information (ENSAI)	Sheng, TH (corresponding author), Penn State Univ, Dept Stat, 326 Thomas Bldg, University Pk, PA 16802 USA.	txs514@psu.edu		Solea, Eftychia/0000-0003-0528-8675	U.S. National Science Foundation;  [DMS-1713078]	U.S. National Science Foundation(National Science Foundation (NSF)); 	Bing Li?s research is supported in part by the U.S. National Science Foundation DMS-1713078.	Allen GI, 2012, IEEE International Conference on Bioinformatics and Biomedicine BIBM, P1, DOI DOI 10.1109/BIBM.2012.6392619; [Anonymous], 2014, R PACKAGE VERSION 1; Azzalini A, 1999, J ROY STAT SOC B, V61, P579, DOI 10.1111/1467-9868.00194; Azzalini A, 1996, BIOMETRIKA, V83, P715, DOI 10.1093/biomet/83.4.715; AZZALINI A, 1985, SCAND J STAT, V12, P171; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Bickel PJ, 2008, ANN STAT, V36, P199, DOI 10.1214/009053607000000758; Bickel PJ, 2008, ANN STAT, V36, P2577, DOI 10.1214/08-AOS600; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Cai T, 2011, J AM STAT ASSOC, V106, P594, DOI 10.1198/jasa.2011.tm10155; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Capitanio A, 2003, SCAND J STAT, V30, P129, DOI 10.1111/1467-9469.00322; Fellinghauer B, 2013, COMPUT STAT DATA AN, V64, P132, DOI 10.1016/j.csda.2013.02.022; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gao X, 2012, STAT SINICA, V22, P1123, DOI 10.5705/ss.2009.210; GLOWINSKI R, 1975, REV FR AUTOMAT INFOR, V9, P41; Han S, 2019, J CANCER, V10, P441, DOI 10.7150/jca.30041; Harris N, 2013, J MACH LEARN RES, V14, P3365; HENZE N, 1986, SCAND J STAT, V13, P271; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jordan Michael I., 1999, Learning in Graphical Models; Knight K, 2000, ANN STAT, V28, P1356; Li B., 2019, A Graduate Course on Statistical Inference; Li B, 2018, J AM STAT ASSOC, V113, P1637, DOI 10.1080/01621459.2017.1356726; Li B, 2014, J AM STAT ASSOC, V109, P1188, DOI 10.1080/01621459.2014.882842; Liu H, 2012, ANN STAT, V40, P2293, DOI 10.1214/12-AOS1037; Liu H, 2009, J MACH LEARN RES, V10, P2295; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Ortiz A, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00132; Rothman AJ, 2008, ELECTRON J STAT, V2, P494, DOI 10.1214/08-EJS176; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Voorman A, 2014, BIOMETRIKA, V101, P85, DOI 10.1093/biomet/ast053; Wan YW, 2016, BIOINFORMATICS, V32, P952, DOI 10.1093/bioinformatics/btv677; Wang HS, 2009, J R STAT SOC B, V71, P671, DOI 10.1111/j.1467-9868.2008.00693.x; Xue LZ, 2012, ANN STAT, V40, P2541, DOI 10.1214/12-AOS1041; Yang E., 2013, ADV NEURAL INFORM PR, P1718; Yin JX, 2011, ANN APPL STAT, V5, P2630, DOI 10.1214/11-AOAS494; Yin PC, 2014, COMMUN INF SYST, V14, P87, DOI 10.4310/CIS.2014.v14.n2.a2; Yuan M, 2007, BIOMETRIKA, V94, P19, DOI 10.1093/biomet/asm018; Yuan M, 2010, J MACH LEARN RES, V11, P2261	41	0	0	0	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	MAR	2023	194								105129	10.1016/j.jmva.2022.105129	http://dx.doi.org/10.1016/j.jmva.2022.105129		DEC 2022	19	Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	7J0HE		Bronze			2024-09-18	WOS:000904267700003
J	Bektas, AB; Ak, Ç; Gönen, M				Bektas, Ayyuce Begum; Ak, Cigdem; Gonen, Mehmet			Fast and interpretable genomic data analysis using multiple approximate kernel learning	BIOINFORMATICS			English	Article; Proceedings Paper	30th Annual Conference on Intelligent Systems for Molecular Biology (ISMB)	JUL 10-14, 2022	Madison, WI				REGULARIZATION; REGRESSION; SELECTION; LASSO	Motivation: Dataset sizes in computational biology have been increased drastically with the help of improved data collection tools and increasing size of patient cohorts. Previous kernel-based machine learning algorithms proposed for increased interpretability started to fail with large sample sizes, owing to their lack of scalability. To overcome this problem, we proposed a fast and efficient multiple kernel learning (MKL) algorithm to be particularly used with large-scale data that integrates kernel approximation and group Lasso formulations into a conjoint model. Our method extracts significant and meaningful information from the genomic data while conjointly learning a model for out-of-sample prediction. It is scalable with increasing sample size by approximating instead of calculating distinct kernel matrices. Results: To test our computational framework, namely, Multiple Approximate Kernel Learning (MAKL), we demonstrated our experiments on three cancer datasets and showed that MAKL is capable to outperform the baseline algorithm while using only a small fraction of the input features. We also reported selection frequencies of approximated kernel matrices associated with feature subsets (i.e. gene sets/pathways), which helps to see their relevance for the given classification task. Our fast and interpretable MKL algorithm producing sparse solutions is promising for computational biology applications considering its scalability and highly correlated structure of genomic datasets, and it can be used to discover new biomarkers and new therapeutic guidelines.	[Bektas, Ayyuce Begum] Koc Univ, Grad Sch Sci & Engn, TR-34450 Istanbul, Turkey; [Ak, Cigdem] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Gonen, Mehmet] Koc Univ, Coll Engn, Dept Ind Engn, TR-34450 Istanbul, Turkey; [Gonen, Mehmet] Koc Univ, Sch Med, TR-34450 Istanbul, Turkey	Koc University; Oregon Health & Science University; Koc University; Koc University	Gönen, M (corresponding author), Koc Univ, Coll Engn, Dept Ind Engn, TR-34450 Istanbul, Turkey.; Gönen, M (corresponding author), Koc Univ, Sch Med, TR-34450 Istanbul, Turkey.	mehmetgonen@ku.edu.tr	Gönen, Mehmet/O-7322-2015	Ak, Cigdem/0000-0003-2563-4539	Scientific and Technological Research Council of Turkey (TUBITAK) [EEEAG 117E181]; Turkish Academy of Sciences (TUBA-GEBIP; The Young Scientist Award Program); Science Academy of Turkey (BAGEP; The Young Scientist Award Program)	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish Academy of Sciences (TUBA-GEBIP; The Young Scientist Award Program); Science Academy of Turkey (BAGEP; The Young Scientist Award Program)	This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) [EEEAG 117E181]. M.G. was supported by the Turkish Academy of Sciences (TUBA-GEBIP; The Young Scientist Award Program) and the Science Academy of Turkey (BAGEP; The Young Scientist Award Program).	[Anonymous], 2006, J R STAT SOC B; [Anonymous], 1999, Ph.D. thesis); Antoniadis A, 2001, J AM STAT ASSOC, V96, P939, DOI 10.1198/016214501753208942; Bach FR, 2008, J MACH LEARN RES, V9, P1179; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Cai TT, 2001, J AM STAT ASSOC, V96, P960; Chen T., 2019, xgboost: Extreme Gradient Boosting. R package version 0.82.1; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Gönen M, 2017, CELL SYST, V5, P485, DOI 10.1016/j.cels.2017.09.004; Gönen M, 2011, J MACH LEARN RES, V12, P2211; Guyon I., 1992, NIPS, P147; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Meier L., 2020, Grplasso: Fitting user-specified models with group lasso penalty [R package version 0.4-7]; Peters J, 2017, ADAPT COMPUT MACH LE; Rahimi A., 2007, Advances in neural information processing systems, V20; Rudin W., 2017, Fourier analysis on groups; Scala S, 2006, CLIN CANCER RES, V12, P2427, DOI 10.1158/1078-0432.CCR-05-1940; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Yang JM, 2018, CANCER IMMUNOL RES, V6, P1186, DOI 10.1158/2326-6066.CIR-18-0045	23	1	1	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	JUN 24	2022	38	SUPPL 1		1	SI		77	83		10.1093/bioinformatics/btac241	http://dx.doi.org/10.1093/bioinformatics/btac241			7	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	2L8FB	35758810	Green Published			2024-09-18	WOS:000817250400014
J	Shao, JL; Liu, X; He, WQ				Shao, Jianli; Liu, Xin; He, Wenqing			Kernel Based Data-Adaptive Support Vector Machines for Multi-Class Classification	MATHEMATICS			English	Article						classification; data-adaptive kernel functions; image data; multi-category classifier; predictive models; support vector machine	CLASSIFIERS	Imbalanced data exist in many classification problems. The classification of imbalanced data has remarkable challenges in machine learning. The support vector machine (SVM) and its variants are popularly used in machine learning among different classifiers thanks to their flexibility and interpretability. However, the performance of SVMs is impacted when the data are imbalanced, which is a typical data structure in the multi-category classification problem. In this paper, we employ the data-adaptive SVM with scaled kernel functions to classify instances for a multi-class population. We propose a multi-class data-dependent kernel function for the SVM by considering class imbalance and the spatial association among instances so that the classification accuracy is enhanced. Simulation studies demonstrate the superb performance of the proposed method, and a real multi-class prostate cancer image dataset is employed as an illustration. Not only does the proposed method outperform the competitor methods in terms of the commonly used accuracy measures such as the F-score and G-means, but also successfully detects more than 60% of instances from the rare class in the real data, while the competitors can only detect less than 20% of the rare class instances. The proposed method will benefit other scientific research fields, such as multiple region boundary detection.	[Shao, Jianli; Liu, Xin] Shanghai Univ Finance & Econ, Sch Stat & Management, Shanghai 200433, Peoples R China; [Liu, Xin; He, Wenqing] Univ Western Ontario, Dept Stat & Actuarial Sci, London, ON N6A 3K7, Canada	Shanghai University of Finance & Economics; Western University (University of Western Ontario)	Liu, X (corresponding author), Shanghai Univ Finance & Econ, Sch Stat & Management, Shanghai 200433, Peoples R China.; Liu, X (corresponding author), Univ Western Ontario, Dept Stat & Actuarial Sci, London, ON N6A 3K7, Canada.	jlshao@mail.shufe.edu.cn; liu.xin@mail.shufe.edu.cn; whe@stats.uwo.ca		, Xin/0000-0001-8779-2618	Fundamental Research Funds for the Central Universities; Natural Science and Engineering Research Council of Canada (NSERC); CIHR Team at Image-Guided Prostate Cancer Management at the University of Western Ontario	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Team at Image-Guided Prostate Cancer Management at the University of Western Ontario(Canadian Institutes of Health Research (CIHR))	Liu's research was partially supported by the Fundamental Research Funds for the Central Universities. He's research was partially supported by the Natural Science and Engineering Research Council of Canada (NSERC). The authors thank the CIHR Team at Image-Guided Prostate Cancer Management at the University of Western Ontario. The authors also thank the reviewer team for their constructive comments.	Chawla N., 2004, LEARNING IMBALANCED, VVolume 6, P1; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; Daskalaki S, 2006, APPL ARTIF INTELL, V20, P381, DOI 10.1080/08839510500313653; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P882, DOI 10.1016/j.patrec.2005.10.012; Fung G.M, 2002, MACH LEARN, V1, P21; Fung GM, 2005, MACH LEARN, V59, P77, DOI 10.1007/s10994-005-0463-6; He XS, 2012, PATTERN RECOGN LETT, V33, P71, DOI 10.1016/j.patrec.2011.09.035; Kressel UHG, 1999, ADVANCES IN KERNEL METHODS, P255; Liu X, 2022, J APPL STAT, V49, P1465, DOI 10.1080/02664763.2020.1870669; Maratea Antonio, 2011, Fuzzy Logic and Applications. Proceedings 9th International Workshop, WILF 2011, P196, DOI 10.1007/978-3-642-23713-3_25; Maratea A, 2014, INFORM SCIENCES, V257, P331, DOI 10.1016/j.ins.2013.04.016; Mazurowski MA, 2008, NEURAL NETWORKS, V21, P427, DOI 10.1016/j.neunet.2007.12.031; Menardi G, 2014, DATA MIN KNOWL DISC, V28, P92, DOI 10.1007/s10618-012-0295-5; Suykens J. A. K., 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P900, DOI 10.1109/IJCNN.1999.831072; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; Tibshirani R, 2001, The elements of statistical learning: data mining, inference, and prediction, DOI 10.1007/978-0-387-84858-7; Vapnik V., 1995, STAT LEARNING THEORY; Wang LF, 2007, J AM STAT ASSOC, V102, P583, DOI 10.1198/016214506000001383; Williams P, 2005, LECT NOTES COMPUT SC, V3496, P831; Wu S, 2002, NEURAL PROCESS LETT, V15, P59, DOI 10.1023/A:1013848912046; Xiao-Lei Xia, 2008, 2008 IEEE International Symposium on Industrial Electronics (ISIE 2008), P1230, DOI 10.1109/ISIE.2008.4676989; Zhang Y, 2014, NEURAL COMPUT APPL, V25, P927, DOI 10.1007/s00521-014-1584-2; Zhang ZW, 2014, EUR J OPER RES, V237, P335, DOI 10.1016/j.ejor.2014.01.044	24	9	9	0	13	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-7390		MATHEMATICS-BASEL	Mathematics	MAY	2021	9	9							936	10.3390/math9090936	http://dx.doi.org/10.3390/math9090936			15	Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	SC3VX		gold			2024-09-18	WOS:000650604300001
C	Li, XY; Xiang, J; Wu, FX; Li, M		Park, T; Cho, YR; Hu, X; Yoo, I; Woo, HG; Wang, J; Facelli, J; Nam, S; Kang, M		Li, Xingyi; Xiang, Ju; Wu, Fang-Xiang; Li, Min			A topological AUC-based biomarker ensemble method for the complex disease analysis	2020 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE	IEEE International Conference on Bioinformatics and Biomedicine-BIBM		English	Proceedings Paper	IEEE International Conference on Bioinformatics and Biomedicine (IEEE BIBM)	DEC 16-19, 2020	ELECTR NETWORK	IEEE, Seoul Natl Univ, Bioinformat Inst, Korea Genome Open HRD, Korea Genome Organization, Bio Synergy Res Ctr, Korean Federation of Science and Technology Societies, Seoul Natl Univ, Dept Stat, IEEE Tech Comm Computat Life Sci		AUC; biomarker; complex diseases; topological information; feature selection	ENVIRONMENTAL-FACTORS; EPIDEMIOLOGY	Complex diseases are affected by many factors, and their pathogenic mechanism is complicated, which brings difficulties to the analysis and treatment of diseases. AUC, the area under the ROC curve, is often used as a gold standard to evaluate the performance of a binary classifier. The existing methods of constructing classifier by optimizing AUC are easy to fall into local optimum, and have high time complexity, which is not suitable for real-time analysis of high-dimensional gene expression data. With the rapid development of high-throughput sequencing technology, feature selection and model estimation become the necessary means to reduce the dimension and complexity of data, and the selected important features have the potential as biomarkers to reveal the pathogenesis of diseases. In this paper, we proposed a topological AUC-based biomarker ensemble method for the complex disease analysis, which uses gene expression data and the topological information derived from the protein-protein interaction network to identify biomarkers. The main contribution is to optimize two objectives simultaneously: maximizing the AUC score and minimizing the number of selected features. We applied the proposed method to analyze two types of problems: 1) prognosis of breast cancer, 2) classification of similar diseases. The results show that our method can effectively identify a small set of biomarkers with the powerful classification ability and the biological interpretability.	[Li, Xingyi; Xiang, Ju; Li, Min] Cent South Univ, Sch Comp Sci & Engn, Changsha, Peoples R China; [Xiang, Ju] Changsha Med Univ, Neurosci Res Ctr, Changsha, Peoples R China; [Xiang, Ju] Changsha Med Univ, Dept Basic Med Sci, Changsha, Peoples R China; [Wu, Fang-Xiang] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada; [Wu, Fang-Xiang] Univ Saskatchewan, Div Biomed Engn, Saskatoon, SK S7N 5A9, Canada	Central South University; Changsha Medical University; Changsha Medical University; University of Saskatchewan; University of Saskatchewan	Li, M (corresponding author), Cent South Univ, Sch Comp Sci & Engn, Changsha, Peoples R China.	xingyili@csu.edu.cn; xiangju@foxmail.com; faw341@mail.usask.ca; limin@mail.csu.edu.cn	Li, XingYi/R-3466-2016; LI, MIN/U-3131-2018	Wu, Fang-Xiang/0000-0002-4593-9332	National Natural Science Foundation of China [61832019, 61772552, 61702054]; 111 Project [B18059]; Hunan Provincial Innovation Foundation For Postgraduate [CX20190123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Hunan Provincial Innovation Foundation For Postgraduate	This work was supported in part by the National Natural Science Foundation of China (61832019, 61772552, 61702054), the 111 Project (No. B18059), and the Hunan Provincial Innovation Foundation For Postgraduate (CX20190123).	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Borrebaeck CAK, 2017, NAT REV CANCER, V17, P199, DOI 10.1038/nrc.2016.153; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaprio J, 2002, TWIN RES, V5, P358, DOI 10.1375/twin.5.5.358; Lesterhuis WJ, 2017, NAT REV DRUG DISCOV, V16, P264, DOI 10.1038/nrd.2016.233; Li XY, 2021, IEEE ACM T COMPUT BI, V18, P2483, DOI 10.1109/TCBB.2020.2973148; Li XY, 2020, BRIEF BIOINFORM, V21, P566, DOI 10.1093/bib/bbz017; Liu R, 2014, MED RES REV, V34, P455, DOI 10.1002/med.21293; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Piñero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Rennie J, 2005, P 22 INT C MACH LEAR, P713, DOI DOI 10.1145/1102351.1102441; Shivaswamy PK, 2007, IEEE DATA MINING, P655, DOI 10.1109/ICDM.2007.93; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Volanisa D, 2010, TOXICOL LETT, V193, P131, DOI 10.1016/j.toxlet.2009.12.018; Zou M, 2015, BIOINFORMATICS, V31, P3330, DOI 10.1093/bioinformatics/btv374	19	1	1	0	2	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA	2156-1125	2156-1133	978-1-7281-6215-7	IEEE INT C BIOINFORM			2020							281	286		10.1109/BIBM49941.2020.9313528	http://dx.doi.org/10.1109/BIBM49941.2020.9313528			6	Biochemical Research Methods; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Computer Science; Mathematical & Computational Biology	BR6BW					2024-09-18	WOS:000659487100051
J	Hunt, GJ; Dane, MA; Korkola, JE; Heiser, LM; Gagnon-Bartsch, JA				Hunt, Gregory J.; Dane, Mark A.; Korkola, James E.; Heiser, Laura M.; Gagnon-Bartsch, Johann A.			Automatic Transformation and Integration to Improve Visualization and Discovery of Latent Effects in Imaging Data	JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS			English	Article						Automatic transformation; Data integration; Imaging; Latent variables; PCA; Visualization	PRINCIPAL-COMPONENTS; CELLULAR-RESPONSES; STEM-CELLS; MICROENVIRONMENTS; CANCER	Proper data transformation is an essential part of analysis. Choosing appropriate transformations for variables can enhance visualization, improve efficacy of analytical methods, and increase data interpretability. However, determining appropriate transformations of variables from high-content imaging data poses new challenges. Imaging data produce hundreds of covariates from each of thousands of images in a corpus. Each of these covariates will have a different distribution and needs a potentially different transformation. As such imaging data produce hundreds of covariates, determining an appropriate transformation for each of them is infeasible by hand. In this article, we explore simple, robust, and automatic transformations of high-content image data. A central application of our work is to microenvironment microarray bio-imaging data from the NIH LINCS program. We show that our robust transformations enhance visualization and improve the discovery of substantively relevant latent effects. These transformations enhance analysis of image features individually and also improve data integration approaches when combining together multiple features. We anticipate that the advantages of this work will likely also be realized in the analysis of data from other high-content and highly multiplexed technologies like Cell Painting or Cyclic Immunofluorescence. Software and further analysis can be found at gjhunt.github.io/rr. for this article are available online.	[Hunt, Gregory J.] Coll William & Mary, Dept Math, POB 8795, Williamsburg, VA 23187 USA; [Dane, Mark A.; Korkola, James E.; Heiser, Laura M.] Oregon Hlth & Sci Univ, OHSU Ctr Spatial Syst Biomed, Knight Canc Inst, Dept Biomed Engn, Portland, OR 97201 USA; [Gagnon-Bartsch, Johann A.] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA	William & Mary; Oregon Health & Science University; University of Michigan System; University of Michigan	Hunt, GJ (corresponding author), Coll William & Mary, Dept Math, POB 8795, Williamsburg, VA 23187 USA.	ghunt@wm.edu		Gagnon-Bartsch, Johann/0000-0001-7683-2434	National Science Foundation [DMS-1646108]; National Institutes ofHealth (NIH) [U54HG008100, 1U54CA209988]	National Science Foundation(National Science Foundation (NSF)); National Institutes ofHealth (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge support from the National Science Foundation (grant no. DMS-1646108) and theNational Institutes ofHealth (NIH grant nos. U54HG008100 and 1U54CA209988).	ATKINSON AC, 1986, TECHNOMETRICS, V28, P29, DOI 10.2307/1269601; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bray MA, 2016, NAT PROTOC, V11, P1757, DOI 10.1038/nprot.2016.105; Bryll R, 2003, PATTERN RECOGN, V36, P1291, DOI 10.1016/S0031-3203(02)00121-8; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/NMETH.4397, 10.1038/nmeth.4397]; CARROLL RJ, 1980, J R STAT SOC B, V42, P71; COOK RD, 1983, TECHNOMETRICS, V25, P337, DOI 10.2307/1267855; Croux C, 2005, J MULTIVARIATE ANAL, V95, P206, DOI 10.1016/j.jmva.2004.08.002; GRAY J, 2014, MICROENVIRONMENT PER; Guaraldi G, 2020, LANCET RHEUMATOL, V2, pE474, DOI 10.1016/S2665-9913(20)30173-9; Hastie T, 2015, J MACH LEARN RES, V16, P3367; HE XM, 1990, J AM STAT ASSOC, V85, P446, DOI 10.2307/2289782; HIGUCHI I, 2004, TECHNICAL REPORT; Hu JH, 2006, J AM STAT ASSOC, V101, P41, DOI 10.1198/016214505000000989; Huang JHZ, 2008, ELECTRON J STAT, V2, P678, DOI 10.1214/08-EJS218; Hubert M, 2002, CHEMOMETR INTELL LAB, V60, P101, DOI 10.1016/S0169-7439(01)00188-5; HUBERT M, 2009, TECHNICAL REPORT; Januschke J, 2014, SEMIN CELL DEV BIOL, V34, P116, DOI 10.1016/j.semcdb.2014.02.014; LaBarge MA, 2007, STEM CELL REV, V3, P137, DOI 10.1007/s12015-007-0024-4; LaBarge MA, 2014, ADV DRUG DELIVER REV, V69, P123, DOI 10.1016/j.addr.2014.02.009; LaBarge MA, 2013, CELL STEM CELL, V13, P259, DOI 10.1016/j.stem.2013.08.008; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lin CH, 2017, CELL REP, V21, P533, DOI 10.1016/j.celrep.2017.09.058; Lin CH, 2012, JOVE-J VIS EXP, DOI 10.3791/4152; Lin Jia-Ren, 2016, Curr Protoc Chem Biol, V8, P251, DOI 10.1002/cpch.14; Locantore N, 1999, TEST, V8, P1, DOI 10.1007/BF02595862; Maadooliat M, 2015, J COMPUT GRAPH STAT, V24, P84, DOI 10.1080/10618600.2014.891461; Maman S, 2018, NAT REV CANCER, V18, P359, DOI 10.1038/s41568-018-0006-7; Marazzi A, 2004, STAT IND TECHNOL, P173; Maronna R, 2005, TECHNOMETRICS, V47, P264, DOI 10.1198/004017005000000166; Pelissier FA, 2014, CELL REP, V7, P1926, DOI 10.1016/j.celrep.2014.05.021; Smith R, 2019, JOVE-J VIS EXP, DOI 10.3791/58957; TETI A, 1992, J AM SOC NEPHROL, V2, pS83; Tsujikawa T, 2017, CELL REP, V19, P203, DOI 10.1016/j.celrep.2017.03.037; Watson SS, 2018, CELL SYST, V6, P329, DOI 10.1016/j.cels.2018.02.001; Zimmerman D.L., 2010, Antedependence Models for Longitudinal Data	37	6	6	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1061-8600	1537-2715		J COMPUT GRAPH STAT	J. Comput. Graph. Stat.	OCT 1	2020	29	4					929	941		10.1080/10618600.2020.1741379	http://dx.doi.org/10.1080/10618600.2020.1741379		APR 2020	13	Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	PI0GY	34531645	Green Submitted, Green Accepted			2024-09-18	WOS:000532000700001
J	Noor, S; Akram, W; Ahmed, T; Qurat-ul-Ain				Noor, Saba; Akram, Waseem; Ahmed, Touseef; Qurat-ul-Ain			Predicting COVID-19 Incidence Using Data Mining Techniques: A case study of Pakistan	BRAIN-BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE			English	Article						WEKA; Predictive data mining; COVID-19		The Outbreak of Coronatirus (COVID-19) came to the world in early December 2019. The early cases of conronavirus were reported in Wuhan City, Hubei Province, China. Till May 18, 2020, 198 countries hate been affected by this life-threatening disease. The most common and known traits of COVID-19 are tiredness, fever, and dry cough. In this paper, we hate discussed the Predictive data mining approach for COVID-19 predictions. In Predictive data mining, a model is developed and trained using supervised framing and then it predicts the behavior of provided data. Predictive data mining is a renowned technique known to many health organizations for the classification and prediction of diseases such as Heart disease and various types of cancers etc. There are several factors for comparing the model's accuracy, scalability, and interpretability. This predictive model is compared to the basics of its accuracy. In this proposed approach, are have used WEKA as it provides a vast collection of many machine learning algorithms. The main objective of this paper is to forecast the possible future incidence of corona cases in Pakistan. This study concludes that the number of corona cases will increase swiftly. If the government take proactive steps and strictly implement precautionary measures, then Pakistan may be able to overcome this pandemic.	[Noor, Saba; Ahmed, Touseef; Qurat-ul-Ain] Lahore Garrison Univ, Dept Comp Sci, Lahore, Pakistan; [Akram, Waseem] COMSATS Univ Islamabad, Dept Comp Sci, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Akram, W (corresponding author), COMSATS Univ Islamabad, Dept Comp Sci, Islamabad, Pakistan.	imwaseem.khan@yahoo.com	Akram, Waseem/CAG-4907-2022	Akram, Waseem/0000-0002-7401-5120				Ardabili SF, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3580188, DOI 10.2139/SSRN.3580188]; Avery Christopher., 2020, NATL BUREAU EC RES, DOI [10.3386/w27007, DOI 10.3386/W27007]; Binti Hamzah F. A., 2020, B WHO UNPUB; Chakraborty T, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109850; Fong SJ, 2020, INT J INTERACT MULTI, V6, P132, DOI 10.9781/ijimai.2020.02.002; Janies D, 2008, CLADISTICS, V24, P111, DOI 10.1111/j.1096-0031.2008.00199.x; Li LX, 2020, INFECT DIS MODEL, V5, P282, DOI 10.1016/j.idm.2020.03.002; Li Y., 2020, Annals of Infectious Disease and Epidemiology, V5, P1052; Murray C. J., 2020, FORECASTING COVID 19, P114; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Qasim M., 2020, DATA MODEL PREDICT P; Qin L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072365; Stübinger J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020099; Tiwari S, 2020, DISASTER MED PUBLIC, V14, pE33, DOI 10.1017/dmp.2020.115; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zhang GJ, 2020, FRONT COMPUT SCI-CHI, V14, P430, DOI 10.1007/s11704-018-8052-6	19	5	5	0	8	EDUSOFT PUBLISHING	BACAU	9 MAI STR 82, BACAU, 600065, ROMANIA	2067-3957			BRAIN-BROAD RES ARTI	BRAIN-Broad Res. Artif. Intellect. Neurosci.		2020	11	4					168	184		10.18662/brain/11.4/147	http://dx.doi.org/10.18662/brain/11.4/147			17	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	QD8CZ		gold			2024-09-18	WOS:000615741600010
J	Gutiérrez-Mondragón, MA; König, C; Vellido, A				Gutierrez-Mondragon, Mario A. A.; Konig, Caroline; Vellido, Alfredo			Layer-Wise Relevance Analysis for Motif Recognition in the Activation Pathway of the<i> β2-Adrenergic</i> GPCR Receptor	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						GPCRs; beta 2-adrenergic receptors; proteomics; molecular dynamics; signal pathways; deep learning; convolution networks; interpretability; layer-wise relevance	NEURAL-NETWORK	G-protein-coupled receptors (GPCRs) are cell membrane proteins of relevance as therapeutic targets, and are associated to the development of treatments for illnesses such as diabetes, Alzheimer's, or even cancer. Therefore, comprehending the underlying mechanisms of the receptor functional properties is of particular interest in pharmacoproteomics and in disease therapy at large. Their interaction with ligands elicits multiple molecular rearrangements all along their structure, inducing activation pathways that distinctly influence the cell response. In this work, we studied GPCR signaling pathways from molecular dynamics simulations as they provide rich information about the dynamic nature of the receptors. We focused on studying the molecular properties of the receptors using deep-learning-based methods. In particular, we designed and trained a one-dimensional convolution neural network and illustrated its use in a classification of conformational states: active, intermediate, or inactive, of the beta 2-adrenergic receptor when bound to the full agonist BI-167107. Through a novel explainability-oriented investigation of the prediction results, we were able to identify and assess the contribution of individual motifs (residues) influencing a particular activation pathway. Consequently, we contribute a methodology that assists in the elucidation of the underlying mechanisms of receptor activation-deactivation.	[Gutierrez-Mondragon, Mario A. A.; Konig, Caroline; Vellido, Alfredo] Univ Politecn Catalunya UPC BarcelonaTech, Dept Comp Sci, Barcelona 08034, Spain; [Gutierrez-Mondragon, Mario A. A.; Konig, Caroline; Vellido, Alfredo] Univ Politecn Catalunya UPC BarcelonaTech, Intelligent Data Sci & Artificial Intelligence ID, Barcelona 08034, Spain	Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya	König, C (corresponding author), Univ Politecn Catalunya UPC BarcelonaTech, Dept Comp Sci, Barcelona 08034, Spain.; König, C (corresponding author), Univ Politecn Catalunya UPC BarcelonaTech, Intelligent Data Sci & Artificial Intelligence ID, Barcelona 08034, Spain.				Spanish research project [PID2019-104551RB-I00]	Spanish research project(Spanish Government)	This research was funded by Spanish PID2019-104551RB-I00 research project.	[Anonymous], ADV TECHN BIOL MED, DOI 10.4172/2379-1764.1000139; Arras L, 2022, INFORM FUSION, V81, P14, DOI 10.1016/j.inffus.2021.11.008; Bacciu D., 2018, P 26 EUROPEAN S ARTI; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bera I, 2019, CURR PHARM DESIGN, V25, P3339, DOI 10.2174/1381612825666190903153043; Bernetti M, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13090253; Böhle M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00194; Ceriotti M., 2020, Handbook Mater. Model, P1911, DOI DOI 10.1007/978-3-319-44677-668; Chang S, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8090320; Chen ZQ, 2019, J CHEM INF MODEL, V59, P3353, DOI 10.1021/acs.jcim.9b00332; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cho H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78169-6; Chollet Francois, 2021, DEEP LEARNING PYTHON; Coeckelbergh M, 2020, SCI ENG ETHICS, V26, P2051, DOI 10.1007/s11948-019-00146-8; Congreve M, 2020, CELL, V181, P81, DOI 10.1016/j.cell.2020.03.003; Cui YF, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2672-1; Das A., 2020, Opportunities and Challenges in Explainable Artificial Intelligence (XAI): A Survey; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; Feng JR, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-020-03850-6; Frank M, 2020, COMPUTATION, V8, DOI 10.3390/computation8010015; Ganesan A, 2017, DRUG DISCOV TODAY, V22, P249, DOI 10.1016/j.drudis.2016.11.001; Gunning D, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aay7120; Gutiérrez-Mondragón MA, 2022, LECT NOTES COMPUT SC, P275, DOI 10.1007/978-3-031-07802-6_23; Hochuli J, 2018, J MOL GRAPH MODEL, V84, P96, DOI 10.1016/j.jmgm.2018.06.005; Hollingsworth SA, 2018, NEURON, V99, P1129, DOI 10.1016/j.neuron.2018.08.011; Holzinger A., 2022, INT WORKSH HELD CONJ, V13200; Holzinger A, 2022, LECT NOTES ARTIF INT, V13200, P13, DOI 10.1007/978-3-031-04083-2_2; Hu SS, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3263-x; Iqbal M. S., 2021, DEEP LEARNING UNMANN, P709; Kaiming He, 2015, 2015 IEEE International Conference on Computer Vision (ICCV). Proceedings, P1026, DOI 10.1109/ICCV.2015.123; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kohlhoff KJ, 2014, NAT CHEM, V6, P15, DOI [10.1038/NCHEM.1821, 10.1038/nchem.1821]; König C, 2018, INTERDISCIP SCI, V10, P43, DOI 10.1007/s12539-018-0286-3; Kundu I, 2018, RSC ADV, V8, P12127, DOI 10.1039/c8ra00003d; Lagerström MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li C, 2022, J CHEM INF MODEL, V62, P1399, DOI 10.1021/acs.jcim.2c00085; Lu SY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25020-9; Meyer JG, 2021, CELL REP METHODS, V1, DOI 10.1016/j.crmeth.2021.100003; Montavon G., 2019, Layer-wise relevance propagation: an overview, P193, DOI [10.1007/978-3-030-28954-6_10, 10.1007/978-3-030-28954-610, DOI 10.1007/978-3-030-28954-610]; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plante A, 2019, MOLECULES, V24, DOI 10.3390/molecules24112097; Preuer K., 2019, EXPLAINABLE INTERPRE, P331, DOI DOI 10.1007/978-3-030-28954-6_18; Rodríguez-Espigares I, 2020, NAT METHODS, V17, P777, DOI 10.1038/s41592-020-0884-y; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Saba L, 2019, EUR J RADIOL, V114, P14, DOI 10.1016/j.ejrad.2019.02.038; Samek W, 2017, IEEE T NEUR NET LEAR, V28, P2660, DOI 10.1109/TNNLS.2016.2599820; Santana CA, 2022, NUCLEIC ACIDS RES, V50, pW392, DOI 10.1093/nar/gkac323; Smyth MS, 2000, J CLIN PATHOL-MOL PA, V53, P8, DOI 10.1136/mp.53.1.8; Sun M., 2022, BIORXIV, DOI [10.1101/2022.03.15.484500, DOI 10.1101/2022.03.15.484500]; Torrens-Fontanals M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165933; Trask A., 2019, Grokking deep learning; Ullah I, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12010136; Vellido A, 2020, NEURAL COMPUT APPL, V32, P18069, DOI 10.1007/s00521-019-04051-w; Weidman S., 2019, Deep Learning from Scratch: Building with Python from First Principles; Wen B, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201900335; Yadav P, 2022, COMPUT STRUCT BIOTEC, V20, P2564, DOI 10.1016/j.csbj.2022.05.016; Zang B, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21134536	60	1	1	2	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-6596	1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN	2023	24	2							1155	10.3390/ijms24021155	http://dx.doi.org/10.3390/ijms24021155			22	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	8F4YT	36674669	gold, Green Published			2024-09-18	WOS:000919671400001
J	Yu, X; Dong, MC; Yang, DZ; Wang, LF; Wang, HJ; Ma, LY				Yu, Xia; Dong, Mengchao; Yang, Dongzhu; Wang, Lianfang; Wang, Hongjie; Ma, Liyong			Deep learning for differentiating benign from malignant tumors on breast-specific gamma image	TECHNOLOGY AND HEALTH CARE			English	Article						Breast-specific gamma imaging (BSGI); deep learning; convolutional neural network; breast tumor	CANCER PATIENTS	BACKGROUND: Breast diseases are a significant health threat for women. With the fast-growing BSGI data, it is becoming increasingly critical for physicians to accurately diagnose benign as well as malignant breast tumors. OBJECTIVE: The purpose of this study is to diagnose benign and malignant breast tumors utilizing the deep learning model, with the input of breast-specific gamma imaging (BSGI). METHODS: A benchmark dataset including 144 patients with benign tumors and 87 patients with malignant tumors was collected and divided into a training dataset and a test dataset according to the ratio of 8:2. The convolutional neural network ResNet18 was employed to develop a new deep learning model. The model proposed was compared with neural network and autoencoder models. Accuracy, specificity, sensitivity and ROC were used to evaluate the performance of different models. RESULTS: The accuracy, specificity and sensitivity of the model proposed are 99.1%, 98.8% and 99.3% respectively, which achieves the best performance among all methods. Additionally, the Grad-CAM method is used to analyze the interpretability of the diagnostic results based on the deep learning model. CONCLUSION: This study demonstrates that the proposed deep learning method could help physicians diagnose benign and malignant breast tumors quickly as well as reliably.	[Yu, Xia; Wang, Hongjie] Weihai Maternal & Children Hlth Hosp, Weihai, Shandong, Peoples R China; [Dong, Mengchao; Wang, Lianfang; Ma, Liyong] Harbin Inst Technol, Sch Informat Sci & Engn, Weihai, Shandong, Peoples R China; [Yang, Dongzhu] Weihai Municipal Hosp, Weihai, Shandong, Peoples R China	Harbin Institute of Technology	Ma, LY (corresponding author), Harbin Inst Technol, Sch Informat Sci & Engn, Weihai, Shandong, Peoples R China.	maly@hitwh.edu.cn	Ma, Liyong/A-3468-2009	Ma, Liyong/0000-0002-0718-379X	Shandong Province Medical and Health Science and Technology Development Plan Project [2019WS221, 2018WS111]; Shandong Province Key RD Program [2019GGX104078, 2019GGX101054]	Shandong Province Medical and Health Science and Technology Development Plan Project; Shandong Province Key RD Program	This work was supported by the Shandong Province Medical and Health Science and Technology Development Plan Project (2019WS221, 2018WS111) and the Shandong Province Key R&D Program (2019GGX104078, 2019GGX101054).	Ben Ali R, 2020, MULTIMED TOOLS APPL, V79, P25237, DOI 10.1007/s11042-020-09056-5; Boldbaatar EA, 2019, NEURAL PROCESS LETT, V50, P2037, DOI 10.1007/s11063-018-9931-4; Hizukuri A, 2021, J DIGIT IMAGING, V34, P116, DOI 10.1007/s10278-020-00394-2; Holbrook A, 2015, AM J ROENTGENOL, V204, P252, DOI 10.2214/AJR.14.13525; Kim BS, 2012, ANN NUCL MED, V26, P131, DOI 10.1007/s12149-011-0544-5; Kim J, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21154968; Lin Q, 2020, IET IMAGE PROCESS, V14, P3300, DOI 10.1049/iet-ipr.2019.1690; Ma LY, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/6212759; Murtaza G, 2020, ARTIF INTELL REV, V53, P1655, DOI 10.1007/s10462-019-09716-5; Muzahir S, 2020, AM J ROENTGENOL, V215, P1512, DOI 10.2214/AJR.20.22883; Narayanan D, 2018, PET CLIN, V13, P363, DOI 10.1016/j.cpet.2018.02.008; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Sun MJ, 2022, BIOMED SIGNAL PROCES, V71, DOI 10.1016/j.bspc.2021.103167; Sun Y, 2013, EUR J NUCL MED MOL I, V40, P450, DOI 10.1007/s00259-012-2279-5; Tsakok MT, 2021, EUR J RADIOL, V137, DOI 10.1016/j.ejrad.2021.109553; Tsujimoto M, 2021, NUCL MED COMMUN, V42, P877, DOI 10.1097/MNM.0000000000001409; Ullah MN, 2019, NUCL INSTRUM METH A, V946, DOI 10.1016/j.nima.2019.162631; Yin L, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-20-5877; Zhang AM, 2017, HELL J NUCL MED, V20, P26, DOI 10.1967/s002449910503; Zhang YY, 2021, J NEUROSCI METH, V353, DOI 10.1016/j.jneumeth.2021.109098	20	1	1	2	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0928-7329	1878-7401		TECHNOL HEALTH CARE	Technol. Health Care		2023	31			1			S61	S67		10.3233/THC-236007	http://dx.doi.org/10.3233/THC-236007			7	Health Care Sciences & Services; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Engineering	G2BY1	37038782	Green Published, hybrid			2024-09-18	WOS:000987286600008
J	Dieter, J; Dominick, F; Knurr, A; Ahlbrandt, J; Ückert, F				Dieter, Julia; Dominick, Friederike; Knurr, Alexander; Ahlbrandt, Janko; Ueckert, Frank			Analysis of Not Structurable Oncological Study Eligibility Criteria for Improved Patient-Trial Matching	METHODS OF INFORMATION IN MEDICINE			English	Article						oncological eligibility criteria; structurability; patient-trial matching		Background Higher enrolment rates of cancer patients into clinical trials are necessary to increase cancer survival. As a prerequisite, an improved semiautomated matching of patient characteristics with clinical trial eligibility criteria is needed. This is based on the computer interpretability, i.e., structurability of eligibility criteria texts. To increase structurability, the common content, phrasing, and structuring problems of oncological eligibility criteria need to be better understood. Objectives We aimed to identify oncological eligibility criteria that were not possible to be structured by our manual approach and categorize them by the underlying structuring problem. Our results shall contribute to improved criteria phrasing in the future as a prerequisite for increased structurability. Methods The inclusion and exclusion criteria of 159 oncological studies from the Clinical Trial Information System of the National Center for Tumor Diseases Heidelberg were manually structured and grouped into content-related subcategories. Criteria identified as not structurable were analyzed further and manually categorized by the underlying structuring problem. Results The structuring of criteria resulted in 4,742 smallest meaningful components (SMCs) distributed across seven main categories (Diagnosis, Therapy, Laboratory, Study, Findings, Demographics, and Lifestyle, Others). A proportion of 645 SMCs (13.60%) was not possible to be structured due to content- and structure-related issues. Of these, a subset of 415 SMCs (64.34%) was considered not remediable, as supplementary medical knowledge would have been needed or the linkage among the sentence components was too complex. The main category "Diagnosis and Study" contained these two subcategories to the largest parts and thus were the least structurable. In the inclusion criteria, reasons for lacking structurability varied, while missing supplementary medical knowledge was the largest factor within the exclusion criteria. Conclusion Our results suggest that further improvement of eligibility criterion phrasing only marginally contributes to increased structurability. Instead, physician-based confirmation of the matching results and the exclusion of factors harming the patient or biasing the study is needed.	[Dieter, Julia; Dominick, Friederike; Knurr, Alexander; Ahlbrandt, Janko; Ueckert, Frank] German Canc Res Ctr, Dept Med Informat Translat Oncol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Dieter, J (corresponding author), German Canc Res Ctr, Dept Med Informat Translat Oncol, D-69120 Heidelberg, Germany.	j.dieter@dkfz-heidelberg.de						Ateya MB, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0239-x; Bruland P, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0259-3; Chow CJ, 2013, J AM COLL SURGEONS, V216, P774, DOI 10.1016/j.jamcollsurg.2012.12.036; Deutsches Institut fur Medizinische Dokumentation und Information (DIMDI), Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme 10. Revision-German Modification-Version 2015 (2015); Division of Medical Informatics for Translational Oncology, EL SCI REC; Doods J, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-18; Goyal J, 2012, BJU INT, V110, pE575, DOI 10.1111/j.1464-410X.2012.11286.x; Köpcke F, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-37; Luo ZH, 2011, J BIOMED INFORM, V44, P927, DOI 10.1016/j.jbi.2011.06.001; Luo Zhihui, 2010, AMIA Annu Symp Proc, V2010, P487; Metz James M, 2005, J Med Internet Res, V7, pe24, DOI 10.2196/jmir.7.3.e24; Niland J., 2007, KNOWLEDGE REPRESENTA; Ross Jessica, 2010, Summit Transl Bioinform, V2010, P46; Sahoo SS, 2014, CANCER INFORM, V13, P157, DOI 10.4137/CIN.S19454; Sordo M, 2004, STUD HEALTH TECHNOL, V107, P164; Stiller CA, 2012, ANN ONCOL, V23, P2464, DOI 10.1093/annonc/mds183; Tu SW, 2011, J BIOMED INFORM, V44, P239, DOI 10.1016/j.jbi.2010.09.007; Weng CH, 2011, J AM MED INFORM ASSN, V18, pI116, DOI 10.1136/amiajnl-2011-000321; Weng Chunhua, 2011, AMIA Annu Symp Proc, V2011, P1489; Weng CH, 2010, J BIOMED INFORM, V43, P451, DOI 10.1016/j.jbi.2009.12.004	20	1	1	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0026-1270	2511-705X		METHOD INFORM MED	Methods Inf. Med.	MAY	2021	60	01/02					9	20		10.1055/s-0041-1724107	http://dx.doi.org/10.1055/s-0041-1724107		APR 2021	12	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	UK8NH	33890270	Green Published, hybrid			2024-09-18	WOS:000642291600001
J	Belharbi, S; Rony, J; Dolz, J; Ben Ayed, I; Mccaffrey, L; Granger, E				Belharbi, Soufiane; Rony, Jerome; Dolz, Jose; Ben Ayed, Ismail; Mccaffrey, Luke; Granger, Eric			Deep Interpretable Classification and Weakly-Supervised Segmentation of Histology Images via Max-Min Uncertainty	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Image segmentation; Uncertainty; Histopathology; Predictive models; Standards; Training; Solid modeling; Deep weakly-supervised learning; image classification; semantic segmentation; histology images; interpretability	CONVOLUTIONAL NETWORKS	Weakly-supervised learning (WSL) has recently triggered substantial interest as it mitigates the lack of pixel-wise annotations. Given global image labels, WSL methods yield pixel-level predictions (segmentations), which enable to interpret class predictions. Despite their recent success, mostly with natural images, such methods can face important challenges when the foreground and background regions have similar visual cues, yielding high false-positive rates in segmentations, as is the case in challenging histology images. WSL training is commonly driven by standard classification losses, which implicitly maximize model confidence, and locate the discriminative regions linked to classification decisions. Therefore, they lack mechanisms for modeling explicitly non-discriminative regions and reducing false-positive rates. We propose novel regularization terms, which enable the model to seek both non-discriminative and discriminative regions, while discouraging unbalanced segmentations. We introduce high uncertainty as a criterion to localize non-discriminative regions that do not affect classifier decision, and describe it with original Kullback-Leibler (KL) divergence losses evaluating the deviation of posterior predictions from the uniform distribution. Our KL terms encourage high uncertainty of the model when the latter inputs the latent non-discriminative regions. Our loss integrates: (i) a cross-entropy seeking a foreground, where model confidence about class prediction is high; (ii) a KL regularizer seeking a background, where model uncertainty is high; and (iii) log-barrier terms discouraging unbalanced segmentations. Comprehensive experiments and ablation studies over the public GlaS colon cancer data and a Camelyon16 patch-based benchmark for breast cancer show substantial improvements over state-of-the-art WSL methods, and confirm the effect of our new regularizers (our code is publicly available at https://github.com/sbelharbi/deep-wsl-histo-min-max-uncertainty).	[Belharbi, Soufiane; Rony, Jerome; Ben Ayed, Ismail; Granger, Eric] Ecole Technol Super ETS, Dept Syst Engn, Lab Imagerie Vis & Intelligence Artificielle LIVI, Montreal, PQ H3C 1K3, Canada; [Dolz, Jose] Ecole Technol Super ETS, Dept Comp Engn, Lab Imagerie Vis & Intelligence Artificielle LIVI, Montreal, PQ H3C 1K3, Canada; [Mccaffrey, Luke] McGill Univ, Rosalind & Morris Goodman Canc Inst, Gerald Bronfman Dept Oncol, Montreal, PQ H3A 0G4, Canada	University of Quebec; Ecole de Technologie Superieure - Canada; University of Quebec; Ecole de Technologie Superieure - Canada; McGill University	Belharbi, S (corresponding author), Ecole Technol Super ETS, Dept Syst Engn, Lab Imagerie Vis & Intelligence Artificielle LIVI, Montreal, PQ H3C 1K3, Canada.	soufiane.belharbi.1@ens.etsmtl.ca; jerome.rony.1@ens.etsmtl.ca; jose.dolz@etsmtl.ca; ismail.benayed@etsmtl.ca; luke.mccaffrey@mcgill.ca; eric.granger@etsmtl.ca	Dolz, Jose/Y-5756-2019	Granger, Eric/0000-0001-6116-7945; Belharbi, Soufiane/0000-0001-6326-380X; Dolz, Jose/0000-0002-2436-7750; Rony, Jerome/0000-0002-6359-6142	Canadian Institute of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Compute Canada	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Compute Canada	This work was supported in part by the Canadian Institute of Health Research (CIHR), in part by the Natural Sciences and Engineering Research Council of Canada (NSERC), and in part by the Compute Canada.	[Anonymous], 2014, WORKSHOP TRACK P; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bateson M, 2019, LECT NOTES COMPUT SC, V11765, P326, DOI 10.1007/978-3-030-32245-8_37; Bau D, 2017, PROC CVPR IEEE, P3319, DOI 10.1109/CVPR.2017.354; Bearman A, 2016, LECT NOTES COMPUT SC, V9911, P549, DOI 10.1007/978-3-319-46478-7_34; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Belharbi Jose, 2019, ARXIV190903354; Belharbi S., 2019, ARXIV191110720; Belharbi S., 2022, P IEEECVF WINTER C A, P3490; Belharbi S, 2021, IEEE WINT CONF APPL, P3337, DOI 10.1109/WACV48630.2021.00338; Berthelot D, 2019, ADV NEUR IN, V32; Bhatt U., 2020, P IJCAI, P1; Boyd S., 2004, CONVEX OPTIMIZATION, DOI DOI 10.1017/CBO9780511804441; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Cao CS, 2015, IEEE I CONF COMP VIS, P2956, DOI 10.1109/ICCV.2015.338; Chattopadhay A, 2018, IEEE WINT CONF APPL, P839, DOI 10.1109/WACV.2018.00097; Choe J, 2020, PROC CVPR IEEE, P3130, DOI 10.1109/CVPR42600.2020.00320; Dabkowski P, 2017, ADV NEUR IN, V30; Dai JF, 2015, IEEE I CONF COMP VIS, P1635, DOI 10.1109/ICCV.2015.191; de la Torre J, 2020, NEUROCOMPUTING, V396, P465, DOI 10.1016/j.neucom.2018.07.102; Dolz J, 2018, NEUROIMAGE, V170, P456, DOI 10.1016/j.neuroimage.2017.04.039; Durand T, 2017, PROC CVPR IEEE, P5957, DOI 10.1109/CVPR.2017.631; Escalante H. J, 2018, EXPLAINABLE INTERPRE, V1st, DOI [10.5555/3299408, DOI 10.5555/3299408]; Fong R, 2019, IEEE I CONF COMP VIS, P2950, DOI 10.1109/ICCV.2019.00304; Fong RC, 2017, IEEE I CONF COMP VIS, P3449, DOI 10.1109/ICCV.2017.371; Goh GSW, 2021, INT C PATT RECOG, P4949, DOI 10.1109/ICPR48806.2021.9413242; Gondal WM, 2017, IEEE IMAGE PROC, P2069, DOI 10.1109/ICIP.2017.8296646; Gonzalez-Gonzálo C, 2020, IEEE T MED IMAGING, V39, P3499, DOI 10.1109/TMI.2020.2994463; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Grandvalet Y., 2005, P NEURIPS P NEURIPS, P1; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He L, 2012, COMPUT METH PROG BIO, V107, P538, DOI 10.1016/j.cmpb.2011.12.007; Ilse M, 2018, PR MACH LEARN RES, V80; Jabi M, 2021, IEEE T PATTERN ANAL, V43, P1887, DOI 10.1109/TPAMI.2019.2962683; Jia ZP, 2017, IEEE T MED IMAGING, V36, P2376, DOI 10.1109/TMI.2017.2724070; Keel S, 2019, JAMA OPHTHALMOL, V137, P288, DOI 10.1001/jamaophthalmol.2018.6035; Ker J, 2019, J CLIN NEUROSCI, V66, P239, DOI 10.1016/j.jocn.2019.05.019; Kervadec H., 2019, ARXIV190404205; Kervadec H, 2020, PR MACH LEARN RES, V121, P365; Kervadec H, 2019, LECT NOTES COMPUT SC, V11765, P568, DOI 10.1007/978-3-030-32245-8_63; Kervadec H, 2019, MED IMAGE ANAL, V54, P88, DOI 10.1016/j.media.2019.02.009; Khalsa Siri Sahib S, 2020, CNS Oncol, V9, pCNS56, DOI 10.2217/cns-2020-0003; Khoreva A, 2017, PROC CVPR IEEE, P1665, DOI 10.1109/CVPR.2017.181; Kim Dahun, 2017, IEEE I CONF COMP VIS, P3534, DOI [10.1109/ICCV.2017.382, DOI 10.1109/ICCV.2017.382]; Komura D, 2018, COMPUT STRUCT BIOTEC, V16, P34, DOI 10.1016/j.csbj.2018.01.001; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Li KP, 2018, PROC CVPR IEEE, P9215, DOI 10.1109/CVPR.2018.00960; Lin D, 2016, PROC CVPR IEEE, P3159, DOI 10.1109/CVPR.2016.344; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Long J., 2015, CVPR, P3431; Miyato T, 2019, IEEE T PATTERN ANAL, V41, P1979, DOI 10.1109/TPAMI.2018.2858821; Muller, 2017, ARXIV170808296; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; Oquab M, 2015, PROC CVPR IEEE, P685, DOI 10.1109/CVPR.2015.7298668; Osman Ahmed, 2020, ARXIV PREPRINT ARXIV; Pathak D, 2015, IEEE I CONF COMP VIS, P1796, DOI 10.1109/ICCV.2015.209; Petsiuk V., 2018, BRIT MACH VIS C BMVC; Petsiuk V, 2021, PROC CVPR IEEE, P11438, DOI 10.1109/CVPR46437.2021.01128; Pinheiro PO, 2015, PROC CVPR IEEE, P1713, DOI 10.1109/CVPR.2015.7298780; Quellec G, 2017, MED IMAGE ANAL, V39, P178, DOI 10.1016/j.media.2017.04.012; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Samek, 2020, ARXIV200307631; Sayres R, 2019, OPHTHALMOLOGY, V126, P552, DOI 10.1016/j.ophtha.2018.11.016; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shapcott M, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00052; Singh KK, 2017, IEEE I CONF COMP VIS, P3544, DOI 10.1109/ICCV.2017.381; Sirinukunwattana K, 2017, MED IMAGE ANAL, V35, P489, DOI 10.1016/j.media.2016.08.008; Sirinukunwattana K, 2015, IEEE T MED IMAGING, V34, P2366, DOI 10.1109/TMI.2015.2433900; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Spanhol FA, 2016, IEEE IJCNN, P2560, DOI 10.1109/IJCNN.2016.7727519; Springenberg J., 2015, P ICLR WORKSH; Sudharshan PJ, 2019, EXPERT SYST APPL, V117, P103, DOI 10.1016/j.eswa.2018.09.049; Sun C, 2016, PROC CVPR IEEE, P3485, DOI 10.1109/CVPR.2016.379; Tang M, 2018, PROC CVPR IEEE, P1818, DOI 10.1109/CVPR.2018.00195; Teh Eu Wern, 2016, BRIT MACH VIS C BMVC; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Wei YC, 2017, PROC CVPR IEEE, P6488, DOI 10.1109/CVPR.2017.687; Xu Lin, 2020, J Pathol Inform, V11, P28, DOI 10.4103/jpi.jpi_68_19; Xu Y, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1685-x; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang J, 2016, PROCEEDINGS OF THE ELEVENTH EUROPEAN CONFERENCE ON COMPUTER SYSTEMS, (EUROSYS 2016), DOI 10.1145/2901318.2901336; Zhang QS, 2018, FRONT INFORM TECH EL, V19, P27, DOI 10.1631/FITEE.1700808; Zhang X., 2020, P USENIX SECUR S, P1; Zhang XL, 2018, PROC CVPR IEEE, P1325, DOI 10.1109/CVPR.2018.00144; Zhe Wang, 2017, Medical Image Computing and Computer Assisted Intervention  MICCAI 2017. 20th International Conference. Proceedings: LNCS 10435, P267, DOI 10.1007/978-3-319-66179-7_31; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhou ZH, 2018, NATL SCI REV, V5, P44, DOI 10.1093/nsr/nwx106	89	20	20	2	51	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	MAR	2022	41	3					702	714		10.1109/TMI.2021.3123461	http://dx.doi.org/10.1109/TMI.2021.3123461			13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	ZP2QG	34705638	Green Submitted			2024-09-18	WOS:000766268800018
J	Li, ZF; Li, TC; Zhang, P; Wang, X				Li, Zufei; Li, Tiancheng; Zhang, Pei; Wang, Xiao			A practical online prediction platform to predict the survival status of laryngeal squamous cell carcinoma after 5 years	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article						Online prediction model; Prognosis model; Support vector machines; Laryngeal squamous cell cancer; Machine learning		Objective: Currently, there are few practical tools for predicting the prognosis of laryngeal squamous cell carcinoma (LSCC). This study aims to establish a model and a convenient online prediction platform to predict whether LSCC patients will survive 5 years after diagnosis, providing a reference for further evaluation of patient prognosis. Methods: This is a retrospective study based on data collected from two centers. Center 1 included 117 LSCC patients with survival prognosis data, and center 2 included 33 patients, totaling 150 patients. All data were divided into independent training sets (60 %) and testing sets (40 %). Eight machine learning (ML) algorithms were used to establish models with 11 clinical parameters as input features. The accuracy, sensitivity, specificity, and receiver operating characteristic curve (ROC) of the testing set were used to evaluate the models, and the best model was selected. The model was then developed into a website-based 5-year survival status prediction platform for LSCC. In addition, we also used the SHapley Additive exPlanations (SHAP) tool to conduct interpretability analysis on the parameters of the model. Results: The LSCC 5-year survival status prediction model using the support vector machine (SVM) algorithm achieved the best results, with accuracy, sensitivity, specificity, and area under the ROC curve (AUC) of 85.0 %, 87.5 %, 75.0 %, and 81.2 % respectively. The online platform for predicting the 5-year survival status of LSCC based on this model was successfully established. The SHAP analysis shows that the clinical stage is the most important feature of the model. Conclusion: This study successfully established a ML model and a practical online prediction platform to predict the survival status of laryngeal cancer patients after 5 years, which may help clinicians to better evaluate the prognosis of LSCC. Level of evidence: 3.	[Li, Zufei; Li, Tiancheng] Capital Med Univ, Beijing Chaoyang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing 100020, Peoples R China; [Zhang, Pei] Zibo Cent Hosp, Dept Oncol, Zibo 255035, Peoples R China; [Wang, Xiao] Zibo Cent Hosp, Dept Otolaryngol Head & Neck Surg, Zibo 255035, Peoples R China; [Wang, Xiao] Zibo Cent Hosp, Dept Otolaryngol, 10 Shanghai Rd, Zibo 255035, Shandong, Peoples R China	Capital Medical University	Wang, X (corresponding author), Zibo Cent Hosp, Dept Otolaryngol, 10 Shanghai Rd, Zibo 255035, Shandong, Peoples R China.	mingjinze12@163.com	li, tiancheng/HZJ-3490-2023					Chen P, 2017, ONCOTARGET, V8, P14770, DOI 10.18632/oncotarget.14772; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Howard FM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25881; Huang Q, 2022, TECHNOL CANCER RES T, V21, DOI 10.1177/15330338221133690; Johansen LV, 2003, ACTA ONCOL, V42, P771, DOI 10.1080/02841860310017595; Johnson DE, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00224-3; Megwalu UC, 2014, JAMA OTOLARYNGOL, V140, P855, DOI 10.1001/jamaoto.2014.1671; Obid R, 2019, ORAL MAXIL SURG CLIN, V31, P1, DOI 10.1016/j.coms.2018.09.001; Smith JB, 2020, HEAD NECK-J SCI SPEC, V42, P2330, DOI 10.1002/hed.26246; Verro B, 2023, CANCERS, V15, DOI 10.3390/cancers15205096; Yang B, 2017, CANCER BIOMARK, V19, P65, DOI 10.3233/CBM-160375; Zhang LL, 2019, THERANOSTICS, V9, P2541, DOI 10.7150/thno.32655; Zhong J, 2021, CLIN RADIOL, V76, DOI 10.1016/j.crad.2020.08.030	13	2	2	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	MAY-JUN	2024	45	3							104209	10.1016/j.amjoto.2023.104209	http://dx.doi.org/10.1016/j.amjoto.2023.104209		DEC 2023	6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	IK6M0	38154199				2024-09-18	WOS:001166257600001
J	Massi, MC; Franco, NR; Manzoni, A; Paganoni, AM; Park, HA; Hoffmeister, M; Brenner, H; Chang-Claude, J; Ieva, F; Zunino, P				Massi, Michela C.; Franco, Nicola R.; Manzoni, Andrea; Paganoni, Anna Maria; Park, Hanla A.; Hoffmeister, Michael; Brenner, Hermann; Chang-Claude, Jenny; Ieva, Francesca; Zunino, Paolo			Learning high-order interactions for polygenic risk prediction	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; COLORECTAL-CANCER; HUMAN-DISEASE; EPISTASIS; REGRESSION; SELECTION; MODELS; SCORE	Within the framework of precision medicine, the stratification of individual genetic susceptibility based on inherited DNA variation has paramount relevance. However, one of the most relevant pitfalls of traditional Polygenic Risk Scores (PRS) approaches is their inability to model complex high-order non-linear SNP-SNP interactions and their effect on the phenotype (e.g. epistasis). Indeed, they incur in a computational challenge as the number of possible interactions grows exponentially with the number of SNPs considered, affecting the statistical reliability of the model parameters as well. In this work, we address this issue by proposing a novel PRS approach, called High-order Interactions-aware Polygenic Risk Score (hiPRS), that incorporates high-order interactions in modeling polygenic risk. The latter combines an interaction search routine based on frequent itemsets mining and a novel interaction selection algorithm based on Mutual Information, to construct a simple and interpretable weighted model of user-specified dimensionality that can predict a given binary phenotype. Compared to traditional PRSs methods, hiPRS does not rely on GWAS summary statistics nor any external information. Moreover, hiPRS differs from Machine Learning-based approaches that can include complex interactions in that it provides a readable and interpretable model and it is able to control overfitting, even on small samples. In the present work we demonstrate through a comprehensive simulation study the superior performance of hiPRS w.r.t. state of the art methods, both in terms of scoring performance and interpretability of the resulting model. We also test hiPRS against small sample size, class imbalance and the presence of noise, showcasing its robustness to extreme experimental settings. Finally, we apply hiPRS to a case study on real data from DACHS cohort, defining an interaction-aware scoring model to predict mortality of stage II-III Colon-Rectal Cancer patients treated with oxaliplatin.	[Massi, Michela C.; Franco, Nicola R.; Manzoni, Andrea; Paganoni, Anna Maria; Ieva, Francesca; Zunino, Paolo] Politecn Milan, MOX, Dept Math, Milan, Italy; [Massi, Michela C.; Ieva, Francesca] HDSC Hlth Data Sci Ctr, Human Technopole, Milan, Italy; [Park, Hanla A.; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Park, Hanla A.] Heidelberg Univ, Med Fac, Heidelberg, Germany; [Hoffmeister, Michael; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Canc Epidemiol Grp, Hamburg, Germany	Polytechnic University of Milan; Human Technopole; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf	Massi, MC (corresponding author), Politecn Milan, MOX, Dept Math, Milan, Italy.; Massi, MC (corresponding author), HDSC Hlth Data Sci Ctr, Human Technopole, Milan, Italy.	michela.massi@fht.org	Hoffmeister, Michael/T-7187-2019; Paganoni, Anna/N-9885-2016; Manzoni, Andrea/AGK-7606-2022; Brenner, Hermann/ABE-6383-2020	Manzoni, Andrea/0000-0001-8277-2802; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Massi, Michela Carlotta/0000-0001-5393-8180; Franco, Nicola Rares/0000-0002-4980-5606; Ieva, Francesca/0000-0003-0165-1983; Zunino, Paolo/0000-0002-2470-0189	ERA-NET ERA PerMed / FRRB grant [ERAPERMED2018-244]; German Research Council [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, BR 1704/6-6, CH 117/1-1, HO 5117/2-1, HE 5998/2-1, KL 2354/3-1, RO 2270/8-1, BR 1704/17-1]; Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany; German Federal Ministry of Education and Research [01KH0404, 01ER0814, 01ER0815, 01ER1505A, 01ER1505B, 01GL1712]	ERA-NET ERA PerMed / FRRB grant; German Research Council(German Research Foundation (DFG)); Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	NRF has received funding under the ERA-NET ERA PerMed / FRRB grant agreement No ERAPERMED2018-244, RADprecise - Personalized radiotherapy: incorporating cellular response to irradiation in personalized treatment planning to minimize radiation toxicity. DACHS study was supported by the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, BR 1704/6-6, CH 117/1-1, HO 5117/2-1, HE 5998/2-1, KL 2354/3-1, RO 2270/8-1, BR 1704/17-1), the Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany, and the German Federal Ministry of Education and Research (01KH0404, 01ER0814, 01ER0815, 01ER1505A, 01ER1505B, 01GL1712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2015, CURR OPIN GENET DEV, V33, P10, DOI 10.1016/j.gde.2015.06.005; Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; [Anonymous], 2006, J R STAT SOC B; Ausk Karlee J, 2011, Gastroenterology, V141, P393, DOI 10.1053/j.gastro.2011.05.015; Badré A, 2021, J HUM GENET, V66, P359, DOI 10.1038/s10038-020-00832-7; Basu S, 2018, P NATL ACAD SCI USA, V115, P1943, DOI 10.1073/pnas.1711236115; Behravan H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66907-9; Behravan H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31573-5; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Chasioti D, 2019, TRENDS GENET, V35, P371, DOI 10.1016/j.tig.2019.02.005; Che Ronglin, 2013, Frontiers in Genetics, V4, P138, DOI 10.3389/fgene.2013.00138; Choi SW, 2020, NAT PROTOC, V15, P2759, DOI 10.1038/s41596-020-0353-1; Collins RL, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-4; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Djenouri Y, 2019, INFORM SCIENCES, V496, P363, DOI 10.1016/j.ins.2018.07.020; Djenouri Y, 2018, IEEE ACCESS, V6, P68013, DOI 10.1109/ACCESS.2018.2880275; Fang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033531; Franco NR, 2021, RADIOTHER ONCOL, V159, P241, DOI 10.1016/j.radonc.2021.03.024; Goudarzi M, 2019, ELIFE, V8, DOI [10.7554/eLife.40815, 10.7554/eLife.39725]; Guerrero RF, 2019, GENETICS, V212, P565, DOI 10.1534/genetics.119.302138; Habier D, 2013, GENETICS, V194, P597, DOI 10.1534/genetics.113.152207; Ho DSW, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00267; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hüls A, 2020, EPIGENETICS-US, V15, P1, DOI 10.1080/15592294.2019.1644879; Janssens ACJW, 2019, HUM MOL GENET, V28, pR143, DOI 10.1093/hmg/ddz205; Janssens ACJW, 2019, CLIN CHEM, V65, P609, DOI 10.1373/clinchem.2018.296103; Konuma T, 2021, INFLAMM REGEN, V41, DOI 10.1186/s41232-021-00172-9; Lee KY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.01003; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Lim M, 2015, J COMPUT GRAPH STAT, V24, P627, DOI 10.1080/10618600.2014.938812; Mackay TFC, 2014, GENOME MED, V6, DOI 10.1186/gm561; Mahendran N, 2022, COMPUT BIOL MED, V141, DOI 10.1016/j.compbiomed.2021.105056; Manduchi E, 2022, IEEE ACM T COMPUT BI, V19, P1379, DOI 10.1109/TCBB.2021.3099068; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Massi MC, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.541281; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Multhaup ML, 2019, SCI 23ANDMES TYPE 2, P23; Okser S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004754; Pahl Peter J., 2001, Mathematical foundations of computational engineering: a handbook; Park HA, 2022, CANCER EPIDEM BIOMAR, V31, P352, DOI 10.1158/1055-9965.EPI-21-0814; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sassano M, 2022, BMC CANCER, V22, DOI 10.1186/s12885-021-09143-2; Shi JX, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006493; Silver M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003939; Sohail M, 2019, ELIFE, V8, DOI 10.7554/eLife.39702; Song S, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007565; Staerk L, 2017, CIRC RES, V120, P1501, DOI 10.1161/CIRCRESAHA.117.309732; Takahashi N, 2004, TRENDS GENET, V20, P136, DOI 10.1016/j.tig.2004.01.004; Taylor MB, 2015, TRENDS GENET, V31, P34, DOI 10.1016/j.tig.2014.09.001; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Vilhjálmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Vivian-Griffiths T, 2019, AM J MED GENET B, V180, P80, DOI 10.1002/ajmg.b.32705; Voskoboinik A, 2016, J AM COLL CARDIOL, V68, P2567, DOI 10.1016/j.jacc.2016.08.074; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Zhang F, 2011, IEEE INT C CL COMP, P590, DOI 10.1109/CLUSTER.2011.61; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	59	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2023	18	2							e0281618	10.1371/journal.pone.0281618	http://dx.doi.org/10.1371/journal.pone.0281618			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	D2ED3	36763605	gold, Green Submitted, Green Published			2024-09-18	WOS:000966895700001
J	Hong, JC; Niedzwiecki, D; Palta, M; Tenenbaum, JD				Hong, Julian C.; Niedzwiecki, Donna; Palta, Manisha; Tenenbaum, Jessica D.			Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm	JCO CLINICAL CANCER INFORMATICS			English	Article							ELECTRONIC HEALTH RECORDS; ALL-CAUSE READMISSIONS; CHEMOTHERAPY TOXICITY; OLDER-ADULTS; NECK-CANCER; MODELS; RISK; HEAD; TOOL; RADIOTHERAPY	Purpose Patients undergoing radiotherapy (RT) or chemoradiotherapy (CRT) may require emergency department evaluation or hospitalization. Early identification may direct preventative supportive care, improving outcomes and reducing health care costs. We developed and evaluated a machine learning (ML) approach to predict these events. Methods A total of 8,134 outpatient courses of RT and CRT from a single institution from 2013 to 2016 were identified. Extensive pretreatment data were programmatically extracted and processed from the electronic health record (EHR). Training and internal validation cohorts were randomly generated (3:1 ratio). Gradient tree boosting (GTB), random forest, support vector machine, and least absolute shrinkage and selection operator logistic regression approaches were trained and internally validated based on area under receiver operating characteristic (AUROC) curve. The most predictive ML approach was also evaluated using only disease- and treatment-related factors to assess predictive gain of extensive EHR data. Results All methods had high predictive accuracy, particularly GTB (validation AUROC, 0.798). Extensive EHR data beyond disease and treatment information improved accuracy (delta AUROC, 0.056). A Youden-based cutoff corresponded to validation sensitivity of 81.0% (175 of 216 courses with events) and specificity of 67.3% (1,218 of 1811 courses without events). Interpretability is an important advantage of GTB. Variable importance identified top predictive factors, including treatment (planned RT and systemic therapy), pretreatment encounters (emergency department visits and admissions in the year before treatment), vital signs (weight loss and pain score in the year before treatment), and laboratory values (albumin level at weeks before treatment). Conclusion ML predicts emergency visits and hospitalization during cancer therapy. Incorporating predictions into clinical care algorithms may help direct personalized supportive care, improve quality of care, and reduce costs. A prospective trial investigating ML-assisted direction of increased clinical assessments during RT is planned. (C) 2018 by American Society of Clinical Oncology	[Hong, Julian C.; Niedzwiecki, Donna; Palta, Manisha; Tenenbaum, Jessica D.] Duke Univ, Durham, NC USA	Duke University	Tenenbaum, JD (corresponding author), Duke Univ, Dept Biostat & Bioinformat, Duke Box 2721, Durham, NC 27710 USA.	jessie.tenen-baum@duke.edu	Hong, Julian/X-6397-2018	Hong, Julian/0000-0001-5172-6889; Niedzwiecki, Donna/0000-0002-3566-0450				[Anonymous], INT CLASS DIS 10 REV; [Anonymous], CARDIOLOGIST LEVEL A; Avati A, 2017, IEEE INT C BIOINFORM, P311, DOI 10.1109/BIBM.2017.8217669; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks GA, 2015, JAMA ONCOL, V1, P441, DOI 10.1001/jamaoncol.2015.0828; Chen T., Xgboost: a scalable tree boosting system.Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining;2016; Dean J, 2018, CLIN TRANSL RAD ONCO, V8, P27, DOI 10.1016/j.ctro.2017.11.009; Donzé JD, 2016, JAMA INTERN MED, V176, P496, DOI 10.1001/jamainternmed.2015.8462; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Frizzell JD, 2017, JAMA CARDIOL, V2, P204, DOI 10.1001/jamacardio.2016.3956; Goldstein BA, 2017, J AM MED INFORM ASSN, V24, P198, DOI 10.1093/jamia/ocw042; Grau J, 2015, BIOINFORMATICS, V31, P2595, DOI 10.1093/bioinformatics/btv153; Guidi G, 2015, PHYS MEDICA, V31, P442, DOI 10.1016/j.ejmp.2015.04.009; Handley NR, 2018, J ONCOL PRACT, V14, P306, DOI 10.1200/JOP.17.00081; Horvath MM, 2011, J BIOMED INFORM, V44, P266, DOI 10.1016/j.jbi.2010.11.008; Hu SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146290; Hurria A, 2016, J CLIN ONCOL, V34, P2366, DOI 10.1200/JCO.2015.65.4327; Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625; Karatzoglou A., KERNLAB AN S4 PACKAG; Kuhn M, J STAT SOFT; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; McKenzie H, 2011, SUPPORT CARE CANCER, V19, P963, DOI 10.1007/s00520-010-0913-y; Nguyen OK, 2016, J HOSP MED, V11, P473, DOI 10.1002/jhm.2568; Olson R.S., Data-driven advice for applying machine learning to bioinformatics problems; Panattoni L, 2018, J ONCOL PRACT, V14, pE176, DOI 10.1200/JOP.2017.028191; Pella A, 2011, MED PHYS, V38, P2859, DOI 10.1118/1.3582947; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Peterman A, 2001, J Natl Cancer Inst Monogr, P45; Peters L, 2013, STUD HEALTH TECHNOL, V192, P692, DOI 10.3233/978-1-61499-289-9-692; Quon H, 2017, INT J RADIAT ONCOL, V99, P1271, DOI 10.1016/j.ijrobp.2017.08.004; Rajkomar A, SCALABLE ACCURATE DE; Sadik M, 2014, WORLD J EMERG MED, V5, P85, DOI [10.5847/wjem.j.issn.1920-8642.2014.02.001, 10.5847/wjem.j.1920-8642.2014.02.001]; Terzo L, 2017, CLIN J ONCOL NURS, V21, P363, DOI 10.1188/17.CJON.363-369; Tevis SE, 2015, JAMA SURG, V150, P505, DOI 10.1001/jamasurg.2014.4043; Trister AD, 2017, JAMA ONCOL, V3, P1463, DOI 10.1001/jamaoncol.2017.0473; Uramoto H, 2007, ANTICANCER RES, V27, P1133; Valdes G, 2017, RADIOTHER ONCOL, V125, P392, DOI 10.1016/j.radonc.2017.10.014; Verghese A, 2018, JAMA-J AM MED ASSOC, V319, P19, DOI 10.1001/jama.2017.19198; Waddle MR, 2015, PRACT RADIAT ONCOL, V5, pE245, DOI 10.1016/j.prro.2014.08.004; Wasey J, PACKAGE ICD; Weiskopf NG, 2013, J BIOMED INFORM, V46, P830, DOI 10.1016/j.jbi.2013.06.010; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; Yahya N, 2016, MED PHYS, V43, P2040, DOI 10.1118/1.4944738	46	33	33	0	7	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	2473-4276			JCO CLIN CANCER INFO	JCO Clin. Cancer Info.	AUG 30	2018	2									10.1200/CCI.18.00037	http://dx.doi.org/10.1200/CCI.18.00037			11	Oncology	Emerging Sources Citation Index (ESCI)	Oncology	HQ3TG	30652595	Green Published			2024-09-18	WOS:000462332800001
J	Baptista, D; Ferreira, PG; Rocha, M				Baptista, Delora; Ferreira, Pedro G.; Rocha, Miguel			A systematic evaluation of deep learning methods for the prediction of drug synergy in cancer	PLOS COMPUTATIONAL BIOLOGY			English	Article							CELL-LINES; KINASE INHIBITOR; LUNG-CANCER; RESISTANCE; PAIRS; MECHANISM; CELLMINER; PLATFORM; MODELS; ZD1839	Author summaryCancer therapies often fail because tumor cells become resistant to treatment. One way to overcome resistance is by treating patients with a combination of two or more drugs. Some combinations may be more effective than when considering individual drug effects, a phenomenon called drug synergy. Computational drug synergy prediction methods can help to identify new, clinically relevant drug combinations. In this study, we developed several deep learning models for drug synergy prediction. We examined the effect of using different types of deep learning architectures, and different ways of representing drugs and cancer cell lines. We explored the use of biological prior knowledge to select relevant cell line features, and also tested data-driven feature reduction methods. We tested both precomputed drug features and deep learning methods that can directly learn features from raw representations of molecules. We also evaluated whether including genomic features, in addition to gene expression data, improves the predictive performance of the models. Through these experiments, we were able to identify strategies that will help guide the development of new deep learning models for drug synergy prediction in the future. One of the main obstacles to the successful treatment of cancer is the phenomenon of drug resistance. A common strategy to overcome resistance is the use of combination therapies. However, the space of possibilities is huge and efficient search strategies are required. Machine Learning (ML) can be a useful tool for the discovery of novel, clinically relevant anti-cancer drug combinations. In particular, deep learning (DL) has become a popular choice for modeling drug combination effects. Here, we set out to examine the impact of different methodological choices on the performance of multimodal DL-based drug synergy prediction methods, including the use of different input data types, preprocessing steps and model architectures. Focusing on the NCI ALMANAC dataset, we found that feature selection based on prior biological knowledge has a positive impact-limiting gene expression data to cancer or drug response-specific genes improved performance. Drug features appeared to be more predictive of drug response, with a 41% increase in coefficient of determination (R-2) and 26% increase in Spearman correlation relative to a baseline model that used only cell line and drug identifiers. Molecular fingerprint-based drug representations performed slightly better than learned representations-ECFP4 fingerprints increased R-2 by 5.3% and Spearman correlation by 2.8% w.r.t the best learned representations. In general, fully connected feature-encoding subnetworks outperformed other architectures. DL outperformed other ML methods by more than 35% (R-2) and 14% (Spearman). Additionally, an ensemble combining the top DL and ML models improved performance by about 6.5% (R-2) and 4% (Spearman). Using a state-of-the-art interpretability method, we showed that DL models can learn to associate drug and cell line features with drug response in a biologically meaningful way. The strategies explored in this study will help to improve the development of computational methods for the rational design of effective drug combinations for cancer therapy.	[Baptista, Delora; Rocha, Miguel] Univ Minho, CEB Ctr Biol Engn, Braga, Portugal; [Baptista, Delora; Rocha, Miguel] Associate Lab, LABBELS, Braga, Portugal; [Ferreira, Pedro G.] Univ Porto, Fac Sci, Dept Comp Sci, Porto, Portugal; [Ferreira, Pedro G.] INESC TEC, Porto, Portugal; [Ferreira, Pedro G.] Univ Porto, Ipatimup Inst Mol Pathol & Immunol, Porto, Portugal; [Ferreira, Pedro G.] Univ Porto, i3s Inst Invest & Inovacao Saude, Porto, Portugal	Universidade do Minho; Universidade do Porto; INESC TEC; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Rocha, M (corresponding author), Univ Minho, CEB Ctr Biol Engn, Braga, Portugal.; Rocha, M (corresponding author), Associate Lab, LABBELS, Braga, Portugal.	mrocha@di.uminho.pt	Ferreira, Pedro/JXY-5442-2024; Ferreira, Pedro/J-6379-2013	Baptista, Delora/0000-0002-9258-5303; Rocha, Miguel/0000-0001-8439-8172; Ferreira, Pedro/0000-0003-3838-8664	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/130913/2017]	Portuguese Foundation for Science and Technology (FCT)(Fundacao para a Ciencia e a Tecnologia (FCT))	This study was supported by the Portuguese Foundation for Science and Technology (FCT), through a PhD scholarship (SFRH/BD/130913/2017 awarded to DB) and under the scope of the strategic funding of UIDB/04469/2020 unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Bansal M, 2014, NAT BIOTECHNOL, V32, P1213, DOI 10.1038/nbt.3052; Baptista D, 2022, LECT NOTE NETW SYST, V325, P145, DOI 10.1007/978-3-030-86258-9_15; Baptista D, 2021, BRIEF BIOINFORM, V22, P360, DOI 10.1093/bib/bbz171; Barham P, 2016, NAT NEUROSCI, V16, P486; Bazgir O, 2021, BIOINFORMATICS, V37, pI42, DOI 10.1093/bioinformatics/btab336; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bento AP, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00456-1; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Celebi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45236-6; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chatterjee N, 2019, TRENDS CANCER, V5, P170, DOI 10.1016/j.trecan.2019.02.003; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI [10.1093/nar/gkt1102, 10.1093/nar/gkz1031]; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dong ZH, 2021, Arxiv, DOI arXiv:2105.07082; Drucker H, 1997, ADV NEUR IN, V9, P155; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Falkner S, 2018, PR MACH LEARN RES, V80; Freshour SL, 2021, NUCLEIC ACIDS RES, V49, pD1144, DOI 10.1093/nar/gkaa1084; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gayvert KM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005308; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Goh WWB, 2017, TRENDS BIOTECHNOL, V35, P498, DOI 10.1016/j.tibtech.2017.02.012; Grattarola D, 2021, IEEE COMPUT INTELL M, V16, P99, DOI 10.1109/MCI.2020.3039072; Holbeck SL, 2017, CANCER RES, V77, P3564, DOI 10.1158/0008-5472.CAN-17-0489; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jafari M, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29793-5; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jiang GL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2911-z; Jiang PR, 2020, COMPUT STRUCT BIOTEC, V18, P427, DOI 10.1016/j.csbj.2020.02.006; Ke GL, 2017, ADV NEUR IN, V30; Kim S, 2021, NUCLEIC ACIDS RES, V49, pD1388, DOI 10.1093/nar/gkaa971; Kim Y., 2014, ARXIV14085882, P1, DOI [10.3115/v1/D14-1181, DOI 10.3115/V1/D14-1181]; Kim Y, 2021, J AM MED INFORM ASSN, V28, P42, DOI 10.1093/jamia/ocaa212; Kipf T.N., 2017, INT C LEARN REPR; Kuru HI, 2022, IEEE ACM T COMPUT BI, V19, P2334, DOI 10.1109/TCBB.2021.3086702; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li H., 2018, CANCER RES; Li JQ, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0266382; Li LS, 2018, J MACH LEARN RES, V18; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu PF, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2910-6; Liu Q, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008653; Lundberg SM, 2017, ADV NEUR IN, V30; Lyu BY, 2018, ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P89, DOI 10.1145/3233547.3233588; Ma J, 2021, BIODATA MIN, V14, DOI 10.1186/s13040-021-00278-3; Malyutina A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006752; McInnes L, 2020, Arxiv, DOI [arXiv:1802.03426, 10.21105/joss.00861, DOI 10.48550/ARXIV.1802.03426]; Menden MP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09799-2; Meyer CT, 2020, TRENDS PHARMACOL SCI, V41, P266, DOI 10.1016/j.tips.2020.01.011; Mockus J, 1975, OPTIMIZATION TECHNIQ, P400, DOI [DOI 10.1007/978-3-662-38527-2_55, 10.1007/3-540-07165-2_55]; Morris P, 2020, J CHEM INF MODEL, V60, P4191, DOI 10.1021/acs.jcim.9b01212; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nakano T, 2019, J COMPUT AIDED CHEM, V20, P1, DOI [10.2751/jcac.20.1, 10.2751/jcac.21.1]; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; O'Neil J, 2016, MOL CANCER THER, V15, P1155, DOI 10.1158/1535-7163.MCT-15-0843; Ohta A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00304; Palmer AC, 2019, ELIFE, V8, DOI 10.7554/eLife.50036; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Preto AJ, 2021, PREPRINT; Preuer K, 2018, BIOINFORMATICS, V34, P1538, DOI 10.1093/bioinformatics/btx806; Rajapakse VN, 2018, ISCIENCE, V10, P247, DOI 10.1016/j.isci.2018.11.029; Ramsundar B., 2019, Deep Learning for the Life Sciences: Applying Deep Learning to Genomics, Microscopy, Drug Discovery, and More; Reinhold WC, 2019, CANCER RES, V79, P3514, DOI 10.1158/0008-5472.CAN-18-2047; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Repana D, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1612-0; Rintala TJ, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac229; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rozemberczki B, 2022, Arxiv, DOI [arXiv:2110.15087, DOI 10.48550/ARXIV.2110.15087]; Sen P, 2019, TRENDS PHARMACOL SCI, V40, P811, DOI 10.1016/j.tips.2019.08.008; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Shrikumar A, 2017, PR MACH LEARN RES, V70; Sidorov P, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00509; Sondka Z, 2018, NAT REV CANCER, V18, P696, DOI 10.1038/s41568-018-0060-1; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Tallarida Ronald J, 2011, Genes Cancer, V2, P1003, DOI 10.1177/1947601912440575; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Trastulla L, 2022, MOL SYST BIOL, V18, DOI 10.15252/msb.202211017; van der Meer D, 2019, NUCLEIC ACIDS RES, V47, pD923, DOI 10.1093/nar/gky872; Vaswani A, 2017, ADV NEUR IN, V30; Velickovic Petar, 2017, P INT C LEARN REPR, P1; Vlot AHC, 2019, DRUG DISCOV TODAY, V24, P2286, DOI 10.1016/j.drudis.2019.09.002; Wakeling AE, 2002, CANCER RES, V62, P5749; Wang J., 2021, BRIEF BIOINFORM; Williams CKI, 2000, ADV NEUR IN, V12, P680; Wu LL, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab355; Wu ZQ, 2018, CHEM SCI, V9, P513, DOI 10.1039/c7sc02664a; Xia FF, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab356; Xia FX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2509-3; Yang JN, 2021, J AM MED INFORM ASSN, V28, P2336, DOI 10.1093/jamia/ocab162; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11415-2; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zagidullin B, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab291; Zagidullin B, 2019, NUCLEIC ACIDS RES, V47, pW43, DOI 10.1093/nar/gkz337; Zhang Heming, 2020, AMIA Annu Symp Proc, V2020, P1364; Zhang Tianyu, 2021, Methods Mol Biol, V2194, P223, DOI 10.1007/978-1-0716-0849-4_12; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	111	8	8	11	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	MAR	2023	19	3							e1010200	10.1371/journal.pcbi.1010200	http://dx.doi.org/10.1371/journal.pcbi.1010200			26	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	D3AB0	36952569	Green Submitted, gold, Green Published			2024-09-18	WOS:000967472600003
J	Liu, H; Xie, XD; Wang, B				Liu, Hui; Xie, Xiaodong; Wang, Bin			Deep learning infers clinically relevant protein levels and drug response in breast cancer from unannotated pathology images	NPJ BREAST CANCER			English	Article							ARTIFICIAL-INTELLIGENCE	The computational pathology has been demonstrated to effectively uncover tumor-related genomic alterations and transcriptomic patterns. Although proteomics has indeed shown great potential in the field of precision medicine, few studies have focused on the computational prediction of protein levels from pathology images. In this paper, we assume that deep learning-based pathological features imply the protein levels of tumor biomarkers that are indicative of prognosis and drug response. For this purpose, we propose wsi2rppa, a weakly supervised contrastive learning framework to infer the protein levels of tumor biomarkers from whole slide images (WSIs) in breast cancer. We first conducted contrastive learning-based pre-training on tessellated tiles to extract pathological features, which are then aggregated by attention pooling and adapted to downstream tasks. We conducted extensive evaluation experiments on the TCGA-BRCA cohort (1978 WSIs of 1093 patients with protein levels of 223 biomarkers) and the CPTAC-BRCA cohort (642 WSIs of 134 patients). The results showed that our method achieved state-of-the-art performance in tumor diagnostic tasks, and also performed well in predicting clinically relevant protein levels and drug response. To show the model interpretability, we spatially visualized the WSIs colored the tiles by their attention scores, and found that the regions with high scores were highly consistent with the tumor and necrotic regions annotated by a 10-year experienced pathologist. Moreover, spatial transcriptomic data further verified that the heatmap generated by attention scores agrees greatly with the spatial expression landscape of two typical tumor biomarker genes. In predicting the response to drug trastuzumab treatment, our method achieved a 0.79 AUC value which is much higher than the previous study reported 0.68. These findings showed the remarkable potential of computational pathology in the prediction of clinically relevant protein levels, drug response, and clinical outcomes.	[Liu, Hui; Xie, Xiaodong] Nanjing Tech Univ, Coll Comp & Informat Engn, Nanjing 211816, Jiangsu, Peoples R China; [Wang, Bin] Soochow Univ, Affiliated Hosp 3, Dept Cardiothorac Surg, Changzhou 213110, Jiangsu, Peoples R China	Nanjing Tech University; Soochow University - China	Wang, B (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Cardiothorac Surg, Changzhou 213110, Jiangsu, Peoples R China.	wangbin1987@suda.edu.cn	Liu, Hui/F-7090-2016	Liu, Hui/0000-0001-7158-913X	This work was also supported by the funding granted from Young Talent Development plan of Changzhou Health Commission (CZQM2020034, CZQM2020004), Top Talent of Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project (KY20221388). [62072058, 62372229]; National Natural Science Foundation of China [CZQM2020034, CZQM2020004]; Young Talent Development Plan of Changzhou Health Commission [KY20221388]; Top Talent of Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project; Jiangsu, China; Department of Pathology of Third Affiliated Hospital of Soochow University, Changzhou	This work was also supported by the funding granted from Young Talent Development plan of Changzhou Health Commission (CZQM2020034, CZQM2020004), Top Talent of Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project (KY20221388).; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Development Plan of Changzhou Health Commission; Top Talent of Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project; Jiangsu, China; Department of Pathology of Third Affiliated Hospital of Soochow University, Changzhou	This work was supported by the National Natural Science Foundation of China (Nos. 62072058, 62372229). This work was also supported by the funding granted from the Young Talent Development Plan of Changzhou Health Commission (CZQM2020034, CZQM2020004), Top Talent of Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project (KY20221388). We are very grateful to Dr. Meihua Wang from the Department of Pathology at Changzhou Cancer Hospital, Jiangsu, China. We are also grateful to Dr. Dachuan Zhang from the Department of Pathology of Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China. Thanks for their annotations of the pathology images, as well as their valuable suggestions for this study.	Chen CK, 2022, NAT BIOMED ENG, V6, P1420, DOI 10.1038/s41551-022-00929-8; Cho K, 2014, P 2014 C EMP METH NA, P1724; Coarfa Cristian, 2021, J Biomol Tech, V32, P15, DOI 10.7171/jbt.21-3202-001; Cui M, 2021, LAB INVEST, V101, P412, DOI 10.1038/s41374-020-00514-0; Duffy MJ, 2018, BREAST CANCER RES TR, V170, P213, DOI 10.1007/s10549-018-4753-7; Elmannai H, 2021, INT J COMPUT INT SYS, V14, P1003, DOI 10.2991/ijcis.d.210301.002; Erickson BJ, 2017, RADIOGRAPHICS, V37, P505, DOI 10.1148/rg.2017160130; Farahmand S, 2022, MODERN PATHOL, V35, P44, DOI 10.1038/s41379-021-00911-w; Fu Y, 2020, NAT CANCER, V1, P800, DOI 10.1038/s43018-020-0085-8; Gao Q, 2019, CELL, V179, P561, DOI 10.1016/j.cell.2019.08.052; Ge S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03121-2; Ghebeh H., 2016, Breast Cancer Res. Treatment, V155, P605; Greenwald NF, 2022, NAT BIOTECHNOL, V40, P555, DOI 10.1038/s41587-021-01094-0; Harrison JH Jr, 2021, ARCH PATHOL LAB MED, V145, P1228, DOI [10.5858/arpa.2020-0541-CP), 10.5858/arpa.2020-0541-CP]; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hicks D, 2017, APPL IMMUNOHISTO M M, V25, P313, DOI 10.1097/PAI.0000000000000311; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI [10.1162/neco.1997.9.8.1735, 10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Huang HJ, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac294; Jeselsohn R, 2015, NAT REV CLIN ONCOL, V12, P573, DOI 10.1038/nrclinonc.2015.117; Kather JN, 2020, NAT CANCER, V1, P789, DOI 10.1038/s43018-020-0087-6; Koh DM, 2022, COMMUN MED-LONDON, V2, DOI 10.1038/s43856-022-00199-0; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li B, 2021, PROC CVPR IEEE, P14313, DOI 10.1109/CVPR46437.2021.01409; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/NMETH.2650, 10.1038/nmeth.2650]; Lim E, 2016, BRIT J CANCER, V115, P909, DOI 10.1038/bjc.2016.303; Liu LX, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-22358-y; Lu MY, 2021, NAT BIOMED ENG, V5, P555, DOI 10.1038/s41551-020-00682-w; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Mun DG, 2019, CANCER CELL, V35, P111, DOI 10.1016/j.ccell.2018.12.003; Qian XL, 2019, ONCOTARGETS THER, V12, P1539, DOI 10.2147/OTT.S191317; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Schmauch B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17678-4; Shamai G, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34275-9; Stewart PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11452-x; Strom P, 2020, LANCET ONCOL, V21, P222, DOI 10.1016/S1470-2045(19)30738-7; Tarkhan A, 2022, I S BIOMED IMAGING, DOI 10.1109/ISBI52829.2022.9761661; Wang SD, 2020, CANCER RES, V80, P2056, DOI 10.1158/0008-5472.CAN-19-1629; Wang Y, 2022, ANN ONCOL, V33, P89, DOI 10.1016/j.annonc.2021.09.007; Wang YX, 2021, CANCER RES, V81, P5115, DOI 10.1158/0008-5472.CAN-21-0482; Yeung KT, 2017, MOL ONCOL, V11, P28, DOI 10.1002/1878-0261.12017	40	0	0	6	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2374-4677		NPJ BREAST CANCER	npj Breast Cancer	FEB 27	2024	10	1							18	10.1038/s41523-024-00620-y	http://dx.doi.org/10.1038/s41523-024-00620-y			11	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	JP1O6	38413598	gold, Green Published			2024-09-18	WOS:001174280300001
J	Holmberg, D; Kauppila, JH; Asplund, J; Leijonmarck, W; Mattsson, F; Lagergren, J				Holmberg, Dag; Kauppila, Joonas H.; Asplund, Johannes; Leijonmarck, Wilhelm; Mattsson, Fredrik; Lagergren, Jesper			Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study	GASTRIC CANCER			English	Article						Chemoprevention; Gastric neoplasm; Gastrectomy; Hyperlipidaemia	CANCER	BackgroundStudies have suggested that medication with statins improves survival in patients with gastric cancer, but methodological issues have limited the interpretability and prohibited conclusive results. We aimed to provide valid evidence as to whether statin use improves survival of gastric adenocarcinoma.MethodsThis nationwide and population-based cohort study included virtually all patients who underwent curatively intended surgery (gastrectomy) for gastric adenocarcinoma in Sweden between 2006 and 2015 with follow-up throughout 2019 for disease-specific mortality and 2020 for all-cause mortality. Data came from medical records and national healthcare registries. The exposure was statin use during the year prior to gastrectomy which was compared to no such use during the same period. The outcomes were 5-year disease-specific mortality (main) and 5-year all-cause mortality (secondary). Multivariable Cox regression provided hazard ratios (HR) with 95% confidence intervals (CI), adjusted for age, sex, education, calendar year, comorbidity, low-dose aspirin use, tumour sublocation, pathological tumour stage, neoadjuvant chemotherapy, annual surgeon volume, and surgical radicality.ResultsAmong 1515 participating patients, the mean age was 69 years and 58.4% were men. Statin use, identified in 399 (26.3%) patients, was not associated with any statistically significantly decreased 5-year disease-specific mortality (HR 0.99, 95% CI 0.82-1.21) or 5-year all-cause mortality (HR 0.94, 95% CI 0.79-1.12). No risk reductions were found across subgroups of age, sex, aspirin user status, or tumour stage, or in patients with long-term preoperative of postoperative use of statins, all with point estimates close to 1.ConclusionsPerioperative use of statins does not seem to improve the 5-year survival in patients who undergo gastrectomy with curative intent for gastric adenocarcinoma in Sweden.	[Holmberg, Dag; Kauppila, Joonas H.; Asplund, Johannes; Leijonmarck, Wilhelm; Mattsson, Fredrik; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Retzius St 13A,4th Floor, S-17177 Stockholm, Sweden; [Holmberg, Dag; Kauppila, Joonas H.; Asplund, Johannes; Leijonmarck, Wilhelm; Mattsson, Fredrik; Lagergren, Jesper] Karolinska Univ Hosp, Retzius St 13A, 4th Floor, S-17177 Stockholm, Sweden; [Kauppila, Joonas H.] Oulu Univ Hosp, Dept Surg, Oulu, Finland; [Kauppila, Joonas H.] Univ Oulu, Oulu, Finland; [Lagergren, Jesper] Kings Coll London, Sch Canc & Pharmacol Sci, London, England	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Oulu; University of Oulu; University of London; King's College London	Holmberg, D (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Retzius St 13A,4th Floor, S-17177 Stockholm, Sweden.; Holmberg, D (corresponding author), Karolinska Univ Hosp, Retzius St 13A, 4th Floor, S-17177 Stockholm, Sweden.	dag.holmberg@ki.se	Kauppila, Joonas/P-1363-2015	Holmberg, Dag/0000-0003-1000-5422	Vetenskapsrdet	Vetenskapsrdet(Swedish Research Council)	No Statement Available	Anderson LA, 2015, EUR J CANCER, V51, P2144, DOI 10.1016/j.ejca.2015.07.026; Asplund J, 2021, ACTA ONCOL, V60, P513, DOI 10.1080/0284186X.2021.1874619; Asplund J, 2018, ANN SURG ONCOL, V25, P2693, DOI 10.1245/s10434-018-6627-y; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Brusselaers N, 2017, METHOD INFORM MED, V56, P401, DOI 10.3414/ME17-01-0051; Bujanda L, 2016, ONCOTARGET, V7, P4379, DOI 10.18632/oncotarget.6777; Chung H, 2020, GASTRIC CANCER, V23, P659, DOI 10.1007/s10120-020-01041-z; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Ekström AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Hernán MA, 2016, J CLIN EPIDEMIOL, V79, P70, DOI 10.1016/j.jclinepi.2016.04.014; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Holmberg D, 2022, GASTRIC CANCER, V25, P652, DOI 10.1007/s10120-022-01282-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]; Kim ST, 2014, EUR J CANCER, V50, P2822, DOI 10.1016/j.ejca.2014.08.005; Lévesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Liu Q, 2020, ONCOTARGETS THER, V13, P2057, DOI 10.2147/OTT.S237693; Ludvigsson JF, 2019, EUR J EPIDEMIOL, V34, P423, DOI 10.1007/s10654-019-00511-8; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Nam DH, 2014, ANTICANCER RES, V34, P355; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Singh PP, 2013, ANN ONCOL, V24, P1721, DOI 10.1093/annonc/mdt150; Smyth EC, 2020, LANCET, V396, P635, DOI 10.1016/S0140-6736(20)31288-5; Spence AD, 2019, PHARMACOEPIDEM DR S, V28, P460, DOI 10.1002/pds.4688; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Yang PR, 2020, CANCERS, V12, DOI 10.3390/cancers12082055; Yuan MJ, 2022, INT J CLIN PRACT, V2022, DOI 10.1155/2022/4938539	27	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1436-3291	1436-3305		GASTRIC CANCER	Gastric Cancer	MAY	2024	27	3					590	597		10.1007/s10120-024-01487-5	http://dx.doi.org/10.1007/s10120-024-01487-5		MAR 2024	8	Oncology; Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Gastroenterology & Hepatology	NR1R5	38430275	Green Published, hybrid			2024-09-18	WOS:001171762200001
J	King, MT; Tait, MA; Campbell, R; Müller, F; Rutherford, C; Beckmore, C; Chima, S; Langbecker, D; Shaw, J; Mercieca-Bebber, R				King, Madeleine T.; Tait, Margaret-Ann; Campbell, Rachel; Muller, Fabiola; Rutherford, Claudia; Beckmore, Corinna; Chima, Sophie; Langbecker, Danette; Shaw, Joanne; Mercieca-Bebber, Rebecca			Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops	QUALITY OF LIFE RESEARCH			English	Article						Clinical trial protocols; Patient-reported outcomes; Research waste; Education; Training	QUALITY-OF-LIFE; INCREASING VALUE; REDUCING WASTE; END-POINTS; CANCER; INCLUSION; RCTS	Introduction Failure to incorporate key patient-reported outcome (PRO) content in trial protocols affects the quality and interpretability of the collected data, contributing to research waste. Our group developed evidence-based training specifically addressing PRO components of protocols. We aimed to assess whether 2-day educational workshops improved the PRO completeness of protocols against consensus-based minimum standards provided in the SPIRIT-PRO Extension in 2018. Method Annual workshops were conducted 2011-2017. Participants were investigators/trialists from cancer clinical trials groups. Although developed before 2018, workshops covered 15/16 SPIRIT-PRO items. Participant feedback immediately post-workshop and, retrospectively, in November 2017 was summarised descriptively. Protocols were evaluated against SPIRIT-PRO by two independent raters for workshop protocols (developed post-workshop by participants) and control protocols (contemporaneous non-workshop protocols). SPIRIT-PRO items were assessed for completeness (0 = not addressed, 10 = fully addressed). Mann-Whitney U tests assessed whether workshop protocols scored higher than controls by item and overall. Results Participants (n = 107) evaluated the workshop positively. In 2017, 16/41 survey responders (39%) reported never applying in practice; barriers included role restrictions (14/41, 34%) and lack of time (5/41, 12%). SPIRIT-PRO overall scores did not differ between workshop (n = 13, median = 3.81/10, interquartile range = 3.24) and control protocols (n = 9, 3.51/10 (2.14)), (p = 0.35). Workshop protocols scored higher than controls on two items: 'specify PRO concepts/domains' (p = 0.05); 'methods for handling missing data' (p = 0.044). Conclusion Although participants were highly satisfied with these workshops, the completeness of PRO protocol content generally did not improve. Additional knowledge translation efforts are needed to assist protocol writers address SPIRIT-PRO guidance and avoid research waste that may eventuate from sub-optimal PRO protocol content.	[King, Madeleine T.; Tait, Margaret-Ann; Campbell, Rachel; Muller, Fabiola; Rutherford, Claudia] Univ Sydney, Sch Psychol, Sydney Qual Life Off, Sydney, NSW 2006, Australia; [Muller, Fabiola] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Med Psychol, Amsterdam, Netherlands; [Rutherford, Claudia] Univ Sydney, Sydney Nursing Sch, Canc Nursing Res Unit CNRU, Sydney, NSW, Australia; [Beckmore, Corinna] Breast Canc Trials, Newcastle, NSW, Australia; [Chima, Sophie] Univ Melbourne, Fac Med, Ctr Canc Res,Dept Gen Practice Dent & Hlth Sci, Victorian Comprehens Canc Ctr, Melbourne, Vic, Australia; [Langbecker, Danette] Univ Queensland, Ctr Online Hlth, St Lucia, Qld, Australia; [Shaw, Joanne] Univ Sydney, Sch Psychol, Psycho Oncol Cooperat Res Grp, Sydney, NSW, Australia; [Mercieca-Bebber, Rebecca] Univ Sydney, NHMRC Clin Trial Ctr, Sydney, NSW, Australia	University of Sydney; Vrije Universiteit Amsterdam; University of Amsterdam; University of Sydney; Breast Cancer Trials Australia; University of Melbourne; University of Queensland; University of Sydney; University of Sydney	King, MT (corresponding author), Univ Sydney, Sch Psychol, Sydney Qual Life Off, Sydney, NSW 2006, Australia.	madeleine.king@sydney.edu.au	Campbell, Rachel/HOA-9540-2023; Müller, Fabiola/AFM-7755-2022; Langbecker, Danette/F-4638-2011; Tait, Margaret-Ann/HLW-8204-2023; MerciecaBebber, Rebecca/KPB-5783-2024	Mercieca-Bebber, Rebecca/0000-0003-3708-9099; Muller, Fabiola/0000-0002-0412-7469; Campbell, Dr Rachel/0000-0002-5013-8361	CAUL; Australian Government through Cancer Australia	CAUL; Australian Government through Cancer Australia(Australian Government)	Open Access funding was enabled and organized by CAUL and its Member Institutions. The development and provision of the PROtocol Checklist and the PROtocol Checklist workshop was funded by the Australian Government through Cancer Australia. The authors did not receive support from any organisation for conducting this study or for the submitted work.	Calvert M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045105; Calvert M, 2018, JAMA-J AM MED ASSOC, V319, P483, DOI 10.1001/jama.2017.21903; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan A.-W., 2020, SPIRIT ELECT PROTOCO; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Clark RC., 2020, APPENDIX SYNOPSIS IN; Coens C, 2020, LANCET ONCOL, V21, pE83, DOI 10.1016/S1470-2045(19)30790-9; eviQ Education, 2020, EVIQ ED PROGR EVIQ E; Fay MP, 2018, STAT MED, V37, P3991, DOI 10.1002/sim.7890; Fielding S, 2016, QUAL LIFE RES, V25, P2977, DOI 10.1007/s11136-016-1411-6; Fielding S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-51; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Kyte D, 2019, JNCI-J NATL CANCER I, V111, P1170, DOI 10.1093/jnci/djz038; Kyte D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110229; Kyte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076625; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Lombardi P, 2020, CRIT REV ONCOL HEMAT, V146, DOI 10.1016/j.critrevonc.2020.102877; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Marandino L, 2018, ANN ONCOL, V29, P2288, DOI 10.1093/annonc/mdy449; Mercieca-Bebber R, 2018, PATIENT-RELAT OUTCOM, V9, P353, DOI 10.2147/PROM.S156279; Mercieca-Bebber R, 2018, QUAL LIFE RES, V27, P2581, DOI 10.1007/s11136-018-1921-5; Mercieca-Bebber R, 2017, J PATIENT-REP OUTCOM, V1, DOI 10.1186/s41687-017-0008-3; Mercieca-Bebber R, 2018, CONT CLIN TRIAL COMM, V9, P23, DOI 10.1016/j.conctc.2017.11.009; Mercieca-Bebber R, 2016, QUAL LIFE RES, V25, P2457, DOI 10.1007/s11136-016-1339-x; Mercieca-Bebber R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010938; Palmer MJ, 2018, CLIN TRIALS, V15, P95, DOI 10.1177/1740774517741113; PRAXIS Australia, 2021, PRAXIS AUSTR PROM ET; Reale ML, 2020, LUNG CANCER, V139, P47, DOI 10.1016/j.lungcan.2019.10.022; Retzer A, 2021, CANCER MED-US, V10, P5475, DOI 10.1002/cam4.4111; Schandelmaier S, 2015, ANN ONCOL, V26, P1966, DOI 10.1093/annonc/mdv283; Vanbelle S, 2016, PSYCHOMETRIKA, V81, P399, DOI 10.1007/s11336-014-9439-4; Vodicka E, 2015, CONTEMP CLIN TRIALS, V43, P1, DOI 10.1016/j.cct.2015.04.004	34	0	0	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2022	31	10			SI		2901	2916		10.1007/s11136-022-03127-w	http://dx.doi.org/10.1007/s11136-022-03127-w		MAY 2022	16	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	4N4HC	35553325	hybrid, Green Published			2024-09-18	WOS:000794081200001
J	Shanthanna, H; Busse, JW; Thabane, L; Paul, J; Couban, R; Choudhary, H; Kaushal, A; Suzumura, E; Kim, I; Harsha, P				Shanthanna, Harsha; Busse, Jason W.; Thabane, Lehana; Paul, James; Couban, Rachel; Choudhary, Harman; Kaushal, Alka; Suzumura, Erica; Kim, Isabel; Harsha, Prathiba			Local anesthetic injections with or without steroid for chronic non-cancer pain: a protocol for a systematic review and meta-analysis of randomized controlled trials	SYSTEMATIC REVIEWS			English	Review						Chronic non-cancer pain; Steroid injections; Nerve blocks; Epidurals; Intra articular; Local anesthetic; Systematic review; Meta-analysis	INTERLAMINAR EPIDURAL INJECTIONS; LOW-BACK-PAIN; ACTIVE-CONTROLLED-TRIAL; LUMBAR DISC HERNIATION; DOUBLE-BLIND TRIAL; SUBACROMIAL CORTICOSTEROID INJECTION; OCCIPITAL NERVE INJECTION; TRIGGER POINT INJECTIONS; MANAGING CHRONIC PAIN; SPINAL STENOSIS	Background: Steroids are often combined with local anesthetic (LA) and injected to reduce pain associated with various chronic non-cancer pain (CNCP) complaints. The biological rationale behind injection of a steroid solution is unclear, and it is uncertain whether the addition of steroids offers any additional benefits over injection of LA alone. We propose to conduct a systematic review and meta-analysis to summarize the evidence for using steroids and LA vs. LA alone in the treatment of CNCP. Methods: An experienced librarian will perform a comprehensive search of EMBASE, MEDLINE, and the Cochrane Central Registry of Controlled Trials (CENTRAL) databases with search terms for clinical indications, LA, and steroid agents. We will review bibliographies of all relevant published reviews in the last 5 years for additional studies. Eligible trials will be published in English and randomly allocate patients with CNCP to treatment with steroid and LA injection therapy or injection with LA alone. We will use the guidelines published by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to inform the outcomes that we collect and present. Teams of reviewers will independently and in duplicate assess trial eligibility, abstract data, and assess risk of bias among eligible trials. We will prioritize intention to treat analysis and, when possible, pool outcomes across trials using random effects models. We will report our findings as risk differences, weighted mean differences, or standardized mean differences for individual outcomes. Further, to ensure interpretability of our results, we will present risk differences and measures of relative effect for pain reduction based on anchor-based minimally important clinical differences. We will conduct a priori defined subgroup analyses and use the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to evaluate the certainty of the evidence on an outcome-by-outcome basis. Discussion: Our review will evaluate both the effectiveness and the adverse events associated with steroid plus LA vs. LA alone for CNCP, evaluate the quality of the evidence using the GRADE approach, and prioritize patient-important outcomes guided by IMMPACT recommendations. Our results will facilitate evidence-based management of patients with chronic non-cancer pain and identify key areas for future research.	[Shanthanna, Harsha; Busse, Jason W.; Thabane, Lehana; Paul, James; Couban, Rachel; Kaushal, Alka; Harsha, Prathiba] McMaster Univ, St Josephs Healthcare Hamilton, Dept Anesthesia, 50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada; [Shanthanna, Harsha; Busse, Jason W.; Paul, James; Couban, Rachel] Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Busse, Jason W.; Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Choudhary, Harman] McMaster Univ, Dept Orthoped, Hamilton, ON, Canada; [Suzumura, Erica] Hosp Coracao HCor, Res Inst, Sao Paulo, Brazil; [Kim, Isabel] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; Hospital do Coracao - HCor; McMaster University	Shanthanna, H (corresponding author), McMaster Univ, St Josephs Healthcare Hamilton, Dept Anesthesia, 50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada.; Shanthanna, H (corresponding author), Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada.	shanthh@mcmaster.ca	Couban, Rachel/AAV-1568-2021; Busse, Jason/CAH-3696-2022; Suzumura, Erica A./C-4197-2013	Couban, Rachel/0000-0001-8672-2845; Suzumura, Erica A./0000-0003-1752-6095; Busse, Jason/0000-0002-0178-8712; Shanthanna, Harsha/0000-0002-4105-4465				Aaron DL, 2011, J AM ACAD ORTHOP SUR, V19, P359, DOI 10.5435/00124635-201106000-00006; ADEBAJO AO, 1990, J RHEUMATOL, V17, P1207; Afridi SK, 2006, PAIN, V122, P126, DOI 10.1016/j.pain.2006.01.016; Akgün K, 2004, CLIN RHEUMATOL, V23, P496, DOI 10.1007/s10067-004-0930-7; Akl EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057132; Altay T, 2002, CLIN ORTHOP RELAT R, P127; Alvarez CM, 2005, AM J SPORT MED, V33, P255, DOI 10.1177/0363546504267345; Ambrosini A, 2005, PAIN, V118, P92, DOI 10.1016/j.pain.2005.07.015; Anderberg L, 2007, EUR SPINE J, V16, P321, DOI 10.1007/s00586-006-0142-8; Annaswamy TM, 2011, PM&R, V3, P940, DOI 10.1016/j.pmrj.2011.06.013; [Anonymous], 2005, BMJ-BRIT MED J; [Anonymous], 1991, J NEUROL ORTHOP MED; [Anonymous], 1976, ADV PAIN RES THERAPY; [Anonymous], CHIBA MED J; [Anonymous], J RHEUMATOLOGY; [Anonymous], 2015, BMJ-BRIT MED J, DOI [DOI 10.1136/BMJ.G7647, 10.4271/2015-01-1534]; Armstrong T, 2004, MUSCLE NERVE, V29, P82, DOI 10.1002/mus.10512; ARNER S, 1990, PAIN, V43, P287, DOI 10.1016/0304-3959(90)90026-A; Arroll B, 2005, BRIT J GEN PRACT, V55, P224; Arroll B, 2004, BMJ-BRIT MED J, V328, P869, DOI 10.1136/bmj.38039.573970.7C; Ashkenazi A, 2005, HEADACHE, V45, P350, DOI 10.1111/j.1526-4610.2005.05073.x; Ashkenazi A, 2010, HEADACHE, V50, P943, DOI 10.1111/j.1526-4610.2010.01675.x; Beliveau P, 1971, Rheumatol Phys Med, V11, P40, DOI 10.1093/rheumatology/11.1.40; Benny BV, 2014, SPINE J, V14, P2500, DOI 10.1016/j.spinee.2014.04.003; Benyamin RM, 2012, PAIN PHYSICIAN, V15, pE363; Benyamin RM, 2012, PAIN PHYSICIAN, V15, pE497; Bhatia A, 2015, CAN J ANESTH, V62, P650, DOI 10.1007/s12630-015-0356-5; Bicket MC, 2015, SPINE J, V15, P348, DOI 10.1016/j.spinee.2014.10.011; Bicket MC, 2013, ANESTHESIOLOGY, V119, P907, DOI 10.1097/ALN.0b013e31829c2ddd; Blair B, 1996, J BONE JOINT SURG AM, V78A, P1685, DOI 10.2106/00004623-199611000-00007; Bresnahan BW, 2013, PM&R, V5, P705, DOI 10.1016/j.pmrj.2013.05.012; Buchbinder R, 2003, Cochrane Database Syst Rev, pCD004016; Buenaventura RM, 2009, PAIN PHYSICIAN, V12, P233; Caldwell JR, 1996, DRUGS, V52, P507, DOI 10.2165/00003495-199652040-00004; Chou R, 2015, ANN INTERN MED, V163, P373, DOI 10.7326/M15-0934; Cohen SP, 2013, REGION ANESTH PAIN M, V38, P175, DOI 10.1097/AAP.0b013e31828ea086; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Colen S, 2014, INT J SHOULDER SURG, V8, P114, DOI 10.4103/0973-6042.145252; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; COOMES EN, 1961, BRIT MED J, V1, P20, DOI 10.1136/bmj.1.5218.20; CUCKLER JM, 1985, J BONE JOINT SURG AM, V67A, P63, DOI 10.2106/00004623-198567010-00009; Cummings TM, 2001, ARCH PHYS MED REHAB, V82, P986, DOI 10.1053/apmr.2001.24023; DEVOR M, 1985, PAIN, V22, P127, DOI 10.1016/0304-3959(85)90173-3; Diwan SA, 2012, PAIN PHYSICIAN, V15, pE405; Dogramaci Y, 2009, ARCH ORTHOP TRAUM SU, V129, P1409, DOI 10.1007/s00402-009-0832-x; Dorleijn DMJ, 2014, J ARTHROPLASTY, V29, P1236, DOI 10.1016/j.arth.2013.12.008; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Ebrahim S, 2014, J CLIN EPIDEMIOL, V67, P560, DOI 10.1016/j.jclinepi.2013.11.014; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekeberg OM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3112; Eker HE, 2012, PAIN MED, V13, P443, DOI 10.1111/j.1526-4637.2011.01323.x; Engel A, 2014, PAIN MED, V15, P386, DOI 10.1111/pme.12304; Evans W, 1930, LANCET, V2, P1225; Falco FJE, 2012, PAIN PHYSICIAN, V15, pE909; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; FLANAGAN J, 1988, ANN ROY COLL SURG, V70, P156; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Fukusaki M, 1998, CLIN J PAIN, V14, P148, DOI 10.1097/00002508-199806000-00010; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; HENCH PS, 1949, P STAFF M MAYO CLIN, V24, P181; Hooten WM, 2015, MAYO CLIN PROC, V90, P4, DOI 10.1016/j.mayocp.2014.11.007; Jones KR, 2007, J REHABIL RES DEV, V44, P305, DOI 10.1682/JRRD.2006.05.0051; Karadas Ö, 2012, J REHABIL MED, V44, P601, DOI 10.2340/16501977-0990; Karadas Ö, 2011, AM J PHYS MED REHAB, V90, P287, DOI 10.1097/PHM.0b013e31820639ec; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P397, DOI 10.5435/00124635-200906000-00008; KEPES ER, 1985, PAIN, V22, P33, DOI 10.1016/0304-3959(85)90146-0; KLENERMAN L, 1984, BRIT J RHEUMATOL, V23, P35; Koester MC, 2007, J AM ACAD ORTHOP SUR, V15, P3, DOI 10.5435/00124635-200701000-00002; Krogh TP, 2013, AM J SPORT MED, V41, P1435, DOI 10.1177/0363546512458237; Kruse DW, 2008, CURR REV MUSCULOSKE, V1, P227, DOI 10.1007/s12178-008-9029-0; Lambert RGW, 2007, ARTHRITIS RHEUM, V56, P2278, DOI 10.1002/art.22739; Lambru G, 2012, HEADACHE, V52, P1596, DOI 10.1111/j.1526-4610.2012.02270.x; Leroux E, 2011, LANCET NEUROL, V10, P891, DOI 10.1016/S1474-4422(11)70186-7; Lindenhovius A, 2008, J HAND SURG-AM, V33A, P909, DOI 10.1016/j.jhsa.2008.02.004; Louwerens JKG, 2014, J SHOULDER ELB SURG, V23, P1240, DOI 10.1016/j.jse.2014.02.002; Lu Y, 2014, SPINE, V39, P1314, DOI 10.1097/BRS.0000000000000401; Malik KM, 2013, SPINE J, V13, P1675, DOI 10.1016/j.spinee.2013.06.063; Manchikanti KN, 2012, PAIN PHYSICIAN, V15, pE463; Manchikanti L, 2001, Pain Physician, V4, P101; Manchikanti Laxmaiah, 2015, Surg Neurol Int, V6, pS194, DOI 10.4103/2152-7806.156598; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE491; Manchikanti L, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/585806; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P371; Manchikanti Laxmaiah, 2012, J Pain Res, V5, P227, DOI 10.2147/JPR.S32692; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P273; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pE59; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P13; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P51; Manchikanti L, 2011, SPINE, V36, P1897, DOI 10.1097/BRS.0b013e31823294f2; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P25; Manchikanti L, 2010, PAIN PHYSICIAN, V13, pE357; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P343; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P223; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P801; Marshall S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001554.pub2; McInerney JJ, 2003, EMERG MED J, V20, P218, DOI 10.1136/emj.20.3.218; Misirlioglu TO, 2015, PAIN PHYSICIAN, V18, P163; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nam HS, 2011, ANN REHABIL MED-ARM, V35, P514, DOI 10.5535/arm.2011.35.4.514; Newcomer KL, 2001, CLIN J SPORT MED, V11, P214, DOI 10.1097/00042752-200110000-00002; Ng L, 2005, SPINE, V30, P857, DOI 10.1097/01.brs.0000158878.93445.a0; Olaussen M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003564; Papadopoulos PJ, 2009, CLEV CLIN J MED, V76, P373, DOI 10.3949/ccjm.76a.08096; Parker L, 2014, FAM PRACT, V31, P557, DOI 10.1093/fampra/cmu035; PETRI M, 1987, ARTHRITIS RHEUM-US, V30, P1040, DOI 10.1002/art.1780300911; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; Plafki C, 2000, INT ORTHOP, V24, P40, DOI 10.1007/s002640050010; PRICE R, 1991, BRIT J RHEUMATOL, V30, P39; Quraishi NA, 2012, EUR SPINE J, V21, P214, DOI 10.1007/s00586-011-2008-y; Rathmell JP, 2015, ANESTHESIOLOGY, V122, P974, DOI 10.1097/ALN.0000000000000614; Riew KD, 2006, J BONE JOINT SURG AM, V88A, P1722, DOI 10.2106/JBJS.E.00278; Riew KD, 2000, J BONE JOINT SURG AM, V82A, P1589, DOI 10.2106/00004623-200011000-00012; Rijsdijk M, 2014, ANESTH ANALG, V118, P1097, DOI 10.1213/ANE.0000000000000161; Rinkel WD, 2013, CLIN J PAIN, V29, P1087, DOI 10.1097/AJP.0b013e31828b8e7d; Roberts ST, 2009, PM&R, V1, P657, DOI 10.1016/j.pmrj.2009.04.008; ROGERS P, 1992, Pain Clinic, V5, P67; Sayegh FE, 2009, SPINE, V34, P1441, DOI 10.1097/BRS.0b013e3181a4804a; Scott NA, 2009, PAIN MED, V10, P54, DOI 10.1111/j.1526-4637.2008.00526.x; Shanahan EM, 2003, ANN RHEUM DIS, V62, P400, DOI 10.1136/ard.62.5.400; Sims Susan E G, 2014, Hand (N Y), V9, P419, DOI 10.1007/s11552-014-9642-x; Smidt N, 2002, PAIN, V96, P23, DOI 10.1016/S0304-3959(01)00388-8; Song A, 2014, PM&R, V6, P1143, DOI 10.1016/j.pmrj.2014.06.015; Stahl S, 1997, J BONE JOINT SURG AM, V79A, P1648, DOI 10.2106/00004623-199711000-00006; Stevens T, 2012, CLIN GASTROENTEROL H, V10, P186, DOI 10.1016/j.cgh.2011.09.006; SWERDLOW M, 1970, ANAESTHESIA, V25, P341, DOI 10.1111/j.1365-2044.1970.tb00218.x; Tafazal S, 2009, EUR SPINE J, V18, P1220, DOI 10.1007/s00586-009-1000-2; Thomson CE, 2013, J BONE JOINT SURG AM, V95A, P790, DOI 10.2106/JBJS.I.01780; Tobin J, 2009, HEADACHE, V49, P1521, DOI 10.1111/j.1526-4610.2009.01493.x; Uthman I, 2003, POSTGRAD MED J, V79, P449, DOI 10.1136/pmj.79.934.449; VECCHIO PC, 1993, BRIT J RHEUMATOL, V32, P743; Viera AJ, 2005, FAM MED, V37, P360; Wijayasinghe N, 2014, REGION ANESTH PAIN M, V39, P272, DOI 10.1097/AAP.0000000000000101; WITHRINGTON RH, 1985, SCAND J RHEUMATOL, V14, P76, DOI 10.3109/03009748509102022; Wolf JM, 2011, J HAND SURG-AM, V36A, P1269, DOI 10.1016/j.jhsa.2011.05.014; Wong SHS, 2010, EXPERT OPIN PHARMACO, V11, P2839, DOI 10.1517/14656566.2010.510133	138	23	25	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2046-4053		SYST REV-LONDON	Syst. Rev.		2016	5								18	10.1186/s13643-016-0190-z	http://dx.doi.org/10.1186/s13643-016-0190-z			14	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VH4DM	26831725	Green Published, gold			2024-09-18	WOS:000453148200018
J	El Haji, H; Souadka, A; Patel, BN; Sbihi, N; Ramasamy, G; Patel, BK; Ghogho, M; Banerjee, I				El Haji, Hasna; Souadka, Amine; Patel, Bhavik N.; Sbihi, Nada; Ramasamy, Gokul; Patel, Bhavika K.; Ghogho, Mounir; Banerjee, Imon			Evolution of Breast Cancer Recurrence Risk Prediction: A Systematic Review of Statistical and Machine Learning-Based Models	JCO CLINICAL CANCER INFORMATICS			English	Review							DISTANT RECURRENCE; ASSAY; EXPRESSION; NOMOGRAM; FEATURES; SURGERY	PURPOSE Selection of appropriate adjuvant therapy to ultimately reduce the risk of breast cancer (BC) recurrence is a challenge for medical oncologists. Several automated risk prediction models have been developed using retrospective clinical data and have evolved significantly over the years in terms of predictors of recurrence, data usage, and predictive techniques (statistical/machine learning [ML]). METHODS Following PRISMA guidelines, we performed a systematic literature review of the aforementioned statistical and ML models published between January 2008 and December 2022 through searching five digital databases-PubMed, ScienceDirect, Scopus, Cochrane, and Web of Science. The comprehensive search yielded a total of 163 papers and after a screening process focusing on papers that dealt exclusively with statistical/ML methods, only 23 papers were deemed appropriate for further analysis. We benchmarked the studies on the basis of development, evaluation metrics, and validation strategy with an added emphasis on racial diversity of patients included in the studies. RESULTS In total, 30.4% of the included studies use statistical techniques, while 69.6% are ML-based. Among these, traditional ML models (support vector machines, decision tree, logistic regression, and naive Bayes) are the most frequently used (26.1%) along with deep learning (26.1%). Deep learning and ensemble learning provide the most accurate predictions (AUC = 0.94 each). CONCLUSION ML-based prediction models exhibit outstanding performance, yet their practical applicability might be hindered by limited interpretability and reduced generalization. Moreover, predictive models for BC recurrence often focus on limited variables related to tumor, treatment, molecular, and clinical features. Imbalanced classes and the lack of open-source data sets impede model development and validation. Furthermore, existing models predominantly overlook African and Middle Eastern populations, as they are trained and validated mainly on Caucasian and Asian patients.	[El Haji, Hasna; Patel, Bhavik N.; Ramasamy, Gokul; Patel, Bhavika K.; Banerjee, Imon] Mayo Clin, Dept Radiol, 6161 E Mayo Blvd, Phoenix, AZ 85054 USA; [El Haji, Hasna; Patel, Bhavik N.; Ramasamy, Gokul; Banerjee, Imon] Arizona State Univ, Sch Comp & Augmented Intelligence, Tempe, AZ USA; [El Haji, Hasna; Ghogho, Mounir] Int Univ Rabat, TICLab, Rabat, Morocco; [Souadka, Amine] Mohammed V Univ Rabat, Natl Inst Oncol, Dept Surg Oncol, Rabat, Morocco; [Ghogho, Mounir] Univ Leeds, Fac Engn, Leeds, W Yorkshire, England	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Tempe; Universite Internationale de Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; University of Leeds	El Haji, H (corresponding author), Mayo Clin, Dept Radiol, 6161 E Mayo Blvd, Phoenix, AZ 85054 USA.	elhaji.hasna@mayo.edu	Amine, Souadka/ABB-1728-2020	Ramasamy, Gokul/0000-0001-8401-8061; EL HAJI, Hasna/0009-0000-0437-2731; Banerjee, Imon/0000-0002-3327-8004; Patel, Bhavika/0000-0002-8486-955X; Souadka, Amine/0000-0002-1091-9446	Fulbright grant	Fulbright grant	Supported by Fulbright grant to H.E.H.	Abreu PH, 2016, ACM COMPUT SURV, V49, DOI 10.1145/2988544; Acosta JN, 2022, NAT MED, V28, P1773, DOI 10.1038/s41591-022-01981-2; Akselrod-Ballin A, 2019, RADIOLOGY, V292, P331, DOI 10.1148/radiol.2019182622; Alwohaibi M, 2022, J KING SAUD UNIV-COM, V34, P5192, DOI 10.1016/j.jksuci.2021.05.004; [Anonymous], Outcomes predictor after mastectomy with N1 breast cancer; [Anonymous], SEER Incidence Data, 1975 - 2019; [Anonymous], Metastasis and recurrence of breast cancer; [Anonymous], ATAC-Arimidex, tamoxifen alone or in combination; Baehner Frederick L, 2016, Ecancermedicalscience, V10, P675; Baltres A, 2020, BREAST CANCER-TOKYO, V27, P1007, DOI 10.1007/s12282-020-01100-4; Blake C. L., 1998, UCI REPOSITORY MACHI; Boracchi P, 2008, INT J BIOL MARKER, V23, P199, DOI 10.1177/172460080802300401; Brentnall AR, 2018, STAT METHODS MED RES, V27, P2359, DOI 10.1177/0962280216680245; Carlson JJ, 2013, BREAST CANCER RES TR, V141, P13, DOI 10.1007/s10549-013-2666-z; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Chen MT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10166-8; Chlebowski RT, 2021, JCO ONCOL PRACT, V17, P709, DOI 10.1200/OP.21.00343; Colleoni M, 2016, J CLIN ONCOL, V34, P927, DOI 10.1200/JCO.2015.62.3504; Coughlin SS, 2019, BREAST CANCER RES TR, V177, P537, DOI 10.1007/s10549-019-05340-7; Dawngliani MS, 2021, INT C MOBILE COMPUTI, P17; Dellapasqua S, 2012, BREAST, V21, P621, DOI 10.1016/j.breast.2012.06.003; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Dowsett M, 2018, J CLIN ONCOL, V36, P1941, DOI 10.1200/JCO.2017.76.4258; Engelhardt EG, 2014, J CLIN ONCOL, V32, P238, DOI 10.1200/JCO.2013.50.3417; Gardezi SJS, 2019, J MED INTERNET RES, V21, DOI 10.2196/14464; Gu DX, 2020, ARTIF INTELL MED, V107, DOI 10.1016/j.artmed.2020.101858; Karimi YH, 2021, JCO CLIN CANCER INFO, V5, P469, DOI 10.1200/CCI.20.00165; Kim JY, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.596364; Kim W, 2016, HEALTHC INFORM RES, V22, P89; Kim W, 2012, J BREAST CANCER, V15, P230; Mazo C, 2022, J PERS MED, V12, DOI 10.3390/jpm12091496; MCGEE VE, 1970, J AM STAT ASSOC, V65, P1109, DOI 10.2307/2284278; Mohebian MR, 2017, COMPUT STRUCT BIOTEC, V15, P75, DOI 10.1016/j.csbj.2016.11.004; Nindrea Ricvan Dana, 2018, Asian Pac J Cancer Prev, V19, P1747, DOI 10.22034/APJCP.2018.19.7.1747; Osako T, 2022, CANCER-AM CANCER SOC, V128, P1913, DOI 10.1002/cncr.34144; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n160, 10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Phan NN, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.734015; PROGNOSIS, Using machine learning in clinical diagnosis and prognosis; Rudloff U, 2010, J CLIN ONCOL, V28, P3762, DOI 10.1200/JCO.2009.26.8847; Sanyal J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89033-6; Sittenfeld SMC, 2022, CANCER-AM CANCER SOC, V128, P3057, DOI 10.1002/cncr.34352; Souadka A, 2021, BREAST, V60, P310, DOI 10.1016/j.breast.2021.11.001; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Vazifehdan M, 2019, J KING SAUD UNIV-COM, V31, P175, DOI 10.1016/j.jksuci.2018.01.002; Wang CJ, 2022, BREAST, V63, P61, DOI 10.1016/j.breast.2022.03.007; Wang F, 2019, JAMA ONCOL, V5, P1589, DOI 10.1001/jamaoncol.2019.2803; Wang HY, 2020, ARTIF INTELL MED, V110, DOI 10.1016/j.artmed.2020.101977; Wang XX, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.661109; Wolberg W, 1995, UCI Machine Learning Repository, DOI DOI 10.24432/C5GK50; Wu J, 2020, CLIN RADIOL, V75, DOI 10.1016/j.crad.2019.10.015; Wu XF, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw314; Xin L, 2022, CHINESE MED J-PEKING, V135, P697, DOI 10.1097/CM9.0000000000002056; Yang JL, 2022, COMPUT STRUCT BIOTEC, V20, P333, DOI 10.1016/j.csbj.2021.12.028; Yoo SH, 2020, CLIN BREAST CANCER, V20, P98, DOI 10.1016/j.clbc.2019.07.010; US	56	2	2	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2473-4276			JCO CLIN CANCER INFO	JCO Clin. Cancer Info.		2023	7								e2300049	10.1200/CCI.23.00049	http://dx.doi.org/10.1200/CCI.23.00049			14	Oncology	Emerging Sources Citation Index (ESCI)	Oncology	DP6P1	37566789				2024-09-18	WOS:001133302300091
J	Abdusalomov, A; Rakhimov, M; Karimberdiyev, J; Belalova, G; Cho, YI				Abdusalomov, Akmalbek; Rakhimov, Mekhriddin; Karimberdiyev, Jakhongir; Belalova, Guzal; Cho, Young Im			Enhancing Automated Brain Tumor Detection Accuracy Using Artificial Intelligence Approaches for Healthcare Environments	BIOENGINEERING-BASEL			English	Article						YOLOv5; non-local neural networks; brain tumor; MRI; segmentation; object detection; deep learning		Medical imaging and deep learning models are essential to the early identification and diagnosis of brain cancers, facilitating timely intervention and improving patient outcomes. This research paper investigates the integration of YOLOv5, a state-of-the-art object detection framework, with non-local neural networks (NLNNs) to improve brain tumor detection's robustness and accuracy. This study begins by curating a comprehensive dataset comprising brain MRI scans from various sources. To facilitate effective fusion, the YOLOv5 and NLNNs, K-means+, and spatial pyramid pooling fast+ (SPPF+) modules are integrated within a unified framework. The brain tumor dataset is used to refine the YOLOv5 model through the application of transfer learning techniques, adapting it specifically to the task of tumor detection. The results indicate that the combination of YOLOv5 and other modules results in enhanced detection capabilities in comparison to the utilization of YOLOv5 exclusively, proving recall rates of 86% and 83% respectively. Moreover, the research explores the interpretability aspect of the combined model. By visualizing the attention maps generated by the NLNNs module, the regions of interest associated with tumor presence are highlighted, aiding in the understanding and validation of the decision-making procedure of the methodology. Additionally, the impact of hyperparameters, such as NLNNs kernel size, fusion strategy, and training data augmentation, is investigated to optimize the performance of the combined model.	[Abdusalomov, Akmalbek; Cho, Young Im] Gachon Univ, Dept Comp Engn, Seongnam Si 13120, Gyeonggi Do, South Korea; [Rakhimov, Mekhriddin; Karimberdiyev, Jakhongir] Tashkent Univ Informat Technol, Dept Artificial Intelligence, Tashkent 100200, Uzbekistan; [Belalova, Guzal; Cho, Young Im] Tashkent State Univ Econ, Dept Informat Syst & Technol, Tashkent 100066, Uzbekistan	Gachon University; Tashkent University of Information Technologies; Tashkent State University of Economics	Cho, YI (corresponding author), Gachon Univ, Dept Comp Engn, Seongnam Si 13120, Gyeonggi Do, South Korea.; Cho, YI (corresponding author), Tashkent State Univ Econ, Dept Informat Syst & Technol, Tashkent 100066, Uzbekistan.	akmaljon@gachon.ac.kr; raximov022@gmail.com; jahongirkarimberdiyev618@gmail.com; g.belalova@tsue.uz; yicho@gachon.ac.kr	Abdusalomov, Akmalbek/AEB-6319-2022; Rakhimov, Mekhriddin/HGB-7388-2022	Abdusalomov, Akmalbek/0000-0001-5923-8695; Cho, Young Im/0000-0003-0184-7599	Korea Agency for Technology and Standards [1415181638]; Development of International Standard Technologies based on AI Model Light weighting Technologies [1415181629]; Development of International Standard Technologies based on AI Learning and Inference Technologies [1415180835]	Korea Agency for Technology and Standards; Development of International Standard Technologies based on AI Model Light weighting Technologies; Development of International Standard Technologies based on AI Learning and Inference Technologies	This study was funded by the Korea Agency for Technology and Standards in 2022. The project numbers are 1415181638 (Establishment of standardization basis for BCI and AI Interoperability), 1415181629 (Development of International Standard Technologies based on AI Model Light weighting Technologies), and 1415180835 (Development of International Standard Technologies based on AI Learning and Inference Technologies).	Abdulbaqi HS, 2014, IEEE ST CONF RES DEV; Abdusalomov AB, 2023, CANCERS, V15, DOI 10.3390/cancers15164172; Abdusalomov AB, 2023, SENSORS-BASEL, V23, DOI 10.3390/s23073440; Abdusalomov AB, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22218122; Akinyelu AA, 2022, J IMAGING, V8, DOI 10.3390/jimaging8080205; Aldape K., 2019, Nat. Rev. Clin. Oncol, V16, P8, DOI [10.17863/cam.39643, DOI 10.17863/CAM.39643]; Arifando R, 2023, APPL SCI-BASEL, V13, DOI 10.3390/app13095802; Badza MM, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10061999; Bala D., 2022, P 2022 INT C ENG EM, P1; Bauer S, 2012, IEEE T BIO-MED ENG, V59, P25, DOI 10.1109/TBME.2011.2163406; Bhanothu Y, 2020, INT CONF ADVAN COMPU, P248, DOI [10.1109/icaccs48705.2020.9074375, 10.1109/ICACCS48705.2020.9074375]; Cao XH, 2023, REMOTE SENS-BASEL, V15, DOI 10.3390/rs15010003; Chi C., 2008, P 21 ISPRS C YOUTH F; Choi HS, 2023, INT NEUROUROL J, V27, pS99, DOI 10.5213/inj.2346292.146; Cifci MA, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13061025; Deepak S, 2019, COMPUT BIOL MED, V111, DOI 10.1016/j.compbiomed.2019.103345; Dutta P., 2022, INT C ART INT SMART; Fahmideh MA, 2021, CANCER EPIDEM BIOMAR, V30, P813, DOI 10.1158/1055-9965.EPI-20-1443; Golam M., 2022, Noise Removal from MRI Brain Images Using Median-Filtering Techniques; Gómez-Guzmán MA, 2023, ELECTRONICS-SWITZ, V12, DOI 10.3390/electronics12040955; Gull S, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/3365043; Gurbina M, 2019, 2019 42ND INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS AND SIGNAL PROCESSING (TSP), P505, DOI [10.1109/TSP.2019.8769040, 10.1109/tsp.2019.8769040]; Hasan AM, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8110132; Hussain S, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13081456; Iqbal S., 2024, IEEE Transactions on Fuzzy Systems, P1, DOI [10.1109/tfuzz.2024.3372608, DOI 10.1109/TFUZZ.2024.3372608]; Jansen M., 2015, Masters Thesis, DOI [10.13140/RG.2.2.19469.69606, DOI 10.13140/RG.2.2.19469.69606]; Juntu J, 2005, ADV SOFT COMP, P543; Kalavathi P, 2016, J DIGIT IMAGING, V29, P365, DOI 10.1007/s10278-015-9847-8; Kaur T, 2020, MACH VISION APPL, V31, DOI 10.1007/s00138-020-01069-2; Khan M, 2023, SENSORS-BASEL, V23, DOI 10.3390/s23031471; Lee EQ, 2019, NEURO-ONCOLOGY, V21, P1100, DOI 10.1093/neuonc/noz104; Madhiarasan M, 2022, J ELECTR COMPUT ENG, V2022, DOI 10.1155/2022/5416722; Madhupriya G., 2019, 2019 3rd International Conference on Trends in Electronics and Informatics (ICOEI). Proceedings, P758, DOI 10.1109/ICOEI.2019.8862575; Mahmud MI, 2023, ALGORITHMS, V16, DOI 10.3390/a16040176; Maqsood S, 2022, MEDICINA-LITHUANIA, V58, DOI 10.3390/medicina58081090; Montagnon E, 2020, INSIGHTS IMAGING, V11, DOI 10.1186/s13244-019-0832-5; Mukhiddinov M, 2023, SENSORS-BASEL, V23, DOI 10.3390/s23031080; Mukhiddinov M, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22239384; Nadeem MW, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10020118; Nasimov R., 2024, Internet of Things, Smart Spaces, and Next Generation Networks and Systems, V4543, DOI [10.1007/978-3-031-60997-86, DOI 10.1007/978-3-031-60997-86]; Nguchu B., 2016, Int. J. Electr. Electron. Res, V4, P23; Nodirov J, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22176501; Noreen N, 2021, CMC-COMPUT MATER CON, V67, P3967, DOI 10.32604/cmc.2021.014158; Özkaraca O, 2023, LIFE-BASEL, V13, DOI 10.3390/life13020349; Patil Suraj, 2023, Procedia Computer Science, P2468, DOI 10.1016/j.procs.2023.01.222; Pinto A, 2015, 2015 IEEE 4TH PORTUGUESE MEETING ON BIOENGINEERING (ENBENG); Rakhimov M., 2024, Intelligent Human Computer Interaction, VVolume 14531, DOI [10.1007/978-3-031-53827-816, DOI 10.1007/978-3-031-53827-816]; Rakhimov M., 2022, P 2022 IEEE 16 INT C, P1; Ramamoorthy M, 2022, HEALTHCARE-BASEL, V10, DOI 10.3390/healthcare10071218; Rasheed M, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13081451; Rasheed Z, 2023, BRAIN SCI, V13, DOI 10.3390/brainsci13091320; Reddy S., 2018, International Journal of Recent Technology and Engineering, V7, P448; Rehman MU, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21103322; Risholm P, 2011, NEUROSURG CLIN N AM, V22, P197, DOI 10.1016/j.nec.2010.12.001; Saeed F, 2020, MULTIMED TOOLS APPL, V79, P9083, DOI 10.1007/s11042-019-07785-w; Saeedi S, 2023, BMC MED INFORM DECIS, V23, DOI 10.1186/s12911-023-02114-6; Saydirasulovich SN, 2023, SENSORS-BASEL, V23, DOI 10.3390/s23208374; Shafi ASM, 2021, INFORM MED UNLOCKED, V24, DOI DOI 10.1016/J.IMU.2021.100608; Sharma A, 2023, SUSTAINABILITY-BASEL, V15, DOI 10.3390/su151511893; Shelatkar T, 2022, COMPUT MATH METHOD M, V2022, DOI 10.1155/2022/2858845; Song JH, 2019, COMPUT MATH METHOD M, V2019, DOI 10.1155/2019/4762490; Swati ZNK, 2019, IEEE ACCESS, V7, P17809, DOI 10.1109/ACCESS.2019.2892455; Tagmatova Z, 2023, BIOENGINEERING-BASEL, V10, DOI 10.3390/bioengineering10091031; Taher F, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.959667; Talukder MA, 2023, EXPERT SYST APPL, V230, DOI 10.1016/j.eswa.2023.120534; Tocchio S, 2015, SEMIN PERINATOL, V39, P73, DOI 10.1053/j.semperi.2015.01.002; Tufail Z, 2021, J MED IMAGING, V8, DOI 10.1117/1.JMI.8.1.014003; Ul Haq E, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03535-9; Umirzakova S, 2024, INFORM FUSION, V103, DOI 10.1016/j.inffus.2023.102075; Wang C, 2019, INT GEOSCI REMOTE SE, P584, DOI [10.1109/igarss.2019.8897931, 10.1109/IGARSS.2019.8897931]; Wang SL, 2018, PROC CVPR IEEE, P2589, DOI 10.1109/CVPR.2018.00274; Wozniak M, 2023, NEURAL COMPUT APPL, V35, P14611, DOI 10.1007/s00521-021-05841-x; Wu Y, 2019, INFORM SCIENCES, V490, P317, DOI 10.1016/j.ins.2019.03.080; Yang FY, 2011, IEEE ENG MED BIO, P5573, DOI 10.1109/IEMBS.2011.6091348; Yavuz BB, 2021, INDIAN J CANCER, V58, P210, DOI 10.4103/ijc.IJC_36_19; Yunusov N, 2024, PROCESSES, V12, DOI 10.3390/pr12051039; Zafar A, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12178643	77	0	0	5	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2306-5354		BIOENGINEERING-BASEL	Bioengineering-Basel	JUN	2024	11	6							627	10.3390/bioengineering11060627	http://dx.doi.org/10.3390/bioengineering11060627			23	Biotechnology & Applied Microbiology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Engineering	WK3G0	38927863	gold			2024-09-18	WOS:001254717800001
J	Chen, Y; Shao, ZC; Bian, H; Fang, ZJ; Wang, YF; Cai, YH; Wang, HQ; Liu, GJ; Li, X; Zhang, YB				Chen, Yang; Shao, Zhuchen; Bian, Hao; Fang, Zijie; Wang, Yifeng; Cai, Yuanhao; Wang, Haoqian; Liu, Guojun; Li, Xi; Zhang, Yongbing			dMIL-Transformer: Multiple Instance Learning Via Integrating Morphological and Spatial Information for Lymph Node Metastasis Classification	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Histopathological image analysis; multiple instance learning; whole slide image; lymph node metastasis; Transformer	CANCER	Automated classification of lymph node metastasis (LNM) plays an important role in the diagnosis and prognosis. However, it is very challenging to achieve satisfactory performance in LNM classification, because both the morphology and spatial distribution of tumor regions should be taken into account. To address this problem, this article proposes a two-stage dMIL-Transformer framework, which integrates both the morphological and spatial information of the tumor regions based on the theory of multiple instance learning (MIL). In the first stage, a double Max-Min MIL (dMIL) strategy is devised to select the suspected top-K positive instances from each input histopathology image, which contains tens of thousands of patches (primarily negative). The dMIL strategy enables a better decision boundary for selecting the critical instances compared with other methods. In the second stage, a Transformer-based MIL aggregator is designed to integrate all the morphological and spatial information of the selected instances from the first stage. The self-attention mechanism is further employed to characterize the correlation between different instances and learn the bag-level representation for predicting the LNM category. The proposed dMIL-Transformer can effectively deal with the thorny classification in LNM with great visualization and interpretability. We conduct various experiments over three LNM datasets, and achieve 1.79%-7.50% performance improvement compared with other state-of-the-art methods.	[Chen, Yang; Shao, Zhuchen; Bian, Hao; Fang, Zijie; Wang, Yifeng; Cai, Yuanhao; Wang, Haoqian] Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, Shenzhen 518000, Peoples R China; [Wang, Yifeng; Zhang, Yongbing] Harbin Inst Technol, Shenzhen 518000, Peoples R China; [Liu, Guojun] Harbin Inst Technol, Comp Sci & Technol, Harbin 150000, Peoples R China; [Li, Xi] Peking Univ, Gastroenterol, Shenzhen Hosp, Shenzhen 518036, Peoples R China	Tsinghua University; Tsinghua Shenzhen International Graduate School; Harbin Institute of Technology; Harbin Institute of Technology; Peking University	Zhang, YB (corresponding author), Harbin Inst Technol, Shenzhen 518000, Peoples R China.	cy21@mails.tsinghua.edu.cn; szc21@mails.tsinghua.edu.cn; bianh21@mails.tsinghua.edu.cn; fzj22@mails.tsinghua.edu.cn; wangyifeng@stu.hit.edu.cn; cyh20@mails.tsinghua.edu.cn; wanghaoqian@tsinghua.edu.cn; hitliu@hit.edu.cn; lixi122188@sina.com; ybzhang08@hit.edu.cn	Shao, Zhuchen/IYS-4625-2023; Liu, Guojun/A-9459-2015; Yang, Chen/JZS-9822-2024; Cai, Yuanhao/GLU-1731-2022; Wang, Yifeng/KCL-9606-2024	Chen, Yang/0000-0001-6410-0922; Wang, Yifeng/0000-0001-8317-8434	National Natural Science Foundation of China [62031023]; Shenzhen Science and Technology Project [JCYJ20200109142808034, GXWD20220818170353009]; Guangdong Special Support [2019TX05X187]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Project; Guangdong Special Support	This work was supported in part by the National Natural Science Foundation of China under Grant 62031023,in part by the Shenzhen Science and Technology Project under Grants JCYJ20200109142808034 and GXWD20220818170353009, and in part by Guangdong Special Support under Grant 2019TX05X187.	Aeffner Famke, 2019, J Pathol Inform, V10, P9, DOI 10.4103/jpi.jpi_82_18; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Amores J, 2013, ARTIF INTELL, V201, P81, DOI 10.1016/j.artint.2013.06.003; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Carbonneau MA, 2018, PATTERN RECOGN, V77, P329, DOI 10.1016/j.patcog.2017.10.009; Chikontwe P., MED IMAGE COMPUTING, V12265; Chu XX, 2021, Arxiv, DOI [arXiv:2102.10882, 10.48550/arXiv.2102.10882]; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Das K, 2020, IEEE ACCESS, V8, P213502, DOI 10.1109/ACCESS.2020.3040106; Dosovitskiy A., 2020, INT C LEARNING REPRE; Evans AJ, 2018, ARCH PATHOL LAB MED, V142, P1383, DOI 10.5858/arpa.2017-0496-CP; Feng J, 2017, AAAI CONF ARTIF INTE, P1884; Gao ZY, 2021, LECT NOTES COMPUT SC, V12908, P299, DOI 10.1007/978-3-030-87237-3_29; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hendrycks D, 2020, Arxiv, DOI [arXiv:1606.08415, 10.48550/arXiv.1606.08415]; Heo B, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P11916, DOI 10.1109/ICCV48922.2021.01172; Ilse M., 2018, Attention-based deep multiple instance learning; Khan S, 2022, ACM COMPUT SURV, V54, DOI 10.1145/3505244; Lee B, 2018, LECT NOTES COMPUT SC, V11071, P841, DOI 10.1007/978-3-030-00934-2_93; Lerousseau Marvin, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12265), P470, DOI 10.1007/978-3-030-59722-1_45; Lerousseau M, 2021, LECT NOTES COMPUT SC, V12908, P248, DOI 10.1007/978-3-030-87237-3_24; Li B, 2021, PROC CVPR IEEE, P14313, DOI 10.1109/CVPR46437.2021.01409; Li W., 2019, Medical Image Computing and Computer Assisted Intervention, V11764; Litjens G, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy065; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu XY, 2023, IEEE J BIOMED HEALTH, V27, P1780, DOI 10.1109/JBHI.2023.3249354; Lu MY, 2021, NAT BIOMED ENG, V5, P555, DOI 10.1038/s41551-020-00682-w; Maron O, 1998, ADV NEUR IN, V10, P570; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paszke A, 2019, ADV NEUR IN, V32; Shao Z., 2021, Adv. Neural Inf. Process. Syst., V34, P2136; Shi XS, 2020, AAAI CONF ARTIF INTE, V34, P5742; Srinidhi CL, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101813; Vaswani A, 2017, ADV NEUR IN, V30; Veta M, 2019, MED IMAGE ANAL, V54, P111, DOI 10.1016/j.media.2019.02.012; Wang XD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21674-7; Wentao Zhu, 2017, Medical Image Computing and Computer Assisted Intervention  MICCAI 2017. 20th International Conference. Proceedings: LNCS 10435, P603, DOI 10.1007/978-3-319-66179-7_69; Wright L.., 2019, Ranger - a synergistic optimizer; Xu G, 2019, IEEE I CONF COMP VIS, P10681, DOI 10.1109/ICCV.2019.01078; Xu Y, 2014, MED IMAGE ANAL, V18, P591, DOI 10.1016/j.media.2014.01.010; Yun BX, 2021, Arxiv, DOI arXiv:2103.03604; Zhang H., 2022, IEEECVF C COMPUTER V, P18802; Zhao Y, 2020, PROC CVPR IEEE, P4836, DOI 10.1109/CVPR42600.2020.00489; Zhou Z.-H., 2009, P 26 INT C MACHINE L, P1249; Zhou ZH, 2018, NATL SCI REV, V5, P44, DOI 10.1093/nsr/nwx106	45	2	2	5	16	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194	2168-2208		IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	SEP	2023	27	9					4433	4443		10.1109/JBHI.2023.3285275	http://dx.doi.org/10.1109/JBHI.2023.3285275			11	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	R5AE7	37310831				2024-09-18	WOS:001064467900020
J	Wu, MJ; Gao, YL; Liu, JX; Zhu, R; Wang, J				Wu, Ming-Juan; Gao, Ying-Lian; Liu, Jin-Xing; Zhu, Rong; Wang, Juan			Principal Component Analysis Based on Graph Laplacian and Double Sparse Constraints for Feature Selection and Sample Clustering on Multi-View Data	HUMAN HEREDITY			English	Article						Principal component analysis; Double sparse constraints; Feature selection; Sample clustering; Multi-view data	GENE; CANCER	Principal component analysis (PCA) is a widely used method for evaluating low-dimensional data. Some variants of PCA have been proposed to improve the interpretation of the principal components (PCs). One of the most common methods is sparse PCA which aims at finding a sparse basis to improve the interpretability over the dense basis of PCA. However, the performances of these improved methods are still far from satisfactory because the data still contain redundant PCs. In this paper, a novel method called PCA based on graph Laplacian and double sparse constraints (GDSPCA) is proposed to improve the interpretation of the PCs and consider the internal geometry of the data. In detail, GDSPCA utilizes L-2,L-1-norm and L-1-norm regularization terms simultaneously to enforce the matrix to be sparse by filtering redundant and irrelative PCs, where the L-2,L-1-norm regularization term can produce row sparsity, while the L-1-norm regularization term can enforce element sparsity. This way, we can make a better interpretation of the new PCs in low-dimensional subspace. Meanwhile, the method of GDSPCA integrates graph Laplacian into PCA to explore the geometric structure hidden in the data. A simple and effective optimization solution is provided. Extensive experiments on multi-view biological data demonstrate the feasibility and effectiveness of the proposed approach.	[Wu, Ming-Juan; Liu, Jin-Xing; Zhu, Rong; Wang, Juan] Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao, Peoples R China; [Gao, Ying-Lian] Qufu Normal Univ, Lib Qufu Normal Univ, Yantai Rd 80, Rizhao 276826, Shandong, Peoples R China	Qufu Normal University; Qufu Normal University	Gao, YL (corresponding author), Qufu Normal Univ, Lib Qufu Normal Univ, Yantai Rd 80, Rizhao 276826, Shandong, Peoples R China.	yinliangao@126.com	Liu, Jin-Xing/AAU-7257-2020		National Natural Science Foundation of China [61572284, 61872220, 61702299]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was in part supported by the National Natural Science Foundation of China under grant Nos. 61572284, 61872220, and 61702299.	Alshalalfa Mohammed, 2012, Advances in Bioinformatics, V2012, P373506, DOI 10.1155/2012/373506; [Anonymous], COMPUTER VISION PATT; [Anonymous], INT C MACH LEARN; [Anonymous], INT C COMP VIS; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-78; Chávez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Cheng LH, 2016, ONCOTARGET, V7, P78946, DOI 10.18632/oncotarget.12935; Deng L, 2012, INT J NANOMED, V7, P5053, DOI 10.2147/IJN.S34801; Feng CM, 2017, IEEE T NANOBIOSCI, V16, P257, DOI 10.1109/TNB.2017.2690365; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hu ZF, 2016, IEEE T NEUR NET LEAR, V27, P875, DOI 10.1109/TNNLS.2015.2427451; Law MHC, 2006, IEEE T PATTERN ANAL, V28, P377, DOI 10.1109/TPAMI.2006.56; Lei J, 2015, ANN STAT, V43, P299, DOI 10.1214/14-AOS1273; Li YF, 2018, BRIEF BIOINFORM, V19, P325, DOI 10.1093/bib/bbw113; Liu JX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S3; Melaiu O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085935; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nie F, 2010, INT C NEURAL INFORM; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Shi XS, 2018, NEUROCOMPUTING, V283, P205, DOI 10.1016/j.neucom.2017.12.034; Song J, 2010, J STAT COMPUT SIM, V80, P825, DOI 10.1080/00949650902798129; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Wang YX, 2016, COMPUT BIOL CHEM, V65, P185, DOI 10.1016/j.compbiolchem.2016.09.014; Yang C, 2017, ONCOTARGET, V8, P89021, DOI 10.18632/oncotarget.21643; Yang M, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-57; Yi SY, 2017, PATTERN RECOGN, V61, P524, DOI 10.1016/j.patcog.2016.08.025; Zheng CH, 2016, COMPUT BIOL MED, V72, P22, DOI 10.1016/j.compbiomed.2016.03.002; Zheng CH, 2011, IEEE ACM T COMPUT BI, V8, P1592, DOI 10.1109/TCBB.2011.79; Zhu YH, 2017, MULTIMED TOOLS APPL, V76, P17525, DOI 10.1007/s11042-016-4121-8	34	3	3	1	21	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0001-5652	1423-0062		HUM HERED	Hum. Hered.	SEP	2019	84	1					47	57		10.1159/000501653	http://dx.doi.org/10.1159/000501653			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IZ4BS	31466072				2024-09-18	WOS:000487029900005
J	Briscik, M; Dillies, MA; Déjean, S				Briscik, Mitja; Dillies, Marie-Agnes; Dejean, Sebastien			Improvement of variables interpretability in kernel PCA	BMC BIOINFORMATICS			English	Article						Kernel PCA; Relevant variables; Unsupervised learning; Kernel methods	RACGAP1 EXPRESSION; MAJOR DETERMINANT; ASPM GENE; ADAM10; CANCER; IDENTIFICATION; METASTASIS; BIOMARKER; TARGET; CCNB1	BackgroundKernel methods have been proven to be a powerful tool for the integration and analysis of high-throughput technologies generated data. Kernels offer a nonlinear version of any linear algorithm solely based on dot products. The kernelized version of principal component analysis is a valid nonlinear alternative to tackle the nonlinearity of biological sample spaces. This paper proposes a novel methodology to obtain a data-driven feature importance based on the kernel PCA representation of the data.ResultsThe proposed method, kernel PCA Interpretable Gradient (KPCA-IG), provides a data-driven feature importance that is computationally fast and based solely on linear algebra calculations. It has been compared with existing methods on three benchmark datasets. The accuracy obtained using KPCA-IG selected features is equal to or greater than the other methods' average. Also, the computational complexity required demonstrates the high efficiency of the method. An exhaustive literature search has been conducted on the selected genes from a publicly available Hepatocellular carcinoma dataset to validate the retained features from a biological point of view. The results once again remark on the appropriateness of the computed ranking.ConclusionsThe black-box nature of kernel PCA needs new methods to interpret the original features. Our proposed methodology KPCA-IG proved to be a valid alternative to select influential variables in high-dimensional high-throughput datasets, potentially unravelling new biological and medical biomarkers.	[Briscik, Mitja; Dejean, Sebastien] Univ Toulouse, Inst Math Toulouse, UPS, CNRS,UMR5219, F-31062 Toulouse 9, France; [Dillies, Marie-Agnes] Univ Paris Cite, Inst Pasteur, Bioinformat & Biostat Hub, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Pasteur Network; Universite Paris Cite; Institut Pasteur Paris	Briscik, M (corresponding author), Univ Toulouse, Inst Math Toulouse, UPS, CNRS,UMR5219, F-31062 Toulouse 9, France.	mitja.briscik@math.univ-toulouse.fr	DEJEAN, Sebastien/JDD-5050-2023	DEJEAN, Sebastien/0000-0001-9610-5306; Briscik, Mitja/0000-0001-8851-074X				Abid A, 2019, Arxiv, DOI [arXiv:1901.09346, 10.48550/ARXIV.1901.09346]; Ancona M., 2019, LNCS (LNAI), V11700, P169, DOI [10.1007/ 978- 3- 030-28954-6_9, DOI 10.1007/978-3-030-28954-6_9, DOI 10.1007/978-3-030-28954-69]; Ancona M, 2018, Arxiv, DOI arXiv:1711.06104; Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Brouard C, 2022, NAR GENOM BIOINFORM, V4, DOI 10.1093/nargab/lqac014; Cai D, 2010, P 16 ACM SIGKDD INT; Chai N, 2018, BIOCHEM BIOPH RES CO, V500, P924, DOI 10.1016/j.bbrc.2018.04.201; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen WX, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182062; Chiyonobu N, 2018, AM J PATHOL, V188, P1213, DOI 10.1016/j.ajpath.2018.01.012; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; CRONE LJ, 1995, TECHNOMETRICS, V37, P324, DOI 10.2307/1269916; Zeiler MD, 2013, Arxiv, DOI [arXiv:1311.2901, DOI 10.48550/ARXIV.1311.2901]; Danon L, 2005, Arxiv, DOI [arXiv:cond-mat/0505245, 10.48550/ARXIV.COND-MAT/0505245, DOI 10.48550/ARXIV.COND-MAT/0505245]; Ding K, 2014, MED HYPOTHESES, V83, P359, DOI 10.1016/j.mehy.2014.06.013; Dong Huang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2761, DOI 10.1109/CVPR.2011.5995685; Fang YF, 2014, CANCER BIOL THER, V15, P1268, DOI 10.4161/cbt.29691; Friedman JH, 2009, The Elements of Statistical Learning - Data Mining, Inference and Prediction, V2, P1, DOI DOI 10.1007/B94608; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Girolami M, 2002, IEEE T NEURAL NETWOR, V13, P780, DOI 10.1109/TNN.2002.1000150; He X., 2005, P ADV NEUR INF PROC, V18, P507, DOI DOI 10.5555/2976248.2976312; Heo J, 2022, EXP MOL MED, V54, P801, DOI 10.1038/s12276-022-00786-0; Imaoka H, 2015, CARCINOGENESIS, V36, P346, DOI 10.1093/carcin/bgu327; Jiang LX, 2015, CARCINOGENESIS, V36, P1111, DOI 10.1093/carcin/bgv116; Jin Cheng-Yu, 2020, Aging (Albany NY), V13, P3518, DOI 10.18632/aging.202292; Johnson JE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235885; Knirsch P, 1998, Annual Symposium of the German Association for Pattern Recognition (DAGM), P125; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Krzystanek M, 2016, BIOMARK RES, V4, DOI 10.1186/s40364-016-0058-3; Kwok JTY, 2004, IEEE T NEURAL NETWOR, V15, P1517, DOI 10.1109/TNN.2004.837781; Lee SB, 2010, J INVEST DERMATOL, V130, P763, DOI 10.1038/jid.2009.335; Li JX, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01817-8; Li JD, 2018, ACM COMPUT SURV, V50, DOI 10.1145/3136625; Li MY, 2020, J INT MED RES, V48, DOI 10.1177/0300060519897508; Li Z, 2012, P AAAI C ARTIFICIAL, V26, P1026; Liu XY, 2022, CANCERS, V14, DOI 10.3390/cancers14112658; Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3; Mariette J, 2018, BIOINFORMATICS, V34, P1009, DOI 10.1093/bioinformatics/btx682; Masaeli M, 2010, SDM; Mi SJ, 2016, CLIN CANCER RES, V22, P4676, DOI 10.1158/1078-0432.CCR-15-2116; Mika S., 1998, NIPS; Morse MA, 2019, CLIN CANCER RES, V25, P912, DOI 10.1158/1078-0432.CCR-18-1254; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Nielsen IE, 2022, IEEE SIGNAL PROC MAG, V39, P73, DOI 10.1109/MSP.2022.3142719; Ohmura S, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01393-9; Osako Y, 2019, INT J ONCOL, V54, P1759, DOI 10.3892/ijo.2019.4736; Pliarchopoulou K, 2013, CANCER CHEMOTH PHARM, V71, P245, DOI 10.1007/s00280-012-2002-z; Rahman MA, 2012, J CONTROL RELEASE, V159, P384, DOI 10.1016/j.jconrel.2012.01.045; Rasmussen PM, 2011, NEUROIMAGE, V55, P1120, DOI 10.1016/j.neuroimage.2010.12.035; Reverter F, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-S6; Roth V, 2000, ADV NEUR IN, V12, P568; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruder S, 2017, Arxiv, DOI arXiv:1609.04747; Saigusa S, 2015, GASTRIC CANCER, V18, P84, DOI 10.1007/s10120-014-0355-1; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Sanz H, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2451-4; Schölkopf B, 1999, IEEE T NEURAL NETWOR, V10, P1000, DOI 10.1109/72.788641; Scholkopf B., 1997, Artificial Neural Networks - ICANN '97. 7th International Conference Proceedings, P583, DOI 10.1007/BFb0020217; Scholkopf B, 2003, KERNEL METHODS COMPU; Scholkopf B, 2002, Learning with Kernels: Support Vector Machines, Regularization, Optimization, and Beyond, DOI [DOI 10.7551/MITPRESS/4175.001.0001, 10.7551/ mitpress/4175.001.0001]; Simonyan K, 2014, Arxiv, DOI [arXiv:1312.6034, DOI 10.48550/ARXIV.1312.6034]; Smilkov D, 2017, Arxiv, DOI [arXiv:1706.03825, DOI 10.48550/ARXIV.1706.03825]; Sofi S, 2022, MED ONCOL, V39, DOI 10.1007/s12032-022-01748-2; Sundararajan M, 2017, Arxiv, DOI [arXiv:1703.01365, DOI 10.48550/ARXIV.1703.01365]; Springenberg JT, 2015, Arxiv, DOI [arXiv:1412.6806, 10.48550/arXiv.1412.6806, DOI 10.48550/ARXIV.1412.6806]; Uurtio V, 2019, PR MACH LEARN RES, V97; Wang N, 2014, BRIT J CANCER, V110, P1034, DOI 10.1038/bjc.2013.817; Wang WY, 2013, GASTROENTEROLOGY, V145, P1110, DOI 10.1053/j.gastro.2013.07.040; West AN, 2007, CANCER RES, V67, P600, DOI 10.1158/0008-5472.CAN-06-3767; Xu ZL, 2019, ONCOL LETT, V17, P1865, DOI 10.3892/ol.2018.9762; Yang XMJ, 2005, CANCER RES, V65, P5628, DOI 10.1158/0008-5472.CAN-05-0533; Yang Y, 2011, INT JOINT C ARTIFICI; Zhang JZ, 2003, GENETICS, V165, P2063; Zhao Z., 2007, P 24 INT C MACHINE L, V227, P1151, DOI 10.1145/1273496.1273641; Zhuang LP, 2018, BIOMED RES INT-UK, V2018, DOI 10.1155/2018/7897346	78	0	0	4	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	JUL 12	2023	24	1							282	10.1186/s12859-023-05404-y	http://dx.doi.org/10.1186/s12859-023-05404-y			21	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	M3LZ2	37438763	Green Published, gold			2024-09-18	WOS:001029240200001
C	Zhang, K; Zhe, SD; Cheng, CR; Wei, Z; Chen, ZZ; Chen, HF; Jiang, GF; Qi, Y; Ye, JP			Assoc Comp Machinery	Zhang, Kai; Zhe, Shandian; Cheng, Chaoran; Wei, Zhi; Chen, Zhengzhang; Chen, Haifeng; Jiang, Guofei; Qi, Yuan; Ye, Jieping			Annealed Sparsity via Adaptive and Dynamic Shrinking	KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING			English	Proceedings Paper	22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD)	AUG 13-17, 2016	San Francisco, CA	Assoc Comp Machinery, Assoc Comp Machinery SIGMOD, Assoc Comp Machinery SIGKDD		Sparse regression; adaptive LASSO; multi-task LASSO; regularization path; sparse multi-task learning	VARIABLE SELECTION; MODEL SELECTION; REGRESSION; LASSO	Sparse learning has received tremendous amount of interest in high-dimensional data analysis due to its model interpretability and the low-computational cost. Among the various techniques, adaptive l(1)-regularization is an effective framework to improve the convergence behaviour of the LASSO, by using varying strength of regularization across different features. In the meantime, the adaptive structure makes it very powerful in modelling grouped sparsity patterns as well, being particularly useful in high-dimensional multi-task problems. However, choosing an appropriate, global regularization weight is still an open problem. In this paper, inspired by the annealing technique in material science, we propose to achieve "annealed sparsity" by designing a dynamic shrinking scheme that simultaneously optimizes the regularization weights and model coefficients in sparse (multi-task) learning. The dynamic structures of our algorithm are twofold. Feature-wise ("spatially"), the regularization weights are updated interactively with model coefficients, allowing us to improve the global regularization structure. Iteration-wise ("temporally"), such interaction is coupled with gradually boosted l(1)-regularization by adjusting an equality norm-constraint, achieving an "annealing" effect to further improve model selection. This renders interesting shrinking behaviour in the whole solution path. Our method competes favorably with state-of-the-art methods in sparse (multi-task) learning. We also apply it in expression quantitative trait loci analysis (eQTL), which gives useful biological insights in human cancer (melanoma) study.	[Zhang, Kai; Chen, Zhengzhang; Chen, Haifeng; Jiang, Guofei] NEC Labs Amer, Princeton, NJ 08540 USA; [Zhe, Shandian; Qi, Yuan] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Cheng, Chaoran; Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Ye, Jieping] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	NEC Corporation; Purdue University System; Purdue University; New Jersey Institute of Technology; University of Michigan System; University of Michigan	Zhang, K (corresponding author), NEC Labs Amer, Princeton, NJ 08540 USA.	kzhang@nec-labs.com; szhe@purdue.edu; cc424@njit.edu; zhi.wei@njit.edu; zchen@nec-labs.com; haifeng@nec-labs.com; gfj@nec-labs.com; alanqi@purdue.edu; jpye@umich.edu	Chen, Zhengzhang/HRD-9813-2023; chen, haifeng/GSM-9693-2022; Wei, Zhi/H-4415-2012; cheng, chao/JBJ-8804-2023	Wei, Zhi/0000-0001-6059-4267; Chen, Zhengzhang/0000-0002-6803-0535				Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; [Anonymous], 2009, SLEP: Sparse Learning with Efficient Projections; [Anonymous], 2009, P ADV NEURAL INFORM; [Anonymous], 2006, J R STAT SOC B; Argyriou A, 2008, MACH LEARN, V73, P243, DOI 10.1007/s10994-007-5040-8; Ben-David S, 2003, LECT NOTES ARTIF INT, V2777, P567, DOI 10.1007/978-3-540-45167-9_41; Candès EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Chen S., 2013, SIAM REV, V43, P129; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Fan JQ, 2009, ANN APPL STAT, V3, P521, DOI 10.1214/08-AOAS215; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Figueiredo MAT, 2007, IEEE J-STSP, V1, P586, DOI 10.1109/JSTSP.2007.910281; Huang J, 2008, STAT SINICA, V18, P1603; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kowalski M, 2009, APPL COMPUT HARMON A, V27, P303, DOI 10.1016/j.acha.2009.05.006; Lee S., 2010, Advances in neural information processing systems, P1306; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Obozinski G.R., 2008, Advances in Neural Information Processing Systems, P1217; Puniyani K, 2010, BIOINFORMATICS, V26, pi208, DOI 10.1093/bioinformatics/btq191; Raman Sudhir, 2012, Pattern Recognition. Proceedings Joint 34th DAGM and 36th OAGM Symposium, P317, DOI 10.1007/978-3-642-32717-9_32; Sefton B. M., 2001, CURRENT PROTOCOLS PR, P13; Shevade SK, 2003, BIOINFORMATICS, V19, P2246, DOI 10.1093/bioinformatics/btg308; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swirszcz Grzegorz, 2012, P INT C MACH LEARN; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tropp JA, 2006, SIGNAL PROCESS, V86, P572, DOI 10.1016/j.sigpro.2005.05.030; Van Vlack L.H., 1985, ELEMENTS MAT SCI ENG; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wright JL, 2009, IEEE INT C EMERG; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036733; Zhang K, 2010, BIOINFORMATICS, V26, pi97, DOI 10.1093/bioinformatics/btq181; Zhao P, 2006, J MACH LEARN RES, V7, P2541; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H., 2013, J AM STAT ASSOC, V101, P1418	39	5	6	0	2	ASSOC COMPUTING MACHINERY	NEW YORK	1515 BROADWAY, NEW YORK, NY 10036-9998 USA			978-1-4503-4232-2				2016							1325	1334		10.1145/2939672.2939769	http://dx.doi.org/10.1145/2939672.2939769			10	Computer Science, Artificial Intelligence; Computer Science, Information Systems; Computer Science, Theory & Methods	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science	BN6JM					2024-09-18	WOS:000485529800146
J	Cao, YF; Kunaprayoon, D; Ren, L				Cao, Yufeng; Kunaprayoon, Dan; Ren, Lei			Interpretable AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases	RADIOTHERAPY AND ONCOLOGY			English	Article						Clinical decision-making; Metastases; Interpretable; Deep learning		Purpose: AI modeling physicians' clinical decision-making (CDM) can improve the efficiency and accuracy of clinical practice or serve as a surrogate to provide initial consultations to patients seeking secondary opinions. In this study, we developed an interpretable AI model that predicts dose fractionation for patients receiving radiation therapy for brain metastases with an interpretation of its decision-making process.Materials/Methods: 152 patients with brain metastases treated by radiosurgery from 2017 to 2021 were obtained. CT images and target and organ-at-risk (OAR) contours were extracted. Eight non-image clinical parameters were also extracted and digitized, including age, the number of brain metastasis, ECOG performance status, presence of symptoms, sequencing with surgery (pre-or post-operative radiation therapy), de novo vs. re-treatment, primary cancer type, and metastasis to other sites. 3D convolutional neural networks (CNN) architectures with encoding paths were built based on the CT data and clinical parameters to capture three inputs: (1) Tumor size, shape, and location; (2) The spatial relationship between tumors and OARs; (3) The clinical parameters. The models fuse the features extracted from these three inputs at the decision-making level to learn the input independently to predict dose prescription. Models with different independent paths were developed, including models combining two independent paths (IM-2), three independent paths (IM-3), and ten independent paths (IM-10) at the decision-making level. A class activation score and relative weighting were calculated for each input path during the model prediction to represent the role of each input in the decision-making process, providing an interpretation of the model prediction. The actual prescription in the record was used as ground truth for model training. The model performance was assessed by 19-fold cross-validation, with each fold consisting of randomly selected 128 training, 16 validation, and 8 testing subjects.Result: The dose prescriptions of 152 patient cases included 48 cases with 1 x 24 Gy, 48 cases with 1 x 20-22 Gy, 32 cases with 3 x 9 Gy, and 24 cases with 5 x 6 Gy prescribed by 8 physicians. IM-2 achieved slightly superior performance than IM-3 and IM-10, with 131 (86%) patients classified correctly and 21 (14%) patients misclassified. IM-10 provided the most interpretability with a relative weighting for each input: target (34%), the relationship between target and OAR (35%), ECOG (6%), re-treatment (6%), metastasis to other sites (6%), number of brain metastases (3%), symptomatic (3%), pre/postsurgery (3%), primary cancer type (2%), age (2%), reflecting the importance of the inputs in decision making. The importance ranking of inputs interpreted from the model also matched closely with a physician's own ranking in the decision process.Conclusion: Interpretable CNN models were successfully developed to use CT images and non-image clinical parameters to predict dose prescriptions for brain metastases patients treated by radiosurgery. Models showed high prediction accuracy while providing an interpretation of the decision process, which was validated by the physician. Such interpretability makes the model more transparent, which is crucial for the future clinical adoption of the models in routine practice for CDM assistance.& COPY; 2023 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 187 (2023) 109842	[Cao, Yufeng; Kunaprayoon, Dan; Ren, Lei] Univ Maryland, Dept Radiat Oncol, Baltimore, MD USA; [Ren, Lei] Univ Maryland, Dept Radiat Oncol, Med Phys Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ren, L (corresponding author), Univ Maryland, Dept Radiat Oncol, Med Phys Res, Baltimore, MD 21201 USA.	lren@som.umaryland.edu			NIH [R01EB028324, R01EB032680]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to sincerely thank Dr. Cedric (Xinsheng) Yu for his valuable comments and suggestions on the manuscript. This work is supported by NIH R01EB028324 and R01EB032680.	Cao Y, 2022, Clin Transl Radiat Oncol; Cao YF, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abca53; Chen CF, 2019, ADV NEUR IN, V32; de Hond AAH, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-021-00549-7; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Frid-Adar M, 2018, NEUROCOMPUTING, V321, P321, DOI 10.1016/j.neucom.2018.09.013; Glorot X, 2010, P 13 INT C ART INT S, V9, P249, DOI DOI 10.1109/LGRS.2016.2565705; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Jiang Z, 2021, IEEE Trans Radiat Plasma. Med Sci; Jiang ZR, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abcde8; Jiang ZR, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/ab5da0; Jiang ZR, 2019, IEEE T MED IMAGING, V38, P2705, DOI 10.1109/TMI.2019.2912791; Kingma DP, 2014, ADV NEUR IN, V27; LeBlanc TW, 2017, PSYCHO-ONCOLOGY, V26, P2063, DOI 10.1002/pon.4309; Mohammadi R, 2021, RADIOTHER ONCOL, V159, P231, DOI 10.1016/j.radonc.2021.03.030; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Samek W, 2017, Arxiv, DOI arXiv:1708.08296; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Strickland E, 2019, IEEE SPECTRUM, V56, P24, DOI 10.1109/MSPEC.2019.8678513; Vassantachart A, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-07859-0; Zhang ZY, 2022, PHYS MED BIOL, V67, DOI 10.1088/1361-6560/ac5f6e; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319	23	1	2	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-8140	1879-0887		RADIOTHER ONCOL	Radiother. Oncol.	OCT	2023	187								109842	10.1016/j.radonc.2023.109842	http://dx.doi.org/10.1016/j.radonc.2023.109842		AUG 2023	11	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Radiology, Nuclear Medicine & Medical Imaging	R8JU3	37543055				2024-09-18	WOS:001066772300001
J	Aldughayfiq, B; Ashfaq, F; Jhanjhi, NZ; Humayun, M				Aldughayfiq, Bader; Ashfaq, Farzeen; Jhanjhi, N. Z.; Humayun, Mamoona			Explainable AI for Retinoblastoma Diagnosis: Interpreting Deep Learning Models with LIME and SHAP	DIAGNOSTICS			English	Article						retinoblastoma; explainable AI; deep learning; LIME; SHAP; medical image analysis; InceptionV3; transfer learning	CLASSIFICATION	Retinoblastoma is a rare and aggressive form of childhood eye cancer that requires prompt diagnosis and treatment to prevent vision loss and even death. Deep learning models have shown promising results in detecting retinoblastoma from fundus images, but their decision-making process is often considered a "black box" that lacks transparency and interpretability. In this project, we explore the use of LIME and SHAP, two popular explainable AI techniques, to generate local and global explanations for a deep learning model based on InceptionV3 architecture trained on retinoblastoma and non-retinoblastoma fundus images. We collected and labeled a dataset of 400 retinoblastoma and 400 non-retinoblastoma images, split it into training, validation, and test sets, and trained the model using transfer learning from the pre-trained InceptionV3 model. We then applied LIME and SHAP to generate explanations for the model's predictions on the validation and test sets. Our results demonstrate that LIME and SHAP can effectively identify the regions and features in the input images that contribute the most to the model's predictions, providing valuable insights into the decision-making process of the deep learning model. In addition, the use of InceptionV3 architecture with spatial attention mechanism achieved high accuracy of 97% on the test set, indicating the potential of combining deep learning and explainable AI for improving retinoblastoma diagnosis and treatment.	[Aldughayfiq, Bader; Humayun, Mamoona] Jouf Univ, Coll Comp & Informat Sci, Dept Informat Syst, Sakaka 72388, Saudi Arabia; [Ashfaq, Farzeen; Jhanjhi, N. Z.] Taylors Univ, Sch Comp Sci, Subang Jaya 47500, Malaysia	Al Jouf University; Taylor's University	Humayun, M (corresponding author), Jouf Univ, Coll Comp & Informat Sci, Dept Informat Syst, Sakaka 72388, Saudi Arabia.	bmaldughayfiq@ju.edu.sa; farzeen.ashfaq@sd.taylors.edu.my; noorzaman.jhanjhi@taylors.edu.my; mahumayun@ju.edu.sa	Aldughayfiq, Bader/ABB-3017-2021; Jhanjhi, NZ/F-3051-2011; humayun, Mamoona/J-5644-2019	Jhanjhi, NZ/0000-0001-8116-4733; Ashfaq, Farzeen/0000-0001-5119-603X; Aldughayfiq, Bader/0000-0001-9584-0560; humayun, Mamoona/0000-0001-6339-2257	Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia [223202]	Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia	The authors extend their appreciation to the Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia for funding this research work through project number 223202.	Abramson DH, 2003, PEDIATRICS, V112, P1248, DOI 10.1542/peds.112.6.1248; Adebayo J, 2018, Arxiv, DOI [arXiv:1810.03307, 10.48550/arXiv.1810.03307]; Akter N, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-12147-y; Alwakid G, 2023, HEALTHCARE-BASEL, V11, DOI 10.3390/healthcare11060863; Durai CAD, 2021, Arxiv, DOI [arXiv:2103.07622, DOI 10.48550/ARXIV.2103.07622, 10.48550/arXiv.2103.07622]; Ashfaq F, 2023, SYSTEMS-BASEL, V11, DOI 10.3390/systems11040196; Association A, RETINOBLASTOMA; Atwany MZ, 2022, IEEE ACCESS, V10, P28642, DOI 10.1109/ACCESS.2022.3157632; Badar M, 2020, COMPUT SCI REV, V35, DOI 10.1016/j.cosrev.2019.100203; Barros DMS, 2020, BIOMED ENG ONLINE, V19, DOI 10.1186/s12938-020-00767-2; Bauskar R.L.P., 2020, DETECTION RETINOBLAS; Berry JL., 2019, Clinical Ophthalmic Oncology; Chalakkal RJ, 2019, COMPUT BIOL MED, V108, P317, DOI 10.1016/j.compbiomed.2019.03.019; Chattopadhay A, 2018, IEEE WINT CONF APPL, P839, DOI 10.1109/WACV.2018.00097; Cho SJ, 2021, NEURORADIOLOGY, V63, P499, DOI 10.1007/s00234-020-02538-1; Das D, 2022, MULTIMED TOOLS APPL, V81, P25613, DOI 10.1007/s11042-022-12642-4; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gallie BL, 2007, PEDIATR BLOOD CANCER, V49, P1083, DOI 10.1002/pbc.21350; Ghose N, 2022, SEMIN OPHTHALMOL, V37, P813, DOI 10.1080/08820538.2022.2078165; Gombos DS, 2012, SEMIN FETAL NEONAT M, V17, P239, DOI 10.1016/j.siny.2012.04.003; Goswami M, 2021, COMPUT MED IMAG GRAP, V93, DOI 10.1016/j.compmedimag.2021.101986; Gündüz AK, 2023, EUR J OPHTHALMOL, V33, P2290, DOI 10.1177/11206721231163619; Henning R, 2014, IEEE SW SYMP IMAG, P9, DOI 10.1109/SSIAI.2014.6806016; Honavar SG, 2021, INDIAN J OPHTHALMOL, V69, P1979, DOI 10.4103/ijo.IJO_1917_21; Hull S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011221.pub2; Humayun M, 2022, J HEALTHC ENG, V2022, DOI 10.1155/2022/7028717; Humayun M, 2022, ELECTRONICS-SWITZ, V11, DOI 10.3390/electronics11172748; Humayun M, 2022, COMPUT SYST SCI ENG, V40, P947, DOI 10.32604/csse.2022.019288; Jeba J., 2023, MATLAB CENTRAL FILE; Jebaseeli T., 2023, Computational Methods and Deep Learning for Ophthalmology, P107, DOI [10.1016/B978-0-323-95415-0.00005-X, DOI 10.1016/B978-0-323-95415-0.00005-X]; Jin K, 2022, ACTA OPHTHALMOL, V100, pE512, DOI 10.1111/aos.14928; Jones M., 2020, MALAYS J OPHTHALMOL, V2, P80, DOI [10.35119/myjo.v2i2.151, DOI 10.35119/MYJO.V2I2.151]; Kadry S, 2022, J SUPERCOMPUT, V78, P7321, DOI 10.1007/s11227-021-04181-w; Kaliki S, 2023, INDIAN J OPHTHALMOL, V71, P424, DOI 10.4103/ijo.IJO_1393_22; Khetan V., 2013, FUTURE MED, DOI [10.2217/ebo.12.499, DOI 10.2217/EBO.12.499]; Kumar P, 2023, BIOMED RES INT, V2023, DOI 10.1155/2023/5803661; Lamard M., 2006, P 19 IEEE INT S COMP, P497, DOI [10.1109/CBMS.2006.59, DOI 10.1109/CBMS.2006.59]; Langlotz CP, 2019, RADIOLOGY, V291, P781, DOI 10.1148/radiol.2019190613; Li T, 2021, MED IMAGE ANAL, V69, DOI 10.1016/j.media.2021.101971; Li ZX, 2018, DIABETES CARE, V41, P2509, DOI 10.2337/dc18-0147; Lin FY, 2021, CLIN PERINATOL, V48, P53, DOI 10.1016/j.clp.2020.12.001; Lundberg SM, 2017, ADV NEUR IN, V30; Mandal M, 2022, COLLOID SURFACE B, V220, DOI 10.1016/j.colsurfb.2022.112899; Manjandavida FP, 2019, INDIAN J OPHTHALMOL, V67, P958, DOI 10.4103/ijo.IJO_340_19; Montavon G, 2017, PATTERN RECOGN, V65, P211, DOI 10.1016/j.patcog.2016.11.008; Moothedath A.W., 2023, Global perspectives in ocular oncology, P133; Nawaz M, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22020434; Pogosova N, 2022, LANCET GLOB HEALTH, V10, pE1076, DOI 10.1016/S2214-109X(22)00270-4; Rahdar A., 2023, RES SQ PREPR, DOI [10.21203/rs.3.rs-2648324/v1, DOI 10.21203/RS.3.RS-2648324/V1]; Ramírez-Ortiz MA, 2017, B MED HOSP INFANT M, V74, P41; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Sahlsten J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47181-w; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shrikumar A, 2017, PR MACH LEARN RES, V70; Strijbis VIJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93905-2; Rao BS, 2020, IET IMAGE PROCESS, V14, P2241, DOI 10.1049/iet-ipr.2018.6656; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang R., 2022, MEDRXIV, DOI [10.1101/2022.08.23.22279103, DOI 10.1101/2022.08.23.22279103]	60	18	18	19	49	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	JUN 1	2023	13	11							1932	10.3390/diagnostics13111932	http://dx.doi.org/10.3390/diagnostics13111932			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	I6RJ4	37296784	gold, Green Published			2024-09-18	WOS:001004033100001
J	Girot, C; Volk, A; Walczak, C; Lassau, N; Pitre-Champagnat, S				Girot, Charly; Volk, Andreas; Walczak, Christine; Lassau, Nathalie; Pitre-Champagnat, Stephanie			New method for quantification of intratumoral heterogeneity: a feasibility study on K<SUP>trans</SUP> maps from preclinical DCE-MRI	MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE			English	Article						Tumor biomarker; Cluster analysis; Magnetic resonance imaging; Angiogenesis; Treatment outcome	CONTRAST-ENHANCED ULTRASOUND; PARAMETRIC MAPS; CANCER HETEROGENEITY; TUMOR RESPONSE; THERAPY; PREDICTION; RADIOMICS; BIOMARKER; FEATURES; OUTCOMES	Object To develop new imaging biomarkers of therapeutic efficacy through the quantification of intratumoral microvascular heterogeneity. Materials and methods The described method was a combination of non-supervised clustering and extraction of intratumoral complexity features (ICF): number of non-connected objects, volume fraction. It was applied to a set of 3D DCE-MRI K-trans maps acquired previously on tumor bearing mice prior to and on day 4 of anti-angiogenic treatment. Evolutions of ICF were compared to conventional summary statistics (CSS) and to heterogeneity related whole tumor texture features (TF) on treated (n = 9) and control (n = 6) mice. Results Computed optimal number of clusters per tumor was 4. Several intratumoral features extracted from the clusters were able to monitor a therapy effect. Whereas no feature significantly changed for the control group, 6 features significantly changed for the treated group (4 ICF, 2 CSS). Among these, 5 also significantly differentiated the two groups (3 ICF, 2 CSS). TF failed in demonstrating differences within and between the two groups. Discussion ICF are potential imaging biomarkers for anti-angiogenic therapy assessment. The presented method may be expected to have advantages with respect to texture analysis-based methods regarding interpretability of results and setup of standardized image analysis protocols.	[Girot, Charly; Volk, Andreas; Lassau, Nathalie; Pitre-Champagnat, Stephanie] Univ Paris Saclay, CEA, CNRS, Inserm,BioMaps,Gustave Roussy, 114 Rue Edouard Vaillant, F-94805 Villejuif, France; [Lassau, Nathalie] Gustave Roussy, Dept Radiol, F-94805 Villejuif, France; [Walczak, Christine] Univ Paris Saclay, Inst Curie, INSERM, CNRS, F-91405 Orsay, France	CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Universite PSL; Institut Curie; Universite Paris Saclay; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Girot, C (corresponding author), Univ Paris Saclay, CEA, CNRS, Inserm,BioMaps,Gustave Roussy, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	Charly.girot@universite-paris-saclay.fr	Girot, Charly/AAW-4937-2021; Pitre-Champagnat, Stephanie/HLQ-5511-2023; Volk, Andreas/A-8474-2019	Pitre-Champagnat, Stephanie/0000-0003-0082-6534; Girot, Charly/0000-0002-4464-1999; Volk, Andreas/0000-0003-0915-5458				Alic L, 2011, PHYS MED BIOL, V56, P1601, DOI 10.1088/0031-9155/56/6/006; Andersen EKF, 2011, ACTA ONCOL, V50, P859, DOI 10.3109/0284186X.2011.578586; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Melo FDE, 2013, EMBO REP, V14, P686, DOI 10.1038/embor.2013.92; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Hayes C, 2002, NMR BIOMED, V15, P154, DOI 10.1002/nbm.756; JACKSON JI, 1991, IEEE T MED IMAGING, V10, P473, DOI 10.1109/42.97598; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lassau N, 2014, INVEST RADIOL, V49, P794, DOI 10.1097/RLI.0000000000000085; LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921; Liu J, 2016, J MAGN RESON IMAGING, V44, P445, DOI 10.1002/jmri.25156; Longo DL, 2015, MAGN RESON IMAGING, V33, P725, DOI 10.1016/j.mri.2015.03.005; Luo YJ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3150-7; MacQueen J, 1967, P 5 BERK S MATH STAT, P281; Marusyk Andriy, 2010, Biochim Biophys Acta, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; O'Connor JPB, 2017, SEMIN CELL DEV BIOL, V64, P48, DOI 10.1016/j.semcdb.2016.10.001; O'Connor JPB, 2017, NAT REV CLIN ONCOL, V14, P169, DOI 10.1038/nrclinonc.2016.162; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; Panzeri MM, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/8329041; Pitre-Champagnat S, 2015, INVEST RADIOL, V50, P212, DOI 10.1097/RLI.0000000000000101; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P321, DOI 10.1007/0-387-25465-X_15; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Smith AD, 2010, AM J ROENTGENOL, V194, P157, DOI 10.2214/AJR.09.2941; Tayara ETE., 2011, P INT SOC MAG RESON, V19, P1056; Thibault G, 2017, TOMOGRAPHY, V3, P23, DOI 10.18383/j.tom.2016.00241; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Traverso A, 2018, INT J RADIAT ONCOL, V102, P1143, DOI 10.1016/j.ijrobp.2018.05.053; Vautier J, 2013, MAGN RESON MED, V70, P823, DOI 10.1002/mrm.24504	31	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1352-8661			MAGN RESON MATER PHY	Magn. Reson. Mat. Phys. Biol. Med.	DEC	2021	34	6					845	857		10.1007/s10334-021-00930-3	http://dx.doi.org/10.1007/s10334-021-00930-3		JUN 2021	13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	WU3NZ	34091826				2024-09-18	WOS:000658287500001
J	Prabhu, S; Prasad, K; Hoang, T; Lu, XQ; Sandhya, 				Prabhu, Swathi; Prasad, Keerthana; Hoang, Thuong; Lu, Xuequan; Sandhya, I			Multi-organ squamous cell carcinoma classification using feature interpretation technique for explainability	BIOCYBERNETICS AND BIOMEDICAL ENGINEERING			English	Article						Squamous cell carcinoma; Artificial intelligence; Explainable machine learning; Histopathological images; Deep learning	HISTOPATHOLOGICAL IMAGES; HISTOLOGICAL IMAGES; DIAGNOSIS; TISSUE; IDENTIFICATION	Squamous cell carcinoma is the most common type of cancer that occurs in many organs of the human body. To detect carcinoma, pathologists observe tissue samples at multiple magnifications, which is time-consuming and prone to inter- or intra-observer variability. The key challenge for automation of squamous cell carcinoma diagnosis is to extract the features at low (100x) magnification and explain the decision -making process to healthcare professionals. The existing literature used either machine learning or deep learning models to detect squamous cell carcinoma of specific organs. In this work, we report on the implementation of an explainable diagnostic aid system for squamous cell carcinoma of any organ and present a comparative analysis with state-of-the-art models. A classifier with an ensemble feature selection technique is developed to provide an automatic diagnostic aid for distinguishing between squamous cell carcinoma positive and negative cases based on histopathological images. Moreover, explainable AI techniques such as ELI5, LIME and SHAP are introduced to machine learning model which provides feature interpretability of prediction made by the classifier. The results show that the machine learning model achieved an accuracy of 93.43% and 96.66% on public and multi -centric private datasets, respectively. The proposed CatBoost classifier achieved remarkable performance in diagnosing multi -organ squamous cell carcinoma from low magnification histopathological images, even when various illumination variations were introduced.	[Prabhu, Swathi; Prasad, Keerthana] Manipal Acad Higher Educ, Manipal Sch Informat Sci, Manipal 576104, Karnataka, India; [Hoang, Thuong] Deakin Univ, Fac Sci Engn & Built Environm, Sch Informat Technol, Geelong, Vic 3220, Australia; [Lu, Xuequan] La Trobe Univ, Dept Comp Sci & IT, Melbourne, Vic 3086, Australia; [Sandhya, I] AJ Inst Med Sci & Res Ctr, Dept Pathol, Mangalore 575004, Karnataka, India	Manipal Academy of Higher Education (MAHE); Deakin University; La Trobe University	Prasad, K (corresponding author), Manipal Acad Higher Educ, Manipal Sch Informat Sci, Manipal 576104, Karnataka, India.	keerthana.prasad@manipal.edu	Hoang, Thuong/IQV-0997-2023	Hoang, Thuong/0000-0001-7354-260X	Ma-nipal Academy of Higher Education	Ma-nipal Academy of Higher Education	We gratefully acknowledge the financial support provided by Ma-nipal Academy of Higher Education for funding the publication of this open-access article. This support has enabled us to share our research findings with a wider audience, contributing to advancing knowledge and disseminating scientific research.	Afify HM, 2023, BIOMED SIGNAL PROCES, V83, DOI 10.1016/j.bspc.2023.104704; Akiba T, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2623, DOI 10.1145/3292500.3330701; Amin I, 2021, medRxiv; [Anonymous], 2023, Overview-ELI5 0.11.0 documentation; [Anonymous], 2022, Squamous cell carcinoma | pathology residency and fellowship program; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chen C, 2021, MOBILE DNA-UK, V12, DOI 10.1186/s13100-021-00246-y; Chicco D, 2021, BIODATA MIN, V14, DOI 10.1186/s13040-021-00244-z; Civit-Masot J, 2022, COMPUT METH PROG BIO, V226, DOI 10.1016/j.cmpb.2022.107108; Das DK, 2019, APPL SOFT COMPUT, V83, DOI 10.1016/j.asoc.2019.105642; Das DK, 2018, TISSUE CELL, V53, P111, DOI 10.1016/j.tice.2018.06.004; Das DK, 2017, MULTIDIM SYST SIGN P, V28, P1031, DOI 10.1007/s11045-017-0488-6; Das Madhusmita, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20032131; Das N, 2020, NEURAL NETWORKS, V128, P47, DOI 10.1016/j.neunet.2020.05.003; Halicek M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50313-x; Hamilton NA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-110; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He L, 2012, COMPUT METH PROG BIO, V107, P538, DOI 10.1016/j.cmpb.2011.12.007; Hegde RB, 2019, BIOCYBERN BIOMED ENG, V39, P382, DOI 10.1016/j.bbe.2019.01.005; Hiremath P. S., 2006, ADCOM 2006: Autonomic Computing Fourteenth International Conference on Advanced Computing and Communications, P211; Hosseini ZS, 2019, BIOMED SIGNAL PROCES, V48, P273, DOI 10.1016/j.bspc.2018.09.001; Kanavati F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87644-7; Krishnan MMR, 2012, MICRON, V43, P352, DOI 10.1016/j.micron.2011.09.016; Krishnan MMR, 2011, TISSUE CELL, V43, P318, DOI 10.1016/j.tice.2011.06.005; Li M, 2021, IEEE ACCESS, V9, P53687, DOI 10.1109/ACCESS.2021.3071057; Lundberg SM, 2017, ADV NEUR IN, V30; Masud M, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21030748; Mathialagan P, 2021, Int J Intell Eng Syst, V14, P517; Mete M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S17; Musulin J, 2021, CANCERS, V13, DOI 10.3390/cancers13081784; Nawandhar A, 2020, BIOMED SIGNAL PROCES, V55, DOI 10.1016/j.bspc.2019.101671; Nishio M, 2021, CANCERS, V13, DOI 10.3390/cancers13061192; Noroozi N, 2016, J VIS COMMUN IMAGE R, V40, P128, DOI 10.1016/j.jvcir.2016.06.014; Noroozi N, 2016, COMPUT BIOL MED, V70, P23, DOI 10.1016/j.compbiomed.2015.12.024; Oya K, 2023, J DENT SCI, V18, P322, DOI 10.1016/j.jds.2022.08.017; Panigrahi S, 2022, MATH BIOSCI ENG, V19, P1909, DOI 10.3934/mbe.2022090; Panigrahi S, 2022, J KING SAUD UNIV-COM, V34, P4546, DOI 10.1016/j.jksuci.2020.11.003; Park HJ, 2017, TUBERC RESPIR DIS, V80, P179, DOI 10.4046/trd.2017.80.2.179; Prabhu S, 2022, COMPUT BIOL MED, V142, DOI 10.1016/j.compbiomed.2022.105209; Rahman AU, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22103833; Rahman TY, 2018, J MICROSC-OXFORD, V269, P85, DOI 10.1111/jmi.12611; Rahman TY, 2020, TISSUE CELL, V63, DOI 10.1016/j.tice.2019.101322; Rahman TY, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105114; Ramola A, 2020, ENG REP, V2, DOI 10.1002/eng2.12149; Reinhard E, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.946629; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Shi XS, 2017, MED IMAGE ANAL, V42, P117, DOI 10.1016/j.media.2017.07.009; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; Wang CW, 2013, MACH VISION APPL, V24, P1383, DOI 10.1007/s00138-012-0457-x; WU CM, 1992, IEEE T MED IMAGING, V11, P141, DOI 10.1109/42.141636; Wu M, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181769; Yang H, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01953-2; Zhang SL, 2021, IEEE ACCESS, V9, P48980, DOI 10.1109/ACCESS.2021.3064040; Zhang XF, 2015, MED IMAGE ANAL, V26, P306, DOI 10.1016/j.media.2015.10.005; Zhou ZH, 2002, ARTIF INTELL MED, V24, P25, DOI 10.1016/S0933-3657(01)00094-X	55	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0208-5216			BIOCYBERN BIOMED ENG	Biocybern. Biomed. Eng.	APR-JUN	2024	44	2					312	326		10.1016/j.bbe.2024.03.001	http://dx.doi.org/10.1016/j.bbe.2024.03.001		APR 2024	15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	QV7C6		hybrid			2024-09-18	WOS:001223700400001
J	Yue, ZL; Kshirsagar, MM; Nguyen, T; Suphavilai, C; Neylon, MT; Zhu, LG; Ratliff, T; Chen, JY				Yue, Zongliang; Kshirsagar, Madhura M.; Thanh Nguyen; Suphavilai, Chayaporn; Neylon, Michael T.; Zhu, Liugen; Ratliff, Timothy; Chen, Jake Y.			PAGER: constructing PAGs and new PAG-PAG relationships for network biology	BIOINFORMATICS			English	Article							GENE-SET ENRICHMENT; PATHWAY ANALYSIS; DATABASE; TOOL; EXPRESSION; RESOURCE; VISUALIZATION; ONTOLOGY; CATALOG	In this article, we described a new database framework to perform integrative "gene-set, network, and pathway analysis" (GNPA). In this framework, we integrated heterogeneous data on pathways, annotated list, and gene-sets (PAGs) into a PAG electronic repository (PAGER). PAGs in the PAGER database are organized into P-type, A-type and G-type PAGs with a three-lettercode standard naming convention. The PAGER database currently compiles 44 313 genes from 5 species including human, 38 663 PAGs, 324 830 gene-gene relationships and two types of 3 174 323 PAG-PAG regulatory relationships-co-membership based and regulatory relationship based. To help users assess each PAG's biological relevance, we developed a cohesion measure called Cohesion Coefficient (CoCo), which is capable of disambiguating between biologically significant PAGs and random PAGs with an area-under-curve performance of 0.98. PAGER database was set up to help users to search and retrieve PAGs from its online web interface. PAGER enable advanced users to build PAG-PAG regulatory networks that provide complementary biological insights not found in gene set analysis or individual gene network analysis. We provide a case study using cancer functional genomics data sets to demonstrate how integrative GNPA help improve network biology data coverage and therefore biological interpretability. The PAGER database can be accessible openly at http://discovery.informatics.iupui.edu/PAGER/.	[Yue, Zongliang; Kshirsagar, Madhura M.; Neylon, Michael T.; Zhu, Liugen; Chen, Jake Y.] Indiana Univ Purdue Univ, Indiana Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA; [Thanh Nguyen; Suphavilai, Chayaporn; Chen, Jake Y.] Indiana Univ Purdue Univ, Dept Comp & Informat Sci, Indianapolis, IN 46202 USA; [Ratliff, Timothy] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47906 USA; [Chen, Jake Y.] Wenzhou Med Univ, Inst Biopharmaceut Informat & Technol, WenZhou, Zhe Jiang Prov, Peoples R China	Purdue University System; Purdue University; Purdue University System; Purdue University; Purdue University System; Purdue University; Wenzhou Medical University	Chen, JY (corresponding author), Indiana Univ Purdue Univ, Indiana Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA.		Yue, Zongliang/AHE-3782-2022; Chen, Jake/A-2857-2009	Chen, Jake/0000-0001-8829-7504; Yue, Zongliang/0000-0001-8290-123X; Nguyen, Thanh/0000-0002-8440-1594	National Institute of Health [R21CA173918, DK084454]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors appreciate the partial grant support from the National Institute of Health to Dr Tim Ratliff (R21CA173918 and DK084454) and Dr Jake Chen to complete this work.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Araki H, 2012, FEBS OPEN BIO, V2, P76, DOI 10.1016/j.fob.2012.04.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baxevanis A. D., 2012, CURR PROTOC HUM GENE; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Chen Jake Y, 2006, Comput Syst Bioinformatics Conf, P389; Chen JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S16; Chowbina SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S5; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Elkon R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-110; EllisLab, 2014, COD; Ganter B, 2008, CURR OPIN DRUG DISC, V11, P86; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Hale PJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S16; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S2; Hung Jui-Hung, 2013, Methods Mol Biol, V939, P201, DOI 10.1007/978-1-62703-107-3_13; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim SB, 2007, BIOINFORMATICS, V23, P1697, DOI 10.1093/bioinformatics/btm144; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nam D, 2010, BIOINFORMATICS, V26, pi511, DOI 10.1093/bioinformatics/btq380; Nishimura Darryl, 2001, Biotech Software Internet Rep, V2, P117, DOI [DOI 10.1089/152791601750294344, 10.1089/152791601750294344]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Parikh JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045211; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sivachenko AY, 2007, EXPERT OPIN THER TAR, V11, P411, DOI 10.1517/14728222.11.3.411; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thorn CF, 2010, PHARMACOGENOMICS, V11, P501, DOI [10.2217/pgs.10.15, 10.2217/PGS.10.15]; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Wu X., 2012, J THEOR BIOL, V362, P44; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JF, 2012, HUM MUTAT, V33, pE2341, DOI 10.1002/humu.22096; Zhang F, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S6	51	20	23	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	JUN 15	2015	31	12					250	257		10.1093/bioinformatics/btv265	http://dx.doi.org/10.1093/bioinformatics/btv265			8	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CL0IO	26072489	Green Published, Green Submitted, hybrid			2024-09-18	WOS:000356625700029
J	Song, XR; Chao, HQ; Xu, XN; Guo, HT; Xu, S; Turkbey, B; Wood, BJ; Sanford, T; Wang, G; Yan, PK				Song, Xinrui; Chao, Hanqing; Xu, Xuanang; Guo, Hengtao; Xu, Sheng; Turkbey, Baris; Wood, Bradford J.; Sanford, Thomas; Wang, Ge; Yan, Pingkun			Cross-modal attention for multi-modal image registration	MEDICAL IMAGE ANALYSIS			English	Article						Multi-modal registration; Deep learning; Cross-modal attention; Prostate caner imaging		In the past few years, convolutional neural networks (CNNs) have been proven powerful in extracting image features crucial for medical image registration. However, challenging applications and recent advances in computer vision suggest that CNNs are limited in their ability to understand the spatial correspondence between features, which is at the core of image registration. The issue is further exaggerated when it comes to multi-modal image registration, where the appearances of input images can differ significantly. This paper presents a novel cross-modal attention mechanism for correlating features extracted from the multi-modal input images and mapping such correlation to image registration transformation. To efficiently train the developed network, a contrastive learning-based pre-training method is also proposed to aid the network in extracting high-level features across the input modalities for the following cross-modal attention learning. We validated the proposed method on transrectal ultrasound (TRUS) to magnetic resonance (MR) registration, a clinically important procedure that benefits prostate cancer biopsy. Our experimental results demonstrate that for MR-TRUS registration, a deep neural network embedded with the cross-modal attention block outperforms other advanced CNN-based networks with ten times its size. We also incorporated visualization techniques to improve the interpretability of our network, which helps bring insights into the deep learning based image registration methods. The source code of our work is available at https://github.com/DIAL-RPI/Attention-Reg.	[Song, Xinrui; Chao, Hanqing; Xu, Xuanang; Guo, Hengtao; Wang, Ge; Yan, Pingkun] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Song, Xinrui; Chao, Hanqing; Xu, Xuanang; Guo, Hengtao; Wang, Ge; Yan, Pingkun] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Wood, Bradford J.] NIH, Ctr Intervent Oncol Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Turkbey, Baris] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Sanford, Thomas] Rensselaer Polytech Inst, Ctr Biotechnol, Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rensselaer Polytechnic Institute	Yan, PK (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.; Yan, PK (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	yanp2@rpi.edu	Yan, Pingkun/W-5059-2019; Song, Xinrui/HMP-7253-2023; Chao, Hanqing/LCD-5186-2024; Wang, Ge/AAH-8592-2020; Xu, Xuanang/AAJ-4802-2021; Wood, Bradford/M-7995-2017	Song, Xinrui/0000-0001-5570-1056; Wood, Bradford/0000-0002-4297-0051; Xu, Xuanang/0000-0002-6045-8457; Yan, Pingkun/0000-0002-9779-2141; Guo, Hengtao/0000-0002-4734-026X	National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH) , USA [R21EB028001, R01EB027898]; National Cancer Institute; National Institute of Biomedical Imaging and Bioengineering [R01EB027898, R21EB028001] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH) , USA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH), USA under awards R21EB028001 and R01EB027898, and through an NIH Bench-to-Bedside award made possible by the National Cancer Institute.	Balakrishnan G, 2019, IEEE T MED IMAGING, V38, P1788, DOI 10.1109/TMI.2019.2897538; Bass EJ, 2022, PROSTATE CANCER P D, V25, P174, DOI 10.1038/s41391-021-00449-7; de Vos BD, 2017, LECT NOTES COMPUT SC, V10553, P204, DOI 10.1007/978-3-319-67558-9_24; Fan JF, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101545; Guo HT, 2020, COMPUT MED IMAG GRAP, V84, DOI 10.1016/j.compmedimag.2020.101769; Ha IY, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20051392; Haskins G, 2020, MACH VISION APPL, V31, DOI 10.1007/s00138-020-01060-x; Haskins G, 2019, INT J COMPUT ASS RAD, V14, P417, DOI 10.1007/s11548-018-1875-7; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Heinrich MP, 2019, LECT NOTES COMPUT SC, V11769, P50, DOI 10.1007/978-3-030-32226-7_6; Heinrich MP, 2012, MED IMAGE ANAL, V16, P1423, DOI 10.1016/j.media.2012.05.008; Hering A, 2021, Arxiv, DOI arXiv:2112.04489; Hu JR, 2019, IEEE ACCESS, V7, P132816, DOI 10.1109/ACCESS.2019.2938858; Hu YP, 2018, MED IMAGE ANAL, V49, P1, DOI 10.1016/j.media.2018.07.002; Jaderberg M, 2015, ADV NEUR IN, V28; Kingma DP, 2014, ADV NEUR IN, V27; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Mok Tony C. W., 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12263), P211, DOI 10.1007/978-3-030-59716-0_21; Paszke A., 2017, P 31 C NEUR INF PROC, P1; Pielawski N., 2020, Advances in Neural Information Processing Systems, V33, P18433, DOI 10.48550/arXiv.2006.06325; Rivaz H, 2014, MED IMAGE ANAL, V18, P343, DOI 10.1016/j.media.2013.12.003; Siebert H, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22031107; Simonovsky Martin, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9902, P10, DOI 10.1007/978-3-319-46726-9_2; Song XR, 2021, LECT NOTES COMPUT SC, V12904, P66, DOI 10.1007/978-3-030-87202-1_7; Sun Y, 2015, IEEE T MED IMAGING, V34, P1085, DOI 10.1109/TMI.2014.2375207; Vaswani A, 2017, ADV NEUR IN, V30; Venderink W, 2018, EUR UROL FOCUS, V4, P219, DOI 10.1016/j.euf.2016.07.003; Wang F, 2021, PROC CVPR IEEE, P2495, DOI 10.1109/CVPR46437.2021.00252; Wang XL, 2018, PROC CVPR IEEE, P7794, DOI 10.1109/CVPR.2018.00813; Wein W, 2013, LECT NOTES COMPUT SC, V8149, P34, DOI 10.1007/978-3-642-40811-3_5; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wu GR, 2013, LECT NOTES COMPUT SC, V8150, P649, DOI 10.1007/978-3-642-40763-5_80; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Xu XN, 2022, IEEE T MED IMAGING, V41, P1331, DOI 10.1109/TMI.2021.3139999; Yan PK, 2018, LECT NOTES COMPUT SC, V11046, P197, DOI 10.1007/978-3-030-00919-9_23; Yuanyuan Sun, 2018, Understanding and Interpreting Machine Learning in Medical Image Computing Applications. First International Workshops MLCN 2018, DLF 2018, and iMIMIC 2018. Held in Conjunction with MICCAI 2018. Proceedings: Lecture Notes in Computer Science (LNCS 11038), P43, DOI 10.1007/978-3-030-02628-8_5; Zimmer VA, 2019, INFORM FUSION, V49, P130, DOI 10.1016/j.inffus.2018.09.009	37	19	21	15	81	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1361-8415	1361-8423		MED IMAGE ANAL	Med. Image Anal.	NOV	2022	82								102612	10.1016/j.media.2022.102612	http://dx.doi.org/10.1016/j.media.2022.102612		SEP 2022	9	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Radiology, Nuclear Medicine & Medical Imaging	4X8WY	36126402	Bronze, Green Accepted			2024-09-18	WOS:000861119300010
J	Bertsimas, D; Masiakos, PT; Mylonas, KS; Wiberg, H				Bertsimas, Dimitris; Masiakos, Peter T.; Mylonas, Konstantinos S.; Wiberg, Holly			Prediction of cervical spine injury in young pediatric patients: an optimal trees artificial intelligence approach	JOURNAL OF PEDIATRIC SURGERY			English	Article						Cervical spine trauma; Cervical spine injury; Artificial intelligence; Machine learning; Optimal classification trees	RADIATION-EXPOSURE; CLASSIFICATION; CANCER; TRAUMA; RADIOGRAPHY; SEDATION; CHILDREN; EVENTS; RISK	Background: Cervical spine injuries (CSI) are a major concern in young pediatric trauma patients. The consequences of missed injuries and difficulties in injury clearance for non-verbal patients have led to a tendency to image young children. Imaging, particularly computed tomography (CT) scans, presents risks including radiation-induced carcinogenesis. In this study we leverage machine learning methods to develop highly accurate clinical decision rules to predict pediatric CSI. Methods: The PEDSPINE I registry was used to investigate CSI in blunt trauma patients under the age of three. Predictive models were built using Optimal Classification Trees, a novel machine learning approach offering high accuracy and interpretability, as well as other widely used machine learning methods. Results: The final Optimal Classification Trees model predicts injury based on overall Glasgow Coma Score (GCS) and patient age. This model has a sensitivity of 93.3% and specificity of 82.3% on the full dataset It has comparable or superior peiforrnance to other machine learning methods as well as existing clinical decision rules. Conclusions: This study developed a decision rule that achieves high injury identification while reducing unnecessary imaging. It demonstrates the value of machine learning in improving clinical decision protocols for pediatric trauma. Type of study: Retrospective Prognosis Study. (C) 2019 Elsevier Inc. All rights reserved.	[Bertsimas, Dimitris; Wiberg, Holly] MIT, Operat Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Masiakos, Peter T.; Mylonas, Konstantinos S.] Harvard Med Sch, Massachusetts Gen Hosp, Div Pediat Surg, Warren 11,55 Fruit St, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard Medical School	Masiakos, PT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Pediat Surg, Warren 11,55 Fruit St, Boston, MA 02114 USA.	pmasiakos@partners.org	Mylonas, Konstantinos/GQB-1169-2022; Masiakos, Peter/KCK-1781-2024; Wiberg, Holly/ACW-2759-2022	Mylonas, Konstantinos/0000-0002-2356-6694				Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Anderson RCE, 2010, J NEUROS-PEDIATR, V5, P292, DOI 10.3171/2009.10.PEDS09159; Arbuthnot M, 2017, J PEDIATR SURG, V52, P130, DOI 10.1016/j.jpedsurg.2016.10.031; Bertsimas D, 2018, JCO CLIN CANCER INFO, V2, DOI 10.1200/CCI.18.00003; Bertsimas D, 2018, ANN SURG, V268, P574, DOI 10.1097/SLA.0000000000002956; Bertsimas D, 2017, MACH LEARN, V106, P1039, DOI 10.1007/s10994-017-5633-9; Breiman L. I., 1984, CLASSIFICATION REGRE, V40, P358, DOI DOI 10.1002/WIDM.8; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P517, DOI 10.1001/jama.2017.7797; Chen T., 2021, XGBOOST EXTREME GRAD; Chen YF, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/873595; Coté CJ, 2000, PEDIATRICS, V105, P805, DOI 10.1542/peds.105.4.805; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Friedman J., 2001, GREEDY FUNCTION APPR, V29; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Hoffman JR, 1998, ANN EMERG MED, V32, P461, DOI 10.1016/S0196-0644(98)70176-3; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Miller DD, 2018, AM J MED, V131, P129, DOI 10.1016/j.amjmed.2017.10.035; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pieretti-Vanmarcke R, 2009, J TRAUMA, V67, P543, DOI 10.1097/TA.0b013e3181b57aa1; Sanborn PA, 2005, RADIOLOGY, V237, P288, DOI 10.1148/radiol.2371041415; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9	27	13	15	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	NOV	2019	54	11					2353	2357		10.1016/j.jpedsurg.2019.03.007	http://dx.doi.org/10.1016/j.jpedsurg.2019.03.007			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	JQ3LQ	30928154				2024-09-18	WOS:000498851100024
J	Lee, JS; Wu, WK				Lee, Jiann-Shu; Wu, Wen-Kai			Breast Tumor Tissue Image Classification Using DIU-Net	SENSORS			English	Article						soft segmentation; DIU-Net; joint training	TEXTURE CLASSIFICATION; DATASET	Inspired by the observation that pathologists pay more attention to the nuclei regions when analyzing pathological images, this study utilized soft segmentation to imitate the visual focus mechanism and proposed a new segmentation-classification joint model to achieve superior classification performance for breast cancer pathology images. Aiming at the characteristics of different sizes of nuclei in pathological images, this study developed a new segmentation network with excellent cross-scale description ability called DIU-Net. To enhance the generalization ability of the segmentation network, that is, to avoid the segmentation network from learning low-level features, we proposed the Complementary Color Conversion Scheme in the training phase. In addition, due to the disparity between the area of the nucleus and the background in the pathology image, there is an inherent data imbalance phenomenon, dice loss and focal loss were used to overcome this problem. In order to further strengthen the classification performance of the model, this study adopted a joint training scheme, so that the output of the classification network can not only be used to optimize the classification network itself, but also optimize the segmentation network. In addition, this model can also provide the pathologist model's attention area, increasing the model's interpretability. The classification performance verification of the proposed method was carried out with the BreaKHis dataset. Our method obtains binary/multi-class classification accuracy 97.24/93.75 and 98.19/94.43 for 200x and 400x images, outperforming existing methods.	[Lee, Jiann-Shu; Wu, Wen-Kai] Natl Univ Tainan, Dept Comp Sci & Informat Engn, Tainan 700, Taiwan	National University Tainan	Lee, JS (corresponding author), Natl Univ Tainan, Dept Comp Sci & Informat Engn, Tainan 700, Taiwan.	cslee@mail.nutn.edu.tw			Ministry of Science and Technology;  [MOST 108-2221-E-024-011-MY3]	Ministry of Science and Technology(Spanish Government); 	This work was supported by the Ministry of Science and Technology under Grant MOST 108-2221-E-024-011-MY3.	Adeshina SA, 2018, INT CONF ELECT COMP; Alom M.Z., 2018, arXiv; [Anonymous], 4 INT C LEARNING REP; Araújo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Bardou D, 2018, IEEE ACCESS, V6, P24680, DOI 10.1109/ACCESS.2018.2831280; Booz Allen Hamilton, 2018, DATA SCI BOWL KAGGLE; Boyle P., 2008, World Cancer Report 2008; Chan A, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160558; Chen D. Z., 2019, arXiv; Chun M.C., 2018, MED NEWS TODAY; Das K, 2018, I S BIOMED IMAGING, P578, DOI 10.1109/ISBI.2018.8363642; Gelasca ED, 2008, IEEE IMAGE PROC, P1816, DOI 10.1109/ICIP.2008.4712130; George K, 2020, COMPUT METH PROG BIO, V194, DOI 10.1016/j.cmpb.2020.105531; Gour M, 2020, INT J IMAG SYST TECH, V30, P621, DOI 10.1002/ima.22403; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; Hamilton NA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-110; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He L., 2010, Seq. Genome Analysis Methods Appl., V15, P271; He L, 2012, COMPUT METH PROG BIO, V107, P538, DOI 10.1016/j.cmpb.2011.12.007; Horvat JV, 2019, RADIOGRAPHICS, V39, P307, DOI 10.1148/rg.2019180124; Hu CH, 2021, INT J IMAG SYST TECH, V31, P1583, DOI [10.1002/ima.22548, 10.1109/ICME51207.2021.9428297]; Jannesari M, 2018, IEEE INT C BIOINFORM, P2405, DOI 10.1109/BIBM.2018.8621307; Jiang Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214587; Kahya MA., 2017, J Appl Math Bioinform, V7, P49; Kumar N, 2017, IEEE T MED IMAGING, V36, P1550, DOI 10.1109/TMI.2017.2677499; Lim C.N., 2019, BORNEO J MED SCI BJM, V13, DOI [10.51200/bjms.v13i1.1178, DOI 10.51200/BJMS.V13I1.1178]; Naylor P, 2019, IEEE T MED IMAGING, V38, P448, DOI 10.1109/TMI.2018.2865709; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Oktay O., 2018, Medical Imaging with Deep Learning, DOI DOI 10.48550/ARXIV; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rublee E., 2011, ICCV, P2564; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Szegedy C., 2015, P IEEE C COMP VIS PA, P1; World Health Organization, US; Zhou ZW, 2018, LECT NOTES COMPUT SC, V11045, P3, DOI 10.1007/978-3-030-00889-5_1	36	1	1	0	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	DEC	2022	22	24							9838	10.3390/s22249838	http://dx.doi.org/10.3390/s22249838			15	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	7G6JM	36560207	gold, Green Published			2024-09-18	WOS:000902628000001
J	Pham, TS; Legrain, A; De Causmaecker, P; Rousseau, LM				Pham, Tu San; Legrain, Antoine; De Causmaecker, Patrick; Rousseau, Louis-Martin			A Prediction-Based Approach for Online Dynamic Appointment Scheduling: A Case Study in Radiotherapy Treatment	INFORMS JOURNAL ON COMPUTING			English	Article						operations research; radiotherapy scheduling; uncertainty; patient scheduling; explainability	HEALTH-CARE; PATIENT; TIME; DEMAND; OPTIMIZATION; ALLOCATION; DELAYS; MODEL	Patient scheduling is a difficult task involving stochastic factors, such as the unknown arrival times of patients. Similarly, the scheduling of radiotherapy for cancer treatments needs to handle patients with different urgency levels when allocating resources. High-priority patients may arrive at any time, and there must be resources available to accommodate them. A common solution is to reserve a flat percentage of treatment capacity for emergency patients. However, this solution can result in overdue treatments for urgent patients, a failure to fully exploit treatment capacity, and delayed treatments for low-priority patients. This problem is especially severe in large and crowded hospitals. In this paper, we propose a prediction-based approach for online dynamic radiotherapy scheduling that dynamically adapts the present scheduling decision based on each incoming patient and the current allocation of resources. Our approach is based on a regression model trained to recognize the links between patients' arrival patterns and their ideal waiting time in optimal off-line solutions when all future arrivals are known in advance. When our prediction-based approach is compared with flat-reservation policies, it does a better job of preventing overdue treatments for emergency patients and also maintains comparable waiting times for the other patients. We also demonstrate how our proposed approach supports explainability and interpretability in scheduling decisions using Shapley additive explanation values.	[Pham, Tu San; Legrain, Antoine; Rousseau, Louis-Martin] Polytech Montreal, Montreal, PQ H3T 1J4, Canada; [Pham, Tu San; Legrain, Antoine; Rousseau, Louis-Martin] CIRRELT, Montreal, PQ H3T 1J4, Canada; [Legrain, Antoine] GERAD, Montreal, PQ H3T 2A7, Canada; [De Causmaecker, Patrick] Katholieke Univ Leuven, B-8500 Kortrijk, Belgium	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Universite de Montreal; KU Leuven	Pham, TS (corresponding author), Polytech Montreal, Montreal, PQ H3T 1J4, Canada.; Pham, TS (corresponding author), CIRRELT, Montreal, PQ H3T 1J4, Canada.	tu-san.pham@polymtl.ca; antoine.legrain@polymtl.ca; patrick.decausmaecker@kuleuven.be; louis-martin.rousseau@polymtl.ca	; De Causmaecker, Patrick/E-5635-2017	Rousseau, Louis-Martin/0000-0001-6949-6014; Pham, Tu San/0000-0002-3599-4530; De Causmaecker, Patrick/0000-0002-6763-1945	Mitacs Acceleration [IT26995]; Canada Research Chair in Analytics and Logistics in Healthcare (HANALOG)	Mitacs Acceleration; Canada Research Chair in Analytics and Logistics in Healthcare (HANALOG)	Mitacs Acceleration IT26995 and Canada Research Chair in Analytics and Logistics in Healthcare (HANALOG) .	Barton MB, 2014, RADIOTHER ONCOL, V112, P140, DOI 10.1016/j.radonc.2014.03.024; Burke E. K., 2011, ARXIV; Castro E, 2012, J SCHEDULING, V15, P333, DOI 10.1007/s10951-011-0239-8; Cayirli T, 2003, PROD OPER MANAG, V12, P519, DOI 10.1111/j.1937-5956.2003.tb00218.x; Ceschia S, 2016, J SCHEDULING, V19, P377, DOI 10.1007/s10951-014-0407-8; Ceschia S, 2012, ARTIF INTELL MED, V56, P199, DOI 10.1016/j.artmed.2012.09.001; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Coles CE, 2003, CLIN ONCOL-UK, V15, P47, DOI 10.1053/clon.2002.0178; Conforti D, 2008, 4OR-Q J OPER RES, V6, P263, DOI 10.1007/S10288-007-0050-8; Conforti D, 2010, EUR J OPER RES, V201, P289, DOI 10.1016/j.ejor.2009.02.016; Frimodig S, 2019, LECT NOTES COMPUT SC, V11802, P421, DOI 10.1007/978-3-030-30048-7_25; Gerchak Y, 1996, MANAGE SCI, V42, P321, DOI 10.1287/mnsc.42.3.321; Gocgun Y, 2018, HEALTH CARE MANAG SC, V21, P317, DOI 10.1007/s10729-016-9388-9; Gupta D, 2008, IIE TRANS, V40, P800, DOI 10.1080/07408170802165880; Kapamara T., 2006, P 18 INT C SYST ENG, P201, DOI DOI 10.1111/J.1937-5956.2011.01221.X; Kapamara T, 2009, P 35 INT C OP RES AP; Lamiri M, 2008, EUR J OPER RES, V185, P1026, DOI 10.1016/j.ejor.2006.02.057; Larsen E, 2022, INFORMS J COMPUT, V34, P227, DOI 10.1287/ijoc.2021.1091; Legrain A, 2015, HEALTH CARE MANAG SC, V18, P110, DOI 10.1007/s10729-014-9270-6; Mackillop WJ, 2007, RADIOTHER ONCOL, V84, P1, DOI 10.1016/j.radonc.2007.05.006; Marynissen J, 2019, EUR J OPER RES, V272, P407, DOI 10.1016/j.ejor.2018.03.001; Maschler J, 2016, PATAT 2016, P223; Maschler J, 2020, INT T OPER RES, V27, P458, DOI 10.1111/itor.12579; Patrick J, 2008, OPER RES, V56, P1507, DOI 10.1287/opre.1080.0590; Petrovic S., 2006, Proceedings of the 25th Workshop of the UK Planning and Scheduling Special Interest Group, P105; Petrovic S, 2008, LECT NOTES ENG COMP, P722; Pham TS, 2022, HEALTH CARE MANAG SC, V25, P191, DOI 10.1007/s10729-021-09579-9; Salah Haya, 2022, Computers & Industrial Engineering, V169, DOI 10.1016/j.cie.2022.108270; Sauré A, 2020, EUR J OPER RES, V280, P254, DOI 10.1016/j.ejor.2019.06.040; Sauré A, 2012, EUR J OPER RES, V223, P573, DOI 10.1016/j.ejor.2012.06.046; Schütz HJ, 2012, EUR J OPER RES, V218, P239, DOI 10.1016/j.ejor.2011.09.007; Srinivas S, 2018, EXPERT SYST APPL, V102, P245, DOI [10.1016/j.eswa.2018.02.022, 10.1016/J.eswa.2018.02.022]; Tyldesley S, 2011, INT J RADIAT ONCOL, V79, P1507, DOI 10.1016/j.ijrobp.2009.12.070; Vermeulen IB, 2009, ARTIF INTELL MED, V46, P67, DOI 10.1016/j.artmed.2008.07.019; Vieira B, 2020, HEALTH CARE MANAG SC, V23, P520, DOI 10.1007/s10729-020-09510-8; Vieira B, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0390-4; Vogl P, 2019, J SCHEDULING, V22, P137, DOI 10.1007/s10951-018-0574-0; Zhu YH, 2019, COMPUT OPER RES, V104, P98, DOI 10.1016/j.cor.2018.12.001	38	0	0	10	31	INFORMS	CATONSVILLE	5521 RESEARCH PARK DR, SUITE 200, CATONSVILLE, MD 21228 USA	1091-9856	1526-5528		INFORMS J COMPUT	INFORMS J. Comput.	JUL-AUG	2023	35	4					844	868		10.1287/ijoc.2023.1289	http://dx.doi.org/10.1287/ijoc.2023.1289		APR 2023	26	Computer Science, Interdisciplinary Applications; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Operations Research & Management Science	T8ZS3					2024-09-18	WOS:000976434600001
J	Langthaler, S; Sajic, JL; Rienmüller, T; Weinberg, SH; Baumgartner, C				Langthaler, Sonja; Lozanovic Sajic, Jasmina; Rienmueller, Theresa; Weinberg, Seth H.; Baumgartner, Christian			Ion Channel Modeling beyond State of the Art: A Comparison with a System Theory-Based Model of the Shaker-Related Voltage-Gated Potassium Channel Kv1.1	CELLS			English	Article						ion channels; electrophysiology; computational model; Hodgkin-Huxley; hidden Markov model; system and control theory	SUBUNITS; INACTIVATION	The mathematical modeling of ion channel kinetics is an important tool for studying the electrophysiological mechanisms of the nerves, heart, or cancer, from a single cell to an organ. Common approaches use either a Hodgkin-Huxley (HH) or a hidden Markov model (HMM) description, depending on the level of detail of the functionality and structural changes of the underlying channel gating, and taking into account the computational effort for model simulations. Here, we introduce for the first time a novel system theory-based approach for ion channel modeling based on the concept of transfer function characterization, without a priori knowledge of the biological system, using patch clamp measurements. Using the shaker-related voltage-gated potassium channel Kv1.1 (KCNA1) as an example, we compare the established approaches, HH and HMM, with the system theory-based concept in terms of model accuracy, computational effort, the degree of electrophysiological interpretability, and methodological limitations. This highly data-driven modeling concept offers a new opportunity for the phenomenological kinetic modeling of ion channels, exhibiting exceptional accuracy and computational efficiency compared to the conventional methods. The method has a high potential to further improve the quality and computational performance of complex cell and organ model simulations, and could provide a valuable new tool in the field of next-generation in silico electrophysiology.	[Langthaler, Sonja; Lozanovic Sajic, Jasmina; Rienmueller, Theresa; Baumgartner, Christian] Graz Univ Technol, Inst Hlth Care Engn European Testing Ctr Med Devi, A-8010 Graz, Austria; [Lozanovic Sajic, Jasmina] Univ Belgrade, Fac Mech Engn, Innovat Ctr, Belgrade 11000, Serbia; [Weinberg, Seth H.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Weinberg, Seth H.] Ohio State Univ, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43081 USA	Graz University of Technology; University of Belgrade; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Baumgartner, C (corresponding author), Graz Univ Technol, Inst Hlth Care Engn European Testing Ctr Med Devi, A-8010 Graz, Austria.	s.langthaler@tugraz.at; j.lozanovicsajic@tugraz.at; theresa.rienmueller@tugraz.at; weinberg.147@osu.edu; christian.baumgartner@tugraz.at	Rienmüller, Theresa/AGX-6123-2022; Baumgartner, Christian/ITV-9408-2023	Rienmuller, Theresa/0000-0002-9623-106X; Langthaler, Sonja/0000-0001-5160-4910; Baumgartner, Christian/0000-0002-3763-5195; Weinberg, Seth/0000-0003-1170-0419; Lozanovic, Jasmina/0000-0002-5717-4269				Ågren R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44564-x; Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Andreozzi E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53662-9; [Anonymous], 2011, Principles of Computational Modelling in Neuroscience; [Anonymous], 2010, MODERN CONTROL SYSTE; [Anonymous], 2009, MODERN CONTROL ENG; [Anonymous], 1999, System Indentification - Theory for the User; Aryani Dharma., 2014, IFAC Proceedings Volumes, V47, P4122, DOI [10.3182/20140824-6-ZA-1003.01100, DOI 10.3182/20140824-6-ZA-1003.01100]; Bähring R, 2004, MOL MEMBR BIOL, V21, P19, DOI 10.1080/09687680310001597749; Beheshti Mohammadali, 2016, Critical Reviews in Biomedical Engineering, V44, P99, DOI 10.1615/CritRevBiomedEng.2016016454; Bett GCL, 2011, BIOPHYS J, V100, P11, DOI 10.1016/j.bpj.2010.11.011; Carbonell-Pascual B, 2016, J THEOR BIOL, V399, P92, DOI 10.1016/j.jtbi.2016.03.039; D'Adamo MC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082935; D'Adamo M, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00525; Destexhe A, 2009, COMPUT NEUROSCI-MIT, P107; Dössel O, 2002, BIOMED TECH, V47, P250; EKEBERG O, 1991, BIOL CYBERN, V65, P81, DOI 10.1007/BF00202382; Fink M, 2009, PHILOS T R SOC A, V367, P2161, DOI 10.1098/rsta.2008.0301; Glasscock E, 2019, CHANNELS, V13, P299, DOI 10.1080/19336950.2019.1635864; Gulbis JM, 1999, CELL, V97, P943, DOI 10.1016/S0092-8674(00)80805-3; Hasan S, 2020, PFLUG ARCH EUR J PHY, V472, P899, DOI 10.1007/s00424-020-02414-0; Hatton WJ, 2001, J PHYSIOL-LONDON, V533, P315, DOI 10.1111/j.1469-7793.2001.0315a.x; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hou PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089975; Lampert A, 2014, PROG MOL BIOL TRANSL, V123, P1, DOI 10.1016/B978-0-12-397897-4.00009-7; Langthaler S, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009091; Ljung L., 2014, SYSTEM IDENTIFICATIO; Maffeo C, 2012, CHEM REV, V112, P6250, DOI 10.1021/cr3002609; Michaelevski I, 2007, PFLUG ARCH EUR J PHY, V454, P477, DOI 10.1007/s00424-007-0223-5; Nelson M., ELECTROPHYSIOLOGICAL; Nelson ME, 2011, WIRES SYST BIOL MED, V3, P74, DOI 10.1002/wsbm.95; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ranjan R, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00358; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rudy B., 2009, ENCY NEUROSCIENCE, P397; Sigg D, 2014, J GEN PHYSIOL, V144, P6, DOI 10.1085/jgp.201311130; Tytgat J, 1997, BRIT J PHARMACOL, V122, P1417, DOI 10.1038/sj.bjp.0701545; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Yang YM, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms6110, 10.1038/ncomms5564]; Yarov-Yarovoy Vladimir, 2014, Drug Discov Today Dis Models, V14, P3; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	42	5	5	1	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	JAN	2022	11	2							239	10.3390/cells11020239	http://dx.doi.org/10.3390/cells11020239			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	YN3HB	35053355	Green Published, gold			2024-09-18	WOS:000747151200001
J	Bigirumurame, T; Uwimpuhwe, G; Wason, J				Bigirumurame, Theophile; Uwimpuhwe, Germaine; Wason, James			Sequential multiple assignment randomized trial studies should report all key components: a systematic review	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Review						Sequential multiple assignment randomized trial; Adaptive intervention; Dynamic treatment regimens; Adaptive treatment strategies; Multistage treatment strategies; Treatment policies	ADAPTIVE TREATMENT STRATEGIES; SMART DESIGN; CANCER-PATIENTS; INTERVENTIONS; MANAGEMENT; CESSATION; SURVIVAL; PATIENT	Objective: Sequential Multiple Assignment Randomized Trial (SMART) designs allow multiple randomizations of participants; this allows assessment of stage-specific questions (individual randomizations) and adaptive interventions (i.e. treatment strategies). We assessed the quality of reporting of the information required to design SMART studies. Study design and setting: We systematically searched four databases (PubMed, Ovid, Web of Science and Scopus) for all trial reports, protocols, reviews, and methodological papers which mentioned SMART designs up to June 15, 2020. Results: Of the 157 selected records, 12 (7.64%) were trial reports, 24 (15.29%) were study protocols, 91 (58%) were methodological papers, and 30 (19.1%) were review papers. All these trials were powered using stage-specific aims. Only four (33.33%) of these trials reported parameters required for sample size calculations. A small number of the trials (16.67 %) were interested in determining the best embedded adaptive interventions. Most of the trials did not report information about multiple testing adjustment. Furthermore, most of records reported designs that were mainly focused on stage-specific aims. Conclusions: Some features of SMART designs are seldomly reported and/or used. Furthermore, studies using this design tend to not adequately report information about all the design parameters, limiting their transparency and interpretability. (c) 2021 Elsevier Inc. All rights reserved.	[Bigirumurame, Theophile; Wason, James] Newcastle Univ, Populat Hlth Sci Inst, Biostat Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Uwimpuhwe, Germaine] Univ Durham, Durham Res Methods Ctr, Durham, England	Newcastle University - UK; Durham University	Bigirumurame, T (corresponding author), Newcastle Univ, Populat Hlth Sci Inst, Biostat Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	theophile.bigirumurame@newcastle.ac.uk	Bigirumurame, Theophile/AAW-5816-2021; Wilson, James/A-5704-2009	Bigirumurame, Theophile/0000-0003-2387-4918; Wason, James/0000-0002-4691-126X				[Anonymous], 1999, STAT MED, V18, P1905; [Anonymous], 2020, PROJECTS USING SMART; August GJ, 2018, J SCHOOL PSYCHOL, V66, P85, DOI 10.1016/j.jsp.2017.10.001; Belzer ME, 2018, JMIR RES PROTOC, V7, DOI 10.2196/11183; Buchholz SW, 2020, CONTEMP CLIN TRIALS, V89, DOI 10.1016/j.cct.2019.105921; Candlish J, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3206-x; Chakraborty B, 2014, ANNU REV STAT APPL, V1, P447, DOI 10.1146/annurev-statistics-022513-115553; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Chow JC, 2019, REM SPEC EDUC, V40, P267, DOI 10.1177/0741932518759422; Comins CA, 2019, RES NURS HEALTH, V42, P107, DOI 10.1002/nur.21928; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fatori D, 2018, J ANXIETY DISORD, V58, P42, DOI 10.1016/j.janxdis.2018.07.002; Fernandez ME, 2020, IMPLEMENT SCI, V15, DOI 10.1186/s13012-020-0967-2; Flynn D, 2018, CONTEMP CLIN TRIALS, V73, P68, DOI 10.1016/j.cct.2018.08.008; Fu SS, 2017, CONTEMP CLIN TRIALS, V60, P86, DOI 10.1016/j.cct.2017.07.002; Hemming K, 2020, PROSPECTIVE REPORTIN; Inwani I, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.8200; Jiang RC, 2017, J ROY STAT SOC B, V79, P1165, DOI 10.1111/rssb.12201; Johnson JE, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0807-9; Karp JF, 2019, AM J GERIAT PSYCHIAT, V27, P1035, DOI 10.1016/j.jagp.2019.03.011; Kelleher SA, 2017, CONTEMP CLIN TRIALS, V57, P51, DOI 10.1016/j.cct.2017.04.001; Kidwell KM, 2014, CLIN TRIALS, V11, P445, DOI 10.1177/1740774514525691; Kilbourne AM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0808-8; Kim JS, 2019, AERA OPEN, V5, DOI 10.1177/2332858419872701; Lavori PW, 2008, ANNU REV MED, V59, P443, DOI 10.1146/annurev.med.59.062606.122232; Lei H, 2012, ANNU REV CLIN PSYCHO, V8, P21, DOI 10.1146/annurev-clinpsy-032511-143152; McKay JR, 2015, J CONSULT CLIN PSYCH, V83, P1021, DOI 10.1037/a0039534; Miller CK, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1127-4; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Naar-King S, 2016, J CLIN CHILD ADOLESC, V45, P428, DOI 10.1080/15374416.2014.971459; Nahum-Shani I, 2017, ADDICTION, V112, P901, DOI 10.1111/add.13743; Nahum-Shani I, 2012, PSYCHOL METHODS, V17, P478, DOI 10.1037/a0029373; Nahum-Shani I, 2012, PSYCHOL METHODS, V17, P457, DOI 10.1037/a0029372; O'Keefe VM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7996-2; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n160, 10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Pallmann P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1017-7; Pelham WE, 2016, J CLIN CHILD ADOLESC, V45, P396, DOI 10.1080/15374416.2015.1105138; Petry NM, 2018, J CONSULT CLIN PSYCH, V86, P799, DOI 10.1037/ccp0000330; Pistorello J, 2018, ARCH SUICIDE RES, V22, P644, DOI 10.1080/13811118.2017.1392915; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Schmitz JM, 2018, CONTEMP CLIN TRIALS, V65, P109, DOI 10.1016/j.cct.2017.12.015; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sikorskii A, 2017, RES NURS HEALTH, V40, P501, DOI 10.1002/nur.21836; Song MK, 2016, NURS OUTLOOK, V64, P299, DOI 10.1016/j.outlook.2016.04.008; Swartz MS, 2008, PSYCHIAT SERV, V59, P500, DOI 10.1176/ps.2008.59.5.500; Tamura RN, 2016, CONTEMP CLIN TRIALS, V46, P48, DOI 10.1016/j.cct.2015.11.010; Team RC. R Foundation for Statistical Computing, 2016, VIENN AUSTR R LANG E; Thall PF, 2007, JNCI-J NATL CANCER I, V99, P1613, DOI 10.1093/jnci/djm189; The University of Texas MD Anderson Center, 2010, STPLAN DOUBL PREC ST; Zhong XB, 2019, CONTEMP CLIN TRIALS, V85, DOI 10.1016/j.cct.2019.105830	53	9	11	4	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	FEB	2022	142						152	160		10.1016/j.jclinepi.2021.11.007	http://dx.doi.org/10.1016/j.jclinepi.2021.11.007		DEC 2021	9	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	YD3UV	34763037	Green Submitted, Green Accepted			2024-09-18	WOS:000740342300007
C	Koriakina, N; Sladoje, N; Lindblad, J		Petkovic, T; Petrinovic, D; Loncaric, S		Koriakina, Nadezhda; Sladoje, Natasa; Lindblad, Joakim			The Effect of Within-Bag Sampling on End-to-End Multiple Instance Learning	PROCEEDINGS OF THE 12TH INTERNATIONAL SYMPOSIUM ON IMAGE AND SIGNAL PROCESSING AND ANALYSIS (ISPA 2021)	International Symposium on Image and Signal Processing and Analysis		English	Proceedings Paper	12th International Symposium on Image and Signal Processing and Analysis (ISPA)	SEP 13-15, 2021	ELECTR NETWORK	Univ Zagreb, Fac Elect Engn & Comp, Croatian Acad Sci & Arts, European Assoc Signal Proc, IEEE Signal Proc Soc, IEEE Croatia Sect, Signal Proc Chapter		Multiple Instance Learning; sampling; deep learning; attention; interpretability; memory management	CANCER	End-to-end multiple instance learning (MIL) is an important concept with a wide range of applications. It is gaining increased popularity in the (bio)medical imaging community since it may provide a possibility to, while relying only on weak labels assigned to large regions, obtain more fine-grained information. However, processing very large bags in end-to-end MIL is problematic due to computer memory constraints. We propose within-bag sampling as one way of applying end-to-end MIL methods on very large data. We explore how different levels of sampling affect the performance of a well-known high-performing end-to-end attention-based MIL method, to understand the conditions when sampling can be utilized. We compose two new datasets tailored for the purpose of the study, and propose a strategy for sampling during MIL inference to arrive at reliable bag labels as well as instance level attention weights. We perform experiments without and with different levels of sampling, on the two publicly available datasets, and for a range of learning settings. We observe that in most situations the proposed bag-level sampling can be applied to end-to-end MIL without performance loss, supporting its confident usage to enable end-to-end MIL also in scenarios with very large bags. We share the code as open source at https://github.com/MIDA-group/SampledABMIL	[Koriakina, Nadezhda; Sladoje, Natasa; Lindblad, Joakim] Uppsala Univ, Ctr Image Anal, Dept Informat Technol, Uppsala, Sweden	Uppsala University	Koriakina, N (corresponding author), Uppsala Univ, Ctr Image Anal, Dept Informat Technol, Uppsala, Sweden.		Lindblad, Joakim/F-1960-2016	Koriakina, Nadezhda/0000-0002-2891-5435; Lindblad, Joakim/0000-0001-7312-8222; Sladoje, Natasa/0000-0002-6041-6310	Swedish Research Council [2018-05973]	Swedish Research Council(Swedish Research Council)	A part of computations was enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) at Chalmers Centre for Computational Science and Engineering (C3SE), partially funded by the Swedish Research Council through grant no. 2018-05973.	Akbar S, 2018, Arxiv, DOI arXiv:1812.00884; Buslaev A, 2020, INFORMATION, V11, DOI 10.3390/info11020125; Dehaene O, 2020, Arxiv, DOI [arXiv:2012.03583, DOI 10.48550/ARXIV.2012.03583]; Gildenblat J, 2020, Arxiv, DOI arXiv:2008.10548; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Howard J., Imagewang; Ilse M, 2018, PR MACH LEARN RES, V80; Jiahao Lu, 2020, Image Analysis and Recognition. 17th International Conference (ICIAR 2020). Proceedings. Lecture Notes in Computer Science (LNCS 12132), P249, DOI 10.1007/978-3-030-50516-5_22; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lerousseau M, 2020, Arxiv, DOI arXiv:2009.01592; Li B, 2021, PROC CVPR IEEE, P14313, DOI 10.1109/CVPR46437.2021.01409; Liu G Q, 2012, PMLR, P253; Lu MY, 2021, NAT BIOMED ENG, V5, P555, DOI 10.1038/s41551-020-00682-w; Maron O, 1998, ADV NEUR IN, V10, P570; Monsonego J, 2001, BRIT J CANCER, V84, P360, DOI 10.1054/bjoc.2000.1588; Paszke A, 2019, ADV NEUR IN, V32; Pinckaers H, 2021, IEEE T MED IMAGING, V40, P1817, DOI 10.1109/TMI.2021.3066295; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sharma Y, 2021, PR MACH LEARN RES, V143, P682; Tavolara Thomas E., 2021, Proceedings of SPIE - Progress in Biomedical Optics and Imaging, V11603, DOI 10.1117/12.2581945; Yadav C, 2019, ADV NEUR IN, V32; Zhao X, 2020, LECT NOTES COMPUT SC, V12113, P107, DOI 10.1007/978-3-030-59416-9_7	22	2	2	0	1	IEEE	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017 USA	1845-5921		978-1-6654-2639-8	INT SYMP IMAGE SIG			2021							183	188		10.1109/ISPA52656.2021.9552170	http://dx.doi.org/10.1109/ISPA52656.2021.9552170			6	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science; Engineering; Imaging Science & Photographic Technology	BU0AR					2024-09-18	WOS:000866471200030
J	Schwabe, D; Becker, K; Seyferth, M; Klass, A; Schaeffter, T				Schwabe, Daniel; Becker, Katinka; Seyferth, Martin; Klass, Andreas; Schaeffter, Tobias			The METRIC-framework for assessing data quality for trustworthy AI in medicine: a systematic review	NPJ DIGITAL MEDICINE			English	Review							ARTIFICIAL-INTELLIGENCE; NOISE; CLASSIFICATION; IMPACT; MODEL; DIMENSIONS; PREDICTION; CANCER	The adoption of machine learning (ML) and, more specifically, deep learning (DL) applications into all major areas of our lives is underway. The development of trustworthy AI is especially important in medicine due to the large implications for patients' lives. While trustworthiness concerns various aspects including ethical, transparency and safety requirements, we focus on the importance of data quality (training/test) in DL. Since data quality dictates the behaviour of ML products, evaluating data quality will play a key part in the regulatory approval of medical ML products. We perform a systematic review following PRISMA guidelines using the databases Web of Science, PubMed and ACM Digital Library. We identify 5408 studies, out of which 120 records fulfil our eligibility criteria. From this literature, we synthesise the existing knowledge on data quality frameworks and combine it with the perspective of ML applications in medicine. As a result, we propose the METRIC-framework, a specialised data quality framework for medical training data comprising 15 awareness dimensions, along which developers of medical ML applications should investigate the content of a dataset. This knowledge helps to reduce biases as a major source of unfairness, increase robustness, facilitate interpretability and thus lays the foundation for trustworthy AI in medicine. The METRIC-framework may serve as a base for systematically assessing training datasets, establishing reference datasets, and designing test datasets which has the potential to accelerate the approval of medical ML products.	[Schwabe, Daniel; Becker, Katinka; Seyferth, Martin; Klass, Andreas; Schaeffter, Tobias] Phys Tech Bundesanstalt, Div Med Phys & Metrol Informat Technol, Berlin, Germany; [Schaeffter, Tobias] Tech Univ Berlin, Dept Med Engn, Berlin, Germany; [Schaeffter, Tobias] Einstein Ctr Digital Future, Berlin, Germany	Physikalisch-Technische Bundesanstalt (PTB); Technical University of Berlin	Schwabe, D (corresponding author), Phys Tech Bundesanstalt, Div Med Phys & Metrol Informat Technol, Berlin, Germany.	daniel.schwabe@ptb.de	Schwabe, Daniel/O-4038-2017	Becker, Katinka/0009-0007-9663-6722; Seyferth, Martin/0009-0000-5930-287X	European Commission (EC); EU project TEF-Health [101100700]; European Union's Digital Europe programme	European Commission (EC)(European Union (EU)European Commission Joint Research Centre); EU project TEF-Health; European Union's Digital Europe programme	The authors acknowledge funding by the EU project TEF-Health. The project TEF-Health has received funding from the European Union's Digital Europe programme under grant agreement no. 101100700. We would like to thank Stefan Haufe for valuable input on the manuscript. We further thank the project partners of the TEF-Health project for feedback on our study.	Achiam OJ, 2023, Arxiv, DOI [arXiv:2303.08774, 10.48550/arXiv.2303.08774, DOI 10.48550/ARXIV.2303.08774]; Adadi A, 2018, IEEE ACCESS, V6, P52138, DOI 10.1109/ACCESS.2018.2870052; Agnew C, 2023, IEEE ACCESS, V11, P25174, DOI 10.1109/ACCESS.2023.3256723; Ahmadi M, 2017, ACTA MEDICA MEDITERR, V33, P313, DOI 10.19193/0393-6384_2017_2_047; AI H, 2019, High-level expert group on artificial intelligence, V6; Almutiry O, 2013, INTERNATIONAL CONFERENCE ON INFORMATION SOCIETY (I-SOCIETY 2013), P153; Althnian A, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11020796; Alzubaidi L, 2023, INT J INTELL SYST, V2023, DOI 10.1155/2023/4459198; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 2021, WHO Technical Report Series, V1033; [Anonymous], 2004, Directive 2004/9/EC of the European Parliament and of the Council of 11 February 2004 on the inspection and verification of good laboratory practice (GLP); [Anonymous], 1997, Data Quality for the Information Age; Ardila D, 2019, NAT MED, V25, P954, DOI 10.1038/s41591-019-0447-x; Arnold M, 2019, IBM J RES DEV, V63, DOI 10.1147/JRD.2019.2942288; Arora A, 2023, NAT MED, V29, DOI 10.1038/s41591-023-02608-w; Bai M, 2023, EUR RADIOL, V33, P3544, DOI 10.1007/s00330-022-09330-0; Bailly A, 2022, COMPUT METH PROG BIO, V213, DOI 10.1016/j.cmpb.2021.106504; Ballou DP, 1999, COMMUN ACM, V42, P73, DOI 10.1145/291469.291471; Bansal A., 1993, Journal of Management Information Systems, V10, P11; Barakat MS, 2017, HEALTH INF SCI SYST, V5, DOI 10.1007/s13755-017-0039-4; Barragán-Montero AM, 2021, PHYS MEDICA, V83, P52, DOI 10.1016/j.ejmp.2021.02.026; Batini C, 2015, J DATABASE MANAGE, V26, P60, DOI 10.4018/JDM.2015010103; Bender E.M., 2018, Trans. Assoc. Comput. Linguist., V6, P587, DOI 10.1162/tacla00041; Benedick PL, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21186195; Bian J, 2020, J AM MED INFORM ASSN, V27, P1999, DOI 10.1093/jamia/ocaa245; BISHOP CM, 1995, NEURAL COMPUT, V7, P108, DOI 10.1162/neco.1995.7.1.108; Black A, 2020, Dimensions of data quality (ddq); BlakeR Mangiameli P, 2011, Journal of Data and Information Quality, V2, P1, DOI DOI 10.1145/1891879.1891881; Bloland P, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6709-1; Buda M, 2018, NEURAL NETWORKS, V106, P249, DOI 10.1016/j.neunet.2018.07.011; Cai L., 2015, DATA SCI J, V14, P2, DOI [10.5334/dsj-2015-002, DOI 10.5334/DSJ-2015-002]; Corrales DC, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10070248; Candemir S, 2021, RADIOL-ARTIF INTELL, V3, DOI 10.1148/ryai.2021210014; Cao WP, 2020, NEURAL COMPUT APPL, V32, P12685, DOI 10.1007/s00521-020-04719-8; Chan Kitty S, 2010, Med Care Res Rev, V67, P503, DOI 10.1177/1077558709359007; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Che ZP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24271-9; Chen H, 2014, INT J ENV RES PUB HE, V11, P5170, DOI 10.3390/ijerph110505170; Chen J., 2021, PREPRINT, DOI [DOI 10.48550/ARXIV.2102.04306, 10.48550/arxiv.2102.04306]; Chui Michael., 2023, The state of AI in 2023: Generative AI's breakout year; Commission E., 2020, The assessment list for trustworthy artificial intelligence (ALTAI); Costa D, 2023, LECT NOTES ARTIF INT, V14116, P364, DOI 10.1007/978-3-031-49011-8_29; Council of the European Union and European Parliament, 2021, Proposal for a regulation of the European Parliament and of the Council laying down harmonised rules on artificial intelligence (Artificial Intelligence Act) and amending certain Union legislative acts; Cui JH, 2024, WELD WORLD, V68, P855, DOI 10.1007/s40194-024-01710-y; DAMA UK Working Group on Quality Dimensions, 2013, Technical Report; Declerck J, 2024, JMIR MED INF, V12, DOI 10.2196/51560; Deloitte GmbH Wirtschaftsprufungsgesellschaft, Trustworthy AI; Deng L, 2018, IEEE SIGNAL PROC MAG, V35, P180, DOI 10.1109/MSP.2017.2762725; Derry A, 2022, BIOCOMPUT-PAC SYM, P10; Deshsorn K, 2024, J POWER SOURCES, V597, DOI 10.1016/j.jpowsour.2024.234127; Dodge S, 2016, 2016 EIGHTH INTERNATIONAL CONFERENCE ON QUALITY OF MULTIMEDIA EXPERIENCE (QOMEX); Eder J., 2020, Data quality for medical data lakelands; Eid FE, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01674-5; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; europa.eu, EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines, V4; European Medicines Agency, 2022, Data quality framework for EU medicines regulation; European society of radiology, EIBALL - European Imaging Biomarkers Alliance; Fan FJ, 2022, BIOORGAN MED CHEM, V72, DOI 10.1016/j.bmc.2022.117003; Fawaz HI, 2019, IEEE IJCNN, DOI 10.1109/ijcnn.2019.8851936; FEINSTEIN AR, 1988, SCIENCE, V242, P1257, DOI 10.1126/science.3057627; Feng SY, 2021, Arxiv, DOI [arXiv:2105.03075, DOI 10.48550/ARXIV.2105.03075, 10.48550/arXiv.2105.03075]; Food and Drug Administration, 2019, Proposed regulatory framework for modifications to artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD); Frénay B, 2014, IEEE T NEUR NET LEAR, V25, P845, DOI 10.1109/TNNLS.2013.2292894; Furui S, 2012, IEEE SIGNAL PROC MAG, V29, P16, DOI 10.1109/MSP.2012.2209906; Gao J, 2016, PROCEEDINGS 2016 IEEE SYMPOSIUM ON SERVICE-ORIENTED SYSTEM ENGINEERING SOSE 2016, P433, DOI 10.1109/SOSE.2016.63; Gebhardt M, 1998, TENTH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT - PROCEEDINGS, P229, DOI 10.1109/SSDM.1998.688130; Gebru T, 2021, COMMUN ACM, V64, P86, DOI 10.1145/3458723; Geiger RS, 2020, FAT* '20: PROCEEDINGS OF THE 2020 CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, P325, DOI 10.1145/3351095.3372862; Ghotra B, 2015, 2015 IEEE/ACM 37TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, VOL 1, P789, DOI 10.1109/ICSE.2015.91; Glocker B, 2019, Arxiv, DOI [arXiv:1910.04597, DOI 10.48550/ARXIV.1910.04597]; Grandvalet Y, 1997, NEURAL COMPUT, V9, P1093, DOI 10.1162/neco.1997.9.5.1093; Gudivada V., 2017, INT J ADV SOFTW, V10, P1, DOI DOI 10.1007/S40745-020-00253-5; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Günes AM, 2023, MED PHYS, V50, P6421, DOI 10.1002/mp.16437; Guo LL, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-06484-1; Habib A, 2019, IEEE ACCESS, V7, P93275, DOI 10.1109/ACCESS.2019.2927726; Hatamizadeh A, 2022, LECT NOTES COMPUT SC, V12962, P272, DOI 10.1007/978-3-031-08999-2_22; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He TX, 2019, 11TH ASIA-PACIFIC SYMPOSIUM ON INTERNETWARE (INTERNETWARE 2019), DOI 10.1145/3361242.3361260; Hernandez-Boussard T, 2020, J AM MED INFORM ASSN, V27, P2011, DOI 10.1093/jamia/ocaa088; Holland S., 2020, Data Prot. Privacy, V12, P1, DOI DOI 10.5040/9781509932771.CH-001; Hong S., 2021, P ISMRM SMRT ANN M E; Hoyt GM, 2009, INT REV ECON EDUC, V8, P158, DOI 10.1016/S1477-3880(15)30073-6; Hu JL, 2023, ENG GEOL, V324, DOI 10.1016/j.enggeo.2023.107254; Hukkelas Hakon, 2023, 2023 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P140, DOI 10.1109/CVPRW59228.2023.00019; Ijab MT, 2019, MALAYS J COMPUT SCI, P25, DOI 10.22452/mjcs.sp2019no1.2; Institute of Electrical and Electronics Engineers, 1991, IEEE Standard Computer Dictionary: A Compilation of IEEE Standard Computer Glossaries, DOI [10.1109/IEEESTD.1990.101064, DOI 10.1109/IEEESTD.1990.101064, 10.1109/IEEESTD.1991.106963, DOI 10.1109/IEEESTD.1991.106963]; Interessengemeinschaft der Benannten Stellen fur Medizinprodukte in Deutschland - IG-NB, 2022, Questionnaire Artificial Intelligence (AI) in medical devices; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2016, Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2); International Organization for Standardization and International Electrotechnical Commission, 2008, ISO 25012; Ito A, 2021, IEEE T INF FOREN SEC, V16, P3790, DOI 10.1109/TIFS.2021.3092050; Jaramillo D, 2022, RADIOLOGY, V302, P511, DOI 10.1148/radiol.211891; Jaspers TJM, 2024, LECT NOTES COMPUT SC, V14313, P32, DOI 10.1007/978-3-031-47076-9_4; Jenkinson C, 2003, J CLIN EPIDEMIOL, V56, P843, DOI 10.1016/S0895-4356(03)00148-3; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Johnson JM, 2020, INFORM SYST FRONT, V22, P1113, DOI 10.1007/s10796-020-10022-7; Johnson JM, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0192-5; Johnson Steven G, 2015, AMIA Annu Symp Proc, V2015, P1937; Jouseau R, 2022, LECT NOTES COMPUT SC, V13756, P82, DOI 10.1007/978-3-031-21753-1_9; Juddoo S, 2018, APPL SYST INNOV, V1, DOI 10.3390/asi1040043; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kahn Michael G, 2016, EGEMS (Wash DC), V4, P1244; Kahneman D., 2011, THINKING FAST SLOW; Kale A, 2023, DATA INTELLIGENCE, V5, P139, DOI 10.1162/dint_a_00119; Karahan S, P 2016 INT C BIOM SP, P1; Karimi D, 2020, MED IMAGE ANAL, V65, DOI 10.1016/j.media.2020.101759; Khatri V, 2010, COMMUN ACM, V53, P148, DOI 10.1145/1629175.1629210; Kim B, 2019, PROC CVPR IEEE, P9004, DOI 10.1109/CVPR.2019.00922; Kim JY, 2022, INFORM TECHNOL PEOPL, V35, P861, DOI 10.1108/ITP-04-2019-0173; Kim KH, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11199188; Kim W, 2003, DATA MIN KNOWL DISC, V7, P81, DOI 10.1023/A:1021564703268; Krizhevsky A., 2009, .. Sci. Dep. Univ. Toronto; Lake SE, 2022, ASTRON COMPUT, V40, DOI 10.1016/j.ascom.2022.100617; Laney D., 2001, 3D DATA MANAGEMENT C; Larochelle H, 2009, J MACH LEARN RES, V10, P1; Lee JH, 2024, IEEE ACCESS, V12, P8346, DOI 10.1109/ACCESS.2024.3352146; Lewis AE, 2023, J AM MED INFORM ASSN, V30, P1730, DOI 10.1093/jamia/ocad120; Li B, 2023, ACM COMPUT SURV, V55, DOI 10.1145/3555803; Li Y, 2023, DIGIT COMMUN NETW, V9, P1061, DOI 10.1016/j.dcan.2021.12.001; Li Y, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.811241; Li YJ, 2021, 2021 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING (EMNLP 2021), P6332; Liaw Siaw-Teng, 2014, Inform Prim Care, V21, P199, DOI 10.14236/jhi.v21i4.87; Lim LLY, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-52; Lindquist M, 2004, DRUG SAFETY, V27, P857, DOI 10.2165/00002018-200427120-00003; Liu CH, 2023, J GLOB INF MANAG, V31, P25, DOI 10.4018/JGIM.316236; Liu HC, 2023, ACM T INTEL SYST TEC, V14, DOI 10.1145/3546872; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Long J., 2001, P 6 INT C INF QUAL, P370; Loshin D., 2011, Dimensions of data quality; Ma JX, 2022, IEEE COMPUT SOC CONF, P4849, DOI 10.1109/CVPRW56347.2022.00532; Malossini A, 2006, BIOINFORMATICS, V22, P2114, DOI 10.1093/bioinformatics/btl346; Mashoufi M, 2023, METHOD INFORM MED, V62, P5, DOI 10.1055/s-0043-1761500; Masko D., 2015, IMPACT IMBALANCED TR; Mazumder M., 2024, Adv. Neural Inf. Process. Syst., V36; Mehrabi N, 2021, ACM COMPUT SURV, V54, DOI 10.1145/3457607; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Michel E, 2000, MED INFORM INTERNET, V25, P147, DOI 10.1080/14639230050058329; Mitchell M, 2019, FAT*'19: PROCEEDINGS OF THE 2019 CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, P220, DOI 10.1145/3287560.3287596; Mo L, 2008, 2008 INTERNATIONAL SEMINAR ON FUTURE INFORMATION TECHNOLOGY AND MANAGEMENT ENGINEERING, PROCEEDINGS, P525, DOI 10.1109/FITME.2008.146; Motamedi M., 2021, arXiv, DOI [DOI 10.48550/ARXIV.2110.03613, 10.48550/arxiv.2110.03613]; Muehlematter UJ, 2021, LANCET DIGIT HEALTH, V3, pE195, DOI 10.1016/S2589-7500(20)30292-2; Muller NM, 2019, IEEE IJCNN, DOI DOI 10.1109/ijcnn.2019.8851920; Nahm M., 2012, Clinical research informatics, P175; National Cancer Institute US, QIN - Quantitative Imaging Network; Nikolados EM, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34902-5; Northcutt CG, 2021, J ARTIF INTELL RES, V70, P1373; Nuha FU, 2018, PROCEDIA COMPUT SCI, V144, P133, DOI 10.1016/j.procs.2018.10.513; Onofrey JA, 2019, I S BIOMED IMAGING, P348, DOI [10.1109/isbi.2019.8759295, 10.1109/ISBI.2019.8759295]; Ovadia Y, 2019, ADV NEUR IN, V32; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n160, 10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Pan YC, 2023, IEEE T INTELL TRANSP, V24, P6955, DOI 10.1109/TITS.2023.3256442; Pei YT, 2021, IEEE T PATTERN ANAL, V43, P1239, DOI 10.1109/TPAMI.2019.2950923; Peterson JC, 2019, IEEE I CONF COMP VIS, P9616, DOI 10.1109/ICCV.2019.00971; Pipino LL., 2002, COMMUN ACM, V45, P211, DOI [DOI 10.1145/505248.506010, 10.1145/505248.506010]; Pooch Eduardo H. P., 2020, Thoracic Image Analysis. Second International Workshop, TIA 2020. Held in Conjunction with MICCAI 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12502), P74, DOI 10.1007/978-3-030-62469-9_7; Pushkarna M., 2022, P ACM C FAIRN ACC TR; Qi ZX, 2021, J COMPUT SCI TECH-CH, V36, P806, DOI 10.1007/s11390-021-1344-6; Radiological Society of North America, ABOUT US; Radlinski L, 2023, ELECTRONICS-SWITZ, V12, DOI 10.3390/electronics12071656; Ramasamy A., 2020, J. Inf. Syst. Technol. Manag., DOI [10.4301/S1807-177520201700317, DOI 10.4301/S1807-177520201700317]; Ranjan R, 2023, COMPUT ELECTRON AGR, V205, DOI 10.1016/j.compag.2023.107644; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Remedios SW, 2020, MED PHYS, V47, P89, DOI 10.1002/mp.13880; Rolnick D, 2018, Arxiv, DOI arXiv:1705.10694; Rombach R, 2022, PROC CVPR IEEE, P10674, DOI 10.1109/CVPR52688.2022.01042; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rostamzadeh N., 2022, P ACM C FAIRN ACC TR; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sahu A, 2020, IEEE INT WORK TECH, P49, DOI 10.1109/cqr47547.2020.9101394; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmarje L., 2022, Is one annotation enough? A data-centric image classification benchmark for noisy and ambiguous label estimation; Schmidt CO, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-021-01252-7; Schnabel L., 2019, P 2 INT C ART INT IN; Sebastian-Coleman L., 2012, Measuring data quality for ongoing improvement: a data quality assessment framework; Sebastiao YV, 2021, INJURY EPIDEMIOL, V8, DOI 10.1186/s40621-021-00298-x; Sha LL, 2023, EXPERT SYST APPL, V228, DOI 10.1016/j.eswa.2023.120323; Shimizu Ayame, 2021, iiWAS2021: The 23rd International Conference on Information Integration and Web Intelligence, P87, DOI 10.1145/3487664.3487677; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Sidi F., 2012, 2012 International Conference on Information Retrieval & Knowledge Management (CAMP), P300, DOI 10.1109/InfRKM.2012.6204995; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Smilkov D, 2017, Arxiv, DOI [arXiv:1706.03825, DOI 10.48550/ARXIV.1706.03825]; Snodgrass S., 2017, P AAAI C ART INT INT, V13, P122; Souibgui M, 2019, PROCEDIA COMPUT SCI, V159, P676, DOI 10.1016/j.procs.2019.09.223; Stvilia B, 2007, J AM SOC INF SCI TEC, V58, P1720, DOI 10.1002/asi.20652; Sukhbaatar S, 2015, Arxiv, DOI [arXiv:1406.2080, DOI 10.48550/ARXIV.1406.2080]; Sun C, 2017, IEEE I CONF COMP VIS, P843, DOI 10.1109/ICCV.2017.97; Suresh H, 2021, PROCEEDINGS OF 2021 ACM CONFERENCE ON EQUITY AND ACCESS IN ALGORITHMS, MECHANISMS, AND OPTIMIZATION, EAAMO 2021, DOI 10.1145/3465416.3483305; Syed R, 2023, J MED INTERNET RES, V25, DOI 10.2196/42615; Tahar K, 2023, METHOD INFORM MED, DOI 10.1055/a-2006-1018; Taran Vlad, 2020, Advances in Computer Science for Engineering and Education II. Advances in Intelligent Systems and Computing (AISC 938), P183, DOI 10.1007/978-3-030-16621-2_17; Teoh ER, 2017, J SAFETY RES, V63, P57, DOI 10.1016/j.jsr.2017.08.008; The STANDING Together Collaboration, 2023, Recommendations for diversity, inclusivity, and generalisability in artificial intelligence health technologies and health datasets, DOI [10.5281/zenodo.10048356, DOI 10.5281/ZENODO.10048356]; Tran N, 2022, IEEE ACCESS, V10, P121900, DOI 10.1109/ACCESS.2022.3211313; Twala B, 2013, INTELL DATA ANAL, V17, P1115, DOI 10.3233/IDA-130623; UK Government, 2023, Chair's Summary of the AI Safety Summit 2023; Vanbrabant L, 2019, SIMUL MODEL PRACT TH, V91, P83, DOI 10.1016/j.simpat.2018.12.002; Vaswani A, 2017, ADV NEUR IN, V30; VDE Verband der Elektrotechnik Elektronik Informationstechnik e.V, 2022, VDE SPEC90012v1.0 (en); Verma RM, 2019, PROCEEDINGS OF THE 2019 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'19), P2605, DOI 10.1145/3319535.3363267; Vilça L, 2024, IEEE ACCESS, V12, P32532, DOI 10.1109/ACCESS.2024.3371020; Vincent P, 2008, P 25 INT C MACH LEAR, P1096, DOI 10.1145/1390156.1390294; Volkmann N, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11092655; von Eschenbach W.J., 2021, Philos. Technol., V34, P1607, DOI [DOI 10.1007/S13347-021-00477-0, 10.1007/S13347-021-00477-0]; Wang F, 2018, LECT NOTES COMPUT SC, V11213, P780, DOI 10.1007/978-3-030-01240-3_47; Wang LF, 2023, LANDSCAPE ECOL, V38, P4009, DOI 10.1007/s10980-023-01771-2; Wang R. Y., 1996, Journal of Management Information Systems, V12, P5; Wang RX, 2016, IEEE T IMAGE PROCESS, V25, P2117, DOI 10.1109/TIP.2016.2541318; Wang SR, 2022, IEEE T IMAGE PROCESS, V31, P6369, DOI 10.1109/TIP.2022.3211468; Wang Zhonghao, 2020, P IEEECVF C COMPUTER; Wei J., 2021, arXiv; Weiskopf NG, 2013, J AM MED INFORM ASSN, V20, P144, DOI 10.1136/amiajnl-2011-000681; Wesemeyer T, 2021, PROC SPIE, V11601, DOI 10.1117/12.2582226; Whang SE, 2023, VLDB J, V32, P791, DOI 10.1007/s00778-022-00775-9; Whittlestone J., 2019, Ethical and societal implications of algorithms, data, and artificial intelligence: A roadmap for research; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Wook M, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00439-5; Xiao H, 2017, Arxiv, DOI [arXiv:1708.07747, DOI 10.48550/ARXIV.1708.07747]; Xu G, 2024, EXPERT SYST APPL, V237, DOI 10.1016/j.eswa.2023.121686; Xu HJ, 2002, IND MANAGE DATA SYST, V102, P47, DOI 10.1108/02635570210414668; Xu S., 2023, Data quality matters: A case study of obsolete comment detection; Yoon V. Y., 2000, Information Resources Management Journal, V13, P5, DOI 10.4018/irmj.2000070101; Zemel Rich, 2013, INT C MACHINE LEARNI, P325; Zengin MS, 2023, TURK J ELECTR ENG CO, V31, P1206, DOI 10.55730/1300-0632.4043; Zha D., 2023, arXiv, DOI [10.48550/arXiv.2303.10158, DOI 10.48550/ARXIV.2303.10158]; Zhang H., 2023, P 40 INT C MACHINE L, V202, P41550; Zhao J., 2017, P 22 C EMP METH NAT, P2979; Zhong XT, 2021, NPJ COMPUT MATER, V7, DOI 10.1038/s41524-021-00616-3; Zhou Y, 2011, ADV INTEL SOFT COMPU, V106, P19; Zhu Simeng, 2022, Int J Med Inform, V165, P104828, DOI 10.1016/j.ijmedinf.2022.104828	230	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2398-6352			NPJ DIGIT MED	npj Digit. Med.	AUG 3	2024	7	1							203	10.1038/s41746-024-01196-4	http://dx.doi.org/10.1038/s41746-024-01196-4			30	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	A5M8G	39097662				2024-09-18	WOS:001282977800001
J	D'Angelo, G; Della-Morte, D; Pastore, D; Donadel, G; De Stefano, A; Palmieri, F				D'Angelo, Gianni; Della-Morte, David; Pastore, Donatella; Donadel, Giulia; De Stefano, Alessandro; Palmieri, Francesco			Identifying patterns in multiple biomarkers to diagnose diabetic foot using an explainable genetic programming-based approach	FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE			English	Article						Diabetic Foot; Explainable Artificial Intelligence (XAI); Interpretability; Explainability; Genetic programming (GP); Symbolic regression (SR); Machine Learning	ULCERS	Diabetes mellitus is a global health problem, recognized as the seventh cause of death in the world. One of the most debilitating complications of diabetes mellitus is the diabetic foot (DF), resulting in an increased risk of hospitalization and significant morbidity and mortality. Amputation above or below the knee is a feared complication and the mortality in these patients is higher than for most forms of cancer. Identifying and interpreting relationships existing among the factors involved in DF diagnosis is still challenging. Although machine learning approaches have proven to achieve great accuracy in DF prediction, few advances have been performed in understanding how they make such predictions, resulting in mistrust of their use in real contexts. In this study, we present an approach based on Genetic Programming to build a simple global explainable classifier, named X-GPC, which, unlike existing tools such as LIME and SHAP, provides a global interpretation of the DFU diagnosis through a mathematical model. Also, an easy consultable 3d graph is provided, which could be used by the medical staff to figure out the patients' situation and take decisions for patients' healing. Experimental results obtained by using a real-world dataset have shown the ability of the proposal to diagnose DF with an accuracy of 100% outperforming other techniques of the state-of-the-art.(c) 2022 Elsevier B.V. All rights reserved.	[D'Angelo, Gianni; Palmieri, Francesco] Univ Salerno, Dept Comp Sci, Fisciano, SA, Italy; [Della-Morte, David] Univ Miami, Miller Sch Med, Dept Neurol, Clin Res Bldg, Miami, FL 33136 USA; [Della-Morte, David; Pastore, Donatella] San Raffaele Telematic Univ, Dept Human Sci & Promot Qual Life, Rome, Italy; [Donadel, Giulia] Tor Vergata Univ, Dept Clin Sci & Translat Med, Rome, Italy; [Della-Morte, David; De Stefano, Alessandro] Tor Vergata Univ, Dept Syst Med, Rome, Italy	University of Salerno; University of Miami; University of Rome Tor Vergata; University of Rome Tor Vergata	D'Angelo, G (corresponding author), Univ Salerno, Dept Comp Sci, Fisciano, SA, Italy.	giadangelo@unisa.it; ddellamorte@med.miami.edu; donatella.pastore@uniroma5.it; donadel@uniroma2.it; alessandrodestefano6@virgilio.it; fpalmieri@unisa.it	Della-Morte, David/K-1011-2018; Palmieri, Francesco/AAT-9080-2020; Donadel, Giulia/M-1900-2019; D'ANGELO, Gianni/ABF-8706-2020					Albrecht J.P., 2016, Em European Data Protection Law Review, V2, P287, DOI DOI 10.21552/EDPL/2016/3/4; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS15, DOI 10.2337/dc21-S002; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS151, DOI 10.2337/dc21-S011; [Anonymous], 2006, CROSSOVER SINGLE OBJ; [Anonymous], 2016, Diabetes Care; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Czerwinska U., 2022, LECT NOTES COMPUT SC, P275, DOI [10.1007/978-3-030-88389-8_14, DOI 10.1007/978-3-030-88389-8_14]; D'Angelo G, 2022, INFORM PROCESS MANAG, V59, DOI 10.1016/j.ipm.2022.102930; D'Angelo G, 2022, SOFT COMPUT, V26, P1779, DOI 10.1007/s00500-022-06757-x; D'Angelo G, 2021, INT J INTELL SYST, V36, P7080, DOI 10.1002/int.22581; D'Angelo G, 2021, IEEE INTERNET THINGS, V8, P12518, DOI 10.1109/JIOT.2020.3032935; D'Angelo G, 2021, APPL SOFT COMPUT, V105, DOI 10.1016/j.asoc.2021.107234; D'Angelo G, 2023, NEURAL COMPUT APPL, V35, P13861, DOI 10.1007/s00521-021-05913-y; D'Angelo G, 2020, INT J INTELL SYST, V35, P1680, DOI 10.1002/int.22268; Elia S, 2020, SOFT COMPUT, V24, P7281, DOI 10.1007/s00500-019-04344-1; Everett E, 2018, ANN NY ACAD SCI, V1411, P153, DOI 10.1111/nyas.13569; Gandomi A.H., 2015, Handbook of Genetic Programming Applications, DOI [10.1007/978-3-319-20883-1, DOI 10.1007/978-3-319-20883-1]; Goadrich M, 2006, ACM INT C PROCEEDING, P233, DOI 10.1145/1143844.1143874; Hanif A, 2021, IEEE INT ENTERP, P81, DOI 10.1109/EDOCW52865.2021.00036; KOZA JR, 1994, STAT COMPUT, V4, P87, DOI 10.1007/BF00175355; Lundberg SM, 2017, ADV NEUR IN, V30; Makridakis S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194889; Markus AF, 2021, J BIOMED INFORM, V113, DOI 10.1016/j.jbi.2020.103655; Marom Nadav David, 2010, 2010 IEEE 26th Convention of Electrical & Electronics Engineers in Israel (IEEEI 2010), P555, DOI 10.1109/EEEI.2010.5662159; Molnar C., 2022, Interpretable Machine Learning: A Guide for Making Black Box Models Explainable, V2nd ed., DOI DOI 10.1007/S10290-014-0202-9; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Pastore D, 2022, EUR REV MED PHARMACO, V26, P558, DOI 10.26355/eurrev_202201_27883; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Sarker Iqbal H, 2021, SN Comput Sci, V2, P160, DOI 10.1007/s42979-021-00592-x; Searson D.P., 2015, Handbook of Genetic Programming Applications; Tukey J. W, 1977, ADDISON WESLEY SERIE; Witten IH, 2011, MOR KAUF D, P1	33	26	26	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-739X	1872-7115		FUTURE GENER COMP SY	Futur. Gener. Comp. Syst.	MAR	2023	140						138	150		10.1016/j.future.2022.10.019	http://dx.doi.org/10.1016/j.future.2022.10.019		NOV 2022	13	Computer Science, Theory & Methods	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	9C7DQ					2024-09-18	WOS:000935574100003
J	Pai, S; Bader, GD				Pai, Shraddha; Bader, Gary D.			Patient Similarity Networks for Precision Medicine	JOURNAL OF MOLECULAR BIOLOGY			English	Review						precision medicine; machine learning; patient classifier; genomics; networks	GENOME-WIDE ASSOCIATION; BREAST-CANCER; RISK SCORE; GENETIC RISK; CARDIOVASCULAR-DISEASE; MOLECULAR PORTRAITS; PREDICTION; SCHIZOPHRENIA; INTEGRATION; INDIVIDUALS	Clinical research and practice in the 21st century is poised to be transformed by analysis of computable electronic medical records and population-level genome-scale patient profiles. Genomic data capture genetic and environmental state, providing information on heterogeneity in disease and treatment outcome, but genomic-based clinical risk scores are limited. Achieving the goal of routine precision medicine that takes advantage of these rich genomics data will require computational methods that support heterogeneous data, have excellent predictive performance, and ideally, provide biologically interpretable results. Traditional machine-learning approaches excel at performance, but often have limited interpretability. Patient similarity networks are an emerging paradigm for precision medicine, in which patients are clustered or classified based on their similarities in various features, including genomic profiles. This strategy is analogous to standard medical diagnosis, has excellent performance, is interpretable, and can preserve patient privacy. We review new methods based on patient similarity networks, including Similarity Network Fusion for patient clustering and netDx for patient classification. While these methods are already useful, much work is required to improve their scalability for contemporary genetic cohorts, optimize parameters, and incorporate a wide range of genomics and clinical data. The coming 5 years will provide an opportunity to assess the utility of network-based algorithms for precision medicine. (C) 2018 The Authors. Published by Elsevier Ltd.	[Pai, Shraddha; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Bader, Gary D.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bader, GD (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.	gary.bader@utoronto.ca			NRNB (U.S. National Institutes of Health, National Center for Research Resources) [P41 GM103504]	NRNB (U.S. National Institutes of Health, National Center for Research Resources)	This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources, Grant No. P41 GM103504). We thank Ruth Isserlin for providing prepared data for the ependymoma classification example.	Abraham G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004137; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Andersen AM, 2017, JAMA PSYCHIAT, V74, P1153, DOI 10.1001/jamapsychiatry.2017.2269; [Anonymous], NETDX INTERPRETABLE; [Anonymous], DEEPNF DEEP NETWORK; Bendl J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004962; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Braun KVE, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0304-4; Brindle P, 2006, HEART, V92, P1595, DOI 10.1136/hrt.2006.092346; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen F, 2017, BIOINFORMATICS, V33, P871, DOI 10.1093/bioinformatics/btw758; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho H, 2016, CELL SYST, V3, P540, DOI 10.1016/j.cels.2016.10.017; Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI [10.1093/nar/gkt1102, 10.1093/nar/gkz1031]; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; den Hollander P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00250; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engchuan W, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S7; Escott-Price V, 2017, NEUROBIOL AGING, V49, DOI 10.1016/j.neurobiolaging.2016.07.018; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Farshidfar F, 2017, CELL REP, V19, P2878, DOI 10.1016/j.celrep.2017.06.008; Farshidfar F, 2017, CELL REP, V18, P2780, DOI [10.1016/j.celrep.2017.06.008, 10.1016/j.celrep.2017.02.033]; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Franzén O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970; Friend SH, 2011, NAT BIOTECHNOL, V29, P215, DOI 10.1038/nbt.1794; Gaonkar B, 2015, MED IMAGE ANAL, V24, P190, DOI 10.1016/j.media.2015.06.008; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Gerstung M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6901; Gradishar WJ, 2017, J NATL COMPR CANC NE, V15, P433, DOI 10.6004/jnccn.2017.0044; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harrison PJ, 2015, J PSYCHOPHARMACOL, V29, P85, DOI 10.1177/0269881114553647; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; Ikeda M, 2018, MOL PSYCHIATR, V23, P639, DOI 10.1038/mp.2016.259; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Katsnelson A, 2013, NAT MED, V19, P249, DOI 10.1038/nm0313-249; Kennedy SH, 2012, CURR PHARM DESIGN, V18, P5976; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kucera Mike, 2016, F1000Res, V5, P1717; Kuzniewicz MW, 2017, JAMA PEDIATR, V171, P365, DOI 10.1001/jamapediatrics.2016.4678; Ledford H, 2016, NATURE, V532, P427, DOI 10.1038/nature.2016.19797; Lee AJ, 2014, BRIT J CANCER, V110, P535, DOI 10.1038/bjc.2013.730; Li L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9364; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Märtens K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11512; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peña-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pratt D, 2015, CELL SYST, V1, P302, DOI 10.1016/j.cels.2015.10.001; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rana JS, 2016, J AM COLL CARDIOL, V67, P2118, DOI 10.1016/j.jacc.2016.02.055; Rasmussen PM, 2011, NEUROIMAGE, V55, P1120, DOI 10.1016/j.neuroimage.2010.12.035; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Romero P, 2005, GENOME BIOL, V6; Ruffalo M, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0471-8; Sanchez-Roige S, 2018, NAT NEUROSCI, V21, P16, DOI 10.1038/s41593-017-0032-x; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Stephen J, 2014, BRIT J CANCER, V111, P2242, DOI 10.1038/bjc.2014.530; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tang G, 2011, BREAST CANCER RES TR, V127, P133, DOI 10.1007/s10549-010-1331-z; TRUETT J, 1967, J CHRON DIS, V20, P511, DOI 10.1016/0021-9681(67)90082-3; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wallden B, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0129-6; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Webb S, 2018, NATURE, V554, P555, DOI 10.1038/d41586-018-02174-z; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Xu ZL, 2013, JNCI-J NATL CANCER I, V105, P694, DOI 10.1093/jnci/djt045; Yousefi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11817-6; Yuan Y, 2014, NAT BIOTECHNOL, V32, P644, DOI 10.1038/nbt.2940; Zhang LY, 2006, J UROLOGY, V176, P1392, DOI 10.1016/j.juro.2006.06.103; Zhang ZF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175822	105	68	76	2	32	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836	1089-8638		J MOL BIOL	J. Mol. Biol.	SEP 14	2018	430	18	A		SI		2924	2938		10.1016/j.jmb.2018.05.037	http://dx.doi.org/10.1016/j.jmb.2018.05.037			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT8MA	29860027	Green Accepted, hybrid			2024-09-18	WOS:000444790400005
C	Pulido, SD; Bocanegra, AJ; López, JM; Forero, MG; Cancino, SL		Tescher, AG; Ebrahimi, T		Pulido, Sergio D.; Bocanegra, Alvaro J.; Lopez, Juan M.; Forero, Manuel G.; Cancino, Sandra L.			Feature Relevance in Dermoscopy Images by the Use of ABCD Standard	APPLICATIONS OF DIGITAL IMAGE PROCESSING XLIII	Proceedings of SPIE		English	Proceedings Paper	Conference on Applications of Digital Image Processing XLIII	AUG 24-SEP 04, 2020	ELECTR NETWORK	SPIE		Classification; Dermoscopy; Segmentation; Interpretable features	MELANOMAS; DIAGNOSIS; CANCER; RULE	The use of complex classification algorithms such as deep learning techniques does not allow the researchers to identify the most discriminant features for tumor classification as they lack interpretability. This study aims to develop an algorithm capable of differentiating a set of dermoscopic images depending on whether the tumor is benign or malignant. The priority of this research is to obtain the importance of each extracted feature. This work is focused on the ABCD rule feature analysis and it aims to find the relevance of each feature and its performance in a classification model. A relevant aspect of this study is the use of a heterogeneous database, where the images were uploaded by different sources worldwide. A combination of novel and previously used features are analyzed and their importance is computed by the use of a Gaussian mixture model. After selecting the most discriminant features, a set of classification models was applied to find the best model with the less quantity of features. We found that a total of 65.89% of the features could be omitted with a loss in accuracy, sensibility and specificity equal or lower than 2%. While similar performance measures have been employed in other studies, most results are not comparable, as the databases used were more homogeneous. In the remaining studies, sensitivity values are comparable, with the main difference that the proposed model is interpretable.	[Pulido, Sergio D.; Bocanegra, Alvaro J.; Lopez, Juan M.; Cancino, Sandra L.] Escuela Colombiana Ingn Julio Garavito, AK 45 205-59, Bogota, Colombia; [Forero, Manuel G.] Univ Ibague, Fac Ingn, Carrera 22 Calle 67, Ibague, Colombia		Pulido, SD (corresponding author), Escuela Colombiana Ingn Julio Garavito, AK 45 205-59, Bogota, Colombia.	sergio.pulido@mail.escuelaing.edu.co	Benitez, Suzana/W-9917-2018	Bocanegra Perez, Alvaro Jose/0000-0002-3083-8379; Forero, Manuel/0000-0001-9972-8621; Lopez Lopez, Juan Manuel/0000-0002-3595-3317				Abbasi NR, 2004, JAMA-J AM MED ASSOC, V292, P2771, DOI 10.1001/jama.292.22.2771; Agarwal A, 2017, 2017 4TH IEEE UTTAR PRADESH SECTION INTERNATIONAL CONFERENCE ON ELECTRICAL, COMPUTER AND ELECTRONICS (UPCON), P632, DOI 10.1109/UPCON.2017.8251123; Angelina S., 2012, 2012 International Conference on Computing, Electronics and Electrical Technologies (ICCEET 2012), P970, DOI 10.1109/ICCEET.2012.6203833; [Anonymous], 2006, Pattern Recognition and Machine Learning; [Anonymous], 2002, P 5 NORD SIGN PROC S; Barata C, 2014, IEEE SYST J, V8, P965, DOI 10.1109/JSYST.2013.2271540; Carcagnì P, 2019, LECT NOTES COMPUT SC, V11751, P335, DOI 10.1007/978-3-030-30642-7_30; Collaboration I. S. I, OVERVIEW; de Salud y Protecci~on Social M. and Colciencias, 2014, GUIA PRACTICA CLINIC; Fan HD, 2017, COMPUT BIOL MED, V85, P75, DOI 10.1016/j.compbiomed.2017.03.025; Garnavi R, 2015, INT J MED MED SCI, V1, P126; Gómez C, 2017, PROC SPIE, V10572, DOI 10.1117/12.2285957; Gulati S, 2018, INT C INN BIOINSP CO, P350; Jaworek-Korjakowska J, 2016, BIOMED RES INT, V8; Jaworek-Korjakowska J, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/496202; Khazaei Z, 2019, WORLD CANCER RES J, V6; Kim D, 2019, EMERG MARK FINANC TR, P1, DOI [DOI 10.1080/15404.96X.2019.1588725, DOI 10.1080/1540496X.2019.1588725]; Maron RC, 2019, EUR J CANCER, V119, P57, DOI 10.1016/j.ejca.2019.06.013; McGuire S, 2016, ADV NUTR, V7, P418, DOI 10.3945/an.116.012211; Müller KR, 2009, AN BRAS DERMATOL, V84, P593, DOI 10.1590/S0365-05962009000600004; NACHBAR F, 1994, J AM ACAD DERMATOL, V30, P551, DOI 10.1016/S0190-9622(94)70061-3; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pardo, 2015, INCIDENCIA MORTALIDA; Pathan S., 2019, BIOMED PHARMACOL J, V12, P107, DOI [10.13005/bpj/1619, DOI 10.13005/bpj/1619]; Ramezani M, 2019, J MED SIGNALS SENS, V4, P281; Ruela M, 2017, COMP M BIO BIO E-IV, V5, P127, DOI 10.1080/21681163.2015.1029080; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Zhou Y, 2010, SKIN RES TECHNOL, V16, P66, DOI 10.1111/j.1600-0846.2009.00403.x	28	1	1	0	1	SPIE-INT SOC OPTICAL ENGINEERING	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA	0277-786X	1996-756X	978-1-5106-3827-3	PROC SPIE			2020	11510								115101M	10.1117/12.2567946	http://dx.doi.org/10.1117/12.2567946			14	Computer Science, Software Engineering; Imaging Science & Photographic Technology	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science; Imaging Science & Photographic Technology	BR1HL					2024-09-18	WOS:000632397900045
J	Azizi, A; Azizi, M; Nasri, M				Azizi, Abdellah; Azizi, Mostafa; Nasri, Mbarek			Artificial Intelligence Techniques in Medical Imaging: A Systematic Review	INTERNATIONAL JOURNAL OF ONLINE AND BIOMEDICAL ENGINEERING			English	Review						artificial intelligence (AI); machine learning (ML); deep learning (DL); medical imaging; classification; detection; segmentation	BREAST-CANCER; SEGMENTATION; CLASSIFICATION; NETWORKS	This scientific review presents a comprehensive overview of medical imaging modalities and their diverse applications in artificial intelligence (AI)-based disease classification and seg-mentation. The paper begins by explaining the fundamental concepts of AI, machine learning (ML), and deep learning (DL). It provides a summary of their different types to establish a solid foundation for the subsequent analysis. The prmary focus of this study is to conduct a systematic review of research articles that examine disease classification and segmentation in different anatomical regions using AI methodologies. The analysis includes a thorough exam-ination of the results reported in each article, extracting important insights and identifying emerging trends. Moreover, the paper critically discusses the challenges encountered during these studies, including issues related to data availability and quality, model generalization, and interpretability. The aim is to provide guidance for optimizing technique selection. The analysis highlights the prominence of hybrid approaches, which seamlessly integrate ML and DL techniques, in achieving effective and relevant results across various disease types. The promising potential of these hybrid models opens up new opportunities for future research in the field of medical diagnosis. Additionally, addressing the challenges posed by the limited availability of annotated medical images through the incorporation of medical image synthe-sis and transfer learning techniques is identified as a crucial focus for future research efforts.	[Azizi, Abdellah; Azizi, Mostafa; Nasri, Mbarek] Mohammed I Univ, Lab MATSI, ESTO, Oujda, Morocco	Mohammed First University of Oujda	Azizi, A (corresponding author), Mohammed I Univ, Lab MATSI, ESTO, Oujda, Morocco.	abdellah.azizi@ump.ac.ma	AZIZI, Mostafa/AAG-2276-2019					Albawi S, 2017, I C ENG TECHNOL; Altan G, 2022, ENG SCI TECHNOL, V34, DOI 10.1016/j.jestch.2021.101091; Aly M., 2005, Neural Netw., V19, P1; Alzubaidi L, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00444-8; Ameer SF, 2020, INT J ONLINE BIOMED, V16, P140, DOI 10.3991/ijoe.v16i05.12999; Ammar A, 2021, COMPUT MED IMAG GRAP, V88, DOI 10.1016/j.compmedimag.2021.101864; Anderson J., 2022, Medical Image Analysis, V47; [Anonymous], 2022, CT Scan; Araújo JDL, 2022, COMPUT BIOL MED, V140, DOI 10.1016/j.compbiomed.2021.105095; Ardila D, 2019, NAT MED, V25, P954, DOI 10.1038/s41591-019-0447-x; Aswathy SU, 2020, INT J BIOMED ENG TEC, V33, P386, DOI 10.1504/IJBET.2020.108993; Ayodele TO., 2010, Types of machine learning algorithms," in, V3, P19, DOI [DOI 10.5772/9385, 10.5772/9385]; Diniz JOB, 2022, EXPERT SYST APPL, V196, DOI 10.1016/j.eswa.2022.116632; Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; Bhagat N, 2022, MATER TODAY-PROC, V51, P2233, DOI 10.1016/j.matpr.2021.11.368; Bidkar PS, 2022, GENE EXPR PATTERNS, V45, DOI 10.1016/j.gep.2022.119248; Brown J., 2023, Journal of Medical Imaging, V15; Chen B., 2021, NeuroImage: Clinical, V35; Chen J, 2021, COMPUT METH PROG BIO, V200, DOI 10.1016/j.cmpb.2020.105878; Chen Y., 2020, Journal of Medical Informatics, V42, P318; Chen Y., 2022, NeuroImage, V54; Cover T. M., 2006, Elements of Information Theory, V2nd; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Creswell A, 2018, IEEE SIGNAL PROC MAG, V35, P53, DOI 10.1109/MSP.2017.2765202; Das A, 2019, COGN SYST RES, V54, P165, DOI 10.1016/j.cogsys.2018.12.009; De A, 2021, EXPERT SYST APPL, V169, DOI 10.1016/j.eswa.2020.114338; Duran A, 2022, MED IMAGE ANAL, V77, DOI 10.1016/j.media.2021.102347; Duszak Jr D. J., 2014, J. Am. Coll. Radiol., V11, P1044, DOI [10.1016/j.jacr.2014.07.008, DOI 10.1016/J.JACR.2014.07.008]; El-Askary NS, 2022, EXPERT SYST APPL, V193, DOI 10.1016/j.eswa.2021.116489; Elaziz MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235187; Erikson B., 2017, Journal of Medical Imaging, V4; Fang X, 2020, INT J COMPUT ASS RAD, V15, P963, DOI 10.1007/s11548-020-02147-6; Ferber J., 1999, Multi-agent systems: an introduction to distributed artificial intelligence, V1; Garcia G., 2023, Medical Imaging Journal, V28; Garcia G., 2022, Journal of Biomedical Optics, V53, P1234; Gaur P, 2022, BIOMED SIGNAL PROCES, V71, DOI 10.1016/j.bspc.2021.103076; Gill KS, 2016, AI SOC, V31, P137, DOI [10.1007/s00146-016-0651-x, 10.1007/s00146-014-0576-1]; Glatard T, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00012; Goehler A, 2020, J AM COLL RADIOL, V17, P1475, DOI 10.1016/j.jacr.2020.06.033; Goertzel B., 2009, Artificial General Intelligence; Greene D, 2008, COGN TECHNOL, P51, DOI 10.1007/978-3-540-75171-7_3; Gu JX, 2018, PATTERN RECOGN, V77, P354, DOI 10.1016/j.patcog.2017.10.013; Hambarde P, 2020, BIOCYBERN BIOMED ENG, V40, P1421, DOI 10.1016/j.bbe.2020.07.011; Herent P, 2019, DIAGN INTERV IMAG, V100, P219, DOI 10.1016/j.diii.2019.02.008; Hu RY, 2022, INFORM PROCESS MANAG, V59, DOI 10.1016/j.ipm.2021.102782; Huang ZW, 2022, COMPUT METH PROG BIO, V223, DOI 10.1016/j.cmpb.2022.106993; Jain A. K., 2004, Handbook of biometrics, V428, DOI [10.1007/b97485, DOI 10.1007/B97485]; Jiang Y., 2021, Ultrasound in Medicine & Biology, V47, P1234; Johnson B., 2019, Medical Image Analysis, V29, P12; Johnson C., 2023, Journal of Nuclear Cardiology, V49, P789; Johnson C., 2023, Journal of Biophotonics, V55, P1123; Juneja M, 2022, COMPUT ELECTR ENG, V101, DOI 10.1016/j.compeleceng.2022.108009; Juneja M, 2020, MULTIMED TOOLS APPL, V79, P15531, DOI 10.1007/s11042-019-7460-4; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kalteh AM, 2008, ENVIRON MODELL SOFTW, V23, P835, DOI 10.1016/j.envsoft.2007.10.001; Kaplan A, 2019, BUS HORIZONS, V62, P15, DOI 10.1016/j.bushor.2018.08.004; Karthik R, 2022, BIOCYBERN BIOMED ENG, V42, P963, DOI 10.1016/j.bbe.2022.07.006; Khairandish MO, 2022, IRBM, V43, P290, DOI 10.1016/j.irbm.2021.06.003; Khan SI, 2022, J KING SAUD UNIV-COM, V34, P6217, DOI 10.1016/j.jksuci.2021.08.004; Kim K., 2021, IEEE Transactions on Biomedical Engineering, V68, P876; Kim K., 2023, Gastrointestinal Endoscopy, V48, P789; Kim KC, 2021, COMPUT METH PROG BIO, V200, DOI 10.1016/j.cmpb.2020.105833; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Kononenko I.I. B., 1998, Machine learning and data mining: Methods and applications; Kumari, 2017, INT J COMPUT APPL, V160, P11, DOI [10.5120/ijca2017913083, DOI 10.5120/IJCA2017913083]; Lal S, 2021, COMPUT BIOL MED, V128, DOI 10.1016/j.compbiomed.2020.104075; Lavanya M, 2021, INT J BIOMED ENG TEC, V37, P185, DOI 10.1504/IJBET.2021.119504; Le Roux N, 2008, NEURAL COMPUT, V20, P1631, DOI 10.1162/neco.2008.04-07-510; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee H., 2023, Journal of Nuclear Medicine, V53, P1123; Lee J., 2020, IEEE Transactions on Medical Imaging, V39, P2492; Lewis P. R., 2011, Proceedings of the 2011 Fifth IEEE Conference on Self-Adaptive and Self-Organizing Systems Workshops (SASOW 2011), P102, DOI 10.1109/SASOW.2011.25; Li M., 2021, IEEE Transactions on Medical Imaging, V40, P1755; Li P, 2015, MOL PSYCHIATR, V20, P1339, DOI 10.1038/mp.2014.182; Li Q, 2021, COMPUT METH PROG BIO, V209, DOI 10.1016/j.cmpb.2021.106333; Li WQ, 2022, ENG APPL ARTIF INTEL, V114, DOI 10.1016/j.engappai.2022.105102; Loey M, 2022, COMPUT BIOL MED, V142, DOI 10.1016/j.compbiomed.2022.105213; Maity S, 2019, J MANAG DEV, V38, P651, DOI 10.1108/JMD-03-2019-0069; Mann S., 2009, Physics Today, V62, P30, DOI [10.1063/PT.3.1246, DOI 10.1063/PT.3.1246]; Martinez C., 2019, IEEE Transactions on Medical Imaging, V38, P564; Mbarki W, 2020, INTERDISCIP NEUROSUR, V22, DOI 10.1016/j.inat.2020.100837; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Mou L, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101874; Nayak DR, 2022, COMPUT ELECTR ENG, V102, DOI 10.1016/j.compeleceng.2022.108238; Nishio M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200721; Nour M, 2020, APPL SOFT COMPUT, V97, DOI 10.1016/j.asoc.2020.106580; Ongsulee P, 2018, 2017 15th International Conference on ICT and Knowledge Engineering (ICT KE), P1, DOI [DOI 10.1109/ICTKE.2017.8259629, 10.1109/ictke.2017.8259629]; Osisanwo F. Y., 2017, Int. J. Comput. Trends Technol. (IJCTT), V48, P128, DOI [DOI 10.14445/22312803/IJCTT-V48P126, 10.14445/22312803/IJCTT-V48P126]; Patel D., 2021, Computers in Biology and Medicine, V128; Patel D., 2022, Medical Image Analysis, V49; Qureshi I, 2021, MULTIMED TOOLS APPL, V80, P11691, DOI 10.1007/s11042-020-10238-4; Rabinowitz NC, 2018, PR MACH LEARN RES, V80; Rai HM, 2022, APPL INTELL, V52, P5366, DOI 10.1007/s10489-021-02696-6; Rajendran R., 2012, International Journal of Science, Engineering and Management, V3, P12; Rasheed Mohammed, 2021, Journal of Physics: Conference Series, DOI 10.1088/1742-6596/1999/1/012080; Rath A, 2021, BIOMED SIGNAL PROCES, V68, DOI 10.1016/j.bspc.2021.102820; Ray Susmita, 2019, 2019 International Conference on Machine Learning, Big Data, Cloud and Parallel Computing (COMITCon), P35, DOI 10.1109/COMITCon.2019.8862451; Ruijters P. J. L., 2015, Journal of Digital Imaging, V28, P486, DOI [10.1007/s10278-015-9794-x, DOI 10.1007/S10278-015-9794-X]; Salama WM, 2021, ALEX ENG J, V60, P4701, DOI 10.1016/j.aej.2021.03.048; Salvi M, 2021, ARTIF INTELL MED, V115, DOI 10.1016/j.artmed.2021.102076; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sekaran R, 2022, COMPUT BIOL MED, V149, DOI 10.1016/j.compbiomed.2022.105990; Shavlik J. W., 1990, Readings in Machine Learning; Sherstinsky A, 2020, PHYSICA D, V404, DOI 10.1016/j.physd.2019.132306; Shia WC, 2021, COMPUT MED IMAG GRAP, V87, DOI 10.1016/j.compmedimag.2020.101829; Singh A, 2016, PROCEEDINGS OF THE 10TH INDIACOM - 2016 3RD INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT, P1310; Smith A., 2023, Neurosurgery, V52, P1234; Smith A., 2022, Medical Imaging Journal, V25; Smith A., 2020, Medical Imaging Journal, V28; Smith J., 2023, Ultrasound in Medicine & Biology, V49, P1897; Sodickson S., 2020, Goldman-Cecil Medicine, V26th, P74; Sun ML, 2017, NEUROCOMPUTING, V224, P96, DOI 10.1016/j.neucom.2016.10.049; Sunsuhi GS, 2022, BIOMED SIGNAL PROCES, V78, DOI 10.1016/j.bspc.2022.103863; Thompson A., 2023, European Journal of Nuclear Medicine and Molecular Imaging, V52, P1234; Tsoumakas G., 2007, INT J DATA WAREHOUS, V2007, P1; van der Maaten L. J. P., 2009, J Mach Learn Res, V10, P66; Vankdothu R, 2022, COMPUT ELECTR ENG, V101, DOI 10.1016/j.compeleceng.2022.107960; Vankdothua R., 2022, MEAS SENS, V24; Viji KSA, 2020, MATER TODAY-PROC, V24, P1944, DOI 10.1016/j.matpr.2020.03.622; Wang KF, 2017, IEEE-CAA J AUTOMATIC, V4, P588, DOI 10.1109/JAS.2017.7510583; Wang LV, 2012, Biomedical optics: principles and imaging; Wang Y., 2021, Medical Physics, V48, P1268; Williams D., 2021, Medical Imaging Journal, V31, P889; Younis YS, 2022, J NANOMATER, V2022, DOI 10.1155/2022/2641239; Zagzebski J. A., 2013, Essentials of ultrasound physics; Zhang L, 2021, ALEX ENG J, V60, P897, DOI 10.1016/j.aej.2020.10.018; Zhang X., 2017, Medical Image Analysis, V40, P61; Zhao S, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101826; Zhao ZJ, 2020, ENG APPL ARTIF INTEL, V91, DOI 10.1016/j.engappai.2020.103571; Zhu X., 2005, Technical Report 1530	130	0	0	2	4	Int Federation Engineering Education Societies-IFEES	Fairfax	4400 University Drive, MS 4A3, Fairfax, VA, UNITED STATES		2626-8493		INT J ONLINE BIOMED	Int. J. Online Biomed. Eng.		2023	19	17					66	97		10.3991/ijoe.v19i17.42431	http://dx.doi.org/10.3991/ijoe.v19i17.42431			32	Computer Science, Interdisciplinary Applications	Emerging Sources Citation Index (ESCI)	Computer Science	CR8F6		gold			2024-09-18	WOS:001127054400007
J	Maghsoudi, Z; Nguyen, H; Tavakkoli, A; Nguyen, T				Maghsoudi, Zeynab; Nguyen, Ha; Tavakkoli, Alireza; Nguyen, Tin			A comprehensive survey of the approaches for pathway analysis using multi-omics data integration	BRIEFINGS IN BIOINFORMATICS			English	Review						integrative pathway analysis; multi-omics integration; multi-cohort analysis; pathway graph transformation	GENE SET ENRICHMENT; RANK AGGREGATION; MICROARRAY DATA; GENOMICS DATA; EXPRESSION; CANCER; TOOL; METAANALYSIS; TRANSCRIPTOMICS; VISUALIZATION	Pathway analysis has been widely used to detect pathways and functions associated with complex disease phenotypes. The proliferation of this approach is due to better interpretability of its results and its higher statistical power compared with the gene-level statistics. A plethora of pathway analysis methods that utilize multi-omics setup, rather than just transcriptomics or proteomics, have recently been developed to discover novel pathways and biomarkers. Since multi-omics gives multiple views into the same problem, different approaches are employed in aggregating these views into a comprehensive biological context. As a result, a variety of novel hypotheses regarding disease ideation and treatment targets can be formulated. In this article, we review 32 such pathway analysis methods developed for multi-omics and multi-cohort data. We discuss their availability and implementation, assumptions, supported omics types and databases, pathway analysis techniques and integration strategies. A comprehensive assessment of each method's practicality, and a thorough discussion of the strengths and drawbacks of each technique will be provided. The main objective of this survey is to provide a thorough examination of existing methods to assist potential users and researchers in selecting suitable tools for their data and analysis purposes, while highlighting outstanding challenges in the field that remain to be addressed for future development.	[Maghsoudi, Zeynab; Nguyen, Ha; Tavakkoli, Alireza; Nguyen, Tin] Univ Nevada, Dept Comp Sci & Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Nguyen, T (corresponding author), Univ Nevada, Dept Comp Sci & Engn, Reno, NV 89557 USA.	tinn@unr.edu	Tavakkoli, Alireza/AAL-7053-2021; Nguyen, Tin/F-4420-2018	Nguyen, Ha/0000-0003-2338-3537; Nguyen, Tin/0000-0001-8001-9470; , Zeynab/0000-0003-1165-3472	NSF [2001385, 2019609]; Direct For Computer & Info Scie & Enginr; Office of Advanced Cyberinfrastructure (OAC) [2001385] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr; Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was partially supported by NSF under grant numbers 2001385 and 2019609. Any opinions, findings and conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of any of the funding agencies.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alaimo S, 2016, ONCOTARGET, V7, P54572, DOI 10.18632/oncotarget.9788; Arakawa Kazuharu, 2013, Methods Mol Biol, V985, P459, DOI 10.1007/978-1-62703-299-5_23; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berger B, 2013, NAT REV GENET, V14, P333, DOI 10.1038/nrg3433; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Calura E, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku354; Canzler S, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03910-x; Canzler S, 2020, ARCH TOXICOL, V94, P371, DOI 10.1007/s00204-020-02656-y; Carlevaro-Fita J, 2019, NUCLEIC ACIDS RES, V47, pW523, DOI 10.1093/nar/gkz410; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Cavalli G, 2019, NATURE, V571, P489, DOI 10.1038/s41586-019-1411-0; Cerami Ethan G, 2011, Nucleic Acids Res, V39, pD685, DOI 10.1093/nar/gkq1039; Chen JX, 2021, NUCLEIC ACIDS RES, V49, pD969, DOI 10.1093/nar/gkaa806; Chen X, 2008, BIOINFORMATICS, V24, P2474, DOI 10.1093/bioinformatics/btn458; Chen X, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1697; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; COX DR, 1972, J R STAT SOC B, V34, P187; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Diaz D, 2017, BIOCOMPUT-PAC SYM, P390, DOI 10.1142/9789813207813_0037; Dijkstra E.W., 1959, Numerische Mathematik, V1, P269, DOI DOI 10.1007/BF01386390; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dutta B, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-10; EDGINGTON ES, 1972, J PSYCHOL, V80, P351, DOI 10.1080/00223980.1972.9924813; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Eicher T, 2020, METABOLITES, V10, DOI 10.3390/metabo10050202; Eichner J, 2014, J CHROMATOGR B, V966, P77, DOI 10.1016/j.jchromb.2014.04.030; Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Farrell A, 2014, J PROTEOME RES, V13, P3144, DOI 10.1021/pr500219b; Feichtinger J, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas055; Fisher R. A., 1946, Statistical methods for research workers.; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Geistlinger L, 2011, BIOINFORMATICS, V27, pI366, DOI 10.1093/bioinformatics/btr228; Glaab E, 2010, BIOINFORMATICS, V26, P1271, DOI 10.1093/bioinformatics/btq131; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Graw S, 2021, MOL OMICS, V17, P170, DOI 10.1039/d0mo00041h; Greenblum SI, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-133; Griss J, 2020, MOL CELL PROTEOMICS, V19, DOI 10.1074/mcp.TIR120.002155; Gu ZG, 2013, BIOINFORMATICS, V29, P658, DOI 10.1093/bioinformatics/btt008; Gu ZG, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-56; Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; Hernández-de-Diego R, 2018, NUCLEIC ACIDS RES, V46, pW503, DOI 10.1093/nar/gky466; Hosack D., 2003, GENOME BIOL, V4, pR70, DOI DOI 10.1186/GB-2003-4-10-R70; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r23; Nguyen H, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa190; Nguyen H, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00155; Jendoubi T, 2021, METABOLITES, V11, DOI 10.3390/metabo11030184; Jewison T, 2014, NUCLEIC ACIDS RES, V42, pD478, DOI 10.1093/nar/gkt1067; Jiang YX, 2020, METHODS, V173, P16, DOI 10.1016/j.ymeth.2019.06.013; Jin ZL, 2018, GENES DIS, V5, P1, DOI 10.1016/j.gendis.2018.01.002; Joshi P, 2022, METHODS, V198, P76, DOI 10.1016/j.ymeth.2021.10.002; Kaever A, 2015, METABOLOMICS, V11, P764, DOI 10.1007/s11306-014-0734-y; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kanehisa M, 2021, NUCLEIC ACIDS RES, V49, pD545, DOI 10.1093/nar/gkaa970; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Karp PD, 2019, BRIEF BIOINFORM, V20, P1085, DOI 10.1093/bib/bbx085; Kaspi A, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06856-9; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kofler R, 2012, BIOINFORMATICS, V28, P2084, DOI 10.1093/bioinformatics/bts315; Kohl M, 2014, BBA-PROTEINS PROTEOM, V1844, P52, DOI 10.1016/j.bbapap.2013.02.029; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Korcsmáros T, 2010, BIOINFORMATICS, V26, P2042, DOI 10.1093/bioinformatics/btq310; Korotkevich G, 2019, bioRxiv, DOI [10.1101/060012, 10.1101/060012, DOI 10.1101/060012]; Kristensen VN, 2014, NAT REV CANCER, V14, P299, DOI 10.1038/nrc3721; Kuo TC, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-64; Lee AH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08794-x; Li CQ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt161; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Lian H, 2008, BIOSTATISTICS, V9, P411, DOI 10.1093/biostatistics/kxm042; Liptk T., 1958, Magyar Tud. Akad. Mat. Kutato Int. Kozl, V3, P171; Loughin TM, 2004, COMPUT STAT DATA AN, V47, P467, DOI 10.1016/j.csda.2003.11.020; Luo WJ, 2017, NUCLEIC ACIDS RES, V45, pW501, DOI 10.1093/nar/gkx372; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; MacNeil SM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0189-4; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Martini P, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz324; Massa MS, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-121; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Meng C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-162; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Montague E, 2014, OMICS, V18, P335, DOI 10.1089/omi.2014.0061; Nguyen H, 2021, NUCLEIC ACIDS RES, V49, pW114, DOI 10.1093/nar/gkab421; Nguyen T, 2017, P IEEE, V105, P496, DOI 10.1109/JPROC.2015.2507119; Nguyen T, 2016, BIOINFORMATICS, V32, P409, DOI 10.1093/bioinformatics/btv588; Nicora G, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01030; Nishimura Darryl, 2001, Biotech Software Internet Rep, V2, P117, DOI [DOI 10.1089/152791601750294344, 10.1089/152791601750294344]; Odom, 2019, PATHWAYPCA INTEGRATI; Odom GJ, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.783713; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ogris C, 2016, NUCLEIC ACIDS RES, V44, pW105, DOI 10.1093/nar/gkw356; Paczkowska M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13983-9; Parrella P, 2010, BREAST CARE, V5, P66, DOI 10.1159/000309138; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pinu FR, 2019, METABOLITES, V9, DOI 10.3390/metabo9040076; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romero P, 2005, GENOME BIOL, V6; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sergushichev A., 2016, BIORXIV, DOI DOI 10.1101/060012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen K, 2010, BIOINFORMATICS, V26, P1316, DOI 10.1093/bioinformatics/btq148; Shojaie A, 2009, J COMPUT BIOL, V16, P407, DOI 10.1089/cmb.2008.0081; Shu L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3198-9; Snyder A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002309; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Stöckel D, 2016, BIOINFORMATICS, V32, P1502, DOI 10.1093/bioinformatics/btv770; Stouffer S.A., 1949, The American Soldier: Adjustment during Army Life, VVolume 1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian I, 2020, BIOINFORM BIOL INSIG, V14, DOI 10.1177/1177932219899051; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Sun HQ, 2014, BIOINFORMATICS, V30, P737, DOI 10.1093/bioinformatics/btt576; Tarca AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-136; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Nguyen T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60981-9; Tippett L.H.C., 1931, The Methods of Statistics; Tokimatsu T, 2005, PLANT PHYSIOL, V138, P1289, DOI 10.1104/pp.105.060525; Tsai CA, 2009, BIOINFORMATICS, V25, P897, DOI 10.1093/bioinformatics/btp098; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Nguyen TM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1790-4; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang YP, 2010, BIOMARK INSIGHTS, V5, P69; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; WILKINSON B, 1951, PSYCHOL BULL, V48, P156, DOI 10.1037/h0059111; Wotschofsky Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148746; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029; Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141; Xia JG, 2013, NUCLEIC ACIDS RES, V41, pW63, DOI 10.1093/nar/gkt338; Yamamoto S, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar052; Yoon SH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r37; Yu CJ, 2020, J BIOMED INFORM, V112, DOI 10.1016/j.jbi.2020.103605; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao TJ, 2021, GENOMICS, V113, P2744, DOI 10.1016/j.ygeno.2021.05.040; Zhu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17031-8	166	17	22	6	41	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1467-5463	1477-4054		BRIEF BIOINFORM	Brief. Bioinform.	NOV	2022	23	6								10.1093/bib/bbac435	http://dx.doi.org/10.1093/bib/bbac435		OCT 2022	19	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	8A4VG	36252928	hybrid, Green Published			2024-09-18	WOS:000868869400001
J	Li, ML; Zhang, W				Li, Menglu; Zhang, Wen			PHIAF: prediction of phage-host interactions with GAN-based data augmentation and sequence-based feature fusion	BRIEFINGS IN BIOINFORMATICS			English	Article						phage-host interactions; generative adversarial network; feature fusion; attention mechanism	PROTEINS; CANCER; CELLS	Phage therapy has become one of the most promising alternatives to antibiotics in the treatment of bacterial diseases, and identifying phage-host interactions (PHIs) helps to understand the possible mechanism through which a phage infects bacteria to guide the development of phage therapy. Compared with wet experiments, computational methods of identifying PHIs can reduce costs and save time and are more effective and economic. In this paper, we propose a PHI prediction method with a generative adversarial network (GAN)-based data augmentation and sequence-based feature fusion (PHIAF). First, PHIAF applies a GAN-based data augmentation module, which generates pseudo PHIs to alleviate the data scarcity. Second, PHIAF fuses the features originated from DNA and protein sequences for better performance. Third, PHIAF utilizes an attention mechanism to consider different contributions of DNA/protein sequence-derived features, which also provides interpretability of the prediction model. In computational experiments, PHIAF outperforms other state-of-the-art PHI prediction methods when evaluated via 5-fold cross-validation (AUC and AUPR are 0.88 and 0.86, respectively). An ablation study shows that data augmentation, feature fusion and an attention mechanism are all beneficial to improve the prediction performance of PHIAF. Additionally, four new PHIs with the highest PHIAF score in the case study were verified by recent literature. In conclusion, PHIAF is a promising tool to accelerate the exploration of phage therapy.	[Li, Menglu; Zhang, Wen] Huazhong Agr Univ, Coll Informat, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Zhang, W (corresponding author), Huazhong Agr Univ, Coll Informat, Wuhan 430070, Peoples R China.	zhangwen@mail.hzau.edu.cn	Li, Menglu/GQP-7156-2022; Zhang, Wen/W-7471-2019	Zhang, Wen/0000-0001-5221-2628	National Natural Science Foundation of China [62072206, 61772381]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Fundamental Research Funds for the Central Universities [2662021JC008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (62072206, 61772381); Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; the Fundamental Research Funds for the Central Universities (2662021JC008).	Ahlgren NA, 2017, NUCLEIC ACIDS RES, V45, P39, DOI 10.1093/nar/gkw1002; Alguwaizani S, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/1391265; Boeckaerts D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81063-4; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Chen Z, 2020, BRIEF BIOINFORM, V21, P1047, DOI 10.1093/bib/bbz041; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chuai GH, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1459-4; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Deng YF, 2020, BIOINFORMATICS, V36, P4316, DOI 10.1093/bioinformatics/btaa501; Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048; Galiez C, 2017, BIOINFORMATICS, V33, P3113, DOI 10.1093/bioinformatics/btx383; Gao NL, 2018, NUCLEIC ACIDS RES, V46, pD700, DOI 10.1093/nar/gkx1124; Gao X, 2020, NEUROCOMPUTING, V396, P487, DOI 10.1016/j.neucom.2018.10.109; Goodfellow I., 2020, ADV NEUR IN, V63, P139, DOI DOI 10.1145/3422622; Górski A, 2020, MED RES REV, V40, P459, DOI 10.1002/med.21593; Häuser R, 2012, ADV VIRUS RES, V83, P219, DOI 10.1016/B978-0-12-394438-2.00006-2; Hassel B, 2013, TOXINS, V5, P73, DOI 10.3390/toxins5010073; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kadri SS, 2020, CRIT CARE MED, V48, P939, DOI 10.1097/CCM.0000000000004371; Khan S, 2020, ACS OMEGA, V5, P7254, DOI 10.1021/acsomega.9b04042; Khan S, 2019, CRIT REV CL LAB SCI, V56, P1, DOI 10.1080/10408363.2018.1517144; Khan S, 2017, ONCOTARGET, V8, P30830, DOI 10.18632/oncotarget.8306; Khan S, 2015, CRIT REV ONCOL HEMAT, V96, P475, DOI 10.1016/j.critrevonc.2015.05.002; Leite DMC, 2018, IEEE INT C BIOINFORM, P1818, DOI 10.1109/BIBM.2018.8621433; Leite DMC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2388-7; Li JH, 2020, INFECT DRUG RESIST, V13, P2433, DOI 10.2147/IDR.S258037; Li JX, 2020, BREAST CANCER-TOKYO, V27, P621, DOI [10.1007/s12282-020-01058-3, 10.1093/bib/bbaa159]; Li ML, 2021, IEEE ACM T COMPUT BI, V18, P1801, DOI 10.1109/TCBB.2020.3017386; Liu D, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3082-0; Lopez-Paz David, 2017, INT C LEARN REPR; Lu CY, 2021, BMC BIOL, V19, DOI 10.1186/s12915-020-00938-6; Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066; Mock F, 2021, BIOINFORMATICS, V37, P318, DOI 10.1093/bioinformatics/btaa705; Pires DP, 2020, FEMS MICROBIOL REV, V44, P684, DOI 10.1093/femsre/fuaa017; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rakov C, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10040375; Russell DA, 2017, BIOINFORMATICS, V33, P784, DOI 10.1093/bioinformatics/btw711; Stokes JM, 2020, CELL, V180, P688, DOI 10.1016/j.cell.2020.01.021; Tang X, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab123; Towse A, 2017, HEALTH POLICY, V121, P1025, DOI 10.1016/j.healthpol.2017.07.011; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vaswani A, 2017, ADV NEUR IN, V30; Villarroel J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050116; Wan C, 2020, NAT MACH INTELL, V2, P540, DOI 10.1038/s42256-020-0222-1; Wang WL, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa044; Wei LS, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab041; Xu WX, 2019, IEEE T NANOBIOSCI, V18, P136, DOI 10.1109/TNB.2019.2891239; Xu YG, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa506; Yi X, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101552; Young F, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007894, 10.1371/journal.pcbi.1007894.r001, 10.1371/journal.pcbi.1007894.r002, 10.1371/journal.pcbi.1007894.r003, 10.1371/journal.pcbi.1007894.r004, 10.1371/journal.pcbi.1007894.r005, 10.1371/journal.pcbi.1007894.r006]; Zhan YC, 2018, MICROBIOL RESOUR ANN, V7, DOI 10.1128/MRA.00959-18; Zhang MG, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1473-7; Zhang QH, 2019, IEEE ACM T COMPUT BI, V16, P1184, DOI 10.1109/TCBB.2018.2819660; Zhang SJ, 2020, BRIEF BIOINFORM, V21, P1038, DOI 10.1093/bib/bbz037; Zhu JY, 2017, IEEE I CONF COMP VIS, P2242, DOI 10.1109/ICCV.2017.244	55	20	21	3	42	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1467-5463	1477-4054		BRIEF BIOINFORM	Brief. Bioinform.	JAN 17	2022	23	1							bbab348	10.1093/bib/bbab348	http://dx.doi.org/10.1093/bib/bbab348			10	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	ZK5AS	34472593				2024-09-18	WOS:000763000800155
J	García-Sosa, AT				Garcia-Sosa, Alfonso T.			Androgen Receptor Binding Category Prediction with Deep Neural Networks and Structure-, Ligand-, and Statistically Based Features	MOLECULES			English	Article						machine learning; artificial intelligence; androgen receptor; random forest; deep neural network		Substances that can modify the androgen receptor pathway in humans and animals are entering the environment and food chain with the proven ability to disrupt hormonal systems and leading to toxicity and adverse effects on reproduction, brain development, and prostate cancer, among others. State-of-the-art databases with experimental data of human, chimp, and rat effects by chemicals have been used to build machine-learning classifiers and regressors and to evaluate these on independent sets. Different featurizations, algorithms, and protein structures lead to different results, with deep neural networks (DNNs) on user-defined physicochemically relevant features developed for this work outperforming graph convolutional, random forest, and large featurizations. The results show that these user-provided structure-, ligand-, and statistically based features and specific DNNs provided the best results as determined by AUC (0.87), MCC (0.47), and other metrics and by their interpretability and chemical meaning of the descriptors/features. In addition, the same features in the DNN method performed better than in a multivariate logistic model: validation MCC = 0.468 and training MCC = 0.868 for the present work compared to evaluation set MCC = 0.2036 and training set MCC = 0.5364 for the multivariate logistic regression on the full, unbalanced set. Techniques of this type may improve AR and toxicity description and prediction, improving assessment and design of compounds. Source code and data are available on github.	[Garcia-Sosa, Alfonso T.] Univ Tartu, Inst Chem, Ravila 14a, EE-54011 Tartu, Estonia	University of Tartu	García-Sosa, AT (corresponding author), Univ Tartu, Inst Chem, Ravila 14a, EE-54011 Tartu, Estonia.	alfonsog@ut.ee	Garcia-Sosa, Alfonso T./E-4551-2015	Garcia-Sosa, Alfonso T./0000-0003-0542-4446	Haridus- ja teadusministeerium [IUT34-14]	Haridus- ja teadusministeerium	This research was funded by Haridus- ja teadusministeerium, grant IUT34-14.	[Anonymous], MHFP6 FINGERPRINTS; [Anonymous], PANDAS TOOLS 0253; [Anonymous], scikit learn; [Anonymous], Open Babel; [Anonymous], T MAP; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cheung AS, 2014, ENDOCR-RELAT CANCER, V21, pR371, DOI 10.1530/ERC-14-0172; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Forssen P, 2020, ANAL CHEM, V92, P11520, DOI 10.1021/acs.analchem.0c02475; Forssén P, 2018, ANAL CHEM, V90, P5366, DOI 10.1021/acs.analchem.8b00504; Garcia-Sosa A.T., 2021, COMBINED DOCKING CHE; García-Sosa AT, 2019, FUTURE MED CHEM, V11, P2247, DOI 10.4155/fmc-2019-0006; García-Sosa AT, 2009, QSAR COMB SCI, V28, P815, DOI 10.1002/qsar.200810174; Glisic S, 2016, MOLECULES, V21, DOI 10.3390/molecules21050589; González-Medina M, 2017, J CHEM INF MODEL, V57, P1735, DOI 10.1021/acs.jcim.7b00253; Jiménez-Luna J, 2020, NAT MACH INTELL, V2, P573, DOI 10.1038/s42256-020-00236-4; Khamparia A, 2020, CIRC SYST SIGNAL PR, V39, P776, DOI 10.1007/s00034-019-01306-8; Kleinstreuer NC, 2017, CHEM RES TOXICOL, V30, P946, DOI 10.1021/acs.chemrestox.6b00347; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mansouri K, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP5580; Martinez-Mayorga K, 2020, EXPERT OPIN DRUG DIS, V15, P293, DOI 10.1080/17460441.2020.1696307; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Nadal M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14388; Peña-Guerrero J, 2021, WIRES COMPUT MOL SCI, V11, DOI 10.1002/wcms.1513; PubChem, NATL I HLTH NIH; Pustokhina IV, 2020, IEEE ACCESS, V8, P92907, DOI 10.1109/ACCESS.2020.2993008; Raj RJS, 2020, IEEE ACCESS, V8, P58006, DOI 10.1109/ACCESS.2020.2981337; Schneider P, 2020, NAT REV DRUG DISCOV, V19, P353, DOI 10.1038/s41573-019-0050-3; Schrodinger LLC, 2019, VIRTUAL SCREENING WO; Schrodinger LLC, 2019, PROTEIN PREPARATION; Sifakis S, 2017, ENVIRON TOXICOL PHAR, V51, P56, DOI 10.1016/j.etap.2017.02.024; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; Trisciuzzi D, 2017, J CHEM INF MODEL, V57, P2874, DOI 10.1021/acs.jcim.7b00420; Varela-Santos S, 2021, INFORM SCIENCES, V545, P403, DOI 10.1016/j.ins.2020.09.041; Viira B, 2016, BIOORGAN MED CHEM, V24, P2519, DOI 10.1016/j.bmc.2016.04.018; Winter R, 2019, CHEM SCI, V10, P1692, DOI 10.1039/c8sc04175j; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yosipof A, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00162; Zorn KM, 2020, ENVIRON SCI TECHNOL, V54, P13690, DOI 10.1021/acs.est.0c03984	39	2	2	1	14	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1420-3049		MOLECULES	Molecules	MAR	2021	26	5							1285	10.3390/molecules26051285	http://dx.doi.org/10.3390/molecules26051285			18	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	QW1OA	33652992	Green Submitted, gold, Green Published			2024-09-18	WOS:000628425700001
J	Shea, M; Audibert, C; Stewart, M; Gentile, B; Merino, D; Hong, A; Lassiter, L; Caze, A; Leff, J; Allen, J; Sigal, E				Shea, Michael; Audibert, Celine; Stewart, Mark; Gentile, Brittany; Merino, Diana; Hong, Agnes; Lassiter, Laura; Caze, Alexis; Leff, Jonathan; Allen, Jeff; Sigal, Ellen			How Oncologists Perceive the Availability and Quality of Information Generated From Patient-Reported Outcomes (PROs)	JOURNAL OF PATIENT EXPERIENCE			English	Article						cancer; health information technology; medical decision-making; survey data	CLINICAL-TRIALS; CARE	Background: Despite increased incorporation of patient-reported outcome (PRO) measures into clinical trials, information generated from PROs remains largely absent from drug labeling and electronic health records, giving rise to concerns that such information is not adequately informing clinical practice. Objective: To evaluate oncologists' perceptions concerning the availability and quality of information generated from PRO measures. Additionally, to identify whether an association exists between perceptions of availability and attitudes concerning quality. Method: An online, 11-item questionnaire was developed to capture clinician perspectives on the availability and use of PRO data to inform practice. The survey also asked respondents to rate information on the basis of 4 quality metrics: "usefulness," "interpretability," "accessibility," and "scientific rigor." Results: Responses were received from 298 of 1301 invitations sent (22.9% response rate). Perceptions regarding the availability of PRO information differed widely among respondents and did not appear to be linked to practice setting. Ratings of PRO quality were generally consistent, with average ratings for the 4 quality metrics between "satisfactory" and "good." A relationship was observed between ratings of PRO data quality and perceptions of the availability. Conclusion: Oncologists' attitudes toward the quality of information generated from PRO measures are favorable but not enthusiastic. These attitudes may improve as the availability of PRO data increases, given the association we observed between oncologists' ratings of the quality of PRO information and their perceptions of its availability.	[Shea, Michael; Stewart, Mark; Merino, Diana; Lassiter, Laura; Allen, Jeff; Sigal, Ellen] Friends Canc Res, Washington, DC USA; [Audibert, Celine] Deerfield Inst, Epalinges, Switzerland; [Gentile, Brittany] Genentech Inc, Patient Ctr Outcomes Res PCOR Grp, San Francisco, CA USA; [Hong, Agnes] Genentech Inc, San Francisco, CA USA; [Caze, Alexis] Deerfield Management, Res & Consulting Grp, New York, NY USA; [Leff, Jonathan] Deerfield Management, New York, NY USA	Roche Holding; Genentech; Roche Holding; Genentech	Audibert, C (corresponding author), Deerfield Management, Route Corniche 3a, CH-1066 Epalinges, Switzerland.	caudibert@deerfield.com		Stewart, Mark/0000-0002-4847-0736				[Anonymous], 1995, CLIN MEASUREMENT DRU; Basch E, 2015, JAMA ONCOL, V1, P375, DOI 10.1001/jamaoncol.2015.0530; Basch E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju244; Bottomley A, 2016, LANCET ONCOL, V17, pE510, DOI 10.1016/S1470-2045(16)30510-1; European Medicines Agency, 2016, Appendix 2 to the Guideline on the Evaluation of Anticancer Medicinal Products in Man - the Use of Patient-Reported Outcome (PRO) Measures in Oncology Studies; Gensheimer SG, 2018, PATIENT, V11, P591, DOI 10.1007/s40271-018-0321-9; Gnanasakthy A, 2017, VALUE HEALTH, V20, P420, DOI 10.1016/j.jval.2016.10.006; Gnanasakthy A, 2016, J CLIN ONCOL, V34, P1928, DOI 10.1200/JCO.2015.63.6480; Kluetz PG, 2018, LANCET ONCOL, V19, pE267, DOI 10.1016/S1470-2045(18)30097-4; LeBlanc TW, 2017, NAT REV CLIN ONCOL, V14, P763, DOI 10.1038/nrclinonc.2017.153; Levit L., 2013, Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population; Board on Health Care Services; Institute of Medicine; Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis; Mesa RA, 2013, J CLIN ONCOL, V31, P1285, DOI 10.1200/JCO.2012.44.4489; Sutter PS, 2017, ENV HIST AMER SOUTH, P5; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; U.S. Food and Drug Administration, 2016, 21 CENT CUR ACT; US Food and Drug Administration, 2017, PRESCR DRUG US FEE A; Vodicka E, 2015, CONTEMP CLIN TRIALS, V43, P1, DOI 10.1016/j.cct.2015.04.004	17	1	1	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2374-3743	2374-3735		J PATIENT EXPERIENCE	J. Patient Experience	APR	2020	7	2					217	224		10.1177/2374373519837256	http://dx.doi.org/10.1177/2374373519837256			8	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	LM6KP	32851143	Green Published, gold			2024-09-18	WOS:000532358700014
J	Jiménez, A; Merino, MJ; Parras, J; Zazo, S				Jimenez, Ana; Merino, Maria Jose; Parras, Juan; Zazo, Santiago			Explainable drug repurposing via path based knowledge graph completion	SCIENTIFIC REPORTS			English	Article						Drug repurposing; Heterogeneous knowledge graphs; Knowledge graph completion; Interpretability; Hetionet; Rule-based link prediction	PHASE-II; PACLITAXEL; CANCER; PREDNISONE; STEROIDS; THERAPY; TRIAL	Drug repurposing aims to find new therapeutic applications for existing drugs in the pharmaceutical market, leading to significant savings in time and cost. The use of artificial intelligence and knowledge graphs to propose repurposing candidates facilitates the process, as large amounts of data can be processed. However, it is important to pay attention to the explainability needed to validate the predictions. We propose a general architecture to understand several explainable methods for graph completion based on knowledge graphs and design our own architecture for drug repurposing. We present XG4Repo (eXplainable Graphs for Repurposing), a framework that takes advantage of the connectivity of any biomedical knowledge graph to link compounds to the diseases they can treat. Our method allows methapaths of different types and lengths, which are automatically generated and optimised based on data. XG4Repo focuses on providing meaningful explanations to the predictions, which are based on paths from compounds to diseases. These paths include nodes such as genes, pathways, side effects, or anatomies, so they provide information about the targets and other characteristics of the biomedical mechanism that link compounds and diseases. Paths make predictions interpretable for experts who can validate them and use them in further research on drug repurposing. We also describe three use cases where we analyse new uses for Epirubicin, Paclitaxel, and Predinisone and present the paths that support the predictions.	[Jimenez, Ana; Merino, Maria Jose; Parras, Juan; Zazo, Santiago] Univ Politecn Madrid, Informat Proc & Telecommun Ctr, ETSI Telecomunicac, Avda Complutense 30, Madrid 28040, Spain	Universidad Politecnica de Madrid; Centro de I+D+I en Procesado de la Informacion Telecomunicaciones (IPT)	Parras, J (corresponding author), Univ Politecn Madrid, Informat Proc & Telecommun Ctr, ETSI Telecomunicac, Avda Complutense 30, Madrid 28040, Spain.	j.parras@upm.es	Parras, Juan/Y-6229-2019	ZAZO BELLO, SANTIAGO/0000-0001-9073-7927; Parras, Juan/0000-0002-7028-3179; Jimenez, Ana/0009-0003-8679-4680	European Commission [101057619, REPO4EU]; European Union [22.00115]; Swiss State Secretariat for Education, Research and Innovation (SERI); Horizon Europe - Pillar II [101057619] Funding Source: Horizon Europe - Pillar II	European Commission(European Union (EU)European Commission Joint Research Centre); European Union(European Union (EU)); Swiss State Secretariat for Education, Research and Innovation (SERI); Horizon Europe - Pillar II(European Union (EU)Horizon Europe - Pillar II)	This project is funded by the European Union under grant agreement No. 101057619 (REPO4EU). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them. This work was also partly supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract No. 22.00115.	Ali M, 2021, J MACH LEARN RES, V22; Beck BR, 2020, COMPUT STRUCT BIOTEC, V18, P784, DOI 10.1016/j.csbj.2020.03.025; Chen J, 2016, ONCOL REP, V36, P2697, DOI 10.3892/or.2016.5124; Danishuddin M, 2015, METHODS, V71, P135, DOI 10.1016/j.ymeth.2014.10.019; Daowd A, 2022, LECT NOTES COMPUT SC, V13263, P24, DOI 10.1007/978-3-031-09342-5_3; Das R, 2018, Arxiv, DOI arXiv:1711.05851; Domingo-Fernandez DB, 2022, PLOS COMPUT BIOL, V18, DOI 10.1371/journal.pcbi.1009909; Ehrlich A, 2004, J AM ACAD DERMATOL, V50, P533, DOI 10.1016/j.jaad.2003.09.018; Feng W, 2019, N-S ARCH PHARMACOL, V392, P605, DOI 10.1007/s00210-019-01615-4; Fournier CN, 2018, AMYOTROPH LAT SCL FR, V19, P242, DOI 10.1080/21678421.2017.1421666; Fred Hutchinson Cancer Center, 2010, ClinicalTrials.gov Identifier: NCT00410657; Gao ZX, 2022, J BIOMED INFORM, V132, DOI 10.1016/j.jbi.2022.104133; Gogineni AK, 2022, Arxiv, DOI arXiv:2212.03911; Gronchi A, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.10003; Gurbuz O, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.814093; Gysi DM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025581118; Hamed EM, 2023, PHARMACEUTICALS-BASE, V16, DOI 10.3390/ph16060868; Hamilton WL., 2020, Graph Representation Learning. Synthesis Lectures on Artificial Intelligence and Machine Learning, DOI DOI 10.1007/978-3-031-01588-5; Himmelstein DS, 2017, ELIFE, V6, DOI 10.7554/eLife.26726; Hu L, 2024, BRIEF BIOINFORM, V25, DOI 10.1093/bib/bbae067; Janssen Research & Development, 2022, ClinicalTrials.gov; Jardim MR, 2007, ARQ NEURO-PSIQUIAT, V65, P969, DOI 10.1590/S0004-282X2007000600009; Kampan NC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/413076; Katsaounis P, 2018, ANN GASTROENTEROL, V31, P65, DOI 10.20524/aog.2017.0215; Kong DH, 2022, INT J NANOMED, V17, P1087, DOI 10.2147/IJN.S346948; Li RP, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P2642; Liu YS, 2020, Arxiv, DOI arXiv:2007.05292; Ma C., 2022, BioRxiv, V2022, P11; Meilicke C, 2020, Arxiv, DOI arXiv:2004.04412; Meilicke C, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P3137; Memorial Sloan Kettering Cancer Center, 2022, ClinicalTrials.gov; OHSU Knight Cancer Institute, 2023, ClinicalTrials.gov Identifier: NCT03878524; Ott S., 2021, arXiv; PARRILLO JE, 1989, NEW ENGL J MED, V321, P1061, DOI 10.1056/NEJM198910193211601; Parvathaneni V, 2019, DRUG DISCOV TODAY, V24, P2076, DOI 10.1016/j.drudis.2019.06.014; Qu M., 2021, INT C LEARN REPR; Rosenthal SA, 2015, INT J RADIAT ONCOL, V93, P294, DOI 10.1016/j.ijrobp.2015.05.024; Saberian N, 2019, BIOINFORMATICS, V35, P3672, DOI 10.1093/bioinformatics/btz156; Sadegh S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27138-2; Safran HP, 2022, LANCET ONCOL, V23, P259, DOI 10.1016/S1470-2045(21)00718-X; Shah SK, 2006, J AM OSTEOPATH ASSOC, V106, P653; Su XR, 2023, IEEE J BIOMED HEALTH, V27, P562, DOI 10.1109/JBHI.2022.3219213; Thafar MA, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00447-2; UNICANCER, 2016, ClinicalTrials.gov Identifier: NCT00003852; University of Pisa, 2018, ClinicalTrials.gov Identifier: NCT03668418; URETSKY BF, 1987, CIRCULATION, V76, P827, DOI 10.1161/01.CIR.76.4.827; Verhelst H, 2005, SEIZURE-EUR J EPILEP, V14, P412, DOI 10.1016/j.seizure.2005.07.002; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xu R, 2009, ANTICANCER RES, V29, P261; Xuan P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070705; Yang K, 2023, BRIEF BIOINFORM, V24, DOI 10.1093/bib/bbac518; Zeng XX, 2020, J PROTEOME RES, V19, P4624, DOI 10.1021/acs.jproteome.0c00316; Zhang K, 2023, BIOINFORMATICS, V39, pi158, DOI 10.1093/bioinformatics/btad261; Zhang R, 2021, J BIOMED INFORM, V115, DOI 10.1016/j.jbi.2021.103696; Zhang W, 2019, PROCEEDINGS OF THE TWELFTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'19), P96, DOI 10.1145/3289600.3291014; Zhao BW, 2023, BIOINFORMATICS, V39, DOI 10.1093/bioinformatics/btad451; Zhao BW, 2024, IEEE T EMERG TOP COM, V12, P163, DOI 10.1109/TETC.2023.3239949; Zhao BW, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac384; Zhao S, 2022, BLOOD, V140, P6579, DOI 10.1182/blood-2022-166829; Zhu YJ, 2020, HEALTH INFORM J, V26, P2737, DOI 10.1177/1460458220937101; Zhu ZC, 2022, Arxiv, DOI [arXiv:2202.08320, 10.48550/ARXIV.2202.08320]	61	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 18	2024	14	1							16587	10.1038/s41598-024-67163-x	http://dx.doi.org/10.1038/s41598-024-67163-x			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZB5J8	39025897	gold, Green Published			2024-09-18	WOS:001272840900002
J	Chen, HO; Cui, YC; Lin, PC; Chiang, JH				Chen, Hui-O; Cui, Yuan-Chi; Lin, Peng-Chan; Chiang, Jung-Hsien			An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response Prediction	JOURNAL OF PERSONALIZED MEDICINE			English	Article						multi-omics; drug response; latent alignment; deep learning; attention module		By using omics, we can now examine all components of biological systems simultaneously. Deep learning-based drug prediction methods have shown promise by integrating cancer-related multi-omics data. However, the complex interaction between genes poses challenges in accurately projecting multi-omics data. In this research, we present a predictive model for drug response that incorporates diverse types of omics data, comprising genetic mutation, copy number variation, methylation, and gene expression data. This study proposes latent alignment for information mismatch in integration, which is achieved through an attention module capturing interactions among diverse types of omics data. The latent alignment and attention modules significantly improve predictions, outperforming the baseline model, with MSE = 1.1333, F1-score = 0.5342, and AUROC = 0.5776. High accuracy was achieved in predicting drug responses for piplartine and tenovin-6, while the accuracy was comparatively lower for mitomycin-C and obatoclax. The latent alignment module exclusively outperforms the baseline model, enhancing the MSE by 0.2375, the F1-score by 4.84%, and the AUROC by 6.1%. Similarly, the attention module only improves these metrics by 0.1899, 2.88%, and 2.84%, respectively. In the interpretability case study, panobinostat exhibited the most effective predicted response, with a value of -4.895. We provide reliable insights for drug selection in personalized medicine by identifying crucial genetic factors influencing drug response.	[Chen, Hui-O; Cui, Yuan-Chi] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 701, Taiwan; [Chen, Hui-O; Cui, Yuan-Chi] Natl Cheng Kung Univ, Inst Med Informat, Tainan 701, Taiwan; [Lin, Peng-Chan; Chiang, Jung-Hsien] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Oncol, Tainan 701, Taiwan; [Lin, Peng-Chan; Chiang, Jung-Hsien] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Genom Med, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Lin, PC; Chiang, JH (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Oncol, Tainan 701, Taiwan.; Lin, PC; Chiang, JH (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Genom Med, Tainan 701, Taiwan.	pengchan@mail.ncku.edu.tw; jchiang@mail.ncku.edu.tw			National Science and Technology Council (NSTC), Taiwan [NSTC 111-2634-F-006-011, NSTC 112-2314-B-006-085, NSTC 112-2622-8-006-019-IE]; National Cheng Kung University [NCKUH-11202042, NCKUH-11210015, NCKUH-11209008]; Higher Education Sprout Project, Ministry of Education	National Science and Technology Council (NSTC), Taiwan(National Science and Technology Council (NSTC) Zambia); National Cheng Kung University; Higher Education Sprout Project, Ministry of Education	This work was funded in part by the National Science and Technology Council (NSTC), Taiwan, under research grant numbers NSTC 111-2634-F-006-011, NSTC 112-2314-B-006-085, and NSTC 112-2622-8-006-019-IE, and the National Cheng Kung University (grant numbers NCKUH-11202042, NCKUH-11210015 and NCKUH-11209008). This research was funded in part by the Higher Education Sprout Project, Ministry of Education to the Headquarters of University Advancement at National Cheng Kung University (NCKU). All authors have read and approved the manuscript.	Adam G, 2020, NPJ PRECIS ONCOL, V4, DOI 10.1038/s41698-020-0122-1; Chiu YC, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0460-9; Emdadi A, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00075; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gillespie M, 2022, NUCLEIC ACIDS RES, V50, pD687, DOI 10.1093/nar/gkab1028; Guan NN, 2019, MOL THER-NUCL ACIDS, V17, P164, DOI 10.1016/j.omtn.2019.05.017; Huang L, 2023, BIOLOGY-BASEL, V12, DOI 10.3390/biology12101313; Ille AM, 2023, TRENDS BIOCHEM SCI, V48, P1014, DOI 10.1016/j.tibs.2023.09.004; Khan D, 2022, J PERS MED, V12, DOI 10.3390/jpm12050674; Liu PF, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2910-6; Malik V, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07524-2; Meyer UA, 2013, ANNU REV PHARMACOL, V53, P475, DOI 10.1146/annurev-pharmtox-010510-100502; Paczkowska M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13983-9; Park A, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-39179-2; Picard M, 2021, COMPUT STRUCT BIOTEC, V19, P3735, DOI [10.1016/j.csbj.2021.06.030, 10.1016/j.csbj.2021.06.0302001-0370/]; Reel PS, 2021, BIOTECHNOL ADV, V49, DOI 10.1016/j.biotechadv.2021.107739; Shapiro JA, 2009, ANN NY ACAD SCI, V1178, P6, DOI 10.1111/j.1749-6632.2009.04990.x; Sharifi-Noghabi H, 2019, BIOINFORMATICS, V35, pI501, DOI 10.1093/bioinformatics/btz318; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Theodoridis Thomas, 2020, P IEEE CVF C COMP VI, P960; Wang CH, 2022, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-022-04964-9	21	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4426		J PERS MED	J. Pers. Med.	JUL	2024	14	7							694	10.3390/jpm14070694	http://dx.doi.org/10.3390/jpm14070694			13	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	ZS6B4	39063948	Green Submitted, gold			2024-09-18	WOS:001277309400001
J	Jiang, J; Zhao, RR; Li, X; Chang, LL				Jiang, Jiang; Zhao, Ruirui; Li, Xuan; Chang, Leilei			Data-Driven Thyroid Nodule Diagnosis Using Belief Rule Base	DIAGNOSTICS			English	Article						data-driven; thyroid nodule diagnosis; belief rule base	MISSING DATA; MULTIPLE IMPUTATION; EXPERT-SYSTEM; CANCER; CLASSIFICATION; PREDICTION	Doctors' diagnosis preferences are different, which makes them adopt different assumptions in medical decision making. Taking the diagnosis of thyroid nodules as an example, this study compares three assumptions, namely deletion, imputation based on the distribution (distribution), and benign by default (benign). For deletion, which is the most used assumption, the clinical reports with missing features would be deleted. For distribution, the missing features would be replaced with a distribution of features with respective probabilities. Besides the two assumptions, certain doctors have also stated that they leave benign features unrecorded because they think that such benign features are irrelevant to the final diagnosis. Under the benign assumption, the missing features would be replaced with benign features. The three assumptions are tested comparatively. Moreover, the belief rule base (BRB) is used to construct the diagnostic model under the three assumptions since it is essentially a white-box approach that can provide good interpretability and direct access to doctors and patients. A total of 3766 clinical reports on thyroid nodule diagnosis were collected from ten radiologists over a seven-year period. Case study results validate that the benign by default assumption has produced the optimal results, although different doctors could present varied tendencies towards different assumptions. Guidance and suggestions for doctors' practical work have been made based on the study results to improve work efficiency and diagnostic accuracy.	[Jiang, Jiang; Zhao, Ruirui; Li, Xuan] Natl Univ Def Technol, Coll Syst Engn, Changsha 410073, Peoples R China; [Chang, Leilei] Hangzhou Dianzi Univ, Sch Automat, Hangzhou 310018, Peoples R China; [Chang, Leilei] First Affiliated Hosp USTC, Dept Ultrasound, Hefei 230002, Peoples R China	National University of Defense Technology - China; Hangzhou Dianzi University	Chang, LL (corresponding author), Hangzhou Dianzi Univ, Sch Automat, Hangzhou 310018, Peoples R China.; Chang, LL (corresponding author), First Affiliated Hosp USTC, Dept Ultrasound, Hefei 230002, Peoples R China.	leileichang@hotmail.com	Chang, Leilei/GQH-1862-2022	Chang, Leilei/0000-0002-0126-0635	National Natural Science Foundation of China [71901212, 72071206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grants 71901212 and 72071206.	Austin PC, 2021, CAN J CARDIOL, V37, P1322, DOI 10.1016/j.cjca.2020.11.010; Bernardi S, 2020, THYROID, V30, P1759, DOI 10.1089/thy.2020.0202; Biondi B, 2005, NAT CLIN PRACT ENDOC, V1, P32, DOI 10.1038/ncpendmet0020; Carpenter JR, 2021, BIOMETRICAL J, V63, P915, DOI 10.1002/bimj.202000196; Castellana M, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz170; Chang LL, 2019, INFORM SCIENCES, V476, P106, DOI 10.1016/j.ins.2018.10.004; Chang LL, 2022, IEEE T CYBERNETICS, V52, P10364, DOI 10.1109/TCYB.2021.3063285; Choi R, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12071638; Chowdhury T., 2018, INT J COMPUT SCI MOB, V7, P195; Fu C, 2019, SCI CHINA INFORM SCI, V62, DOI 10.1007/s11432-019-9866-3; Fu C, 2020, ANN OPER RES, V293, P833, DOI 10.1007/s10479-018-3093-7; García-Laencina PJ, 2010, NEURAL COMPUT APPL, V19, P263, DOI 10.1007/s00521-009-0295-6; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Horton NJ, 2001, AM STAT, V55, P244, DOI 10.1198/000313001317098266; Horvath E, 2017, EUR RADIOL, V27, P2619, DOI 10.1007/s00330-016-4605-y; Horvath E, 2009, J CLIN ENDOCR METAB, V94, P1748, DOI 10.1210/jc.2008-1724; Hossain MS, 2018, SOFT COMPUT, V22, P7571, DOI 10.1007/s00500-017-2732-2; Hossain MS, 2017, IEEE T SUST COMPUT, V2, P140, DOI 10.1109/TSUSC.2017.2697768; Hughes RA, 2019, INT J EPIDEMIOL, V48, P1294, DOI 10.1093/ije/dyz032; Kant R, 2020, AM FAM PHYSICIAN, V102, P298; Khan SI, 2020, J BIG DATA-GER, V7, DOI 10.1186/s40537-020-00313-w; Kong GL, 2021, IEEE T SYST MAN CY-S, V51, P7131, DOI 10.1109/TSMC.2020.2967885; Little R., 2002, STAT ANAL MISSING DA; Luo L, 2019, COMPUT IND ENG, V131, P82, DOI 10.1016/j.cie.2019.03.038; Madley-Dowd P, 2019, J CLIN EPIDEMIOL, V110, P63, DOI 10.1016/j.jclinepi.2019.02.016; Ospina NS, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6670; Papini E, 2020, EUR THYROID J, V9, P172, DOI 10.1159/000508484; Park JY, 2009, THYROID, V19, P1257, DOI 10.1089/thy.2008.0021; Qi ZF, 2022, SYMMETRY-BASEL, V14, DOI 10.3390/sym14081622; Rosar F, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12081934; Sperrin M, 2020, J CLIN EPIDEMIOL, V125, P183, DOI 10.1016/j.jclinepi.2020.03.028; Tian J, 2014, APPL INTELL, V40, P376, DOI 10.1007/s10489-013-0469-x; Veres C, 2010, PHYS MED BIOL, V55, pN507, DOI 10.1088/0031-9155/55/21/N02; Wang YM, 2006, EUR J OPER RES, V174, P1885, DOI 10.1016/j.ejor.2004.09.059; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wu J, 2022, COMPUT BIOL MED, V140, DOI 10.1016/j.compbiomed.2021.105104; Xia XW, 2021, INFORM SCIENCES, V549, P116, DOI 10.1016/j.ins.2020.11.015; Yang JB, 2006, IEEE T SYST MAN CY A, V36, P266, DOI 10.1109/TSMCA.2005.851270; Zhou ZJ, 2021, IEEE T SYST MAN CY-S, V51, P4944, DOI 10.1109/TSMC.2019.2944893	39	0	0	1	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	OCT	2022	12	10							2299	10.3390/diagnostics12102299	http://dx.doi.org/10.3390/diagnostics12102299			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5O4QG	36291988	Green Published, gold			2024-09-18	WOS:000872459500001
J	Tabriz, ER; Ramezani, M; Heydari, A; Aledavood, SA; Jamali, J				Tabriz, Elahe Ramezanzade; Ramezani, Monir; Heydari, Abbas; Aledavood, Seyed Amir; Jamali, Jamshid			Development and psychometric properties of Health-Promoting Lifestyle Scale in Colorectal Cancer Survivors (HPLS-CRCS): a mixed-method study	BMC CANCER			English	Article						Lifestyle; Health promotion; Colorectal cancer; Survivors; Scale; Psychometrics	QUALITY-OF-LIFE; METHODOLOGICAL QUALITY; SYSTEMATIC REVIEWS; PHYSICAL-ACTIVITY; DIETARY PATTERNS; QUESTIONNAIRE; CHEMOTHERAPY; IMPACT	BackgroundDetecting a health-promoting lifestyle in colorectal cancer (CRC) survivors is of paramount importance to manage disease complications, prevent their recurrence, and enhance survival; however, no specialized tool has yet been provided to measure the lifestyle of these patients. Accordingly, this study aimed to develop and determine the psychometric properties of the Health-Promoting Lifestyle Scale in CRC Survivors (HPLS-CRCS).MethodsThis study was a mixed study with an exploratory sequential design in two phases. Concept analysis was performed in the first phase according to Schwartz-Barcott and Kim's (2000) hybrid model to explain the concept, identify dimensions, and generate items. In the second phase, psychometrics including validity (face, content, and construct) and reliability (internal consistency and stability) were determined. Responsiveness, interpretability, ease of use, item weighting, and scale scoring were also determined.ResultsAfter explaining the concept, an initial scale encompassing 211 items was developed, content and item analyses were conducted, and the items decreased to 89 items after the face validity assessment. For construct validity, confirmatory factor analysis (CFA) was conducted with a sample size of 500 survivors, and convergent validity was performed for the Persian version of the Health-Promoting Lifestyle Profile II (HPLP-II). Accordingly, 80 items were classified into six factors: activity and rest, spiritual growth, health responsibility, nutrition, interpersonal relationships, and psychological management, with RMSEA = 0.055, chi 2/df = 2.484, and chi 2 = 6816.516. The reliability of the scale was confirmed, Cronbach's alpha was between 0.865 and 0.928, and the intraclass correlation coefficient (ICC), the standard error of measurement (SEM), the minimal important change (MIC), and the smallest detectable change (SDC) were 0.896, 3.36, 13.86, and 19.87, respectively.ConclusionThe HPLS-CRCS consists of 80 items in six dimensions and is a valid and reliable scale for evaluating the health-promoting lifestyle in CRC survivors. Using this scale to evaluate the healthy lifestyle in these survivors can lead healthcare providers to detect deficiencies and plan the lifestyle of CRC survivors during the post-treatment period.	[Tabriz, Elahe Ramezanzade] Mashhad Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Mashhad, Iran; [Ramezani, Monir; Heydari, Abbas] Mashhad Univ Med Sci, Nursing & Midwifery Care Res Ctr, Mashhad, Iran; [Ramezani, Monir] Mashhad Univ Med Sci, Sch Nursing & Midwifery, Ebne Sina St,POB 9137913199, Mashhad, Iran; [Aledavood, Seyed Amir] Mashhad Univ Med Sci, Canc Res Ctr, Mashhad, Iran; [Jamali, Jamshid] Mashhad Univ Med Sci, Sch Hlth, Dept Biostat, Mashhad, Iran; [Jamali, Jamshid] Mashhad Univ Med Sci, Social Determinants Hlth Res Ctr, Mashhad, Iran	Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science	Ramezani, M (corresponding author), Mashhad Univ Med Sci, Nursing & Midwifery Care Res Ctr, Mashhad, Iran.; Ramezani, M (corresponding author), Mashhad Univ Med Sci, Sch Nursing & Midwifery, Ebne Sina St,POB 9137913199, Mashhad, Iran.	Ramezanimn@mums.ac.ir	Ramezanzade Tabriz, Elahe/GRJ-8448-2022; aledavood, seyed/ABE-2949-2020; Heydari, Abbas/D-8087-2011; Ramezani, Monir/ACW-3557-2022; Jamali, Jamshid/B-1915-2012	Jamali, Jamshid/0000-0002-9681-8231; Ramezanzade Tabriz, Elahe/0000-0003-4945-7530; ramezani, monir/0000-0003-2089-2379	We are grateful to the Research and Technology Administration of the Mashhad University of Medical Sciences for their financial support.; Research and Technology Administration of the Mashhad University of Medical Sciences	We are grateful to the Research and Technology Administration of the Mashhad University of Medical Sciences for their financial support.; Research and Technology Administration of the Mashhad University of Medical Sciences	We are grateful to the Research and Technology Administration of the Mashhad University of Medical Sciences for their financial support.	Abedi H, 2014, J Urmia Nurs Midwifery Fac, V11, P944; Aliakbari Dehkordi M., 2020, Health Psychol, V9, P161; Anderson AS, 2013, SUPPORT CARE CANCER, V21, P35, DOI 10.1007/s00520-012-1487-7; Assarroudi A, 2018, J RES NURS, V23, P42, DOI 10.1177/1744987117741667; Ayre C, 2014, MEAS EVAL COUNS DEV, V47, P79, DOI 10.1177/0748175613513808; Babai S., 2008, Int J Behav Sci, V2, P75; Balhareth A, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1697-2; Bohn SKH, 2021, SUPPORT CARE CANCER, V29, P289, DOI 10.1007/s00520-020-05445-6; Breedveld-Peters JJL, 2018, BRIT J NUTR, V120, P188, DOI 10.1017/S0007114518000661; Breukink SO, 2013, J SEX MED, V10, P74, DOI 10.1111/jsm.12037; Brown T.A, 2015, Confirmatory Factor Analysis for Applied Research, Vsecond; Chen CP, 2013, INT J NURS STUD, V50, P90, DOI 10.1016/j.ijnurstu.2012.09.001; Denlinger CS, 2011, CANCER PREV RES, V4, P502, DOI 10.1158/1940-6207.CAPR-11-0098; Dunn J, 2013, PSYCHO-ONCOLOGY, V22, P1759, DOI 10.1002/pon.3210; Eshaghi SR., 2010, Payesh, V9, P91; Feng YL, 2017, EUR J CANCER PREV, V26, P201, DOI 10.1097/CEJ.0000000000000245; Garwood V, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092725; Ghanavati A, 2014, BULL ENVIRON PHARMAC, V3, P92; Gillis A J, 1997, Can J Nurs Res, V29, P29; Gordon LG, 2015, EUR J CANCER CARE, V24, P854, DOI 10.1111/ecc.12345; Groen WG, 2018, CANCER TREAT REV, V69, P188, DOI 10.1016/j.ctrv.2018.07.012; Guba E.G., 1994, HDB QUALITATIVE RES, P105, DOI DOI 10.1093/INTQHC/MZM042; Hair J., 2010, Multivariate data analysis: A global perspective; Han CJ, 2020, CANCER NURS, V43, pE132, DOI 10.1097/NCC.0000000000000785; Hong QN, 2018, EDUC INFORM, V34, P285, DOI 10.3233/EFI-180221; Jenkinson C, 2003, J PUBLIC HEALTH MED, V25, P197, DOI 10.1093/pubmed/fdg049; Juniper EF, 1997, J CLIN EPIDEMIOL, V50, P233, DOI 10.1016/S0895-4356(96)00377-0; Kline R.B., 2016, Principles and practice of structural equation modeling; Kyriazos T. A., 2018, Psychology, V9, P2207, DOI [10.4236/psych.2018.98126, DOI 10.4236/PSYCH.2018.98126]; Lee J, 2015, HEMATOL ONCOL CLIN N, V29, P1, DOI 10.1016/j.hoc.2014.09.005; Lin Yu-Hua, 2009, Chang Gung Med J, V32, P650; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Mahfouz EM, 2014, CENT EUR J PUBL HEAL, V22, P215, DOI 10.21101/cejph.a3919; McCullough ML, 2013, J CLIN ONCOL, V31, P2773, DOI 10.1200/JCO.2013.49.1126; Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086]; Mokkink LB, 2018, User Manual, V78, P37; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mond JM, 2004, J CLIN EPIDEMIOL, V57, P1167, DOI 10.1016/j.jclinepi.2004.02.017; Mulder FECM, 2022, J CANCER SURVIV, V16, P1055, DOI 10.1007/s11764-021-01096-6; Munro B.H., 2005, Statistical methods for health care research, V5th; National Comprehensive Cancer Network, 2021, NCCN clinical practice guidelines in oncology (NCCN guidelines). Survivorship Version, P52; NEVO B, 1985, J EDUC MEAS, V22, P287, DOI 10.1111/j.1745-3984.1985.tb01065.x; Nunally J. C., 1978, Pyschometric Theory; Pekmezi DW, 2011, ACTA ONCOL, V50, P167, DOI 10.3109/0284186X.2010.529822; Pender N., 2014, Health Promotion in Nursing Practice, V7th; Polit D.F., 2016, MEASUREMENT MEASUREM; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Ramezani M, 2019, NURS ETHICS, V26, P753, DOI 10.1177/0969733017734411; Ramezanzade Tabriz E., 2022, Evidence Based Care, V12, P63, DOI [10.22038/ebcj.2022.62819.2627, DOI 10.22038/EBCJ.2022.62819.2627]; Ramezanzade Tabriz E., 2023, J Caring Sci, V12, P2; Rohde G, 2017, CANCER NURS, V40, P209, DOI 10.1097/NCC.0000000000000385; Schwartz-Barcott D, 2000, CONCEPT DEV NURSING, P129; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tabriz ER, 2021, ASIA-PAC J ONCOL NUR, V8, P696, DOI 10.4103/apjon.apjon-2132; Tantoy IY, 2016, CANCER NURS, V39, P437, DOI 10.1097/NCC.0000000000000343; Tay L, 2013, APPL PSYCHOL-HLTH WE, V5, P28, DOI 10.1111/aphw.12000; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Tollosa DN, 2019, J CANCER SURVIV, V13, P327, DOI 10.1007/s11764-019-00754-0; Van Blarigan EL, 2015, J CLIN ONCOL, V33, P1825, DOI 10.1200/JCO.2014.59.7799; van Zutphen M, 2019, J CANCER SURVIV, V13, P956, DOI 10.1007/s11764-019-00812-7; VanAntwerp C A, 1995, J Pediatr Health Care, V9, P251, DOI 10.1016/S0891-5245(05)80059-8; WALKER SN, 1987, NURS RES, V36, P76; Waltz CF., 2017, MEASUREMENT NURSING, V5th; Wang HH, 2015, INT J NURS PRACT, V21, P923, DOI 10.1111/ijn.12344; Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x; Whittemore R, 2005, NURS RES, V54, P56; WILSON DMC, 1984, CAN FAM PHYSICIAN, V30, P1863; Yang Z, 2023, BMC NURS, V22, DOI 10.1186/s12912-023-01426-2; Zhang Y, 2009, HANDB INFO SYST, V4, P421	69	1	1	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2407		BMC CANCER	BMC Cancer	OCT 3	2023	23	1							931	10.1186/s12885-023-11436-7	http://dx.doi.org/10.1186/s12885-023-11436-7			13	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	T7DC9	37789256	gold, Green Published			2024-09-18	WOS:001079540500002
J	Tritchler, D; Towle-Miller, LM; Miecznikowski, JC				Tritchler, David; Towle-Miller, Lorin M.; Miecznikowski, Jeffrey C.			Balanced Functional Module Detection in genomic data	BIOINFORMATICS ADVANCES			English	Article							ENDOMETRIAL; SELECTION; CANCER	MotivationHigh-dimensional genomic data can be analyzed to understand the effects of variables on a target variable such as a clinical outcome. For understanding the underlying biological mechanism affecting the target, it is important to discover the complete set of relevant variables. Thus variable selection is a primary goal, which differs from a prediction criterion. Of special interest are functional modules, cooperating sets of variables affecting the target which can be characterized by a graph. In applications such as social networks, the concept of balance in undirected signed graphs characterizes the consistency of associations within the network. This property requires that the module variables have a joint effect on the target outcome with no internal conflict, an efficiency that may be applied to biological networks.ResultsIn this paper, we model genomic variables in signed undirected graphs for applications where the set of predictor variables influences an outcome. Consequences of the balance property are exploited to implement a new module discovery algorithm, balanced Functional Module Detection (bFMD), which selects a subset of variables from high-dimensional data that compose a balanced functional module. Our bFMD algorithm performed favorably in simulations as compared to other module detection methods. Additionally, bFMD detected interpretable results in an application using RNA-seq data obtained from subjects with Uterine Corpus Endometrial Carcinoma using the percentage of tumor invasion as the outcome of interest. The variables selected by bFMD have improved interpretability due to the logical consistency afforded by the balance property.Supplementary information are available at Bioinformatics Advances online.	[Tritchler, David; Towle-Miller, Lorin M.; Miecznikowski, Jeffrey C.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA; [Tritchler, David] Univ Toronto, Biostat Div, Toronto, ON M5S 1A1, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto	Towle-Miller, LM (corresponding author), SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA.	lorinmil@buffalo.edu			New York State Department of Health [Empire Clinical Research Investigator Program]	New York State Department of Health [Empire Clinical Research Investigator Program]	This work was supported by the New York State Department of Health [Empire Clinical Research Investigator Program to L.M.T.-M.].	[Anonymous], 2009, Graphical Models in Applied Multivariate Statistics; Anufriev M, 2015, J BANK FINANC, V61, pS241, DOI 10.1016/j.jbankfin.2015.08.034; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bianconi G, 2018, MULTILAYER NETWORKS: STRUCTURE AND FUNCTION, DOI 10.1093/oso/9780198753919.001.0001; BORONOW RC, 1984, OBSTET GYNECOL, V63, P825; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Chartrand G., 1977, Introductory Graph Theory; Edwards D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-18; Edwards David, 2000, Introduction to Graphical Modelling, V2nd; Fallah S, 2008, STAT APPL GENET MOL, V7; Ge LP, 2021, ONCOGENE, V40, P2323, DOI 10.1038/s41388-021-01655-2; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Harary F., 1954, MICH MATH J, V2, P143, DOI [10.1307/mmj/1028989917, DOI 10.1307/MMJ/1028989917]; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P401, DOI 10.1007/978-1-4419-8819-5_15; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kempers MJE, 2011, LANCET ONCOL, V12, P49, DOI 10.1016/S1470-2045(10)70265-5; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mackey L., 2008, Proceedings of the 21stInternational Conference on Neural Information Processing Systems, P1017; Meyer C.D., 2000, MATRIX ANAL APPL LIN; Miecznikowski JC, 2016, STAT APPL GENET MOL, V15, P1, DOI 10.1515/sagmb-2015-0026; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moravcikova E, 2017, INT J CANCER, V141, P2050, DOI 10.1002/ijc.30906; Reynolds A. P., 1992, Journal of Mathematical Modelling and Algorithms, V5, P475, DOI DOI 10.1007/S10852-005-9022-1; Schweizer P, 2001, CANCER RES, V61, P2813; Sigg C. D., 2008, P 25 INT C MACH LEAR, P960, DOI DOI 10.1145/1390156.1390277; Sulaimanov N, 2016, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0052-y; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Towle-Miller LM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255579; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; WERMUTH N, 1980, J AM STAT ASSOC, V75, P963, DOI 10.2307/2287189; Wermuth N., 2013, Robustness and Complex Data Structures, P331; Wermuth N, 2012, INT STAT REV, V80, P415, DOI 10.1111/j.1751-5823.2012.00195.x; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002975	38	0	0	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2635-0041		BIOINFORM ADV	Bioinform. Adv.	JUN 9	2021	1	1							vbab018	10.1093/bioadv/vbab018	http://dx.doi.org/10.1093/bioadv/vbab018			9	Mathematical & Computational Biology	Emerging Sources Citation Index (ESCI)	Mathematical & Computational Biology	EX9N0	36700111	gold, Green Submitted, Green Published			2024-09-18	WOS:001142351000025
J	Ayton, SG; Treviño, V				Ayton, Sarah G.; Trevino, Victor			MuTATE-an R package for comprehensive multi-objective molecular modeling	BIOINFORMATICS			English	Article								Motivation Comprehensive multi-omics studies have driven advances in disease modeling for effective precision medicine but pose a challenge for existing machine-learning approaches, which have limited interpretability across clinical endpoints. Automated, comprehensive disease modeling requires a machine-learning approach that can simultaneously identify disease subgroups and their defining molecular biomarkers by explaining multiple clinical endpoints. Current tools are restricted to individual endpoints or limited variable types, necessitate advanced computation skills, and require resource-intensive manual expert interpretation.Results We developed Multi-Target Automated Tree Engine (MuTATE) for automated and comprehensive molecular modeling, which enables user-friendly multi-objective decision tree construction and visualization of relationships between molecular biomarkers and patient subgroups characterized by multiple clinical endpoints. MuTATE incorporates multiple targets throughout model construction and allows for target weights, enabling construction of interpretable decision trees that provide insights into disease heterogeneity and molecular signatures. MuTATE eliminates the need for manual synthesis of multiple non-explainable models, making it highly efficient and accessible for bioinformaticians and clinicians. The flexibility and versatility of MuTATE make it applicable to a wide range of complex diseases, including cancer, where it can improve therapeutic decisions by providing comprehensive molecular insights for precision medicine. MuTATE has the potential to transform biomarker discovery and subtype identification, leading to more effective and personalized treatment strategies in precision medicine, and advancing our understanding of disease mechanisms at the molecular level.Availability and implementation MuTATE is freely available at GitHub (https://github.com/SarahAyton/MuTATE) under the GPLv3 license.	[Ayton, Sarah G.; Trevino, Victor] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Mexico; [Ayton, Sarah G.] Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey, Mexico; [Trevino, Victor] Tecnol Monterrey, Inst Obes Res, Monterrey, Mexico	Tecnologico de Monterrey; Tecnologico de Monterrey; Tecnologico de Monterrey	Treviño, V (corresponding author), Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Mexico.; Treviño, V (corresponding author), Tecnol Monterrey, Inst Obes Res, Monterrey, Mexico.		Trevino, Victor/C-9219-2009		Tecnologico de Monterrey; Consejo Nacional de Ciencia y Tecnologa; Google	Tecnologico de Monterrey; Consejo Nacional de Ciencia y Tecnologa(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Google(Google Incorporated)	The authors would like to thank Alejandra Guardado-Mendez, Harley Richkter, and the Bioinformatics research group who provided feedback, ideas, and suggestions for the MuTATE package. They also thank Tecnologico de Monterrey and Consejo Nacional de Ciencia y Tecnologia for their support of work done by S.G.A., and Google for their support of work done by S.G.A. and V.T.	Adlung L, 2021, MED-CAMBRIDGE, V2, P642, DOI 10.1016/j.medj.2021.04.006; Alfaro E, 2013, J STAT SOFTW, V54, P1; Alvarez EM, 2022, LANCET ONCOL, V23, P27, DOI 10.1016/S1470-2045(21)00581-7; Ayton SG, 2022, GENET MED, V24, P15, DOI 10.1016/j.gim.2021.09.006; Banegas-Luna AJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094394; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Couckuyt A, 2022, HUM GENET, V141, P1451, DOI 10.1007/s00439-022-02439-8; Engelhardt D, 2021, TRENDS CANCER, V7, P293, DOI 10.1016/j.trecan.2021.01.006; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Jeong JY, 2020, INFORM SCIENCES, V507, P240, DOI 10.1016/j.ins.2019.08.034; Meinshausen N., 2005, P 22 INT C MACH LEAR, P737; Meinshausen N., 2018, J Mach Learn Res, V19, P1; Quinlan JR., 1993, P 10 INT C INT C MAC, P236, DOI DOI 10.1016/B978-1-55860-307-3.50037-X; Schapire RE., 1999, Ann Stat, V27, P851; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Wang F, 2020, ANN INTERN MED, V172, P59, DOI 10.7326/M19-2548; Wang W., 2012, P AS C MACH LEARN, P507; Wickham H., 2022, devtools: Tools to Make Developing R Packages Easier; Xu DN, 2020, IEEE T NEUR NET LEAR, V31, P2409, DOI 10.1109/TNNLS.2019.2945133; Yoon CH, 2022, J MED ETHICS, V48, P581, DOI 10.1136/medethics-2020-107102; Yung A, 2021, JMIR CANCER, V7, DOI 10.2196/31616; Zhang J., 2019, IEEE Access, V7, P72880; Zhou Z-H., 2012, IEEE Trans Knowl Data Eng, V24, P2169	24	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1367-4811		BIOINFORMATICS	Bioinformatics	SEP 2	2023	39	9							btad507	10.1093/bioinformatics/btad507	http://dx.doi.org/10.1093/bioinformatics/btad507			4	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	R9WP1	37688581	gold			2024-09-18	WOS:001067783700005
C	Jamzad, A; Fooladgar, F; Connolly, L; Srikanthan, D; Syeda, A; Kaufmann, M; Ren, KYM; Merchant, S; Engel, J; Varma, S; Fichtinger, G; Rudan, JF; Mousavi, P		Greenspan, H; Madabhushi, A; Mousavi, P; Salcudean, S; Duncan, J; Syeda-Mahmood, T; Taylor, R		Jamzad, Amoon; Fooladgar, Fahimeh; Connolly, Laura; Srikanthan, Dilakshan; Syeda, Ayesha; Kaufmann, Martin; Ren, Kevin Y. M.; Merchant, Shaila; Engel, Jay; Varma, Sonal; Fichtinger, Gabor; Rudan, John F.; Mousavi, Parvin			Bridging Ex-Vivo Training and Intra-operative Deployment for Surgical Margin Assessment with Evidential Graph Transformer	MEDICAL IMAGE COMPUTING AND COMPUTER ASSISTED INTERVENTION, MICCAI 2023, PT VII	Lecture Notes in Computer Science		English	Proceedings Paper	26th International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI)	OCT 08-12, 2023	Vancouver, CANADA			Intra-operative deployment; Uncertainty estimation; Interpretation; Graph transformer network; Breast cancer margin		PURPOSE: The use of intra-operative mass spectrometry along with Graph Transformer models showed promising results for margin detection on ex-vivo data. Although highly interpretable, these methods lack the ability to handle the uncertainty associated with intra-operative decision making. In this paper for the first time, we propose Evidential Graph Transformer network, a combination of attention mapping and uncertainty estimation to increase the performance and interpretability of surgical margin assessment. METHODS: The Evidential Graph Transformer was formulated to output the uncertainty estimation along with intermediate attentions. The performance of the model was compared with different baselines in an ex-vivo cross-validation scheme, with extensive ablation study. The association of the model with clinical features were explored. The model was further validated for a prospective ex-vivo data, as well as a breast conserving surgery intra-operative data. RESULTS: The purposed model outperformed all baselines, statistically significantly, with average balanced accuracy of 91.6%. When applied to intra-operative data, the purposed model improved the false positive rate of the baselines. The estimated attention distribution for status of different hormone receptors agreed with reported metabolic findings in the literature. CONCLUSION: Deployment of ex-vivo models is challenging due to the tissue heterogeneity of intra-operative data. The proposed Evidential Graph Transformer is a powerful tool that while providing the attention distribution of biochemical subbands, improve the surgical deployment power by providing decision confidence.	[Jamzad, Amoon; Connolly, Laura; Srikanthan, Dilakshan; Syeda, Ayesha; Fichtinger, Gabor; Mousavi, Parvin] Queens Univ, Sch Comp, Kingston, ON, Canada; [Kaufmann, Martin; Merchant, Shaila; Engel, Jay; Rudan, John F.] Queens Univ, Dept Surg, Kingston, ON, Canada; [Ren, Kevin Y. M.; Varma, Sonal] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Fooladgar, Fahimeh] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; McMaster University; University of British Columbia	Jamzad, A (corresponding author), Queens Univ, Sch Comp, Kingston, ON, Canada.	a.jamzad@queensu.ca		Srikanthan, Dilakshan/0000-0002-7564-5458				Ahmedt-Aristizabal D, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21144758; Akbarifar F, 2021, PROC SPIE, V11598, DOI 10.1117/12.2582045; Balog J, 2015, ANGEW CHEM INT EDIT, V54, P11059, DOI 10.1002/anie.201502770; Budczies J, 2015, INT J CANCER, V136, P1619, DOI 10.1002/ijc.29152; Demas DM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00686; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Durasov N, 2021, PROC CVPR IEEE, P13534, DOI 10.1109/CVPR46437.2021.01333; Dwivedi V.P, 2021, METHODS APPL; Gal Y, 2016, PR MACH LEARN RES, V48; Hargreaves AC, 2014, J SURG ONCOL, V110, P21, DOI 10.1002/jso.23645; Jamzad A, 2021, LECT NOTES COMPUT SC, V12907, P88, DOI 10.1007/978-3-030-87234-2_9; Josang A, 2016, ARTIF INTELL-FOUND, P1, DOI 10.1007/978-3-319-42337-1; Kim S, 2013, ENDOCR-RELAT CANCER, V20, P339, DOI 10.1530/ERC-12-0398; Kipf TN, 2017, 5 INT C LEARN REPR I; Lakshminarayanan B, 2017, ADV NEUR IN, V30; Santilli AML, 2021, I S BIOMED IMAGING, P980, DOI 10.1109/ISBI48211.2021.9433829; Santilli AML, 2021, INT J COMPUT ASS RAD, V16, P861, DOI 10.1007/s11548-021-02381-6; Sensoy M, 2018, ADV NEUR IN, V31; Syeda A, 2023, Self-supervision and uncertainty estimation in surgical margin detection	19	0	0	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0302-9743	1611-3349	978-3-031-43989-6; 978-3-031-43990-2	LECT NOTES COMPUT SC			2023	14226						562	571		10.1007/978-3-031-43990-2_53	http://dx.doi.org/10.1007/978-3-031-43990-2_53			10	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods; Radiology, Nuclear Medicine & Medical Imaging	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science; Radiology, Nuclear Medicine & Medical Imaging	BW1RL					2024-09-18	WOS:001109636000053
J	Li, J; Wang, DX; Zhang, CX				Li, Jia; Wang, Dongxu; Zhang, Chenxin			Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer	FRONTIERS IN ONCOLOGY			English	Article						CD276; pathomics; prognostic biomarkers; colon cancer; machine learning; histopathological images	IMMUNE CHECKPOINT; PD-L1 EXPRESSION; GENE SIGNATURE; PROGNOSIS; VALIDATION; CARCINOMA; NIVOLUMAB	CD276 is a promising prognostic indicator and an attractive therapeutic target in various malignancies. However, current methods for CD276 detection are time-consuming and expensive, limiting extensive studies and applications of CD276. We aimed to develop a pathomic model for CD276 prediction from H&E-stained pathological images, and explore the underlying mechanism of the pathomic features by associating the pathomic model with transcription profiles. A dataset of colon adenocarcinoma (COAD) patients was retrieved from the Cancer Genome Atlas (TCGA) database. The dataset was divided into the training and validation sets according to the ratio of 8:2 by a stratified sampling method. Using the gradient boosting machine (GBM) algorithm, we established a pathomic model to predict CD276 expression in COAD. Univariate and multivariate Cox regression analyses were conducted to assess the predictive performance of the pathomic model for overall survival in COAD. Gene Set Enrichment Analysis (GESA) was performed to explore the underlying biological mechanisms of the pathomic model. The pathomic model formed by three pathomic features for CD276 prediction showed an area under the curve (AUC) of 0.833 (95%CI: 0.784-0.882) in the training set and 0.758 (95%CI: 0.637-0.878) in the validation set, respectively. The calibration curves and Hosmer-Lemeshow goodness of fit test showed that the prediction probability of high/low expression of CD276 was in favorable agreement with the real situation in both the training and validation sets (P=0.176 and 0.255, respectively). The DCA curves suggested that the pathomic model acquired high clinical benefit. All the subjects were categorized into high pathomic score (PS) (PS-H) and low PS (PS-L) groups according to the cutoff value of PS. Univariate and multivariate Cox regression analysis indicated that PS was a risk factor for overall survival in COAD. Furthermore, through GESA analysis, we found several immune and inflammatory-related pathways and genes were associated with the pathomic model. We constructed a pathomics-based machine learning model for CD276 prediction directly from H&E-stained images in COAD. Through integrated analysis of the pathomic model and transcriptomics, the interpretability of the pathomic model provide a theoretical basis for further hypothesis and experimental research.	[Li, Jia; Wang, Dongxu] 983rd Hosp Joint Logist Support Force PLA, Dept Gastroenterol, Tianjin, Peoples R China; [Zhang, Chenxin] 983rd Hosp Joint Logist Support Force PLA, Dept Gen Surg, Tianjin, Peoples R China		Wang, DX (corresponding author), 983rd Hosp Joint Logist Support Force PLA, Dept Gastroenterol, Tianjin, Peoples R China.; Zhang, CX (corresponding author), 983rd Hosp Joint Logist Support Force PLA, Dept Gen Surg, Tianjin, Peoples R China.	dongxuwang36@yahoo.com; zhangcx254@163.com	Wang, Jiali/IQU-4490-2023		Science and Technology "Incubation" project of the 983rd Hospital of Joint Logistic Support Force of PLA [983YN23F009, 983YN23F013]; Tianjin Health Research Project [TJWJ2023MS069]; Tianjin Key Medical Discipline (Specialty) Construction Project [TJYXZDXK-077D]	Science and Technology "Incubation" project of the 983rd Hospital of Joint Logistic Support Force of PLA; Tianjin Health Research Project; Tianjin Key Medical Discipline (Specialty) Construction Project	The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded by the Science and Technology "Incubation" project of the 983rd Hospital of Joint Logistic Support Force of PLA (983YN23F009 and 983YN23F013), Tianjin Health Research Project (TJWJ2023MS069), and Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-077D).	Ahluwalia P, 2021, CANCERS, V13, DOI 10.3390/cancers13010155; Altan M, 2017, CLIN CANCER RES, V23, P5202, DOI 10.1158/1078-0432.CCR-16-3107; Batenchuk C, 2020, J CLIN ONCOL, V38; Bera K, 2019, NAT REV CLIN ONCOL, V16, P703, DOI 10.1038/s41571-019-0252-y; Bonk S, 2020, PATHOL INT, V70, P733, DOI 10.1111/pin.12999; Cao R, 2020, THERANOSTICS, V10, P11080, DOI 10.7150/thno.49864; Chen DX, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34703-w; Chen LY, 2021, CANCER MED-US, V10, P4615, DOI 10.1002/cam4.3965; Choueiri TK, 2021, NEW ENGL J MED, V384, P829, DOI 10.1056/NEJMoa2026982; Cong F, 2017, ONCOL LETT, V14, P7185, DOI 10.3892/ol.2017.7142; Fang QX, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00185-z; Gao DZ, 2022, ASIAN J SURG, V45, P2788, DOI 10.1016/j.asjsur.2022.06.029; Getu AA, 2023, MOL CANCER, V22, DOI 10.1186/s12943-023-01751-9; Gocher AM, 2022, NAT REV IMMUNOL, V22, P158, DOI 10.1038/s41577-021-00566-3; Guo BW, 2023, J PATHOL CLIN RES, V9, P223, DOI 10.1002/cjp2.312; Guo Christina, 2023, Eur Urol, V83, P224, DOI 10.1016/j.eururo.2022.09.004; Gupta R, 2019, CURR PATHOBIOL REP, V7, P73, DOI 10.1007/s40139-019-00200-x; Jiang W, 2023, BIOENG TRANSL MED, V8, DOI 10.1002/btm2.10526; Kobayashi T, 2023, ONCOL LETT, V25, DOI 10.3892/ol.2022.13587; Lee G, 2017, EUR UROL FOCUS, V3, P457, DOI 10.1016/j.euf.2016.05.009; Lee JY, 2023, HEPATOLOGY, V78, P258, DOI 10.1097/HEP.0000000000000364; Lee JH, 2023, DIAGN PATHOL, V18, DOI 10.1186/s13000-023-01320-0; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li H, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.636451; Li M, 2018, PATHOL RES PRACT, V214, P784, DOI 10.1016/j.prp.2017.12.014; Liang YC, 2021, J INFLAMM RES, V14, P3809, DOI 10.2147/JIR.S321852; Liao LL, 2022, FRONT BIOENG BIOTECH, V10, DOI 10.3389/fbioe.2022.822835; Liu HJ, 2023, NAT COMMUN, V14, DOI 10.1038/s41467-023-36881-7; Lv LL, 2022, J TRANSL MED, V20, DOI 10.1186/s12967-022-03262-5; Niazi MKK, 2019, LANCET ONCOL, V20, pE253, DOI 10.1016/S1470-2045(19)30154-8; Omori S, 2023, INVEST NEW DRUG, V41, P356, DOI 10.1007/s10637-023-01353-8; Rasic P, 2021, WORLD J GASTRO ONCOL, V13, P799, DOI 10.4251/wjgo.v13.i8.799; Scribner JA, 2020, MOL CANCER THER, V19, P2235, DOI 10.1158/1535-7163.MCT-20-0116; Shamai G, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34275-9; Shi W, 2023, SCI TRANSL MED, V15, DOI 10.1126/scitranslmed.adf6724; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tanikawa C, 2017, EBIOMEDICINE, V20, P109, DOI 10.1016/j.ebiom.2017.05.017; Turkki R, 2019, BREAST CANCER RES TR, V177, P41, DOI 10.1007/s10549-019-05281-1; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMc1509660, 10.1056/NEJMoa1504030]; van Pelt GW, 2018, HISTOPATHOLOGY, V73, P197, DOI 10.1111/his.13489; Vernooij JEM, 2023, ANAESTHESIA, V78, P607, DOI 10.1111/anae.15988; Wang FF, 2014, CANCER INVEST, V32, P262, DOI 10.3109/07357907.2014.909826; Wang XL, 2019, INT CONF MEASURE, P1, DOI [10.1109/ICMIC48233.2019.9068567, 10.1109/TCYB.2019.2935141]; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Yu YF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.28086; Zekri L, 2023, MOL THER, V31, P1033, DOI 10.1016/j.ymthe.2023.02.010; Zeng H, 2021, GYNECOL ONCOL, V163, P171, DOI 10.1016/j.ygyno.2021.07.015; Zhai WY, 2022, FRONT GENET, V12, DOI 10.3389/fgene.2021.798131; Zhang W, 2021, CLIN COLORECTAL CANC, V20, P161, DOI 10.1016/j.clcc.2021.02.002; Zhao BH, 2022, J HEMATOL ONCOL, V15, DOI 10.1186/s13045-022-01364-7; Zhao K, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103054; Zhou WT, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.701006	52	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2234-943X			FRONT ONCOL	Front. Oncol.	JAN 8	2024	13								1232192	10.3389/fonc.2023.1232192	http://dx.doi.org/10.3389/fonc.2023.1232192			16	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	GL5I2	38260829	Green Published, gold			2024-09-18	WOS:001152832600001
J	Pang, J; Yang, MH; Li, J; Zhong, XX; Shen, XY; Chen, T; Qian, LY				Pang, Jin; Yang, Mohan; Li, Jun; Zhong, Xiaoxiao; Shen, Xiangyu; Chen, Ting; Qian, Liyuan			Interpretable machine learning model based on the systemic inflammation response index and ultrasound features can predict central lymph node metastasis in cN0T1-T2 papillary thyroid carcinoma	GLAND SURGERY			English	Article						Central lymph node metastasis (CLNM); papillary thyroid cancer (PTC); systemic inflammation response index (SIRI); machine learning (ML); shapley additive explanations (SHAP)	PROGNOSTIC VALUE; SURVIVAL; CANCER	Background: It is arguable whether individuals with T1-T2 papillary thyroid cancer (PTC) who have a clinically negative (cN0) diagnosis should undergo prophylactic central lymph node dissection (pCLND) on a routine basis. Many inflammatory indices, including the neutrophil-to-lymphocyte ratio (NLR), plateletto -lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and systemic immune -inflammatory index (SII), have been reported in PTC. However, the associations between the systemic inflammation response index (SIRI) and the risk of central lymph node metastasis (CLNM) remain unclear. Methods: Retrospective research involving 1,394 individuals with cN0T1-T2 PTC was carried out, and the included patients were randomly allocated into training (70%) and testing (30%) subgroups. The preoperative inflammatory indices and ultrasound (US) features were used to train the models. To assess the forecasting factors as well as drawing nomograms, the least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were utilized. Then eight interpretable models based on machine learning (ML) algorithms were constructed, including decision tree (DT), K -nearest neighbor (KNN), support vector machine (SVM), artificial neural network (ANN), random forest (RF), extreme gradient boosting (XGBoost), light gradient boosting machine (LightGBM), and categorical boosting (CatBoost). The performance of the models was evaluated by incorporating the area under the precision -recall curve (auPR) and the area under the receiver operating characteristic curve (auROC), as well as other conventional metrics. The interpretability of the optimum model was illustrated via the shapley additive explanations (SHAP) approach. Results: Younger age, larger tumor size, capsular invasion, location (lower and isthmus), unclear margin, microcalcifications, color Doppler flow imaging (CDFI) blood flow, and higher SIRI (>= 0.77) were independent positive predictors of CLNM, whereas female sex and Hashimoto thyroiditis were independent negative predictors, and nomograms were subsequently constructed. Taking into account both the auROC and auPR, the RF algorithm showed the best performance, and superiority to XGBoost, CatBoost and ANN. In addition, the role of key variables was visualized in the SHAP plot. Conclusions: An interpretable ML model based on the SIRI and US features can be used to predict CLNM in individuals with cN0T1-T2 PTC.	[Pang, Jin; Li, Jun; Shen, Xiangyu; Chen, Ting; Qian, Liyuan] Cent South Univ, Xiangya Hosp 3, Dept Breast & Thyroid Surg, 138 Tongzipo Rd, Changsha, Peoples R China; [Yang, Mohan] Cent South Univ, Xiangya Hosp 3, Dept Urol, Changsha, Peoples R China; [Zhong, Xiaoxiao] Cent South Univ, Xiangya Hosp 3, Dept Gen Surg, Changsha, Peoples R China	Central South University; Central South University; Central South University	Qian, LY (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Breast & Thyroid Surg, 138 Tongzipo Rd, Changsha, Peoples R China.	qianliyuan2014@126.com	JIN, PANG/KHW-2660-2024					Ali S, 2023, COMPUT BIOL MED, V166, DOI 10.1016/j.compbiomed.2023.107555; Baud G, 2022, CANCERS, V14, DOI 10.3390/cancers14215462; Cai H, 2023, WORLD J SURG ONCOL, V21, DOI 10.1186/s12957-023-03056-z; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Dong J, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08458-4; Duan XZ, 2023, BMC CANCER, V23, DOI 10.1186/s12885-023-10889-0; Duque-Santana V, 2023, ONCOLOGY-BASEL, V101, P349, DOI 10.1159/000526450; Feng JW, 2020, J ENDOCRINOL INVEST, V43, P1807, DOI 10.1007/s40618-020-01326-1; Feng JW, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1030045; Hancock JT, 2020, J BIG DATA-GER, V7, DOI 10.1186/s40537-020-00369-8; Huai QL, 2023, CANCER SCI, V114, P4484, DOI 10.1111/cas.15964; Huang CY, 2023, BMC CANCER, V23, DOI 10.1186/s12885-023-10982-4; Huang YY, 2022, CANCER CONTROL, V29, DOI 10.1177/10732748221115236; Hutchinson KA, 2023, OTOLARYNG HEAD NECK, V168, P392, DOI 10.1177/01945998221099799; Ke GL, 2017, ADV NEUR IN, V30; Kufel J, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13152582; Li JC, 2022, EJSO-EUR J SURG ONC, V48, P1272, DOI 10.1016/j.ejso.2022.04.001; Lu YF, 2023, J FORMOS MED ASSOC, V122, P1141, DOI 10.1016/j.jfma.2023.05.003; Luo ZY, 2022, ENDOCRINE, V78, P484, DOI 10.1007/s12020-022-03173-x; Makino T, 2023, BIOMEDICINES, V11, DOI 10.3390/biomedicines11020533; Meng CY, 2021, GLAND SURG, V10, P961, DOI 10.21037/gs-20-747; Ngiam KY, 2019, LANCET ONCOL, V20, pE262, DOI 10.1016/S1470-2045(19)30149-4; Nohara Y, 2022, COMPUT METH PROG BIO, V214, DOI 10.1016/j.cmpb.2021.106584; Pacheco-Barcia V, 2020, PANCREATOLOGY, V20, P254, DOI 10.1016/j.pan.2019.12.010; Pinheiro RA, 2023, CANCERS, V15, DOI 10.3390/cancers15030943; Pizzato M, 2022, LANCET DIABETES ENDO, V10, P264, DOI 10.1016/S2213-8587(22)00035-3; Privitera F, 2023, J CLIN MED, V12, DOI 10.3390/jcm12051956; Satapathy P, 2023, INT J SURG, V109, P1550, DOI 10.1097/JS9.0000000000000421; Shan MJ, 2023, BMC CANCER, V23, DOI 10.1186/s12885-023-11406-z; Song LL, 2019, CANCER MANAG RES, V11, P8451, DOI 10.2147/CMAR.S219163; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Wang WL, 2023, EJSO-EUR J SURG ONC, V49, P1147, DOI 10.1016/j.ejso.2023.02.011; Wang WL, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.917794; Wang Y, 2023, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1094012; Wu YJ, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.577537; Yang JX, 2023, FRONT ENDOCRINOL, V14, DOI 10.3389/fendo.2023.1176512; Yu ST, 2023, INT J SURG, V109, P1264, DOI 10.1097/JS9.0000000000000316; Zhang ZY, 2021, GLAND SURG, V10, P1368, DOI 10.21037/gs-20-666; Zhao LQ, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.995630	39	1	1	2	4	AME PUBLISHING COMPANY	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2227-684X	2227-8575		GLAND SURG	Gland Surg.	NOV	2023	12	11								10.21037/gs-23-349	http://dx.doi.org/10.21037/gs-23-349			17	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GQ5H4	38107491	Green Published, gold			2024-09-18	WOS:001154143400013
J	Huynh, BN; Groendahl, AR; Tomic, O; Liland, KH; Knudtsen, IS; Hoebers, F; van Elmpt, W; Malinen, E; Dale, E; Futsaether, CM				Huynh, Bao Ngoc; Groendahl, Aurora Rosvoll; Tomic, Oliver; Liland, Kristian Hovde; Knudtsen, Ingerid Skjei; Hoebers, Frank; van Elmpt, Wouter; Malinen, Eirik; Dale, Einar; Futsaether, Cecilia Marie			Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics	FRONTIERS IN MEDICINE			English	Article						machine learning; deep learning; artificial intelligence; feature selection; radiomics; head and neck cancer; interpretability; outcome prediction	LOCAL TUMOR-CONTROL; PROGNOSTIC VALUE; PET	BackgroundRadiomics can provide in-depth characterization of cancers for treatment outcome prediction. Conventional radiomics rely on extraction of image features within a pre-defined image region of interest (ROI) which are typically fed to a classification algorithm for prediction of a clinical endpoint. Deep learning radiomics allows for a simpler workflow where images can be used directly as input to a convolutional neural network (CNN) with or without a pre-defined ROI.PurposeThe purpose of this study was to evaluate (i) conventional radiomics and (ii) deep learning radiomics for predicting overall survival (OS) and disease-free survival (DFS) for patients with head and neck squamous cell carcinoma (HNSCC) using pre-treatment 18F-fluorodeoxuglucose positron emission tomography (FDG PET) and computed tomography (CT) images.Materials and methodsFDG PET/CT images and clinical data of patients with HNSCC treated with radio(chemo)therapy at Oslo University Hospital (OUS; n = 139) and Maastricht University Medical Center (MAASTRO; n = 99) were collected retrospectively. OUS data was used for model training and initial evaluation. MAASTRO data was used for external testing to assess cross-institutional generalizability. Models trained on clinical and/or conventional radiomics features, with or without feature selection, were compared to CNNs trained on PET/CT images without or with the gross tumor volume (GTV) included. Model performance was measured using accuracy, area under the receiver operating characteristic curve (AUC), Matthew's correlation coefficient (MCC), and the F1 score calculated for both classes separately.ResultsCNNs trained directly on images achieved the highest performance on external data for both endpoints. Adding both clinical and radiomics features to these image-based models increased performance further. Conventional radiomics including clinical data could achieve competitive performance. However, feature selection on clinical and radiomics data lead to overfitting and poor cross-institutional generalizability. CNNs without tumor and node contours achieved close to on-par performance with CNNs including contours.ConclusionHigh performance and cross-institutional generalizability can be achieved by combining clinical data, radiomics features and medical images together with deep learning models. However, deep learning models trained on images without contours can achieve competitive performance and could see potential use as an initial screening tool for high-risk patients.	[Huynh, Bao Ngoc; Groendahl, Aurora Rosvoll; Tomic, Oliver; Liland, Kristian Hovde; Futsaether, Cecilia Marie] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway; [Knudtsen, Ingerid Skjei] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Knudtsen, Ingerid Skjei; Malinen, Eirik] Oslo Univ Hosp, Dept Med Phys, Oslo, Norway; [Hoebers, Frank; van Elmpt, Wouter] Maastricht Univ, Med Ctr, Dept Radiat Oncol MAASTRO, Maastricht, Netherlands; [Hoebers, Frank; van Elmpt, Wouter] Maastricht Univ, Med Ctr, GROW Sch Oncol & Reprod, Maastricht, Netherlands; [Malinen, Eirik] Univ Oslo, Dept Phys, Oslo, Norway; [Dale, Einar] Oslo Univ Hosp, Dept Oncol, Oslo, Norway	Norwegian University of Life Sciences; Norwegian University of Science & Technology (NTNU); University of Oslo; Maastricht University; Maastricht University; University of Oslo; University of Oslo	Futsaether, CM (corresponding author), Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway.	cecilia.futsaether@nmbu.no	Tomic, Oliver/IZD-7313-2023; Liland, Kristian/I-5871-2012	Knudtsen, Ingerid Skjei/0000-0001-9313-2878; Huynh, Bao Ngoc/0000-0001-5210-132X	Norwegian Cancer Society [160907-2014, 182672-2016]	Norwegian Cancer Society(Norwegian Cancer Society)	The collection of the OUS dataset used in the present study was conducted as part of work supported by the Norwegian Cancer Society (grant numbers 160907-2014 and 182672-2016).	Adebayo J, 2020, Arxiv, DOI arXiv:1810.03292; Adeoye J, 2023, J BIG DATA-GER, V10, DOI 10.1186/s40537-023-00703-w; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Afshar P, 2019, IEEE SIGNAL PROC MAG, V36, P132, DOI 10.1109/MSP.2019.2900993; Andrearczyk Vincent, 2022, Head and Neck Tumor Segmentation and Outcome Prediction: Second Challenge, HECKTOR 2021, Held in Conjunction with MICCAI 2021, Proceedings. Lecture Notes in Computer Science (13209), P1, DOI 10.1007/978-3-030-98253-9_1; Apostolova I, 2014, EUR RADIOL, V24, P2077, DOI 10.1007/s00330-014-3269-8; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Berisha V, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00521-5; Bird D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1867-8; Bogowicz M, 2017, ACTA ONCOL, V56, P1531, DOI 10.1080/0284186X.2017.1346382; Bogowicz M, 2017, INT J RADIAT ONCOL, V99, P921, DOI 10.1016/j.ijrobp.2017.06.002; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Cheng NM, 2021, CLIN CANCER RES, V27, P3948, DOI 10.1158/1078-0432.CCR-20-4935; Cho HH, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02814-7; DAHANCA, 2013, Radiotherapy guidelines 2013; Diamant A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39206-1; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; Gonçalves M, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12112733; Groendahl AR, 2023, FRONT VET SCI, V10, DOI 10.3389/fvets.2023.1143986; Groendahl AR, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abe553; Gudi S, 2017, J MED IMAGING RADIAT, V48, P184, DOI 10.1016/j.jmir.2016.11.003; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Halperin E., 2007, Perez and Brady's principles and practice of radiation oncology, V5th; Hooker S., 2019, Advances in neural information processing systems, P32; Jenul A., 2021, J. Open Sour. Softw., V6, P3323, DOI DOI 10.21105/JOSS.03323; Jenul A, 2021, IEEE ACCESS, V9, P152333, DOI 10.1109/ACCESS.2021.3126429; Keek SA, 2021, CANCERS, V13, DOI 10.3390/cancers13133271; Kleppe A, 2021, NAT REV CANCER, V21, P199, DOI 10.1038/s41568-020-00327-9; Kunhoth J, 2022, Arxiv, DOI arXiv:2206.13043; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lechner M, 2022, NAT REV CLIN ONCOL, V19, P306, DOI 10.1038/s41571-022-00603-7; Liu ZR, 2020, AGING-US, V12, P14593, DOI 10.18632/aging.103508; Lydiatt WM, 2017, CA-CANCER J CLIN, V67, P122, DOI 10.3322/caac.21389; Marusyk A, 2020, CANCER CELL, V37, P471, DOI 10.1016/j.ccell.2020.03.007; Meng Mingyuan, 2023, Head and Neck Tumor Segmentation and Outcome Prediction: Third Challenge, HECKTOR 2022, Held in Conjunction with MICCAI 2022, Proceedings. Lecture Notes in Computer Science (13626), P135, DOI 10.1007/978-3-031-27420-6_14; Moan JM, 2019, RADIOTHER ONCOL, V140, P54, DOI 10.1016/j.radonc.2019.05.019; Moe YM, 2021, EUR J NUCL MED MOL I, V48, P2782, DOI 10.1007/s00259-020-05125-x; Montagne C., 2013, 6 INT C BIOINSP SYST; Parmar C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00272; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Pfister DG, 2020, J NATL COMPR CANC NE, V18, P873, DOI 10.6004/jnccn.2020.0031; Reyes M, 2020, RADIOL-ARTIF INTELL, V2, DOI 10.1148/ryai.2020190043; Schouten CS, 2016, HEAD NECK-J SCI SPEC, V38, P529, DOI 10.1002/hed.23920; Segedin B, 2016, RADIOL ONCOL, V50, P254, DOI 10.1515/raon-2016-0023; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Smilkov D, 2017, Arxiv, DOI [arXiv:1706.03825, DOI 10.48550/ARXIV.1706.03825]; Studer E, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11071940; Tan MX, 2019, PR MACH LEARN RES, V97; Springenberg JT, 2015, Arxiv, DOI [arXiv:1412.6806, 10.48550/arXiv.1412.6806, DOI 10.48550/ARXIV.1412.6806]; Tortora M, 2023, CANCERS, V15, DOI 10.3390/cancers15041174; Vallières M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10371-5; van Dijk LV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48184-3; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wang X, 2021, J THORAC DIS, V13, P1327, DOI 10.21037/jtd-20-2981; Wang YL, 2022, COMPUT METH PROG BIO, V222, DOI 10.1016/j.cmpb.2022.106948; Wong LM, 2022, CANCERS, V14, DOI 10.3390/cancers14143433; Yang Y, 2021, COMPUT BIOL MED, V139, DOI 10.1016/j.compbiomed.2021.104887; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhai TT, 2021, ORAL ONCOL, V112, DOI 10.1016/j.oraloncology.2020.105083; Zhai TT, 2020, RADIOTHER ONCOL, V146, P58, DOI 10.1016/j.radonc.2020.02.005; Zhai TT, 2019, ORAL ONCOL, V95, P178, DOI 10.1016/j.oraloncology.2019.06.020; Zhang XP, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.773840; Zwanenburg A, 2020, RADIOLOGY, V295, P328, DOI 10.1148/radiol.2020191145; Zwanenburg A, 2019, EUR J NUCL MED MOL I, V46, P2638, DOI 10.1007/s00259-019-04391-8	68	8	8	3	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	AUG 30	2023	10								1217037	10.3389/fmed.2023.1217037	http://dx.doi.org/10.3389/fmed.2023.1217037			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	R6MV0	37711738	Green Published, gold			2024-09-18	WOS:001065486500001
J	Siciarz, P; McCurdy, B				Siciarz, Pawel; McCurdy, Boyd			U-net architecture with embedded Inception-ResNet-v2 image encoding modules for automatic segmentation of organs-at-risk in head and neck cancer radiation therapy based on computed tomography scans	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						deep learning; automatic segmentation; medical imaging; radiation therapy; head and neck cancer; U-net; computed tomography		Purpose. The purpose of this study was to utilize a deep learning model with an advanced inception module to automatically contour critical organs on the computed tomography (CT) scans of head and neck cancer patients who underwent radiation therapy treatment and interpret the clinical suitability of the model results through activation mapping. Materials and methods. This study included 25 critical organs that were delineated by expert radiation oncologists. Contoured medical images of 964 patients were sourced from a publicly available TCIA database. The proportion of training, validation, and testing samples for deep learning model development was 65%, 25%, and 10% respectively. The CT scans and segmentation masks were augmented with shift, scale, and rotate transformations. Additionally, medical images were pre-processed using contrast limited adaptive histogram equalization to enhance soft tissue contrast while contours were subjected to morphological operations to ensure their structural integrity. The segmentation model was based on the U-Net architecture with embedded Inception-ResNet-v2 blocks and was trained over 100 epochs with a batch size of 32 and an adaptive learning rate optimizer. The loss function combined the Jaccard Index and binary cross entropy. The model performance was evaluated with Dice Score, Jaccard Index, and Hausdorff Distances. The interpretability of the model was analyzed with guided gradient-weighted class activation mapping. Results. The Dice Score, Jaccard Index, and mean Hausdorff Distance averaged over all structures and patients were 0.82 +/- 0.10, 0.71 +/- 0.10, and 1.51 +/- 1.17 mm respectively on the testing data sets. The Dice Scores for 86.4% of compared structures was within range or better than published interobserver variability derived from multi-institutional studies. The average model training time was 8 h per anatomical structure. The full segmentation of head and neck anatomy by the trained network required only 6.8 s per patient. Conclusions. High accuracy obtained on a large, multi-institutional data set, short segmentation time and clinically-realistic prediction reasoning make the model proposed in this work a feasible solution for head and neck CT scan segmentation in a clinical environment.	[Siciarz, Pawel] CancerCare Manitoba, Dept Med Phys, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada; [Siciarz, Pawel; McCurdy, Boyd] Univ Manitoba, Dept Phys & Astron, Allen Bldg, Winnipeg, MB R3T 2N2, Canada; [McCurdy, Boyd] CancerCare Manitoba, Dept Med Phys, Radiat Oncol Phys Grp, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada; [McCurdy, Boyd] Univ Manitoba, Dept Radiol, GA216-820 Sherbrook St, Winnipeg, MB R3T 2N2, Canada	CancerCare Manitoba Foundation; University of Manitoba; CancerCare Manitoba Foundation; University of Manitoba	Siciarz, P (corresponding author), CancerCare Manitoba, Dept Med Phys, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.; Siciarz, P (corresponding author), Univ Manitoba, Dept Phys & Astron, Allen Bldg, Winnipeg, MB R3T 2N2, Canada.	psiciarz@cancercare.mb.ca; bmccurdy2@cancercare.mb.ca		Siciarz, Pawel/0000-0002-7953-7729	Natural Sciences and Engineering Research Council of Canada; University of Manitoba	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Manitoba	The authors would like to acknowledge the financial support of the Natural Sciences and Engineering Research Council of Canada (Discovery Grant) as well as the University of Manitoba.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Abadi M, 2016, ACM SIGPLAN NOTICES, V51, P1, DOI [10.1145/2951913.2976746, 10.1145/3022670.2976746]; Aliotta E, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab205c; [Anonymous], 1912, NEW PHYTOL, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X]; Baek S., 2019, ARXIV190311593; Bejarano Tatiana, 2018, TCIA; Bosch WR., 2015, **DATA OBJECT**, DOI 10.7937/K9/TCIA.2015.7AKGJUPZ; Buslaev A, 2020, INFORMATION, V11, DOI 10.3390/info11020125; Cardenas CE, 2019, SEMIN RADIAT ONCOL, V29, P185, DOI 10.1016/j.semradonc.2019.02.001; Campos GFC, 2019, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-019-0445-4; Chollet, KERAS; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Conibear J., 2018, THESIS UCL U COLL LO; Diamant A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39206-1; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eaton-Rosen Z., 2018, Improving data augmentation for medical image segmentation; Elhalawani H, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.77; Fu YB, 2021, PHYS MEDICA, V85, P107, DOI 10.1016/j.ejmp.2021.05.003; Gao YH, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101831; Gorthi S, 2009, IEEE J-STSP, V3, P135, DOI 10.1109/JSTSP.2008.2011104; Grossberg AJ, 2018, SCI DATA, V5, DOI [10.1038/s41597-018-0002-5, 10.1038/sdata.2018.173]; Halicek M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50313-x; Hausdorff F., 1991, Set Theory; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Ho D, 2019, PR MACH LEARN RES, V97; Khened M, 2019, MED IMAGE ANAL, V51, P21, DOI 10.1016/j.media.2018.10.004; Kingma DP, 2014, ADV NEUR IN, V27; Kosmin M, 2019, RADIOTHER ONCOL, V135, P130, DOI 10.1016/j.radonc.2019.03.004; Kwan JYY, 2018, INT J RADIAT ONCOL, V102, P1107, DOI 10.1016/j.ijrobp.2018.01.057; Lee H, 2019, NAT BIOMED ENG, V3, P173, DOI 10.1038/s41551-018-0324-9; Lim S., 2019, Advances in Neural Information Processing Systems; Liu F, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101873; Rhee DJ, 2019, MED PHYS, V46, P5086, DOI 10.1002/mp.13814; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sandström H, 2018, ACTA ONCOL, V57, P1515, DOI 10.1080/0284186X.2018.1473636; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Szegedy C., 2016, PROC IEEE C COMPUTER; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Taha AA, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0068-x; Tang H, 2019, NAT MACH INTELL, V1, P480, DOI 10.1038/s42256-019-0099-z; Vallières M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10371-5; van Rooij W, 2019, INT J RADIAT ONCOL, V104, P677, DOI 10.1016/j.ijrobp.2019.02.040; Vrtovec T, 2020, MED PHYS, V47, pE929, DOI 10.1002/mp.14320; Wee Leonard, 2019, TCIA, V3; Xie Q., 2019, Unsupervised data augmentation for consistency training; Zhu WT, 2019, MED PHYS, V46, P576, DOI 10.1002/mp.13300	47	13	14	4	16	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	JUN 7	2022	67	11							115007	10.1088/1361-6560/ac530e	http://dx.doi.org/10.1088/1361-6560/ac530e			42	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	2H6EG	35134792				2024-09-18	WOS:000814384800001
J	Filippini, T; Malavolti, M; Borrelli, F; Izzo, AA; Fairweather-Tait, SJ; Horneber, M; Vinceti, M				Filippini, Tommaso; Malavolti, Marcella; Borrelli, Francesca; Izzo, Angelo A.; Fairweather-Tait, Susan J.; Horneber, Markus; Vinceti, Marco			Green tea (Camellia sinensis) for the prevention of cancer	COCHRANE DATABASE OF SYSTEMATIC REVIEWS			English	Review							LIFE-STYLE FACTORS; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; SQUAMOUS-CELL CARCINOMA; RANDOMIZED CONTROLLED-TRIAL; DOSE-RESPONSE METAANALYSIS; UPPER AERODIGESTIVE TRACT; TOTAL FLUID CONSUMPTION; POPULATION-BASED COHORT; HUMAN PROSTATE-CANCER	Background This review is an update of a previously published review in the Cochrane Database of Systematic Reviews (2009, Issue 3).Tea is one of the most commonly consumed beverages worldwide. Teas from the plant Camellia sinensis can be grouped into green, black and oolong tea, and drinking habits vary cross-culturally. C sinensis contains polyphenols, one subgroup being catechins. Catechins are powerful antioxidants, and laboratory studies have suggested that these compounds may inhibit cancer cell proliferation. Some experimental and nonexperimental epidemiological studies have suggested that green tea may have cancer-preventative eGects. Objectives To assess possible associations between green tea consumption and the risk of cancer incidence and mortality as primary outcomes, and safety data and quality of life as secondary outcomes. Search methods We searched eligible studies up to January 2019 in CENTRAL, MEDLINE, Embase, ClinicalTrials.gov, and reference lists of previous reviews and included studies. Selection criteria We included all epidemiological studies, experimental (i.e. randomised controlled trials (RCTs)) and nonexperimental (non-randomised studies, i.e. observational studies with both cohort and case-control design) that investigated the association of green tea consumption with cancer risk or quality of life, or both. Data collection and analysis Two or more review authors independently applied the study criteria, extracted data and assessed methodological quality of studies. We summarised the results according to diagnosis of cancer type. Main results In this review update, we included in total 142 completed studies (11 experimental and 131 nonexperimental) and two ongoing studies. This is an additional 10 experimental and 85 nonexperimental studies from those included in the previous version of the review. Eleven experimental studies allocated a total of 1795 participants to either green tea extract or placebo, all demonstrating an overall high methodological quality based on 'Risk of bias' assessment. For incident prostate cancer, the summary risk ratio (RR) in the green teasupplemented participants was 0.50 (95% confidence interval (CI) 0.18 to 1.36), based on three studies and involving 201 participants (low-certainty evidence). The summary RR for gynaecological cancer was 1.50 (95% CI 0.41 to 5.48; 2 studies, 1157 participants; lowcertainty evidence). No evidence of eGect of non-melanoma skin cancer emerged (summary RR 1.00, 95% CI 0.06 to 15.92; 1 study, 1075 participants; low-certainty evidence). In addition, adverse eGects of green tea extract intake were reported, including gastrointestinal disorders, elevation of liver enzymes, and, more rarely, insomnia, raised blood pressure and skin/subcutaneous reactions. Consumption of green tea extracts induced a slight improvement in quality of life, compared with placebo, based on three experimental studies. In nonexperimental studies, we included over 1,100,000 participants from 46 cohort studies and 85 case-control studies, which were on average of intermediate to high methodological quality based on Newcastle-Ottawa Scale 'Risk of bias' assessment. When comparing the highest intake of green tea with the lowest, we found a lower overall cancer incidence (summary RR 0.83, 95% CI 0.65 to 1.07), based on three studies, involving 52,479 participants (low-certainty evidence). Conversely, we found no association between green tea consumption and cancer-related mortality (summary RR 0.99, 95% CI 0.91 to 1.07), based on eight studies and 504,366 participants (low-certainty evidence). For most of the site-specific cancers we observed a decreased RR in the highest category of green tea consumption compared with the lowest one. AKer stratifying the analysis according to study design, we found strongly conflicting results for some cancer sites: oesophageal, prostate and urinary tract cancer, and leukaemia showed an increased RR in cohort studies and a decreased RR or no diGerence in casecontrol studies. Authors' conclusions Overall, findings from experimental and nonexperimental epidemiological studies yielded inconsistent results, thus providing limited evidence for the beneficial eGect of green tea consumption on the overall risk of cancer or on specific cancer sites. Some evidence of a beneficial eGect of green tea at some cancer sites emerged from the RCTs and from case-control studies, but their methodological limitations, such as the low number and size of the studies, and the inconsistencies with the results of cohort studies, limit the interpretability of the RR estimates. The studies also indicated the occurrence of several side eGects associated with high intakes of green tea. In addition, the majority of included studies were carried out in Asian populations characterised by a high intake of green tea, thus limiting the generalisability of the findings to other populations. Well conducted and adequately powered RCTs would be needed to draw conclusions on the possible beneficial eGects of green tea consumption on cancer risk.	[Filippini, Tommaso; Malavolti, Marcella; Vinceti, Marco] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Res Ctr Environm Nutr & Genet Epidemiol CREAGEN, Via Campi 287, I-41125 Modena, Italy; [Borrelli, Francesca; Izzo, Angelo A.] Univ Naples Federico II, Sch Med & Surg, Dept Pharm, Naples, Italy; [Fairweather-Tait, Susan J.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Horneber, Markus] Paracelsus Med Univ, Klinikum Nuremberg, Div Oncol & Hematol, Dept Internal Med, Nurnberg, Germany; [Vinceti, Marco] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Universita di Modena e Reggio Emilia; University of Naples Federico II; University of East Anglia; Klinikum Nurnberg Nord; Boston University	Vinceti, M (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Res Ctr Environm Nutr & Genet Epidemiol CREAGEN, Via Campi 287, I-41125 Modena, Italy.	marco.vinceti@unimore.it	Fairweather-Tait, Susan/K-4251-2012; Vinceti, Marco/O-2509-2015; Izzo, Angelo/F-9612-2015; Borrelli, Francesca/AAC-6715-2022; Filippini, Tommaso/D-5023-2016	Filippini, Tommaso/0000-0003-2100-0344; Fairweather-Tait, Susan/0000-0002-1413-5569; Borrelli, Francesca/0000-0002-2695-3294; Izzo, Angelo/0000-0002-8557-2133	Pilkington Family Trusts, UK; AG Biologische Krebstherapie, Deutsche Krebshilfe, Bonn, Germany; Cochrane Gyneacological Cancer Review Group, UK; Nordic Cochrane Centre/ViFab, Denmark	Pilkington Family Trusts, UK; AG Biologische Krebstherapie, Deutsche Krebshilfe, Bonn, Germany; Cochrane Gyneacological Cancer Review Group, UK; Nordic Cochrane Centre/ViFab, Denmark	Internal sources Pilkington Family Trusts, UK. External sources AG Biologische Krebstherapie, Deutsche Krebshilfe, Bonn, Germany. Cochrane Gyneacological Cancer Review Group, UK. Nordic Cochrane Centre/ViFab, Denmark.	Ahmad MR, 2012, J PAK MED ASSOC, V62, P236; Ahmad N, 1999, NUTR REV, V57, P78, DOI 10.1111/j.1753-4887.1999.tb06927.x; Allen NE, 2011, BRIT J CANCER, V104, P1487, DOI 10.1038/bjc.2011.90; Allen NE, 2004, CANCER CAUSE CONTROL, V15, P911, DOI 10.1007/s10552-004-1683-y; Alsanad SM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1372-x; Amarasinghe HK, 2013, J ORAL PATHOL MED, V42, P656, DOI 10.1111/jop.12067; [Anonymous], B UASVM FOOD SCI TEC; [Anonymous], CHINA CANC; [Anonymous], NEWCASTLE OTTAWA SCA; [Anonymous], J CLIN ONCOLOGY S; [Anonymous], USDA DATABASE FLAVON; [Anonymous], CLUJUL MED S6; [Anonymous], CANC PREVENTION R S1; [Anonymous], 2017, COCHRANE HDB SYSTEMA; [Anonymous], J CLIN ONCOLOGY; [Anonymous], MOL BASEL SWITZERLAN; [Anonymous], ACAD J GUANGZHOU MED; [Anonymous], 2016, NUTRACEUTICALS EFFIC; [Anonymous], ASIA PACIFIC J PUB S; [Anonymous], CANC PREVENTION R S1; [Anonymous], SCIENCE; [Anonymous], 2017, COCHRANE HDB SYSTEMA; [Anonymous], JAPANESE J CANC RES; [Anonymous], RECHERCHES CHIRURGIC; [Anonymous], FAO INT GROUP TEA SU; [Anonymous], BIOMED RES INT, DOI DOI 10.1155/2016/5730569; [Anonymous], ERS FOOD AV CAP DAT; [Anonymous], GAN NO RINSHO; [Anonymous], CANC EPIDEMIOLOGY BI; [Anonymous], CANC PREVENTION R S1; [Anonymous], J CLIN ONCOLOGY S15; [Anonymous], EUROPEAN J SURG ONCO; [Anonymous], 2015, GRADEPRO GDT; Arts ICW, 2001, INT J CANCER, V92, P298, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1187>3.0.CO;2-8; Asgari MM, 2011, NUTR CANCER, V63, P314, DOI 10.1080/01635581.2011.523496; Askari F, 2014, ASIAN PAC J CANCER P, V15, P2159, DOI 10.7314/APJCP.2014.15.5.2159; Aslam AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012040.pub2; Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Azeem K, 2013, Klin Onkol, V26, P257; Bailey HD, 2017, CANCER CAUSE CONTROL, V28, P719, DOI 10.1007/s10552-017-0900-4; Bamia C, 2015, INT J CANCER, V136, P1899, DOI 10.1002/ijc.29214; Bandera EV, 2010, CANCER CAUSE CONTROL, V21, P1467, DOI 10.1007/s10552-010-9575-9; Bao PP, 2015, EPIDEMIOLOGY, V26, P909, DOI 10.1097/EDE.0000000000000373; Baroudi O, 2014, TUMOR BIOL, V35, P5815, DOI 10.1007/s13277-014-1771-x; Bates MN, 2007, CANCER LETT, V246, P268, DOI 10.1016/j.canlet.2006.03.005; Beltz Lisa Ann, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P389; Berroukche A, 2012, ONCOLOGIE, V14, P674, DOI 10.1007/s10269-012-2227-9; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Bianchi GD, 2000, AM J EPIDEMIOL, V151, P377, DOI 10.1093/oxfordjournals.aje.a010217; Blumenthal M., 2003, ABC CLIN GUIDE HERBS, V1st; Boehm K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005004.pub2; Bonaventure A, 2013, CANCER CAUSE CONTROL, V24, P783, DOI 10.1007/s10552-013-0161-9; Bonner MR, 2005, MUTAT RES-GEN TOX EN, V582, P53, DOI 10.1016/j.mrgentox.2004.12.008; Booth A, 2008, HEALTH INFO LIBR J, V25, P313, DOI 10.1111/j.1471-1842.2008.00825.x; Borges G, 2018, MOL ASPECTS MED, V61, P18, DOI 10.1016/j.mam.2017.11.002; Borges G, 2016, FREE RADICAL BIO MED, V99, P128, DOI 10.1016/j.freeradbiomed.2016.08.001; Borrelli F, 2004, ALIMENT PHARM THER, V19, P497, DOI 10.1111/j.1365-2036.2004.01884.x; Brausi M, 2008, EUR UROL, V54, P472, DOI 10.1016/j.eururo.2008.03.100; Butler LM, 2015, AM J EPIDEMIOL, V181, P397, DOI 10.1093/aje/kwu304; Butler LM, 2011, MOL NUTR FOOD RES, V55, P931, DOI 10.1002/mnfr.201100058; Chang B, 2014, NUTR CANCER, V66, P1109, DOI 10.1080/01635581.2014.951730; Chen F, 2017, EUR J CLIN NUTR, V71, P481, DOI 10.1038/ejcn.2016.208; Chen F, 2017, ONCOTARGET, V8, P50091, DOI 10.18632/oncotarget.15096; Chen F, 2016, J CANCER RES CLIN, V142, P995, DOI 10.1007/s00432-016-2123-6; Chen Fa, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P683; Chen K, 2014, EUR J CANCER PREV, V23, P353, DOI 10.1097/CEJ.0000000000000033; Chen M, 2019, CHEM-BIOL INTERACT, V307, P125, DOI 10.1016/j.cbi.2019.04.029; Chen PC, 2007, ANAL CHIM ACTA, V594, P32, DOI 10.1016/j.aca.2007.05.012; Chen YK, 2009, NUTRITION, V25, P753, DOI 10.1016/j.nut.2009.02.002; Chen YT, 2017, ONCOTARGET, V8, P37367, DOI 10.18632/oncotarget.16959; Chen ZH, 2011, ASIAN PAC J CANCER P, V12, P229; Chyou P H, 1993, Ann Epidemiol, V3, P211; CHYOU PH, 1995, INT J CANCER, V60, P616, DOI 10.1002/ijc.2910600508; Crew KD, 2015, J HUM NUTR DIET, V28, P272, DOI 10.1111/jhn.12229; D'Arena G, 2013, INT J IMMUNOPATH PH, V26, P117, DOI 10.1177/039463201302600111; Dai Q, 2010, ANN EPIDEMIOL, V20, P74, DOI 10.1016/j.annepidem.2009.09.005; Deandrea S, 2010, EUR J CANCER PREV, V19, P18, DOI 10.1097/CEJ.0b013e328330eb1a; Demeule Michel, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P441, DOI 10.2174/1568011023353930; DENIS LJ, 1993, EUR UROL, V25, P29; Diniz C, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600912; Dostal AM, 2015, FOOD CHEM TOXICOL, V83, P26, DOI 10.1016/j.fct.2015.05.019; Dryden GW, 2013, INFLAMM BOWEL DIS, V19, P1904, DOI 10.1097/MIB.0b013e31828f5198; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eisenstein M, 2019, NATURE, V566, pS6, DOI 10.1038/d41586-019-00397-2; Emami H, 2014, J RES MED SCI, V19, P445; European Network for Health Technology Assessment (EUnetHTA), 2017, PROC INF RETR SYST R; Fang XX, 2015, EUR J CANCER, V51, P2820, DOI 10.1016/j.ejca.2015.09.010; Ferrucci LM, 2014, EUR J CANCER PREV, V23, P296, DOI 10.1097/CEJ.0000000000000037; Filippini T, 2019, J TRACE ELEM MED BIO, V52, P293, DOI 10.1016/j.jtemb.2019.01.012; Fu JY, 2013, ORAL ONCOL, V49, P918, DOI 10.1016/j.oraloncology.2013.05.002; Fujiki H, 1999, J CANCER RES CLIN, V125, P589, DOI 10.1007/s004320050321; Fujino Y, 2002, PREV MED, V35, P121, DOI 10.1006/pmed.2002.1066; Fukao A., 1995, J Epidemiol, V5, P153, DOI 10.2188/jea.5.153; Galanis DJ, 1998, INT J EPIDEMIOL, V27, P173, DOI 10.1093/ije/27.2.173; Galanis DJ, 1997, CANCER, V79, P1840, DOI 10.1002/(SICI)1097-0142(19970501)79:9<1840::AID-CNCR29>3.0.CO;2-X; Gao CM, 2002, CANCER LETT, V188, P95, DOI 10.1016/S0304-3835(02)00115-5; Gao Jing, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P323; Gao Y, 2009, CANCER CAUSE CONTROL, V20, P1997, DOI 10.1007/s10552-009-9394-z; GAO YT, 1994, JNCI-J NATL CANCER I, V86, P855, DOI 10.1093/jnci/86.11.855; Gao Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149032; Garcia FAR, 2014, GYNECOL ONCOL, V132, P377, DOI 10.1016/j.ygyno.2013.12.034; Gianfredi V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121886; Goodman MT, 2003, NUTR CANCER, V46, P23, DOI 10.1207/S15327914NC4601_03; Green CJ, 2014, J EPIDEMIOL, V24, P146, DOI 10.2188/jea.JE20130063; Grumann M, 2001, ONKOLOGIE, V24, P10, DOI 10.1159/000050275; Guo YM, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006426, 10.1097/md.0000000000006426]; Guo ZJ, 2019, IRAN J PUBLIC HEALTH, V48, P1566; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; Hakim IA, 2000, CANCER EPIDEM BIOMAR, V9, P727; [韩仁强 HAN Renqiang], 2008, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V28, P354; HARA N, 1984, Nutrition and Cancer, V6, P220, DOI 10.1080/01635588509513828; He F, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000008816, 10.1097/md.0000000000008816]; Hemelt M, 2010, INT J CANCER, V127, P638, DOI 10.1002/ijc.25084; Higgins JP, 2011, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoshiyama Y, 2004, BRIT J CANCER, V90, P135, DOI 10.1038/sj.bjc.6601512; Hoshiyama Y, 2002, BRIT J CANCER, V87, P309, DOI 10.1038/sj.bjc.6600487; HOSHIYAMA Y, 1992, JPN J CANCER RES, V83, P937, DOI 10.1111/j.1349-7006.1992.tb02004.x; Hou IC, 2013, WORLD J GASTROENTERO, V19, P3713, DOI 10.3748/wjg.v19.i24.3713; Hsu WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041779; Huang X, 1999, J Epidemiol, V9, P40; Huang YQ, 2016, NUTRITION, V32, P3, DOI 10.1016/j.nut.2015.05.021; Huang YH, 2017, PUBLIC HEALTH NUTR, V20, P3183, DOI 10.1017/S1368980017002208; Ide R, 2008, ORAL DIS, V14, P314, DOI 10.1111/j.1601-0825.2007.01378.x; Ide R, 2007, ANN EPIDEMIOL, V17, P821, DOI 10.1016/j.annepidem.2007.04.003; Il'yasova D, 2003, CANCER CAUSE CONTROL, V14, P767, DOI 10.1023/A:1026371307954; Imai K, 1997, PREV MED, V26, P769, DOI 10.1006/pmed.1997.0242; INOUE M, 1994, INT J CANCER, V56, P494, DOI 10.1002/ijc.2910560407; Inoue M, 1998, CANCER CAUSE CONTROL, V9, P209, DOI 10.1023/A:1008890529261; Inoue M, 2009, GUT, V58, P1323, DOI 10.1136/gut.2008.166710; Inoue M, 2001, CANCER LETT, V167, P175, DOI 10.1016/S0304-3835(01)00486-4; Inoue M, 1997, J CLIN EPIDEMIOL, V50, P69, DOI 10.1016/S0895-4356(96)00297-1; Inoue M, 2008, CARCINOGENESIS, V29, P1967, DOI 10.1093/carcin/bgn177; Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923; Ishikawa A, 2006, J EPIDEMIOL, V16, P185, DOI 10.2188/jea.16.185; Ishizuka H, 2003, EUR J EPIDEMIOL, V18, P401, DOI 10.1023/A:1024237927985; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; Iwai Nobuo, 2002, J Epidemiol, V12, P191; Iwasaki M, 2014, NUTR CANCER, V66, P57, DOI 10.1080/01635581.2014.847963; Iwasaki M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2756; Iwasaki M, 2010, BREAST CANCER RES TR, V124, P827, DOI 10.1007/s10549-010-0916-x; Jacob SA, 2017, NUTR CANCER, V69, P353, DOI 10.1080/01635581.2017.1285037; Jatoi A, 2003, CANCER-AM CANCER SOC, V97, P1442, DOI 10.1002/cncr.11200; Ji BT, 1996, CANCER, V77, P2449, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2449::AID-CNCR6>3.0.CO;2-H; Ji BT, 1997, INT J CANCER, V70, P255, DOI 10.1002/(SICI)1097-0215(19970127)70:3<255::AID-IJC1>3.0.CO;2-W; Jia Xianjie, 2016, Wei Sheng Yan Jiu, V45, P771; Jia Y, 2012, ASIAN PAC J CANCER P, V13, P5299, DOI 10.7314/APJCP.2012.13.10.5299; Jian L, 2004, INT J CANCER, V108, P130, DOI 10.1002/ijc.11550; Jian L, 2007, ASIA PAC J CLIN NUTR, V16, P453; Jin Zi-yi, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P114; Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0; Kakuta Y, 2009, CANCER CAUSE CONTROL, V20, P617, DOI 10.1007/s10552-008-9272-0; KATO I, 1990, JPN J CANCER RES, V81, P1101, DOI 10.1111/j.1349-7006.1990.tb02520.x; KATO I, 1990, CANCER RES, V50, P6559; Kerimi A, 2018, ANTIOXID REDOX SIGN, V29, P1633, DOI 10.1089/ars.2017.7086; Key TJ, 1999, BRIT J CANCER, V81, P1248, DOI 10.1038/sj.bjc.6690837; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Khan MAM, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-13843-w, 10.1038/srep41995]; Kikuchi N, 2006, BRIT J CANCER, V95, P371, DOI 10.1038/sj.bjc.6603230; Koizumi Y, 2003, CANCER EPIDEM BIOMAR, V12, P472; KONO S, 1991, J CLIN EPIDEMIOL, V44, P1255, DOI 10.1016/0895-4356(91)90158-6; KONO S, 1988, JPN J CANCER RES, V79, P1067, DOI 10.1111/j.1349-7006.1988.tb01528.x; Kubik A, 2008, NEOPLASMA, V55, P192; Kubík AK, 2004, EUR J CANCER PREV, V13, P471, DOI 10.1097/00008469-200412000-00002; Kumar NB, 2017, ONCOTARGET, V8, P99093, DOI 10.18632/oncotarget.18858; Kumar NB, 2016, ONCOTARGET, V7, P70794, DOI 10.18632/oncotarget.12222; Kumar NB, 2015, CANCER PREV RES, V8, P879, DOI 10.1158/1940-6207.CAPR-14-0324; Kuo YC, 2009, CANCER CAUSE CONTROL, V20, P57, DOI 10.1007/s10552-008-9217-7; Kurahashi N, 2008, AM J EPIDEMIOL, V167, P71, DOI 10.1093/aje/kwm249; Kurahashi N, 2009, CANCER SCI, V100, P284, DOI 10.1111/j.1349-7006.2008.01027.x; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Kuwahara Y, 2000, SCAND J GASTROENTERO, V35, P476, DOI 10.1080/003655200750023723; Lane JA, 2018, CANCER PREV RES, V11, P687, DOI 10.1158/1940-6207.CAPR-18-0147; Langendam MW, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-81; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Lee AH, 2013, CANCER EPIDEMIOL, V37, P54, DOI 10.1016/j.canep.2012.10.003; LEE HH, 1990, ANTICANCER RES, V10, P875; Lee KJ, 2007, INT J CANCER, V121, P1312, DOI 10.1002/ijc.22778; Lee PMY, 2017, PROSTATE CANCER P D, V20, P318, DOI 10.1038/pcan.2017.18; Leung ACY, 2016, CANCER EPIDEMIOL, V45, P119, DOI 10.1016/j.canep.2016.10.010; Lewis JE, 2005, MATURITAS, V50, P209, DOI 10.1016/j.maturitas.2004.06.015; Li L, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-167; Li ML, 2014, BIOMED ENVIRON SCI, V27, P707, DOI 10.3967/bes2014.089; Li M, 2016, CANCER EPIDEMIOL, V40, P73, DOI 10.1016/j.canep.2015.11.013; Li Q, 2008, BRIT J CANCER, V99, P1179, DOI 10.1038/sj.bjc.6604645; Li X, 2018, Zhonghua Yu Fang Yi Xue Za Zhi, V52, P511, DOI 10.3760/cma.j.issn.0253-9624.2018.05.010; Li YL, 2011, CANCER EPIDEMIOL, V35, P362, DOI 10.1016/j.canep.2011.01.005; Liao SS, 2001, VITAM HORM, V62, P1, DOI 10.1016/S0083-6729(01)62001-6; Lin IH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030951; Lin YW, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-38; Lin YS, 2008, PANCREAS, V37, P25, DOI 10.1097/MPA.0b013e318160a5e2; Liu JX, 2016, EUR J EPIDEMIOL, V31, P853, DOI 10.1007/s10654-016-0173-3; Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746; Liu P, 2017, EUR J NUTR, V56, P603, DOI 10.1007/s00394-015-1104-x; Liu P, 2015, LEUKEMIA RES, V39, P164, DOI 10.1016/j.leukres.2014.11.020; Liu SZ, 2014, ASIAN PAC J CANCER P, V15, P7947, DOI 10.7314/APJCP.2014.15.18.7947; Luo JF, 2010, BREAST CANCER RES TR, V120, P693, DOI 10.1007/s10549-009-0487-x; Luo JH, 2007, EUR J CANCER PREV, V16, P542, DOI 10.1097/CEJ.0b013e32809b4d30; Maiti TK, 2003, BIOCHEM BIOPH RES CO, V308, P64, DOI 10.1016/S0006-291X(03)01338-X; Makiuchi T, 2016, CANCER SCI, V107, P76, DOI 10.1111/cas.12843; Malir F, 2014, TOXINS, V6, P3438, DOI 10.3390/toxins6123438; Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S; Mao XQ, 2011, ASIAN PAC J CANCER P, V12, P2179; Marberger M, 2013, ADV THER, V30, P309, DOI 10.1007/s12325-013-0022-7; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meader N, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-82; Micali S, 2017, ARCH ITAL UROL ANDRO, V89, P197, DOI 10.4081/aiua.2017.3.197; Michikawa T, 2011, CANCER CAUSE CONTROL, V22, P985, DOI 10.1007/s10552-011-9771-2; Milani RF, 2019, J TRACE ELEM MED BIO, V52, P111, DOI 10.1016/j.jtemb.2018.12.004; Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311; Mizoo T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-565; MIZUNO S, 1992, JPN J CLIN ONCOL, V22, P286; Montague JA, 2012, CANCER CAUSE CONTROL, V23, P1635, DOI 10.1007/s10552-012-0041-8; Montella M, 2009, NUTR CANCER, V61, P76, DOI 10.1080/01635580802670754; Montella M, 2007, INT J CANCER, V120, P1555, DOI 10.1002/ijc.22509; Mu Li-na, 2003, Zhonghua Yufang Yixue Zazhi, V37, P171; Mu Li-na, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P192; Mu LN, 2005, INT J CANCER, V116, P972, DOI 10.1002/ijc.21137; Nagano J, 2000, INT J CANCER, V86, P132, DOI 10.1002/(SICI)1097-0215(20000401)86:1<132::AID-IJC21>3.0.CO;2-M; Nagano J, 2001, CANCER CAUSE CONTROL, V12, P501, DOI 10.1023/A:1011297326696; Naganuma T, 2009, AM J EPIDEMIOL, V170, P730, DOI 10.1093/aje/kwp187; Nagle CM, 2010, CANCER CAUSE CONTROL, V21, P1485, DOI 10.1007/s10552-010-9577-7; Najafi MN, 2018, PHYTOTHER RES, V32, P1855, DOI 10.1002/ptr.6124; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Nakachi K, 1998, JPN J CANCER RES, V89, P254, DOI 10.1111/j.1349-7006.1998.tb00556.x; Nakachi K, 2003, AGEING RES REV, V2, P1, DOI 10.1016/S1568-1637(02)00047-8; Nakamura K, 2011, JPN J CLIN ONCOL, V41, P225, DOI 10.1093/jjco/hyq185; Nechuta S, 2012, AM J CLIN NUTR, V96, P1056, DOI 10.3945/ajcn.111.031419; Ni CX, 2017, NUTR CANCER, V69, P211, DOI 10.1080/01635581.2017.1263754; Nordic Cochrane Centre, 2014, Review manager. In (Version 5.3); Oba S, 2006, CANCER LETT, V244, P260, DOI 10.1016/j.canlet.2005.12.037; Odegaard AO, 2015, J NUTR, V145, P595, DOI 10.3945/jn.114.200253; Ogawa T, 2016, INT J CANCER, V139, P2714, DOI 10.1002/ijc.30405; OGUNI I, 1992, Preventive Medicine, V21, P332; Ohno Y, 1985, Natl Cancer Inst Monogr, V69, P229; Ohno Y, 2001, J Epidemiol, V11, P144; Oze I, 2014, INT J CANCER, V135, P391, DOI 10.1002/ijc.28653; Parodi S, 2017, CANCER EPIDEMIOL, V47, P81, DOI 10.1016/j.canep.2017.01.005; Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649; Peng XE, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0156-3; Peng XE, 2013, GENE, V521, P105, DOI 10.1016/j.gene.2013.02.029; Pisters KMW, 2001, J CLIN ONCOL, V19, P1830, DOI 10.1200/JCO.2001.19.6.1830; Podwika W, 2018, BIOL TRACE ELEM RES, V183, P389, DOI 10.1007/s12011-017-1140-x; Preedy VR, 2014, PROCESSING AND IMPACT ON ANTIOXIDANTS IN BEVERAGES, pXIII; Qin J, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-172; Rahmani AH, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/925640; Rashidi B, 2017, BIOMED PHARMACOTHER, V89, P949, DOI 10.1016/j.biopha.2017.01.161; Ren A, 1991, Zhonghua Liu Xing Bing Xue Za Zhi, V12, P200; Romano B, 2013, PHYTOTHER RES, V27, P1588, DOI 10.1002/ptr.5023; Roshdy E, 2013, INT J WOMENS HEALTH, V5, P477, DOI 10.2147/IJWH.S41021; Rothwell JA, 2017, CURR OPIN CLIN NUTR, V20, P512, DOI 10.1097/MCO.0000000000000424; Ruan Hong-Lian, 2010, Front Med China, V4, P448, DOI 10.1007/s11684-010-0280-6; Saito E, 2015, ANN EPIDEMIOL, V25, P512, DOI 10.1016/j.annepidem.2015.03.007; Samavat H, 2017, CANCER PREV RES, V10, P710, DOI 10.1158/1940-6207.CAPR-17-0187; Samavat H, 2015, CANCER CAUSE CONTROL, V26, P1405, DOI 10.1007/s10552-015-0632-2; Sang LX, 2013, NUTR CANCER, V65, P802, DOI 10.1080/01635581.2013.805423; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Sasazuki S, 2004, CANCER CAUSE CONTROL, V15, P483, DOI 10.1023/B:CACO.0000036449.68454.42; Sasazuki S, 2008, CANCER EPIDEM BIOMAR, V17, P343, DOI 10.1158/1055-9965.EPI-07-0428; Sasazuki S, 2012, JPN J CLIN ONCOL, V42, P335, DOI 10.1093/jjco/hys009; Sauvaget C, 2005, CANCER CAUSE CONTROL, V16, P773, DOI 10.1007/s10552-005-5385-x; Sawada N, 2017, J EPIDEMIOL, V27, P2, DOI 10.1016/j.je.2016.09.001; Scalbert Augustin, 2000, Journal of Nutrition, V130, p2073S; Schröder L, 2019, ONCOL REP, V41, P387, DOI 10.3892/or.2018.6789; Seo AY, 2013, J GASTROEN HEPATOL, V28, P121; Setiawan VW, 2001, INT J CANCER, V92, P600, DOI 10.1002/ijc.1231; SEVERSON RK, 1989, CANCER RES, V49, P1857; Sharpe E, 2016, FOOD CHEM, V192, P380, DOI 10.1016/j.foodchem.2015.07.005; Shibata K, 2000, J Epidemiol, V10, P310; SHIM JS, 1995, CANCER EPIDEM BIOMAR, V4, P387; Shimazu T, 2008, INT J CANCER, V123, P2406, DOI 10.1002/ijc.23760; Shin CM, 2018, CLIN NUTR, V37, P452, DOI 10.1016/j.clnu.2017.01.014; Shrubsole MJ, 2009, J NUTR, V139, P310, DOI 10.3945/jn.108.098699; Sinicrope FA, 2017, GASTROENTEROLOGY, V152, pS839, DOI 10.1016/S0016-5085(17)32897-4; Song YJ, 2008, CANCER EPIDEM BIOMAR, V17, P712, DOI 10.1158/1055-9965.EPI-07-2511; Sonoda T, 2004, CANCER SCI, V95, P238, DOI 10.1111/j.1349-7006.2004.tb02209.x; Spies JB, 2002, OBSTET GYNECOL, V99, P290, DOI 10.1016/S0029-7844(01)01702-1; Stingl JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-360; Suganuma M, 1999, MUTAT RES-FUND MOL M, V428, P339, DOI 10.1016/S1383-5742(99)00059-9; Sun CL, 2007, CARCINOGENESIS, V28, P2143, DOI 10.1093/carcin/bgm171; Sun CL, 2002, CARCINOGENESIS, V23, P1497, DOI 10.1093/carcin/23.9.1497; Suzuki E, 2009, ANN EPIDEMIOL, V19, P732, DOI 10.1016/j.annepidem.2009.06.003; Suzuki Y, 2005, J EPIDEMIOL, V15, P118, DOI 10.2188/jea.15.118; Suzuki Y, 2004, BRIT J CANCER, V90, P1361, DOI 10.1038/sj.bjc.6601652; TAJIMA K, 1985, JPN J CANCER RES, V76, P705; Takezaki T, 2001, BRIT J CANCER, V84, P1199, DOI 10.1054/bjoc.2001.1722; Takezaki T, 2000, CANCER CAUSE CONTROL, V11, P597, DOI 10.1023/A:1008909129756; Tamura T, 2018, NUTR CANCER, V70, P1210, DOI 10.1080/01635581.2018.1512638; Tang J, 2015, BRIT J NUTR, V114, P673, DOI 10.1017/S0007114515002329; TEWES FJ, 1990, ENVIRON RES, V52, P23, DOI 10.1016/S0013-9351(05)80148-3; Tong GX, 2014, ASIAN PAC J CANCER P, V15, P8765, DOI 10.7314/APJCP.2014.15.20.8765; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Tse LA, 2017, ENVIRON INT, V107, P1, DOI 10.1016/j.envint.2017.06.012; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; Tsubono Y, 1997, PREV MED, V26, P704, DOI 10.1006/pmed.1997.0194; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Ugai T, 2018, INT J CANCER, V142, P1130, DOI 10.1002/ijc.31135; Ugai T, 2017, CANCER EPIDEM BIOMAR, V26, P1352, DOI 10.1158/1055-9965.EPI-17-0231; Ui A, 2009, CANCER CAUSE CONTROL, V20, P1939, DOI 10.1007/s10552-009-9388-x; Vieira AR, 2017, ANN ONCOL, V28, P1788, DOI 10.1093/annonc/mdx171; Wakai K, 2004, INT J UROL, V11, P11, DOI 10.1111/j.1442-2042.2004.00740.x; WAKAI K, 1993, JPN J CANCER RES, V84, P1223, DOI 10.1111/j.1349-7006.1993.tb02826.x; Wang GP, 2012, CANCER EPIDEMIOL, V36, P177, DOI 10.1016/j.canep.2011.09.006; Wang J, 2013, BRIT J CANCER, V108, P2372, DOI 10.1038/bjc.2013.190; Wang JM, 2007, EUR J GASTROEN HEPAT, V19, P171, DOI 10.1097/MEG.0b013e32800ff77a; Wang J, 2012, CANCER EPIDEMIOL, V36, pE354, DOI 10.1016/j.canep.2012.08.004; Wang LF, 2014, NUTRITION, V30, P1122, DOI 10.1016/j.nut.2014.02.023; Wang L, 2013, WOMEN HEALTH, V53, P20, DOI 10.1080/03630242.2012.732680; Wang Li Dong, 2002, Gan To Kagaku Ryoho, V29 Suppl 1, P159; Wang M, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P95; Wang N, 2008, EPIDEMIOLOGY, V19, P761, DOI 10.1097/EDE.0b013e3181811603; Wang PW, 2010, CANCER PREV RES, V3, P985, DOI 10.1158/1940-6207.CAPR-09-0210; Wang QX, 2012, CANCER EPIDEMIOL, V36, P439, DOI 10.1016/j.canep.2012.05.002; Wang Y, 2015, SURG ONCOL, V24, P67, DOI 10.1016/j.suronc.2015.02.002; Wang ZM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-287; Wang ZH, 2012, NUTR CANCER, V64, P1143, DOI 10.1080/01635581.2012.718031; Webster AD, 2018, MATURITAS, V108, P1, DOI 10.1016/j.maturitas.2017.10.013; Weng H, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00693; Wilkens LR, 1996, CANCER EPIDEM BIOMAR, V5, P161; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI 10.1093/ajcn/81.1.243S; Williamson G, 2018, COMPR REV FOOD SCI F, V17, P1054, DOI 10.1111/1541-4337.12351; Wu AH, 2003, CANCER RES, V63, P7526; Wu AH, 2003, INT J CANCER, V106, P574, DOI 10.1002/ijc.11259; Wu M, 2009, INT J CANCER, V124, P1907, DOI 10.1002/ijc.24142; Wu SH, 2013, ASIA PAC J CLIN NUTR, V22, P128, DOI 10.6133/apjcn.2013.22.1.15; Wu Yun-jie, 2009, Zhonghua Yufang Yixue Zazhi, V43, P581, DOI 10.3760/cma.j.issn.0253-9624.2009.07.011; Wyatt KM, 2001, FERTIL STERIL, V76, P125, DOI 10.1016/S0015-0282(01)01847-7; Xiong JP, 2017, ONCOTARGET, V8, P39649, DOI 10.18632/oncotarget.16963; Xu WH, 2007, AM J EPIDEMIOL, V166, P1420, DOI 10.1093/aje/kwm242; Xu XY, 2020, CRIT REV FOOD SCI, V60, P1693, DOI 10.1080/10408398.2019.1588223; Xu Xiaoqin, 2013, Wei Sheng Yan Jiu, V42, P211; Yan L J, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1531, DOI 10.3760/cma.j.issn.0254-6450.2016.11.019; Yang CS, 2019, J AGR FOOD CHEM, V67, P5446, DOI 10.1021/acs.jafc.8b05242; Yang CS, 2011, PHARMACOL RES, V64, P113, DOI 10.1016/j.phrs.2011.03.001; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 1997, ENVIRON HEALTH PERSP, V105, P971, DOI 10.1289/ehp.97105s4971; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097; Yang G, 2011, CARCINOGENESIS, V32, P1684, DOI 10.1093/carcin/bgr186; Ye WM, 1998, WORLD J GASTROENTERO, V4, P516, DOI 10.3748/wjg.v4.i6.516; Yi MS, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900389; Yiannakopoulou EC, 2014, PHARMACOLOGY, V94, P245, DOI 10.1159/000369170; Yu FF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-197; YU GP, 1995, CANCER CAUSE CONTROL, V6, P532, DOI 10.1007/BF00054162; YU GP, 1991, CANCER CAUSE CONTROL, V2, P169, DOI 10.1007/BF00056210; Yu JY, 2017, DIABETES METAB J, V41, P251; Yu ZM, 2017, CANCER PREV RES, V10, P571, DOI [10.1158/1940-6207.capr-17-0160, 10.1158/1940-6207.CAPR-17-0160]; Yuan JM, 2007, INT J CANCER, V120, P1344, DOI 10.1002/ijc.22460; Zeegers MPA, 2001, INT J EPIDEMIOL, V30, P353, DOI 10.1093/ije/30.2.353; Zeegers MPA, 2001, CANCER CAUSE CONTROL, V12, P231, DOI 10.1023/A:1011245627593; Zeng JL, 2014, NUTRIENTS, V6, P4640, DOI 10.3390/nu6114640; Zhang C, 2015, EUR J EPIDEMIOL, V30, P103, DOI 10.1007/s10654-014-9960-x; Zhang M, 2008, BRIT J CANCER, V98, P168, DOI 10.1038/sj.bjc.6604140; Zhang M, 2004, INT J CANCER, V112, P465, DOI 10.1002/ijc.20456; Zhang M, 2002, CANCER EPIDEM BIOMAR, V11, P713; Zhang M, 2007, CARCINOGENESIS, V28, P1074, DOI 10.1093/carcin/bgl252; Zhang M, 2009, INT J CANCER, V124, P1404, DOI 10.1002/ijc.24047; Zhang SC, 2013, ASIAN PAC J CANCER P, V14, P7127, DOI 10.7314/APJCP.2013.14.12.7127; Zhang Xuan-Dong, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P290; Zhang XH, 2006, INT J CANCER, V118, P3089, DOI 10.1002/ijc.21748; Zhang YF, 2015, EUR J CANCER PREV, V24, P353, DOI 10.1097/CEJ.0000000000000094; Zhang ZZ, 2016, NUTR CANCER, V68, P1309, DOI 10.1080/01635581.2016.1224365; Zhao LG, 2017, J EPIDEMIOL, V27, P36, DOI 10.1016/j.je.2016.08.004; Zheng JS, 2013, NUTR CANCER, V65, P1, DOI 10.1080/01635581.2013.741762; Zheng JS, 2011, NUTR CANCER, V63, P663, DOI 10.1080/01635581.2011.570895; Zheng P, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-165; ZHENG TZ, 1993, ORAL ONCOL, V29B, P45, DOI 10.1016/0964-1955(93)90010-C; Zhong LJ, 2001, EPIDEMIOLOGY, V12, P695, DOI 10.1097/00001648-200111000-00019; Zhong SL, 2014, TUMOR BIOL, V35, P5205, DOI 10.1007/s13277-014-1675-9; Zhou Q, 2016, ARCH GYNECOL OBSTET, V293, P143, DOI 10.1007/s00404-015-3811-1; Zhu HF, 2016, GENE, V579, P52, DOI 10.1016/j.gene.2015.12.050	372	81	84	2	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-493X	1361-6137		COCHRANE DB SYST REV	Cochrane Database Syst Rev.		2020		3							CD005004	10.1002/14651858.CD005004.pub3	http://dx.doi.org/10.1002/14651858.CD005004.pub3			277	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY6KZ	32118296	Green Published, Green Accepted			2024-09-18	WOS:000522683100042
J	Zhao, QL; Chang, CW; Yang, XF; Zhao, L				Zhao, Qilong; Chang, Chih-Wei; Yang, Xiaofeng; Zhao, Liang			Robust explanation supervision for false positive reduction in pulmonary nodule detection	MEDICAL PHYSICS			English	Article						deep learning; explainable AI; pulmonary nodule detection	IMAGE DATABASE CONSORTIUM; LUNG-CANCER; CT SCANS; CLASSIFICATION; DIAGNOSIS; RESOURCE	BackgroundLung cancer is the deadliest and second most common cancer in the United States due to the lack of symptoms for early diagnosis. Pulmonary nodules are small abnormal regions that can be potentially correlated to the occurrence of lung cancer. Early detection of these nodules is critical because it can significantly improve the patient's survival rates. Thoracic thin-sliced computed tomography (CT) scanning has emerged as a widely used method for diagnosing and prognosis lung abnormalities.PurposeThe standard clinical workflow of detecting pulmonary nodules relies on radiologists to analyze CT images to assess the risk factors of cancerous nodules. However, this approach can be error-prone due to the various nodule formation causes, such as pollutants and infections. Deep learning (DL) algorithms have recently demonstrated remarkable success in medical image classification and segmentation. As an ever more important assistant to radiologists in nodule detection, it is imperative ensure the DL algorithm and radiologist to better understand the decisions from each other. This study aims to develop a framework integrating explainable AI methods to achieve accurate pulmonary nodule detection.MethodsA robust and explainable detection (RXD) framework is proposed, focusing on reducing false positives in pulmonary nodule detection. Its implementation is based on an explanation supervision method, which uses nodule contours of radiologists as supervision signals to force the model to learn nodule morphologies, enabling improved learning ability on small dataset, and enable small dataset learning ability. In addition, two imputation methods are applied to the nodule region annotations to reduce the noise within human annotations and allow the model to have robust attributions that meet human expectations. The 480, 265, and 265 CT image sets from the public Lung Image Database Consortium and Image Database Resource Initiative (LIDC-IDRI) dataset are used for training, validation, and testing.ResultsUsing only 10, 30, 50, and 100 training samples sequentially, our method constantly improves the classification performance and explanation quality of baseline in terms of Area Under the Curve (AUC) and Intersection over Union (IoU). In particular, our framework with a learnable imputation kernel improves IoU from baseline by 24.0% to 80.0%. A pre-defined Gaussian imputation kernel achieves an even greater improvement, from 38.4% to 118.8% from baseline. Compared to the baseline trained on 100 samples, our method shows less drop in AUC when trained on fewer samples. A comprehensive comparison of interpretability shows that our method aligns better with expert opinions.ConclusionsA pulmonary nodule detection framework was demonstrated using public thoracic CT image datasets. The framework integrates the robust explanation supervision (RES) technique to ensure the performance of nodule classification and morphology. The method can reduce the workload of radiologists and enable them to focus on the diagnosis and prognosis of the potential cancerous pulmonary nodules at the early stage to improve the outcomes for lung cancer patients.	[Zhao, Qilong; Zhao, Liang] Emory Univ, Dept Comp Sci, Atlanta, GA USA; [Chang, Chih-Wei; Yang, Xiaofeng] Emory Univ, Dept Radiat Oncol, Atlanta, GA USA; [Chang, Chih-Wei; Yang, Xiaofeng] Emory Univ, Winship Canc Inst, Atlanta, GA USA; [Zhao, Liang] Emory Univ, Dept Comp Sci, Atlanta, GA 30308 USA	Emory University; Emory University; Emory University; Emory University	Zhao, L (corresponding author), Emory Univ, Dept Comp Sci, Atlanta, GA 30308 USA.	liang.zhao@emory.edu	Zhao, Liang/F-2300-2010; Wang, Yifan/KDO-8319-2024	Chang, Chih-Wei/0000-0002-3818-4381	National Institutes of Health; NSF [2007716, 2007976, 1942594, 1907805, 1841520, 1755850]; Meta Research Award; NEC Lab, Amazon Research Award; Oracle for Research Grant Award; Cisco Faculty Research Award, COMPUTING RESEARCH ASSOCIATION / NSF [2021CIF-Emory-05]; Department of Homeland Security (DHS) [17STCIN00001]; National Cancer Institute; Foundation for the National Institutes of Health;  [R01CA215718];  [R01CA272991];  [R56EB033332];  [R01EB032680]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Meta Research Award; NEC Lab, Amazon Research Award; Oracle for Research Grant Award; Cisco Faculty Research Award, COMPUTING RESEARCH ASSOCIATION / NSF; Department of Homeland Security (DHS)(United States Department of Homeland Security (DHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; 	This work is supported by the National Institutes of Health under Award Number R01CA215718, R01CA272991, R56EB033332 and R01EB032680, the NSF grant number 2007716, No. 2007976, No. 1942594, No. 1907805, No. 1841520, and No. 1755850, Meta Research Award, NEC Lab, Amazon Research Award, Oracle for Research Grant Award, Cisco Faculty Research Award, COMPUTING RESEARCH ASSOCIATION / NSF Sub: 2021CIF-Emory-05. Also, the Department of Homeland Security (DHS) has supported this work via the grant with grant number 17STCIN00001. The authors acknowledge the National Cancer Institute and the Foundation for the National Institutes of Health, and their critical role in the creation of the free publicly available LIDC/IDRI Database used in this study.	Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Armato SG, 2004, RADIOLOGY, V232, P739, DOI 10.1148/radiol.2323032035; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bojarski M., 2016, VISUALBACKPROP VISUA, V2; Chang CW, 2022, PHYS MED BIOL, V67, DOI 10.1088/1361-6560/ac9663; Chang CW, 2022, PHYS MED BIOL, V67, DOI 10.1088/1361-6560/ac6ebc; Chang CW, 2019, INT J THERM SCI, V135, P559, DOI 10.1016/j.ijthermalsci.2018.09.002; Chen H, 2018, NEUROIMAGE, V170, P446, DOI 10.1016/j.neuroimage.2017.04.041; Chen HM, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00699-2; Chen H, 2019, J THORAC DIS, V11, P3360, DOI 10.21037/jtd.2019.08.19; Christ P.F., 2016, AUTOMATIC LIVER LESI; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Diederich S, 2006, Cancer Imaging, V6, pS42, DOI 10.1102/1470-7330.2006.9004; Fuhrman JD, 2022, MED PHYS, V49, P1, DOI 10.1002/mp.15359; Fukui H, 2019, PROC CVPR IEEE, P10697, DOI 10.1109/CVPR.2019.01096; Gao Yuyang, 2022, Proceedings of the ACM on Human-Computer Interaction, DOI 10.1145/3555590; Gao Y., 2022, GOING XAI SYSTEMATIC; Gao Y., 2022, P 28 ACM SIGKDD C KN; Hancock MC, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.4.044504; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Hu M., 2023, END END BRAIN TUMOR; Huff DT, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abcd17; Jin HS, 2018, MED PHYS, V45, P2097, DOI 10.1002/mp.12846; Kadry S., 2020, Development of a Machine-Learning System to Classify Lung CT Scan Images into Normal/COVID-19 Class; Kingma DP, 2014, ADV NEUR IN, V27; Linsley D., 2018, LEARNING WHAT ATTEND; Liu L, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abfbf4; McNitt-Gray MF, 2007, PROC SPIE, V6514, DOI 10.1117/12.713754; Mei J, 2022, IEEE T PATTERN ANAL, V44, P4374, DOI 10.1109/TPAMI.2021.3065086; Mitsuhara M., 2019, EMBEDDING HUMAN KNOW; Montavon G., 2019, Layer-wise relevance propagation: an overview, P193, DOI [10.1007/978-3-030-28954-6_10, 10.1007/978-3-030-28954-610, DOI 10.1007/978-3-030-28954-610]; Montavon G, 2017, PATTERN RECOGN, V65, P211, DOI 10.1016/j.patcog.2016.11.008; Paing MP, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112329; Pan SY, 2023, MED PHYS, V50, P3027, DOI 10.1002/mp.16135; Paszke A, 2019, ADV NEUR IN, V32; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Shen HF, 2021, EXTENDED ABSTRACTS OF THE 2021 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'21), DOI 10.1145/3411763.3451798; van Ginneken B, 2015, I S BIOMED IMAGING, P286, DOI 10.1109/ISBI.2015.7163869; Wang G., 2019, BRAINL GLIOM MULT SC; Way TW, 2006, MED PHYS, V33, P2323, DOI 10.1118/1.2207129; Winkels M, 2019, MED IMAGE ANAL, V55, P15, DOI 10.1016/j.media.2019.03.010; Wu WH, 2020, MED PHYS, V47, P4054, DOI 10.1002/mp.14248; Wu Z, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/aba87c; Yang Y, 2023, MED PHYS, V50, P1905, DOI 10.1002/mp.16221; Zhang FL, 2023, MED PHYS, V50, P3549, DOI 10.1002/mp.16158; Zhang GB, 2018, COMPUT BIOL MED, V103, P287, DOI 10.1016/j.compbiomed.2018.10.033; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhou Z., 2019, MED IM COMP COMP ASS; Zhou Zongwei, 2018, Deep Learn Med Image Anal Multimodal Learn Clin Decis Support (2018), V11045, P3, DOI [10.1007/978-3-030-00889-5_1, 10.1007/978-3-030-00689-1_1]	53	2	2	8	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	MAR	2024	51	3					1687	1701		10.1002/mp.16937	http://dx.doi.org/10.1002/mp.16937		JAN 2024	15	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	KV2F0	38224306				2024-09-18	WOS:001142195600001
J	Mashayekh-Amiri, S; Jafarabadi, MA; Hosseinzadeh, M; Kanani, ES; Mirghafourvand, M				Mashayekh-Amiri, Sepideh; Jafarabadi, Mohammad Asghari; Hosseinzadeh, Mina; Kanani, Elham seyed; Mirghafourvand, Mojgan			Measurement properties of the Iranian version of the breast cancer perception scale (BCPS) according to the COSMIN checklist	BMC CANCER			English	Article						Breast cancer; Perception; Psychometric; Patient-reported outcome (PRO); COSMIN checklist; Reliability; Iranian validation	SCREENING PRACTICES; WOMEN; QUALITY; RISK; BELIEFS	Background Breast cancer is a prevalent cancer characterized by its aggressive nature and potential to cause mortality among women. The rising mortality rates and women's inadequate perception of the disease's severity in developing countries highlight the importance of screening using conventional methods and reliable scales. Since the validity and reliability of the breast cancer perception scale (BCPS) have not been established in the Iranian context. Therefore, this study aimed to determine the measurement properties of the BCPS in women residing in Tabriz, Iran.Methods The present study comprised a cross-sectional design, encompassing a sample of 372 Iranian women. The participants were selected through a multi-stage cluster random sampling technique conducted over a period spanning from November 2022 to February 2023. The measurement properties of the Iranian version of BCPS were assessed following the guidelines outlined in the COSMIN checklist. This involved conducting various steps, including the translation process, reliability testing (internal consistency, test-retest reliability, and measurement error), and methodological tests for validity (content validity, face validity, construct validity, and hypothesis testing). The study also investigated the factors of responsiveness and interpretability. The presence of floor and ceiling effects was assessed.Results The internal consistency of the scale was assessed using Cronbach's alpha, yielding a satisfactory value of 0.68. Additionally, McDonald's omega (95% CI) was computed, resulting in a value of 0.70 (0.66 to 0.74). Furthermore, the test-retest reliability was evaluated, revealing a high intraclass correlation coefficient (ICC) of 0.97 (95% CI: 0.94 to 0.99). The CVI, CVR, and impact scores of the BCPS were determined to be 0.98, 0.95, and 3.70, respectively, indicating favorable levels of content and face validity. To assess construct validity, an examination of the Exploratory Factor Analysis (EFA) was conducted on a set of 24 items. This analysis revealed the presence of six distinct factors, which collectively accounted for 52% of the cumulative variance. The fit indices of the validity model (CFI = 0.91, NFI = 0.96, RFI = 0.94, TLI = 0.90, chi 2/df = 2.03, RMSEA = 0.055 and SRMR = 0.055) were confirmed during the confirmatory factor analysis (CFA). The overall score of BCPS exhibited a ceiling effect of 0.3%. The floor effect observed in the overall score (BCPS) was found to be 0.5%. Concerning the validation of the hypothesis, Spearman's correlation coefficient of 0.55 was obtained between the BCPS and the QLICP-BR V2.0. This correlation value signifies a statistically significant association. Furthermore, it is worth noting that the minimum important change (MIC) of 3.92 exhibited a higher value compared to the smallest detectable change (SDC) of 3.70, thus suggesting a satisfactory level of response.Conclusions The obtained findings suggest that the Iranian version of the BCPS demonstrates satisfactory psychometric properties for assessing the perception of breast cancer among Iranian women. Furthermore, it exhibits favorable responsiveness to clinical variations. Consequently, it can serve as a screening instrument for healthcare professionals to comprehend breast cancer and as a reliable tool in research endeavors.	[Mashayekh-Amiri, Sepideh] Tabriz Univ Med Sci, Fac Nursing & Midwifery, Midwifery Dept, Students Res Comm, Tabriz, Iran; [Jafarabadi, Mohammad Asghari] Cabrini Hlth, Cabrini Res, Melbourne, Vic 3144, Australia; [Jafarabadi, Mohammad Asghari] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Publ Hlth & Preventat Med, Melbourne, Vic 3800, Australia; [Jafarabadi, Mohammad Asghari] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran; [Hosseinzadeh, Mina] Tabriz Univ Med Sci, Nursing & Midwifery Fac, Dept Community Hlth Nursing, Tabriz, Iran; [Kanani, Elham seyed] Tabriz Univ Med Sci, Fac Nursing & Midwifery, Dept Community Hlth Nursing, Tabriz, Iran; [Mirghafourvand, Mojgan] Tabriz Univ Med Sci, Fac Nursing & Midwifery, Social Determinants Hlth Res Ctr, Dept Midwifery, Tabriz, Iran; [Mirghafourvand, Mojgan] Tabriz Univ Med Sci, Med Philosophy & Hist Res Ctr, Tabriz, Iran	Tabriz University of Medical Science; Cabrini Health; Monash University; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Mirghafourvand, M (corresponding author), Tabriz Univ Med Sci, Fac Nursing & Midwifery, Social Determinants Hlth Res Ctr, Dept Midwifery, Tabriz, Iran.; Mirghafourvand, M (corresponding author), Tabriz Univ Med Sci, Med Philosophy & Hist Res Ctr, Tabriz, Iran.	mirghafourvand@gmail.com	Mirghafourvand, Mojgan/AAW-3741-2020; Hosseinzadeh, Mina/D-5449-2017		Tabriz University of Medical Sciences; Vice-chancellor for Research of Tabriz University of Medical Sciences	Tabriz University of Medical Sciences; Vice-chancellor for Research of Tabriz University of Medical Sciences	We should thank the Vice-chancellor for Research of Tabriz University of Medical Sciences for their financial support and the invaluable participation of women would be appreciated.	Abdel-Aziz S B, 2018, J Prev Med Hyg, V59, pE20, DOI 10.15167/2421-4248/jpmh2018.59.1.689; Aduayi V., 2015, INT J MED SCI PUBLIC, V4, P1449, DOI [DOI 10.5455/IJMSPH.2015, 10.5455/ijmsph.2015.02052015299, DOI 10.5455/IJMSPH.2015.02052015299]; Aguirre-Camacho A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249562; Akbari M., 2008, Cancer in Iran; [Anonymous], 2010, Process of translation and adaptation of instruments; Banning M, 2010, J CANCER EDUC, V25, P349, DOI 10.1007/s13187-010-0051-8; Berry Tanya R, 2016, Health Psychol Open, V3, p2055102916657673, DOI 10.1177/2055102916657673; Brinton LA, 2000, PLAST RECONSTR SURG, V105, P919, DOI 10.1097/00006534-200003000-00014; Çeber E, 2006, CANCER NURS, V29, P244; Chowdhury S, 2011, JFRH, V5; Comrey A. L., 2013, 1 COURSE FACTOR ANAL; Darvishpour Azar, 2018, Open Access Maced J Med Sci, V6, P949, DOI 10.3889/oamjms.2018.183; Donnelly TT, 2013, ASIAN PAC J CANCER P, V14, P4519, DOI 10.7314/APJCP.2013.14.8.4519; Ferlay J., 2012, V1. 0; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Fletcher SW, 2003, NEW ENGL J MED, V348, P1672, DOI 10.1056/NEJMcp021804; Fouladi N, 2013, ASIAN PAC J CANCER P, V14, P6857, DOI 10.7314/APJCP.2013.14.11.6857; GAIL MH, 1989, JNCI-J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; George Tayo O, 2019, Open Access Maced J Med Sci, V7, P1700, DOI 10.3889/oamjms.2019.221; Giaquinto AN, 2022, CA-CANCER J CLIN, V72, P524, DOI 10.3322/caac.21754; Glanz K., 2008, HLTH BEHAV HLTH ED, DOI DOI 10.1249/00005768-199112000-00016; GREEN LW, 1974, HEALTH EDUC QUART, V2, P324, DOI 10.1177/109019817400200401; Gulledge Caleb M, 2019, JB JS Open Access, V4, DOI 10.2106/JBJS.OA.19.00015; Hajian-Tilaki K, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01238-z; Harerimana A, 2020, NURS EDUC TODAY, V92, DOI 10.1016/j.nedt.2020.104490; Hashemi-Ghasemabadi M, 2017, PSYCHO-ONCOLOGY, V26, P625, DOI 10.1002/pon.4198; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Izanloo A, 2018, ECANCERMEDICALSCIENC, V12, DOI 10.3332/ecancer.2018.806; Jin RQ, 2021, EUR J ONCOL NURS, V52, DOI 10.1016/j.ejon.2021.101972; Kalfoss M, 2019, SAGE OPEN NURS, V5, DOI 10.1177/2377960818816810; Kardan-Souraki Maryam, 2019, Open Access Maced J Med Sci, V7, P637, DOI 10.3889/oamjms.2019.045; Katapodi MC, 2010, CANCER NURS, V33, P64, DOI 10.1097/NCC.0b013e3181b430f9; Kazeminia M, 2022, INDIAN J GYNECOL ONC, V20, DOI 10.1007/s40944-022-00613-4; Khazir Z, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_63_19; Kwok C, 2016, CANCER NURS, V39, P367, DOI 10.1097/NCC.0000000000000325; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Lebel S, 2008, FUTURE ONCOL, V4, P717, DOI 10.2217/14796694.4.5.717; Masoudiyekta L., 2015, Jundishapur J Chronic Dis Care, V4, pe30234; Mehejabin F, 2022, HEALTH SCI REP-US, V5, DOI 10.1002/hsr2.840; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Nia HS, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-01049-8; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Nunnally J. C., 1994, Psychometric Theory 3E; Omidi Z, 2022, J RES MED SCI, V27, DOI 10.4103/jrms.jrms_1390_20; Osei E, 2021, J ONCOL, V2021, DOI 10.1155/2021/8811353; PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205; Pohl RF, 2004, COGNITIVE ILLUSIONS: A HANDBOOK ON FALLACIES AND BIASES IN THINKING, JUDGEMENT AND MEMORY, P1; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Rakhshkhorshid M, 2018, EUR J BREAST HEALTH, V14, P144, DOI 10.5152/ejbh.2018.3757; Razi S., 2015, Arak Medical University Journal, V18, P17; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sedeta Ephrem Tadele, 2023, JOURNAL OF CLINICAL ONCOLOGY, V41; Seyf A A, 2016, Measurement, test and educational evaluation, V7th; Shamshirian A, 2020, HORM MOL BIOL CLIN I, V41, DOI 10.1515/hmbci-2020-0021; Sheppard VB, 2010, J NATL MED ASSOC, V102, P461, DOI 10.1016/S0027-9684(15)30553-8; Siegel Rebecca L, 2024, CA Cancer J Clin, V74, P12, DOI 10.3322/caac.21820; Soerjomataram I, 2021, NAT REV CLIN ONCOL, V18, P663, DOI 10.1038/s41571-021-00514-z; Sohbet R., 2017, GUMUSHANE U J HLTH S, V6, P113; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Suwankhong D., 2021, Malays J Med Health Sci, V17, P36; Taylan S, 2021, EUR J BREAST HEALTH, V17, P95, DOI 10.4274/ejbh.galenos.2020.6088; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Vetter L, 2016, BREAST CANCER RES TR, V156, P289, DOI 10.1007/s10549-016-3748-5; Vraga EK, 2018, J HEALTH COMMUN, V23, P181, DOI 10.1080/10810730.2017.1421730; Waltz C., 1983, Nursing research: Design, statistics, and computer analysis, V2nd; Wang Q.X., 2017, Chin Nurs Res, V4, P158, DOI DOI 10.1016/J.CNRE.2017.10.002; Weinstein Neil D., 1999, Journal of the National Cancer Institute Monographs, P15; Yang Z, 2023, BMC NURS, V22, DOI 10.1186/s12912-023-01426-2; Yew WC, 2021, RELIGIONS, V12, DOI 10.3390/rel12121098	71	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2407		BMC CANCER	BMC Cancer	JUN 18	2024	24	1							743	10.1186/s12885-024-12493-2	http://dx.doi.org/10.1186/s12885-024-12493-2			17	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	UY3T6	38890612	gold			2024-09-18	WOS:001251592700003
J	Yang, L; Shao, D; Huang, ZX; Geng, MX; Zhang, N; Chen, L; Wang, X; Liang, D; Pang, ZF; Hu, ZL				Yang, Lin; Shao, Dan; Huang, Zhenxing; Geng, Mengxiao; Zhang, Na; Chen, Long; Wang, Xi; Liang, Dong; Pang, Zhi-Feng; Hu, Zhanli			Few-shot segmentation framework for lung nodules via an optimized active contour model	MEDICAL PHYSICS			English	Article						computed tomography; few-shot segmentation framework; lung nodule; optimized active contour model	ANATOMICAL PRIOR INFORMATION; IMAGE SEGMENTATION; PULMONARY NODULES; DRIVEN	BackgroundAccurate segmentation of lung nodules is crucial for the early diagnosis and treatment of lung cancer in clinical practice. However, the similarity between lung nodules and surrounding tissues has made their segmentation a longstanding challenge.PurposeExisting deep learning and active contour models each have their limitations. This paper aims to integrate the strengths of both approaches while mitigating their respective shortcomings.MethodsIn this paper, we propose a few-shot segmentation framework that combines a deep neural network with an active contour model. We introduce heat kernel convolutions and high-order total variation into the active contour model and solve the challenging nonsmooth optimization problem using the alternating direction method of multipliers. Additionally, we use the presegmentation results obtained from training a deep neural network on a small sample set as the initial contours for our optimized active contour model, addressing the difficulty of manually setting the initial contours.ResultsWe compared our proposed method with state-of-the-art methods for segmentation effectiveness using clinical computed tomography (CT) images acquired from two different hospitals and the publicly available LIDC dataset. The results demonstrate that our proposed method achieved outstanding segmentation performance according to both visual and quantitative indicators.ConclusionOur approach utilizes the output of few-shot network training as prior information, avoiding the need to select the initial contour in the active contour model. Additionally, it provides mathematical interpretability to the deep learning, reducing its dependency on the quantity of training samples.	[Yang, Lin; Huang, Zhenxing; Geng, Mengxiao; Zhang, Na; Liang, Dong; Hu, Zhanli] Chinese Acad Sci, Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Yang, Lin; Geng, Mengxiao; Pang, Zhi-Feng] Henan Univ, Coll Math & Stat, Kaifeng, Peoples R China; [Shao, Dan] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Nucl Med, Guangzhou, Peoples R China; [Zhang, Na; Liang, Dong; Hu, Zhanli] Chinese Acad Sci, Key Lab Biomed Imaging Sci & Syst, Shenzhen, Peoples R China; [Chen, Long; Wang, Xi] Kunming Med Univ, Dept PET CT Ctr, Kunming, Peoples R China; [Chen, Long; Wang, Xi] Kunming Med Univ, Yunnan Canc Hosp, Canc Ctr Yunnan Prov, Dept Thorac Canc 1,Affiliated Hosp 3, Kunming, Peoples R China; [Hu, Zhanli] Chinese Acad Sci, Shenzhen Inst Adv Technol, Key Lab Biomed Imaging Sci & Syst, Ibhe Xueyuan St 1068, Shenzhen 518055, Guangdong, Peoples R China; [Pang, Zhi-Feng] Henan Univ, Coll Math & Stat, Kaifeng 475004, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Henan University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; Chinese Academy of Sciences; Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Henan University	Hu, ZL (corresponding author), Chinese Acad Sci, Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.; Hu, ZL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Key Lab Biomed Imaging Sci & Syst, Ibhe Xueyuan St 1068, Shenzhen 518055, Guangdong, Peoples R China.; Pang, ZF (corresponding author), Henan Univ, Coll Math & Stat, Kaifeng 475004, Peoples R China.	zhifengpang@henu.edu.cn; zl.hu@siat.ac.cn	Liu, Yu/KFS-0769-2024; , zhifengpang/AAE-6852-2020	Pang, Zhi-Feng/0000-0001-6824-3509	National Natural Science Foundation of China; Shenzhen Excellent Technological Innovation Talent Training Project of China [RCJC20200714114436080]; Shenzhen Science and Technology Program of China [JCYJ20220818101804009]; National Natural Science Foundation of Henan Province [232300420108]; Shenzhen Science and Technology Program [RCBS20210706092218043]; China Postdoctoral Science Foundation [2022M713290]; Climbering Foundation of the National Cancer Center [NCC201925B02]; Science and Technology Major Project of Henan Province [221100310200]; Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases of China;  [82372038];  [12071345];  [62101540]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Excellent Technological Innovation Talent Training Project of China; Shenzhen Science and Technology Program of China; National Natural Science Foundation of Henan Province; Shenzhen Science and Technology Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Climbering Foundation of the National Cancer Center; Science and Technology Major Project of Henan Province; Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases of China; ; ; 	This work was supported by the National Natural Science Foundation of China (82372038, 12071345, 62101540), the Shenzhen Excellent Technological Innovation Talent Training Project of China (RCJC20200714114436080), the Shenzhen Science and Technology Program of China (JCYJ20220818101804009), the National Natural Science Foundation of Henan Province (No. 232300420108), the Shenzhen Science and Technology Program (RCBS20210706092218043), the China Postdoctoral Science Foundation (2022M713290), the Climbering Foundation of the National Cancer Center (NCC201925B02), the Science and Technology Major Project of Henan Province (No. 221100310200), and the Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases of China.	Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Bagci U, 2011, IEEE ENG MED BIO, P8479, DOI 10.1109/IEMBS.2011.6092092; Boscolo R, 2002, RADIOGRAPHICS, V22, P437, DOI 10.1148/radiographics.22.2.g02mr26437; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chan TF, 1999, SIAM J SCI COMPUT, V20, P1964, DOI 10.1137/S1064827596299767; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Chen ZX, 2023, BIOMED SIGNAL PROCES, V86, DOI 10.1016/j.bspc.2023.105225; Chuang KS, 2006, COMPUT MED IMAG GRAP, V30, P9, DOI 10.1016/j.compmedimag.2005.10.001; Fang JX, 2021, APPL SOFT COMPUT, V100, DOI 10.1016/j.asoc.2020.106982; Fang JX, 2021, INFORM SCIENCES, V546, P397, DOI 10.1016/j.ins.2020.08.078; FREEDMAN DA, 1981, ANN STAT, V9, P1218, DOI 10.1214/aos/1176345638; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Huang ZX, 2023, QUANT IMAG MED SURG, V13, P4447, DOI 10.21037/qims-22-1114; Huang ZX, 2022, COMPUT METH PROG BIO, V227, DOI 10.1016/j.cmpb.2022.107199; Huang ZX, 2022, IEEE T RADIAT PLASMA, V6, P829, DOI 10.1109/TRPMS.2022.3150322; Huang ZX, 2022, EUR J NUCL MED MOL I, V49, P2482, DOI 10.1007/s00259-022-05731-x; Huang ZX, 2021, IEEE J BIOMED HEALTH, V25, P3416, DOI 10.1109/JBHI.2021.3061758; Huang ZX, 2021, NEUROCOMPUTING, V428, P104, DOI 10.1016/j.neucom.2020.10.077; Kostis WJ, 2003, IEEE T MED IMAGING, V22, P1259, DOI 10.1109/TMI.2003.817785; Kuang Z, 2020, COMPUT METH PROG BIO, V194, DOI 10.1016/j.cmpb.2020.105546; Lee Y, 2001, IEEE T MED IMAGING, V20, P595, DOI 10.1109/42.932744; Li W., 2023, INTERDISCIP MED, V1; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Mehta R, 2017, I S BIOMED IMAGING, P437, DOI 10.1109/ISBI.2017.7950555; Miranda M., 2007, Annales de la Faculte des Sciences de Toulouse, Mathematiques, V16, P125, DOI 10.5802/afst.1142; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Nobis F, 2019, 2019 SYMPOSIUM ON SENSOR DATA FUSION: TRENDS, SOLUTIONS, APPLICATIONS (SDF 2019), DOI 10.1109/sdf.2019.8916629; Pang ZF, 2023, SIGNAL PROCESS, V205, DOI 10.1016/j.sigpro.2022.108881; Plueimpitiwiriyawej C, 2005, IEEE T MED IMAGING, V24, P593, DOI 10.1109/TMI.2005.843740; Qamar S, 2020, FUTURE GENER COMP SY, V108, P613, DOI 10.1016/j.future.2019.11.021; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Setzer S, 2009, LECT NOTES COMPUT SC, V5567, P464, DOI 10.1007/978-3-642-02256-2_39; Shi TY, 2022, IEEE T BIO-MED ENG, V69, P108, DOI 10.1109/TBME.2021.3087612; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Usman M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69817-y; Wang D, 2022, PATTERN RECOGN, V130, DOI 10.1016/j.patcog.2022.108794; Wang HY, 2021, MED PHYS, V48, P5259, DOI 10.1002/mp.15089; Wang S, 2017, MED IMAGE ANAL, V40, P172, DOI 10.1016/j.media.2017.06.014; Wu BT, 2018, I S BIOMED IMAGING, P1109, DOI 10.1109/ISBI.2018.8363765; Yang YJ, 2020, SIGNAL PROCESS, V173, DOI 10.1016/j.sigpro.2020.107564; Zhao BC, 2020, MED IMAGE ANAL, V65, DOI 10.1016/j.media.2020.101786; Zhao YQ, 2005, P ANN INT IEEE EMBS, P6492, DOI 10.1109/IEMBS.2005.1615986; Zhou Zongwei, 2018, Deep Learn Med Image Anal Multimodal Learn Clin Decis Support (2018), V11045, P3, DOI [10.1007/978-3-030-00889-5_1, 10.1007/978-3-030-00689-1_1]; Zhu QK, 2020, IEEE T MED IMAGING, V39, P753, DOI 10.1109/TMI.2019.2935018	45	0	0	8	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	APR	2024	51	4					2788	2805		10.1002/mp.16933	http://dx.doi.org/10.1002/mp.16933		JAN 2024	18	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	MW8A3	38189528				2024-09-18	WOS:001142080100001
J	You, DAL; Li, RQ; Liang, SP; Sun, MM; Ou, XJ; Yuan, FY; Shen, LM; Wu, XD				You, Dianlong; Li, Ruiqi; Liang, Shunpan; Sun, Miaomiao; Ou, Xinju; Yuan, Fuyong; Shen, Limin; Wu, Xindong			Online Causal Feature Selection for Streaming Features	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Prediction algorithms; Feature extraction; Time series analysis; Predictive models; GSM; Lung cancer; Heuristic algorithms; Causal feature selection (CFS); Markov blanket (MB); prediction accuracy; streaming feature	MARKOV BLANKET INDUCTION; LOCAL CAUSAL; DISCOVERY	Recently, causal feature selection (CFS) has attracted considerable attention due to its outstanding interpretability and predictability performance. Such a method primarily includes the Markov blanket (MB) discovery and feature selection based on Granger causality. Representatively, the max-min MB (MMMB) can mine an optimal feature subset, i.e., MB; however, it is unsuitable for streaming features. Online streaming feature selection (OSFS) via online process streaming features can determine parents and children (PC), a subset of MB; however, it cannot mine the MB of the target attribute (T), i.e., a given feature, thus resulting in insufficient prediction accuracy. The Granger selection method (GSM) establishes a causal matrix of all features by performing excessively time; however, it cannot achieve a high prediction accuracy and only forecasts fixed multivariate time series data. To address these issues, we proposed an online CFS for streaming features (OCFSSFs) that mine MB containing PC and spouse and adopt the interleaving PC and spouse learning method. Furthermore, it distinguishes between PC and spouse in real time and can identify children with parents online when identifying spouses. We experimentally evaluated the proposed algorithm on synthetic datasets using precision, recall, and distance. In addition, the algorithm was tested on real-world and time series datasets using classification precision, the number of selected features, and running time. The results validated the effectiveness of the proposed algorithm.	[You, Dianlong; Li, Ruiqi; Liang, Shunpan; Sun, Miaomiao; Yuan, Fuyong; Shen, Limin] Yanshan Univ, Sch Informat Sci & Engn, Qinhuangdao 066004, Hebei, Peoples R China; [Ou, Xinju] Yanshan Univ, Sch Arts & Design, Qinhuangdao 066004, Hebei, Peoples R China; [Wu, Xindong] Hefei Univ Technol, Key Lab Knowledge Engn Big Data, Minist Educ, Hefei 230009, Peoples R China; [Wu, Xindong] Mininglamp Acad Sci, Mininglamp Technol, Beijing 100102, Peoples R China	Yanshan University; Yanshan University; Hefei University of Technology	You, DAL; Liang, SP (corresponding author), Yanshan Univ, Sch Informat Sci & Engn, Qinhuangdao 066004, Hebei, Peoples R China.	youdianlong@sina.com; liruiqi960207@qq.com; liangshunpan@ysu.edu.cn; sunmiaomiao.ysu@qq.com; ouxj@ysu.edu.cn; fyyuan@ysu.edu.cn; shenllmm@sina.com; wuxindong@mininglamp.com	Wu, Xindong/AAB-6713-2022	Shen, Limin/0000-0002-9325-2279; You, Dianlong/0000-0002-3674-7822	National Natural Science Foundation of China [61772450]; Natural Science Foundation of Hebei Province [F2021203038, G2021203010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported in part by the National Natural Science Foundation of China under Grant 61772450 and in part by the Natural Science Foundation of Hebei Province under Grant F2021203038 and Grant G2021203010.	Aliferis C F, 2003, AMIA Annu Symp Proc, P21; Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Cai J, 2018, NEUROCOMPUTING, V300, P70, DOI 10.1016/j.neucom.2017.11.077; Chivukula AS, 2018, LECT NOTES ARTIF INT, V11320, P692, DOI 10.1007/978-3-030-03991-2_62; Deb, 2019, J MATH SCI-U TOKYO, V237, P754, DOI DOI 10.1007/S10958-019-04201-4; Dua K. T. E. D, 2017, UCI MACHINE LEARNING; Fu TC, 2011, ENG APPL ARTIF INTEL, V24, P164, DOI 10.1016/j.engappai.2010.09.007; Guyon I., 2011, NIPS MINISYMPOSIUM C, P115; Guyon I, 2006, STUD FUZZ SOFT COMP, V207, P237; Heskes T, 2013, P 27 C ANN C UNCART, P1; Hu XG, 2018, FRONT COMPUT SCI-CHI, V12, P479, DOI 10.1007/s11704-016-5489-3; Hua ZS, 2020, APPL SOFT COMPUT, V87, DOI 10.1016/j.asoc.2019.105957; Jia XP, 2013, P IEEE, V101, P676, DOI 10.1109/JPROC.2012.2229082; Koller D., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P284; Kui Yu, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P1163, DOI 10.1109/ICDM.2010.82; Kumar V., 2014, SmartCR, DOI DOI 10.6029/SMARTCR.2014.03.007; Lagani V, 2017, J STAT SOFTW, V80, DOI 10.18637/jss.v080.i07; Lakhal L, 2017, DBKDA 2017 9 INT C A, P97; Li JD, 2018, ACM COMPUT SURV, V50, DOI 10.1145/3136625; Lin YJ, 2017, IEEE T FUZZY SYST, V25, P1491, DOI 10.1109/TFUZZ.2017.2735947; Ling ZL, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3335676; Malioutov D, 2016, FINANCIAL SIGNAL PRO, P41; Medhat F, 2017, IEEE DATA MINING, P979, DOI 10.1109/ICDM.2017.125; Pan WK, 2019, KNOWL INF SYST, V58, P295, DOI 10.1007/s10115-018-1154-5; Saqlain SM, 2019, KNOWL INF SYST, V58, P139, DOI 10.1007/s10115-018-1185-y; Scheines R, 1993, CAUSATION PREDICTION, V83, P1; Sun GL, 2018, FUTURE GENER COMP SY, V89, P606, DOI 10.1016/j.future.2018.05.060; Sun YQ, 2015, MACH LEARN, V101, P377, DOI 10.1007/s10994-014-5460-1; Toch E, 2019, KNOWL INF SYST, V58, P501, DOI 10.1007/s10115-018-1186-x; Tsamardinos I, 2003, P 16 INT FLAIRS C, P376; Tsamardinos I, 2003, P 9 ACM SIGKDD INT C, P673, DOI DOI 10.1145/956750.956838; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Visweswaran S, 2019, CAUSE EFFECT PAIRS M, P359; Wang D, 2012, COLLABORATECOM, P40, DOI 10.4108/icst.collaboratecom.2012.250689; Wang H, 2020, INFORM SCIENCES, V509, P227, DOI 10.1016/j.ins.2019.09.010; Wu X, 2021, IEEE T NEUR NET LEAR, V32, P1831, DOI 10.1109/TNNLS.2020.2991336; Wu XD, 2014, IEEE T KNOWL DATA EN, V26, P97, DOI 10.1109/TKDE.2013.109; Wu XD, 2013, IEEE T PATTERN ANAL, V35, P1178, DOI 10.1109/TPAMI.2012.197; Wu XY, 2020, IEEE T CYBERNETICS, V50, P4983, DOI 10.1109/TCYB.2019.2940509; Yang J, 2019, IEEE INT C BIOINFORM, P1318, DOI [10.1109/bibm47256.2019.8983306, 10.1109/BIBM47256.2019.8983306]; Yinghan Hong, 2018, International Journal of Wireless and Mobile Computing, V15, P310; Yu K, 2020, ACM COMPUT SURV, V53, DOI 10.1145/3409382; Yu K, 2020, IEEE T NEUR NET LEAR, V31, P2005, DOI 10.1109/TNNLS.2019.2927636; Yu K, 2020, IEEE T PATTERN ANAL, V42, P2240, DOI 10.1109/TPAMI.2019.2908373; Yu K, 2017, IEEE T NEUR NET LEAR, V28, P2775, DOI 10.1109/TNNLS.2016.2602365; Yu K, 2016, ACM T KNOWL DISCOV D, V11, DOI 10.1145/2976744; Yu K, 2016, KNOWL-BASED SYST, V113, P1, DOI 10.1016/j.knosys.2016.08.026; Yu K, 2015, ACM T KNOWL DISCOV D, V9, DOI 10.1145/2700409; Zhou J., 2005, P 11 ACM SIGKDD INT, P384, DOI DOI 10.1145/1081870.1081914	50	17	17	4	66	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	MAR	2023	34	3					1563	1577		10.1109/TNNLS.2021.3105585	http://dx.doi.org/10.1109/TNNLS.2021.3105585		SEP 2021	15	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	D2LU1	34473627				2024-09-18	WOS:000732899300001
J	Sinha, T; Khan, A; Awan, M; Bokhari, SFH; Ali, K; Amir, M; Jadhav, AN; Bakht, D; Puli, ST; Burhanuddin, M				Sinha, Tanya; Khan, Aiman; Awan, Manahil; Bokhari, Syed Faqeer Hussain; Ali, Khawar; Amir, Maaz; Jadhav, Aneesh N.; Bakht, Danyal; Puli, Sai Teja; Burhanuddin, Mohammad			Artificial Intelligence and Machine Learning in Predicting the Response to Immunotherapy in Non-small Cell Lung Carcinoma: A Systematic Review	CUREUS JOURNAL OF MEDICAL SCIENCE			English	Article						clinical variables; genomic data; radiomics; deep learning; nsclc; non-small cell lung carcinoma; immunotherapy response; predictive biomarkers; machine learning; artificial intelligence	OUTCOMES	Non-small cell lung carcinoma (NSCLC) is a prevalent and aggressive form of lung cancer, with a poor prognosis for metastatic disease. Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized the management of NSCLC, but response rates are highly variable. Identifying reliable predictive biomarkers is crucial to optimize patient selection and treatment outcomes. This systematic review aimed to evaluate the current state of artificial intelligence (AI) and machine learning (ML) applications in predicting the response to immunotherapy in NSCLC. A comprehensive literature search identified 19 studies that met the inclusion criteria. The studies employed diverse AI/ML techniques, including deep learning, artificial neural networks, support vector machines, and gradient boosting methods, applied to various data modalities such as medical imaging, genomic data, clinical variables, and immunohistochemical markers. Several studies demonstrated the ability of AI/ML models to accurately predict immunotherapy response, progression-free survival, and overall survival in NSCLC patients. However, challenges remain in data availability, quality, and interpretability of these models. Efforts have been made to develop interpretable AI/ML techniques, but further research is needed to improve transparency and explainability. Additionally, translating AI/ML models from research settings to clinical practice poses challenges related to regulatory approval, data privacy, and integration into existing healthcare systems. Nonetheless, the successful implementation of AI/ML models could enable personalized treatment strategies, improve treatment outcomes, and reduce unnecessary toxicities and healthcare costs associated with ineffective treatments.	[Sinha, Tanya] Tribhuvan Univ, Internal Med, Kathmandu, Nepal; [Khan, Aiman] Liaquat Coll Med & Dent, Med, Karachi, Pakistan; [Awan, Manahil] Liaquat Natl Hosp, Med Coll, Gen Practice, Karachi, Pakistan; [Bokhari, Syed Faqeer Hussain] King Edward Med Univ, Surg, Lahore, Pakistan; [Ali, Khawar; Amir, Maaz] King Edward Med Univ, Med & Surg, Lahore, Pakistan; [Jadhav, Aneesh N.] Bharat Ratna Dr Babasaheb Ambedkar Mem Hosp, Pediat, Mumbai, India; [Bakht, Danyal] Mayo Hosp, Med & Surg, Lahore, Pakistan; [Puli, Sai Teja] Bhaskar Med Coll, Internal Med, Hyderabad, India; [Burhanuddin, Mohammad] Bhaskar Med Coll, Med, Hyderabad, India	Tribhuvan University	Ali, K (corresponding author), King Edward Med Univ, Med & Surg, Lahore, Pakistan.	dr.khawarali28@gmail.com	Amir, 212-maaz/LDE-7895-2024	Bokhari, Dr. Syed Faqeer Hussain/0000-0002-6937-9894				Ali S, 2023, INFORM FUSION, V99, DOI 10.1016/j.inffus.2023.101805; Arbour KC, 2021, CANCER DISCOV, V11, P59, DOI 10.1158/2159-8290.CD-20-0419; Ben Abdallah FC, 2014, REV MAL RESPIR, V31, P214, DOI 10.1016/j.rmr.2013.09.002; Benzekry S, 2021, CANCERS, V13, DOI 10.3390/cancers13246210; Celi Leo Anthony, 2022, PLOS Digit Health, V1, pe0000022, DOI 10.1371/journal.pdig.0000022; Gao Q, 2023, J HEMATOL ONCOL, V16, DOI 10.1186/s13045-023-01456-y; Gridelli C, 2015, NAT REV DIS PRIMERS, V1, DOI [10.1038/nrdp.2015.9, 10.1038/nrdp.2015.48]; Hassija V, 2024, COGN COMPUT, V16, P45, DOI 10.1007/s12559-023-10179-8; He BX, 2022, TRANSL LUNG CANCER R, V11, P670, DOI 10.21037/tlcr-22-244; He BX, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000550; Javaid M., 2022, INT J INTELL NETW, V3, P58, DOI [10.1016/J.IJIN.2022.05.002, DOI 10.1016/J.IJIN.2022.05.002, 10.1016/j.ijin.2022.05.002, 10. 1016/j.ijin.2022.05.002]; Khadirnaikar S, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-31426-w; Khorrami M, 2020, CANCER IMMUNOL RES, V8, P108, DOI 10.1158/2326-6066.CIR-19-0476; Li B, 2024, EUR J RADIOL OPEN, V12, DOI 10.1016/j.ejro.2024.100549; Li SQ, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1024707; Liao JZ, 2023, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.998222; Liu ZC, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.989275; Mino-Kenudson M, 2022, J THORAC ONCOL, V17, P1335, DOI 10.1016/j.jtho.2022.09.109; Moeckel C, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24076710; Ni SQ, 2024, HELIYON, V10, DOI 10.1016/j.heliyon.2024.e29840; Peng J, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.960459; Prelaj A, 2023, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.1078822; Prelaj A, 2022, CANCERS, V14, DOI 10.3390/cancers14020435; Rajendran S, 2024, PATTERNS, V5, DOI 10.1016/j.patter.2023.100913; Shojaei P, 2024, COMPUTERS, V13, DOI 10.3390/computers13020041; Siah KW, 2019, JCO CLIN CANCER INFO, V3, P1, DOI 10.1200/CCI.19.00046; Trebeschi S, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.609054; Vanguri RS, 2022, NAT CANCER, V3, P1151, DOI 10.1038/s43018-022-00416-8; Varlamova EV, 2024, CANCERS, V16, DOI 10.3390/cancers16061100; Wang L, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.829634; Wang LL, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.11999; Wei FF, 2023, J IMMUNOTHER CANCER, V11, DOI 10.1136/jitc-2023-006788; Yang Y, 2021, AM J TRANSL RES, V13, P743; Yolchuyeva S, 2024, J TRANSL MED, V22, DOI 10.1186/s12967-024-04854-z; Yolchuyeva S, 2023, CANCERS, V15, DOI 10.3390/cancers15153829	35	2	2	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2168-8184		CUREUS J MED SCIENCE	Cureus J Med Sci	MAY 28	2024	16	5							e61220	10.7759/cureus.61220	http://dx.doi.org/10.7759/cureus.61220			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WU3I7	38939246	gold, Green Published			2024-09-18	WOS:001257344600005
J	Jin, HQ; Yin, GS				Jin, Huaqing; Yin, Guosheng			Bayesian enhancement two-stage design with error control for phase II clinical trials	STATISTICS IN MEDICINE			English	Article						BET design; binary endpoint; cancer; phase II trial; posterior error rate; Simon's design	SINGLE-ARM; DRUG DEVELOPMENT; 3-STAGE DESIGNS; FREQUENTIST	Phase II clinical trials make a critical decision of go or no-go to a subsequent phase III studies. A considerable proportion of promising drugs identified in phase II trials fail the confirmative efficacy test in phase III. Recognizing the low posterior probabilities ofH(1)when accepting the drug under Simon's two-stage design, the Bayesian enhancement two-stage (BET) design is proposed to strengthen the passing criterion. Under the BET design, the lengths of highest posterior density (HPD) intervals, posterior probabilities ofH(0)andH(1)are computed to calibrate the design parameters, aiming to improve the stability of the trial characteristics and strengthen the evidence for proceeding the drug development forward. However, from a practical perspective, the HPD interval length lacks transparency and interpretability. To circumvent this problem, we propose the BET design with error control (BETEC) by replacing the HPD interval length with the posterior error rate. The BETEC design can achieve a balance between the posterior false positive rate and false negative rate and, more importantly, it has an intuitive and clear interpretation. We compare our method with the BET design and Simon's design through extensive simulation studies. As an illustration, we further apply BETEC to two recent clinical trials, and investigate its performance in comparison with other competitive designs. Being both efficient and intuitive, the BETEC design can serve as an alternative toolbox for implementing phase II single-arm trials.	[Jin, Huaqing; Yin, Guosheng] Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Peoples R China	University of Hong Kong	Yin, GS (corresponding author), Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Peoples R China.	gyin@hku.hk	Yin, Guosheng/D-3214-2009	Yin, Guosheng/0000-0003-3276-1392	Research Grants Council of Hong Kong [17307218]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	We would like to thank two anonymous referees and associate editor for their insightful suggestions in greatly improving the quality of this article. The research was supported by a grant No. 17307218 for Guosheng Yin from the Research Grants Council of Hong Kong.	Brown SR, 2014, STAT PRACT, P1, DOI 10.1002/9781118763612; Chen K, 2008, CONTEMP CLIN TRIALS, V29, P32, DOI 10.1016/j.cct.2007.04.008; Chen TT, 1997, STAT MED, V16, P2701, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2701::AID-SIM704>3.0.CO;2-1; Cristofanilli M, 2010, CLIN CANCER RES, V16, P1904, DOI 10.1158/1078-0432.CCR-09-2282; Dong GH, 2012, STAT MED, V31, P2055, DOI 10.1002/sim.5330; Englert S, 2014, FLEXIBLE DESIGNS SIN; Englert S, 2013, BIOMETRICAL J, V55, P955, DOI 10.1002/bimj.201200220; ENSIGN LG, 1994, STAT MED, V13, P1727, DOI 10.1002/sim.4780131704; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; Gan HK, 2012, J NATL CANCER I, V104, P590, DOI 10.1093/jnci/djs141; GEHAN EA, 1961, J CHRON DIS, V13, P346, DOI 10.1016/0021-9681(61)90060-1; Grayling MJ, 2019, JNCI-J NATL CANCER I, V111, P1255, DOI 10.1093/jnci/djz126; Grayling MJ, 2016, PHARM STAT, V15, P143, DOI 10.1002/pst.1726; Lee JL, 2008, CLIN TRIALS, V5, P93, DOI 10.1177/1740774508089279; Lee SJ, 2000, STAT SCI, V15, P95; Lin Y, 2004, BIOMETRICS, V60, P482, DOI 10.1111/j.0006-341X.2004.00193.x; Mandel JJ, 2018, NEURO-ONCOLOGY, V20, P113, DOI 10.1093/neuonc/nox144; Mander AP, 2010, CONTEMP CLIN TRIALS, V31, P572, DOI 10.1016/j.cct.2010.07.008; Ritchie G, 2018, JAMA ONCOL, V4, P522, DOI 10.1001/jamaoncol.2017.5236; Sadeghi S, 2019, J CLIN ONCOL, V37, P2682, DOI 10.1200/JCO.19.00861; Sambucini V, 2015, J BIOPHARM STAT, V25, P474, DOI 10.1080/10543406.2014.920856; Shan GG, 2016, STAT BIOSCI, V8, P351, DOI 10.1007/s12561-016-9152-1; Shan GG, 2016, STAT MED, V35, P1257, DOI 10.1002/sim.6794; Shi HL, 2020, PHARM STAT, V19, P454, DOI 10.1002/pst.2005; Shi HL, 2018, BIOMETRICS, V74, P1055, DOI 10.1111/biom.12864; Shi HL, 2018, STAT METHODS MED RES, V27, P158, DOI 10.1177/0962280215625681; Shi HL, 2017, BAYESIAN ANAL, V12, P31, DOI 10.1214/15-BA988; Shuster Jonathan, 2002, J Biopharm Stat, V12, P39, DOI 10.1081/BIP-120005739; Silvani A, 2019, J NEURO-ONCOL, V142, P455, DOI 10.1007/s11060-019-03116-z; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Tan SB, 2002, STAT MED, V21, P1991, DOI 10.1002/sim.1176; THALL PF, 1994, BIOMETRICS, V50, P337, DOI 10.2307/2533377; Van Norman GA, 2019, JACC-BASIC TRANSL SC, V4, P428, DOI 10.1016/j.jacbts.2019.02.005; Verger E, 2005, INT J RADIAT ONCOL, V61, P185, DOI 10.1016/j.ijrobp.2004.04.061; Wang YG, 2005, STAT METHODS MED RES, V14, P445, DOI 10.1191/0962280205sm410oa; Yin G., 2012, Clinical Trial Design: Bayesian Frequentist Adaptive Methods, V1st	36	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	DEC 20	2020	39	29					4452	4465		10.1002/sim.8734	http://dx.doi.org/10.1002/sim.8734		AUG 2020	14	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	OR9AB	32854163				2024-09-18	WOS:000562928500001
J	Song, YD; Zhou, GY; Zhou, YC; Xu, YK; Zhang, J; Zhang, KT; He, PY; Chen, MW; Liu, YP; Sun, JR; Hu, CG; Li, M; Liao, MJ; Zhang, YY; Liao, WJ; Zhou, YP				Song, Yangda; Zhou, Guangyao; Zhou, Yucheng; Xu, Yikai; Zhang, Jing; Zhang, Ketao; He, Pengyuan; Chen, Maowei; Liu, Yanping; Sun, Jiarun; Hu, Chengguang; Li, Meng; Liao, Minjun; Zhang, Yongyuan; Liao, Weijia; Zhou, Yuanping			Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study	HEPATOLOGY INTERNATIONAL			English	Article						Machine learning; Intrahepatic cholangiocarcinoma; Recurrence; Radiomics; CT; Multicenter study; LightGBM; Prediction model; Biliary tract cancer; Recurrence-free survival	STAGING SYSTEM; DIAGNOSIS; LIGHTGBM; NETWORK; IMAGES	ObjectivesIn this multicenter study, we sought to develop and validate a preoperative model for predicting early recurrence (ER) risk after curative resection of intrahepatic cholangiocarcinoma (ICC) through artificial intelligence (AI)-based CT radiomics approach.Materials and methodsA total of 311 patients (Derivation: 160; Internal and two external validations: 36, 74 and 61) from 8 medical centers who underwent curative resection were collected retrospectively. In derivation cohort, radiomics and clinical-radiomics models for ER prediction were constructed by LightGBM (a machine learning algorithm). A clinical model was also developed for comparison. Model performance was validated in internal and two external cohorts by ROC. In addition, we investigated the interpretability of the LightGBM model.ResultsThe combined clinical-radiomics model that included 15 radiomic features and 3 clinical features (CA19-9 > 1000 U/ml, vascular invasion and tumor margin), resulting in the area under the curves (AUCs) of 0.974 (95% CI 0.946-1.000) in the derivation cohort, and 0.871-0.882 (95% CI 0.672-0.962) in the internal and external validation cohorts, respectively, which are higher than the AJCC 8th TNM staging system (AUCs: 0.686-0.717, p all < 0.05). Especially, the sensitivity of this machine learning model could reach 94.6% on average for all the cohorts.ConclusionsThis AI-driven combined radiomics model may provide as a useful tool to preoperatively predict ER and improve therapeutic management of ICC patients.	[Song, Yangda; Zhou, Guangyao; He, Pengyuan; Liu, Yanping; Sun, Jiarun; Hu, Chengguang; Li, Meng; Liao, Minjun; Zhou, Yuanping] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China; [Song, Yangda; Sun, Jiarun; Li, Meng; Liao, Minjun; Zhou, Yuanping] Southern Med Univ, Dept Infect Dis, Guangzhou 510515, Peoples R China; [Song, Yangda; Sun, Jiarun; Li, Meng; Liao, Minjun; Zhou, Yuanping] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou 510515, Peoples R China; [Zhou, Guangyao] Wenzhou Med Univ, Dept Infect Dis, Affiliated Hosp 2, Wenzhou 325027, Peoples R China; [Zhou, Yucheng] Southern Med Univ, Hosp Integrated TCM & Western Med, Dept Gen Surg, Guangzhou 510315, Peoples R China; [Xu, Yikai; Zhang, Jing] Southern Med Univ, Nanfang Hosp, Dept Radiol, Guangzhou 510515, Peoples R China; [Zhang, Ketao] Southern Med Univ, Dept Hepatobiliary Surg, Shunde Hosp, Foshan 528308, Guangdong, Peoples R China; [He, Pengyuan] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Infect Dis, Zhuhai, Guangdong, Peoples R China; [Chen, Maowei] Guangxi Med Univ, Dept Infect Dis, Wuming Hosp, Nanning 530199, Guangxi, Peoples R China; [Liu, Yanping] Guilin Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Guilin 421001, Guangxi, Peoples R China; [Zhang, Yongyuan] HBVtech, Germantown, MD 20874 USA; [Liao, Weijia] Guilin Med Univ, Lab Hepatobiliary & Pancreat Surg, Affiliated Hosp, Guilin 541001, Guangxi, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Wenzhou Medical University; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University; Guangxi Medical University; Guilin Medical University; Guilin Medical University	Zhou, YP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.; Zhou, YP (corresponding author), Southern Med Univ, Dept Infect Dis, Guangzhou 510515, Peoples R China.; Zhou, YP (corresponding author), Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou 510515, Peoples R China.; Zhang, YY (corresponding author), HBVtech, Germantown, MD 20874 USA.; Liao, WJ (corresponding author), Guilin Med Univ, Lab Hepatobiliary & Pancreat Surg, Affiliated Hosp, Guilin 541001, Guangxi, Peoples R China.	yongyuanzhang@hbvtech.com; liaoweijia288@163.com; yuanpingzhou@163.com	Liao, Wei-Jia/AAH-7279-2021; Zhou, Yucheng/ABG-5374-2021; chen, ying/HHS-8254-2022	Zhou, Yuanping/0000-0002-2493-396X				Baessler B, 2019, INVEST RADIOL, V54, P221, DOI 10.1097/RLI.0000000000000530; Banales JM, 2020, NAT REV GASTRO HEPAT, V17, P557, DOI 10.1038/s41575-020-0310-z; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chaiteerakij R, 2014, AM J GASTROENTEROL, V109, P1881, DOI 10.1038/ajg.2014.327; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Huang YQ, 2016, J CLIN ONCOL, V34, P2157, DOI 10.1200/JCO.2015.65.9128; Hwang S, 2015, J GASTROINTEST SURG, V19, P1291, DOI 10.1007/s11605-015-2803-6; Jeong SS, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3464-5; Jhaveri KS, 2015, J MAGN RESON IMAGING, V42, P1165, DOI 10.1002/jmri.24810; Ji GW, 2019, RADIOLOGY, V290, P90, DOI 10.1148/radiol.2018181408; Ju Y, 2019, IEEE ACCESS, V7, P28309, DOI 10.1109/ACCESS.2019.2901920; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lee AJ, 2018, CHIN CLIN ONCOL, V7, DOI 10.21037/cco.2018.07.03; Liang WJ, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00360; Lundberg SM, 2017, ADV NEUR IN, V30; Ma XJ, 2018, ELECTRON COMMER R A, V31, P24, DOI 10.1016/j.elerap.2018.08.002; Mavros MN, 2014, JAMA SURG, V149, P565, DOI 10.1001/jamasurg.2013.5137; Nie K, 2016, CLIN CANCER RES, V22, P5256, DOI 10.1158/1078-0432.CCR-15-2997; Park HJ, 2021, EUR RADIOL, V31, P8638, DOI 10.1007/s00330-021-07926-6; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Saha SK, 2016, ONCOLOGIST, V21, P594, DOI 10.1634/theoncologist.2015-0446; Sirica AE, 2019, HEPATOLOGY, V69, P1803, DOI 10.1002/hep.30289; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Weber SM, 2015, HPB, V17, P669, DOI 10.1111/hpb.12441; Weber SM, 2001, J AM COLL SURGEONS, V193, P384, DOI 10.1016/S1072-7515(01)01016-X; Wu RY, 2021, J GASTROINTEST SURG, V25, P145, DOI 10.1007/s11605-020-04557-y; Xu L, 2019, THERANOSTICS, V9, P5374, DOI 10.7150/thno.34149; Zhang H, 2016, CANCER LETT, V379, P198, DOI 10.1016/j.canlet.2015.09.008; Zhang XF, 2018, BRIT J SURG, V105, P848, DOI 10.1002/bjs.10676; Zhu Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97796-1; Zou XL, 2019, J MAGN RESON IMAGING, V49, P975, DOI 10.1002/jmri.26253; Zwanenburg A, 2019, EUR J NUCL MED MOL I, V46, P2638, DOI 10.1007/s00259-019-04391-8	38	8	8	1	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	AUG	2023	17	4					1016	1027		10.1007/s12072-023-10487-z	http://dx.doi.org/10.1007/s12072-023-10487-z		FEB 2023	12	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	N1NX6	36821045				2024-09-18	WOS:000937641200001
C	Lucieri, A; Bajwa, MN; Braun, SA; Malik, MI; Dengel, A; Ahmed, S			IEEE	Lucieri, Adriano; Bajwa, Muhammad Naseer; Braun, Stephan Alexander; Malik, Muhammad Imran; Dengel, Andreas; Ahmed, Sheraz			On Interpretability of Deep Learning based Skin Lesion Classifiers using Concept Activation Vectors	2020 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN)	IEEE International Joint Conference on Neural Networks (IJCNN)		English	Proceedings Paper	International Joint Conference on Neural Networks (IJCNN) held as part of the IEEE World Congress on Computational Intelligence (IEEE WCCI)	JUL 19-24, 2020	ELECTR NETWORK	IEEE, IEEE Computat Intelligence Soc, Int Neural Network Soc		Skin Lesion Classification; Medical Image Analysis; Computer-Aided Diagnosis; Explainable Artificial Intelligence; Concept Activation Vectors; Convolutional Neural Networks	VARIABILITY; DERMOSCOPY; MELANOMA; CANCER	Deep learning based medical image classifiers have shown remarkable prowess in various application areas like ophthalmology, dermatology, pathology, and radiology. However, the acceptance of these Computer-Aided Diagnosis (CAD) systems in real clinical setups is severely limited primarily because their decision-making process remains largely obscure. This work aims at elucidating a deep learning based medical image classifier by verifying that the model learns and utilizes similar disease-related concepts as described and employed by dermatologists. We used a well-trained and high performing neural network developed by REasoning for COmplex Data (RECOD) Lab for classification of three skin tumours, i.e. Melanocytic Naevi, Melanoma and Seborrheic Keratosis and performed a detailed analysis on its latent space. Two well established and publicly available skin disease datasets, PH2 and derm7pt, are used for experimentation. Human understandable concepts are mapped to RECOD image classification model with the help of Concept Activation Vectors (CAVs), introducing a novel training and significance testing paradigm for CAVs. Our results on an independent evaluation set clearly shows that the classifier learns and encodes human understandable concepts in its latent representation. Additionally, TCAV scores (Testing with CAVs) suggest that the neural network indeed makes use of disease-related concepts in the correct way when making predictions. We anticipate that this work can not only increase confidence of medical practitioners on CAD but also serve as a stepping stone for further development of CAV-based neural network interpretation methods.	[Lucieri, Adriano] Hsch Pforzheim, Kaiserslautern, Germany; [Lucieri, Adriano; Bajwa, Muhammad Naseer; Dengel, Andreas] Tech Univ Kaiserslautern, Kaiserslautern, Germany; [Lucieri, Adriano; Bajwa, Muhammad Naseer; Dengel, Andreas; Ahmed, Sheraz] German Res Ctr Artificial Intelligence GmbH DFKI, Smart Data & Knowledge Serv, Kaiserslautern, Germany; [Braun, Stephan Alexander] Univ Klinikum Munster, Dept Dermatol, Munster, Germany; [Braun, Stephan Alexander] Univ Klinikum Dusseldorf, Dept Dermatol, Munster, Germany; [Malik, Muhammad Imran] Natl Univ Sci & Technol NUST, Islamabad, Pakistan; [Malik, Muhammad Imran] Natl Ctr Artificial Intelligence, Islamabad, Pakistan	University of Kaiserslautern; German Research Center for Artificial Intelligence (DFKI); University of Munster; National University of Sciences & Technology - Pakistan	Lucieri, A (corresponding author), Hsch Pforzheim, Kaiserslautern, Germany.; Lucieri, A (corresponding author), Tech Univ Kaiserslautern, Kaiserslautern, Germany.; Lucieri, A (corresponding author), German Res Ctr Artificial Intelligence GmbH DFKI, Smart Data & Knowledge Serv, Kaiserslautern, Germany.		Bajwa, Muhammad/AAK-5770-2020; Malik, Muhammad/R-1305-2019; Lucieri, Adriano/KFS-5924-2024	Lucieri, Adriano/0000-0003-1473-4745	National University of Science and Technology (NUST), Pakistan through Prime Minister's Programme for Development of PhDs in Science and Technology; BMBF project ExplAINN [01IS19074]; BMBF project DeFuseNN [01IW17002]	National University of Science and Technology (NUST), Pakistan through Prime Minister's Programme for Development of PhDs in Science and Technology; BMBF project ExplAINN(Federal Ministry of Education & Research (BMBF)); BMBF project DeFuseNN(Federal Ministry of Education & Research (BMBF))	This work is funded by National University of Science and Technology (NUST), Pakistan through Prime Minister's Programme for Development of PhDs in Science and Technology, BMBF projects ExplAINN (01IS19074) and DeFuseNN (01IW17002).	American Cancer Society, 2017, CANC FACTS FIG 2017; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bajwa MN, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0842-8; Braun RP, 2002, ARCH DERMATOL, V138, P1556, DOI 10.1001/archderm.138.12.1556; Chang J, 2018, WOODH PUBL SER BIOM, P119, DOI 10.1016/B978-0-08-100936-9.00008-3; Codella NCF, 2018, I S BIOMED IMAGING, P168, DOI 10.1109/ISBI.2018.8363547; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fortina AB, 2012, SKIN RES TECHNOL, V18, P311, DOI 10.1111/j.1600-0846.2011.00572.x; FRIEDMAN RJ, 1985, CA-CANCER J CLIN, V35, P130, DOI 10.3322/canjclin.35.3.130; Ghorbani Amirata, 2019, ARXIV190203129; Ghorbani Amirata., 2019, bioRxiv, page, P681676; Graziani Mara, 2018, Understanding and Interpreting Machine Learning in Medical Image Computing Applications. First International Workshops MLCN 2018, DLF 2018, and iMIMIC 2018. Held in Conjunction with MICCAI 2018. Proceedings: Lecture Notes in Computer Science (LNCS 11038), P124, DOI 10.1007/978-3-030-02628-8_14; Graziani M, 2019, PROC SPIE, V10950, DOI 10.1117/12.2512584; Guo P., 2018, ARXIV180508969; Hancock B, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P1884; Hendricks LA, 2018, LECT NOTES COMPUT SC, V11206, P269, DOI 10.1007/978-3-030-01216-8_17; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.21254, 10.3322/caac.20073]; Jing B., 2017, ARXIV171108195; Jolly S, 2018, INT C PATT RECOG, P1085, DOI 10.1109/ICPR.2018.8545624; Kawahara J, 2019, IEEE J BIOMED HEALTH, V23, P538, DOI 10.1109/JBHI.2018.2824327; Kim Been, 2017, arXiv:1711.11279; Kittler H, 2016, J AM ACAD DERMATOL, V74, P1093, DOI 10.1016/j.jaad.2015.12.038; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Mendonca Teresa, 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), P5437, DOI 10.1109/EMBC.2013.6610779; Menegola A., 2017, arXiv preprint arXiv:1703.04819; Menzies SW, 1996, MELANOMA RES, V6, P55, DOI 10.1097/00008390-199602000-00008; Muller, 2017, ARXIV170808296; Munir M., 2019, ARXIV190506175; Palacio S, 2018, PROC CVPR IEEE, P3108, DOI 10.1109/CVPR.2018.00328; Ruiz ES, 2019, J AM ACAD DERMATOL, V80, P275, DOI 10.1016/j.jaad.2018.04.035; Selvaraju R. R., 2016, arXiv preprint arXiv:1611.07450; Smilkov D., 2017, SmoothGrad: Removing noise by adding noise; Srivastava S., 2017, P 2017 C EMP METH NA, P1527, DOI DOI 10.18653/V1/D17-1161; Sundararajan M, 2017, PR MACH LEARN RES, V70; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Wu J., 2018, ARXIV181101051; Young K., 2019, ARXIV190806612; Zhang SH, 2017, PROC CVPR IEEE, P4264, DOI 10.1109/CVPR.2017.454; Zhao H., 2017, AI GOOD GLOBAL SUMMI	41	26	29	1	4	IEEE	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017 USA	2161-4393		978-1-7281-6926-2	IEEE IJCNN			2020										10.1109/ijcnn48605.2020.9206946	http://dx.doi.org/10.1109/ijcnn48605.2020.9206946			10	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science	BQ9MM		Green Submitted			2024-09-18	WOS:000626021402110
J	Chen, GH				Chen, George H.			Survival Kernets: Scalable and Interpretable Deep Kernel Survival Analysis with an Accuracy Guarantee	JOURNAL OF MACHINE LEARNING RESEARCH			English	Article						survival analysis; kernel methods; neural networks; scalability; interpretability	K-MEANS; CANCER; COMORBIDITY; CONSISTENCY; FRAMEWORK; SYSTEM; INDEX; AGE	Kernel survival analysis models estimate individual survival distributions with the help of a kernel function, which measures the similarity between any two data points. Such a kernel function can be learned using deep kernel survival models. In this paper, we present a new deep kernel survival model called a survival kernet, which scales to large datasets in a manner that is amenable to model interpretation and also theoretical analysis. Specifically, the training data are partitioned into clusters based on a recently developed training set compression scheme for classification and regression called kernel netting that we extend to the survival analysis setting. At test time, each data point is represented as a weighted combination of these clusters, and each such cluster can be visualized. For a special case of survival kernets, we establish a finite-sample error bound on predicted survival distributions that is, up to a log factor, optimal. Whereas scalability at test time is achieved using the aforementioned kernel netting compression strategy, scalability during training is achieved by a warm-start procedure based on tree ensembles such as XGBOOST and a heuristic approach to accelerating neural architecture search. On four standard survival analysis datasets of varying sizes (up to roughly 3 million data points), we show that survival kernets are highly competitive compared to various baselines tested in terms of time-dependent concordance index. Our code is available at: https://github.com/ georgehc/survival-kernets	[Chen, George H.] Carnegie Mellon Univ, Heinz Coll Informat Syst & Publ Policy, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Chen, GH (corresponding author), Carnegie Mellon Univ, Heinz Coll Informat Syst & Publ Policy, Pittsburgh, PA 15213 USA.	GEORGECHEN@CMU.EDU			NSF CAREER award [2047981]; Health Resources and Services Administration [234-2005-370011C]	NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This work was supported in part by NSF CAREER award #2047981, and by Health Resources and Services Administration contract 234-2005-370011C. The content is the responsibility of the author alone and does not necessarily reflect the views or policies of the National Science Foundation or the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. We thank Shu Hu for pointing out some typos in an earlier draft, and we thank the anonymous reviewers for very helpful feedback.	Agarwal A, 2021, J AM STAT ASSOC, V116, P1731, DOI 10.1080/01621459.2021.1928513; Akiba T, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2623, DOI 10.1145/3292500.3330701; Andoni A, 2015, ADV NEUR IN, V28; Andoni A, 2015, ACM S THEORY COMPUT, P793, DOI 10.1145/2746539.2746553; Antolini L, 2005, STAT MED, V24, P3927, DOI 10.1002/sim.2427; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Athey S, 2019, ANN STAT, V47, P1148, DOI 10.1214/18-AOS1709; Banerjee A, 2005, J MACH LEARN RES, V6, P1345; Ben-David S, 2007, LECT NOTES COMPUT SC, V4539, P20, DOI 10.1007/978-3-540-72927-3_4; Beran R., 1981, Technical report; Biau G, 2012, J MACH LEARN RES, V13, P1063; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Borg I., 2005, MODERN MULTIDIMENSIO; Breiman Leo, 2000, Technical report 577; Bronstein AM, 2006, P NATL ACAD SCI USA, V103, P1168, DOI 10.1073/pnas.0508601103; BROWN CC, 1975, BIOMETRICS, V31, P863, DOI 10.2307/2529811; Chagny G, 2014, ELECTRON J STAT, V8, P2352, DOI 10.1214/14-EJS956; Chapfuwa P, 2018, PR MACH LEARN RES, V80; Chapfuwa Paidamoyo, 2020, C HLTH INF LEARN; Chen CF, 2019, ADV NEUR IN, V32; Chen GH, 2019, PR MACH LEARN RES, V97; Chen GH, 2018, FOUND TRENDS MACH LE, V10, P337, DOI 10.1561/2200000064; Chen George H., 2020, MACH LEARN HEALTHC C; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; COX DR, 1972, J R STAT SOC B, V34, P187; DABROWSKA DM, 1989, ANN STAT, V17, P1157, DOI 10.1214/aos/1176347261; Danks D, 2022, PR MACH LEARN RES, V151; de Silva Vin, 2002, Advances in Neural Information Processing Systems; Denil M, 2014, PR MACH LEARN RES, V32; Dipchand AI, 2018, ANN CARDIOTHORAC SUR, V7, P31, DOI 10.21037/acs.2018.01.07; Engelhard Matthew, 2020, MACH LEARN HEALTHC C; Ester M., 1996, P INT C KNOWL DISC D, VVolume 96, P226, DOI DOI 10.5555/3001460.3001507; Foekens JA, 2000, CANCER RES, V60, P636; Fotso S, 2018, Arxiv, DOI [arXiv:1801.05512, DOI 10.48550/ARXIV.1801.05512]; Fränti P, 2019, PATTERN RECOGN, V93, P95, DOI 10.1016/j.patcog.2019.04.014; Frey C, 2007, J GASTROINTEST SURG, V11, P733, DOI 10.1007/s11605-007-0164-5; Friedman JH, 2009, The Elements of Statistical Learning - Data Mining, Inference and Prediction, V2, P1, DOI DOI 10.1007/B94608; Gensheimer MF, 2019, PEERJ, V7, DOI 10.7717/peerj.6257; Giunchiglia E, 2018, LECT NOTES COMPUT SC, V11141, P23, DOI 10.1007/978-3-030-01424-7_3; Goldstein Mark, 2020, Advances in Neural Information Processing Systems; Haider H, 2020, J MACH LEARN RES, V21; Hanneke S, 2021, ANN STAT, V49, P2129, DOI 10.1214/20-AOS2029; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Kalbfleisch JD., 1980, The Statistical Analysis of Failure Time Data; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katzman JL, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0482-1; Kingma Diederik P, 2015, ICLR; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Kontorovich Aryeh, 2017, Advances in Neural Information Processing Systems; Kpotufe S, 2017, J MACH LEARN RES, V18; Kumar A, 2010, ANN IEEE SYMP FOUND, P299, DOI 10.1109/FOCS.2010.35; Kvamme H, 2021, LIFETIME DATA ANAL, V27, P710, DOI 10.1007/s10985-021-09532-6; Kvamme H, 2019, J MACH LEARN RES, V20; Le-Khac PH, 2020, IEEE ACCESS, V8, P193907, DOI 10.1109/ACCESS.2020.3031549; Lee C, 2018, AAAI CONF ARTIF INTE, P2314; Li LH, 2020, LECT NOTES ARTIF INT, P371, DOI 10.1007/978-3-030-59137-3_33; Liu Weiyang, 2021, INT C ART INT STAT; Malkov YA, 2020, IEEE T PATTERN ANAL, V42, P824, DOI 10.1109/TPAMI.2018.2889473; Manduchi Laura, 2022, INT C LEARN REPR; Nagpal Chirag, 2021, MACH LEARN HEALTHC C; Papaspiliopoulos O, 2020, QUANT FINANC, V20, P1591, DOI 10.1080/14697688.2020.1813475; Paszke A, 2019, ADV NEUR IN, V32; Prokhorenkova Liudmila, 2020, INT C MACH LEARN; Rakhlin Alexander, 2006, Advances in Neural Information Processing Systems; Ranganath Rajesh, 2016, MACH LEARN HEALTHC C; Russo MJ, 2010, ANN SURG, V251, P144, DOI 10.1097/SLA.0b013e3181b5db3c; SCHUMACHER M, 1994, J CLIN ONCOL, V12, P2086, DOI 10.1200/JCO.1994.12.10.2086; Sopik V, 2018, BREAST CANCER RES TR, V170, P647, DOI 10.1007/s10549-018-4796-9; Tang WJ, 2022, J MACH LEARN RES, V23; van Eeghen EE, 2015, J GASTROINTEST ONCOL, V6, P605, DOI 10.3978/j.issn.2078-6891.2015.070; von Luxburg U, 2010, FOUND TRENDS MACH LE, V2, P235, DOI 10.1561/2200000008; Wager S, 2018, J AM STAT ASSOC, V113, P1228, DOI 10.1080/01621459.2017.1319839; Wang Tongzhou, 2020, INT C MACH LEARN; Wu Zhiliang, 2021, MACH LEARN HEALTHC C; Yoon J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194985; Zhao H., 2021, INT JOINT C ART INT; Zhong QX, 2022, ANN STAT, V50, P1348, DOI 10.1214/21-AOS2153; Zhong Qixian, 2021, Advances in Neural Information Processing Systems	78	0	0	2	2	MICROTOME PUBL	BROOKLINE	31 GIBBS ST, BROOKLINE, MA 02446 USA	1532-4435			J MACH LEARN RES	J. Mach. Learn. Res.		2024	25								40					78	Automation & Control Systems; Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Computer Science	KL2A1					2024-09-18	WOS:001180039000001
J	Yin, J; Qiu, JJ; Qian, W; Ji, L; Yang, D; Jiang, JW; Wang, JR; Lan, L				Yin, Jin; Qiu, Jia-Jun; Qian, Wei; Ji, Lin; Yang, Dan; Jiang, Jing-Wen; Wang, Jun-Ren; Lan, Lan			A radiomics signature to identify malignant and benign liver tumors on plain CT images	JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY			English	Article						Radiomics signature; texture analysis; liver tumor; logistic regression model; classification between malignant and benign tumors	TEXTURE ANALYSIS; CLASSIFICATION; SELECTION; FEATURES; DIAGNOSIS; WAVELET; LESIONS; CANCER; MRI	BACKGROUND: In regular examinations, it may be difficult to visually identify benign and malignant liver tumors based on plain computed tomography (CT) images. RCAD (radiomics-based computer-aided diagnosis) has proven to be helpful and provide interpretability in clinical use. OBJECTIVE: This work aims to develop a CT-based radiomics signature and investigate its correlation with malignant/benign liver tumors. METHODS: We retrospectively analyzed 168 patients of hepatocellular carcinoma (malignant) and 117 patients of hepatic hemangioma (benign). Texture features were extracted from plain CT images and used as candidate features. A radiomics signaturewas developed from the candidate features. We performed logistic regression analysis and used a multiple-regression coefficient (termed as R) to assess the correlation between the developed radiomics signature and malignant/benign liver tumors. Finally, we built a logistic regression model to classify benign and malignant liver tumors. RESULTS: Thirteen features were chosen from 1223 candidate features to constitute the radiomics signature. The logistic regression analysis achieved an R = 0.6745, which was much larger than R-alpha = 0.3703 (the critical value of R at significant level alpha = 0.001). The logistic regression model achieved an average AUC of 0.87. CONCLUSIONS: The developed radiomics signature was statistically significantly correlated with malignant/benign liver tumors (p < 0.001). It has potential to help enhance physicians' diagnostic abilities and play an important role in RCADs.	[Yin, Jin; Qiu, Jia-Jun; Jiang, Jing-Wen; Wang, Jun-Ren; Lan, Lan] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Peoples R China; [Yin, Jin] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Peoples R China; [Qian, Wei] Univ Texas El Paso, Dept Elect & Comp Engn, El Paso, TX 79968 USA; [Ji, Lin; Yang, Dan] Sichuan Univ, West China Hosp, Dept Radiol, 37 Guoxue Alley, Chengdu 610000, Peoples R China	Sichuan University; University of Electronic Science & Technology of China; University of Texas System; University of Texas El Paso; Sichuan University	Ji, L (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, 37 Guoxue Alley, Chengdu 610000, Peoples R China.	jilin2@sina.com	lan, lan/IXD-5278-2023; 殷, 进/KFS-2569-2024; Qian, Wei/B-8231-2013; YANG, Dan/HHD-2733-2022; Liu, yuqing/KEI-3260-2024	Wang, Junren/0000-0001-6612-1671				Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Banik S, 2013, INT J COMPUT ASS RAD, V8, P121, DOI 10.1007/s11548-012-0681-x; Bi WL, 2019, CA-CANCER J CLIN, V69, P127, DOI 10.3322/caac.21552; BREIMAN L, 1995, TECHNOMETRICS, V37, P373, DOI 10.2307/1269730; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Criminisi A, 2004, IEEE T IMAGE PROCESS, V13, P1200, DOI 10.1109/TIP.2004.833105; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gonzalez R.C., 2020, DIGITAL IMAGE PROCES, P830; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hasebroock KM, 2009, EXPERT OPIN DRUG MET, V5, P403, DOI [10.1517/17425250902873796 , 10.1517/17425250902873796]; Kumar SS, 2013, COMPUT ELECTR ENG, V39, P1516, DOI 10.1016/j.compeleceng.2013.02.008; Le Meur O, 2013, IEEE T IMAGE PROCESS, V22, P3779, DOI 10.1109/TIP.2013.2261308; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; MathWorks, 2020, CHOOS CLASS OPT; Mayerhoefer ME, 2010, J MAGN RESON IMAGING, V32, P352, DOI 10.1002/jmri.22268; Mougiakakou SG, 2007, ARTIF INTELL MED, V41, P25, DOI 10.1016/j.artmed.2007.05.002; Ng F, 2013, EUR J RADIOL, V82, P342, DOI 10.1016/j.ejrad.2012.10.023; Qiu JJ, 2018, J MED IMAG HEALTH IN, V8, P1835, DOI 10.1166/jmihi.2018.2516; Qiu JJ, 2018, J MED IMAG HEALTH IN, V8, P1539, DOI 10.1166/jmihi.2018.2507; Rao S.J., 2003, Journal of the American Statistical Association, V98, P257, DOI DOI 10.1198/JASA.2003.S263; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Strzelecki M, 2013, NUCL INSTRUM METH A, V702, P137, DOI 10.1016/j.nima.2012.09.006; Sun ZQ, 2019, J X-RAY SCI TECHNOL, V27, P1021, DOI 10.3233/XST-190574; Szczypinski PM, 2009, COMPUT METH PROG BIO, V94, P66, DOI 10.1016/j.cmpb.2008.08.005; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang T, 2019, J X-RAY SCI TECHNOL, V27, P773, DOI 10.3233/XST-190526; Yang XF, 2012, MED PHYS, V39, P5732, DOI 10.1118/1.4747526; Zhang SH, 2017, PROC CVPR IEEE, P4264, DOI 10.1109/CVPR.2017.454; Zhou Y, 2017, ABDOM RADIOL, V42, P1695, DOI 10.1007/s00261-017-1072-0	32	7	8	2	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0895-3996	1095-9114		J X-RAY SCI TECHNOL	J. X-Ray Sci. Technol.		2020	28	4					683	694		10.3233/XST-200675	http://dx.doi.org/10.3233/XST-200675			12	Instruments & Instrumentation; Optics; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Instruments & Instrumentation; Optics; Physics	MU1LU	32568166				2024-09-18	WOS:000555433500006
J	Amirkhani, A; Mosavi, MR; Mohammadi, K; Papageorgiou, EI				Amirkhani, Abdollah; Mosavi, Mohammad R.; Mohammadi, Karim; Papageorgiou, Elpiniki, I			A novel hybrid method based on fuzzy cognitive maps and fuzzy clustering algorithms for grading celiac disease	NEURAL COMPUTING & APPLICATIONS			English	Article						Fuzzy cognitive map; Celiac disease; Fuzzy c-means; Nonlinear Hebbian learning	HEBBIAN LEARNING ALGORITHM; TIME-SERIES; PERFORMANCE; PREDICTION; DIAGNOSIS	This paper presents a new method based on fuzzy cognitive map (FCM) and possibilistic fuzzy c-means (PFCM) clustering algorithm for categorizing celiac disease (CD). CD is a complex disorder whose development is affected by genetics (HLA alleles) and gluten ingestion. The celiac patients who are not treated are at a high risk of cancer, malignant lymphoma, and small bowel neoplasia. Therefore, CD diagnosis and grading are of paramount importance. The proposed FCM models human thinking for the purpose of classifying patients suffering from CD. We used the latest grading method where three grades A, B1, and B2 are used. To improve FCM efficiency and classification capability, a nonlinear Hebbian learning algorithm is applied for adjusting the FCM weights. To this end, 89 cases are studied. Three experts extracted seven main determinant characteristics of CD which were considered as FCM concepts. The mutual effects of these concepts on one another and on the final concept were expressed in the form of fuzzy rules and linguistic variables. Using the center of gravity defuzzifier, we obtained the numerical values of these weights and obtained the total weight matrix. Ultimately, combining the FCM model with PFCM algorithm, we obtained the grades A, B1, and B2 accuracies as 88, 90, and 91%, respectively. The main advantage of the proposed FCM is the good transparency and interpretability in the decision-making procedure, which make it a suitable tool for daily usage in the clinical practice.	[Amirkhani, Abdollah; Mosavi, Mohammad R.; Mohammadi, Karim] Iran Univ Sci & Technol, Dept Elect Engn, Tehran 1684613114, Iran; [Papageorgiou, Elpiniki, I] Technol Educ Inst Cent Greece, Comp Engn Dept, Lamia, Greece	Iran University Science & Technology	Mosavi, MR (corresponding author), Iran Univ Sci & Technol, Dept Elect Engn, Tehran 1684613114, Iran.	amirkhani@elec.iust.ac.ir; m_mosavi@iust.ac.ir; mohammadi@iust.ac.ir; epapageorgiou@teiste.gr	Mosavi, Mohammad Reza/P-3505-2018; Mohammadi, Karim/T-5571-2018; Amirkhani, Abdollah/C-6743-2019; PAPAGEORGIOU, ELPINIKI/AAG-7122-2020	PAPAGEORGIOU, ELPINIKI/0000-0003-2498-9661				Amirkhani A, 2015, 2015 22ND IRANIAN CONFERENCE ON BIOMEDICAL ENGINEERING (ICBME), P115, DOI 10.1109/ICBME.2015.7404127; Amirkhani A, 2016, ISA T, V60, P128, DOI 10.1016/j.isatra.2015.11.007; Amirkhani A, 2014, ARAB J SCI ENG, V39, P3723, DOI 10.1007/s13369-014-1012-z; [Anonymous], 1973, PhD Thesis; AXELROD R.M., 1976, The Structure of Decisions: Cognitive Maps of Political Elites; Babuska R, 2002, PROCEEDINGS OF THE 2002 IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOL 1 & 2, P1081, DOI 10.1109/FUZZ.2002.1006654; Bueno S, 2009, EXPERT SYST APPL, V36, P5221, DOI 10.1016/j.eswa.2008.06.072; Corazza GR, 2005, J CLIN PATHOL, V58, P573, DOI 10.1136/jcp.2004.023978; Diri B, 2008, EXPERT SYST APPL, V34, P628, DOI 10.1016/j.eswa.2006.10.016; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Georgopoulos VC, 2003, ARTIF INTELL MED, V29, P261, DOI 10.1016/S0933-3657(02)00076-3; Hassoun M.H., 1995, Fundamentals of Artificial Neural Networks; Honda K., 2001, P 1 ASIA PACIFIC C W, P394; Kannappan A, 2011, EXPERT SYST APPL, V38, P1282, DOI 10.1016/j.eswa.2010.06.069; Kim J, 2016, EXPERT SYST APPL, V57, P311, DOI 10.1016/j.eswa.2016.03.043; KOSKO B, 1986, INT J MAN MACH STUD, V24, P65, DOI 10.1016/S0020-7373(86)80040-2; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mourhir A, 2016, ENVIRON MODELL SOFTW, V77, P81, DOI 10.1016/j.envsoft.2015.11.018; Namkoong Y., 2010, IEEE INT C FUZZY SYS, P1; Nasiriyan-Rad H, 2016, IEEE 23 IR C BIOM EN; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Pal NR, 2005, IEEE T FUZZY SYST, V13, P517, DOI 10.1109/TFUZZ.2004.840099; Papageorgiou E, 2003, LECT NOTES ARTIF INT, V2903, P256; Papageorgiou EI, 2006, ARTIF INTELL MED, V36, P59, DOI 10.1016/j.artmed.2005.04.001; Papageorgiou EI, 2005, J INTELL INF SYST, V25, P95, DOI 10.1007/s10844-005-0864-9; Papageorgiou EI, 2004, INT J APPROX REASON, V37, P219, DOI 10.1016/j.ijar.2004.01.001; Papageorgiou E, 2008, SER MED PHYS BIOMED, P173; Papageorgiou EI, 2006, INT J HUM-COMPUT ST, V64, P727, DOI 10.1016/j.ijhcs.2006.02.009; Papageorgiou EI, 2013, IEEE T FUZZY SYST, V21, P66, DOI 10.1109/TFUZZ.2012.2201727; Papageorgiou EI, 2012, IEEE T SYST MAN CY C, V42, P150, DOI 10.1109/TSMCC.2011.2138694; Papageorgiou EI, 2012, IEEE T INF TECHNOL B, V16, P143, DOI 10.1109/TITB.2011.2175937; Papageorgiou EI, 2012, COMPUT METH PROG BIO, V105, P233, DOI 10.1016/j.cmpb.2011.09.006; Papageorgiou EI, 2011, APPL SOFT COMPUT, V11, P500, DOI 10.1016/j.asoc.2009.12.010; Papakostas GA, 2008, INT J PATTERN RECOGN, V22, P1461, DOI 10.1142/S0218001408006910; Song HJ, 2010, IEEE T FUZZY SYST, V18, P233, DOI 10.1109/TFUZZ.2009.2038371; Stach W, 2005, FUZZY SET SYST, V153, P371, DOI 10.1016/j.fss.2005.01.009; Stach W., 2010, THESIS; Stach W, 2008, IEEE T FUZZY SYST, V16, P61, DOI 10.1109/TFUZZ.2007.902020; Stylios CD, 2000, J INTELL FUZZY SYST, V8, P83; Timm H, 2004, FUZZY SET SYST, V147, P3, DOI 10.1016/j.fss.2003.11.009; Zhang DQ, 2003, NEURAL PROCESS LETT, V18, P155, DOI 10.1023/B:NEPL.0000011135.19145.1b; Zhang JS, 2004, IEEE T FUZZY SYST, V12, P209, DOI 10.1109/TFUZZ.2004.825079; Zhang LY, 2016, KNOWL-BASED SYST, V99, P51, DOI 10.1016/j.knosys.2016.01.048	44	29	29	0	17	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0941-0643	1433-3058		NEURAL COMPUT APPL	Neural Comput. Appl.	SEP	2018	30	5					1573	1588		10.1007/s00521-016-2765-y	http://dx.doi.org/10.1007/s00521-016-2765-y			16	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	GQ9NV					2024-09-18	WOS:000442107400014
J	Mergui, JL; Gondry, J; Hocquemiller, R; Carcopino, X				Mergui, J. -L.; Gondry, J.; Hocquemiller, R.; Carcopino, X.			Revision of the French colposcopic terminology	GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE			English	Article						Colposcopy; Classification; Diagnostic; Screening; Intraepithelial lesion; Cervical cancer	INTERNATIONAL-FEDERATION; CERVICAL-PATHOLOGY; INTRAEPITHELIAL NEOPLASIA; RANDOM BIOPSY; DIAGNOSIS; ACCURACY	Objectives. - To revise the 1983 colposcopic terminology form the French Society of Colposcopy and cervicovaginal pathology (SFCPCV).Methods. - All the three following steps of colposcopic examination were considered for the description of various colposcopic features: inspection without coloration, followed by the application of acetic acid and iodine staining. This revised terminology now includes the different possible colposcopic aspects of the normal cervix, including the ectropion and the normal transformation zone. It also includes colposcopic appearance of abnormal glandular cervical epithelium and of vaginal epithelium. The revised nomenclature was reviewed by all the board of the SFCPCV and was finally approved during the 45th annual conference of the SFCPCV.Results. - Abnormal transformation zone grade (TAG) 1a and 1b have been brought together under the sole TAG1 designation. TAG2a and TAG2b now correspond to TAG2, whereas TAG2c corresponds to TAG3. Colposcopic report should mention the interpretability of the colposcopic examination, with the precise type of the squamocolumnar junction (1, 2 or 3), the colposcopic impression, the size of any TAG and finally mention whether one or multiple biopsies were taken and their precise location. Colposcopic impression must give priority to the most pejorative colposcopic aspect which takes precedence over others.Conclusion. - When performing colposcopy, one should keep in mind that this examination only relies on the interpretation of various colposcopic signs and images with this not guaranteeing for diagnosis. Only histological analysis of a possible guided cervical biopsy provides for a precise diagnosis.& COPY; 2023 Published by Elsevier Masson SAS.	[Mergui, J. -L.; Gondry, J.; Hocquemiller, R.; Carcopino, X.] Soc Francaise colposcopie & pathol cervicovaginale, Paris, France; [Gondry, J.] Univ Picardie Jules Verne, Ctr hosp Univ Amiens Picardie, Serv Gynecol Obstet, Amiens, France; [Hocquemiller, R.] Hop La Pitie Salpetriere, APHP, Serv Chirurg gynecol, Paris, France; [Carcopino, X.] Univ Avignon, Aix Marseille Univ AMU, Ctr hosp Univ Nord, APHM,Serv Chirurg gynecol,CNRS,IRD,IMBE,UMR 7263, F-13397 Marseille, France; [Carcopino, X.] Hop Nord Marseille, APHM, Serv Chirurg gynecol, Chemin Bourrely, F-13015 Marseille, France	Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Avignon Universite; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Carcopino, X (corresponding author), Hop Nord Marseille, APHM, Serv Chirurg gynecol, Chemin Bourrely, F-13015 Marseille, France.	xavier.carcopino-tusoli@ap-hm.fr						Beyer DA, 2017, J GYNECOL OBSTET HUM, V46, P643, DOI 10.1016/j.jogoh.2017.07.002; Boonlikit S, 2010, J OBSTET GYNAECOL RE, V36, P94, DOI 10.1111/j.1447-0756.2009.01108.x; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; BRET J, 1960, COLPOSCOPIE; Brown BH, 2019, EUR J OBSTET GYN R B, V240, P182, DOI 10.1016/j.ejogrb.2019.07.003; Cantor SB, 2008, OBSTET GYNECOL, V111, P7, DOI 10.1097/01.AOG.0000295870.67752.b4; Carcopino X, 2011, EMC TECHNIQUES CHIRU, V666, P46163, DOI [10.1016/S2211-0666, DOI 10.1016/S2211-0666]; Chen Q, 2016, J LOW GENIT TRACT DI, V20, P207, DOI 10.1097/LGT.0000000000000184; Coupez F, 1983, GYNECOL, V34, P215; Fan Aiping, 2018, Oncotarget, V9, P9166, DOI 10.18632/oncotarget.24074; Haute Autorite de Sante/, 2019, EV RECH PAP HUM HPV; Institut National du Cancer, 2019, SURV POSTTH LES PREC; Institut National du Cancer, 2017, COND AT DEV FEMM AY; Leroy J., 2008, GYNECOL OBSTET PRAT; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; Nam K, 2010, J LOW GENIT TRACT DI, V14, P346, DOI 10.1097/LGT.0b013e3181e9635b; Nikolopoulos M, 2021, CYTOPATHOLOGY, V32, P751, DOI 10.1111/cyt.13027; Preaubert L, 2016, J LOW GENIT TRACT DI, V20, P15, DOI 10.1097/LGT.0000000000000156; Redman CWE, 2021, EUR J OBSTET GYN R B, V256, P57, DOI 10.1016/j.ejogrb.2020.06.029; Rezniczek GA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11091598; Ruan YT, 2020, ARCH GYNECOL OBSTET, V302, P1529, DOI 10.1007/s00404-020-05740-x; Sianturi M H, 1997, J Obstet Gynaecol Res, V23, P79; Stafl A, 1976, Obstet Gynecol, V48, P123; STAFL A, 1991, OBSTET GYNECOL, V77, P313, DOI 10.1097/00006250-199102000-00032; Ullal A, 2009, CYTOPATHOLOGY, V20, P359, DOI 10.1111/j.1365-2303.2008.00566.x; Underwood M, 2012, BJOG-INT J OBSTET GY, V119, P1293, DOI 10.1111/j.1471-0528.2012.03444.x; Vercellino GF, 2013, OBSTET GYNECOL, V121, P624, DOI 10.1097/AOG.0b013e3182835831; Walker P, 2003, OBSTET GYNECOL, V101, P175, DOI 10.1016/S0029-7844(02)02581-4; Zhang B, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01395-1; Zhou Q, 2020, CANCER MANAG RES, V12, P5987, DOI 10.2147/CMAR.S257875	30	2	2	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2468-7197	2468-7189		GYNECOL OBST FERT SE	Gynecol. Obstet. Fertil. Senol.	MAY	2023	51	5					239	248		10.1016/j.gofs.2023.02.004	http://dx.doi.org/10.1016/j.gofs.2023.02.004		MAY 2023	10	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	M3HZ5	36858178	Bronze			2024-09-18	WOS:001029135900001
J	Pan, XX; Burgman, B; Wu, ER; Huang, JH; Sahni, N; Yi, SS				Pan, Xingxin; Burgman, Brandon; Wu, Erxi; Huang, Jason H.; Sahni, Nidhi; Yi, S. Stephen			i-Modern: Integrated multi-omics network model identifies potential therapeutic targets in glioma by deep learning with interpretability	COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL			English	Article						Multi-omics; Deep learning model; Data integration; Patient stratification; Glioma	PROGNOSTIC-FACTOR; INCIDENCE TRENDS; GENOMIC ANALYSIS; NEURAL-NETWORKS; EXPRESSION; PROGRESSION; PROLIFERATION; SURVIVAL; TUMORS; IDH1	Effective and precise classification of glioma patients for their disease risks is critical to improving early diagnosis and patient survival. In the recent past, a significant amount of multi-omics data derived from cancer patients has emerged. However, a robust framework for integrating multi-omics data types to efficiently and precisely subgroup glioma patients and predict survival prognosis is still lacking. In addition, effective therapeutic targets for treating glioma patients with poor prognoses are in dire need. To begin to resolve this difficulty, we developed i-Modern, an integrated Multi-omics deep learning network method, and optimized a sophisticated computational model in gliomas that can accurately stratify patients based on their prognosis. We built a survival-associated predictive framework integrating transcription profile, miRNA expression, somatic mutations, copy number variation (CNV), DNA methylation, and protein expression. This framework achieved promising performance in distinguishing high-risk glioma patients from those with good prognoses. Furthermore, we constructed multiple fully connected neural networks that are trained on prioritized multi-omics signatures or even only potential single-omics signatures, based on our customized scoring system. Together, the landmark multi-omics signatures we identified may serve as potential therapeutic targets in gliomas. (c) 2022 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Pan, Xingxin; Burgman, Brandon; Wu, Erxi; Yi, S. Stephen] Univ Texas Austin, Livestrong Canc Inst, Dell Med Sch, Dept Oncol, Austin, TX 78712 USA; [Burgman, Brandon] Univ Texas Austin, Coll Nat Sci, Interdisciplinary Life Sci Grad Programs ILSGP, Austin, TX 78712 USA; [Wu, Erxi; Huang, Jason H.] Baylor Scott & White Hlth, Neurosci Inst, Temple, TX 76502 USA; [Wu, Erxi; Huang, Jason H.] Baylor Scott & White Hlth, Dept Neurosurg, Temple, TX 76502 USA; [Wu, Erxi; Huang, Jason H.; Yi, S. Stephen] Texas A&M Univ, Coll Med, Dept Surg, Hlth Sci Ctr, Temple, TX 76508 USA; [Wu, Erxi] Texas A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, College Stn, TX 77843 USA; [Sahni, Nidhi] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77230 USA; [Sahni, Nidhi] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Sahni, Nidhi] Baylor Coll Med, Quantitat & Computat Biosci Program, Houston, TX 77030 USA; [Yi, S. Stephen] Univ Texas Austin, Oden Inst Computat Engn & Sci ICES, Dept Biomed Engn, Austin, TX 78712 USA; [Yi, S. Stephen] Univ Texas Austin, Livestrong Canc Inst, Austin, TX 78712 USA; [Wu, Erxi; Huang, Jason H.] Baylor Scott & White Hlth, Temple, TX 76508 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Baylor Health Care System; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Baylor Health Care System	Sahni, N (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77230 USA.; Yi, SS (corresponding author), Univ Texas Austin, Livestrong Canc Inst, Austin, TX 78712 USA.; Wu, ER; Huang, JH (corresponding author), Baylor Scott & White Hlth, Temple, TX 76508 USA.	erxi.wu@bswhealth.org; jason.huang@bswhealth.org; nsahni@mdanderson.org; stephen.yi@austin.utexas.edu	Huang, Jason/J-4739-2019; Yi, Song/ABG-6526-2020	Pan, Xingxin/0000-0002-4429-4878; Yi, Song (Stephen)/0000-0003-0047-8103				Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Behr SC, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.93999; Benitez JM, 1997, IEEE T NEURAL NETWOR, V8, P1156, DOI 10.1109/72.623216; Bethke L, 2008, CANCER EPIDEM BIOMAR, V17, P987, DOI 10.1158/1055-9965.EPI-07-2807; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chaudhary Kumardeep, 2018, Clin Cancer Res, V24, P1248, DOI 10.1158/1078-0432.CCR-17-0853; Chen QJ, 2016, AAAI CONF ARTIF INTE, P338; Cheng J, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1477-1; CHOUCAIR AK, 1986, J NEUROSURG, V65, P654, DOI 10.3171/jns.1986.65.5.0654; Cook PJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15987; Dong CH, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04107-7; Gillet E, 2014, J NEURO-ONCOL, V118, P131, DOI 10.1007/s11060-014-1407-4; Han S, 2020, BRIT J CANCER, V122, P1580, DOI 10.1038/s41416-020-0814-x; Hess KR, 2004, CANCER, V101, P2293, DOI 10.1002/cncr.20621; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Kingma DP, 2014, ADV NEUR IN, V27; Li JH, 2018, ONCOL LETT, V15, P3496, DOI 10.3892/ol.2018.7786; Liu B, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100778; Liu HJ, 2018, CELL PHYSIOL BIOCHEM, V51, P528, DOI 10.1159/000495274; Liu Q, 2015, J CELL BIOCHEM, V116, P1213, DOI 10.1002/jcb.25073; Lönn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; Mizobuchi Y, 2008, NEURO-ONCOLOGY, V10, P244, DOI 10.1215/15228517-2008-016; NELSON D F, 1988, NCI (National Cancer Institute) Monographs, P279; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohnishi A, 2003, J NEUROPATH EXP NEUR, V62, P1052, DOI 10.1093/jnen/62.10.1052; Olden JD, 2002, ECOL MODEL, V154, P135, DOI 10.1016/S0304-3800(02)00064-9; Pan XX, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100807; Park JM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113384; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Phillips LM, 2016, J PATHOL, V239, P355, DOI 10.1002/path.4734; Prechelt L, 1998, NEURAL NETWORKS, V11, P761, DOI 10.1016/S0893-6080(98)00010-0; Qin YY, 2017, THERANOSTICS, V7, P1663, DOI 10.7150/thno.17886; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Singh R, 2016, BIOINFORMATICS, V32, P639, DOI 10.1093/bioinformatics/btw427; Spino M, 2019, CLIN CANCER RES, V25, P1261, DOI 10.1158/1078-0432.CCR-18-2312; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takouda J, 2021, PHARMACOL RES PERSPE, V9, DOI 10.1002/prp2.749; Tan J, 2015, BIOCOMPUT-PAC SYM, P132; Tao T, 2014, TUMOR BIOL, V35, P9053, DOI 10.1007/s13277-014-1974-1; Tu JJ, 2022, ONCOGENE, V41, P2444, DOI 10.1038/s41388-022-02236-7; Van der Laan MJ, 2003, J STAT COMPUT SIM, V73, P575, DOI 10.1080/0094965031000136012; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Wang HW, 2021, J CANCER, V12, P5193, DOI 10.7150/jca.59948; Wang J, 2020, CNS NEUROSCI THER, V26, P297, DOI 10.1111/cns.13197; Wei L, 2018, BIOINFORMATICS, V34, P1615, DOI 10.1093/bioinformatics/btx812; Wei LQ, 2021, ASN NEURO, V13, DOI 10.1177/17590914211001218; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Xiang Q, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-252; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Xu R, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1266-9; Xue Q, 2017, ONCOL LETT, V13, P1325, DOI 10.3892/ol.2017.5567; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yu Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00320; Zaman S, 2019, ONCOL REP, V41, P1359, DOI 10.3892/or.2018.6896; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhao HY, 2017, PATHOL RES PRACT, V213, P626, DOI 10.1016/j.prp.2017.04.025; Zhou Y, 2016, EUR REV MED PHARMACO, V20, P3035	62	13	13	3	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2001-0370			COMPUT STRUCT BIOTEC	Comp. Struct. Biotechnol. J..		2022	20						3511	3521		10.1016/j.csbj.2022.06.058	http://dx.doi.org/10.1016/j.csbj.2022.06.058		JUL 2022	11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	6I8DG	35860408	gold, Green Published			2024-09-18	WOS:000886361200011
J	Wilms, I; Croux, C				Wilms, Ines; Croux, Christophe			Robust sparse canonical correlation analysis	BMC SYSTEMS BIOLOGY			English	Article						Canonical correlation analysis; Penalized estimation; Robust estimation	REGRESSION SHRINKAGE; REGULATORY NETWORKS; SELECTION; CLASSIFICATION; ASSOCIATION; EFFICIENT; MODEL; LASSO; CCA	Background: Canonical correlation analysis (CCA) is a multivariate statistical method which describes the associations between two sets of variables. The objective is to find linear combinations of the variables in each data set having maximal correlation. In genomics, CCA has become increasingly important to estimate the associations between gene expression data and DNA copy number change data. The identification of such associations might help to increase our understanding of the development of diseases such as cancer. However, these data sets are typically high-dimensional, containing a lot of variables relative to the number of objects. Moreover, the data sets might contain atypical observations since it is likely that objects react differently to treatments. We discuss a method for Robust Sparse CCA, thereby providing a solution to both issues. Sparse estimation produces canonical vectors with some of their elements estimated as exactly zero. As such, their interpretability is improved. Robust methods can cope with atypical observations in the data. Results: We illustrate the good performance of the Robust Sparse CCA method by several simulation studies and three biometric examples. Robust Sparse CCA considerably outperforms its main alternatives in (1) correctly detecting the main associations between the data sets, in (2) accurately estimating these associations, and in (3) detecting outliers. Conclusions: Robust Sparse CCA delivers interpretable canonical vectors, while at the same time coping with outlying observations. The proposed method is able to describe the associations between high-dimensional data sets, which are nowadays commonplace in genomics. Furthermore, the Robust Sparse CCA method allows to characterize outliers.	[Wilms, Ines; Croux, Christophe] Katholieke Univ Leuven, Leuven Stat Res Ctr LStat, Naamsestr 69, B-3000 Leuven, Belgium	KU Leuven	Wilms, I (corresponding author), Katholieke Univ Leuven, Leuven Stat Res Ctr LStat, Naamsestr 69, B-3000 Leuven, Belgium.	ines.wilms@kuleuven.be	; Croux, Christophe/E-4386-2016	Wilms, Ines/0000-0003-3269-4601; Croux, Christophe/0000-0003-2912-3437	FWO (Research Foundation Flanders) [11N9913N]	FWO (Research Foundation Flanders)(FWO)	Financial support from the FWO (Research Foundation Flanders, number 11N9913N) is gratefully acknowledged.	Adrover JG, 2015, J MULTIVARIATE ANAL, V133, P356, DOI 10.1016/j.jmva.2014.09.007; Alfons A, 2014, ROBUST METHODS HIGH; Alfons A, 2013, ANN APPL STAT, V7, P226, DOI 10.1214/12-AOAS575; An BG, 2013, COMPUT STAT DATA AN, V62, P93, DOI 10.1016/j.csda.2012.12.017; [Anonymous], 2003, Robust Regression and Outlier Detection; August E, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-25; Branco JA, 2005, COMPUTATION STAT, V20, P203, DOI 10.1007/BF02789700; Brillinger D. R., 1975, Time Series: Data Analysis and Theory; Chalise P, 2012, COMPUT STAT DATA AN, V56, P245, DOI 10.1016/j.csda.2011.07.012; Chen J, 2013, BIOSTATISTICS, V14, P244, DOI 10.1093/biostatistics/kxs038; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Croux C., 2002, Revue de Statistique Appliquee, V50, P5; Cruz-Cano R, 2014, COMPUT STAT DATA AN, V70, P88, DOI 10.1016/j.csda.2013.09.020; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Freund R.J., 1979, American Statistical Association Proceedings of the Statistical Computing Section, P111; Fujita A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-39; Gao MZC, 2014, SPARSE CCA ADAPTIVE; Gonzalez I, 2008, J STAT SOFTW, V23, P1; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Iaci R, 2010, BIOMETRICS, V66, P1107, DOI 10.1111/j.1541-0420.2010.01396.x; Izenman A. J., 1975, Journal of Multivariate Analysis, V5, P248, DOI 10.1016/0047-259X(75)90042-1; Johnson A.R., 1998, Applied multivariate statistical analysis; Kudraszow NL, 2011, WORKING PAPER; Li JY, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S4-S5; Li YF, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S4-S6; Lykou A, 2010, COMPUT STAT DATA AN, V54, P3144, DOI 10.1016/j.csda.2009.08.002; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; ROUSSEEUW PJ, 1990, J AM STAT ASSOC, V85, P633, DOI 10.2307/2289995; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Steinke F, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-51; Sun LA, 2011, IEEE T PATTERN ANAL, V33, P194, DOI 10.1109/TPAMI.2010.160; Taskinen S, 2006, J MULTIVARIATE ANAL, V97, P359, DOI 10.1016/j.jmva.2005.03.005; Tenenhaus A, 2014, BIOSTATISTICS, V15, P569, DOI 10.1093/biostatistics/kxu001; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Visuri S, 2000, J STAT PLAN INFER, V91, P557, DOI 10.1016/S0378-3758(00)00199-3; Waaijenborg S, 2008, STAT APPL GENET MOL, V7; Wilms I, 2015, BIOMETRICAL J, V57, P834, DOI 10.1002/bimj.201400226; Witten D, 2011, PENALIZED MULTIVARIA; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Yin JX, 2011, ANN APPL STAT, V5, P2630, DOI 10.1214/11-AOAS494; Zhou H.H., 2013, ARXIV13116186; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	43	20	27	0	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1752-0509		BMC SYST BIOL	BMC Syst. Biol.	AUG 11	2016	10								72	10.1186/s12918-016-0317-9	http://dx.doi.org/10.1186/s12918-016-0317-9			13	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	DV6CZ	27516087	Green Published, Green Submitted, gold, Green Accepted			2024-09-18	WOS:000383019800001
J	Peikert, T; Duan, FH; Rajagopalan, S; Karwoski, RA; Clay, R; Robb, RA; Qin, ZL; Sicks, J; Bartholmai, BJ; Maldonado, F				Peikert, Tobias; Duan, Fenghai; Rajagopalan, Srinivasan; Karwoski, Ronald A.; Clay, Ryan; Robb, Richard A.; Qin, Ziling; Sicks, Jorean; Bartholmai, Brian J.; Maldonado, Fabien			Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial	PLOS ONE			English	Article							BRONCHIAL GENOMIC CLASSIFIER; RISK STRATIFICATION; DIAGNOSTIC EVALUATION; CLINICAL UTILITY; CANCER; ADENOCARCINOMA; PROBABILITY; VALIDATION; PERFORMANCE; MALIGNANCY	Purpose Optimization of the clinical management of screen-detected lung nodules is needed to avoid unnecessary diagnostic interventions. Herein we demonstrate the potential value of a novel radiomics-based approach for the classification of screen-detected indeterminate nodules. Material and methods Independent quantitative variables assessing various radiologic nodule features such as sphericity, flatness, elongation, spiculation, lobulation and curvature were developed from the NLST dataset using 726 indeterminate nodules (all >= 7 mm, benign, n = 318 and malignant, n = 408). Multivariate analysis was performed using least absolute shrinkage and selection operator (LASSO) method for variable selection and regularization in order to enhance the prediction accuracy and interpretability of the multivariate model. The bootstrapping method was then applied for the internal validation and the optimism-corrected AUC was reported for the final model. Results Eight of the originally considered 57 quantitative radiologic features were selected by LASSO multivariate modeling. These 8 features include variables capturing Location: vertical location (Offset carina centroid z), Size: volume estimate (Minimum enclosing brick), Shape: flatness, Density: texture analysis (Score Indicative of Lesion/Lung Aggression/ Abnormality (SILA) texture), and surface characteristics: surface complexity (Maximum shape index and Average shape index), and estimates of surface curvature (Average positive mean curvature and Minimum mean curvature), all with P<0.01. The optimism-corrected AUC for these 8 features is 0.939. Conclusions Our novel radiomic LDCT-based approach for indeterminate screen-detected nodule characterization appears extremely promising however independent external validation is needed.	[Peikert, Tobias; Clay, Ryan] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Duan, Fenghai; Qin, Ziling] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Duan, Fenghai; Qin, Ziling; Sicks, Jorean] Brown Univ, Sch Publ Hlth, Ctr Stat Sci, Providence, RI 02912 USA; [Rajagopalan, Srinivasan; Karwoski, Ronald A.; Robb, Richard A.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Bartholmai, Brian J.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Maldonado, Fabien] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, 221 Kirkland Hall, Nashville, TN 37235 USA	Mayo Clinic; Brown University; Brown University; Mayo Clinic; Mayo Clinic; Vanderbilt University	Maldonado, F (corresponding author), Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, 221 Kirkland Hall, Nashville, TN 37235 USA.	Fabien.Maldonado@vanderbilt.edu			Department of Defense [W81XWH-15-1-0110]	Department of Defense(United States Department of Defense)	This work is funded by the Department of Defense Lung Cancer Program W81XWH-15-1-0110 (Fabien Maldonado).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Al-Ameri A, 2015, LUNG CANCER, V89, P27, DOI 10.1016/j.lungcan.2015.03.018; Callister M E J, 2015, Thorax, V70 Suppl 2, pii1, DOI 10.1136/thoraxjnl-2015-207168; Daly S, 2013, J THORAC ONCOL, V8, P31, DOI 10.1097/JTO.0b013e31827627f8; Ferguson JS, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0217-1; Field JK, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20400; Foley F, 2016, SEMIN THORAC CARDIOV, V28, P120, DOI 10.1053/j.semtcvs.2015.12.015; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gould MK, 2015, AM J RESP CRIT CARE, V192, P1208, DOI 10.1164/rccm.201505-0990OC; Grove O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118261; Hawkins S, 2016, J THORAC ONCOL, V11, P2120, DOI 10.1016/j.jtho.2016.07.002; Herder GJ, 2004, EUR J NUCL MED MOL I, V31, P1231, DOI 10.1007/s00259-004-1552-7; Horeweg N, 2014, LANCET ONCOL, V15, P1332, DOI 10.1016/S1470-2045(14)70389-4; Jemal A., 2019, CA-CANCER J CLIN, V69, P7, DOI [10.3322/caac.21551, DOI 10.3322/caac.20073, DOI 10.3322/CAAC.21332]; Kalpathy-Cramer J, 2016, TOMOGRAPHY, V2, P430, DOI 10.18383/j.tom.2016.00235; Kauczor HU, 2015, EUR RADIOL, V25, P2519, DOI 10.1007/s00330-015-3697-0; MacMahon H, 2017, RADIOLOGY, V284, P228, DOI 10.1148/radiol.2017161659; Maldonado F, 2016, J THORAC DIS, V8, pE1438, DOI 10.21037/jtd.2016.10.33; Maldonado F, 2015, AM J RESP CRIT CARE, V192, P737, DOI 10.1164/rccm.201503-0443OC; Maldonado F, 2013, J THORAC ONCOL, V8, P452, DOI 10.1097/JTO.0b013e3182843721; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Nakajima EC, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-3723; Oudkerk M, 2017, LANCET ONCOL, V18, pE754, DOI [10.1016/S1470-2045(17)30861-6, 10.1016/s1470-2045(17)30861-6]; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Raghunath S, 2014, J THORAC ONCOL, V9, P1698, DOI 10.1097/JTO.0000000000000319; Silvestri GA, 2015, NEW ENGL J MED, V373, P243, DOI 10.1056/NEJMoa1504601; Soardi GA, 2015, EUR RADIOL, V25, P155, DOI 10.1007/s00330-014-3396-2; Sozzi G, 2014, J CLIN ONCOL, V32, P768, DOI 10.1200/JCO.2013.50.4357; Steyerberg, 2009, CLIN PREDICTION MODE; Swensen SJ, 1999, MAYO CLIN PROC, V74, P319, DOI 10.4065/74.4.319; Tanoue LT, 2015, AM J RESP CRIT CARE, V191, P19, DOI 10.1164/rccm.201410-1777CI; Vachani A, 2016, CHEST, V150, P210, DOI 10.1016/j.chest.2016.02.636; Vachani A, 2015, J THORAC ONCOL, V10, P629, DOI 10.1097/JTO.0000000000000447; van Riel SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185032; Wilson R, 2017, TRANSL LUNG CANCER R, V6, P86, DOI 10.21037/tlcr.2017.01.04; Wu WM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00071	38	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196910	10.1371/journal.pone.0196910	http://dx.doi.org/10.1371/journal.pone.0196910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758038	Green Published, gold, Green Submitted			2024-09-18	WOS:000432082900018
J	Kong, XR; Wang, MC; Gray, R				Kong, Xiangrong; Wang, Mei-Cheng; Gray, Ronald			Analysis of Longitudinal Multivariate Outcome Data From Couples Cohort Studies: Application to HPV Transmission Dynamics	JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION			English	Article						Alternating logistic regression; Clustered binary data; Composite likelihood; Markov transition model; Pairwise likelihood	HUMAN-PAPILLOMAVIRUS INFECTIONS; COMPOSITE LIKELIHOOD APPROACH; LOGISTIC-REGRESSION; MALE CIRCUMCISION; BINARY DATA; VIRAL LOAD; SEXUAL TRANSMISSIBILITY; NATURAL-HISTORY; MODELS; WOMEN	We consider a specific situation of correlated data where multiple outcomes are repeatedly measured on each member of a couple. Such multivariate longitudinal data from couples may exhibit multi-faceted correlations that can be further complicated if there are polygamous partnerships. An example is data from cohort studies on human papillomavirus (HPV) transmission dynamics in heterosexual couples. HPV is a common sexually transmitted disease with 14 known oncogenic types causing anogenital cancers. The binary outcomes on the multiple types measured in couples over time may introduce inter-type, intra-couple, and temporal correlations. Simple analysis using generalized estimating equations or random effects models lacks interpretability and cannot fully use the available information. We developed a hybrid modeling strategy using Markov transition models together with pairwise composite likelihood for analyzing such data. The method can be used to identify risk factors associated with HPV transmission and persistence, estimate difference in risks between male-to-female and female-to-male HPV transmission, compare type-specific transmission risks within couples, and characterize the inter-type and intra-couple associations. Applying the method to HPV couple data collected in a Ugandan male circumcision (MC) trial, we assessed the effect of MC and the role of gender on risks of HPV transmission and persistence. Supplementary materials for this article are available online.	[Kong, Xiangrong; Wang, Mei-Cheng] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Kong, Xiangrong; Wang, Mei-Cheng] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Gray, Ronald] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Populat & Family Hlth Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kong, XR (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	xikong@jhsph.edu; mcwang@jhsph.edu; rgray@jhsph.edu	KONG, XIANGRONG/B-5098-2010; zhen, wang/KBA-3844-2024		NIH National Institute of Allergy and Infectious Diseases [K25AI114461]; Center for Global Health of Johns Hopkins University; Center for AIDS Research (CFAR) of Johns Hopkins University	NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Global Health of Johns Hopkins University; Center for AIDS Research (CFAR) of Johns Hopkins University	This work was partially supported by grant K25AI114461 from the NIH National Institute of Allergy and Infectious Diseases, by a faculty grant from the Center for Global Health of Johns Hopkins University, and by an International Scholar Award from the Center for AIDS Research (CFAR) of Johns Hopkins University.	Agresti A., 2012, CATEGORICAL DATA ANA; BONNEY GE, 1987, BIOMETRICS, V43, P951, DOI 10.2307/2531548; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Burchell AN, 2006, AM J EPIDEMIOL, V163, P534, DOI 10.1093/aje/kwj077; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Burchell AN, 2011, J INFECT DIS, V204, P1723, DOI 10.1093/infdis/jir644; Burchell AN, 2010, SEX TRANSM DIS, V37, P34, DOI 10.1097/OLQ.0b013e3181b35693; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Bureau A, 2003, STAT MED, V22, P441, DOI 10.1002/sim.1270; By K, 2014, COMPUT METH PROG BIO, V113, P557, DOI 10.1016/j.cmpb.2013.09.017; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Cherpes TL, 2005, CLIN INFECT DIS, V40, P1422, DOI 10.1086/429622; Chib S, 2006, J AM STAT ASSOC, V101, P685, DOI 10.1198/016214505000000871; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Crowder M., 1986, ECONOMET THEOR, V2, P305, DOI DOI 10.1017/S0266466600011646; Davis MA, 2013, INT J CANCER, V133, P1247, DOI 10.1002/ijc.28100; Doorbar J, 2013, CURR OPIN VIROL, V3, P416, DOI 10.1016/j.coviro.2013.06.003; Firth D., 1992, J ROYAL STAT SOC B, V45, P28; FitzGerald PEB, 1998, BIOMETRICS, V54, P909, DOI 10.2307/2533845; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Franco EL, 2006, VACCINE, V24, P242, DOI 10.1016/j.vaccine.2006.06.038; Geys H, 1999, J AM STAT ASSOC, V94, P734, DOI 10.2307/2669986; Giuliano AR, 2008, J INFECT DIS, V198, P827, DOI 10.1086/591095; Gravitt Patti E, 2012, Open Virol J, V6, P198, DOI 10.2174/1874357901206010198; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Halfon P, 2010, J CLIN VIROL, V48, P246, DOI 10.1016/j.jcv.2010.05.008; Heagerty PJ, 1998, J AM STAT ASSOC, V93, P1099, DOI 10.2307/2669853; Hernandez BY, 2008, EMERG INFECT DIS, V14, P888, DOI 10.3201/eid1406.070616; Hjort N., 2007, SCANDINAVIAN J STAT, V35, P64; Kang M, 2004, STAT METHODS MED RES, V13, P139, DOI 10.1191/0962280204sm358ra; Kang MH, 2007, BIOSTATISTICS, V8, P252, DOI 10.1093/biostatistics/kxl006; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Kleinbaum DG., 2002, LOGISTIC REGRESSION, DOI DOI 10.1111/J.1467-985X.2004.298_12.X; Kong XR, 2010, STAT MED, V29, P2880, DOI 10.1002/sim.4062; Kong XR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-40; Kuk AYC, 2007, BIOMETRIKA, V94, P939, DOI 10.1093/biomet/asm051; Kuk AYC, 2004, BIOMETRIKA, V91, P758, DOI 10.1093/biomet/91.3.758; Kuk AYC, 2000, STAT PROBABIL LETT, V47, P329, DOI 10.1016/S0167-7152(99)00174-1; LECESSIE S, 1994, J R STAT SOC C-APPL, V43, P95; LIANG KY, 1989, J AM STAT ASSOC, V84, P447, DOI 10.2307/2289928; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lin SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077684; Lindsay B. G., 1988, CONT MATH, V80, P220, DOI DOI 10.1090/CONM/080/999014; Little R., 2002, STAT ANAL MISSING DA; McCullagh P., 1989, GEN LINEAR MODELS; Mitchell CE, 2011, STAT MED, V30, P2160, DOI 10.1002/sim.4257; Molenberghs G., 2006, MODELS DISCRETE LONG; Morse S., 2003, ATLAS SEXUALLY TRANS; Moscicki AB, 2013, J INFECT DIS, V208, P403, DOI 10.1093/infdis/jit175; Nyitray AG, 2014, J INFECT DIS, V209, P1007, DOI 10.1093/infdis/jit615; O'Brien LM, 2004, J R STAT SOC C-APPL, V53, P177, DOI 10.1046/j.0035-9254.2003.05296.x; Palefsky JM, 2010, J ADOLESCENT HEALTH, V46, pS12, DOI 10.1016/j.jadohealth.2010.01.010; Parner ET, 2001, SCAND J STAT, V28, P295, DOI 10.1111/1467-9469.00238; Rowhani-Rahbar A, 2009, SEX TRANSM DIS, V36, P261, DOI 10.1097/OLQ.0b013e3181901906; Ten Have TR, 1999, BIOMETRICS, V55, P85, DOI 10.1111/j.0006-341X.1999.00085.x; Tota JE, 2013, AM J EPIDEMIOL, V178, P625, DOI 10.1093/aje/kwt018; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Varin C, 2008, ASTA-ADV STAT ANAL, V92, P1, DOI 10.1007/s10182-008-0060-7; Varin C, 2011, STAT SINICA, V21, P5; Widdice LE, 2010, J ADOLESCENT HEALTH, V47, P151, DOI 10.1016/j.jadohealth.2010.01.006; Wilson L., 2014, INT J CANCER, V134, P1889; Winer RL, 2014, INT J CANCER, V134, P1889, DOI 10.1002/ijc.28509; World Health Organization International Agency for Research on Cancer, 2007, IARC MON EV CARC RIS; Xi LF, 2011, J INFECT DIS, V203, P1425, DOI 10.1093/infdis/jir049; Zhao YS, 2005, CAN J STAT, V33, P335, DOI 10.1002/cjs.5540330303	66	3	4	1	15	AMER STATISTICAL ASSOC	ALEXANDRIA	732 N WASHINGTON ST, ALEXANDRIA, VA 22314-1943 USA	0162-1459	1537-274X		J AM STAT ASSOC	J. Am. Stat. Assoc.	JUN	2015	110	510					472	485		10.1080/01621459.2014.991394	http://dx.doi.org/10.1080/01621459.2014.991394			14	Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	CM1JN	26195849	Green Accepted, Green Submitted			2024-09-18	WOS:000357437300002
J	Xu, YN; Cui, XR; Zhang, LY; Zhao, TY; Wang, YD				Xu, Yining; Cui, Xinran; Zhang, Liyuan; Zhao, Tianyi; Wang, Yadong			Metastasis-related gene identification by compound constrained NMF and a semisupervised cluster approach using pancancer multiomics features	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Pancancer; Metastasis-related gene; Immune-related gene; Constraint NMF; Semisupervised learning		In recent years, with the gradual increase in pancancer-related research, more attention has been given to the field of pancancer metastasis. However, the molecular mechanism of pancancer metastasis is very unclear, and identification methods for pancancer metastasis-related genes are still lacking. In view of this research status, we developed a novel pipeline to identify pancancer metastasis-related genes based on compound constrained nonnegative matrix factorization (CCNMF). To solve the above problems, the following modules were designed. A correntropy operator and feature similarity fusion (FSF) were first adopted to process the multiomics features of genes; thus, the influences caused by irrelevant biomolecular patterns, manifested as non-Gaussian noise, were minimized. CCNMF was then adopted to handle the above features with compound constraints consisting of a gene relation network and a "metastasis-related"gene set, which maximizes the biological interpretability of the metafeatures generated by NMF. Since a negative set of pancancer "metastasis-related"genes could hardly be obtained, semisupervised analyses were performed on gene features acquired by each step in our pipeline to examine our method's effect. 83% of the 236 candidates identified by the above method were associated with the metastasis of one or more cancers, 71.9% candidates were identified immune-related in pancancer in addition to the hallmark genes. Our study provides an effective and interpretable method for identifying metastasis-related as well as immune-related genes, and the method is successfully applied to TCGA pancancer data.	[Xu, Yining; Cui, Xinran; Zhang, Liyuan; Wang, Yadong] Harbin Inst Technol, Fac Comp, 92 Xidazhi St,TIB 20, Harbin 150000, Peoples R China; [Zhao, Tianyi] Harbin Inst Technol, Sch Med & Hlth, 92 Xidazhi St,TIB 20, Harbin 150000, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Wang, YD (corresponding author), Harbin Inst Technol, Fac Comp, 92 Xidazhi St,TIB 20, Harbin 150000, Peoples R China.; Zhao, TY (corresponding author), Harbin Inst Technol, Sch Med & Hlth, 92 Xidazhi St,TIB 20, Harbin 150000, Peoples R China.	16b903051@stu.hit.edu.cn; 1996cxr@gmail.com; zly2020@hit.edu.cn; zty2009@hit.edu.cn; ydwang@hit.edu.cn	wang, ya/HQZ-7558-2023		Natural Science Foundation of China; Interdisciplinary Research Foundation of HIT, China;  [62102116]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Interdisciplinary Research Foundation of HIT, China; 	Acknowledgments The results shown in this publication are in part based upon data generated by the TCGA Research Network: https:// www.cancer.gov/tcga. The data supporting this publication of the cancer immune gene set are available at ImmPort (https:// www.immport.org) under study accession number SDY1234. This work has been supported by Natural Science Foundation of China (62102116) and Interdisciplinary Research Foundation of HIT, China.	Adabor ES, 2020, COMPUT BIOL MED, V125, DOI 10.1016/j.compbiomed.2020.104017; Bhattacharya S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.15; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; Caspi R, 2020, NUCLEIC ACIDS RES, V48, pD445, DOI 10.1093/nar/gkz862; Doja MN, 2020, CURR BIOINFORM, V15, P174, DOI 10.2174/1574893614666190902152142; Dorrity MW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15351-4; Feng CM, 2019, IEEE T NEUR NET LEAR, V30, P2926, DOI 10.1109/TNNLS.2019.2893190; Jiang D, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00995; Kanehisa M, 2021, NUCLEIC ACIDS RES, V49, pD545, DOI 10.1093/nar/gkaa970; Liu HF, 2012, IEEE T PATTERN ANAL, V34, P1299, DOI 10.1109/TPAMI.2011.217; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu WF, 2007, IEEE T SIGNAL PROCES, V55, P5286, DOI 10.1109/TSP.2007.896065; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Peng W, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab432; Rappoport N, 2018, NUCLEIC ACIDS RES, V46, P10546, DOI 10.1093/nar/gky889; Roy B, 2022, COMPUT BIOL MED, V141, DOI 10.1016/j.compbiomed.2021.105001; Smieja M, 2020, NEURAL NETWORKS, V127, P193, DOI 10.1016/j.neunet.2020.04.017; Spurr J., 2018, SCI REP-UK, V8, P1; Su L, 2021, COMPUT BIOL MED, V137, DOI 10.1016/j.compbiomed.2021.104788; Suresh NT, 2021, CURR BIOINFORM, V16, P433, DOI 10.2174/1574893615999200724145434; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tsai CA, 2021, CURR BIOINFORM, V16, P406, DOI 10.2174/1574893615999200629124444; Wang JJY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-107; Wu Cen, 2019, High Throughput, V8, DOI 10.3390/ht8010004; Yang H., 2022, BIORXIV; Zeng K, 2014, NEUROCOMPUTING, V138, P209, DOI 10.1016/j.neucom.2014.01.043; Zhang Z, 2019, GENES-BASEL, V10, DOI 10.3390/genes10070531	27	3	4	2	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	DEC	2022	151		A						106263	10.1016/j.compbiomed.2022.106263	http://dx.doi.org/10.1016/j.compbiomed.2022.106263		NOV 2022	7	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	7C9SB	36371902				2024-09-18	WOS:000900142700005
J	Pereira, TO; Abbasi, M; Oliveira, RI; Guedes, RA; Salvador, JAR; Arrais, JP				Pereira, Tiago O.; Abbasi, Maryam; Oliveira, Rita I.; Guedes, Romina A.; Salvador, Jorge A. R.; Arrais, Joel P.			Artificial intelligence for prediction of biological activities and generation of molecular hits using stereochemical information	JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN			English	Article						Deep reinforcement learning; De novo drug design; Attention mechanism; Stereochemical information; Interpretability	DRUG DISCOVERY; CANCER	In this work, we develop a method for generating targeted hit compounds by applying deep reinforcement learning and attention mechanisms to predict binding affinity against a biological target while considering stereochemical information. The novelty of this work is a deep model Predictor that can establish the relationship between chemical structures and their corresponding pIC(50) values. We thoroughly study the effect of different molecular descriptors such as ECFP4, ECFP6, SMILES and RDKFingerprint. Also, we demonstrated the importance of attention mechanisms to capture long-range dependencies in molecular sequences. Due to the importance of stereochemical information for the binding mechanism, this information was employed both in the prediction and generation processes. To identify the most promising hits, we apply the self-adaptive multi-objective optimization strategy. Moreover, to ensure the existence of stereochemical information, we consider all the possible enumerated stereoisomers to provide the most appropriate 3D structures. We evaluated this approach against the Ubiquitin-Specific Protease 7 (USP7) by generating putative inhibitors for this target. The predictor with SMILES notations as descriptor plus bidirectional recurrent neural network using attention mechanism has the best performance. Additionally, our methodology identify the regions of the generated molecules that are important for the interaction with the receptor's active site. Also, the obtained results demonstrate that it is possible to discover synthesizable molecules with high biological affinity for the target, containing the indication of their optimal stereochemical conformation.	[Pereira, Tiago O.; Abbasi, Maryam; Arrais, Joel P.] Univ Coimbra, Ctr Informat & Syst, Dept Informat Engn, Coimbra, Portugal; [Abbasi, Maryam] Polytech Inst Coimbra, Appl Res Inst, Coimbra, Portugal; [Oliveira, Rita I.; Guedes, Romina A.; Salvador, Jorge A. R.] Univ Coimbra, Fac Pharm, Lab Pharmaceut Chem, Coimbra, Portugal; [Oliveira, Rita I.; Guedes, Romina A.; Salvador, Jorge A. R.] Ctr Innovat Biomed & Biotechnol, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Abbasi, Maryam] Polytech Inst Coimbra, Res Ctr Nat Resources Environm & Soc CERNAS, P-3045601 Coimbra, Bencanta, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Pereira, TO (corresponding author), Univ Coimbra, Ctr Informat & Syst, Dept Informat Engn, Coimbra, Portugal.	top@dei.uc.pt; jpa@dei.uc.pt	Abbasi, Maryam/AGS-6377-2022; Pereira, Tania/AGK-0991-2022; SALVADOR, JORGE A. R./N-7174-2017	Abbasi, Maryam/0000-0002-9011-0734; Oliveira, Rita Isabel/0000-0002-1511-4364; SALVADOR, JORGE A. R./0000-0003-0779-6083; Guedes, Romina/0000-0002-4397-7968; O. Pereira, Tiago/0000-0003-2487-0097	Not applicable.	Not applicable.	Not applicable.	Bahdanau D, 2016, Arxiv, DOI arXiv:1409.0473; Ban FQ, 2017, J CHEM INF MODEL, V57, P1018, DOI 10.1021/acs.jcim.7b00137; Benhenda M, 2017, ARXIV; Bian YM, 2021, J MOL MODEL, V27, DOI 10.1007/s00894-021-04674-8; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Brown N, 2006, CURR OPIN DRUG DISC, V9, P419; Brown N, 2019, J CHEM INF MODEL, V59, P1096, DOI 10.1021/acs.jcim.8b00839; Chen SY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094546; Cui WQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00733; Elton DC, 2019, MOL SYST DES ENG, V4, P828, DOI 10.1039/c9me00039a; Ertl P, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-8; Gallo LH, 2017, CELL CYCLE, V16, P634, DOI 10.1080/15384101.2017.1288326; Gómez-Bombarelli R, 2018, ACS CENTRAL SCI, V4, P268, DOI 10.1021/acscentsci.7b00572; Goodfellow I, 2020, COMMUN ACM, V63, P139, DOI 10.1145/3422622; Guimaraes GL, 2017, ARXIV, DOI DOI 10.48550/ARXIV.1705.10843; Inc CCG., 2016, MOL OP ENV MOE; Jensen JH, 2019, CHEM SCI, V10, P3567, DOI 10.1039/c8sc05372c; Méndez-Lucio O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13807-w; Oliveira RI, 2022, FRONT CHEM, V10, DOI 10.3389/fchem.2022.1005727; Pedreira JGB, 2019, CURR TOP MED CHEM, V19, P1679, DOI 10.2174/1568026619666190620144142; Pereira T, 2021, J CHEMINFORMATICS, V13, DOI 10.1186/s13321-021-00498-z; Polykovskiy D, 2018, MOL PHARMACEUT, V15, P4398, DOI 10.1021/acs.molpharmaceut.8b00839; Popova M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap7885; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Saikia S, 2019, CURR DRUG TARGETS, V20, P501, DOI 10.2174/1389450119666181022153016; Santos BP, 2021, COMP MED SY, P172, DOI 10.1109/CBMS52027.2021.00067; Segler MHS, 2018, ACS CENTRAL SCI, V4, P120, DOI 10.1021/acscentsci.7b00512; Shen WF, 2023, J CHEMINFORMATICS, V15, DOI 10.1186/s13321-022-00675-8; Spiegel JO, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00429-4; Ståhl N, 2019, J CHEM INF MODEL, V59, P3166, DOI 10.1021/acs.jcim.9b00325; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Nguyen TT, 2020, ENG APPL ARTIF INTEL, V96, DOI 10.1016/j.engappai.2020.103915; Wang ZR, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00427; Wouters OJ, 2020, JAMA-J AM MED ASSOC, V323, P844, DOI 10.1001/jama.2020.1166; Wu J, 2018, J MED CHEM, V61, P422, DOI 10.1021/acs.jmedchem.7b00498; Xue WW, 2018, ACS CHEM NEUROSCI, V9, P1128, DOI 10.1021/acschemneuro.7b00490; Yuan T, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01080	37	1	1	3	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-654X	1573-4951		J COMPUT AID MOL DES	J. Comput.-Aided Mol. Des.	DEC	2023	37	12					791	806		10.1007/s10822-023-00539-9	http://dx.doi.org/10.1007/s10822-023-00539-9		OCT 2023	16	Biochemistry & Molecular Biology; Biophysics; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Computer Science	W1DE9	37847342	hybrid, Green Published			2024-09-18	WOS:001084114500001
J	Mei, XY; Liu, ZL; Robson, PM; Marinelli, B; Huang, MQ; Doshi, A; Jacobi, A; Cao, CD; Link, KE; Yang, TM; Wang, Y; Greenspan, H; Deyer, T; Fayad, ZA; Yang, Y				Mei, Xueyan; Liu, Zelong; Robson, Philip M.; Marinelli, Brett; Huang, Mingqian; Doshi, Amish; Jacobi, Adam; Cao, Chendi; Link, Katherine E.; Yang, Thomas; Wang, Ying; Greenspan, Hayit; Deyer, Timothy; Fayad, Zahi A.; Yang, Yang			RadImageNet: An Open Radiologic Deep Learning Research Dataset for Effective Transfer Learning	RADIOLOGY-ARTIFICIAL INTELLIGENCE			English	Article							CANCER	Purpose: To demonstrate the value of pretraining with millions of radiologic images compared with ImageNet photographic images on downstream medical applications when using transfer learning. Materials and Methods: This retrospective study included patients who underwent a radiologic study between 2005 and 2020 at an outpatient imaging facility. Key images and associated labels from the studies were retrospectively extracted from the original study interpretation. These images were used for RadImageNet model training with random weight initiation. The RadImageNet models were compared with ImageNet models using the area under the receiver operating characteristic curve (AUC) for eight classification tasks and using Dice scores for two segmentation problems. Results: The RadImageNet database consists of 1.35 million annotated medical images in 131 872 patients who underwent CT, MRI, and US for musculoskeletal, neurologic, oncologic, gastrointestinal, endocrine, abdominal, and pulmonary pathologic conditions. For transfer learning tasks on small datasets-thyroid nodules (US), breast masses (US), anterior cruciate ligament injuries (MRI), and meniscal tears (MRI)-the RadImageNet models demonstrated a significant advantage (P < .001) to ImageNet models (9.4%, 4.0%, 4.8%, and 4.5% AUC improvements, respectively). For larger datasets-pneumonia (chest radiography), COVID-19 (CT), SARS-CoV-2 (CT), and intracranial hemorrhage (CT)-the RadImageNet models also illustrated improved AUC (P < .001) by 1.9%, 6.1%, 1.7%, and 0.9%, respectively. Additionally, lesion localizations of the RadImageNet models were improved by 64.6% and 16.4% on thyroid and breast US datasets, respectively. Conclusion: RadImageNet pretrained models demonstrated better interpretability compared with ImageNet models, especially for smaller radiologic datasets.	[Mei, Xueyan; Liu, Zelong; Robson, Philip M.; Cao, Chendi; Link, Katherine E.; Yang, Thomas; Greenspan, Hayit; Fayad, Zahi A.; Yang, Yang] Icahn Sch Med Mt Sinai, Leon & Norma Hess Ctr Sci & Med, Biomed Engn & Imaging Inst, 1470 Madison Ave, New York, NY 10029 USA; [Robson, Philip M.; Marinelli, Brett; Huang, Mingqian; Doshi, Amish; Jacobi, Adam; Fayad, Zahi A.; Yang, Yang] Icahn Sch Med Mt Sinai, Leon & Norma Hess Ctr Sci & Med, Dept Diagnost Intervent & Mol Radiol, 1470 Madison Ave, New York, NY 10029 USA; [Wang, Ying] Univ Oklahoma, Dept Math, Okla, SK, Canada; [Deyer, Timothy] Cornell Med, Dept Radiol, New York, NY USA; [Deyer, Timothy] East River Med Imaging, Dept Radiol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Yang, Y (corresponding author), Icahn Sch Med Mt Sinai, Leon & Norma Hess Ctr Sci & Med, Biomed Engn & Imaging Inst, 1470 Madison Ave, New York, NY 10029 USA.; Yang, Y (corresponding author), Icahn Sch Med Mt Sinai, Leon & Norma Hess Ctr Sci & Med, Dept Diagnost Intervent & Mol Radiol, 1470 Madison Ave, New York, NY 10029 USA.	yy5cc@virginia.edu	Yang, Yang/H-7280-2019; Fayad, Zahi/AER-0041-2022; Liu, Zelong/LEM-1003-2024	Jacobi, Adam/0000-0002-9057-9129; Marinelli, Brett/0000-0003-3220-1360; Yang, Yang/0000-0002-2841-4243; Mei, Xueyan/0000-0001-7224-7318; Link, Katie/0000-0003-2387-0116				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agrawal P, 2014, LECT NOTES COMPUT SC, V8695, P329, DOI 10.1007/978-3-319-10584-0_22; Al-Dhabyani W, 2020, DATA BRIEF, V28, DOI 10.1016/j.dib.2019.104863; Bien N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002699; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cheplygina V, 2019, MED IMAGE ANAL, V54, P280, DOI 10.1016/j.media.2019.03.009; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; David HA, 1997, AM STAT, V51, P9, DOI 10.2307/2684684; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Flanders AE, 2020, RADIOL-ARTIF INTELL, V2, DOI [10.1148/ryai.2020190211, 10.1148/ryai.2020209002]; Ghesu F, 2022, Arxiv, DOI arXiv:2201.01283; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Langlotz CP, 2019, RADIOLOGY, V291, P781, DOI 10.1148/radiol.2019190613; Lee H, 2019, NAT BIOMED ENG, V3, P173, DOI 10.1038/s41551-018-0324-9; Mei XY, 2020, NAT MED, V26, P1224, DOI [10.1038/s41591-020-0931-3, 10.1101/2020.04.12.20062661]; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Parakh A, 2019, RADIOL-ARTIF INTELL, V1, DOI 10.1148/ryai.2019180066; Pedraza L, 2015, PROC SPIE, V9287, DOI 10.1117/12.2073532; Razali NM., 2011, J Stat Model Anal, V2, P21, DOI DOI 10.1515/BILE-2015-0008; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Seeram E., 2015, Computed Tomography: Physical Principles, Clinical Applications, and Quality Control; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shih G, 2019, RADIOL-ARTIF INTELL, V1, DOI 10.1148/ryai.2019180041; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Walsh SLF, 2018, LANCET RESP MED, V6, P837, DOI 10.1016/S2213-2600(18)30286-8; Wang XS, 2017, PROC CVPR IEEE, P3462, DOI 10.1109/CVPR.2017.369; Xie YT, 2019, LECT NOTES COMPUT SC, V11134, P476, DOI 10.1007/978-3-030-11024-6_37; Zatz L.M., 1981, TECHNICAL ASPECTS CO, P3853; Zhang K, 2020, CELL, V181, P1423, DOI 10.1016/j.cell.2020.04.045	36	81	85	2	5	RADIOLOGICAL SOC NORTH AMERICA (RSNA)	OAK BROOK	820 JORIE BLVD, SUITE 200, OAK BROOK, ILLINOIS, UNITED STATES	2638-6100			RADIOL-ARTIF INTELL	Radiology-Artificial Intelligence	SEP	2022	4	5							e210315	10.1148/ryai.210315	http://dx.doi.org/10.1148/ryai.210315			9	Computer Science, Artificial Intelligence; Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Computer Science; Radiology, Nuclear Medicine & Medical Imaging	P2KK8	36204533	Green Published			2024-09-18	WOS:001048978300011
C	Shakeri, E; Mohammed, E; Crump, T; Weis, E; Shields, CL; Ferenczy, SR; Far, B			IEEE	Shakeri, Esmaeil; Mohammed, Emad; Crump, Trafford; Weis, Ezekiel; Shields, Carol L.; Ferenczy, Sandor R.; Far, Behrouz			Deep Learning-Based Detection and Classification of Uveal Melanoma Using Convolutional Neural Networks and SHAP Analysis	2023 IEEE 24TH INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION FOR DATA SCIENCE, IRI	IEEE International Conference on Information Reuse and Integration		English	Proceedings Paper	IEEE 24th International Conference on Information Reuse and Integration for Data Science (IRI)	AUG 04-06, 2023	Bellevue, WA	IEEE, IEEE Comp Soc, Soc Informat Reuse & Integrat, IEEE TCMC		Uveal melanoma; Classification; Choroidal nevus; Deep learning; Detection; SHAP analysis	DIABETIC-RETINOPATHY; VALIDATION	Uveal melanoma (UM) is a severe intraocular cancer in adults aged 50-80, often originating from choroidal nevus, a common intraocular tumour. This transformation can lead to vision loss, metastasis, and even death. Early prediction of UM can reduce the risk of death. In this study, we employed transfer learning techniques and four convolutional neural network (CNN)-based architectures to detect UM and enhance the interpretation of diagnostic results. To accomplish this, we manually gathered 854 RGB fundus images from two distinct datasets, representing the right and left eyes of 854 unique patients (427 lesions and 427 non-lesions). Preprocessing steps, such as image conversion, resizing, and data augmentation, were performed before training and validating the classification results. We utilized InceptionV3, Xception, DenseNet121, and DenseNet169 pre-trained models to improve the generalizability and performance of our results, evaluating each architecture on an external validation set. Addressing the issue of interpretability in deep learning (DL) models to minimize the blackbox problem, we employed the SHapley Additive exPlanations (SHAP) analysis approach to identify regions of an eye image that contribute most to the prediction of choroidal nevus (CN). The performance results of the DL models revealed that DenseNet169 achieved the highest accuracy 89%, and lowest loss value 0.65%, for the binary classification of CN. The SHAP findings demonstrate that this method can serve as a tool for interpreting classification results by providing additional context information about individual sample images and facilitating a more comprehensive evaluation of binary classification in CN.	[Shakeri, Esmaeil; Mohammed, Emad; Far, Behrouz] Univ Calgary, Schulich Sch Engn, Dept Elect & Software Engn, Calgary, AB, Canada; [Crump, Trafford; Weis, Ezekiel] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Shields, Carol L.; Ferenczy, Sandor R.] Thomas Jefferson Univ, Wills Eye Hosp, Ocular Oncol Serv, Philadelphia, PA 19107 USA	University of Calgary; University of Calgary; Jefferson University	Shakeri, E (corresponding author), Univ Calgary, Schulich Sch Engn, Dept Elect & Software Engn, Calgary, AB, Canada.	esmaeil.shakerihosse@ucalgary.ca; eamohamm@ucalgary.ca; tcrump@ucalgary.ca; ezekiel@ualberta.ca; carolshields@gmail.com; sandor@shields.md; far@ucalgary.ca	Weis, Ezekiel/A-7246-2008; Crump, Trafford/AAK-5945-2021					Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Ahmed I. O., 2018, Journal of Clinical Engineering, V43, P22; Alaslani Maram G., 2018, International Journal of Computer Science & Information Technology, V10, P65, DOI 10.5121/ijcsit.2018.10206; Carletta J., 1996, arXiv; Chollet F., 2018, Astrophysics Source Code Library ascl:1806.022; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Covert I., 2020, Advances in Neural Information Processing Systems, V33, P17212; Dai HC, 1997, PHYS EARTH PLANET IN, V101, P177, DOI 10.1016/S0031-9201(97)00004-6; Elsharif A. A. E. F., 2022, International Journal of Academic Engineering Research (IJAER), V6; eyecancer, About us; Ganguly B., 2019, 2019 INT C COMP EL C, P1; Dos Santos CFG, 2022, ACM COMPUT SURV, V54, DOI 10.1145/3510413; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Guo H., 2004, SIGKDD EXPLOR NEWSL, V6, P30, DOI [DOI 10.1145/1007730.1007736, 10.1145/ 1007730.1007736]; Haykin S, 1999, Neural networks: A comprehensive foundation; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Helwan A, 2021, medRxiv; Hinterstoisser S, 2019, LECT NOTES COMPUT SC, V11129, P682, DOI 10.1007/978-3-030-11009-3_42; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Jeelani H, 2018, I S BIOMED IMAGING, P357, DOI 10.1109/ISBI.2018.8363592; Kaliki S, 2017, EYE, V31, P241, DOI 10.1038/eye.2016.275; Kingma DP, 2014, ADV NEUR IN, V27; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kugelman J, 2020, IEEE ACCESS, V8, P43537, DOI 10.1109/ACCESS.2020.2977355; LeCun Yann, 2015, Lenet-5, convolutional neural networks; Liang YT, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON IT IN MEDICINE AND EDUCATION, VOLS 1 AND 2, PROCEEDINGS, P670, DOI 10.1109/ITME.2008.4743950; Lundberg SM, 2017, ADV NEUR IN, V30; McCullagh P., 1989, GEN LINEAR MODELS; N. E. M. Association, 1997, NEMA PS, V3; Nirthika Rajendran, 2020, 2020 IEEE 15th International Conference on Industrial and Information Systems (ICIIS), P144, DOI 10.1109/ICIIS51140.2020.9342711; Oyedotun O. K., 2014, International Journal of Scientific & Engineering Research, V5, P421; Oyedotun O, 2017, TURK J ELECTR ENG CO, V25, P1106, DOI 10.3906/elk-1507-190; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rafi T. H., 2021, 2021 IEEE C COMP INT, P1; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Sengupta S, 2020, ARTIF INTELL MED, V102, DOI 10.1016/j.artmed.2019.101758; Shakeri E., 2023, SN Computer Science, V4, P433; Shakeri E, 2022, 2022 IEEE 23RD INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION FOR DATA SCIENCE (IRI 2022), P166, DOI 10.1109/IRI54793.2022.00046; Shakeri E, 2021, IEEE ENG MED BIO, P2472, DOI 10.1109/EMBC46164.2021.9630317; Sheet SSM, 2022, ICT EXPRESS, V8, P142, DOI 10.1016/j.icte.2021.05.002; Shields CL, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.2.24; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P981, DOI 10.1001/archophthalmol.2009.151; Shorfuzzaman M, 2021, ACM T MULTIM COMPUT, V17, DOI 10.1145/3469841; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Sinha A., 2021, 2021 7 INT C BIOS IM, P1; Sumich P, 1998, ARCH OPHTHALMOL-CHIC, V116, P645, DOI 10.1001/archopht.116.5.645; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Yadav S., 2022, Sadhana, V47, P1; Zabor EC, 2022, OCUL ONCOL PATHOL, V8, P71, DOI 10.1159/000521541	50	0	0	5	8	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA	2835-5768		979-8-3503-3458-6	Infor Reuse and Inte			2023							215	220		10.1109/IRI58017.2023.00044	http://dx.doi.org/10.1109/IRI58017.2023.00044			6	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science	BV6WD					2024-09-18	WOS:001063198500037
J	Wu, YP; Pei, CH; Ruan, CY; Wang, RF; Yang, Y; Zhang, YC				Wu, Yingpei; Pei, Chaohan; Ruan, Chunyang; Wang, Ruofei; Yang, Yun; Zhang, Yanchun			Bayesian networks and chained classifiers based on SVM for traditional chinese medical prescription generation	WORLD WIDE WEB-INTERNET AND WEB INFORMATION SYSTEMS			English	Article						Multi-label classification; Bayes classifier chain; Cost sensitive SVM; TCM	CLASSIFICATION	Traditional Chinese Medicine(TCM) is playing an increasingly prominent role in lung cancer treatment, as it can prolong patients' survival, improve their quality of life, and reduce the adverse effects of radiotherapy and chemotherapy. However, the effectiveness of TCM treatment depends more on the personal experience of doctors, and the standardization of TCM prescriptions needs to be strengthened. In this study, we use TCM clinical prescriptions to train a standardized TCM prescription generation model to provide an auxiliary prescription reference for physicians. However, in our initial experiments, we found two severe problems in the dataset. The first problem is a strong correlation between each herb; for instance, some herbs often appear together to treat specific symptoms. The second is a severe class imbalance within each label, a few herbs always appear in most prescriptions, but most herbs have a low frequency of occurrence in the total dataset. To solve the correlation between each herb label, we adopt the Bayes Classifier Chain(BCC) algorithm, whose basic classifier is Cost-Sensitive SVM targeted to the class imbalance of the label. Based on this, we also improve the BCC method according to the characteristics of TCM prescription dataset. In our BCC classifier, the Directed Acyclic Graph (DAG) construction method has high interpretability in the scenario of TCM prescription. After combining multi-label learning algorithms with several SVM algorithms and comparing their performance in detail, we find that BBC+CS-SVM best deals with class imbalance within the label in multi-label classification problems.	[Wu, Yingpei; Pei, Chaohan] Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China; [Pei, Chaohan; Wang, Ruofei; Zhang, Yanchun] Guangzhou Univ, Cyberspace Inst Adv Technol, Guangzhou, Peoples R China; [Ruan, Chunyang] Shanghai Int Studies Univ, Sch Econ & Finance, Shanghai, Peoples R China; [Yang, Yun] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai 200071, Peoples R China; [Yang, Yun] Shanghai Municipal Hosp Tradit Chinese Med, Oncol Inst Tradit Chinese Med, Shanghai 200071, Peoples R China; [Wu, Yingpei; Zhang, Yanchun] Zhejiang Lab Regenerate Med Vis & Brain Hlth, Oujiang Lab, Wenzhou 325001, Zhejiang, Peoples R China	Fudan University; Guangzhou University; Shanghai International Studies University; Shanghai University of Traditional Chinese Medicine; Oujiang Laboratory	Ruan, CY (corresponding author), Shanghai Int Studies Univ, Sch Econ & Finance, Shanghai, Peoples R China.	cyruan16@fudan.edu.cn	Zhang, Zixuan/JSL-3603-2023		National Science Foundation of China [61672161]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Foundation of China (No. 61672161).	Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; [Anonymous], 2018, ARXIV180109030; [Anonymous], 2012, ARXIV12120975; [Anonymous], 2015, EVID BASED COMPLEMEN; Bach FR, 2006, J MACH LEARN RES, V7, P1713; Chaohan Pei, 2020, Web and Big Data. 4th International Joint Conference, APWeb-WAIM 2020. Lecture Notes in Computer Science (LNCS 12317), P748, DOI 10.1007/978-3-030-60259-8_55; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen C., 2004, Using Random Forest to Learn Imbalanced Data; Dembczynski K., 2010, P 27 INT C MACH LEAR, P279; Gonçalves EC, 2013, PROC INT C TOOLS ART, P469, DOI 10.1109/ICTAI.2013.76; Kubat M., 1997, P 14 INT C MACH LEAR, P179; Li CJ, 2020, IEEE INT C BIOINFORM, P1560, DOI 10.1109/BIBM49941.2020.9313476; Liu XY, 2009, IEEE T SYST MAN CY B, V39, P539, DOI 10.1109/TSMCB.2008.2007853; MA J, 2016, INT C P2P PAR GRID C, P157; Read J, 2015, PATTERN RECOGN, V48, P2096, DOI 10.1016/j.patcog.2015.01.004; Read J, 2011, MACH LEARN, V85, P333, DOI 10.1007/s10994-011-5256-5; Ruan CY, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P3346; Ruan CY, 2019, LECT NOTES COMPUT SC, V11448, P310, DOI 10.1007/978-3-030-18590-9_35; Ruan CY, 2017, IEEE INT C BIOINFORM, P417, DOI 10.1109/BIBM.2017.8217685; Sucar LE, 2014, PATTERN RECOGN LETT, V41, P14, DOI 10.1016/j.patrec.2013.11.007; Torre L A, 2015, A Cancer Journal for Clinicians, V65, P87; Tsoumakas G, 2007, LECT NOTES ARTIF INT, V4701, P406; Vaswani A, 2017, ADV NEUR IN, V30; Wu G., 2003, 20 INT C MACHINE LEA, P816; Xu Q, 2019, IEEE ACCESS, V7, P76167, DOI 10.1109/ACCESS.2019.2921318; Yao L, 2018, IEEE T KNOWL DATA EN, V30, P1007, DOI 10.1109/TKDE.2017.2787158; Zhang T, 2004, ANN STAT, V32, P56	27	3	3	6	25	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1386-145X	1573-1413		WORLD WIDE WEB	World Wide Web	MAY	2022	25	3			SI		1447	1468		10.1007/s11280-021-00981-5	http://dx.doi.org/10.1007/s11280-021-00981-5		DEC 2021	22	Computer Science, Information Systems; Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	1D5UO					2024-09-18	WOS:000728776900002
J	Jiménez, F; Martínez, C; Miralles-Pechuán, L; Sánchez, G; Sciavicco, G				Jimenez, Fernando; Martinez, Carlos; Miralles-Pechuan, Luis; Sanchez, Gracia; Sciavicco, Guido			Multi-Objective Evolutionary Rule-Based Classification with Categorical Data	ENTROPY			English	Article						multi-objective evolutionary algorithms; rule-based classifiers; interpretable machine learning; categorical data	ALGORITHMS; OPTIMIZATION; SYSTEMS; INTERPRETABILITY; PERFORMANCE; ACCURACY	The ease of interpretation of a classification model is essential for the task of validating it. Sometimes it is required to clearly explain the classification process of a model's predictions. Models which are inherently easier to interpret can be effortlessly related to the context of the problem, and their predictions can be, if necessary, ethically and legally evaluated. In this paper, we propose a novel method to generate rule-based classifiers from categorical data that can be readily interpreted. Classifiers are generated using a multi-objective optimization approach focusing on two main objectives: maximizing the performance of the learned classifier and minimizing its number of rules. The multi-objective evolutionary algorithms ENORA and NSGA-II have been adapted to optimize the performance of the classifier based on three different machine learning metrics: accuracy, area under the ROC curve, and root mean square error. We have extensively compared the generated classifiers using our proposed method with classifiers generated using classical methods such as PART, JRip, OneR and ZeroR. The experiments have been conducted in full training mode, in 10-fold cross-validation mode, and in train/test splitting mode. To make results reproducible, we have used the well-known and publicly available datasets Breast Cancer, Monk's Problem 2, Tic-Tac-Toe-Endgame, Car, kr-vs-kp and Nursery. After performing an exhaustive statistical test on our results, we conclude that the proposed method is able to generate highly accurate and easy to interpret classification models.	[Jimenez, Fernando; Martinez, Carlos; Sanchez, Gracia] Univ Murcia, Dept Informat & Commun Engn, E-30071 Murcia, Spain; [Miralles-Pechuan, Luis] Univ Coll Dublin, Ctr Appl Data Analyt Res CeADAR, Dublin D04 4, Ireland; [Sciavicco, Guido] Univ Ferrara, Dept Math & Comp Sci, I-44121 Ferrara, Italy	University of Murcia; University College Dublin; University of Ferrara	Jiménez, F (corresponding author), Univ Murcia, Dept Informat & Commun Engn, E-30071 Murcia, Spain.	fernan@um.es; carlos.martinez6@um.es; luis.miralles@ucd.ie; gracia@um.es; scvgdu@unife.it	Miralles, Luis/O-2472-2016; Cortés, Carlos/AAE-3949-2019; Jimenez, Fernando/AFG-8431-2022	Sanchez, Gracia/0000-0001-6408-5523; Martinez Cortes, Carlos/0000-0002-5029-3089; Sciavicco, Guido/0000-0002-9221-879X; Jimenez, Fernando/0000-0001-5844-4163	European Regional Development Fund (ERDF)	European Regional Development Fund (ERDF)(European Union (EU))	This study was partially supported by computing facilities of Extremadura Research Centre for Advanced Technologies (CETA-CIEMAT), funded by the European Regional Development Fund (ERDF). CETA-CIEMAT belongs to CIEMAT and the Government of Spain.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1023/A:1022689900470; [Anonymous], 2004, OPTIMIZATION THEORY; [Anonymous], 1991, Linear Programming, DOI DOI 10.1007/978-0-8176-4844-2; [Anonymous], 2016, PROC INT C ED DATA M; Antonelli M, 2017, IEEE T FUZZY SYST, V25, P249, DOI 10.1109/TFUZZ.2016.2578341; Bao CT, 2017, J COMPUT SCI-NETH, V23, P31, DOI 10.1016/j.jocs.2017.09.015; Bertsekas D. P., 1999, Nonlinear Programming; Bishop CM, 2006, PATTERN RECOGNITION, V1, DOI [DOI 10.1117/1, DOI 10.1117/1.2819119]; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Cano A., 2011, Proceedings of the 2011 11th International Conference on Intelligent Systems Design and Applications (ISDA), P325, DOI 10.1109/ISDA.2011.6121676; Coello CAC., 2002, Evolutionary Algorithms for Solving Multi-Objective Problems, DOI [DOI 10.1007/978-1-4757-5184-0, 10.1007/978-1-4757-5184-0]; Cohen WW, 1995, P 12 INT C MACH LEAR, P115, DOI [10.1016/B978-1-55860-377-6.50023-2, DOI 10.1016/B978-1-55860-377-6.50023-2]; Collette Y., 2004, Multiobjective Optimization: Principles and Case Studies, DOI [DOI 10.1007/978-3-662-08883-8, 10.1007/978-3-662-08883-8]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Davalo E., 1991, NEURAL NETWORKS; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, Multi-Objective Optimization Using Evolutionary Algorithms, VVolume16; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; Ducange P., 2017, P IEEE INT C FUZZ SY, P1; Ducange P, 2010, SOFT COMPUT, V14, P713, DOI 10.1007/s00500-009-0460-y; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Furnkranz Johannes, 1994, MACH LEARN P 1994, P70, DOI https://doi.org/10.1016/B978-1-55860-335-6.50017-9; Gacto MJ, 2011, INFORM SCIENCES, V181, P4340, DOI 10.1016/j.ins.2011.02.021; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gorzalczany MB, 2016, APPL SOFT COMPUT, V40, P206, DOI 10.1016/j.asoc.2015.11.037; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Ishibuchi H, 1997, FUZZY SET SYST, V89, P135, DOI 10.1016/S0165-0114(96)00098-X; Jiménez F, 2017, NEUROCOMPUTING, V234, P75, DOI 10.1016/j.neucom.2016.12.045; Jiménez F, 2013, J INTELL FUZZY SYST, V25, P441, DOI 10.3233/IFS-130651; Jiménez F, 2001, ADV SOFT COMP, P167; Jiménez F, 2002, IEEE C EVOL COMPUTAT, P1133, DOI 10.1109/CEC.2002.1004402; Jiménez F, 2017, EXPERT SYST, V34, DOI 10.1111/exsy.12173; Jiménez F, 2015, 2015 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (IEEE SSCI), P488, DOI 10.1109/SSCI.2015.78; Jiménez F, 2014, ARTIF INTELL MED, V60, P197, DOI 10.1016/j.artmed.2013.12.006; Jin YC, 2000, IEEE T FUZZY SYST, V8, P212, DOI 10.1109/91.842154; Carmona CJ, 2010, IEEE T FUZZY SYST, V18, P958, DOI 10.1109/TFUZZ.2010.2060200; Kohavi R, 1995, P 14 INT JOINT C ART, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; Liu H, 2015, STUD BIG DATA, V10, P245, DOI 10.1007/978-3-319-16829-6_10; Maros I., 1996, AAdvances in Linear and Integer Programming, P1; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michalski R. S., 1969, Proceedings of the 5th Yugoslavian international symposium of information processing, P125; Mukhopadhyay A, 2014, IEEE T EVOLUT COMPUT, V18, P4, DOI 10.1109/TEVC.2013.2290086; Mukhopadhyay A, 2014, IEEE T EVOLUT COMPUT, V18, P20, DOI 10.1109/TEVC.2013.2290082; Novak V., 2012, Mathematical principles of fuzzy logic; Quinlan J. R., 2014, C4.5: Programs for Machine Learning; Rajput A., 2011, International Journal of Computer Science and Security, P201; Rey MI, 2017, KNOWL-BASED SYST, V127, P67, DOI 10.1016/j.knosys.2016.12.028; Russell S., 2021, Artificial Intelligense: A Modern Appraoach, Global Edition, V4th; Sinha S.M., 2006, Mathematical Programming: Theory and Methods; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Sulzmann J., 2011, RULE STACKING APPROA, P323; Thrun S., MONKS PROBLEM 2 DATA; Thrun S B., 1991, The MONK's problems - a performance comparison of different learning algorithms; Witten IH, 2011, MOR KAUF D, P403, DOI 10.1016/B978-0-12-374856-0.00010-9; Zitzler E., 2000, Evolutionary Computation, V8, P173, DOI 10.1162/106365600568202; Zitzler E, 2003, IEEE T EVOLUT COMPUT, V7, P117, DOI 10.1109/TEVC.2003.810758	59	6	7	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1099-4300		ENTROPY-SWITZ	Entropy	SEP	2018	20	9							684	10.3390/e20090684	http://dx.doi.org/10.3390/e20090684			33	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	GY1YI	33265773	Green Submitted, gold, Green Published			2024-09-18	WOS:000448333000062
J	Song, KC; Zhou, YH				Song, Kuncheng; Zhou, Yi-Hui			C3NA: correlation and consensus-based cross-taxonomy network analysis for compositional microbial data	BMC BIOINFORMATICS			English	Article						Co-occurrence network analysis; Microbiome; R package; Consensus clustering; Module preservation analysis		Background Studying the co-occurrence network structure of microbial samples is one of the critical approaches to understanding the perplexing and delicate relationship between the microbe, host, and diseases. It is also critical to develop a tool for investigating co-occurrence networks and differential abundance analyses to reveal the disease-related taxa-taxa relationship. In addition, it is also necessary to tighten the co-occurrence network into smaller modules to increase the ability for functional annotation and interpretability of these taxa-taxa relationships. Also, it is critical to retain the phylogenetic relationship among the taxa to identify differential abundance patterns, which can be used to resolve contradicting functions reported by different studies. Results In this article, we present Correlation and Consensus-based Cross-taxonomy Network Analysis (C3NA), a user-friendly R package for investigating compositional microbial sequencing data to identify and compare co-occurrence patterns across different taxonomic levels. C3NA contains two interactive graphic user interfaces (Shiny applications), one of them dedicated to the comparison between two diagnoses, e.g., disease versus control. We used C3NA to analyze two well-studied diseases, colorectal cancer, and Crohn's disease. We discovered clusters of study and disease-dependent taxa that overlap with known functional taxa studied by other discovery studies and differential abundance analyses. Conclusion C3NA offers a new microbial data analyses pipeline for refined and enriched taxa-taxa co-occurrence network analyses, and the usability was further expanded via the built-in Shiny applications for interactive investigation.	[Song, Kuncheng; Zhou, Yi-Hui] North Carolina State Univ, Bioinformat Res Ctr, Biol Sci, Raleigh, NC 27695 USA	North Carolina State University	Zhou, YH (corresponding author), North Carolina State Univ, Bioinformat Res Ctr, Biol Sci, Raleigh, NC 27695 USA.	yihui_zhou@ncsu.edu	Zhou, Yi-Hui/Q-3004-2018; Song, Kuncheng/JFJ-4149-2023	Song, Kuncheng/0000-0002-8680-1970; Zhou, Yi-Hui/0000-0002-4092-7463	CFF [KNOWLE21XX0]; NSF [2133504]; Directorate For Engineering; Div Of Engineering Education and Centers [2133504] Funding Source: National Science Foundation	CFF; NSF(National Science Foundation (NSF)); Directorate For Engineering; Div Of Engineering Education and Centers(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study is partially supported by Dr. Zhou's start-up, CFF KNOWLE21XX0 and NSF 2133504.	Ai DM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00826; Bakhtiarizadeh MR, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00453; Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cao YP, 2019, J AM STAT ASSOC, V114, P759, DOI 10.1080/01621459.2018.1442340; Caparrós E, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1949096; Chen LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17840-y; Csardi G., 2022, Int. J. Complex Syst., V1695, P1; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Glassner KL, 2020, J ALLERGY CLIN IMMUN, V145, P16, DOI 10.1016/j.jaci.2019.11.003; Hale VL, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0586-6; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15258; Li J, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.841552; Lin H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17041-7; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Mallick H, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009442; Mancabelli L, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix153; McGregor K, 2020, BIOINFORMATICS, V36, P1840, DOI 10.1093/bioinformatics/btz824; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mo ZC, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00138-20; Mori G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28671-9; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nearing JT, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28034-z; Nearing JT., bioRxiv, DOI DOI 10.1101/2021.05.10.443486; Olovo CV, 2021, J CELL MOL MED, V25, P10783, DOI 10.1111/jcmm.17010; Pearson K., 2022, R SOC LOND P, V60, P489; Peschel S, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa290; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ricanek P, 2012, CLIN EXP GASTROENTER, V5, P173, DOI 10.2147/CEG.S33858; Saus E, 2019, MOL ASPECTS MED, V69, P93, DOI 10.1016/j.mam.2019.05.001; Sobhani I, 2019, P NATL ACAD SCI USA, V116, P24285, DOI 10.1073/pnas.1912129116; Strehl A., 2022, J MACH LEARN RES, V3, P583; Sultan S, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.715506; Vacca M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040573; Wu YD, 2021, NAT COMMUN, V12, DOI [10.1038/s41467-021-21280-7, 10.1038/s41467-021-23265-y]; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang Q, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01938-w	46	1	1	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	NOV 8	2022	23	1							468	10.1186/s12859-022-05027-9	http://dx.doi.org/10.1186/s12859-022-05027-9			16	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	6A0JI	36348267	gold, Green Published			2024-09-18	WOS:000880348900002
J	Lin, JY; Trinquart, L				Lin, Jingyi; Trinquart, Ludovic			Doubly-robust estimator of the difference in restricted mean times lost with competing risks data	STATISTICAL METHODS IN MEDICAL RESEARCH			English	Article						Restricted mean times lost; competing risks; pseudo-observations; inverse-probability-weighting; fine-gray model; doubly-robust estimator	PROPENSITY SCORE; SURVIVAL-TIME; PROPORTIONAL-HAZARDS; PSEUDO-OBSERVATIONS; CAUSAL INFERENCE; LIFE; ADJUSTMENT; MODELS	In the context of competing risks data, the subdistribution hazard ratio has limited clinical interpretability to measure treatment effects. An alternative is the difference in restricted mean times lost (RMTL), which gives the mean time lost to a specific cause of failure between treatment groups. In non-randomized studies, the average causal effect is conventionally used for decision-making about treatment and public health policies. We show how the difference in RMTL can be estimated by contrasting the integrated cumulative incidence functions from a Fine-Gray model. We also show how the difference in RMTL can be estimated by using inverse probability of treatment weighting and contrasts between weighted non-parametric estimators of the area below the cumulative incidence. We use pseudo-observation approaches to estimate both component models and we integrate them into a doubly-robust estimator. We demonstrate that this estimator is consistent when either component is correctly specified. We conduct simulation studies to assess its finite-sample performance and demonstrate its inherited consistency property from its component models. We also examine the performance of this estimator under varying degrees of covariate overlap and under a model misspecification of nonlinearity. We apply the proposed method to assess biomarker-treatment interaction in subpopulations of the POPLAR and OAK randomized controlled trials of second-line therapy for advanced non-small-cell lung cancer.	[Lin, Jingyi; Trinquart, Ludovic] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Trinquart, Ludovic] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Trinquart, Ludovic] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA	Boston University; Tufts Medical Center; Tufts University	Lin, JY (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	jl705@bu.edu	Lin, Jingyi/KXR-5008-2024; Trinquart, Ludovic/H-4961-2019	Trinquart, Ludovic/0000-0002-3028-4900; Lin, Jingyi/0000-0002-1501-7660				Andersen PK, 2013, STAT MED, V32, P5278, DOI 10.1002/sim.5903; Andersen PK, 2017, STAT MED, V36, P2669, DOI 10.1002/sim.7297; Andersen PK, 2004, LIFETIME DATA ANAL, V10, P335, DOI 10.1007/s10985-004-4771-0; Andersen PK, 2003, BIOMETRIKA, V90, P15, DOI 10.1093/biomet/90.1.15; Austin PC, 2021, STAT MED, V40, P4200, DOI 10.1002/sim.9023; Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Binder N, 2014, LIFETIME DATA ANAL, V20, P303, DOI 10.1007/s10985-013-9247-7; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Cai WX, 2020, BIOMETRICS, V76, P722, DOI 10.1111/biom.13172; Chatton A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65917-x; Chen PY, 2001, BIOMETRICS, V57, P1030, DOI 10.1111/j.0006-341X.2001.01030.x; Conner SC, 2021, STAT MED, V40, P2177, DOI 10.1002/sim.8896; Conner SC, 2019, STAT MED, V38, P3832, DOI 10.1002/sim.8206; Díaz I, 2019, LIFETIME DATA ANAL, V25, P439, DOI 10.1007/s10985-018-9428-5; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Gandara DR, 2018, NAT MED, V24, P1441, DOI 10.1038/s41591-018-0134-3; Graw F, 2009, LIFETIME DATA ANAL, V15, P241, DOI 10.1007/s10985-008-9107-z; Hernan MA., 2021, CAUSAL INFERENCE WHA; Hu LY, 2021, STAT MED, V40, P4691, DOI 10.1002/sim.9090; Jazic I, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw154; Kang JDY, 2007, STAT SCI, V22, P523, DOI 10.1214/07-STS227; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KARRISON T, 1987, J AM STAT ASSOC, V82, P1169, DOI 10.2307/2289396; Karrison T, 2018, CLIN TRIALS, V15, P178, DOI 10.1177/1740774518759281; Keil AP, 2018, AM J EPIDEMIOL, V187, P891, DOI 10.1093/aje/kwx385; Klein JP, 2008, COMPUT METH PROG BIO, V89, P289, DOI 10.1016/j.cmpb.2007.11.017; Li F, 2018, J AM STAT ASSOC, V113, P390, DOI 10.1080/01621459.2016.1260466; Lok JJ, 2018, LIFETIME DATA ANAL, V24, P201, DOI 10.1007/s10985-017-9393-4; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Morris TP, 2019, STAT MED, V38, P2074, DOI 10.1002/sim.8086; Mozumder SI, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-021-01213-0; Overgaard M, 2017, ANN STAT, V45, P1988, DOI 10.1214/16-AOS1516; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; RUBIN DB, 1978, ANN STAT, V6, P34, DOI 10.1214/aos/1176344064; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Suzukawa A, 2002, J JPN STAT SOC, V32, P77, DOI [10.14490/jjss.32.77, DOI 10.14490/JJSS.32.77]; Tian L, 2020, BIOMETRICS, V76, P1157, DOI 10.1111/biom.13237; Tian L, 2014, BIOSTATISTICS, V15, P222, DOI 10.1093/biostatistics/kxt050; Trinquart L, 2016, J CLIN ONCOL, V34, P1813, DOI 10.1200/JCO.2015.64.2488; Uno H, 2014, J CLIN ONCOL, V32, P2380, DOI 10.1200/JCO.2014.55.2208; VanderWeele TJ, 2011, ANN INTERN MED, V154, P680, DOI 10.7326/0003-4819-154-10-201105170-00008; Wang X, 2018, LIFETIME DATA ANAL, V24, P176, DOI 10.1007/s10985-017-9391-6; Weir IR, 2019, ANN ONCOL, V30, P96, DOI 10.1093/annonc/mdy462; Zhang M, 2012, BIOMETRICS, V68, P999, DOI 10.1111/j.1541-0420.2012.01759.x; Zhao LH, 2018, JAMA CARDIOL, V3, P357, DOI 10.1001/jamacardio.2018.0127; Zucker DM, 1998, J AM STAT ASSOC, V93, P702, DOI 10.2307/2670120	52	3	3	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0962-2802	1477-0334		STAT METHODS MED RES	Stat. Methods Med. Res.	OCT	2022	31	10					1881	1903	09622802221102625	10.1177/09622802221102625	http://dx.doi.org/10.1177/09622802221102625		MAY 2022	23	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Mathematics	4Z0US	35607287				2024-09-18	WOS:000803976700001
J	Afshar, P; Oikonomou, A; Naderkhani, F; Tyrrell, PN; Plataniotis, KN; Farahani, K; Mohammadi, A				Afshar, Parnian; Oikonomou, Anastasia; Naderkhani, Farnoosh; Tyrrell, Pascal N.; Plataniotis, Konstantinos N.; Farahani, Keyvan; Mohammadi, Arash			3D-MCN: A 3D Multi-scale Capsule Network for Lung Nodule Malignancy Prediction	SCIENTIFIC REPORTS			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; IMAGES; INFORMATION	Despite the advances in automatic lung cancer malignancy prediction, achieving high accuracy remains challenging. Existing solutions are mostly based on Convolutional Neural Networks (CNNs), which require a large amount of training data. Most of the developed CNN models are based only on the main nodule region, without considering the surrounding tissues. Obtaining high sensitivity is challenging with lung nodule malignancy prediction. Moreover, the interpretability of the proposed techniques should be a consideration when the end goal is to utilize the model in a clinical setting. Capsule networks (CapsNets) are new and revolutionary machine learning architectures proposed to overcome shortcomings of CNNs. Capitalizing on the success of CapsNet in biomedical domains, we propose a novel model for lung tumor malignancy prediction. The proposed framework, referred to as the 3D Multi-scale Capsule Network (3D-MCN), is uniquely designed to benefit from: (i) 3D inputs, providing information about the nodule in 3D; (ii) Multi-scale input, capturing the nodule's local features, as well as the characteristics of the surrounding tissues, and; (iii) CapsNet-based design, being capable of dealing with a small number of training samples. The proposed 3D-MCN architecture predicted lung nodule malignancy with a high accuracy of 93.12%, sensitivity of 94.94%, area under the curve (AUC) of 0.9641, and specificity of 90% when tested on the LIDC-IDRI dataset. When classifying patients as having a malignant condition (i.e., at least one malignant nodule is detected) or not, the proposed model achieved an accuracy of 83%, and a sensitivity and specificity of 84% and 81% respectively.	[Afshar, Parnian; Naderkhani, Farnoosh; Mohammadi, Arash] Concordia Inst Informat Syst Engn, Montreal, PQ, Canada; [Oikonomou, Anastasia] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada; [Tyrrell, Pascal N.] Univ Toronto, Dept Med Imaging, Dept Stat Sci, Toronto, ON, Canada; [Plataniotis, Konstantinos N.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Farahani, Keyvan] Natl Canc Inst NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD USA	University of Toronto; Sunnybrook Research Institute; Sunnybrook Health Science Center; University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mohammadi, A (corresponding author), Concordia Inst Informat Syst Engn, Montreal, PQ, Canada.	arash.monammadi@concordia.ca	Tyrrell, Pascal/GWC-6317-2022	Tyrrell, Pascal/0000-0003-2277-3824	Natural Sciences and Engineering Research Council (NSERC) of Canada through the NSERC [RGPIN 2019 06966]	Natural Sciences and Engineering Research Council (NSERC) of Canada through the NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partially supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada through the NSERC Discovery Grant RGPIN 2019 06966.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Afshar P, 2019, INT CONF ACOUST SPEE, P1368, DOI 10.1109/ICASSP.2019.8683759; Afshar P, 2019, IEEE SIGNAL PROC MAG, V36, P132, DOI 10.1109/MSP.2019.2900993; Afshar P, 2018, IEEE IMAGE PROC, P3129, DOI 10.1109/ICIP.2018.8451379; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Brosch T., 2015, LECT NOTES COMPUTER, P9351; Causey JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27569-w; Cha KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09315-w; Chaddad A, 2018, MED BIOL ENG COMPUT, V56, P2287, DOI 10.1007/s11517-018-1858-4; Chen CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192002; Chollet F., 2015, Keras; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Coroller TP, 2016, RADIOTHER ONCOL, V119, P480, DOI 10.1016/j.radonc.2016.04.004; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Hao J, 2012, IEEE ICC; Huynh E, 2016, RADIOTHER ONCOL, V120, P258, DOI 10.1016/j.radonc.2016.05.024; Jacobs C, 2014, MED IMAGE ANAL, V18, P374, DOI 10.1016/j.media.2013.12.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kumar D, 2017, LECT NOTES COMPUT SC, V10317, P54, DOI 10.1007/978-3-319-59876-5_7; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lao JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10649-8; Li Z., 2017, Sci. Rep, V7, P1, DOI DOI 10.1038/S41598-017-05225-Z; Liu K, 2017, INT J IMAG SYST TECH, V27, P12, DOI 10.1002/ima.22206; Nibali A, 2017, INT J COMPUT ASS RAD, V12, P1799, DOI 10.1007/s11548-017-1605-6; Oakden-Rayner L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01931-w; Oikonomou A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22357-y; Park JE, 2019, KOREAN J RADIOL, V20, P1124, DOI 10.3348/kjr.2018.0070; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Sabour S., 2017, Advances in Neural Information Processing Systems, (NIPS), P3856, DOI DOI 10.5555/3294996.3295142; Shen W, 2017, PATTERN RECOGN, V61, P663, DOI 10.1016/j.patcog.2016.05.029; Siegel R L, 2016, J CLIN, V66, P7; Sudre C. H., 2017, LECT NOTES COMPUTER, P10553; Sun WB, 2016, IEEE ICC, DOI 10.1109/ICC.2016.7511076; Tafti AP, 2018, IEEE INT CONF HEALT, P412, DOI 10.1109/ICHI.2018.00078; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; XIE Y, 2016, LECT NOTES COMPUTER, P87; Yamashita R, 2018, INSIGHTS IMAGING, V9, P611, DOI 10.1007/s13244-018-0639-9; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhang YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46349	42	35	37	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAY 14	2020	10	1							7948	10.1038/s41598-020-64824-5	http://dx.doi.org/10.1038/s41598-020-64824-5			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA8AX	32409715	gold, Green Published			2024-09-18	WOS:000560040700005
J	Yui, K; Imataka, G; Shiohama, T				Yui, Kunio; Imataka, George; Shiohama, Tadashi			Lipid Peroxidation of the Docosahexaenoic Acid/Arachidonic Acid Ratio Relating to the Social Behaviors of Individuals with Autism Spectrum Disorder: The Relationship with Ferroptosis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						autistic social behavior; arachidonic acid; docosahexaenoic acid ferroptosis; lipid peroxidation; malondialdehyde-modified low-density lipoprotein	POLYUNSATURATED FATTY-ACIDS; OXIDATIVE STRESS; ANTIOXIDANT ENZYMES; SEX-DIFFERENCES; DHA; SUPPLEMENTATION; CHILDREN; LIPOPROTEINS; BIOMARKERS; CANCER	Polyunsaturated fatty acids (PUFAs) undergo lipid peroxidation and conversion into malondialdehyde (MDA). MDA reacts with acetaldehyde to form malondialdehyde-modified low-density lipoprotein (MDA-LDL). We studied unsettled issues in the association between MDA-LDL and the pathophysiology of ASD in 18 individuals with autism spectrum disorders (ASD) and eight age-matched controls. Social behaviors were assessed using the social responsiveness scale (SRS). To overcome the problem of using small samples, adaptive Lasso was used to enhance the interpretability accuracy, and a coefficient of variation was used for variable selections. Plasma levels of the MDA-LDL levels (91.00 +/- 16.70 vs. 74.50 +/- 18.88) and the DHA/arachidonic acid (ARA) ratio (0.57 +/- 0.16 vs. 0.37 +/- 0.07) were significantly higher and the superoxide dismutase levels were significantly lower in the ASD group than those in the control group. Total SRS scores in the ASD group were significantly higher than those in the control group. The unbeneficial DHA/ARA ratio induced ferroptosis via lipid peroxidation. Multiple linear regression analysis and adaptive Lasso revealed an association of the DHA/ARA ratio with total SRS scores and increased MDA-LDL levels in plasma, resulting in neuronal deficiencies. This unbeneficial DHA/ARA-ratio-induced ferroptosis contributes to autistic social behaviors and is available for therapy.	[Yui, Kunio; Shiohama, Tadashi] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba 2608677, Japan; [Yui, Kunio; Imataka, George] Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi 3210293, Japan	Chiba University; Dokkyo Medical University	Yui, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Pediat, Chiba 2608677, Japan.; Yui, K (corresponding author), Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi 3210293, Japan.	yui16@bell.ocn.ne.jp; geo@dokkyomed.ac.jp; asuha_hare@chiba-u.jp	Imataka, George/AIC-1442-2022	Imataka, George/0000-0002-7691-0460; Shiohama, Tadashi/0000-0003-0076-5882	The authors thank Yuki Shiko (Chiba Universty Hospital Clinical Research Center) for his conducting of adaptive Lasso.	The authors thank Yuki Shiko (Chiba Universty Hospital Clinical Research Center) for his conducting of adaptive Lasso.	The authors thank Yuki Shiko (Chiba Universty Hospital Clinical Research Center) for his conducting of adaptive Lasso.	Afif IY, 2022, BIOENGINEERING-BASEL, V9, DOI 10.3390/bioengineering9020048; Al-Gadani Y, 2009, CLIN BIOCHEM, V42, P1032, DOI 10.1016/j.clinbiochem.2009.03.011; Alic L, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1010893; Altun H, 2018, PSYCHIAT CLIN PSYCH, V28, P408, DOI 10.1080/24750573.2018.1470360; An JR, 2022, NEUROCHEM RES, V47, P279, DOI 10.1007/s11064-021-03442-7; Asperti M, 2021, FREE RADICAL BIO MED, V169, P294, DOI 10.1016/j.freeradbiomed.2021.04.024; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Baliga K, 2022, BMC MED EDUC, V22, DOI 10.1186/s12909-022-03697-w; Beggiato A, 2017, AUTISM RES, V10, P680, DOI 10.1002/aur.1715; Brouwers H, 2020, J IMMUNOL, V205, P2840, DOI 10.4049/jimmunol.1801653; Childress AC, 2018, J CHILD ADOL PSYCHOP, V28, P606, DOI 10.1089/cap.2018.0057; Cho S, 2023, MOL AUTISM, V14, DOI 10.1186/s13229-023-00545-6; Constantino J.H., 2012, Western Psychological Services; Davis DJ, 2017, BRAIN BEHAV IMMUN, V59, P38, DOI 10.1016/j.bbi.2016.09.003; Davis-Bruno K, 2011, BIRTH DEFECTS RES B, V92, P240, DOI 10.1002/bdrb.20311; de Souza I, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23136879; Delesderrier Emilia, 2023, Cell Physiol Biochem, V57, P24, DOI 10.33594/000000620; Dierge E, 2021, CELL METAB, V33, P1701, DOI 10.1016/j.cmet.2021.05.016; Dziobek I, 2007, PSYCHIAT RES, V149, P321, DOI 10.1016/j.psychres.2006.02.003; Fourchet F, 2013, PHYS THER SPORT, V14, P28, DOI 10.1016/j.ptsp.2012.02.004; Frackowiak J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-61; Gao Y D, 2021, Beijing Da Xue Xue Bao Yi Xue Ban, V53, P1107; Gomez-Gomez A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23063219; Gonzalez-Fraguela ME, 2012, FREE RADICAL BIO MED, V53, pS21, DOI 10.1016/j.freeradbiomed.2012.10.048; Greene RK, 2019, BIOL PSYCHOL, V142, P1, DOI 10.1016/j.biopsycho.2018.12.008; Hashimoto M, 2009, J NUTR BIOCHEM, V20, P965, DOI 10.1016/j.jnutbio.2008.08.009; Hoffman DR, 2009, PROSTAG LEUKOTR ESS, V81, P151, DOI 10.1016/j.plefa.2009.05.003; Huun MU, 2018, J PERINAT MED, V46, P209, DOI 10.1515/jpm-2016-0334; Ismail E.A. R., 2015, Journal of Multidisciplinary Engineering Science and Technology, V2, P388; Ji M, 2011, CLIN CHEM LAB MED, V49, P2021, DOI 10.1515/CCLM.2011.669; Ji Y, 2023, FRONT PSYCHIATRY, V14, DOI 10.3389/fpsyt.2023.1151596; Kitano S, 2004, ANAL CHIM ACTA, V509, P229, DOI 10.1016/j.aca.2003.12.040; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Krombach T, 2020, J AUTISM DEV DISORD, V50, P551, DOI 10.1007/s10803-019-04283-8; Lawrence GD, 2021, ADV NUTR, V12, P647, DOI 10.1093/advances/nmab013; Lee JY, 2020, P NATL ACAD SCI USA, V117, P32433, DOI 10.1073/pnas.2006828117; Li J, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/3999083; Li MW, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24032203; Liao YL, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15111440; Lichou F, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0235-1; Liu H, 2023, ARCH BIOCHEM BIOPHYS, V734, DOI 10.1016/j.abb.2022.109488; Liu L, 2022, BIOCHEM BIOPH RES CO, V623, P1, DOI 10.1016/j.bbrc.2022.07.041; Liu LC, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.911119; Liu Q, 2017, REPROD FERT DEVELOP, V29, P940, DOI [10.1071/RD15424, 10.1071/rd15424]; Liu Q, 2018, CELL PHYSIOL BIOCHEM, V50, P1245, DOI 10.1159/000494579; Liu XK, 2022, FRONT PSYCHIATRY, V13, DOI 10.3389/fpsyt.2022.813304; Marimunti M, 2007, MOL CELL BIOCHEM, V298, P161, DOI 10.1007/s11010-006-9362-9; McAnulty SR, 2010, MED SCI SPORT EXER, V42, P1704, DOI 10.1249/MSS.0b013e3181d85bd1; Meguid NA, 2011, BIOL TRACE ELEM RES, V143, P58, DOI 10.1007/s12011-010-8840-9; Metherel AH, 2021, LIPIDS, V56, P211, DOI 10.1002/lipd.12291; Moll I, 2021, EUR J PAEDIATR NEURO, V32, P56, DOI 10.1016/j.ejpn.2021.03.010; Mortensen MS, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12050804; Mu HS, 2023, CELL BIOCHEM BIOPHYS, V81, P285, DOI 10.1007/s12013-023-01134-3; Mu YW, 2022, CHEMOSPHERE, V291, DOI 10.1016/j.chemosphere.2021.132944; Nababan SHH, 2017, ARCH BIOCHEM BIOPHYS, V623, P64, DOI 10.1016/j.abb.2017.04.009; Nieradko-Iwanicka B, 2022, BIOMED PHARMACOTHER, V156, DOI 10.1016/j.biopha.2022.113785; Ogawa K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005455; Okuda M, 2009, J NUTR SCI VITAMINOL, V55, P231, DOI 10.3177/jnsv.55.231; Ornoy A, 2019, NEUROTOXICOL TERATOL, V71, P64, DOI 10.1016/j.ntt.2018.01.005; Ozturk OH, 2010, J PHYSIOL BIOCHEM, V66, P205, DOI 10.1007/s13105-010-0025-7; Packiasabapathy S, 2020, BMC ANESTHESIOL, V20, DOI 10.1186/s12871-020-00972-5; Park MW, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101947; Sakayori N, 2016, STEM CELLS, V34, P470, DOI 10.1002/stem.2246; Sarajlic P, 2023, NUTR METAB CARDIOVAS, V33, P1206, DOI 10.1016/j.numecd.2023.03.007; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Shahmirzai Reza, 2017, Acta Med Iran, V55, P612; Shortreed SM, 2017, BIOMETRICS, V73, P1111, DOI 10.1111/biom.12679; Simundic AM, 2014, CLIN CHIM ACTA, V432, P33, DOI 10.1016/j.cca.2013.11.008; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Sipsock D, 2021, AUTISM RES, V14, P2524, DOI 10.1002/aur.2625; Stalenhoef AFH, 2008, CURR OPIN LIPIDOL, V19, P355, DOI 10.1097/MOL.0b013e328304b63c; Wahid A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183518; Walker CG, 2014, BRIT J NUTR, V111, P679, DOI 10.1017/S0007114513002985; Wang YW, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24129835; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; White-Springer SH, 2021, J ANIM SCI, V99, DOI 10.1093/jas/skab177; Yang B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00642; Yang F, 2023, ANAL CHEM, V95, P12514, DOI 10.1021/acs.analchem.3c02462; Yang L, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-05070-7; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yui K, 2017, ENVIRON SCI POLLUT R, V24, P9635, DOI 10.1007/s11356-017-8595-3; Zhang H, 2023, FRONT ONCOL, V13, DOI 10.3389/fonc.2023.1098357; Zheng JS, 2019, AM J CLIN NUTR, V109, P1527, DOI 10.1093/ajcn/nqz030; Zoroglu SS, 2004, EUR ARCH PSY CLIN N, V254, P143, DOI 10.1007/s00406-004-0456-7	84	1	1	4	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-6596	1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2023	24	19							14796	10.3390/ijms241914796	http://dx.doi.org/10.3390/ijms241914796			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	U2VY6	37834244	Green Published, gold			2024-09-18	WOS:001083442600001
J	Holton, M; Ellis, J; Anderson, E				Holton, Michael; Ellis, Jennifer; Anderson, Evan			Authors' response to the letter to the editor on "characterization of asbestos exposures associated with the use of facial makeups" RESPONSE	RISK ANALYSIS			English	Letter							TALC MINERS; CLEAVAGE FRAGMENTS; LUNG-CANCER; MESOTHELIOMA; NONASBESTOS; MORTALITY; MILLERS; UPDATE	We appreciate the opportunity to respond to the comments of the letter writer. The writer states in his Letter to the Editor that the findings in our publication are not interpretable and/or cannot be generalized due to the lack of understanding of the source mine and bulk content of the cosmetic talc used in the facial makeups. In brief, we performed an exposure simulation study using established industrial hygiene methods, planned and conducted by Certified Industrial Hygienists (CIHs), to assess asbestos exposures during the use of facial makeups that were found to contain very low levels of asbestos below the conventional detection limits of X-ray diffraction and polarized light microscopy. In total, 54 personal air samples and 72 area samples were collected from six different products. Out of the 126 samples collected and analyzed, asbestos was only found in eight samples (five personal samples and three area samples). A 95th percentile 24-h time-weighted average (TWA) result of 0.00008 fibers/cubic centimeter was calculated based on censored data and an assumed three applications per day. We believe these results may be of utility to understand the risk of low-level asbestos content in facial makeups regardless of source or bulk content, as described in our study, and do not find the writer's assertion of generalizability or interpretability to be compelling reasons not to apply our results, as is, for prospective purposes.	[Holton, Michael; Ellis, Jennifer; Anderson, Evan] Ramboll US Consulting, Princeton, NJ USA; [Holton, Michael] Michael Holton, Ramboll US Consulting, Princeton, NJ USA		Holton, M (corresponding author), Michael Holton, Ramboll US Consulting, Princeton, NJ USA.	mholton@ramboll.com						Addison J., 2000, REGUL TOXICOL PHARM, V44; Addison J, 2008, REGUL TOXICOL PHARM, V52, pS187, DOI 10.1016/j.yrtph.2007.10.001; [Anonymous], 2011, CURRENT INTELLIGENCE; [Anonymous], 1993, METHOD DETERMINATION; [Anonymous], 1984, ASB FIB NON HLTH RIS, DOI DOI 10.17226/509; Berman DW, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802276167; Boffetta P, 2018, TOXICOL APPL PHARM, V361, P100, DOI 10.1016/j.taap.2018.09.021; Campbell W.J., 1977, SELECTED SILICATE MI, V8751 of; Ciocan C, 2022, ENVIRON RES, V203, DOI 10.1016/j.envres.2021.111865; Coggiola M, 2003, AM J IND MED, V44, P63, DOI 10.1002/ajim.10240; Dell LD, 2021, RISK ANAL, V41, P1674, DOI 10.1111/risa.13673; FDA, 2022, TALC; Gamble JF, 2008, REGUL TOXICOL PHARM, V52, pS154, DOI 10.1016/j.yrtph.2007.09.020; Garabrant DH, 2018, TOXICOL APPL PHARM, V361, P127, DOI 10.1016/j.taap.2018.07.003; Ierardi AM, 2022, INHAL TOXICOL, V34, P135, DOI 10.1080/08958378.2022.2053251; Ilgren EB., 2017, ENVIRON POLLUT, V6, P6, DOI DOI 10.5539/EP.V6N2P6; Keeton KA, 2018, RISK ANAL, V38, P1524, DOI 10.1111/risa.13169; Kominsky J.R., 1993, EVALUATION 3 CLEANIN; Korchevskiy AA, 2022, INHAL TOXICOL, V34, P24, DOI 10.1080/08958378.2021.2024304; Lee R, 2015, INT J OCCUP ENV HEAL, V21, P337, DOI 10.1080/10773525.2015.1122370; Longo W.E., 2019, MAS 2019; Marsh GM, 2019, INHAL TOXICOL, V31, P213, DOI 10.1080/08958378.2019.1645768; Mossman BT, 2008, REGUL TOXICOL PHARM, V52, pS200, DOI 10.1016/j.yrtph.2007.10.004; Occupational Safety and Health Administration (OSHA), 1992, FED REGISTER, V57, P24310; OSHA, 1994, FED REGISTER, V59, P40964; Pira E, 2017, J OCCUP ENVIRON MED, V59, P659, DOI 10.1097/JOM.0000000000000992; ROHL AN, 1976, J TOXICOL ENV HEALTH, V2, P255, DOI 10.1080/15287397609529432; Rohl AN., 1979, Dusts and disease, P393; RUBINO GF, 1976, J OCCUP ENVIRON MED, V18, P186, DOI 10.1097/00043764-197603000-00013; Rubino GF., 1979, DUSTS DIS, P357; Strohmeier BR, 2010, INT GEOL REV, V52, P801, DOI 10.1080/00206811003679836; USP, 2020, TALC ROUNDT PAN DISC; Van Orden DR, 2008, INDOOR BUILT ENVIRON, V17, P58, DOI 10.1177/1420326X07087006; Weill D, 2018, TOXICOL APPL PHARM, V361, P1, DOI 10.1016/j.taap.2018.11.005; WHO, 2010, IARC MONOG EVAL CARC, V95, P9; Williams C, 2013, ENVIRON GEOCHEM HLTH, V35, P357, DOI 10.1007/s10653-012-9500-0; WYLIE AG, 1985, AM IND HYG ASSOC J, V46, P197, DOI 10.1080/15298668591394653; Wylie AG, 2020, J APPL TOXICOL, V40, P515, DOI 10.1002/jat.3923; Zolondick AA, 2021, PRECIS CANC MED, V4, P27, DOI DOI 10.21037/PCM-21-12	39	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4332	1539-6924		RISK ANAL	Risk Anal.	OCT	2022	42	10					2142	2144		10.1111/risa.14012	http://dx.doi.org/10.1111/risa.14012			3	Public, Environmental & Occupational Health; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Mathematics; Mathematical Methods In Social Sciences	6G6TE	36377135				2024-09-18	WOS:000884884700005
J	Kang, SS; Chen, ZY; Li, LQ; Lu, W; Qi, XS; Tan, S				Kang, Susu; Chen, Zhiyuan; Li, Laquan; Lu, Wei; Qi, X. Sharon; Tan, Shan			Learning feature fusion via an interpretation method for tumor segmentation on PET/CT	APPLIED SOFT COMPUTING			English	Article						Tumor segmentation; PET/CT images; Feature fusion; Network interpretation; Deep learning	IMAGES	Accurate tumor segmentation of multi-modality PET/CT images plays a vital role in computer-aided cancer diagnosis and treatment. It is crucial to rationally fuse the complementary information in multi-modality PET/CT segmentation. However, existing methods usually lack interpretability and fail to sufficiently identify and aggregate critical information from different modalities. In this study, we proposed a novel segmentation framework that incorporated an interpretation module into the multi-modality segmentation backbone. The interpretation module highlighted critical features from each modality based on their contributions to the segmentation performance. To provide explicit supervision for the interpretation module, we introduced a novel interpretation loss with two fusion schemes: strengthened fusion and perturbed fusion. The interpretation loss guided the interpretation module to focus on informative features, enhancing its effectiveness in generating meaningful interpretable masks. Under the guidance of the interpretation module, the proposed approach can fully exploit meaningful features from each modality, leading to better integration of multi-modality information and improved segmentation performance. Ablative and comparative experiments were conducted on two PET/CT tumor segmentation datasets. The proposed approach surpassed the baseline by 1.4 and 1.8 Dices on two datasets, respectively, indicating the improvement achieved by the interpretation method. Furthermore, the proposed approach outperformed the best comparison approach by 0.9 and 0.6 Dices on two datasets, respectively. In addition, visualization and perturbation experiments further illustrated the effectiveness of the interpretation method in highlighting critical features.	[Kang, Susu; Chen, Zhiyuan; Tan, Shan] Huazhong Univ Sci & Technol, Sch Artificial Intelligence & Automat, Key Lab Image Informat Proc & Intelligent Control, Minist Educ China, 1037 Luo Yu Rd, Wuhan 430074, Hubei, Peoples R China; [Li, Laquan] Chongqing Univ Posts & Telecommun, Sch Sci, 2 Chong Wen Rd, Chongqing 400065, Peoples R China; [Lu, Wei] Mem Sloan Kettering Canc Ctr, Dept Med Phys, 1275 York Ave, New York, NY 10065 USA; [Qi, X. Sharon] Univ Calif Los Angeles, Sch Med, Dept Radiat Oncol, 10833 Le Conte Ave, Los Angeles, CA 90001 USA; [Kang, Susu] Huazhong Univ Sci & Technol, Innovat Inst, 1037 Luo Yu Rd, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Chongqing University of Posts & Telecommunications; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Huazhong University of Science & Technology	Tan, S (corresponding author), Huazhong Univ Sci & Technol, Sch Artificial Intelligence & Automat, Key Lab Image Informat Proc & Intelligent Control, Minist Educ China, 1037 Luo Yu Rd, Wuhan 430074, Hubei, Peoples R China.	shantan@hust.edu.cn	Chen, Zhiyuan/ABQ-8641-2022	Kang, Susu/0000-0003-2619-7836; Qi, xiangrong/0000-0002-8112-6830	National Natural Sci-ence Foundation of China [61672253, 61901074, 62071197]	National Natural Sci-ence Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Sci-ence Foundation of China under Grants 61672253, 61901074 and 62071197.	Chen H, 2018, NEUROIMAGE, V170, P446, DOI 10.1016/j.neuroimage.2017.04.041; Dabkowski P, 2017, ADV NEUR IN, V30; Dewalle-Vignion AS, 2011, IEEE T MED IMAGING, V30, P409, DOI 10.1109/TMI.2010.2083681; Diao ZS, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/ac299a; El Naqa I, 2007, MED PHYS, V34, P4738, DOI 10.1118/1.2799886; Fong RC, 2017, IEEE I CONF COMP VIS, P3449, DOI 10.1109/ICCV.2017.371; Fu XH, 2021, IEEE J BIOMED HEALTH, V25, P3507, DOI 10.1109/JBHI.2021.3059453; Gatidis S, 2022, SCI DATA, V9, DOI 10.1038/s41597-022-01718-3; Han DF, 2011, LECT NOTES COMPUT SC, V6801, P245, DOI 10.1007/978-3-642-22092-0_21; Hatt M, 2009, IEEE T MED IMAGING, V28, P881, DOI 10.1109/TMI.2008.2012036; He XY, 2023, SIMUL MODEL PRACT TH, V126, DOI 10.1016/j.simpat.2023.102769; Hoyer L, 2019, ADV NEUR IN, V32; Huang L, 2022, LECT NOTES COMPUT SC, V13435, P401, DOI 10.1007/978-3-031-16443-9_39; Ju W, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2488902; Kingma D. P., 2017, arXiv; Koker T, 2021, IEEE IMAGE PROC, P394, DOI 10.1109/ICIP42928.2021.9506345; Kumar A, 2020, IEEE T MED IMAGING, V39, P204, DOI 10.1109/TMI.2019.2923601; Lelandais B, 2014, MED IMAGE ANAL, V18, P1247, DOI 10.1016/j.media.2014.06.014; Lenis Dimitrios, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12261), P315, DOI 10.1007/978-3-030-59710-8_31; Li KP, 2018, PROC CVPR IEEE, P9215, DOI 10.1109/CVPR.2018.00960; Li LQ, 2017, COMPUT VIS IMAGE UND, V155, P173, DOI 10.1016/j.cviu.2016.10.002; Li YY, 2023, VISUAL COMPUT, V39, P2223, DOI 10.1007/s00371-021-02328-7; Lian CF, 2019, IEEE T IMAGE PROCESS, V28, P755, DOI 10.1109/TIP.2018.2872908; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; Paszke A, 2019, ADV NEUR IN, V32; Peiris H, 2022, LECT NOTES COMPUT SC, V13435, P162, DOI 10.1007/978-3-031-16443-9_16; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Sinha A, 2021, IEEE J BIOMED HEALTH, V25, P121, DOI 10.1109/JBHI.2020.2986926; Srivastava Nitish, 2012, Advances in Neural Information Processing Systems, V25; Sun Jesse, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12264), P797, DOI 10.1007/978-3-030-59719-1_77; Valverde S, 2017, NEUROIMAGE, V155, P159, DOI 10.1016/j.neuroimage.2017.04.034; van der Velden BHM, 2022, MED IMAGE ANAL, V79, DOI 10.1016/j.media.2022.102470; Wang LW, 2015, Arxiv, DOI [arXiv:1505.02496, DOI 10.48550/ARXIV.1505.02496, 10.48550/arXiv.1505.02496]; Xu L, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/2391925; Xu Y, 2022, FRONT NEUROSCI-SWITZ, V16, DOI 10.3389/fnins.2022.1009581; Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061; Zhao XM, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/aaf44b; Zhong ZS, 2018, I S BIOMED IMAGING, P228, DOI 10.1109/ISBI.2018.8363561; Zhou BL, 2018, Arxiv, DOI [arXiv:1806.02891, 10.48550/arXiv.1806.02891]; Zhou TX, 2022, PATTERN RECOGN, V124, DOI 10.1016/j.patcog.2021.108417; Zhu ZQ, 2023, INFORM FUSION, V91, P376, DOI 10.1016/j.inffus.2022.10.022	43	1	1	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1568-4946	1872-9681		APPL SOFT COMPUT	Appl. Soft. Comput.	NOV	2023	148								110825	10.1016/j.asoc.2023.110825	http://dx.doi.org/10.1016/j.asoc.2023.110825		OCT 2023	12	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	W0IG0					2024-09-18	WOS:001088546000001
J	Picart-Armada, S; Fernández-Albert, F; Vinaixa, M; Yanes, O; Perera-Lluna, A				Picart-Armada, Sergio; Fernandez-Albert, Francesc; Vinaixa, Maria; Yanes, Oscar; Perera-Lluna, Alexandre			FELLA: an R package to enrich metabolomics data	BMC BIOINFORMATICS			English	Article						Metabolomics; Pathways; Network analysis; Data mining; Knowledge representation	FUMARATE-HYDRATASE; REVEALS ALTERATIONS; LIVER; CANCER; CELLS	BackgroundPathway enrichment techniques are useful for understanding experimental metabolomics data. Their purpose is to give context to the affected metabolites in terms of the prior knowledge contained in metabolic pathways. However, the interpretation of a prioritized pathway list is still challenging, as pathways show overlap and cross talk effects.ResultsWe introduce FELLA, an R package to perform a network-based enrichment of a list of affected metabolites. FELLA builds a hierarchical representation of an organism biochemistry from the Kyoto Encyclopedia of Genes and Genomes (KEGG), containing pathways, modules, enzymes, reactions and metabolites. In addition to providing a list of pathways, FELLA reports intermediate entities (modules, enzymes, reactions) that link the input metabolites to them. This sheds light on pathway cross talk and potential enzymes or metabolites as targets for the condition under study. FELLA has been applied to six public datasets -three from Homo sapiens, two from Danio rerio and one from Mus musculus- and has reproduced findings from the original studies and from independent literature.ConclusionsThe R package FELLA offers an innovative enrichment concept starting from a list of metabolites, based on a knowledge graph representation of the KEGG database that focuses on interpretability. Besides reporting a list of pathways, FELLA suggests intermediate entities that are of interest per se. Its usefulness has been shown at several molecular levels on six public datasets, including human and animal models. The user can run the enrichment analysis through a simple interactive graphical interface or programmatically. FELLA is publicly available in Bioconductor under the GPL-3 license.	[Picart-Armada, Sergio; Fernandez-Albert, Francesc; Perera-Lluna, Alexandre] Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind, B2SLab, E-08028 Barcelona, Spain; [Picart-Armada, Sergio; Fernandez-Albert, Francesc; Perera-Lluna, Alexandre] CIBER, BBN, Networking Biomed Res Ctr, Subject Area Bioengn Biomat & Nanomed, Madrid 28029, Spain; [Picart-Armada, Sergio; Perera-Lluna, Alexandre] Hosp St Joan Deu, Inst Recerca Pediat, Barcelona 08950, Spain; [Vinaixa, Maria; Yanes, Oscar] Univ Rovira & Virgili, DEEA, Dept Elect Engn, Metabol Platform,IISPV, Tarragona 43003, Spain; [Vinaixa, Maria; Yanes, Oscar] CIBERDEM, CIBER Diabet & Associated Metab Dis, Madrid 28029, Spain; [Fernandez-Albert, Francesc] Takeda Cambridge Ltd, Cambridge CB4 0PZ, England	Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Picart-Armada, S (corresponding author), Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind, B2SLab, E-08028 Barcelona, Spain.; Picart-Armada, S (corresponding author), CIBER, BBN, Networking Biomed Res Ctr, Subject Area Bioengn Biomat & Nanomed, Madrid 28029, Spain.	sergi.picart@upc.edu	Yanes, Oscar/N-3630-2016; Vinaixa, Maria/AAB-1176-2020; Vinaixa Crevillent, Maria/L-7236-2014	Vinaixa Crevillent, Maria/0000-0001-9804-0171; Picart-Armada, Sergio/0000-0002-6426-8204; Fernandez-Albert, Francesc/0000-0001-5561-0701	Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2014-57466-P, TEC2014-60337-R, DPI2017-89827-R]; CIBERDEM of Instituto de Investigacion Carlos III (ISCIII); CIBER-BBN of Instituto de Investigacion Carlos III (ISCIII)	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); CIBERDEM of Instituto de Investigacion Carlos III (ISCIII); CIBER-BBN of Instituto de Investigacion Carlos III (ISCIII)	This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2014-57466-P to OY, TEC2014-60337-R and DPI2017-89827-R to AP]. OY, AP and SP thank for funding CIBERDEM and CIBER-BBN, both initiatives of Instituto de Investigacion Carlos III (ISCIII). SP thanks the AGAUR FI-scholarship programme. The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	[Anonymous], 1999, WWW 1999; [Anonymous], 2006, INTERJOURNALCOMPLEX; BEISEL WR, 1975, ANNU REV MED, V26, P9, DOI 10.1146/annurev.me.26.020175.000301; Blake JACKDM, 2015, Res, V43, P56, DOI [10.1093/nar/gku1179, DOI 10.1093/NAR/GKU1179]; Chang W., SHINY WEB APPL FRAME; Chen LY, 2015, J PROTEOME RES, V14, P3982, DOI 10.1021/acs.jproteome.5b00443; Decuypere S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004480; Fernández-Albert F, 2014, BIOINFORMATICS, V30, P1937, DOI 10.1093/bioinformatics/btu136; Fitch CD, 2000, BBA-MOL BASIS DIS, V1535, P45, DOI 10.1016/S0925-4439(00)00081-8; Godoy P, 2016, ARCH TOXICOL, V90, P2513, DOI 10.1007/s00204-016-1761-4; Gogiashvili M, 2017, ANAL BIOANAL CHEM, V409, P1591, DOI 10.1007/s00216-016-0100-1; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kessler N, 2013, BIOINFORMATICS, V29, P2452, DOI 10.1093/bioinformatics/btt414; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Lehtonen HJ, 2007, HUM PATHOL, V38, P793, DOI 10.1016/j.humpath.2006.10.011; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Picart-Armada S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189012; Pithukpakorn M, 2006, J MED GENET, V43, P755, DOI 10.1136/jmg.2006.041087; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Seo YJ, 2011, CYTOKINE GROWTH F R, V22, P55, DOI 10.1016/j.cytogfr.2010.12.001; Singh KK, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-14; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Vermeersch KA, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0134-y; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Ziarrusta H, 2018, CHEMOSPHERE, V211, P624, DOI 10.1016/j.chemosphere.2018.08.013	33	59	63	3	30	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	DEC 22	2018	19								538	10.1186/s12859-018-2487-5	http://dx.doi.org/10.1186/s12859-018-2487-5			9	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	HF4NG	30577788	gold, Green Published			2024-09-18	WOS:000454209300001
J	Vinga, S				Vinga, Susana			Structured sparsity regularization for analyzing high-dimensional omics data	BRIEFINGS IN BIOINFORMATICS			English	Review							GENERALIZED LINEAR-MODELS; ADAPTIVE ELASTIC-NET; VARIABLE SELECTION; LOGISTIC-REGRESSION; GENE SELECTION; COX REGRESSION; SURVIVAL ANALYSIS; LASSO; PREDICTION; CANCER	The development of new molecular and cell technologies is having a significant impact on the quantity of data generated nowadays. The growth of omics databases is creating a considerable potential for knowledge discovery and, concomitantly, is bringing new challenges to statistical learning and computational biology for health applications. Indeed, the high dimensionality of these data may hamper the use of traditional regression methods and parameter estimation algorithms due to the intrinsic non-identifiability of the inherent optimization problem. Regularized optimization has been rising as a promising and useful strategy to solve these ill-posed problems by imposing additional constraints in the solution parameter space. In particular, the field of statistical learning with sparsity has been significantly contributing to building accurate models that also bring interpretability to biological observations and phenomena. Beyond the now-classic elastic net, one of the best-known methods that combine lasso with ridge penalizations, we briefly overview recent literature on structured regularizers and penalty functions that have been applied in biomedical data to build parsimonious models in a variety of underlying contexts, from survival to generalized linear models. These methods include functions of l(k)-norms and network-based penalties that take into account the inherent relationships between the features. The successful application to omics data illustrates the potential of sparse structured regularization for identifying disease's molecular signatures and for creating high-performance clinical decision support systems towards more personalized healthcare. Supplementary information: Supplementary data are available at Briefings in Bioinformatics online.	[Vinga, Susana] Univ Lisbon, Inst Super Tecn, INESC ID, Lisbon, Portugal; [Vinga, Susana] Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal	Universidade de Lisboa; INESC-ID; Universidade de Lisboa	Vinga, S (corresponding author), INESC ID, R Alves Redol 9, P-1000029 Lisbon, Portugal.	susanavinga@tecnico.ulisboa.pt	Vinga, Susana/B-8450-2008		Fundacao para a Ciencia e a Tecnologia (FCT) [UIDB/50021/2020, UIDB/50022/2020, PTDC/CCI-CIF/29877/2017, DSAIPA/DS/0026/2019]; Fundação para a Ciência e a Tecnologia [PTDC/CCI-CIF/29877/2017, DSAIPA/DS/0026/2019] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Fundacao para a Ciencia e a Tecnologia (FCT)); Fundação para a Ciência e a Tecnologia(Fundacao para a Ciencia e a Tecnologia (FCT))	Fundacao para a Ciencia e a Tecnologia (FCT) through projects UIDB/50021/2020 (INESC-ID); UIDB/50022/2020 (LAETA, IDMEC); PTDC/CCI-CIF/29877/2017 (PREDICT); DSAIPA/DS/0026/2019 (MATISSE).	Algamal ZY, 2018, COMPUT BIOL MED, V97, P145, DOI 10.1016/j.compbiomed.2018.04.018; Algamal ZY, 2015, COMPUT BIOL MED, V67, P136, DOI 10.1016/j.compbiomed.2015.10.008; Alhamzawi R, 2018, MATH BIOSCI, V303, P75, DOI 10.1016/j.mbs.2018.06.004; Ang JC, 2016, IEEE ACM T COMPUT BI, V13, P971, DOI 10.1109/TCBB.2015.2478454; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bach F, 2012, STAT SCI, V27, P450, DOI 10.1214/12-STS394; Baker S, 2017, BIOINFORMATICS, V33, P3973, DOI 10.1093/bioinformatics/btx454; Basu A, 2018, BIOINFORMATICS, V34, P3332, DOI 10.1093/bioinformatics/bty199; Bondell HD, 2008, BIOMETRICS, V64, P115, DOI 10.1111/j.1541-0420.2007.00843.x; Boulesteix AL, 2011, BRIEF BIOINFORM, V12, P215, DOI 10.1093/bib/bbq085; Bühlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Candia J, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2778-5; Cawley GC, 2006, BIOINFORMATICS, V22, P2348, DOI 10.1093/bioinformatics/btl386; Chai H, 2015, COMPUT BIOL MED, V64, P283, DOI 10.1016/j.compbiomed.2014.09.002; Cheng W, 2014, BIOINFORMATICS, V30, P139, DOI 10.1093/bioinformatics/btu293; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI [10.1093/nar/gkt1102, 10.1093/nar/gkz1031]; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Delgado FM, 2019, ARTIF INTELL MED, V95, P133, DOI 10.1016/j.artmed.2018.10.006; Demchak B, 2018, J MOL BIOL, V430, P2873, DOI 10.1016/j.jmb.2018.07.019; Dirmeier S, 2018, BIOINFORMATICS, V34, P896, DOI 10.1093/bioinformatics/btx677; Fan JQ, 2010, STAT SINICA, V20, P101; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Figueiredo MAT, 2016, JMLR WORKSH CONF PRO, V51, P930; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fröhlich H, 2014, BIOMETRICAL J, V56, P287, DOI 10.1002/bimj.201300035; Gong HJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S1-S3; Handl L, 2019, BIOINFORMATICS, V35, pI154, DOI 10.1093/bioinformatics/btz338; Hastie T., 2015, Statistical Learning with Sparsity: The Lasso and Generalizations; Huang HH, 2019, EXPERT SYST APPL, V135, P102, DOI 10.1016/j.eswa.2019.06.016; Huang HH, 2018, COMPUT METH PROG BIO, V164, P65, DOI 10.1016/j.cmpb.2018.06.004; Huang HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149675; Huang HH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/713953; Iuliano A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00208; Jardillier R, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201800103; Jenatton R, 2011, J MACH LEARN RES, V12, P2777; Jeong HH, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S8; Jiang HK, 2018, COMPUT BIOL MED, V100, P203, DOI 10.1016/j.compbiomed.2018.07.009; Kalbfleisch J, 2002, STAT ANAL FAILURE TI; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khan MHR, 2016, STAT COMPUT, V26, P725, DOI 10.1007/s11222-015-9555-8; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Kong YC, 2018, BIOINFORMATICS, V34, P3727, DOI 10.1093/bioinformatics/bty429; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Li CY, 2010, ANN APPL STAT, V4, P1498, DOI 10.1214/10-AOAS332; Li X, 2018, STAT MED, V37, P473, DOI 10.1002/sim.7526; Liang Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-198; Liu C, 2014, APPL SOFT COMPUT, V14, P498, DOI 10.1016/j.asoc.2013.09.006; Liu XY, 2020, IEEE ACM T COMPUT BI, V17, P1329, DOI 10.1109/TCBB.2019.2897301; Liu ZQ, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0159-z; Lopes MB, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3390-4; Lopes MB, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2937-8; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; Ma SG, 2011, BRIEF BIOINFORM, V12, P714, DOI 10.1093/bib/bbq090; Manzoni C, 2018, BRIEF BIOINFORM, V19, P286, DOI 10.1093/bib/bbw114; Mazumder R, 2011, J AM STAT ASSOC, V106, P1125, DOI 10.1198/jasa.2011.tm09738; Min WW, 2018, IEEE ACM T COMPUT BI, V15, P944, DOI 10.1109/TCBB.2016.2640303; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Novianti PW, 2017, BIOINFORMATICS, V33, P1572, DOI 10.1093/bioinformatics/btw837; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Ozturk K, 2018, J MOL BIOL, V430, P2875, DOI 10.1016/j.jmb.2018.06.016; Park H, 2017, IEEE ACM T COMPUT BI, V14, P771, DOI 10.1109/TCBB.2016.2561937; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ren J, 2019, GENET EPIDEMIOL, V43, P276, DOI 10.1002/gepi.22194; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Senn S, 2018, NATURE, V563, P619, DOI 10.1038/d41586-018-07535-2; Sharma A, 2015, INT J MACH LEARN CYB, V6, P443, DOI 10.1007/s13042-013-0226-9; Shi XJ, 2015, BRIEF BIOINFORM, V16, P735, DOI 10.1093/bib/bbu049; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Sun H, 2014, STAT SINICA, V24, P1433, DOI 10.5705/ss.2012.317; Sung JY, 2012, BIOTECHNOL J, V7, P946, DOI 10.1002/biot.201100305; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI [10.1093/nar/gky1131, 10.1093/nar/gkac1000]; Tang ZX, 2018, BIOINFORMATICS, V34, P901, DOI 10.1093/bioinformatics/btx684; Tang ZX, 2017, GENETICS, V205, P77, DOI 10.1534/genetics.116.192195; Ternès N, 2018, BIOINFORMATICS, V34, P112, DOI 10.1093/bioinformatics/btx560; Ternès N, 2016, STAT MED, V35, P2561, DOI 10.1002/sim.6927; Torang A, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2994-z; van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139; van de Wiel MA, 2016, STAT MED, V35, P368, DOI 10.1002/sim.6732; Veríssimo A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1310-4; Witten DM, 2010, STAT METHODS MED RES, V19, P29, DOI 10.1177/0962280209105024; Wu C, 2015, BRIEF BIOINFORM, V16, P873, DOI 10.1093/bib/bbu046; Wu MY, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0951-7; Wu S, 2018, APPL SCI, V8; Xu ZB, 2010, SCI CHINA INFORM SCI, V53, P1159, DOI 10.1007/s11432-010-0090-0; Yang Y, 2013, STAT INTERFACE, V6, P167; Yang ZY, 2018, IEEE ACCESS, V6, P68586, DOI 10.1109/ACCESS.2018.2880198; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhang HH, 2007, BIOMETRIKA, V94, P691, DOI 10.1093/biomet/asm037; Zhang W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002975; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735; Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625	93	27	30	4	44	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1467-5463	1477-4054		BRIEF BIOINFORM	Brief. Bioinform.	JAN	2021	22	1			SI		77	87		10.1093/bib/bbaa122	http://dx.doi.org/10.1093/bib/bbaa122			11	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	RF6KC	32597465				2024-09-18	WOS:000634950200008
J	Ferdinandov, D; Kostov, V; Hadzhieva, M; Shivarov, V; Petrov, P; Bussarsky, A; Pashov, AD				Ferdinandov, Dilyan; Kostov, Viktor; Hadzhieva, Maya; Shivarov, Velizar; Petrov, Peter; Bussarsky, Assen; Pashov, Anastas Dimitrov			Reactivity Graph Yields Interpretable IgM Repertoire Signatures as Potential Tumor Biomarkers	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						IgM repertoire; immunodiagnostics; glioblastoma; CCNB1; HPV; HTLV; IgOme	POSITIVE SELECTION; NATURAL ANTIBODIES; B-1 CELLS; B-CELLS	Combining adaptive and innate immunity induction modes, the repertoire of immunoglobulin M (IgM) can reflect changes in the internal environment including malignancies. Previously, it was shown that a mimotope library reflecting the public IgM repertoire of healthy donors (IgM IgOme) can be mined for efficient probes of tumor biomarker antibody reactivities. To better explore the interpretability of this approach for IgM, solid tumor-related profiles of IgM reactivities to linear epitopes of actual tumor antigens and viral epitopes were studied. The probes were designed as oriented planar microarrays of 4526 peptide sequences (as overlapping 15-mers) derived from 24 tumor-associated antigens and 209 cancer-related B cell epitopes from 30 viral antigens. The IgM reactivity in sera from 21 patients with glioblastoma multiforme, brain metastases of other tumors, and non-tumor-bearing neurosurgery patients was thus probed in a proof-of-principle study. A graph representation of the binding data was developed, which mapped the cross-reactivity of the mixture of IgM (poly)specificities, delineating different antibody footprints in the features of the graph-neighborhoods and cliques. The reactivity graph mapped the major features of the IgM repertoire such as the magnitude of the reactivity (titer) and major cross-reactivities, which correlated with blood group reactivity, non-self recognition, and even idiotypic specificities. A correlation between an aspect of this image of the IgM IgOme, namely, small cliques reflecting rare self-reactivities and the capacity of subsets of the epitopes to separate the diagnostic groups studied was found. In this way, the graph representation helped the feature selection in its filtering step and provided reduced feature sets, which, after recursive feature elimination, produced a classifier containing 51 peptide reactivities separating the three diagnostic groups with an unexpected efficiency. Thus, IgM IgOme approaches to repertoire studies is greatly augmented when self/viral antigens are used and the data are represented as a reactivity graph. This approach is most general, and if it is applicable to tumors in immunologically privileged sites, it can be applied to any solid tumors, for instance, breast or lung cancer.	[Ferdinandov, Dilyan; Bussarsky, Assen] St Ivan Rilski Univ Hosp, Clin Neurosurg, Sofia 1431, Bulgaria; [Kostov, Viktor; Hadzhieva, Maya; Pashov, Anastas Dimitrov] Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Sofia 1113, Bulgaria; [Shivarov, Velizar] Med Univ Pleven, Dept Expt Res, Pleven 5800, Bulgaria; [Petrov, Peter] Bulgarian Acad Sci, Inst Math & Informat, Sofia 1113, Bulgaria	Medical University Sofia; Bulgarian Academy of Sciences; Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences; Medical University Pleven; Bulgarian Academy of Sciences	Pashov, AD (corresponding author), Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Sofia 1113, Bulgaria.	a_pashov@microbio.bas.bg	Shivarov, Velizar/B-4553-2008; Pashov, Anastas/AAE-7997-2019; Ferdinandov, Dilyan/Y-1093-2018	Shivarov, Velizar/0000-0001-5362-7999; Ferdinandov, Dilyan/0000-0002-0923-612X; Pashov, Anastas/0000-0002-6033-3566				Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; BAKER FB, 1975, J AM STAT ASSOC, V70, P31, DOI 10.2307/2285371; Barabasi AL, 2016, NETWORK SCIENCE, P1; Bastian M, 2009, INT AAAI C WEBL SOC, V3, DOI [10.1609/icwsm.v3i1.13937, DOI 10.1609/ICWSM.V3I1.13937]; Baumgarth N, 2022, J IMMUNOL, V209, P1621, DOI 10.4049/jimmunol.2200406; Baumgarth N, 2017, J IMMUNOL, V199, P3387, DOI 10.4049/jimmunol.1700943; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Cerruela-García G, 2022, J CHEM INF MODEL, V62, P1618, DOI 10.1021/acs.jcim.1c01578; Díaz-Zaagoza M, 2015, ONCOL REP, V34, P1106, DOI 10.3892/or.2015.4095; Dunn J. C., 1974, Journal of Cybernetics, V4, P95, DOI 10.1080/01969727408546059; Edelsbrunner H., 2010, Computational Topology, DOI [DOI 10.1090/MBK/069, 10.1090/mbk/069]; Frietze KM, 2020, METHODS MOL BIOL, V2070, P157, DOI 10.1007/978-1-4939-9853-1_9; Frietze KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171511; Garaud S, 2011, J IMMUNOL, V186, P4835, DOI 10.4049/jimmunol.1003050; Gaudin E, 2004, J EXP MED, V199, P843, DOI 10.1084/jem.20030955; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Grant C. E., 2021, bioRxiv, DOI DOI 10.1101/2021.09.02.458722; Greiff V, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0169-8; Grönwall C, 2014, J CLIN IMMUNOL, V34, pS12, DOI 10.1007/s10875-014-0025-4; Gupta S, 2017, ONCOTARGET, V8, P58443, DOI 10.18632/oncotarget.16997; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; Hennings Leah, 2011, Cancers (Basel), V3, P4151, DOI 10.3390/cancers3044151; Hughes AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040201; Janeway J.C.A., 1996, IMMUNOBIOLOGY IMMUNE, V2nd, P389; Legutki JB, 2010, VACCINE, V28, P4529, DOI 10.1016/j.vaccine.2010.04.061; Mao JN, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-121; Megremis S, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01932-6; Merbl Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006053; Miho E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09278-8; Mock A, 2015, ONCOTARGET, V6, P13579, DOI 10.18632/oncotarget.3791; Pashov A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02796; Pashova S, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.865232; Pashova S, 2017, HUM VACC IMMUNOTHER, V13, P314, DOI 10.1080/21645515.2017.1264786; Quách TD, 2016, J IMMUNOL, V196, P1060, DOI 10.4049/jimmunol.1501843; Rawat K, 2022, J IMMUNOL, V209, P1252, DOI 10.4049/jimmunol.2200447; Reyneveld GI, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02139; Roffo G, 2020, Arxiv, DOI arXiv:2006.08184; Roney MSI, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1330; Ryvkin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041469; Schneider C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010524; Stafford P, 2016, MOL CELL PROTEOMICS, V15, P1610, DOI 10.1074/mcp.M115.054601; Syed P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13895; Übelhart R, 2015, EUR J IMMUNOL, V45, P2971, DOI 10.1002/eji.201444622; Vale AM, 2015, Mol. Biol. B cells, P99, DOI DOI 10.1016/B978-0-12-397933-9.00007-2; VARELA F, 1991, P NATL ACAD SCI USA, V88, P5917, DOI 10.1073/pnas.88.13.5917; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016; Vollmers HP, 2005, HISTOL HISTOPATHOL, V20, P927, DOI 10.14670/HH-20.927; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007; Yam-Puc JC, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102038; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	51	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-6596	1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB	2023	24	3							2597	10.3390/ijms24032597	http://dx.doi.org/10.3390/ijms24032597			24	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	8U6CH	36768923	Green Published, gold			2024-09-18	WOS:000930037300001
J	Stephens, H; Li, XY; Sheng, Y; Wu, QW; Ge, YR; Wu, QJ				Stephens, Hunter; Li, Xinyi; Sheng, Yang; Wu, Qiuwen; Ge, Yaorong; Wu, Q. Jackie			A reinforcement learning agent for head and neck intensity-modulated radiation therapy	FRONTIERS IN PHYSICS			English	Article						reinforcement learning; radiation therapy; automated treatment planning; head and neck cancer; interpretable machine learning	SQUAMOUS-CELL CARCINOMA; TREATMENT PLAN QUALITY; AT-RISK; IMRT; RADIOTHERAPY; VOLUME; VALIDATION	Head and neck (HN) cancers pose a difficult problem in the planning of intensity-modulated radiation therapy (IMRT) treatment. The primary tumor can be large and asymmetrical, and multiple organs at risk (OARs) with varying dose-sparing goals lie close to the target volume. Currently, there is no systematic way of automating the generation of IMRT plans, and the manual options face planning quality and long planning time challenges. In this article, we present a reinforcement learning (RL) model for the purposes of providing automated treatment planning to reduce clinical workflow time as well as providing a better starting point for human planners to modify and build upon. Several models with progressing complexity are presented, including the relevant plan dosimetry analysis and model interpretations of the resulting strategies learned by the auto-planning agent. Models were trained on a set of 40 patients and validated on a set of 20 patients. The presented models are shown to be consistent with the requirements of an RL model to be underpinned by a Markov decision process (MDP). In-depth interpretability of the models is presented by examination of the decision space using action hyperplanes. The auto-planning agent was able to generate plans with superior reduction in the mean dose of the left and right parotid glands by approximately 7 Gy +/-+/- 2.5 Gy (p < 0.01) over a starting, static template plan with only pre-defined general prescription information. RL plans were comparable to a human expert's clinical plans for the primary (44 Gy), boost (26 Gy) , and the summed plans (70 Gy) with p-values of 0.43, 0.72, and 0.67, respectively, for the dosimetric endpoints and uniform target coverage normalization. The RL planning agent was able to produce the plans used in validation in an average of 13.58 min, with a minimum and a maximum planning time of 2.27 and 44.82 min, respectively.	[Stephens, Hunter; Li, Xinyi; Sheng, Yang; Wu, Qiuwen; Wu, Q. Jackie] Duke Univ, Dept Radiat Oncol, Durham, NC 27708 USA; [Ge, Yaorong] Univ North Carolina Charlotte, Dept Software & Informat Syst, Charlotte, NC USA	Duke University; University of North Carolina; University of North Carolina Charlotte	Wu, QJ (corresponding author), Duke Univ, Dept Radiat Oncol, Durham, NC 27708 USA.	jackie.wu@duke.edu	li, xinyi/KEI-6391-2024	Wu, Qiuwen/0000-0003-0748-7280	National Institutes of Health10.13039/100000002	National Institutes of Health10.13039/100000002(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USAOffice of the Administrator (NIH))	No Statement Available	Anand AK, 2006, CLIN ONCOL-UK, V18, P497, DOI 10.1016/j.clon.2006.04.014; Appenzoller LM, 2012, MED PHYS, V39, P7446, DOI 10.1118/1.4761864; Brodin NP, 2018, ORAL ONCOL, V86, P8, DOI 10.1016/j.oraloncology.2018.08.018; Chang ATY, 2016, INT J RADIAT ONCOL, V95, P981, DOI 10.1016/j.ijrobp.2016.02.017; DAWES C, 1973, ARCH ORAL BIOL, V18, P337, DOI 10.1016/0003-9969(73)90156-8; Deasy JO, 2010, INT J RADIAT ONCOL, V76, pS58, DOI 10.1016/j.ijrobp.2009.06.090; Gao Y, 2023, RADIOTHER ONCOL, V184, DOI 10.1016/j.radonc.2023.109685; Gupta T, 2012, RADIOTHER ONCOL, V104, P343, DOI 10.1016/j.radonc.2012.07.001; Hunt MA, 2006, INT J RADIAT ONCOL, V66, P296, DOI 10.1016/j.ijrobp.2006.05.028; Hussein M, 2016, RADIOTHER ONCOL, V120, P473, DOI 10.1016/j.radonc.2016.06.022; Kubo K, 2017, PHYS MEDICA, V44, P199, DOI 10.1016/j.ejmp.2017.06.026; Kuo YH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018474; Lee N, 2007, HEAD NECK-J SCI SPEC, V29, P387, DOI 10.1002/hed.20332; Li N, 2017, INT J RADIAT ONCOL, V97, P164, DOI 10.1016/j.ijrobp.2016.10.005; Moore KL, 2011, INT J RADIAT ONCOL, V81, P545, DOI 10.1016/j.ijrobp.2010.11.030; Nelms BE, 2012, PRACT RADIAT ONCOL, V2, P296, DOI 10.1016/j.prro.2011.11.012; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Scaggion A, 2018, PHYS MEDICA, V53, P86, DOI 10.1016/j.ejmp.2018.08.016; Shen CY, 2020, MED PHYS, V47, P2329, DOI 10.1002/mp.14114; Sheng Y, 2021, QUANT IMAG MED SURG, V11, P4859, DOI 10.21037/qims-21-208; Sprouts D, 2022, BIOMED PHYS ENG EXPR, V8, DOI 10.1088/2057-1976/ac6d82; Stephens H, 2022, BIOMED PHYS ENG EXPR, V8, DOI 10.1088/2057-1976/ac35f8; Sutton RS., 1998, Adaptive computation and machine learning series, P344; Tol JP, 2015, INT J RADIAT ONCOL, V91, P612, DOI 10.1016/j.ijrobp.2014.11.014; Wang HL, 2023, FRONT ONCOL, V13, DOI 10.3389/fonc.2023.1124458; Wang ZH, 2012, LARYNGOSCOPE, V122, P291, DOI 10.1002/lary.22434; Wu BB, 2009, MED PHYS, V36, P5497, DOI 10.1118/1.3253464; Yuan LL, 2014, MED PHYS, V41, DOI 10.1118/1.4862075; Yuan LL, 2012, MED PHYS, V39, P6868, DOI 10.1118/1.4757927; Zhang JH, 2021, INT J RADIAT ONCOL, V109, P1076, DOI 10.1016/j.ijrobp.2020.10.019; Zhu XF, 2011, MED PHYS, V38, P719, DOI 10.1118/1.3539749	31	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-424X			FRONT PHYS-LAUSANNE	Front. Physics	FEB 1	2024	12								1331849	10.3389/fphy.2024.1331849	http://dx.doi.org/10.3389/fphy.2024.1331849			15	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	HS7G8		gold			2024-09-18	WOS:001161555000001
J	Krishnan, SN; Barua, S; Frankel, TL; Rao, AR				Krishnan, Santhoshi N.; Barua, Souptik; Frankel, Timothy L.; Rao, Arvind			Towards the characterization of the tumor microenvironment through dictionary learning-based interpretable classification of multiplexed immunofluorescence images	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						dictionary learning; immunotherapy; pancreatic malignancies; spatial analysis; cancer informatics; histology image analysis; explainability	HETEROGENEITY; IMMUNE; CELLS	Objective. Histology image analysis is a crucial diagnostic step in staging and treatment planning, especially for cancerous lesions. With the increasing adoption of computational methods for image analysis, significant strides are being made to improve the performance metrics of image segmentation and classification frameworks. However, many developed frameworks effectively function as black boxes, granting minimal context to the decision-making process. Thus, there is a need to develop methods that offer reasonable discriminatory power and a biologically-informed intuition to the decision-making process. Approach. In this study, we utilized and modified a discriminative feature-based dictionary learning (DFDL) paradigm to generate a classification framework that allows for discrimination between two distinct clinical histologies. This framework allows us (i) to discriminate between 2 clinically distinct diseases or histologies and (ii) provides interpretable group-specific representative dictionary image patches, or 'atoms', generated during classifier training. This implementation is performed on multiplexed immunofluorescence images from two separate patient cohorts- a pancreatic cohort consisting of cancerous and non-cancerous tissues and a metastatic non-small cell lung cancer (mNSCLC) cohort of responders and non-responders to an immunotherapeutic treatment regimen. The analysis was done at both the image-level and subject-level. Five cell types were selected, namely, epithelial cells, cytotoxic lymphocytes, antigen presenting cells, HelperT cells, and T-regulatory cells, as our phenotypes of interest. Results. We showed that DFDL had significant discriminant capabilities for both the pancreatic pathologies cohort (subject-level AUC-0.8878) and the mNSCLC immunotherapy response cohort (subject-level AUC-0.7221). The secondary analysis also showed that more than 50% of the obtained dictionary atoms from the classifier contained biologically relevant information. Significance. Our method shows that the generated dictionary features can help distinguish patients presenting two different histologies with strong sensitivity and specificity metrics. These features allow for an additional layer of model interpretability, a highly desirable element in clinical applications for identifying novel biological phenomena.	[Krishnan, Santhoshi N.; Barua, Souptik; Rao, Arvind] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA; [Krishnan, Santhoshi N.; Rao, Arvind] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Frankel, Timothy L.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Rao, Arvind] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Rao, Arvind] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Rao, Arvind] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	Rice University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Krishnan, SN; Rao, AR (corresponding author), Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA.; Krishnan, SN; Rao, AR (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Rao, AR (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.; Rao, AR (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Rao, AR (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	snk2@rice.edu; ukarvind@med.umich.edu	Barua, Souptik/HKW-0272-2023	Barua, Souptik/0000-0002-1675-8874	National Cancer Institute [R37CA214955] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Al-Shaikhli SDS, 2014, IEEE IMAGE PROC, P2774, DOI 10.1109/ICIP.2014.7025561; Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; [Anonymous], 2009, Graphical Models in Applied Multivariate Statistics; [Anonymous], 2018, MATLAB VERS 9 5 0 12; Antonelli L, 2019, BIOMED SIGNAL PROCES, V52, P264, DOI 10.1016/j.bspc.2019.04.032; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baez Cruz R.E., 2015, THESIS U NACL COLOMB; Barua S, 2018, CANCER INFORM, V17, DOI 10.1177/1176935118782880; Barua S, 2018, LUNG CANCER, V117, P73, DOI 10.1016/j.lungcan.2018.01.022; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Borchers Hans W, 2023, CRAN; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; DIGGLE P, 1985, J R STAT SOC C-APPL, V34, P138; Everitt B, 2011, The Cambridge Dictionary of Statistics; Fassler DJ, 2020, DIAGN PATHOL, V15, DOI 10.1186/s13000-020-01003-0; Foucher ED, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01044; Fu T, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01103-4; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Hainmueller J, 2017, KRLS: kernel-based regularized least squares package; Halim L, 2017, CELL REP, V20, P757, DOI 10.1016/j.celrep.2017.06.079; Heindl A, 2015, LAB INVEST, V95, P377, DOI 10.1038/labinvest.2014.155; Krishnan SN, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-06602-z; Lazarus J, 2019, ANN SURG ONCOL, V26, P2821, DOI 10.1245/s10434-019-07508-3; Lazarus J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121932; Madabhushi Anant, 2009, Imaging Med, V1, P7, DOI 10.2217/IIM.09.9; Miyatani Y, 2016, IEEE WINT CONF APPL; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; Pournelle G. H., 1953, Journal of Mammalogy, V34, P133, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Ramirez I, 2010, PROC CVPR IEEE, P3501, DOI 10.1109/CVPR.2010.5539964; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Romo D, 2014, PROC SPIE, V9041, DOI 10.1117/12.2043935; Schafer J, CORPCOR EFFICIENT ES; Shirale NN, 2018, 2018 4TH INTERNATIONAL CONFERENCE FOR CONVERGENCE IN TECHNOLOGY (I2CT); SPAMS, SPARSE MOD SOFTW; Surace M, 2020, METHOD ENZYMOL, V635, P33, DOI 10.1016/bs.mie.2019.07.039; Tan WCC, 2020, CANCER COMMUN, V40, P135, DOI 10.1002/cac2.12023; Trapletti A., 2022, Tseries: time series analysis and computational finance (software); Vu T H., 2015, 2015 IEEE 12 INT S B, DOI [10.1109/isbi.2015.7164037, DOI 10.1109/ISBI.2015.7164037]; Vu TH, 2017, IEEE T IMAGE PROCESS, V26, P5160, DOI 10.1109/TIP.2017.2729885; Vu TH, 2016, IEEE T MED IMAGING, V35, P738, DOI 10.1109/TMI.2015.2493530; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhao RC, 2021, ARCH COMPUT METHOD E, V28, P463, DOI 10.1007/s11831-019-09383-3; Zhu SJ, 2018, J VIS COMMUN IMAGE R, V55, P243, DOI 10.1016/j.jvcir.2018.06.001	45	0	0	0	2	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	JAN 7	2023	68	1							014002	10.1088/1361-6560/aca86a	http://dx.doi.org/10.1088/1361-6560/aca86a			13	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	8B2NP	36541756	hybrid, Green Published			2024-09-18	WOS:000916765700001
J	May, M; Heiss, R; Koehnen, J; Wetzl, M; Wiesmueller, M; Treutlein, C; Braeuer, L; Uder, M; Kopp, M				May, Matthias; Heiss, Rafael; Koehnen, Julia; Wetzl, Matthias; Wiesmueller, Marco; Treutlein, Christoph; Braeuer, Lars; Uder, Michael; Kopp, Markus			Personalized Chest Computed Tomography <i>Minimum Diagnostic Radiation Dose Levels for the Detection of Fibrosis, Nodules, and Pneumonia</i>	INVESTIGATIVE RADIOLOGY			English	Article						personalized medicine; chest CT; CT; pneumonia; ultra-low-dose CT; radiation dose reduction; lung cancer screening	ITERATIVE RECONSTRUCTION; LUNG-CANCER; PULMONARY NODULES; CT; PROTOCOLS; EQUIVALENT; REDUCTION; PERFORMANCE; SEVERITY; EXPOSURE	Objectives: The purpose of this study was to evaluate the minimum diagnostic radiation dose level for the detection of high-resolution (HR) lung structures, pulmonary nodules (PNs), and infectious diseases (IDs). Materials and Methods: A preclinical chest computed tomography (CT) trial was performedwith a human cadaverwithout known lung diseasewith incremental radiation dose using tin filter-based spectral shaping protocols. A subset of protocols for full diagnostic evaluation of HR, PN, and ID structures was translated to clinical routine. Also, a minimum diagnostic radiation dose protocol was defined (MIN). These protocols were prospectively applied over 5 months in the clinical routine under consideration of the individual clinical indication. We compared radiation dose parameters, objective and subjective image quality (IQ). Results: The HR protocolwas performed in 38 patients (43%), PN in 21 patients (24%), ID in 20 patients (23%), andMIN in 9 patients (10%). Radiation dose differed significantly among HR, PN, and ID (5.4, 1.2, and 0.6 mGy, respectively; P < 0.001). Differences between ID and MIN (0.2 mGy) were not significant (P = 0.262). Dose-normalized contrast-to-noise ratio was comparable among all groups (P = 0.087). Overall IQ was perfect for the HR protocol (median, 5.0) and decreased for PN (4.5), ID-CT (4.3), and MIN-CT (2.5). The delineation of disease-specific findings was high in all dedicated protocols (HR, 5.0; PN, 5.0; ID, 4.5). The MIN protocol had borderline IQ for PN and ID lesions but was insufficient for HR structures. The dose reductions were 78% (PN), 89% (ID), and 97% (MIN) compared with the HR protocols. Conclusions: Personalized chest CT tailored to the clinical indications leads to substantial dose reduction without reducing interpretability. More than 50% of patients can benefit from such individual adaptation in a clinical routine setting. Personalized radiation dose adjustments with validated diagnostic IQ are especially preferable for evaluating ID and PN lesions.	[May, Matthias; Heiss, Rafael; Koehnen, Julia; Wetzl, Matthias; Wiesmueller, Marco; Treutlein, Christoph; Uder, Michael; Kopp, Markus] Univ Hosp Erlangen, Dept Radiol, D-91054 Erlangen, Germany; [Braeuer, Lars] Friedrich Alexander Univ Erlangen Nuremberg, Inst Anat, Chair 2, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Kopp, M (corresponding author), Univ Hosp Erlangen, Dept Radiol, D-91054 Erlangen, Germany.	Markus.kopp@uk-erlangen.de						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adrian H, 2016, EUR RADIOL, V26, P3643, DOI 10.1007/s00330-015-4192-3; Agostini A, 2020, RADIOL MED, V125, P365, DOI 10.1007/s11547-020-01179-x; Becker N, 2012, J CANCER RES CLIN, V138, P1475, DOI 10.1007/s00432-012-1228-9; Chelala L, 2021, AM J ROENTGENOL, V216, P1411, DOI 10.2214/AJR.20.24807; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Eberhard M, 2019, J THORAC DIS, V11, P3515, DOI 10.21037/jtd.2019.08.12; Garin N, 2019, CURR OPIN PULM MED, V25, P242, DOI 10.1097/MCP.0000000000000567; Gordic S, 2014, INVEST RADIOL, V49, P465, DOI 10.1097/RLI.0000000000000037; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hammond E, 2018, MED PHYS, V45, P3657, DOI 10.1002/mp.13057; Homayounieh F, 2021, RADIOLOGY, V298, pE141, DOI 10.1148/radiol.2020203453; Hu-Wang E, 2019, CHEST, V155, P528, DOI 10.1016/j.chest.2018.09.007; Kastner J, 2021, RADIOLOGY, V300, P199, DOI 10.1148/radiol.2021203704; Khawaja RDA, 2014, EUR J RADIOL, V83, P1934, DOI 10.1016/j.ejrad.2014.06.024; Kim Y, 2015, AM J ROENTGENOL, V204, P1197, DOI 10.2214/AJR.14.13629; Kroft LJM, 2019, J THORAC IMAG, V34, P179, DOI 10.1097/RTI.0000000000000404; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee C, 2020, RADIOLOGY; Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672; Loeve M, 2009, RADIOLOGY, V253, P223, DOI 10.1148/radiol.2532090306; Lyu PJ, 2020, INVEST RADIOL, V55, P412, DOI 10.1097/RLI.0000000000000689; Martin MD, 2017, RADIOGRAPHICS, V37, P1975, DOI 10.1148/rg.2017170051; Martini K, 2016, EUR J RADIOL, V85, P360, DOI 10.1016/j.ejrad.2015.11.036; Martini K, 2019, EUR J RADIOL, V121, DOI 10.1016/j.ejrad.2019.108720; Mathieu KB, 2014, J APPL CLIN MED PHYS, V15, P271, DOI 10.1120/jacmp.v15i2.4515; May MS, 2017, NEURORADIOLOGY, V59, P169, DOI 10.1007/s00234-016-1780-0; Messerli M, 2017, EUR RADIOL, V27, P3290, DOI 10.1007/s00330-017-4739-6; Nemoto M, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00079-2020; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Newell JD, 2015, INVEST RADIOL, V50, P40, DOI 10.1097/RLI.0000000000000093; Saltybaeva N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155722; Suntharalingam S, 2018, ACAD RADIOL, V25, P153, DOI 10.1016/j.acra.2017.08.011; Tesche C, 2017, EUR J RADIOL, V91, P29, DOI 10.1016/j.ejrad.2017.03.011; Upchurch CP, 2018, CHEST, V153, P601, DOI 10.1016/j.chest.2017.07.035; Vardhanabhuti V, 2017, EUR J RADIOL, V91, P130, DOI 10.1016/j.ejrad.2017.04.006; Vonder M, 2021, TRANSL LUNG CANCER R, V10, P1154, DOI 10.21037/tlcr-20-808; Wendel F, 2005, ROFO-FORTSCHR RONTG, V177, P1424, DOI 10.1055/s-2005-858564; Wu J, 2020, INVEST RADIOL, V55, P257, DOI 10.1097/RLI.0000000000000670; Wuest W, 2016, EUR RADIOL, V26, P4155, DOI 10.1007/s00330-016-4263-0; Xu XL, 2019, EUR RADIOL, V29, P4529, DOI 10.1007/s00330-018-5969-y; Zhang M, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170658	43	7	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-9996	1536-0210		INVEST RADIOL	Invest. Radiol.	MAR	2022	57	3					148	156		10.1097/RLI.0000000000000822	http://dx.doi.org/10.1097/RLI.0000000000000822			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	E8SB2	34468413	hybrid, Green Published			2024-09-18	WOS:000978163800002
J	Yu, T; Lin, N; Zhong, XW; Zhang, XY; Zhang, XS; Chen, YH; Liu, JQ; Hu, WL; Duan, HL; Si, JM				Yu, Tao; Lin, Ne; Zhong, Xingwei; Zhang, Xiaoyan; Zhang, Xinsen; Chen, Yihe; Liu, Jiquan; Hu, Weiling; Duan, Huilong; Si, Jianmin			Multi-label recognition of cancer-related lesions with clinical priors on white-light endoscopy	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Computer aided diagnosis; Class activation maps; Endoscopy; Neural networks; Multi-label classification	PRECANCEROUS LESIONS	Deep learning-based computer-aided diagnosis techniques have demonstrated encouraging performance in endoscopic lesion identification and detection, and have reduced the rate of missed and false detections of disease during endoscopy. However, the interpretability of the model-based results has not been adequately addressed by existing methods. This phenomenon is directly manifested by a significant bias in the representation of feature localization. Good recognition models experience severe feature localization errors, particularly for lesions with subtle morphological features, and such unsatisfactory performance hinders the clinical deployment of models. To effectively alleviate this problem, we proposed a solution to optimize the localization bias in feature representations of cancer-related recognition models that is difficult to accurately label and identify in clinical practice. Optimization was performed in the training phase of the model through the proposed data augmentation method and auxiliary loss function based on clinical priors. The data augmentation method, called partial jigsaw, can "break" the spatial structure of lesion-independent image blocks and enrich the data feature space to decouple the interference of background features on the space and focus on fine-grained lesion features. The annotation-based auxiliary loss function used class activation maps for sample distribution correction and led the model to present localization representation converging on the gold standard annotation of visualization maps. The results show that with the improvement of our method, the precision of model recognition reached an average of 92.79%, an F1-score of 92.61%, and accuracy of 95.56% based on a dataset constructed from 23 hospitals. In addition, we quantified the evaluation representation of visualization feature maps. The improved model yielded significant offset correction results for visualized feature maps compared with the baseline model. The average visualization-weighted positive coverage improved from 51.85% to 83.76%. The proposed approach did not change the deployment capability and inference speed of the original model and can be incorporated into any state-of-the-art neural network. It also shows the potential to provide more accurate localization inference results and assist in clinical examinations during endoscopies.	[Yu, Tao; Zhang, Xiaoyan; Zhang, Xinsen; Chen, Yihe; Liu, Jiquan; Duan, Huilong] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China; [Lin, Ne; Zhong, Xingwei; Hu, Weiling; Si, Jianmin] Zhejiang Univ, Sir Run Run Shaw Hosp, Med Sch, Dept Gastroenterol, Hangzhou, Peoples R China; [Hu, Weiling; Si, Jianmin] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Liu, JQ (corresponding author), Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Key Lab Biomed Engn, Minist Educ, Hangzhou, Peoples R China.; Hu, WL (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Med Sch, Dept Gastroenterol, Hangzhou, Peoples R China.	liujq@zju.edu.cn	Liu, Jiquan/JDD-5204-2023	liu, jiquan/0000-0001-5994-6472	National Natural Science Foundation of China [827 804]; Zhejiang Province Key Research and Development Program [2021C03111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Key Research and Development Program	This work was supported in part by the National Natural Science Foundation of China (No.31 771 072) , the National Natural Science Foundation of China (No. 827 804) , and the Zhejiang Province Key Research and Development Program (No.2021C03111 Demonstration of innovative medical device application based on service model of medical community) .	Bochkovskiy A., 2020, PREPRINT, DOI DOI 10.48550/ARXIV.2004.10934; Chattopadhay A, 2018, IEEE WINT CONF APPL, P839, DOI 10.1109/WACV.2018.00097; Chen ZT, 2019, AAAI CONF ARTIF INTE, P3379; Cho TS, 2010, PROC CVPR IEEE, P183, DOI 10.1109/CVPR.2010.5540212; Desai S, 2020, IEEE WINT CONF APPL, P972, DOI [10.1109/wacv45572.2020.9093360, 10.1109/WACV45572.2020.9093360]; Ding XH, 2021, PROC CVPR IEEE, P13728, DOI 10.1109/CVPR46437.2021.01352; Dosovitskiy Alexey, 2010, ARXIV201011929; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Gao SH, 2021, IEEE T PATTERN ANAL, V43, P652, DOI 10.1109/TPAMI.2019.2938758; Guimaraes P, 2020, GUT, V69, P4, DOI 10.1136/gutjnl-2019-319347; He K., 2015, PROC CVPR IEEE, DOI [DOI 10.1109/CVPR.2016.90, 10.1109/CVPR.2016.90]; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; Horiuchi Y, 2020, DIGEST DIS SCI, V65, P1355, DOI 10.1007/s10620-019-05862-6; Hu H., 2020, GASTROINTEST ENDOSC, DOI [10.1016/j. gie.2020.11.014. S0016510720350070, DOI 10.1016/J.GIE.2020.11.014.S0016510720350070]; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Ikenoyama Y, 2021, DIGEST ENDOSC, V33, P141, DOI 10.1111/den.13688; Itoh T, 2018, ENDOSC INT OPEN, V6, pE139, DOI 10.1055/s-0043-120830; Jocher Glenn, 2021, Zenodo; Joyce J. M., 2011, International Encyclopedia of Statistical Science, P720, DOI [DOI 10.1007/978-3-642-04898-2_327, 10.1007/978-3-642-04898-2327, DOI 10.1007/978-3-642-04898-2327]; Law H., 2018, ARXIV180801244ARXIV1; Lee JH, 2019, SURG ENDOSC, V33, P3790, DOI 10.1007/s00464-019-06677-2; Lim JH, 2013, GUT LIVER, V7, P41, DOI 10.5009/gnl.2013.7.1.41; Lin N, 2021, CLIN TRANSL GASTROEN, V12, DOI 10.14309/ctg.0000000000000385; Ling TS, 2021, ENDOSCOPY, V53, P469, DOI 10.1055/a-1229-0920; Liu W., 2016, LECT NOTES COMPUT SC, DOI DOI 10.1007/978-3-319-46448-0_2; Liu Z., INT C COMP VIS ICCV; Loshchilov I., 2016, PREPRINT; MORSON BC, 1962, JAMA-J AM MED ASSOC, V179, P311, DOI 10.1001/jama.1962.03050050001001; Muhammad M. Bany, 2020, ARXIV200800299; Nayyar Z, 2021, CMC-COMPUT MATER CON, V68, P2041, DOI 10.32604/cmc.2021.015916; Paszke A, 2019, ADV NEUR IN, V32; Ren S., 2015, IEEETransactionsonPatternAnalysisandMachineIntelligence, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Rugge M, 2013, BEST PRACT RES CL GA, V27, P205, DOI 10.1016/j.bpg.2012.12.007; Ruoyi Du, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12365), P153, DOI 10.1007/978-3-030-58565-5_10; Saito H, 2020, GASTROINTEST ENDOSC, V92, P144, DOI 10.1016/j.gie.2020.01.054; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Sun G., ECCV; Tan MX, 2019, PR MACH LEARN RES, V97; Ueyama H, 2021, J GASTROEN HEPATOL, V36, P482, DOI 10.1111/jgh.15190; Wang C.-Y., 2019, ARXIV191111929; Wang C, 2019, INT SYMP NEXTGEN, DOI 10.1109/isne.2019.8896546; Wang H., 2019, Score-cam: Improved visual explanations via score-weighted class activation mapping; Wonho Bae, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12360), P618, DOI 10.1007/978-3-030-58555-6_37; Yan T, 2021, WORLD J GASTROENTERO, V27, P2531, DOI 10.3748/wjg.v27.i20.2531; Yan T, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104026; Zhang H, 2022, IEEE COMPUT SOC CONF, P2735, DOI 10.1109/CVPRW56347.2022.00309; Zhang X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214133; Zhang YQ, 2020, DIGEST LIVER DIS, V52, P566, DOI 10.1016/j.dld.2019.12.146; Zheng WF, 2019, CLIN TRANSL GASTROEN, V10, DOI 10.14309/ctg.0000000000000109; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhu Y, 2019, GASTROINTEST ENDOSC, V89, P806, DOI 10.1016/j.gie.2018.11.011	52	8	8	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	APR	2022	143								105255	10.1016/j.compbiomed.2022.105255	http://dx.doi.org/10.1016/j.compbiomed.2022.105255		FEB 2022	12	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	0V1JC	35151153	hybrid			2024-09-18	WOS:000788100500002
J	Belue, MJ; Harmon, SA; Lay, NS; Daryanani, A; Phelps, TE; Choyke, PL; Turkbey, B				Belue, Mason J.; Harmon, Stephanie A.; Lay, Nathan S.; Daryanani, Asha; Phelps, Tim E.; Choyke, Peter L.; Turkbey, Baris			The Low Rate of Adherence to Checklist for Artificial Intelligence in Medical Imaging Criteria Among Published Prostate MRI Artificial Intelligence Algorithms	JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY			English	Article						AI; CLAIM; classi fi cation; detection; prostate cancer; study rigor	CANCER DETECTION; CLINICALLY SIGNIFICANT; GLEASON SCORE; RADIOMICS; CLASSIFICATION; VALIDATION; DIAGNOSIS; FEATURES; IMAGES	Objective: To determine the rigor, generalizability, and reproducibility of published classification and detection artificial intelligence (AI) models for prostate cancer (PCa) on MRI using the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) guidelines, a 42-item checklist that is considered a measure of best practice for presenting and reviewing medical imaging AI research.Materials and methods: This review searched English literature for studies proposing PCa AI detection and classification models on MRI. Each study was evaluated with the CLAIM checklist. The additional outcomes for which data were sought included measures of AI model performance (eg, area under the curve [AUC], sensitivity, specificity, free-response operating characteristic curves), training and validation and testing group sample size, AI approach, detection versus classification AI, public data set utilization, MRI sequences used, and definition of gold standard for ground truth. The percentage of CLAIM checklist fulfillment was used to stratify studies into quartiles. Wilcoxon's rank-sum test was used for pair-wise comparisons.Results: In all, 75 studies were identified, and 53 studies qualified for analysis. The original CLAIM items that most studies did not fulfill includes item 12 (77% no): de-identification methods; item 13 (68% no): handling missing data; item 15 (47% no): rationale for choosing ground truth reference standard; item 18 (55% no): measurements of inter-and intrareader variability; item 31 (60% no): inclusion of validated interpretability maps; item 37 (92% no): inclusion of failure analysis to elucidate AI model weaknesses. An AUC score versus percentage CLAIM fulfillment quartile revealed a significant difference of the mean AUC scores between quartile 1 versus quartile 2 (0.78 versus 0.86, P = .034) and quartile 1 versus quartile 4 (0.78 versus 0.89, P = .003) scores. Based on additional information and outcome metrics gathered in this study, additional measures of best practice are defined. These new items include disclosure of public dataset usage, ground truth definition in comparison to other referenced works in the defined task, and sample size power calculation.Conclusion: A large proportion of AI studies do not fulfill key items in CLAIM guidelines within their methods and results sections. The percentage of CLAIM checklist fulfillment is weakly associated with improved AI model performance. Additions or supplementations to CLAIM are recommended to improve publishing standards and aid reviewers in determining study rigor.	[Belue, Mason J.; Harmon, Stephanie A.; Lay, Nathan S.; Daryanani, Asha; Phelps, Tim E.; Choyke, Peter L.; Turkbey, Baris] NCI, Artificial Intelligence Resource, Mol Imaging Branch, NIH, Bethesda, MD USA; [Turkbey, Baris] NCI, Artificial Intelligence Resource, Mol Imaging Branch, 10 Ctr Dr,MSC 1182,Bldg 10,Room B3B85, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Turkbey, B (corresponding author), NCI, Artificial Intelligence Resource, Mol Imaging Branch, 10 Ctr Dr,MSC 1182,Bldg 10,Room B3B85, Bethesda, MD 20892 USA.	turkbeyi@mail.nih.gov	Choyke, Peter/C-8809-2011		National Cancer Institute; National Institutes of Health (NIH); NIH Medical Research Scholars Program	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Medical Research Scholars Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USAOffice of the Administrator (NIH))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH) . The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. Additional research support was provided by the NIH Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and contributions to the Foundation for the NIH from the Doris Duke Charitable Foundation, the American Association for Dental Research, and the Colgate-Palmolive Company.	Abraham B, 2018, COMPUT MED IMAG GRAP, V69, P60, DOI 10.1016/j.compmedimag.2018.08.006; Aldoj N, 2020, EUR RADIOL, V30, P1243, DOI 10.1007/s00330-019-06417-z; Algohary A, 2020, CANCERS, V12, DOI 10.3390/cancers12082200; Antonelli M, 2019, EUR RADIOL, V29, P4754, DOI 10.1007/s00330-019-06244-2; Aphinives C, 2021, EGYPT J RADIOL NUC M, V52, DOI 10.1186/s43055-021-00467-4; Arif M, 2020, EUR RADIOL, V30, P6582, DOI 10.1007/s00330-020-07008-z; Dinh AH, 2018, RADIOLOGY, V287, P525, DOI 10.1148/radiol.2017171265; Bandos AI, 2009, BIOMETRICS, V65, P247, DOI 10.1111/j.1541-0420.2008.01049.x; Belue MJ, 2022, ACAD RADIOL, V29, P1404, DOI 10.1016/j.acra.2022.01.009; Bernatz S, 2020, EUR RADIOL, V30, P6757, DOI 10.1007/s00330-020-07064-5; Bonekamp D, 2021, UROLOGE, V60, P576, DOI 10.1007/s00120-021-01492-x; Bonekamp D, 2018, RADIOLOGY, V289, P128, DOI 10.1148/radiol.2018173064; Borstelmann SM, 2020, ACAD RADIOL, V27, P13, DOI 10.1016/j.acra.2019.07.030; Campa R, 2019, ABDOM RADIOL, V44, P264, DOI 10.1007/s00261-018-1712-z; Cao RM, 2021, J MAGN RESON IMAGING, V54, P474, DOI 10.1002/jmri.27595; Cao RM, 2019, IEEE T MED IMAGING, V38, P2496, DOI 10.1109/TMI.2019.2901928; Chen Q, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819858363; Cuocolo R, 2019, EUR J RADIOL, V116, P144, DOI 10.1016/j.ejrad.2019.05.006; Dhinagar NJ, 2020, J MED IMAGING, V7, DOI 10.1117/1.JMI.7.6.064501; Diaz O, 2021, PHYS MEDICA, V83, P25, DOI 10.1016/j.ejmp.2021.02.007; Ellmann S, 2020, CANCERS, V12, DOI 10.3390/cancers12092366; Gaur Sonia, 2018, Oncotarget, V9, P33804, DOI 10.18632/oncotarget.26100; Germanese D, 2019, IEEE INT C BIOINF BI, P972, DOI 10.1109/BIBE.2019.00181; Gholizadeh N, 2020, J APPL CLIN MED PHYS, V21, P179, DOI 10.1002/acm2.12992; Giannini V, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11060973; Ginsburg SB, 2017, J MAGN RESON IMAGING, V46, P184, DOI 10.1002/jmri.25562; Hagiwara A, 2020, INVEST RADIOL, V55, P601, DOI 10.1097/RLI.0000000000000666; Hamm CA, 2020, RADIOLOGE, V60, P48, DOI 10.1007/s00117-019-00613-0; Harmon SA, 2019, DIAGN INTERV RADIOL, V25, P183, DOI 10.5152/dir.2019.19125; Hectors SJ, 2019, J UROLOGY, V202, P498, DOI 10.1097/JU.0000000000000272; Hou Y, 2021, EUR J NUCL MED MOL I, V48, P3805, DOI 10.1007/s00259-021-05381-5; Ishioka J, 2018, BJU INT, V122, P411, DOI 10.1111/bju.14397; Jonsson Comprehensive Cancer Center, 2021, INT QUANT MRI ART IN; Kan YS, 2020, EUR RADIOL, V30, P6274, DOI 10.1007/s00330-020-06958-8; Karimi Davood, 2017, Medical Image Computing and Computer Assisted Intervention  MICCAI 2017. 20th International Conference. Proceedings: LNCS 10435, P391, DOI 10.1007/978-3-319-66179-7_45; Khalvati F, 2018, BMC MED IMAGING, V18, DOI 10.1186/s12880-018-0258-4; Khosravi P, 2021, J MAGN RESON IMAGING, V54, P462, DOI 10.1002/jmri.27599; Kiraly Atilla P., 2017, Medical Image Computing and Computer Assisted Intervention  MICCAI 2017. 20th International Conference. Proceedings: LNCS 10435, P489, DOI 10.1007/978-3-319-66179-7_56; Krishna S, 2019, EUR RADIOL, V29, P1133, DOI 10.1007/s00330-018-5664-z; Kwon D, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.3.034502; Lay N, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.2.024506; Le MH, 2017, PHYS MED BIOL, V62, P6497, DOI 10.1088/1361-6560/aa7731; Lemaître G, 2017, IEEE ENG MED BIO, P3138, DOI 10.1109/EMBC.2017.8037522; Li J., 2021, PREPRINT; Li J, 2018, EUR J RADIOL, V98, P61, DOI 10.1016/j.ejrad.2017.11.001; Liu SF, 2017, PROC SPIE, V10134, DOI 10.1117/12.2277121; Liu Y, 2017, 2017 10 INT C IM SIG, P1, DOI DOI 10.1109/CISP-BMEI.2017.8302240; Mazzetti S, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aab956; Mehralivand S, 2022, ACAD RADIOL, V29, P1159, DOI 10.1016/j.acra.2021.08.019; Mehralivand S, 2020, AM J ROENTGENOL, V215, P903, DOI 10.2214/AJR.19.22573; Min XD, 2019, EUR J RADIOL, V115, P16, DOI 10.1016/j.ejrad.2019.03.010; Mongan J, 2020, RADIOL-ARTIF INTELL, V2, DOI 10.1148/ryai.2020200029; Mudgal Keshav Shree, 2020, BJR Open, V2, P20190020, DOI 10.1259/bjro.20190020; Nelson CR., 2020, OPEN ARTIF INTELL J, V6, P1, DOI 10.2174/1874061802006010001; Penzkofer T, 2021, EUR RADIOL, V31, P9567, DOI 10.1007/s00330-021-08021-6; Prostate Cancer Facts, KEY STAT PROST CANC; Sackett J, 2021, ACAD RADIOL, V28, P199, DOI 10.1016/j.acra.2020.01.031; Sanford T, 2020, J MAGN RESON IMAGING, V52, P1499, DOI 10.1002/jmri.27204; Schelb P, 2021, ROFO-FORTSCHR RONTG, V193, P559, DOI 10.1055/a-1290-8070; Schelb P, 2019, RADIOLOGY, V293, P607, DOI 10.1148/radiol.2019190938; Si LP, 2022, EUR RADIOL, V32, P1353, DOI 10.1007/s00330-021-08190-4; Smith L, 2019, DEEP LEARNING COMBIN; Sobecki P, 2021, PEERJ, V9, DOI 10.7717/peerj.11006; Song Y, 2018, J MAGN RESON IMAGING, V48, P1570, DOI 10.1002/jmri.26047; Suarez-Ibarrola R, 2022, EUR UROL FOCUS, V8, P409, DOI 10.1016/j.euf.2021.03.020; Sugano D, 2020, CURR OPIN UROL, V30, P754, DOI 10.1097/MOU.0000000000000822; Sumathipala Y, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.4.044507; Sun Y, 2018, ACTA ONCOL, V57, P1540, DOI 10.1080/0284186X.2018.1468084; Syer T, 2021, CANCERS, V13, DOI 10.3390/cancers13133318; Tataru OS, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11020354; Thon A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185995; Toivonen J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217702; Transin S, 2019, DIAGN INTERV IMAG, V100, P801, DOI 10.1016/j.diii.2019.06.012; Truong M, 2019, EUR UROL ONCOL, V2, P257, DOI 10.1016/j.euo.2018.08.008; Tsehay Y, 2017, I S BIOMED IMAGING, P642, DOI 10.1109/ISBI.2017.7950602; van Leeuwen KG, 2021, EUR RADIOL, V31, P3797, DOI 10.1007/s00330-021-07892-z; Varghese B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38381-x; Viswanath SE, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0308-6; Wang J, 2017, EUR RADIOL, V27, P4082, DOI 10.1007/s00330-017-4800-5; Wang XG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15720-y; Wang ZW, 2018, IEEE T MED IMAGING, V37, P1127, DOI 10.1109/TMI.2017.2789181; Westphalen AC, 2020, RADIOLOGY, V296, P76, DOI 10.1148/radiol.2020190646; Wildeboer RR, 2020, COMPUT METH PROG BIO, V189, DOI 10.1016/j.cmpb.2020.105316; Willemink MJ, 2020, RADIOLOGY, V295, P4, DOI 10.1148/radiol.2020192224; Winkel DJ, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10110951; Woznicki P, 2020, CANCERS, V12, DOI 10.3390/cancers12071767; Xie JK, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.604266; Xu HL, 2019, INT J COMPUT ASS RAD, V14, P1647, DOI 10.1007/s11548-019-01967-5; Yang X, 2017, MED IMAGE ANAL, V42, P212, DOI 10.1016/j.media.2017.08.006; Yoo S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55972-4; Yuan YX, 2019, MED PHYS, V46, P756, DOI 10.1002/mp.13367; Zhiyu Liu, 2019, Artificial Intelligence in Radiation Therapy. First International Workshop, AIRT 2019. Held in Conjunction with MICCAI 2019. Proceedings. Lecture Notes in Computer Science (LNCS 11850), P43, DOI 10.1007/978-3-030-32486-5_6; Zhong XR, 2019, ABDOM RADIOL, V44, P2030, DOI 10.1007/s00261-018-1824-5; Zhu YL, 2017, MED PHYS, V44, P1028, DOI 10.1002/mp.12116	94	12	12	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1546-1440	1558-349X		J AM COLL RADIOL	J. Am. Coll. Radiol.	FEB	2023	20	2					134	145		10.1016/j.jacr.2022.05.022	http://dx.doi.org/10.1016/j.jacr.2022.05.022		FEB 2023	12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	M1OS1	35922018	Bronze, Green Accepted			2024-09-18	WOS:001027932200001
J	Wei, JH; Lu, SJ; Liu, WC; Liu, H; Feng, L; Tao, YZ; Pu, ZL; Liu, Q; Hu, ZH; Wang, HS; Li, WL; Kang, W; Yin, CL; Feng, Z				Wei, Jihu; Lu, Shijin; Liu, Wencai; Liu, He; Feng, Lin; Tao, Yizi; Pu, Zhanglin; Liu, Qiang; Hu, Zhaohui; Wang, Haosheng; Li, Wenle; Kang, Wei; Yin, Chengliang; Feng, Zhe			A machine learning-based model for clinical prediction of distal metastasis in chondrosarcoma: a multicenter, retrospective study	PEERJ			English	Article						Chondrosarcoma; Distant metastases; Risk factor; Machine learning	LOCALLY RECURRENT CHONDROSARCOMA; SOFT-TISSUE SARCOMAS; ADJUVANT CHEMOTHERAPY; BONE CANCER; SURVIVAL; RISK; TUMOR	Background. The occurrence of distant metastases (DM) limits the overall survival (OS) of patients with chondrosarcoma (CS). Early diagnosis and treatment of CS remains a great challenge in clinical practice. The aim of this study was to investigate metastatic factors and develop a risk stratification model for clinicians' decision making. Methods. Six machine learning (ML) algorithms, including logistic regression (LR), plain Bayesian classifier (NBC), decision tree (DT), random forest (RF), gradient boosting machine (GBM) and extreme gradient boosting (XGBoost). A 10-fold cross validation was performed for each model separately, multicenter data was used as external validation, and the best (highest AUC) model was selected to build the network calculator. Results. A total of 1,385 patients met the inclusion criteria, including 82 (5.9%) patients with metastatic CS. Multivariate logistic regression analysis showed that the risk of DM was significantly higher in patients with higher pathologic grades, T-stage, N stage, and non-left primary lesions, as well as those who did not receive surgery and chemotherapy. The AUC of the six ML algorithms for predicting DM ranged from 0.911-0.985, with the extreme gradient enhancement algorithm (XGBoost) having the highest AUC. Therefore, we used the XGB model and uploaded the results to an online risk calculator for estimating DM risk. Conclusions. In this study, combined with adequate SEER case database and external validation with data from multicenter institutions in different geographic regions, we confirmed that CS, T, N, laterality, and grading of surgery and chemotherapy were independent risk factors for DM. Based on the easily available clinical risk factors, machine learning algorithms built the XGB model that predicts the best outcome for DM. An online risk calculator helps simplify the patient assessment process and provides decision guidance for precision medicine and long-term cancer surveillance, which contributes to the interpretability of the model.	[Wei, Jihu; Liu, He; Feng, Lin; Tao, Yizi; Pu, Zhanglin; Feng, Zhe] Guangxi Univ Chinese Med, Fac Postgrad, Nanning, Guangxi, Peoples R China; [Lu, Shijin] Guangxi Univ Chinese Med, Ctr Translat Med Res Integrat Chinese & Western Me, Ruikang Hosp Affiliated, Nanning, Guangxi, Peoples R China; [Liu, Wencai] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, Shanghai, Peoples R China; [Liu, Qiang] Xianyang Cent Hosp, Dept Orthoped, Xianyang, Peoples R China; [Hu, Zhaohui] Liuzhou Peoples Hosp, Dept Spine Surg, Liuzhou 545006, Guangxi Provinc, Peoples R China; [Wang, Haosheng] Second Hosp Jilin Univ, Dept Orthopaed, Changchun, Peoples R China; [Li, Wenle] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Peoples R China; [Li, Wenle] Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, Xianmen, Fujian, Peoples R China; [Kang, Wei; Yin, Chengliang] Macau Univ Sci & Technol, Fac Med, Taipa, Macao, Peoples R China; [Kang, Wei] Guangzhou Lab, Dept Math Phys & Interdisciplinary Studies, Bioland Laborarory, Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou 510005, Guangdong, Peoples R China; [Feng, Zhe] Guangxi Univ Chinese Med, Joint & Sports Med Surg Div, Dept Cardiothorac Surg, Ruikang Hosp, Nanning, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine; Shanghai Jiao Tong University; Jilin University; Xiamen University; Xiamen University; Macau University of Science & Technology; Bioland Lab; Guangzhou Laboratory; Guangxi University of Chinese Medicine	Feng, Z (corresponding author), Guangxi Univ Chinese Med, Fac Postgrad, Nanning, Guangxi, Peoples R China.; Li, WL (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Peoples R China.; Li, WL (corresponding author), Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, Xianmen, Fujian, Peoples R China.; Feng, Z (corresponding author), Guangxi Univ Chinese Med, Joint & Sports Med Surg Div, Dept Cardiothorac Surg, Ruikang Hosp, Nanning, Guangxi, Peoples R China.	drlee0910@163.com; fengzhe2076@126.com	yin, chengliang/ADP-5778-2022; QIAN, LIU/S-1353-2019; hu, zhaohui/JMC-4500-2023; Liu, Wencai/AGB-1668-2022	Liu, Wencai/0000-0002-5350-3125; Kang, Wei/0000-0002-7994-3524	National Natural Science Foundation of China [82260944]; Key research and development programs of Guangxi, China [2021AB09011]; Innovation Project of Guangxi Graduate Education of GXUCM [YCBXJ2023006]; Guangxi Science and Technology Major Program [GUIKEAA23023035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key research and development programs of Guangxi, China; Innovation Project of Guangxi Graduate Education of GXUCM; Guangxi Science and Technology Major Program	This work was supported by grants from National Natural Science Foundation of China (82260944) , the Key research and development programs of Guangxi, China (2021AB09011) and the Innovation Project of Guangxi Graduate Education of GXUCM, (YCBXJ2023006) . The Guangxi Science and Technology Major Program, Grant No. GUIKEAA23023035 supported the APC of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Anfinsen KP, 2011, CANCER EPIDEM BIOMAR, V20, P1770, DOI 10.1158/1055-9965.EPI-11-0136; Basile G, 2020, CANCER-AM CANCER SOC, V126, P5098, DOI 10.1002/cncr.33189; Biermann JS, 2017, J NATL COMPR CANC NE, V15, P155, DOI 10.6004/jnccn.2017.0017; Bindiganavile S, 2015, CANCER RES TREAT, V47, P897, DOI 10.4143/crt.2014.135; Bongers MER, 2020, CLIN ORTHOP RELAT R, V478, P2300, DOI 10.1097/CORR.0000000000001305; Bongers MER, 2019, CLIN ORTHOP RELAT R, V477, P2296, DOI 10.1097/CORR.0000000000000748; Casali PG, 2018, ANN ONCOL, V29, P51, DOI 10.1093/annonc/mdy096; Chan CM, 2015, J BONE JOINT SURG AM, V97A, P420, DOI 10.2106/JBJS.N.00678; Chen X, 2017, EJSO-EUR J SURG ONC, V43, P1718, DOI 10.1016/j.ejso.2017.05.022; Duffaud F, 2019, LANCET ONCOL, V20, P120, DOI 10.1016/S1470-2045(18)30742-3; Fromm J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4741-7; Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238; Gao RR, 2023, ESC HEART FAIL, V10, P2248, DOI 10.1002/ehf2.14371; Giuffrida AY, 2009, J BONE JOINT SURG AM, V91A, P1063, DOI 10.2106/JBJS.H.00416; Gronchi A, 2012, J CLIN ONCOL, V30, P850, DOI 10.1200/JCO.2011.37.7218; Jeong W, 2018, J CLIN PATHOL, V71, P579, DOI 10.1136/jclinpath-2018-205071; Kamal AF, 2015, J ORTHOP SURG-HONG K, V23, P365, DOI 10.1177/230949901502300323; Laitinen MK, 2019, BONE JOINT J, V101B, P266, DOI 10.1302/0301-620X.101B3.BJJ-2018-0881.R1; Li GQ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.630355; Li WL, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.880305; Miwa S, 2021, CANCERS, V13, DOI 10.3390/cancers13143558; Nazarizadeh A, 2021, J BONE ONCOL, V29, DOI 10.1016/j.jbo.2021.100377; Ngiam KY, 2019, LANCET ONCOL, V20, pE262, DOI 10.1016/S1470-2045(19)30149-4; Pereira HM, 2021, BRIT J RADIOL, V94, DOI 10.1259/bjr.20201391; PRITCHARD DJ, 1980, CANCER-AM CANCER SOC, V45, P149, DOI 10.1002/1097-0142(19800101)45:1<149::AID-CNCR2820450125>3.0.CO;2-A; Radaelli S, 2014, EXPERT REV ANTICANC, V14, P689, DOI 10.1586/14737140.2014.885840; Roos E, 2016, ANN SURG ONCOL, V23, P811, DOI 10.1245/s10434-015-4932-2; Sheen H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225242; Song KH, 2018, INT ORTHOP, V42, P2941, DOI 10.1007/s00264-018-3942-7; Strander H, 2003, ACTA ONCOL, V42, P516, DOI 10.1080/02841860310014732; Streitbuerger A, 2012, J BONE JOINT SURG BR, V94B, P122, DOI 10.1302/0301-620X.94B1.26876; Thio QCBS, 2018, CLIN ORTHOP RELAT R, V476, P2040, DOI 10.1097/CORR.0000000000000433; Thorkildsen J, 2020, J SURG ONCOL, V121, P1115, DOI 10.1002/jso.25883; Thorkildsen J, 2019, ACTA ONCOL, V58, P273, DOI 10.1080/0284186X.2018.1554260; Tsuda Y, 2019, BONE JOINT J, V101B, P1313, DOI 10.1302/0301-620X.101B9.BJJ-2019-0190.R1; Wan L, 2019, CLIN ORTHOP RELAT R, V477, P2508, DOI 10.1097/CORR.0000000000000846; Wang J, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-02045-w; Wang Z, 2019, J CANCER, V10, P2457, DOI 10.7150/jca.30388; Weinschenk RC, 2021, J AM ACAD ORTHOP SUR, V29, P553, DOI 10.5435/JAAOS-D-20-01188; Whelan J, 2012, INT J CANCER, V131, pE508, DOI 10.1002/ijc.26426; Yamazawa E, 2022, CANCERS, V14, DOI 10.3390/cancers14133264; Yue Q, 2022, BMC GASTROENTEROL, V22, DOI 10.1186/s12876-022-02586-2; Zhang L, 2021, J BONE ONCOL, V30, DOI 10.1016/j.jbo.2021.100385	44	1	1	4	5	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	DEC 18	2023	11								e16485	10.7717/peerj.16485	http://dx.doi.org/10.7717/peerj.16485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP2Q8	38130920	gold, Green Published			2024-09-18	WOS:001133198700007
J	Wang, HX; Zhang, C; Li, QR; Tian, T; Huang, R; Qiu, JJ; Tian, R				Wang, Hongxi; Zhang, Chao; Li, Qianrui; Tian, Tian; Huang, Rui; Qiu, Jiajun; Tian, Rong			Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches	BMC CANCER			English	Article						Papillary thyroid cancer; Recurrence; Machine learning; Prediction model	MANAGEMENT GUIDELINES; ASSOCIATION; CARCINOMA; SURVIVAL; NODULES	Background Although papillary thyroid cancer (PTC) patients are known to have an excellent prognosis, up to 30% of patients experience disease recurrence after initial treatment. Accurately predicting disease prognosis remains a challenge given that the predictive value of several predictors remains controversial. Thus, we investigated whether machine learning (ML) approaches based on comprehensive predictors can predict the risk of structural recurrence for PTC patients. Methods A total of 2244 patients treated with thyroid surgery and radioiodine were included. Twenty-nine perioperative variables consisting of four dimensions (demographic characteristics and comorbidities, tumor-related variables, lymph node (LN)-related variables, and metabolic and inflammatory markers) were analyzed. We applied five ML algorithms-logistic regression (LR), support vector machine (SVM), extreme gradient boosting (XGBoost), random forest (RF), and neural network (NN)-to develop the models. The area under the receiver operating characteristic (AUC-ROC) curve, calibration curve, and variable importance were used to evaluate the models' performance. Results During a median follow-up of 45.5 months, 179 patients (8.0%) experienced structural recurrence. The non-stimulated thyroglobulin, LN dissection, number of LNs dissected, lymph node metastasis ratio, N stage, comorbidity of hypertension, comorbidity of diabetes, body mass index, and low-density lipoprotein were used to develop the models. All models showed a greater AUC (AUC = 0.738 to 0.767) than did the ATA risk stratification (AUC = 0.620, DeLong test: P < 0.01). The SVM, XGBoost, and RF model showed greater sensitivity (0.568, 0.595, 0.676), specificity (0.903, 0.857, 0.784), accuracy (0.875, 0.835, 0.775), positive predictive value (PPV) (0.344, 0.272, 0.219), negative predictive value (NPV) (0.959, 0.959, 0.964), and F1 score (0.429, 0.373, 0.331) than did the ATA risk stratification (sensitivity = 0.432, specificity = 0.770, accuracy = 0.742, PPV = 0.144, NPV = 0.938, F1 score = 0.216). The RF model had generally consistent calibration compared with the other models. The Tg and the LNR were the top 2 important variables in all the models, the N stage was the top 5 important variables in all the models. Conclusions The RF model achieved the expected prediction performance with generally good discrimination, calibration and interpretability in this study. This study sheds light on the potential of ML approaches for improving the accuracy of risk stratification for PTC patients.	[Wang, Hongxi; Li, Qianrui; Tian, Tian; Huang, Rui; Tian, Rong] Sichuan Univ, West China Hosp, Dept Nucl Med, 37 Guoxue Alley, Chengdu 610041, Peoples R China; [Zhang, Chao; Qiu, Jiajun] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Tian, R (corresponding author), Sichuan Univ, West China Hosp, Dept Nucl Med, 37 Guoxue Alley, Chengdu 610041, Peoples R China.; Qiu, JJ (corresponding author), Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu 610041, Peoples R China.	qiujiajun@wchscu.cn; rongtiannuclear@126.com	Wang, Hongxi/KMA-2633-2024		The 1<middle dot>3<middle dot>5 Project for Disciplines of Excellence, West China Hospital, Sichuan University	The 1<middle dot>3<middle dot>5 Project for Disciplines of Excellence, West China Hospital, Sichuan University	Not applicable.	Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; [Anonymous], 2019, 2019 IEEE C EV COMP; Banerjee M, 2018, J CLIN ENDOCR METAB, V103, P2720, DOI 10.1210/jc.2018-00511; Barrett BJ, 2021, Springer US: New York, NY, P319; Bennin KE, 2022, IET SOFTW, V16, P185, DOI 10.1049/sfw2.12052; Borzooei S, 2024, EUR ARCH OTO-RHINO-L, V281, P2095, DOI 10.1007/s00405-023-08299-w; Chen DW, 2020, CANCER-AM CANCER SOC, V126, P1512, DOI 10.1002/cncr.32670; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen WJ, 2020, CANCER MANAG RES, V12, P1809, DOI 10.2147/CMAR.S239296; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Francis GL, 2015, THYROID, V25, P716, DOI 10.1089/thy.2014.0460; Gravesteijn BY, 2021, J NEUROTRAUM, V38, P1842, DOI 10.1089/neu.2020.7218; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Ito Y, 2012, WORLD J SURG, V36, P1274, DOI 10.1007/s00268-012-1423-5; Jajroudi M, 2014, TECHNOL CANCER RES T, V13, P353, DOI 10.7785/tcrt.2012.500384; Jang SW, 2023, CANCERS, V15, DOI 10.3390/cancers15020550; Kim SY, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000027493; Kong GL, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01271-2; LASSO RR, 2016, 2016 IEEE INT C ADV; Lee J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50069-4; Lee JH, 2021, IRAN J PUBLIC HEALTH, V50, P1372, DOI 10.18502/ijph.v50i7.6626; Li CL, 2020, J ENDOCRINOL INVEST, V43, P1283, DOI 10.1007/s40618-020-01216-6; Li LR, 2022, METAB SYNDR RELAT D, V20, P466, DOI 10.1089/met.2022.0033; Liu WC, 2021, CANCER MED-US, V10, P2802, DOI 10.1002/cam4.3776; Montazeri M, 2016, TECHNOL HEALTH CARE, V24, P31, DOI 10.3233/THC-151071; Morris C, 2021, ACCIDENT ANAL PREV, V159, DOI 10.1016/j.aap.2021.106240; Mourad M, 2020, Thyroid Cancer Prognosis Sci Rep, V10, P5176; Nahm FS, 2022, KOREAN J ANESTHESIOL, V75, P25, DOI 10.4097/kja.21209; Offi C, 2021, ACTA OTORHINOLARYNGO, V41, P31, DOI 10.14639/0392-100X-N1089; Park YM, 2021, Sci Rep, V11; Parvathareddy SK, 2022, ENDOCR CONNECT, V11, DOI 10.1530/EC-21-0518; Rahman ST, 2020, THYROID, V30, P1518, DOI 10.1089/thy.2019.0654; Revilla G, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms241311153; Ritter A, 2020, J CLIN ENDOCR METAB, V105, pE2145, DOI 10.1210/clinem/dgaa152; Shi P, 2022, GLAND SURG, V11, P358, DOI 10.21037/gs-21-905; Shmilovici A, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P257, DOI 10.1007/0-387-25465-X_12; Svozil D, 1997, CHEMOMETR INTELL LAB, V39, P43, DOI 10.1016/S0169-7439(97)00061-0; Tian T, 2021, J CLIN ENDOCR METAB, V106, pE4688, DOI 10.1210/clinem/dgab445; Tong JH, 2021, CLIN MED INSIGHTS-ON, V15, DOI 10.1177/11795549211000017; Trésallet C, 2014, SURGERY, V156, P1145, DOI 10.1016/j.surg.2014.04.020; Tuttle RM, 2017, THYROID, V27, P751, DOI 10.1089/thy.2017.0102; Vaisman F, 2012, CLIN ENDOCRINOL, V77, P132, DOI 10.1111/j.1365-2265.2012.04342.x; Wessler BS, 2015, CIRC-CARDIOVASC QUAL, V8, P368, DOI 10.1161/CIRCOUTCOMES.115.001693; Yanli Liu, 2012, Information Computing and Applications. Proceedings of the Third International Conference, ICICA 2012, P246, DOI 10.1007/978-3-642-34062-8_32; Zhou CY, 2021, TECHNOL CANCER RES T, V20, DOI 10.1177/15330338211027910	47	3	3	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2407		BMC CANCER	BMC Cancer	APR 8	2024	24	1							427	10.1186/s12885-024-12146-4	http://dx.doi.org/10.1186/s12885-024-12146-4			12	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	NI5D2	38589799	gold			2024-09-18	WOS:001199827900005
J	Wang, D; Lee, SH; Geng, HZ; Zhong, HY; Plastaras, J; Wojcieszynski, A; Caruana, R; Xiao, Y				Wang, Du; Lee, Sang Ho; Geng, Huaizhi; Zhong, Haoyu; Plastaras, John; Wojcieszynski, Andrzej; Caruana, Richard; Xiao, Ying			Interpretable machine learning for predicting pathologic complete response in patients treated with chemoradiation therapy for rectal adenocarcinoma	FRONTIERS IN ARTIFICIAL INTELLIGENCE			English	Article						interpretable machine learning; radiomics; dosiomics; multi-view input data analysis; rectal cancer; pathologic complete response; clinical image processing	CELL LUNG-CANCER; TEXTURE ANALYSIS; RADIOMICS; HETEROGENEITY; RESISTANCE	PurposePathologic complete response (pCR) is a critical factor in determining whether patients with rectal cancer (RC) should have surgery after neoadjuvant chemoradiotherapy (nCRT). Currently, a pathologist's histological analysis of surgical specimens is necessary for a reliable assessment of pCR. Machine learning (ML) algorithms have the potential to be a non-invasive way for identifying appropriate candidates for non-operative therapy. However, these ML models' interpretability remains challenging. We propose using explainable boosting machine (EBM) to predict the pCR of RC patients following nCRT. MethodsA total of 296 features were extracted, including clinical parameters (CPs), dose-volume histogram (DVH) parameters from gross tumor volume (GTV) and organs-at-risk, and radiomics (R) and dosiomics (D) features from GTV. R and D features were subcategorized into shape (S), first-order (L1), second-order (L2), and higher-order (L3) local texture features. Multi-view analysis was employed to determine the best set of input feature categories. Boruta was used to select all-relevant features for each input dataset. ML models were trained on 180 cases from our institution, with 37 cases from RTOG 0822 clinical trial serving as the independent dataset for model validation. The performance of EBM in predicting pCR on the test dataset was evaluated using ROC AUC and compared with that of three state-of-the-art black-box models: extreme gradient boosting (XGB), random forest (RF) and support vector machine (SVM). The predictions of all black-box models were interpreted using Shapley additive explanations. ResultsThe best input feature categories were CP+DVH+S+R_L1+R_L2 for all models, from which Boruta-selected features enabled the EBM, XGB, RF, and SVM models to attain the AUCs of 0.820, 0.828, 0.828, and 0.774, respectively. Although EBM did not achieve the best performance, it provided the best capability for identifying critical turning points in response scores at distinct feature values, revealing that the bladder with maximum dose >50 Gy, and the tumor with maximum2DDiameterColumn >80 mm, elongation <0.55, leastAxisLength >50 mm and lower variance of CT intensities were associated with unfavorable outcomes. ConclusionsEBM has the potential to enhance the physician's ability to evaluate an ML-based prediction of pCR and has implications for selecting patients for a "watchful waiting" strategy to RC therapy.	[Wang, Du; Lee, Sang Ho; Geng, Huaizhi; Zhong, Haoyu; Plastaras, John; Wojcieszynski, Andrzej; Xiao, Ying] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Caruana, Richard] Microsoft Res, Redmond, WA USA	University of Pennsylvania; Microsoft	Lee, SH (corresponding author), Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	sangho.lee@pennmedicine.upenn.edu	Lee, Sang Ho/B-9149-2017	Lee, Sang Ho/0000-0002-4634-4904	National Cancer Institute [U24CA180803 (IROC), U10CA180868 (NRG)]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partially supported by grants U24CA180803 (IROC) and U10CA180868 (NRG) from the National Cancer Institute.	Aker M, 2019, DIS COLON RECTUM, V62, P163, DOI 10.1097/DCR.0000000000001224; [Anonymous], 2012, COL CANC STAT; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen FY, 2021, ACAD RADIOL, V28, pS87, DOI 10.1016/j.acra.2020.09.024; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen XJ, 2022, INT J COLORECTAL DIS, V37, P1621, DOI 10.1007/s00384-022-04157-z; Crimi F, 2020, RADIOL MED, V125, P1216, DOI 10.1007/s11547-020-01215-w; Cui YF, 2019, EUR RADIOL, V29, P1211, DOI 10.1007/s00330-018-5683-9; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; De Jay N, 2013, BIOINFORMATICS, V29, P2365, DOI 10.1093/bioinformatics/btt383; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; El Sissy C, 2020, CLIN CANCER RES, V26, P5198, DOI 10.1158/1078-0432.CCR-20-0337; Fernandez LM, 2020, DIS COLON RECTUM, V63, P1053, DOI 10.1097/DCR.0000000000001707; Frame F.M., 2017, J CANCER METAS TREAT, V3, P302, DOI [10.20517/2394-4722.2017.34, DOI 10.20517/2394-4722.2017.34]; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Giraud P, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00174; Gong YUT, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00047; Habr-Gama A, 2019, DIS COLON RECTUM, V62, P802, DOI 10.1097/DCR.0000000000001338; He B, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0887-8; Jamal-Hanjani M, 2015, CLIN CANCER RES, V21, P1258, DOI 10.1158/1078-0432.CCR-14-1429; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lao JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10649-8; Lee SH, 2021, INT J RADIAT ONCOL, V110, P1451, DOI 10.1016/j.ijrobp.2021.02.030; Lee SH, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/ab8531; Li YQ, 2019, CANCER MED-US, V8, P7244, DOI 10.1002/cam4.2636; Liang B, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00269; Liu ZY, 2017, CLIN CANCER RES, V23, P7253, DOI 10.1158/1078-0432.CCR-17-1038; Lou Y, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P623, DOI 10.1145/2487575.2487579; Lundberg SM, 2017, ADV NEUR IN, V30; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Nie K, 2016, CLIN CANCER RES, V22, P5256, DOI 10.1158/1078-0432.CCR-15-2997; Nori H, 2019, Arxiv, DOI [arXiv:1909.09223, 10.48550/arXiv.1909.09223, DOI 10.48550/ARXIV.1909.09223]; Rossi L, 2018, RADIOTHER ONCOL, V129, P548, DOI 10.1016/j.radonc.2018.07.027; Sao Juliao GP, 2020, ANN SURG, V272, P138, DOI 10.1097/SLA.0000000000003286; Sun Weijing, 2020, Am Soc Clin Oncol Educ Book, V40, P1, DOI 10.1200/EDBK_279871; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Wang JZ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51629-4	42	4	4	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-8212		FRONT ARTIF INTELL	Front. Artif. Intell.	DEC 7	2022	5								1059033	10.3389/frai.2022.1059033	http://dx.doi.org/10.3389/frai.2022.1059033			14	Computer Science, Artificial Intelligence; Computer Science, Information Systems	Emerging Sources Citation Index (ESCI)	Computer Science	7Z9JZ	36568580	Green Published, gold			2024-09-18	WOS:000915868500001
J	Alshamlan, HM				Alshamlan, Hala M.			DQB: A novel dynamic quantitive classification model using artificial bee colony algorithm with application on gene expression profiles	SAUDI JOURNAL OF BIOLOGICAL SCIENCES			English	Article						Classification rule; Artificial Bee Colony Algorithm; Quantitive rule-based classification model; Microarray; Gene expression profile; ABC; Cancer gene selection	MICROARRAY DATA; MOLECULAR CLASSIFICATION; PREDICTION; CANCER; DISCOVERY; SELECTION; TUMOR	In the medical domain, it is very significant to develop a rule-based classification model. This is because it has the ability to produce a comprehensible and understandable model that accounts for the predictions. Moreover, it is desirable to know not only the classification decisions but also what leads to these decisions. In this paper, we propose a novel dynamic quantitative rule-based classification model, namely DQB, which integrates quantitative association rule mining and the Artificial Bee Colony (ABC) algorithm to provide users with more convenience in terms of understandability and interpretability via an accurate class quantitative association rule-based classifier model. As far as we know, this is the first attempt to apply the ABC algorithm in mining for quantitative rule-based classifier models. In addition, this is the first attempt to use quantitative rule-based classification models for classifying microarray gene expression profiles. Also, in this research we developed a new dynamic local search strategy named DLS, which is improved the local search for artificial bee colony (ABC) algorithm. The performance of the proposed model has been compared with well-known quantitative-based classification methods and bioinspired meta-heuristic classification algorithms, using six gene expression profiles for binary and multi-class cancer datasets. From the results, it can be concludes that a considerable increase in classification accuracy is obtained for the DQB when compared to other available algorithms in the literature, and it is able to provide an interpretable model for biologists. This confirms the significance of the proposed algorithm in the constructing a classifier rule-based model, and accordingly proofs that these rules obtain a highly qualified and meaningful knowledge extracted from the training set, where all subset of quantitive rules report close to 100% classification accuracy with a minimum number of genes. It is remarkable that apparently (to the best of our knowledge) several new genes were discovered that have not been seen in any past studies. For the applicability demand, based on the results acqured from microarray gene expression analysis, we can conclude that DQB can be adopted in a different real world applications with some modifications. (c) 2018 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University.	[Alshamlan, Hala M.] King Saud Univ, Informat Technol Dept, Riyadh, Saudi Arabia; [Alshamlan, Hala M.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	King Saud University; Massachusetts Institute of Technology (MIT)	Alshamlan, HM (corresponding author), King Saud Univ, Informat Technol Dept, Riyadh, Saudi Arabia.	halshamlan@ksu.edu.sa	Alshamlan, Hala/HHN-0722-2022		Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud University	Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud University(King Saud University)	This research project was supported by a grant from the Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud University.	Abdi MJ, 2013, ENG APPL ARTIF INTEL, V26, P603, DOI 10.1016/j.engappai.2012.01.017; Al-Maqaleh B. M., 2012, INT J COMPUT APPL, V41, P40; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alshamlan Hala M., 2016, International Journal of Machine Learning and Computing, V6, P184, DOI 10.18178/ijmlc.2016.6.3.596; Alshamlan H. M., 2013, P WORLD C ENG, P2; Alshamlan H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/604910; Alshamlan HM, 2015, COMPUT BIOL CHEM, V56, P49, DOI 10.1016/j.compbiolchem.2015.03.001; [Anonymous], 1997, Proceedings of the Fourteenth International Conference on Machine Learning; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bijlani R, 2003, BIOINFORMATICS, V19, P62, DOI 10.1093/bioinformatics/19.1.62; Celik M., 2011, 2011 International Symposium on Innovations in Intelligent Systems and Applications (INISTA 2011), P96, DOI 10.1109/INISTA.2011.5946053; Cheng-San Yang, 2008, IAENG International Journal of Computer Science, V35, P285; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; El Akadi A, 2009, 2009 IEEE/ACS INTERNATIONAL CONFERENCE ON COMPUTER SYSTEMS AND APPLICATIONS, VOLS 1 AND 2, P69, DOI 10.1109/AICCSA.2009.5069306; Giugno R., 2013, PLOS ONE, V8; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Holden N., 2008, J ARTIFICIAL EVOLUTI, V2, P1; Huang HL, 2007, BIOSYSTEMS, V90, P516, DOI 10.1016/j.biosystems.2006.12.003; Huang HL, 2007, BIOSYSTEMS, V90, P78, DOI 10.1016/j.biosystems.2006.07.002; Iwen MA, 2008, PROC INT CONF DATA, P1062, DOI 10.1109/ICDE.2008.4497515; Jaiswal A., 2013, INT J EMERG SCI ENG, V18, P91; Javad A.M., 2012, COMPUT MATH METH MED; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kianmehr K, 2008, ARTIF INTELL MED, V44, P7, DOI 10.1016/j.artmed.2008.05.002; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee CP, 2011, APPL SOFT COMPUT, V11, P208, DOI 10.1016/j.asoc.2009.11.010; Liu Y, 2004, LECT NOTES COMPUT SC, V3309, P291; Liu Y., 2004, RULE DISCOVERY PARTI, P291, DOI [10.1007/978-3-540-30483-8_35, DOI 10.1007/978-3-540-30483-8_35]; Ma BLWHY., 1998, P 4 INT C KNOWL DISC; Mohd Afizi M. S., 2011, Modern Applied Science, V5, P217; Otero FEB, 2008, LECT NOTES COMPUT SC, V5217, P48, DOI 10.1007/978-3-540-87527-7_5; Parpinelli RS, 2002, DATA MINING: A HEURISTIC APPROACH, P191; Parpinelli RS, 2002, IEEE T EVOLUT COMPUT, V6, P321, DOI 10.1109/TEVC.2002.802452; Peng SH, 2003, FEBS LETT, V555, P358, DOI 10.1016/S0014-5793(03)01275-4; Qi S., 2007, ADV COMPUT SCI, V71, P157; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salleb-Aouissi A, 2013, J MACH LEARN RES, V14, P3153; Sousa T, 2004, PARALLEL COMPUT, V30, P767, DOI 10.1016/j.parco.2003.12.015; Talebi M., 2014, 2014 IR C INT SYST I, P1; Wang XS, 2009, CANCER INFORM, V7, P123; Yan XW, 2009, EXPERT SYST APPL, V36, P3066, DOI 10.1016/j.eswa.2008.01.028; Yu Hualong, 2009, Genomics Proteomics & Bioinformatics, V7, P200, DOI 10.1016/S1672-0229(08)60050-9	44	3	3	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1319-562X			SAUDI J BIOL SCI	Saudi J. Biol. Sci.	JUL	2018	25	5					932	946		10.1016/j.sjbs.2018.01.017	http://dx.doi.org/10.1016/j.sjbs.2018.01.017			15	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	GL7HO	30108444	gold, Green Published			2024-09-18	WOS:000437368700014
J	An, FP; Li, XW; Ma, XM				An, Fengping; Li, Xiaowei; Ma, Xingmin			Medical Image Classification Algorithm Based on Visual Attention Mechanism-MCNN	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article								Due to the complexity of medical images, traditional medical image classification methods have been unable to meet the actual application needs. In recent years, the rapid development of deep learning theory has provided a technical approach for solving medical image classification. However, deep learning has the following problems in the application of medical image classification. First, it is impossible to construct a deep learning model with excellent performance according to the characteristics of medical images. Second, the current deep learning network structure and training strategies are less adaptable to medical images. Therefore, this paper first introduces the visual attention mechanism into the deep learning model so that the information can be extracted more effectively according to the problem of medical images, and the reasoning is realized at a finer granularity. It can increase the interpretability of the model. Additionally, to solve the problem of matching the deep learning network structure and training strategy to medical images, this paper will construct a novel multiscale convolutional neural network model that can automatically extract high-level discriminative appearance features from the original image, and the loss function uses the Mahalanobis distance optimization model to obtain a better training strategy, which can improve the robust performance of the network model. The medical image classification task is completed by the above method. Based on the above ideas, this paper proposes a medical classification algorithm based on a visual attention mechanism-multiscale convolutional neural network. The lung nodules and breast cancer images were classified by the method in this paper. The experimental results show that the accuracy of medical image classification in this paper is not only higher than that of traditional machine learning methods but also improved compared with other deep learning methods, and the method has good stability and robustness.	[An, Fengping; Li, Xiaowei] Huaiyin Normal Univ, Sch Phys & Elect Elect Engn, Huaian 223300, Peoples R China; [Ma, Xingmin] North China Inst Comp Technol, Syst Dept 2, Beijing 100083, Peoples R China	Huaiyin Normal University	An, FP (corresponding author), Huaiyin Normal Univ, Sch Phys & Elect Elect Engn, Huaian 223300, Peoples R China.	anfengping@163.com; 8201711036@hytc.edu.cn; maxingmin1983@163.com		AN, FENGPING/0000-0002-2220-2987	Natural Science Foundation of Jiangsu Province [BK20201479]; National Natural Science Foundation of China [61701188]; China Postdoctoral Science Foundation [2019M650512]; Hebei IoT Monitoring Engineering Technology Research Center [IOT202004]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hebei IoT Monitoring Engineering Technology Research Center	This paper is supported by the Natural Science Foundation of Jiangsu Province (No. BK20201479), the National Natural Science Foundation of China (No. 61701188), China Postdoctoral Science Foundation (No. 2019M650512), and Hebei IoT Monitoring Engineering Technology Research Center funded project (No. IOT202004).	Akhtar N, 2018, IEEE ACCESS, V6, P14410, DOI 10.1109/ACCESS.2018.2807385; Alickovic E, 2019, INT C MED BIOL ENG, P519; Amodei D, DEEP SPEECH 2 END TO, P173; [Anonymous], 2017, ADV NEURAL INF PROCE; Anthimopoulos M, 2016, IEEE T MED IMAGING, V35, P1207, DOI 10.1109/TMI.2016.2535865; Cheng JZ, 2016, SCI REP-UK, V6, DOI [10.1038/srep24454, 10.1038/srep25671]; Dey N, 2016, CLASSIFICATION CLUST, DOI [10.4018/978-1-5225-0140-4, DOI 10.4018/978-1-5225-0140-4]; Ding SY, 2015, PATTERN RECOGN, V48, P2993, DOI 10.1016/j.patcog.2015.04.005; Tran D, 2015, IEEE I CONF COMP VIS, P4489, DOI 10.1109/ICCV.2015.510; El-Baz A., 2016, FRONT BIOSCI-LANDMRK; Erickson BJ, 2017, RADIOGRAPHICS, V37, P505, DOI 10.1148/rg.2017160130; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fayek HM, 2017, NEURAL NETWORKS, V92, P60, DOI 10.1016/j.neunet.2017.02.013; Fernandes SL, 2017, J MED IMAG HEALTH IN, V7, P1841, DOI 10.1166/jmihi.2017.2280; Firmino M, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-015-0120-7; Frid-Adar M, 2018, NEUROCOMPUTING, V321, P321, DOI 10.1016/j.neucom.2018.09.013; Ghosh S, 2017, IEEE REG 10 HUMANIT, P792, DOI 10.1109/R10-HTC.2017.8289075; Greff K, 2017, IEEE T NEUR NET LEAR, V28, P2222, DOI 10.1109/TNNLS.2016.2582924; He K., 2016, P IEEE C COMP VIS PA, P770; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Karabatak M, 2015, MEASUREMENT, V72, P32, DOI 10.1016/j.measurement.2015.04.028; Kawahara J, 2016, LECT NOTES COMPUT SC, V10019, P164, DOI 10.1007/978-3-319-47157-0_20; Khuriwal Naresh, 2018, 2018 International Conference on Advances in Computing, Communication Control and Networking (ICACCCN). Proceedings, P98, DOI 10.1109/ICACCCN.2018.8748777; Khuriwal N., 2018, 2018 3 INT C WORKSH, P1, DOI DOI 10.1109/ICRAIE.2018.8710426; Kontschieder P, 2015, IEEE I CONF COMP VIS, P1467, DOI 10.1109/ICCV.2015.172; Lan T, 2018, J MED IMAG HEALTH IN, V8, P464, DOI 10.1166/jmihi.2018.2345; Lee JG, 2017, KOREAN J RADIOL, V18, P570, DOI 10.3348/kjr.2017.18.4.570; Lee MC, 2010, ARTIF INTELL MED, V50, P43, DOI 10.1016/j.artmed.2010.04.011; Mao KM, 2016, J MED IMAG HEALTH IN, V6, P1679, DOI 10.1166/jmihi.2016.1871; Miao DQ, 2011, INT J APPROX REASON, V52, P1103, DOI 10.1016/j.ijar.2011.05.006; Nie Dong, 2016, Med Image Comput Comput Assist Interv, V9901, P212, DOI 10.1007/978-3-319-46723-8_25; Payan A., 2015, arXiv; Peikari M., 2018, MED IMAGING DIGITAL, P10581; Plis SM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00229; Schilham AMR, 2006, MED IMAGE ANAL, V10, P247, DOI 10.1016/j.media.2005.09.003; Schmid V.J., 2014, PATTERN RECOGN; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Sekaran K, 2020, MULTIMED TOOLS APPL, V79, P10233, DOI 10.1007/s11042-019-7419-5; Setio AAA, 2016, IEEE T MED IMAGING, V35, P1160, DOI 10.1109/TMI.2016.2536809; Suetens P, 2017, FUNDAMENTALS OF MEDICAL IMAGING, 3RD EDITION, P1, DOI 10.1017/9781316671849; Suk HI, 2013, LECT NOTES COMPUT SC, V8150, P583, DOI 10.1007/978-3-642-40763-5_72; Suk HI, 2014, NEUROIMAGE, V101, P569, DOI 10.1016/j.neuroimage.2014.06.077; Suzuki K, 2005, IEEE T MED IMAGING, V24, P1138, DOI 10.1109/TMI.2005.852048; Suzuki K, 2003, MED PHYS, V30, P1602, DOI 10.1118/1.1580485; Suzuki K, 2017, RADIOL PHYS TECHNOL, V10, P257, DOI 10.1007/s12194-017-0406-5; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Takahashi N, 2018, IEEE T MULTIMEDIA, V20, P513, DOI 10.1109/TMM.2017.2751969; Way TW, 2009, MED PHYS, V36, P3086, DOI 10.1118/1.3140589; Wu G, 2015, J MED IMAG HEALTH IN, V5, P184, DOI 10.1166/jmihi.2015.1382; Wu GR, 2016, IEEE T BIO-MED ENG, V63, P1505, DOI 10.1109/TBME.2015.2496253; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Zhang C., P 25 ACM INT C MULT, P1955; Zhang Q, 2016, ULTRASONICS, V72, P150, DOI 10.1016/j.ultras.2016.08.004; Zhang RK, 2017, IEEE J BIOMED HEALTH, V21, P41, DOI 10.1109/JBHI.2016.2635662	54	14	14	2	50	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	FEB 20	2021	2021								6280690	10.1155/2021/6280690	http://dx.doi.org/10.1155/2021/6280690			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	QR6LU	33688390	Green Published, gold			2024-09-18	WOS:000625328600002
J	Pacal, I; Celik, O; Bayram, B; Cunha, A				Pacal, Ishak; Celik, Omer; Bayram, Bilal; Cunha, Antonio			Enhancing EfficientNetv2 with global and efficient channel attention mechanisms for accurate MRI-Based brain tumor classification	CLUSTER COMPUTING-THE JOURNAL OF NETWORKS SOFTWARE TOOLS AND APPLICATIONS			English	Article						Brain cancer diagnosis; Deep learning; EfficientNetv2; ECA; GAM; Grad-CAM	EPIDEMIOLOGY	The early and accurate diagnosis of brain tumors is critical for effective treatment planning, with Magnetic Resonance Imaging (MRI) serving as a key tool in the non-invasive examination of such conditions. Despite the advancements in Computer-Aided Diagnosis (CADx) systems powered by deep learning, the challenge of accurately classifying brain tumors from MRI scans persists due to the high variability of tumor appearances and the subtlety of early-stage manifestations. This work introduces a novel adaptation of the EfficientNetv2 architecture, enhanced with Global Attention Mechanism (GAM) and Efficient Channel Attention (ECA), aimed at overcoming these hurdles. This enhancement not only amplifies the model's ability to focus on salient features within complex MRI images but also significantly improves the classification accuracy of brain tumors. Our approach distinguishes itself by meticulously integrating attention mechanisms that systematically enhance feature extraction, thereby achieving superior performance in detecting a broad spectrum of brain tumors. Demonstrated through extensive experiments on a large public dataset, our model achieves an exceptional high-test accuracy of 99.76%, setting a new benchmark in MRI-based brain tumor classification. Moreover, the incorporation of Grad-CAM visualization techniques sheds light on the model's decision-making process, offering transparent and interpretable insights that are invaluable for clinical assessment. By addressing the limitations inherent in previous models, this study not only advances the field of medical imaging analysis but also highlights the pivotal role of attention mechanisms in enhancing the interpretability and accuracy of deep learning models for brain tumor diagnosis. This research sets the stage for advanced CADx systems, enhancing patient care and treatment outcomes.	[Pacal, Ishak] Igdir Univ, Fac Engn, Dept Comp Engn, TR-76000 Igdir, Turkiye; [Celik, Omer] Suleyman Demirel Univ, Social Sci Inst, Hlth Management Dept, TR-32000 Isparta, Turkiye; [Bayram, Bilal] Univ Hlth Sci, Van Educ & Res Hosp, Dept Neurol, TR-65000 Van, Turkiye; [Cunha, Antonio] Univ Tras Os Montes & Alto Douro, Dept Comp Sci, Vila Real, Portugal; [Cunha, Antonio] Univ Minho, ALGORITMI Ctr, Guimaraes, Portugal	Igdir University; Suleyman Demirel University; Van Training & Research Hospital; University of Health Sciences Turkey; University of Tras-os-Montes & Alto Douro; Universidade do Minho	Pacal, I (corresponding author), Igdir Univ, Fac Engn, Dept Comp Engn, TR-76000 Igdir, Turkiye.	ishak.pacal@igdir.edu.tr; d2040232964@ogr.sdu.edu.tr; bayrambilal3@gmail.com; acunha@utad.pt	Pacal, Ishak/HJJ-1662-2023; Cunha, Antonio/O-4088-2015	Cunha, Antonio/0000-0002-3458-7693	Trkiye Sagbreve;limath;k Enstitleri Bascedil;kanlimath;gbreve;imath;	Trkiye Sagbreve;limath;k Enstitleri Bascedil;kanlimath;gbreve;imath;	No Statement Available	Alanazi MF, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22010372; Ali S, 2022, ARCH COMPUT METHOD E, V29, P4871, DOI 10.1007/s11831-022-09758-z; Anantharajan S., 2024, MEASUREMENT SENSORS, V31, P101026, DOI 10.1016/j.measen.2024.101026; [Anonymous], Brain Tumor MRI Dataset | Kaggle; Awuah Wireko Andrew, 2024, World Neurosurg X, V23, P100301, DOI 10.1016/j.wnsx.2024.100301; Azhagiri M, 2024, MULTIMED TOOLS APPL, DOI 10.1007/s11042-024-18143-w; Bhagyalaxmi K, 2024, MULTIMED TOOLS APPL, DOI 10.1007/s11042-024-18129-8; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Celard P, 2023, NEURAL COMPUT APPL, V35, P2291, DOI 10.1007/s00521-022-07953-4; Celik M, 2024, EXPERT SYST APPL, V238, DOI 10.1016/j.eswa.2023.122159; Chahal PK, 2020, MULTIMED TOOLS APPL, V79, P21771, DOI 10.1007/s11042-020-08898-3; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Deepak S, 2023, NEUROCOMPUTING, V520, P94, DOI 10.1016/j.neucom.2022.11.039; Farajzadeh N, 2023, EXPERT SYST APPL, V224, DOI 10.1016/j.eswa.2023.119963; Farooq MU, 2023, COMPUT BIOL MED, V167, DOI 10.1016/j.compbiomed.2023.107570; Ghassemi N, 2020, BIOMED SIGNAL PROCES, V57, DOI 10.1016/j.bspc.2019.101678; Habiba SU., 2023, LECT NOTES NETWORKS, V569, P550, DOI [10.1007/978-3-031-19958-5_52/COVER, DOI 10.1007/978-3-031-19958-5_52/COVER]; Han K, 2019, GHOSTNET MORE FEATUR; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Herholz K, 2012, SEMIN NUCL MED, V42, P356, DOI 10.1053/j.semnuclmed.2012.06.001; Howard A, 2019, IEEE I CONF COMP VIS, P1314, DOI 10.1109/ICCV.2019.00140; Huang G, 2016, LECT NOTES COMPUT SC, V9908, P646, DOI 10.1007/978-3-319-46493-0_39; Jyothi P, 2023, ARTIF INTELL REV, V56, P2923, DOI 10.1007/s10462-022-10245-x; Karaman A, 2023, APPL INTELL, V53, P15603, DOI 10.1007/s10489-022-04299-1; Karaman A, 2023, EXPERT SYST APPL, V221, DOI 10.1016/j.eswa.2023.119741; Kolides A, 2023, SIMUL MODEL PRACT TH, V126, DOI 10.1016/j.simpat.2023.102754; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kunduracioglu I, 2024, J PLANT DIS PROTECT, V131, P1061, DOI 10.1007/s41348-024-00896-z; Lamba N, 2021, NEURO-ONCOLOGY, V23, P1447, DOI 10.1093/neuonc/noab101; Leblebicioglu Kurtulus Ikbal, 2024, J Stomatol Oral Maxillofac Surg, P101818, DOI 10.1016/j.jormas.2024.101818; Levy AS., 2024, EXPLORING LANDSCAPE, V181, P108; Liu Y, 2021, HOFFMANN GLOBAL ATTE; Liu Z, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P9992, DOI 10.1109/ICCV48922.2021.00986; Liu ZH, 2023, COMPLEX INTELL SYST, V9, P1001, DOI 10.1007/s40747-022-00815-5; Lubbad M, 2024, NEURAL COMPUT APPL, DOI 10.1007/s00521-023-09375-2; Lubbad MAH, 2024, J IMAGING INFORM MED, DOI 10.1007/s10278-024-01086-x; Mandle AK., 2024, INT J INFORM TECHNOL, DOI [10.1007/s41870-024-01782-5, DOI 10.1007/S41870-024-01782-5]; Mehnatkesh H, 2023, EXPERT SYST APPL, V213, DOI 10.1016/j.eswa.2022.119087; Mehta S, 2022, SEPARABLE SELF ATTEN; Muezzinoglu T, 2023, J DIGIT IMAGING, V36, P973, DOI 10.1007/s10278-023-00789-x; Myers D, 2024, CLUSTER COMPUT, V27, P1, DOI 10.1007/s10586-023-04203-7; Mzoughi H, 2020, J DIGIT IMAGING, V33, P903, DOI 10.1007/s10278-020-00347-9; Nazir M, 2021, COMPUT MED IMAG GRAP, V91, DOI 10.1016/j.compmedimag.2021.101940; Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8; Özkaraca O, 2023, LIFE-BASEL, V13, DOI 10.3390/life13020349; Pacal I, 2024, KNOWL-BASED SYST, V289, DOI 10.1016/j.knosys.2024.111482; Pacal I, 2024, INT J MACH LEARN CYB, V15, P3579, DOI 10.1007/s13042-024-02110-w; Pacal I, 2024, EXPERT SYST APPL, V238, DOI 10.1016/j.eswa.2023.122099; Pacal I, 2023, NEURAL COMPUT APPL, V35, P18813, DOI 10.1007/s00521-023-08757-w; Pacal I, 2021, COMPUT BIOL MED, V134, DOI 10.1016/j.compbiomed.2021.104519; PKA Vasu J, 2023, FASTVIT FAST HYBRID; Rahman T., 2023, MEAS SENS, V26, P100694; Rao PK, 2023, BIOMED SIGNAL PROCES, V82, DOI 10.1016/j.bspc.2022.104549; Rehman A, 2020, CIRC SYST SIGNAL PR, V39, P757, DOI 10.1007/s00034-019-01246-3; Remzan N, 2024, MULTIMED TOOLS APPL, DOI 10.1007/s11042-024-18780-1; Roth HR, 2016, IEEE T MED IMAGING, V35, P1170, DOI 10.1109/TMI.2015.2482920; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Sajjad M, 2019, J COMPUT SCI-NETH, V30, P174, DOI 10.1016/j.jocs.2018.12.003; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Sharif MI, 2022, COMPLEX INTELL SYST, V8, P3007, DOI 10.1007/s40747-021-00321-0; Siegel Rebecca L, 2024, CA Cancer J Clin, V74, P12, DOI 10.3322/caac.21820; Siegel RL, 2023, CA-CANCER J CLIN, V73, P233, DOI 10.3322/caac.21772; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Swati ZNK, 2019, COMPUT MED IMAG GRAP, V75, P34, DOI 10.1016/j.compmedimag.2019.05.001; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Tabatabaei S, 2023, BIOMED SIGNAL PROCES, V86, DOI 10.1016/j.bspc.2023.105119; Tan MX, 2021, PR MACH LEARN RES, V139, P7102; Tan MX, 2019, PR MACH LEARN RES, V97; Tang Y, 2022, GHOSTNETV2 ENHANCE C; Touvron H, 2021, RESMLP FEEDFORWARD N; Touvron H, AI DEIT 3 REVENGE VI, P1; Tu ZZ, 2022, LECT NOTES COMPUT SC, V13684, P459, DOI 10.1007/978-3-031-20053-3_27; Tummala S, 2022, CURR ONCOL, V29, P7498, DOI 10.3390/curroncol29100590; Ullah Z, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-36311-0; Ullah Z, 2023, EXPERT SYST APPL, V216, DOI 10.1016/j.eswa.2022.119475; Ullah Z, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-022-27266-9; Ullah Z, 2022, INFORM SCIENCES, V608, P1541, DOI 10.1016/j.ins.2022.07.044; Villanueva-Meyer JE, 2017, NEUROSURGERY, V81, P397, DOI 10.1093/neuros/nyx103; Wang J, 2021, MOBILE NETW APPL, V26, P351, DOI 10.1007/s11036-020-01672-7; Wang N, 2023, BIOMED OPT EXPRESS, V14, DOI 10.1364/BOE.477311; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Wu B G, 2020, 2020 IEEE CVF C COMP, P11531; Younis A, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12147282; Yu P, 2023, INCEPTIONNEXT INCEPT; Yu W, 2022, METAFORMER BASELINES; Zador AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11786-6; Zebari NA, 2024, CAAI T INTELL TECHNO, V9, P790, DOI 10.1049/cit2.12276; Zulfiqar F, 2023, BIOMED SIGNAL PROCES, V84, DOI 10.1016/j.bspc.2023.104777	89	5	5	6	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1386-7857	1573-7543		CLUSTER COMPUT	Cluster Comput.	NOV	2024	27	8					11187	11212		10.1007/s10586-024-04532-1	http://dx.doi.org/10.1007/s10586-024-04532-1		MAY 2024	26	Computer Science, Information Systems; Computer Science, Theory & Methods	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	F3I5B		hybrid			2024-09-18	WOS:001228188100003
J	Frasca, F; Matteucci, M; Leone, M; Morelli, MJ; Masseroli, M				Frasca, Fabrizio; Matteucci, Matteo; Leone, Michele; Morelli, Marco J.; Masseroli, Marco			Accurate and highly interpretable prediction of gene expression from histone modifications	BMC BIOINFORMATICS			English	Article						Gene expression regulation; Histone modifications; Epigenetics; Interpretability	CHROMATIN	Background Histone Mark Modifications (HMs) are crucial actors in gene regulation, as they actively remodel chromatin to modulate transcriptional activity: aberrant combinatorial patterns of HMs have been connected with several diseases, including cancer. HMs are, however, reversible modifications: understanding their role in disease would allow the design of 'epigenetic drugs' for specific, non-invasive treatments. Standard statistical techniques were not entirely successful in extracting representative features from raw HM signals over gene locations. On the other hand, deep learning approaches allow for effective automatic feature extraction, but at the expense of model interpretation. Results Here, we propose ShallowChrome, a novel computational pipeline to model transcriptional regulation via HMs in both an accurate and interpretable way. We attain state-of-the-art results on the binary classification of gene transcriptional states over 56 cell-types from the REMC database, largely outperforming recent deep learning approaches. We interpret our models by extracting insightful gene-specific regulative patterns, and we analyse them for the specific case of the PAX5 gene over three differentiated blood cell lines. Finally, we compare the patterns we obtained with the characteristic emission patterns of ChromHMM, and show that ShallowChrome is able to coherently rank groups of chromatin states w.r.t. their transcriptional activity. Conclusions In this work we demonstrate that it is possible to model HM-modulated gene expression regulation in a highly accurate, yet interpretable way. Our feature extraction algorithm leverages on data downstream the identification of enriched regions to retrieve gene-wise, statistically significant and dynamically located features for each HM. These features are highly predictive of gene transcriptional state, and allow for accurate modeling by computationally efficient logistic regression models. These models allow a direct inspection and a rigorous interpretation, helping to formulate quantifiable hypotheses.	[Frasca, Fabrizio; Matteucci, Matteo; Leone, Michele; Masseroli, Marco] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Frasca, Fabrizio] Imperial Coll London, Dept Comp, London, England; [Morelli, Marco J.] Osped San Raffaele, Ctr Omics Sci, Milan, Italy	Polytechnic University of Milan; Imperial College London; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Frasca, F (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy.; Frasca, F (corresponding author), Imperial Coll London, Dept Comp, London, England.	f.frasca18@imperial.ac.uk	Morelli, Marco/AAN-1879-2020	Leone, Michele/0000-0002-2618-5985	ERC [693174]; European Research Council [20162021]	ERC(European Research Council (ERC)); European Research Council(European Research Council (ERC))	This work was supported by the ERC Advanced Grant 693174 "Data-Driven Genomic Computing (GeCo)". project (20162021), funded by the European Research Council, which covered also the publication costs. The funding body did not have any role in the design of the study and in the collection, analysis and interpretation of the data, as well as in writing the manuscript.	Agarwal V, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107663; [Anonymous], 2015, P INT C LEARN REPR; Avsec Z, 2021, NAT METHODS, V18, P1196, DOI 10.1038/s41592-021-01252-x; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Cheng C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r15; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Costa IG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S29; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Ernst J, 2017, NAT PROTOC, V12, P2478, DOI 10.1038/nprot.2017.124; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fuxa M, 2007, J IMMUNOL, V178, P8221, DOI 10.4049/jimmunol.178.12.8221-a; Heyn P, 2019, NAT GENET, V51, P96, DOI 10.1038/s41588-018-0274-x; Hlady RA, 2019, HEPATOLOGY, V69, P639, DOI 10.1002/hep.30211; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim AY, 2016, MOL CARCINOGEN, V55, P1411, DOI 10.1002/mc.22384; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Long MD, 2019, ONCOGENE, V38, P421, DOI 10.1038/s41388-018-0450-6; Lu YY, 2018, ADV NEUR IN, V31; Lundberg SM, 2017, ADV NEUR IN, V30; Masseroli M, 2019, BIOINFORMATICS, V35, P729, DOI 10.1093/bioinformatics/bty688; Masseroli M, 2015, BIOINFORMATICS, V31, P1881, DOI 10.1093/bioinformatics/btv048; Miller Jaime L, 2013, Subcell Biochem, V61, P289, DOI 10.1007/978-94-007-4525-4_13; Patnaik S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00588; Phillips T., 2008, Nature Education, V1, P199; Sekhon A, 2018, BIOINFORMATICS, V34, P891, DOI 10.1093/bioinformatics/bty612; Sharifi-Zarchi A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4353-7; Singh R, 2017, ADV NEUR IN, V30; Singh R, 2016, BIOINFORMATICS, V32, P639, DOI 10.1093/bioinformatics/btw427; Södersten E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03538-9; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; Zeng WW, 2020, BIOINFORMATICS, V36, P496, DOI 10.1093/bioinformatics/btz562; Zhang LR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5278-5; Zhou J, 2018, NAT GENET, V50, P1171, DOI 10.1038/s41588-018-0160-6	39	1	1	2	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	APR 26	2022	23	1							151	10.1186/s12859-022-04687-x	http://dx.doi.org/10.1186/s12859-022-04687-x			17	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	0U6MJ	35473556	gold, Green Published			2024-09-18	WOS:000787763300001
J	Camillo, LPD; Lapierre, LR; Singh, R				de Lima Camillo, Lucas Paulo; Lapierre, Louis R.; Singh, Ritambhara			A pan-tissue DNA-methylation epigenetic clock based on deep learning	NPJ AGING			English	Article							LIFE-SPAN; CANCER; AGE; DIFFERENTIATION; SENESCENCE; BIOMARKERS; CELLS	Several age predictors based on DNA methylation, dubbed epigenetic clocks, have been created in recent years, with the vast majority based on regularized linear regression. This study explores the improvement in the performance and interpretation of epigenetic clocks using deep learning. First, we gathered 142 publicly available data sets from several human tissues to develop AltumAge, a neural network framework that is a highly accurate and precise age predictor. Compared to ElasticNet, AltumAge performs better for within-data set and cross-data set age prediction, being particularly more generalizable in older ages and new tissue types. We then used deep learning interpretation methods to learn which methylation sites contributed to the final model predictions. We observe that while most important CpG sites are linearly related to age, some highly-interacting CpG sites can influence the relevance of such relationships. Using chromatin annotations, we show that the CpG sites with the highest contribution to the model predictions were related to gene regulatory regions in the genome, including proximity to CTCF binding sites. We also found age-related KEGG pathways for genes containing these CpG sites. Lastly, we performed downstream analyses of AltumAge to explore its applicability and compare its age acceleration with Horvath's 2013 model. We show that our neural network approach predicts higher age acceleration for tumors, for cells that exhibit age-related changes in vitro, such as immune and mitochondrial dysfunction, and for samples from patients with multiple sclerosis, type 2 diabetes, and HIV, among other conditions. Altogether, our neural network approach provides significant improvement and flexibility compared to current epigenetic clocks for both performance and model interpretability.	[de Lima Camillo, Lucas Paulo; Singh, Ritambhara] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Lapierre, Louis R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI USA; [Singh, Ritambhara] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Camillo, LPD; Singh, R (corresponding author), Brown Univ, Dept Comp Sci, Providence, RI 02912 USA.; Singh, R (corresponding author), Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA.	lucas_camillo@alumni.brown.edu; ritambhara@brown.edu	Lapierre, Louis/J-7604-2019	de Lima Camillo, Lucas Paulo/0000-0001-8166-0761; Lapierre, Louis/0000-0002-8154-141X	National Institute on Aging [AG051810, AG068922]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	L.R.L. is funded by a R01 (AG051810) and R21(AG068922) from the National Institute on Aging.	Alpaydin E, 1999, NEURAL COMPUT, V11, P1885, DOI 10.1162/089976699300016007; Ambatipudi S, 2017, EUR J CANCER, V75, P299, DOI 10.1016/j.ejca.2017.01.014; Arik SO, 2021, AAAI CONF ARTIF INTE, V35, P6679; Bahdanau D, 2016, Arxiv, DOI arXiv:1409.0473; Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Carriere J, 2021, IMMUNOLOGY, V163, P363, DOI 10.1111/imm.13372; Chen L, 2019, J GERONTOL A-BIOL, V74, P91, DOI 10.1093/gerona/gly223; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Camillo LPD, 2021, GEROSCIENCE, V43, P463, DOI 10.1007/s11357-021-00358-6; de Torre-Minguela C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00043; Du YM, 2019, INT J CLIN EXP PATHO, V12, P711; El Khoury LY, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1810-4; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fahy GM, 2019, AGING CELL, V18, DOI 10.1111/acel.13028; Fiorito G, 2019, AGING-US, V11, P2045, DOI 10.18632/aging.101900; Fitzgerald KN, 2021, AGING-US, V13, P9419, DOI 10.18632/aging.202913; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Galkin F, 2021, AGING DIS, V12, P1252, DOI 10.14336/AD.2020.1202; Goodfellow I. J., 2015, ARXIV14126572, V1050, P20; Guo L, 2017, STEM CELL REP, V9, P1780, DOI 10.1016/j.stemcr.2017.10.022; Han Y, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00807-2; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Holzscheck N, 2021, NPJ AGING MECH DIS, V7, DOI 10.1038/s41514-021-00068-5; Horvath S., 2020, bioRxiv, DOI DOI 10.1101/2020.05.07.082917; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0; Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Kadra A, 2021, ADV NEUR IN; Kanehisa M, 2020, PROTEIN SCI, V29, P28, DOI 10.1002/pro.3711; Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414; Levine ME, 2016, P NATL ACAD SCI USA, V113, P9327, DOI 10.1073/pnas.1604558113; Levine ME, 2015, AGING-US, V7, P690, DOI 10.18632/aging.100809; Levy JJ, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3443-8; Liu ZY, 2020, AGING CELL, V19, DOI 10.1111/acel.13229; Lozoya OA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005707; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Lu YY, 2018, ADV NEUR IN, V31; Lundberg SM, 2017, ADV NEUR IN, V30; Mahadevan S, 2014, HUM MOL GENET, V23, P706, DOI 10.1093/hmg/ddt457; Manukyan M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04789; Marecková K, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102458; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nuñez JK, 2021, CELL, V184, P2503, DOI 10.1016/j.cell.2021.03.025; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; Olova N, 2019, AGING CELL, V18, DOI 10.1111/acel.12877; Putin E, 2016, AGING-US, V8, P1021, DOI 10.18632/aging.100968; Putker M, 2015, ANTIOXID REDOX SIGN, V22, P15, DOI 10.1089/ars.2014.6056; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sae-Lee C, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800092; Sarkar TJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15174-3; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Smilkov D, 2017, Arxiv, DOI [arXiv:1706.03825, DOI 10.48550/ARXIV.1706.03825]; Sugrue VJ, 2021, ELIFE, V10, DOI 10.7554/eLife.64932; Sundararajan M, 2017, PR MACH LEARN RES, V70; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thompson MJ, 2018, AGING-US, V10, P2832, DOI 10.18632/aging.101590; Wang YZ, 2018, EPIGENETICS-US, V13, P975, DOI 10.1080/15592294.2018.1526028; Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479; Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629; Xie WB, 2018, CANCER CELL, V33, P309, DOI 10.1016/j.ccell.2018.01.008; Yuan T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004996; Zhao LJ, 2020, AGING DIS, V11, P927, DOI 10.14336/AD.2019.0820; Zheng YN, 2016, EBIOMEDICINE, V5, P68, DOI 10.1016/j.ebiom.2016.02.008; Zhou WD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw967; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	70	33	33	1	2	NATURE PUBL GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2731-6068		NPJ AGING	npj Aging	APR 19	2022	8	1							4	10.1038/s41514-022-00085-y	http://dx.doi.org/10.1038/s41514-022-00085-y			15	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	7J2UP		hybrid, Green Submitted, Green Published			2024-09-18	WOS:000904439800001
J	Deziel, NC; Clark, CJ; Casey, JA; Bell, ML; Plata, DL; Saiers, JE				Deziel, Nicole C.; Clark, Cassandra J.; Casey, Joan A.; Bell, Michelle L.; Plata, Desiree L.; Saiers, James E.			Assessing Exposure to Unconventional Oil and Gas Development: Strengths, Challenges, and Implications for Epidemiologic Research	CURRENT ENVIRONMENTAL HEALTH REPORTS			English	Article						Unconventional oil and gas; Exposure assessment; Children's health; Epidemiologic studies	INDOOR RADON CONCENTRATIONS; WASTE-WATER; BIRTH OUTCOMES; DRINKING-WATER; RESIDENTIAL-MOBILITY; INDUCED EARTHQUAKES; ORGANIC-COMPOUNDS; CANCER INCIDENCE; WEST-VIRGINIA; SHALE	Purpose of Review Epidemiologic studies have observed elevated health risks in populations living near unconventional oil and gas development (UOGD). In this narrative review, we discuss strengths and limitations of UOG exposure assessment approaches used in or available for epidemiologic studies, emphasizing studies of children's health outcomes. Recent Findings Exposure assessment challenges include (1) numerous potential stressors with distinct spatiotemporal patterns, (2) critical exposure windows that cover long periods and occur in the past, and (3) limited existing monitoring data coupled with the resource-intensiveness of collecting new exposure measurements to capture spatiotemporal variation. All epidemiologic studies used proximity-based models for exposure assessment as opposed to surveys, biomonitoring, or environmental measurements. Nearly all studies used aggregate (rather than pathway-specific) models, which are useful surrogates for the complex mix of potential hazards. Summary Simple and less-specific exposure assessment approaches have benefits in terms of scalability, interpretability, and relevance to specific policy initiatives such as set-back distances. More detailed and specific models and metrics, including dispersion methods and stressor-specific models, could reduce exposure misclassification, illuminate underlying exposure pathways, and inform emission control and exposure mitigation strategies. While less practical in a large population, collection of multi-media environmental and biological exposure measurements would be feasible in cohort subsets. Such assessments are well-suited to provide insights into the presence and magnitude of exposures to UOG-related stressors in relation to spatial surrogates and to better elucidate the plausibility of observed effects in both children and adults.	[Deziel, Nicole C.; Clark, Cassandra J.] Yale Sch Publ Hlth, Dept Environm Hlth Sci, 60 Coll St, New Haven, CT 06510 USA; [Casey, Joan A.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, 630 West 168th St,Room 16-416, New York, NY 10032 USA; [Bell, Michelle L.; Saiers, James E.] Yale Sch Environm, 195 Prospect St, New Haven, CT 06511 USA; [Plata, Desiree L.] MIT, Parsons Lab, Dept Civil & Environm Engn, 15 Vassar St, Cambridge, MA 02139 USA	Yale University; Columbia University; Massachusetts Institute of Technology (MIT)	Deziel, NC (corresponding author), Yale Sch Publ Hlth, Dept Environm Hlth Sci, 60 Coll St, New Haven, CT 06510 USA.	Nicole.deziel@yale.edu; cassie.clark@yale.edu; jac2250@cumc.columbia.edu; michelle.bell@yale.edu; dplata@mit.edu; james.saiers@yale.edu	Casey, Joan/H-6405-2019; Bell, Michelle/Y-4608-2018	BELLO, AMINU/0000-0001-5021-5542	U.S. Environmental Protection Agency [CR839249]; National Institute of Environmental Health Sciences under the National Institutes of Health [F31ES031441]; Yale Cancer Center [T32CA250803]; Yale Institute for Biospheric Studies; National Institutes of Health [R00 ES027023]; EPA [CR839249, 1098938] Funding Source: Federal RePORTER; National Institute of Environmental Health Sciences [F31ES031441, R00ES027023] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences under the National Institutes of Health; Yale Cancer Center; Yale Institute for Biospheric Studies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was developed under Assistance Agreement No. CR839249 awarded by the U.S. Environmental Protection Agency to Yale University. It has not been formally reviewed by EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication. JAC was funded by the National Institutes of Health R00 ES027023. CJC was also supported by the National Institute of Environmental Health Sciences under the National Institutes of Health [F31ES031441], the Yale Cancer Center [T32CA250803], and the Yale Institute for Biospheric Studies.	Abramzon S, 2014, J INFRASTRUCT SYST, V20, DOI 10.1061/(ASCE)IS.1943-555X.0000203; Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Akob DM, 2016, ENVIRON SCI TECHNOL, V50, P5517, DOI 10.1021/acs.est.6b00428; Allshouse WB, 2019, ENVIRON SCI TECHNOL, V53, P7126, DOI 10.1021/acs.est.9b00052; Allshouse WB, 2017, ENVIRON SCI TECHNOL, V51, P10243, DOI 10.1021/acs.est.7b02084; Apergis N, 2019, ENVIRON SCI POLLUT R, V26, P32360, DOI 10.1007/s11356-019-06478-z; Axelsson G, 2013, INT J ENV RES PUB HE, V10, P1418, DOI 10.3390/ijerph10041418; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Beleche T, 2018, ECON HUM BIOL, V31, P69, DOI 10.1016/j.ehb.2018.08.001; Bell ML, 2018, J EXPO SCI ENV EPID, V28, P470, DOI 10.1038/s41370-018-0026-0; Bell ML, 2012, J EXPO SCI ENV EPID, V22, P429, DOI 10.1038/jes.2012.42; Boslett A, 2021, RESOUR ENERGY ECON, V64, DOI 10.1016/j.reseneeco.2021.101220; Brantley SL, 2014, INT J COAL GEOL, V126, P140, DOI 10.1016/j.coal.2013.12.017; Brown VJ, 2014, ENVIRON HEALTH PERSP, V122, pA50, DOI 10.1289/ehp.122-A50; Burgos WD, 2017, ENVIRON SCI TECHNOL, V51, P8851, DOI 10.1021/acs.est.7b01696; Burnett JW, 2021, RESOUR ENERGY ECON, V63, DOI 10.1016/j.reseneeco.2020.101212; Busby C., 2017, Journal of Environmental Protection, V8, P381; Caron-Beaudoin É, 2021, J EXPO SCI ENV EPID, V31, P53, DOI 10.1038/s41370-020-0245-z; Caron-Beaudoin É, 2019, J EXPO SCI ENV EPID, V29, P613, DOI 10.1038/s41370-019-0144-3; Caron-Beaudoin E, 2018, ENVIRON INT, V110, P131, DOI 10.1016/j.envint.2017.10.022; Casey JA, 2019, ENVIRON RES, V177, DOI 10.1016/j.envres.2019.108598; Casey Joan A, 2018, Environ Epidemiol, V2, pe016, DOI 10.1097/EE9.0000000000000016; Casey JA, 2019, SCI TOTAL ENVIRON, V650, P2974, DOI 10.1016/j.scitotenv.2018.10.043; Casey JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29747-2; Casey JA, 2016, EPIDEMIOLOGY, V27, pE37, DOI 10.1097/EDE.0000000000000537; Casey JA, 2015, ENVIRON HEALTH PERSP, V123, P1130, DOI 10.1289/ehp.1409014; Caulton DR, 2014, P NATL ACAD SCI USA, V111, P6237, DOI 10.1073/pnas.1316546111; Clancy SA, 2018, SCI TOTAL ENVIRON, V626, P1463, DOI 10.1016/j.scitotenv.2018.01.177; Clark CJ, 2021, ENERGY RES SOC SCI, V76, DOI 10.1016/j.erss.2021.102070; Clark CJ, ENVIRON SCI TECHNOL, V2022; Colborn T, 2014, HUM ECOL RISK ASSESS, V20, P86, DOI 10.1080/10807039.2012.749447; Cozzarelli IM, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142909; Currie J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603021; Cushing LJ, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP6394; Czolowski ED, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP1535, 10.1289/ehp1535]; Davies RJ, 2014, MAR PETROL GEOL, V56, P239, DOI 10.1016/j.marpetgeo.2014.03.001; Denham A, 2019, PUBLIC HEALTH, V168, P17, DOI 10.1016/j.puhe.2018.11.020; Denham A, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2021.110872; Deziel NC, 2021, ENVIRON HEALTH PERSP, V129, DOI 10.1289/EHP9715; Deziel NC, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2020.109124; Deziel NC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194203; DiGiulio DC, 2016, ENVIRON SCI TECHNOL, V50, P4524, DOI 10.1021/acs.est.5b04970; Down A, 2015, APPL GEOCHEM, V60, P3, DOI 10.1016/j.apgeochem.2015.01.018; Drollette BD, 2015, P NATL ACAD SCI USA, V112, P13184, DOI 10.1073/pnas.1511474112; Eitrheim ES, 2016, ENVIRON SCI TECH LET, V3, P425, DOI 10.1021/acs.estlett.6b00439; Elliott EG, 2018, ENVIRON RES, V167, P550, DOI 10.1016/j.envres.2018.08.022; Elliott EG, 2017, SCI TOTAL ENVIRON, V576, P138, DOI 10.1016/j.scitotenv.2016.10.072; Elliott EG, 2017, J EXPO SCI ENV EPID, V27, P90, DOI 10.1038/jes.2015.81; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Elser H, 2020, ENERGY RES SOC SCI, V70, DOI 10.1016/j.erss.2020.101798; Elsner M, 2016, ENVIRON SCI TECHNOL, V50, P3290, DOI 10.1021/acs.est.5b02818; Ferrar KJ, 2013, INT J OCCUP ENV HEAL, V19, P104, DOI 10.1179/2049396713Y.0000000024; Ferrar KJ, 2013, ENVIRON SCI TECHNOL, V47, P3472, DOI 10.1021/es301411q; Finkel ML, 2016, PUBLIC HEALTH, V141, P198, DOI 10.1016/j.puhe.2016.09.008; Fisher MP, 2018, J ENVIRON PSYCHOL, V55, P90, DOI 10.1016/j.jenvp.2017.12.008; Fontenot BE, 2013, ENVIRON SCI TECHNOL, V47, P10032, DOI 10.1021/es4011724; Franklin M, 2019, ENVIRON SCI TECHNOL, V53, P2220, DOI 10.1021/acs.est.8b05355; Fryzek J, 2013, J OCCUP ENVIRON MED, V55, P796, DOI 10.1097/JOM.0b013e318289ee02; Garcia-Gonzales DA, 2019, ANNU REV PUBL HEALTH, V40, P283, DOI 10.1146/annurev-publhealth-040218-043715; Getzinger GJ, 2015, ENVIRON SCI TECHNOL, V49, P8347, DOI 10.1021/acs.est.5b00471; Gilbert ES, 2009, INT J RADIAT BIOL, V85, P467, DOI 10.1080/09553000902883836; Goetz JD, 2015, ENVIRON SCI TECHNOL, V49, P7012, DOI 10.1021/acs.est.5b00452; Gonzalez DJX, 2020, ENVIRON EPIDEMIOL, V4, DOI 10.1097/EE9.0000000000000099; Graham J, 2015, ACCIDENT ANAL PREV, V74, P203, DOI 10.1016/j.aap.2014.11.003; Harkness JS, 2015, ENVIRON SCI TECHNOL, V49, P1955, DOI 10.1021/es504654n; Hays J, 2017, SCI TOTAL ENVIRON, V580, P448, DOI 10.1016/j.scitotenv.2016.11.118; Hays J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154164; Hill EL, 2022, J HEALTH ECON, V82, DOI 10.1016/j.jhealeco.2022.102595; Hill EL, 2018, J HEALTH ECON, V61, P134, DOI 10.1016/j.jhealeco.2018.07.004; Hoelzer K, 2016, ENVIRON SCI TECHNOL, V50, P8036, DOI 10.1021/acs.est.6b00430; James A, 2017, J ENVIRON ECON MANAG, V84, P125, DOI 10.1016/j.jeem.2016.12.004; Janitz AE, 2019, ENVIRON INT, V122, P381, DOI 10.1016/j.envint.2018.12.011; Jemielita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131093; Johnson NP, 2020, SEX TRANSM DIS, V47, P254, DOI 10.1097/OLQ.0000000000001127; Johnston JE, 2021, ENVIRON RES, V197, DOI 10.1016/j.envres.2021.111088; Kassotis CD, 2016, ENVIRON HEALTH PERSP, V124, P256, DOI 10.1289/ehp.1409535; Kim B, 2017, J ECON BEHAV ORGAN, V140, P354, DOI 10.1016/j.jebo.2017.05.014; Koehler K, 2018, ENVIRON SCI TECHNOL, V52, P6061, DOI 10.1021/acs.est.8b00507; Komarek TM, 2018, ANN REGIONAL SCI, V61, P113, DOI 10.1007/s00168-018-0861-x; Kondash AJ, 2017, SCI TOTAL ENVIRON, V574, P314, DOI 10.1016/j.scitotenv.2016.09.069; Lauer NE, 2018, ENVIRON SCI TECHNOL, V52, P955, DOI 10.1021/acs.est.7b04952; Lauer NE, 2016, ENVIRON SCI TECHNOL, V50, P5389, DOI 10.1021/acs.est.5b06349; Lee D, 2020, CURR ENV HLTH REP, V7, P129, DOI 10.1007/s40572-020-00267-4; Li L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19086-0; Li LX, 2022, NAT ENERGY, V7, P177, DOI 10.1038/s41560-021-00970-y; Li WY, 2018, ENVIRON INT, V121, P1210, DOI 10.1016/j.envint.2018.10.039; Lian QG, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03206-1; Lupo PJ, 2010, PAEDIATR PERINAT EP, V24, P200, DOI 10.1111/j.1365-3016.2010.01096.x; Ma Zqiang., Journal of Epidemiology and Public Health Reviews, DOI DOI 10.16966/2471-8211.107; Macey GP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-82; Maloney KO, 2017, SCI TOTAL ENVIRON, V581, P369, DOI [10.1016/j.scitotenv2016.12.142, 10.1016/j.scitotenv.2016.12.142]; Maloney KO, 2012, ENVIRON PRAC, V14, P278, DOI 10.1017/S146604661200035X; McAlexander TP, 2020, J AM COLL CARDIOL, V76, P2862, DOI 10.1016/j.jacc.2020.10.023; McKenzie LM, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.104949; McKenzie LM, 2019, ENVIRON RES, V170, P56, DOI 10.1016/j.envres.2018.12.004; McKenzie LM, 2018, ENVIRON SCI TECHNOL, V52, P4514, DOI 10.1021/acs.est.7b05983; McKenzie LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170423; McKenzie LM, 2016, ENVIRON SCI TECHNOL, V50, P11471, DOI 10.1021/acs.est.6b04391; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McMahon PB, 2019, ENVIRON SCI TECHNOL, V53, P8027, DOI 10.1021/acs.est.9b01440; Menclova AK, 2020, HEALTH ECON, V29, P1705, DOI 10.1002/hec.4162; Morrone Michele., 2015, Journal of Appalachian Studies, V21, P207, DOI DOI 10.5406/JAPPASTUD.21.2.0207; Muehlenbachs L, 2015, AM ECON REV, V105, P3633, DOI 10.1257/aer.20140079; National Research Council, 2006, HUM BIOM ENV CHEM; Nyhan MM, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.04.066; Nyhan MM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008245; Palmeiro-Silva YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191340; Paulik LB, 2018, ENVIRON POLLUT, V241, P397, DOI 10.1016/j.envpol.2018.05.010; Pedersen M, 2007, INT J HYG ENVIR HEAL, V210, P479, DOI 10.1016/j.ijheh.2007.01.013; Peng LZ, 2018, HEALTH ECON, V27, P956, DOI 10.1002/hec.3649; Physicians for Social Responsibility, 2021, FRACK FOR CHEM; Quitoriano V, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.00120; Rasmussen SG, 2016, JAMA INTERN MED, V176, P1334, DOI 10.1001/jamainternmed.2016.2436; Rich AL, 2013, NEW SOLUT, V23, P117, DOI 10.2190/NS.23.1.h; Roy AA, 2014, J AIR WASTE MANAGE, V64, P19, DOI 10.1080/10962247.2013.826151; Shi W, 2020, ENV CHEM OIL GAS APP; SHUSTERMAN D, 1992, ARCH ENVIRON HEALTH, V47, P76, DOI 10.1080/00039896.1992.9935948; Soriano MA, 2020, WATER RESOUR RES, V56, DOI 10.1029/2020WR028005; Soriano MA, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac10e0; Sovacool BK, 2014, RENEW SUST ENERG REV, V37, P249, DOI 10.1016/j.rser.2014.04.068; Stacy SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126425; Stringfellow WT, 2014, J HAZARD MATER, V275, P37, DOI 10.1016/j.jhazmat.2014.04.040; Sumner AJ, 2020, ENVIRON SCI-PROC IMP, V22, P945, DOI 10.1039/c9em00505f; Sumner AJ, 2019, ENVIRON SCI TECHNOL, V53, P8216, DOI 10.1021/acs.est.9b01896; Sumner AJ, 2018, ENVIRON SCI TECHNOL, V52, P9097, DOI 10.1021/acs.est.8b01591; Sumner AJ, 2018, ENVIRON SCI-PROC IMP, V20, P318, DOI 10.1039/c7em00470b; Tang IW, 2021, ENVIRON RES, V194, DOI 10.1016/j.envres.2020.110511; Torres L, 2018, SCI TOTAL ENVIRON, V626, P867, DOI 10.1016/j.scitotenv.2018.01.171; Tran KV, 2021, ENVIRON EPIDEMIOL, V5, DOI 10.1097/EE9.0000000000000172; Tran KV, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP5842; Turley B, 2020, WATER-SUI, V12, DOI 10.3390/w12010147; Tustin AW, 2016, ENVIRON HEALTH PERSP; US Energy Information Administration, 2020, US OIL NAT GAS WELLS; US Energy Information Administration, US ANN EST SHAL GAS; US Environmental Protection Agency, 2016, EPA600R16236F USEPA; US Environmental Protection Agency, 2019, EPA100B19001 USEPA; Warner NR, 2012, P NATL ACAD SCI USA, V109, P11961, DOI 10.1073/pnas.1121181109; Warren JL, 2018, AM J EPIDEMIOL, V187, P992, DOI 10.1093/aje/kwx335; Wen T, 2018, ENVIRON SCI TECHNOL, V52, P7149, DOI 10.1021/acs.est.8b01123; Whitworth KW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180966; Whitworth KW, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2622; Willis M, 2020, INT J EPIDEMIOL, V49, P1883, DOI 10.1093/ije/dyaa115; Willis MD, 2021, ENVIRON HEALTH PERSP, V129, DOI 10.1289/EHP7678; Willis MD, 2018, ENVIRON RES, V166, P402, DOI 10.1016/j.envres.2018.06.022; Willow A.J., 2016, Anthropologica, V58, P166, DOI [10.3138/anth.582.T01, DOI 10.3138/anth.582.T01, DOI 10.3138/ANTH.582.T01]; Xu YQ, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00076	146	13	13	9	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2196-5412		CURR ENV HLTH REP	Curr. Environ. Health Rep.	SEP	2022	9	3					436	450		10.1007/s40572-022-00358-4	http://dx.doi.org/10.1007/s40572-022-00358-4		MAY 2022	15	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	3Q2UT	35522388	hybrid, Green Published			2024-09-18	WOS:000791669500001
C	Jarosik, P; Lewandowski, M; Klimonda, Z; Byra, M			IEEE	Jarosik, Piotr; Lewandowski, Marcin; Klimonda, Ziemowit; Byra, Michal			Pixel-Wise Deep Reinforcement Learning Approach for Ultrasound Image Denoising	INTERNATIONAL ULTRASONICS SYMPOSIUM (IEEE IUS 2021)	IEEE International Ultrasonics Symposium		English	Proceedings Paper	IEEE International Ultrasonics Symposium (IEEE IUS)	SEP 11-16, 2021	ELECTR NETWORK	IEEE, IEEE Ultrason, Ferroelect & Frequency Control Soc		deep reinforcement learning; ultrasound imaging; image denoising; filtration; breast cancer		Ultrasound (US) imaging is widely used for the tissue characterization. However, US images commonly suffer from speckle noise, which degrades perceived image quality. Various deep learning approaches have been proposed for US image denoising, but most of them lack the interpretability of how the network is processing the US image (black box problem). In this work, we utilize a deep reinforcement learning (RL) approach, the pixelRL, to US image denoising. The technique utilizes a set of easily interpretable and commonly used filtering operations applied in a pixel-wise manner. In RL, software agents act in an unknown environment and receive appropriate numerical rewards. In our case, each pixel of the input US image has an agent and state of the environment is the current US image. Agents iteratively denoise the US image by executing the following pixel-wise pre-defined actions: Gaussian, bilateral, median and box filtering, pixel value increment/decrement and no action. The proposed approach can be used to generate action maps depicting operations applied to process different parts of the US image. Agents were pre-trained on natural gray-scale images and evaluated on the breast mass US images. To enable the evaluation, we artificially corrupted the US images with noise. Compared with the reference (noise free US images), filtration of the images with the proposed method increased the average peak signal-to-noise ratio (PSNR) score from 14 dB to 26 dB and increased the structure similarity index score from 0.22 to 0.54. Our work confirms that it is feasible to use pixel-wise RL techniques for the US image denoising.	[Jarosik, Piotr; Lewandowski, Marcin; Klimonda, Ziemowit; Byra, Michal] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland	Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Jarosik, P (corresponding author), Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland.	pjarosik@ippt.pan.pl	Byra, Michał/AAK-2839-2021	Jarosik, Piotr/0000-0001-5198-5012				Byra M, 2020, LECT NOTES COMPUT SC, V11867, P41, DOI 10.1007/978-3-030-31332-6_4; Cammarasana S., 2021, arXiv; Furuta R, 2020, IEEE T MULTIMEDIA, V22, P1704, DOI 10.1109/TMM.2019.2960636; Gupta N, 2005, IEEE T MED IMAGING, V24, P743, DOI 10.1109/TMI.2005.847401; Hyun D, 2019, IEEE T ULTRASON FERR, V66, P898, DOI 10.1109/TUFFC.2019.2903795; Jarosik P, 2020, BIOCYBERN BIOMED ENG, V40, P977, DOI 10.1016/j.bbe.2020.04.002; Karaoglu O, 2022, ENG SCI TECHNOL, V29, DOI 10.1016/j.jestch.2021.06.010; Lan YC, 2020, IEEE ACCESS, V8, P195327, DOI 10.1109/ACCESS.2020.3034230; Li WT, 2020, AAAI CONF ARTIF INTE, V34, P792; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Ma KD, 2017, IEEE T IMAGE PROCESS, V26, P1004, DOI 10.1109/TIP.2016.2631888; Mnih V, 2016, PR MACH LEARN RES, V48; Murdoch W. J., 2019, P NATL ACAD SCI, V116, p22 071; Nugroho HA, 2016, 2016 INTERNATIONAL ELECTRONICS SYMPOSIUM (IES), P450, DOI 10.1109/ELECSYM.2016.7861048; Piotrzkowska-Wróblewska H, 2017, MED PHYS, V44, P6105, DOI 10.1002/mp.12538; Ramos-Llordén G, 2015, IEEE T IMAGE PROCESS, V24, P345, DOI 10.1109/TIP.2014.2371244; Roth S, 2005, PROC CVPR IEEE, P860; Sagheer SVM, 2020, BIOMED SIGNAL PROCES, V61, DOI 10.1016/j.bspc.2020.102036; Shen YT, 2021, EUR J RADIOL, V139, DOI 10.1016/j.ejrad.2021.109717; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1	20	5	5	3	8	IEEE	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017 USA	1948-5719		978-0-7381-1209-1	IEEE INT ULTRA SYM			2021										10.1109/IUS52206.2021.9593591	http://dx.doi.org/10.1109/IUS52206.2021.9593591			4	Acoustics; Engineering, Biomedical; Engineering, Electrical & Electronic; Remote Sensing	Conference Proceedings Citation Index - Science (CPCI-S)	Acoustics; Engineering; Remote Sensing	BT4NE					2024-09-18	WOS:000832095000260
J	Jin, WN; Fatehi, M; Abhishek, K; Mallya, M; Toyota, B; Hamarneh, G				Jin, Weina; Fatehi, Mostafa; Abhishek, Kumar; Mallya, Mayur; Toyota, Brian; Hamarneh, Ghassan			Artificial intelligence in glioma imaging: challenges and advances	JOURNAL OF NEURAL ENGINEERING			English	Review						glioma imaging; brain radiomics; machine learning; deep learning	NEURAL-NETWORKS; DEEP; CLASSIFICATION; SEGMENTATION; TEMOZOLOMIDE; NEUROSCIENCE; MUTATIONS; SYSTEM; CANCER; 1P/19Q	Primary brain tumors including gliomas continue to pose significant management challenges to clinicians. While the presentation, the pathology, and the clinical course of these lesions are variable, the initial investigations are usually similar. Patients who are suspected to have a brain tumor will be assessed with computed tomography (CT) and magnetic resonance imaging (MRI). The imaging findings are used by neurosurgeons to determine the feasibility of surgical resection and plan such an undertaking. Imaging studies are also an indispensable tool in tracking tumor progression or its response to treatment. As these imaging studies are non-invasive, relatively cheap and accessible to patients, there have been many efforts over the past two decades to increase the amount of clinically-relevant information that can be extracted from brain imaging. Most recently, artificial intelligence (AI) techniques have been employed to segment and characterize brain tumors, as well as to detect progression or treatment-response. However, the clinical utility of such endeavours remains limited due to challenges in data collection and annotation, model training, and the reliability of AI-generated information. We provide a review of recent advances in addressing the above challenges. First, to overcome the challenge of data paucity, different image imputation and synthesis techniques along with annotation collection efforts are summarized. Next, various training strategies are presented to meet multiple desiderata, such as model performance, generalization ability, data privacy protection, and learning with sparse annotations. Finally, standardized performance evaluation and model interpretability methods have been reviewed. We believe that these technical approaches will facilitate the development of a fully-functional AI tool in the clinical care of patients with gliomas.	[Jin, Weina; Abhishek, Kumar; Mallya, Mayur; Hamarneh, Ghassan] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada; [Fatehi, Mostafa] Univ British Columbia, Div Neurosurg, Vancouver, BC, Canada; [Toyota, Brian] Queens Univ, Dept Surg, Kingston Gen Hosp, Kingston, ON, Canada	Simon Fraser University; University of British Columbia; Queens University - Canada	Jin, WN (corresponding author), Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada.	weinaj@sfu.ca; fatehi@alumni.ubc.ca; kabhishe@sfu.ca; mmallya@sfu.c; hamarneh@sfu.ca	Hamarneh, Ghassan/AAE-6673-2021; Kulkarni, Abhishek/KFQ-9655-2024	Fatehi, Mostafa/0000-0002-1460-3254; Mallya, Mayur/0000-0002-9432-4262; Hamarneh, Ghassan/0000-0001-5040-7448; Jin, Weina/0000-0001-9253-4779; Abhishek, Kumar/0000-0002-7341-9617	Natural Sciences and Engineering Research Council of Canada (NSERC); Simon Fraser University Big Data The Next Big Question Fund	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University Big Data The Next Big Question Fund	Partial funding for this project is provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) and Simon Fraser University Big Data The Next Big Question Fund.	Abadi M, 2016, CCS'16: PROCEEDINGS OF THE 2016 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P308, DOI 10.1145/2976749.2978318; Ahmad A, 2019, I S BIOMED IMAGING, P372, DOI [10.1109/isbi.2019.8759313, 10.1109/ISBI.2019.8759313]; Alex V, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.041311; [Anonymous], ADV NEURAL INFORM PR; [Anonymous], 2015, CoRR abs/1511.05644; [Anonymous], 2018, ARXIV PREPRINT ARXIV; [Anonymous], P 3 INT C LEARNING R; [Anonymous], 2016, ARXIV160601100; [Anonymous], P 29 C ART INT; [Anonymous], 2019, ARXIV190401569; [Anonymous], 2018, ARXIV181102496; [Anonymous], PROC CVPR IEEE; [Anonymous], 2019, ARXIV190209159; [Anonymous], THESIS KTH; [Anonymous], 2017, ARXIV PREPRINT ARXIV; [Anonymous], ARXIV171209923; [Anonymous], 2017, 2017 IEEE INT C BIOI, DOI DOI 10.1109/BIBM.2017.8217751; [Anonymous], INT C MED IM DEEP LE; [Anonymous], ICLR WORKSH; [Anonymous], 2017, COMMUN ACM, DOI DOI 10.1145/3065386; [Anonymous], ARXIV191010035; [Anonymous], 2017, PROC CVPR IEEE, DOI DOI 10.1109/CVPR.2017.632; [Anonymous], ADV NEURAL INFORM PR; [Anonymous], INT C MED IM COMP CO; [Anonymous], ARXIV190411319; [Anonymous], BELG NETH ART C BNAI; [Anonymous], SURVEY NEURAL UNPUB; [Anonymous], BRIDGING AI DEV END; [Anonymous], 2019, PMLR; [Anonymous], 2017, IEEE I CONF COMP VIS, DOI DOI 10.1109/ICCV.2017.244; [Anonymous], 2015, PROCIEEE CONFCOMPUT; [Anonymous], ICLR 2019 WORKSH AI; [Anonymous], 2019, INT C MED IM DEEP LE; [Anonymous], 1 C MED IM DEEP LEAR; Arjovsky M., 2017, ARXIV170107875; Azmi Reza, 2013, J Med Signals Sens, V3, P94; Bailey P, 1929, J PATHOL BACTERIOL, V32, P735, DOI 10.1002/path.1700320403; Bien N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002699; Blessy SAPS, 2015, TECHNOL HEALTH CARE, V23, P23, DOI 10.3233/THC-140876; Booth TC, 2020, CLIN RADIOL, V75, P20, DOI 10.1016/j.crad.2019.07.001; Buckner JC, 2016, NEW ENGL J MED, V374, P1344, DOI 10.1056/NEJMoa1500925; Cai CJ, 2019, CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3290605.3300234; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Chang P, 2018, AM J NEURORADIOL, V39, P1201, DOI 10.3174/ajnr.A5667; Chartsias A, 2018, IEEE T MED IMAGING, V37, P803, DOI 10.1109/TMI.2017.2764326; Chen LL, 2018, PROC SPIE, V10574, DOI 10.1117/12.2293394; Chen X., 2018, ARXIV180604972; Cheplygina V, 2019, MED IMAGE ANAL, V54, P280, DOI 10.1016/j.media.2019.03.009; Choi KS, 2019, NEURO-ONCOLOGY, V21, P1197, DOI 10.1093/neuonc/noz095; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Cruz SS, 2020, NEUROINFORMATICS, V18, P59, DOI 10.1007/s12021-019-09426-x; Dalca AV, 2019, IEEE T MED IMAGING, V38, P504, DOI 10.1109/TMI.2018.2866692; Dar SUH, 2019, IEEE T MED IMAGING, V38, P2375, DOI 10.1109/TMI.2019.2901750; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.10; Doshi-Velez Finale., 2017, arXiv: Machine Learning; Dunn GP, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.12.FOCUS12355; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Elsken T, 2019, J MACH LEARN RES, V20; Enguehard J, 2019, IEEE ACCESS, V7, P11093, DOI 10.1109/ACCESS.2019.2891970; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gilvary C, 2019, TRENDS PHARMACOL SCI, V40, P555, DOI 10.1016/j.tips.2019.06.001; Goodfellow J., 2015, P NEURIPS, DOI DOI 10.1145/3422622; Gordon L, 2019, JAMA SURG, V154, P1064, DOI 10.1001/jamasurg.2019.2821; Grande-Barreto J, 2018, IEEE INT AUT MEET; Gutman DA, 2013, RADIOLOGY, V267, P560, DOI 10.1148/radiol.13120118; Han C, 2018, I S BIOMED IMAGING, P734, DOI 10.1109/ISBI.2018.8363678; Havaei M, 2017, MED IMAGE ANAL, V35, P18, DOI 10.1016/j.media.2016.05.004; He JX, 2019, NAT MED, V25, P30, DOI 10.1038/s41591-018-0307-0; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Holzinger Andreas, 2016, Brain Inform, V3, P119, DOI 10.1007/s40708-016-0042-6; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Huang J, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00506; Huang P, 2019, LECT NOTES COMPUT SC, V11766, P155, DOI 10.1007/978-3-030-32248-9_18; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Jang BS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31007-2; Jha P, 2010, NEUROSURGERY, V67, P1681, DOI 10.1227/NEU.0b013e3181f743f5; Jin CB, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19102361; Jog A, 2017, MED IMAGE ANAL, V35, P475, DOI 10.1016/j.media.2016.08.009; Karani N, 2018, LECT NOTES COMPUT SC, V11070, P476, DOI 10.1007/978-3-030-00928-1_54; Kazuhiro K, 2018, TOMOGRAPHY, V4, P159, DOI 10.18383/j.tom.2018.00042; Kelly CJ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1426-2; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Keshavan A, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00029; Kingma D. P., 2013, CORR; Konyushkova K., 2017, NEURIPS, V30, P4225; Konyushkova K, 2015, IEEE I CONF COMP VIS, P2974, DOI 10.1109/ICCV.2015.340; Korfiatis P, 2019, CLIN RADIOL, V74, P367, DOI 10.1016/j.crad.2019.01.028; Kwon G, 2019, LECT NOTES COMPUT SC, V11766, P118, DOI 10.1007/978-3-030-32248-9_14; Lee D., 2019, ARXIV190504105; Lewis D. D., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P3; Li AG, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-38; Lotan E, 2019, AM J ROENTGENOL, V212, P26, DOI 10.2214/AJR.18.20218; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Macyszyn L, 2016, NEURO-ONCOLOGY, V18, P417, DOI 10.1093/neuonc/nov127; Maier O, 2017, MED IMAGE ANAL, V35, P250, DOI 10.1016/j.media.2016.07.009; Marx V, 2013, NAT METHODS, V10, P1069, DOI 10.1038/nmeth.2695; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Mlynarski P, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.3.034002; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Pereira Sergio, 2018, Understanding and Interpreting Machine Learning in Medical Image Computing Applications. First International Workshops MLCN 2018, DLF 2018, and iMIMIC 2018. Held in Conjunction with MICCAI 2018. Proceedings: Lecture Notes in Computer Science (LNCS 11038), P106, DOI 10.1007/978-3-030-02628-8_12; Pereira S, 2018, MED IMAGE ANAL, V44, P228, DOI 10.1016/j.media.2017.12.009; Phong LT, 2018, IEEE T INF FOREN SEC, V13, P1333, DOI 10.1109/TIFS.2017.2787987; Prasetyawan P, 2018, PROCEEDINGS OF THE 2018 INTERNATIONAL CONFERENCE ON APPLIED ENGINEERING (ICAE); Prechelt Lutz, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P53, DOI 10.1007/978-3-642-35289-8_5; Radford A., 2016, P 4 INT C LEARN REPR, P1; Rathore S, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-1392; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roskams J, 2016, NEURON, V92, P658, DOI 10.1016/j.neuron.2016.10.045; Rudie JD, 2019, RADIOLOGY, V290, P607, DOI 10.1148/radiol.2018181928; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shah P, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0148-3; Sharma A, 2020, IEEE T MED IMAGING, V39, P1170, DOI 10.1109/TMI.2019.2945521; Shaver MM, 2019, CANCERS, V11, DOI 10.3390/cancers11060829; Sheller MJ, 2019, LECT NOTES COMPUT SC, V11383, P92, DOI 10.1007/978-3-030-11723-8_9; Shin HC, 2018, LECT NOTES COMPUT SC, V11037, P1, DOI 10.1007/978-3-030-00536-8_1; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun HR, 2013, J NEURO-ONCOL, V113, P277, DOI 10.1007/s11060-013-1107-5; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tateishi K, 2017, NEUROSURGERY, V64, P134, DOI 10.1093/neuros/nyx247; Vaughan JW, 2018, J MACH LEARN RES, V18; Vepakomma P., 2018, ARXIV181203288; Villanueva-Meyer JE, 2019, AM J ROENTGENOL, V212, P52, DOI 10.2214/AJR.18.20328; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Wang DD, 2019, I C OPT COMMUN NETW, DOI [10.1109/icocn.2019.8934212, 10.1145/3290605.3300831]; Wang P, 2019, GUT, V68, P1813, DOI 10.1136/gutjnl-2018-317500; Weller M, 2015, ACTA NEUROPATHOL, V129, P679, DOI 10.1007/s00401-015-1409-0; Woo CW, 2017, NAT NEUROSCI, V20, P365, DOI 10.1038/nn.4478; Yurt M, 2019, ARXIV190911504; Zbontar J., 2018, ARXIV181108839; Zech JR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002683; Zhang C., 2016, ABS161103530 CORR; Zheng Q, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00069; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhou M, 2018, AM J NEURORADIOL, V39, P208, DOI 10.3174/ajnr.A5391; Zinn PO, 2017, NEUROSURGERY, V64, P203, DOI 10.1093/neuros/nyx316	141	26	27	5	49	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	APR	2020	17	2							021002	10.1088/1741-2552/ab8131	http://dx.doi.org/10.1088/1741-2552/ab8131			17	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	LL0SV	32191935	Green Submitted			2024-09-18	WOS:000531268000001
J	Metzcar, J; Jutzeler, CR; Macklin, P; Köhn-Luque, A; Brüningk, SC				Metzcar, John; Jutzeler, Catherine R.; Macklin, Paul; Kohn-Luque, Alvaro; Bruningk, Sarah C.			A review of mechanistic learning in mathematical oncology	FRONTIERS IN IMMUNOLOGY			English	Review						mathematical modeling; machine learning; deep learning; ODE (ordinary differential equation); mechanistic learning	INFORMED NEURAL-NETWORKS; MODELS; CANCER; GLIOBLASTOMA; SURVIVAL	Mechanistic learning refers to the synergistic combination of mechanistic mathematical modeling and data-driven machine or deep learning. This emerging field finds increasing applications in (mathematical) oncology. This review aims to capture the current state of the field and provides a perspective on how mechanistic learning may progress in the oncology domain. We highlight the synergistic potential of mechanistic learning and point out similarities and differences between purely data-driven and mechanistic approaches concerning model complexity, data requirements, outputs generated, and interpretability of the algorithms and their results. Four categories of mechanistic learning (sequential, parallel, extrinsic, intrinsic) of mechanistic learning are presented with specific examples. We discuss a range of techniques including physics-informed neural networks, surrogate model learning, and digital twins. Example applications address complex problems predominantly from the domain of oncology research such as longitudinal tumor response predictions or time-to-event modeling. As the field of mechanistic learning advances, we aim for this review and proposed categorization framework to foster additional collaboration between the data- and knowledge-driven modeling fields. Further collaboration will help address difficult issues in oncology such as limited data availability, requirements of model transparency, and complex input data which are embraced in a mechanistic learning framework Data and knowledge both drive the progress of research and are the cornerstones of modeling. Depending on the emphasis, both data-driven (exemplified by machine and deep learning) and knowledge-driven (exemplified by mechanistic mathematical modeling) models generate novel results and insights. Mechanistic learning describes approaches that employ both data and knowledge in a complimentary and balanced way.	[Metzcar, John; Macklin, Paul] Luddy Sch Informat Comp & Engn, Intelligent Syst Engn, Bloomington, IN USA; [Metzcar, John] Luddy Sch Informat Comp & Engn, Informat, Bloomington, IN USA; [Jutzeler, Catherine R.; Bruningk, Sarah C.] Eidgenoss TH Zurich ETH, Dept Hlth Sci & Technol D HEST, Zurich, Switzerland; [Jutzeler, Catherine R.; Bruningk, Sarah C.] Swiss Inst Bioinformat SIB, Lausanne, Switzerland; [Kohn-Luque, Alvaro] Univ Oslo, Fac Med, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Kohn-Luque, Alvaro] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol Res Support Serv, Oslo, Norway	Swiss Institute of Bioinformatics; University of Oslo; University of Oslo	Brüningk, SC (corresponding author), Eidgenoss TH Zurich ETH, Dept Hlth Sci & Technol D HEST, Zurich, Switzerland.; Brüningk, SC (corresponding author), Swiss Inst Bioinformat SIB, Lausanne, Switzerland.				NSF [1735095]; Swiss National Science Foundation [PZ00P3_186101]; Cancer Moonshot funds from the National Cancer Institute, Leidos Biomedical Research [21X126F]; Indiana University Luddy Faculty Fellowship [237718, 332645]; Botnar Research Center for Child Health Postdoctoral Excellence Programme [PEP-2021-1008]; ETH Zurich; Swiss National Science Foundation (SNF) [PZ00P3_186101] Funding Source: Swiss National Science Foundation (SNF)	NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Cancer Moonshot funds from the National Cancer Institute, Leidos Biomedical Research; Indiana University Luddy Faculty Fellowship; Botnar Research Center for Child Health Postdoctoral Excellence Programme; ETH Zurich(ETH Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. JM was supported by NSF 1735095 - NRT: Interdisciplinary Training in Complex Networks and Systems. CJ was supported by the Swiss National Science Foundation (Ambizione Grant [PZ00P3_186101]). PM was supported in part by Cancer Moonshot funds from the National Cancer Institute, Leidos Biomedical Research Subcontract 21X126F, and by an Indiana University Luddy Faculty Fellowship. AK-L's work was funded by the research centers BigInsight (Norges Forskningsrad project number 237718) and Integreat (Norges Forskningsrad project number 332645). SB was supported by the Botnar Research Center for Child Health Postdoctoral Excellence Programme (#PEP-2021-1008). Open access funding by ETH Zurich.	Akasiadis C, 2022, COMPUT INTELL-US, V38, P1379, DOI 10.1111/coin.12515; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; [Anonymous], 2002, MATH BIOL; Augustin Maximilian, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12371), P228, DOI 10.1007/978-3-030-58574-7_14; Ayensa-Jiménez J, 2022, PLOS COMPUT BIOL, V18, DOI 10.1371/journal.pcbi.1010019; Baker RE, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0660; Baptista D, 2023, PLOS COMPUT BIOL, V19, DOI 10.1371/journal.pcbi.1010200; Baptista D, 2021, BRIEF BIOINFORM, V22, P360, DOI 10.1093/bib/bbz171; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Bender E.A., 1978, An introduction to mathematical modeling, V1st; Benzekry S, 2021, JCO CLIN CANCER INFO, V5, P81, DOI 10.1200/CCI.20.00092; Benzekry S, 2020, CLIN PHARMACOL THER, V108, P471, DOI 10.1002/cpt.1951; Bigarré C, 2023, COMPUT METH PROG BIO, V231, DOI 10.1016/j.cmpb.2023.107401; Blair RH, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00227; Bonate PL., 2010, Preclinical Drug Development; Brüningk SC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99507-2; Brummer AB, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1115536; Bruningk SC, 2021, PMLR, P730; Brunton SL, 2022, SIAM REV, V64, P229, DOI 10.1137/21M1401243; Brunton SL, 2016, P NATL ACAD SCI USA, V113, P3932, DOI 10.1073/pnas.1517384113; Bull JA, 2023, PLOS COMPUT BIOL, V19, DOI 10.1371/journal.pcbi.1010994; Cao XN, 2023, BIG DATA SOC, V10, DOI 10.1177/20539517231169731; Chen R. T., 2018, arXiv; Ciccolini J, 2020, JCO PRECIS ONCOL, V4, P486, DOI 10.1200/PO.19.00381; Culos A, 2020, NAT MACH INTELL, V2, P619, DOI 10.1038/s42256-020-00232-8; Cuomo S, 2022, J SCI COMPUT, V92, DOI 10.1007/s10915-022-01939-z; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; Elfring J, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21020438; Elmarakeby HA, 2021, NATURE, V598, P348, DOI 10.1038/s41586-021-03922-4; Ezhov I, 2023, MED IMAGE ANAL, V83, DOI 10.1016/j.media.2022.102672; Fabris F, 2016, BIOINFORMATICS, V32, P2988, DOI 10.1093/bioinformatics/btw363; Fertig EJ, 2021, MED-CAMBRIDGE, V2, P1004, DOI 10.1016/j.medj.2021.08.007; Fox G, 2019, IEEE SYM PARA DISTR, P422, DOI 10.1109/IPDPSW.2019.00081; Gaudelet T, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab159; Geron A., 2019, HANDS ON MACHINE LEA, DOI DOI 10.1201/9780367816377; Ghaderi N, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031316; Gherman IM, 2023, PLOS COMPUT BIOL, V19, DOI 10.1371/journal.pcbi.1010988; Greene CS, 2020, CANCER CELL, V38, P613, DOI 10.1016/j.ccell.2020.10.014; Grönquist P, 2021, PHILOS T R SOC A, V379, DOI 10.1098/rsta.2020.0092; Gu YQ, 2022, Arxiv, DOI arXiv:2204.00313; Guimerà R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aav6971; Haber E, 2018, INVERSE PROBL, V34, DOI 10.1088/1361-6420/aa9a90; Hackenberg M, 2022, BIOMETRICAL J, V64, P1426, DOI 10.1002/bimj.202000366; Hatzikirou H, 2022, PHYS LIFE REV, V40, P1, DOI 10.1016/j.plrev.2022.01.002; Hernandez-Boussard T, 2021, NAT MED, V27, P2065, DOI 10.1038/s41591-021-01558-5; Hossain I., 2023, Biologically informed NeuralODEs for genome-wide regulatory dynamics, DOI [10.21203/rs.3.rs-2675584/v1, DOI 10.21203/RS.3.RS-2675584/V1]; Igual L., 2017, Introduction to Data Science, P1; Jackson PR, 2015, B MATH BIOL, V77, P846, DOI 10.1007/s11538-015-0067-7; Jain RK., 2022, GlioMod: spatiotemporal-aware glioblastoma multiforme tumor growth modeling with deep encoder-decoder networks, DOI [10.1101/2022.11.06.22282010, DOI 10.1101/2022.11.06.22282010]; Janssen JM, 2022, CTS-CLIN TRANSL SCI, V15, P1916, DOI 10.1111/cts.13300; Jiang HY, 2022, J SUPERCOMPUT, V78, P1807, DOI 10.1007/s11227-021-03901-6; Jiang ZC, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-31236-0; Jyothi P, 2023, ARTIF INTELL REV, V56, P2923, DOI 10.1007/s10462-022-10245-x; Kacprzyk K., 2022, INT C LEARNING REPRE, DOI [10.48550/arXiv.2206.10586, DOI 10.48550/ARXIV.2206.10586]; Kann BH, 2021, CANCER CELL, V39, P916, DOI 10.1016/j.ccell.2021.04.002; Kather JN, 2018, CANCER RES, V78, P5155, DOI 10.1158/0008-5472.CAN-18-1126; Kaul R, 2023, WIRES DATA MIN KNOWL, V13, DOI 10.1002/widm.1480; Kaur I, 2022, J BIOMED INFORM, V128, DOI 10.1016/j.jbi.2022.104026; Khajanchi S, 2019, APPL MATH COMPUT, V340, P180, DOI 10.1016/j.amc.2018.08.018; Kidger P., 2021, PREPRINT; Kielland A., 2023, Integrating Biological Domain Knowledge in Machine Learning Models for Cancer Precision Medicine; Kim Y., 2018, Introd. Implement. Kalman Filter, V1, P1, DOI DOI 10.5772/INTECHOPEN.80600; Knights J, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2012.25; Ladbury C, 2022, TRANSL CANCER RES, DOI 10.21037/tcr-22-1626; Lagergren JH, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008462; Lai TL, 2006, J PHARMACOKINET PHAR, V33, P49, DOI 10.1007/s10928-005-9000-2; Lee SY, 2022, MATHEMATICS-BASEL, V10, DOI 10.3390/math10060898; Li MM, 2022, NAT BIOMED ENG, V6, P1353, DOI 10.1038/s41551-022-00942-x; Li WT, 2022, J HYDROL, V605, DOI 10.1016/j.jhydrol.2021.127301; Liang BS, 2023, IEEE T MED IMAGING, V42, P2865, DOI 10.1109/TMI.2023.3267349; Lima EABF, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008845; Linardatos P, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23010018; Lipková J, 2019, IEEE T MED IMAGING, V38, P1875, DOI 10.1109/TMI.2019.2902044; Liu XF, 2022, Arxiv, DOI [arXiv:2208.07422, 10.1561/116.00000192]; Lorenzo G, 2023, Arxiv, DOI arXiv:2308.14925; Lu SC, 2022, JMIR MED INF, V10, DOI 10.2196/33182; Lu Y., 2020, Adv. Neural Inf. Process. Syst., V33, P3094, DOI DOI 10.48550/ARXIV.2004.08867; Macklin P, 2017, CELL SYST, V5, P92, DOI 10.1016/j.cels.2017.08.005; Mavroudis P. D., 2023, FRONT SYST BIOL, V3, DOI [10.3389/fsysb.2023.1180948, DOI 10.3389/FSYSB.2023.1180948]; McDonald Thomas O., 2023, Nature Reviews Bioengineering, DOI DOI 10.1038/S44222-023-00089-7; McMahon SJ, 2019, CANCERS, V11, DOI 10.3390/cancers11020205; Messenger DA, 2021, J COMPUT PHYS, V443, DOI 10.1016/j.jcp.2021.110525; Molnar C., 2022, Interpretable Machine Learning: A Guide for Making Black Box Models Explainable, V2nd ed., DOI DOI 10.1007/S10290-014-0202-9; Moon Intae, 2022, arXiv, DOI [10.48550/arXiv.2204.09633, DOI 10.48550/ARXIV.2204.09633]; Mourtzis D., 2021, Procedia CIRP, V104, P1686, DOI DOI 10.1016/J.PROCIR.2021.11.284; Nikolenko S. I., 2021, Springer Optimization and Its Applications, P2021, DOI DOI 10.1007/978-3-030-75178-4; Obot OU., 2022, Advances in Medical Technologies and Clinical Practice, P1; Ozik J, 2019, MOL SYST DES ENG, V4, P747, DOI 10.1039/c9me00036d; Pérez-Aliacar M, 2021, COMPUT BIOL MED, V135, DOI 10.1016/j.compbiomed.2021.104547; Pesonen H, 2023, INT STAT REV, V91, P243, DOI 10.1111/insr.12522; Provost F, 2013, BIG DATA, V1, P51, DOI 10.1089/big.2013.1508; Przedborski M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02393-7; Qian Z., 2021, ADV NEURAL INF PROCE, V34, P11364; Qian Z., 2022, International Conference on Learning Representations; Rackauckas C, 2021, Arxiv, DOI arXiv:2001.04385; Raissi M, 2019, J COMPUT PHYS, V378, P686, DOI 10.1016/j.jcp.2018.10.045; Rajpurkar P, 2022, NAT MED, V28, P31, DOI 10.1038/s41591-021-01614-0; Rawat RR, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0084-4; Renardy M, 2019, CURR OPIN BIOMED ENG, V11, P109, DOI 10.1016/j.cobme.2019.09.012; Ribba B, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.12; Rocha HL, 2022, COMPUT METHOD APPL M, V399, DOI 10.1016/j.cma.2022.115412; Rocha HL, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102935; Rockne RC, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.19.00010; Rockne RC, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/ab1a09; Roscher R, 2020, IEEE ACCESS, V8, P42200, DOI 10.1109/ACCESS.2020.2976199; Ru JT, 2023, COMPUT BIOL MED, V159, DOI 10.1016/j.compbiomed.2023.106884; Sager S, 2023, J CANCER RES CLIN, V149, P5475, DOI 10.1007/s00432-023-04633-1; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Sharma A., 2020, J SCI RES, V64, P221, DOI DOI 10.37398/JSR.2020.640232; Sung W, 2022, INT J RADIAT ONCOL, V112, P1055, DOI 10.1016/j.ijrobp.2021.11.008; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; von Rueden L, 2020, LECT NOTES COMPUT SC, V12080, P548, DOI 10.1007/978-3-030-44584-3_43; Wan ZB, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.705323; Wang HW, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190366; Wang Q, 2022, Annals of Data Science, V9, P187, DOI DOI 10.1007/S40745-020-00253-5; Weinan E, 2017, COMMUN MATH STAT, V5, P1, DOI 10.1007/s40304-017-0103-z; Wendland P, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00666-x; Wieland FG, 2021, CURR OPIN SYST BIOL, V25, P60, DOI 10.1016/j.coisb.2021.03.005; Wu CY, 2022, BIOPHYS REV-US, V3, DOI 10.1063/5.0086789; Yasemi M, 2021, PROCESSES, V9, DOI 10.3390/pr9020322; Yazdani A, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007575; Yeom S, 2018, P IEEE COMPUT SECUR, P268, DOI 10.1109/CSF.2018.00027; Yin AY, 2019, CPT-PHARMACOMET SYST, V8, P720, DOI 10.1002/psp4.12450; Zhang W, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0029-7; Zheng A., 2018, Feature Engineering for Machine Learning, V1; Zhu A., 2022, SIAM Undergrad Res Online, V15, DOI [10.1137/22S1472814, DOI 10.1137/22S1472814]	126	1	1	6	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	MAR 12	2024	15								1363144	10.3389/fimmu.2024.1363144	http://dx.doi.org/10.3389/fimmu.2024.1363144			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME3K7	38533513	Green Published, Green Submitted, gold			2024-09-18	WOS:001191909200001
J	Guo, XY; Chatterjee, N; Dutta, D				Guo, Xinyu; Chatterjee, Nilanjan; Dutta, Diptavo			Subset-based method for cross-tissue transcriptome-wide association studies improves power and interpretability	HUMAN GENETICS AND GENOMICS ADVANCES			English	Article							HISTORY; CANCER; LOCI	Integrating results from genome-wide association studies (GWASs) and studies of molecular phenotypes such as gene expressions can improve our understanding of the biological functions of trait-associated variants and can help prioritize candidate genes for downstream analysis. Using reference expression quantitative trait locus (eQTL) studies, several methods have been proposed to identify gene-trait associations, primarily based on gene expression imputation. To increase the statistical power by leveraging substantial eQTL sharing across tissues, meta-analysis methods aggregating such gene-based test results across multiple tissues or contexts have been developed as well. However, most existing meta-analysis methods have limited power to identify associations when the gene has weaker associations in only a few tissues and cannot identify the subset of tissues in which the gene is "activated." For this, we developed a cross-tissue subset-based transcriptome-wide association study (CSTWAS) meta-analysis method that improves power under such scenarios and can extract the set of potentially associated tissues. To improve applicability, CSTWAS uses only GWAS summary statistics and pre-computed correlation matrices to identify a subset of tissues that have the maximal evidence of gene-trait association. Through numerical simulations, we found that CSTWAS can maintain a well-calibrated type-I error rate, improves power especially when there is a small number of associated tissues for a gene-trait association, and identifies an accurate associated tissue set. By analyzing GWAS summary statistics of three complex traits and diseases, we demonstrate that CSTWAS could identify biological meaningful signals while providing an interpretation of disease etiology by extracting a set of potentially associated tissues.	[Guo, Xinyu] Univ Southern Calif, Dept Quantitat & Computat Biol, Los Angeles, CA 90007 USA; [Chatterjee, Nilanjan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21218 USA; [Chatterjee, Nilanjan] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Dutta, Diptavo] NCI, Integrat Tumor Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA	University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dutta, D (corresponding author), NCI, Integrat Tumor Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA.	diptavo.dutta@nih.gov	Dutta, Diptavo/U-9297-2019	Dutta, Diptavo/0000-0002-6634-9040	Intramural Research Program of NIH; National Human Genome Research Institute [1 R01 HG010480-01]	Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study is funded by the Intramural Research Program of NIH and National Human Genome Research Institute (1 R01 HG010480-01) .	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Barbeira AN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007889; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Cao C, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009405; Claussnitzer M, 2020, NATURE, V577, P179, DOI 10.1038/s41586-019-1879-7; Dong Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep43614; Dutta D, 2021, AM J HUM GENET, V108, P669, DOI 10.1016/j.ajhg.2021.02.016; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Ferreira MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08053-5; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; HOSKING JRM, 1987, TECHNOMETRICS, V29, P339, DOI 10.2307/1269343; Hou LM, 2016, TUMOR BIOL, V37, P16337, DOI 10.1007/s13277-016-5421-3; Hu YM, 2019, NAT GENET, V51, P568, DOI 10.1038/s41588-019-0345-7; Huan TX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12228-z; Huang TT, 2017, INT J ONCOL, V50, P1501, DOI 10.3892/ijo.2017.3927; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Knijnenburg TA, 2009, BIOINFORMATICS, V25, pI161, DOI 10.1093/bioinformatics/btp211; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Mancuso N, 2019, NAT GENET, V51, P675, DOI 10.1038/s41588-019-0367-1; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Ni D., 2021, bioRxiv, DOI [DOI 10.1101/2021, 10.1101/2021]; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Qi G., 2022, bioRxiv, DOI [10.1101/2022.06.03.494686, DOI 10.1101/2022.06.03.494686]; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Rashkin SR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18246-6; Rhee EP, 2022, KIDNEY INT, V101, P814, DOI 10.1016/j.kint.2022.01.014; Ross KA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-12; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Su R, 2020, J AM STAT ASSOC, V115, P1079, DOI 10.1080/01621459.2019.1660170; Tin A, 2019, NAT GENET, V51, P1459, DOI 10.1038/s41588-019-0504-x; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Vosa U, 2021, NAT GENET, V53, P1300, DOI 10.1038/s41588-021-00913-z; Wainberg M, 2019, NAT GENET, V51, P592, DOI 10.1038/s41588-019-0385-z; Wang XK, 2020, J CANCER, V11, P1869, DOI 10.7150/jca.39163; Wang XR, 2021, ASIAN J PSYCHIATR, V59, DOI 10.1016/j.ajp.2021.102648; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yu YF, 2017, HUM HERED, V83, P283, DOI 10.1159/000496867	44	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2666-2477			HUM GENET GENOM ADV	Hum. Genet. Genom. Adv.	APR 11	2024	5	2							100283	10.1016/j.xhgg.2024.100283	http://dx.doi.org/10.1016/j.xhgg.2024.100283		APR 2024	13	Genetics & Heredity	Emerging Sources Citation Index (ESCI)	Genetics & Heredity	QG5S3	38491773	gold, Green Published, Green Submitted			2024-09-18	WOS:001219745200001
J	Gomatam, A; Hirlekar, BU; Singh, KD; Murty, US; Dixit, VA				Gomatam, Anish; Hirlekar, Bhakti Umesh; Singh, Krishan Dev; Murty, Upadhyayula Suryanarayana; Dixit, Vaibhav A.			Improved QSAR models for PARP-1 inhibition using data balancing, interpretable machine learning, and matched molecular pair analysis	MOLECULAR DIVERSITY			English	Article; Early Access						PARP-1 inhibitor; Machine learning; QSAR; Data balancing; MMPA	IN-SILICO; PREDICTION; OPTIMIZATION; SOLUBILITY; REGRESSION; ENSEMBLES; SELECTION; DOCKING; DESIGN	The poly (ADP-ribose) polymerase-1 (PARP-1) enzyme is an important target in the treatment of breast cancer. Currently, treatment options include the drugs Olaparib, Niraparib, Rucaparib, and Talazoparib; however, these drugs can cause severe side effects including hematological toxicity and cardiotoxicity. Although in silico models for the prediction of PARP-1 activity have been developed, the drawbacks of these models include low specificity, a narrow applicability domain, and a lack of interpretability. To address these issues, a comprehensive machine learning (ML)-based quantitative structure-activity relationship (QSAR) approach for the informed prediction of PARP-1 activity is presented. Classification models built using the Synthetic Minority Oversampling Technique (SMOTE) for data balancing gave robust and predictive models based on the K-nearest neighbor algorithm (accuracy 0.86, sensitivity 0.88, specificity 0.80). Regression models were built on structurally congeneric datasets, with the models for the phthalazinone class and fused cyclic compounds giving the best performance. In accordance with the Organization for Economic Cooperation and Development (OECD) guidelines, a mechanistic interpretation is proposed using the Shapley Additive Explanations (SHAP) to identify the important topological features to differentiate between PARP-1 actives and inactives. Moreover, an analysis of the PARP-1 dataset revealed the prevalence of activity cliffs, which possibly negatively impacts the model's predictive performance. Finally, a set of chemical transformation rules were extracted using the matched molecular pair analysis (MMPA) which provided mechanistic insights and can guide medicinal chemists in the design of novel PARP-1 inhibitors.	[Gomatam, Anish; Hirlekar, Bhakti Umesh; Singh, Krishan Dev; Murty, Upadhyayula Suryanarayana; Dixit, Vaibhav A.] Govt India, Natl Inst Pharmaceut Educ & Res, Dept Med Chem,NIPER Guwahati, Dept Pharmaceut,Minist Chem & Fertilizers, PO Changsari, Gauhati 781101, Assam, India	National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Dixit, VA (corresponding author), Govt India, Natl Inst Pharmaceut Educ & Res, Dept Med Chem,NIPER Guwahati, Dept Pharmaceut,Minist Chem & Fertilizers, PO Changsari, Gauhati 781101, Assam, India.	vaibhavadixit@gmail.com	Dixit, Vaibhav/R-2355-2016		Ministry of Electronics and Information technology [(4)12/2021-ITEA]; Ministry of Electronics and Information Technology (MeitY); NIPER Guwahati	Ministry of Electronics and Information technology; Ministry of Electronics and Information Technology (MeitY)(Ministry of Electronics and Information Technology (MEITY), Government of India); NIPER Guwahati	VAD, AG, and USN M acknowledge the funding from the Ministry of Electronics and Information Technology (MeitY), Govt. of India, New Delhi (project reference number No(4)12/2021-ITEA). BUH and KDS acknowledge NIPER Guwahati for financial support and travel grants.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Afantitis A, 2008, QSAR COMB SCI, V27, P432, DOI 10.1002/qsar.200730083; Ai DQ, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.971369; Alexander DLJ, 2015, J CHEM INF MODEL, V55, P1316, DOI 10.1021/acs.jcim.5b00206; [Anonymous], Resources for drug discovery; Awad M., 2015, Effic. Learn. Mach., P67, DOI [10.1007/978-1-4302-5990-94, DOI 10.1007/978-1-4302-5990-94]; Banerjee A, 2023, CHEM RES TOXICOL, V36, P1518, DOI 10.1021/acs.chemrestox.3c00155; Bao SN, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-21-1883; Bentéjac C, 2021, ARTIF INTELL REV, V54, P1937, DOI 10.1007/s10462-020-09896-5; Berrar D., 2018, ENCY BIOINFORMATICS, V1, P403, DOI [10.1016/B978-0-12-809633-8.20473-1, 10.1016/b978-0-12-809633-8.20473-1]; Blagus R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-106; Bregman H, 2016, Quinazoline Compounds and Derivatives Thereof, Patent No. 9505749; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruin MAC, 2022, CLIN PHARMACOKINET, V61, P1649, DOI 10.1007/s40262-022-01167-6; Costantino G, 2001, J MED CHEM, V44, P3786, DOI 10.1021/jm010116l; Cruz-Monteagudo M, 2014, DRUG DISCOV TODAY, V19, P1069, DOI 10.1016/j.drudis.2014.02.003; de Ville B, 2013, WIRES COMPUT STAT, V5, P448, DOI 10.1002/wics.1278; Deisenroth M.P., 2020, Mathematics for machine learning, DOI DOI 10.1017/9781108679930; Dossetter AG, 2013, DRUG DISCOV TODAY, V18, P724, DOI 10.1016/j.drudis.2013.03.003; Eklund M, 2012, MOL INFORM, V31, P173, DOI 10.1002/minf.201100142; Farrés J, 2015, CELL DEATH DIFFER, V22, P1144, DOI 10.1038/cdd.2014.202; Fatima S, 2012, J RECEPT SIG TRANSD, V32, P214, DOI 10.3109/10799893.2012.693087; Gandhi V, 2016, Inhibitors of Poly(ADP-Ribose)Polymerase, Patent No. 9283222; Gomatam A., 2023, Current trends in computational modelling for drug discovery; Griffen E, 2011, J MED CHEM, V54, P7739, DOI 10.1021/jm200452d; Halder AK, 2015, J BIOMOL STRUCT DYN, V33, P1756, DOI 10.1080/07391102.2014.969772; Hirlekar BU, 2023, EUR J MED CHEM, V252, DOI 10.1016/j.ejmech.2023.115300; Hussain J, 2010, J CHEM INF MODEL, V50, P339, DOI 10.1021/ci900450m; Hyunho L, 2019, Tricyclic Derivative Compound, Method for Preparing Same, and Pharmaceutical Composition Comprising Same, Patent No. 10464919; Kim M-H, 2014, Tricyclic Derivative or Pharmaceutically Acceptable Salts Thereof, Preparation Method Thereof, and Pharmaceutical Composition Containing the Same, Patent No. 8815891; Kim S, 2023, NUCLEIC ACIDS RES, V51, pD1373, DOI 10.1093/nar/gkac956; Kleandrova VV, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.634663; KNIME, Open for Innovation; Kocev D, 2013, PATTERN RECOGN, V46, P817, DOI 10.1016/j.patcog.2012.09.023; Korkmaz S, 2020, J CHEM INF MODEL, V60, P4180, DOI 10.1021/acs.jcim.9b01162; Kramer C, 2014, J MED CHEM, V57, P3786, DOI 10.1021/jm500317a; Labute P, 2000, J MOL GRAPH MODEL, V18, P464, DOI 10.1016/S1093-3263(00)00068-1; Leach AG, 2006, J MED CHEM, V49, P6672, DOI 10.1021/jm0605233; LEARDI R, 1992, J CHEMOMETR, V6, P267, DOI 10.1002/cem.1180060506; Lerksuthirat T, 2022, EXCLI J, V22, P84, DOI 10.17179/excli2022-5602; Lind AP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219774; Maggiora GM, 2006, J CHEM INF MODEL, V46, P1535, DOI 10.1021/ci060117s; Mauri A., 2020, Methods Pharm Toxicol, DOI [10.1007/978-1-0716-0150-1_32/COVER, DOI 10.1007/978-1-0716-0150-1_32/COVER]; Melagraki G, 2010, CHEM BIOL DRUG DES, V76, P397, DOI 10.1111/j.1747-0285.2010.01029.x; Melagraki G, 2009, MOL DIVERS, V13, P301, DOI 10.1007/s11030-009-9115-2; Mendez D, 2019, NUCLEIC ACIDS RES, V47, pD930, DOI 10.1093/nar/gky1075; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Murtagh F., 1991, Neurocomputing, V2, P183; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Ossovskaya Valeria, 2010, Genes Cancer, V1, P812, DOI 10.1177/1947601910383418; Papadatos G, 2010, J CHEM INF MODEL, V50, P1872, DOI 10.1021/ci100258p; Ramadan SK, 2020, RSC ADV, V10, P29475, DOI 10.1039/d0ra05943a; Ramos-Pérez I, 2022, EXPERT SYST APPL, V188, DOI 10.1016/j.eswa.2021.116015; Reilly SW, 2018, J MED CHEM, V61, P5367, DOI 10.1021/acs.jmedchem.8b00576; Revathi P, 2021, STRUCT CHEM, V32, P2035, DOI 10.1007/s11224-021-01765-3; Rewatkar PV, 2011, MED CHEM RES, V20, P877, DOI 10.1007/s00044-010-9414-2; Rodríguez-Pérez R, 2020, J COMPUT AID MOL DES, V34, P1013, DOI 10.1007/s10822-020-00314-0; Rodríguez-Pérez R, 2020, J MED CHEM, V63, P8761, DOI 10.1021/acs.jmedchem.9b01101; Roy K, 2012, CURR COMPUT-AID DRUG, V8, P135; Sandhu D, 2022, BRIT J CLIN PHARMACO, V88, P742, DOI 10.1111/bcp.15015; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Speck-Planche A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11121832; Speck-Planche A, 2019, MOL DIVERS, V23, P555, DOI 10.1007/s11030-018-9890-8; Speck-Planche A, 2017, MOL DIVERS, V21, P511, DOI 10.1007/s11030-017-9731-1; Stumpfe D, 2019, ACS OMEGA, V4, P14360, DOI 10.1021/acsomega.9b02221; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Tian XJ, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.851246; Todeschini R., 2010, Molecular descriptors for chemoinformatics, V2; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; Tuv E, 2009, J MACH LEARN RES, V10, P1341; Uyank G. K., 2013, Procedia-Social and Behavioral Sciences, V106, P234, DOI [https://doi.org/10.1016/j.sbspro.2013.12.027, DOI 10.1016/J.SBSPRO.2013.12.027, 10.1016/j.sbspro.2013.12.027]; Velagapudi UK, 2021, EXPERT OPIN THER PAT, V31, P609, DOI 10.1080/13543776.2021.1886275; Vignaux PA, 2023, CHEM RES TOXICOL, V36, P188, DOI 10.1021/acs.chemrestox.2c00283; Watt J, 2016, MACHINE LEARNING REFINED: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P1, DOI 10.1017/CBO9781316402276; Wu YH, 2021, REMOTE SENS ENVIRON, V253, DOI 10.1016/j.rse.2020.112206; Xu T, 2022, J MED CHEM, V65, P4590, DOI 10.1021/acs.jmedchem.1c01372; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.37; Zhao Y, 2020, EUR J MED CHEM, V203, DOI 10.1016/j.ejmech.2020.112570; Zhou C, 2017, Fused Tetra or Penta-Cyclic dihydrodiazepinoncarbazolones as PARP Inhibitors, Patent No. 9617273	80	0	0	6	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1381-1991	1573-501X		MOL DIVERS	Mol. Divers.	2024 FEB 20	2024										10.1007/s11030-024-10809-9	http://dx.doi.org/10.1007/s11030-024-10809-9		FEB 2024	18	Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Medicinal; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	ID7S3	38374474				2024-09-18	WOS:001164459400001
J	Zaror, C; Pardo, Y; Espinoza-Espinoza, G; Pont, A; Muñoz-Millán, P; Martínez-Zapata, MJ; Vilagut, G; Forero, CG; Garin, O; Alonso, J; Ferrer, M				Zaror, Carlos; Pardo, Yolanda; Espinoza-Espinoza, Gerardo; Pont, Angels; Munoz-Millan, Patricia; Jose Martinez-Zapata, Maria; Vilagut, Gemma; Forero, Carlos G.; Garin, Olatz; Alonso, Jordi; Ferrer, Montse			Assessing oral health-related quality of life in children and adolescents: a systematic review and standardized comparison of available instruments	CLINICAL ORAL INVESTIGATIONS			English	Review						Oral health; Quality of life; Questionnaires; Psychometrics; Outcome assessment; Child	TRAUMATIC DENTAL INJURIES; PERCEPTIONS QUESTIONNAIRE; PARENTAL PERCEPTIONS; IMPACT; RELIABILITY; VALIDITY; RESPONSIVENESS; PREVALENCE; DISEASES; CANCER	ObjectivesTo obtain a systematic and standardized evaluation of the current evidence on development process, metric properties, and administration issues of oral health-related quality of life instruments available for children and adolescents.Materials and methodsA systematic search until October 2016 was conducted in PubMed, Embase, Lilacs, SciELO, and Cochrane databases. Articles with information regarding the development process, metric properties, and administration issues of pediatric instruments measuring oral health-related quality of life were eligible for inclusion. Two researchers independently evaluated each instrument applying the Evaluating Measures of Patient-Reported Outcomes (EMPRO) tool. An overall and seven attribute-specific EMPRO scores were calculated (range 0-100, worst to best): measurement model, reliability, validity, responsiveness, interpretability, burden, and alternative forms.ResultsWe identified 18 instruments evaluated in 132 articles. From five instruments designed for preschoolers, the Early Childhood Oral Health Impact Scale (ECOHIS) obtained the highest overall EMPRO score (82.2). Of nine identified for schoolchildren and adolescents, the best rated instrument was the Child Perceptions Questionnaire 11-14 (82.1). Among the four instruments developed for any age, the Family Impact Scale (FIS) obtained the highest scores (80.3).ConclusionThe evidence supports the use of the ECOHIS for preschoolers, while the age is a key factor when choosing among the four recommended instruments for schoolchildren and adolescents. Instruments for specific conditions, symptoms, or treatments need further research on metric properties.Clinical relevanceOur results facilitate decision-making on the correct oral health-related quality of life instrument selection for any certain study purpose and population during the childhood and adolescence life cycle.	[Zaror, Carlos; Munoz-Millan, Patricia] Univ La Frontera, Fac Dent, Dept Pediat Dent & Orthodont, Manuel Montt 112, Temuco, Chile; [Zaror, Carlos; Espinoza-Espinoza, Gerardo; Munoz-Millan, Patricia] Univ La Frontera, Fac Dent, Ctr Res Epidemiol Econ & Oral Publ Hlth CIEESPO, Temuco, Chile; [Zaror, Carlos; Pardo, Yolanda; Ferrer, Montse] Univ Autonoma Barcelona, Barcelona, Spain; [Pardo, Yolanda; Pont, Angels; Vilagut, Gemma; Forero, Carlos G.; Garin, Olatz; Alonso, Jordi; Ferrer, Montse] Hosp del Mar Med Res Inst IMIM, Hlth Serv Res Grp, Doctor Aiguader 88, Barcelona 08003, Spain; [Pardo, Yolanda; Pont, Angels; Jose Martinez-Zapata, Maria; Vilagut, Gemma; Forero, Carlos G.; Garin, Olatz; Alonso, Jordi; Ferrer, Montse] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Espinoza-Espinoza, Gerardo] Univ La Frontera, Fac Med, Dept Publ Hlth, Temuco, Chile; [Jose Martinez-Zapata, Maria] Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Forero, Carlos G.; Garin, Olatz; Alonso, Jordi] UPF, Barcelona, Spain	Universidad de La Frontera; Universidad de La Frontera; Autonomous University of Barcelona; Hospital del Mar Research Institute; Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de La Frontera; Pompeu Fabra University	Zaror, C (corresponding author), Univ La Frontera, Fac Dent, Dept Pediat Dent & Orthodont, Manuel Montt 112, Temuco, Chile.; Zaror, C (corresponding author), Univ La Frontera, Fac Dent, Ctr Res Epidemiol Econ & Oral Publ Hlth CIEESPO, Temuco, Chile.; Zaror, C; Ferrer, M (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.; Ferrer, M (corresponding author), Hosp del Mar Med Res Inst IMIM, Hlth Serv Res Grp, Doctor Aiguader 88, Barcelona 08003, Spain.; Ferrer, M (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.	carlos.zaror@ufrontera.cl; mferrer@imim.es	Zaror, Carlos/AFY-3761-2022; Martinez-Zapata, Maria José/HME-2661-2023; Garin, Olatz/K-5468-2013; Pardo, Yolanda/B-1338-2015; Vilagut, Gemma/N-8718-2014; Garcia Forero, Carlos/B-4771-2009; Alonso, Jordi/A-5514-2010; Pont, Angels/B-1368-2015; Ferrer, Montserrat/A-5510-2010	Pardo, Yolanda/0000-0003-4982-5495; Zaror, Carlos/0000-0001-6942-6956; Vilagut, Gemma/0000-0002-3714-226X; Garcia Forero, Carlos/0000-0002-5245-0076; Martinez-Zapata/0000-0002-5836-1138; Alonso, Jordi/0000-0001-8627-9636; Pont, Angels/0000-0002-0602-552X; Ferrer, Montserrat/0000-0001-9867-7391	Miguel Servet research contract from the Instituto de Salud Carlos III; European Social Fund [CP15/00116]; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014 SGR 748]; Convenio de Desempeno Regional, FRO 1301, Universidad de La Frontera [UNT15-0012]	Miguel Servet research contract from the Instituto de Salud Carlos III; European Social Fund(European Social Fund (ESF)); Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya(Generalitat de Catalunya); Convenio de Desempeno Regional, FRO 1301, Universidad de La Frontera	Ma. Jose Martinez is funded by a Miguel Servet research contract from the Instituto de Salud Carlos III and European Social Fund (CP15/00116).r Montse Ferrer is partially funded by the Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya (2014 SGR 748).r This project was funded by a grant from the Convenio de Desempeno Regional, FRO 1301, Universidad de La Frontera, No. UNT15-0012.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Abanto J, 2014, INT J PAEDIATR DENT, V24, P373, DOI 10.1111/ipd.12081; Abanto J, 2011, COMMUNITY DENT ORAL, V39, P105, DOI 10.1111/j.1600-0528.2010.00580.x; Akram AJ, 2011, ORTHOD CRANIOFAC RES, V14, P160, DOI 10.1111/j.1601-6343.2011.01517.x; Aldrigui JM, 2014, COMMUNITY DENT ORAL, V42, P30, DOI 10.1111/cdoe.12053; Antonarakis GS, 2013, COMMUNITY DENT HLTH, V30, P189, DOI 10.1922/CDH_3225Antonarakis07; Barbosa T S, 2008, Int J Dent Hyg, V6, P93, DOI 10.1111/j.1601-5037.2007.00276.x; Barbosa T S, 2008, Int J Dent Hyg, V6, P108, DOI 10.1111/j.1601-5037.2007.00271.x; Barrêtto ER, 2011, PEDIATR DENT, V33, P228; Bendo CB, 2014, COMMUNITY DENT ORAL, V42, P216, DOI 10.1111/cdoe.12078; Broder HL, 2007, COMMUNITY DENT ORAL, V35, P8, DOI 10.1111/j.1600-0528.2007.00401.x; Do LG, 2012, J DENT RES, V91, P536, DOI 10.1177/0022034511434355; Filstrup Sara L, 2003, Pediatr Dent, V25, P431; Fyffe HE, 1999, COMMUNITY DENT HLTH, V16, P72; Garin O, 2014, HEART FAIL REV, V19, P359, DOI 10.1007/s10741-013-9394-7; Gherunpong Sudaduang, 2004, Community Dent Health, V21, P161; Gibbons CJ, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00178; Gilchrist F, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-40; Gomes MC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-55; Huntington NL, 2011, J PUBLIC HEALTH DENT, V71, P185, DOI 10.1111/j.1752-7325.2011.00247.x; Jokovic A, 2004, PEDIATR DENT, V26, P512; Jokovic A, 2003, J PUBLIC HEALTH DENT, V63, P67; Jokovic A, 2002, J DENT RES, V81, P459, DOI 10.1177/154405910208100705; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Khurana V, 2017, EUR J NEUROL, V24, P1099, DOI 10.1111/ene.13339; Kragt L, 2016, CLIN ORAL INVEST, V20, P1881, DOI 10.1007/s00784-015-1681-3; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149181; Kumar S, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0433-7; Lee GHM, 2011, COMMUNITY DENT ORAL, V39, P372, DOI 10.1111/j.1600-0528.2010.00604.x; Locker D, 2004, COMMUNITY DENT ORAL, V32, P10, DOI 10.1111/j.1600-0528.2004.00114.x; Locker D, 2002, COMMUNITY DENT ORAL, V30, P438, DOI 10.1034/j.1600-0528.2002.00015.x; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mandall NA, 2006, COMMUNITY DENT HLTH, V23, P69; Maratia S, 2016, QUAL LIFE RES, V25, P2467, DOI 10.1007/s11136-016-1284-8; Marshman Z, 2007, COMMUNITY DENT HLTH, V24, P198; Marshman Z, 2005, COMMUNITY DENT HLTH, V22, P151; Mathur Vijay Prakash, 2014, Indian J Dent Res, V25, P559, DOI 10.4103/0970-9290.147078; Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086]; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; O'Brien C, 2007, J ORTHOD, V34, P185, DOI 10.1179/146531207225022185; O'Brien K, 2006, AM J ORTHOD DENTOFAC, V129, P536, DOI 10.1016/j.ajodo.2004.10.014; Pahel BT, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-6; Patel N, 2016, J ORTHOD, V43, P7, DOI 10.1080/14653125.2015.1114712; Piovesan C., 2009, Revista Odonto Ciencia, V24, P81; Reissmann DR, 2017, QUAL LIFE RES, V26, P881, DOI 10.1007/s11136-016-1427-y; Schmidt S, 2014, QUAL LIFE RES, V23, P2169, DOI 10.1007/s11136-014-0678-8; Schmidt S, 2014, J SHOULDER ELB SURG, V23, P434, DOI 10.1016/j.jse.2013.09.029; Shin HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116011; Sinclair S, 2017, PATIENT, V10, P389, DOI 10.1007/s40271-016-0209-5; Sischo L, 2011, J DENT RES, V90, P1264, DOI 10.1177/0022034511399918; Steele MM, 2009, CHILD HEALTH CARE, V38, P228, DOI 10.1080/02739610903038818; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Tsakos G, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-62; Valderas JM, 2008, VALUE HEALTH, V11, P700, DOI 10.1111/j.1524-4733.2007.00309.x; Versloot J, 2004, Eur J Paediatr Dent, V5, P170; Wallander JL, 2001, J CLIN PSYCHOL, V57, P571, DOI 10.1002/jclp.1029; Wogelius P, 2009, BMC ORAL HEALTH, V9, P11, DOI DOI 10.1186/1472-6831-9-11; Zaror C, 2018, COMMUNITY DENT ORAL, V46, P88, DOI 10.1111/cdoe.12333; Zaror Sánchez Carlos, 2011, Int. J. Odontostomat., V5, P171; Zhou Y, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-66	60	57	60	1	15	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	JAN	2019	23	1					65	79		10.1007/s00784-018-2406-1	http://dx.doi.org/10.1007/s00784-018-2406-1			15	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	HH5YT	29569021				2024-09-18	WOS:000455805600006
J	Dalaei, F; Dijkhorst, PJ; Möller, S; Klassen, AF; de Vries, CEE; Poulsen, L; Kaur, MN; Thomsen, JB; Hoogbergen, M; Voineskos, SH; Repo, JP; Opyrchal, J; Paul, MA; Busch, KH; Cogliandro, A; Rose, M; Cano, SJ; Pusic, AL; Sorensen, JA				Dalaei, Farima; Dijkhorst, Phillip J.; Moller, Soren; Klassen, Anne F.; de Vries, Claire E. E.; Poulsen, Lotte; Kaur, Manraj N.; Thomsen, Jorn Bo; Hoogbergen, Maarten; Voineskos, Sophocles H.; Repo, Jussi P.; Opyrchal, Jakub; Paul, Marek Adam; Busch, Kay-Hendrik; Cogliandro, Annalisa; Rose, Michael; Cano, Stefan J.; Pusic, Andrea L.; Sorensen, Jens A.			Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study	AESTHETIC SURGERY JOURNAL			English	Article; Early Access							QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; MASSIVE WEIGHT-LOSS; BREAST-CANCER; ABDOMINOPLASTY; SATISFACTION	Background The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important.Objectives The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q.Methods Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively.Results A total of 12,554 assessments from 3237 participants (mean age 42.5 +/- 9.3 years; BMI 28.9 +/- 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales.Conclusions The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients' BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.	[Dalaei, Farima; Poulsen, Lotte; Thomsen, Jorn Bo; Sorensen, Jens A.] Odense Univ Hosp, Res Unit Plast Surg, Odense, Denmark; [Dalaei, Farima; Moller, Soren; Poulsen, Lotte; Thomsen, Jorn Bo; Sorensen, Jens A.] Univ Southern Denmark, JB Winslows Vej 4,Entrance 20,Penthouse 2nd Floor,, DK-5000 Odense C, Denmark; [Dijkhorst, Phillip J.] OLVG West Hosp, Dept Surg, Amsterdam, Netherlands; [Dijkhorst, Phillip J.] Dutch Obes Clin NOK, Amsterdam, Netherlands; [Moller, Soren] Odense Univ Hosp, Open Patient data Explorat Network OPEN, Odense, Denmark; [Klassen, Anne F.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [de Vries, Claire E. E.] OLVG West Hosp, Dept Surg, Amsterdam, Netherlands; [Kaur, Manraj N.] Harvard Univ, Brigham & Womens Hosp, Boston, MA USA; [Hoogbergen, Maarten] Catharina Hosp, Eindhoven, Netherlands; [Voineskos, Sophocles H.] Univ Toronto, Li Ka Shing Knowledge Inst, Dept Surg, Div Plast Surg, Toronto, ON, Canada; [Repo, Jussi P.] Tampere Univ Hosp, Dept Orthoped & Traumatol, Tampere, Finland; [Repo, Jussi P.] Univ Tampere, Tampere, Finland; [Opyrchal, Jakub] Maria Sklodowska Curie Mem Natl Canc Ctr, Dept Oncol & Reconstruct Surg, Gliwice, Poland; [Busch, Kay-Hendrik] Johanniter Krankenhaus & Waldkrankenahaus Bonn, Dept Plast Surg, Bonn, Germany; [Cogliandro, Annalisa] Univ Campus Biomed Roma, Fdn Policlin Univ Campus Biomed, Dept Med & Surg, Res Unit Plast Reconstruct & Aesthet Surg, Rome, Italy; [Rose, Michael] Zealand Univ Hosp, Dept Plast & Breast Surg, Roskilde, Denmark; [Rose, Michael] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Cano, Stefan J.] Modus Outcomes Ltd, Cheltenham, England; [Pusic, Andrea L.] Harvard Univ, Brigham & Womens Hosp, Dept Surg, Boston, MA USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; McMaster University; Harvard University; Brigham & Women's Hospital; Catharina Hospital; University of Toronto; Li Ka Shing Knowledge Institute; Tampere University; Tampere University Hospital; University Campus Bio-Medico - Rome Italy; Fondazione Policlinico Universitario Campus Bio-Medico; Lund University; Harvard University; Brigham & Women's Hospital	Dalaei, F (corresponding author), Univ Southern Denmark, JB Winslows Vej 4,Entrance 20,Penthouse 2nd Floor,, DK-5000 Odense C, Denmark.; Dalaei, F (corresponding author), Odense Univ Hosp, Dept Plast Surg, JB Winslows Vej 4,Entrance 20,Penthouse 2nd Floor, DK-5000 Odense C, Denmark.	farima.dalaei@gmail.com	, Annalisa/ADW-5837-2022	Klassen, Anne/0000-0003-4720-0096; Kaur, Manraj/0000-0002-1911-0395; Klassen, Anne/0000-0002-0256-4075; Thomsen, Jorn Bo/0000-0002-7368-6133; de Vries, Claire/0000-0001-8885-9546; Dalaei, Farima/0000-0003-2305-7758; Poulsen, Lotte/0000-0003-4205-806X; Dijkhorst;Dijkhorst, Phillip;Phillip/0000-0003-2913-8559	Region of Southern Denmark [21/17592]; Odense University Hospital PhD Foundation [A5006]; Jascha Fund [2021-0183]; Canadian Institutes for Health Research Fellowship Award	Region of Southern Denmark; Odense University Hospital PhD Foundation; Jascha Fund; Canadian Institutes for Health Research Fellowship Award(Canadian Institutes of Health Research (CIHR))	This study was funded by the following grants: the Region of Southern Denmark (21/17592); the Odense University Hospital PhD Foundation (A5006); and the Jascha Fund (2021-0183). Dr Kaur is funded by the Canadian Institutes for Health Research Fellowship Award (2020-2024).	Administration, 2020, UFaD; Aldaqal SM, 2012, N AM J MED SCI, V4, P94, DOI 10.4103/1947-2714.93386; Altieri MS, 2017, OBES SURG, V27, P2981, DOI 10.1007/s11695-017-2732-4; Alvarez AH, 2023, OBES SURG, V33, P2428, DOI 10.1007/s11695-023-06683-3; Baillot A, 2017, OBES SURG, V27, P2488, DOI 10.1007/s11695-017-2814-3; Barone M, 2018, AESTHET PLAST SURG, V42, P1506, DOI 10.1007/s00266-018-1232-9; Barone M, 2018, AESTHET PLAST SURG, V42, P1320, DOI 10.1007/s00266-018-1146-6; Berkane Y, 2024, PLAST RECONSTR SURG, V153, p1101e, DOI 10.1097/PRS.0000000000010683; Brozek JL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-69; Christopher AN, 2022, J SURG RES, V270, P348, DOI 10.1016/j.jss.2021.09.035; Chu JJ, 2023, ANN SURG ONCOL, V30, P4075, DOI 10.1245/s10434-023-13222-y; Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences, V2nd ed, DOI https://doi.org/10.4324/9780203771587; Crosby RD, 2004, J CLIN EPIDEMIOL, V57, P1153, DOI 10.1016/j.jclinepi.2004.04.004; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; Dalaei F, 2024, ANN SURG, V279, P1008, DOI 10.1097/SLA.0000000000006244; Dalaei F, 2023, PRS-GLOB OPEN, V11, DOI 10.1097/GOX.0000000000005401; Dalaei F, 2022, CLIN OBES, V12, DOI 10.1111/cob.12528; de Vet HCW, 2010, J CLIN EPIDEMIOL, V63, P37, DOI 10.1016/j.jclinepi.2009.03.011; de Vries CEE, 2018, OBES REV, V19, P1395, DOI 10.1111/obr.12710; de Vries CEE, 2022, Patient-centered outcomes research in bariatric and body contouring surgery; de Vries CEE, 2021, OBES SURG, V31, P3637, DOI 10.1007/s11695-021-05462-2; de Vries CEE, 2020, CLIN PLAST SURG, V47, P429, DOI 10.1016/j.cps.2020.03.003; Dreifuss SE, 2016, SURG OBES RELAT DIS, V12, P412, DOI 10.1016/j.soard.2015.08.509; ElAbd R, 2021, AESTHET PLAST SURG, V45, P1064, DOI 10.1007/s00266-020-02016-2; Elfanagely O, 2021, AESTHET PLAST SURG, V45, P1620, DOI 10.1007/s00266-021-02129-2; Eton DT, 2004, J CLIN EPIDEMIOL, V57, P898, DOI 10.1016/j.jclinepi.2004.01.012; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; King MT, 2011, EXPERT REV PHARM OUT, V11, P171, DOI [10.1586/erp.11.9, 10.1586/ERP.11.9]; Klassen AF, 2018, PLAST RECONSTR SURG, V142, P1600, DOI 10.1097/PRS.0000000000004978; Klassen AF, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0802-x; Klassen AF, 2016, PRS-GLOB OPEN, V4, DOI 10.1097/GOX.0000000000000665; Lo Torto F, 2021, EUR J PLAST SURG, V44, P459, DOI 10.1007/s00238-020-01779-w; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; Mocquard C, 2021, OBES SURG, V31, P4985, DOI 10.1007/s11695-021-05654-w; Mou D, 2021, SURG ENDOSC, V35, P4609, DOI 10.1007/s00464-020-07886-w; Mouelhi Y, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01344-w; Mundy LR, 2017, PLAST RECONSTR SURG, V139, p1046E, DOI 10.1097/PRS.0000000000003241; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Paul MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229138; Poulsen L., 2015, Ugeskr Laeger, V177, pV12140668, DOI [10.1093/asj/sjae162, DOI 10.1093/ASJ/SJAE162]; Poulsen L, 2023, PLAST RECONSTR SURG, V151, P1307, DOI 10.1097/PRS.0000000000010165; Poulsen L, 2018, AESTHET SURG J, V38, P990, DOI 10.1093/asj/sjy081; Poulsen L, 2017, PLAST RECONSTR SURG, V140, P491, DOI 10.1097/PRS.0000000000003605; Redelmeier DA, 1996, J CLIN EPIDEMIOL, V49, P1215, DOI 10.1016/S0895-4356(96)00206-5; Repo JP, 2019, J PLAST RECONSTR AES, V72, P933, DOI 10.1016/j.bjps.2019.02.017; Sadeghi P, 2022, J CLIN MED, V11, DOI 10.3390/jcm11154315; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Terwee CB, 2021, QUAL LIFE RES, V30, P2729, DOI 10.1007/s11136-021-02925-y; University of Oxford Department of Public Health, 2013, Patient-reported outcome measurement: a structured review of patient-reported outcome measures for patients undergoing cosmetic surgical procedures; US Food and Drug Administration, ( FDA) USFD 2009; Voineskos SH, 2020, PLAST RECONSTR SURG, V145, p11E, DOI 10.1097/PRS.0000000000006317; Voineskos SH, 2018, ANNU REV MED, V69, P467, DOI 10.1146/annurev-med-060116-022831; Wyrwich KW, 2005, QUAL LIFE RES, V14, P285, DOI 10.1007/s11136-004-0705-2	53	0	0	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1090-820X	1527-330X		AESTHET SURG J	Aesthet. Surg. J.	2024 AUG 21	2024										10.1093/asj/sjae162	http://dx.doi.org/10.1093/asj/sjae162		AUG 2024	13	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	D2U2A	39041862	hybrid			2024-09-18	WOS:001294780600001
J	Dasari, CM; Bhukya, R				Dasari, Chandra Mohan; Bhukya, Raju			Explainable deep neural networks for novel viral genome prediction	APPLIED INTELLIGENCE			English	Article						Splice sites; Interpretable; Convolution neural network; Motif; Splicing; Learned filters	HUMAN PAPILLOMAVIRUSES; SEQUENCES; VIRUSES; SEARCH; TOOL; DIVERSITY; ALIGNMENT; DETECTS; VIREMIA	Viral infection causes a wide variety of human diseases including cancer and COVID-19. Viruses invade host cells and associate with host molecules, potentially disrupting the normal function of hosts that leads to fatal diseases. Novel viral genome prediction is crucial for understanding the complex viral diseases like AIDS and Ebola. While most existing computational techniques classify viral genomes, the efficiency of the classification depends solely on the structural features extracted. The state-of-the-art DNN models achieved excellent performance by automatic extraction of classification features, but the degree of model explainability is relatively poor. During model training for viral prediction, proposed CNN, CNN-LSTM based methods (EdeepVPP, EdeepVPP-hybrid) automatically extracts features. EdeepVPP also performs model interpretability in order to extract the most important patterns that cause viral genomes through learned filters. It is an interpretable CNN model that extracts vital biologically relevant patterns (features) from feature maps of viral sequences. The EdeepVPP-hybrid predictor outperforms all the existing methods by achieving 0.992 mean AUC-ROC and 0.990 AUC-PR on 19 human metagenomic contig experiment datasets using 10-fold cross-validation. We evaluate the ability of CNN filters to detect patterns across high average activation values. To further asses the robustness of EdeepVPP model, we perform leave-one-experiment-out cross-validation. It can work as a recommendation system to further analyze the raw sequences labeled as 'unknown' by alignment-based methods. We show that our interpretable model can extract patterns that are considered to be the most important features for predicting virus sequences through learned filters.	[Dasari, Chandra Mohan; Bhukya, Raju] Natl Inst Technol, Warangal 506004, Telangana, India	National Institute of Technology (NIT System); National Institute of Technology Warangal	Dasari, CM (corresponding author), Natl Inst Technol, Warangal 506004, Telangana, India.	chandu.nitw44@gmail.com; raju@nitw.ac.in		DASARI, CHANDRA MOHAN/0000-0002-0515-4979				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amgarten D, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00304; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; [Anonymous], 2015, ARXIV; Assaf R, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P6488; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bartoszewicz J. M., 2020, BIORXIV; Bartoszewicz JM, 2021, NAR GENOM BIOINFORM, V3, DOI 10.1093/nargab/lqab004; Bohte S, 2018, ARXIV 180604931; Bzhalava D, 2016, INT J CANCER, V138, P2212, DOI 10.1002/ijc.29666; Bzhalava D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05807; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Bzhalava D, 2012, VIROLOGY, V432, P427, DOI 10.1016/j.virol.2012.06.022; Bzhalava Z, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2340-x; Bzhalava Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190938; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daglarli Evren, 2020, ADV APPL DEEP LEARN; Deng L., 2015, Speech and Audio Processing for Coding, Enhancement and Recognition, P153; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eickholt J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-88; Ekström J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Escalante H.J., 2018, Explainable and Interpretable Models in Computer Vision and Machine Learning, DOI 10.1007/978-3-319-98131-4; Fabijanska A, 2019, IEEE ACCESS, V7, P81297, DOI 10.1109/ACCESS.2019.2923687; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Gao X, 2018, IEEE ACCESS, V6, P24340, DOI 10.1109/ACCESS.2018.2825996; Glorot X., 2011, 14 INT C ARTIF INTEL, P315; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Haoyu Liang, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12347), P622, DOI 10.1007/978-3-030-58536-5_37; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI [10.1162/neco.1997.9.8.1735, 10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hou T, 2020, IEEEACM T COMPUTATIO; Hurwitz BL, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw077; Johansson H, 2013, VIROLOGY, V440, P1, DOI [10.1016/j.virol.2013.01.023, 10.1016/j.virol.2013.07.015]; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Khawaldeh S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110326; Kimura M, 2008, SOIL SCI PLANT NUTR, V54, P1, DOI 10.1111/j.1747-0765.2007.00197.x; Kiranyaz S, 2021, MECH SYST SIGNAL PR, V151, DOI 10.1016/j.ymssp.2020.107398; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Nielsen Michael A, 2015, Neural Networks and Deep Learning, V25; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Nowicki M, 2018, J COMPUT BIOL, V25, P871, DOI 10.1089/cmb.2018.0079; Pineda-Peña AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Pope PE, 2019, PROC CVPR IEEE, P10764, DOI 10.1109/CVPR.2019.01103; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; Ren J, 2020, QUANT BIOL, V8, P64, DOI 10.1007/s40484-019-0187-4; Ren J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0283-5; Reyesa A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/pnas.1514285112; Rizzo R., 2016, Computational intelligence methods for bioinformatics and biostatistics, P129, DOI [DOI 10.1007/978-3-319-44332-410, DOI 10.1007/978-3-319-44332-4]; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Shrikumar A, 2017, PR MACH LEARN RES, V70; Singh A, 2020, J IMAGING, V6, DOI 10.3390/jimaging6060052; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; Spencer M, 2015, IEEE ACM T COMPUT BI, V12, P103, DOI 10.1109/TCBB.2014.2343960; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sun F, 2018, ARXIV 180607810; Sutskever I, 2014, ADV NEUR IN, V27; Tampuu A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222271; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Wang S, 2015, INT J MOL SCI, V16, P17315, DOI 10.3390/ijms160817315; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC; Zhang QS, 2018, PROC CVPR IEEE, P8827, DOI 10.1109/CVPR.2018.00920; Zhang S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1025; Zuallaert J, 2018, BIOINFORMATICS, V34, P4180, DOI 10.1093/bioinformatics/bty497	72	28	29	2	19	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0924-669X	1573-7497		APPL INTELL	Appl. Intell.	FEB	2022	52	3					3002	3017		10.1007/s10489-021-02572-3	http://dx.doi.org/10.1007/s10489-021-02572-3		JUN 2021	16	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	YY8RB	34764607	Green Published, Bronze			2024-09-18	WOS:000666954600005
J	Chen, SQ; Yu, JZ; Chamouni, S; Wang, YQ; Li, YF				Chen, Shanquan; Yu, Jiazhou; Chamouni, Sarah; Wang, Yuqi; Li, Yunfei			Integrating machine learning and artificial intelligence in life-course epidemiology: pathways to innovative public health solutions	BMC MEDICINE			English	Review						Machine learning; Artificial intelligence; Life course; Epidemiology; Public health	CANCER; DETERMINANTS; SHIFT; CARE; AI	The integration of machine learning (ML) and artificial intelligence (AI) techniques in life-course epidemiology offers remarkable opportunities to advance our understanding of the complex interplay between biological, social, and environmental factors that shape health trajectories across the lifespan. This perspective summarizes the current applications, discusses future potential and challenges, and provides recommendations for harnessing ML and AI technologies to develop innovative public health solutions. ML and AI have been increasingly applied in epidemiological studies, demonstrating their ability to handle large, complex datasets, identify intricate patterns and associations, integrate multiple and multimodal data types, improve predictive accuracy, and enhance causal inference methods. In life-course epidemiology, these techniques can help identify sensitive periods and critical windows for intervention, model complex interactions between risk factors, predict individual and population-level disease risk trajectories, and strengthen causal inference in observational studies. By leveraging the five principles of life-course research proposed by Elder and Shanahan-lifespan development, agency, time and place, timing, and linked lives-we discuss a framework for applying ML and AI to uncover novel insights and inform targeted interventions. However, the successful integration of these technologies faces challenges related to data quality, model interpretability, bias, privacy, and equity. To fully realize the potential of ML and AI in life-course epidemiology, fostering interdisciplinary collaborations, developing standardized guidelines, advocating for their integration in public health decision-making, prioritizing fairness, and investing in training and capacity building are essential. By responsibly harnessing the power of ML and AI, we can take significant steps towards creating healthier and more equitable futures across the life course.	[Chen, Shanquan; Chamouni, Sarah] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England; [Yu, Jiazhou] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Wang, Yuqi] UCL, Dept Comp Sci, London WC1E 6BT, England; [Li, Yunfei] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm 17164, Sweden	University of London; London School of Hygiene & Tropical Medicine; Chinese University of Hong Kong; University of London; University College London; Karolinska Institutet	Chen, SQ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.; Li, YF (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm 17164, Sweden.	Shanquan.chen@lshtm.ac.uk; yunfei.li@ki.se		Yu, Jiazhou/0000-0002-9249-2721	Karolinska Institute	Karolinska Institute(Karolinska Institutet)	None	Ahmad OF, 2020, TECH INNOVAT GASTROI, V22, P80, DOI 10.1016/j.tgie.2019.150636; Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923; Bhagwat N, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006376; Bi QF, 2019, AM J EPIDEMIOL, V188, P2222, DOI 10.1093/aje/kwz189; Buchholz O, 2023, STUD HIST PHILOS SCI, V102, P60, DOI 10.1016/j.shpsa.2023.10.004; Char DS, 2020, AM J BIOETHICS, V20, P7, DOI 10.1080/15265161.2020.1819469; Chen RJ, 2022, CANCER CELL, V40, P865, DOI 10.1016/j.ccell.2022.07.004; Chen RJ, 2021, NAT BIOMED ENG, V5, P493, DOI 10.1038/s41551-021-00751-8; Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004; Chu JB, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01151-9; Credit K, 2023, J GEOGR SYST, DOI 10.1007/s10109-023-00413-0; Cui YF, 2023, J ROY STAT SOC B, V85, P179, DOI 10.1093/jrsssb/qkac001; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; Dogan O, 2021, COMPLEX INTELL SYST, V7, P2655, DOI 10.1007/s40747-021-00424-8; Eisbach S, 2024, NEW IDEAS PSYCHOL, V73, DOI 10.1016/j.newideapsych.2024.101077; Elder Jr GH., 2007, Handbook of Child Psychology. Volume 1; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Ferri-Garcíia R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231500; Finlayson SG, 2021, NEW ENGL J MED, V385, P283, DOI 10.1056/NEJMc2104626; Fletcher RR, 2021, FRONT ARTIF INTELL, V3, DOI 10.3389/frai.2020.561802; Gandhi A., 2019, EC'20: Proceedings of the 21st ACM Conference on Economics and Computation: 2019; Gao XR, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-27551-1; Glicksberg BS, 2024, J AM MED INFORM ASSN, V31, DOI 10.1093/jamia/ocae103; Grueso S, 2021, ALZHEIMERS RES THER, V13, DOI 10.1186/s13195-021-00900-w; Guevara M, 2024, NPJ DIGIT MED, V7, DOI 10.1038/s41746-023-00970-0; Hamilton Alisa J, 2021, Antimicrob Steward Healthc Epidemiol, V1, pe28, DOI 10.1017/ash.2021.192; Hinson JS, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00646-1; Homburg M, 2023, J MED INTERNET RES, V25, DOI 10.2196/49944; Huang C, 2022, Applied Time Series Analysis and Forecasting with Python, P341; Hunter E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208775; Jawadekar N, 2023, AM J EPIDEMIOL, V192, P1155, DOI 10.1093/aje/kwad043; Kang Q, 2021, ENVIRON SCI TECHNOL, V55, P13400, DOI 10.1021/acs.est.1c02204; Kim S, 2024, PREV MED REP, V42, DOI 10.1016/j.pmedr.2024.102723; Lee EY, 2021, J AM ACAD DERMATOL, V84, P1458, DOI 10.1016/j.jaad.2020.06.1019; Littmann M, 2020, NAT MACH INTELL, V2, P18, DOI 10.1038/s42256-019-0139-8; Liu XS, 2024, ENVIRON SCI TECHNOL, V58, P3869, DOI 10.1021/acs.est.3c06511; London AJ, 2022, CELL REP MED, V3, DOI 10.1016/j.xcrm.2022.100622; Lu L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26990-6; Lundberg SM, 2020, NAT MACH INTELL, V2, P56, DOI 10.1038/s42256-019-0138-9; Mao ST, 2023, IEEE T NEUR NET LEAR, V34, P6983, DOI 10.1109/TNNLS.2022.3145365; McCrary MR, 2024, J CUTAN PATHOL, V51, P689, DOI 10.1111/cup.14631; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; Nestor B, 2019, MACHINE LEARNING HEA; Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023; Park YJ, 2024, BMC MED INFORM DECIS, V24, DOI 10.1186/s12911-024-02459-6; Patra BG, 2021, J AM MED INFORM ASSN, V28, P2716, DOI 10.1093/jamia/ocab170; Rajkomar A, 2018, ANN INTERN MED, V169, P866, DOI 10.7326/M18-1990; Rajpurkar P, 2022, NAT MED, V28, P31, DOI 10.1038/s41591-021-01614-0; Rim TH, 2021, LANCET DIGIT HEALTH, V3, pE306, DOI 10.1016/S2589-7500(21)00043-1; Salganik MJ, 2020, P NATL ACAD SCI USA, V117, P8398, DOI 10.1073/pnas.1915006117; Sharma D, 2022, J AM HEART ASSOC, V11, DOI 10.1161/JAHA.121.022576; Smit LC, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039681; Stojanov R, 2021, J MED INTERNET RES, V23, DOI 10.2196/28229; Su C, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0780-3; Subramaniam S, 2022, SUSTAINABILITY-BASEL, V14, DOI 10.3390/su14169951; Swanson K, 2023, CELL, V186, P1772, DOI 10.1016/j.cell.2023.01.035; Tang AS, 2024, NATURE AGING, V4, DOI 10.1038/s43587-024-00573-8; Tran KA, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00968-x; Volovici V, 2022, NAT MED, V28, P1996, DOI 10.1038/s41591-022-01961-6; Wagner C, 2024, LANCET PUBLIC HEALTH, V9, pe261, DOI 10.1016/S2468-2667(24)00018-5; Waljee AK, 2022, GUT, V71, P1259, DOI 10.1136/gutjnl-2022-327211; Ward A, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00331-1; Wassink-Vossen S, 2019, EUR PSYCHIAT, V62, P90, DOI 10.1016/j.eurpsy.2019.09.003; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; Wiens J, 2018, CLIN INFECT DIS, V66, P149, DOI 10.1093/cid/cix731; Williams CYK, 2024, JAMA NETW OPEN, V7, DOI 10.1001/jamanetworkopen.2024.8895; Wu ZC, 2024, J HAZARD MATER, V465, DOI 10.1016/j.jhazmat.2023.133099; Ye CY, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9268; Zhang B, 2023, J MULTIDISCIP HEALTH, V16, P1779, DOI 10.2147/JMDH.S410301; Zhou Q, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00524-2; Zhu YD, 2022, AGE AGEING, V51, DOI 10.1093/ageing/afab191	71	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	SEP 2	2024	22	1							354	10.1186/s12916-024-03566-x	http://dx.doi.org/10.1186/s12916-024-03566-x			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	E4F7L	39218895	gold			2024-09-18	WOS:001302583300002
J	Wong, JS; Reformat, M; Parent, E; Lou, ED				Wong, Jason; Reformat, Marek; Parent, Eric; Lou, Edmond			Validity and accuracy of automatic cobb angle measurement on 3D spinal ultrasonographs for children with adolescent idiopathic scoliosis: SOSORT 2024 award winner	EUROPEAN SPINE JOURNAL			English	Article; Early Access						Machine learning; Adolescent idiopathic scoliosis; Cobb angle; Ultrasound; Measurement reliability	CORONAL CURVATURE; BREAST-CANCER; RELIABILITY	PurposeUltrasonography for scoliosis is a novel imaging method that does not expose children with adolescent idiopathic scoliosis (AIS) to radiation. A single ultrasound scan provides 3D spinal views directly. However, measuring ultrasonograph parameters is challenging, time-consuming, and requires considerable training. This study aimed to validate a machine learning method to measure the coronal curve angle on ultrasonographs automatically.MethodsA total of 144 3D spinal ultrasonographs were extracted to train and validate a machine learning model. Among the 144 images, 70 were used for training, and 74 consisted of 144 curves for testing. Automatic coronal curve angle measurements were validated by comparing them with manual measurements performed by an experienced rater. The inter-method intraclass correlation coefficient (ICC2,1), standard error of measurement (SEM), and percentage of measurements within clinical acceptance (<= 5 degrees) were analyzed.ResultsThe automatic method detected 125/144 manually measured curves. The averages of the 125 manual and automatic coronal curve angle measurements were 22.4 +/- 8.0 degrees and 22.9 +/- 8.7 degrees, respectively. Good reliability was achieved with ICC2,1 = 0.81 and SEM = 1.4 degrees. A total of 75% (94/125) of the measurements were within clinical acceptance. The average measurement time per ultrasonograph was 36 +/- 7 s. Additionally, the algorithm displayed the predicted centers of laminae to illustrate the measurement.ConclusionThe automatic algorithm measured the coronal curve angle with moderate accuracy but good reliability. The algorithm's quick measurement time and interpretability can make ultrasound a more accessible imaging method for children with AIS. However, further improvements are needed to bring the method to clinical use.	[Wong, Jason; Reformat, Marek; Lou, Edmond] Univ Alberta, Dept Elect & Comp Engn, Donadeo ICE 11-263,9211-116 St NW, Edmonton, AB T6G 1H9, Canada; [Parent, Eric] Univ Alberta, Dept Phys Therapy, Edmonton, AB T6G 2G4, Canada	University of Alberta; University of Alberta	Lou, ED (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Donadeo ICE 11-263,9211-116 St NW, Edmonton, AB T6G 1H9, Canada.	elou@ualberta.ca		Lou, Edmond/0000-0002-7531-8377; Wong, Jason/0000-0003-2500-0368	NSERC; Natural Sciences and Engineering Research Council of Canada (NSERC); Women and Children's Health Research Institute; Alberta Innovates	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Women and Children's Health Research Institute; Alberta Innovates	We would like to acknowledge the financial support from the Natural Sciences and Engineering Research Council of Canada (NSERC), the Women and Children's Health Research Institute, and Alberta Innovates. The authors would also like to thank the Industry Sandbox & AI Computing (ISAIC) at the University of Alberta for using their supercomputer, which made this research possible.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Chen W, 2016, EUR SPINE J, V25, P3265, DOI 10.1007/s00586-016-4492-6; Chen W, 2013, J CHILD ORTHOP, V7, P521, DOI 10.1007/s11832-013-0539-y; Doody MM, 2000, SPINE, V25, P2052; Ge SH, 2020, IEEE ENG MED BIO, P2101, DOI 10.1109/EMBC44109.2020.9176211; Greiner KA, 2002, AM FAM PHYSICIAN, V65, P1817; HOFFMAN DA, 1989, JNCI-J NATL CANCER I, V81, P1307, DOI 10.1093/jnci/81.17.1307; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Sayed T, 2022, SPINE DEFORM, V10, P501, DOI 10.1007/s43390-021-00466-5; Simony A, 2016, EUR SPINE J, V25, P3366, DOI 10.1007/s00586-016-4747-2; Tang YW, 2022, IEEE INT ULTRA SYM, DOI 10.1109/IUS54386.2022.9958621; The pandas development team, 2023, ABOUT US; Van Goethem J, 2007, NEUROIMAG CLIN N AM, V17, P105, DOI 10.1016/j.nic.2006.12.001; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vo QN, 2016, Reliability of three-dimensional ultrasound parameters and their correlation with the progression of adolescent idiopathic scoliosis; Vo QN, 2019, MED BIOL ENG COMPUT, V57, P2115, DOI 10.1007/s11517-019-02015-9; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Wong YS, 2019, ULTRASOUND MED BIOL, V45, P2866, DOI 10.1016/j.ultrasmedbio.2019.07.006; Zheng R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198792; Zheng R, 2016, SPINE, V41, P404, DOI 10.1097/BRS.0000000000001244; Zhou GQ, 2020, ULTRASOUND MED BIOL, V46, P828, DOI 10.1016/j.ultrasmedbio.2019.11.012	21	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	2024 JUL 10	2024										10.1007/s00586-024-08376-6	http://dx.doi.org/10.1007/s00586-024-08376-6		JUL 2024	9	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	YM6Z8	38987512	hybrid			2024-09-18	WOS:001268958000001
J	Hu, JY; Gu, XJ; Wang, ZQ; Gu, XS				Hu, Jingyu; Gu, Xiaojing; Wang, Zhiqiang; Gu, Xingsheng			Mixture of calibrated networks for domain generalization in brain tumor segmentation	KNOWLEDGE-BASED SYSTEMS			English	Article						Domain generalization; Brain tumor segmentation; Convolutional neural network; Model calibration	CONVOLUTIONAL NEURAL-NETWORKS; MEDICAL IMAGE-ANALYSIS; AUGMENTATION	Recent advances in deep learning for brain tumor segmentation demonstrate good performance when the training data and test data share the same distribution. However, medical images are often faced with distribution shifts due to different grades of cancers, various imaging qualities, and data from different medical institutions. Model calibration is highly related to domain generalization ability, and well-calibrated deep models show good domain generalization ability. Besides, ensemble learning is an implicit method for model calibration where domain shift problems can be alleviated by combining multiple models. In this paper, we aim to improve the generalization ability by explicitly calibrating the model in an ensemble. We proposed Mixture of Calibrated Networks (MCN) where multiple networks are jointly learned on the source and the augmented domain. We introduce a temperature scale to each network in an ensemble, which can be seen as the uncertainty of each domain to calibrate the predicted probabilities. These temperature scales form an uncertainty-aware loss to adaptively weigh the losses of multiple networks. The expectation-maximization (EM) algorithm is used to learn the parameters and explicitly model the relationship between key parameters, achieving better interpretability and robust parameter estimation. Moreover, we introduce an orthogonal constraint between convolutional kernels from the corresponding layer of multiple sub-networks, which keeps the diversity of sub-networks. We conduct extensive experiments on the brain tumor segmentation dataset from BRATS 2018, BRATS 2019, BRATS 2020, and FeTS 2021. Our proposed approach consistently improves the generalization performance and shows better calibration over inter-domain methods and intra-domain methods. (c) 2023 Elsevier B.V. All rights reserved.	[Hu, Jingyu; Gu, Xiaojing; Wang, Zhiqiang; Gu, Xingsheng] East China Univ Sci & Technol, Key Lab Smart Mfg Energy Chem Proc, Minist Educ, MeiLongLu 130, Shanghai 200237, Peoples R China	East China University of Science & Technology	Gu, XJ; Gu, XS (corresponding author), East China Univ Sci & Technol, Key Lab Smart Mfg Energy Chem Proc, Minist Educ, MeiLongLu 130, Shanghai 200237, Peoples R China.	jyhu@mail.ecust.edu.cn; xjinggu@ecust.edu.cn; wangzq@mail.ecust.edu.cn; xsgu@ecust.edu.cn	Hu, Jingyu/KHU-2823-2024	Jingyu, Hu/0000-0002-1082-4586; gu, xingsheng/0000-0001-7180-1989				Abràmoff MD, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0040-6; Ayinde BO, 2019, IEEE T NEUR NET LEAR, V30, P2650, DOI 10.1109/TNNLS.2018.2885972; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Carneiro G, 2020, MED IMAGE ANAL, V62, DOI 10.1016/j.media.2020.101653; Chen C, 2021, LECT NOTES COMPUT SC, V12903, P149, DOI 10.1007/978-3-030-87199-4_14; Chen C, 2019, LECT NOTES COMPUT SC, V11766, P184, DOI 10.1007/978-3-030-32248-9_21; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Ding Y, 2022, IEEE J BIOMED HEALTH, V26, P1570, DOI 10.1109/JBHI.2021.3122328; Dodge SF, 2018, IEEE T IMAGE PROCESS, V27, P5553, DOI 10.1109/TIP.2018.2855966; Gal Y, 2016, PR MACH LEARN RES, V48; Gong Y, 2021, P IEEE CVF INT C COM, P8958; Gu R, 2021, LECT NOTES COMPUT SC, V12903, P241, DOI 10.1007/978-3-030-87199-4_23; Guan H, 2022, IEEE T BIO-MED ENG, V69, P1173, DOI [10.1109/TBME.2021.3117407, 10.1145/3476779.3476780]; Guo CA, 2017, PR MACH LEARN RES, V70; Havaei M, 2017, MED IMAGE ANAL, V35, P18, DOI 10.1016/j.media.2016.05.004; Hu JY, 2022, NEUROCOMPUTING, V504, P68, DOI 10.1016/j.neucom.2022.06.058; Hu K, 2019, IEEE ACCESS, V7, P92615, DOI 10.1109/ACCESS.2019.2927433; Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z; Jiayun Wang, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P11502, DOI 10.1109/CVPR42600.2020.01152; Kao PY, 2019, LECT NOTES COMPUT SC, V11384, P128, DOI 10.1007/978-3-030-11726-9_12; Kendall A, 2017, 31 ANN C NEURAL INFO, V30; Kendall A, 2018, PROC CVPR IEEE, P7482, DOI 10.1109/CVPR.2018.00781; Lakshminarayanan B, 2017, ADV NEUR IN, V30; Li D, 2018, AAAI CONF ARTIF INTE, P3490; Li P, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P8866, DOI 10.1109/ICCV48922.2021.00876; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Luo ZR, 2021, IEEE J BIOMED HEALTH, V25, P737, DOI 10.1109/JBHI.2020.2998146; Ma NN, 2018, LECT NOTES COMPUT SC, V11218, P122, DOI 10.1007/978-3-030-01264-9_8; Mancini M, 2018, IEEE IMAGE PROC, P1353, DOI 10.1109/ICIP.2018.8451318; Mehrtash A, 2020, IEEE T MED IMAGING, V39, P3868, DOI 10.1109/TMI.2020.3006437; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Mukhoti Jishnu, 2020, P ADV NEUR INF PRO, V33, P15288; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Paszke A, 2019, ADV NEUR IN, V32; Peng X., 2022, IEEE Transactions on Pattern Analysis and Machine Intelligence; Peng Z., 2019, INT C MACH LEARN, P5102; Pereira S, 2016, IEEE T MED IMAGING, V35, P1240, DOI 10.1109/TMI.2016.2538465; Qiao FC, 2021, PROC CVPR IEEE, P6786, DOI 10.1109/CVPR46437.2021.00672; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Shaw R, 2019, PR MACH LEARN RES, V102, P427; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Thulasidasan S, 2019, ADV NEUR IN, V32; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Wald Y, 2021, ADV NEUR IN, V34; Wang JD, 2021, PROCEEDINGS OF THE THIRTIETH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, IJCAI 2021, P4627; Wang ZZ, 2021, KNOWL-BASED SYST, V228, DOI 10.1016/j.knosys.2021.107245; Wilcoxon F, 1992, Springer Series in Statistics, P196, DOI DOI 10.1007/978-1-4612-4380-9_16; Xu YW, 2019, LECT NOTES COMPUT SC, V11384, P222, DOI 10.1007/978-3-030-11726-9_20; Zhang H., 2018, INT C LEARN REPR, P1, DOI DOI 10.48550/ARXIV.1710.09412; Zhang L, 2020, IEEE T MED IMAGING, V39, P2531, DOI 10.1109/TMI.2020.2973595; Zhao S., 2020, Adv. Neural Inf. Process. Syst., V33, P16096; Zhou KY, 2021, IEEE T IMAGE PROCESS, V30, P8008, DOI 10.1109/TIP.2021.3112012; Zhou XY, 2021, EXPERT SYST APPL, V170, DOI 10.1016/j.eswa.2021.114566	55	4	4	5	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0950-7051	1872-7409		KNOWL-BASED SYST	Knowledge-Based Syst.	JUN 21	2023	270								110520	10.1016/j.knosys.2023.110520	http://dx.doi.org/10.1016/j.knosys.2023.110520		APR 2023	13	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	M6WB6					2024-09-18	WOS:001031589300001
J	Aday, JS; Heifets, BD; Pratscher, SD; Bradley, E; Rosen, R; Woolley, JD				Aday, Jacob S.; Heifets, Boris D.; Pratscher, Steven D.; Bradley, Ellen; Rosen, Raymond; Woolley, Joshua D.			Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials	PSYCHOPHARMACOLOGY			English	Review						Psychedelics; Psychedelic therapy; Clinical trials; Treatment expectations; Expectancies; Placebo effect; Masking; Recommendations	PATIENT-REPORTED OUTCOMES; MYSTICAL-TYPE EXPERIENCES; LIFE-THREATENING CANCER; PLACEBO-RESPONSE; PSILOCYBIN TREATMENT; DESIGN; ANXIETY; BLIND; PSYCHOTHERAPY; REGRESSION	Rationale Psychedelic research continues to garner significant public and scientific interest with a growing number of clinical studies examining a wide range of conditions and disorders. However, expectancy effects and effective condition masking have been raised as critical limitations to the interpretability of the research. Objective In this article, we review the many methodological challenges of conducting psychedelic clinical trials and provide recommendations for improving the rigor of future research. Results Although some challenges are shared with psychotherapy and pharmacology trials more broadly, psychedelic clinical trials have to contend with several unique sources of potential bias. The subjective effects of a high-dose psychedelic are often so pronounced that it is difficult to mask participants to their treatment condition; the significant hype from positive media coverage on the clinical potential of psychedelics influences participants' expectations for treatment benefit; and participant unmasking and treatment expectations can interact in such a way that makes psychedelic therapy highly susceptible to large placebo and nocebo effects. Specific recommendations to increase the success of masking procedures and reduce the influence of participant expectancies are discussed in the context of study development, participant recruitment and selection, incomplete disclosure of the study design, choice of active placebo condition, as well as the measurement of participant expectations and masking efficacy. Conclusion Incorporating the recommended design elements is intended to reduce the risk of bias in psychedelic clinical trials and thereby increases the ability to discern treatment-specific effects of psychedelic therapy.	[Aday, Jacob S.; Bradley, Ellen; Rosen, Raymond; Woolley, Joshua D.] Univ Calif San Francisco, San Francisco VA Med Ctr, Dept Psychiat & Behav Sci, 401 Parnassus Ave, San Francisco, CA 94143 USA; [Heifets, Boris D.] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Pratscher, Steven D.] Univ Florida, Pain Res & Intervent Ctr Excellence, Dept Community Dent & Behav Sci, Gainesville, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Stanford University; State University System of Florida; University of Florida	Aday, JS (corresponding author), Univ Calif San Francisco, San Francisco VA Med Ctr, Dept Psychiat & Behav Sci, 401 Parnassus Ave, San Francisco, CA 94143 USA.	jacob.aday@ucsf.edu; bheifets@stanford.edu; spratscher@ufl.edu; Ellen.Bradley@ucsf.edu; raymondrosen@gmail.com; josh.woolley@ucsf.edu	Aday, Jacob/AAS-4707-2020; Woolley, Joshua/AAX-6019-2020	Aday, Jacob/0000-0003-0578-8530; Heifets, Boris/0000-0003-1474-0379				Aday JS, 2021, ACS PHARMACOL TRANSL, V4, P424, DOI 10.1021/acsptsci.1c00014; Aday JS, 2020, NEUROSCI BIOBEHAV R, V113, P179, DOI 10.1016/j.neubiorev.2020.03.017; Aday JacobS., 2020, Drug Science, Policy and Law, V6, DOI DOI 10.1177/2050324520974484; Aday JS, 2021, THESIS CENTRAL MICHI; [Anonymous], 2009, Guidance for industry: Patient-Reported outcome measures: Use in medical product development to support labeling claims; ATLAS LY, 2021, TRENDS COGN SCI; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; BARSKY AJ, 1983, AM J PSYCHIAT, V140, P273; Basoglu M, 1997, ARCH GEN PSYCHIAT, V54, P744; Bedi G, 2010, BIOL PSYCHIAT, V68, P1134, DOI 10.1016/j.biopsych.2010.08.003; Bershad AK, 2019, NEUROPSYCHOPHARMACOL, V44, P1698, DOI 10.1038/s41386-019-0402-z; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Bishop MD, 2019, PHYSIOTHER THEOR PR, V35, P70, DOI 10.1080/09593985.2018.1440676; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Burke MJ, 2021, NAT MED, V27, P1687, DOI 10.1038/s41591-021-01524-1; BURNS JW, 2021, PAIN; Calvert M, 2018, JAMA-J AM MED ASSOC, V319, P483, DOI 10.1001/jama.2017.21903; Campbell CM, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000697; Carbonaro TM, 2018, PSYCHOPHARMACOLOGY, V235, P521, DOI 10.1007/s00213-017-4769-4; Carhart-Harris RL, 2015, PSYCHOPHARMACOLOGY, V232, P785, DOI 10.1007/s00213-014-3714-z; Carhart-Harris RL, 2022, J PSYCHOPHARMACOL, V36, P6, DOI 10.1177/02698811211008567; Bouso JC, 2013, PSYCHOPHARMACOLOGY, V230, P415, DOI 10.1007/s00213-013-3167-9; Carpenter D E., 2020, Forbes; Colagiuri B, 2010, PSYCHOPHARMACOLOGY, V208, P433, DOI 10.1007/s00213-009-1743-9; Colloca L, 2020, NEW ENGL J MED, V382, P554, DOI 10.1056/NEJMra1907805; Constantino MJ, 2018, PSYCHOTHERAPY, V55, P473, DOI 10.1037/pst0000169; Constantino MJ, 2011, J CLIN PSYCHOL, V67, P184, DOI 10.1002/jclp.20754; Cunningham JA, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-150; Cusack CM, 2020, NOVA RELIG, V24, P31, DOI 10.1525/nr.2020.24.1.31; D'Onofrio G, 2012, ANN EMERG MED, V60, P181, DOI 10.1016/j.annemergmed.2012.02.006; Davis AK, 2021, JAMA PSYCHIAT, V78, P481, DOI 10.1001/jamapsychiatry.2020.3285; de Wit H, 2021, BIOL PSYCHIAT, V89, pE61, DOI [10.1016/j.biopsych.2021.01.0162021, 10.1016/j.biopsych.2021.01.016]; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dewey D, 2015, PSYCHIAT RES, V230, P300, DOI 10.1016/j.psychres.2015.09.009; Deyo RA, 2014, FOCUS ARTICLE REPORT; DOBLIN R, 1991, J TRANSPERSONAL PSY, V23, P1; Doering Bettina K, 2014, Handb Exp Pharmacol, V225, P273, DOI 10.1007/978-3-662-44519-8_15; Doward LC, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-89; Dragalin V, 2011, EUR NEUROPSYCHOPHARM, V21, P153, DOI 10.1016/j.euroneuro.2010.09.004; Dupuis D, 2021, CAN PSYCHEDELICS REA; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Earleywine M, 2021, J PSYCHOPHARMACOL, V35, P841, DOI 10.1177/0269881121997099; Eaves ER, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0531-9; Eisner B, 1997, J PSYCHOACTIVE DRUGS, V29, P213; Enck P, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00456; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Erpelding N, 2020, CLIN J PAIN, V36, P950, DOI 10.1097/AJP.0000000000000873; Evans K, 2021, CONTEMP CLIN TRIALS, V107, DOI 10.1016/j.cct.2021.106503; Fadiman J, 2011, The psychedelic explorer's guide: Safe, therapeutic, and sacred journeys; Ferrari R, 2010, J RHEUMATOL, V37, P2387, DOI 10.3899/jrheum.100513; Fillingim RB, 2005, MAYO CLIN PROC, V80, P1119, DOI 10.4065/80.9.1119; FISHER S, 1993, J NERV MENT DIS, V181, P345, DOI 10.1097/00005053-199306000-00002; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Flowers EP, 2018, PSYCHOL SPORT EXERC, V39, P213, DOI 10.1016/j.psychsport.2018.08.014; Freedland KE, 2020, HEALTH PSYCHOL, V39, P539, DOI 10.1037/hea0000867; Furukawa TA, 2014, ACTA PSYCHIAT SCAND, V130, P181, DOI 10.1111/acps.12275; Gewandter JS, 2020, J PAIN, V21, P931, DOI 10.1016/j.jpain.2019.12.003; Glowacki DR, 2020, PROCEEDINGS OF THE 2020 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'20), DOI 10.1145/3313831.3376649; Gold SM, 2017, LANCET PSYCHIAT, V4, P725, DOI 10.1016/S2215-0366(17)30153-0; Griffiths RR, 2008, J PSYCHOPHARMACOL, V22, P621, DOI 10.1177/0269881108094300; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Griffiths RR, 2016, J PSYCHOPHARMACOL, V30, P1181, DOI 10.1177/0269881116675513; Grob CS, 2011, ARCH GEN PSYCHIAT, V68, P71, DOI 10.1001/archgenpsychiatry.2010.116; Gukasyan N, 2022, TRANSCULT PSYCHIATRY, V59, P652, DOI 10.1177/1363461520983684; Haijen ECHM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00897; Hartogsohn, 2021, AM TRIP SET SETTING; Hartogsohn I, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00129; Hartogsohn I, 2016, J PSYCHOPHARMACOL, V30, P1259, DOI 10.1177/0269881116677852; Heifets BD, 2019, JAMA PSYCHIAT, V76, P657, DOI 10.1001/jamapsychiatry.2019.0766; Hengartner MP, 2020, BMJ EVID-BASED MED, V25, P46, DOI 10.1136/bmjebm-2019-111161; Hieronymus F, 2018, MOL PSYCHIATR, V23, P1731, DOI 10.1038/mp.2017.147; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holbein MEB, 2015, CTS-CLIN TRANSL SCI, V8, P526, DOI 10.1111/cts.12255; HORTON DM, 2021, AM J PSYCHOTHER; Horvath AO, 2011, PSYCHOTHERAPY, V48, P9, DOI 10.1037/a0022186; Hróbjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Hróbjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Ivanova A, 2016, J BIOPHARM STAT, V26, P167, DOI 10.1080/10543406.2015.1092028; Johnson MW, 2017, NEUROTHERAPEUTICS, V14, P734, DOI 10.1007/s13311-017-0542-y; Johnson MW, 2014, J PSYCHOPHARMACOL, V28, P983, DOI 10.1177/0269881114548296; Jones BDM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.25531; JUUL S, 2020, BMJ EVID-BASED MED; Kaertner LS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81446-7; Kaptchuk TJ, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m1668; Katz N, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000854; Kobak KA, 2007, J CLIN PSYCHOPHARM, V27, P1, DOI 10.1097/JCP.0b013e31802eb4b7; Kogo Y, 2002, J HUMANIST PSYCHOL, V42, P82, DOI 10.1177/002216702237125; Kolahi J, 2009, COMMUNITY DENT ORAL, V37, P477, DOI 10.1111/j.1600-0528.2009.00494.x; Kube T, 2017, DRUG DISCOV TODAY, V22, P729, DOI 10.1016/j.drudis.2016.11.022; Kuypers KPC, 2019, J PSYCHOPHARMACOL, V33, P1039, DOI 10.1177/0269881119857204; Laferton JAC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00233; Leake GJ, 1977, ALCOHOL HEALTH RES W, V11; LEARY T, 1963, J NERV MENT DIS, V137, P561, DOI 10.1097/00005053-196312000-00007; Ledford, 2019, SEX DRUGS MIND CONTR; Leger RF, 2022, J PSYCHOPHARMACOL, V36, P20, DOI 10.1177/02698811211044688; Lynn S.J., 2017, Psychology of Consciousness: Theory, Research, and Practice, V1, P23, DOI DOI 10.1037/CNS0000105; MacLean KA, 2012, J SCI STUD RELIG, V51, P721, DOI 10.1111/j.1468-5906.2012.01685.x; Majic T, 2015, J PSYCHOPHARMACOL, V29, P241, DOI 10.1177/0269881114568040; Marks M, 2021, NAT MED, V27, P1669, DOI 10.1038/s41591-021-01530-3; Marton T, 2019, BIOL PSYCHIAT, V85, pE75, DOI 10.1016/j.biopsych.2019.02.008; Mataix-Cols D, 2021, JAMA PSYCHIAT, V78, P943, DOI 10.1001/jamapsychiatry.2021.1419; Mathieu E, 2014, J CLIN EPIDEMIOL, V67, P667, DOI 10.1016/j.jclinepi.2014.02.001; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Mercieca-Bebber R, 2018, PATIENT-RELAT OUTCOM, V9, P353, DOI 10.2147/PROM.S156279; Miller FG, 2005, PLOS MED, V2, P853, DOI 10.1371/journal.pmed.0020262; Mithoefer MC, 2019, PSYCHOPHARMACOLOGY, V236, P2735, DOI 10.1007/s00213-019-05249-5; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Mundt JM, 2017, ANN BEHAV MED, V51, P307, DOI 10.1007/s12160-016-9854-0; Murphy-Beiner A, 2020, PSYCHOPHARMACOLOGY, V237, P1161, DOI 10.1007/s00213-019-05445-3; Muthukumaraswamy SD, 2021, EXPERT REV CLIN PHAR, V14, P1133, DOI 10.1080/17512433.2021.1933434; Oehen P, 2013, J PSYCHOPHARMACOL, V27, P40, DOI 10.1177/0269881112464827; Olson DE, 2021, ACS PHARMACOL TRANSL, V4, P563, DOI 10.1021/acsptsci.0c00192; Olson JA, 2020, PSYCHOPHARMACOLOGY, V237, P1371, DOI 10.1007/s00213-020-05464-5; Pace BA, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.733185; Pahnke W. N., 1963, DRUGS MYSTICISM ANAL; Pallmann P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1017-7; Patterson B, 2016, J PSYCHIATR RES, V83, P112, DOI 10.1016/j.jpsychires.2016.08.015; Peciña M, 2015, MOL PSYCHIATR, V20, P416, DOI 10.1038/mp.2014.164; Pecina M, 2015, JAMA PSYCHIAT, V72, P1087, DOI 10.1001/jamapsychiatry.2015.1335; Pedersen ER, 2014, J INTERPERS VIOLENCE, V29, P824, DOI 10.1177/0886260513505705; Planès S, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.208; Pollan M., 2018, How to change your mind: What the new science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence; Prideaux, 2021, BBCPAGE; Puente I., 2014, Journal of Transpersonal Research, V6, P40; RABKIN JG, 1986, PSYCHIAT RES, V19, P75, DOI 10.1016/0165-1781(86)90094-6; Reckweg J, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.760671; Reissig CJ, 2012, PSYCHOPHARMACOLOGY, V223, P1, DOI 10.1007/s00213-012-2680-6; ROHSENOW DJ, 1981, ADDICT BEHAV, V6, P107, DOI 10.1016/0306-4603(81)90003-4; Rosenkranz MA, 2019, CURR OPIN PSYCHOL, V28, P179, DOI 10.1016/j.copsyc.2018.12.022; ROSENTHAL D, 1956, PSYCHOL BULL, V53, P294, DOI 10.1037/h0044068; Ross S, 2016, J PSYCHOPHARMACOL, V30, P1165, DOI 10.1177/0269881116675512; Roulet TJ, 2017, ORGAN RES METHODS, V20, P487, DOI 10.1177/1094428117698745; Russ S. L., 2017, Psychology of Consciousness: Theory, Research, and Practice, V4, P38, DOI DOI 10.1037/CNS0000119; Rutherford BR, 2013, AM J PSYCHIAT, V170, P723, DOI 10.1176/appi.ajp.2012.12040474; Rutter M, 2007, PERSPECT PSYCHOL SCI, V2, P377, DOI 10.1111/j.1745-6916.2007.00050.x; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; Schenberg EE, 2021, EXPERT REV CLIN PHAR, V14, P1317, DOI 10.1080/17512433.2021.1951473; Scott AJ, 2022, PSYCHIAT RES, V307, DOI 10.1016/j.psychres.2021.114297; Scott AJ, 2022, JAMA PSYCHIAT, V79, P42, DOI 10.1001/jamapsychiatry.2021.3204; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4672; Sessa B, 2014, J PSYCHOACTIVE DRUGS, V46, P57, DOI 10.1080/02791072.2014.877322; Sherman KJ, 2010, SPINE, V35, P1471, DOI 10.1097/BRS.0b013e3181c2a8d3; Siegel A. N., 2021, J PSYCHIATR RES; SMART RG, 1966, Q J STUD ALCOHOL, V27, P469; Smith SM, 2020, PAIN, V161, P2446, DOI 10.1097/j.pain.0000000000001952; Smith SM, 2017, J PAIN, V18, P757, DOI 10.1016/j.jpain.2017.02.429; Smith WR, 2021, J MED ETHICS, V47, P807, DOI 10.1136/medethics-2020-106070; Solowij N, 2019, EUR ARCH PSY CLIN N, V269, P17, DOI 10.1007/s00406-019-00978-2; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Szigeti B, 2021, ELIFE, V10, DOI 10.7554/eLife.62878; Tambling RB, 2012, CONTEMP FAM THER, V34, P402, DOI 10.1007/s10591-012-9201-y; Tamura RN, 2007, CLIN TRIALS, V4, P309, DOI 10.1177/1740774507081217; Thapar A, 2019, PSYCHOL MED, V49, P1079, DOI 10.1017/S0033291718003896; Timmermann C, 2021, PSYCHEDELICS ALTER M, DOI 10.31234/osf.io/f6sjk; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; US Food and Drug Administration, 2020, GUIDANCE IND FDA STA; Uthaug MV, 2021, PSYCHOPHARMACOLOGY, V238, P1899, DOI 10.1007/s00213-021-05817-8; van Elk M, 2022, PSYCHOPHARMACOLOGY, V239, P1705, DOI 10.1007/s00213-021-05857-0; Vase L, 2019, BRIT J ANAESTH, V123, pE254, DOI 10.1016/j.bja.2019.01.040; Vîsla A, 2018, PSYCHOTHER RES, V28, P446, DOI 10.1080/10503307.2016.1218089; Wampold BE., 2016, Psychol. Conscious. Theory Res. Pract, V3, P108, DOI DOI 10.1037/CNS0000045; Webb CA, 2010, J CONSULT CLIN PSYCH, V78, P200, DOI 10.1037/a0018912; Weiss B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84746-0; WHITNEY CW, 1992, PAIN, V50, P281, DOI 10.1016/0304-3959(92)90032-7; Williams MT, 2020, J PSYCHEDELIC STUD, V4, P1, DOI 10.1556/2054.2019.032; Williams NR, 2018, AM J PSYCHIAT, V175, P1205, DOI 10.1176/appi.ajp.2018.18020138; Williams NR, 2019, MOL PSYCHIATR, V24, P1779, DOI 10.1038/s41380-019-0503-4; Wilsey B, 2016, CANNABIS CANNABINOID, V1, P139, DOI 10.1089/can.2016.0016; Wolfson PE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75706-1; Yaden DB, 2021, ACS PHARMACOL TRANSL, V4, P568, DOI 10.1021/acsptsci.0c00194; Yockey RA, 2020, DRUG ALCOHOL DEPEN, V212, DOI 10.1016/j.drugalcdep.2020.108071; Yoo SK, 2014, ASIA PAC EDUC REV, V15, P271, DOI 10.1007/s12564-014-9320-2; Yoon G, 2019, JAMA PSYCHIAT, V76, P337, DOI 10.1001/jamapsychiatry.2018.3990; Younger J, 2012, CLIN TRIALS, V9, P767, DOI 10.1177/1740774512465064; Zhu ZW, 2014, SENSOR MATER, V26, P319, DOI 10.11919/j.issn.1002-0829.214173	178	76	76	4	18	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2022	239	6			SI		1989	2010		10.1007/s00213-022-06123-7	http://dx.doi.org/10.1007/s00213-022-06123-7		APR 2022	22	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	1V0RC	35359159	Green Submitted, Green Accepted	Y	N	2024-09-18	WOS:000777372300001
J	Lv, J; Peng, QK; Chen, X; Sun, Z				Lv, Jia; Peng, Qinke; Chen, Xiao; Sun, Zhi			A multi-objective heuristic algorithm for gene expression microarray data classification	EXPERT SYSTEMS WITH APPLICATIONS			English	Article						Microarray; Gene selection; Small number of selected genes; Multi-objective; Heuristic algorithm	FEATURE-SELECTION; PROSTATE-CANCER; PREDICTION; PATTERNS; SYSTEM; AUTISM; TUMOR; COST	Microarray data has significant potential in clinical medicine, which always owns a large quantity of genes relative to the samples' number. Finding a subset of discriminatory genes (features) through intelligent algorithms has been trend. Based on this, building a disease prognosis expert system will bring a great effect on clinical medicine. In addition, the fewer the selected genes are, the less cost the disease prognosis expert system is. So the small gene set with high classification accuracy is what we need. In this paper, a multi-objective model is built according to the analytic hierarchy process (AHP), which treats the classification accuracy absolutely important than the number of selected genes. And a multi-objective heuristic algorithm called MOEDA is proposed to solve the model, which is an improvement of Univariate Marginal Distribution Algorithm. Two main rules are designed, one is 'Higher and Fewer Rule' which is used for evaluating and sorting individuals and the other is 'Forcibly Decrease Rule' which is used for generate potential individuals with high classification accuracy and fewer genes. Our proposed method is tested on both binary-class and multi-class microarray datasets. The results show that the gene set selected by MOEDA not only results in higher accuracies, but also keep a small scale, which cannot only save computational time but also improve the interpretability and application of the result with the simple classification model. The proposed MOEDA opens up a new way for the heuristic algorithms applying on microarray gene expression data. (C) 2016 Elsevier Ltd. All rights reserved.	[Lv, Jia; Peng, Qinke; Chen, Xiao; Sun, Zhi] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Syst Engn Inst, Xianning Rd, Xian 710049, Peoples R China	Xi'an Jiaotong University	Peng, QK (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Syst Engn Inst, Xianning Rd, Xian 710049, Peoples R China.	answer_lv@stu.xjtu.edu.cn; qkpeng@mail.xjtu.edu.cn; xchen_xjtu@163.com; sun.zhi@stu.xjtu.edu.cn			National Natural Science Foundation of China [61173111, 60774086]; Ph. D. Programs Foundation of Ministry of Education of China [20090201110027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was jointly supported by the National Natural Science Foundation of China (grant numbers 61173111, 60774086) and the Ph. D. Programs Foundation of Ministry of Education of China (grant number 20090201110027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; [Anonymous], STAT APPL GENETICS M; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Chen KH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-49; Chen YC, 2014, COMPUT BIOL MED, V48, P1, DOI 10.1016/j.compbiomed.2014.02.006; Chuang LY, 2011, COMPUT BIOL MED, V41, P228, DOI 10.1016/j.compbiomed.2011.02.004; Dessì N, 2015, EXPERT SYST APPL, V42, P4632, DOI 10.1016/j.eswa.2015.01.069; Du BG, 2015, EXPERT SYST APPL, V42, P4253, DOI 10.1016/j.eswa.2015.01.056; Gao SY, 2015, AUTOMATICA, V59, P19, DOI 10.1016/j.automatica.2015.06.005; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Huang JJ, 2007, PATTERN RECOGN LETT, V28, P1825, DOI 10.1016/j.patrec.2007.05.011; Kar S, 2015, EXPERT SYST APPL, V42, P612, DOI 10.1016/j.eswa.2014.08.014; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim H, 2013, COMPUT BIOL MED, V43, P1363, DOI 10.1016/j.compbiomed.2013.06.014; Latkowski T, 2015, COMPUT BIOL MED, V56, P82, DOI 10.1016/j.compbiomed.2014.11.004; Latkowski T, 2015, EXPERT SYST APPL, V42, P864, DOI 10.1016/j.eswa.2014.08.043; Li YH, 2015, MOL DIAGN THER, V19, P169, DOI 10.1007/s40291-015-0140-9; Lotfi E, 2014, COMPUT BIOL MED, V54, P180, DOI 10.1016/j.compbiomed.2014.09.008; Nanni L, 2012, BIOINFORMATICS, V28, P1151, DOI 10.1093/bioinformatics/bts108; Park CH, 2015, EXPERT SYST APPL, V42, P2336, DOI 10.1016/j.eswa.2014.10.044; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Qi YS, 2013, GENOMICS, V101, P38, DOI 10.1016/j.ygeno.2012.09.004; Rocke DM, 2009, BIOINFORMATICS, V25, P701, DOI 10.1093/bioinformatics/btp038; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-375; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Sun SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102541; Sun X, 2012, NEUROCOMPUTING, V97, P86, DOI 10.1016/j.neucom.2012.05.001; Sun X, 2012, PATTERN RECOGN, V45, P2992, DOI 10.1016/j.patcog.2012.02.001; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Tong MCX, 2013, COMPUT BIOL MED, V43, P729, DOI 10.1016/j.compbiomed.2013.03.010; Wang LP, 2007, IEEE ACM T COMPUT BI, V4, P40, DOI 10.1109/TCBB.2007.1006; Wang XS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-391; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yang CH, 2010, J MED BIOL ENG, V30, P23; You WJ, 2014, EXPERT SYST APPL, V41, P1463, DOI 10.1016/j.eswa.2013.08.043; You WJ, 2014, KNOWL-BASED SYST, V55, P15, DOI 10.1016/j.knosys.2013.10.004; Zhou WG, 2014, COMPUT BIOL MED, V47, P66, DOI 10.1016/j.compbiomed.2014.01.014	42	47	47	0	82	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0957-4174	1873-6793		EXPERT SYST APPL	Expert Syst. Appl.	OCT 15	2016	59						13	19		10.1016/j.eswa.2016.04.020	http://dx.doi.org/10.1016/j.eswa.2016.04.020			7	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Operations Research & Management Science	DN7BO					2024-09-18	WOS:000377230500002
J	Oh, JH; Kim, HG; Lee, KM; Ryu, CW				Oh, Jang-Hoon; Kim, Hyug-Gi; Lee, Kyung Mi; Ryu, Chang-Woo			Reliable quality assurance of X-ray mammography scanner by evaluation the standard mammography phantom image using an interpretable deep learning model	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Artificial intelligence; Deep learning; Interpretability; Explainability; Mammography; Phantom; Quality Control	ACCREDITATION PHANTOM	Objective: Mammography is the initial examination to detect breast cancer symptoms, and quality control of mammography devices is crucial to maintain accurate diagnosis and to safeguard against degradation of performance. The objective of this study was to assist radiologists in mammography phantom image evaluation by developing and validating an interpretable deep learning model capable of objectively evaluating the quality of standard phantom images for mammography.Materials and Methods: A total of 2,208 mammography phantom images were collected for periodic accreditation of the scanner from 1,755 institutions. The dataset was randomly split into training (1,808 images) and testing (400 images) datasets with subgroups (76 images) for the multi-reader study. To develop an interpretable model that contains two deep learning networks in series, five processing steps were performed: mammography phantom detection, phantom object detection, post-processing, score evaluation, and a report with a comment about ambiguous results. Results: For phantom detection, the accuracy and mean intersection over union (mIOU) were 1.00 and 0.938 in the test dataset, respectively. During phantom object detection, a total of 6,369 out of 6,400 objects were detected as the correct object class, and the accuracy and mIOU were 0.995 and 0.813, respectively. The predicted score for each object showed a consensus of 97.40% excluding ambiguous points and 59.10% for ambiguous points of the groups.Conclusions: The interpretable deep learning model using large-scale data from multiple centers shows high performance and reasonable object scoring, successfully validating the reliability and feasibility of mammography phantom image quality management.	[Oh, Jang-Hoon] Kyung Hee Univ, Grad Sch, Dept Biomed Sci & Technol, 23 Kyungheedae Ro, Seoul 02447, South Korea; [Kim, Hyug-Gi; Lee, Kyung Mi] Kyung Hee Univ, Coll Med, Dept Radiol, Kyung Hee Univ Hosp, 23 Kyungheedae Ro, Seoul 02447, South Korea; [Ryu, Chang-Woo] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Radiol, Coll Med, 892 Dongnam Ro, Seoul 05278, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital	Lee, KM (corresponding author), Kyung Hee Univ, Coll Med, Dept Radiol, Kyung Hee Univ Hosp, 23 Kyungheedae Ro, Seoul 02447, South Korea.; Ryu, CW (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Radiol, Coll Med, 892 Dongnam Ro, Seoul 05278, South Korea.	bandilee@khu.ac.kr; md.cwryu@gmail.com	Ryu, Chang/IAJ-9854-2023		National Research Foundation of Korea (NRF) - Government of South Korea (Ministry of Science and ICT, MSIT) [NRF-2019R1F1A1063095, NRF-2020R1C1C1006623, NRF-2021R1F1A1050515]; National Research Foundation of Korea (NRF) - Government of South Korea (Ministry of Science and ICT, MSIT) [NRF-2019R1F1A1063095, NRF-2020R1C1C1006623, NRF-2021R1F1A1050515]; Central Medical Sevice (CMS) Research Fund; Ministry of Science and ICT; NIPA	National Research Foundation of Korea (NRF) - Government of South Korea (Ministry of Science and ICT, MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); National Research Foundation of Korea (NRF) - Government of South Korea (Ministry of Science and ICT, MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Central Medical Sevice (CMS) Research Fund; Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); NIPA	KML received grants from the National Research Foundation of Korea (NRF) grant funded by the Government of South Korea (Ministry of Science and ICT, MSIT) (NRF-2020R1C1C1006623) . HGK received grants from the National Research Foundation of Korea (NRF) grant funded by the Government of South Korea (Ministry of Science and ICT, MSIT) (NRF-2021R1F1A1050515) . CWR received grants from the Central Medical Sevice (CMS) Research Fund. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Government of South Korea (Ministry of Science and ICT, MSIT) (NRF-2019R1F1A1063095, NRF-2020R1C1C1006623, and NRF-2021R1F1A1050515) . This research was results of a study on the ?HPC Support? Project, supported by the ?Ministry of Science and ICT? and NIPA. The authors would also like to thank the Korean Institute for Accreditation of Medical Imaging (KIAMI) for its kind assistance in providing and analyzing the data.	Aboutalib SS, 2018, CLIN CANCER RES, V24, P5902, DOI 10.1158/1078-0432.CCR-18-1115; ACR, 2018, Technical Report; BROOKS KW, 1994, INVEST RADIOL, V29, P42, DOI 10.1097/00004424-199401000-00006; Faes L, 2019, LANCET DIGIT HEALTH, V1, pE232, DOI 10.1016/S2589-7500(19)30108-6; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Ho SY, 2020, PATTERNS, V1, DOI 10.1016/j.patter.2020.100129; Huda W, 2002, ACAD RADIOL, V9, P764, DOI 10.1016/S1076-6332(03)80345-8; Kim HG, 2019, QUANT IMAG MED SURG, V9, P942, DOI 10.21037/qims.2019.05.15; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Norgeot B, 2020, NAT MED, V26, P1320, DOI 10.1038/s41591-020-1041-y; Redmon J, 2017, PROC CVPR IEEE, P6517, DOI 10.1109/CVPR.2017.690; Shen L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48995-4; Slusarczyk-Kacprzyk W, 2016, POL J RADIOL, V81, P386, DOI 10.12659/PJR.897304; van den Ende C, 2017, INT J CANCER, V141, P1295, DOI 10.1002/ijc.30794; Wang JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27327; Yala A, 2019, RADIOLOGY, V292, P60, DOI 10.1148/radiol.2019182716	16	5	5	3	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	SEP	2022	154								110369	10.1016/j.ejrad.2022.110369	http://dx.doi.org/10.1016/j.ejrad.2022.110369		JUN 2022	10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	2N4WQ	35691109				2024-09-18	WOS:000818381600010
J	Vrotsou, K; Avila, M; Machón, M; Mateo-Abad, M; Pardo, Y; Garin, O; Zaror, C; González, N; Escobar, A; Cuéllar, R				Vrotsou, Kalliopi; Avila, Monica; Machon, Monica; Mateo-Abad, Maider; Pardo, Yolanda; Garin, Olatz; Zaror, Carlos; Gonzalez, Nerea; Escobar, Antonio; Cuellar, Ricardo			Constant-Murley Score: systematic review and standardized evaluation in different shoulder pathologies	QUALITY OF LIFE RESEARCH			English	Review						Constant-Murley score; Systematic review; Shoulder pathologies; EMPRO tool; Standardized evaluation; Psychometric properties	QUALITY-OF-LIFE; REPORTED OUTCOME MEASURES; AVAILABLE INSTRUMENTS; RELIABILITY; INSTABILITY; RESPONSIVENESS; QUESTIONNAIRE; CLINICIAN; CANCER; EMPRO	Purpose The objective of this study was to evaluate the psychometric properties of the Constant-Murley Score (CMS) in various shoulder pathologies, based on a systematic review and expert standardized evaluations. Methods A systematic review was performed in MEDLINE and EMBASE databases. Titles and abstracts were reviewed and finally the included articles were grouped according to patients' pathologies. Two expert evaluators independently assessed the CMS properties of reliability, validity, responsiveness to change, interpretability and burden score in each group, using the EMPRO (Evaluating Measures of Patient Reported Outcomes) tool. The CMS properties were assessed per attribute and overall for each considered group. Only the concept and measurement model was assessed globally. Results Five individual pathologies (i.e. subacromial, fractures, arthritis, instability and frozen shoulder) and two additional groups (i.e. various pathologies and healthy subjects) were considered. Overall EMPRO scores ranged from 58.6 for subacromial to 30.6 points for instability. Responsiveness to change was the only quality to obtain at least 50 points across all groups, but for frozen shoulder. Insufficient information was obtained in relation to the concept and measurement model and great variability was seen in the other evaluated attributes. Conclusions The current evidence does not support the CMS as a gold standard in shoulder evaluation. Its use is advisable for subacromial pathology; but data are inconclusive for other shoulder conditions. Prospective studies exploring the psychometric properties of the scale, particularly for fractures, arthritis, instability and frozen shoulder are needed.	[Vrotsou, Kalliopi; Machon, Monica; Mateo-Abad, Maider] Inst Biodonostia, Unidad Invest Atenc Primaria OSIS Gipuzkoa, Paseo Dr Beguiristain S-N, San Sebastian 20014, Spain; [Vrotsou, Kalliopi; Machon, Monica; Gonzalez, Nerea; Escobar, Antonio] Red Invest Serv Salud Enfermedades Cron REDISSEC, Bilbao, Spain; [Vrotsou, Kalliopi; Mateo-Abad, Maider] Ctr Invest Cronicidad Kronikgune, Baracaldo, Spain; [Avila, Monica; Pardo, Yolanda; Garin, Olatz] Hosp del Mar, IMIM, Med Res Inst, Hlth Serv Res Unit, Barcelona, Spain; [Avila, Monica; Pardo, Yolanda; Garin, Olatz] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Avila, Monica; Garin, Olatz] Univ Pompeu Fabra, Barcelona, Spain; [Zaror, Carlos] Univ La Frontera, Dept Paediat Dent & Orthodont, Fac Dent, Temuco, Chile; [Gonzalez, Nerea] Hosp Galdakao Usansolo, Unidad Invest, Galdakao, Spain; [Escobar, Antonio] Hosp Univ Basurto, Unidad Invest, Bilbao, Spain; [Cuellar, Ricardo] Hosp Univ Donostia, Serv Traumatol & Cirugia Ortoped, San Sebastian, Spain; [Zaror, Carlos] Univ San Sebastian, Fac Dent, Puerto Montt, Chile	Instituto de Investigacion Sanitaria Biogipuzkoa; Hospital del Mar Research Institute; Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Universidad de La Frontera; Galdakao Hospital; Basurto Hospital; Universidad San Sebastian	Vrotsou, K (corresponding author), Inst Biodonostia, Unidad Invest Atenc Primaria OSIS Gipuzkoa, Paseo Dr Beguiristain S-N, San Sebastian 20014, Spain.; Vrotsou, K (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Bilbao, Spain.; Vrotsou, K (corresponding author), Ctr Invest Cronicidad Kronikgune, Baracaldo, Spain.	kalliopi.vrotsoukanari@osakidetza.eus; mmavilap@gmail.com; monica.machonsobrado@osakidetza.eus; maider.mateoabad@osakidetza.eus; ypardo@imim.es; ogarin@imim.es; carlos.zaror@ufrontera.cl; nerea.gonzalezhernandez@osakidetza.eus; antonio.escobarmartinez@osakidetza.eus; ricardo.cuellargutierrez@osakidetza.eus	González, Nerea/L-5979-2017; Garin, Olatz/K-5468-2013; Zaror, Carlos/AFY-3761-2022; Pardo, Yolanda/B-1338-2015	Pardo, Yolanda/0000-0003-4982-5495; Zaror, Carlos/0000-0001-6942-6956	Health Department of the Basque Country Government [2013111087]	Health Department of the Basque Country Government	This study was funded by the Health Department of the Basque Country Government (No.: 2013111087). The funding source was not involved in any phase of the current project.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Altman DG., 1996, PRACTICAL STAT MED R, V7th; Angst F, 2008, ARTHRIT RHEUM-ARTHR, V59, P391, DOI 10.1002/art.23318; Angst F, 2011, ARTHRIT CARE RES, V63, pS174, DOI 10.1002/acr.20630; [Anonymous], 2007, REHABILITACION; Baker P, 2008, J SHOULDER ELB SURG, V17, P37, DOI 10.1016/j.jse.2007.04.019; Bankes MJK, 1998, J SHOULDER ELB SURG, V7, P116, DOI 10.1016/S1058-2746(98)90220-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blonna D, 2012, J SHOULDER ELB SURG, V21, P4, DOI 10.1016/j.jse.2011.07.014; Christie A, 2009, J SHOULDER ELB SURG, V18, P89, DOI 10.1016/j.jse.2008.07.008; Conboy VB, 1996, J BONE JOINT SURG BR, V78B, P229, DOI 10.1302/0301-620X.78B2.0780229; Constant CR, 2008, J SHOULDER ELB SURG, V17, P355, DOI 10.1016/j.jse.2007.06.022; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Dawson J, 1999, J BONE JOINT SURG BR, V81B, P420, DOI 10.1302/0301-620X.81B3.9044; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Garin O, 2014, HEART FAIL REV, V19, P359, DOI 10.1007/s10741-013-9394-7; Huang HM, 2015, AM J SPORT MED, V43, P2572, DOI 10.1177/0363546514565096; Kirkley A, 2003, ARTHROSCOPY, V19, P1109, DOI 10.1016/j.arthro.2003.10.030; Levy O, 2014, CLIN ORTHOP RELAT R, V472, P294, DOI 10.1007/s11999-013-3249-3; Lillkrona U, 2008, J SHOULDER ELB SURG, V17, P362, DOI 10.1016/j.jse.2007.06.013; Mahabier KC, 2017, J SHOULDER ELB SURG, V26, pE1, DOI 10.1016/j.jse.2016.07.072; Maratia S, 2016, QUAL LIFE RES, V25, P2467, DOI 10.1007/s11136-016-1284-8; McDowell I, 2006, Measuring Health: A Guide to Rating Scales and Questionnaires; Mitchell LE, 2013, RES DEV DISABIL, V34, P2419, DOI 10.1016/j.ridd.2013.04.013; Murphy RJ., 2010, BMJ Clin Evid, V2010, P1107; Oh JH, 2009, AM J SPORT MED, V37, P1161, DOI 10.1177/0363546508330135; Othman A, 2004, ACTA ORTHOP SCAND, V75, P114, DOI 10.1080/00016470410001708230; Plancher KD, 2009, ARTHROSCOPY, V25, P897, DOI 10.1016/j.arthro.2009.03.017; Rocourt MHH, 2008, J SHOULDER ELB SURG, V17, P364, DOI 10.1016/j.jse.2007.06.024; Roy JS, 2010, J SHOULDER ELB SURG, V19, P157, DOI 10.1016/j.jse.2009.04.008; Schmidt S, 2014, QUAL LIFE RES, V23, P2169, DOI 10.1007/s11136-014-0678-8; Schmidt S, 2014, J SHOULDER ELB SURG, V23, P434, DOI 10.1016/j.jse.2013.09.029; Sinclair S, 2017, PATIENT, V10, P389, DOI 10.1007/s40271-016-0209-5; Slobogean GP, 2011, INJURY, V42, P248, DOI 10.1016/j.injury.2010.11.046; Valderas JM, 2008, VALUE HEALTH, V11, P700, DOI 10.1111/j.1524-4733.2007.00309.x; vandenEnde CHM, 1996, J RHEUMATOL, V23, P2043; Walton MJ, 2007, J SHOULDER ELB SURG, V16, P285, DOI 10.1016/j.jse.2006.08.002; Yian EH, 2005, J SHOULDER ELB SURG, V14, P128, DOI 10.1016/j.jse.2004.07.003	38	80	97	1	15	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	SEP	2018	27	9					2217	2226		10.1007/s11136-018-1875-7	http://dx.doi.org/10.1007/s11136-018-1875-7			10	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	GR7IJ	29748823	hybrid, Green Published			2024-09-18	WOS:000442862200001
J	Pau, S; Perniciano, A; Pes, B; Rubattu, D; Jia, HM				Pau, Simone; Perniciano, Alessandra; Pes, Barbara; Rubattu, Dario; Jia, Heming			An Evaluation of Feature Selection Robustness on Class Noisy Data	INFORMATION			English	Article						feature selection; high-dimensional and imbalanced data; noisy data; robustness to noise	GENE-EXPRESSION; LABEL NOISE; CLASSIFICATION; CANCER; SIMILARITY; PREDICTION	With the increasing growth of data dimensionality, feature selection has become a crucial step in a variety of machine learning and data mining applications. In fact, it allows identifying the most important attributes of the task at hand, improving the efficiency, interpretability, and final performance of the induced models. In recent literature, several studies have examined the strengths and weaknesses of the available feature selection methods from different points of view. Still, little work has been performed to investigate how sensitive they are to the presence of noisy instances in the input data. This is the specific field in which our work wants to make a contribution. Indeed, since noise is arguably inevitable in several application scenarios, it would be important to understand the extent to which the different selection heuristics can be affected by noise, in particular class noise (which is more harmful in supervised learning tasks). Such an evaluation may be especially important in the context of class-imbalanced problems, where any perturbation in the set of training records can strongly affect the final selection outcome. In this regard, we provide here a two-fold contribution by presenting (i) a general methodology to evaluate feature selection robustness on class noisy data and (ii) an experimental study that involves different selection methods, both univariate and multivariate. The experiments have been conducted on eight high-dimensional datasets chosen to be representative of different real-world domains, with interesting insights into the intrinsic degree of robustness of the considered selection approaches.	[Pau, Simone; Perniciano, Alessandra; Pes, Barbara; Rubattu, Dario; Jia, Heming] Univ Cagliari, Dept Math & Comp Sci, Via Osped 72, I-09124 Cagliari, Italy	University of Cagliari	Perniciano, A (corresponding author), Univ Cagliari, Dept Math & Comp Sci, Via Osped 72, I-09124 Cagliari, Italy.	alessandra.pernician@unica.it; pes@unica.it		Pes, Barbara/0000-0003-3983-6844; Perniciano, Alessandra/0009-0003-8956-5058	This research was supported by the ASTRID project (Fondazione di Sardegna, L.R. 7 agosto 2007, n degrees7, CUP: F75F21001220007).; ASTRID project (Fondazione di Sardegna);  [F75F21001220007]	This research was supported by the ASTRID project (Fondazione di Sardegna, L.R. 7 agosto 2007, n degrees7, CUP: F75F21001220007).; ASTRID project (Fondazione di Sardegna); 	This research was supported by the ASTRID project (Fondazione di Sardegna, L.R. 7 agosto 2007, n degrees 7, CUP: F75F21001220007).	Abu Shanab A, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION (IRI), P372, DOI 10.1109/IRI.2018.00062; Almugren N, 2019, IEEE ACCESS, V7, P78533, DOI 10.1109/ACCESS.2019.2922987; Altidor W, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION (IRI), P240, DOI 10.1109/IRI.2011.6009553; Anyfamis D, 2007, INT FED INFO PROC, P21; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bolon-Canedo V., 2022, Advances in Selected Artificial Intelligence Areas: World Outstanding Women in Artificial Intelligence, P11, DOI DOI 10.1007/978-3-030-93052-3_2; Bolón-Canedo V, 2016, PROG ARTIF INTELL, V5, P65, DOI 10.1007/s13748-015-0080-y; Bolón-Canedo V, 2013, KNOWL INF SYST, V34, P483, DOI 10.1007/s10115-012-0487-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cannas LM, 2013, PATTERN RECOGN LETT, V34, P1446, DOI 10.1016/j.patrec.2013.05.011; Cannas LM, 2010, IFIP ADV INF COMM TE, V340, P297, DOI 10.1007/978-3-642-16327-2_36; Debole F, 2005, J AM SOC INF SCI TEC, V56, P584, DOI 10.1002/asi.20147; Dessì N, 2015, LECT NOTES COMPUT SC, V9375, P416, DOI 10.1007/978-3-319-24834-9_48; Dessí N, 2015, LECT NOTES ARTIF INT, V9101, P191, DOI 10.1007/978-3-319-19066-2_19; Dessì N, 2015, EXPERT SYST APPL, V42, P4632, DOI 10.1016/j.eswa.2015.01.069; Fang Li, 2011, 2011 9th IEEE International Conference on Control and Automation (ICCA 2011), P750, DOI 10.1109/ICCA.2011.6138076; Fawzi A., 2016, P ADV NEUR INF PROC, P1632; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Frénay B, 2014, IEEE T NEUR NET LEAR, V25, P845, DOI 10.1109/TNNLS.2013.2292894; Frénay B, 2014, COMPUT STAT DATA AN, V71, P832, DOI 10.1016/j.csda.2013.05.001; Gamberger D, 2000, APPL ARTIF INTELL, V14, P205, DOI 10.1080/088395100117124; García S, 2015, INTEL SYST REF LIBR, V72, P107, DOI 10.1007/978-3-319-10247-4_5; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gupta S, 2019, PROCEDIA COMPUT SCI, V161, P466, DOI 10.1016/j.procs.2019.11.146; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He S, 2015, INFORM SCIENCES, V291, P1, DOI 10.1016/j.ins.2014.08.048; Jiang LJ, 2022, BIOMETRICS, V78, P1155, DOI 10.1111/biom.13481; Johnson JM, 2022, ACM J DATA INF QUAL, V14, DOI 10.1145/3492546; Khaire UM, 2022, J KING SAUD UNIV-COM, V34, P1060, DOI 10.1016/j.jksuci.2019.06.012; Kim S, 2011, 2011 33RD INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE), P481, DOI 10.1145/1985793.1985859; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Manca MM, 2022, IEEE ACCESS, V10, P64043, DOI 10.1109/ACCESS.2022.3183228; Nettleton DF, 2010, ARTIF INTELL REV, V33, P275, DOI 10.1007/s10462-010-9156-z; Nogueira S, 2018, J MACH LEARN RES, V18; Pes B., 2018, HYBRID ARTIFICIAL IN; Pes B, 2017, 2017 IEEE 26TH INTERNATIONAL CONFERENCE ON ENABLING TECHNOLOGIES - INFRASTRUCTURE FOR COLLABORATIVE ENTERPRISES (WETICE), P170, DOI 10.1109/WETICE.2017.28; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Sánchez JS, 2003, PATTERN RECOGN LETT, V24, P1015, DOI 10.1016/S0167-8655(02)00225-8; Saseendran A., 2019, Mach. Learn. Res, DOI [10.13140/RG.2.2.25669.91369, DOI 10.13140/RG.2.2.25669.91369]; Shanthini A, 2019, SOFT COMPUT, V23, P8597, DOI 10.1007/s00500-019-03968-7; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Tan PN., 2016, Introduction to data mining; Tsanas A, 2014, IEEE T NEUR SYS REH, V22, P181, DOI 10.1109/TNSRE.2013.2293575; Urbanowicz RJ, 2018, J BIOMED INFORM, V85, P189, DOI 10.1016/j.jbi.2018.07.014; Van Hulse J, 2009, DATA KNOWL ENG, V68, P1513, DOI 10.1016/j.datak.2009.08.005; Walden R.H., 2008, 2008 IEEE Compound Semiconductor Integrated Circuits Symposium, P1, DOI [10.1109/BIBM.2012.6392713, DOI 10.1109/BIBM.2012.6392713]; Wang HJ, 2015, INT J SOFTW ENG KNOW, V25, P1467, DOI 10.1142/S0218194015400288; Witten IH, 2011, MOR KAUF D, P1; Witten IH, 2017, DATA MINING: PRACTICAL MACHINE LEARNING TOOLS AND TECHNIQUES, 4TH EDITION, P553; Zhang WS, 2006, BIOINFORMATICS, V22, P317, DOI 10.1093/bioinformatics/bti738; Zhu XQ, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P378; Zhu XQ, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P297, DOI 10.1109/ICDM.2004.10108	52	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2078-2489		INFORMATION	Information	AUG	2023	14	8							438	10.3390/info14080438	http://dx.doi.org/10.3390/info14080438			19	Computer Science, Information Systems	Emerging Sources Citation Index (ESCI)	Computer Science	Q2LD6		gold			2024-09-18	WOS:001055874000001
J	van der Putten, J; Struyvenberg, M; de Groof, J; Scheeve, T; Curvers, W; Schoon, E; Bergman, JJGHM; de With, PHN; van der Sommen, F				van der Putten, Joost; Struyvenberg, Maarten; de Groof, Jeroen; Scheeve, Thom; Curvers, Wouter; Schoon, Erik; Bergman, Jacques J. G. H. M.; de With, Peter H. N.; van der Sommen, Fons			Deep principal dimension encoding for the classification of early neoplasia in Barrett's Esophagus with volumetric laser endomicroscopy	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						Deep learning; Segmentation; Classification; Volumetric laser endomicroscopy	ADENOCARCINOMA; DISEASE	Barrett cancer is a treatable disease when detected at an early stage. However, current screening protocols are often not effective at finding the disease early. Volumetric Laser Endomicroscopy (VLE) is a promising new imaging tool for finding dysplasia in Barrett's esophagus (BE) at an early stage, by acquiring cross-sectional images of the microscopic structure of BE up to 3-mm deep. However, interpretation of VLE scans is difficult for medical doctors due to both the size and subtlety of the gray-scale data. Therefore, algorithms that can accurately find cancerous regions are very valuable for the interpretation of VLE data. In this study, we propose a fully-automatic multi-step Computer-Aided Detection (CAD) algorithm that optimally leverages the effectiveness of deep learning strategies by encoding the principal dimension in VLE data. Additionally, we show that combining the encoded dimensions with conventional machine learning techniques further improves results while maintaining interpretability. Furthermore, we train and validate our algorithm on a new histopathologically validated set of in-vivo VLE snapshots. Additionally, an independent test set is used to assess the performance of the model. Finally, we compare the performance of our algorithm against previous state-of-the-art systems. With the encoded principal dimension, we obtain an Area Under the Curve (AUC) and F-1 score of 0.93 and 87.4% on the test set respectively. We show this is a significant improvement compared to the state-of-the-art of 0.89 and 83.1%, respectively, thereby demonstrating the effectiveness of our approach. (C) 2020 The Author(s). Published by Elsevier Ltd.	[van der Putten, Joost; Scheeve, Thom; de With, Peter H. N.; van der Sommen, Fons] Eindhoven Univ Technol, VCA Res Grp, Eindhoven, Netherlands; [Struyvenberg, Maarten; de Groof, Jeroen; Bergman, Jacques J. G. H. M.] Amsterdam UMC, Amsterdam, Netherlands; [Curvers, Wouter; Schoon, Erik] Catharina Hosp, Eindhoven, Netherlands	Eindhoven University of Technology; University of Amsterdam; Catharina Hospital	van der Putten, J (corresponding author), Eindhoven Univ Technol, VCA Res Grp, Eindhoven, Netherlands.	j.a.v.d.putten@tue.nl	Bergman, Jacques/AAS-2500-2021; van der Sommen, Fons/AEW-0479-2022	van der Sommen, Fons/0000-0002-3593-2356; Bergman, Jacques/0000-0001-7548-6955; Scheeve, Thom/0000-0002-8288-0368				Alain G, 2016, ICLR WORKSH; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; [Anonymous], 2018, MATLAB DEEP LEARN TO; [Anonymous], 1995, INT C; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; DASARATHY BV, 1991, PATTERN RECOGN LETT, V12, P497, DOI 10.1016/0167-8655(91)80014-2; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Galloway M.M., 1974, NASA STIRECON TECHNI, P75; Gonzalo N, 2010, REV ESP CARDIOL, V63, P893, DOI 10.1016/S0300-8932(10)70201-3; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He K., 2016, ARXIV151203385, DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Iandola F. N., 2016, ARXIV160207360; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Kingma D. P., 2017, arXiv; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Pech O, 2014, GASTROENTEROLOGY, V146, P652, DOI 10.1053/j.gastro.2013.11.006; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Qi X, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337314; Quan T. M., 2016, Fusionnet: a deep fully residual convolutional neural network for image segmentation in connectomics; Ribeiro E, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6584725; Rodriguez-Diaz E, 2015, GASTROENTEROLOGY, V148, pS91; Rollins AM, 1998, OPT EXPRESS, V3, P219, DOI 10.1364/OE.3.000219; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Skacel M, 2000, AM J GASTROENTEROL, V95, P3383; SMEETON NC, 1985, BIOMETRICS, V41, P795; Smith LN, 2017, IEEE WINT CONF APPL, P464, DOI 10.1109/WACV.2017.58; Solaymani-Dodaran M, 2004, GUT, V53, P1070, DOI 10.1136/gut.2003.028076; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Swager AF, 2017, GASTROINTEST ENDOSC, V86, P464, DOI 10.1016/j.gie.2017.01.030; Swager AF, 2017, GASTROINTEST ENDOSC, V86, P839, DOI 10.1016/j.gie.2017.03.011; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Ughi GJ, 2012, INT J CARDIOVAS IMAG, V28, P229, DOI 10.1007/s10554-011-9824-3; van der Putten J, 2019, PROC SPIE, V10949, DOI 10.1117/12.2512192; van der Sommen F, 2018, COMPUT MED IMAG GRAP, V67, P9, DOI 10.1016/j.compmedimag.2018.02.007; van der Sommen F, 2018, GASTROENTEROLOGY, V154, P1876, DOI 10.1053/j.gastro.2018.01.070; Wilcoxon Frank, 1970, Sel Tables Math Stat, V1, P171; Wu ST, 2018, MULTIMED TOOLS APPL, V77, P10437, DOI 10.1007/s11042-017-4440-4; Zhou T, 2017, COMPUT BIOL MED, V85, P1, DOI 10.1016/j.compbiomed.2017.03.031	40	9	9	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	MAR	2020	80								101701	10.1016/j.compmedimag.2020.101701	http://dx.doi.org/10.1016/j.compmedimag.2020.101701			10	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	KR8FD	32044547	Green Published, hybrid			2024-09-18	WOS:000517850500009
J	Shen, JJ; Wang, S; Dong, YF; Sun, H; Wang, XC; Tang, ZX				Shen, Junjie; Wang, Shuo; Dong, Yongfei; Sun, Hao; Wang, Xichao; Tang, Zaixiang			A non-negative spike-and-slab lasso generalized linear stacking prediction modeling method for high-dimensional omics data	BMC BIOINFORMATICS			English	Article						Stacking Bayesian method; Non-negative spike-and-slab prior; Omics segmentation	VARIABLE SELECTION; R PACKAGE; REGRESSION; REGULARIZATION; APPROXIMATION; EXPRESSION; GENES	Background High-dimensional omics data are increasingly utilized in clinical and public health research for disease risk prediction. Many previous sparse methods have been proposed that using prior knowledge, e.g., biological group structure information, to guide the model-building process. However, these methods are still based on a single model, offen leading to overconfident inferences and inferior generalization.Results We proposed a novel stacking strategy based on a non-negative spike-and-slab Lasso (nsslasso) generalized linear model (GLM) for disease risk prediction in the context of high-dimensional omics data. Briefly, we used prior biological knowledge to segment omics data into a set of sub-data. Each sub-model was trained separately using the features from the group via a proper base learner. Then, the predictions of sub-models were ensembled by a super learner using nsslasso GLM. The proposed method was compared to several competitors, such as the Lasso, grlasso, and gsslasso, using simulated data and two open-access breast cancer data. As a result, the proposed method showed robustly superior prediction performance to the optimal single-model method in high-noise simulated data and real-world data. Furthermore, compared to the traditional stacking method, the proposed nsslasso stacking method can efficiently handle redundant sub-models and identify important sub-models.Conclusions The proposed nsslasso method demonstrated favorable predictive accuracy, stability, and biological interpretability. Additionally, the proposed method can also be used to detect new biomarkers and key group structures.	[Shen, Junjie; Dong, Yongfei; Sun, Hao; Wang, Xichao; Tang, Zaixiang] Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Dis, Dept Biostat,Suzhou Med Coll,MOE Key Lab Geriatr D, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Wang, Shuo] Univ Freiburg, Inst Med Biometry & Stat, Fac Med, D-79085 Freiburg, Germany; [Wang, Shuo] Univ Freiburg, Med Ctr, D-79085 Freiburg, Germany	Soochow University - China; University of Freiburg; University of Freiburg	Tang, ZX (corresponding author), Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Dis, Dept Biostat,Suzhou Med Coll,MOE Key Lab Geriatr D, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.	tangzx@suda.edu.cn			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the reviewers and the associate editor for their constructive suggestions and comments that have improved the manuscript. We acknowledge the contributions of the TCGA Research Network and the METABRIC team.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.3.CO;2-X; Ashley EA, 2016, NAT REV GENET, V17, P507, DOI 10.1038/nrg.2016.86; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Bembom O, 2007, STAT APPL GENET MOL, V6; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; Breheny P, 2009, STAT INTERFACE, V2, P369; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Buch G, 2023, STAT MED, V42, P331, DOI 10.1002/sim.9620; Chen X, 2010, STAT PROBABIL LETT, V80, P1313, DOI 10.1016/j.spl.2010.04.011; Chen X, 2009, J COMPUT BIOL, V16, P265, DOI 10.1089/cmb.2008.12TT; Clarke B, 2004, J MACH LEARN RES, V4, P683, DOI 10.1162/153244304773936090; Clyde Merlise, 2013, Bayesian Theory and Applications, P483, DOI DOI 10.1093/ACPROF:OSO/9780199695607.003.0024; Dimitriadou E., 2008, TU Wien, R package, V1, P5; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fröhlich F, 2018, CELL SYST, V7, P567, DOI 10.1016/j.cels.2018.10.013; Giannikaki E, 1997, ANTICANCER RES, V17, P2123; Grimonprez Q, 2023, J STAT SOFTW, V106, P1, DOI 10.18637/jss.v106.i03; Gupta GK, 2020, CANCERS, V12, DOI 10.3390/cancers12092392; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Kohavi R., 1995, IJCAI; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Lin YW, 2017, CHEMOMETR INTELL LAB, V168, P62, DOI 10.1016/j.chemolab.2017.07.004; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Naimi AI, 2018, EUR J EPIDEMIOL, V33, P459, DOI 10.1007/s10654-018-0390-z; Phillips RV, 2023, INT J EPIDEMIOL, V52, P1276, DOI 10.1093/ije/dyad023; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Sagi O, 2018, WIRES DATA MIN KNOWL, V8, DOI 10.1002/widm.1249; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Stiglic G, 2014, AMIA ANN S P; Subhan MA, 2023, CANCERS, V15, DOI 10.3390/cancers15082204; Tang ZX, 2017, GENETICS, V205, P77, DOI 10.1534/genetics.116.192195; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang LF, 2007, BIOINFORMATICS, V23, P1486, DOI 10.1093/bioinformatics/btm125; Wei Z, 2007, BIOSTATISTICS, V8, P265, DOI 10.1093/biostatistics/kxl007; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Yao YL, 2022, BAYESIAN ANAL, V17, P1043, DOI 10.1214/21-BA1287; Yao YL, 2018, BAYESIAN ANAL, V13, P917, DOI 10.1214/17-BA1091; Yi NJ, 2019, BIOINFORMATICS, V35, P1419, DOI 10.1093/bioinformatics/bty803; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuan M, 2006, J ROY STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zeng YH, 2016, CANCER INFORM, V15, P179, DOI 10.4137/CIN.S40043; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhang XY, 2017, GENETICS, V205, P89, DOI 10.1534/genetics.116.189191; Zhang YP, 2023, MILITARY MED RES, V10, DOI 10.1186/s40779-023-00458-8; Zhong CM, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.855078	54	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	MAR 20	2024	25	1							119	10.1186/s12859-024-05741-6	http://dx.doi.org/10.1186/s12859-024-05741-6			20	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	LZ2F2	38509499	Green Published, gold			2024-09-18	WOS:001190562800001
J	Li, TH; Wang, CC; Zhang, L; Chen, X				Li, Tian-Hao; Wang, Chun-Chun; Zhang, Li; Chen, Xing			SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction	BRIEFINGS IN BIOINFORMATICS			English	Article						cell line; drug; random matrix projection; synergistic drug combination; Siamese network		Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of high -throughput data, computational methods are becoming efficient tools to predict potential synergistic drug combinations. Considering the limitations of the previous computational methods, we developed a new model named Siamese Network and Random Matrix Projection for AntiCancer Drug Combination prediction (SNRMPACDC). Firstly, the Siamese convolutional network and random matrix projection were used to process the features of the two drugs into drug combination features. Then, the features of the cancer cell line were processed through the convolutional network. Finally, the processed features were integrated and input into the multi -layer perceptron network to get the predicted score. Compared with the traditional method of splicing drug features into drug combination features, SNRMPACDC improved the interpretability of drug combination features to a certain extent. In addition, the introduction of convolutional networks can better extract the potential information in the features. SNRMPACDC achieved the root mean -squared error of 15.01 and the Pearson correlation coefficient of 0.75 in 5 -fold cross -validation of regression prediction for response data. In addition, SNRMPACDC achieved the AUC of 0.91 +/- 0.03 and the AUPR of 0.62 +/- 0.05 in 5 -fold cross -validation of classification prediction of synergistic or not. These results are almost better than all the previous models. SNRMPACDC would be an effective approach to infer potential anticancer synergistic drug combinations.	[Li, Tian-Hao; Wang, Chun-Chun; Zhang, Li] China Univ Min & Technol, Sch Informat & Control Engn, Beijing, Peoples R China; [Chen, Xing] China Univ Min & Technol, Beijing, Peoples R China; [Chen, Xing] China Univ Min & Technol, Artificial Intelligence Res Inst, Beijing, Peoples R China; [Chen, Xing] China Univ Min & Technol, Inst Bioinformat, Beijing, Peoples R China; [Chen, Xing] China Univ Min & Technol, Big Data Res Ctr, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology	Chen, X (corresponding author), China Univ Min & Technol, Artificial Intelligence Res Inst, Xuzhou 221116, Jiangsu, Peoples R China.	xingchen@amss.an.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342; Wang, Chun-Chun/0000-0002-6795-4007	National Natural Science Foundation of China [61972399, 11631014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (Grant No. 61972399 and 11631014).	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Amzallag A, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2642-7; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Breiman L., 2001, Mach. Learn, V45, P5; Bromley J., 1993, International Journal of Pattern Recognition and Artificial Intelligence, V7, P669, DOI 10.1142/S0218001493000339; Bulusu KC, 2016, DRUG DISCOV TODAY, V21, P225, DOI 10.1016/j.drudis.2015.09.003; Cao DS, 2013, BIOINFORMATICS, V29, P1092, DOI 10.1093/bioinformatics/btt105; Celebi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45236-6; Chen X, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004975; Cheng FX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09186-x; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230; Ding PJ, 2019, IEEE J BIOMED HEALTH, V23, P1336, DOI 10.1109/JBHI.2018.2852274; Eraslan G, 2019, NAT REV GENET, V20, P389, DOI 10.1038/s41576-019-0122-6; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gayvert KM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005308; Hashemifar S, 2018, BIOINFORMATICS, V34, P802, DOI 10.1093/bioinformatics/bty573; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Hinselmann G, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-3; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Huang Y, 2017, ONCOL REP, V37, P705, DOI 10.3892/or.2016.5315; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jeon M, 2019, BIOINFORMATICS, V35, P5249, DOI 10.1093/bioinformatics/btz411; Ji XJ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00600; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Klambauer G, 2017, TOXICOL LETT, V280, pS69, DOI 10.1016/j.toxlet.2017.07.175; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Malyutina A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006752; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; O'Neil J, 2016, MOL CANCER THER, V15, P1155, DOI 10.1158/1535-7163.MCT-15-0843; Preuer K, 2018, BIOINFORMATICS, V34, P1538, DOI 10.1093/bioinformatics/btx806; Roth AD., 2017, ANN ONCOL, V11; Singh PK, 2016, ARCH TOXICOL, V90, P1785, DOI 10.1007/s00204-015-1587-5; Su R, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab534; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391; Tonekaboni SAM, 2018, BRIEF BIOINFORM, V19, P263, DOI 10.1093/bib/bbw104; Tooker P, 2007, CANCER RES, V67, P4425, DOI 10.1158/0008-5472.CAN-06-4495; Wei P, 2019, PROC CVPR IEEE, P5757, DOI 10.1109/CVPR.2019.00591; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Wu LL, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab355; Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001; Zagoruyko S, 2015, PROC CVPR IEEE, P4353, DOI 10.1109/CVPR.2015.7299064; Zhang CZ, 2019, SYN SYST BIOTECHNO, V4, P67, DOI 10.1016/j.synbio.2018.10.002; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	21	21	5	35	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1467-5463	1477-4054		BRIEF BIOINFORM	Brief. Bioinform.		2023	24	1								10.1093/bib/bbac503	http://dx.doi.org/10.1093/bib/bbac503		NOV 2022	9	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	L5FJ2	36418927				2024-09-18	WOS:000891995500001
J	Sloshower, J; Skosnik, PD; Safi-Aghdam, H; Pathania, S; Syed, S; Pittman, B; D'Souza, DC				Sloshower, Jordan; Skosnik, Patrick D.; Safi-Aghdam, Hamideh; Pathania, Surbhi; Syed, Shariful; Pittman, Brian; D'Souza, Deepak Cyril			Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						Psilocybin; psychedelics; major depressive disorder; depression	LIFE-THREATENING CANCER; EXPERIENCE QUESTIONNAIRE; ANXIETY	Background: Several early phase studies have demonstrated that psilocybin-assisted therapy has rapid-acting and persisting antidepressant effects from just one or two doses. However, methodological limitations (e.g., placebo-control, blinding) limit interpretability of the existing literature. Methods: In an exploratory placebo-controlled, within-subject, fixed-order study, individuals with moderate to severe major depressive disorder were administered placebo (n = 19) followed by psilocybin (0.3 mg/kg) (n = 15) 4 weeks later. Dosing sessions were embedded within an manualized course of psychotherapy. Enhanced blinding procedures were used. Depression, anxiety, and quality of life were measured over a 16-week study period. Results: Depression and anxiety significantly improved following both placebo and psilocybin with no significant difference in the degree of change between the two conditions. However, antidepressant effect sizes were larger after psilocybin (d ' = 1.02-2.27) than after placebo (d ' = 0.65-0.99) and there were high rates of response (66.7%) and remission (46.7%) following psilocybin administration. Antidepressant effects following psilocybin persisted, on average, for 2 months and there were persisting improvements in mood-related quality of life domains. The strength of mystical-type experience during psilocybin dosing was not correlated with subsequent antidepressant effects. Conclusions: The results of this exploratory study highlight the complex interplay between expectancy, therapy effects, and drug/placebo effects in psychedelic-assisted psychotherapy studies. Nonetheless, the acute and persisting clinical improvements observed following psilocybin support further study of its potential in the treatment of major depression. Future studies should more explicitly mitigate and measure expectancy effects and assess the impact of repeated dosing and different forms of psychotherapeutic support.	[Sloshower, Jordan; Skosnik, Patrick D.; Safi-Aghdam, Hamideh; Syed, Shariful; Pittman, Brian; D'Souza, Deepak Cyril] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Sloshower, Jordan; Skosnik, Patrick D.; Safi-Aghdam, Hamideh; Pathania, Surbhi; Syed, Shariful; D'Souza, Deepak Cyril] VA Connecticut Healthcare Syst, West Haven, CT USA; [D'Souza, Deepak Cyril] Yale Univ, Sch Med, Dept Psychiat, 950 Campbell Ave, New Haven, CT 06516 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	D'Souza, DC (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 950 Campbell Ave, New Haven, CT 06516 USA.	Deepak.dsouza@yale.edu	Skosnik, Patrick/D-6466-2016	Sloshower, Jordan/0000-0001-7709-5931; Syed, Shariful/0000-0002-8636-8089				Aday JS, 2022, PSYCHOPHARMACOLOGY, V239, P1989, DOI 10.1007/s00213-022-06123-7; Agin-Liebes GI, 2020, J PSYCHOPHARMACOL, V34, P155, DOI 10.1177/0269881119897615; Barrett FS, 2016, J PSYCHOPHARMACOL, V30, P1279, DOI 10.1177/0269881116678781; Barrett FS, 2015, J PSYCHOPHARMACOL, V29, P1182, DOI 10.1177/0269881115609019; Butler M, 2022, PSYCHOPHARMACOLOGY, V239, P3047, DOI 10.1007/s00213-022-06221-6; Carhart-Harris R, 2021, NEW ENGL J MED, V384, P1402, DOI 10.1056/NEJMoa2032994; Carhart-Harris RL, 2016, LANCET PSYCHIAT, V3, P619, DOI 10.1016/S2215-0366(16)30065-7; D'Souza DC, 2022, NEUROPSYCHOPHARMACOL, V47, P1854, DOI 10.1038/s41386-022-01344-y; Dakwar E, 2020, AM J PSYCHIAT, V177, P125, DOI 10.1176/appi.ajp.2019.19070684; Dakwar E, 2019, AM J PSYCHIAT, V176, P923, DOI 10.1176/appi.ajp.2019.18101123; Davis AK, 2021, JAMA PSYCHIAT, V78, P481, DOI 10.1001/jamapsychiatry.2020.3285; First M., 2015, Structured Clinical Interview for DSM- 5-Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV); Garcia-Romeu A, 2016, EXP CLIN PSYCHOPHARM, V24, P229, DOI 10.1037/pha0000084; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Griffiths RR, 2016, J PSYCHOPHARMACOL, V30, P1181, DOI 10.1177/0269881116675513; Griffiths RR, 2011, PSYCHOPHARMACOLOGY, V218, P649, DOI 10.1007/s00213-011-2358-5; Grob CS, 2011, ARCH GEN PSYCHIAT, V68, P71, DOI 10.1001/archgenpsychiatry.2010.116; Gukasyan N, 2022, J PSYCHOPHARMACOL, V36, P151, DOI 10.1177/02698811211073759; Gukasyan N, 2022, TRANSCULT PSYCHIATRY, V59, P652, DOI 10.1177/1363461520983684; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; International Society for CNS Drug Development, 2003, GRID-HAMD-17 Structured Interview Guide; MacLean KA, 2011, J PSYCHOPHARMACOL, V25, P1453, DOI 10.1177/0269881111420188; Madsen MK, 2019, NEUROPSYCHOPHARMACOL, V44, P1328, DOI 10.1038/s41386-019-0324-9; Malcolm B, 2022, PSYCHOPHARMACOLOGY, V239, P1881, DOI 10.1007/s00213-021-05876-x; Metzner R., 1965, PSYCHEDELIC REV, V5, P3; Michaels TI, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1824-6; Muthukumaraswamy SD, 2021, EXPERT REV CLIN PHAR, V14, P1133, DOI 10.1080/17512433.2021.1933434; Roseman L, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00974; Ross S, 2016, J PSYCHOPHARMACOL, V30, P1165, DOI 10.1177/0269881116675512; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Schenberg EE, 2021, EXPERT REV CLIN PHAR, V14, P1317, DOI 10.1080/17512433.2021.1951473; Schindler EAD, 2021, NEUROTHERAPEUTICS, V18, P534, DOI 10.1007/s13311-020-00962-y; Sloshower J, 2020, J CONTEXT BEHAV SCI, V15, P12, DOI 10.1016/j.jcbs.2019.11.002; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams JBW, 2008, INT CLIN PSYCHOPHARM, V23, P120, DOI 10.1097/YIC.0b013e3282f948f5	37	36	37	6	37	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	JUL	2023	37	7					698	706		10.1177/02698811231154852	http://dx.doi.org/10.1177/02698811231154852		MAR 2023	9	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	M4ZH4	36938991		Y	N	2024-09-18	WOS:000953673300001
J	Fu, Q; Dong, HB				Fu, Qiang; Dong, Hongbin			Spiking Neural Network Based on Multi-Scale Saliency Fusion for Breast Cancer Detection	ENTROPY			English	Article						spiking neural network; YOLO; medical image; object detection		Deep neural networks have been successfully applied in the field of image recognition and object detection, and the recognition results are close to or even superior to those from human beings. A deep neural network takes the activation function as the basic unit. It is inferior to the spiking neural network, which takes the spiking neuron model as the basic unit in the aspect of biological interpretability. The spiking neural network is considered as the third-generation artificial neural network, which is event-driven and has low power consumption. It modulates the process of nerve cells from receiving a stimulus to firing spikes. However, it is difficult to train spiking neural network directly due to the non-differentiable spiking neurons. In particular, it is impossible to train a spiking neural network using the back-propagation algorithm directly. Therefore, the application scenarios of spiking neural network are not as extensive as deep neural network, and a spiking neural network is mostly used in simple image classification tasks. This paper proposed a spiking neural network method for the field of object detection based on medical images using the method of converting a deep neural network to spiking neural network. The detection framework relies on the YOLO structure and uses the feature pyramid structure to obtain the multi-scale features of the image. By fusing the high resolution of low-level features and the strong semantic information of high-level features, the detection precision of the network is improved. The proposed method is applied to detect the location and classification of breast lesions with ultrasound and X-ray datasets, and the results are 90.67% and 92.81%, respectively.	[Fu, Qiang; Dong, Hongbin] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin 150001, Peoples R China	Harbin Engineering University	Dong, HB (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin 150001, Peoples R China.	donghongbin@hrbeu.edu.cn	Fu, Qi/HTT-2030-2023	Fu, Qiang/0000-0002-3498-5915	Natural Science Foundation of Heilongjiang Province [LH2020F023]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This research was funded by the Natural Science Foundation of Heilongjiang Province under Grant LH2020F023.	Al-Dhabyani W, 2020, DATA BRIEF, V28, DOI 10.1016/j.dib.2019.104863; Aly GH, 2021, COMPUT METH PROG BIO, V200, DOI 10.1016/j.cmpb.2020.105823; Balter LJT, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116098; Benhammou Y, 2020, NEUROCOMPUTING, V375, P9, DOI 10.1016/j.neucom.2019.09.044; Castro L, 2020, COGNITION, V204, DOI 10.1016/j.cognition.2020.104350; Esfeh JM, 2020, CLIN MOL HEPATOL, V26, P54, DOI 10.3350/cmh.2019.0039; Fu Q, 2021, NEUROCOMPUTING, V419, P47, DOI 10.1016/j.neucom.2020.07.109; Fu Q, 2019, IEEE SYS MAN CYBERN, P152, DOI [10.1109/smc.2019.8914526, 10.1109/SMC.2019.8914526]; Gerstner W., 2002, SPIKING NEURON MODEL; Girshick R., 2014, P IEEE C COMPUTER VI, P580, DOI 10.1109/CVPR.2014.81; Girshick R, 2012, RIGID TEMPLATES TRAM; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Hadadi I, 2021, RADIOGRAPHY, V27, P1027, DOI 10.1016/j.radi.2021.04.002; He KM, 2015, IEEE T PATTERN ANAL, V37, P1904, DOI 10.1109/TPAMI.2015.2389824; Heath M, 2001, IWDM 2000: 5TH INTERNATIONAL WORKSHOP ON DIGITAL MAMMOGRAPHY, P212; Heath M, 1998, COMP IMAG VIS, V13, P457; Huang R, 2018, IEEE INT CONF BIG DA, P2503, DOI 10.1109/BigData.2018.8621865; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Liu W, 2016, LECT NOTES COMPUT SC, V9905, P21, DOI 10.1007/978-3-319-46448-0_2; Malisiewicz T, 2011, IEEE I CONF COMP VIS, P89, DOI 10.1109/ICCV.2011.6126229; Perrone-Bertolotti M, 2020, NEUROIMAGE, V210, DOI 10.1016/j.neuroimage.2020.116574; Redmon J, 2018, Arxiv, DOI [arXiv:1804.02767, DOI 10.1109/CVPR.2017.690]; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Rezaei Z, 2021, EXPERT SYST APPL, V182, DOI 10.1016/j.eswa.2021.115204; Rueckauer B, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00682; Sánchez-Cauce R, 2021, COMPUT METH PROG BIO, V204, DOI 10.1016/j.cmpb.2021.106045; Saunders DJ, 2019, NEURAL NETWORKS, V119, P332, DOI 10.1016/j.neunet.2019.08.016; Singla C, 2022, MATER TODAY-PROC, V49, P3098, DOI 10.1016/j.matpr.2020.10.951; Surendhar S. P. A., 2021, MATER TODAY-PROC; Wang TX, 2021, NEUROCOMPUTING, V425, P96, DOI 10.1016/j.neucom.2020.10.100; Yang B, 2021, PHOTODIAGN PHOTODYN, V33, DOI 10.1016/j.pdpdt.2021.102199; Zhang S, 2018, PROC CVPR IEEE, P4203, DOI 10.1109/CVPR.2018.00442; Zhang XL, 2017, NEUROIMAGE, V163, P231, DOI 10.1016/j.neuroimage.2017.09.050	35	3	3	5	36	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1099-4300		ENTROPY-SWITZ	Entropy	NOV	2022	24	11							1543	10.3390/e24111543	http://dx.doi.org/10.3390/e24111543			17	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	6B5JC	36359633	gold, Green Published			2024-09-18	WOS:000881367800001
J	Woodbright, MD; Morshed, A; Browne, M; Ray, B; Moore, S				Woodbright, Mitchell D.; Morshed, Ahsan; Browne, Matthew; Ray, Biplob; Moore, Steven			Toward Transparent AI for Neurological Disorders: A Feature Extraction and Relevance Analysis Framework	IEEE ACCESS			English	Article						Feature extraction; Convolutional neural networks; Neurological diseases; Medical diagnostic imaging; Neurons; Alzheimer's disease; Brain cancer; Tumors; Epilepsy; Artificial intelligence; Explainable AI; brain tumor; deep learning; epilepsy; explainable artificial intelligence; feature extraction		The lack of interpretability and transparency in deep learning architectures has raised concerns among professionals in various industries and academia. One of the main concerns is the ability to trust these architectures' without being provided any insight into the decision-making process. Despite these concerns, researchers continue to explore new models and architectures that do not incorporate explainability into their main construct. In the medical industry, it is crucial to provide explanations of any decision, as patient health outcomes can vary according to decisions made. Furthermore, in medical research, incorrectly diagnosed neurological conditions are a high-cost error that contributes significantly to morbidity and mortality. Therefore, the development of new transparent techniques for neurological conditions is critical. This paper presents a novel Autonomous Relevance Technique for an Explainable neurological disease prediction framework called ART-Explain. The proposed technique autonomously extracts features from within the deep learning architecture to create novel visual explanations of the resulting prediction. ART-Explain is an end-to-end autonomous explainable technique designed to present an intuitive and holistic overview of a prediction made by a deep learning classifier. To evaluate the effectiveness of our approach, we benchmark it with other state-of-the-art techniques using three data sets of neurological disorders. The results demonstrate the generalisation capabilities of our technique and its suitability for real-world applications. By providing transparent insights into the decision-making process, ART-Explain can improve end-user trust and enable a better understanding of classification outcomes in the detection of neurological diseases.	[Woodbright, Mitchell D.] Cent Queensland Univ, Sch Engn & Technol, Bundaberg, Qld 4670, Australia; [Morshed, Ahsan; Ray, Biplob] Cent Queensland Univ, Sch Engn & Technol, Melbourne, Vic 3000, Australia; [Browne, Matthew] Cent Queensland Univ, Sch Med Hlth & Appl Sci, Bundaberg, Qld 4670, Australia; [Moore, Steven] Cent Queensland Univ, Sch Engn & Technol, Rockhampton, Qld 4702, Australia	Central Queensland University; Central Queensland University; Central Queensland University; Central Queensland University	Woodbright, MD (corresponding author), Cent Queensland Univ, Sch Engn & Technol, Bundaberg, Qld 4670, Australia.	m.woodbright@cqu.edu.au	Morshed, Ahsan/AAK-2685-2021; Ray, Biplob/V-1620-2019	Browne, Matthew/0000-0002-2668-6229; Ray, Biplob/0000-0002-3016-1695				Acharya UR, 2018, COMPUT BIOL MED, V100, P270, DOI 10.1016/j.compbiomed.2017.09.017; Alzheimer's Disease Neuroimaging Initiative, US; Andrzejak RG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061907; Australian Institute of Health Welfare, Epilepsy in Australia; Australian Institute of Health Welfare, Dementia in Australia; Bhuvaji S, Brain Tumor Classification Dataset2020; Cancer Australia, Brain Cancer in Australia Statistics; Chaki J, 2023, BIOMED SIGNAL PROCES, V80, DOI 10.1016/j.bspc.2022.104223; Cheng J, 2017, DATASET; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Cohen W. W., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P115; Gautam S, 2022, I S BIOMED IMAGING, DOI 10.1109/ISBI52829.2022.9761651; Hamada A, Br35H: brain tumor detection 2020 version 5 2020; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Hussain S, 2018, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON COMMUNICATION AND ELECTRONICS SYSTEMS (ICCES 2018), P743, DOI 10.1109/CESYS.2018.8723966; James SL, 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, 10.1016/S1474-4422(19)30034-1, 10.1016/S1474-4422(18)30499-X]; kaggle, Alzheimer MRI preprocessed dataset; Kaggle, Brain Tumor MRI Dataset; Kumar S., Tech. Rep.; Li ZW, 2022, IEEE T NEUR NET LEAR, V33, P6999, DOI 10.1109/TNNLS.2021.3084827; Moscovitz I., How to Perform Explainable Machine LearningClassification-Without Any Trees; Mursalin M, 2017, NEUROCOMPUTING, V241, P204, DOI 10.1016/j.neucom.2017.02.053; Nickparvar M., Brain Tumor MRI Dataset; Pahde F, 2023, Arxiv, DOI arXiv:2303.12641; Peker M, 2016, IEEE J BIOMED HEALTH, V20, P108, DOI 10.1109/JBHI.2014.2387795; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Selvaraju R. R., 2016, Grad-CAM: Why did you say that?; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Sonvane S., The RIPPER Algorithm; Sriraam Natarajan, 2019, 2019 2nd International Conference on Signal Processing and Communication (ICSPC). Proceedings, P263, DOI 10.1109/ICSPC46172.2019.8976611; Tjoa E, 2021, IEEE T NEUR NET LEAR, V32, P4793, DOI 10.1109/TNNLS.2020.3027314; UKB, EEG Data Download; Valliani AA, 2019, NEUROL THER, V8, P351, DOI 10.1007/s40120-019-00153-8; Wang LN, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19060222; Woodbright M, 2021, NEUROCOMPUTING, V444, P30, DOI 10.1016/j.neucom.2021.02.052; Zeng W, 2020, ARTIF INTELL REV, V53, P3059, DOI 10.1007/s10462-019-09755-y	38	0	0	5	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2024	12						37731	37743		10.1109/ACCESS.2024.3375877	http://dx.doi.org/10.1109/ACCESS.2024.3375877			13	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	LW4W4		gold			2024-09-18	WOS:001189835000001
J	Jiang, BB; Zhang, YP; Zhang, L; de Bock, GH; Vliegenthart, R; Xie, XQ				Jiang, Beibei; Zhang, Yaping; Zhang, Lu; H. de Bock, Geertruida; Vliegenthart, Rozemarijn; Xie, Xueqian			Human-recognizable CT image features of subsolid lung nodules associated with diagnosis and classification by convolutional neural networks	EUROPEAN RADIOLOGY			English	Article						Artificial intelligence; Deep learning; Adenocarcinoma of lung; X-ray computed tomography	CANCER	Objectives The interpretability of convolutional neural networks (CNNs) for classifying subsolid nodules (SSNs) is insufficient for clinicians. Our purpose was to develop CNN models to classify SSNs on CT images and to investigate image features associated with the CNN classification. Methods CT images containing SSNs with a diameter of <= 3 cm were retrospectively collected. We trained and validated CNNs by a 5-fold cross-validation method for classifying SSNs into three categories (benign and preinvasive lesions [PL], minimally invasive adenocarcinoma [MIA], and invasive adenocarcinoma [IA]) that were histologically confirmed or followed up for 6.4 years. The mechanism of CNNs on human-recognizable CT image features was investigated and visualized by gradient-weighted class activation map (Grad-CAM), separated activation channels and areas, and DeepDream algorithm. Results The accuracy was 93% for classifying 586 SSNs from 569 patients into three categories (346 benign and PL, 144 MIA, and 96 IA in 5-fold cross-validation). The Grad-CAM successfully located the entire region of image features that determined the final classification. Activated areas in the benign and PL group were primarily smooth margins (p < 0.001) and ground-glass components (p = 0.033), whereas in the IA group, the activated areas were mainly part-solid (p < 0.001) and solid components (p < 0.001), lobulated shapes (p < 0.001), and air bronchograms (p < 0.001). However, the activated areas for MIA were variable. The DeepDream algorithm showed the image features in a human-recognizable pattern that the CNN learned from a training dataset. Conclusion This study provides medical evidence to interpret the mechanism of CNNs that helps support the clinical application of artificial intelligence.	[Jiang, Beibei; Zhang, Yaping; Zhang, Lu; Xie, Xueqian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Radiol, Haining Rd 100, Shanghai 200080, Peoples R China; [H. de Bock, Geertruida] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Dept Radiol, Univ Med Ctr Groningen, Hanzepl 1, NL-9713 GZ Groningen, Netherlands	Shanghai Jiao Tong University; University of Groningen; University of Groningen	Xie, XQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Radiol, Haining Rd 100, Shanghai 200080, Peoples R China.	xiexueqian@hotmail.com	zhang, lu/GRO-2969-2022; Chen, Su/IXX-1915-2023; Xie, Xueqian/AAE-2292-2022; de Bock, Geertruida H./F-6529-2014	Jiang, Beibei/0000-0003-3182-5032; de Bock, Geertruida H./0000-0003-3104-4471; Xie, Xueqian/0000-0002-6669-0097	National Natural Science Foundation of China [81971612]; Ministry of Science and Technology of China [2016YFE0103000]; Shanghai Municipal Education Commission - Gaofeng Clinical Medicine Grant Support [20181814]; Shanghai Jiao Tong University [ZH2018ZDB10]; Clinical Research Innovation Plan of Shanghai General Hospital [CTCCR-2018B04, CTCCR-2019D05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Education Commission - Gaofeng Clinical Medicine Grant Support; Shanghai Jiao Tong University; Clinical Research Innovation Plan of Shanghai General Hospital	This study has received funding from the National Natural Science Foundation of China (project no. 81971612), Ministry of Science and Technology of China (2016YFE0103000), Shanghai Municipal Education Commission - Gaofeng Clinical Medicine Grant Support (20181814), Shanghai Jiao Tong University (ZH2018ZDB10), and Clinical Research Innovation Plan of Shanghai General Hospital (CTCCR-2018B04, CTCCR-2019D05). The funders played no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alpert JB, 2018, RADIOL CLIN N AM, V56, P339, DOI 10.1016/j.rcl.2018.01.002; [Anonymous], 2015, INCEPTIONISM GOING D; Blagus R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0723-9; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Gong J, 2020, EUR RADIOL, V30, P1847, DOI 10.1007/s00330-019-06533-w; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Horeweg N, 2014, LANCET ONCOL, V15, P1342, DOI 10.1016/S1470-2045(14)70387-0; Kim H, 2014, DIAGN INTERV RADIOL, V20, P47, DOI 10.5152/dir.2013.13223; Lee HW, 2019, J THORAC ONCOL, V14, P1370, DOI 10.1016/j.jtho.2019.05.005; Li JX, 2018, J THORAC DIS, V10, pS797, DOI 10.21037/jtd.2018.04.25; MacMahon H, 2017, RADIOLOGY, V284, P228, DOI 10.1148/radiol.2017161659; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nair A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01359-2018; Nakkiran P, 2021, J STAT MECH-THEORY E, V2021, DOI 10.1088/1742-5468/ac3a74; Olah C., 2017, Distill, V2, P7, DOI DOI 10.23915/DISTILL.00007; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Qin ZW, 2018, MATH FDN COMPUT, V1, P149, DOI 10.3934/mfc.2018008; Schubert, 2020, OPENAI MICROSCOPE OP; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Silva M, 2018, J THORAC ONCOL, V13, P1454, DOI 10.1016/j.jtho.2018.06.013; Son JY, 2016, EUR RADIOL, V26, P43, DOI 10.1007/s00330-015-3816-y; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang SP, 2018, QUANT IMAG MED SURG, V8, P491, DOI 10.21037/qims.2018.06.03; Wang S, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00986-2018; Xie XQ, 2013, CANCER IMAGING, V13, P391, DOI 10.1102/1470-7330.2013.9043; Yamashita R, 2018, INSIGHTS IMAGING, V9, P611, DOI 10.1007/s13244-018-0639-9; YANAGAWA M, 2019, MEDICINE, V98; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang Q., 2017, Interpreting cnn knowledge via an explanatory graph; Zhao W, 2018, CANCER RES, V78, P6881, DOI 10.1158/0008-5472.CAN-18-0696; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319	34	14	15	0	18	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	OCT	2021	31	10					7303	7315		10.1007/s00330-021-07901-1	http://dx.doi.org/10.1007/s00330-021-07901-1		APR 2021	13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	US5IT	33847813				2024-09-18	WOS:000639745000001
J	Elguebaly, T; Bouguila, N				Elguebaly, Tarek; Bouguila, Nizar			A hierarchical nonparametric Bayesian approach for medical images and gene expressions classification	SOFT COMPUTING			English	Article						Mixture models; Gamma distribution; Feature selection; Nonparametric Bayes; MCMC; Gibbs sampling; Mammography; Gene expression	CONTENT-BASED RETRIEVAL; FEATURE-SELECTION; MIXTURE; CANCER; DISTRIBUTIONS; DATABASES; INFERENCE; TISSUE; MODEL	Lately, the enormous generation of databases in almost every aspect of life has created a great demand for new powerful tools for turning data into useful information. Therefore, researchers were encouraged to explore and develop new machine learning ideas and methods. Mixture models are one of the machine learning techniques receiving considerable attention due to their ability to handle efficiently and effectively multidimensional data. In this paper, we represent a solution for two challenging issues: modeling non-Gaussian data and determining the set of relevant features in the data. The problem of modeling non-Gaussian data largely present in several computer vision, image processing, medical, and Bioinformatics applications is accomplished by the development of a generative infinite Gamma mixture model. The Gamma is chosen for its ability to handle long-tailed distributions, which allows it to have a good approximation to data with outliers. The proposed model, which can be viewed as a Dirichlet process mixture of Gamma distributions, takes into account the feature selection problem by determining a set of relevant features for each data cluster which provides better interpretability and generalization capabilities. We propose then an efficient algorithm to learn this infinite model's parameters by estimating all its posterior quantities of interest using Markov Chain Monte Carlo (MCMC) simulations. Thus, our algorithm is able to perform model selection, parameter learning, and feature selection simultaneously in a single step for the Gamma Mixture model. Furthermore, we show how the model can be used, while comparing it with other popular models in the literature, in two challenging applications namely medical images and gene expressions classification.	[Elguebaly, Tarek] Concordia Univ, Elect & Comp Engn Dept ECE, Montreal, PQ H3G 1T7, Canada; [Bouguila, Nizar] Concordia Univ, CIISE, Montreal, PQ H3G 1T7, Canada	Concordia University - Canada; Concordia University - Canada	Bouguila, N (corresponding author), Concordia Univ, CIISE, Montreal, PQ H3G 1T7, Canada.	t_elgue@encs.concordia.ca; nizar.bouguila@concordia.ca						Allili MS, 2010, IEEE T CIRC SYST VID, V20, P1373, DOI 10.1109/TCSVT.2010.2077483; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alto H, 2005, J ELECTRON IMAGING, V14, DOI 10.1117/1.1902996; [Anonymous], 2007, BAYESIAN CHOICE DECI; [Anonymous], 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1; [Anonymous], 2006, An Introduction to Bayesian Analysis - Theory and Methods; AYKROYD RG, 1991, PHILOS T ROY SOC A, V337, P323, DOI 10.1098/rsta.1991.0128; Bouguila N, 2012, EXPERT SYST APPL, V39, P6641, DOI 10.1016/j.eswa.2011.12.038; Bouguila N, 2010, IEEE T NEURAL NETWOR, V21, P107, DOI 10.1109/TNN.2009.2034851; Bouguila N, 2008, MACHINE LEARN SIGN P, P297, DOI 10.1109/MLSP.2008.4685496; Boutemedjet S, 2009, IEEE T PATTERN ANAL, V31, P1429, DOI 10.1109/TPAMI.2008.155; Boys RJ, 2004, BIOMETRICS, V60, P573, DOI 10.1111/j.0006-341X.2004.00206.x; BRZAKOVIC D, 1990, IEEE T MED IMAGING, V9, P233, DOI 10.1109/42.57760; Buciu I, 2009, 2009 2ND INTERNATIONAL SYMPOSIUM ON APPLIED SCIENCES IN BIOMEDICAL AND COMMUNICATION TECHNOLOGIES (ISABEL 2009), P8; Camastra F, 2003, PATTERN RECOGN, V36, P2945, DOI 10.1016/S0031-3203(03)00176-6; Chan HP, 1998, MED PHYS, V25, P2007, DOI 10.1118/1.598389; Cho S.B., 2003, P 1 AS PAC BIOINF C, V19, P189; Dahmen J., 2000, P 6 INT RIAO C CONTE, P551; Elguebaly T, 2011, LECT NOTES COMPUT SC, V6753, P201, DOI 10.1007/978-3-642-21593-3_21; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Forstner W., 1994, Computer Vision - ECCV '94. Third European Conference on Computer Vision. Proceedings. Vol.II, P383, DOI 10.1007/BFb0028370; Giger M.L., 2003, P SPIE MED IM IM PRO, P183; GILKS WR, 1993, J R STAT SOC B, V55, P39; GLAD IK, 1995, BIOMETRIKA, V82, P237; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoff PD, 2006, BAYESIAN ANAL, V1, P321, DOI 10.1214/06-BA111; Huang YH, 2005, IEEE T BIO-MED ENG, V52, P1801, DOI 10.1109/TBME.2005.856295; Karlis D, 2001, J STAT PLAN INFER, V93, P93, DOI 10.1016/S0378-3758(00)00207-X; Katzer M, 2003, IEEE T NANOBIOSCI, V2, P202, DOI 10.1109/TNB.2003.817023; Keysers D, 2000, INT C PATT RECOG, P38, DOI 10.1109/ICPR.2000.906014; Law MHC, 2004, IEEE T PATTERN ANAL, V26, P1154, DOI 10.1109/TPAMI.2004.71; Li T, 2004, BIOINFORMATICS, V20, P2429, DOI 10.1093/bioinformatics/bth267; Li YH, 2009, IEEE T PATTERN ANAL, V31, P953, DOI 10.1109/TPAMI.2008.261; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1, DOI 10.1002/0471721182; MILLER P, 1992, IMAGE VISION COMPUT, V10, P277, DOI 10.1016/0262-8856(92)90042-2; Mladenic D., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P234, DOI 10.1145/1008992.1009034; Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653; Neemuchwala H, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P10, DOI 10.1109/ICIP.2001.958038; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Paddock SM, 2006, COMPUT STAT DATA AN, V50, P3243, DOI 10.1016/j.csda.2005.05.008; PAPPAS TN, 1992, IEEE T SIGNAL PROCES, V40, P901, DOI 10.1109/78.127962; Powell D, 2005, P INT SYST DYN C, P17; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; Raftery A.E., 1996, Implementing MCMC, P115, DOI DOI 10.1007/978-1-4899-4485-6.1269; Raftery Adrian E., 1992, Statistical Science, V7, P493, DOI DOI 10.1214/SS/1177011143; Rangayyan RM, 2000, MED BIOL ENG COMPUT, V38, P487, DOI 10.1007/BF02345742; Rangayyan RM, 1997, IEEE T MED IMAGING, V16, P799, DOI 10.1109/42.650876; Rasmussen CE, 2000, ADV NEUR IN, V12, P554; Sahiner B, 2000, MED PHYS, V27, P1509, DOI 10.1118/1.599017; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soltanian-Zadeh H, 2004, PATTERN RECOGN, V37, P1973, DOI 10.1016/j.patcog.2003.03.001; SPIEGELHALTER DJ, 1984, J ROY STAT SOC A, V147, P35, DOI 10.2307/2981737; Suri J.S., 2006, RECENT ADV BREAST IM; Tagare HD, 1997, J AM MED INFORM ASSN, V4, P184, DOI 10.1136/jamia.1997.0040184; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Tibshirani R, 2001, The elements of statistical learning: data mining, inference, and prediction, DOI 10.1007/978-0-387-84858-7; Tuceryan M., 1998, HDB PATTERN RECOGNIT, P207; Welsh JB, 2001, CANCER RES, V61, P5974; WILD P, 1993, J ROY STAT SOC C-APP, V42, P701; Wu X., 2010, P 27 INT C MACHINE L, P1159; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Xu WL, 2008, BIOINFORMATION, V2, P301, DOI 10.6026/97320630002301; Yukinawa N, 1996, BMC GENOMICS, V7; ZINK S, 1993, INVEST RADIOL, V28, P366, DOI 10.1097/00004424-199304000-00019; Ziou D, 2004, INT C PATT RECOG, P68, DOI 10.1109/ICPR.2004.1334042; Ziou D, 2009, INT J REMOTE SENS, V30, P771, DOI 10.1080/01431160802392646; Zou FM, 2008, COMP MED SY, P41, DOI 10.1109/CBMS.2008.117	69	13	13	0	13	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1432-7643	1433-7479		SOFT COMPUT	Soft Comput.	JAN	2015	19	1			SI		189	204		10.1007/s00500-014-1242-8	http://dx.doi.org/10.1007/s00500-014-1242-8			16	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	AY2GS					2024-09-18	WOS:000347407500018
J	Srivastava, N; Tayal, DK				Srivastava, Neha; Tayal, Devendra K.			Assessing gene stability and gene affinity in microarray data classification using an extended relieff algorithm	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article; Early Access						Gene selection; Gene affinity information; Microarray data; ReliefF method; SVM; MLP	FEATURE-SELECTION; PREDICTION; CANCER	Microarray data have become an integral part of the clinical and drug discovery process. Due to its voluminous and heterogeneous nature, the question arises of the interpretability and stability of the traditional gene selection method. To enhance the stability of the gene selection method, so that the results are better explicable, an ameliorated Extended ReliefF gene selection algorithm is proposed. It encodes gene affinity information using a new mathematical formula based on Bayes' theorem and Manhattan distance for calculating the nearest neighbor in a pooled sample. It works in four aspects: initializing sample gene weight, improving gene weight, maximizing sample gene weight and finally adopting mutation operation. The proposed method selects the most informative genes which are highly perceptive to the prognosis of the disease. Further, to accomplish the accuracy and stability of the algorithm, soft classification is performed on Relieved_F, STIR, VLS-RelifF, I-RelieF, conventional ReliefF and proposed extended ReliefF algorithms using three classifiers namely Support Vector Machine (SVM), Multilayer Perceptron (MLP) and Random Forest (RF) on ten microarray datasets. According to the findings, MLP training times are much longer than those of RF and SVM. From a network perspective, SVM is much faster at training, whereas MLP excels in terms of accuracy. With a rise in gene similarity among the genes selected from the multiple training sets, the approach becomes more stable. As a result, it can be seen that the recommended gene selection algorithm greatly outperforms the other feature selection methods in terms of accuracy and stability.	[Srivastava, Neha; Tayal, Devendra K.] Indira Gandhi Delhi Tech Univ Women, James Church,New Church Rd,Opp St,Kashmere Gate, New Delhi 110006, Delhi, India	Indira Gandhi Delhi Technical University for Women (IGDTUW)	Srivastava, N (corresponding author), Indira Gandhi Delhi Tech Univ Women, James Church,New Church Rd,Opp St,Kashmere Gate, New Delhi 110006, Delhi, India.	nehasrivastava012329@gmail.com; devendrakumartayal@gmail.com	AGARWAL, NIDHI/AIA-5341-2022	AGARWAL, NIDHI/0000-0002-9044-8989	Data Science Research of Interdisciplinary Cyber-Physical Systems (ICPS) Programme of the Department of Science and Technology (DST),New Delhi, Government of India, India [T-54]	Data Science Research of Interdisciplinary Cyber-Physical Systems (ICPS) Programme of the Department of Science and Technology (DST),New Delhi, Government of India, India	This work is funded under the Data Science Research of Interdisciplinary Cyber-Physical Systems (ICPS) Programme of the Department of Science and Technology (DST) [Sanction Number T-54], New Delhi, Government of India, India.	Ahmad S, 2022, CLUSTER COMPUT, V25, P3733, DOI 10.1007/s10586-022-03598-z; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2016, IEEE Energy Conversion Congress and Exposition ECCE; Chaki J, 2020, MULTIMED TOOLS APPL, V79, P11163, DOI 10.1007/s11042-019-7181-8; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Dashtban M, 2017, GENOMICS, V109, P91, DOI 10.1016/j.ygeno.2017.01.004; Dhanalakshmi R, 2019, J SCI IND RES INDIA, V78, P158; Drotár P, 2015, COMPUT BIOL MED, V66, P1, DOI 10.1016/j.compbiomed.2015.08.010; Furlanello C, 2003, NEURAL NETWORKS, V16, P641, DOI 10.1016/S0893-6080(03)00103-5; Ghosh A, 2016, GENE, V583, P112, DOI 10.1016/j.gene.2016.02.015; Giurcaneanu CD, 2003, SEVENTH INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS, VOL 2, PROCEEDINGS, P57, DOI 10.1109/ISSPA.2003.1224814; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Goncalves J, 2002, IEEE ENG MED BIOL, V21, P154, DOI 10.1109/MEMB.2002.1175154; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hinrichs A, 2019, J COMPLEXITY, V50, P25, DOI 10.1016/j.jco.2018.08.003; K CS.K MundayoorS, 2015, ARC J Int J Res Stud Biosci (IJRSB), V3, P201; Khan MW, 2012, GENOMICS, V100, P65, DOI 10.1016/j.ygeno.2012.05.014; Kumar M, 2015, PROCEDIA COMPUT SCI, V54, P301, DOI 10.1016/j.procs.2015.06.035; Kumar M, 2015, KNOWL-BASED SYST, V89, P584, DOI 10.1016/j.knosys.2015.09.005; Kumar V., 2014, SmartCR, DOI DOI 10.6029/SMARTCR.2014.03.007; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nyo MT, 2022, MULTIMED TOOLS APPL, V81, P43837, DOI 10.1007/s11042-022-13215-1; Pang H, 2012, IEEE ACM T COMPUT BI, V9, P1422, DOI 10.1109/TCBB.2012.63; Perthame É, 2016, STAT COMPUT, V26, P783, DOI 10.1007/s11222-015-9569-2; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Ram PK, 2023, MULTIMED TOOLS APPL, V82, P13453, DOI 10.1007/s11042-022-13964-z; Ray SS, 2016, IEEE T NEUR NET LEAR, V27, P1890, DOI 10.1109/TNNLS.2015.2460994; Ruan JH, 2019, GENOMICS, V111, P17, DOI 10.1016/j.ygeno.2016.07.005; Sharma A, 2012, IEEE ACM T COMPUT BI, V9, P754, DOI 10.1109/TCBB.2011.151; Sheela CJJ, 2022, J KING SAUD UNIV-COM, V34, P557, DOI 10.1016/j.jksuci.2019.04.006; Somol P, 2010, IEEE T PATTERN ANAL, V32, P1921, DOI 10.1109/TPAMI.2010.34; Srivastava N, 2017, Def Life Sci, VJ2, P399, DOI [10.14429/dlsj.2.11029, DOI 10.14429/DLSJ.2.11029]; Sucharita S, 2024, MULTIMED TOOLS APPL, V83, P21319, DOI 10.1007/s11042-023-16353-2; Dang TH, 2016, 2016 3RD INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING (BME-HUST), P14, DOI 10.1109/BME-HUST.2016.7782082; Tu K, 2004, GENOMICS, V84, P922, DOI 10.1016/j.ygeno.2004.08.005; Yates, 1999, Modern information retrieval; Zahiri J, 2013, GENOMICS, V102, P237, DOI 10.1016/j.ygeno.2013.05.006	37	0	0	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	2023 OCT 17	2023										10.1007/s11042-023-17149-0	http://dx.doi.org/10.1007/s11042-023-17149-0		OCT 2023	16	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	U5AL0					2024-09-18	WOS:001084922000018
J	Liu, CL; Tain, YL; Lin, YC; Hsu, CN				Liu, Chien-Liang; Tain, You-Lin; Lin, Yun-Chun; Hsu, Chien-Ning			Prediction and Clinically Important Factors of Acute Kidney Injury Non-recovery	FRONTIERS IN MEDICINE			English	Article						acute kidney injury; kidney function recovery; machine learning; risk prediction; interpretability; electronic health records-EHR	LONG-TERM OUTCOMES; RENAL RECOVERY; VALIDATION; MORTALITY; SURVIVORS; AKI	ObjectiveThis study aimed to identify phenotypic clinical features associated with acute kidney injury (AKI) to predict non-recovery from AKI at hospital discharge using electronic health record data. MethodsData for hospitalized patients in the AKI Recovery Evaluation Study were derived from a large healthcare delivery system in Taiwan between January 2011 and December 2017. Living patients with AKI non-recovery were used to derive and validate multiple predictive models. In total, 64 candidates variables, such as demographic characteristics, comorbidities, healthcare services utilization, laboratory values, and nephrotoxic medication use, were measured within 1 year before the index admission and during hospitalization for AKI. ResultsAmong the top 20 important features in the predictive model, 8 features had a positive effect on AKI non-recovery prediction: AKI during hospitalization, serum creatinine (SCr) level at admission, receipt of dialysis during hospitalization, baseline comorbidity of cancer, AKI at admission, baseline lymphocyte count, baseline potassium, and low-density lipoprotein cholesterol levels. The predicted AKI non-recovery risk model using the eXtreme Gradient Boosting (XGBoost) algorithm achieved an area under the receiver operating characteristic (AUROC) curve statistic of 0.807, discrimination with a sensitivity of 0.724, and a specificity of 0.738 in the temporal validation cohort. ConclusionThe machine learning model approach can accurately predict AKI non-recovery using routinely collected health data in clinical practice. These results suggest that multifactorial risk factors are involved in AKI non-recovery, requiring patient-centered risk assessments and promotion of post-discharge AKI care to prevent AKI complications.	[Liu, Chien-Liang; Lin, Yun-Chun] Natl Yang Min Chiao Tung Univ, Dept Ind Engn & Management, Hsinchu, Taiwan; [Tain, You-Lin] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Tain, You-Lin] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University	Hsu, CN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan.; Hsu, CN (corresponding author), Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.	chien_ning_hsu@hotmail.com	Zhang, Xiaoxi/KBP-8753-2024; Tain, You-Lin/H-2827-2019; Hsu, Chien-Ning/GLS-4014-2022	Tain, You-Lin/0000-0002-7059-6407; Liu, Chien-Liang/0000-0002-2724-7199	Kaohsiung Chang Gung Memorial Hospital [CMRPG8K0101, CORPG8L0041]	Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was funded by Kaohsiung Chang Gung Memorial Hospital (CMRPG8K0101 and CORPG8L0041 to C-NH). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Abu-Alfa AK, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.10.056; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Collins GS, 2015, CIRCULATION, V131, P211, DOI 10.1161/CIRCULATIONAHA.114.014508; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Guthrie G, 2022, AM J KIDNEY DIS, V79, P488, DOI 10.1053/j.ajkd.2021.05.019; Hansrivijit P, 2020, J CRIT CARE, V60, P13, DOI 10.1016/j.jcrc.2020.07.012; Heung M, 2016, AM J KIDNEY DIS, V67, P742, DOI 10.1053/j.ajkd.2015.10.019; Hsu CN, 2020, J MED INTERNET RES, V22, DOI 10.2196/16903; Itenov TS, 2018, CRIT CARE RESUSC, V20, P54; James MT, 2020, NAT REV NEPHROL, V16, P193, DOI 10.1038/s41581-019-0247-z; James MT, 2017, JAMA-J AM MED ASSOC, V318, P1787, DOI 10.1001/jama.2017.16326; Kellum JA, 2017, AM J RESP CRIT CARE, V195, P784, DOI 10.1164/rccm.201604-0799OC; Lee BJ, 2019, KIDNEY INT REP, V4, P571, DOI 10.1016/j.ekir.2019.01.015; Liang KV, 2016, CLIN J AM SOC NEPHRO, V11, P30, DOI 10.2215/CJN.01290215; Lundberg SM, 2017, ADV NEUR IN, V30; Macedo E, 2014, NEPHRON CLIN PRACT, V127, P4, DOI 10.1159/000363704; Ogbadu J, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172711; Panitchote A, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1439-2; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Porta C, 2015, NAT REV NEPHROL, V11, P354, DOI 10.1038/nrneph.2015.15; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Sawhney S, 2017, AM J KIDNEY DIS, V69, P18, DOI 10.1053/j.ajkd.2016.05.018; Shao SC, 2019, PHARMACOEPIDEM DR S, V28, P593, DOI 10.1002/pds.4713; Siew ED, 2020, AM J KIDNEY DIS, V75, P204, DOI 10.1053/j.ajkd.2019.05.031; Siew ED, 2019, AM J NEPHROL, V49, P449, DOI 10.1159/000499862; Siew ED, 2012, CLIN J AM SOC NEPHRO, V7, P712, DOI 10.2215/CJN.10821011; Silver SA, 2021, CLIN J AM SOC NEPHRO, V16, P1005, DOI 10.2215/CJN.17331120; Stevens LM, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006556; Tomasev N, 2019, NATURE, V572, P116, DOI 10.1038/s41586-019-1390-1; Weller S, 2017, NEPHRON, V137, P287, DOI 10.1159/000478538; Xiao YQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72651-x; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	33	5	5	2	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	JAN 17	2022	8								789874	10.3389/fmed.2021.789874	http://dx.doi.org/10.3389/fmed.2021.789874			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR3BB	35111778	Green Published, gold			2024-09-18	WOS:000749868800001
J	Li, JJY; Chen, YEL; Tong, X				Li, Jingyi Jessica; Chen, Yiling Elaine; Tong, Xin			A flexible model-free prediction-based framework for feature ranking	JOURNAL OF MACHINE LEARNING RESEARCH			English	Article						model-free; marginal feature ranking; binary classification; classical and Neyman-Pearson paradigms; sampling bias	RATES	Despite the availability of numerous statistical and machine learning tools for joint feature modeling, many scientists investigate features marginally, i.e., one feature at a time. This is partly due to training and convention but also roots in scientists' strong interests in simple visualization and interpretability. As such, marginal feature ranking for some predictive tasks, e.g., prediction of cancer driver genes, is widely practiced in the process of scientific discoveries. In this work, we focus on marginal ranking for binary classification, one of the most common predictive tasks. We argue that the most widely used marginal ranking criteria, including the Pearson correlation, the two-sample t test, and two-sample Wilcoxon rank-sum test, do not fully take feature distributions and prediction objectives into account. To address this gap in practice, we propose two ranking criteria corresponding to two prediction objectives: the classical criterion (CC) and the Neyman-Pearson criterion (NPC), both of which use model-free nonparametric implementations to accommodate diverse feature distributions. Theoretically, we show that under regularity conditions, both criteria achieve sample-level ranking that is consistent with their population-level counterpart with high probability. Moreover, NPC is robust to sampling bias when the two class proportions in a sample deviate from those in the population. This property endows NPC good potential in biomedical research where sampling biases are ubiquitous. We demonstrate the use and relative advantages of CC and NPC in simulation and real data studies. Our model-free objective-based ranking idea is extendable to ranking feature subsets and generalizable to other prediction tasks and learning objectives.	[Li, Jingyi Jessica; Chen, Yiling Elaine] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Tong, Xin] Univ Southern Calif, Marshall Business Sch, Dept Data Sci & Operat, Los Angeles, CA 90007 USA	University of California System; University of California Los Angeles; University of Southern California	Li, JJY (corresponding author), Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA.	JLI@STAT.UCLA.EDU; YILING0210@UCLA.EDu; XINT@MARSHALL.USC.EDU	Li, Jingyi/I-2779-2019; Chen, Yuxuan/IWL-8267-2023					[Anonymous], INT JOINT C ART INT; Audibert JY, 2007, ANN STAT, V35, P608, DOI 10.1214/009053606000001217; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Cannon Adam, 2002, Tech. Rep. LA-UR, P02; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleischer T, 2014, GENOME BIOL, V15, DOI [10.1186/PREACCEPT-2333349012841587, 10.1186/s13059-014-0435-x]; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI [10.1007/978-1-4614-7138-7, 10.1007/978-1-4614-7138-7_1]; Jeon Jouhyun., 2019, JNCI-J NATL CANCER I; Koltchinskii Vladimir., 2011, LECT NOTES MATH, P1; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Liang F, 2016, INT J ONCOL, V49, P1046, DOI 10.3892/ijo.2016.3599; Lin Y, 2002, DATA MIN KNOWL DISC, V6, P259, DOI 10.1023/A:1015469627679; Lindqvist BM, 2014, EPIGENETICS-US, V9, P1149, DOI 10.4161/epi.29632; Lundberg SM, 2017, ADV NEUR IN, V30; Lyu J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba6784; Mammen E, 1999, ANN STAT, V27, P1808; Neyman J, 1928, BIOMETRIKA, V20A, P175, DOI 10.1093/biomet/20A.1-2.175; POLONIK W, 1995, ANN STAT, V23, P855, DOI 10.1214/aos/1176324626; Privat M, 2018, INT J MED SCI, V15, P46, DOI 10.7150/ijms.20508; Raykar VC, 2010, J COMPUT GRAPH STAT, V19, P205, DOI 10.1198/jcgs.2010.09046; Rigollet P, 2009, BERNOULLI, V15, P1154, DOI 10.3150/09-BEJ184; Scott C, 2005, IEEE T INFORM THEORY, V51, P3806, DOI 10.1109/TIT.2005.856955; Székely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tong X, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1659; Tong X, 2013, J MACH LEARN RES, V14, P3011; Tong Xin., J MACH LEARN RES, V21, P1; Trevor Hastie, 2009, The elements of statistical learning, V2nd, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; WAND MP, 1994, COMPUTATION STAT, V9, P97; Zadrozny B, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P435, DOI 10.1109/icdm.2003.1250950; Zhao AQ, 2016, J MACH LEARN RES, V17, P1	32	0	0	0	1	MICROTOME PUBL	BROOKLINE	31 GIBBS ST, BROOKLINE, MA 02446 USA	1532-4435			J MACH LEARN RES	J. Mach. Learn. Res.		2021	22								124					54	Automation & Control Systems; Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Computer Science	SU5KG					2024-09-18	WOS:000663175600001
J	Pouly, M; Koller, T; Gottfrois, P; Lionetti, S				Pouly, Marc; Koller, Thomas; Gottfrois, Philippe; Lionetti, Simone			Artificial intelligence in image analysis-fundamentals and new developments	HAUTARZT			German	Article						Computer-assisted image analysis; Deep learning; Visual features; Diagnostic imaging; Image analysis applications	CANCER	Background Since 2017, there have been several reports of artificial intelligence (AI) achieving comparable performance to human experts on medical image analysis tasks. With the first ratification of a computer vision algorithm as a medical device in 2018, the way was paved for these methods to eventually become an integral part of modern clinical practice. Objectives The purpose of this article is to review the main developments that have occurred over the last few years in AI for image analysis, in relation to clinical applications and dermatology. Materials and methods Following the annual ImageNet challenge, we review classical methods of machine learning for image analysis and demonstrate how these methods incorporated human expertise but failed to meet industrial requirements regarding performance and scalability. With the rise of deep learning based on artificial neural networks, these limitations could be overcome. We discuss important aspects of this technology including transfer learning and report on recent developments such as explainable AI and generative models. Results Deep learning models achieved performance on a par with human experts in a broad variety of diagnostic tasks and were shown to be suitable for industrialization. Therefore, current developments focus less on further improving accuracy but rather address open issues such as interpretability and applicability under clinical conditions. Upcoming generative models allow for entirely new applications. Conclusions Deep learning has a history of remarkable success and has become the new technical standard for image analysis. The dramatic improvement these models brought over classical approaches enables applications in a rapidly increasing number of clinical fields. In dermatology, as in many other domains, artificial intelligence still faces considerable challenges but is undoubtedly developing into an essential tool of modern medicine.	[Pouly, Marc; Koller, Thomas; Lionetti, Simone] Hsch Luzern, Informat, Suurstoffi 1, CH-6343 Rotkreuz, Switzerland; [Gottfrois, Philippe] Univ Basel, Dept Biomed Engn, Allschwil, Switzerland	University of Basel	Pouly, M (corresponding author), Hsch Luzern, Informat, Suurstoffi 1, CH-6343 Rotkreuz, Switzerland.	marc.pouly@hslu.ch		Lionetti, Simone/0000-0001-7305-8957				Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672; He K, 2016, IDENTITY MAPPINGS DE, P770, DOI [10.1007/978-3-319-46493-0_38, DOI 10.1007/978-3-319-46493-0_38, DOI 10.1109/CVPR.2016.90]; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Liu XX, 2019, LANCET DIGIT HEALTH, V1, pE271, DOI 10.1016/S2589-7500(19)30123-2; Liu Y, 2020, NAT MED, V26, P900, DOI 10.1038/s41591-020-0842-3; McCulloch W S, 1943, Bulletin of Mathematical Biophysics, V5, P115, DOI DOI 10.1007/BF02459570; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Salvador A, 2019, INVERSE COOKING RECI; Schnurle S, 2017, USING SUPPORT VECTOR	12	6	6	1	26	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0017-8470	1432-1173		HAUTARZT	Hautarzt	SEP	2020	71	9			SI		660	668		10.1007/s00105-020-04663-7	http://dx.doi.org/10.1007/s00105-020-04663-7		AUG 2020	9	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	NJ0ZK	32789670	hybrid			2024-09-18	WOS:000559437300001
J	Li, Y; Chen, PJ; Li, ZY; Su, H; Yang, L; Zhong, DR				Li, Yuan; Chen, Pingjun; Li, Zhiyuan; Su, Hai; Yang, Lin; Zhong, Dingrong			Rule-based automatic diagnosis of thyroid nodules from intraoperative frozen sections using deep learning	ARTIFICIAL INTELLIGENCE IN MEDICINE			English	Article						Thyroid nodule; Frozen section; Whole slide image; Deep learning; Rule-based protocol	NUCLEAR FEATURES; PATHOLOGY; EFFICIENT; CANCER	Frozen sections provide a basis for rapid intraoperative diagnosis that can guide surgery, but the diagnoses often challenge pathologists. Here we propose a rule-based system to differentiate thyroid nodules from intraoperative frozen sections using deep learning techniques. The proposed system consists of three components: (1) automatically locating tissue regions in the whole slide images (WSIs), (2) splitting located tissue regions into patches and classifying each patch into predefined categories using convolutional neural networks (CNN), and (3) integrating predictions of all patches to form the final diagnosis with a rule-based system. To be specific, we fine-tune the InceptionV3 model for thyroid patch classification by replacing the last fully connected layer with three outputs representing the patch's probabilities of being benign, uncertain, or malignant. Moreover, we design a rule-based protocol to integrate patches' predictions to form the final diagnosis, which provides interpretability for the proposed system. On 259 testing slides, the system correctly predicts 95.3% (61/64) of benign nodules and 96.7% (148/153) of malignant nodules, and classify 16.2% (42/259) slides as uncertain, including 19 benign and 16 malignant slides, which are a sufficiently small number to be manually examined by pathologists or fully processed through permanent sections. Besides, the system allows the localization of suspicious regions along with the diagnosis. A typical whole slide image, with 80, 000 x 60, 000 pixels, can be diagnosed within 1 min, thus satisfying the time requirement for intraoperative diagnosis. To the best of our knowledge, this is the first study to apply deep learning to diagnose thyroid nodules from intraoperative frozen sections. The code is released at https://github.com/PingjunChen/ThyroidRule.	[Li, Yuan; Li, Zhiyuan] Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China; [Chen, Pingjun; Su, Hai; Yang, Lin] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Zhong, Dingrong] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; State University System of Florida; University of Florida; China-Japan Friendship Hospital	Yang, L (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.; Zhong, DR (corresponding author), China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China.	lin.yang@bme.ufl.edu; 748803069@qq.com	Chen, Pingjun/AAU-6822-2020; li, zhiyuan/HGD-9581-2022	Chen, Pingjun/0000-0003-0528-1713				Albores-Saavedra J, 2006, ENDOCR PATHOL, V17, P1, DOI 10.1385/EP:17:1:1; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Benediktsson H, 2007, ARCH PATHOL LAB MED, V131, P1636; Borrelli N, 2017, MODERN PATHOL, V30, P39, DOI [10.1038/modpathol.2016.157, 10.1038/nnodpathol.2016.157]; Chen J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-S1-S2; Chen Pingjun, 2019, J Open Source Softw, V4, DOI 10.21105/joss.01148; Chen PJ, 2018, LAB INVEST, V98, P586; Cho U, 2017, MODERN PATHOL, V30, P810, DOI 10.1038/modpathol.2017.9; Collins Kim A., 2015, Acad Forensic Pathol, V5, P526, DOI DOI 10.23907/2015.058; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; Dong Yan., 2017, Cancer and Clinical Oncology, V6, P51; Ertosun Mehmet Gunhan, 2015, AMIA Annu Symp Proc, V2015, P1899; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Field AS, 2016, CYTOPATHOLOGY, V27, P313, DOI 10.1111/cyt.12372; Guevara N, 2015, EUR ANN OTORHINOLARY, V132, P67, DOI 10.1016/j.anorl.2014.02.006; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; He B, 2019, ARTIF INTELL MED, V93, P43, DOI 10.1016/j.artmed.2018.05.001; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hou L, 2016, PROC CVPR IEEE, P2424, DOI 10.1109/CVPR.2016.266; Ilse M., 2018, Attention-based deep multiple instance learning; Kahmke Russel, 2013, Int J Otolaryngol, V2013, P496138, DOI 10.1155/2013/496138; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Nishiyama RH, 2000, WORLD J SURG, V24, P898, DOI 10.1007/s002680010157; Novis DA, 1996, ARCH PATHOL LAB MED, V120, P1087; Ren S., 2015, IEEETransactionsonPatternAnalysisandMachineIntelligence, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Robboy SJ, 2013, ARCH PATHOL LAB MED, V137, P1723, DOI 10.5858/arpa.2013-0200-OA; Ruder S., 2017, ARXIV; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Serag Ahmed., 2018, A multi-level deep learning algorithm to estimate tumor content and cellularity of prostate cancer; Shi XS, 2017, MED IMAGE ANAL, V42, P117, DOI 10.1016/j.media.2017.07.009; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Bui TD, 2019, ARTIF INTELL MED, V97, P1, DOI 10.1016/j.artmed.2019.04.005; Wang HB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.034003; Wang XL, 2019, INT CONF MEASURE, P1, DOI [10.1109/ICMIC48233.2019.9068567, 10.1109/TCYB.2019.2935141]; Wei JW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40041-7; Xie YP, 2018, LAB INVEST, V98, P113; Xie YP, 2018, MED IMAGE ANAL, V44, P245, DOI 10.1016/j.media.2017.07.003; Xing FY, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3037-5; Xing Fuyong, 2016, IEEE Rev Biomed Eng, V9, P234, DOI 10.1109/RBME.2016.2515127; Xu J, 2016, NEUROCOMPUTING, V191, P214, DOI 10.1016/j.neucom.2016.01.034; Zhang ZZ, 2019, NAT MACH INTELL, V1, P236, DOI 10.1038/s42256-019-0052-1; Zhang ZZ, 2021, IEEE T PATTERN ANAL, V43, P1733, DOI 10.1109/TPAMI.2019.2955476	46	21	21	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0933-3657	1873-2860		ARTIF INTELL MED	Artif. Intell. Med.	AUG	2020	108								101918	10.1016/j.artmed.2020.101918	http://dx.doi.org/10.1016/j.artmed.2020.101918			10	Computer Science, Artificial Intelligence; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	NW4AN	32972671	Green Accepted			2024-09-18	WOS:000574951400010
J	Tschandl, P; Argenziano, G; Razmara, M; Yap, J				Tschandl, P.; Argenziano, G.; Razmara, M.; Yap, J.			Diagnostic accuracy of content-based dermatoscopic image retrieval with deep classification features	BRITISH JOURNAL OF DERMATOLOGY			English	Article							PERFORMANCE	Background Automated classification of medical images through neural networks can reach high accuracy rates but lacks interpretability. Objectives To compare the diagnostic accuracy obtained by using content-based image retrieval (CBIR) to retrieve visually similar dermatoscopic images with corresponding disease labels against predictions made by a neural network. Methods A neural network was trained to predict disease classes on dermatoscopic images from three retrospectively collected image datasets containing 888, 2750 and 16 691 images, respectively. Diagnosis predictions were made based on the most commonly occurring diagnosis in visually similar images, or based on the top-1 class prediction of the softmax output from the network. Outcome measures were area under the receiver operating characteristic curve (AUC) for predicting a malignant lesion, multiclass-accuracy and mean average precision (mAP), measured on unseen test images of the corresponding dataset. Results In all three datasets the skin cancer predictions from CBIR (evaluating the 16 most similar images) showed AUC values similar to softmax predictions (0.842, 0.806 and 0.852 vs. 0.830, 0.810 and 0.847, respectively; P > 0.99 for all). Similarly, the multiclass-accuracy of CBIR was comparable with softmax predictions. Compared with softmax predictions, networks trained for detecting only three classes performed better on a dataset with eight classes when using CBIR (mAP 0.184 vs. 0.368 and 0.198 vs. 0.403, respectively). Conclusions Presenting visually similar images based on features from a neural network shows comparable accuracy with the softmax probability-based diagnoses of convolutional neural networks. CBIR may be more helpful than a softmax classifier in improving diagnostic accuracy of clinicians in a routine clinical setting.	[Tschandl, P.] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada; [Tschandl, P.] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Argenziano, G.] Univ Campania, Dept Dermatol, Naples, Italy; [Razmara, M.; Yap, J.] MetaOptima Technol Inc, Vancouver, BC, Canada	Simon Fraser University; Medical University of Vienna; Universita della Campania Vanvitelli	Tschandl, P (corresponding author), Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada.; Tschandl, P (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	philipp.tschandl@meduniwien.ac.at	; Argenziano, Giuseppe/E-5926-2010	Tschandl, Philipp/0000-0003-0391-7810; Argenziano, Giuseppe/0000-0003-1413-8214	MetaOptima Technology Inc.	MetaOptima Technology Inc.	MetaOptima Technology Inc.	[Anonymous], DEEPSEEK CONTENT BAS; [Anonymous], 2017 INT S BIOM IM I; [Anonymous], ATTENTIVE EXPLANATIO; [Anonymous], WHAT DO WE NEED BUIL; [Anonymous], 2000, Interactive atlas of dermoscopy; [Anonymous], CHEXNET RADIOLOGIST; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dreiseitl Stephan, 2007, AMIA Annu Symp Proc, P191; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Finlayson S.G., ADVERSARIAL ATTACKS; Girardi Dominic, 2016, Brain Inform, V3, P133, DOI 10.1007/s40708-016-0038-2; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Haenssle HA, 2018, ANN ONCOL, V29, P1836, DOI 10.1093/annonc/mdy166; Han SS, 2018, J INVEST DERMATOL, V138, P1529, DOI 10.1016/j.jid.2018.01.028; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; HOLM S, 1979, SCAND J STAT, V6, P65; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kawahara J, 2019, IEEE J BIOMED HEALTH, V23, P538, DOI 10.1109/JBHI.2018.2824327; Menzies SW, 2005, ARCH DERMATOL, V141, P1388, DOI 10.1001/archderm.141.11.1388; Monheit G, 2011, ARCH DERMATOL, V147, P188, DOI 10.1001/archdermatol.2010.302; Parkhi O. M., 2015, Deep face recognition; Paszke A., 2017, P 31 C NEUR INF PROC, P1; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; R Core Team, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Shi XS, 2018, PATTERN RECOGN, V81, P14, DOI 10.1016/j.patcog.2018.03.015; Tschandl P, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.161; Wickham H., 2016, GGPLOT2 ELEGANT GRAP	29	45	46	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JUL	2019	181	1					155	165		10.1111/bjd.17189	http://dx.doi.org/10.1111/bjd.17189			11	Dermatology	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology	IH0LH	30207594	Green Published, Green Submitted, hybrid			2024-09-18	WOS:000474182100033
J	Yin, MY; Liu, L; Gao, JW; Lin, JX; Qu, ST; Xu, W; Liu, XL; Xu, CF; Zhu, JZ				Yin, Minyue; Liu, Lu; Gao, Jingwen; Lin, Jiaxi; Qu, Shuting; Xu, Wei; Liu, Xiaolin; Xu, Chunfang; Zhu, Jinzhou			Deep learning for pancreatic diseases based on endoscopic ultrasound: A systematic review	INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS			English	Review						Endoscopic ultrasonography; Deep learning; Systematic review; Convolutional neural networks; Pancreatic diseases	CONVOLUTIONAL NEURAL-NETWORK; ARTIFICIAL-INTELLIGENCE; DIFFERENTIAL-DIAGNOSIS; GASTRIC-CANCER; EUS IMAGES; ELASTOGRAPHY; FUTURE	Background and aims: Endoscopic ultrasonography (EUS) is one of the main examinations in pancreatic diseases. A series of the studies reported the application of deep learning (DL)-assisted EUS in the diagnosis of pancreatic diseases. This systematic review is to evaluate the role of DL algorithms in assisting EUS diagnosis of pancreatic diseases.Methods: Literature search were conducted in PubMed and Semantic Scholar databases. Studies that developed DL models for pancreatic diseases based on EUS were eligible for inclusion. This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and quality assessment of the included studies was performed according to the IJMEDI checklist.Results: A total of 23 studies were enrolled into this systematic review, which could be categorized into three groups according to computer vision tasks: classification, detection and segmentation. Seventeen studies focused on the classification task, among which five studies developed simple neural network (NN) models while twelve studies constructed convolutional NN (CNN) models. Three studies were concerned the detection task and five studies were the segmentation task, all based on CNN architectures. All models presented in the studies per-formed well based on EUS images, videos or voice. According to the IJMEDI checklist, six studies were recog-nized as high-grade quality, with scores beyond 35 points.Conclusions: DL algorithms show great potential in EUS images/videos/voice for pancreatic diseases. However, there is room for improvement such as sample sizes, multi-center cooperation, data preprocessing, model interpretability, and code sharing.	[Yin, Minyue; Liu, Lu; Gao, Jingwen; Lin, Jiaxi; Qu, Shuting; Xu, Wei; Liu, Xiaolin; Xu, Chunfang; Zhu, Jinzhou] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou 215000, Peoples R China; [Yin, Minyue; Liu, Lu; Gao, Jingwen; Lin, Jiaxi; Qu, Shuting; Xu, Wei; Liu, Xiaolin; Xu, Chunfang; Zhu, Jinzhou] Suzhou Clin Ctr Digest Dis, Suzhou 215000, Peoples R China; [Xu, Chunfang; Zhu, Jinzhou] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, 188 Shizi St, Suzhou 215006, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Xu, CF; Zhu, JZ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, 188 Shizi St, Suzhou 215006, Jiangsu, Peoples R China.	xuchunfang@suda.edu.cn; jzzhu@zju.edu.cn	Liu, Xiaolin/JXL-2314-2024; Yin, Minyue/GRJ-2214-2022; Xu, Wei/JCO-9731-2023	ZHU, JINZHOU/0000-0003-0544-9248; Xu, Wei/0000-0002-8113-9746	National Natural Science Foundation of China [82000540]; Suzhou Clinical Center of Digestive Diseases [Szlcyxzx202101]; Science and Technology Plan of Suzhou City [SKY2021038]; Youth Program of Suzhou Health Committee [KJXW2019001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Clinical Center of Digestive Diseases; Science and Technology Plan of Suzhou City; Youth Program of Suzhou Health Committee	Funding This research was supported by National Natural Science Foundation of China (82000540) , Suzhou Clinical Center of Digestive Diseases (Szlcyxzx202101) , Science and Technology Plan of Suzhou City (SKY2021038) and Youth Program of Suzhou Health Committee (KJXW2019001) .	Ahmad OF, 2022, DIGEST ENDOSC, V34, P862, DOI 10.1111/den.14187; Ahmad OF, 2021, LANCET GASTROENTEROL, V6, P678, DOI 10.1016/S2468-1253(21)00254-5; An P, 2020, GASTRIC CANCER, V23, P884, DOI 10.1007/s10120-020-01071-7; Athavale AM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.11176; Boehm KM, 2022, NAT CANCER, V3, P723, DOI 10.1038/s43018-022-00388-9; Bonmati E, 2022, IEEE T MED IMAGING, V41, P1311, DOI 10.1109/TMI.2021.3139023; Brand B, 2000, SCAND J GASTROENTERO, V35, P1221; Brunt EM, 2022, J HEPATOL, V76, P1030, DOI 10.1016/j.jhep.2022.01.011; Byrne MF, 2019, GUT, V68, P94, DOI 10.1136/gutjnl-2017-314547; Cabitza F, 2021, INT J MED INFORM, V153, DOI 10.1016/j.ijmedinf.2021.104510; Chen XH, 2021, IEEE T MED IMAGING, V40, P735, DOI 10.1109/TMI.2020.3035789; Chhatbar V., 2021, 2021 2 GLOB C ADV TE, P1; Das A, 2008, GASTROINTEST ENDOSC, V67, P861, DOI 10.1016/j.gie.2007.08.036; DeWitt JM, 2021, CLIN GASTROENTEROL H, V19, P24, DOI 10.1016/j.cgh.2020.09.029; Dumitrescu E.A., 2022, DIAGNOSTICS, P12; Durak S, 2021, MED BIOL ENG COMPUT, V59, P1563, DOI 10.1007/s11517-021-02398-8; Ebigbo A, 2021, GASTROINTEST ENDOSC, V93, P1342, DOI 10.1016/j.gie.2021.01.012; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Feng RW, 2021, IEEE J BIOMED HEALTH, V25, P3700, DOI 10.1109/JBHI.2020.3040269; Fleurentin A., 2022, COMP M BIO BIO E-IV, P1; Fusaroli P, 2016, GASTROINTEST ENDOSC, V84, P587, DOI 10.1016/j.gie.2016.06.006; Hamet P, 2017, METABOLISM, V69, pS36, DOI 10.1016/j.metabol.2017.01.011; Hirai K, 2022, GASTRIC CANCER, V25, P382, DOI 10.1007/s10120-021-01261-x; Hirasawa T, 2018, GASTRIC CANCER, V21, P653, DOI 10.1007/s10120-018-0793-2; Horiuchi Y, 2020, DIGEST DIS SCI, V65, P1355, DOI 10.1007/s10620-019-05862-6; Huang YJ, 2021, IEEE T CYBERNETICS, V51, P5397, DOI 10.1109/TCYB.2020.2980145; Iglesias-García J, 2012, REV ESP ENFERM DIG, V104, P315, DOI 10.4321/s1130-01082012000600006; Ikenoue T., PLOS ONE; Iwasa Y, 2021, J CLIN MED, V10, DOI 10.3390/jcm10163589; Jaramillo M., 2022, PROC SPIE; Jin C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22188-y; Kisilev P., LECT NOTES COMPUT SC, P121; Kitano M, 2019, J GASTROENTEROL, V54, P19, DOI 10.1007/s00535-018-1519-2; Kuwahara T., ENDOSCOPY; Kuwahara T, 2019, CLIN TRANSL GASTROEN, V10, DOI 10.14309/ctg.0000000000000045; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Lu L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26990-6; Lu Y, 2017, MED ULTRASON, V19, P150, DOI 10.11152/mu-987; Machicado JD, 2021, GASTROINTEST ENDOSC, V94, P78, DOI 10.1016/j.gie.2020.12.054; Marya NB, 2021, GUT, V70, P1335, DOI 10.1136/gutjnl-2020-322821; Narang A, 2021, JAMA CARDIOL, V6, P624, DOI 10.1001/jamacardio.2021.0185; Nguon L.S., 2021, DIAGNOSTICS, P11; Norton ID, 2001, GASTROINTEST ENDOSC, V54, P625, DOI 10.1067/mge.2001.118644; Oh S., 2021, SENSORS BASEL SWITZE, V22; Ozdemir O, 2020, IEEE T MED IMAGING, V39, P1419, DOI 10.1109/TMI.2019.2947595; Ozkan M, 2016, ENDOSC ULTRASOUND, V5, P101, DOI 10.4103/2303-9027.180473; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n160, 10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Preuss K, 2022, CANCERS, V14, DOI 10.3390/cancers14071654; Ren SA, 2020, EUR J RADIOL, V133, DOI 10.1016/j.ejrad.2020.109360; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/S0140-6736(18)32203-7; Ruano J, 2022, ULTRASOUND MED BIOL, V48, P1602, DOI 10.1016/j.ultrasmedbio.2022.04.006; Saftoiu A, 2008, GASTROINTEST ENDOSC, V68, P1086, DOI 10.1016/j.gie.2008.04.031; Saftoiu A, 2012, CLIN GASTROENTEROL H, V10, P84, DOI 10.1016/j.cgh.2011.09.014; Schima W, 2020, CANCER IMAGING, V20, DOI 10.1186/s40644-020-00324-z; Seo K, 2022, CANCERS, V14, DOI 10.3390/cancers14205111; Shen Y., 2021, IEEE/ACM Trans. Comput. Biol. Bioinform.; Singhi AD, 2019, GASTROENTEROLOGY, V156, P2024, DOI 10.1053/j.gastro.2019.01.259; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tang AL, 2023, CANCER MED-US, V12, P7962, DOI 10.1002/cam4.5578; Tang SY, 2022, CIRC-ARRHYTHMIA ELEC, V15, DOI 10.1161/CIRCEP.122.010850; Tian G, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.973652; Tonozuka R, 2021, J HEPATO-BIL-PAN SCI, V28, P95, DOI 10.1002/jhbp.825; Udristoiu AL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251701; Vilas-Boas F, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12092041; Wang S., 2021, IEEE Trans Cybern; Yamashita Y, 2019, DIGEST ENDOSC, V31, P125, DOI 10.1111/den.13290; Yuan HY, 2021, INT J COMPUT ASS RAD, V16, P2269, DOI 10.1007/s11548-021-02478-y; Zhang BL, 2018, PANCREATOLOGY, V18, P833, DOI 10.1016/j.pan.2018.07.008; Zhang J, 2020, GASTROINTEST ENDOSC, V92, P874, DOI 10.1016/j.gie.2020.04.071; Zhou Y, 2022, INT J MED INFORM, V157, DOI 10.1016/j.ijmedinf.2021.104641	71	6	6	3	15	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1386-5056	1872-8243		INT J MED INFORM	Int. J. Med. Inform.	JUN	2023	174								105044	10.1016/j.ijmedinf.2023.105044	http://dx.doi.org/10.1016/j.ijmedinf.2023.105044		MAR 2023	10	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	A8OW9	36948061				2024-09-18	WOS:000957666600001
J	Bao, LJ; Wang, Z; Wu, ZX; Luo, H; Yu, JH; Kang, Y; Cao, DS; Hou, TJ				Bao, Lingjie; Wang, Zhe; Wu, Zhenxing; Luo, Hao; Yu, Jiahui; Kang, Yu; Cao, Dongsheng; Hou, Tingjun			Kinome-wide polypharmacology profiling of small molecules by multi-task graph isomorphism network approach	ACTA PHARMACEUTICA SINICA B			English	Article						Kinome-wide polypharmacology; Machine learning; Kinases; Graph neural networks; Artificial intelligence	DRUG DISCOVERY; TARGETING EGFR; KINASES; CANCER	Prediction of the interactions between small molecules and their targets play important roles in various applications of drug development, such as lead discovery, drug repurposing and elucidation of potential drug side effects. Therefore, a variety of machine learning-based models have been developed to predict these interactions. In this study, a model called auxiliary multi-task graph isomorphism network with uncertainty weighting (AMGU) was developed to predict the inhibitory activities of small molecules against 204 different kinases based on the multi-task Graph Isomorphism Network (MT-GIN) with the auxiliary learning and uncertainty weighting strategy. The calculation results illustrate that the AMGU model outperformed the descriptor-based models and state-of-the-art graph neural networks (GNN) models on the internal test set. Furthermore, it also exhibited much better performance on two external test sets, suggesting that the AMGU model has enhanced generalizability due to its great transfer learning capacity. Then, a nai spacing diaeresis ve model-agnostic interpretable method for GNN called edges masking was devised to explain the underlying predictive mechanisms, and the consistency of the interpretability results for 5 typical epidermal growth factor receptor (EGFR) inhibitors with their structure-activity relationships could be observed. Finally, a free online web server called KIP was developed to predict the kinome-wide polypharmacology effects of small molecules (http://cadd.zju.edu.cn/kip).(c) 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Bao, Lingjie; Wang, Zhe; Wu, Zhenxing; Luo, Hao; Yu, Jiahui; Kang, Yu; Hou, Tingjun] Innovat Inst Artificial Intelligence Med Zhejiang, Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China; [Hou, Tingjun] Zhejiang Univ, State Key Lab CAD&CG, Hangzhou 310058, Peoples R China; [Cao, Dongsheng] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 410013, Peoples R China	Zhejiang University; Zhejiang University; Central South University	Kang, Y; Hou, TJ (corresponding author), Innovat Inst Artificial Intelligence Med Zhejiang, Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China.; Hou, TJ (corresponding author), Zhejiang Univ, State Key Lab CAD&CG, Hangzhou 310058, Peoples R China.; Cao, DS (corresponding author), Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 410013, Peoples R China.	tingjunhou@zju.edu.cn; oriental-cds@163.com; yukang@zju.edu.cn	Liu, Yilin/JWP-9153-2024; Luo, Hao/ADO-9726-2022; Zhang, Lijun/JEZ-7925-2023; zhao, wenqing/KEZ-9488-2024; li, Shang/KHU-3233-2024; Yu, Jiahui/A-8382-2015; Kang, Yu/L-2912-2013; Hou, Tingjun/C-7492-2011	Kang, Yu/0000-0002-0999-8802; Zhang, Xiaofeng/0000-0003-2738-3286; Cao, Dongsheng/0000-0003-3604-3785; Hou, Tingjun/0000-0001-7227-2580; wang, zhe/0000-0003-4102-1353	National Key Research and Development Program of China [2021YFF1201400]; National Natural Science Foundation of China [21575128, 81773632, 22173118]; Natural Science Foundation of Zhejiang Province (China) [LZ19H300001]; Science and Technology Innovation Program of Hunan Province (China) [2021RC4011]	National Key Research and Development Program of China(National Key Research & Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province (China)(Natural Science Foundation of Zhejiang Province); Science and Technology Innovation Program of Hunan Province (China)	This work was financially supported by National Key Research and Development Program of China (2021YFF1201400) , National Natural Science Foundation of China (21575128, 81773632, 22173118) , and Natural Science Foundation of Zhejiang Province (LZ19H300001, China) , and Science and Technology Innovation Program of Hunan Province (2021RC4011, China) .	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Attwood MM, 2021, NAT REV DRUG DISCOV, V20, P839, DOI 10.1038/s41573-021-00252-y; Avram S, 2018, J CHEM INF MODEL, V58, P957, DOI 10.1021/acs.jcim.7b00729; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brownlee J, IMBALANCED CLASSIFIC; Burger MC, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0085-3; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Chen T., 2016, arXiv; Chen Zhao, 2017, arXiv; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cruz M, 2013, Arxiv, DOI arXiv:1212.1704; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; de la Vega de Leon A, 2018, Journal of Cheminformatics, V10, P1; Drewry DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181585; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Essegian D, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100128; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feichtenhofer C, 2016, PROC CVPR IEEE; Ferrè F, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00196; Ghosh AK, 2019, CHEMMEDCHEM, V14, P889, DOI 10.1002/cmdc.201900107; Head Tim, 2022, Zenodo, DOI 10.5281/ZENODO.6451894; Hu Y, 2015, J MED CHEM, V58, P315, DOI 10.1021/jm501237k; Ioffe S, P INT C MACH LEARN, P448; Ismail RSM, 2016, FUTUR J PHARM SCI, V2, P9, DOI 10.1016/j.fjps.2016.02.001; Janssen APA, 2019, J CHEM INF MODEL, V59, P1221, DOI 10.1021/acs.jcim.8b00640; Jiang DJ, 2021, J CHEMINFORMATICS, V13, DOI 10.1186/s13321-020-00479-8; Kamath S, 2006, MED RES REV, V26, P569, DOI 10.1002/med.20070; Kingma D. P., 2017, arXiv; Kipf T.N., 2017, INT C LEARN REPR; Landrum Gregory, 2014, Zenodo; Li MF, 2021, ACS OMEGA, V6, P27233, DOI 10.1021/acsomega.1c04017; Li XT, 2020, J MED CHEM, V63, P8723, DOI 10.1021/acs.jmedchem.9b00855; Liu Y, 1909, ARXIV; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Merget B, 2017, J MED CHEM, V60, P474, DOI 10.1021/acs.jmedchem.6b01611; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Paszke A, 1912, ARXIV; Riniker S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-43; Rodríguez-Pérez R, 2019, ACS OMEGA, V4, P4367, DOI 10.1021/acsomega.9b00298; Roskoski R Jr, 2021, PHARMACOL RES, V165, DOI 10.1016/j.phrs.2021.105463; Ruder S, 2017, Arxiv, DOI arXiv:1706.05098; Sener O., 2019, arXiv; Shrestha A, 2019, IEEE ACCESS, V7, P53040, DOI 10.1109/ACCESS.2019.2912200; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sutherland JJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1425, DOI 10.1016/j.bbapap.2012.12.023; Tang J, 2014, J CHEM INF MODEL, V54, P735, DOI 10.1021/ci400709d; Tucker JA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147560; Vandenhende S, 2022, IEEE T PATTERN ANAL, V44, P3614, DOI 10.1109/TPAMI.2021.3054719; Velickovic P., 2017, ARXIV171010903, V1050, P48510; Wang M, 2019, 2019 C EMPIRICAL MET, P1909; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Wu ZQ, 2018, CHEM SCI, V9, P513, DOI 10.1039/c7sc02664a; Wu ZX, 2021, J MED CHEM, V64, P6924, DOI 10.1021/acs.jmedchem.1c00421; Xiong ZP, 2020, J MED CHEM, V63, P8749, DOI 10.1021/acs.jmedchem.9b00959; Xu K, ARXIV; Yang K, 2019, J CHEM INF MODEL, V59, P3370, DOI 10.1021/acs.jcim.9b00237; Ying Rex, 2019, Adv Neural Inf Process Syst, V32, P9240; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang XC, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab152	62	12	12	8	22	INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES	BEIJING	C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, 100050, PEOPLES R CHINA	2211-3835	2211-3843		ACTA PHARM SIN B	Acta Pharm. Sin. B	JAN	2023	13	1					54	67		10.1016/j.apsb.2022.05.004	http://dx.doi.org/10.1016/j.apsb.2022.05.004		FEB 2023	14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	8V4EN	36815050	gold, Green Published			2024-09-18	WOS:000930585400001
J	Rebora, P; Galimberti, S; Valsecchi, MG				Rebora, Paola; Galimberti, Stefania; Valsecchi, Maria Grazia			Using multiple timescale models for the evaluation of a time-dependent treatment	STATISTICS IN MEDICINE			English	Article						hazard; time-dependent treatment; survival; multiple timescales; piece-wise Poisson model	ACUTE LYMPHOBLASTIC-LEUKEMIA; MULTISTATE MODELS; COMPETING RISKS; GRAPHICAL REPRESENTATION; SURVIVAL CURVES; BREAST-CANCER; LEXIS DIAGRAM; KAPLAN-MEIER; MATCHED DATA; TRANSPLANTATION	In survival analysis, the absolute measure of cumulative risk provided by the Kaplan-Meier estimator is still the most used quantity for its easy calculation and direct interpretability. However, for describing the survival after an intervention that may occur at different times from baseline observation, the Kaplan-Meier estimator generally yields to biased results if intervention is considered as fixed at baseline. The main focus of the present paper is to extend the use of a multiple timescale model in the presence of a time dependent intervention. The aim is to obtain 1) an estimate of treatment effect in terms of hazard ratios by flexible modeling, 2) a valid prediction tool, i.e. estimate of prognosis for a patient who changes treatment later in time, and 3) an appropriate graphical representation of survival in the presence of a time dependent treatment change, accounting for different timescales. We will show the advantages of this approach on the comparison of chemotherapy versus transplant in children with high-risk acute lymphoblastic leukemia in first remission. We considered a model with two timescales that accounts for the change in treatment at different times in the disease course. An alternative approach to survival estimates is also proposed which has some advantages over the traditional landmark approach: it uses all the data available to plot survival from the date of remission, it avoids the arbitrary choice of a landmark time and explicitly models the change in hazard due to transplant. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Rebora, Paola; Galimberti, Stefania; Valsecchi, Maria Grazia] Univ Milano Bicocca, Dept Hlth Sci, Ctr Biostat Clin Epidemiol, Monza, Italy	University of Milano-Bicocca	Rebora, P (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Ctr Biostat Clin Epidemiol, Via Cadore 48, Monza, Italy.	paola.rebora@unimib.it	galimberti, stefania/H-2594-2012; Valsecchi, Maria/K-8891-2016; REBORA, PAOLA/M-9098-2016	, sara/0000-0001-7899-5966; REBORA, PAOLA/0000-0003-0606-5852; GALIMBERTI, STEFANIA/0000-0003-1504-7242	European Commission [FP7-HEALTH-F2-2011 261474]	European Commission(European Union (EU)European Commission Joint Research Centre)	This research was supported by a grant from the European Commission (FP7-HEALTH-F2-2011 261474). We are indebted to the reviewers for their precious comments and suggestions.	Andersen PK, 2012, STAT MED, V31, P1074, DOI 10.1002/sim.4385; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; [Anonymous], 2004, ANAL SURVIVAL DATA C; Aricò M, 2010, J CLIN ONCOL, V28, P4755, DOI 10.1200/JCO.2010.30.1325; Balduzzi A, 2008, HAEMATOLOGICA, V93, P925, DOI 10.3324/haematol.12291; Brand R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074368; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Conter V, 2014, BLOOD, V123, P1470, DOI 10.1182/blood-2013-10-532598; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Efron B, 2002, J R STAT SOC B, V64, P899, DOI 10.1111/1467-9868.00368; FEUER EJ, 1992, STAT MED, V11, P455, DOI 10.1002/sim.4780110408; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; Galimberti S, 2002, STAT MED, V21, P3847, DOI 10.1002/sim.1357; Galimberti S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-16; Glidden DV, 2002, BIOMETRICS, V58, P361, DOI 10.1111/j.0006-341X.2002.00361.x; Griffin BA, 2012, STAT MED, V31, P3320, DOI 10.1002/sim.5347; Iacobelli S, 2013, STAT MED, V32, P5315, DOI 10.1002/sim.5976; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEIDING N, 1990, PHILOS T ROY SOC A, V332, P487, DOI 10.1098/rsta.1990.0128; KLEIN JP, 1993, STAT MED, V12, P2315, DOI 10.1002/sim.4780122408; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Lee M, 2015, INT J CANCER, V136, P1948, DOI 10.1002/ijc.29239; Lee Y., 2006, GEN LINEAR MODELS RA, V106; MANTEL N, 1974, J AM STAT ASSOC, V69, P81, DOI 10.2307/2285503; Meier-Hirmer C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-80; Parast L, 2014, J AM STAT ASSOC, V109, P384, DOI 10.1080/01621459.2013.842488; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rebora P, 2014, BSHAZARD NONPARAMETR; Rebora P, 2008, J NATL CANCER I, V100, P721, DOI 10.1093/jnci/djn146; Rebora P, 2014, R J, V6, P114; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Thiébaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; vansHouwelingen HC, 2011, DYNAMIC PREDICTION C; Whitehead J., 1980, Applied Statistics, V29, P268, DOI 10.2307/2346901; Yudi Pawitan, 2001, ALL LIKELIHOOD STAT	36	5	5	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	DEC 10	2015	34	28					3648	3660		10.1002/sim.6597	http://dx.doi.org/10.1002/sim.6597			13	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	CV0KX	26215851				2024-09-18	WOS:000363940700002
J	Kim, C; Gadgil, SU; Degrave, AJ; Omiye, JA; Cai, ZR; Daneshjou, R; Lee, SI				Kim, Chanwoo; Gadgil, Soham U.; Degrave, Alex J.; Omiye, Jesutofunmi A.; Cai, Zhuo Ran; Daneshjou, Roxana; Lee, Su-In			Transparent medical image AI via an image-text foundation model grounded in medical literature	NATURE MEDICINE			English	Article							ARTIFICIAL-INTELLIGENCE; SKIN-CANCER	Building trustworthy and transparent image-based medical artificial intelligence (AI) systems requires the ability to interrogate data and models at all stages of the development pipeline, from training models to post-deployment monitoring. Ideally, the data and associated AI systems could be described using terms already familiar to physicians, but this requires medical datasets densely annotated with semantically meaningful concepts. In the present study, we present a foundation model approach, named MONET (medical concept retriever), which learns how to connect medical images with text and densely scores images on concept presence to enable important tasks in medical AI development and deployment such as data auditing, model auditing and model interpretation. Dermatology provides a demanding use case for the versatility of MONET, due to the heterogeneity in diseases, skin tones and imaging modalities. We trained MONET based on 105,550 dermatological images paired with natural language descriptions from a large collection of medical literature. MONET can accurately annotate concepts across dermatology images as verified by board-certified dermatologists, competitively with supervised models built on previously concept-annotated dermatology datasets of clinical images. We demonstrate how MONET enables AI transparency across the entire AI system development pipeline, from building inherently interpretable models to dataset and model auditing, including a case study dissecting the results of an AI clinical trial. By learning to pair dermatological images and related concepts in a self-supervised manner, a visual-language foundation model is shown to have comparable performance to supervised models for concept annotation and is used to scrutinize model decisions for enhanced interpretability and accountability of medical imaging applications.	[Kim, Chanwoo; Gadgil, Soham U.; Degrave, Alex J.; Lee, Su-In] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA; [Degrave, Alex J.] Univ Washington, Med Scientist Training Program, Seattle, WA USA; [Omiye, Jesutofunmi A.; Daneshjou, Roxana] Stanford Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Omiye, Jesutofunmi A.; Daneshjou, Roxana] Stanford Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Cai, Zhuo Ran] Stanford Univ, Program Clin Res & Technol, Stanford, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Stanford University; Stanford University	Lee, SI (corresponding author), Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA.; Daneshjou, R (corresponding author), Stanford Sch Med, Dept Dermatol, Stanford, CA 94305 USA.; Daneshjou, R (corresponding author), Stanford Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA.	roxanad@stanford.edu; suinlee@cs.washington.edu	Daneshjou, Roxana/ABE-7764-2021	Kim, Chanwoo/0000-0002-1950-1230; Lee, Su-In/0000-0001-5833-5215; Daneshjou, Roxana/0000-0001-7988-9356	National Science Foundation [CAREER DBI-1552309, DBI-1759487]; National Institutes of Health (NIH) [R35 GM 128638, R01 AG061132]; NIH [5T32 AR007422-38]; Stanford Catalyst Program	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Catalyst Program	We thank C. Lin and other people in S.-I.L.'s lab for helpful discussions. The members of S.-I.L.'s lab, including C.K., S.U.G., A.J.D. and S.-I.L., received support from the National Science Foundation (grant nos. CAREER DBI-1552309 and DBI-1759487) and the National Institutes of Health (NIH, grant nos. R35 GM 128638 and R01 AG061132). R.D. was supported by the NIH (5T32 AR007422-38) and the Stanford Catalyst Program.	Abid A, 2022, PR MACH LEARN RES, P66; Agbai ON, 2014, J AM ACAD DERMATOL, V70, P748, DOI 10.1016/j.jaad.2013.11.038; [Anonymous], 2022, PMC Open Access Subset; Arun N, 2021, RADIOL-ARTIF INTELL, V3, DOI 10.1148/ryai.2021200267; Bedoya AD, 2022, J AM MED INFORM ASSN, V29, P1631, DOI 10.1093/jamia/ocac078; Bissoto A, 2019, IEEE COMPUT SOC CONF, P2766, DOI 10.1109/CVPRW.2019.00335; Cassidy B, 2022, MED IMAGE ANAL, V75, DOI 10.1016/j.media.2021.102305; Chung Y, 2020, IEEE T KNOWL DATA EN, V32, P2284, DOI 10.1109/TKDE.2019.2916074; Coalition for Health AI, 2023, Blueprint for Tustworthy AI Implementation Guidance and Assurance for Healthcare; Codella N, 2019, Arxiv, DOI [arXiv:1902.03368, 10.48550/arXiv.1902.03368]; Codella NCF, 2018, I S BIOMED IMAGING, P168, DOI 10.1109/ISBI.2018.8363547; Combalia M, 2019, arXiv, DOI 10.48550/arXiv.1908.02288; Combalia M, 2022, LANCET DIGIT HEALTH, V4, pE330, DOI 10.1016/S2589-7500(22)00021-8; Corbin CK, 2023, J AM MED INFORM ASSN, V30, P1532, DOI 10.1093/jamia/ocad114; Crabb? J., 2022, ADV NEUR INF PROCESS, V35, P2590; Daneshjou R., 2022, Adv Neural Inf Process Syst, V35, P18157; Daneshjou R, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abq6147; Daneshjou R, 2021, JAMA DERMATOL, V157, P1362, DOI 10.1001/jamadermatol.2021.3129; DeGrave AJ, 2024, LANCET, V403, P717, DOI 10.1038/s41551-023-01160-9; DeGrave AJ, 2021, NAT MACH INTELL, V3, P610, DOI 10.1038/s42256-021-00338-7; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dosovitskiy A., 2020, P INT C LEARN REP, P1; Eyuboglu S, 2022, 10 INT C LEARN REPR; Feng J, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00611-y; Gamper J, 2021, PROC CVPR IEEE, P16544, DOI 10.1109/CVPR46437.2021.01628; Goel K., 2021, 9 INT C LEARN REPR I; Groh M., 2022, P ACM HUM COMP INT A, P1; Groh M, 2021, IEEE COMPUT SOC CONF, P1820, DOI 10.1109/CVPRW53098.2021.00201; Gutman D., 2016, SKIN LESION ANAL MEL; Han SS, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-20632-7; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Huang Z, 2023, NAT MED, V29, P2307, DOI 10.1038/s41591-023-02504-3; Janizek Joseph D., 2020, CHIL '20: Proceedings of the Conference on Health, Inference, and Learning, P69, DOI 10.1145/3368555.3384458; Jeyakumar JV, 2022, Arxiv, DOI arXiv:2206.10129; Jiang LY, 2023, NATURE, V619, P357, DOI 10.1038/s41586-023-06160-y; Jones OT, 2022, LANCET DIGIT HEALTH, V4, pE466, DOI 10.1016/S2589-7500(22)00023-1; Kawahara J, 2019, IEEE J BIOMED HEALTH, V23, P538, DOI 10.1109/JBHI.2018.2824327; Kim B, 2018, PR MACH LEARN RES, V80; Kingma D. P., 2017, arXiv; Klimiene U., 2022, 2 WORKSH INT MACH LE; Koh PW, 2020, PR MACH LEARN RES, V119; Lanchantin J, 2021, PROC CVPR IEEE, P16473, DOI 10.1109/CVPR46437.2021.01621; Lara MAR, 2023, SCI DATA, V10, DOI 10.1038/s41597-023-02630-0; Leming M, 2022, ARTIF INTELL MED, V129, DOI 10.1016/j.artmed.2022.102309; Lester JC, 2020, BRIT J DERMATOL, V183, P593, DOI 10.1111/bjd.19258; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Louie P, 2018, SOC SCI MED, V202, P38, DOI 10.1016/j.socscimed.2018.02.023; Lundberg SM, 2017, ADV NEUR IN, V30; Marchetti MA, 2023, NPJ DIGIT MED, V6, DOI 10.1038/s41746-023-00872-1; Massie JP, 2021, J NATL MED ASSOC, V113, P88, DOI 10.1016/j.jnma.2020.07.013; Massie JP, 2019, PRS-GLOB OPEN, V7, DOI 10.1097/GOX.0000000000002563; Memorial Sloan Kettering Cancer Center, 2022, ISIC Archive, DOI [10.34970/151324, DOI 10.34970/151324]; Mendonça T, 2013, IEEE ENG MED BIO, P5437; Navarrete-Dechent C, 2021, J INVEST DERMATOL, V141, P1325, DOI 10.1016/j.jid.2020.06.040; Navarrete-Dechent C, 2018, J INVEST DERMATOL, V138, P2277, DOI 10.1016/j.jid.2018.04.040; Nevitt M., Protocol for the cohort study; Oakden-Rayner Luke, 2020, Proc ACM Conf Health Inference Learn (2020), V2020, P151, DOI 10.1145/3368555.3384468; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pianykh OS, 2020, RADIOLOGY, V297, P6, DOI 10.1148/radiol.2020200038; Radford A, 2021, PR MACH LEARN RES, V139; Rajpurkar P, 2018, 1 C MED IM DEEP LEAR; Reyes M, 2020, RADIOL-ARTIF INTELL, V2, DOI 10.1148/ryai.2020190043; Rigel DS, 2005, ARCH DERMATOL, V141, P1032, DOI 10.1001/archderm.141.8.1032; Rotemberg V, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00815-z; Sagawa Shiori, 2020, INT C LEARN REPR ICL; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Sennrich R, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1715; Sierro TJ, 2022, J AM ACAD DERMATOL, V86, P373, DOI 10.1016/j.jaad.2021.07.005; Singh C, 2021, Arxiv, DOI arXiv:2103.13455; Singhal K, 2023, NATURE, V620, P172, DOI 10.1038/s41586-023-06291-2; suinleelab/MONET, 2024, Github; Sun X, 2021, arXiv, DOI DOI 10.48550/ARXIV.2110.10470; Sundararajan M, 2017, PR MACH LEARN RES, V70; Tan MX, 2021, PR MACH LEARN RES, V139, P7102; Tiu E, 2022, NAT BIOMED ENG, V6, P1399, DOI 10.1038/s41551-022-00936-9; Tschandl P, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.161; Vokinger KN, 2021, LANCET DIGIT HEALTH, V3, pE337, DOI 10.1016/S2589-7500(21)00076-5; Wang Zifeng, 2022, Proc Conf Empir Methods Nat Lang Process, V2022, P3876, DOI 10.18653/v1/2022.emnlp-main.256; Winkler JK, 2019, JAMA DERMATOL, V155, P1135, DOI 10.1001/jamadermatol.2019.1735; Wu C, 2022, PR MACH LEARN RES, V182, P648; Yuksekgonul M., 2023, 11 INT C LEARN REPR; Zhao QY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19784-9; Zhu JY, 2017, IEEE I CONF COMP VIS, P2242, DOI 10.1109/ICCV.2017.244	84	3	3	11	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR 1	2024	30	3								10.1038/s41591-024-02887-x	http://dx.doi.org/10.1038/s41591-024-02887-x			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	YC6P7	38627560				2024-09-18	WOS:001266331000041
J	Wang, SW; Arizmendi, CJ; Chen, DD; Lin, L; Blalock, DV; Huang, IC; Thissen, D; DeWalt, DA; Pan, W; Reeve, BB				Wang, Suwei; Arizmendi, Cara J.; Chen, Dandan; Lin, Li; Blalock, Dan V.; Huang, I-Chan; Thissen, David; DeWalt, Darren A.; Pan, Wei; Reeve, Bryce B.			Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life	JOURNAL OF BIOPHARMACEUTICAL STATISTICS			English	Article; Early Access						LPA; AYA; HRQOL; chronic conditions; PROMIS	SYMPTOM CLUSTER RESEARCH; CHILDREN; OUTCOMES; NUMBER; CANCER; MODELS	The impact of chronic diseases on health-related quality of life (HRQOL) in adolescents and young adults (AYAs) is understudied. Latent profile analysis (LPA) can identify profiles of AYAs based on their HRQOL scores reflecting physical, mental, and social well-being. This paper will (1) demonstrate how to use LPA to identify profiles of AYAs based on their scores on multiple HRQOL indicators; (2) explore associations of demographic and clinical factors with LPA-identified HRQOL profiles of AYAs; and (3) provide guidance on the selection of adult or pediatric versions of Patient-Reported Outcomes Measurement Information System (R) (PROMIS (R)) in AYAs. A total of 872 AYAs with chronic conditions completed the adult and pediatric versions of PROMIS measures of anger, anxiety, depression, fatigue, pain interference, social health, and physical function. The optimal number of LPA profiles was determined by model fit statistics and clinical interpretability. Multinomial regression models examined clinical and demographic factors associated with profile membership. As a result of the LPA, AYAs were categorized into 3 profiles: Minimal, Moderate, and Severe HRQOL Impact profiles. Comparing LPA results using either the pediatric or adult PROMIS T-scores found approximately 71% of patients were placed in the same HRQOL profiles. AYAs who were female, had hypertension, mental health conditions, chronic pain, and those on medication were more likely to be placed in the Severe HRQOL Impact Profile. Our findings may facilitate clinicians to screen AYAs who may have low HRQOL due to diseases or treatments with the identified risk factors without implementing the HRQOL assessment.	[Wang, Suwei; Arizmendi, Cara J.; Chen, Dandan; Lin, Li; Pan, Wei; Reeve, Bryce B.] Duke Univ, Ctr Hlth Measurement, Dept Populat Hlth Sci, Sch Med, Durham, NC USA; [Blalock, Dan V.] Duke Univ, Dept Psychiat & Behav Sci, Sch Med, Durham, NC USA; [Blalock, Dan V.] Durham Vet Affairs Med Ctr, Hlth Serv Res & Dev, Durham, NC USA; [Huang, I-Chan] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN USA; [Thissen, David] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA; [DeWalt, Darren A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Pan, Wei] Duke Univ, Sch Nursing, Div Clin Hlth Syst & Analyt, Durham, NC USA; [Reeve, Bryce B.] Duke Univ, Dept Pediat, Sch Med, Durham, NC USA; [Reeve, Bryce B.] Duke Univ, Ctr Hlth Measurement, Dept Populat Hlth Sci, Sch Med, 215 Morris St,Suite 210,Box 104023, Durham, NC 27701 USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; St Jude Children's Research Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University	Reeve, BB (corresponding author), Duke Univ, Ctr Hlth Measurement, Dept Populat Hlth Sci, Sch Med, 215 Morris St,Suite 210,Box 104023, Durham, NC 27701 USA.	bryce.reeve@duke.edu	Reeve, Bryce/AAE-7657-2019; Huang, I-Chan/N-8100-2018; Chen, Dandan/AAH-7141-2020; li, yifang/JVM-8060-2024		AstraZeneca; United States Department of Veterans Affairs Health Services Research and Development (HSR&D) Service Award [19035 (IK2HX003085-01A)]; Takeda Pharmaceuticals U.S.A.	AstraZeneca(AstraZeneca); United States Department of Veterans Affairs Health Services Research and Development (HSR&D) Service Award(US Department of Veterans Affairs); Takeda Pharmaceuticals U.S.A.(Takeda Pharmaceutical Company Ltd)	The work was supported by the~AstraZeneca [MaRS Post-Doc Education Agreement]; United States Department of Veterans Affairs Health Services Research and Development (HSR&D) Service [Career Development Award 19-035 (IK2HX003085-01A]; Takeda Pharmaceuticals U.S.A. [MaRS Post-Doc Education Agreement]	[Anonymous], 2011, CLOSING GAP RES CANC; Aubin S, 2011, J ADOLESC YOUNG ADUL, V1, P3, DOI 10.1089/jayao.2011.1505; Bakk Z, 2021, BRIT J MATH STAT PSY, V74, P340, DOI 10.1111/bmsp.12227; Bakk Z, 2018, PSYCHOMETRIKA, V83, P871, DOI 10.1007/s11336-017-9592-7; Bakk Z, 2016, STRUCT EQU MODELING, V23, P278, DOI 10.1080/10705511.2015.1049698; Barsevick AM, 2013, CURR OPIN SUPPORT PA, V7, P36, DOI 10.1097/SPC.0b013e32835defac; Blalock D. V., 2020, PSYCHOL TEST ASSESSM, V62, P417; Bolck A, 2004, POLIT ANAL, V12, P3, DOI 10.1093/pan/mph001; Bonnie R., 2014, Investing In The Health And Well-Being Of Young Adults; Buckner TW, 2014, PEDIATR BLOOD CANCER, V61, P1282, DOI [10.1002/pbc.24969, 10.1002/pbc.25029]; CDC, 2021, HLTH REL QUAL LIF; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Cella D F, 1990, Oncology (Williston Park), V4, P29; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Collins L. M., 2010, Latent class and latent tran si tion anal y sis: With appli ca tions in the social behav ioral, and health sci ences; Colver A, 2015, LANCET, V385, P705, DOI 10.1016/S0140-6736(14)61229-0; Davis PJ, 2003, PAIN MED, V4, P215, DOI 10.1046/j.1526-4637.2003.03027.x; Devinsky O, 1999, EPILEPSIA, V40, P1715, DOI 10.1111/j.1528-1157.1999.tb01588.x; Gignac GE, 2016, PERS INDIV DIFFER, V102, P74, DOI 10.1016/j.paid.2016.06.069; Granado E. A., 2015, COMP 3 EFFECT SIZES; Hallstrand TS, 2003, PEDIATR PULM, V36, P536, DOI 10.1002/ppul.10395; Hinds PS, 2021, J PAIN SYMPTOM MANAG, V61, P1188, DOI 10.1016/j.jpainsymman.2020.10.017; Huberty CJ, 2000, EDUC PSYCHOL MEAS, V60, P543, DOI 10.1177/0013164400604004; Jennes-Coussens M, 2006, AUTISM, V10, P403, DOI 10.1177/1362361306064432; Kamp-Becker Inge, 2010, Psychosoc Med, V7, DOI 10.3205/psm000065; Kim HJ, 2013, CURR OPIN SUPPORT PA, V7, P45, DOI 10.1097/SPC.0b013e32835bf28b; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lanza ST, 2010, J DRUG ISSUES, V40, P93, DOI 10.1177/002204261004000106; Laursen B, 2006, MERRILL PALMER QUART, V52, P377, DOI 10.1353/mpq.2006.0029; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; McCutcheon AL, 1987, Latent class analysis; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mclust, GAUSSIAN MIXTURE MOD; Miaskowski Christine, 2006, Oncol Nurs Forum, V33, pE79, DOI 10.1188/06.ONF.E79-E89; NCI (National Cancer Institute), AD YOUNG AD CANC; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Oberski D, 2016, HUM-COMPUT INT-SPRIN, P275, DOI 10.1007/978-3-319-26633-6_12; Parkinson KN, 2015, ARCH DIS CHILD, V100, P779, DOI 10.1136/archdischild-2014-307498; Pemberger S, 2005, SUPPORT CARE CANCER, V13, P49, DOI 10.1007/s00520-004-0724-0; Reeve BB, 2016, QUAL LIFE RES, V25, P823, DOI 10.1007/s11136-015-1143-z; Revicki DA, 2014, DIALOGUES CLIN NEURO, V16, P127; SIEGRIST J, 1989, SOC SCI MED, V29, P463, DOI 10.1016/0277-9536(89)90295-5; Sprangers MAG, 2002, ACTA ONCOL, V41, P229, DOI 10.1080/02841860260088764; Spurk D, 2020, J VOCAT BEHAV, V120, DOI 10.1016/j.jvb.2020.103445; STEWART DW, 1981, J MARKETING RES, V18, P51, DOI 10.2307/3151313; Tulsky DS, 2019, QUAL LIFE RES, V28, P1217, DOI 10.1007/s11136-018-2073-3; Uzark K, 2008, PEDIATRICS, V121, pE1060, DOI 10.1542/peds.2006-3778; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Wang J., 2012, STRUCTURAL EQUATION; Wang J., 2010, ADV APPL STAT SCI, V3, P1; Wang S., 2022, HLTH RELATED QUALITY; Wardenaar K. J., 2021, LATENT PROFILE ANAL, DOI [10.31234/osf.io/wzftr, DOI 10.31234/OSF.IO/WZFTR]	54	11	11	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1054-3406	1520-5711		J BIOPHARM STAT	J. Biopharm. Stat.	2023 MAY 14	2023										10.1080/10543406.2023.2210684	http://dx.doi.org/10.1080/10543406.2023.2210684		MAY 2023	14	Pharmacology & Pharmacy; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Mathematics	G5MQ6	37183393				2024-09-18	WOS:000989599500001
J	Wolsztynski, E; O'Sullivan, F; Eary, JF				Wolsztynski, Eric; O'Sullivan, Finbarr; Eary, Janet F.			Spatially coherent modeling of 3D FDG-PET data for assessment of intratumoral heterogeneity and uptake gradients	JOURNAL OF MEDICAL IMAGING			English	Article						heterogeneity; uptake gradient; positron emission tomography; sarcoma; spatial statistics; tumor characterization	F-18-FDG PET; TEXTURE ANALYSIS	Purpose: Radiomics have become invaluable for non-invasive cancer patient risk prediction, and the community now turns to exogenous assessment, e.g., from genomics, for interpretability of these agnostic analyses. Yet, some opportunities for clinically interpretable modeling of positron emission tomography (PET) imaging data remain unexplored, that could facilitate insightful characterization at voxel level. Approach: Here, we present a novel deformable tubular representation of the distribution of tracer uptake within a volume of interest, and derive interpretable prognostic summaries from it. This data-adaptive strategy yields a 3D-coherent and smooth model fit, and a profile curve describing tracer uptake as a function of voxel location within the volume. Local trends in uptake rates are assessed at each voxel via the calculation of gradients derived from this curve. Intratumoral heterogeneity can also be assessed directly from it. Results: We illustrate the added value of this approach over previous strategies, in terms of volume rendering and coherence of the structural representation of the data. We further demonstrate consistency of the implementation via simulations, and prognostic potential of heterogeneity and statistical summaries of the uptake gradients derived from the model on a clinical cohort of 158 sarcoma patients imaged with F-18-fluorodeoxyglucose-PET, in multivariate prognostic models of patient survival. Conclusions: The proposed approach captures uptake characteristics consistently at any location, and yields a description of variations in uptake that holds prognostic value complementarily to structural heterogeneity. This creates opportunities for monitoring of local areas of greater interest within a tumor, e.g., to assess therapeutic response in avid locations. (C) 2022 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Wolsztynski, Eric; O'Sullivan, Finbarr] Univ Coll Cork, Stat Dept, Cork, Ireland; [Wolsztynski, Eric; O'Sullivan, Finbarr] Insight SFI Res Ctr Data Analyt, Cork, Ireland; [Eary, Janet F.] NCI, Bethesda, MD 20892 USA	University College Cork; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wolsztynski, E (corresponding author), Univ Coll Cork, Stat Dept, Cork, Ireland.; Wolsztynski, E (corresponding author), Insight SFI Res Ctr Data Analyt, Cork, Ireland.	eric.w@ucc.ie		Wolsztynski, Eric/0000-0001-9770-9769	Science Foundation Ireland [PI-11/1027, 12/RC/2289-P2]; European Regional Development Fund; National Institutes of Health / National Cancer Institute [ROI-CA-65537]	Science Foundation Ireland(Science Foundation Ireland); European Regional Development Fund(European Union (EU)); National Institutes of Health / National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This publication has emanated from research conducted with the financial support of Science Foundation Ireland under Grant Nos. PI-11/1027 and 12/RC/2289-P2, the latter being co-funded under the European Regional Development Fund. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. This work was also partly funded under National Institutes of Health / National Cancer Institute Grant No. ROI-CA-65537. This work complies with ethical standards.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bodalal Z, 2019, ABDOM RADIOL, V44, P1960, DOI 10.1007/s00261-019-02028-w; Da-Ano R, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/aba798; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Eary JF, 2014, J BONE JOINT SURG AM, V96A, P152, DOI 10.2106/JBJS.M.00062; Eary JF, 2008, J NUCL MED, V49, P1973, DOI 10.2967/jnumed.108.053397; Ferreira M, 2021, EUR J NUCL MED MOL I, V48, P3432, DOI 10.1007/s00259-021-05303-5; GILL PE, 1978, SIAM J NUMER ANAL, V15, P977, DOI 10.1137/0715063; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Grömping U, 2010, J STAT SOFTW, V33, P1; Hatt M, 2019, IEEE T RADIAT PLASMA, V3, P104, DOI 10.1109/TRPMS.2019.2899538; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hyun OJ, 2016, J NUCL MED, V57, P735, DOI 10.2967/jnumed.115.162412; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; Jones-Todd CM, 2019, STAT MED, V38, P1421, DOI 10.1002/sim.8046; Kuhn M., 2016, CARET CLASSIFICATION; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lasocki A, 2020, AM J NEURORADIOL, V41, P1982, DOI 10.3174/ajnr.A6769; Lo Gullo R, 2020, INSIGHTS IMAGING, V11, DOI 10.1186/s13244-019-0795-6; Locke Landon W, 2011, Int J Mol Imaging, V2011, P356730, DOI 10.1155/2011/356730; López OV, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00032; Meinshausen N, 2010, J ROY STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; O'Sullivan F, 2011, IEEE T MED IMAGING, V30, P2059, DOI 10.1109/TMI.2011.2160984; Orlhac F, 2021, EUR RADIOL, V31, P2272, DOI 10.1007/s00330-020-07284-9; Orlhac F, 2016, J NUCL MED, V57, P1823, DOI 10.2967/jnumed.116.173708; Pinker K, 2018, J MAGN RESON IMAGING, V47, P604, DOI 10.1002/jmri.25870; Rahmim A, 2012, IEEE NUCL SCI CONF R, P2227; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Simon N, 2011, J STAT SOFTW, V39, P1; Soussan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094017; Team R Development Core, 2021, R LANG ENV STAT COMP; Vallières M, 2018, J NUCL MED, V59, P189, DOI 10.2967/jnumed.117.200501; Wahba G., 1990, SPLINE MODELS OBSERV; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wolsztynski E, 2017, MIA; Wolsztynski E, VOLUMETRICS; Wolsztynski E, 2014, IEEE NUCL SCI S MED; Wolsztynski E, 2019, IEEE T RADIAT PLASMA, V3, P421, DOI [10.1109/TRPMS.2019.2912433, 10.1109/trpms.2019.2912433]; Wolsztynski E, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.2.024502; Ye JM, 1998, J AM STAT ASSOC, V93, P120, DOI 10.2307/2669609; Zwanenburg A, 2020, RADIOLOGY, V295, P328, DOI 10.1148/radiol.2020191145	41	0	0	0	0	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	2329-4302	2329-4310		J MED IMAGING	J. Med. Imaging	JUL 1	2022	9	4							045003	10.1117/1.JMI.9.4.045003	http://dx.doi.org/10.1117/1.JMI.9.4.045003			20	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	4E4NE	35915767	Green Published			2024-09-18	WOS:000847803200012
J	Rezaei, H; Saeed, AFM; Abdi, K; Ebadi, A; Gheshlagh, RG; Kurdi, A				Rezaei, Hayedeh; Saeed, Ali Faiek M.; Abdi, Kamel; Ebadi, Abbas; Gheshlagh, Reza Ghanei; Kurdi, Amanj			Translation and Validation of the Farsi Version of the Pain Management Self-Efficacy Questionnaire	JOURNAL OF PAIN RESEARCH			English	Article						validation; pain; self-efficacy; pain management	NURSES KNOWLEDGE; CANCER PAIN; PREDICTORS; ATTITUDES; VALIDITY; ANXIETY; PEOPLE	Introduction: Pain management is a complex process that is managed through a multidisciplinary team in which nurses have a significant role. The present study aimed at translating and examining the psychometric properties of the Pain Management Self-Efficacy Questionnaire (PMSEQ) among Iranian nurses. Methods: This was a cross-sectional, methodological study conducted in 2019 among nurses working in two teaching hospitals in Sanandaj (Tohid and Kosar). The participants were selected using a convenience sampling method. Responsiveness; interpretability; and face, content, and construct validities were examined using exploratory and confirmatory factor analyses. In addition, internal consistency and stability were examined using the Cronbach's alpha and test-retest, respectively. Results: Overall, 410 nurses (210 for the EFA and 200 for the CFA) were included in the sample. In the exploratory factor analysis, two factors of comprehensive pain assessment and pain management with eigenvalues of 6.36 and 1.91, respectively, were extracted. The two factors together explained 56.64% of the variance of nurses' pain management self-efficacy. The confirmatory factor analysis indicated that the model had a moderate fit to the data (RMSEA: 0.12; NFI: 0.84; NNFI: 0.86; CFI: 0.88; IFI: 0.88; RFI: 0.81; GFI: 0.76; AGFI: 0.69; PGFI: 0.59; RMR: 0.09; standardized RMR: 0.09). Total questionnaire and the two factors (i.e. comprehensive pain assessment and pain management) had internal consistency coefficients of 0.891, 0.876, and 0.803, respectively. Conclusion: The Farsi version of PMSEQ had good internal consistency and reliability, as well as content and construct validity, and can be used in future studies.	[Rezaei, Hayedeh; Gheshlagh, Reza Ghanei] Kurdistan Univ Med Sci, Fac Nursing & Midwifery, Dept Nursing, Sanandaj, Iran; [Saeed, Ali Faiek M.] Bayan Univ, Coll Business Adm & Econ, Dept Management, Erbil, Kurdistan, Iraq; [Abdi, Kamel] Komar Univ Sci & Technol, Fac Med, Nursing Dept, Sulimaniya City, Kurdistan Regio, Iraq; [Ebadi, Abbas] Baqiyatallah Univ Med Sci, Behav Sci Res Ctr, Life Style Inst, Tehran, Iran; [Gheshlagh, Reza Ghanei] Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran; [Kurdi, Amanj] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Pharmacoepidemiol & Pharm Practice, Glasgow, Lanark, Scotland; [Kurdi, Amanj] Hawler Med Univ, Coll Pharm, Dept Pharmacol, Erbil, Iraq	Kurdistan University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Kurdistan University of Medical Sciences; University of Strathclyde; Hawler Medical University	Gheshlagh, RG (corresponding author), Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran.	rezaghanei30@gmail.com	Ebadi, Abbas/S-3847-2018; Rezaei, hayedeh/AAW-6453-2021; abdi, kamel/GQQ-2875-2022; Kurdi, Amanj/P-1217-2017; Ghanei Gheshlagh, Reza/S-7043-2017	Kurdi, Amanj/0000-0001-5036-1988; Al-HAYALY, ALI FAIEK/0000-0002-1789-9089; Ghanei Gheshlagh, Reza/0000-0002-7414-8134	Kurdistan University of Medical Sciences	Kurdistan University of Medical Sciences	The present study received financial support from the Kurdistan University of Medical Sciences.	[Anonymous], 2014, HDB UNIVARIATE MULTI; [Anonymous], Process of translation and adaptation of instruments; [Anonymous], 2016, SCALE DEV THEORY APP; Asadi Noghabi AA, 2012, HAYAT, V18, P54; Aziato L, 2014, PAIN MANAG NURS, V15, P265, DOI 10.1016/j.pmn.2012.10.002; Aziznejadroshan P., 2015, Journal of Babol University of Medical Sciences, V17, P57; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Barlow JH, 2002, PATIENT EDUC COUNS, V46, P11, DOI 10.1016/S0738-3991(01)00146-X; Buckelew SP, 1995, ARTHRIT CARE RES, V8, P43, DOI 10.1002/art.1790080110; Chiang LC, 2006, J PAIN SYMPTOM MANAG, V32, P82, DOI 10.1016/j.jpainsymman.2006.01.011; Chung Joanne W Y, 2003, Nurs Health Sci, V5, P13, DOI 10.1046/j.1442-2018.2003.00130.x; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; de Boer MJ, 2012, EUR J PAIN, V16, P1044, DOI 10.1002/j.1532-2149.2012.00136.x; De Ruddere L, 2014, J PAIN, V15, P262, DOI 10.1016/j.jpain.2013.11.002; Duke G, 2013, PAIN MANAG NURS, V14, P11, DOI 10.1016/j.pmn.2010.03.006; Edwards H E, 2001, Nurs Health Sci, V3, P35, DOI 10.1046/j.1442-2018.2001.00069.x; Galinski M, 2010, PREHOSP EMERG CARE, V14, P334, DOI 10.3109/10903121003760218; Keller A, 2008, PAIN MED, V9, P680, DOI 10.1111/j.1526-4637.2007.00333.x; Kerns RD, 2018, ANN INTERN MED, V168, P517, DOI 10.7326/M18-0061; Kumar KH, 2016, J CASE RES INQ, V3, P87, DOI DOI 10.15713/INS.JCRI.112; Kurnia TA., 2019, Jurnal Ners, V13, P219, DOI [10.20473/jn.v13i2.9986, DOI 10.20473/JN.V13I2.9986]; Lai YH, 2003, J PAIN SYMPTOM MANAG, V26, P1016, DOI 10.1016/S0885-3924(03)00330-0; Macindo JRB, 2018, J ADV NURS, V74, P1993, DOI 10.1111/jan.13582; Meredith P, 2006, PAIN, V123, P146, DOI 10.1016/j.pain.2006.02.025; Middleton Carolyn, 2003, Nurs Times, V99, P28; Mokhlesi SS., 2017, J RAFSANJAN U MED SC, V15, P955; Morriss W., 2011, ESSENTIAL PAIN MANAG; Nia HS, 2014, IRAN J PSYCHIATR BEH, V8, P29; Okuyama T, 2004, JPN J CLIN ONCOL, V34, P37, DOI 10.1093/jjco/hyh004; Oshvandi K, 2017, J NURS EDUC, V6, P31; Oslund Sarah, 2009, Proc (Bayl Univ Med Cent), V22, P211; Plichta S. B., 2013, Munro s statistical methods for health care research; Polit D F., 2015, Measurement and the Measurement of Change, V1st; READY LB, 1995, ANESTHESIOLOGY, V82, P1071; Ruben MA, 2015, PATIENT EDUC COUNS, V98, P1197, DOI 10.1016/j.pec.2015.07.009; Sardá J, 2007, STRESS HEALTH, V23, P185, DOI 10.1002/smi.1135; Sharif Nia H., 2015, J MILITARY MED, V17, P145; Sharif Nia H., 2016, Hayat, V22, P229; Shirazi M, 2016, J IRAN SOC ANAESTHES, V32, P43; Song WJ, 2015, PAIN MANAG NURS, V16, P456, DOI 10.1016/j.pmn.2014.09.001; Trail-Mahan T, 2013, PAIN MANAG NURS, V14, P277, DOI 10.1016/j.pmn.2011.06.001; Treede RD, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000643; Twycross A, 2007, INT J NURS STUD, V44, P869, DOI 10.1016/j.ijnurstu.2006.03.010; Vakili MM, 2012, Journal of Hayat, V18, P5; Vincent CV, 2010, J PAIN, V11, P854, DOI 10.1016/j.jpain.2009.12.003; Wells-Federman Carol, 2002, Pain Manag Nurs, V3, P131, DOI 10.1053/jpmn.2002.127178; Wilcox CE, 2015, PAIN MED, V16, P2121, DOI 10.1111/pme.12785; Woby SR, 2007, EUR J PAIN, V11, P711, DOI 10.1016/j.ejpain.2006.10.009	48	2	2	0	5	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-7090			J PAIN RES	J. Pain Res.		2020	13						719	727		10.2147/JPR.S246077	http://dx.doi.org/10.2147/JPR.S246077			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LA9KM	32308471	Green Accepted, Green Published, gold			2024-09-18	WOS:000524259100001
J	Ahirwar, SS; Rizwan, R; Sethi, S; Shahid, Z; Malviya, S; Khandia, R; Agarwal, A; Kotnis, A				Ahirwar, Sonu Singh; Rizwan, Rehma; Sethi, Samdish; Shahid, Zainab; Malviya, Shivani; Khandia, Rekha; Agarwal, Amit; Kotnis, Ashwin			Comparative Analysis of Published Database Predicting MicroRNA Binding in 3′UTR of mRNA in Diverse Species	MICRORNA			English	Review						miRNA; RNA; 3 ' UTR; databases; disease; genes; SNPs; cancer	MANUALLY CURATED DATABASE; TARGET PREDICTION; GENE; RESOURCE; TARBASE; INFORMATION; VARIANTS; CATALOG; MIRDB; SITES	Background Micro-RNAs are endogenous non-coding RNA moieties of 22-27 nucleotides that play a crucial role in the regulation of various biological processes and make them useful prognostic and diagnostic biomarkers. Discovery and experimental validation of miRNA is a laborious and time-consuming process. For early prediction, multiple bioinformatics databases are available for miRNA target prediction; however, their utility can confuse amateur researchers in selecting the most appropriate tools for their study. Objective This descriptive review aimed to analyse the usability of the existing database based on the following criteria: accessibility, efficiency, interpretability, updatability, and flexibility for miRNA target prediction of 3'UTR of mRNA in diverse species so that the researchers can utilize the database most appropriate to their research. Methods A systematic literature search was performed in PubMed, Google Scholar and Scopus databases up to November 2022. >= 10,000 articles found online, including similar to 130 miRNA tools, which contain various information on miRNA. Out of them, 31 databases that provide information on validated 3'UTR miRNAs target databases were included and analysed in this review. Results These miRNA database tools are being used in varied areas of biological research to select the most suitable miRNA for their experimental validation. These databases, updated until the year 2021, consist of miRNA-related data from humans, animals, mice, plants, viruses etc. They contain 525-29806351 data entries, and information from most databases is freely available on the online platform. Conclusion Reviewed databases provide significant information, but not all information is accurate or up-to-date. Therefore, Diana-TarBase and miRWalk are the most comprehensive and up-to-date databases.	[Ahirwar, Sonu Singh; Rizwan, Rehma; Sethi, Samdish; Shahid, Zainab; Kotnis, Ashwin] All India Inst Med Sci Bhopal, Dept Biochem, AIIMS Bhopal, Bhopal, Madhya Pradesh, India; [Agarwal, Amit] All India Inst Med Sci Bhopal, Dept Neurosurg, Bhopal 462020, Madhya Pradesh, India; [Malviya, Shivani; Khandia, Rekha] Barkatullah Univ, Dept Biochem & Genet, Bhopal 462026, Madhya Pradesh, India; [Kotnis, Ashwin] All India Inst Med Sci Bhopal, Dept Biochem, Bhopal 462020, Madhya Pradesh, India	All India Institute of Medical Sciences (AIIMS) Bhopal; All India Institute of Medical Sciences (AIIMS) Bhopal; Barkatullah University; All India Institute of Medical Sciences (AIIMS) Bhopal	Kotnis, A (corresponding author), All India Inst Med Sci Bhopal, Dept Biochem, Bhopal 462020, Madhya Pradesh, India.	ashwin.biochemistry@aiimsbhopal.edu.in	Kotnis, Ashwin/ABH-1746-2022; Ahirwar, Dr Sonu S/ACN-0515-2022	Ahirwar, Dr Sonu S/0000-0003-2914-3665; Kotnis, Ashwin/0000-0002-0995-6266				Akhtar MM, 2016, NUCLEIC ACIDS RES, V44, P24, DOI 10.1093/nar/gkv1221; Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Backes C, 2018, NUCLEIC ACIDS RES, V46, pD160, DOI 10.1093/nar/gkx851; Baras AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143066; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Bhattacharya A, 2013, NUCLEIC ACIDS RES, V41, pD977, DOI 10.1093/nar/gks1138; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chen L, 2019, BRIEF BIOINFORM, V20, P1836, DOI 10.1093/bib/bby054; Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Coronnello C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002830; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Dweep H, 2013, CURR GENOMICS, V14, P127, DOI 10.2174/1389202911314020005; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garcia-Moreno A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091252; Georgakilas G, 2016, NUCLEIC ACIDS RES, V44, pD190, DOI 10.1093/nar/gkv1254; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hua X, 2018, NUCLEIC ACIDS RES, V46, pD168, DOI 10.1093/nar/gkx996; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jin HY, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00328; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriventseva EV, 2008, NUCLEIC ACIDS RES, V36, pD271, DOI 10.1093/nar/gkm845; Laganà A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YJ, 2015, DRUG DEVELOP RES, V76, P389, DOI 10.1002/ddr.21278; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li SC, 2008, NUCLEIC ACIDS RES, V36, pD184, DOI 10.1093/nar/gkm610; Lindow M, 2007, DNA CELL BIOL, V26, P339, DOI 10.1089/dna.2006.0551; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Yin, 2018, BMC Bioinformatics, V19, P275, DOI 10.1186/s12859-018-2287-y; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Maxwell EK, 2015, NUCLEIC ACIDS RES, V43, P3886, DOI 10.1093/nar/gkv256; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Mullany LE, 2015, CANCER INFORM, V14, P121, DOI 10.4137/CIN.S32716; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Ruepp Andreas, 2012, Methods Mol Biol, V822, P249, DOI 10.1007/978-1-61779-427-8_17; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Russo F, 2018, NUCLEIC ACIDS RES, V46, pD354, DOI 10.1093/nar/gkx854; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Sticht C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206239; Thomas LF, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr414; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Vergoulis T, 2015, BIOINFORMATICS, V31, P1502, DOI 10.1093/bioinformatics/btu819; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wilkins OM, 2019, CANCER EPIDEM BIOMAR, V28, P127, DOI 10.1158/1055-9965.EPI-18-0002; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yue M, 2018, NUCLEIC ACIDS RES, V46, pD181, DOI 10.1093/nar/gkx1035; Zhang SH, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-33; Zheng H, 2013, INT J MOL SCI, V14, P8179, DOI 10.3390/ijms14048179; Zorc M, 2015, POULTRY SCI, V94, P2037, DOI 10.3382/ps/pev170	72	0	0	2	2	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	2211-5366	2211-5374		MICRORNA	MicroRNA		2024	13	1					2	13		10.2174/0122115366261005231018070640	http://dx.doi.org/10.2174/0122115366261005231018070640			12	Biochemistry & Molecular Biology	Emerging Sources Citation Index (ESCI)	Biochemistry & Molecular Biology	UA9A9	37929739				2024-09-18	WOS:001245447600003
J	Simone, P; Laura, F; Gianfranco, B; Luciano, M; Giulia, S; Niccoló, T; Pietro, L; Ivan, M; Francesca, C; Marco, B				Simone, Pernice; Laura, Follia; Gianfranco, Balbo; Luciano, Milanesi; Giulia, Sartini; Niccolo, Totis; Pietro, Lio; Ivan, Merelli; Francesca, Cordero; Marco, Beccuti			Integrating Petri Nets and Flux Balance Methods in Computational Biology Models: a Methodological and Computational Practice	FUNDAMENTA INFORMATICAE			English	Article						Computational biology; Petri Nets and Flux Balance Analysis	PARAMETER-ESTIMATION; GENE-EXPRESSION; GROWTH	Computational Biology is a fast-growing field that is enriched by different data-driven methodological approaches and by findings and applications in a broad range of biological areas. Fundamental to these approaches are the mathematical and computational models used to describe the different states at microscopic (for example a biochemical reaction), mesoscopic (the signalling effects at tissue level), and macroscopic levels (physiological and pathological effects) of biological processes. In this paper we address the problem of combining two powerful classes of methodologies: Flux Balance Analysis (FBA) methods which are now producing a revolution in biotechnology and medicine, and Petri Nets (PNs) which allow system generalisation and are central to various mathematical treatments, for example Ordinary Differential Equation (ODE) specification of the biosystem under study. While the former is limited to modelling metabolic networks, i.e. does not account for intermittent dynamical signalling events, the latter is hampered by the need for a large amount of metabolic data. A first result presented in this paper is the identification of three types of cross-talks between PNs and FBA methods and their dependencies on available data. We exemplify our insights with the analysis of a pancreatic cancer model. We discuss how our reasoning framework provides a biologically and mathematically grounded decision making setting for the integration of regulatory, signalling, and metabolic networks and greatly increases model interpretability and reusability. We discuss how the parameters of PN and FBA models can be tuned and combined together so to highlight the computational effort needed to perform this task. We conclude with speculations and suggestions on this new promising research direction.	[Simone, Pernice; Laura, Follia; Gianfranco, Balbo; Francesca, Cordero; Marco, Beccuti] Univ Torino, Dept Comp Sci, Turin, Italy; [Luciano, Milanesi; Ivan, Merelli] CNR, Inst Biomend Technol, Milan, Italy; [Giulia, Sartini; Niccolo, Totis] Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy; [Pietro, Lio] Univ Cambridge, Comp Lab, Cambridge, England	University of Turin; Consiglio Nazionale delle Ricerche (CNR); University of Turin; University of Cambridge	Pietro, L (corresponding author), Univ Cambridge, Comp Lab, Cambridge, England.	pl219@cam.ac.uk	pernice, simone/IXM-9593-2023; P. Lió, Pietro/AAV-3358-2021	Lio, Pietro/0000-0002-0540-5053; pernice, simone/0000-0001-7124-4676				Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Amparore Elvio Gilberto, 2014, Application and Theory of Petri Nets and Concurrency. 35th International Conference, PETRI NETS 2014. Proceedings: LNCS 8489, P354, DOI 10.1007/978-3-319-07734-5_19; Angione C, 2015, SCI REPORTS, P5; Angione C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0912-1; Aster R.C., 2005, PAR EST INV PROBL 3; Beccuti M, 2019, LECT NOTES COMPUT SC, V11339, P626, DOI 10.1007/978-3-030-10549-5_49; Beccuti M, 2015, COMPUT J, V58, P23, DOI 10.1093/comjnl/bxt111; Besozzi D, 2016, LECT NOTES COMPUT SC, V9709, P24, DOI 10.1007/978-3-319-40189-8_3; Cazzaniga P, 2014, METABOLITES, V4, P1034, DOI 10.3390/metabo4041034; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; Colom J, 1989, CONVEX GEOMETRY SEMI, P79, DOI [10.1007/3-540-53863-1_22, DOI 10.1007/3-540-53863-1_22]; Cordero F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S11; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; D Maranas C, 2016, OPTIMIZATION METHODS; Drëger A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-5; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Feller W, 1968, INTRO PROBABILITY TH, V1; Fisher BC, 2013, WHAT YOU THINK ADD/ADHD IS, IT ISN'T: SYMPTOMS AND NEUROPSYCHOLOGICAL TESTING THROUGH TIME, P29; Fogel D.B., 1995, EVOLUTIONARY COMPUTA; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Heirendt L., 2018, NAT PROTOC; Herajy M, 2018, COMPUT BIOL CHEM, V76, P87, DOI 10.1016/j.compbiolchem.2018.05.023; Hill A. V., 1910, J. Physiol, V40, P4, DOI DOI 10.1038/NRN2055; Hofestadt R., 1994, Systems Analysis and Modelling Simulation, V16, P113; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kurtz T. G., 1978, Stochastic Processes & their Applications, V6, P223, DOI 10.1016/0304-4149(78)90020-0; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Marsan M.A., 1995, MODELLING GEN STOCHA; Milanesi L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-I1; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; MOLLOY MK, 1982, IEEE T COMPUT, V31, P913, DOI 10.1109/TC.1982.1676110; Moretto M, 2016, NUCLEIC ACIDS RES, V44, pD620, DOI 10.1093/nar/gkv1251; Mosca E, 2009, NUOVO CIMENTO C, V32, P165, DOI 10.1393/ncc/i2009-10400-2; Nobile MS, 2018, IEEE C EVOL COMPUTAT, P925, DOI 10.1109/CEC.2018.8477873; Nobile MS, 2018, SWARM EVOL COMPUT, V39, P70, DOI 10.1016/j.swevo.2017.09.001; Nobile MS, 2017, BRIEF BIOINFORM, V18, P870, DOI 10.1093/bib/bbw058; O Voit E., 2000, COMPUTATIONAL ANAL B; Palsson B.O., 2011, Systems Biology: Simulation of Dynamic Network States; Peterson L, 1981, NET THEORY MODELING; Puchalka J, 2004, BIOPHYS J, V86, P1357, DOI 10.1016/S0006-3495(04)74207-1; Reddy V N, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P328; Roy M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00217; Runarsson TP, 2000, IEEE T EVOLUT COMPUT, V4, P284, DOI 10.1109/4235.873238; Silva M., 1992, RECENT ADV MATH THEO, VII, P35; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stelling J., 2004, OPINION MICROBIOLOGY, V7; Totis Niccolo, 2017, ACM SIGMETRICS Performance Evaluation Review, V44, P91, DOI 10.1145/3092819.3092830; Vijayakumar S, 2017, METHOD MOL BIOL, P389, DOI [10.1007/978-1-4939-7528-018, DOI 10.1007/978-1-4939-7528-018]; Vijayakumar S, 2018, OPTIMIZATION MULTIOM, P389; Vijayakumar S, 2018, BRIEF BIOINFORM, V19, P1218, DOI 10.1093/bib/bbx053; Yang L, 2019, BMC SYST BIOL, V13, DOI 10.1186/s12918-018-0675-6	55	3	3	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0169-2968	1875-8681		FUND INFORM	Fundam. Inform.		2020	171	1-4			SI		367	392		10.3233/FI-2020-1888	http://dx.doi.org/10.3233/FI-2020-1888			26	Computer Science, Software Engineering; Mathematics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematics	KF7IR					2024-09-18	WOS:000509413400021
J	Speck-Planche, A				Speck-Planche, Alejandro			Combining Ensemble Learning with a Fragment-Based Topological Approach To Generate New Molecular Diversity in Drug Discovery: In Silico Design of Hsp90 Inhibitors	ACS OMEGA			English	Article							QUADRATIC FINGERPRINTS; PREDICTION; MODEL; QSAR; POTENT; ATOM; PERMEABILITY; MACHINE; INDEXES; CANCER	Machine learning methods have revolutionized modern science, providing fast and accurate solutions to multiple problems. However, they are commonly treated as "black boxes". Therefore, in important scientific fields such as medicinal chemistry and drug discovery, machine learning methods are restricted almost exclusively to the task of performing predictions of large and heterogeneous data sets of chemicals. The lack of interpretability prevents the full exploitation of the machine learning models as generators of new chemical knowledge. This work focuses on the development of an ensemble learning model for the prediction and design of potent dual heat shock protein 90 (Hsp90) inhibitors. The model displays accuracy higher than 80% in both training and test sets. To use the ensemble model as a generator of new chemical knowledge, three steps were followed. First, a physicochemical and/or structural interpretation was provided for each molecular descriptor present in the ensemble learning model. Second, the term "pseudolinear equation" was introduced within the context of machine learning to calculate the relative quantitative contributions of different molecular fragments to the inhibitory activity against the two Hsp90 isoforms studied here. Finally, by assembling the fragments with positive contributions, new molecules were designed, being predicted as potent Hsp90 inhibitors. According to Lipinski's rule of five, the designed molecules were found to exhibit potentially good oral bioavailability, a primordial property that chemicals must have to pass early stages in drug discovery. The present approach based on the combination of ensemble learning and fragment-based topological design holds great promise in drug discovery, and it can be adapted and applied to many different scientific disciplines.	[Speck-Planche, Alejandro] Hosp del Mar, Res Program Biomed Informat GRIB, Med Res Inst IMIM, Barcelona 08003, Spain	Hospital del Mar Research Institute; Hospital del Mar	Speck-Planche, A (corresponding author), Hosp del Mar, Res Program Biomed Informat GRIB, Med Res Inst IMIM, Barcelona 08003, Spain.	alejspivanovich@yahoo.es	Speck-Planche, Alejandro/D-6805-2014	Speck-Planche, Alejandro/0000-0002-9544-9016	Spanish Juan de la Cierva program [FJCI-2015-25572]	Spanish Juan de la Cierva program(Spanish Government)	A.S.-P. acknowledges the Spanish Juan de la Cierva program (Grant: FJCI-2015-25572) for the financial support.	Alonso N, 2013, ACS CHEM NEUROSCI, V4, P1393, DOI 10.1021/cn400111n; Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; [Anonymous], 1895, P R SOC LOND; BASKIN II, 1995, J CHEM INF COMP SCI, V35, P527, DOI 10.1021/ci00025a021; Bediaga H, 2018, ACS COMB SCI, V20, P621, DOI 10.1021/acscombsci.8b00090; Blay V, 2018, J CHEM INF MODEL, V58, P2414, DOI 10.1021/acs.jcim.8b00383; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Casañola-Martin GM, 2010, CHEM BIOL DRUG DES, V76, P538, DOI 10.1111/j.1747-0285.2010.01032.x; Casañola-Martín GM, 2008, J BIOMOL SCREEN, V13, P1014, DOI 10.1177/1087057108326078; Ezzat A, 2017, METHODS, V129, P81, DOI 10.1016/j.ymeth.2017.05.016; Ferreira da Costa Joana, 2018, ACS Chem Neurosci, V9, P2572, DOI 10.1021/acschemneuro.8b00083; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gómez-Bombarelli R, 2018, ACS CENTRAL SCI, V4, P268, DOI 10.1021/acscentsci.7b00572; González-Díaz H, 2014, J CHEM INF MODEL, V54, P744, DOI 10.1021/ci400716y; González-Díaz H, 2013, CURR TOP MED CHEM, V13, P1713; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kadurin A, 2017, MOL PHARMACEUT, V14, P3098, DOI 10.1021/acs.molpharmaceut.7b00346; Kaneko H, 2018, J CHEM INF MODEL, V58, P480, DOI 10.1021/acs.jcim.7b00649; Kleandrova VV, 2016, ACS COMB SCI, V18, P490, DOI 10.1021/acscombsci.6b00063; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; Lee K, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1960-x; Lei TL, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0117-7; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lo YC, 2018, DRUG DISCOV TODAY, V23, P1538, DOI 10.1016/j.drudis.2018.05.010; Marrero-Ponce Y, 2005, BIOORGAN MED CHEM, V13, P2881, DOI 10.1016/j.bmc.2005.02.015; Marrero-Ponce Y, 2011, EUR J MED CHEM, V46, P5736, DOI 10.1016/j.ejmech.2011.07.053; Martínez-Arzate SG, 2017, J PROTEOME RES, V16, P4093, DOI 10.1021/acs.jproteome.7b00477; Marzaro G, 2011, EUR J MED CHEM, V46, P2185, DOI 10.1016/j.ejmech.2011.02.072; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Marrero RM, 2015, SAR QSAR ENVIRON RES, V26, P943, DOI 10.1080/1062936X.2015.1104517; Moon H, 2007, ARTIF INTELL MED, V41, P197, DOI 10.1016/j.artmed.2007.07.003; Ponce YM, 2003, INT J MOL SCI, V4, P512, DOI 10.3390/i4080512; Prado-Prado FJ, 2010, BIOORGAN MED CHEM, V18, P2225, DOI 10.1016/j.bmc.2010.01.068; Putin E, 2018, J CHEM INF MODEL, V58, P1194, DOI 10.1021/acs.jcim.7b00690; Robinson RLM, 2017, J CHEM INF MODEL, V57, P1773, DOI 10.1021/acs.jcim.6b00753; Romero-Durán FJ, 2016, NEUROPHARMACOLOGY, V103, P270, DOI 10.1016/j.neuropharm.2015.12.019; Sahigara F, 2012, MOLECULES, V17, P4791, DOI 10.3390/molecules17054791; Segler MHS, 2018, ACS CENTRAL SCI, V4, P120, DOI 10.1021/acscentsci.7b00512; Simón-Vidal L, 2018, J CHEM INF MODEL, V58, P1384, DOI 10.1021/acs.jcim.8b00286; Speck-Planche A, 2017, MED CHEM RES, V26, P2345, DOI 10.1007/s00044-017-1936-4; Speck-Planche A, 2017, ACS COMB SCI, V19, P501, DOI 10.1021/acscombsci.7b00039; Speck-Planche A, 2017, MOL DIVERS, V21, P511, DOI 10.1007/s11030-017-9731-1; Speck-Planche A, 2015, CURR TOP MED CHEM, V15, P1801, DOI 10.2174/1568026615666150506144814; Speck-Planche A, 2014, FUTURE MED CHEM, V6, P2013, DOI [10.4155/FMC.14.136, 10.4155/fmc.14.136]; Speck-Planche A, 2014, ACS COMB SCI, V16, P78, DOI 10.1021/co400115s; Speck-Planche A, 2012, CURR TOP MED CHEM, V12, P1734; Speck-Planche A, 2012, CHEMOMETR INTELL LAB, V111, P39, DOI 10.1016/j.chemolab.2011.11.010; Tenorio-Borroto E, 2014, EUR J MED CHEM, V72, P206, DOI 10.1016/j.ejmech.2013.08.035; Todeschini R., 2009, MOL DESCRIPTORS CHEM; Valdés-Martini JR, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0211-5; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Zabinsky RA, 2019, SEMIN CELL DEV BIOL, V88, P21, DOI 10.1016/j.semcdb.2018.05.015; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02365-0; Zhang L, 2017, DRUG DISCOV TODAY, V22, P1680, DOI 10.1016/j.drudis.2017.08.010	54	27	27	3	16	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	NOV	2018	3	11					14704	14716		10.1021/acsomega.8b02419	http://dx.doi.org/10.1021/acsomega.8b02419			13	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	HC7PB	30555986	gold, Green Published			2024-09-18	WOS:000451992500018
J	Zou, M; Zhang, PJ; Wen, XY; Chen, LN; Tian, YP; Wang, Y				Zou, Meng; Zhang, Peng-Jun; Wen, Xin-Yu; Chen, Luonan; Tian, Ya-Ping; Wang, Yong			A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors	METHODS			English	Article						Translational bioinformatics; Multi-biomarker; Colorectal cancer; Mixed integer programming	ISCHEMIA MODIFIED ALBUMIN; FECAL OCCULT-BLOOD; GENE-EXPRESSION; EUROPEAN GROUP; CANCER; DISEASE; MARKERS; SERUM; RISK; INTERLEUKIN-10	Multi-biomarker panels can capture the nonlinear synergy among biomarkers and they are important to aid in the early diagnosis and ultimately battle complex diseases. However, identification of these multi-biomarker panels from case and control data is challenging. For example, the exhaustive search method is computationally infeasible when the data dimension is high. Here, we propose a novel method, MILP_k, to identify serum-based multi-biomarker panel to distinguish colorectal cancers (CRC) from benign colorectal tumors. Specifically, the multi-biomarker panel detection problem is modeled by a mixed integer programming to maximize the classification accuracy. Then we measured the serum profiling data for 101 CRC patients and 95 benign patients. The 61 biomarkers were analyzed individually and further their combinations by our method. We discovered 4 biomarkers as the optimal small multi-biomarker panel, including known CRC biomarkers CEA and IL-10 as well as novel biomarkers IMA and NSE. This multi-biomarker panel obtains leave-one-out cross-validation (LOOCV) accuracy to 0.7857 by nearest centroid classifier. An independent test of this panel by support vector machine (SVM) with threefold cross validation gets an AUC 0.8438. This greatly improves the predictive accuracy by 20% over the single best biomarker. Further extension of this 4-biomarker panel to a larger 13-biomarker panel improves the LOOCV to 0.8673 with independent AUC 0.8437. Comparison with the exhaustive search method shows that our method dramatically reduces the searching time by 1000-fold. Experiments on the early cancer stage samples reveal two panel of biomarkers and show promising accuracy. The proposed method allows us to select the subset of biomarkers with best accuracy to distinguish case and control samples given the number of selected biomarkers. Both receiver operating characteristic curve and precision-recall curve show our method's consistent performance gain in accuracy. Our method also shows its advantage in capturing synergy among selected biomarkers. The multi-biomarker panel far outperforms the simple combination of best single features. Close investigation of the multi-biomarker panel illustrates that our method possesses the ability to remove redundancy and reveals complementary biomarker combinations. In addition, our method is efficient and can select multi-biomarker panel with more than 5 biomarkers, for which the exhaustive methods fail. In conclusion, we propose a promising model to improve the clinical data interpretability and to serve as a useful tool for other complex disease studies. Our small multi-biomarker panel, CEA, IL-10, IMA, and NSE, may provide insights on the disease status of colorectal diseases. The implementation of our method in MATLAB is available via the website: http://doc.aporc.org/wiki/MILP_k. (C) 2015 Elsevier Inc. All rights reserved.	[Zou, Meng; Wang, Yong] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing 100080, Peoples R China; [Zhang, Peng-Jun; Wen, Xin-Yu; Tian, Ya-Ping] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, State Key Lab Kidney Dis, Beijing 100853, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol,Innovat Ctr Cell Signaling Netw, Shanghai 200233, Peoples R China; [Chen, Luonan] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Center for Excellence in Molecular Cell Science, CAS; ShanghaiTech University	Chen, LN (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200233, Peoples R China.	zoumeng@amss.ac.cn; zhangpj301@gmail.com; wendy36500@163.com; lnchen@sibs.ac.cn; tianyp61@gmail.com; ywang@amss.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13040700]; National Natural Science Foundation of China (NSFC) [11422108, 11131009, 61171007]; NSFC [61134013, 91439103, 81071413]; Knowledge Innovation Program of the Chinese Academy of Sciences (CAS) [KSCX2-EW-R-01]; National High Technology Research and Development Program 863 [2011AA02A111]; National Science and Technology Infrastructure [2009BAI86B05]; China Postdoctoral Science Foundation [2013M532110]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences (CAS)(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Science and Technology Infrastructure; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB13040700). MZ and YW are supported by The National Natural Science Foundation of China (NSFC) under Grants nos. 11422108, 11131009 and 61171007. LNC is supported by NSFC under Grants nos. 61134013 and 91439103, and by the Knowledge Innovation Program of the Chinese Academy of Sciences (CAS) (KSCX2-EW-R-01). PJZ, XYW, and YPT are supported by the National High Technology Research and Development Program 863 (2011AA02A111), National Science and Technology Infrastructure (2009BAI86B05) and NSFC (81071413). PJZ is also supported by China Postdoctoral Science Foundation funded project (2013M532110). The author thanks the editor and reviewers for their suggestions to improve the manuscript.	Alas S, 2001, CLIN CANCER RES, V7, P709; Amaldi E, 1998, THEOR COMPUT SCI, V209, P237, DOI 10.1016/S0304-3975(97)00115-1; American Cancer Society, 2013, COL CANC EARL DET; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; BARON JA, 1994, MED DECIS MAKING, V14, P107, DOI 10.1177/0272989X9401400202; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; BOYKO EJ, 1994, MED DECIS MAKING, V14, P175, DOI 10.1177/0272989X9401400210; Brynskov J, 2002, GUT, V51, P37, DOI 10.1136/gut.51.1.37; Charikar M, 2000, ANN IEEE SYMP FOUND, P631; Chen L., 2012, Microwave and Millimeter Wave Technology (ICMMT), 2012 International Conference on, V2, P1; Chen L., 2010, Modelling Biomolecular Networks in Cells: Structures and Dynamics; Chen L., 2009, BIOMOLECULAR NETWORK, V10, DOI DOI 10.1002/9780470488065; Copur S, 2001, Clin Colorectal Cancer, V1, P55, DOI 10.3816/CCC.2001.n.006; Csiszár A, 2004, PATHOL ONCOL RES, V10, P109, DOI 10.1007/BF02893465; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Duffy MJ, 2003, EUR J CANCER, V39, P718, DOI 10.1016/S0959-8049(02)00811-0; Famulski W, 2001, FOLIA HISTOCHEM CYTO, V39, P155; García-Bilbao A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-43; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Guyon I., 2003, J MACH LEARN RES, V3, P1157; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; He DN, 2012, J MOL CELL BIOL, V4, P140, DOI 10.1093/jmcb/mjs011; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Jessup JM, 2004, INT J CANCER, V111, P332, DOI 10.1002/ijc.20264; Kohrman AQ, 2015, MOL BIOL CELL, V26; LAWLER EL, 1966, OPER RES, V14, P699, DOI 10.1287/opre.14.4.699; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Li M, 2013, BRIEF BIOINFORM, DOI 10.1093/bib/bbt027; Liang Zhen-tao, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P863; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Lippi G, 2007, CANCER TREAT REV, V33, P427, DOI 10.1016/j.ctrv.2007.02.006; Liu R., 2013, MED RES REV; Liu R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00813; Liu XP, 2012, J AM MED INFORM ASSN, V19, P241, DOI 10.1136/amiajnl-2011-000658; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Masaeli Mahdokht, 2010, P 2010 SIAM INT C DA, P619, DOI [10.1137/1.9781611972801, DOI 10.1137/1.9781611972801]; Mathurin P, 1998, HEPATOLOGY, V27, P868, DOI 10.1002/hep.510270333; Merika E, 2010, IN VIVO, V24, P607; Newton KF, 2012, COLORECTAL DIS, V14, P3, DOI 10.1111/j.1463-1318.2010.02439.x; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Ouyang DL, 2005, AM J GASTROENTEROL, V100, P1393, DOI 10.1111/j.1572-0241.2005.41427.x; Pewsner D, 2004, BMJ-BRIT MED J, V329, P209, DOI 10.1136/bmj.329.7459.209; Qin GM, 2014, J THEOR BIOL, V362, P9, DOI 10.1016/j.jtbi.2014.06.007; Ren XW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1288; Sbarouni E, 2008, HELL J CARDIOL, V49, P260; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SEGAL HL, 1963, P NATL ACAD SCI USA, V50, P912, DOI 10.1073/pnas.50.5.912; Siegel RL., 2020, ANTI-CANCER DRUG, V70, P7, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]; Sinha MK, 2004, EMERG MED J, V21, P29, DOI 10.1136/emj.2003.006007; Smolders B, 2007, STROKE, V38, P1959, DOI 10.1161/STROKEAHA.106.480657; Song W, 2012, J MOL CELL BIOL, V4, P197, DOI 10.1093/jmcb/mjs029; Srivastava S, 2001, CLIN CANCER RES, V7, P1118; Sun SY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02268; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Tanaka T, 2010, INT J MOL SCI, V11, P3209, DOI 10.3390/ijms11093209; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang Y, 2012, NANO, V7, DOI 10.1142/S1793292012500427; Wen ZS, 2013, J AM MED INFORM ASSN, V20, P659, DOI 10.1136/amiajnl-2012-001168; Wild N, 2010, CLIN CANCER RES, V16, P6111, DOI 10.1158/1078-0432.CCR-10-0119; Yu H, 2013, J KOREAN SURG SOC, V84, P231, DOI 10.4174/jkss.2013.84.4.231; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zhang PJ, 2013, FUTURE ONCOL, V9, P1017, DOI [10.2217/fon.13.71, 10.2217/FON.13.71]; Zhang W., 2014, J THEOR BIOL; Zins K, 2007, CANCER RES, V67, P1038, DOI 10.1158/0008-5472.CAN-06-2295	69	19	19	1	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	JUL 15	2015	83						3	17		10.1016/j.ymeth.2015.05.011	http://dx.doi.org/10.1016/j.ymeth.2015.05.011			15	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9GK	25980368				2024-09-18	WOS:000358755100002
J	Wani, NA; Kumar, R; Mamta; Bedi, J; Rida, I				Wani, Niyaz Ahmad; Kumar, Ravinder; Mamta; Bedi, Jatin; Rida, Imad			Explainable AI-driven IoMT fusion: Unravelling techniques, opportunities, and challenges with Explainable AI in healthcare	INFORMATION FUSION			English	Article						Artificial Intelligence; Healthcare; Deep learning; Internet of Things (IoT); Internet of Medical Things (IoMT); Explainable Artificial Intelligence (XAI); Interpretability; Explainability	ARTIFICIAL-INTELLIGENCE MODEL; ACTIVITY RECOGNITION; PHYSICAL-ACTIVITY; NEURAL-NETWORKS; BREAST-CANCER; INDUSTRY 4.0; BLACK-BOX; INTERNET; CLASSIFICATION; THINGS	Background and Objective: Artificial Intelligence (AI) has shown significant advancements across several industries, including healthcare, using better fusion methodologies, improved data accessibility, and heightened processing capabilities. Although deep learning algorithms excel in challenging scenarios, their widespread adoption presents a challenge due to their need for more transparency. The advent of Explainable AI (XAI) has addressed this limitation by offering AI -driven systems with attributes such as transparency, interpretability, and reliability. The need for transparency in critical sectors like healthcare has prompted an increased academic focus on investigating and understanding these frameworks. The present paper thoroughly examines the latest research and advancements in Explainable Artificial Intelligence (XAI), specifically focusing on its integration into the Internet of Medical Things (IoMT) in healthcare settings. The last section tackles outstanding issues concerning XAI and IoMT and outlines prospective directions for further research. Methods: A thorough investigation was carried out across many scholarly databases and online digital libraries, such as IEEE Xplore, ACM Digital Library, Wiley Interscience, Taylor and Francis, ScienceDirect, Scopus, Springer, Google Scholar, Citeseer Library, Semantic Scholar, and other relevant sources. An analysis was conducted on articles published from March 2004 to February 2024, specifically focusing on AI models that explain different healthcare issues. The search query included "Explainable AI"in conjunction with "Open Black Box, Healthcare, Transparent Models, Interpretable Deep Learning, Machine Learning, Medical Information System, Accountability, Smart Healthcare, and Responsible AI", indicating the field's dynamic nature. The authors also examined various techniques and datasets to elucidate healthcare difficulties, including incorporating the Internet of Medical Things (IoMT). Results: The evaluation included more than 105 published models that used clinical data input to diagnose diverse disorders, focusing on incorporating Internet of Medical Things (IoMT) components. In addition to illness diagnosis, these models also elucidate the decisions made. The models were classified according to the input data, used methodologies, and integration of the Internet of Medical Things (IoMT). The categorization included machine learning and deep learning methodologies, particularly on explainability models connected to the Internet of Medical Things (IoMT). These models were classified as model -agnostic, model -specific, global, local, ante -hoc, and post -hoc. Conclusion: This extensive study examines machine learning, and deep learning models developed based on clinical data and associated with the Internet of Medical Things (IoMT) for illness detection. These models improve efficiency and accuracy and provide essential assistance to medical personnel. Explaining each choice made by individuals contributes to the acceleration of sickness detection, resulting in decreased medical expenses for patients and healthcare systems. The integration of Explainable Artificial Intelligence (XAI) and the Internet of Medical Things (IoMT) highlights a fundamental change in healthcare towards more transparent and linked systems, leading to significant breakthroughs in medical decision -making.	[Wani, Niyaz Ahmad; Kumar, Ravinder; Bedi, Jatin] Thapar Inst Engn & Technol, Comp Sci & Engn Dept, Patiala, India; [Mamta] Punjab Engn Coll, Comp Sci & Engn Dept, Chandigarh, India; [Rida, Imad] Univ Technol Compiegne, Ctr Rech Royallieu, Lab Biomecan & Bioingn, UMR 7338, Compiegne, France	Thapar Institute of Engineering & Technology; Punjab Engineering College (Deemed University); Centre National de la Recherche Scientifique (CNRS); Universite de Technologie de Compiegne; CNRS - Institute for Engineering & Systems Sciences (INSIS)	Bedi, J (corresponding author), Thapar Inst Engn & Technol, Comp Sci & Engn Dept, Patiala, India.	neyaz32@gmail.com; ravinder@thapar.edu; mamtadabra@pec.edu.in; jatin.bedi@thapar.edu; imad.rida@utc.fr	Rida, Imad/AAA-5044-2022; Wani, Niyaz/ABI-4499-2022	Wani, Niyaz/0000-0002-7656-3374; RIDA, Imad/0000-0003-2789-5070				Abbasi-Asl R, 2020, Arxiv, DOI arXiv:1705.07356; Abdar M, 2023, INFORM FUSION, V90, P364, DOI 10.1016/j.inffus.2022.09.023; Abdulhay E, 2023, FRONT HUM NEUROSCI, V17, DOI 10.3389/fnhum.2023.1287959; Adadi A., 2020, EMBEDDED SYSTEMS ART, V1076, P327, DOI DOI 10.1007/978-981-15-0947-6_31; Adadi A, 2018, IEEE ACCESS, V6, P52138, DOI 10.1109/ACCESS.2018.2870052; Agarwal Rishabh, 2021, Advances in Neural Information Processing Systems, V34; Al-Timemy AH, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13101689; Al-Timemy AH, 2022, COGN COMPUT, V14, P1627, DOI 10.1007/s12559-021-09880-3; Al-Turjman F, 2020, COMPUT COMMUN, V150, P644, DOI 10.1016/j.comcom.2019.12.030; Alammar Z, 2023, CANCERS, V15, DOI 10.3390/cancers15154007; Alanazi T, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12123060; Albahri AS, 2024, INT J INF TECH DECIS, DOI 10.1142/S0219622024500019; Albahri AS, 2023, INFORM FUSION, V96, P156, DOI 10.1016/j.inffus.2023.03.008; Alonso JM, 2020, IEEE INT CONF FUZZY, DOI 10.1109/fuzz48607.2020.9177770; Alonso JM, 2020, IEEE INT CONF FUZZY, DOI 10.1109/fuzz48607.2020.9177725; Alshehri F, 2023, IMAGE VISION COMPUT, V140, DOI 10.1016/j.imavis.2023.104865; Alzubaidi L, 2024, PLOS ONE, V19, DOI 10.1371/journal.pone.0299545; Alzubaidi L, 2023, IEEE ENG MED BIO, DOI 10.1109/EMBC40787.2023.10340309; Alzubaidi L, 2023, INT J INTELL SYST, V2023, DOI 10.1155/2023/4459198; Alzubaidi L, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00444-8; Amoroso N, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11114881; Amparore E, 2021, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.479; Nguyen A, 2016, ADV NEUR IN, V29; [Anonymous], 2014, Int. J. DataMiningKnowl. Manage. Process.; [Anonymous], 2017, Duke L. Tech. Rev.; Antoniadi AM, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11115088; Anysz H, 2020, MATERIALS, V13, DOI 10.3390/ma13102317; Arras L., 2017, ARXIV; Arya G., 2023, IEEE Access; Aslam N, 2022, SUSTAINABILITY-BASEL, V14, DOI 10.3390/su14127375; Assaf R, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P6488; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baehrens D, 2010, J MACH LEARN RES, V11, P1803; Balagurunathan Y, 2021, PHYS MEDICA, V83, P72, DOI 10.1016/j.ejmp.2021.02.024; Barclay I, 2021, UBICOMP/ISWC '21 ADJUNCT: PROCEEDINGS OF THE 2021 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING AND PROCEEDINGS OF THE 2021 ACM INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, P264, DOI 10.1145/3460418.3479344; Bardhan I, 2015, INFORM SYST RES, V26, P19, DOI 10.1287/isre.2014.0553; Arrieta AB, 2020, INFORM FUSION, V58, P82, DOI 10.1016/j.inffus.2019.12.012; Bastani O, 2019, Arxiv, DOI arXiv:1705.08504; Berk RA, 2013, CRIMINOL PUBLIC POL, V12, P513, DOI 10.1111/1745-9133.12047; Biswas R, 2020, KUNSTL INTELL, V34, P571, DOI 10.1007/s13218-020-00679-2; Blendowski M, 2019, PR MACH LEARN RES, V102, P73; Bloniarz A, 2016, JMLR WORKSH CONF PRO, V51, P1450; Bonanno D, 2017, PROC SPIE, V10207, DOI 10.1117/12.2268001; Bonidia RP, 2020, IEEE ACCESS, V8, P181683, DOI 10.1109/ACCESS.2020.3028039; Brereton P, 2007, J SYST SOFTWARE, V80, P571, DOI 10.1016/j.jss.2006.07.009; Callegari C, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11104697; Carletti M, 2019, IEEE SYS MAN CYBERN, P21, DOI 10.1109/SMC.2019.8913901; Carrington AM, 2023, IEEE T PATTERN ANAL, V45, P329, DOI 10.1109/TPAMI.2022.3145392; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Chamola V, 2023, IEEE ACCESS, V11, P78994, DOI 10.1109/ACCESS.2023.3294569; Chandrasekaran J, 2021, IEEE ICST WORKSHOP, P35, DOI 10.1109/ICSTW52544.2021.00019; Chang YW, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.542394; Chattopadhay A, 2018, IEEE WINT CONF APPL, P839, DOI 10.1109/WACV.2018.00097; Chen HY, 2020, IEEE ACCESS, V8, P134246, DOI 10.1109/ACCESS.2020.3006491; Chen J, 2020, 58TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2020), P3143; Chen JH, 2020, Arxiv, DOI arXiv:2001.02767; Chen M, 2018, IEEE WIREL COMMUN, V25, P70, DOI 10.1109/MWC.2018.1700216; Chen YF, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6a23; Chittajallu DR, 2019, I S BIOMED IMAGING, P66, DOI [10.1109/isbi.2019.8759428, 10.1109/ISBI.2019.8759428]; Cho J, 2019, IEEE INT CONF BIG DA, P4817, DOI 10.1109/BigData47090.2019.9006592; Chong YW, 2019, IEEE SENS J, V19, P9047, DOI 10.1109/JSEN.2019.2925638; Chou YL, 2022, INFORM FUSION, V81, P59, DOI 10.1016/j.inffus.2021.11.003; Collins JW, 2022, EUR UROL FOCUS, V8, P613, DOI 10.1016/j.euf.2021.04.006; Cortez P., 2011, Proceedings 2011 IEEE Symposium on Computational Intelligence and Data Mining (CIDM 2011), P341, DOI 10.1109/CIDM.2011.5949423; Das A., 2020, arXiv, DOI DOI 10.48550/ARXIV.2006.11371; Dave D, 2020, Arxiv, DOI arXiv:2011.03195; De T, 2020, PROCEDIA COMPUT SCI, V168, P40, DOI 10.1016/j.procs.2020.02.255; Delacroix S, 2021, COMPUT LAW SECUR REV, V40, DOI 10.1016/j.clsr.2020.105520; Dindorf C, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21186323; Doshi-Velez F, 2017, Arxiv, DOI arXiv:1702.08608; Dujmovic J, 2020, IEEE INT CONF FUZZY, DOI 10.1109/fuzz48607.2020.9177578; Dunjko V, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aab406; Eisenstadt V, 2018, LECT NOTES ARTIF INT, V11156, P78, DOI 10.1007/978-3-030-01081-2_6; El-Sappagh S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82098-3; Elhoseny M, 2018, IEEE ACCESS, V6, P20596, DOI 10.1109/ACCESS.2018.2817615; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Emaminejad N, 2022, AUTOMAT CONSTR, V139, DOI 10.1016/j.autcon.2022.104298; Fadhel MA, 2024, INFORM FUSION, V107, DOI 10.1016/j.inffus.2024.102317; Fallahpoor M, 2024, COMPUT METH PROG BIO, V243, DOI 10.1016/j.cmpb.2023.107880; Féraud R, 2002, NEURAL NETWORKS, V15, P237, DOI 10.1016/S0893-6080(01)00127-7; Fernández RR, 2020, INFORM FUSION, V63, P196, DOI 10.1016/j.inffus.2020.07.001; Ferreyra E., 2019, 2019 IEEE INT C FUZZ, P1; Fisher A, 2019, J MACH LEARN RES, V20; Guiñazú MF, 2020, INFORM FUSION, V55, P150, DOI 10.1016/j.inffus.2019.08.006; Galhotra S, 2021, INT CONF MANAGE DATA, P577, DOI 10.1145/3448016.3458455; Gandolfi M, 2023, IEEE J BIOMED HEALTH, V27, P263, DOI 10.1109/JBHI.2022.3220179; Ghafouri-Fard S, 2019, J MOL NEUROSCI, V68, P515, DOI 10.1007/s12031-019-01311-1; Gibbons RD, 2013, J CLIN PSYCHIAT, V74, P669, DOI 10.4088/JCP.12m08338; Gilpin LH, 2018, PR INT CONF DATA SC, P80, DOI 10.1109/DSAA.2018.00018; Giuste F, 2023, IEEE REV BIOMED ENG, V16, P5, DOI 10.1109/RBME.2022.3185953; González-Gonzalo C, 2022, PROG RETIN EYE RES, V90, DOI 10.1016/j.preteyeres.2021.101034; Goyal Y, 2020, Arxiv, DOI arXiv:1907.07165; Graziani M, 2020, COMPUT BIOL MED, V123, DOI 10.1016/j.compbiomed.2020.103865; Green D.P., 2010, ANN SUMMER M SOC POL, P100; Gu DH, 2020, IEEE T MULTIMEDIA, V22, P1720, DOI 10.1109/TMM.2020.2971170; Guidotti R, 2018, Arxiv, DOI arXiv:1805.10820; Guidotti R, 2019, IEEE INTELL SYST, V34, P14, DOI 10.1109/MIS.2019.2957223; Gulum M.A., 2020, Heterogeneous Data Management, Polystores, and Analytics for Healthcare, P120; Gunning D, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aay7120; Gunning D, 2019, AI MAG, V40, P44, DOI 10.1609/aimag.v40i2.2850; Hamon R, 2022, IEEE COMPUT INTELL M, V17, P72, DOI 10.1109/MCI.2021.3129960; Han M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19163607; Han S, 2015, ADV NEUR IN, V28; Haspiel J, 2018, ACMIEEE INT CONF HUM, P119, DOI 10.1145/3173386.3177057; Hassan MR, 2022, FUTURE GENER COMP SY, V127, P462, DOI 10.1016/j.future.2021.09.030; Hassan SI, 2021, IEEE ACCESS, V9, P32517, DOI 10.1109/ACCESS.2021.3057865; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hendricks LA, 2016, LECT NOTES COMPUT SC, V9908, P3, DOI 10.1007/978-3-319-46493-0_1; Hicks SA, 2018, PROCEEDINGS OF THE 9TH ACM MULTIMEDIA SYSTEMS CONFERENCE (MMSYS'18), P369, DOI 10.1145/3204949.3208129; Ho CWL, 2021, SEMIN NEPHROL, V41, P282, DOI 10.1016/j.semnephrol.2021.05.009; Holzinger A, 2017, Arxiv, DOI arXiv:1712.09923; Holzinger A, 2022, INFORM FUSION, V79, P263, DOI 10.1016/j.inffus.2021.10.007; Holzinger A, 2021, INFORM FUSION, V71, P28, DOI 10.1016/j.inffus.2021.01.008; Holzinger A, 2019, WIRES DATA MIN KNOWL, V9, DOI 10.1002/widm.1312; Hossain S, 2024, IEEE J BIOMED HEALTH, V28, P1261, DOI 10.1109/JBHI.2023.3266614; Howard A, 2017, IEEE WORK ADV ROBOT; Howell C., 2018, P FAT C, P1; Hu JY, 2020, IEEE T VEH TECHNOL, V69, P14413, DOI 10.1109/TVT.2020.3034800; Huang LC, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03842-6; Hussain F, 2021, Arxiv, DOI [arXiv:2101.03613, 10.48550/arXiv.2101.03613, DOI 10.48550/ARXIV.2101.03613]; Islam MM, 2023, INFORM FUSION, V94, P17, DOI 10.1016/j.inffus.2023.01.015; Islam SMR, 2015, IEEE ACCESS, V3, P678, DOI 10.1109/ACCESS.2015.2437951; Itani S, 2020, APPL SOFT COMPUT, V91, DOI 10.1016/j.asoc.2020.106250; Thiagarajan JJ, 2016, Arxiv, DOI arXiv:1611.07429; Jansen C, 2019, CHAOS, V29, DOI 10.1063/1.5128003; Jing YK, 2018, AAPS J, V20, DOI 10.1208/s12248-018-0210-0; Katuwal GJ, 2016, Arxiv, DOI [arXiv:1610.09045, DOI 10.48550/ARXIV.1610.09045]; Jung MK, 2023, IEEE J BIOMED HEALTH, V27, P1903, DOI 10.1109/JBHI.2023.3240460; Kakhi K, 2022, BIOCYBERN BIOMED ENG, V42, P749, DOI 10.1016/j.bbe.2022.05.008; Kavya R, 2021, BIOMED SIGNAL PROCES, V69, DOI 10.1016/j.bspc.2021.102681; Kazemitabar SJ, 2017, ADV NEUR IN, V30; Keele S., 2007, Technical report; Keneni BM, 2019, IEEE ACCESS, V7, P17001, DOI 10.1109/ACCESS.2019.2893141; Kerasidou Angeliki, 2021, J Oral Biol Craniofac Res, V11, P612, DOI 10.1016/j.jobcr.2021.09.004; Khan MA, 2023, SUSTAINABILITY-BASEL, V15, DOI 10.3390/su15108120; Khedkar S., 2019, HEALTHCARE APRIL 8 2; Kim KG, 2016, HEALTHC INFORM RES, V22, P351, DOI 10.4258/hir.2016.22.4.351; Kitchenham B, 2009, INFORM SOFTWARE TECH, V51, P7, DOI 10.1016/j.infsof.2008.09.009; Kletz S, 2019, HEALTHC TECHNOL LETT, V6, P197, DOI 10.1049/htl.2019.0077; Knight W., 2018, MIT Technol. Rev., V6; Kouki P, 2020, ACM T INTERACT INTEL, V10, DOI 10.1145/3365843; Koutras D, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20174828; Kumar A., 2022, Neural Comput. Appl., P1; Kumar A, 2022, J KING SAUD UNIV-COM, V34, P2192, DOI 10.1016/j.jksuci.2022.03.002; Kurakin A, 2017, Arxiv, DOI arXiv:1611.01236; Kwon BC, 2019, IEEE T VIS COMPUT GR, V25, P299, DOI 10.1109/TVCG.2018.2865027; La Gatta V, 2021, EXPERT SYST APPL, V179, DOI 10.1016/j.eswa.2021.115045; Lakkaraju H, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1675, DOI 10.1145/2939672.2939874; Lamy JB, 2019, ARTIF INTELL MED, V94, P42, DOI 10.1016/j.artmed.2019.01.001; Larasati R., 2021, CEUR Workshop Proceedings, V2903; Le T, 2020, KDD '20: PROCEEDINGS OF THE 26TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P238, DOI 10.1145/3394486.3403066; Lee SM, 2018, Arxiv, DOI arXiv:1805.11393; Lei J, 2018, J AM STAT ASSOC, V113, P1094, DOI 10.1080/01621459.2017.1307116; Letham B, 2015, ANN APPL STAT, V9, P1350, DOI 10.1214/15-AOAS848; Li JJ, 2022, INFORM FUSION, V79, P229, DOI 10.1016/j.inffus.2021.10.018; Lin YS, 2020, Arxiv, DOI arXiv:2009.10639; Lindsay L., 2020, INT C ADV COMP DAT S, P76; Liu Q, 2014, J MED BIOL ENG, V34, P299, DOI 10.5405/jmbe.1522; Loh HW, 2022, COMPUT METH PROG BIO, V226, DOI 10.1016/j.cmpb.2022.107161; Longo L, 2024, INFORM FUSION, V106, DOI 10.1016/j.inffus.2024.102301; Lorente MPS, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11083321; Loyola-González O, 2020, IEEE ACCESS, V8, P52370, DOI 10.1109/ACCESS.2020.2980581; Lucieri A, 2021, Arxiv, DOI arXiv:2103.05112; Lundberg SM, 2017, ADV NEUR IN, V30; Magdalena L, 2018, IEEE INT CONF FUZZY; Magesh PR, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104041; Mahajan A., 2019, Cancer Res Stat Treat, V2, P182, DOI [DOI 10.4103/CRST.CRST_50_19, 10.4103/CRST.CRST_50_19, 10.4103/crst.crst_50_19]; Malioutov DM, 2017, STUD BIG DATA, V32, P95, DOI 10.1007/978-3-319-54024-5_5; Manickam P, 2022, BIOSENSORS-BASEL, V12, DOI 10.3390/bios12080562; Maouche I., 2023, IEEE Transactions on Biomedical Engineering; Mars C., 2020, Res. Gate; Martínez-Agüero S, 2022, FUTURE GENER COMP SY, V133, P68, DOI 10.1016/j.future.2022.02.021; McFarland M., 2018, CNNMoney. Version, V809, P3; Meldo A, 2020, ARTIF INTELL MED, V108, DOI 10.1016/j.artmed.2020.101952; Meng T, 2020, INFORM FUSION, V57, P115, DOI 10.1016/j.inffus.2019.12.001; Mirchi N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229596; Mishra S., 2017, ISMIR, P537; Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086]; Monteath I., 2018, P 2 WORKSH EXPL ART, P104; Moreno-Sanchez P.A., 2021, An explainable classification model for chronic kidney disease patients; Moreno-Sanchez PA, 2021, Arxiv, DOI arXiv:2108.10717; Moreno-Sanchez PA, 2023, IEEE ACCESS, V11, P38359, DOI 10.1109/ACCESS.2023.3264270; Moretti DV, 2003, INT J PSYCHOPHYSIOL, V47, P199, DOI 10.1016/S0167-8760(02)00153-8; Mueller H, 2022, NEW BIOTECHNOL, V70, P67, DOI 10.1016/j.nbt.2022.05.002; Muhammad G, 2021, INFORM FUSION, V76, P355, DOI 10.1016/j.inffus.2021.06.007; Muhammad G, 2021, INFORM FUSION, V72, P80, DOI 10.1016/j.inffus.2021.02.013; Muller J., 2020, Comput. Graph.; Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116; Murray B.J., 2020, INT C INF PROC MAN U, P114, DOI [DOI 10.1007/978-3-030-50153-2, 10.1007/978-3-030-50153-2]; Musallam YK, 2021, BIOMED SIGNAL PROCES, V69, DOI 10.1016/j.bspc.2021.102826; Nazar Mobeen, 2021, IEEE Access; Nazir S, 2023, COMPUT BIOL MED, V156, DOI 10.1016/j.compbiomed.2023.106668; NECHES R, 1985, IEEE T SOFTWARE ENG, V11, P1337, DOI 10.1109/TSE.1985.231882; Nicora G, 2022, J BIOMED INFORM, V127, DOI 10.1016/j.jbi.2022.103996; Noorbakhsh-Sabet N, 2019, AM J MED, V132, P795, DOI 10.1016/j.amjmed.2019.01.017; Okay F.Y., 2021, 2021 INT S NETW COMP, P1; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Ongsulee P, 2017, INT CONF ICT KNOWL, P92; Oprescu AM, 2022, INFORM FUSION, V83, P53, DOI 10.1016/j.inffus.2022.03.011; Oramas J, 2019, Arxiv, DOI arXiv:1712.06302; Oztekin F, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13020226; Pal NR, 2020, FRONT ROBOT AI, V7, DOI 10.3389/frobt.2020.00076; Papanastasopoulos Z, 2020, PROC SPIE, V11314, DOI 10.1117/12.2549298; Pawar U, 2020, AICS, P169; Pawar U, 2020, 2020 INTERNATIONAL CONFERENCE ON CYBER SITUATIONAL AWARENESS, DATA ANALYTICS AND ASSESSMENT (CYBER SA 2020), DOI 10.1109/cybersa49311.2020.9139655; Payrovnaziri SN, 2020, J AM MED INFORM ASSN, V27, P1173, DOI 10.1093/jamia/ocaa053; Peng JH, 2020, COMPUT COMMUN, V157, P402, DOI 10.1016/j.comcom.2020.04.045; Peng JF, 2021, J MED SYST, V45, DOI 10.1007/s10916-021-01736-5; Pintelas E, 2020, J IMAGING, V6, DOI 10.3390/jimaging6060037; Plumb G, 2018, ADV NEUR IN, V31; Prakash AJ, 2023, IEEE SENSOR LETT, V7, DOI 10.1109/LSENS.2023.3268677; Qi J, 2020, INFORM FUSION, V55, P269, DOI 10.1016/j.inffus.2019.09.002; Rahman MA, 2021, SUSTAIN CITIES SOC, V72, DOI 10.1016/j.scs.2021.103083; Ramos-Soto A, 2018, COMM COM INF SC, V853, P40, DOI 10.1007/978-3-319-91473-2_4; Ras Gabrielle, 2018, Explainable and Interpretable Models in Computer Vision and Machine Learning, P19, DOI DOI 10.1007/978-3-319-98131-42; Rasheed K, 2022, COMPUT BIOL MED, V149, DOI 10.1016/j.compbiomed.2022.106043; Rehman A, 2021, ENERGIES, V14, DOI 10.3390/en14196414; Rehse JR, 2019, KUNSTL INTELL, V33, P181, DOI 10.1007/s13218-019-00586-1; Ribeiro MT, 2018, AAAI CONF ARTIF INTE, P1527; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Rieke N, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00323-1; Riquelme F, 2020, IMAGE VISION COMPUT, V101, DOI 10.1016/j.imavis.2020.103968; Rossi F., 2018, J. Int. Aff., V72, P127; Rostami Mehrdad, 2022, Inform Med Unlocked, V30, P100941, DOI 10.1016/j.imu.2022.100941; Rucco M, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8050770; Rutkowski T, 2019, INT J AP MAT COM-POL, V29, P595, DOI 10.2478/amcs-2019-0044; Saba T, 2020, J INFECT PUBLIC HEAL, V13, P1567, DOI [10.1016/j.jiph.2020.06.027, 10.1016/j.ijph.2020.06.027]; Sabol P, 2020, J BIOMED INFORM, V109, DOI 10.1016/j.jbi.2020.103523; Sachan S, 2021, EXPERT SYST APPL, V185, DOI 10.1016/j.eswa.2021.115597; Saharan S, 2023, IEEE T INTELL TRANSP, V24, P4217, DOI 10.1109/TITS.2022.3230851; Saharan S, 2020, FUTURE GENER COMP SY, V106, P622, DOI 10.1016/j.future.2020.01.031; Saharan S, 2020, COMPUT COMMUN, V150, P603, DOI 10.1016/j.comcom.2019.12.003; Saheb T, 2021, COMPUT BIOL MED, V135, DOI 10.1016/j.compbiomed.2021.104660; Sarathy Nikhil, 2020, 2020 IEEE 18th International Symposium on Intelligent Systems and Informatics (SISY), P155, DOI 10.1109/SISY50555.2020.9217095; Sarp S, 2021, INNOV SMART GRID TEC, DOI 10.1109/ISGT49243.2021.9372263; Sarp S, 2021, ELECTRONICS-SWITZ, V10, DOI 10.3390/electronics10121406; Schetinin V, 2007, IEEE T INF TECHNOL B, V11, P312, DOI 10.1109/TITB.2006.880553; Schonhof R., 2021, Procedia CIRP, V100, P331, DOI DOI 10.1016/J.PROCIR.2021.05.075; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Senatore R, 2019, INFORMATION, V10, DOI 10.3390/info10010030; Seroussi Brigitte, 2020, Yearb Med Inform, V29, P7, DOI 10.1055/s-0040-1702029; Setchi Rossitza, 2020, Procedia Computer Science, V176, P3057, DOI 10.1016/j.procs.2020.09.198; Shad HA, 2021, 2021 IEEE REGION 10 CONFERENCE (TENCON 2021), P720, DOI 10.1109/TENCON54134.2021.9707468; Sheikh A, 2021, LANCET DIGIT HEALTH, V3, pE383, DOI 10.1016/S2589-7500(21)00005-4; Shen SW, 2019, EXPERT SYST APPL, V128, P84, DOI 10.1016/j.eswa.2019.01.048; Shi ZK, 2019, LECT NOTES ARTIF INT, V11888, P617, DOI 10.1007/978-3-030-35231-8_45; Shoeibi A., 2022, Information Fusion; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan K, 2014, Arxiv, DOI [arXiv:1312.6034, DOI 10.48550/ARXIV.1312.6034]; Smith L., 2017, Future of Privacy Forum; Soares E, 2020, APPL SOFT COMPUT, V94, DOI 10.1016/j.asoc.2020.106449; Sokol K, 2020, FAT* '20: PROCEEDINGS OF THE 2020 CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, P56, DOI 10.1145/3351095.3372870; Srinivasu PN, 2022, MOB INF SYST, V2022, DOI 10.1155/2022/8167821; Strumbelj E, 2014, KNOWL INF SYST, V41, P647, DOI 10.1007/s10115-013-0679-x; Sun KH, 2020, IEEE ACCESS, V8, P129169, DOI 10.1109/ACCESS.2020.3009852; Sun YN, 2019, IEEE ACCESS, V7, P183339, DOI 10.1109/ACCESS.2019.2960617; Sundararajan M, 2017, PR MACH LEARN RES, V70; Tabik S, 2020, IEEE J BIOMED HEALTH, V24, P3595, DOI 10.1109/JBHI.2020.3037127; Tan SR, 2018, Arxiv, DOI arXiv:1710.06169; Tan W., 2021, Ann. Transl. Med., V9; Tang ZQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10212-1; Thapa C, 2021, COMPUT BIOL MED, V129, DOI 10.1016/j.compbiomed.2020.104130; Springenberg JT, 2015, Arxiv, DOI [arXiv:1412.6806, 10.48550/arXiv.1412.6806, DOI 10.48550/ARXIV.1412.6806]; Tosun AB, 2020, ADV ANAT PATHOL, V27, P241, DOI 10.1097/PAP.0000000000000264; Ribeiro MT, 2016, Arxiv, DOI [arXiv:1606.05386, 10.48550/arXiv.1606.05386]; Ullah K, 2016, IEEE INT CONF INTELL, P372, DOI 10.1109/INTELSE.2016.7475151; van der Velden BHM, 2022, MED IMAGE ANAL, V79, DOI 10.1016/j.media.2022.102470; van Lent M, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P900; Vishnu S, 2020, PR INT CONF DEVICE C, P101, DOI 10.1109/ICDCS48716.2020.243558; Wachter S., 2017, Harv JL Technol, V31, P841; Wang DD, 2019, I C OPT COMMUN NETW, DOI [10.1109/icocn.2019.8934212, 10.1145/3290605.3300831]; Wang Linda, 2020, Sci Rep, V10, P19549, DOI 10.1038/s41598-020-76550-z; Wang X, 2019, AAAI CONF ARTIF INTE, P5329; Wang XG, 2021, SOFT COMPUT, V25, P12203, DOI 10.1007/s00500-021-05888-x; Wani NA, 2024, COMPUT METH PROG BIO, V243, DOI 10.1016/j.cmpb.2023.107879; Weber RO, 2018, LECT NOTES ARTIF INT, V11156, P431, DOI 10.1007/978-3-030-01081-2_29; Wei X, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.927007; Wenzel Markus, 2020, IEEE Communications Standards Magazine, V4, P64, DOI 10.1109/MCOMSTD.001.2000006; Wu HR, 2021, 2021 CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: HUMAN LANGUAGE TECHNOLOGIES (NAACL-HLT 2021), P1942; Xie X, 2021, INFORM FUSION, V76, P168, DOI 10.1016/j.inffus.2021.05.017; Xin Yang, 2017, Medical Image Computing and Computer Assisted Intervention  MICCAI 2017. 20th International Conference. Proceedings: LNCS 10435, P426, DOI 10.1007/978-3-319-66179-7_49; Xu LD, 2014, IEEE T IND INFORM, V10, P2233, DOI 10.1109/TII.2014.2300753; Yadav SP, 2020, MED BIOL ENG COMPUT, V58, P669, DOI 10.1007/s11517-020-02136-6; Yang G, 2022, INFORM FUSION, V77, P29, DOI 10.1016/j.inffus.2021.07.016; Yang H., 2017, PR MACH LEARN RES, V70, P3921; Yeboah D, 2020, IEEE ACCESS, V8, P180690, DOI 10.1109/ACCESS.2020.3027453; Yeganejou M, 2020, IEEE T FUZZY SYST, V28, P1407, DOI 10.1109/TFUZZ.2019.2946520; Yeom SK, 2021, PATTERN RECOGN, V115, DOI 10.1016/j.patcog.2021.107899; Yoo TK, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.2.8; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zeldam S., 2018, Automated Failure Diagnosis in Aviation Maintenance Using Explainable Artificial Intelligence (XAI); Zeng NY, 2022, IEEE T INSTRUM MEAS, V71, DOI 10.1109/TIM.2022.3153997; Zerka F, 2020, IEEE ACCESS, V8, P183939, DOI 10.1109/ACCESS.2020.3029445; Zhang K, 2022, IEEE T COMPUT SOC SY, V9, P419, DOI 10.1109/TCSS.2021.3096824; Zhao GS, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3337967; Zheng Q, 2019, MED IMAGE ANAL, V56, P80, DOI 10.1016/j.media.2019.06.001; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhou V., 2019, Towards Data Sci.; Zou J, 2018, NATURE, V559, P324, DOI 10.1038/d41586-018-05707-8; Zou Lin, 2023, IEEE Transactions on Artificial Intelligence, P242, DOI 10.1109/TAI.2022.3153754	301	0	0	17	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1566-2535	1872-6305		INFORM FUSION	Inf. Fusion	OCT	2024	110								102472	10.1016/j.inffus.2024.102472	http://dx.doi.org/10.1016/j.inffus.2024.102472		MAY 2024	33	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	TV7Y7					2024-09-18	WOS:001244112800001
J	Dabass, M; Vashisth, S; Vig, R				Dabass, Manju; Vashisth, Sharda; Vig, Rekha			MTU: A multi-tasking U-net with hybrid convolutional learning and attention modules for cancer classification and gland Segmentation in Colon Histopathological Images	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Colorectal histopathology images; Deep learning; Residual learning; Multi-scalar features; Attention mechanism; Cancer classification; Automated gland segmentation		A clinically comparable multi-tasking computerized deep U-Net-based model is demonstrated in this paper. It intends to offer clinical gland morphometric information and cancer grade classification to be provided as referential opinions for pathologists in order to abate human errors. It embraces enhanced feature learning capability that aids in extraction of potent multi-scale features; efficacious semantic gap recovery during feature concatenation; and successful interception of resolution-degradation and vanishing gradient problems while performing moderate computations. It is proposed by integrating three unique novel structural components namely Hybrid Convolutional Learning Units in the encoder and decoder, Attention Learning Units in skip connection, and Multi-Scalar Dilated Transitional Unit as the transitional layer in the traditional U-Net architecture. These units are composed of the amalgamated phenomenon of multi-level convolutional learning through conventional, atrous, residual, depth-wise, and point-wise convolutions which are further incorporated with target-specific attention learning and enlarged effectual receptive field size. Also, pre-processing techniques of patch-sampling, augmentation (color and morphological), stain-normalization, etc. are employed to burgeon its generalizability. To build network invariance towards digital variability, exhaustive experiments are conducted using three public datasets (Colorectal Adenocarcinoma Gland (CRAG), Gland Segmentation (GlaS) challenge, and Lung Colon-25000 (LC-25K) dataset)) and then its robustness is verified using an in-house private dataset of Hospital Colon (HosC). For the cancer classification, the proposed model achieved results of Accuracy (CRAG(95%), GlaS(97.5%), LC-25K(99.97%), HosC(99.45%)), Precision (CRAG(0.9678), GlaS(0.9768), LC-25K(1), HosC(1)), F1-score (CRAG(0.968), GlaS(0.977), LC 25K(0.9997), HosC(0.9965)), and Recall (CRAG(0.9677), GlaS(0.9767), LC-25K(0.9994), HosC(0.9931)). For the gland detection and segmentation, the proposed model achieved competitive results of F1-score (CRAG(0.924), GlaS(Test A(0.949), Test B(0.918)), LC-25K(0.916), HosC(0.959)); Object-Dice Index (CRAG(0.959), GlaS(Test A(0.956), Test B(0.909)), LC-25K(0.929), HosC(0.922)), and Object-Hausdorff Distance (CRAG(90.47), GlaS(Test A(23.17), Test B(71.53)), LC-25K(96.28), HosC(85.45)). In addition, the activation mappings for testing the interpretability of the classification decision-making process are reported by utilizing techniques of Local Interpretable Model-Agnostic Explanations, Occlusion Sensitivity, and Gradient-Weighted Class Activation Mappings. This is done to provide further evidence about the model's self-learning capability of the comparable patterns considered relevant by pathologists without any pre-requisite for annotations. These activation mapping visualization outcomes are evaluated by proficient pathologists, and they delivered these images with a class-path validation score of (CRAG(9.31), GlaS(9.25), LC-25K(9.05), and HosC(9.85)). Furthermore, the seg-path validation score of (GlaS (Test A(9.40), Test B(9.25)), CRAG(9.27), LC-25K(9.01), HosC(9.19)) given by multiple pathologists is included for the final segmented outcomes to substantiate the clinical relevance and suitability for facilitation at the clinical level. The proposed model will aid pathologists to formulate an accurate diagnosis by providing a referential opinion during the morphology assessment of histopathology images. It will reduce unintentional human error in cancer diagnosis and consequently will enhance patient survival rate.	[Dabass, Manju; Vashisth, Sharda; Vig, Rekha] NorthCap Univ, EECE Dept, Gurugram 122017, India	The Northcap University	Dabass, M (corresponding author), NorthCap Univ, EECE Dept, Gurugram 122017, India.	manjurashi87@gmail.com	Vashisth, Sharda/HHS-8370-2022; dabass, manju/GLN-3022-2022; Vig, Rekha/KIB-5038-2024	dabass, manju/0000-0002-9040-3158; Vig, Rekha/0000-0002-0789-8840; Vashisth, Sharda/0000-0002-1730-4866				Adiwijaya U. N., 2018, J. Comput. Sci, V14, P1521, DOI DOI 10.3844/JCSSP.2018.1521.1530; Albashish D, 2022, PEERJ COMPUT SCI, V8, DOI 10.7717/peerj-cs.1031; Ali M, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11081485; Alinsaif S, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01327-3; Babu T., 2020, Prediction of normal and grades of cancer on colon biopsy images at different magnifications using minimal robust texture and morphological features, V11, DOI [10.37506/v11/i1/2020/ijphrd/193905, DOI 10.37506/V11/I1/2020/IJPHRD/193905]; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Banwari A, 2018, INT J E-HEALTH MED C, V9, P1, DOI 10.4018/IJEHMC.2018040101; Black-Schaffer WS, 2016, ACAD PATHOL, V3, DOI 10.1177/2374289516665393; Borkowski A.A., 2019, Lung and colon cancer histopathological image dataset (lc25000); Bukhari S.U.K., 2020, medRxiv; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Chen H, 2016, PROC CVPR IEEE, P2487, DOI 10.1109/CVPR.2016.273; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen Z, 2021, IEEE J BIOMED HEALTH, V25, P1673, DOI 10.1109/JBHI.2020.3024262; Clevert D.-A., 2016, 4 INT C LEARN REPR I; Dabass M., 2020, COMMUN COMPUT PHYS, V1230, DOI [10.1007/978-981-15-5830-6_27, DOI 10.1007/978-981-15-5830-6_27]; Dabass M., 2021, LECT NOTES ELECT ENG, V668, DOI [10.1007/978-981-15-5341-7_85, DOI 10.1007/978-981-15-5341-7_85]; Dabass M., 2020, COMMUN COMPUT PHYS, V1229, DOI [10.1007/978-981-15-5827-6_9, DOI 10.1007/978-981-15-5827-6_9]; Dabass M., 2019, 5 GRADE CANC CLASSIF, DOI [10.1201/9780429444272-3, DOI 10.1201/9780429444272-3]; Dabass M., 2018, 2018 4 INT C COMPUTI, DOI DOI 10.1109/CCAA.2018.8777616; Dabass M., 2021, Inf. Med. Unlocked, V27, DOI 10.1016/j.imu.2021.100784; Dabass M, 2022, COMPUT BIOL MED, V147, DOI 10.1016/j.compbiomed.2022.105680; Dabass M, 2018, COMM COM INF SC, V799, P234, DOI 10.1007/978-981-10-8527-7_21; Graham Simon, 2019, Digital Pathology. 15th European Congress, ECDP 2019. Proceedings: Lecture Notes in Computer Science (LNCS 11435), P109, DOI 10.1007/978-3-030-23937-4_13; Graham S, 2019, MED IMAGE ANAL, V52, P199, DOI 10.1016/j.media.2018.12.001; Guan QJ, 2020, PATTERN RECOGN LETT, V130, P259, DOI 10.1016/j.patrec.2018.10.027; Haryanto T., 2021, Inform. Med. Unlocked, V23, DOI 10.1016/j.imu.2021.100565; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Nguyen HN, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95985-6; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/TPAMI.2019.2913372, 10.1109/CVPR.2018.00745]; Iizuka O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58467-9; Kainz P, 2017, PEERJ, V5, DOI 10.7717/peerj.3874; Kather JN, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002730; Ma ZX, 2019, ADV INTELL SYST COMP, V762, P379, DOI 10.1007/978-3-319-91211-0_34; Masud M, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21030748; Maung R, 2016, Diagn Histopathol, V22, DOI DOI 10.1016/J.MPDHP.2016.07.004; Raza SEA, 2017, COMM COM INF SC, V723, P698, DOI 10.1007/978-3-319-60964-5_61; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Roberto GF, 2019, COMPUT GRAPH-UK, V84, P134, DOI 10.1016/j.cag.2019.08.008; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sabour S, 2017, ADV NEUR IN, V30; Salvi M, 2021, COMPUT BIOL MED, V128, DOI 10.1016/j.compbiomed.2020.104129; Salvi M, 2020, COMPUT METH PROG BIO, V193, DOI 10.1016/j.cmpb.2020.105506; Saroja B., 2019, Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization, V7, P1, DOI 10.1080/21681163.2017.1350603; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Sena P, 2019, ONCOL LETT, V18, P6101, DOI 10.3892/ol.2019.10928; Shaban MT, 2019, I S BIOMED IMAGING, P953, DOI [10.1109/ISBI.2019.8759152, 10.1109/isbi.2019.8759152]; Shapcott M, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00052; Shelhamer E, 2017, IEEE T PATTERN ANAL, V39, P640, DOI 10.1109/TPAMI.2016.2572683; Sirinukunwattana K, 2017, MED IMAGE ANAL, V35, P489, DOI 10.1016/j.media.2016.08.008; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Togaçar M, 2021, COMPUT BIOL MED, V137, DOI 10.1016/j.compbiomed.2021.104827; Wang HY, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101846; Wang P., 2020, LECT NOTES COMPUT<D>, V12535, DOI [10.1007/978-3-030-66415-2_22.LNCS, DOI 10.1007/978-3-030-66415-2_22.LNCS]; Wen ZJ, 2021, IEEE J BIOMED HEALTH, V25, P1185, DOI 10.1109/JBHI.2020.3015844; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Xi Y, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2021.101174; Yildirim M, 2022, INT J IMAG SYST TECH, V32, P155, DOI 10.1002/ima.22623; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang J., 2019, IEEE T MED IMAG, V38, DOI 10.1109/TMI.2019.2893944; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zhao P, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00670	62	6	6	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	NOV	2022	150								106095	10.1016/j.compbiomed.2022.106095	http://dx.doi.org/10.1016/j.compbiomed.2022.106095		SEP 2022	26	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	6O5CR	36179516				2024-09-18	WOS:000890259600002
J	Dogan, T; Guzelcan, EA; Baumann, M; Koyas, A; Atas, H; Baxendale, I; Martin, M; Cetin-Atalay, R				Dogan, Tunca; Guzelcan, Ece Akhan; Baumann, Marcus; Koyas, Altay; Atas, Heval; Baxendale, Ian; Martin, Maria; Cetin-Atalay, Rengul			Protein domain-based prediction of drug/compound-target interactions and experimental validation on LIM kinases	PLOS COMPUTATIONAL BIOLOGY			English	Article							WEB SERVER; DISCOVERY; TUMOR; CHEMOGENOMICS; DYNAMICS; CHEMBL; DRUGS	Predictive approaches such as virtual screening have been used in drug discovery with the objective of reducing developmental time and costs. Current machine learning and network-based approaches have issues related to generalization, usability, or model interpretability, especially due to the complexity of target proteins' structure/function, and bias in system training datasets. Here, we propose a new method "DRUIDom" (DRUg Interacting Domain prediction) to identify bio-interactions between drug candidate compounds and targets by utilizing the domain modularity of proteins, to overcome problems associated with current approaches. DRUIDom is composed of two methodological steps. First, ligands/compounds are statistically mapped to structural domains of their target proteins, with the aim of identifying their interactions. As such, other proteins containing the same mapped domain or domain pair become new candidate targets for the corresponding compounds. Next, a million-scale dataset of small molecule compounds, including those mapped to domains in the previous step, are clustered based on their molecular similarities, and their domain associations are propagated to other compounds within the same clusters. Experimentally verified bioactivity data points, obtained from public databases, are meticulously filtered to construct datasets of active/interacting and inactive/non-interacting drug/compound-target pairs (similar to 2.9M data points), and used as training data for calculating parameters of compound-domain mappings, which led to 27,032 high-confidence associations between 250 domains and 8,165 compounds, and a finalized output of similar to 5 million new compound-protein interactions. DRUIDom is experimentally validated by syntheses and bioactivity analyses of compounds predicted to target LIM-kinase proteins, which play critical roles in the regulation of cell motility, cell cycle progression, and differentiation through actin filament dynamics. We showed that LIMK-inhibitor-2 and its derivatives significantly block the cancer cell migration through inhibition of LIMK phosphorylation and the downstream protein cofilin. One of the derivative compounds (LIMKi-2d) was identified as a promising candidate due to its action on resistant Mahlavu liver cancer cells. The results demonstrated that DRUIDom can be exploited to identify drug candidate compounds for intended targets and to predict new target proteins based on the defined compound-domain relationships. Datasets, results, and the source code of DRUIDom are fully-available at: https://github.com/cansyl/DRUIDom.	[Dogan, Tunca] Hacettepe Univ, Dept Comp Engn, Ankara, Turkey; [Dogan, Tunca] Hacettepe Univ, Inst Informat, Ankara, Turkey; [Dogan, Tunca; Guzelcan, Ece Akhan; Koyas, Altay; Atas, Heval; Cetin-Atalay, Rengul] Middle East Tech Univ, Grad Sch Informat, CanSyL, Ankara, Turkey; [Guzelcan, Ece Akhan] Hacettepe Univ, Ctr Genom & Rare Dis & Biobank Rare Dis, Ankara, Turkey; [Baumann, Marcus] Univ Coll Dublin, Sch Chem, Dublin, Ireland; [Baxendale, Ian] Univ Durham, Dept Chem, Durham, England; [Martin, Maria] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England; [Cetin-Atalay, Rengul] Univ Chicago, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	Hacettepe University; Hacettepe University; Middle East Technical University; Hacettepe University; University College Dublin; Durham University; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Chicago	Dogan, T (corresponding author), Hacettepe Univ, Dept Comp Engn, Ankara, Turkey.; Dogan, T (corresponding author), Hacettepe Univ, Inst Informat, Ankara, Turkey.; Dogan, T; Cetin-Atalay, R (corresponding author), Middle East Tech Univ, Grad Sch Informat, CanSyL, Ankara, Turkey.; Cetin-Atalay, R (corresponding author), Univ Chicago, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA.	tuncadogan@gmail.com; rengul@uchicago.edu	Ataş Güvenilir, Heval/AEP-0155-2022; martin, maria/AGS-7663-2022; Baumann, Marcus/ISV-0154-2023; Baxendale, Ian/GSI-9354-2022; Baumann, Marcus/E-5338-2011; Dogan, Tunca/B-5274-2017; Baxendale, Ian/G-4117-2012; Cetin-Atalay, Rengul/O-9826-2014	Baumann, Marcus/0000-0002-6996-5893; Atas Guvenilir, Heval/0000-0003-3180-7010; Dogan, Tunca/0000-0002-1298-9763; Baxendale, Ian/0000-0003-1297-1552; Cetin-Atalay, Rengul/0000-0003-2408-6606; Martin, Maria-Jesus/0000-0001-5454-2815; Koyas, Altay/0000-0002-5436-6038; AKHAN, ECE/0000-0003-3239-5679				Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Buontempo F, 2011, INVEST NEW DRUG, V29, P1303, DOI 10.1007/s10637-010-9486-3; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; Croft DR, 2011, CELL RES, V21, P666, DOI 10.1038/cr.2010.154; Dalke A, 2019, J CHEMINFORMATICS, V11, DOI 10.1186/s13321-019-0398-8; Dan S, 2002, CANCER RES, V62, P1139; Dogan T, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkab543; Dogan T, 2018, PEERJ, V6, DOI 10.7717/peerj.5298; Dogan T, 2016, BIOINFORMATICS, V32, P2264, DOI 10.1093/bioinformatics/btw114; Dogan T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075458; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; England KS, 2014, MEDCHEMCOMM, V5, P1879, DOI [10.1039/c4md00291a, 10.1039/C4MD00291A]; Ersahin T, 2015, MOL BIOSYST, V11, P1946, DOI 10.1039/c5mb00101c; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI [10.1001/jamaoncol.2018.2706, 10.1001/jamaoncol.2016.5688]; Gamell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072850; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; Ghosh S, 2006, CURR OPIN CHEM BIOL, V10, P194, DOI 10.1016/j.cbpa.2006.04.002; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guo D, 2021, Zhonghua Gan Zang Bing Za Zhi, V29, P427, DOI 10.3760/cma.j.cn501113-20191113-00419; Hopkins AL, 2009, NATURE, V462, P167, DOI 10.1038/462167a; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kahraman DC, 2017, MEDCHEMCOMM, V8, P81, DOI 10.1039/c6md00392c; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kim Sunghwan, 2019, Nucleic Acids Res, V47, pD1102, DOI 10.1093/nar/gky1033; Kobren SN, 2019, NUCLEIC ACIDS RES, V47, P582, DOI 10.1093/nar/gky1224; Kruger FA, 2015, BIOINFORMATICS, V31, P776, DOI 10.1093/bioinformatics/btu711; Kruger FA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S11; Labbé CM, 2015, NUCLEIC ACIDS RES, V43, pW448, DOI 10.1093/nar/gkv306; Lagoutte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24925; Landrum G, RDKIT OPEN SOURCE CH; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lee H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-269; Li Q., 2012, J PROTEOME SCI COMPU, V1, DOI [10.7243/2050-2273-1-6, DOI 10.7243/2050-2273-1-6]; Lin XQ, 2020, MOLECULES, V25, DOI 10.3390/molecules25061375; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Maggiora G, 2014, J MED CHEM, V57, P3186, DOI 10.1021/jm401411z; Mardilovich K, 2015, ONCOTARGET, V6, P38469, DOI 10.18632/oncotarget.6288; Mendez D, 2019, NUCLEIC ACIDS RES, V47, pD930, DOI 10.1093/nar/gky1075; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Menyhárt O, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181006; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pan ZH, 2021, ONCOGENE, V40, P2581, DOI 10.1038/s41388-021-01736-2; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Po'uha ST, 2010, ONCOGENE, V29, P597, DOI 10.1038/onc.2009.367; Powers D. M. W., 2011, J MACH LEARN TECHNOL, V2, P37; Rifaioglu AS, 2020, CHEM SCI, V11, P2531, DOI 10.1039/c9sc03414e; Rifaioglu AS, 2019, BRIEF BIOINFORM, V20, P1878, DOI 10.1093/bib/bby061; Riley R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r89; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Scior T, 2012, J CHEM INF MODEL, V52, P867, DOI 10.1021/ci200528d; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Sun JM, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0203-5; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wong LLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068843; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zhou W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020246	73	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	NOV	2021	17	11							e1009171	10.1371/journal.pcbi.1009171	http://dx.doi.org/10.1371/journal.pcbi.1009171			34	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	XH4QL	34843456	Green Accepted, Green Published, gold, Green Submitted			2024-09-18	WOS:000725421000008
J	Loers, JU; Vermeirssen, V				Loers, Jens Uwe; Vermeirssen, Vanessa			SUBATOMIC: a SUbgraph BAsed mulTi-OMIcs clustering framework to analyze integrated multi-edge networks	BMC BIOINFORMATICS			English	Article						Composite subgraphs; Multi-edge networks; Network analysis; Multi-omics; Modules; Gene regulation; Topology; Hypoxia; Gene function prediction; Gene regulatory networks	TRANSCRIPTION FACTORS; UP-REGULATION; HYPOXIA; RECEPTOR; GENES; DIFFERENTIATION; NORMALIZATION; DUPLICATION; EXPRESSION; DISCOVERY	Background: Representing the complex interplay between different types of biomolecules across different omics layers in multi-omics networks bears great potential to gain a deep mechanistic understanding of gene regulation and disease. However, multi-omics networks easily grow into giant hairball structures that hamper biological interpretation. Module detection methods can decompose these networks into smaller interpretable modules. However, these methods are not adapted to deal with multi-omics data nor consider topological features. When deriving very large modules or ignoring the broader network context, interpretability remains limited. To address these issues, we developed a SUbgraph BAsed mulTi-OMIcs Clustering framework (SUBATOMIC), which infers small and interpretable modules with a specific topology while keeping track of connections to other modules and regulators. Results: SUBATOMIC groups specific molecular interactions in composite network subgraphs of two and three nodes and clusters them into topological modules. These are functionally annotated, visualized and overlaid with expression profiles to go from static to dynamic modules. To preserve the larger network context, SUBATOMIC investigates statistically the connections in between modules as well as between modules and regulators such as miRNAs and transcription factors. We applied SUBATOMIC to analyze a composite Homo sapiens network containing transcription factor-target gene, miRNA-target gene, protein-protein, homologous and co-functional interactions from different databases. We derived and annotated 5586 modules with diverse topological, functional and regulatory properties. We created novel functional hypotheses for unannotated genes. Furthermore, we integrated modules with condition specific expression data to study the influence of hypoxia in three cancer cell lines. We developed two prioritization strategies to identify the most relevant modules in specific biological contexts: one considering GO term enrichments and one calculating an activity score reflecting the degree of differential expression. Both strategies yielded modules specifically reacting to low oxygen levels. Conclusions: We developed the SUBATOMIC framework that generates interpretable modules from integrated multi-omics networks and applied it to hypoxia in cancer. SUBATOMIC can infer and contextualize modules, explore condition or disease specific modules, identify regulators and functionally related modules, and derive novel gene functions for uncharacterized genes. The software is available at https://github.com/ CBIGR/SUBATOMIC.	[Loers, Jens Uwe; Vermeirssen, Vanessa] Canc Res Inst Ghent CRIG, Lab Computat Biol Integr & Gene Regulat CBIGR, Ghent, Belgium; [Loers, Jens Uwe; Vermeirssen, Vanessa] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Loers, Jens Uwe; Vermeirssen, Vanessa] Univ Ghent, Dept Biomol Med, Ghent, Belgium	Ghent University; Ghent University; Ghent University	Vermeirssen, V (corresponding author), Canc Res Inst Ghent CRIG, Lab Computat Biol Integr & Gene Regulat CBIGR, Ghent, Belgium.; Vermeirssen, V (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Vermeirssen, V (corresponding author), Univ Ghent, Dept Biomol Med, Ghent, Belgium.	vanessa.vermeirssen@ugent.be	Vermeirssen, Vanessa/U-7142-2018		BOF Starting Grant [BOF/STA/201909/030]; BOF PhD scholarship from Ghent University	BOF Starting Grant; BOF PhD scholarship from Ghent University	J.L. is supported by a BOF PhD scholarship from Ghent University, and this work was also funded by a BOF Starting Grant BOF/STA/201909/030 'Multi-omics data integration to elucidate the causes of complex diseases'.	Alcalá-Corona SA, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.701331; [Anonymous], 1912, NEW PHYTOL, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X]; Azad AKM, 2017, METHODS MOL BIOL, V1526, P119, DOI 10.1007/978-1-4939-6613-4_7; Azad AKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070498; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baur B, 2020, CURR OPIN SYST BIOL, V23, P38, DOI 10.1016/j.coisb.2020.09.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10345; Bhat Shakil Ahmad, 2016, Noncoding RNA Res, V1, P43, DOI 10.1016/j.ncrna.2016.11.002; Bodein A., 2021, NUCLEIC ACIDS RES, V18, P551; Bodein A, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00963; Bonnet E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003983; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chaanine AH, 2016, AM J PHYSIOL-HEART C, V311, pH1540, DOI 10.1152/ajpheart.00549.2016; Chen PS, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00658-7; Chen QY, 2016, BIOCHEM BIOPH RES CO, V474, P168, DOI 10.1016/j.bbrc.2016.04.090; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Defoort J, 2018, NUCLEIC ACIDS RES, V46, P6480, DOI 10.1093/nar/gky468; Demeyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061183; Depoix CL, 2017, MOL HUM REPROD, V23, P199, DOI 10.1093/molehr/gax002; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Dolinski K, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-43; Durmaz A, 2021, PACIFIC SYMPOSIUM ON BICOMPUTING 2021, P261; Gao N, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.598817; Garcia-Alonso L, 2019, GENOME RES, V29, P1363, DOI 10.1101/gr.240663.118; Garcia-Alonso L, 2018, CANCER RES, V78, P769, DOI 10.1158/0008-5472.CAN-17-1679; Geng H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07411-7; Ghiassian SD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004120; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Guo Y, 2016, RNA, V22, P1663, DOI 10.1261/rna.048025.114; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hiraga T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113523; Horn RA, 2012, MATRIX ANAL; Hou L, 2014, HUM MOL GENET, V23, P2780, DOI 10.1093/hmg/ddt668; Houbraken M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097896; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Nguyen H, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00155; Hwang S, 2019, NUCLEIC ACIDS RES, V47, pD573, DOI 10.1093/nar/gky1126; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Klemm SL, 2019, NAT REV GENET, V20, P207, DOI 10.1038/s41576-018-0089-8; Klopfenstein DV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28948-z; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kumar B, 2016, ONCOTARGET, V7, P72593, DOI 10.18632/oncotarget.12241; Lan X, 2016, SCIENCE, V352, P1009, DOI 10.1126/science.aad8411; Lander AD, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-40; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee JW, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0235-1; Levine E, 2001, NEURAL COMPUT, V13, P2573, DOI 10.1162/089976601753196030; Li HY, 2018, J CELL PHYSIOL, V233, P641, DOI 10.1002/jcp.25924; Li YP, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.590576; Liu YS, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-03964-5; Lu XG, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07628-9; Lu XG, 2021, SIGNAL IMAGE VIDEO P, V15, P681, DOI 10.1007/s11760-020-01638-y; Manke T, 2003, J MOL BIOL, V333, P75, DOI 10.1016/j.jmb.2003.08.004; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Menendez MT, 2015, MBIO, V6, DOI 10.1128/mBio.00462-15; Michoel T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056111; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Moon S, 2022, BIOINFORMATICS, V38, P2287, DOI 10.1093/bioinformatics/btac080; Morozova N, 2012, RNA, V18, P1635, DOI 10.1261/rna.032284.112; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Olbryt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105104; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Piccolo SR, 2012, GENOMICS, V100, P337, DOI 10.1016/j.ygeno.2012.08.003; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Rios-Colon L, 2021, CANCERS, V13, DOI 10.3390/cancers13246302; Saelens W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03424-4; Shah R, 2009, BRIT J CANCER, V100, P1687, DOI 10.1038/sj.bjc.6605042; Shan FB, 2020, J CELL PHYSIOL, V235, P141, DOI 10.1002/jcp.28953; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi WJ, 2019, BIOINFORMATICS, V35, P4336, DOI 10.1093/bioinformatics/btz226; Shinsky SA, 2015, J BIOL CHEM, V290, P6361, DOI 10.1074/jbc.M114.627646; Silverbush D, 2019, CELL SYST, V8, P456, DOI 10.1016/j.cels.2019.04.005; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Sysol JR, 2018, AM J PHYSIOL-LUNG C, V314, pL461, DOI 10.1152/ajplung.00057.2017; Tian WD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s7; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; Todd VM, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02648-3; Türei D, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.20209923; Türei D, 2016, NAT METHODS, V13, P965, DOI 10.1038/nmeth.4077; Urizar-Arenaza I, 2019, MOL CELL PROTEOMICS, V18, pS118, DOI 10.1074/mcp.RA118.001133; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wang BB, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03769-y; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang XK, 2022, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202101228; Wang ZL, 2021, ONCOGENE, V40, P1458, DOI 10.1038/s41388-020-01635-y; Watts ER, 2019, TRENDS MOL MED, V25, P33, DOI 10.1016/j.molmed.2018.10.006; Williams RM, 2019, DEV CELL, V51, P255, DOI 10.1016/j.devcel.2019.10.003; Winkler S, 2022, BMC BIOINFORMATICS, V23, DOI 10.1186/s12859-022-04670-6; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Wu C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-82; Wu S, 2022, CURR OPIN CHEM BIOL, V66, DOI 10.1016/j.cbpa.2021.102101; Xu KB, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.181057; Xu R, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.682762; Yao Q, 2019, CURR OPIN CHEM BIOL, V51, P11, DOI 10.1016/j.cbpa.2019.01.024; Zhang C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00160; Zhang J, 2014, CANCER INFORM, V13, P137, DOI 10.4137/CIN.S14021; Zhang ZR, 2018, DEV GROWTH DIFFER, V60, P197, DOI 10.1111/dgd.12537; Zhao YZ, 2014, ARCH BIOCHEM BIOPHYS, V543, P40, DOI 10.1016/j.abb.2013.12.010; Zhou YC, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0959-1; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51; Zoppi J, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-020-03921-8	108	4	4	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	SEP 5	2022	23	1							363	10.1186/s12859-022-04908-3	http://dx.doi.org/10.1186/s12859-022-04908-3			31	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	4H7XF	36064320	Green Published, Green Submitted, gold			2024-09-18	WOS:000850089900001
J	Ahamed, MF; Islam, MR; Nahiduzzaman, M; Karim, MJ; Ayari, MA; Khandakar, A				Ahamed, Md. Faysal; Islam, Md. Rabiul; Nahiduzzaman, Md.; Karim, Md. Jawadul; Ayari, Mohamed Arselene; Khandakar, Amith			Automated Detection of Colorectal Polyp Utilizing Deep Learning Methods With Explainable AI	IEEE ACCESS			English	Article						Solid modeling; Location awareness; Gastrointestinal tract; Training; Reliability; Real-time systems; Localization; segmentation; YOLOv8; TR-SE-Net; squeeze-and-excite network; colonoscopy; deep learning; Kvasir-SEG; CVC-ClinicDB; PolypGen; ETIS-LaribPolypDB; EDD 2020; BKAI-IGH; explainable AI (XAI)	SEGMENTATION; VALIDATION; POLYPECTOMY	Detecting colorectal polyps promptly and accurately is crucial in preventing the progression of colorectal cancer. These polyps cause severe conditions in the colon or rectum, presenting a significant diagnostic challenge. Traditional manual detection through medical imaging is not only bulky and prone to errors but also incurs substantial costs, requiring expert endoscopist. Inefficient detection and treatment can lead to critical health complications. Addressing these issues, we extensively employed various configurations of the state-of-the-art YOLOv8 (n-nano, s-small, m-medium, l-large, and x-extra-large) models for effective polyp localization. Complementing this, we proposed a novel TR-SE-Net model for segmentation, integrating Squeeze-and-Excite Networks (SE-Net) to elevate performance and real-time processing capabilities. The Kvasir-SEG dataset is utilized for training and testing models, supplemented by external validation CVC-ClinicDB, PolypGen, ETIS-LaribPolypDB, EDD 2020, and BKAI-IGH to confirm their efficacy in processing unseen, real-time data. This study delves into the interpretability of these models using explainable AI (XAI), such as eigen visualization for localization and heatmap analysis for segmentation. This exploration provides deeper insights into the decision-making processes of the models, thereby enhancing their reliability. Notably, the YOLOv8m model showcased remarkable prediction speed (approximately 16.61 ms) and excelled in precision (0.946), recall (0.771), F1-score (0.85), mAP(50) (0.886), and mAP(50-95) (0.695), catering to diverse clinical scenarios. The TR-SE-Net demonstrated significant improvements in segmentation performances, including DSC (0.8754), F2-score (0.8786), precision (0.9027), recall (0.8879), accuracy (0.9647), competitive mIoU (0.7961), FPS (54), parameters (27.27 million), and flops (10.59 GMac). Furthermore, A graphical Computer Aided Diagnosis (CAD) system developed utilizing both models can substantially reduce the miss rate because segmentation will assist in polyp detection or vice versa if localization fails. Conclusively, integrating these advanced computer-aided methods substantially enhances colonoscopy procedures by mitigating the risks of colorectal cancer.	[Ahamed, Md. Faysal; Islam, Md. Rabiul] Rajshahi Univ Engn & Technol, Dept Comp Sci & Engn, Rajshahi 6204, Bangladesh; [Nahiduzzaman, Md.; Karim, Md. Jawadul] Rajshahi Univ Engn & Technol, Dept Elect & Comp Engn, Rajshahi 6204, Bangladesh; [Ayari, Mohamed Arselene] Qatar Univ, Dept Civil & Environm Engn, Doha 2713, Qatar; [Ayari, Mohamed Arselene] Qatar Univ, Technol Innovat & Engn Educ Unit TIEE, Doha, Qatar; [Khandakar, Amith] Qatar Univ, Dept Elect Engn, Doha, Qatar	Rajshahi University of Engineering & Technology (RUET); Rajshahi University of Engineering & Technology (RUET); Qatar University; Qatar University; Qatar University	Ayari, MA (corresponding author), Qatar Univ, Dept Civil & Environm Engn, Doha 2713, Qatar.; Ayari, MA (corresponding author), Qatar Univ, Technol Innovat & Engn Educ Unit TIEE, Doha, Qatar.	ArslanA@qu.edu.qa	Islam, Md Rabiul/AHB-4557-2022; Ayari, Arslan/R-7691-2019; Nahiduzzaman, Md/GWZ-7870-2022	Nahiduzzaman, Md./0000-0003-4126-0389; Karim, Md. Jawadul/0009-0006-4226-3652; Ayari, Mohamed Arselene/0000-0002-8663-886X; Ahamed, Md. Faysal/0000-0002-7014-3205; Khandakar, Amith/0000-0001-7068-9112	UREP30-196-2-058 from Qatar Research, Development and Innovation (QRDI)	UREP30-196-2-058 from Qatar Research, Development and Innovation (QRDI)	No Statement Available	Ahamed MF, 2023, SENSORS-BASEL, V23, DOI 10.3390/s23187724; Al Amin Md, 2022, 2022 IEEE International Women in Engineering (WIE) Conference on Electrical and Computer Engineering (WIECON-ECE), P58, DOI 10.1109/WIECON-ECE57977.2022.10151209; Ali D., Sci.Data, V10; Ali S, 2021, MED IMAGE ANAL, V70, DOI 10.1016/j.media.2021.102002; Andren-Sandberg A., 2001, Surgical treatment. Evidence-Based and ProblemOriented, P843; Bernal J, 2017, IEEE T MED IMAGING, V36, P1231, DOI 10.1109/TMI.2017.2664042; Bernal J, 2015, COMPUT MED IMAG GRAP, V43, P99, DOI 10.1016/j.compmedimag.2015.02.007; blog.roboflow, Train YOLOv8 on a Custom Dataset; Bochkovskiy A, 2020, Arxiv, DOI arXiv:2004.10934; Borgli H, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00622-y; Cancer Net, Colorectal Cancer: Stages; Carrinho P, 2023, EXPERT SYST APPL, V232, DOI 10.1016/j.eswa.2023.120834; Chen LCE, 2018, LECT NOTES COMPUT SC, V11211, P833, DOI 10.1007/978-3-030-01234-2_49; Chitradevi B., 2014, INT J INNOVATIVE RES, V2, P6466; Lima ACD, 2023, IEEE ACCESS, V11, P76108, DOI 10.1109/ACCESS.2023.3297097; Diakogiannis FI, 2020, ISPRS J PHOTOGRAMM, V162, P94, DOI 10.1016/j.isprsjprs.2020.01.013; Du J, 2018, J PHYS CONF SER, V1004, DOI 10.1088/1742-6596/1004/1/012029; Elkarazle K, 2023, IEEE ACCESS, V11, P69295, DOI 10.1109/ACCESS.2023.3291783; Galdran Adrian, 2021, Pattern Recognition. ICPR 2020 International Workshops and Challenges. Proceedings. Lecture Notes in Computer Science (LNCS 12661), P293, DOI 10.1007/978-3-030-68763-2_22; Ghose P, 2023, MULTIMED TOOLS APPL, DOI 10.1007/s11042-023-17138-3; Guo QQ, 2022, IEEE ACCESS, V10, P52971, DOI 10.1109/ACCESS.2022.3175858; Guo YB, 2019, VISAPP: PROCEEDINGS OF THE 14TH INTERNATIONAL JOINT CONFERENCE ON COMPUTER VISION, IMAGING AND COMPUTER GRAPHICS THEORY AND APPLICATIONS, VOL 4, P632, DOI 10.5220/0007698806320641; He CS, 2023, APPL SCI-BASEL, V13, DOI 10.3390/app131910800; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; healthline, Colon Polyp Size and Type Charts; Hong LTT, 2021, IEEE ACCESS, V9, P156987, DOI 10.1109/ACCESS.2021.3129480; Hossain MS, 2023, IEEE ACCESS, V11, P95889, DOI 10.1109/ACCESS.2023.3310541; Hu J., 2018, IEEE C COMP VIS PATT, P7132, DOI DOI 10.1109/CVPR.2018.00745; Huang C-H., 2021, arXiv, DOI DOI 10.48550/ARXIV.2101.07172; Ige AO, 2023, IEEE ACCESS, V11, P16142, DOI 10.1109/ACCESS.2023.3244789; Islam M, 2020, LECT NOTES COMPUT SC, V11992, P262, DOI 10.1007/978-3-030-46640-4_25; Jha Debesh, 2021, MultiMedia Modeling. 27th International Conference, MMM 2021. Proceedings. Lecture Notes in Computer Science (LNCS 12573), P218, DOI 10.1007/978-3-030-67835-7_19; Jha D, 2024, LECT NOTES COMPUT SC, V14315, P125, DOI 10.1007/978-3-031-47679-2_10; Jha D, 2021, COMP MED SY, P37, DOI 10.1109/CBMS52027.2021.00014; Jha D, 2021, IEEE ACCESS, V9, P40496, DOI 10.1109/ACCESS.2021.3063716; Jha D, 2020, COMP MED SY, P558, DOI 10.1109/CBMS49503.2020.00111; Jha D, 2020, LECT NOTES COMPUT SC, V11962, P451, DOI 10.1007/978-3-030-37734-2_37; Jha D, 2019, IEEE INT SYM MULTIM, P225, DOI 10.1109/ISM46123.2019.00049; Jocher A., 2023, YOLO by Ultralytics; Kim B.-D., 2021, IEEE Access, V9, DOI [10.1109/ACCESS.2021.3099936.14J.S.C., DOI 10.1109/ACCESS.2021.3099936.14J.S.C]; Kim T, 2021, PROCEEDINGS OF THE 29TH ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA, MM 2021, P2167, DOI 10.1145/3474085.3475375; Kornblith S, 2019, PROC CVPR IEEE, P2656, DOI 10.1109/CVPR.2019.00277; Lee JY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65387-1; Lewis J, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-28530-2; Lin TY, 2017, IEEE I CONF COMP VIS, P2999, DOI 10.1109/ICCV.2017.324; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Liu M, 2019, IEEE ACCESS, V7, P75058, DOI [10.1109/access.2019.2921027, 10.1109/ACCESS.2019.2921027]; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lou S., 2022, SPIE, DOI [10.1117/12.2611802.26, DOI 10.1117/12.2611802.26]; Ma MX, 2016, BEST PRACT RES CL GA, V30, P749, DOI 10.1016/j.bpg.2016.09.009; Duc NT, 2022, IEEE ACCESS, V10, P80575, DOI 10.1109/ACCESS.2022.3195241; Lan PN, 2021, LECT NOTES COMPUT SC, V13018, P15, DOI 10.1007/978-3-030-90436-4_2; Pogorelov K, 2017, PROCEEDINGS OF THE 8TH ACM MULTIMEDIA SYSTEMS CONFERENCE (MMSYS'17), P170, DOI 10.1145/3083187.3083216; Pogorelov K, 2017, PROCEEDINGS OF THE 8TH ACM MULTIMEDIA SYSTEMS CONFERENCE (MMSYS'17), P164, DOI 10.1145/3083187.3083212; Reddy Jillella Sai Charan, 2022, 2022 1st International Conference on the Paradigm Shifts in Communication, Embedded Systems, Machine Learning and Signal Processing (PCEMS)., P104, DOI 10.1109/PCEMS55161.2022.9807988; Redmon J., 2018, arXiv; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Ren Z., 2023, IEEE Access, V11; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sasmal P, 2021, IEEE ACCESS, V9, P153004, DOI 10.1109/ACCESS.2021.3126835; Shimin Ou, 2021, 2021 IEEE 2nd International Conference on Information Technology, Big Data and Artificial Intelligence (ICIBA), P1106, DOI 10.1109/ICIBA52610.2021.9688145; Shin Y, 2018, IEEE ACCESS, V6, P56007, DOI 10.1109/ACCESS.2018.2872717; Shin Y, 2018, IEEE ACCESS, V6, P40950, DOI 10.1109/ACCESS.2018.2856402; Silva J, 2014, INT J COMPUT ASS RAD, V9, P283, DOI 10.1007/s11548-013-0926-3; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Smedsrud PH, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00920-z; Tran ST, 2022, IEEE ACCESS, V10, P65951, DOI 10.1109/ACCESS.2022.3184773; Tan M., 2020, P IEEE CVF C COMP VI, P10778, DOI DOI 10.48550/ARXIV.1911.09070; Tomar Nikhil Kumar, 2021, Pattern Recognition. ICPR International Workshops and Challenges. Proceedings. Lecture Notes in Computer Science (LNCS 12668), P307, DOI 10.1007/978-3-030-68793-9_23; Valanarasu JMJ, 2022, LECT NOTES COMPUT SC, V13435, P23, DOI 10.1007/978-3-031-16443-9_3; Wang CY, 2023, PROC CVPR IEEE, P7464, DOI 10.1109/CVPR52729.2023.00721; Wang P, 2018, NAT BIOMED ENG, V2, P741, DOI 10.1038/s41551-018-0301-3; Wang Ruxin, 2022, Med Image Anal, V78, P102395, DOI 10.1016/j.media.2022.102395; [王亚刚 Wang Yagang], 2020, [计算机科学与探索, Journal of Frontiers of Computer Science & Technology], V14, P1243; Wang Y, 2015, COMPUT METH PROG BIO, V120, P164, DOI 10.1016/j.cmpb.2015.04.002; Wen Y, 2023, IEEE ACCESS, V11, P16183, DOI 10.1109/ACCESS.2023.3245519; Yeung M, 2021, COMPUT BIOL MED, V137, DOI 10.1016/j.compbiomed.2021.104815; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660; Zhou ZW, 2018, LECT NOTES COMPUT SC, V11045, P3, DOI 10.1007/978-3-030-00889-5_1; Zhu XK, 2021, IEEE INT CONF COMP V, P2778, DOI 10.1109/ICCVW54120.2021.00312	81	0	0	5	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2024	12						78074	78100		10.1109/ACCESS.2024.3402818	http://dx.doi.org/10.1109/ACCESS.2024.3402818			27	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	TL9W8		gold			2024-09-18	WOS:001241545600001
J	Torres-Lacomba, M; Navarro-Brazález, B; Bailón-Cerezo, J; Vergara-Pérez, F; de la Rosa-díaz, I; Prieto-Gómez, V				Torres-Lacomba, Maria; Navarro-Brazalez, Beatriz; Bailon-Cerezo, Javier; Vergara-Perez, Fernando; de la Rosa-diaz, Irene; Prieto-Gomez, Virginia			Assessment Tools of Patient Competences: The Spanish Version of the R-NPQ and Three Practical Cases in Women with Breast Cancer and Persistent Pain	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						breast cancer; patient competence assessment; competence assessment tools; pain; patient education; revised neurophysiology of pain questionnaire (R-NPQ); Spanish validation	EDUCATION-PROGRAM; EFFICACY; QUALITY; NEUROPHYSIOLOGY; INTERVENTIONS; QUESTIONNAIRE; TRANSLATION; PREVALENCE; MANAGEMENT; SURVIVORS	Persistent pain following treatment for breast cancer (PPBCT) is a prevalent and complex clinical issue. Education together with physiotherapy have been shown to lessen pain and disability in chronic pain. Although the evaluation of the patient's competences is a major part of the educational program, the published educational programs rarely describe the tools used to assess competences, especially regarding those related to decision-making and problem-solving. The aim of this study was to provide two competences assessment tools: the cross-cultural adaptation and validation of the Spanish version of the Revised Neurophysiology of Pain Questionnaire (R-NPQ) and practical cases of women with PPBCT. The Spanish cross-cultural adaptation was conducted following recognized criteria. Measurement properties testing included an analysis of construct validity (known-groups approach), reliability (internal consistency and test-retest reliability), responsiveness, interpretability, and feasibility. To promote a tool that would allow evaluation of the educational program competences, a group of experts developed three cases extracted from real contexts by means of an iterative process. A total of 80 women with PPBCT (mean age 56 years) and 81 physiotherapy students (mean age 20 years) participated in the measurement properties analysis. The three developed cases were presented to the same 80 women with PPBCT before and after the educational program. As we expected, students showed a significantly higher score (p < 0.001) than did women with PPBCT in the R-NPQ questionnaire, with a large effect size (d = 2.49), demonstrating good construct validity. The Cronbach alpha was 0.90 (95% CI, 0.87-0.92) and the intraclass correlation coefficient was 0.82 (95% CI, 0.73-0.88). A large effect size (5.2) was found, as we expected, between baseline and post-treatment scores, suggesting adequate responsiveness. In addition, identifying and analyzing, decision making, communicating needs, knowing how to manage, and problem-solving skills were evaluated through the three practical cases. Most women (88.75%) reached the highest level in the assessment rubric of the proposed practical cases. The Spanish R-NPQ is a comprehensible, valid, reliable, and responsive tool for Spanish women with PPBCT. The practical cases are a useful competence assessment tool and were well accepted by women with PPBCT. Further studies are needed to investigate more competence assessment tools and to investigate whether the achievement of different levels of competences has an effect on health behaviors.	[Torres-Lacomba, Maria; Navarro-Brazalez, Beatriz; Bailon-Cerezo, Javier; Vergara-Perez, Fernando; de la Rosa-diaz, Irene; Prieto-Gomez, Virginia] Univ Alcala, Physiotherapy Dept, Physiotherapy Womens Hlth FPSM Res Grp, Fac Med & Hlth Sci, Madrid 28801, Spain; [Bailon-Cerezo, Javier; de la Rosa-diaz, Irene] Univ Autonoma Madrid, Dept Phys Therapy, Univ La Salle, Ctr Super Estudios, Madrid 28049, Spain	Universidad de Alcala; Autonomous University of Madrid	Bailón-Cerezo, J (corresponding author), Univ Alcala, Physiotherapy Dept, Physiotherapy Womens Hlth FPSM Res Grp, Fac Med & Hlth Sci, Madrid 28801, Spain.; Bailón-Cerezo, J (corresponding author), Univ Autonoma Madrid, Dept Phys Therapy, Univ La Salle, Ctr Super Estudios, Madrid 28049, Spain.	maria.torres@uah.es; b.navarro@uah.es; bailonfisioterapia@gmail.com; fernando.vergara@uah.es; irenedelarosadiaz@gmail.com; v.prieto@uah.es	Bailón-Cerezo, Javier/HJG-5525-2022; Torres-Lacomba, Maria/A-5896-2017; de la Rosa Diaz, Irene/N-5726-2017	Navarro Brazalez, Beatriz/0000-0002-9939-7946; Bailon-Cerezo, Javier/0000-0002-0852-7312; Torres-Lacomba, Maria/0000-0002-7051-3130; Vergara-Perez, Fernando/0000-0002-6417-8452; Prieto Gomez, Virginia/0000-0003-0833-4083; de la Rosa Diaz, Irene/0000-0002-7103-7279				Adam R, 2015, PATIENT EDUC COUNS, V98, P269, DOI 10.1016/j.pec.2014.11.003; Baartman L., 2007, Studies in Educational Evaluation, V33, P258, DOI DOI 10.1016/J.STUEDUC.2007.07.004; Baartman L.K. J., 2007, Educational Research Review, V2, P114, DOI [10.1016/j.edurev.2007.06.001, DOI 10.1016/J.EDUREV.2007.06.001]; Blömeke S, 2015, Z PSYCHOL, V223, P3, DOI 10.1027/2151-2604/a000194; Bovbjerg DH, 2019, ACTA ONCOL, V58, P763, DOI 10.1080/0284186X.2019.1574023; Bryant F.B., 1995, Reading and Understanding Multivariate Statistics; Catley MJ, 2013, J PAIN, V14, P818, DOI 10.1016/j.jpain.2013.02.008; Chimenti RL, 2018, PHYS THER, V98, P302, DOI 10.1093/ptj/pzy030; Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences, V2nd ed, DOI https://doi.org/10.4324/9780203771587; Cumberland WG, 2018, AM ANN DEAF, V163, P90, DOI 10.1353/aad.2018.0014; da Silva FP, 2019, J MANIP PHYSIOL THER, V42, P503, DOI 10.1016/j.jmpt.2018.12.007; Dafni U, 2019, BREAST CARE, V14, P344, DOI 10.1159/000503219; Davidson M, 2014, BRIT J SPORT MED, V48, P792, DOI 10.1136/bjsports-2012-091704; De Groef A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025742; Demoulin C, 2017, PHYSIOTHER THEOR PR, V33, P880, DOI 10.1080/09593985.2017.1359865; Falla D., 2021, J PHYSIOTHER; Feeney LR, 2018, IRISH J MED SCI, V187, P877, DOI 10.1007/s11845-018-1760-y; Gagnayre R, 2006, PEDAGOGIE MED, V7, P31, DOI DOI 10.1051/PMED:2006021; Campayo JG, 2008, MED CLIN-BARCELONA, V131, P487; Giacalone A, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.6416; Guerrero AVS, 2018, CLIN J PAIN, V34, P838, DOI 10.1097/AJP.0000000000000601; Hamood R, 2018, BREAST CANCER RES TR, V167, P157, DOI 10.1007/s10549-017-4485-0; Hulbert-Williams NJ, 2015, EUR J CANCER CARE, V24, P15, DOI 10.1111/ecc.12223; Janssen-Noordman AMB, 2006, MED TEACH, V28, P447, DOI 10.1080/01421590600825276; Jho HJ, 2013, SUPPORT CARE CANCER, V21, P1963, DOI 10.1007/s00520-013-1756-0; Lagger G, 2010, PATIENT EDUC COUNS, V79, P283, DOI 10.1016/j.pec.2010.03.015; Lokhoff J., 2010, TUNING ED STRUCTURES; Louw A, 2016, PHYSIOTHER THEOR PR, V32, P332, DOI 10.1080/09593985.2016.1194646; Magee D, 2019, PAIN MANAG, V9, P63, DOI 10.2217/pmt-2018-0031; Meeus JNM, 2014, PHYS THER, V94, P730, DOI 10.2522/ptj.20130258; Mejdahl MK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1865; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Nijs J, 2019, BRAZ J PHYS THER, V23, P367, DOI 10.1016/j.bjpt.2018.12.003; Nijs J, 2016, ACTA ONCOL, V55, P659, DOI 10.3109/0284186X.2016.1167958; Nogueira Leandro Alberto Calazans, 2018, J. bras. psiquiatr., V67, P273; Patrick Donald L, 2003, J Natl Cancer Inst, V95, P1110; Prevost V, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5836-5; Richter M, 2019, SCHMERZ, V33, P244, DOI 10.1007/s00482-019-0366-2; Sánchez-Sánchez B, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052377; Sato F, 2014, TOHOKU J EXP MED, V232, P115, DOI 10.1620/tjem.232.115; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Therapeutic Patient Education, 1998, CONTINUING ED PROGRA; van der Vleuten CPM, 2005, MED EDUC, V39, P309, DOI 10.1111/j.1365-2929.2005.02094.x; Wang K, 2018, BREAST, V42, P113, DOI 10.1016/j.breast.2018.08.105; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x	45	8	8	0	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAY	2021	18	9							4463	10.3390/ijerph18094463	http://dx.doi.org/10.3390/ijerph18094463			16	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	SB8IF	33922314	gold, Green Published			2024-09-18	WOS:000650230100001
J	Thomaz, EBAF; Costa, EM; Queiroz, RCD; Emmi, DT; Ribeiro, AGA; da Silva, NC; Hugo, FN; Figueiredo, N				Abreu Fonseca Thomaz, Erika Barbara; Costa, Elisa Miranda; de Sousa Queiroz, Rejane Christine; Emmi, Danielle Tupinamba; Araujo Ribeiro, Ana Graziela; da Silva, Nubia Cristina; Hugo, Fernando Neves; Figueiredo, Nilcema			Advances and weaknesses of the work process of the oral cancer care network in Brazil: A latent class transition analysis	COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY			English	Article						epidemiologic studies; mouth neoplasms; oral cancer; quality of health care; secondary care centers	HEALTH-CARE; SURVIVAL; MANAGEMENT; COVERAGE; ACCESS; SYSTEM	Objective To analyse the provision of oral cancer (OC) care services in the Dental Specialties Centers (Centros de Especialidades Odontologicas-CEO) in Brazil and identify changes over two cycles of external evaluation of the Program for the Improvement of Access and Quality-PMAQ, in 2014 and 2018. Method This is a nationwide panel ecological study, including 916 CEO. Data from interviews with managers and dentists of the CEO were used, including variables related to training on OC, clinical protocols, biopsies, referral for diagnosis and treatment, and registration of users with OC. We carried out Latent Transition Analysis (LTA) to identify patterns (latent status LS) of service adequacy and work processes' changes between the two assessment cycles. We tested models with three, four, and five LS, selecting the one with the best conceptual interpretability and good model fit parameters. Data from the LS were plotted on choropleth and hotspots maps in Brazil allowing us to identify areas with the better or worse provision of specialized OC services. Results The model with four LS was chosen. The four LS were named: 1.'Most indicators inadequate for OC care' (the worst); 2. 'Most indicators suitable for OC care' (the best); 3. 'CEO with a poor relation with Primary Health Care (PHC) services'; and 4. 'CEO with a poor relation with tertiary hospital services'. The comparison of the LS transition between the two cycles revealed that 419 (45.7%) CEO remained in the same LS (1 -> 1, 3 -> 4, 2 -> 2); 228 (24.9%) switched to a worse status (2 -> 1, 2 -> 4, 3 -> 1) and 269 (29.4%) switched to a better LS (1 -> 2, 1 -> 4, 3 -> 2). While the majority of the CEO improved, we identified a decline of 17.8% in those who reported performing biopsies and 18.3% in the number of CEO that had hospitals for referring confirmed OC cases. Almost all Brazilian states had CEO that improved the work process. The Southeast and South regions had the highest percentage of CEO with the better work process in both cycles. Hotspots showed areas concentrating improvements in the work process in the Northeast region. However, some hotspots in the North revealed some CEO where the work process deteriorated or remained unsatisfactory. Conclusions There are regional inequities in the provision of OC care in CEO. Most services improved their work process or remained stable. However, the biopsies and the referral to hospital care for confirmed cases declined, indicating that CEO need to improve planning and care provision to reduce OC morbimortality.	[Abreu Fonseca Thomaz, Erika Barbara; Costa, Elisa Miranda; de Sousa Queiroz, Rejane Christine] Univ Fed Maranhao, Publ Hlth Dept, Rua Barao de Itapary 155, BR-65020070 Sao Luis, Maranhao, Brazil; [Emmi, Danielle Tupinamba] Fed Univ Para, Dent Fac, Belem, Para, Brazil; [Araujo Ribeiro, Ana Graziela] Univ Fed Maranhao, Dent Dept, Sao Luis, Maranhao, Brazil; [da Silva, Nubia Cristina] Methods Analyt & Technol Hlth Consortium, Belo Horizonte, MG, Brazil; [Hugo, Fernando Neves] Univ Fed Rio Grande do Sul, Dept Prevent & Social Dent, Porto Alegre, RS, Brazil; [Figueiredo, Nilcema] Univ Fed Pernambuco, Acad Area Social Med, Recife, PE, Brazil	Universidade Federal do Maranhao; Universidade Federal do Para; Universidade Federal do Maranhao; Universidade Federal do Rio Grande do Sul; Universidade Federal de Pernambuco	Thomaz, EBAF (corresponding author), Univ Fed Maranhao, Publ Hlth Dept, Rua Barao de Itapary 155, BR-65020070 Sao Luis, Maranhao, Brazil.	erika.barbara@ufma.br	THOMAZ, ERIKA/AAU-7762-2021; Hugo, Fernando/H-6789-2019; QUEIROZ, REJANE CHRISTINE DE SOUSA/HJI-3769-2023	Silva Rocha, Nubia/0000-0002-0809-2152; Hugo, Fernando/0000-0003-2222-7719; Ribeiro, Ana Graziela/0000-0001-7191-3497; Emmi, Danielle/0000-0002-6046-0717	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Ministerio da Saude	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Saude	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Ministerio da Saude	Almutlaqah MA, 2018, J INT SOC PREV COMMU, V8, P431, DOI 10.4103/jispcd.JISPCD_205_18; de Goes PSA, 2012, CAD SAUDE PUBLICA, V28, pS81, DOI 10.1590/S0102-311X2012001300009; Ribeiro AGA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247101; Boschiero MN, 2021, ANN GLOB HEALTH, V87, DOI 10.5334/aogh.3182; Casotti E, 2016, CIENC SAUDE COLETIVA, V21, P1573, DOI 10.1590/1413-81232015215.10742; Chaves Sônia Cristina Lima, 2018, Saúde debate, V42, P76, DOI 10.1590/0103-11042018s206; da Cunha AR, 2022, ORAL DIS, V28, P925, DOI 10.1111/odi.13620; da Cunha AR, 2020, CIENC SAUDE COLETIVA, V25, P3075, DOI 10.1590/1413-81232020258.31282018; Bonfante GMD, 2014, CAD SAUDE PUBLICA, V30, P983; Donabedian A, 1986, QRB Qual Rev Bull, V12, P99; ESRI, 2016, ArcGIS Desktop: Release 10.4.1. Software; Perea LME, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000251, 10.11606/s1518-8787.2018052000251]; Freire AR, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010238; Ghantous Yasmine, 2017, Harefuah, V156, P645; Goes PS Angeiras, 2018, Pesqui Bras Odontopediatria Clin Integr, V18, P1; Harzheim E, 2020, CIENC SAUDE COLETIVA, V25, P1361, DOI 10.1590/1413-81232020254.35062019; Rocha TAH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3700-z; Hung M, 2020, WORLD J CLIN ONCOL, V11, P918, DOI 10.5306/wjco.v11.i11.918; Hwang WT, 2003, LIFETIME DATA ANAL, V9, P261, DOI 10.1023/A:1025884719728; Ilhan B, 2021, ORAL ONCOL, V116, DOI 10.1016/j.oraloncology.2021.105254; Kowalski LP, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1507; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Lanza ST, 2010, J DRUG ISSUES, V40, P93, DOI 10.1177/002204261004000106; Laronde DM, 2014, COMMUNITY DENT ORAL, V42, P375, DOI 10.1111/cdoe.12093; Leal RVS, 2021, PHYSIS-REV SAUDE COL, V31, P1; Macinko J, 2017, J AMBUL CARE MANAG, V40, pS4, DOI 10.1097/JAC.0000000000000189; Menezes RG, 2021, Z VGL POLITIKWISSENS, V15, P229, DOI 10.1007/s12286-021-00491-8; Messadi Diana V, 2009, J Calif Dent Assoc, V37, P789; Miranda A, 2020, ORAL ONCOL, V102, DOI 10.1016/j.oraloncology.2019.104551; Morris AJ, 2001, BRIT DENT J, V191, P660; Muthen L.K., 2012, MPLUS USERS GUIDE VE; Pucca GA, 2015, J DENT RES, V94, P1333, DOI 10.1177/0022034515599979; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Rasella D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002570; Raymundo MLB, 2021, MED ORAL PATOL ORAL, V26, pE78, DOI 10.4317/medoral.24009; RODRIGUES Larycia Vicente, 2019, RGO, Rev. Gaúch. Odontol., V67, pe20190027, DOI 10.1590/1981-86372019000273565; Russo G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241017; de Mello ALSF, 2014, CIENC SAUDE COLETIVA, V19, P205, DOI 10.1590/1413-81232014191.1748; Scherer CI, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005961; Seo BY, 2016, J KOR ASSOC ORAL MAX, V42, P31, DOI 10.5125/jkaoms.2016.42.1.31; de Lima FLT, 2020, CIENC SAUDE COLETIVA, V25, P3201, DOI 10.1590/1413-81232020258.17182018; Thavarool SB, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-018-1550-z; Torres-Pereira CC, 2012, CAD SAUDE PUBLICA, V28, pS30, DOI 10.1590/S0102-311X2012001300005; Wang TT, 2020, B WORLD HEALTH ORGAN, V98, P719, DOI 10.2471/BLT.19.247288; Wong TJ, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08198-5	45	7	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0301-5661	1600-0528		COMMUNITY DENT ORAL	Community Dentist. Oral Epidemiol.	FEB	2022	50	1			SI		38	47		10.1111/cdoe.12711	http://dx.doi.org/10.1111/cdoe.12711			10	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	XX2QR	34967970				2024-09-18	WOS:000736147600007
J	Dong, ZH; Zhang, HM; Chen, YX; Payne, PRO; Li, FH				Dong, Zehao; Zhang, Heming; Chen, Yixin; Payne, Philip R. O.; Li, Fuhai			Interpreting the Mechanism of Synergism for Drug Combinations Using Attention-Based Hierarchical Graph Pooling	CANCERS			English	Article						drug response prediction; graph neural networks; interpretability	CANCER; ENCYCLOPEDIA; NETWORKS	Simple Summary This paper introduces a novel graph neural network (a hierarchical graph pooling model), SANEpool, to effectively detect core sub-networks of significant genes for predicting the synergy score of drug/drug combinations in cancer. SANEpool successfully addresses the limitations of the un-transparency in the prediction process of previous computational AI models for drug synergy prediction, while providing the superior predictive performance than popular baselines on numerous drug-synergy prediction datasets. The success of SANEpool indicates that significant gene-gene interactions and gene-drug interactions play a crucial role in designing powerful deep learning models to provide accurate prediction and to reveal the mechanism of the synergy (MoS).Abstract Synergistic drug combinations provide huge potentials to enhance therapeutic efficacy and to reduce adverse reactions. However, effective and synergistic drug combination prediction remains an open question because of the unknown causal disease signaling pathways. Though various deep learning (AI) models have been proposed to quantitatively predict the synergism of drug combinations, the major limitation of existing deep learning methods is that they are inherently not interpretable, which makes the conclusions of AI models untransparent to human experts, henceforth limiting the robustness of the model conclusion and the implementation ability of these models in real-world human-AI healthcare. In this paper, we develop an interpretable graph neural network (GNN) that reveals the underlying essential therapeutic targets and the mechanism of the synergy (MoS) by mining the sub-molecular network of great importance. The key point of the interpretable GNN prediction model is a novel graph pooling layer, a self-attention-based node and edge pool (henceforth SANEpool), that can compute the attention score (importance) of genes and connections based on the genomic features and topology. As such, the proposed GNN model provides a systematic way to predict and interpret the drug combination synergism based on the detected crucial sub-molecular network. Experiments on various well-adopted drug-synergy-prediction datasets demonstrate that (1) the SANEpool model has superior predictive ability to generate accurate synergy score prediction, and (2) the sub-molecular networks detected by the SANEpool are self-explainable and salient for identifying synergistic drug combinations.	[Dong, Zehao; Chen, Yixin] Washington Univ St Louis, Dept Comp Sci & Engn, St Louis, MO 63130 USA; [Zhang, Heming; Payne, Philip R. O.; Li, Fuhai] Washington Univ, Inst Informat Data Sci & Biostat, Sch Med, St Louis, MO 63110 USA; [Li, Fuhai] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Li, FH (corresponding author), Washington Univ, Inst Informat Data Sci & Biostat, Sch Med, St Louis, MO 63110 USA.; Li, FH (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	zehao.dong@wustl.edu; hemingzhang@wustl.edu; chen@cse.wustl.edu; prpayne@wustl.edu; fuhai.li@wustl.edu	dong, zehao/KVX-8046-2024; Payne, Philip/E-3841-2011		Children's Discovery Institute (CDI) [M-II-2019-802]; United States National Library of Medicine (NLM) [1R01LM013902-01A1]	Children's Discovery Institute (CDI); United States National Library of Medicine (NLM)	This work is partially supported by the Children's Discovery Institute (CDI) M-II-2019-802, and United States National Library of Medicine (NLM) 1R01LM013902-01A1 to Fuhai Li.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bento AP, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00456-1; Burkart N, 2021, J ARTIF INTELL RES, V70, P245; Cangea C, 2018, Arxiv, DOI arXiv:1811.01287; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Carvalho DV, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8080832; Chandrasekaran S, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156777; Chen D, 2016, MOL BIOSYST, V12, P614, DOI 10.1039/c5mb00599j; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cheng JP, 2016, Arxiv, DOI arXiv:1601.06733; Crino L, 1997, J CLIN ONCOL, V15, P297, DOI 10.1200/JCO.1997.15.1.297; Dai HJ, 2016, PR MACH LEARN RES, V48; Defferrard M, 2017, Arxiv, DOI arXiv:1606.09375; DEVITA VT, 1975, CANCER, V35, P98, DOI 10.1002/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO;2-B; Devlin J, 2019, Arxiv, DOI arXiv:1810.04805; Dong Z., 2023, P 11 INT C LEARN REP; Dong Z., 2022, PMLR, P5360; Dong ZH, 2021, Arxiv, DOI arXiv:2105.07082; Feng JR, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-020-03850-6; Fout A, 2017, ADV NEUR IN, V30; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Holbeck SL, 2017, CANCER RES, V77, P3564, DOI 10.1158/0008-5472.CAN-17-0489; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Hosseini SR, 2023, BRIEF BIOINFORM, V24, DOI 10.1093/bib/bbac588; Jaaks P, 2022, NATURE, V603, P166, DOI 10.1038/s41586-022-04437-2; Janizek J.D., 2018, Explainable machine learning prediction of synergistic drug combinations for precision cancer medicine, P331769, DOI [10.1101/331769, DOI 10.1101/331769]; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Ke-Jia Xu, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P382, DOI 10.1109/ISB.2011.6033183; Kuru HI, 2022, IEEE ACM T COMPUT BI, V19, P2334, DOI 10.1109/TCBB.2021.3086702; Hamilton WL, 2018, Arxiv, DOI arXiv:1706.02216; Lee J, 2019, PR MACH LEARN RES, V97; Li P, 2015, BIOINFORMATICS, V31, P2007, DOI 10.1093/bioinformatics/btv080; Liu Q, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008653; Monti F., 2017, Geometric matrix completion with recurrent multi-graph neural networks; Mott BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13891; Kipf TN, 2017, Arxiv, DOI [arXiv:1609.02907, DOI 10.48550/ARXIV.1609.02907]; Niepert M, 2016, PR MACH LEARN RES, V48; O'Neil J, 2016, MOL CANCER THER, V15, P1155, DOI 10.1158/1535-7163.MCT-15-0843; Pan RQ, 2017, CANCER CELL, V32, P748, DOI 10.1016/j.ccell.2017.11.003; Parikh A.P., 2016, arXiv; Podolsky SH, 2011, NEW ENGL J MED, V365, P488, DOI 10.1056/NEJMp1106161; Preuer K, 2018, BIOINFORMATICS, V34, P1538, DOI 10.1093/bioinformatics/btx806; Radic-Sarikas B, 2017, MOL CANCER THER, V16, P88, DOI 10.1158/1535-7163.MCT-16-0235; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Schlichtkrull M, 2018, LECT NOTES COMPUT SC, V10843, P593, DOI 10.1007/978-3-319-93417-4_38; Schutt KT, 2017, Arxiv, DOI arXiv:1706.08566; Shuhendler AJ, 2010, BREAST CANCER RES TR, V119, P255, DOI 10.1007/s10549-008-0271-3; Sidorov P, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00509; Vaswani A, 2017, ADV NEUR IN, V30; Veličkovic P, 2018, Arxiv, DOI arXiv:1710.10903; Verma S, 2018, Arxiv, DOI arXiv:1805.08090; Wang JX, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab390; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Wu ZK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S7; Xu K., 2018, 7 INT C LEARNING REP, DOI DOI 10.48550/ARXIV.1810.00826; Yan S., 2020, Advances in Neural Information Processing Systems, V33, P12486; Yang JCH, 2018, CLIN LUNG CANCER, V19, P27, DOI 10.1016/j.cllc.2017.06.013; Yao JJ, 2021, ARCH PATHOL LAB MED, V145, P692, DOI 10.5858/arpa.2020-0513-RA; Yi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093960; Ying R, 2018, ADV NEUR IN, V31; Ying R, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P974, DOI 10.1145/3219819.3219890; Zhang MH, 2020, Arxiv, DOI [arXiv:1904.12058, 10.48550/arXiv.1904.12058]; Zhang MH, 2018, AAAI CONF ARTIF INTE, P4438; Zhang MH, 2018, ADV NEUR IN, V31; Zhang P, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac403; Zhang Tianyu, 2021, Methods Mol Biol, V2194, P223, DOI 10.1007/978-1-0716-0849-4_12; Zitnik M, 2018, BIOINFORMATICS, V34, P457, DOI 10.1093/bioinformatics/bty294	70	2	2	10	36	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	SEP	2023	15	17							4210	10.3390/cancers15174210	http://dx.doi.org/10.3390/cancers15174210			18	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	R2BL9	37686486	Green Submitted, Green Published, gold			2024-09-18	WOS:001062443500001
J	Piai, V; Prins, JB; Verdonck-de Leeuw, IM; Leemans, CR; Terhaard, CHJ; Langendijk, JA; de Jong, RJB; Smit, JH; Takes, RP; Kessels, RPC				Piai, Vitoria; Prins, Judith B.; Verdonck-de Leeuw, Irma M.; Leemans, C. Rene; Terhaard, Chris H. J.; Langendijk, Johannes A.; de Jong, Robert J. Baatenburg; Smit, Johannes H.; Takes, Robert P.; Kessels, Roy P. C.			Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment	JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY			English	Article							QUALITY-OF-LIFE; COGNITIVE FUNCTION; CHEMORADIATION; PREVALENCE; MEMORY; INDEX	IMPORTANCE Head and neck cancer (HNC) and its treatment may negatively alter neurocognitive and speech functioning. However, the prevalence of neurocognitive impairment among patients with HNC before treatment is poorly studied, and the association between neurocognitive and speech functioning is unknown, which hampers good interpretability of the effect of HNC treatment on neurocognitive and speech function. OBJECTIVES To document neurocognitive functioning in patients with HNC before treatment and to investigate the association between neurocognitive and speech functioning. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of newly diagnosed patients with HNC before treatment using a large sample obtained in a nationwide, multicenter setting (Netherlands Quality of Life and Biomedical Cohort Study in Head and Neck Cancer [NET-QUBIC] project). MAIN OUTCOME AND MEASURES Objective neuropsychological measures of delayed recall, letter fluency, and executive functioning, as well as patient-reported outcome measures on neurocognitive speech and functioning, were collected before treatment. RESULTS In total, 254 patients with HNC participated (71.7% male), with a mean (SD) age of 62 (10) years. The response rate ranged from 81.9% (208 of 254) to 84.6%(215 of 254). Objective neurocognitive measures indicated that 4.7%(10 of 212) to 15.0%(32 of 214) of patients were initially seen with moderate to severe cognitive impairment. Mild to moderate impairment was found in 12.3%(26 of 212) to 26.2%(56 of 214) of patients. The most altered domains were delayed recall and letter fluency. Seven percent (15 of 208) of the patients reported high levels of everyday neurocognitive failure, and 42.6%(89 of 209) reported speech problems. Objective neurocognitive function was not significantly associated with patient-reported neurocognitive or speech functioning, but the results from patient-reported outcome measures were significantly correlated. CONCLUSIONS AND RELEVANCE Results of this study demonstrate a high prevalence of impaired speech functioning among patients with HNC before treatment, which is in line with previous findings. A novel finding is that neurocognitive impairment is also highly prevalent as objectively measured and as self-perceived. Understanding the reason why patients with HNC are initially seen with neurocognitive impairment before the start of treatment is important because this impairment may complicate patient-clinician interaction and alter treatment adherence and because treatment itself may further worsen cognitive functioning. In addition, low self-perceived neurocognitive and speech functioning before treatment may decrease a patient's confidence in communicative participation and perceived quality of life. Disentangling the associations between objective and patient-reported neurocognitive and speech functions is an important area for future research.	[Piai, Vitoria; Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Med Neurosci, Dept Med Psychol, Postbus 9101, NL-6500 HB Nijmegen, Netherlands; [Piai, Vitoria; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit, Nijmegen, Netherlands; [Prins, Judith B.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Med Psychol, Nijmegen, Netherlands; [Verdonck-de Leeuw, Irma M.; Leemans, C. Rene] Vrije Univ Amsterdam, Amsterdam UMC, Dept Otolaryngol Head & Neck Surg, Canc Ctr Amsterdam, Amsterdam, Netherlands; [Verdonck-de Leeuw, Irma M.; Terhaard, Chris H. J.] Vrije Univ, Dept Clin Neuro & Dev Psychol, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Terhaard, Chris H. J.] Univ Med Ctr, Dept Radiotherapy, Utrecht, Netherlands; [Langendijk, Johannes A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [de Jong, Robert J. Baatenburg] Erasmus MC, Erasmus Canc Inst, Dept Otolaryngol & Head & Neck Surg, Rotterdam, Netherlands; [Smit, Johannes H.] Vrije Univ Amsterdam, Amsterdam UMC, Psychiat, Amsterdam Publ Hlth, Amsterdam, Netherlands; [Takes, Robert P.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Otorhinolaryngol & Head & Neck Surg, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Piai, V (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Ctr Med Neurosci, Dept Med Psychol, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.	v.piai@radboudumc.nl	Prins, Judith/C-8522-2013; Kessels, Roy/D-1902-2010; Takes, R.P./L-4680-2015; Sundström, Johan/A-6286-2009; Piai, Vitoria/D-5777-2012	Langendijk, Johannes A./0000-0003-1083-372X; Verdonck-de Leeuw, Irma/0000-0002-4507-4607; Piai, Vitoria/0000-0002-4860-5952; Leemans, C. Rene/0000-0001-7887-083X	Dutch Cancer Society (KWF-Alpe d'HuZes); Language in Interaction from the Netherlands Organisation for Scientific Research	Dutch Cancer Society (KWF-Alpe d'HuZes); Language in Interaction from the Netherlands Organisation for Scientific Research	This study was supported by the Dutch Cancer Society (KWF-Alpe d'HuZes) and by Language in Interaction from the Netherlands Organisation for Scientific Research. This study was carried out using the research infrastructure within the Netherlands Quality of Life and Biomedical Cohort Study in Head and Neck Cancer (NET-QUBIC) project sponsored by the Dutch Cancer Society (KWF-Alpe d'HuZes). Dr Piai was supported by Language in Interaction from the Netherlands Organisation for Scientific Research.	[Anonymous], 2017, R LANG ENV STAT COMP; [Anonymous], 2012, NEUROPSYCHOLOGICAL A; Arlinger S, 2003, INT J AUDIOL, V42, pS17; Bolt S, 2016, JAMA OTOLARYNGOL, V142, P1145, DOI 10.1001/jamaoto.2016.1198; Bond SM, 2016, SUPPORT CARE CANCER, V24, P4433, DOI 10.1007/s00520-016-3284-1; Bond SM, 2012, SUPPORT CARE CANCER, V20, P149, DOI 10.1007/s00520-010-1081-9; Borggreven PA, 2007, EUR ARCH OTO-RHINO-L, V264, P651, DOI 10.1007/s00405-007-0249-5; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bruijnen CJWH, 2019, J SUBST USE, V24, P47, DOI 10.1080/14659891.2018.1497102; Cnossen IC, 2012, SUPPORT CARE CANCER, V20, P2925, DOI 10.1007/s00520-012-1422-y; de Vent NR, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01601; Duff K, 2016, APPL NEUROPSYCH-ADUL, V23, P179, DOI 10.1080/23279095.2015.1030019; Dwivedi RC, 2009, CANCER TREAT REV, V35, P417, DOI 10.1016/j.ctrv.2009.04.013; Hilari K, 2003, APHASIOLOGY, V17, P365, DOI 10.1080/02687030244000725; Hsiao KY, 2010, INT J RADIAT ONCOL, V77, P722, DOI 10.1016/j.ijrobp.2009.06.080; Isenberg-Grzeda E, 2017, CURR OPIN SUPPORT PA, V11, P24, DOI 10.1097/SPC.0000000000000257; Levelt W. J. M., 1989, SPEAKING INTENTION A; Piai V, 2015, HUM BRAIN MAPP, V36, P2767, DOI 10.1002/hbm.22806; Ponds R., 2006, TIJDSCHRIFT NEUROPSY, V2006, P37; Rinkel RN, 2008, HEAD NECK-J SCI SPEC, V30, P868, DOI 10.1002/hed.20795; Rinkel RN, 2016, EUR ARCH OTO-RHINO-L, V273, P1849, DOI 10.1007/s00405-015-3680-z; Roelofs A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00307; Rogers SN, 2006, BRIT J ORAL MAX SURG, V44, P283, DOI 10.1016/j.bjoms.2005.06.025; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Sinha P, 2018, JAMA OTOLARYNGOL, V144, P978, DOI 10.1001/jamaoto.2018.0283; van Nieuwenhuizen AJ, 2014, SUPPORT CARE CANCER, V22, P3321, DOI 10.1007/s00520-014-2359-0; Welsh LC, 2014, CLIN ONCOL-UK, V26, P765, DOI 10.1016/j.clon.2014.06.014; Wilbers J, 2015, NEURO-ONCOL PRACT, V2, P144, DOI 10.1093/nop/npv012; Williams AM, 2017, JAMA OTOLARYNGOL, V143, P1228, DOI 10.1001/jamaoto.2017.2014; Williams AM, 2017, OTOLARYNG HEAD NECK, V157, P808, DOI 10.1177/0194599817709235	30	10	10	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6181	2168-619X		JAMA OTOLARYNGOL	JAMA Otolaryngol-Head Neck Surg.	MAR	2019	145	3					251	257		10.1001/jamaoto.2018.3981	http://dx.doi.org/10.1001/jamaoto.2018.3981			7	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	HP9GT	30676629	Green Published, Bronze			2024-09-18	WOS:000462001800012
J	Warth, M; Stoffel, M; Koehler, F; Bardenheuer, HJ; Kessler, J; Ditzen, B				Warth, Marco; Stoffel, Martin; Koehler, Friederike; Bardenheuer, Hubert J.; Kessler, Jens; Ditzen, Beate			Characteristics of salivary cortisol and alpha-amylase as psychobiological study outcomes in palliative care research	BMC PALLIATIVE CARE			English	Article						Stress response; Corticosteroid; Autonomous nervous system; Cancer; Oncology; Palliative care	HEART-RATE-VARIABILITY; BREAST-CANCER PATIENTS; DIURNAL CORTISOL; PERFORMANCE STATUS; STRESS-MANAGEMENT; SERUM CORTISOL; MUSIC-THERAPY; ASSOCIATION; SLEEP; PREDICTOR	Background: Psychosocial interventions are rapidly emerging in palliative care. However, randomized trials often fail to provide evidence for their effectiveness with regard to patient-reported outcomes. Stress biomarkers could complement self-report data, but little is known about their feasibility, acceptance, and interpretability. Methods: Therefore, we designed a randomized crossover trial in which 42 patients in a palliative care unit participated in both a brief mindfulness intervention (MI) and a resting state control condition (CC) on two consecutive afternoons. On each day, we collected four saliva samples in 20-min intervals using Salivettes (c) to determine salivary cortisol (sCort) and alpha-amylase (sAA) concentration levels. At all measurement points, self-rated well-being and stress as well as cardiovascular markers were assessed. Baseline measurements further included self-rated quality of life and clinician-rated functional status. Results: 78.6% of the patients provided the maximum number of 8 saliva samples and 62.2% reported no subjective difficulties with the sampling procedures. 66.6% (sCort) and 69.6% (sAA) of all possible samples were finally included in the analysis. Xerostomia and nausea were the main reasons for missing data. Higher sCort levels were associated with higher heart rate and lower quality of life, functional status, and heart rate variability. Corticosteroid and sedative medication as well as time since last meal were identified as potential confounders. Regarding reactivity to the MI, we found an overall decrease in sCort levels over time (b = -.03, p =.01), but this effect did not differ significantly between the study conditions (b =.03, p =.21). sAA levels were higher in men than in women. Trajectories over time did not significantly differ between the two conditions (b = -.02, p =.80) and associations with other stress and health-related constructs were weak. Conclusions: Findings indicate that sCort might serve as a psychobiological outcome in future palliative care trials. However, future research should refine the exact measurement and conceptualization strategies for sCort in palliative care research. High attrition rates should be expected in patients with xerostomia or nausea.	[Warth, Marco; Stoffel, Martin; Koehler, Friederike; Ditzen, Beate] Univ Hosp Heidelberg, Inst Med Psychol, Ctr Psychosocial Med, Bergheimer Str 20, D-69115 Heidelberg, Germany; [Warth, Marco; Stoffel, Martin; Koehler, Friederike; Ditzen, Beate] Heidelberg Univ, Bergheimer Str 20, D-69115 Heidelberg, Germany; [Warth, Marco] SRH Univ Heidelberg, Sch Therapeut Sci, Ludwig Guttmann Str 6, D-66120 Heidelberg, Germany; [Bardenheuer, Hubert J.; Kessler, Jens] Univ Hosp Heidelberg, Dept Anesthesiol, Neuenheimer Feld 131, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Warth, M (corresponding author), Univ Hosp Heidelberg, Inst Med Psychol, Ctr Psychosocial Med, Bergheimer Str 20, D-69115 Heidelberg, Germany.	marco.warth@srh.de	Warth, Marco/AAC-4685-2019; Koehler, Friederike/IWU-3614-2023	Ditzen, Beate/0000-0001-5853-4572; Koehler, Friederike/0000-0002-0877-7100	Deutsche Forschungsgemeinschaft; Heidelberg University; Projekt DEAL; Medical Faculty at Heidelberg University; H.W. & J. Hector Stiftung; Sonnen-Blau. Gemeinnuetzige Morgott-Schupp-Stiftung fuer fruehkindliche Erziehung und Palliativversorgung; Josef und Gertud-Juengling-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg University; Projekt DEAL; Medical Faculty at Heidelberg University; H.W. & J. Hector Stiftung; Sonnen-Blau. Gemeinnuetzige Morgott-Schupp-Stiftung fuer fruehkindliche Erziehung und Palliativversorgung; Josef und Gertud-Juengling-Stiftung	For the publication fee we acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme "Open Access Pub-likationskosten" as well as by Heidelberg University. Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Medical Faculty at Heidelberg University; the "H.W. & J. Hector Stiftung"; by "Sonnen-Blau. Gemeinnuetzige Morgott-Schupp-Stiftung fuer fruehkindliche Erziehung und Palliativversorgung"; and by the "Josef und Gertud-Juengling-Stiftung"	Abercrombie HC, 2004, PSYCHONEUROENDOCRINO, V29, P1082, DOI 10.1016/j.psyneuen.2003.11.003; Adam EK, 2009, PSYCHONEUROENDOCRINO, V34, P1423, DOI 10.1016/j.psyneuen.2009.06.011; Allmendinger IDC., 2016, RANDOMISIERTE KONTRO; [Anonymous], WHO Definition of Palliative Care 2017; Bernabé DG, 2012, J CLIN PATHOL, V65, P934, DOI 10.1136/jclinpath-2012-200695; Black DS, 2017, CANCER-AM CANCER SOC, V123, P3088, DOI 10.1002/cncr.30698; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Bränström R, 2013, PSYCHOSOMATICS, V54, P158, DOI 10.1016/j.psym.2012.04.007; Brincks AM, 2017, MULTIVAR BEHAV RES, V52, P149, DOI 10.1080/00273171.2016.1256753; Caraceni A, 2002, J PAIN SYMPTOM MANAG, V23, P239, DOI 10.1016/S0885-3924(01)00409-2; Chang YM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57792-3; Charalambous A, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/270876; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen SR, 2017, PALLIATIVE MED, V31, P120, DOI 10.1177/0269216316659603; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fleming M, 2020, SUPPORT CARE CANCER, V28, P1121, DOI 10.1007/s00520-019-04908-9; Ho RTH, 2018, PSYCHONEUROENDOCRINO, V87, P119, DOI 10.1016/j.psyneuen.2017.10.012; Hulett JM, 2019, BIOL RES NURS, V21, P318, DOI 10.1177/1099800419835321; KABATZINN J, 1999, STRESSBEWALTIGUNG DU; Kim HM, 2016, AM J HOSP PALLIAT ME, V33, P281, DOI 10.1177/1049909114563065; Krygier JR, 2013, INT J PSYCHOPHYSIOL, V89, P305, DOI 10.1016/j.ijpsycho.2013.06.017; Kwekkeboom KL, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.29_suppl.5; Lengacher CA, 2012, J HOLIST NURS, V30, P170, DOI 10.1177/0898010111435949; Lissoni P, 2007, IN VIVO, V21, P647; Lundström S, 2003, PALLIATIVE MED, V17, P503, DOI 10.1191/0269216303pm780oa; Matousek Rose H, 2010, Complement Ther Clin Pract, V16, P13, DOI 10.1016/j.ctcp.2009.06.004; Moraes LJ, 2018, PSYCHOL HEALTH MED, V23, P635, DOI 10.1080/13548506.2017.1417607; Mori I, 2020, J PAIN SYMPTOM MANAG, V60, P87, DOI 10.1016/j.jpainsymman.2020.02.011; Nakayama H, 2009, J MUSIC THER, V46, P160, DOI 10.1093/jmt/46.2.160; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Phillips KM, 2008, PSYCHOSOM MED, V70, P1044, DOI 10.1097/PSY.0b013e318186fb27; Pinheiro J., 2022, nlme: Linear and Nonlinear Mixed Effects Models; Pinherio JC., 2000, MIXED EFFECTS MODELS, DOI [10.1007/978-1-4419-0318-1, DOI 10.1007/B98882]; Poll EM, 2007, CLIN CHIM ACTA, V382, P15, DOI 10.1016/j.cca.2007.03.009; Potter J, 2003, PALLIATIVE MED, V17, P310, DOI 10.1191/0269216303pm760oa; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Quintana DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00805; R Core Team, 2020, R LANG ENV STAT COMP; Raghavendra RM, 2009, INTEGR CANCER THER, V8, P37, DOI 10.1177/1534735409331456; Rao RM, 2017, INDIAN J PALLIAT CAR, V23, P253, DOI 10.4103/IJPC.IJPC_102_17; ROILA F, 1991, ANN ONCOL, V2, P437, DOI 10.1093/oxfordjournals.annonc.a057981; Ryan R, 2017, PSYCHONEUROENDOCRINO, V79, P134, DOI 10.1016/j.psyneuen.2017.01.025; Ryan R, 2016, ANN BEHAV MED, V50, P210, DOI 10.1007/s12160-015-9753-9; Sharpley CF, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12671; Sharpley CF, 2017, PSYCHO-ONCOLOGY, V26, P1400, DOI 10.1002/pon.4327; Strahler J, 2017, NEUROSCI BIOBEHAV R, V83, P657, DOI 10.1016/j.neubiorev.2017.08.015; Sultan A, 2018, BIOL RHYTHM RES, V49, P680, DOI 10.1080/09291016.2017.1410016; Suzuki K, 2015, SUPPORT CARE CANCER, V23, P2129, DOI 10.1007/s00520-014-2585-5; Tang MT, 2020, CANCER NURS, V43, P238, DOI 10.1097/NCC.0000000000000804; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tell D, 2014, PSYCHOSOM MED, V76, P519, DOI 10.1097/PSY.0000000000000097; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Wan C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040353; Warth M, 2020, EUR J CANCER CARE, V29, DOI 10.1111/ecc.13249; Warth M, 2019, PALLIATIVE MED, V33, P332, DOI 10.1177/0269216318818011; Warth M, 2015, DTSCH ARZTEBL INT, V112, P788, DOI 10.3238/arztebl.2015.0788; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; Zeitzer JM, 2016, BREAST CANCER RES TR, V158, P43, DOI 10.1007/s10549-016-3864-2; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.60	60	5	6	3	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-684X			BMC PALLIAT CARE	BMC Palliat. Care	DEC 22	2022	21	1							226	10.1186/s12904-022-01085-1	http://dx.doi.org/10.1186/s12904-022-01085-1			13	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	7H5XT	36550454	gold, Green Published			2024-09-18	WOS:000903276800001
J	Zhang, LL; Huang, DF; Gao, JZ; Song, D; Hong, JH; Zhang, Y; Tang, HY; Zhang, LC				Zhang Lili; Huang Danfei; Gao Junzhao; Song Dong; Hong Jinghui; Zhang Yong; Tang Hongyu; Zhang Lechao			Polarization Multi-parameter Recognition and Texture Feature Analysis of Cancerous Tissue	ACTA PHOTONICA SINICA			Chinese	Article						Polarization imaging; Muller matrix; Polarization parameters; Texture features; Cancerous tissue	MUELLER MATRIX	At present, microscopic observation of pathological sections is still the gold standard for pathological diagnosis of cancer. The complex production process and manual detection process of pathological sections make pathological detection subjective and inefficient. Polarization imaging technology is sensitive to sub wavelength structures, and exploring an objective and efficient method for identifying cancerous tissue using polarization images has unique advantages in enhancing pathological diagnostic capabilities. In this article, based on the Muller matrix measurement scheme of double wave plate rotation method, a backscatter polarization imaging system is built and upgrated equipped with a tunable zoom microscope lens to meet the requirements of different resolution fields. The slice data of unstained lung cancer and basal cell cancerare collected, and the Muller matrix is obtained from 30 polarization intensity images based on the Fourier coefficient relationship. In order to enhance the interpretability and strong correlation of the original data analysis paradigm in which the meaning of the Mueller matrix elements is unclear and the interpretation of the information for a single polarization parameter is limited, we report a polarization multi-parameter feature recognition and texture feature analysis method for cancerous tissue. To overcome the limitation that a single Muller matrix image cannot accurately and comprehensively identify the structure of pathological tissue, we introduce rotation invariants to obtain a high-dimensional polarization parameter set, then select regions of interest randomly and generate polarization multi-parameter feature curves to achieve multi-dimensional feature extraction and visualization of pathological regions, solving the problem of direct use of Muller matrix affected by direction. At the same time, in order to further obtain organizational information from derived parameters, 4 texture attributes from gray level co-occurrence matrix and 6 texture attributes from Tamura are calculated to assist in quantitative analysis. The proposed method is experimental verified, the following results are obtained: the characteristic curves of polarization parameter set obtained from 20 random samples in the normal and cancerous regions of lung cancer have a very high degree of overlap respectively, indicating that the polarization characteristics of the same type of tissue are generally similar, but appear to be significantly different in comparison, which perfectly conforms the previous analysis of a single parameter. The visualized polarization multi-parameter feature curve displays the complete polarization characteristics of normal and cancerous tissue of lung cancer in a very concise and clear manner, while also clearly showing the difference in curve trends between normal and cancerous tissue. This method is also applicable to basal cell carcinoma. The information distribution characteristics of normal and cancerous tissue of lung cancer are analyzed by fixing the texture dimension and polarization dimension respectively. When the texture feature is fixed, each polarization parameter has different degrees of discrimination effect. For example, when the contrast attribute is fixed, all the polarization parameters except for the parameter indicating linear polarization ability have good discrimination for lung cancer tissue and can be used as auxiliary tools for quantitative analysis; when the polarization dimension is fixed, the distribution of values for different textures on normal and cancerous tissue is different. For example, for the parameter indicating the angle of phase delay, the texture contrast, correlation, energy, and homogeneity of cancerous tissue are generally higher than those of normal tissue, and their corresponding six Tamura features have good discrimination, all of which have the potential to be used for quantitative analysis. According to the above research process and results, the fitted polarization multi-parameter feature curve restores the original high-dimensional polarization parameter set to two demensions, which can visually and efficiently identify the distribution of polarization differences between normal and cancerous tissue, and can intuitively obtain the information about the differences between different types of tissues in various polarization dimensions. At the same time, the results of texture analysis of lung cancer show that when the texture dimension is fixed, a single texture attribute can be a common quantitative indicator for multiple polarization images; when the polarization dimension is fixed, different texture attributes are expected to be multiple auxiliary quantitative indicators for a single polarization dimension. This method is fast and efficient, providing a new idea for auxiliary pathological detection and demonstrating good application prospects in clinical practice.	[Zhang Lili; Huang Danfei; Gao Junzhao; Zhang Yong; Tang Hongyu; Zhang Lechao] Changchun Univ Sci & Technol, Coll Optoelect Engn, Changchun 130022, Peoples R China; [Zhang Lili; Huang Danfei; Gao Junzhao; Zhang Yong; Tang Hongyu; Zhang Lechao] Changchun Univ Sci & Technol, Zhongshan Res Inst, Zhongshan 528437, Peoples R China; [Song Dong; Hong Jinghui] First Hosp Jilin Univ, Changchun 130021, Peoples R China	Changchun University of Science & Technology; Changchun University of Science & Technology; Jilin University	Huang, DF (corresponding author), Changchun Univ Sci & Technol, Coll Optoelect Engn, Changchun 130022, Peoples R China.; Huang, DF (corresponding author), Changchun Univ Sci & Technol, Zhongshan Res Inst, Zhongshan 528437, Peoples R China.	1345539914@qq.com; huangd_f@163.com	li, jia/GVT-7587-2022		National Natural Science Foundation of China [61893096014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Foundation item: National Natural Science Foundation of China (No. 61893096014)	CHEN Siyang, 2022, Cancer detection method of intraoperative biopsy by Muller matrix; Chen Y, 2023, IEEE T MED IMAGING, V42, P304, DOI 10.1109/TMI.2022.3210113; Dong Y, 2017, BIOMED OPT EXPRESS, V8, P3643, DOI 10.1364/BOE.8.003643; Gao J, 2023, ACTA PHOTONICA SINIC, V52, DOI 10.3788/gzxb20235202.0210003; He C, 2021, LIGHT-SCI APPL, V10, DOI 10.1038/s41377-021-00639-x; He HH, 2019, J LIGHTWAVE TECHNOL, V37, P2534, DOI 10.1109/JLT.2018.2868845; He HH, 2012, J INNOV OPT HEAL SCI, V5, DOI 10.1142/S1793545812500174; Hu FY, 2020, IEEE ACM T COMPUT BI, V17, P1187, DOI 10.1109/TCBB.2019.2905553; Li PC, 2018, OPT EXPRESS, V26, P3791, DOI 10.1364/OE.26.003791; Lu SY, 1996, J OPT SOC AM A, V13, P1106, DOI 10.1364/JOSAA.13.001106; Si L, 2022, OPT EXPRESS, V30, P8676, DOI 10.1364/OE.451612; Sun MH, 2014, BIOMED OPT EXPRESS, V5, P4223, DOI 10.1364/BOE.5.004223; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; Unternaehrer J, 2020, J CLIN PATHOL, V73, P341, DOI 10.1136/jclinpath-2019-206155; WANG Ye, 2016, Modular Muller matrix microscope and its application	16	0	0	0	0	SCIENCE PRESS	EPHRATA	300 WEST CHESNUT ST, EPHRATA, PA 17522 USA	1004-4213			ACTA PHOTONICA SINIC	Acta Photonica Sinica	JUN	2024	53	6			SI				0610002	10.3788/gzxb20245306.0610002	http://dx.doi.org/10.3788/gzxb20245306.0610002			15	Optics	Emerging Sources Citation Index (ESCI)	Optics	YI6A0					2024-09-18	WOS:001267888100005
J	Bang, CS; Lee, JJ; Baik, GH				Bang, Chang Seok; Lee, Jae Jun; Baik, Gwang Ho			Computer-Aided Diagnosis of Diminutive Colorectal Polyps in Endoscopic Images: Systematic Review and Meta-analysis of Diagnostic Test Accuracy	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Review						artificial intelligence; deep learning; polyps; colon; colonoscopy; diminutive	SOCIETY TASK-FORCE; ARTIFICIAL-INTELLIGENCE; HISTOLOGY; CLASSIFICATION; CANCER; RECOMMENDATIONS; PREVALENCE; LESIONS	Background: Most colorectal polyps are diminutive and benign, especially those in the rectosigmoid colon, and the resection of these polyps is not cost-effective. Advancements in image-enhanced endoscopy have improved the optical prediction of colorectal polyp histology. However, subjective interpretability and inter- and intraobserver variability prohibits widespread implementation. The number of studies on computer-aided diagnosis (CAD) is increasing; however, their small sample sizes limit statistical significance. Objective: This review aims to evaluate the diagnostic test accuracy of CAD models in predicting the histology of diminutive colorectal polyps by using endoscopic images. Methods: Core databases were searched for studies that were based on endoscopic imaging, used CAD models for the histologic diagnosis of diminutive colorectal polyps, and presented data on diagnostic performance. A systematic review and diagnostic test accuracy meta-analysis were performed. Results: Overall, 13 studies were included. The pooled area under the curve, sensitivity, specificity, and diagnostic odds ratio of CAD models for the diagnosis of diminutive colorectal polyps (adenomatous or neoplastic vs nonadenomatous or nonneoplastic) were 0.96 (95% CI 0.93-0.97), 0.93 (95% CI 0.91-0.95), 0.87 (95% CI 0.76-0.93), and 87 (95% CI 38-201), respectively. The meta-regression analysis showed no heterogeneity, and no publication bias was detected. Subgroup analyses showed robust results. The negative predictive value of CAD models for the diagnosis of adenomatous polyps in the rectosigmoid colon was 0.96 (95% CI 0.95-0.97), and this value exceeded the threshold of the diagnosis and leave strategy. Conclusions: CAD models show potential for the optical histological diagnosis of diminutive colorectal polyps via the use of endoscopic images.	[Bang, Chang Seok; Baik, Gwang Ho] Hallym Univ, Coll Med, Dept Internal Med, Sakju Ro 77, Chunchon 24253, South Korea; [Bang, Chang Seok; Baik, Gwang Ho] Hallym Univ, Coll Med, Inst Liver & Digest Dis, Chunchon, South Korea; [Bang, Chang Seok; Lee, Jae Jun] Hallym Univ, Coll Med, Inst New Frontier Res, Chunchon, South Korea; [Bang, Chang Seok; Lee, Jae Jun] Chuncheon Sacred Heart Hosp, Div Big Data & Artificial Intelligence, Chunchon, South Korea; [Lee, Jae Jun] Hallym Univ, Coll Med, Dept Anesthesiol & Pain Med, Chunchon, South Korea	Hallym University; Hallym University; Hallym University; Hallym University	Bang, CS (corresponding author), Hallym Univ, Coll Med, Dept Internal Med, Sakju Ro 77, Chunchon 24253, South Korea.	csbang@hallym.ac.kr	Bang, Chang SEOK/I-9689-2019	Bang, Chang Seok/0000-0003-4908-5431; Baik, Gwang Ho/0000-0003-1419-7484	Technology Development Program - Ministry of SMEs and Startups (Korea) [S2931703]	Technology Development Program - Ministry of SMEs and Startups (Korea)(Ministry of SMEs & Startups (MSS), Republic of Korea)	This work was supported by the Technology Development Program (S2931703) and funded by the Ministry of SMEs and Startups (Korea).	Abadir AP, 2020, CLIN ENDOSC, V53, P132; Aziz M, 2020, J GASTROEN HEPATOL, V35, P1676, DOI 10.1111/jgh.15070; Bang CS, 2021, GASTROINTEST ENDOSC, V93, P1006, DOI 10.1016/j.gie.2020.11.025; Bang CS, 2020, J MED INTERNET RES, V22, DOI 10.2196/21983; Bang CS, 2020, KOR J GASTROENTEROL, V75, P120, DOI 10.4166/kjg.2020.75.3.120; Barua I, 2021, ENDOSCOPY, V53, P277, DOI 10.1055/a-1201-7165; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Byrne MF, 2019, GUT, V68, P94, DOI 10.1136/gutjnl-2017-314547; Chen PJ, 2018, GASTROENTEROLOGY, V154, P568, DOI 10.1053/j.gastro.2017.10.010; Cho BJ, 2020, AM J GASTROENTEROL, V115, P70, DOI 10.14309/ajg.0000000000000476; Gross S, 2011, GASTROINTEST ENDOSC, V74, P1354, DOI 10.1016/j.gie.2011.08.001; Gupta N, 2012, GASTROINTEST ENDOSC, V75, P1022, DOI 10.1016/j.gie.2012.01.020; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Hassan C, 2021, GASTROINTEST ENDOSC, V93, P77, DOI 10.1016/j.gie.2020.06.059; Horiuchi H, 2019, SCAND J GASTROENTERO, V54, P800, DOI 10.1080/00365521.2019.1627407; Jin EH, 2020, GASTROENTEROLOGY, V158, P2169, DOI [10.1053/j.gastro.2020.02.036, 10.1053/j.gastro.2020.02.03]; Kaltenbach T, 2020, GASTROENTEROLOGY, V158, P1095, DOI 10.1053/j.gastro.2019.12.018; Kandel P, 2019, CLIN ENDOSC, V52, P239, DOI 10.5946/ce.2018.136; Kominami Y, 2016, GASTROINTEST ENDOSC, V83, P643, DOI 10.1016/j.gie.2015.08.004; Kudo S, 2020, CLIN GASTROENTEROL H, V18, P1874, DOI 10.1016/j.cgh.2019.09.009; Li JL, 2021, EUR J GASTROEN HEPAT, V33, P1041, DOI 10.1097/MEG.0000000000001906; Lieberman D, 2008, GASTROENTEROLOGY, V135, P1100, DOI 10.1053/j.gastro.2008.06.083; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; Lui TKL, 2020, GASTROINTEST ENDOSC, V92, P11, DOI 10.1016/j.gie.2020.02.033; Mason SE, 2019, AM J GASTROENTEROL, V114, P1219, DOI 10.14309/ajg.0000000000000156; McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163; Mori Y, 2018, ANN INTERN MED, V169, P357, DOI 10.7326/M18-0249; Mori Y, 2016, ENDOSCOPY, V48, P1110, DOI 10.1055/s-0042-113609; Pu LZCT, 2020, GASTROINTEST ENDOSC, V92, P891, DOI 10.1016/j.gie.2020.02.042; Qumseya BJ, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.14; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rex DK, 2017, AM J GASTROENTEROL, V112, P1016, DOI 10.1038/ajg.2017.174; Rex DK, 2011, GASTROINTEST ENDOSC, V73, P419, DOI 10.1016/j.gie.2011.01.023; Rodriguez-Diaz E, 2021, GASTROINTEST ENDOSC, V93, P662, DOI 10.1016/j.gie.2020.09.018; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sánchez-Montes C, 2019, ENDOSCOPY, V51, P261, DOI 10.1055/a-0732-5250; Shahidi N, 2020, GASTROENTEROLOGY, V158, P783, DOI 10.1053/j.gastro.2019.10.024; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wong MCS, 2020, CLIN GASTROENTEROL H, V18, P553, DOI 10.1016/j.cgh.2019.07.016; Yang YJ, 2019, WORLD J GASTROENTERO, V25, P1666, DOI 10.3748/wjg.v25.i14.1666; Zachariah R, 2020, AM J GASTROENTEROL, V115, P138, DOI 10.14309/ajg.0000000000000429; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhang YC, 2021, J LAPAROENDOSC ADV S, V31, P1143, DOI 10.1089/lap.2020.0777	44	11	14	1	9	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY East, Unit 1100, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	AUG 25	2021	23	8							e29682	10.2196/29682	http://dx.doi.org/10.2196/29682			21	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	UH1QM	34432643	Green Published, gold			2024-09-18	WOS:000689714100002
J	Hübner, S; Haijen, E; Kaelen, M; Carhart-Harris, RL; Kettner, H				Hubner, Sebastian; Haijen, Eline; Kaelen, Mendel; Carhart-Harris, Robin Lester; Kettner, Hannes			Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						attrition; digital data; dropout; educational level; personality; psychedelics; web-based research; web-based survey	LIFE-THREATENING CANCER; PERSONALITY-TRAITS; EXPERIENCE QUESTIONNAIRE; PRETREATMENT PREDICTORS; PSILOCYBIN TREATMENT; ANXIETY; DEPRESSION; VALIDATION; THERAPY; EXPECTATIONS	Background: The resurgence of research and public interest in the positive psychological effects of psychedelics, together with advancements in digital data collection techniques, have brought forth a new type of research design, which involves prospectively gathering large-scale naturalistic data from psychedelic users; that is, before and after the use of a psychedelic compound. A methodological limitation of such studies is their high attrition rate, particularly owing to participants who stop responding after initial study enrollment. Importantly, study dropout can introduce systematic biases that may affect the interpretability of results. Objective: Based on a previously collected sample (baseline n=654), here we investigated potential determinants of study attrition in web-based prospective studies on psychedelic use. Methods: Logistic regression models were used to examine demographic, psychological trait and state, and psychedelic-specific predictors of dropout. Predictors were assessed 1 week before, 1 day after, and 2 weeks after psychedelic use, with attrition being defined as noncompletion of the key endpoint 4 weeks post experience. Results: Predictors of attrition were found among demographic variables including age (beta=0.024; P=.007) and educational levels, as well as personality traits, specifically conscientiousness (beta=-0.079; P=.02) and extraversion (beta=0.082; P=.01). Contrary to prior hypotheses, neither baseline attitudes toward psychedelics nor the intensity of acute challenging experiences were predictive of dropout. Conclusions: The baseline predictors of attrition identified here are consistent with those reported in longitudinal studies in other scientific disciplines, suggesting their transdisciplinary relevance. Moreover, the lack of an association between attrition and psychedelic advocacy or negative drug experiences in our sample contextualizes concerns about problematic biases in these and related data.	[Hubner, Sebastian; Haijen, Eline; Kaelen, Mendel; Carhart-Harris, Robin Lester; Kettner, Hannes] Imperial Coll London, Ctr Psychedel Res, Du Cane Rd,Burlington Danes Bldg, London W12 0TY, England	Imperial College London	Kettner, H (corresponding author), Imperial Coll London, Ctr Psychedel Res, Du Cane Rd,Burlington Danes Bldg, London W12 0TY, England.	hannes.kettner17@imperial.ac.uk	Haijen, Eline/GXI-0083-2022	Carhart-Harris, Robin/0000-0002-6062-7150; Kettner, Hannes/0000-0001-9482-0998	Centre for Psychedelic Research; Ad Astra Chandaria Foundation; Nikean Foundation; Tamas family; Alex Mosley Trust	Centre for Psychedelic Research; Ad Astra Chandaria Foundation; Nikean Foundation; Tamas family; Alex Mosley Trust	RCH and his group are funded by supporters of the Centre for Psychedelic Research. RCH and HK are supported by the Ad Astra Chandaria Foundation, the Nikean Foundation, Tim Ferriss, Anton Bilton, the Tamas family, and the Alex Mosley Trust. We are grateful to Kenneth Jonck and Nikolai Lassen from the PsychedelicSurvey platform [42].	Agosti V, 1996, AM J DRUG ALCOHOL AB, V22, P29, DOI 10.3109/00952999609001643; Almlund M, 2011, HBK ECON, V4, P1; Anderson B, 2019, BIOL PSYCHIAT, V85, pS182, DOI 10.1016/j.biopsych.2019.03.460; Barrett FS, 2016, J PSYCHOPHARMACOL, V30, P1279, DOI 10.1177/0269881116678781; Barrett FS, 2015, J PSYCHOPHARMACOL, V29, P1182, DOI 10.1177/0269881115609019; Becker R., 2018, Bulletin de Methodologie Sociologique, V139, P74, DOI [DOI 10.1177/0759106318762456, 10.1177/075910631876245, DOI 10.1177/075910631876245]; BENNETT GA, 1986, J PSYCHOSOM RES, V30, P567, DOI 10.1016/0022-3999(86)90029-2; Boekhout JM, 2019, J MED INTERNET RES, V21, DOI 10.2196/13416; Bogenschutz MP, 2015, J PSYCHOPHARMACOL, V29, P289, DOI 10.1177/0269881114565144; Brown M, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.5710; Cano MA, 2012, INT J ADV COUNS, V34, P231, DOI 10.1007/s10447-012-9153-9; Carhart-Harris RL, 2018, PSYCHOPHARMACOLOGY, V235, P399, DOI 10.1007/s00213-017-4771-x; Carhart-Harris RL, 2018, J PSYCHOPHARMACOL, V32, P725, DOI 10.1177/0269881118754710; Carhart-Harris RL, 2016, LANCET PSYCHIAT, V3, P619, DOI 10.1016/S2215-0366(16)30065-7; Clark MM, 1996, ADDICT BEHAV, V21, P509, DOI 10.1016/0306-4603(95)00081-X; Claus RE, 2002, J PSYCHOACTIVE DRUGS, V34, P69, DOI 10.1080/02791072.2002.10399938; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Daly J E, 2000, Violence Vict, V15, P137; Davis MJ, 1999, ANN BEHAV MED, V21, P339, DOI 10.1007/BF02895967; de Graaf R, 2000, AM J EPIDEMIOL, V152, P1039, DOI 10.1093/aje/152.11.1039; Elsey J.W. B., 2017, Drug Science, Policy and Law, V3, p2050324517723232, DOI DOI 10.1177/2050324517723232; Fabricatore AN, 2009, BEHAV RES THER, V47, P685, DOI 10.1016/j.brat.2009.05.004; Froese T, 2016, ECON BOT, V70, P103, DOI 10.1007/s12231-016-9342-2; Gill RS, 2012, CAN J SURG, V55, P239, DOI 10.1503/cjs.035710; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Griffiths RR, 2016, J PSYCHOPHARMACOL, V30, P1181, DOI 10.1177/0269881116675513; Grob CS, 2011, ARCH GEN PSYCHIAT, V68, P71, DOI 10.1001/archgenpsychiatry.2010.116; Grutzmacher SK, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/mhealth.9967; Haijen ECHM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00897; Hansson I, 2018, J RES PERS, V77, P133, DOI 10.1016/j.jrp.2018.10.002; HELSON R, 1992, PSYCHOL AGING, V7, P46, DOI 10.1037/0882-7974.7.1.46; Helson R, 2002, J RES PERS, V36, P287, DOI 10.1016/S0092-6566(02)00010-7; Honas JJ, 2003, OBES RES, V11, P888, DOI 10.1038/oby.2003.122; Jamieson G. A., 2005, Australian Journal of Clinical Experimental Hypnosis, V33, P119; Jiandani Dishay, 2016, BMC Obes, V3, P14, DOI 10.1186/s40608-016-0098-0; Johnson MW, 2014, J PSYCHOPHARMACOL, V28, P983, DOI 10.1177/0269881114548296; Joyce AS, 2007, INT J GROUP PSYCHOTH, V57, P269, DOI 10.1521/ijgp.2007.57.3.269; Kaertner LS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81446-7; Kettner H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245147; Khadjesari Z, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1523; Kiefer D., 2020, INTEGR MED ALERT, V24; Krebs Teri S, 2013, F1000Res, V2, P98, DOI 10.12688/f1000research.2-98.v1; Lamers F, 2012, COMPR PSYCHIAT, V53, P63, DOI 10.1016/j.comppsych.2011.01.011; LEE RM, 1995, J COUNS PSYCHOL, V42, P232, DOI 10.1037/0022-0167.42.2.232; Lee S, 2006, SOC SCI COMPUT REV, V24, P460, DOI 10.1177/0894439306288085; Lugtig P, 2014, SOCIOL METHOD RES, V43, P699, DOI 10.1177/0049124113520305; Lumsden J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8473; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mason NL, 2019, J PSYCHOACTIVE DRUGS, V51, P123, DOI 10.1080/02791072.2019.1580804; McDonald Bennett, 2017, JMIR Public Health Surveill, V3, pe73, DOI 10.2196/publichealth.7424; Meade A.W., 2013, 28 ANN M SOC IND ORG; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; Nestler S, 2015, INT J INTERNET SCI, V10, P37; Nour MM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00269; Nutt D, 2020, CELL, V181, P24, DOI 10.1016/j.cell.2020.03.020; Olver ME, 2011, J CONSULT CLIN PSYCH, V79, P6, DOI 10.1037/a0022200; Palhano-Fontes F, 2019, PSYCHOL MED, V49, P655, DOI 10.1017/S0033291718001356; PEKARIK G, 1984, ADDICT BEHAV, V9, P413, DOI 10.1016/0306-4603(84)90044-3; Peters ER, 1999, SCHIZOPHRENIA BULL, V25, P553, DOI 10.1093/oxfordjournals.schbul.a033401; Barbosa PCR, 2009, J PSYCHOACTIVE DRUGS, V41, P205, DOI 10.1080/02791072.2009.10400530; Richardson CR, 2010, J MED INTERNET RES, V12, P138, DOI 10.2196/jmir.1338; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Roseman L, 2019, J PSYCHOPHARMACOL, V33, P1076, DOI 10.1177/0269881119855974; Roseman L, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00974; Ross S, 2016, J PSYCHOPHARMACOL, V30, P1165, DOI 10.1177/0269881116675512; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Satherley N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121950; Sayre SL, 2002, AM J DRUG ALCOHOL AB, V28, P55, DOI 10.1081/ADA-120001281; Sessa B, 2018, PSYCHOPHARMACOLOGY, V235, P551, DOI 10.1007/s00213-017-4713-7; Soler J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00224; Spector Paul E, 1998, J Occup Health Psychol, V3, P356, DOI 10.1037/1076-8998.3.4.356; Spriggs MJ, 2021, EAT WEIGHT DISORD-ST, V26, P1265, DOI 10.1007/s40519-020-01000-8; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Srivastava S., 1999, HDB PERSONALITY THEO, V2, P102; Studerus E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012412; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; TOPP BW, 1986, J POLICE SCI ADMIN, V14, P234; TSUSHIMA WT, 1991, J CLIN PSYCHOL, V47, P199, DOI 10.1002/1097-4679(199103)47:2<199::AID-JCLP2270470204>3.0.CO;2-H; Uthaug MV, 2019, PSYCHOPHARMACOLOGY, V236, P2653, DOI 10.1007/s00213-019-05236-w; Uthaug MV, 2018, PSYCHOPHARMACOLOGY, V235, P2979, DOI 10.1007/s00213-018-4988-3; van Spijker BAJ, 2014, SUICIDE LIFE-THREAT, V44, P408, DOI 10.1111/sltb.12084; Vroling MS, 2016, EUR EAT DISORD REV, V24, P494, DOI 10.1002/erv.2474; Ward MK, 2017, COMPUT HUM BEHAV, V76, P417, DOI 10.1016/j.chb.2017.06.032; Warnick EM, 2012, CHILD ADOL MENT H-UK, V17, P76, DOI 10.1111/j.1475-3588.2011.00606.x; Wheeler E, 2008, SURG OBES RELAT DIS, V4, P515, DOI 10.1016/j.soard.2008.01.013; YASSREED EM, 1993, ADDICT BEHAV, V18, P431, DOI 10.1016/0306-4603(93)90060-M; Yockey RA, 2020, DRUG ALCOHOL DEPEN, V212, DOI 10.1016/j.drugalcdep.2020.108071; Zeifman RJ, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00782; Zhou HT, 2016, J PERS SOC PSYCHOL, V111, P493, DOI 10.1037/pspa0000056	89	8	8	0	7	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY East, Unit 1100, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	JUL 28	2021	23	7							e25973	10.2196/25973	http://dx.doi.org/10.2196/25973			14	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	TR2AM	34319246	Green Published, Green Submitted, gold			2024-09-18	WOS:000678773100002
C	Shah, T; Li, L; Chen, A; Krishnan, R; Soans, R; Vajdi, A; Cristescu, R		Tomaszewski, JE; Ward, AD		Shah, Tosha; Li, Lin; Chen, Antong; Krishnan, Radha; Soans, Rajath; Vajdi, Amir; Cristescu, Razvan			HER2 Prediction from breast H&E-stained whole slide Images: A comparison between ROI-based supervised learning and multiple-instance-learning approaches	DIGITAL AND COMPUTATIONAL PATHOLOGY, MEDICAL IMAGING 2024	Progress in Biomedical Optics and Imaging		English	Proceedings Paper	Conference on Medical Imaging - Digital and Computational Pathology	FEB 19-21, 2024	San Diego, CA	SPIE, Carnegie Hill Partners		HER2; H&E; weakly-supervised; attention; multiple instance learning; Vision Transformer		Human epidermal growth factor receptor 2 (HER2) serves as a prognostic and predictive biomarker for breast cancer. Recently, there has been an increasing number of studies evaluating the feasibility of utilizing H&E WSIs for determining HER2 status through innovative data-driven deep learning methods, taking advantage of the ubiquitous availability of H&E WSIs. One of the main challenges with these data-driven methods is the need for large-scale datasets with high quality annotations, which can be expensive to curate. Therefore, in this study, we explored both the region-of-interest (ROI)-based supervised and the attention-based multiple-instance-learning (MIL) weakly supervised methods for predicting HER2 status on H&E WSIs to evaluate whether avoiding labor-intensive tumor annotation will compromise the final prediction performance. The ROI-based method involved an Inception-v3 along with an aggregation step to combine the patch-level predictions into a WSI-level prediction. On the other hand, the attention-based MIL methods explored ImageNet pretrained ResNet, H&E image pretrained ResNet, and H&E image pretrained vision transformer (ViT) as encoders for WSI-level HER2 prediction. Experiments are carried out on N = 355 WSIs available in public domain with HER2 status determined by IHC and ISH and annotations of breast invasive carcinoma. The dataset was split into training/validation/test set with 80/10/10 ratio. Our results demonstrate that the attention-based ViT MIL method is able to reach similar accuracy as the ROI-based method on the independent test set (AUC of 0.79 (95% CI: 0.63-0.95) versus 0.88 (95% CI: 0.63-0.9) respectively), and thus reduces the burden of labor-intensive annotations. Furthermore, the attention mechanism enhances interpretability of the results and offers insights into the reliability of the predictions.	[Shah, Tosha; Li, Lin; Chen, Antong; Soans, Rajath] Merck & Co Inc, Image Data Analyt, West Point, PA 08889 USA; [Vajdi, Amir] Merck & Co Inc, Precis Oncol Biomarkers, Boston, MA USA; [Krishnan, Radha] MSD UK Ltd, Clin Imaging & Pathol, London, England; [Cristescu, Razvan] Merck & Co Inc, Translat Canc Genom Analyt, Boston, MA USA	Merck & Company; Merck & Company; Merck & Company	Shah, T (corresponding author), Merck & Co Inc, Image Data Analyt, West Point, PA 08889 USA.							Anand Deepak, 2020, J Pathol Inform, V11, P19, DOI 10.4103/jpi.jpi_10_20; [Anonymous], CANC GENOME ATLAS PR; [Anonymous], Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning | Nature Medicine; [Anonymous], Breast Cancer HER2 Status | HER2 Positive Breast Cancer; [Anonymous], Breast Cancer Statistics | How Common Is Breast Cancer? Accessed June 22, 2022; Ayana G, 2024, AM J PATHOL, V194, P402, DOI 10.1016/j.ajpath.2023.11.015; Chen R. J., 2022, arXiv, DOI DOI 10.48550/ARXIV.2203.00585; Conde-Sousa E, 2022, J IMAGING, V8, DOI 10.3390/jimaging8080213; Farahmand S, 2022, MODERN PATHOL, V35, P44, DOI 10.1038/s41379-021-00911-w; Ilse M, 2018, Arxiv, DOI arXiv:1802.04712; Janowczyk A, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00157; Lutnick B., 2021, SPIE, V1603, P109; Naik N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19334-3; Venetis K, 2022, FRONT MOL BIOSCI, V9, DOI 10.3389/fmolb.2022.834651; Wolff AC, 2018, ARCH PATHOL LAB MED, V142, P1364, DOI 10.5858/arpa.2018-0902-SA	15	0	0	1	1	SPIE-INT SOC OPTICAL ENGINEERING	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA	1605-7422		978-1-5106-7171-3; 978-1-5106-7170-6	PRO BIOMED OPT IMAG			2024	12933								129330R	10.1117/12.3006884	http://dx.doi.org/10.1117/12.3006884			8	Computer Science, Information Systems; Optics; Radiology, Nuclear Medicine & Medical Imaging	Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science; Optics; Radiology, Nuclear Medicine & Medical Imaging	BW9QK					2024-09-18	WOS:001219295700023
J	van Gogh, S; Wang, ZT; Rawlik, M; Etmann, C; Mukherjee, S; Schönlieb, CB; Angst, F; Boss, A; Stampanoni, M				van Gogh, Stefano; Wang, Zhentian; Rawlik, Michal; Etmann, Christian; Mukherjee, Subhadip; Schonlieb, Carola-Bibiane; Angst, Florian; Boss, Andreas; Stampanoni, Marco			INSIDEnet: Interpretable NonexpanSIve Data-Efficient network for denoising in grating interferometry breast CT	MEDICAL PHYSICS			English	Article						image denoising; interpretable machine learning; breast CT	RAY; ALGORITHM	Purpose Breast cancer is the most common malignancy in women. Unfortunately, current breast imaging techniques all suffer from certain limitations: they are either not fully three dimensional, have an insufficient resolution or low soft-tissue contrast. Grating interferometry breast computed tomography (GI-BCT) is a promising X-ray phase contrast modality that could overcome these limitations by offering high soft-tissue contrast and excellent three-dimensional resolution. To enable the transition of this technology to clinical practice, dedicated data-processing algorithms must be developed in order to effectively retrieve the signals of interest from the measured raw data. Methods This article proposes a novel denoising algorithm that can cope with the high-noise amplitudes and heteroscedasticity which arise in GI-BCT when operated in a low-dose regime to effectively regularize the ill-conditioned GI-BCT inverse problem. We present a data-driven algorithm called INSIDEnet, which combines different ideas such as multiscale image processing, transform-domain filtering, transform learning, and explicit orthogonality to build an Interpretable NonexpanSIve Data-Efficient network (INSIDEnet). Results We apply the method to simulated breast phantom datasets and to real data acquired on a GI-BCT prototype and show that the proposed algorithm outperforms traditional state-of-the-art filters and is competitive with deep neural networks. The strong inductive bias given by the proposed model's architecture allows to reliably train the algorithm with very limited data while providing high model interpretability, thus offering a great advantage over classical convolutional neural networks (CNNs). Conclusions The proposed INSIDEnet is highly data-efficient, interpretable, and outperforms state-of-the-art CNNs when trained on very limited training data. We expect the proposed method to become an important tool as part of a dedicated plug-and-play GI-BCT reconstruction framework, needed to translate this promising technology to the clinics.	[van Gogh, Stefano; Rawlik, Michal; Stampanoni, Marco] Paul Scherrer Inst, Photon Sci Div, Xray Tomog Grp, Forsch Str 111, CH-5232 Villigen, Switzerland; [van Gogh, Stefano; Rawlik, Michal; Stampanoni, Marco] Swiss Fed Inst Technol, Dept Elect Engn & Informat Technol, Xray Tomog Grp, Zurich, Switzerland; [Wang, Zhentian] Tsinghua Univ, Dept Engn Phys, Beijing, Peoples R China; [Wang, Zhentian] Tsinghua Univ, Key Lab Particle & Radiat Imaging, Minist Educ, Beijing, Peoples R China; [Etmann, Christian; Mukherjee, Subhadip; Schonlieb, Carola-Bibiane] Univ Cambridge, Ctr Math Sci, Cambridge Image Anal Grp, Cambridge, England; [Angst, Florian; Boss, Andreas] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Tsinghua University; Tsinghua University; University of Cambridge; University of Zurich; University Zurich Hospital	van Gogh, S (corresponding author), Paul Scherrer Inst, Photon Sci Div, Xray Tomog Grp, Forsch Str 111, CH-5232 Villigen, Switzerland.	stefano.van-gogh@psi.ch	Wang, Zhentian/AGQ-1868-2022; van Gogh, Stefano/JZE-3604-2024; Mukherjee, Subhadip/IUQ-6348-2023; Rawlik, Michał/AGW-1215-2022; Stampanoni, Marco Francesco Mario/J-4099-2013	Rawlik, Michal/0000-0002-1232-4497; Stampanoni, Marco Francesco Mario/0000-0001-7486-6681; van Gogh, Stefano/0000-0001-5856-1124	Promedica Stiftung; ETH-Research Commission [ETH-12 20-2]; SNF [CRSII5 183568]; Swisslos Lottery Fund of Kanton Aargau	Promedica Stiftung; ETH-Research Commission; SNF; Swisslos Lottery Fund of Kanton Aargau	Promedica Stiftung; ETH-Research Commission, Grant/Award Number: ETH-12 20-2; SNF, Grant/Award Number: CRSII5 183568; Swisslos Lottery Fund of Kanton Aargau	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Abdelhamed A, 2019, IEEE COMPUT SOC CONF, P2197, DOI 10.1109/CVPRW.2019.00273; Arboleda C, 2014, OPT EXPRESS, V22, P15447, DOI 10.1364/OE.22.015447; Batson J, 2019, PR MACH LEARN RES, V97; Berger M., NIST Standard Reference Database 8 (XGAM), DOI DOI 10.18434/T48G6X; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Burger Harold Christopher, 2011, Pattern Recognition. Proceedings 33rd DAGM Symposium, P206, DOI 10.1007/978-3-642-23123-0_21; Chang JL, 2017, IEEE I CONF COMP VIS, P5880, DOI [10.1109/ICCV.2017.626, 10.1109/ICCV.2017.627]; D'Orsi C.J., 2013, Breast Imaging Reporting and Data SystemACR BI-RADS Atlas; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Davis TJ, 1996, J OPT SOC AM A, V13, P1193, DOI 10.1364/JOSAA.13.001193; Diemoz PC, 2014, J PHYS CONF SER, V499, DOI 10.1088/1742-6596/499/1/012006; Ge YS, 2021, IEEE T BIO-MED ENG, V68, P1751, DOI 10.1109/TBME.2020.3011119; Huang ZF, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2219405; Kalender WA, 2017, EUR RADIOL, V27, P1081, DOI 10.1007/s00330-016-4459-3; Kingma D. P., 2017, arXiv; Kottler C, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2723064; Lehtinen J, 2018, PR MACH LEARN RES, V80; Loberg M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0525-z; Loibl S, 2021, LANCET, V397, P1750, DOI 10.1016/S0140-6736(20)32381-3; Longo R, 2019, J SYNCHROTRON RADIAT, V26, P1343, DOI 10.1107/S1600577519005502; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Olivo A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772193; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Raupach R, 2012, MED PHYS, V39, P4761, DOI 10.1118/1.4736529; Raupach R, 2011, PHYS MED BIOL, V56, P2219, DOI 10.1088/0031-9155/56/7/020; Ravishankar S, 2013, IEEE T IMAGE PROCESS, V22, P4598, DOI 10.1109/TIP.2013.2274384; Ravishankar S, 2013, IEEE T SIGNAL PROCES, V61, P1072, DOI 10.1109/TSP.2012.2226449; Reehorst ET, 2019, IEEE T COMPUT IMAG, V5, P52, DOI 10.1109/TCI.2018.2880326; Revol V, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3465334; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Shim S, 2020, INVEST RADIOL, V55, P515, DOI 10.1097/RLI.0000000000000662; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Talbot H.F., 1836, The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science, V9, P401; Trockman A., 2021, 9 INT C LEARN REPR; Ulyanov D, 2018, PROC CVPR IEEE, P9446, DOI 10.1109/CVPR.2018.00984; van Aarle W, 2015, ULTRAMICROSCOPY, V157, P35, DOI 10.1016/j.ultramic.2015.05.002; Vila-Comamala J, 2021, OPT EXPRESS, V29, P2049, DOI 10.1364/OE.414174; von Teuffenbach M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06729-4; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; White D.R., 1992, J. Int. Comm. Radiat. Units Meas, Vos24, P1; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006	43	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	JUN	2022	49	6					3729	3748		10.1002/mp.15595	http://dx.doi.org/10.1002/mp.15595		MAR 2022	20	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	1Y4TZ	35257395	Green Published, hybrid			2024-09-18	WOS:000772542000001
J	Diaz-del-Pino, S; Trelles-Martinez, R; Gonzalez-Fernández, FA; Guil, N				Diaz-del-Pino, Sergio; Trelles-Martinez, Roberto; Gonzalez-Fernandez, F. A.; Guil, Nicolas			Artificial intelligence to assist specialists in the detection of haematological diseases	HELIYON			English	Article						Aiding clinicians; Hemograms; Machine learning; Classification; Artificial intelligence; Assist; Neural network; Anaemia; Complete blood count; Haematology; Diagnosis	THALASSEMIA	Artificial intelligence, particularly the growth of neural network research and development, has become an invaluable tool for data analysis, offering unrivalled solutions for image generation, natural language processing, and personalised suggestions. In the meantime, biomedicine has been presented as one of the pressing challenges of the 21st century. The inversion of the age pyramid, the increase in longevity, and the negative environment due to pollution and bad habits of the population have led to a necessity of research in the methodologies that can help to mitigate and fight against these changes.The combination of both fields has already achieved remarkable results in drug discovery, cancer prediction or gene activation. However, challenges such as data labelling, architecture improvements, interpretability of the models and translational implementation of the proposals still remain. In haematology, conventional protocols follow a stepwise approach that includes several tests and doctor-patient interactions to make a diagnosis. This procedure results in sig-nificant costs and workload for hospitals.In this paper, we present an artificial intelligence model based on neural networks to support practitioners in the identification of different haematological diseases using only rutinary and inexpensive blood count tests. In particular, we present both binary and multiclass classification of haematological diseases using a specialised neural network architecture where data is studied and combined along it, taking into account the clinical knowledge of the problem, obtaining results up to 96% accuracy for the binary classification experiment. Furthermore, we compare this method against traditional machine learning algorithms such as gradient boosting decision trees and transformers for tabular data. The use of these machine learning techniques could reduce the cost and decision time and improve the quality of life for both specialists and patients while producing more precise diagnoses.	[Diaz-del-Pino, Sergio; Guil, Nicolas] Univ Malaga, Comp Architecture Dept, Malaga, Spain; [Trelles-Martinez, Roberto] Fdn Alcorcon Univ Hosp Madrid, Hematol & Hemotherapy Serv, Madrid, Spain; [Gonzalez-Fernandez, F. A.] Clin San Carlos Univ Hosp Madrid, Hematol & Hemotherapy Serv, Madrid, Spain	Universidad de Malaga	Diaz-del-Pino, S (corresponding author), Univ Malaga, Comp Architecture Dept, Malaga, Spain.	sergiodiazdp@uma.es	Guil, Nicolas/AAM-6160-2020	Diaz-del-Pino, Sergio/0000-0002-9501-3300; Trelles-Martinez, Roberto-Oswaldo/0000-0001-9410-9717	European project [676559]; Spanish national project Plataforma de Recursos Biomoleculares y Bioinformaticos [ISCIII-PT13.0001.0012, ISCIII-PT17.0009.0022]; Fondo Europeo de Desarrollo Regional [UMA18-FEDERJA-156, UMA20-FEDERJA-059]; Junta de Andalucia [P18-FR-3130]; Instituto de Investigacion Biomedica de Malaga IBIMA; University of Malaga Spain	European project; Spanish national project Plataforma de Recursos Biomoleculares y Bioinformaticos; Fondo Europeo de Desarrollo Regional(European Union (EU)); Junta de Andalucia(Junta de Andalucia); Instituto de Investigacion Biomedica de Malaga IBIMA; University of Malaga Spain	This work has been partially supported by the European project (grant no. 676559) (European Union) , the Spanish national project Plataforma de Recursos Biomoleculares y Bioinformaticos (ISCIII-PT13.0001.0012 and ISCIII-PT17.0009.0022) (Spain) , the Fondo Europeo de Desarrollo Regional (UMA18-FEDERJA-156, UMA20-FEDERJA-059) (Andalucia, Spain) , the Junta de Andalucia (P18-FR-3130) (Andalucia, Spain) , the Instituto de Investigacion Biomedica de Malaga IBIMA and the University of Malaga (Spain) .	Agarap A. F., 2018, PREPRINT; Agrawal S, 2015, PROCEDIA COMPUT SCI, V60, P769, DOI 10.1016/j.procs.2015.08.234; Akter F., 2018, J COMPUT COMMUN, V6, P76, DOI [10.4236/jcc.2018.64007, DOI 10.4236/JCC.2018.64007]; AlAgha AS, 2018, ARTIF INTELL MED, V88, P70, DOI 10.1016/j.artmed.2018.04.009; Alsuliman T, 2020, CURR RES TRANSL MED, V68, P245, DOI 10.1016/j.retram.2020.01.002; Amendolia SR, 2003, CHEMOMETR INTELL LAB, V69, P13, DOI 10.1016/S0169-7439(03)00094-7; Arik S.O., 2019, PREPRINT; Arrizabalaga Amuch astegui B., 2017, ERITROPATOLOGIA; Baskin II, 2016, EXPERT OPIN DRUG DIS, V11, P785, DOI 10.1080/17460441.2016.1201262; Brancaleoni V, 2016, INT J LAB HEMATOL, V38, P32, DOI 10.1111/ijlh.12527; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Caballero J.V., 2008, CROMATOGRAFIA LIQUID; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cristea M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041439; Eetemadi A, 2019, BIOINFORMATICS, V35, P2226, DOI 10.1093/bioinformatics/bty945; Fahad SKA, 2018, 2018 INTERNATIONAL CONFERENCE ON SMART COMPUTING AND ELECTRONIC ENTERPRISE (ICSCEE); Dos Santos CFG, 2023, ACM COMPUT SURV, V55, DOI 10.1145/3490235; Guncar G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18564-8; Hao J, 2018, IEEE INT C BIOINFORM, P381, DOI 10.1109/BIBM.2018.8621345; Holzinger A, 2021, COMM COM INF SC, V1524, P427, DOI 10.1007/978-3-030-93736-2_33; Holzinger A, 2022, INFORM FUSION, V79, P263, DOI 10.1016/j.inffus.2021.10.007; Kaestner L, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102986; Kaestner L, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00387; Leung KY, 2004, PRENATAL DIAG, V24, P899, DOI 10.1002/pd.1035; Lundberg SM, 2017, ADV NEUR IN, V30; Mallappallil M, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120934839; Castro FM, 2017, LECT NOTES COMPUT SC, V10306, P257, DOI 10.1007/978-3-319-59147-6_23; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Radakovich N, 2020, CURR HEMATOL MALIG R, V15, P203, DOI 10.1007/s11899-020-00575-4; Rao Q, 2018, PROCEEDINGS 2018 IEEE/ACM 1ST INTERNATIONAL WORKSHOP ON SOFTWARE ENGINEERING FOR AI IN AUTONOMOUS SYSTEMS (SEFAIAS), P35, DOI 10.1145/3194085.3194087; Statista Search Department, 2022, VOL DAT INF CREAT CA; Taud H., 2018, Geomatic Approaches for Modeling Land Change Scenarios, P451; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Vaswani A, 2017, ADV NEUR IN, V30; Vijayarani S., 2015, INDIAN J SCI TECHNOL, V8, P1; Yousefian F., 2017, INT J ADV RES COMPUT, V6, P1, DOI [10.17148/IJARCCE.2017.6847, DOI 10.17148/IJARCCE.2017.6847]; Zhang ZH, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.32	40	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2405-8440		HELIYON	Heliyon	MAY	2023	9	5							e15940	10.1016/j.heliyon.2023.e15940	http://dx.doi.org/10.1016/j.heliyon.2023.e15940		MAY 2023	10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	O2OO9	37215889	Green Published, gold			2024-09-18	WOS:001042267300001
J	Shen, ZF; Hu, JT; Wu, HY; Chen, ZS; Wu, WX; Lin, JY; Xu, ZX; Kong, JQ; Lin, TX				Shen, Zefeng; Hu, Jintao; Wu, Haiyang; Chen, Zeshi; Wu, Weixia; Lin, Junyi; Xu, Zixin; Kong, Jianqiu; Lin, Tianxin			Global research trends and foci of artificial intelligence-based tumor pathology: a scientometric study	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						Bibliometric analysis; Artificial intelligence; Tumor; Pathology; VOSviewer; Citespace	CONVOLUTIONAL NEURAL-NETWORK; DIGITAL PATHOLOGY; METAANALYSIS; CHALLENGES; IMPACT	Background With the development of digital pathology and the renewal of deep learning algorithm, artificial intelligence (AI) is widely applied in tumor pathology. Previous researches have demonstrated that AI-based tumor pathology may help to solve the challenges faced by traditional pathology. This technology has attracted the attention of scholars in many fields and a large amount of articles have been published. This study mainly summarizes the knowledge structure of AI-based tumor pathology through bibliometric analysis, and discusses the potential research trends and foci. Methods Publications related to AI-based tumor pathology from 1999 to 2021 were selected from Web of Science Core Collection. VOSviewer and Citespace were mainly used to perform and visualize co-authorship, co-citation, and co-occurrence analysis of countries, institutions, authors, references and keywords in this field. Results A total of 2753 papers were included. The papers on AI-based tumor pathology research had been continuously increased since 1999. The United States made the largest contribution in this field, in terms of publications (1138, 41.34%), H-index (85) and total citations (35,539 times). We identified the most productive institution and author were Harvard Medical School and Madabhushi Anant, while Jemal Ahmedin was the most co-cited author. Scientific Reports was the most prominent journal and after analysis, Lecture Notes in Computer Science was the journal with highest total link strength. According to the result of references and keywords analysis, "breast cancer histopathology" "convolutional neural network" and "histopathological image" were identified as the major future research foci. Conclusions AI-based tumor pathology is in the stage of vigorous development and has a bright prospect. International transboundary cooperation among countries and institutions should be strengthened in the future. It is foreseeable that more research foci will be lied in the interpretability of deep learning-based model and the development of multi-modal fusion model.	[Shen, Zefeng; Hu, Jintao; Chen, Zeshi; Lin, Junyi; Xu, Zixin; Kong, Jianqiu; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Wu, Haiyang] Tianjin Med Univ, Grad Sch, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Wu, Weixia] Southern Med Univ, Zhujiang Hosp, 253 Gongye Rd M, Guangzhou 510282, Peoples R China; [Kong, Jianqiu; Lin, Tianxin] Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China	Sun Yat Sen University; Tianjin Medical University; Southern Medical University - China	Kong, JQ; Lin, TX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Kong, JQ; Lin, TX (corresponding author), Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China.	kongjq5@mail.sysu.edu.cn; lintx@mail.sysu.edu.cn	Shen, Zefeng/HNC-3769-2023; Lin, Junyi/LEM-1620-2024; zhang, jingxing/KCY-4726-2024	Shen, Zefeng/0000-0002-4279-4879	GuangDong Basic and Applied Basic Research Foundation [2020A1515111119]; National Key Research and Development Program of China [2018YFA0902803]; National Natural Science Foundation of China [81825016, 81961128027, 81772719, 82002682, 81972731, 81773026]; Key Areas Research and Development Program of Guangdong [2018B010109006]; Natural Science Foundation of Guangdong Province [2019A1515010188, 2018A030313261]; Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme; Guangdong Provincial Clinical Research Center for Urological Diseases [2020B1111170006]; China Postdoctoral Science Foundation [2021M703709]	GuangDong Basic and Applied Basic Research Foundation; National Key Research and Development Program of China(National Key Research & Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Areas Research and Development Program of Guangdong; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme; Guangdong Provincial Clinical Research Center for Urological Diseases; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the GuangDong Basic and Applied Basic Research Foundation (Grant No. 2020A1515111119), the National Key Research and Development Program of China (Grant No. 2018YFA0902803), the National Natural Science Foundation of China (Grant No. 81825016, 81961128027, 81772719, 82002682, 81972731, 81773026), the Key Areas Research and Development Program of Guangdong (Grant No. 2018B010109006), the Natural Science Foundation of Guangdong Province (Grant No 2019A1515010188, 2018A030313261), Project Supported by Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme (for Tianxin Lin), and Guangdong Provincial Clinical Research Center for Urological Diseases (2020B1111170006), the China Postdoctoral Science Foundation (2021M703709).	Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Ayton SG, 2022, GENET MED, V24, P15, DOI 10.1016/j.gim.2021.09.006; Baxi V, 2022, MODERN PATHOL, V35, P23, DOI 10.1038/s41379-021-00919-2; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bejnordi BE, 2018, MODERN PATHOL, V31, P1502, DOI 10.1038/s41379-018-0073-z; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Bera K, 2019, NAT REV CLIN ONCOL, V16, P703, DOI 10.1038/s41571-019-0252-y; Brandt JS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.025; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai J, 2019, GUT, V68, P2195, DOI 10.1136/gutjnl-2019-318882; Calderaro J, 2021, GUT, V70, P1183, DOI 10.1136/gutjnl-2020-322880; Cao R, 2020, THERANOSTICS, V10, P11080, DOI 10.7150/thno.49864; Cheek J, 2006, QUAL HEALTH RES, V16, P423, DOI 10.1177/1049732305285701; Chen CM, 2014, EXPERT OPIN BIOL TH, V14, P1295, DOI 10.1517/14712598.2014.920813; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Eldridge RC, 2022, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.796067; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Haenssle HA, 2020, ANN ONCOL, V31, P137, DOI 10.1016/j.annonc.2019.10.013; Hamet P, 2017, METABOLISM, V69, pS36, DOI 10.1016/j.metabol.2017.01.011; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hoda SA., 2018, AM J CLIN PATHOL, V149, P548, DOI [10.1093/ajcp/aqy016, DOI 10.1093/AJCP/AQY016]; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Jiang AM, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/3617775; Jiang GF, 2021, IEEE T MED IMAGING, V40, P2080, DOI 10.1109/TMI.2021.3071544; Kent MN, 2017, JAMA DERMATOL, V153, P1285, DOI 10.1001/jamadermatol.2017.3284; Li C, 2020, INT J INFECT DIS, V96, P696, DOI 10.1016/j.ijid.2020.05.014; Li M, 2020, IEEE T MED IMAGING, V39, P2289, DOI 10.1109/TMI.2020.2968472; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Ma D, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.731933; Ma X, 2019, P NATL ACAD SCI USA, V116, P11090, DOI 10.1073/pnas.1906812116; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; McCarthy J, 2006, AI MAG, V27, P12; Mercan C, 2018, IEEE T MED IMAGING, V37, P316, DOI 10.1109/TMI.2017.2758580; Mishra S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195773; Naik N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19334-3; Niazi MKK, 2019, LANCET ONCOL, V20, pE253, DOI 10.1016/S1470-2045(19)30154-8; Pan Y, 2022, MED RES REV, V42, P441, DOI 10.1002/med.21847; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Shen ZF, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.843735; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Siegel RL, 2021, CA-CANCER J CLIN, V71, P359, DOI [10.3322/caac.21387, 10.3322/caac.21669]; Smith DR, 2008, CONTACT DERMATITIS, V59, P133, DOI 10.1111/j.1600-0536.2008.01405.x; Stahlschmidt SR, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab569; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Synnestvedt Marie B, 2005, AMIA Annu Symp Proc, P724; Unternaehrer J, 2020, J CLIN PATHOL, V73, P341, DOI 10.1136/jclinpath-2019-206155; Vaickus LJ, 2019, CANCER CYTOPATHOL, V127, P98, DOI 10.1002/cncy.22099; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Wu HY, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.787228; Wu HY, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.706105; Wu HY, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.646626; Xu J, 2016, IEEE T MED IMAGING, V35, P119, DOI 10.1109/TMI.2015.2458702; Xu ZJ, 2021, ACTA PHARM SIN B, V11, P3393, DOI 10.1016/j.apsb.2021.02.007; Yeung AWK, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00037; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z; Zhang YD, 2020, INFORM FUSION, V64, P149, DOI 10.1016/j.inffus.2020.07.006; Zhao J, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0785-5; Zhuang Y, 2014, INFORM SCIENCES, V263, P60, DOI 10.1016/j.ins.2013.10.013	66	31	31	12	82	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	SEP 6	2022	20	1							409	10.1186/s12967-022-03615-0	http://dx.doi.org/10.1186/s12967-022-03615-0			17	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	4I4PK	36068536	gold, Green Published			2024-09-18	WOS:000850560000001
J	Jannasch, F; Riordan, F; Andersen, LF; Schulze, MB				Jannasch, Franziska; Riordan, Fiona; Andersen, Lene F.; Schulze, Matthias B.			Exploratory dietary patterns: a systematic review of methods applied in pan-European studies and of validation studies	BRITISH JOURNAL OF NUTRITION			English	Review						Systematic literature reviews; Exploratory dietary pattern methods; Dietary patterns; Pan-European studies; DEterminants of DIet and Physical ACtivity knowledge hub; Validation	FOOD-FREQUENCY QUESTIONNAIRE; REDUCED-RANK REGRESSION; CLUSTER-ANALYSIS; OLDER EUROPEANS; RELATIVE VALIDITY; DIETSCAN PROJECT; COHORT; REPRODUCIBILITY; CANCER; WOMEN	Besides a priori approaches, using previous knowledge about food characteristics, exploratory dietary pattern (DP) methods, using data at hand, are commonly applied. This systematic literature review aimed to identify exploratory methods on DP in pan-European studies and to inform the development of the DEterminants of DIet and Physical ACtivity (DEDIPAC) toolbox of methods suitable for use in future European studies. The search was conducted in three databases on prospective studies in healthy, free-living people across the whole life span. To identify validated DP methods, an additional search without regional restrictions was conducted. Studies including at least two European countries were retained. The search resulted in six pan-European studies applying principal component/factor analysis (PC/FA) (n 5) or cluster analysis (n 2). The criteria to retain PC/factors ranged from the application of the eigenvalue>1 criterion, the scree plot and/or the interpretability criterion. Furthermore, seven validation studies were identified: DP, derived by PC/FA (n 6) or reduced rank regression (RRR) (n 1) were compared using dietary information from FFQ (n 6) or dietary history (n 1) as study instrument and dietary records (n 6) or 24-h dietary recalls (n 1) as reference. The correlation coefficients for the derived DP ranged from modest to high. To conclude, PC/FA was predominantly applied using the eigenvalue criterion and scree plot to retain DP, but a better description of the applied criteria is highly recommended to enable a standardised application of the method. Research gaps were identified for the methods cluster analysis and RRR, as well as for validation studies on DP.	[Jannasch, Franziska; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, D-14558 Nuthetal, Germany; [Jannasch, Franziska; Schulze, Matthias B.] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Riordan, Fiona] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork T12 K8AF, Ireland; [Andersen, Lene F.] Univ Oslo, Dept Nutr, N-0372 Oslo, Norway	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University College Cork; University of Oslo	Jannasch, F (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, D-14558 Nuthetal, Germany.	franziska.jannasch@dife.de	Andersen, Lene/ABC-1337-2021; Schulze, Matthias B./AAH-6906-2021	Schulze, Matthias B./0000-0002-0830-5277	DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Federal Ministry of Education and Research, Germany	DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF))	The preparation of this paper was supported by the DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub. This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agency supporting this work is Federal Ministry of Education and Research, Germany.	Ambrosini GL, 2011, BRIT J NUTR, V105, P625, DOI 10.1017/S0007114510004137; Appannah G, 2014, BRIT J NUTR, V112, P609, DOI 10.1017/S0007114514001111; Asghari G, 2012, BRIT J NUTR, V108, P1109, DOI 10.1017/S0007114511006313; Balder HF, 2003, J NUTR, V133, P4246, DOI 10.1093/jn/133.12.4246; Bamia C, 2005, BRIT J NUTR, V94, P100, DOI 10.1079/BJN20051456; Bamia C, 2007, PUBLIC HEALTH NUTR, V10, P590, DOI 10.1017/S1368980007382487; Crozier SR, 2008, BRIT J NUTR, V99, P869, DOI 10.1017/S0007114507831746; Devlin UM, 2012, P NUTR SOC, V71, P599, DOI 10.1017/S0029665112000729; Dixon LB, 2004, AM J CLIN NUTR, V80, P1003, DOI 10.1093/ajcn/80.4.1003; Hatcher L., 1998, STEP BY STEP APPROAC; Haveman-Nies A, 1998, J AM DIET ASSOC, V98, P1297, DOI 10.1016/S0002-8223(98)00290-9; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Imamura F, 2009, AM J CLIN NUTR, V90, P1075, DOI 10.3945/ajcn.2009.28009; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; Kröger J, 2014, DIABETOLOGIA, V57, P321, DOI 10.1007/s00125-013-3092-9; Lakerveld J., 2014, International Journal of Behavioral Nutrition and Physical Activity, V11; Li F, 2015, BRIT J NUTR, V113, P16, DOI 10.1017/S000711451400289X; Lo Siou G, 2011, AM J EPIDEMIOL, V173, P956, DOI 10.1093/aje/kwq458; Louis-Walthouwer MJ, 2014, APPETITE, V82, P154, DOI 10.1016/j.appet.2014.07.025; Männistö S, 2005, CANCER CAUSE CONTROL, V16, P725, DOI 10.1007/s10552-005-1763-7; Menotti A, 1999, EUR J EPIDEMIOL, V15, P507, DOI 10.1023/A:1007529206050; Nanri A, 2012, J EPIDEMIOL, V22, P205, DOI 10.2188/jea.JE20110087; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Okubo H, 2010, PUBLIC HEALTH NUTR, V13, P1080, DOI 10.1017/S1368980009993211; Pala V, 2013, EUR J CLIN NUTR, V67, P1042, DOI 10.1038/ejcn.2013.145; Rodríguez-Monforte M, 2015, BRIT J NUTR, V114, P1341, DOI 10.1017/S0007114515003177; Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675; Weikert C, 2016, CURR OPIN CLIN NUTR, V19, P341, DOI 10.1097/MCO.0000000000000308; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	33	25	28	0	10	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0007-1145	1475-2662		BRIT J NUTR	Br. J. Nutr.	SEP 28	2018	120	6					601	611		10.1017/S0007114518001800	http://dx.doi.org/10.1017/S0007114518001800			11	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	GS3QO	30064527	Green Published, hybrid			2024-09-18	WOS:000443535000001
J	Li, XT; Wong, KC				Li, Xiangtao; Wong, Ka-Chun			Evolutionary Multiobjective Clustering and Its Applications to Patient Stratification	IEEE TRANSACTIONS ON CYBERNETICS			English	Article						Clustering; density peaks; multiobjective optimization; patient stratification	GENE-EXPRESSION DATA; CANCER SUBTYPES; ALGORITHM; VALIDITY; OPTIMIZATION; PERFORMANCE	Patient stratification has a major role in enabling efficient and personalized medicine. An important task in patient stratification is to discover disease subtypes for effective treatment. To achieve this goal, the research on clustering algorithms for patient stratification has brought attention from both academia and medical community over the past decades. However, existing clustering algorithms suffer from realistic restrictions such as experimental noises, high dimensionality, and poor interpretability. In particular, the existing clustering algorithms usually determine clustering quality using only one internal evaluation function. Unfortunately, it is obvious that one internal evaluation function is hard to be fitted and robust for all datasets. Therefore, in this paper, a novel multiobjective framework called multiobjective clustering algorithm by fast search and find of density peaks is proposed to address those limitations altogether. In the proposed framework, a parameter candidate population is evolved under multiple objectives to select features and evaluate clustering densities automatically. To guide the multiobjective evolution, five cluster validity indices including compactness, separation, Calinski-Harabasz index, Davies-Bouldin index, and Dunn index, are chosen as the objective functions, capturing multiple characteristics of the evolving clusters. Multiobjective differential evolution algorithm based on decomposition is adopted to optimize those five objective functions simultaneously. To demonstrate its effectiveness, extensive experiments have been conducted, comparing the proposed algorithm with 45 algorithms including nine state-of-the-art clustering algorithms, five multiobjective evolutionary algorithms, and 31 baseline algorithms under different objective subsets on 94 datasets featuring 35 real patient stratification datasets, 55 synthetic datasets based on a real human transcription regulation network model, and four other medical datasets. The numerical results reveal that the proposed algorithm can achieve better or competitive solutions than the others. Besides, time complexity analysis, convergence analysis, and parameter analysis are conducted to demonstrate the robustness of the proposed algorithm from different perspectives.	[Li, Xiangtao] Northeast Normal Univ, Dept Comp Sci & Informat Technol, Changchun 130117, Jilin, Peoples R China; [Wong, Ka-Chun] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Peoples R China	Northeast Normal University - China; City University of Hong Kong	Wong, KC (corresponding author), City Univ Hong Kong, Dept Comp Sci, Hong Kong, Peoples R China.	lixt314@nenu.edu.cn; kc.w@cityu.edu.hk	Wong, Ka-Chun/L-7160-2019; Yin, Minghao/E-9611-2015	WONG, Ka Chun/0000-0001-6062-733X; Yin, Minghao/0000-0002-6226-2394; Li, xiangtao/0000-0001-9089-1799	Research Grants Council of the Hong Kong Special Administrative Region [CityU 21200816, CityU 11203217]; National Natural Science Foundation of China [61603087]; Natural Science Foundation of Jilin Province [20160101253JC]; Fundamental Research Funds of Northeast Normal University [2412017FZ026]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Fundamental Research Funds of Northeast Normal University	This work was supported in part by the Research Grants Council of the Hong Kong Special Administrative Region under Grant CityU 21200816 and Grant CityU 11203217, in part by the National Natural Science Foundation of China under Grant 61603087, in part by the Natural Science Foundation of Jilin Province under Grant 20160101253JC, and in part by the Fundamental Research Funds of Northeast Normal University under Grant 2412017FZ026. This paper was recommended by Associate Editor S. Mostaghim. (Corresponding author: Ka-Chun Wong.)	Armano G, 2016, EXPERT SYST APPL, V55, P184, DOI 10.1016/j.eswa.2016.02.009; Bader J, 2011, EVOL COMPUT, V19, P45, DOI 10.1162/EVCO_a_00009; Botafogo R. A., 1991, Third ACM Conference on Hypertext Proceedings, P63, DOI 10.1145/122974.122981; Bresin E, 2013, J AM SOC NEPHROL, V24, P475, DOI 10.1681/ASN.2012090884; Chang Y, 2016, GENOMICS, V107, P51, DOI 10.1016/j.ygeno.2016.01.004; Coello CAC, 2004, IEEE T EVOLUT COMPUT, V8, P256, DOI 10.1109/tevc.2004.826067; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Amorim RC, 2012, PATTERN RECOGN, V45, P1061, DOI 10.1016/j.patcog.2011.08.012; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2014, Search Methodologies, P403, DOI [DOI 10.1007/978-1-4614-6940-7_15, 10.1007/978-1-4614-6940-715, DOI 10.1007/978-1-4614-6940-715]; Diaz Diana, 2016, Machine Learning, Optimization and Big Data. Second International Workshop, MOD 2016. Revised Selected Papers: LNCS 10122, P193, DOI 10.1007/978-3-319-51469-7_16; Ester M., 1996, P INT C KNOWL DISC D, VVolume 96, P226, DOI DOI 10.5555/3001460.3001507; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Galdi P, 2015, LECT N BIOINFORMAT, V8623, P57, DOI 10.1007/978-3-319-24462-4_5; Graim K, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0256-3; Günes S, 2010, EXPERT SYST APPL, V37, P7922, DOI 10.1016/j.eswa.2010.04.043; Handl J, 2007, IEEE T EVOLUT COMPUT, V11, P56, DOI 10.1109/TEVC.2006.877146; Huang JZX, 2005, IEEE T PATTERN ANAL, V27, P657, DOI 10.1109/TPAMI.2005.95; Iam-on N, 2010, BIOINFORMATICS, V26, P1513, DOI 10.1093/bioinformatics/btq226; Inkaya T, 2015, APPL SOFT COMPUT, V28, P301, DOI 10.1016/j.asoc.2014.11.060; Jaskowiak PA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S2; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Jing LP, 2005, LECT NOTES ARTIF INT, V3518, P802; Josephs EA, 2015, NUCLEIC ACIDS RES, V43, P8924, DOI 10.1093/nar/gkv892; Khakabimamaghani S, 2016, BIOCOMPUT-PAC SYM, P345; Law M. H., 2004, P COMP VIS PATT REC, V2, P1; Liu HF, 2017, BIOINFORMATICS, V33, P2691, DOI 10.1093/bioinformatics/btx167; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; Maulik U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-27; Modha DS, 2003, MACH LEARN, V52, P217, DOI 10.1023/A:1024016609528; Mukhopadhyay A, 2009, IEEE T EVOLUT COMPUT, V13, P991, DOI 10.1109/TEVC.2009.2012163; Nock R, 2006, IEEE T PATTERN ANAL, V28, P1223, DOI 10.1109/TPAMI.2006.168; Pakhira MK, 2004, PATTERN RECOGN, V37, P487, DOI 10.1016/j.patcog.2003.06.005; PAL NR, 1995, IEEE T FUZZY SYST, V3, P370, DOI 10.1109/91.413225; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Saha S, 2009, PATTERN RECOGN LETT, V30, P1392, DOI 10.1016/j.patrec.2009.07.015; Sengee N, 2008, IEEE T CONSUM ELECTR, V54, P1329, DOI 10.1109/TCE.2008.4637624; Suresh K, 2009, FUND INFORM, V97, P381, DOI 10.3233/FI-2009-208; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wagstaff K., 2001, ICML, P577, DOI [10.5555/645530.655669, DOI 10.1109/TPAMI.2002.1017616]; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Wang LN, 2012, INT J PATTERN RECOGN, V26, DOI 10.1142/S0218001412500103; Wiwie C, 2015, NAT METHODS, V12, P1033, DOI [10.1038/NMETH.3583, 10.1038/nmeth.3583]; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wong KC, 2014, APPL SOFT COMPUT, V23, P61, DOI 10.1016/j.asoc.2014.05.034; Wu J, 2017, CLIN CANCER RES, V23, P3334, DOI 10.1158/1078-0432.CCR-16-2415; Yang SX, 2013, IEEE T EVOLUT COMPUT, V17, P721, DOI 10.1109/TEVC.2012.2227145; Yu J, 2011, COMPUT MATH APPL, V62, P2200, DOI 10.1016/j.camwa.2011.07.005; Zavala GR, 2014, STRUCT MULTIDISCIP O, V49, P537, DOI 10.1007/s00158-013-0996-4; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Zitzler E, 2001, 103 TIK SWISS FED I	53	22	24	2	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2267	2168-2275		IEEE T CYBERNETICS	IEEE T. Cybern.	MAY	2019	49	5					1680	1693		10.1109/TCYB.2018.2817480	http://dx.doi.org/10.1109/TCYB.2018.2817480			14	Automation & Control Systems; Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Computer Science	HO1LM					2024-09-18	WOS:000460667400011
J	Barge, W; Kumar, D; Giusto, D; Kramer, J; Behara, R; Jakate, S; Bishehsari, F; Losurdo, J; Lee, S; Singh, S; Melson, J				Barge, William; Kumar, Deepak; Giusto, Deborah; Kramer, Jason; Behara, Rama; Jakate, Shriram; Bishehsari, Faraz; Losurdo, John; Lee, Salina; Singh, Shubha; Melson, Joshua			Alternative approaches to polyp extraction in colonoscopy: a proof of principle study	GASTROINTESTINAL ENDOSCOPY			English	Article							INTERVAL CANCER; SERRATED POLYPS; RESECTION; BOWEL	Background and Aims: A limitation of determination of the completeness of resection in polypectomy is polyp fragmentation. When a polyp fragments, the pathologist cannot determine resection completeness. Alternative approaches to reduce polyp fragmentation include reducing shearing forces on the polyp or removing polyps through the instrument channel. The primary aim of this study was to assess fragmentation of polyps extracted using different approaches from conventional polyp retrieval. Methods: Polyps (5-15 mm) resected by cold snare or cautery by 3 colonoscopists were extracted from the colonoscope using 1 of 4 techniques. Method I was the conventional method of pressing the suction valve button and retrieving the polyp through a trap. Method II involved removing the suction valve, covering the open suction valve cylinder with a finger. Method III used a Roth Net polyp retriever placed through the instrument channel. Method IV involved connecting a polyp trap to suction onto the instrument channel port. Fragmentation was defined as multiple pieces of the specimen in formalin, as grossly described by the pathologist. Alternative approaches (methods II, III, and IV) were all compared with the conventional method (method I). Results: The method I fragmentation rate of polyps was 60.3% (123/204). Method II extraction reduced fragmentation to 43.0% (52/121, P = .003), proving that fragmentation occurs with passage through the suction valve channel. Method III had a lower fragmentation rate of 23.1% (6/26, P < .001). Method IV likewise showed a reduced fragmentation rate of 18.5% (5/27, P < .001). Conclusions: Polyp fragmentation is reduced by removal of the suction valve button. There is also a decrease in fragmentation rates in removing the polyp by connecting the polyp trap to the instrument port. Our study suggests that decreasing polyp fragmentation and improving pathology margin interpretability is possible through methods that extract polyps through the instrument port with currently available devices.	[Barge, William; Kumar, Deepak; Giusto, Deborah; Kramer, Jason; Behara, Rama; Jakate, Shriram; Bishehsari, Faraz; Losurdo, John; Lee, Salina; Singh, Shubha; Melson, Joshua] Rush Univ, Med Ctr, Dept Gastroenterol, 1725 W Harrison St,Suite 207, Chicago, IL 60612 USA	Rush University	Melson, J (corresponding author), Rush Univ, Med Ctr, Dept Gastroenterol, 1725 W Harrison St,Suite 207, Chicago, IL 60612 USA.	joshua_melson@rush.edu		Barge, William/0000-0003-3420-9972; Bishehsari, Faraz/0000-0001-5644-2586	Swim Across America for Cancer-Rush University Translational Sciences Consortium fund [56618]	Swim Across America for Cancer-Rush University Translational Sciences Consortium fund	The authors acknowledge the financial support of a grant from Swim Across America for Cancer-Rush University Translational Sciences Consortium fund 56618.	Agarwal A, 2018, SURG ENDOSC, V32, P1871, DOI 10.1007/s00464-017-5876-3; Benedict M, 2015, WORLD J GASTROENTERO, V21, P12735, DOI 10.3748/wjg.v21.i45.12735; Burgess NG, 2014, GASTROINTEST ENDOSC, V80, P307, DOI 10.1016/j.gie.2014.03.050; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Foss FA, 2012, HISTOPATHOLOGY, V61, P47, DOI 10.1111/j.1365-2559.2011.04154.x; Leung K, 2010, GASTROINTEST ENDOSC, V71, P111, DOI 10.1016/j.gie.2009.05.010; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Pohl H, 2010, CLIN GASTROENTEROL H, V8, P858, DOI 10.1016/j.cgh.2010.06.028; Robertson DJ, 2008, GASTROENTEROLOGY, V134, pA111; Samadder NJ, 2014, GASTROENTEROLOGY, V146, P950, DOI 10.1053/j.gastro.2014.01.013; Wong NACS, 2009, HISTOPATHOLOGY, V55, P63, DOI 10.1111/j.1365-2559.2009.03329.x	11	16	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	SEP	2018	88	3					536	541		10.1016/j.gie.2018.05.015	http://dx.doi.org/10.1016/j.gie.2018.05.015			6	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	GQ3GJ	29885336				2024-09-18	WOS:000441549400015
J	Chevalier, BAM; Watson, BM; Barras, MA; Cottrell, WN				Chevalier, Bernadette A. M.; Watson, Bernadette M.; Barras, Michael A.; Cottrell, William Neil			Examining hospital pharmacists' goals for medication counseling within the communication accommodation theoretical framework	RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY			English	Article						Communication accommodation theory; Hospital pharmacist; Communication; Focus group	QUALITY-OF-LIFE; CARE; DISCHARGE; PERCEPTIONS; STRATEGIES; ADHERENCE; OUTCOMES; PROGRAM; CANCER; ELDERS	Background: Medication counseling opportunities are key times for pharmacists to speak to patients about their medications and any changes made during their hospital stay. Communication Accommodation Theory (CAT) posits that an individual's goals drive their communication behavior. The way in which pharmacists communicate with patients may be determined by the goals they set for these medication counseling sessions. Objectives: To examine hospital pharmacists' goals in patient medication counseling within the CAT framework. Methods: Hospital pharmacist focus groups were held in two teaching hospitals. Interested pharmacists attended a focus group designed to elicit their goals in patient medication counseling. Focus groups were audio recorded and transcribed verbatim. NVivo software was used to assist in coding and organization. The codes were reviewed for reliability by pharmacists independent of the focus groups. An inductive thematic analysis was applied to the data. Results: Six 1 h focus groups were conducted with a total of 24 pharmacists participating. Saturation of information was achieved after four focus groups. Greater than 80% consensus was achieved for reliability of the identified codes. Patient-centered themes constructed from these codes were to build rapport, to empower patients and to improve patients' experience, health and safety. Exemplars provided by pharmacists for the goals of building rapport and empowering patients were aligned with five CAT communication behaviors (approximation, interpretability, discourse management, emotional expression and interpersonal control). Conclusions: Patient-centered goals described by hospital pharmacists for medication counseling aligned well with CAT behaviors necessary for effective communication. Further research using the CAT framework to examine the effectiveness of hospital pharmacist-patient exchanges that include both participants' perspectives is required to better understand how well pharmacists communicate with patients. (C) 2015 Elsevier Inc. All rights reserved.	[Chevalier, Bernadette A. M.; Cottrell, William Neil] Univ Queensland, Pharm Australia Ctr Excellence, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia; [Watson, Bernadette M.] Univ Queensland, Sch Psychol, Room 408,McElwain Bldg, St Lucia, Qld 4072, Australia; [Barras, Michael A.] Royal Brisbane & Womans Hosp, Dept Pharm, Butterfield St, Herston, Qld 4029, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital	Chevalier, BAM (corresponding author), Univ Queensland, Pharm Australia Ctr Excellence, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia.	b.chevalier@uq.edu.au	Barras, Michael/AAJ-4078-2020; Watson, Bernadette/H-1146-2014; Cottrell, Neil/N-4609-2013; Chevalier, Bernadette/J-1785-2014	Barras, Michael/0000-0001-8105-0090; Watson, Bernadette/0000-0003-2419-7752; Cottrell, Neil/0000-0002-0149-444X; Chevalier, Bernadette/0000-0003-2809-1170	Metro North and South Hospital and Health Services	Metro North and South Hospital and Health Services	We gratefully acknowledge the support provided by Metro North and South Hospital and Health Services in the conduct of this research.	Aujoulat I, 2007, PATIENT EDUC COUNS, V66, P13, DOI 10.1016/j.pec.2006.09.008; Austin S, 2013, ENCY AUTISM SPECTRUM, P982; Babalola O.O., 2001, International Journal of Pharmacy Practice, V9, P97; Berger BA, 2005, Communication skills for pharmacists: building relationships, improving patient care; BOURHIS RY, 1989, SOC SCI MED, V28, P339, DOI 10.1016/0277-9536(89)90035-X; Braaf S, 2015, INT J PERS CENT MED, V4, P90, DOI DOI 10.5750/IJPCM.V4I2.446; COUPLAND N, 1988, LANG SOC, V17, P1, DOI 10.1017/S0047404500012574; Crotty Maria, 2004, Am J Geriatr Pharmacother, V2, P257, DOI 10.1016/j.amjopharm.2005.01.001; Gasiorek J, 2012, HUM COMMUN RES, V38, DOI 10.1111/j.1468-2958.2012.01426.x; Giles H., 2008, COMMUNICATION ACCOMM; Golant M, 2003, CANCER NURS, V26, P37, DOI 10.1097/00002820-200302000-00005; Greenhill N, 2010, INT J PHARM PRACT S2, P25; Greenhill N, 2011, PATIENT EDUC COUNS, V83, P423, DOI 10.1016/j.pec.2011.04.036; Heh J, 2014, PAIN MANAG NURS, V15, P466, DOI 10.1016/j.pmn.2012.03.007; Hewett DG, 2009, SOC SCI MED, V69, P1732, DOI 10.1016/j.socscimed.2009.09.048; Jain P, 2011, PATIENT EDUC COUNS, V84, P98, DOI 10.1016/j.pec.2010.06.022; Jones E, 1999, J LANG SOC PSYCHOL, V18, P123, DOI 10.1177/0261927X99018002001; Jones L, 2007, PATIENT EDUC COUNS, V69, P206, DOI 10.1016/j.pec.2007.08.014; Jones L, 2012, J LANG SOC PSYCHOL, V31, P415, DOI 10.1177/0261927X12446612; Jorge J, 2011, PAIN MANAG NURS, V12, P173, DOI 10.1016/j.pmn.2010.12.005; Knier S, 2015, REHABIL NURS, V40, P30, DOI 10.1002/rnj.164; Lagacé M, 2012, J AGING STUD, V26, P335, DOI 10.1016/j.jaging.2012.03.002; Li HZ, 2008, HEALTH EDUC, V108, P411, DOI 10.1108/09654280810900026; McCorkle R, 2011, CA-CANCER J CLIN, V61, P50, DOI 10.3322/caac.20093; Murad MS, 2014, RES SOC ADMIN PHARM, V10, P1, DOI 10.1016/j.sapharm.2013.03.002; O'Toole G., 2012, Communication: Core interpersonal skills for health professionals, V2nd; Pilnick A, 2003, SOC SCI MED, V56, P835, DOI 10.1016/S0277-9536(02)00082-5; Puia D, 2014, PAIN MANAG NURS, V15, P229, DOI 10.1016/j.pmn.2012.09.001; Rantucci MJ., 2007, PHARM TALKING PATIEN; Riley R, 2013, PATIENT EDUC COUNS, V91, P65, DOI 10.1016/j.pec.2012.11.009; RYAN EB, 1994, INT J AGING HUM DEV, V39, P273, DOI 10.2190/NPWX-3GDV-NG4B-KCA3; RYAN EB, 1986, LANG COMMUN, V6, P1, DOI 10.1016/0271-5309(86)90002-9; RYAN EB, 1995, J LANG SOC PSYCHOL, V14, P144, DOI 10.1177/0261927X95141008; Schermer M., 2002, DIFFERENT FACES AUTO; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Scholl I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107828; Spence MM, 2014, J MANAG CARE SPEC PH, V20, P1036, DOI 10.18553/jmcp.2014.20.10.1036; Storm M, 2014, INT J INTEGR CARE, V14; Stowasser D.A., 2002, Journal of Pharmacy Practice and Research, V32, P133, DOI [10.1002/jppr2002322133, DOI 10.1002/JPPR2002322133]; Tomko John R, 2013, Hosp Pharm, V48, P314, DOI 10.1310/hpj4804-314.test; van Dam HA, 2003, PATIENT EDUC COUNS, V51, P17, DOI 10.1016/S0738-3991(02)00122-2; Warden BA, 2014, AM J HEALTH-SYST PH, V71, P134, DOI 10.2146/ajhp130103; Watson B, 2002, J LANG SOC PSYCHOL, V21, P32, DOI 10.1177/0261927X02021001003; Watson B., 1999, International Journal of Applied Linguistics, V9, P167, DOI DOI 10.1111/J.1473-4192.1999.TB00170.X; Watson B, 2007, PALGRAVE ADV, P108; Wei L, 2014, J THORAC DIS, V6, P656, DOI 10.3978/j.issn.2072-1439.2014.06.20; Wiggins BS, 2013, PHARMACOTHERAPY, V33, P558, DOI 10.1002/phar.1231; Wilcock Michael, 2011, Int J Pharm Pract, V19, P400, DOI 10.1111/j.2042-7174.2011.00133.x; Williams A., 1999, International Journal of Applied Linguistics, V9, P151, DOI [10.1111/j.1473-4192.1999.tb00169.x, DOI 10.1111/J.1473-4192.1999.TB00169.X]	49	4	8	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7411	1934-8150		RES SOC ADMIN PHARM	Res. Soc. Adm. Pharm.	SEP-OCT	2016	12	5					747	755		10.1016/j.sapharm.2015.10.008	http://dx.doi.org/10.1016/j.sapharm.2015.10.008			9	Public, Environmental & Occupational Health; Pharmacology & Pharmacy	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Pharmacology & Pharmacy	DU5SG	26626590				2024-09-18	WOS:000382271000007
J	Brundage, MD; Smith, KC; Little, EA; Bantug, ET; Snyder, CF				Brundage, Michael D.; Smith, Katherine C.; Little, Emily A.; Bantug, Elissa T.; Snyder, Claire F.		PRO Data Presentation Stakeholder	Communicating patient-reported outcome scores using graphic formats: results from a mixed-methods evaluation	QUALITY OF LIFE RESEARCH			English	Article						Patient-reported outcomes; Clinical trials; Clinical practice; Communication	QUALITY-OF-LIFE; CLINICAL-TRIALS; PATIENTVIEWPOINT; INFORMATION; ISSUES	Patient-reported outcomes (PROs) promote patient-centered care by using PRO research results ("group-level data") to inform decision making and by monitoring individual patient's PROs ("individual-level data") to inform care. We investigated the interpretability of current PRO data presentation formats. This cross-sectional mixed-methods study randomized purposively sampled cancer patients and clinicians to evaluate six group-data or four individual-data formats. A self-directed exercise assessed participants' interpretation accuracy and ratings of ease-of-understanding and usefulness (0 = least to 10 = most) of each format. Semi-structured qualitative interviews explored helpful and confusing format attributes. We reached thematic saturation with 50 patients (44 % < college graduate) and 20 clinicians. For group-level data, patients rated simple line graphs highest for ease-of-understanding and usefulness (median 8.0; 33 % selected for easiest to understand/most useful) and clinicians rated simple line graphs highest for ease-of-understanding and usefulness (median 9.0, 8.5) but most often selected line graphs with confidence limits or norms (30 % for each format for easiest to understand/most useful). Qualitative results support that clinicians value confidence intervals, norms, and p values, but patients find them confusing. For individual-level data, both patients and clinicians rated line graphs highest for ease-of-understanding (median 8.0 patients, 8.5 clinicians) and usefulness (median 8.0, 9.0) and selected them as easiest to understand (50, 70 %) and most useful (62, 80 %). The qualitative interviews supported highlighting scores requiring clinical attention and providing reference values. This study has identified preferences and opportunities for improving on current formats for PRO presentation and will inform development of best practices for PRO presentation. Both patients and clinicians prefer line graphs across group-level data and individual-level data formats, but clinicians prefer greater detail (e.g., statistical details) for group-level data.	[Brundage, Michael D.] Queens Univ, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada; [Smith, Katherine C.; Bantug, Elissa T.; Snyder, Claire F.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA; [Smith, Katherine C.; Snyder, Claire F.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Little, Emily A.; Snyder, Claire F.] Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA	Queens University - Canada; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Brundage, MD (corresponding author), Queens Univ, Queens Canc Res Inst, 10 Stuart St,Level 2, Kingston, ON K7L 3N6, Canada.	michael.brundage@krcc.on.ca			Patient-Centered Outcomes Research Institute (PCORI) Award [R-1410-24904]	Patient-Centered Outcomes Research Institute (PCORI) Award(Patient-Centered Outcomes Research Institute - PCORI)	This analysis was (partially) supported by a Patient-Centered Outcomes Research Institute (PCORI) Award (R-1410-24904). All statements in this report, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee. Drs. Snyder and Smith are members of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NCI P30 CA 006973). The funding sources had no role in study design, data collection, analysis, interpretation, writing, or decision to submit the manuscript for publication. The PRO Data Presentation Stakeholder Advisory Board includes Neil K. Aaronson, PhD (Netherlands Cancer Institute); Patricia A. Ganz, MD (University of California-Los Angeles and Jonsson Comprehensive Cancer Center); Ravin Garg, MD (Anne Arundel Medical Center); Michael Fisch, MD (M.D. Anderson Cancer Center); Bryce B. Reeve, PhD (University of North Carolina at Chapel Hill and Lineberger Comprehensive Cancer Center); Marc Silver (author of Breast Cancer Husband-How to Help Your Wife (and Yourself) Through Diagnosis, Treatment, and Beyond); Eden Stotsky-Himelfarb (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins); Ellen Stovall (National Coalition for Cancer Survivorship); Matthew Zachary (Stupid Cancer). The Johns Hopkins Clinical Research Network (JHCRN) site investigators and staff include: Ravin Garg, MD, and Steven P. DeMartino, CCRC, CRT, RPFT (Anne Arundel Medical Center), Melissa Gerstenhaber, MAS, MSN, RN, CCRN (JHCRN/Anne Arundel Medical Center); Gary Cohen, MD, and Cynthia MacInnis, BS, CCRP (Greater Baltimore Medical Center); James Zabora, ScD, MSW (Inova Health System), and Sandra Schaefer, BSN, RN, OCN (JHCRN/Inova Health System); Paul Zorsky, MD, Lynne Armiger, MSN, CRNP, ANP-C, Sandra L. Heineken, BS, RN, OCN, and Nancy J. Mayonado, MS (Peninsula Regional Medical Center); Michael Carducci, MD (Johns Hopkins Sibley Memorial Hospital); Carolyn Hendricks, MD, Melissa Hyman, RN, BSN, OCN, and Barbara Squiller, MSN, MPH, CRNP (Suburban Hospital). Finally, we are most grateful to the patients and clinicians who participated in this study.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Acquadro C., 2003, VALUE HEALTH, V6, P522; [Anonymous], 2009, FED REGISTER, V74, P65132; [Anonymous], 2012, PROMIS SOFTWARE DEMO; [Anonymous], CURR OPIN SUPPORT PA; Au HJ, 2010, EXPERT REV PHARM OUT, V10, P119, DOI [10.1586/erp.10.15, 10.1586/ERP.10.15]; Berry DL, 2011, J CLIN ONCOL, V29, P1029, DOI 10.1200/JCO.2010.30.3909; Bezjak A, 2001, QUAL LIFE RES, V10, P1, DOI 10.1023/A:1016692804023; Brundage M, 2005, J CLIN ONCOL, V23, P6949, DOI 10.1200/JCO.2005.12.514; Brundage M., 2005, 12 ANN C INT SOC QUA; Brundage M, 2011, QUAL LIFE RES, V20, P979, DOI 10.1007/s11136-011-9848-0; Bruner DW, 2007, J CLIN ONCOL, V25, P5051, DOI 10.1200/JCO.2007.11.3324; Creswell J. W., 2017, Qualitative inquiry research design: Choosing among five approaches", V4th; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Jones JB, 2007, QUAL LIFE RES, V16, P1407, DOI 10.1007/s11136-007-9235-z; Lipscomb J., 2005, Outcomes Assessment in Cancer: Measures, Methods and Applications; McNair AGK, 2010, J CLIN ONCOL, V28, P738, DOI 10.1200/JCO.2009.23.9111; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; PROQOLID, 2012, PAT REP OUTC QUAL; Santana MJ, 2010, QUAL LIFE RES, V19, P371, DOI 10.1007/s11136-010-9599-3; Snyder CF, 2013, PSYCHO-ONCOLOGY, V22, P895, DOI 10.1002/pon.3087; Snyder CF, 2009, QUAL LIFE RES, V18, P793, DOI 10.1007/s11136-009-9497-8; Snyder CF, 2009, LANCET, V374, P369, DOI 10.1016/S0140-6736(09)61400-8; TILL JE, 1994, QUAL LIFE RES, V3, P279, DOI 10.1007/BF00434902; Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078	26	76	81	0	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24	10					2457	2472		10.1007/s11136-015-0974-y	http://dx.doi.org/10.1007/s11136-015-0974-y			16	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CR0LO	26012839	Green Accepted			2024-09-18	WOS:000361010400016
J	Afzal, HB; Jahangir, T; Mei, YY; Madden, A; Sarker, A; Kim, S				Afzal, Hanin B.; Jahangir, Tasfia; Mei, Yiyang; Madden, Annabelle; Sarker, Abeed; Kim, Sangmi			Can adverse childhood experiences predict chronic health conditions? Development of trauma-informed, explainable machine learning models	FRONTIERS IN PUBLIC HEALTH			English	Article						behavioral risk factor surveillance survey; machine learning; adverse childhood experiences; chronic diseases; health behaviors; health outcomes	CHRONIC DISEASE; ARTIFICIAL-INTELLIGENCE; HOUSEHOLD DYSFUNCTION; RISK; CARE; ADULTHOOD; CANCER; TRAJECTORIES; INFLUENZA; OUTCOMES	Introduction Decades of research have established the association between adverse childhood experiences (ACEs) and adult onset of chronic diseases, influenced by health behaviors and social determinants of health (SDoH). Machine Learning (ML) is a powerful tool for computing these complex associations and accurately predicting chronic health conditions.Methods Using the 2021 Behavioral Risk Factor Surveillance Survey, we developed several ML models-random forest, logistic regression, support vector machine, Naive Bayes, and K-Nearest Neighbor-over data from a sample of 52,268 respondents. We predicted 13 chronic health conditions based on ACE history, health behaviors, SDoH, and demographics. We further assessed each variable's importance in outcome prediction for model interpretability. We evaluated model performance via the Area Under the Curve (AUC) score.Results With the inclusion of data on ACEs, our models outperformed or demonstrated similar accuracies to existing models in the literature that used SDoH to predict health outcomes. The most accurate models predicted diabetes, pulmonary diseases, and heart attacks. The random forest model was the most effective for diabetes (AUC = 0.784) and heart attacks (AUC = 0.732), and the logistic regression model most accurately predicted pulmonary diseases (AUC = 0.753). The strongest predictors across models were age, ever monitored blood sugar or blood pressure, count of the monitoring behaviors for blood sugar or blood pressure, BMI, time of last cholesterol check, employment status, income, count of vaccines received, health insurance status, and total ACEs. A cumulative measure of ACEs was a stronger predictor than individual ACEs.Discussion Our models can provide an interpretable, trauma-informed framework to identify and intervene with at-risk individuals early to prevent chronic health conditions and address their inequalities in the U.S.	[Afzal, Hanin B.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada; [Jahangir, Tasfia] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social & Hlth Educ Sci, Atlanta, GA 30322 USA; [Mei, Yiyang] Emory Univ, Sch Law, Atlanta, GA USA; [Madden, Annabelle] Columbia Univ, Teachers Coll, New York, NY USA; [Sarker, Abeed] Emory Univ, Dept Biomed Informat, Sch Med, Atlanta, GA USA; [Kim, Sangmi] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA USA	University of Toronto; Emory University; Rollins School Public Health; Emory University; Columbia University Teachers College; Columbia University; Emory University; Emory University	Jahangir, T (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social & Hlth Educ Sci, Atlanta, GA 30322 USA.	tasfia.jahangir@emory.edu	Sarker, Abeed/W-1044-2019		National Institute of Nursing Research of the National Institutes of Health [K01NR019651]	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the National Institute of Nursing Research of the National Institutes of Health under Award Number K01NR019651.	Abdulazeem H., 2022, Primary Care Res, DOI [10.1101/2022.08.25.22279229, DOI 10.1101/2022.08.25.22279229]; Alanazi Abdullah, 2022, Informatics in Medicine Unlocked, DOI 10.1016/j.imu.2022.100924; Ali S, 2023, INFORM FUSION, V99, DOI 10.1016/j.inffus.2023.101805; Allen H, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.117.004391; Alzubaidi L, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00444-8; Ammar N, 2020, JMIR MED INF, V8, DOI 10.2196/18752; Anda RF, 2008, AM J PREV MED, V34, P396, DOI 10.1016/j.amepre.2008.02.002; Auffray C, 2010, GENOME MED, V2, DOI 10.1186/gm178; Baiden P, 2021, PREV MED REP, V23, DOI 10.1016/j.pmedr.2021.101463; Battineni G, 2020, J PERS MED, V10, DOI 10.3390/jpm10020021; Bauder RA, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-018-0051-3; Behrouzi B, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.8873; Benjet C, 2010, J PSYCHIATR RES, V44, P732, DOI 10.1016/j.jpsychires.2010.01.004; Bhattarai S, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.13529; Blair A, 2019, INT J PUBLIC HEALTH, V64, P1059, DOI 10.1007/s00038-019-01258-5; Bland Jeffrey S, 2018, Integr Med (Encinitas), V17, P16; Cai Tongan., 2018, Appl Comput Math, V7, P146, DOI [10.11648/j.acm.20180703.20, DOI 10.11648/J.ACM.20180703.20]; Camacho S, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph191710670; Campbell DJT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094007; Campbell JA, 2018, J DIABETES COMPLICAT, V32, P1018, DOI 10.1016/j.jdiacomp.2018.09.006; Centers for Disease Control and Prevention, 2022, LLCP 2021 codebook report: Behavioral risk factor surveillance system [internet]; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Chen D, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0122-0; Christopher AS, 2016, AM J PUBLIC HEALTH, V106, P63, DOI 10.2105/AJPH.2015.302925; Collatuzzo G, 2022, MED LAV, V113, DOI 10.23749/mdl.v113i1.12622; Cruz GV, 2022, RHEUMATOL INT, V42, P1053, DOI 10.1007/s00296-021-04916-1; Davenport Thomas, 2019, Future Healthc J, V6, P94, DOI 10.7861/futurehosp.6-2-94; Delpino FM, 2022, PUBLIC HEALTH, V205, P14, DOI 10.1016/j.puhe.2022.01.007; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Exley D, 2015, EUR RESPIR REV, V24, P299, DOI 10.1183/16000617.00004114; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Gallagher SK, 1996, SOC SCI MED, V42, P1691, DOI 10.1016/0277-9536(95)00296-0; Garrido EF, 2018, J EARLY ADOLESCENCE, V38, P661, DOI 10.1177/0272431616687671; Ghassemi M, 2019, LANCET DIGIT HEALTH, V1, pE157, DOI 10.1016/S2589-7500(19)30084-6; Gladieux M, 2023, TOXICS, V11, DOI 10.3390/toxics11030259; Godoy LC, 2021, JAMA CARDIOL, V6, P228, DOI 10.1001/jamacardio.2020.6050; Goldstein E, 2021, PEDIATR RES, V89, P1861, DOI 10.1038/s41390-020-01188-6; Hasanin T, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0274-4; Holman DM, 2016, PEDIATRICS, V138, pS81, DOI 10.1542/peds.2015-4268L; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Hu Z, 2021, CHILD ABUSE NEGLECT, V117, DOI 10.1016/j.chiabu.2021.105088; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Hughes K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2906-3; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Kellum CE, 2023, PEDIATR NEPHROL, V38, P2155, DOI 10.1007/s00467-022-05853-2; Kelly-Irving M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-767; Kim KN, 2022, ENVIRON INT, V161, DOI 10.1016/j.envint.2022.107119; Kino S, 2021, SSM-POPUL HLTH, V15, DOI 10.1016/j.ssmph.2021.100836; Kirk D, 2022, ADV NUTR, V13, P2573, DOI 10.1093/advances/nmac103; Kumar Y, 2022, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03612-z; Larsson SC, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02188-x; LeMasters K, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10409-4; Li CY, 2012, PREV MED, V54, P381, DOI 10.1016/j.ypmed.2012.04.003; Li SQ, 2022, FRONT PSYCHIATRY, V13, DOI 10.3389/fpsyt.2022.918092; Lietzén R, 2021, J PSYCHOSOM RES, V143, DOI 10.1016/j.jpsychores.2021.110388; Luiz APL, 2018, CLIN RHEUMATOL, V37, P2863, DOI 10.1007/s10067-018-4200-5; Lopes S, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1720336; MacNell N, 2023, PLOS ONE, V18, DOI 10.1371/journal.pone.0280387; Madjid M, 2004, TEX HEART I J, V31, P4; Maurya C, 2023, BMC PUBLIC HEALTH, V23, DOI 10.1186/s12889-023-15416-1; McBain H, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1221-5; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Morris Alison, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS52, DOI 10.1513/AnnalsATS.201306-157MG; National Research Council Institute of Medicine board on population health and public health practice division of behavioral and social sciences and education Committee on population panel on understanding cross-National Health Differences among High-Income Countries, 2013, U.S. health in international perspective: Shorter lives, P421; Nelson CA, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3048; Nusinovici S, 2020, J CLIN EPIDEMIOL, V122, P56, DOI 10.1016/j.jclinepi.2020.03.002; O'Leary E, 2023, SSM-POPUL HLTH, V22, DOI 10.1016/j.ssmph.2023.101393; Ospina MB, 2021, J DEV ORIG HLTH DIS, V12, P50, DOI 10.1017/S2040174419000886; Ozieh MN, 2020, AM J PREV MED, V59, pE49, DOI 10.1016/j.amepre.2020.04.005; Palencia-Sanchez F., 2022, Employments condition and chronic disease in the labor market: A systematic literature review [internet]; Pape K, 2021, THORAX, V76, P547, DOI 10.1136/thoraxjnl-2020-214528; Ports KA, 2019, J PEDIATR NURS, V44, P81, DOI 10.1016/j.pedn.2018.10.009; Rashid J, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.860396; Rigolon A, 2018, LANDSCAPE URBAN PLAN, V178, P156, DOI 10.1016/j.landurbplan.2018.05.026; Rodriguez-Miguelez P, 2022, FUNCTION, V3, DOI 10.1093/function/zqac029; Royer MF, 2022, NUTR REV, V80, P2089, DOI 10.1093/nutrit/nuac029; Rubinstein TB, 2020, J PEDIATR-US, V226, P243, DOI 10.1016/j.jpeds.2020.06.046; Saarela M, 2021, SN APPL SCI, V3, DOI 10.1007/s42452-021-04148-9; Sanderson M, 2021, J HEALTH CARE POOR U, V32, P1384, DOI 10.1353/hpu.2021.0139; Santos M, 2023, BEHAV MED, V49, P381, DOI 10.1080/08964289.2022.2077294; Sarker Iqbal H, 2021, SN Comput Sci, V2, P160, DOI 10.1007/s42979-021-00592-x; Schroeder K, 2022, PREV MED REP, V29, DOI 10.1016/j.pmedr.2022.101915; Schweer-Collins M, 2021, MATERN CHILD HLTH J, V25, P1903, DOI 10.1007/s10995-021-03270-9; Secinaro S, 2021, BMC MED INFORM DECIS, V21, DOI 10.1186/s12911-021-01488-9; Siddegowda CJ., 2022, Int J Manag Technol Soc Sci, P28, DOI [10.47992/IJMTS.2581.6012.0209, DOI 10.47992/IJMTS.2581.6012.0209]; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X; Siscovick DS, 2000, AM J EPIDEMIOL, V152, P674, DOI 10.1093/aje/152.7.674; Skiendzielewski K, 2022, PSYCHOL TRAUMA-US, DOI 10.1037/tra0001320; Sonagra M, 2022, PEDIATR RHEUMATOL, V20, DOI 10.1186/s12969-022-00674-x; Song M, 2008, INT J NURS STUD, V45, P1700, DOI 10.1016/j.ijnurstu.2008.04.005; Stafford IS, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0229-3; Su SY, 2015, CIRCULATION, V131, P1674, DOI 10.1161/CIRCULATIONAHA.114.013104; Subramanian M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02658-5; Tan MH, 2023, CHILD ABUSE NEGLECT, V139, DOI 10.1016/j.chiabu.2023.106091; Torres H, 2017, ANN INTERN MED, V166, P472, DOI [10.7326/m16-1256, 10.7326/M16-1256]; van Duin L, 2019, EUR CHILD ADOLES PSY, V28, P1065, DOI 10.1007/s00787-018-1263-4; Walsh D, 2019, J EPIDEMIOL COMMUN H, V73, P1087, DOI 10.1136/jech-2019-212738; Warren-Gash C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01794-2017; Xing HJ, 2009, FUZZY INF ENG, V1, P289, DOI 10.1007/s12543-009-0022-0; Zhang YY, 2022, J DIABETES COMPLICAT, V36, DOI 10.1016/j.jdiacomp.2022.108289; Zhang YN, 2016, IEEE TRUST BIG, P965, DOI [10.1109/TrustCom.2016.161, 10.1109/TrustCom.2016.0163]; Zheng H, 2021, IEEE ACCESS, V9, P113692, DOI 10.1109/ACCESS.2021.3099795; Zuech R, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00460-8	103	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	JAN 15	2024	11								1309490	10.3389/fpubh.2023.1309490	http://dx.doi.org/10.3389/fpubh.2023.1309490			16	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HC4W6	38332940	Green Published, gold			2024-09-18	WOS:001157288300001
J	Katsiki, AD; Karatzas, PE; De Lastic, HX; Georgakilas, AG; Tsitsilonis, O; Vorgias, CE				Katsiki, Anna D.; Karatzas, Pantelis E.; De Lastic, Hector-Xavier; Georgakilas, Alexandros G.; Tsitsilonis, Ourania; Vorgias, Constantinos E.			DExplore: An Online Tool for Detecting Differentially Expressed Genes from mRNA Microarray Experiments	BIOLOGY-BASEL			English	Article						web application; bioinformatics; differential expression analysis; gene expression; gene enrichment analysis; microarrays; response to chemotherapeutics; gene expression profile	REJECTIVE MULTIPLE TEST; FALSE DISCOVERY RATE; NORMALIZATION; REPRODUCIBILITY; SETS; GEO	Simple Summary DExplore is a user-friendly web application addressing challenges in analyzing mRNA microarray experiments for gene expression profiling. For over fifteen years, microarray experiments have played a vital role in understanding gene expression in various conditions. DExplore, built with the R programming language, Shiny package, and Bioconductor, caters to researchers lacking programming skills. It facilitates the detection of differentially expressed genes using data from the NCBI Gene Expression Omnibus (GEO) and integrates with WebGestalt for functional enrichment analysis. DExplore incorporates visualization plots, enhancing the interpretability of analysis results. These plots provide researchers with deeper insights into gene expression patterns, facilitating informed decision-making. The application's versatility extends to a Docker image available on Docker Hub, enabling local usage of data not submitted to GEO. Currently tailored for the Affymetrix platforms, DExplore serves as a powerful application, simplifying the analysis of high-throughput data. This online accessible tool empowers molecular biologists to focus on a smaller number of biologically relevant genes, eliminating complexity and enhancing the utility of publicly available data in advancing gene expression research. DExplore is a free and open-source web application.Abstract Microarray experiments, a mainstay in gene expression analysis for nearly two decades, pose challenges due to their complexity. To address this, we introduce DExplore, a user-friendly web application enabling researchers to detect differentially expressed genes using data from NCBI's GEO. Developed with R, Shiny, and Bioconductor, DExplore integrates WebGestalt for functional enrichment analysis. It also provides visualization plots for enhanced result interpretation. With a Docker image for local execution, DExplore accommodates unpublished data. To illustrate its utility, we showcase two case studies on cancer cells treated with chemotherapeutic drugs. DExplore streamlines microarray data analysis, empowering molecular biologists to focus on genes of biological significance.	[Katsiki, Anna D.; Tsitsilonis, Ourania; Vorgias, Constantinos E.] Natl & Kapodistrian Univ Athens, Sch Sci, Dept Biol, Athens 15784, Greece; [Karatzas, Pantelis E.] Natl Tech Univ Athens NTUA, Sch Chem Engn, Dept Proc Anal & Plant Design, Unit Proc Control & Informat, Zografou Campus, Athens 15780, Greece; [De Lastic, Hector-Xavier; Georgakilas, Alexandros G.] Natl Tech Univ Athens NTUA, Sch Appl Math & Phys Sci, Phys Dept, DNA Damage Lab, Zografou Campus, Athens 15780, Greece	National & Kapodistrian University of Athens	Vorgias, CE (corresponding author), Natl & Kapodistrian Univ Athens, Sch Sci, Dept Biol, Athens 15784, Greece.	cvorgias@biol.uoa.gr	Georgakilas, Alexandros/AAG-9517-2020	Tsitsilonis, Ourania/0000-0001-6954-0740; de Lastic, Hector - Xavier/0000-0001-9462-6562; Georgakilas, Alexandros/0000-0002-5971-0010	SARG-NKUA project	SARG-NKUA project	We wish to express our warmest and most grateful thanks to Nikos C. Papandreou for his critical reading of the manuscript and to Fotis A. Baltoumas for his invaluable help on the creation of the Docker image of DExplore.	Alonso R, 2015, NUCLEIC ACIDS RES, V43, pW117, DOI 10.1093/nar/gkv384; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attali D., 2020, shinyjs: Easily Improve the User Experience of Your Shiny Apps in Seconds; Bailey E., 2015, shinyBS: Twitter Bootstrap Components for Shiny; Bailey ST, 2012, P NATL ACAD SCI USA, V109, P18060, DOI 10.1073/pnas.1018858109; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beaulieu-Jones BK, 2017, NAT BIOTECHNOL, V35, P342, DOI 10.1038/nbt.3780; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chaddad Z, 2023, FRONT PLANT SCI, V14, DOI 10.3389/fpls.2023.1250728; Chang W, 2022, shiny: Web Application Framework for R, DOI [DOI 10.1002/BIMJ.202100112, DOI 10.32614/CRAN.PACKAGE.SHINY]; Christidi E, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03614-x; Danchin A, 2018, MICROB BIOTECHNOL, V11, P588, DOI 10.1111/1751-7915.13284; Di Tommaso P, 2015, PEERJ, V3, DOI 10.7717/peerj.1273; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dudoit S., 2009, Multiple Testing Procedures with Applications to Genomics, DOI [10.1007/978-0-387-98135-2, DOI 10.1007/978-0-387-98135-2]; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Dziuda D.M., 2010, Data Mining for Genomics and Proteomics. Analysis of Gene and Protein Expression Data, DOI [10.1002/9780470593417, DOI 10.1002/9780470593417]; Dziuda Darius., 2010, Data Mining for Genomics and Proteomics: Analysis of Gene and Protein Expression Data; Ewaschuk JB, 2012, LIPIDS, V47, P1019, DOI 10.1007/s11745-012-3717-7; Farhangniya M, 2023, CELL J, V25, P874, DOI [10.22074/cellj.2023.2007217.1368, 10.22074/CELLJ.2023.2007217.1368]; Galili T, 2018, BIOINFORMATICS, V34, P1600, DOI 10.1093/bioinformatics/btx657; Gaman AM, 2020, PHYTOCHEMICALS AS LEAD COMPOUNDS FOR NEW DRUG DISCOVERY, P95, DOI 10.1016/B978-0-12-817890-4.00006-8; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gentleman R., 2019, Annotate: Annotation for Microarrays; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hokamp K, 2004, NUCLEIC ACIDS RES, V32, pW457, DOI 10.1093/nar/gkh446; HOLM S, 1979, SCAND J STAT, V6, P65; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Irizarry R.A., 2003, Statistical applications in genetics and molecular biology, V2, DOI [10.2202/1544-6115.1002, DOI 10.2202/1544-6115.1002]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaksik R, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0077-2; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Khatri P, 2005, BIOINFORMATICS, V21, P3587, DOI 10.1093/bioinformatics/bti565; Kolberg L, 2023, NUCLEIC ACIDS RES, V51, pW207, DOI 10.1093/nar/gkad347; Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Leal-Calvo T, 2020, MOL GENET GENOMICS, V295, P1355, DOI 10.1007/s00438-020-01705-6; Liao Y., Package 'WebGestaltR' 2019; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Newell M, 2019, J NUTR, V149, P46, DOI 10.1093/jn/nxy224; Patel AG, 2012, ELIFE, V1, DOI 10.7554/eLife.00387; Piccolo SR, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0135-4; Pieler R, 2004, BIOINFORMATICS, V20, P1971, DOI 10.1093/bioinformatics/bth174; Pournelle G. H., 1953, Journal of Mammalogy, V34, P133, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Rad LM, 2023, PATHOL RES PRACT, V251, DOI 10.1016/j.prp.2023.154838; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; Sarkar SK, 1998, ANN STAT, V26, P494; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sievert C., 2020, INTERACTIVE WEB BASE; Smyth GK, 2004, Stat Appl Genet Mol Biol, V3, DOI DOI 10.2202/1544-6115.1027; Tárraga J, 2008, NUCLEIC ACIDS RES, V36, pW308, DOI 10.1093/nar/gkn303; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Verducci JS, 2006, PHYSIOL GENOMICS, V25, P355, DOI 10.1152/physiolgenomics.00314.2004; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Xie Y., 2020, DT: A Wrapper of the JavaScript Library "DataTables; Yang F, 2015, MUTAT RES-FUND MOL M, V773, P9, DOI 10.1016/j.mrfmmm.2015.01.007; Ying LH, 2009, PEDIATR NEPHROL, V24, P1643, DOI 10.1007/s00467-008-0808-z; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhu YR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-46	73	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2079-7737		BIOLOGY-BASEL	Biology-Basel	MAY	2024	13	5							351	10.3390/biology13050351	http://dx.doi.org/10.3390/biology13050351			26	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	SF5G6	38785833	gold, Green Published			2024-09-18	WOS:001233049400001
J	Bohannan, ZS; Coffman, F; Mitrofanova, A				Bohannan, Zachary S.; Coffman, Frederick; Mitrofanova, Antonina			Random survival forest model identifies novel biomarkers of event-free survival in high-risk pediatric acute lymphoblastic leukemia	COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL			English	Article						Machine learning; Random survival forest; Genomics; Clinical oncology; Bioinformatics	MINIMAL RESIDUAL DISEASE; PROGNOSTIC-FACTORS; BREAST-CANCER; CHILDREN; PREDICTION; RESISTANCE; MUTATION; CELLS; TREES	High-risk pediatric B-ALL patients experience 5-year negative event rates up to 25%. Although some biomarkers of relapse are utilized in the clinic, their ability to predict outcomes in high-risk patients is limited. Here, we propose a random survival forest (RSF) machine learning model utilizing interpretable genomic inputs to predict relapse/death in high-risk pediatric B-ALL patients. We utilized whole exome sequencing profiles from 156 patients in the TARGET-ALL study (with samples collected at presentation) further stratified into training and test cohorts (109 and 47 patients, respectively). To avoid overfitting and facilitate the interpretation of machine learning results, input genomic variables were engineered using a stepwise approach involving univariable Cox models to select variables directly associated with outcomes, genomic coordinate-based analysis to select mutational hotspots, and correlation analysis to eliminate feature co-linearity. Model training identified 7 genomic regions most predictive of relapse/death-free survival. The test cohort error rate was 12.47%, and a polygenic score based on the sum of the top 7 variables effectively stratified patients into two groups, with significant differences in time to relapse/death (log-rank P = 0.001, hazard ratio = 5.41). Our model outperformed other EFS modeling approaches including an RSF using gold-standard prognostic variables (error rate = 24.35%). Validation in 174 standard-risk patients and 3 patients who failed to respond to induction therapy confirmed that our RSF model and polygenic score were specific to high-risk disease. We propose that our feature selection/engineering approach can increase the clinical interpretability of RSF, and our polygenic score could be utilized for enhance clinical decision-making in high-risk B-ALL. (C) 2022 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.	[Bohannan, Zachary S.; Coffman, Frederick; Mitrofanova, Antonina] Rutgers State Univ, Sch Hlth Profess, Dept Hlth Informat, 65 Bergen St,Suite 120, Newark, NJ 07107 USA	Rutgers University System; Rutgers University New Brunswick; Rutgers University Newark	Mitrofanova, A (corresponding author), Rutgers State Univ, Sch Hlth Profess, Dept Hlth Informat, 65 Bergen St,Suite 120, Newark, NJ 07107 USA.	antonina.mitrofanova@rutgers.edu			Rutgers School of Health Professions Start-up funds; NIH [R01LM013236-01]; NJCCR [COCR21RBG003]; ACS Research Scholar grant [RSG-21-023-01-TBG]	Rutgers School of Health Professions Start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJCCR; ACS Research Scholar grant	Antonina Mitrofanova is supported by Rutgers School of Health Professions Start-up funds, NIH R01LM013236-01, ACS Research Scholar grant RSG-21-023-01-TBG, and NJCCR COCR21RBG003.	Adham Davoud, 2017, Asian Pac J Cancer Prev, V18, P129; Ali Mehreen, 2019, Biophys Rev, V11, P31, DOI 10.1007/s12551-018-0446-z; [Anonymous], 2019, Surveillance, Epidemiology, and End Results Program SEER Stat Databases; [Anonymous], 2019, PIC TOOLK COMP; Auwera GA, 2013, CURR PROTOC BIOINFOR, V43, DOI [10.1002/0471250953.2013.43, DOI 10.1002/0471250953.2013.43]; Berry DA, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.0580; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Boeri C, 2020, CANCER MED-US, V9, P3234, DOI 10.1002/cam4.2811; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Borowitz MJ, 2015, BLOOD, V126, P964, DOI 10.1182/blood-2015-03-633685; Campana D, 2017, BLOOD, V129, P1913, DOI 10.1182/blood-2016-12-725804; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chang SW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-170; Chapman B, **DATA OBJECT**, V2021, DOI 10.5281/zenodo.4686097; Chaudharyl K, 2018, CLIN CANCER RES, V24, P1248, DOI 10.1158/1078-0432.CCR-17-0853; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Ching T, 2017, bioRxiv, DOI [10.1101/142760, 10.1101/142760, DOI 10.1101/142760]; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Coccaro N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122929; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Cooper SL, 2015, PEDIATR CLIN N AM, V62, P61, DOI 10.1016/j.pcl.2014.09.006; De Vivo I, 1998, P NATL ACAD SCI USA, V95, P9471, DOI 10.1073/pnas.95.16.9471; Dlamini Z, 2020, COMPUT STRUCT BIOTEC, V18, P2300, DOI 10.1016/j.csbj.2020.08.019; Eckardt JN, 2020, BLOOD ADV, V4, P6077, DOI 10.1182/bloodadvances.2020002997; Eguether T, 2018, EMBO REP, V19, DOI 10.15252/embr.201846589; Exarchos KP, 2012, IEEE T INF TECHNOL B, V16, P1127, DOI 10.1109/TITB.2011.2165076; Fröhlich H, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1122-7; Gal O, 2019, CANCER INFORM, V18, DOI 10.1177/1176935119835544; Genomics NCI-OoC, 2020, TARG DAT MATR; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; Guo Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-447; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hearn JI, 2020, THROMB HAEMOSTASIS, V120, P671, DOI 10.1055/s-0040-1708483; Heikamp EB, 2018, J PEDIATR-US, V203, P14, DOI 10.1016/j.jpeds.2018.07.039; Hossain MJ, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/865979; Information NCfB, 2019, SRA TOOLK; Ishwaran Hemant, 2011, Statistical Analysis and Data Mining, V4, P115, DOI 10.1002/sam.10103; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Ishwaran H, 2019, STAT MED, V38, P558, DOI 10.1002/sim.7803; Janitza S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201904; Jenks AD, 2018, CELL REP, V23, P3042, DOI 10.1016/j.celrep.2018.05.016; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Kalev-Zylinska ML, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00577; Kato M, 2018, PEDIATR INT, V60, P4, DOI 10.1111/ped.13457; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Larsen EC, 2016, J CLIN ONCOL, V34, P2380, DOI 10.1200/JCO.2015.62.4544; LEBLANC M, 1993, J AM STAT ASSOC, V88, P457, DOI 10.2307/2290325; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Li H, 2013, Aligning sequence reads, clone sequences and assembly contigs with BWAMEM, DOI [10.48550/arXiv.1303.3997, DOI 10.48550/ARXIV.1303.3997]; Li J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01119; Liu HQ, 2018, NAT REV CANCER, V18, P511, DOI 10.1038/s41568-018-0023-6; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Maloney KW, 2020, J CLIN ONCOL, V38, P602, DOI 10.1200/JCO.19.01086; Mao Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27307-2; Mei Y, 2020, J BIOCHEM, V167, P603, DOI 10.1093/jb/mvaa009; Mitchell M.W., 2011, OPEN J STAT, V1, P205, DOI [DOI 10.4236/OJS.2011.13024, 10.4236/ojs.2011.13024]; Nakatsu G, 2018, GASTROENTEROLOGY, V155, P529, DOI 10.1053/j.gastro.2018.04.018; Nindrea Ricvan Dana, 2018, Asian Pac J Cancer Prev, V19, P1747, DOI 10.22034/APJCP.2018.19.7.1747; O'Brien R, 2019, PATTERN RECOGN, V90, P232, DOI 10.1016/j.patcog.2019.01.036; Pang H, 2012, IEEE ACM T COMPUT BI, V9, P1422, DOI 10.1109/TCBB.2012.63; Paule S, 2012, HUM REPROD, V27, P2766, DOI 10.1093/humrep/des203; Radakovich N, 2020, LANCET HAEMATOL, V7, pE541, DOI 10.1016/S2352-3026(20)30121-6; Rosado P, 2013, EXPERT SYST APPL, V40, P4770, DOI 10.1016/j.eswa.2013.02.032; Roshanaei G, 2022, J GASTROINTEST CANC, V53, P64, DOI 10.1007/s12029-020-00544-3; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI [10.1093/nar/gky1131, 10.1093/nar/gkac1000]; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Villanueva A, 2015, HEPATOLOGY, V61, P1945, DOI 10.1002/hep.27732; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Vrooman LM, 2016, CURR HEMATOL MALIG R, V11, P385, DOI 10.1007/s11899-016-0337-y; Wang Hong, 2017, Quant Biosci, V36, P85; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang KJ, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-1537-5; Wu C, 2018, CRIT REV ONCOL HEMAT, V126, P100, DOI 10.1016/j.critrevonc.2018.04.002; Xiaoyi Xu, 2012, 2012 5th International Conference on BioMedical Engineering and Informatics (BMEI), P928, DOI 10.1109/BMEI.2012.6513032; Xie F, 2020, CLIN CANCER RES, V26, P2908, DOI 10.1158/1078-0432.CCR-19-1744; Xu GR, 2017, GENE, V604, P33, DOI 10.1016/j.gene.2016.12.016; Xu JP, 2021, PATHOL RES PRACT, V219, DOI 10.1016/j.prp.2021.153374; Yokoyama S, 2020, CLIN CANCER RES, V26, P2411, DOI 10.1158/1078-0432.CCR-19-1247; Zhu W, 2020, CANCERS, V12, DOI 10.3390/cancers12030603	84	14	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2001-0370			COMPUT STRUCT BIOTEC	Comp. Struct. Biotechnol. J..		2022	20						583	597		10.1016/j.csbj.2022.01.003	http://dx.doi.org/10.1016/j.csbj.2022.01.003		JAN 2022	15	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	2P7FF	35116134	gold, Green Published			2024-09-18	WOS:000819901300009
J	Mahmoudi, S; Bernatz, S; Ackermann, J; Koch, V; Dos Santos, DP; Grünewald, LD; Yel, I; Martin, SS; Scholtz, JE; Stehle, A; Walter, D; Zeuzem, S; Wild, PJ; Vogl, TJ; Kinzler, MN				Mahmoudi, S.; Bernatz, S.; Ackermann, J.; Koch, V.; Dos Santos, D. P.; Gruenewald, L. D.; Yel, I.; Martin, S. S.; Scholtz, J. -E; Stehle, A.; Walter, D.; Zeuzem, S.; Wild, P. J.; Vogl, T. J.; Kinzler, M. N.			Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma	CLINICAL ONCOLOGY			English	Article						Artificial intelligence; Biomarkers; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Machine learning; Predictive medicine	PRIMARY LIVER-CANCER; DIAGNOSIS; MANAGEMENT; IMAGES	Aims: Intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) differ in prognosis and treatment. We aimed to non-invasively differentiate iCCA and HCC by means of radiomics extracted from contrast-enhanced standard-of-care computed tomography (CT). Materials and methods: In total, 94 patients (male, n = 68, mean age 63.3 +/- 12.4 years) with histologically confirmed iCCA (n = 47) or HCC (n = 47) who underwent contrast-enhanced abdominal CT between August 2014 and November 2021 were retrospectively included. The enhancing tumour border was manually segmented in a clinically feasible way by defining three three-dimensional volumes of interest per tumour. Radiomics features were extracted. Intraclass correlation analysis and Pearson metrics were used to stratify robust and non-redundant features with further feature reduction by LASSO (least absolute shrinkage and selection operator). Independent training and testing datasets were used to build four different machine learning models. Performance metrics and feature importance values were computed to increase the models' interpretability. Results: The patient population was split into 65 patients for training (iCCA, n = 32) and 29 patients for testing (iCCA, n = 15). A final combined feature set of three radiomics features and the clinical features age and sex revealed a top test model performance of receiver operating characteristic (ROC) area under the curve (AUC) = 0.82 (95% confidence interval = 0.66-0.98; train ROC AUC = 0.82) using a logistic regression classifier. The model was well calibrated, and the Youden J Index suggested an optimal cut-off of 0.501 to discriminate between iCCA and HCC with a sensitivity of 0.733 and a specificity of 0.857. Conclusions: Radiomics-based imaging biomarkers can potentially help to non-invasively discriminate between iCCA and HCC. (c) 2023 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.	[Mahmoudi, S.; Bernatz, S.; Ackermann, J.; Koch, V.; Dos Santos, D. P.; Gruenewald, L. D.; Yel, I.; Martin, S. S.; Scholtz, J. -E; Vogl, T. J.] Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Frankfurt, Germany; [Bernatz, S.; Wild, P. J.] Goethe Univ, Univ Hosp Frankfurt, Dr Senckenberg Inst Pathol, Frankfurt, Germany; [Bernatz, S.; Vogl, T. J.] Goethe Univ, Frankfurt Canc Inst FCI, Frankfurt, Germany; [Bernatz, S.] Goethe Univ, Univ Canc Ctr Frankfurt UCT, Univ Hosp, Frankfurt, Germany; [Ackermann, J.] Goethe Univ, Inst Comp Sci, Dept Mol Bioinformat, Frankfurt, Germany; [Dos Santos, D. P.] Univ Hosp Cologne, Dept Diagnost & Intervent Radiol, Cologne, Germany; [Stehle, A.; Walter, D.; Zeuzem, S.; Kinzler, M. N.] Goethe Univ, Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Wild, P. J.] Frankfurt Inst Adv Studies FIAS, Frankfurt, Germany; [Mahmoudi, S.] Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; University of Cologne; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Mahmoudi, S (corresponding author), Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	scherwin.mahmoudi@kgu.de	Zeuzem, Stefan/AAE-7435-2019; Pinto dos Santos, Daniel/I-4609-2019	Bernatz, Simon/0000-0002-7758-8100	Frankfurt Research Promotion Program (FFF) of the Faculty of Medicine of the Goethe University	Frankfurt Research Promotion Program (FFF) of the Faculty of Medicine of the Goethe University	AS and MNK were supported by a rotation grant for medical scientists in the Frankfurt Research Promotion Program (FFF) of the Faculty of Medicine of the Goethe University. The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], ACR APPR CRIT CHRON; Ayuso C, 2018, EUR J RADIOL, V101, P72, DOI 10.1016/j.ejrad.2018.01.025; Bakr S, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.041303; Bera K, 2022, NAT REV CLIN ONCOL, V19, P132, DOI 10.1038/s41571-021-00560-7; Bernatz S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93756-x; Bertuccio P, 2013, ANN ONCOL, V24, P1667, DOI 10.1093/annonc/mds652; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; De Cecco CN, 2012, AM J ROENTGENOL, V199, pS98, DOI 10.2214/AJR.12.9207; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Ferrante Nicole D, 2020, Gastroenterol Hepatol (N Y), V16, P506; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Hu R, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-11997-w; Ilyas SI, 2017, J HEPATOL, V67, P632, DOI 10.1016/j.jhep.2017.03.026; Kircher A, 2014, RADIOLOGE, V54, P664, DOI 10.1007/s00117-014-2652-4; Krenzien F, 2022, CANCERS, P14; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Li R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26772; Liam CK, 2015, RESPIROLOGY, V20, P526, DOI 10.1111/resp.12489; Liu XY, 2021, EUR RADIOL, V31, P244, DOI 10.1007/s00330-020-07119-7; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Mahmoudi S, 2022, EUR J RADIOL, V156, DOI 10.1016/j.ejrad.2022.110556; Marrero JA, 2014, AM J GASTROENTEROL, V109, P1328, DOI 10.1038/ajg.2014.213; Nie P, 2020, CANCER IMAGING, V20, DOI 10.1186/s40644-020-00297-z; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Vallat R., 2018, The Journal of Open Source Software, V3, P1026, DOI DOI 10.21105/JOSS.01026; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Wu JJ, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0321-9; Xiang F, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.774117; Xu J, 2012, LIVER INT, V32, P1156, DOI 10.1111/j.1478-3231.2012.02783.x; Xu XL, 2022, COMPUT MATH METHOD M, V2022, DOI 10.1155/2022/5334095; Yamamoto M, 2004, J SURG ONCOL, V87, P80, DOI 10.1002/jso.20091; Yoneyama T, 2014, EUR J RADIOL, V83, P1734, DOI 10.1016/j.ejrad.2014.04.026; Zhang JH, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-19-4668; Zhou Y, 2017, ABDOM RADIOL, V42, P1695, DOI 10.1007/s00261-017-1072-0; Zhu Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97796-1	37	4	4	2	6	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0936-6555	1433-2981		CLIN ONCOL-UK	Clin. Oncol.	MAY	2023	35	5					E312	E318		10.1016/j.clon.2023.01.018	http://dx.doi.org/10.1016/j.clon.2023.01.018		APR 2023	7	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	F2XC9	36804153				2024-09-18	WOS:000981018400001
J	Wang, DQ; Xu, WH; Cheng, XW; Hua, L; Ge, XS; Liu, L; Gao, X				Wang, Dan-qi; Xu, Wen-huan; Cheng, Xiao-wei; Hua, Lei; Ge, Xiao-song; Liu, Li; Gao, Xiang			Interpretable machine learning for predicting the response duration to Sintilimab plus chemotherapy in patients with advanced gastric or gastroesophageal junction cancer	FRONTIERS IN IMMUNOLOGY			English	Article						Sintilimab; immunotherapy; progression-free survival; machine learning; interpretability		Background Sintilimab plus chemotherapy has proven effective as a combination immunotherapy for patients with advanced gastric and gastroesophageal junction adenocarcinoma (GC/GEJC). A multi-center study conducted in China revealed a median progression-free survival (PFS) of 7.1 months. However, the prediction of response duration to this immunotherapy has not been thoroughly investigated. Additionally, the potential of baseline laboratory features in predicting PFS remains largely unexplored. Therefore, we developed an interpretable machine learning (ML) framework, iPFS-SC, aimed at predicting PFS using baseline (pre-treatment) laboratory features and providing interpretations of the predictions.Materials and methods A cohort of 146 patients with advanced GC/GEJC, along with their baseline laboratory features, was included in the iPFS-SC framework. Through a forward feature selection process, predictive baseline features were identified, and four ML algorithms were developed to categorize PFS duration based on a threshold of 7.1 months. Furthermore, we employed explainable artificial intelligence (XAI) methodologies to elucidate the relationship between features and model predictions.Results The findings demonstrated that LightGBM achieved an accuracy of 0.70 in predicting PFS for advanced GC/GEJC patients. Furthermore, an F1-score of 0.77 was attained for identifying patients with PFS durations shorter than 7.1 months. Through the feature selection process, we identified 11 predictive features. Additionally, our framework facilitated the discovery of relationships between laboratory features and PFS.Conclusion A ML-based framework was developed to predict Sintilimab plus chemotherapy response duration with high accuracy. The suggested predictive features are easily accessible through routine laboratory tests. Furthermore, XAI techniques offer comprehensive explanations, both at the global and individual level, regarding PFS predictions. This framework enables patients to better understand their treatment plans, while clinicians can customize therapeutic approaches based on the explanations provided by the model.	[Wang, Dan-qi; Hua, Lei; Liu, Li] Jiangnan Univ, Big Data Ctr, Affiliated Hosp, Wuxi, Peoples R China; [Xu, Wen-huan; Cheng, Xiao-wei; Ge, Xiao-song; Gao, Xiang] Jiangnan Univ, Affiliated Hosp, Dept Oncol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Liu, L (corresponding author), Jiangnan Univ, Big Data Ctr, Affiliated Hosp, Wuxi, Peoples R China.; Gao, X (corresponding author), Jiangnan Univ, Affiliated Hosp, Dept Oncol, Wuxi, Peoples R China.	9862016027@jiangnan.edu.cn; 13606189128@139.com			National Key R&D Program of China [2021YFC0122701]; Scientific Research Program of Wuxi Health Commission [Z202309, M202215]; Taihu Light Technology Research (Medical and Health) [Y20232001]; Research Project of Cutting-Edge Tumor Support Therapy [nphcf-2022-118]	National Key R&D Program of China; Scientific Research Program of Wuxi Health Commission; Taihu Light Technology Research (Medical and Health); Research Project of Cutting-Edge Tumor Support Therapy	The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study has been funded by the National Key R&D Program of China (NO. 2021YFC0122701), the Scientific Research Program of Wuxi Health Commission (NO. Z202309 and NO. M202215), the Taihu Light Technology Research (Medical and Health; NO. Y20232001), and Research Project of Cutting-Edge Tumor Support Therapy (nphcf-2022-118).	Afrash MR, 2023, BMC GASTROENTEROL, V23, DOI 10.1186/s12876-022-02626-x; Al-Shamsi HO, 2016, J GASTROINTEST ONCOL, V7, P499, DOI 10.21037/jgo.2016.06.16; Bai RL, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00912; Baron S, 2023, MIND MACH, V33, P347, DOI 10.1007/s11023-023-09637-x; Bergstra J., 2011, ADV NEURAL INFORM PR, V24, P1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai QC, 2019, GUT, V68, P1576, DOI 10.1136/gutjnl-2018-317556; Hirasawa T, 2018, GASTRIC CANCER, V21, P653, DOI 10.1007/s10120-018-0793-2; Huang PZ, 2016, MOL CLIN ONCOL, V4, P229, DOI 10.3892/mco.2015.705; Leowattana Wattana, 2023, World J Methodol, V13, P79, DOI 10.5662/wjm.v13.i3.79; Liu MM, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0689-4; Lundberg SM, 2017, ADV NEUR IN, V30; Lundberg SM, 2020, NAT MACH INTELL, V2, P56, DOI 10.1038/s42256-019-0138-9; Mortezagholi Asghar, 2019, Asian Pac J Cancer Prev, V20, P2607, DOI 10.31557/APJCP.2019.20.9.2607; Mothilal RK, 2020, FAT* '20: PROCEEDINGS OF THE 2020 CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, P607, DOI 10.1145/3351095.3372850; Newaz A, 2023, Arxiv, DOI [arXiv:2312.08381, 10.48550/arxiv.2312.08381, DOI 10.48550/ARXIV.2312.08381]; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Orillard E, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.763926; Ozdemir S, 2021, TOXICS, V9, DOI 10.3390/toxics9110282; Ozveren A, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-34778-5; Rudin C, 2022, NAT REV METHOD PRIME, V2, DOI 10.1038/s43586-022-00172-0; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Su YH, 2007, CANCER SCI, V98, P37, DOI 10.1111/j.1349-7006.2006.00339.x; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Taninaga J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48769-y; Wang J, 2019, MABS-AUSTIN, V11, P1443, DOI 10.1080/19420862.2019.1654303; Wu XN, 2014, EUR J CANCER PREV, V23, P122, DOI 10.1097/CEJ.0b013e3283627f14; Xu JM, 2023, JAMA-J AM MED ASSOC, V330, P2064, DOI 10.1001/jama.2023.19918; Yoon J, 2023, J GASTRIC CANCER, V23, P207, DOI 10.5230/jgc.2023.23.e10; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13192-8; Zhu Y, 2019, GASTROINTEST ENDOSC, V89, P806, DOI 10.1016/j.gie.2018.11.011	31	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	MAY 22	2024	15								1407632	10.3389/fimmu.2024.1407632	http://dx.doi.org/10.3389/fimmu.2024.1407632			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ4I3	38840913	Green Published, gold			2024-09-18	WOS:001238254700001
J	An, C; Yang, HC; Yu, XL; Han, ZY; Cheng, ZG; Liu, FY; Dou, JP; Li, B; Li, YS; Li, YC; Yu, J; Liang, P				An, Chao; Yang, Hongcai; Yu, Xiaoling; Han, Zhi-Yu; Cheng, Zhigang; Liu, Fangyi; Dou, Jianping; Li, Bing; Li, Yansheng; Li, Yichao; Yu, Jie; Liang, Ping			A Machine Learning Model Based on Health Records for Predicting Recurrence After Microwave Ablation of Hepatocellular Carcinoma	JOURNAL OF HEPATOCELLULAR CARCINOMA			English	Article						microwave ablation; hepatocellular carcinoma; recurrence; machine learning; risk stratification	CANCER	Background and Aim: Early recurrence (ER) presents a challenge for the survival prognosis of patients with hepatocellular carcinoma (HCC). The aim of this study was to investigate machine learning (ML) models using clinical data for predicting ER after microwave ablation (MWA). Methods: Between August 2005 and December 2019, 1574 patients with early-stage HCC underwent MWA at four hospitals were reviewed. Then, 36 clinical data points per patient were collected, and the patients were assigned to the training, internal, and external validation set. Apart from traditional logistic regression (LR), three ML models-random forest, support vector machine, and eXtreme Gradient Boosting (XGBoost)-were built and validated for their predictive ability with the area under ROC curve (AUC). Algorithms such as SHapley Additive exPlanations (SHAP) and local interpretable model-agnostic explanations (LIME) were used to realize their interpretability. Results: The three ML models all outperformed LR (P < 0.001 for all) in predictive ability. When nine variables (tumor number, platelet, alpha-fetoprotein, comorbidity score, white blood cell, cholinesterase, prothrombin time, neutrophils, and etiology) were extracted simultaneously using recursive feature elimination with cross-validation, the XGBoost model achieved the best discrimination among all models, with an AUC value 0.75 (95% CI [confidence interval]: 0.72-0.78) in the training set, 0.74 (95% CI: 0.69-0.80) in the internal validation set, and 0.76 (95% CI: 0.70-0.82) in the external validation set, and it was interpreted depending on the visualization of risk factors by the SHAP and LIME algorithms. The predictive system of post-ablation recurrence risk stratification was provided on online (http://114.251.235.51:8001/) based on XGboost analysis. Conclusion: The XGBoost model based on clinical data can effectively predict ER risk after MWA, which can contribute to surveillance, prevention, and treatment strategies for HCC.	[An, Chao; Yang, Hongcai; Yu, Xiaoling; Han, Zhi-Yu; Cheng, Zhigang; Liu, Fangyi; Dou, Jianping; Yu, Jie; Liang, Ping] PLA Med Coll, Dept Ultrasound, Beijing 100853, Peoples R China; [An, Chao; Yang, Hongcai; Yu, Xiaoling; Han, Zhi-Yu; Cheng, Zhigang; Liu, Fangyi; Dou, Jianping; Yu, Jie; Liang, Ping] Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Med Ctr 5, Beijing 100853, Peoples R China; [Yang, Hongcai] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Li, Bing] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit NLPR, Beijing, Peoples R China; [Li, Yansheng; Li, Yichao] DHC Mediway Technol CO Ltd, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Nankai University; Chinese Academy of Sciences; Institute of Automation, CAS	Yu, J; Liang, P (corresponding author), PLA Med Coll, Dept Ultrasound, Beijing 100853, Peoples R China.; Yu, J; Liang, P (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Med Ctr 5, Beijing 100853, Peoples R China.	yu-jie301@hotmail.com; liangping301@126.com	An, Chao/IZE-5760-2023; CAO, ying/KFA-2972-2024; , Chao/ACI-2245-2022	, Chao/0000-0002-1096-4183; Cheng, Zhigang/0000-0002-5486-6534				Cha Y, 2021, J ENVIRON MANAGE, V291, DOI 10.1016/j.jenvman.2021.112719; Chang WB, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9040178; Chen TY, 2019, AM J KIDNEY DIS, V74, P300, DOI 10.1053/j.ajkd.2019.02.016; Dimitroulis D, 2017, WORLD J GASTROENTERO, V23, P5282, DOI 10.3748/wjg.v23.i29.5282; Eilard MS, 2021, HPB, V23, P394, DOI 10.1016/j.hpb.2020.07.010; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Heo J, 2019, STROKE, V50, P1263, DOI 10.1161/STROKEAHA.118.024293; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]; Kao WY, 2017, RADIOLOGY, V285, P670, DOI 10.1148/radiol.2017162382; Kim CG, 2019, CANCER MED-US, V8, P5023, DOI 10.1002/cam4.2417; Lee S, 2021, ANN SURG, V273, P564, DOI 10.1097/SLA.0000000000003268; Liang P, 2012, GUT, V61, P1100, DOI 10.1136/gutjnl-2011-300975; Lin MY, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.663739; Liu WW, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919874652; Liu XL, 2021, CANCER IMMUNOL RES, V9, P337, DOI 10.1158/2326-6066.CIR-20-0616; Lu P, 2020, APPL OPTICS, V59, P6443, DOI 10.1364/AO.394746; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Oh S, 2021, DIAGNOSTICS, V12, P11, DOI [10.3390/diagnostics12010011, DOI 10.3390/DIAGNOSTICS12010011]; Pan P, 2020, J MED INTERNET RES, V22, DOI 10.2196/23128; Sangiovanni A, 2016, LIVER TRANSPLANT, V22, P161, DOI 10.1002/lt.24382; Shen JX, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2020.100866; Siegel RL, 2021, CA-CANCER J CLIN, V71, P359, DOI [10.3322/caac.21387, 10.3322/caac.21669]; Tahmassebi A, 2019, INVEST RADIOL, V54, P110, DOI 10.1097/RLI.0000000000000518; Vitale A, 2020, HEPATOLOGY, V72, P2206, DOI 10.1002/hep.31187; Wang SJ, 2019, STUD HEALTH TECHNOL, V264, P888, DOI 10.3233/SHTI190351; Yamashita Y, 2018, ANN GASTROENT SURG, V2, P197, DOI 10.1002/ags3.12057; Yang Y, 2021, EUR RADIOL, V31, P3053, DOI 10.1007/s00330-020-07460-x; Yuan CW, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0207-7; Zaitoun MMA, 2021, INT J HYPERTHER, V38, P248, DOI 10.1080/02656736.2021.1887941; Zou ZM, 2021, INSIGHTS IMAGING, V12, DOI 10.1186/s13244-021-00977-9	32	9	9	1	8	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		2253-5969		J HEPATOCELL CARCINO	J. HEPATOCELL. CARCINOMA		2022	9						671	684		10.2147/JHC.S358197	http://dx.doi.org/10.2147/JHC.S358197			14	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	3N7YK	35923613	Green Published, gold			2024-09-18	WOS:000836361900001
J	Shi, HY; Lee, KT; Chiu, CC; Wang, JJ; Sun, DP; Lee, HH				Shi, Hon-Yi; Lee, King-The; Chiu, Chong-Chi; Wang, Jhi-Joung; Sun, Ding-Ping; Lee, Hao-Hsien			5-year recurrence prediction after hepatocellular carcinoma resection: deep learning vs. Cox regression models	AMERICAN JOURNAL OF CANCER RESEARCH			English	Article						Hepatocellular carcinoma; resection; deep learning; recurrence; feature importance	FAMILY SUPPORT; LIVER RESECTION	Deep learning algorithms have yet to be used for predicting clinical prognosis after cancer surgery. Therefore, this study compared performance indices and permutation importance of potential confounders in three models for predicting 5-year recurrence after hepatocellular carcinoma (HCC) resection: a deep-learning deep neural network (DNN) model, a recurrent neural network (RNN) model, and a Cox proportional hazard (CPH) regression model. Data for 725 patients who had received HCC resection at three medical centers in southern Taiwan between April, 2011, and December, 2015, were randomly divided into three datasets: a training dataset containing data for 507 subjects was used for model development, a testing dataset containing data for 109 subjects was used for internal validation, and a validating dataset containing data for 109 subjects was used for external validation. Feature importance analysis was also performed to identify potential predictors of recurrence after HCC resection. Univariate Cox proportional hazards regression analyses were performed to identify potential significant predictors of 5-year recurrence after HCC resection, which were included in the forecasting models (P < 0.05). All performance indices for the DNN model were significantly higher than those for the RNN model and the conventional CPH model (P < 0.001). The most important potential predictor of 5-year recurrence after HCC resection was surgeon volume followed by, in order of importance, hospital volume, preoperative Beck Depression Scale score, preoperative Beck Anxiety Scale score, co-residence with family, tumor stage, and tumor size. The feature importance analysis performed to investigate interpretability in this study elucidated the potential use of deep learning models for predicting recurrence after HCC resection and for identifying predictors of recurrence. Further experiments using the proposed DNN model would clarify its potential uses for developing, promoting, and improving health policies for treating HCC patients after surgery.	[Shi, Hon-Yi; Lee, King-The] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung 80708, Taiwan; [Shi, Hon-Yi] Natl Sun Yat Sen Univ, Dept Business Management, Kaohsiung 80420, Taiwan; [Shi, Hon-Yi] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 80708, Taiwan; [Shi, Hon-Yi] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan; [Lee, King-The] Pk One Int Hosp, Hepatobiliary Pancreat Surg, Kaohsiung 81357, Taiwan; [Chiu, Chong-Chi] E Da Canc Hosp, Dept Gen Surg, Kaohsiung 82445, Taiwan; [Chiu, Chong-Chi] I Shou Univ, Sch Med, Coll Med, Kaohsiung 82445, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan 71004, Taiwan; [Wang, Jhi-Joung] Southern Taiwan Univ Sci & Technol, Allied AI Biomed Ctr, Tainan 71005, Taiwan; [Sun, Ding-Ping] Chi Mei Med Ctr, Dept Surg, Tainan 71004, Taiwan; [Lee, Hao-Hsien] Chi Mei Med Ctr, Dept Surg, 201 Taikang, Tainan 73658, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; E-Da Hospital; I Shou University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Chi Mei Hospital	Lee, HH (corresponding author), Chi Mei Med Ctr, Dept Surg, 201 Taikang, Tainan 73658, Taiwan.	Hao_Hsien@hotmail.com	Shi, Hon-Yi/D-4491-2009	Chiu, Chong-Chi/0000-0002-1696-2648				Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; [Anonymous], 2015, NATURE, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Beck A.T., 1996, Manual for the BDI-II; Beck AT., 1993, Beck anxiety inventory manual; Chang CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086444; Chen SJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004547; Chiu CC, 2015, EJSO-EUR J SURG ONC, V41, P1170, DOI 10.1016/j.ejso.2015.04.023; Franchi E, 2020, GLOB HLTH MED-JPN, V2, P292, DOI 10.35772/ghm.2020.01013; Gelli M, 2020, ANN SURG, V272, P820, DOI 10.1097/SLA.0000000000004259; Given BA, 2001, CA-CANCER J CLIN, V51, P213, DOI 10.3322/canjclin.51.4.213; Hao-Hsien L, 2019, J AFFECT DISORDERS, V246, P361, DOI 10.1016/j.jad.2018.12.085; Ji GW, 2019, EBIOMEDICINE, V50, P156, DOI 10.1016/j.ebiom.2019.10.057; Jin JY, 2021, AM J CANCER RES, V11, P576; Kamen C, 2011, J CLIN PSYCHOL, V67, P215, DOI 10.1002/jclp.20765; Kim M, 2021, ASIAN J SURG, V44, P1389, DOI 10.1016/j.asjsur.2021.03.002; Kumar AMS, 2015, HEPATOB PANCREAT DIS, V14, P269, DOI 10.1016/S1499-3872(15)60382-4; Liu IT, 2021, CANCERS, V13, DOI 10.3390/cancers13215323; Lu CC, 2014, J GASTROINTEST SURG, V18, P1138, DOI 10.1007/s11605-014-2513-5; Luo X, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01287; Mai RY, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-07969-4; Nagendran M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m689; Nam JY, 2020, CANCERS, V12, DOI 10.3390/cancers12102791; Oh HM, 2021, CANCERS, V13, DOI 10.3390/cancers13225816; Shin SW, 2021, ANN SURG, V273, P656, DOI 10.1097/SLA.0000000000004350; Song DJ, 2021, J CANCER RES CLIN, V147, P3757, DOI 10.1007/s00432-021-03617-3; Su JA, 2017, NEUROPSYCH DIS TREAT, V13, P2389, DOI 10.2147/NDT.S135624; Tang S, 2021, CANCER IMAGING, V21, DOI 10.1186/s40644-021-00407-5; Tsai YC, 2021, BMC GASTROENTEROL, V21, DOI 10.1186/s12876-021-01944-w; Wang X, 2020, MOL PSYCHIATR, V25, P3186, DOI 10.1038/s41380-020-00865-6; Westmaas JL, 2020, SUPPORT CARE CANCER, V28, P3791, DOI 10.1007/s00520-019-05193-2; Xu XF, 2019, JAMA SURG, V154, P209, DOI 10.1001/jamasurg.2018.4334; Yu Y, 2019, NEURAL COMPUT, V31, P1235, DOI 10.1162/neco_a_01199; Zhang Y, 2018, CANCER MANAG RES, V10, P3707, DOI 10.2147/CMAR.S175303	33	3	3	0	4	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2156-6976			AM J CANCER RES	Am. J. Cancer Res.		2022	12	6					2876	2890						15	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	3E1OT	35812048				2024-09-18	WOS:000829760200008
J	Gehrmann, S; Dernoncourt, F; Li, YR; Carlson, ET; Wu, JT; Welt, J; Foote, J ; Moseley, ET; Grant, DW; Tyler, PD; Celi, LA				Gehrmann, Sebastian; Dernoncourt, Franck; Li, Yeran; Carlson, Eric T.; Wu, Joy T.; Welt, Jonathan; Foote, John, Jr.; Moseley, Edward T.; Grant, David W.; Tyler, Patrick D.; Celi, Leo A.			Comparing deep learning and concept extraction based methods for patient phenotyping from clinical narratives	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; INFORMATION; IDENTIFICATION; DISEASE; SYSTEM; CANCER; CLASSIFICATION; NORMALIZATION; ALGORITHMS; DISCOVERY	In secondary analysis of electronic health records, a crucial task consists in correctly identifying the patient cohort under investigation. In many cases, the most valuable and relevant information for an accurate classification of medical conditions exist only in clinical narratives. Therefore, it is necessary to use natural language processing (NLP) techniques to extract and evaluate these narratives. The most commonly used approach to this problem relies on extracting a number of clinician-defined medical concepts from text and using machine learning techniques to identify whether a particular patient has a certain condition. However, recent advances in deep learning and NLP enable models to learn a rich representation of (medical) language. Convolutional neural networks (CNN) for text classification can augment the existing techniques by leveraging the representation of language to learn which phrases in a text are relevant for a given medical condition. In this work, we compare concept extraction based methods with CNNs and other commonly used models in NLP in ten phenotyping tasks using 1,610 discharge summaries from the MIMIC-III database. We show that CNNs outperform concept extraction based methods in almost all of the tasks, with an improvement in F1-score of up to 26 and up to 7 percentage points in area under the ROC curve (AUC). We additionally assess the interpretability of both approaches by presenting and evaluating methods that calculate and extract the most salient phrases for a prediction. The results indicate that CNNs are a valid alternative to existing approaches in patient phenotyping and cohort identification, and should be further investigated. Moreover, the deep learning approach presented in this paper can be used to assist clinicians during chart review or support the extraction of billing codes from text by identifying and highlighting relevant phrases for various medical conditions.	[Gehrmann, Sebastian; Dernoncourt, Franck; Li, Yeran; Carlson, Eric T.; Wu, Joy T.; Welt, Jonathan; Foote, John, Jr.; Moseley, Edward T.; Grant, David W.; Tyler, Patrick D.; Celi, Leo A.] MIT Crit Data, Lab Computat Physiol, Cambridge, MA 02139 USA; [Gehrmann, Sebastian] Harvard Univ, Harvard SEAS, Cambridge, MA 02138 USA; [Dernoncourt, Franck; Celi, Leo A.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dernoncourt, Franck] Adobe Res, San Jose, CA USA; [Li, Yeran; Wu, Joy T.] Harvard TH Chan Sch Publ Hlth, Cambridge, MA USA; [Carlson, Eric T.] Philips Res North Amer, Cambridge, MA USA; [Welt, Jonathan] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Foote, John, Jr.] Tufts Univ, Sch Med, Cambridge, MA USA; [Moseley, Edward T.] Univ Massachusetts, Coll Sci & Math, Boston, MA 02125 USA; [Grant, David W.] Washington Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA; [Tyler, Patrick D.] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Adobe Systems Inc.; Harvard University; Harvard T.H. Chan School of Public Health; Philips; Philips Research; Harvard University; Massachusetts General Hospital; Tufts University; University of Massachusetts System; University of Massachusetts Boston; Washington University (WUSTL); Harvard University; Beth Israel Deaconess Medical Center	Gehrmann, S (corresponding author), MIT Crit Data, Lab Computat Physiol, Cambridge, MA 02139 USA.; Gehrmann, S (corresponding author), Harvard Univ, Harvard SEAS, Cambridge, MA 02138 USA.	gehrmann@seas.harvard.edu	Grant, David/HGU-0154-2022	Tyler, Patrick/0000-0001-6156-8722; Gehrmann, Sebastian/0000-0002-8257-9516	Philips Research; National Institute of Biomedical Imaging and Biomedical Engineering [EB017205-01A1]	Philips Research; National Institute of Biomedical Imaging and Biomedical Engineering	Franck Dernoncourt is supported by a grant from Philips Research. Leo Anthony Celi is supported by the R01 grant EB017205-01A1 from the National Institute of Biomedical Imaging (http://grantome.com/grant/NIH/R01-EB017205-01A1) and Biomedical Engineering. The content is solely the responsibility of the authors and does not necessarily represent the official views of Philips Research or the National Institute of Bioimaging and Biomedical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JP, 2016, MAYO CLIN PROC, V91, P1606, DOI 10.1016/j.mayocp.2016.08.008; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P1411, DOI 10.1097/MIB.0b013e31828133fd; [Anonymous], MEDLEE MED LANGUAGE; [Anonymous], 2016, P 1 WORKSH REPR LEAR; [Anonymous], 2013, Adoption of electronic health record systems among U.S. non-federal acute care hospitals: 2008-2012; [Anonymous], 2016, 2016 ICML WORKSHOP H; [Anonymous], 2016, Secondary Analysis of Electronic Health Records, DOI DOI 10.1007/978-3-319-43742-2_28; [Anonymous], 30 AAAI C ART INT; [Anonymous], ARXIV161207843; [Anonymous], AM J EPIDEMIOLOGY; [Anonymous], SEC AN EL HLTH REC; [Anonymous], J AM MED INFORM ASS; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Bates J, 2016, J AM MED INFORM ASSN, V23, pE113, DOI 10.1093/jamia/ocv155; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Breiman L., 1984, STAT PROBABILITY SER; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Chen Lu, 2016, J Grad Med Educ, V8, P39, DOI 10.4300/JGME-D-15-00240.1; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Cooper GF, 1997, ARTIF INTELL MED, V9, P107, DOI 10.1016/S0933-3657(96)00367-3; Denil Misha, 2014, ARXIV14126815; Denny JC, 2012, MED DECIS MAKING, V32, P188, DOI 10.1177/0272989X11400418; Denny JoshuaC., 2003, AMIA; Dernoncourt F, 2017, J AM MED INFORM ASSN, V24, P596, DOI 10.1093/jamia/ocw156; Erhan D, 2010, J MACH LEARN RES, V11, P625; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Farkas R, 2009, J AM MED INFORM ASSN, V16, P601, DOI 10.1197/jamia.M3097; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Halpern Yoni, 2014, AMIA Annu Symp Proc, V2014, P606; Hripcsak G, 2002, RADIOLOGY, V224, P157, DOI 10.1148/radiol.2241011118; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kang N, 2013, J AM MED INFORM ASSN, V20, P876, DOI 10.1136/amiajnl-2012-001173; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Kim Y, 2014, C EMPIRICAL METHODS; Kirby JC, 2016, J AM MED INFORM ASSN, V23, P1046, DOI 10.1093/jamia/ocv202; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lei Tao, 2016, arXiv; Li Jiwei, 2015, VISUALIZING UNDERSTA; Liao KP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1885; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Lingren T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159621; Lipton Z. C., 2016, ARXIV160603490CSSTAT; Luan Y, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P1398; Mikolov T., 2013, NIPS, P3111, DOI DOI 10.5555/2999792.2999959; Mosley JD, 2016, PHARMACOGENOMICS J, V16, P231, DOI 10.1038/tpj.2015.51; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Pivovarov R, 2015, J AM MED INFORM ASSN, V22, P938, DOI 10.1093/jamia/ocv032; Pradhan S, 2015, J AM MED INFORM ASSN, V22, P143, DOI 10.1136/amiajnl-2013-002544; Ranganath A., 2016, P MACH LEARN HEALTHC, P1; Razavian N, 2015, BIG DATA-US, V3, P277, DOI 10.1089/big.2015.0020; Ribeiro M.T., 2016, WHY SHOULD I TRUST Y; Ribeiro M. T., 2016, ICML WORKSH HUM INT; Saeed M, 2002, COMPUT CARDIOL, V29, P641, DOI 10.1109/CIC.2002.1166854; Savova GK, 2012, J AM MED INFORM ASSN, V19, pE83, DOI 10.1136/amiajnl-2011-000295; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Spackman KA, 1997, J AM MED INFORM ASSN, P640; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Strobelt H, 2018, IEEE T VIS COMPUT GR, V24, P667, DOI 10.1109/TVCG.2017.2744158; Stubbs A, 2015, J BIOMED INFORM, V58, pS78, DOI 10.1016/j.jbi.2015.05.009; Sun WY, 2013, J BIOMED INFORM, V46, pS5, DOI 10.1016/j.jbi.2013.07.004; Topaz M, 2016, INT J NURS STUD, V64, P25, DOI 10.1016/j.ijnurstu.2016.09.013; Uzuner Ö, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Uzuner Ö, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Uzuner Ö, 2010, J AM MED INFORM ASSN, V17, P514, DOI 10.1136/jamia.2010.003947; Uzuner Ö, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Wu Yonghui, 2015, AMIA Annu Symp Proc, V2015, P1326; Xia ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078927; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Ye Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174970; Yosinski J., 2015, DEEP LEARNING WORKSH; Zeiler MD, 2010, PROC CVPR IEEE, P2528, DOI 10.1109/CVPR.2010.5539957	79	117	134	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2018	13	2							e0192360	10.1371/journal.pone.0192360	http://dx.doi.org/10.1371/journal.pone.0192360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW4LB	29447188	Green Published, gold, Green Submitted			2024-09-18	WOS:000425283900028
J	Wang, P; Wang, Y; Yuan, ZY; Wang, F; Wang, HQ; Li, Y; Wang, CL; Li, LF				Wang, Peng; Wang, Yao; Yuan, Zhaoying; Wang, Fei; Wang, Hongqian; Li, Ying; Wang, Chengliang; Li, Linfeng			Venous thromboembolism risk assessment of surgical patients in Southwest China using real-world data: establishment and evaluation of an improved venous thromboembolism risk model	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Venous thromboembolism; Risk assessment model; Caprini; Surgical patients; Machine learning	CLINICAL PRESENTATION; PULMONARY-EMBOLISM; MAJOR SURGERY; COMPLICATIONS; EPIDEMIOLOGY; THROMBOSIS; CANCER; VALIDATION; CRITERION; DIAGNOSIS	Background Venous thromboembolism (VTE) risk assessment in surgical patients is important for the appropriate diagnosis and treatment of patients. The commonly used Caprini model is limited by its inadequate ability to discriminate between risk stratums on the surgical population in southwest China and lengthy risk factors. The purpose of this study was to establish an improved VTE risk assessment model that is accurate and simple. Methods This study is based on the clinical data from 81,505 surgical patients hospitalized in the Southwest Hospital of China between January 1, 2019 and June 18, 2021. Among the population, 559 patients developed VTE. An improved VTE risk assessment model, SW-model, was established through Logistic Regression, with comparisons to both Caprini and Random Forest. Results The SW-model incorporated eight risk factors. The area under the curve (AUC) of SW-model (0.807 [0.758, 0.853], 0.804 [0.765, 0.840]), are significantly superior (p = 0.001 and p = 0.044) to those of the Caprini (0.705 [0.652, 0.757], 0.758 [0.719, 0795]) on two test sets, but inferior (p < 0.001 and p = 0.002) to Random Forest (0.854 [0.814, 0.890], 0.839 [0.806, 0.868]). In decision curve analysis, within threshold range from 0.015 to 0.04, the DCA curves of the SW-model are superior to Caprini and two default strategies. Conclusions The SW-model demonstrated a higher discriminative capability to distinguish VTE positive in surgical patients compared with the Caprini model. Compared to Random Forest, Logistic Regression based SW-model provided interpretability which is essential in guarantee the procedure of risk assessment transparent to clinicians.	[Wang, Peng; Wang, Chengliang] Chongqing Univ, Coll Comp Sci, Chongqing, Peoples R China; [Wang, Yao; Li, Linfeng] Yidu Cloud Technol Inc, Beijing, Peoples R China; [Yuan, Zhaoying] Renmin Univ China, Ctr Appl Stat, Beijing, Peoples R China; [Yuan, Zhaoying] Renmin Univ China, Sch Stat, Beijing, Peoples R China; [Wang, Peng; Wang, Fei; Wang, Hongqian; Li, Ying] Southwest Hosp, Med Big Data Ctr, Chongqing, Peoples R China	Chongqing University; Renmin University of China; Renmin University of China; Army Medical University	Wang, CL (corresponding author), Chongqing Univ, Coll Comp Sci, Chongqing, Peoples R China.; Li, LF (corresponding author), Yidu Cloud Technol Inc, Beijing, Peoples R China.	wangcl@cqu.edu.cn; linfeng.li@yiducloud.cn	WANG, Peng/GSN-5263-2022	Wang, Yao/0000-0003-4121-7313	National Key Research and Development Program of China [2018YFC0116702, 2018YFB2101204]	National Key Research and Development Program of China(National Key Research & Development Program of China)	This work was funded by National Key Research and Development Program of China with the reference number No. 2018YFC0116702 and No. 2018YFB2101204.	Ahmad MA, 2018, IEEE INT CONF HEALT, P447, DOI [10.1109/ICHI.2018.00095, 10.1145/3233547.3233667]; Ambrosetti M, 2003, THROMB RES, V112, P203, DOI 10.1016/j.thromres.2003.12.003; Bahl V, 2010, ANN SURG, V251, P344, DOI 10.1097/SLA.0b013e3181b7fca6; Belohlávek J, 2013, EXP CLIN CARDIOL, V18, P129; Bergqvist D, 1997, ANN INTERN MED, V126, P454, DOI 10.7326/0003-4819-126-6-199703150-00006; Bertoletti L, 2012, EUR RESPIR J, V39, P862, DOI 10.1183/09031936.00058811; Bo HX, 2020, J ATHEROSCLER THROMB, V27, P801, DOI 10.5551/jat.51359; Borvik T, 2016, EUR RESPIR J, V47, P473, DOI 10.1183/13993003.00402-2015; Caprini JA, 2005, DM-DIS MON, V51, P70, DOI 10.1016/j.disamonth.2005.02.003; CAPRINI JA, 1991, SEMIN THROMB HEMOST, V17, P304; Caprini JA, 2010, CURR OPIN PULM MED, V16, P448, DOI 10.1097/MCP.0b013e32833c3d3e; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ferroni P, 2017, MED DECIS MAKING, V37, P234, DOI 10.1177/0272989X16662654; Hammond J, 2011, ANN SURG ONCOL, V18, P3240, DOI 10.1245/s10434-011-1723-2; Hong J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191897; Huynh N, 2018, J VASC SURG-VENOUS L, V6, P7, DOI 10.1016/j.jvsv.2017.08.015; Key NS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01461; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Kim JYS, 2015, JAMA SURG, V150, P110, DOI 10.1001/jamasurg.2014.1841; Kim JS, 2018, SPINE, V43, P853, DOI 10.1097/BRS.0000000000002442; Kim MH, 2019, ANN SURG ONCOL, V26, P4037, DOI 10.1245/s10434-019-07633-z; Konstantinides SV, 2019, EUR RESPIR J, V54, DOI [10.1183/13993003.01647-2019, 10.1093/eurheartj/ehz405]; Lee LH, 2017, THROMB HAEMOSTASIS, V117, P2243, DOI 10.1160/TH17-02-0134; Li LF, 2020, ARTIF INTELL MED, V103, DOI 10.1016/j.artmed.2020.101817; Lim W, 2018, BLOOD ADV, V2, P3226, DOI 10.1182/bloodadvances.2018024828; Marietta M, 2020, INTERN EMERG MED, V15, P1375, DOI 10.1007/s11739-020-02432-x; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Nafee T, 2020, RES PRACT THROMB HAE, V4, P230, DOI 10.1002/rth2.12292; NGUYEN G, 1988, BLOOD, V72, P601; Oger E, 2006, J THROMB HAEMOST, V4, P793, DOI 10.1111/j.1538-7836.2006.01856.x; Pannucci CJ, 2011, J AM COLL SURGEONS, V212, P105, DOI 10.1016/j.jamcollsurg.2010.08.018; Park JI, 2021, J NURS SCHOLARSHIP, V53, P278, DOI 10.1111/jnu.12637; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Puurunen MK, 2015, J THROMB HAEMOST, V13, P722; Rogers MAM, 2012, CIRCULATION, V125, P2092, DOI 10.1161/CIRCULATIONAHA.111.084467; Schulman S, 2020, THROMB HAEMOSTASIS, V120, P1642, DOI 10.1055/s-0040-1718532; Seabold S, 2010, P 9 PYTH SCI C, P57, DOI DOI 10.25080/MAJORA-92BF1922-011; Sotunmbi P T, 2006, Afr J Med Med Sci, V35, P345; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6; Virtanen P, 2020, NAT METHODS, V17, P352, DOI 10.1038/s41592-020-0772-5; Wright JM, 2011, J PEDIAT HEMATOL ONC, V33, P261, DOI 10.1097/MPH.0b013e3182134111; Wun T, 2009, BEST PRACT RES CL HA, V22, P9, DOI 10.1016/j.beha.2008.12.001; Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029; Yhim HY, 2014, J THROMB HAEMOST, V12, P1035, DOI 10.1111/jth.12611; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang Z, 2019, CHEST, V155, P342, DOI 10.1016/j.chest.2018.10.040	50	5	5	3	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	MAR 4	2022	22	1							59	10.1186/s12911-022-01795-9	http://dx.doi.org/10.1186/s12911-022-01795-9			11	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	ZN0XI	35246122	gold, Green Published			2024-09-18	WOS:000764767700001
J	Niforou, A; Konstantinidou, V; Naska, A				Niforou, Aikaterini; Konstantinidou, Valentini; Naska, Androniki			Genetic Variants Shaping Inter-individual Differences in Response to Dietary Intakes-A Narrative Review of the Case of Vitamins	FRONTIERS IN NUTRITION			English	Review						genes; diet; nutrigenetics; nutritional status; SNPs; genetic variants; vitamins	D-BINDING PROTEIN; GENOME-WIDE ASSOCIATION; 25-HYDROXYVITAMIN D CONCENTRATIONS; METHYLENETETRAHYDROFOLATE REDUCTASE; GC-GLOBULIN; CIRCULATING CONCENTRATIONS; PLASMA-CONCENTRATIONS; COMMON POLYMORPHISMS; A1298C POLYMORPHISMS; COLORECTAL-CANCER	Recent advances in the field of nutrigenetics have provided evidence on how genetic variations can impact the individuals' response to dietary intakes. An objective and reliable assessment of dietary exposures should rely on combinations of methodologies including frequency questionnaires, short-term recalls or records, together with biological samples to evaluate markers of intake or status and to identify genetic susceptibilities. In an attempt to present current knowledge on how genetic fingerprints contribute to an individual's nutritional status, we present a review of current literature describing associations between genetic variants and levels of well-established biomarkers of vitamin status in free-living and generally healthy individuals. Based on the outcomes of candidate gene, genome-wide-association studies and meta-analyses thereof, we have identified several single nucleotide polymorphisms (SNPs) involved in the vitamins' metabolic pathways. Polymorphisms in genes encoding proteins involved in vitamin metabolism and transport are reported to have an impact on vitamin D status; while genetic variants of vitamin D receptor were most frequently associated with health outcomes. Genetic variations that can influence vitamin E status include SNPs involved in its uptake and transport, such as in SCAR-B1 gene, and in lipoprotein metabolism. Variants of the genes encoding the sodium-dependent vitamin C transport proteins are greatly associated with the body's status on vitamin C. Regarding the vitamins of the B-complex, special reference is made to the widely studied variant in the MTHFR gene. Methodological attributes of genetic studies that may limit the comparability and interpretability of the findings are also discussed. Our understanding of how genes affect our responses to nutritional triggers will enhance our capacity to evaluate dietary exposure and design personalized nutrition programs to sustain health and prevent disease.	[Niforou, Aikaterini; Naska, Androniki] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Konstantinidou, Valentini] MEDOLIALI SL, DNANUTRICOACH, Barcelona, Spain	National & Kapodistrian University of Athens; Athens Medical School	Naska, A (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece.	anaska@med.uoa.gr		Naska, Androniki/0000-0002-1610-1813				Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4149; Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3893; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Andrew T, 2013, BRIT J NUTR, V110, P1672, DOI 10.1017/S0007114513000974; [Anonymous], 2012, EFS2, DOI DOI 10.2903/J.EFSA.2012.2813; [Anonymous], 2016, EFSA J, V14, P145, DOI DOI 10.2903/j.efsa.2016.4484; ARNAUD J, 1993, HUM GENET, V92, P183; Bahrami A, 2018, J CELL PHYSIOL, V233, P4033, DOI 10.1002/jcp.26216; Batai K, 2014, HUM GENET, V133, P1395, DOI 10.1007/s00439-014-1472-y; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Bhan I, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/561214; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Binia A, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0421-7; Block G, 2011, AM J CLIN NUTR, V94, P929, DOI 10.3945/ajcn.111.011460; Bordoni L, 2019, BIOCHIMIE, V160, P156, DOI 10.1016/j.biochi.2019.03.006; Borel P, 2007, J NUTR, V137, P2653, DOI 10.1093/jn/137.12.2653; Borel P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122094; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Bueno O, 2016, J NUTR, V146, P1, DOI 10.3945/jn.115.223685; Cahill LE, 2010, AM J CLIN NUTR, V92, P1494, DOI 10.3945/ajcn.2010.29306; Cahill LE, 2009, J NUTRIGENET NUTRIGE, V2, P292, DOI 10.1159/000314597; Cahill LE, 2009, AM J CLIN NUTR, V90, P1411, DOI 10.3945/ajcn.2009.28327; Carmel R, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013441; Castro R, 2010, CLIN BIOCHEM, V43, P645, DOI 10.1016/j.clinbiochem.2010.01.015; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Chun RF, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00718; Cronin S, 2005, STROKE, V36, P1581, DOI 10.1161/01.STR.0000169946.31639.af; Davis CD, 2011, J NUTRIGENET NUTRIGE, V4, P1, DOI 10.1159/000324175; de Batlle J, 2018, EUR J NUTR, V57, P751, DOI 10.1007/s00394-016-1365-z; Duan LZ, 2018, GENE, V678, P361, DOI 10.1016/j.gene.2018.08.056; Duarte MMMF, 2010, CLIN BIOCHEM, V43, P1118, DOI 10.1016/j.clinbiochem.2010.07.002; Duell EJ, 2013, GENES NUTR, V8, P549, DOI 10.1007/s12263-013-0346-6; Eggermont E, 2006, EUR J PEDIATR, V165, P429, DOI 10.1007/s00431-006-0084-5; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Galmés S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121919; Girona J, 2008, CLIN CHEM LAB MED, V46, P453, DOI 10.1515/CCLM.2008.110; Grarup N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003530; Green R, 2008, FOOD NUTR BULL, V29, pS52, DOI 10.1177/15648265080292S108; Guardiola M, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0665-y; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8; Hansen JG, 2015, J NUTR, V145, P799, DOI 10.3945/jn.114.202093; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; Herrmann M, 2017, CLIN CHEM LAB MED, V55, P3, DOI 10.1515/cclm-2016-0264; Hiraoka M, 2017, CONGENIT ANOM, V57, P142, DOI 10.1111/cga.12232; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1911, DOI 10.1210/jc.2011-0385; HOLLIS BW, 1984, J STEROID BIOCHEM, V21, P81, DOI 10.1016/0022-4731(84)90063-3; Horska A, 2011, EUR J NUTR, V50, P437, DOI 10.1007/s00394-010-0147-2; Huang Y, 2007, J HUM GENET, V52, P73, DOI 10.1007/s10038-006-0082-5; Hustad S, 2007, AM J HUM GENET, V80, P846, DOI 10.1086/513520; IOM (Institute of Medicine), 2000, DIET REF INT VIT C V, P531; JACOB RA, 1990, J NUTR, V120, P1480, DOI 10.1093/jn/120.suppl_11.1480; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; JEFFREY GP, 1987, J HEPATOL, V4, P307, DOI 10.1016/S0168-8278(87)80539-1; Ji X, 2017, CELL PHYSIOL BIOCHEM, V44, P2129, DOI 10.1159/000485952; Jolliffe DA, 2016, J STEROID BIOCHEM, V164, P18, DOI 10.1016/j.jsbmb.2015.12.007; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kwak SY, 2018, ENDOCR J, V65, P881, DOI [10.1507/endocrj.EJ18-0084, 10.1507/endocrj.ej18-0084]; Langlois MR, 1997, AM J CLIN NUTR, V66, P606, DOI 10.1093/ajcn/66.3.606; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Lecompte S, 2011, AM J CLIN NUTR, V93, P644, DOI 10.3945/ajcn.110.004176; Lee Sang-Ah, 2009, J Prev Med Public Health, V42, P360, DOI 10.3961/jpmph.2009.42.6.360; Lucchini V, 2017, CURR OPIN FOOD SCI, V16, P114, DOI 10.1016/j.cofs.2017.11.001; Major JM, 2012, J NUTR, V142, P866, DOI 10.3945/jn.111.156349; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; McNulty H, 2006, CIRCULATION, V113, P74, DOI 10.1161/CIRCULATIONAHA.105.580332; McNulty H, 2002, AM J CLIN NUTR, V76, P436, DOI 10.1093/ajcn/76.2.436; Michels AJ, 2013, ANNU REV NUTR, V33, P45, DOI 10.1146/annurev-nutr-071812-161246; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Molloy Anne M, 2012, Subcell Biochem, V56, P105, DOI 10.1007/978-94-007-2199-9_7; Na N, 2006, CLIN CHIM ACTA, V365, P319, DOI 10.1016/j.cca.2005.09.015; Naska Androniki, 2017, F1000Res, V6, P926, DOI 10.12688/f1000research.10703.1; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Patwardhan VG, 2015, J CLIN LIPIDOL, V9, P652, DOI 10.1016/j.jacl.2015.05.007; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Robien K, 2013, BRIT J NUTR, V109, P493, DOI 10.1017/S0007114512001675; Ross AC, 2011, 2011 I MED US COMMIT; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Schwartz B, 2014, INT J FOOD SCI NUTR, V65, P529, DOI 10.3109/09637486.2014.898258; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Shaghaghi MA, 2016, ADV NUTR, V7, P287, DOI 10.3945/an.115.009225; Shane B, 2008, FOOD NUTR BULL, V29, pS5, DOI 10.1177/15648265080292S103; Shane B, 2018, AM J CLIN NUTR, V108, P1334, DOI 10.1093/ajcn/nqy209; Signorello LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028623; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108; Stanislawska-Sachadyn A, 2010, EUR J CLIN NUTR, V64, P1338, DOI 10.1038/ejcn.2010.157; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Surendran S, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0591-9; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Thuesen BH, 2010, BRIT J NUTR, V103, P1195, DOI 10.1017/S0007114509992947; Timpson NJ, 2010, AM J CLIN NUTR, V92, P375, DOI 10.3945/ajcn.2010.29438; Touvier M, 2015, J INVEST DERMATOL, V135, P378, DOI 10.1038/jid.2014.400; Tsang BL, 2015, AM J CLIN NUTR, V101, P1286, DOI 10.3945/ajcn.114.099994; Voipio AJW, 2015, ANN MED, V47, P253, DOI 10.3109/07853890.2015.1020860; Vollset SE, 2005, MTHFR POLYMORPHISMS, P125; von Castel-Dunwoody KM, 2005, AM J CLIN NUTR, V81, P1436; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Whiting SJ, 2013, Nutrition in the Prevention and Treatment of Disease, VThird, P811; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Wright ME, 2009, CANCER RES, V69, P1429, DOI 10.1158/0008-5472.CAN-08-2343; Xu XJ, 2015, MED SCI MONITOR, V21, P1960, DOI 10.12659/MSM.894793; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Zamel R, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-19; Zanon-Moreno V, 2011, MOL VIS, V17, P2997; Zhao MM, 2013, BIOMED REP, V1, P781, DOI 10.3892/br.2013.134; Zhao Y, 2010, J AGR FOOD CHEM, V58, P4844, DOI 10.1021/jf904464u; Zinck JWR, 2015, AM J CLIN NUTR, V101, P1295, DOI 10.3945/ajcn.115.107219; Zinck John W R, 2014, Front Nutr, V1, P8, DOI 10.3389/fnut.2014.00008; ,, 2013, EFSA Journal, V11, P3418; 2015, COMPUT STRUCT BIOTEC, V13, P64, DOI DOI 10.2903/j.efsa.2015.4150	119	13	13	1	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-861X			FRONT NUTR	Front. Nutr.	DEC 1	2020	7								558598	10.3389/fnut.2020.558598	http://dx.doi.org/10.3389/fnut.2020.558598			18	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	PE6KH	33335908	Green Published, gold			2024-09-18	WOS:000598472200001
J	Teig, CJ; Grotle, M; Bond, MJ; Prinsen, CAC; Engh, MAE; Cvancarova, MS; Kjollesdal, M; Martini, A				Teig, Catherine J.; Grotle, Margreth; Bond, Malcolm J.; Prinsen, Cecilia A. C.; Engh, Marie A. Ellstrom; Cvancarova, Milada S.; Kjollesdal, Moyfrid; Martini, Angelita			Norwegian translation, and validation, of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7)	INTERNATIONAL UROGYNECOLOGY JOURNAL			English	Article						Pelvic organ prolapse; Pelvic floor dysfunction; PFDI-20; PFIQ-7; Quality of life; Questionnaire translation	OF-LIFE QUESTIONNAIRES; ORGAN PROLAPSE; PSYCHOMETRIC EVALUATION; CULTURAL-ADAPTATION; QUALITY; WOMEN; DISORDERS; TERMINOLOGY; INSTRUMENTS; COSMIN	The goal was to translate into Norwegian, and validate, short versions of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7) using a sample of women with symptomatic pelvic organ prolapse and pelvic floor dysfunction. Modified European Organization for Research and Treatment of Cancer Guidelines were used for translation and cultural adaptation. Of 212 eligible Norwegian women who consented to participate, 205 completed the questionnaires, of whom 50 were retested after 1 - 3 weeks, and 76 were tested 6 months after surgery. Reliability, validity and responsiveness were evaluated. Additionally, interpretability, the smallest detectable change, the standard error of measurement, floor and ceiling effects, and the percentages of missing items are reported. Reliability ranged from 0.66 to 0.93 and intraclass correlation coefficients from 0.85 to 0.94. Both construct validity and responsiveness were found to be adequate. The responsiveness of the PFDI-20 was further supported by areas under the curve above 0.70. Estimates were lower for the PFIQ-7. The smallest detectable changes at the individual level were 15 - 21 % and 17 - 27 % for the PFDI-20 and PFIQ-7, respectively. The absolute values of the minimal important changes in the total scores were 48 and 47, respectively. No floor or ceiling effects were evident in the distributions of the PFDI-20 and PFIQ-7 total scores. The translated questionnaires provided adequate reliability, validity and good responsiveness to change. These short versions of the PFDI and PFIQ are robust measuring instruments that will enable symptom severity and health-related quality of life to be evaluated in the Norwegian context.	[Teig, Catherine J.; Bond, Malcolm J.; Martini, Angelita] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia; [Teig, Catherine J.; Engh, Marie A. Ellstrom] Akershus Univ Hosp, Dept Obstet & Gynaecol, Lorenskog, Norway; [Teig, Catherine J.] Akershus Univ Hosp, Div Surg, Pelv Floor Ctr, N-1478 Lorenskog, Norway; [Grotle, Margreth] Oslo Univ Hosp, Oslo & Akershus Univ Coll Appl Sci, Dept Physiotherapy, Fac Hlth Sci, Oslo, Norway; [Grotle, Margreth; Cvancarova, Milada S.] Oslo Univ Hosp, Clin Surg & Neurol, FORMI, Oslo, Norway; [Prinsen, Cecilia A. C.] Vrije Univ Amsterdam, Inst Hlth & Care Res, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Engh, Marie A. Ellstrom] Univ Oslo, Fac Div, Akershus Univ Hosp, Oslo, Norway; [Cvancarova, Milada S.] Oslo Univ Hosp, Oslo & Akershus Univ Coll Appl Sci, Dept Nursing & Hlth Promot, Fac Hlth Sci, Oslo, Norway; [Kjollesdal, Moyfrid] Drammens Gynaecol Private Clin, Drammen, Norway; [Martini, Angelita] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA, Australia	Flinders University South Australia; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; Vrije Universiteit Amsterdam; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); University of Western Australia	Teig, CJ (corresponding author), Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia.; Teig, CJ (corresponding author), Akershus Univ Hosp, Dept Obstet & Gynaecol, Lorenskog, Norway.; Teig, CJ (corresponding author), Akershus Univ Hosp, Div Surg, Pelv Floor Ctr, N-1478 Lorenskog, Norway.	chpl@ahus.no	Bond, Malcolm/A-1345-2008	Martini, Angelita/0000-0003-1886-7115; Bond, Malcolm/0000-0002-1137-7175	Division of Surgery, Akershus University Hospital; Strategic Research Foundation (Strategiske Forskningsmidler), Akershus University Hospital	Division of Surgery, Akershus University Hospital; Strategic Research Foundation (Strategiske Forskningsmidler), Akershus University Hospital	This study was funded by the Division of Surgery, Akershus University Hospital, and the Strategic Research Foundation (Strategiske Forskningsmidler), Akershus University Hospital. The Strategic Research Foundation was not involved in the design, conduct, analysis or interpretation of the study, or the review or approval of the manuscript.	Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Abrams P, 2013, NCONTINENCE; [Anonymous], 1969, DELPHI METHOD EXPT S; [Anonymous], 2011, MEASUREMENT MED PRAC, DOI DOI 10.1017/CBO9780511996214.005; Barber MD, 2011, NEUROUROL URODYNAM, V30, P541, DOI [10.1002/nau.20934, 10.1002/nau.21042]; Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Dewolf L., 2009, EORTC Quality of life Group Translation Procedure; Due U, 2013, ACTA OBSTET GYN SCAN, V92, P1041, DOI 10.1111/aogs.12189; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1149, DOI 10.1016/S0895-4356(98)00106-1; Gelhorn HL, 2012, FEMALE PELVIC MED RE, V18, P221, DOI 10.1097/SPV.0b013e31825e6707; Handa VL, 2008, INT UROGYNECOL J, V19, P1331, DOI 10.1007/s00192-008-0651-6; Kaplan PB, 2012, EUR J OBSTET GYN R B, V162, P229, DOI 10.1016/j.ejogrb.2012.03.004; Maruish ME, 2001, USERS MANUAL SF 36V2; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Rogers RG, 2013, INT UROGYNECOL J, V24, P1091, DOI 10.1007/s00192-012-2020-8; Srikrishna S, 2010, INT UROGYNECOL J, V21, P523, DOI 10.1007/s00192-009-1069-5; Streiner D., 1998, Health measurement scales, V2nd; Teleman P, 2011, ACTA OBSTET GYN SCAN, V90, P483, DOI 10.1111/j.1600-0412.2011.01085.x; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Utomo E, 2014, INT UROGYNECOL J, V25, P531, DOI 10.1007/s00192-013-2263-z	26	16	18	0	4	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-3462	1433-3023		INT UROGYNECOL J	Int. Urogynecol. J.	JUL	2017	28	7					1005	1017		10.1007/s00192-016-3209-z	http://dx.doi.org/10.1007/s00192-016-3209-z			13	Obstetrics & Gynecology; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Urology & Nephrology	EY7GH	28062903				2024-09-18	WOS:000404157400008
J	Saghafian, S; Trichakis, N; Zhu, RH; Shih, HA				Saghafian, Soroush; Trichakis, Nikolaos; Zhu, Ruihao; Shih, Helen A.			Joint patient selection and scheduling under no-shows: Theory and application in proton therapy	PRODUCTION AND OPERATIONS MANAGEMENT			English	Article						appointment scheduling; index rules; no-shows; nonmonotone submodular maximization	HEALTH-CARE; SERVICE; APPROXIMATION; OPTIMIZATION; TRIAGE	We study how to admit and schedule heterogeneous patients by using simple, interpretable, yet effective policies when capacity is scarce, no-show behavior is patient- and time-dependent, service duration and reward are deterministic but patient-dependent, and overtime is costly. Our work is motivated by the aforementioned operational challenges that typically face adopters of new technologies in the healthcare sector. We anchor our study on a partnership with the proton therapy center of Massachusetts General Hospital (MGH), which offers a new radiation technology for cancer patients. We formulate the problem as a nonlinear integer optimization problem. However, as the solution to this formulation lacks both tractability and interpretability, to be relevant to practice, we limit our study to simple and interpretable policies. In particular, we propose a simple index-based rule and derive analytical performance guarantees for it. We also calibrate our model using empirical data from our partner hospital, and conduct a series of experiments to evaluate the performance of our proposed policy under practical circumstances. The analytical performance guarantees and our numerical experiments demonstrate (a) the strong performance of the proposed policies, and (b) their robustness to various practical considerations (e.g., to potential misspecification of no-show probabilities). Our results show that our proposed policy, despite being a simple and interpretable index-based rule, is capable of improving performance by about 20% at an organization such as MGH, and of delivering results that are not far from being optimal across a wide range of parameters that might vary between organizations. This suggests that the proposed policy can be viewed as an effective "one-fits-all" capacity allocation rule that can be used in a variety of environments in which operational challenges such as no-shows and overtime costs need to be navigated using simple and interpretable rules.	[Saghafian, Soroush] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Trichakis, Nikolaos] MIT, Operat Res Ctr, Cambridge, MA 02139 USA; [Zhu, Ruihao] Cornell Univ, SC Johsnon Coll Business, Ithaca, NY USA; [Shih, Helen A.] Massachusetts Gen Hosp, Francis H Burr Proton Therapy Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Cornell University; Harvard University; Massachusetts General Hospital	Trichakis, N (corresponding author), MIT, Operat Res Ctr, Cambridge, MA 02139 USA.	ntrichakis@mit.edu	Shih, Helen/O-7653-2017	Trichakis, Nikolaos/0000-0002-8324-9148				Argon NT, 2008, PROBAB ENG INFORM SC, V22, P301, DOI 10.1017/S0269964808000272; Begen MA, 2011, MATH OPER RES, V36, P240, DOI 10.1287/moor.1110.0489; Bertsimas D, 2013, OPER RES, V61, P73, DOI 10.1287/opre.1120.1138; Bortfeld T, 2008, OPER RES, V56, P1461, DOI 10.1287/opre.1070.0484; BUYUKKOC C, 1985, ADV APPL PROBAB, V17, P237, DOI 10.2307/1427064; Cayirli T, 2003, PROD OPER MANAG, V12, P519, DOI 10.1111/j.1937-5956.2003.tb00218.x; Chan CW, 2017, MANAGE SCI, V63, P2049, DOI 10.1287/mnsc.2016.2441; Chan CW, 2013, M&SOM-MANUF SERV OP, V15, P170, DOI 10.1287/msom.1120.0412; Chan TCY, 2013, EUR J OPER RES, V231, P745, DOI 10.1016/j.ejor.2013.06.003; Chekuri C, 2006, SIAM J COMPUT, V35, P713, DOI 10.1137/S0097539700382820; Cohen R, 2006, INFORM PROCESS LETT, V100, P162, DOI 10.1016/j.ipl.2006.06.003; Diamant A, 2018, PROD OPER MANAG, V27, P58, DOI 10.1111/poms.12783; Feige U, 2006, ANN IEEE SYMP FOUND, P667; Feige U, 2011, SIAM J COMPUT, V40, P1133, DOI 10.1137/090779346; Feldman J, 2014, OPER RES, V62, P794, DOI 10.1287/opre.2014.1286; Feldman M, 2011, ANN IEEE SYMP FOUND, P570, DOI 10.1109/FOCS.2011.46; Fleischer L, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P611, DOI 10.1145/1109557.1109624; Gupta D, 2008, IIE TRANS, V40, P800, DOI 10.1080/07408170802165880; Hassin R, 2008, MANAGE SCI, V54, P565, DOI 10.1287/mnsc.1070.0802; Helm JE, 2014, OPER RES, V62, P1265, DOI 10.1287/opre.2014.1317; Horel Thibaut, 2015, Lecture Notes; Kaandorp Guido C, 2007, Health Care Manag Sci, V10, P217, DOI 10.1007/s10729-007-9015-x; Khuller S, 1999, INFORM PROCESS LETT, V70, P39, DOI 10.1016/S0020-0190(99)00031-9; Kong QX, 2020, MANAGE SCI, V66, P3480, DOI 10.1287/mnsc.2019.3366; Korula N, 2009, LECT NOTES COMPUT SC, V5556, P508, DOI 10.1007/978-3-642-02930-1_42; Krause A., 2005, A note on the budgeted maximization of submodular functions; Kulik A, 2013, MATH OPER RES, V38, P729, DOI 10.1287/moor.2013.0592; LaGanga LR, 2012, PROD OPER MANAG, V21, P874, DOI 10.1111/j.1937-5956.2011.01308.x; Lee J, 2009, ACM S THEORY COMPUT, P323; Liu N, 2010, M&SOM-MANUF SERV OP, V12, P347, DOI 10.1287/msom.1090.0272; Luo JZ, 2012, M&SOM-MANUF SERV OP, V14, P670, DOI 10.1287/msom.1120.0394; Master N, 2018, PROBAB ENG INFORM SC, V32, P1, DOI 10.1017/S0269964816000474; Patrick J, 2008, OPER RES, V56, P1507, DOI 10.1287/opre.1080.0590; Saghafian S., 2019, RWP17010 HKS HARV U; Saghafian S, 2014, M&SOM-MANUF SERV OP, V16, P329, DOI 10.1287/msom.2014.0487; Sauré A, 2020, EUR J OPER RES, V280, P254, DOI 10.1016/j.ejor.2019.06.040; SCHAEFER M, 1976, ANN PROBAB, V4, P502, DOI 10.1214/aop/1176996102; Simic S., 2009, Journal of Inequalities in Pure and Applied Mathematics, V10; Truong VA, 2015, MANAGE SCI, V61, P1584, DOI 10.1287/mnsc.2014.2067; Wang WY, 2014, M&SOM-MANUF SERV OP, V16, P439, DOI 10.1287/msom.2014.0486; Zacharias C, 2024, OPER RES, V72, DOI 10.1287/opre.2022.2342; Zacharias C, 2020, MANAGE SCI, V66, P744, DOI 10.1287/mnsc.2018.3242; Zacharias C, 2014, PROD OPER MANAG, V23, P788, DOI 10.1111/poms.12065; Zeng B, 2010, ANN OPER RES, V178, P121, DOI 10.1007/s10479-009-0569-5	44	3	3	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-1478	1937-5956		PROD OPER MANAG	Prod. Oper. Manag.	FEB	2023	32	2					547	563		10.1111/poms.13886	http://dx.doi.org/10.1111/poms.13886		OCT 2022	17	Engineering, Manufacturing; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Operations Research & Management Science	D3NR6		Green Submitted, hybrid			2024-09-18	WOS:000869608300001
J	Xiong, DY; Park, S; Lim, J; Wang, T; Wang, XL				Xiong, Danyi; Park, Seongoh; Lim, Johan; Wang, Tao; Wang, Xinlei			BAYESIAN MULTIPLE INSTANCE CLASSIFICATION BASED ON HIERARCHICAL PROBIT REGRESSION	ANNALS OF APPLIED STATISTICS			English	Article						Binary classification; Bayesian inference; Gibbs sampling; primary instance; weakly supervised learning	BINARY; CANCER; MODELS	In multiple instance learning (MIL), the response variable is predicted by features (or covariates) of one or more instances, which are collectively denoted as a bag. Learning the relationship between bags and instances is challenging because of the unknown and possibly complicated data generating mechanism regarding how instances contribute to the bag label. MIL has been applied to solve a variety of real -world problems, which have been mostly focused on supervised tasks, such as molecule activity prediction, protein binding affinities prediction, object detection, and computer -aided diagnosis. However, to date, the majority of the off -the -shelf MIL methods are developed in the computer science domain, and they focus on improving the prediction performance while spending little effort on explainability of the algorithm. In this article a Bayesian multiple instance learning model, based on probit regression (MICProB), is proposed, which contributes a significant portion to the suite of statistical methodologies for MIL. MICProB is composed of two nested probit regression models, where the inner model is estimated for predicting primary instances, which are considered as the "important" ones that determine the bag label, and the outer model is for predicting bag -level responses based on the primary instances estimated by the inner model. The posterior distribution of MICProB can be conveniently approximated using a Gibbs sampler, and the prediction for new bags can be performed in a fully integrated Bayesian way. We evaluate the performance of MICProB against 15 benchmark methods and demonstrate its competitiveness in simulation and real -data examples. In addition to its capability of identifying primary instances, as compared to existing optimization -based approaches, MICProB also enjoys great advantages in providing a transparent model structure, straightforward statistical inference of quantities related to model parameters, and favorable interpretability of covariate effects on the bag -level response.	[Xiong, Danyi] Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA; [Park, Seongoh] Sungshin Womens Univ, Dept Stat, Seoul, South Korea; [Lim, Johan] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Wang, Tao] UT Southwestern Med Ctr, Quantitat Biomed Res Ctr, Peter ODonnell Jr Sch Publ Hlth, Dallas, TX USA; [Wang, Xinlei] Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA	Southern Methodist University; Sungshin Women's University; Seoul National University (SNU); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Arlington	Xiong, DY (corresponding author), Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA.	adxiong@smu.edu; bspark6@sungshin.ac.kr; cjohanlim@stats.snu.ac.kr; Tao.Wang@utsouthwestern.edu; xinlei.wang@uta.edu			NIH [R01CA258584, R15GM131390]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP190208]; National Research Foundation of Korea (NRF) - Korean Ministry of Science and ICT [2021R1G1A1005641]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT)(Cancer Prevention & Research Institute of Texas); National Research Foundation of Korea (NRF) - Korean Ministry of Science and ICT(National Research Foundation of Korea)	This work was supported by NIH grants R01CA258584 (PIs: T. Wang and X. Wang) , R15GM131390 (PI: X. Wang) , Cancer Prevention and Research Institute of Texas (CPRIT) grant RP190208 (PI: T. Wang; subcontract PI: X. Wang) , and National Research Foundation of Korea (NRF) grant 2021R1G1A1005641 funded by the Korean Ministry of Science and ICT (PI: S. Park) .	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Amores J, 2013, ARTIF INTELL, V201, P81, DOI 10.1016/j.artint.2013.06.003; Andrews S., 2003, Proceedings of the 15th International Conference on Neural Information Processing Systems, P577; [Anonymous], 2008, WORKSH FAC REAL LIF; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Byers LA, 2015, CANCER-AM CANCER SOC, V121, P664, DOI 10.1002/cncr.29098; Carbonneau MA, 2018, PATTERN RECOGN, V77, P329, DOI 10.1016/j.patcog.2017.10.009; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chen PY, 2017, R J, V9, P446; Chen YX, 2006, IEEE T PATTERN ANAL, V28, P1931, DOI 10.1109/TPAMI.2006.248; Cheplygina V, 2015, PATTERN RECOGN, V48, P264, DOI 10.1016/j.patcog.2014.07.022; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; Cornaby C, 2015, IMMUNOL LETT, V163, P56, DOI 10.1016/j.imlet.2014.11.001; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dietterich TG, 1997, ARTIF INTELL, V89, P31, DOI 10.1016/S0004-3702(96)00034-3; Foulds J, 2010, KNOWL ENG REV, V25, P1, DOI 10.1017/S026988890999035X; Gartner T, 2002, P 19 INT C MACH LEAR, P179; GELMAN A., 2013, Package'arm'. Data Analysis Using Regression and Multilevel/Hierarchical Models; Gelman A, 2013, BAYESIAN DATA ANAL; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Holmes CC, 2006, BAYESIAN ANAL, V1, P145, DOI 10.1214/06-BA105; Huang A, 2013, BAYESIAN ANAL, V8, P439, DOI 10.1214/13-BA815; Ilse M, 2018, PR MACH LEARN RES, V80; Iwahori K, 2015, MOL THER, V23, P171, DOI 10.1038/mt.2014.156; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lu TS, 2021, NAT MACH INTELL, V3, P864, DOI 10.1038/s42256-021-00383-2; Maron O, 1998, ADV NEUR IN, V10, P570; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Park S, 2020, STAT METHODS MED RES, V29, P3032, DOI 10.1177/0962280220914321; Pendergast JF, 1996, INT STAT REV, V64, P89, DOI 10.2307/1403425; Polson NG, 2013, J AM STAT ASSOC, V108, P1339, DOI 10.1080/01621459.2013.829001; Ray S., 2001, ICML 01, P425; Ray S., 2005, P 22 INT C MACH LEAR, P697, DOI DOI 10.1145/1102351.1102439; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Singhi AD, 2019, GASTROENTEROLOGY, V156, P2024, DOI 10.1053/j.gastro.2019.01.259; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Wang J, 2000, 17th International Conference on Machine Learning, P1119; Wang T, 2018, CANCER DISCOV, V8, P1142, DOI 10.1158/2159-8290.CD-17-1246; Wang XG, 2018, PATTERN RECOGN, V74, P15, DOI 10.1016/j.patcog.2017.08.026; Whiteside SK, 2018, TRENDS IMMUNOL, V39, P1021, DOI 10.1016/j.it.2018.10.003; XIONG D., 2024, Supplement to "Bayesian multiple instance classification based on hierarchical probit regression, DOI [10.1214/23-AOAS1780SUPPA, DOI 10.1214/23-AOAS1780SUPPA]; Xiong DY, 2021, COMPUT STRUCT BIOTEC, V19, P3255, DOI 10.1016/j.csbj.2021.05.038; Yang ZM, 2008, INT C COMP SUPP COOP, P165; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zhang Q, 2002, ADV NEUR IN, V14, P1073; Zhang Z, 2021, NAT METHODS, V18, P92, DOI 10.1038/s41592-020-01020-3; Zhou Z.-H., 2009, P 26 INT C MACHINE L, P1249; Zhou ZH, 2007, KNOWL INF SYST, V11, P155, DOI 10.1007/s10115-006-0029-3	51	0	0	7	7	INST MATHEMATICAL STATISTICS-IMS	CLEVELAND	3163 SOMERSET DR, CLEVELAND, OH 44122 USA	1932-6157	1941-7330		ANN APPL STAT	Ann. Appl. Stat.	MAR	2024	18	1					80	99		10.1214/23-AOAS1780	http://dx.doi.org/10.1214/23-AOAS1780			20	Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	HY2E1					2024-09-18	WOS:001162997500013
J	Lee, IC; Huang, JY; Chen, TC; Yen, CH; Chiu, NC; Hwang, HE; Huang, JG; Liu, CA; Chau, GY; Lee, RC; Hung, YP; Chao, Y; Ho, SY; Huang, YH				Lee, I-Cheng; Huang, Jo-Yu; Chen, Ting-Chun; Yen, Chia-Heng; Chiu, Nai-Chi; Hwang, Hsuen-En; Huang, Jia-Guan; Liu, Chien-An; Chau, Gar-Yang; Lee, Rheun-Chuan; Hung, Yi-Ping; Chao, Yee; Ho, Shinn-Ying; Huang, Yi-Hsiang			Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection	LIVER CANCER			English	Article						Hepatocellular carcinoma; Evolutionary learning; Machine learning; Recurrence; Surgery	INTELLIGENCE	Background and Aims: Current prediction models for early recurrence of hepatocellular carcinoma (HCC) after surgical resection remain unsatisfactory. The aim of this study was to develop evolutionary learning-derived prediction models with interpretability using both clinical and radiomic features to predict early recurrence of HCC after surgical resection. Methods: Consecutive 517 HCC patients receiving surgical resection with available contrast-enhanced computed tomography (CECT) images before resection were retrospectively enrolled. Patients were randomly assigned to a training set (n = 362) and a test set (n = 155) in a ratio of 7:3. Tumor segmentation of all CECT images including noncontrast phase, arterial phase, and portal venous phase was manually performed for radiomic feature extraction. A novel evolutionary learning-derived method called genetic algorithm for predicting recurrence after surgery of liver cancer (GARSL) was proposed to design prediction models for early recurrence of HCC within 2 years after surgery. Results: A total of 143 features, including 26 preoperative clinical features, 5 postoperative pathological features, and 112 radiomic features were used to develop GARSL preoperative and postoperative models. The area under the receiver operating characteristic curves (AUCs) for early recurrence of HCC within 2 years were 0.781 and 0.767, respectively, in the training set, and 0.739 and 0.741, respectively, in the test set. The accuracy of GARSL models derived from the evolutionary learning method was significantly better than models derived from other well-known machine learning methods or the early recurrence after surgery for liver tumor (ERASL) preoperative (AUC = 0.687, p < 0.001 vs. GARSL preoperative) and ERASL postoperative (AUC = 0.688, p < 0.001 vs. GARSL postoperative) models using clinical features only. Conclusion: The GARSL models using both clinical and radiomic features significantly improved the accuracy to predict early recurrence of HCC after surgical resection, which was significantly better than other well-known machine learning-derived models and currently available clinical models.	[Lee, I-Cheng; Huang, Yi-Hsiang] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Lee, I-Cheng; Huang, Yi-Hsiang] Natl Yang Ming Chiao Tung Univ, Fac Med, Sch Med, Taipei, Taiwan; [Huang, Jo-Yu; Chen, Ting-Chun; Yen, Chia-Heng; Ho, Shinn-Ying] Natl Yang Ming Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Yen, Chia-Heng] Natl Yang Ming Chiao Tung Univ, Inst Comp Sci & Engn, Hsinchu, Taiwan; [Chiu, Nai-Chi; Hwang, Hsuen-En; Liu, Chien-An; Lee, Rheun-Chuan] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Huang, Jia-Guan] Natl Taiwan Univ, Sch Med, Taipei, Taiwan; [Chau, Gar-Yang] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Hung, Yi-Ping; Chao, Yee] Taipei Vet Gen Hosp, Canc Ctr, Taipei, Taiwan; [Ho, Shinn-Ying] Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Ho, Shinn-Ying] Natl Yang Ming Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices IDS2, Hsinchu, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan; [Ho, Shinn-Ying] Kaohsiung Med Univ, Coll Hlth Sci, Kaohsiung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Huang, YH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Huang, YH (corresponding author), Natl Yang Ming Chiao Tung Univ, Fac Med, Sch Med, Taipei, Taiwan.; Ho, SY (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.; Ho, SY (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Ho, SY (corresponding author), Natl Yang Ming Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices IDS2, Hsinchu, Taiwan.; Huang, YH (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan.; Ho, SY (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Kaohsiung, Taiwan.	syho@nctu.edu.tw; yhhuang@vghtpe.gov.tw	Huang, Yi-Hsiang/ADX-9119-2022; Ho, Shinn-Ying/AFD-8402-2022; CHEN, TINGCHUN/AFD-8400-2022; Yen, Chia-Heng/AAE-8755-2022	Huang, Yi-Hsiang/0000-0001-5241-5425; Yen, Chia-Heng/0000-0002-6646-9253; Ho, Shinn-Ying/0000-0002-1901-8353	Taipei Veterans General Hospital, Taipei, Taiwan [V109E-008-2, V109E-008-2[110]]; Ministry of Science and Technology, Taiwan [MOST 1062634-F-075-001-, MOST 107-2634-F-075-001-, MOST 108-3011F-075-001-, MOST 108-2221-E-009-127-, MOST 108-2218-E029-004-, MOST 109-2221-E-009-129-, MOST 109-2740-B-400-002-]; "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	The study was supported by grants from Taipei Veterans General Hospital, Taipei, Taiwan (V109E-008-2, V109E-008-2[110]) and Ministry of Science and Technology, Taiwan (MOST 1062634-F-075-001-, MOST 107-2634-F-075-001-, MOST 108-3011F-075-001-, MOST 108-2221-E-009-127-, MOST 108-2218-E029-004-, MOST 109-2221-E-009-129-, MOST 109-2740-B-400002-) and was financially supported by the "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan.	Arnold M, 2020, GASTROENTEROLOGY, V159, P335, DOI 10.1053/j.gastro.2020.02.068; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chan AWH, 2018, J HEPATOL, V69, P1284, DOI 10.1016/j.jhep.2018.08.027; Chaudhary Kumardeep, 2018, Clin Cancer Res, V24, P1248, DOI 10.1158/1078-0432.CCR-17-0853; Chen MY, 2021, LIVER CANCER, V10, P38, DOI 10.1159/000512028; Cunha GM, 2021, J HEPATOCELL CARCINO, V8, P513, DOI 10.2147/JHC.S268288; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Ho SY, 2004, IEEE T EVOLUT COMPUT, V8, P522, DOI 10.1109/TEVC.2004.835176; Ho SY, 2004, IEEE T SYST MAN CY B, V34, P609, DOI 10.1109/TSMCB.2003.817090; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ji GW, 2019, EBIOMEDICINE, V50, P156, DOI 10.1016/j.ebiom.2019.10.057; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kim S, 2019, CLIN CANCER RES, V25, P3847, DOI 10.1158/1078-0432.CCR-18-2861; Kudo M, 2020, LIVER CANCER, V9, P367, DOI 10.1159/000507934; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lao JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10649-8; Lee IC, 2010, LIVER INT, V30, P1161, DOI 10.1111/j.1478-3231.2010.02301.x; Nguyen QH, 2021, MATH PROBL ENG, V2021, DOI 10.1155/2021/4832864; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259; Saillard C, 2020, HEPATOLOGY, V72, P2000, DOI 10.1002/hep.31207; Sathipati SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71324-z; Sathipati SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41553-y; Sathipati SY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34604-3; Sathipati SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07739-y; Schwalbe N, 2020, LANCET, V395, P1579, DOI 10.1016/S0140-6736(20)30226-9; Spieler B, 2021, ABDOM RADIOL, V46, P3660, DOI 10.1007/s00261-021-03056-1; Tsai MJ, 2020, BIOINFORMATICS, V36, P3833, DOI 10.1093/bioinformatics/btaa267; Tsai MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18648-5; Vibert E, 2020, J HEPATOL, V72, P262, DOI 10.1016/j.jhep.2019.11.017; Wang WB, 2020, IEEE ACCESS, V8, P139212, DOI 10.1109/ACCESS.2020.3011145; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Xu X, 2019, J HEPATOL, V70, P1133, DOI 10.1016/j.jhep.2019.02.023	35	25	25	2	20	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	2235-1795	1664-5553		LIVER CANCER	Liver Cancer	NOV	2021	10	6					572	582		10.1159/000518728	http://dx.doi.org/10.1159/000518728		SEP 2021	11	Oncology; Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Gastroenterology & Hepatology	XK8EY	34950180	Green Published, gold			2024-09-18	WOS:000698113800001
J	Salaroli, CJ; Pardo, MD				Salaroli, Claudio J.; Pardo, Maria del Carmen			PYE: A Penalized Youden Index Estimator for selecting and combining biomarkers in high-dimensional data	CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS			English	Article						Penalized Youden index Estimator; Kernel smoothing function; Selection and combination of biomarkers; Accelerated proximal gradient method; Disease classification; High-dimensionality	SUPPORT VECTOR MACHINE; GENE SELECTION; DISEASE CLASSIFICATION; VARIABLE SELECTION; ROC METHOD; ALGORITHM; REGRESSION; CANCER; TUMOR; REGULARIZATION	In a classification context, the Youden index, in addition to being a powerful measure of the performance of diagnostic markers and identifying the optimal cut-off point, has also been shown to be an effective measure to be maximized to combine biomarkers. However, in a high-dimensional background, this method may lead to overfitting, mainly due to the noise caused by considering irrelevant regressors. Hence, to reduce this side effect and increase the robustness and interpretability of the solution, the challenge is not only to combine the features but also to select them, obtaining a sparse result. There are several methods to perform feature selection. One of the most performing solution is to adopt regularization techniques. We propose the Penalized Youden Index Estimator (PYE), a method based on the Youden index and various penalization terms, capable of searching for the best selection and combination of biomarkers at the same time, maximizing this index. Depending on the considered regularization term, L 1 , L1, Elastic Net, SCAD, 2 and MCP, we propose different versions of PYE. Being the objective function possibly non-convex, we also propose a modified accelerated proximal gradient algorithm to optimize PYE. To test the effectiveness of our approach, a wide simulation study on synthetic and real high-dimensional datasets is presented, comparing the performance of our proposal with some of the most popular existing methods. The results show how PYE, in its different versions, returns alternative solutions with respect to the considered existing methods. In some cases more sparse, in others with a preferable balance among accuracy, selection, and which biomarkers have been considered relevant.	[Salaroli, Claudio J.; Pardo, Maria del Carmen] Univ Complutense Madrid, Dept Stat & OR, Madrid, Spain; [Pardo, Maria del Carmen] Univ Complutense Madrid, Inst Matemat Interdisciplinar IMI, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Salaroli, CJ (corresponding author), Univ Complutense Madrid, Dept Stat & OR, Madrid, Spain.	mcapardo@ucm.es	Pardo, Maria del Carmen/D-7744-2016	Pardo, Maria del Carmen/0000-0002-4623-6321	Spanish Ministry of Science and Innovation [PID2019-104681RBI00]	Spanish Ministry of Science and Innovation(Spanish Government)	Acknowledgments This work was partially supported by grant PID2019-104681RBI00 of the Spanish Ministry of Science and Innovation. The authors would like to thank the Editor and two Referees for the helpful comments and suggestions.	Al-Thanoon NA, 2018, COMPUT BIOL MED, V103, P262, DOI 10.1016/j.compbiomed.2018.10.034; Alladi SM, 2008, BIOINFORMATION, V3, P130, DOI 10.6026/97320630003130; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alshamlan H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/604910; [Anonymous], 2015, ADV NEURAL INF PROCE; Arevalillo JM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S12-S6; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bach F, 2012, FOUND TRENDS MACH LE, V4, P1, DOI 10.1561/2200000015; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Becker N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-138; Becker N, 2009, BIOINFORMATICS, V25, P1711, DOI 10.1093/bioinformatics/btp286; Belacel N., 2008, Patent No. [WO/2008/022432, 2008022432]; Bo TH, 2002, GENOME BIOL, V3; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; Castellanos-Garzón JA, 2015, ADCAIJ-ADV DISTRIB C, V4, P1; Chandra B, 2011, J BIOMED INFORM, V44, P529, DOI 10.1016/j.jbi.2011.01.001; Chapelle O, 2007, NEURAL COMPUT, V19, P1155, DOI 10.1162/neco.2007.19.5.1155; Chen JJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-74; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Furlanello C, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-54; Gentle JE, 2007, Matrix algebra: theory, computations, and applications in statistics; Golub Todd, 2020, R PACKAGE VERSION 13; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gu B, 2018, Arxiv, DOI arXiv:1612.06003; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Han F, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2773-x; Hastie T, 2001, Series in Statistics; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Horgan RP, 2011, OBSTET GYNAECOL, V13, P189, DOI 10.1576/toag.13.3.189.27672; Huang LT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-25; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Kadota K., 2003, Chem-Bio Informatics Journal, V3, P30; Kecman V, 2005, STUD FUZZ SOFT COMP, V177, P1; Kim S, 2019, MATHEMATICS-BASEL, V7, DOI 10.3390/math7060493; Liang Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-198; Lin HZ, 2011, CAN J STAT, V39, P324, DOI 10.1002/cjs.10107; Ling C.X., 2003, Ijcai, V3, P519; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Lloyd CJ, 2002, STAT PROBABIL LETT, V59, P99, DOI 10.1016/S0167-7152(02)00212-2; Loughrey J, 2005, BCS CONFERENCE S, P33, DOI 10.1007/1-84628-102-4_3; Ma SG, 2005, BIOINFORMATICS, V21, P4356, DOI 10.1093/bioinformatics/bti724; Ma SG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-60; Ma SG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-253; McDermott P, 2016, Arxiv, DOI arXiv:1605.05429; Mekour N, 2019, INT J SOFTW INNOV, V7, P65, DOI 10.4018/IJSI.2019070104; Merk S., 2020, R PACKAGE VERSION 13; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Parikh Neal, 2014, Foundations and Trends in Optimization, V1, P127, DOI 10.1561/2400000003; Pesce LL, 2010, ACAD RADIOL, V17, P960, DOI 10.1016/j.acra.2010.04.001; Qu CW, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab097; Robinson D, 2006, J ROY STAT SOC A STA, V169, P656, DOI 10.1111/j.1467-985X.2006.00430_9.x; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sarker MSR, 2019, MATHEMATICS-BASEL, V7, DOI 10.3390/math7050457; Shevade SK, 2003, BIOINFORMATICS, V19, P2246, DOI 10.1093/bioinformatics/btg308; Silverman BW, 1986, DENSITY ESTIMATION S; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong DL, 2011, ARTIF INTELL MED, V53, P47, DOI 10.1016/j.artmed.2011.06.008; Vapnik V., 1963, Automation and Remote Control, V24, P774; Venton G, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.78; Wang L, 2006, STAT SINICA, V16, P589; Wang YD, 2019, APPL MATH MODEL, V71, P286, DOI 10.1016/j.apm.2019.01.044; Wen F, 2018, IEEE ACCESS, V6, P69883, DOI 10.1109/ACCESS.2018.2880454; Yang XC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9192104; Yin JJ, 2014, STAT MED, V33, P1426, DOI 10.1002/sim.6046; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu Hualong, 2009, Genomics Proteomics & Bioinformatics, V7, P200, DOI 10.1016/S1672-0229(08)60050-9; Yu W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S10-S1; Zeng Y., 2018, SOLUTION PATHS SPARS; Zhang HH, 2006, BIOINFORMATICS, V22, P88, DOI 10.1093/bioinformatics/bti736; Zhang HY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-298; Zhou W, 2014, LEUKEMIA, V28, P1155, DOI 10.1038/leu.2013.383; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou KH, 1998, ACAD RADIOL, V5, P680, DOI 10.1016/S1076-6332(98)80562-X	81	0	0	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0169-7439	1873-3239		CHEMOMETR INTELL LAB	Chemometrics Intell. Lab. Syst.	MAY 15	2023	236								104786	10.1016/j.chemolab.2023.104786	http://dx.doi.org/10.1016/j.chemolab.2023.104786		MAR 2023	15	Automation & Control Systems; Chemistry, Analytical; Computer Science, Artificial Intelligence; Instruments & Instrumentation; Mathematics, Interdisciplinary Applications; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Chemistry; Computer Science; Instruments & Instrumentation; Mathematics	D4BK1		hybrid			2024-09-18	WOS:000968196600001
J	Krekeler, BN; Vitale, K; Yee, J; Powell, R; Rogus-Pulia, N				Krekeler, Brittany N.; Vitale, Kailey; Yee, Joanne; Powell, Ryan; Rogus-Pulia, Nicole			Adherence to Dysphagia Treatment Recommendations: A Conceptual Model	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							HEALTH-CARE PROFESSIONALS; NECK-CANCER PATIENTS; PATIENT ADHERENCE; SELF-EFFICACY; TRANSTHEORETICAL MODEL; MEDICAL-TREATMENT; BELIEF MODEL; VOICE; THERAPY; ADULTS	Purpose: Conceptual models of complex health problems are useful when designing targeted clinical interventions and focused research studies. Understanding and studying patient adherence often involves interplay among many factors that influence whether a patient successfully follows recommendations or completes a therapy program. Functional frameworks serve to arrange these factors visually, increasing interpretability and allowing for empirical testing of relationships among concepts. The purpose of this article is to integrate relevant factors from the literature into a comprehensive framework that describes adherence to dysphagia treatment. Method: Using peer-reviewed, published guidelines regarding conceptual model construction, the authors created a list of potential factors that influence patient adherence to dysphagia-related treatment recommendations. During model construction, following extensive review of the literature and existing theories that have been applied in other areas of health care, factors were identified and grouped into conceptually similar domains (clusters). Clusters were arranged into larger categories that emerged during model optimization. Ultimately, two models were created: one that illustrates the interrelated factors of patient adherence and another that illustrates a subset of modifiable risk factors that a clinical speech-language pathologist may influence when developing a dysphagia treatment plan. Results: Three general categories from 14 factors emerged based on relationships between factors and aspects of patient care: health factors, individual patient factors, and contextual factors. A second model consisting of modifiable risk factors included access, treatment type, patient perceptions, self-efficacy, health literacy, support factors, and provider bias. Conclusions: This conceptual model allows clinicians and researchers to identify and explore the mechanisms driving adherence. Continual refinements of this model should be made as future studies uncover how the interconnectedness of factors affects adherence in dysphagia management. The models we have presented here are ready for clinical application and should also serve researchers as they generate hypotheses and design targeted research questions.	[Krekeler, Brittany N.; Rogus-Pulia, Nicole] Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Krekeler, Brittany N.; Rogus-Pulia, Nicole] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Otolaryngol Head & Neck Surg, Madison, WI 53706 USA; [Krekeler, Brittany N.] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL USA; [Krekeler, Brittany N.; Vitale, Kailey; Yee, Joanne; Rogus-Pulia, Nicole] William S Middleton Mem Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA; [Vitale, Kailey; Yee, Joanne; Powell, Ryan; Rogus-Pulia, Nicole] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Geriatr & Gerontol, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison	Rogus-Pulia, N (corresponding author), Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI 53706 USA.; Rogus-Pulia, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Otolaryngol Head & Neck Surg, Madison, WI 53706 USA.; Rogus-Pulia, N (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA.; Rogus-Pulia, N (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Geriatr & Gerontol, Madison, WI 53715 USA.	npulia@wisc.edu	Yee, Joanne/JEZ-9989-2023; Rogus-Pulia, Nicole/AAE-6673-2020	Vitale, Kailey/0000-0002-3554-0205; Rogus-Pulia, Nicole/0000-0001-7294-4180; Powell, W. Ryan/0000-0001-6340-1520; Krekeler, Brittany/0000-0003-0469-9181; Yee, Joanne/0000-0001-8517-6416	National Institutes of Health (NIH) Grants [1F31AG059351-01, 1K23AG057805-01A1]; Clinical and Translational Science Award program, through the National Center for Advancing Translational Sciences Grant [UL1TR002373]	National Institutes of Health (NIH) Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award program, through the National Center for Advancing Translational Sciences Grant	This work was supported by National Institutes of Health (NIH) Grants 1F31AG059351-01 (awarded to B. N. K.) and 1K23AG057805-01A1 (awarded to N. R. P.) and the Clinical and Translational Science Award program, through the National Center for Advancing Translational Sciences Grant UL1TR002373 (awarded to N. R. P.) The article was partially prepared at the William S. Middleton Veteran Affairs Hospital in Madison, WI; GRECC manuscript #009-2020. The views and content expressed in this article are solely the responsibility of the authors and do not necessarily reflect the position, policy, or official views of the Department of Veteran Affairs, the U.S. government, or the NIH. The authors would like to acknowledge and thank Nadine Connor for her guidance, mentorship, and feedback on this project and Michael Pulia for taking an interest in this work and providing valuable inputs. The authors would also like to thank the laboratory members of the Swallowing and Salivary Bioscience Program for their hard work and continued support.	Abbott J, 1996, THORAX, V51, P1233, DOI 10.1136/thx.51.12.1233; Alsan M, 2019, AM ECON REV, V109, P4071, DOI 10.1257/aer.20181446; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 1996, J MED SPEECH-LANG PA; [Anonymous], 2019, Language Understanding (LUIS); Anthony DL, 2009, HEALTH AFFAIR, V28, P864, DOI 10.1377/hlthaff.28.3.864; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Burgess D, 2007, J GEN INTERN MED, V22, P882, DOI 10.1007/s11606-007-0160-1; Cajigal S, 2017, Patient Prejudice: When Credentials Aren't Enough; Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Catts HW, 2008, J SPEECH LANG HEAR R, V51, P1569, DOI 10.1044/1092-4388(2008/07-0259); Chadwick DD, 2003, AM J MENT RETARD, V108, P202, DOI 10.1352/0895-8017(2003)108<0202:ATEADG>2.0.CO;2; Chan DK, 2009, ARCH PHYS MED REHAB, V90, P1977, DOI 10.1016/j.apmr.2009.05.024; Chew LD, 2004, FAM MED, V36, P588; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Cnossen IC, 2017, EUR ARCH OTO-RHINO-L, V274, P1129, DOI 10.1007/s00405-016-4367-9; Cnossen IC, 2014, J MED INTERNET RES, V16, P282, DOI 10.2196/jmir.2990; Colodny N, 2005, AM J SPEECH-LANG PAT, V14, P61, DOI 10.1044/1058-0360(2005/008); Constantinescu G, 2017, AM J SPEECH-LANG PAT, V26, P1296, DOI 10.1044/2017_AJSLP-17-0040; Crawford H, 2007, DYSPHAGIA, V22, P326, DOI 10.1007/s00455-007-9108-1; DESHARNAIS R, 1986, PSYCHOL REP, V59, P1155, DOI 10.2466/pr0.1986.59.3.1155; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; DiMatteo M R, 1994, JAMA, V271, P83, DOI 10.1001/jama.271.1.79; DiMatteo MR, 2012, HEALTH PSYCHOL REV, V6, P74, DOI 10.1080/17437199.2010.537592; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DUARTE VM, 2013, OTOLARYNG HEAD NECK, V149, P878, DOI DOI 10.1177/0194599813502310; Ducat L, 2014, JAMA-J AM MED ASSOC, V312, P691, DOI 10.1001/jama.2014.8040; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; EARP JA, 1991, HEALTH EDUC RES, V6, P163, DOI 10.1093/her/6.2.163; Edmonds M.F., 2007, Journal of Radiology Nursing, V26, P87, DOI [DOI 10.1016/J.JRADNU.2007.04, 10.1016/j.jradnu.2007.04.003, DOI 10.1016/J.JRADNU.2007.04.003]; Ekberg O, 2002, DYSPHAGIA, V17, P139, DOI 10.1007/s00455-001-0113-5; Feil DG, 2009, INT J PSYCHIAT MED, V39, P199, DOI 10.2190/PM.39.2.h; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Forrest J. L., 2016, EBDM ACTION DEV COMP; Forscher PS, 2017, J EXP SOC PSYCHOL, V72, P133, DOI 10.1016/j.jesp.2017.04.009; Gago J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5583-7; Gell NM, 2015, GERONTOLOGIST, V55, P412, DOI 10.1093/geront/gnt166; Graffigna G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179865; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Greer TM, 2014, HEALTH PSYCHOL, V33, P35, DOI 10.1037/a0032777; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Hapner E, 2009, J VOICE, V23, P337, DOI 10.1016/j.jvoice.2007.10.009; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Holden RJ, 2013, ERGONOMICS, V56, P1669, DOI 10.1080/00140139.2013.838643; Husebo AML, 2013, J CLIN NURS, V22, P4, DOI 10.1111/j.1365-2702.2012.04322.x; Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jones CJ, 2014, HEALTH PSYCHOL REV, V8, P253, DOI 10.1080/17437199.2013.802623; KAPLAN R M, 1990, Annals of Behavioral Medicine, V12, P66, DOI 10.1207/s15324796abm1202_2; Kavookjian H, 2018, LARYNGOSCOPE, V128, P2832, DOI 10.1002/lary.27269; Kirscht J P, 1977, J Community Health, V3, P115, DOI 10.1007/BF01674233; Kraaijenga SAC, 2014, CURR OPIN SUPPORT PA, V8, P152, DOI 10.1097/SPC.0000000000000050; Krekeler BN, 2018, DYSPHAGIA, V33, P173, DOI 10.1007/s00455-017-9852-9; Krisciunas GP, 2012, DYSPHAGIA, V27, P538, DOI 10.1007/s00455-012-9404-2; Kumar R., 2019, Research Methodology: A step-By-Step Guide for Beginners; Lancaster John, 2015, Br J Community Nurs, VSuppl Nutrition, pS28, DOI 10.12968/bjcn.2015.20.Sup6a.S28; Logemann J., 1998, EVALUATION TREATMENT, V2nd, DOI [10.1097/00020840-199812000-00008, DOI 10.1097/00020840-199812000-00008]; Low J, 2001, DYSPHAGIA, V16, P123, DOI 10.1007/s004550011002; Lutfey KE, 2005, HEALTH SERV RES, V40, P1803, DOI 10.1111/j.1475-6773.2005.00433.x; Mackert M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6349; Mashima PA, 2011, OTOLARYNG CLIN N AM, V44, P1305, DOI 10.1016/j.otc.2011.08.007; McCusker J, 2016, HEALTH EDUC BEHAV, V43, P716, DOI 10.1177/1090198116637601; McKenna VS, 2017, AM J SPEECH-LANG PAT, V26, P524, DOI 10.1044/2016_AJSLP-15-0051; McNeely ML, 2012, SUPPORT CARE CANCER, V20, P515, DOI 10.1007/s00520-011-1112-1; Milani RV, 2015, AM J MED, V128, P337, DOI 10.1016/j.amjmed.2014.10.047; Omachonu V.K., 2010, INNOVATION J PUBLIC, V15, P2; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Paranjape R., 2010, MULTIAGENT SYSTEMS H, DOI [10.4018/978-1-60566-772-0, DOI 10.4018/978-1-60566-772-0]; Parker R, 2000, HEALTH PROMOT INT, V15, P277, DOI 10.1093/heapro/15.4.277; Pasternak K, 2020, J VOICE, V34, P559, DOI 10.1016/j.jvoice.2018.12.013; Paul R., 2012, LANGUAGE DISORDERS I; Portone C, 2008, J VOICE, V22, P192, DOI 10.1016/j.jvoice.2006.09.009; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rimer B., 2005, Theory at a glance: a guide for health promotion practice; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Sabat E., 2003, Adherence to Long-Term Therapies: Evidence for Action; Shim JS, 2013, ANN REHABIL MED-ARM, V37, P628, DOI 10.5535/arm.2013.37.5.628; Shinn EH, 2013, HEAD NECK-J SCI SPEC, V35, P1707, DOI 10.1002/hed.23255; Skolasky Richard L, 2008, Spine (Phila Pa 1976), V33, pE784, DOI 10.1097/BRS.0b013e31818027f1; Smith KA, 2018, ANN OTO RHINOL LARYN, V127, P450, DOI 10.1177/0003489418776670; Sura L, 2012, CLIN INTERV AGING, V7, P287, DOI 10.2147/CIA.S23404; van Leer E, 2015, AM J SPEECH-LANG PAT, V24, P164, DOI 10.1044/2015_AJSLP-12-0123; van Leer E, 2012, J VOICE, V26, P447, DOI 10.1016/j.jvoice.2011.05.006; van Leer E, 2008, J VOICE, V22, P688, DOI 10.1016/j.jvoice.2007.01.011; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Wall LR, 2017, DYSPHAGIA, V32, P279, DOI 10.1007/s00455-016-9757-z; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Wright DW, 2009, J AGING SOC POLICY, V21, P172, DOI 10.1080/08959420902732514	92	18	22	1	11	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	JUN	2020	63	6					1641	1657		10.1044/2020_JSLHR-19-00270	http://dx.doi.org/10.1044/2020_JSLHR-19-00270			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	ND2UH	32432958	Green Published			2024-09-18	WOS:000561759600001
J	Davagdorj, K; Lee, JS; Pham, VH; Ryu, KH				Davagdorj, Khishigsuren; Lee, Jong Seol; Van Huy Pham; Ryu, Keun Ho			A Comparative Analysis of Machine Learning Methods for Class Imbalance in a Smoking Cessation Intervention	APPLIED SCIENCES-BASEL			English	Article						smoking; class imbalance; synthetic oversampling; machine learning; decision making; feature importance	CLASSIFICATION; ASSOCIATION; PREDICTORS; NETWORKS; CANCER; SMOTE	Smoking is one of the major public health issues, which has a significant impact on premature death. In recent years, numerous decision support systems have been developed to deal with smoking cessation based on machine learning methods. However, the inevitable class imbalance is considered a major challenge in deploying such systems. In this paper, we study an empirical comparison of machine learning techniques to deal with the class imbalance problem in the prediction of smoking cessation intervention among the Korean population. For the class imbalance problem, the objective of this paper is to improve the prediction performance based on the utilization of synthetic oversampling techniques, which we called the synthetic minority over-sampling technique (SMOTE) and an adaptive synthetic (ADASYN). This has been achieved by the experimental design, which comprises three components. First, the selection of the best representative features is performed in two phases: the lasso method and multicollinearity analysis. Second, generate the newly balanced data utilizing SMOTE and ADASYN technique. Third, machine learning classifiers are applied to construct the prediction models among all subjects and each gender. In order to justify the effectiveness of the prediction models, the f-score, type I error, type II error, balanced accuracy and geometric mean indices are used. Comprehensive analysis demonstrates that Gradient Boosting Trees (GBT), Random Forest (RF) and multilayer perceptron neural network (MLP) classifiers achieved the best performances in all subjects and each gender when SMOTE and ADASYN were utilized. The SMOTE with GBT and RF models also provide feature importance scores that enhance the interpretability of the decision-support system. In addition, it is proven that the presented synthetic oversampling techniques with machine learning models outperformed baseline models in smoking cessation prediction.	[Davagdorj, Khishigsuren; Lee, Jong Seol] Chungbuk Natl Univ, Coll Elect & Comp Engn, Database & Bioinformat Lab, Cheongju 28644, South Korea; [Van Huy Pham; Ryu, Keun Ho] Ton Duc Thang Univ, Fac Informat Technol, Ho Chi Minh City 700000, Vietnam; [Ryu, Keun Ho] Chungbuk Natl Univ, Dept Comp Sci, Coll Elect & Comp Engn, Cheongju 28644, South Korea	Chungbuk National University; Ton Duc Thang University; Chungbuk National University	Ryu, KH (corresponding author), Ton Duc Thang Univ, Fac Informat Technol, Ho Chi Minh City 700000, Vietnam.; Ryu, KH (corresponding author), Chungbuk Natl Univ, Dept Comp Sci, Coll Elect & Comp Engn, Cheongju 28644, South Korea.	suri@dblab.chungbuk.ac.kr; richard@dblab.chungbuk.ac.kr; phamvanhuy@tdtu.edu.vn; khryu@tdtu.edu.vn	Pham, Van Huy/D-1474-2019; Ryu, Keun/AAM-5875-2020; Davagdorj, Khishigsuren/AAC-7723-2021	Pham, Van Huy/0000-0001-9907-4066; Ryu, Keun Ho/0000-0003-0394-9054; Davagdorj, Khishigsuren/0000-0002-9375-7621	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B4010826, 2020R1A2B5B02001717, 2019K2A9A2A06020672]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No.2017R1A2B4010826), (No. 2020R1A2B5B02001717), and (No.2019K2A9A2A06020672).	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Benavoli A, 2016, J MACH LEARN RES, V17; Blok DJ, 2017, PREV MED, V99, P105, DOI 10.1016/j.ypmed.2017.02.012; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campion J., 2008, ADV PSYCHIAT TREATME, V14, P217, DOI DOI 10.1192/APT.BP.108.005710; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Charafeddine R, 2017, PREV MED, V105, P280, DOI 10.1016/j.ypmed.2017.09.016; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Coughlin LN, 2020, NICOTINE TOB RES, V22, P415, DOI 10.1093/ntr/nty259; Dal Pozzolo A, 2014, EXPERT SYST APPL, V41, P4915, DOI 10.1016/j.eswa.2014.02.026; Davagdorj Khishigsuren, 2019, International Journal of Machine Learning and Computing, V9, P83, DOI 10.18178/ijmlc.2019.9.1.769; Davagdorj K, 2019, INT CONF AWARE SCI, P551, DOI 10.1109/icawst.2019.8923252; Dobbins C, 2017, NEUROCOMPUTING, V230, P110, DOI 10.1016/j.neucom.2016.02.088; Douzas G, 2018, EXPERT SYST APPL, V91, P464, DOI 10.1016/j.eswa.2017.09.030; Foulds J, 2006, AM J HEALTH BEHAV, V30, P400, DOI 10.5993/AJHB.30.4.6; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; Guo HX, 2017, EXPERT SYST APPL, V73, P220, DOI 10.1016/j.eswa.2016.12.035; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Heo BM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112571; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hyndman K, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214158; KIM H, 2016, SYMMETRY-BASEL, V8, DOI DOI 10.3390/SYM8060047; Kim Sun-Hee, 2015, Korean J Fam Med, V36, P50, DOI 10.4082/kjfm.2015.36.2.50; Kim YJ, 2014, ASIAN NURS RES, V8, P1, DOI 10.1016/j.anr.2013.09.004; Lee HC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100322; Lee Sungkyu, 2010, J Prev Med Public Health, V43, P283, DOI 10.3961/jpmph.2010.43.4.283; Lemaître G, 2017, J MACH LEARN RES, V18; Li XH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07928-9; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; Mazurowski MA, 2008, NEURAL NETWORKS, V21, P427, DOI 10.1016/j.neunet.2007.12.031; McKinney W., 2010, P 9 PYTH SCI C AUST, P51; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Milcarz M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102244; Monsó E, 2001, TOB CONTROL, V10, P165, DOI 10.1136/tc.10.2.165; Oliphant T.E, 2006, A guide to NumPy, V1, P85; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Poynton MR, 2006, J BIOMED INFORM, V39, P680, DOI 10.1016/j.jbi.2006.02.016; Rigotti NA, 2012, JAMA-J AM MED ASSOC, V308, P1573, DOI 10.1001/jama.2012.13043; Gómez RS, 2016, J APPL STAT, V43, P1831, DOI 10.1080/02664763.2015.1120712; Smit ES, 2014, ADDICT BEHAV, V39, P1318, DOI 10.1016/j.addbeh.2014.04.017; Song YM, 2008, J CLIN ONCOL, V26, P5101, DOI 10.1200/JCO.2008.17.0498; Tan P.-N., 2018, INTRO DATA MINING PE; Le T, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10040079; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; WHO, 2017, WHO REP GLOB TOB EP; World Health Organization (WHO), 2005, WHO TOB FREE IN ROL; Yang E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050966; Yang HK, 2013, JPN J CLIN ONCOL, V43, P45, DOI 10.1093/jjco/hys182; Zeng XC, 2000, J EXP THEOR ARTIF IN, V12, P1, DOI 10.1080/095281300146272; Zhu M, 2018, IEEE ACCESS, V6, P4641, DOI 10.1109/ACCESS.2018.2789428	53	15	16	2	13	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	MAY	2020	10	9							3307	10.3390/app10093307	http://dx.doi.org/10.3390/app10093307			20	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Materials Science; Physics	LR2RC		Green Published, gold			2024-09-18	WOS:000535541900320
J	Guo, SX; Chernavskaia, O; Popp, J; Bocklitz, T				Guo, Shuxia; Chernavskaia, Olga; Popp, Juergen; Bocklitz, Thomas			Spectral reconstruction for shifted-excitation Raman difference spectroscopy (SERDS)	TALANTA			English	Article						Raman spectroscopy; Shifted excitation Raman difference; spectroscopy; Spectral reconstruction; Chemometrics; Fluorescence background	CANCER-CELLS; FLUORESCENCE; IDENTIFICATION; REJECTION; CLASSIFICATION; DIAGNOSIS	Fluorescence emission is one of the major obstacles to apply Raman spectroscopy in biological investigations. It is usually several orders more intense than Raman scattering and hampers further analysis. In cases where the fluorescence emission is too intense to be efficiently removed via routine mathematical baseline correction algorithms, an alternative approach is needed. One alternative approach is shifted-excitation Raman difference spectroscopy (SERDS), where two Raman spectra are recorded with two slightly different excitation wavelengths. Ideally, the fluorescence emission at the two excitations does not change while the Raman spectrum shifts according to the excitation wavelength. Hence the fluorescence is removed in the difference of the two recorded Raman spectra. For better interpretability a spectral reconstruction procedure is necessary to recover the fluorescence-free Raman spectrum. This is challenging due to the intensity variations between the two recorded Raman spectra caused by unavoidable experimental changes as well as the presence of noise. Existent approaches suffer from drawbacks like spectral resolution loss, fluorescence residual, and artefacts. In this contribution, we proposed a reconstruction method based on non-negative least squares (NNLS), where the intensity variations between the two measurements are utilized in the reconstruction model. The method achieved fluorescence-free reconstruction on three real-world SERDS datasets without significant information loss. Thereafter, we quantified the performance of the reconstruction based on artificial datasets from four aspects: reconstructed spectral resolution, precision of reconstruction, signal-to-noise-ratio (SNR), and fluorescence residual. The artificial datasets were constructed with varied Raman to fluorescence intensity ratio (RFIR), SNR, full-width at half-maximum (FWHM), excitation wavelength shift, and fluorescence variation between the two spectra. It was demonstrated that the NNLS approach provides a faithful reconstruction without significantly changing the spectral resolution. Meanwhile, the reconstruction is almost robust to fluorescence variations between the two spectra. Last but not the least the SNR was improved after reconstruction for extremely noisy SERDS datasets.	[Guo, Shuxia; Chernavskaia, Olga; Popp, Juergen; Bocklitz, Thomas] Leibniz Inst Photon Technol, Albert Einstein Str 9, D-07745 Jena, Germany; [Guo, Shuxia; Chernavskaia, Olga; Popp, Juergen; Bocklitz, Thomas] Friedrich Schiller Univ Jena, Inst Phys Chem, Helmholtzweg 4, D-07743 Jena, Germany; [Guo, Shuxia; Chernavskaia, Olga; Popp, Juergen; Bocklitz, Thomas] Friedrich Schiller Univ Jena, Abbe Ctr Photon, Helmholtzweg 4, D-07743 Jena, Germany; [Popp, Juergen] Forsch Campus Jena, InfectoGnost, Philosophenweg 7, D-07743 Jena, Germany	Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Bocklitz, T (corresponding author), Leibniz Inst Photon Technol, Albert Einstein Str 9, D-07745 Jena, Germany.; Bocklitz, T (corresponding author), Friedrich Schiller Univ Jena, Inst Phys Chem, Helmholtzweg 4, D-07743 Jena, Germany.; Bocklitz, T (corresponding author), Friedrich Schiller Univ Jena, Abbe Ctr Photon, Helmholtzweg 4, D-07743 Jena, Germany.	thomas.bocklitz@uni-jena.de	Bocklitz, Thomas/I-3170-2019; Guo, Shuxia/Y-4219-2018	Bocklitz, Thomas/0000-0003-2778-6624	BMBF; EU via the project 'PhotoSkin' [FKZ: 13N13243]; BMBF via the project "Intersept" [FKZ 13N13852]; 'China Scholarship Council' (CSC)	BMBF(Federal Ministry of Education & Research (BMBF)); EU via the project 'PhotoSkin'; BMBF via the project "Intersept"(Federal Ministry of Education & Research (BMBF)); 'China Scholarship Council' (CSC)(China Scholarship Council)	Financial supports of the BMBF and EU via the project 'PhotoSkin' (FKZ: 13N13243), the BMBF via the project "Intersept" (FKZ 13N13852), and the scholarship for S.G. from the 'China Scholarship Council' (CSC) are greatly appreciated.	Adami R, 2013, ANALYST, V138, P6258, DOI 10.1039/c3an01367g; Afseth NK, 2012, CHEMOMETR INTELL LAB, V117, P92, DOI 10.1016/j.chemolab.2012.03.004; Baek SJ, 2015, ANALYST, V140, P250, DOI 10.1039/c4an01061b; Barroso EM, 2015, ANAL CHEM, V87, P2419, DOI 10.1021/ac504362y; Berry B, 2015, BIOTECHNOL PROGR, V31, P566, DOI 10.1002/btpr.2035; Bocklitz TW, 2016, ANAL CHEM, V88, P133, DOI 10.1021/acs.analchem.5b04665; Butler HJ, 2016, NAT PROTOC, V11, P664, DOI 10.1038/nprot.2016.036; Cordero E, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081724; Martins MAD, 2010, BIOMED OPT EXPRESS, V1, P617; Duda R. O., 1973, Pattern classification, V2; Egermann J, 2004, APPL OPTICS, V43, P5564, DOI 10.1364/AO.43.005564; El-Mashtoly SF, 2014, ANALYST, V139, P1155, DOI 10.1039/c3an01993d; Gebrekidan MT, 2016, J RAMAN SPECTROSC, V47, P198, DOI 10.1002/jrs.4775; Guo SX, 2017, ANAL METHODS-UK, V9, P4410, DOI 10.1039/c7ay01363a; Guo SX, 2016, ANALYST, V141, P2396, DOI 10.1039/c6an00041j; Jermyn M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2384; Knorr F, 2010, OPT EXPRESS, V18, P20049, DOI 10.1364/OE.18.020049; Kong K, 2015, ADV DRUG DELIVER REV, V89, P121, DOI 10.1016/j.addr.2015.03.009; Kumar BNV, 2016, ANAL CHEM, V88, P7574, DOI 10.1021/acs.analchem.6b01046; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Lorenz B, 2017, TRENDS MICROBIOL, V25, P413, DOI 10.1016/j.tim.2017.01.002; Matousek P, 2005, APPL SPECTROSC, V59, P848, DOI 10.1366/0003702054280757; Matousek P, 2002, J RAMAN SPECTROSC, V33, P238, DOI 10.1002/jrs.840; Matousek P, 2016, CHEM SOC REV, V45, P1794, DOI 10.1039/c5cs00466g; McCain ST, 2008, OPT EXPRESS, V16, P10975, DOI 10.1364/OE.16.010975; Meyer MW, 2011, ANAL CHIM ACTA, V706, P164, DOI 10.1016/j.aca.2011.08.031; Meyer T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533268; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Osticioli I, 2007, APPL SPECTROSC, V61, P839, DOI 10.1366/000370207781540169; Pallaoro A, 2015, ACS NANO, V9, P4328, DOI 10.1021/acsnano.5b00750; Popp J, 2014, EX VIVO IN VIVO OPTI; Santos IP, 2016, ANAL CHEM, V88, P7683, DOI 10.1021/acs.analchem.6b01592; SHREVE AP, 1992, APPL SPECTROSC, V46, P707, DOI 10.1366/0003702924125122; Stables R, 2017, ANALYST, V142, P98, DOI 10.1039/c6an01583b; Stöckel S, 2012, ANAL CHEM, V84, P9873, DOI 10.1021/ac302250t; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Talari ACS, 2015, APPL SPECTROSC REV, V50, P46, DOI 10.1080/05704928.2014.923902; Vogler N, 2016, J BIOPHOTONICS, V9, P533, DOI 10.1002/jbio.201500237; Walter A, 2012, J RAMAN SPECTROSC, V43, P1058, DOI 10.1002/jrs.3126; Wang WB, 2015, J BIOPHOTONICS, V8, P527, DOI 10.1002/jbio.201400026; Zhao J, 2002, APPL SPECTROSC, V56, P834, DOI 10.1366/000370202760171491	41	16	20	2	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	AUG 15	2018	186						372	380		10.1016/j.talanta.2018.04.050	http://dx.doi.org/10.1016/j.talanta.2018.04.050			9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	GJ1ST	29784376				2024-09-18	WOS:000435048800051
J	Zhu, Y; Zou, L; Tan, TL				Zhu, Ying; Zou, Lin; Tan, Tuck Lee			A clustering group lasso method for quantification of adulteration in black cumin seed oil using Fourier transform infrared spectroscopy	CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS			English	Article						Black cumin seed oil; Oil adulteration; Clustering; Group lasso; Elastic net; Variable selection; Penalized regression	LEAST-SQUARES REGRESSION; NIGELLA-SATIVA; SELECTION; THYMOQUINONE; CLASSIFICATION; STABILITY; VARIABLES	Black cumin seed oil (BCSO) contains a large number of bioactive compounds and thus has many medicinal health benefits and uses. Its high economic profits in the market lead to the frequent occurrence of adulterating this oil with cheaper edible oils such as grape seed oil, walnut oil. It is difficult to detect adulteration as the oil adulterant has similar physical characteristic and even similar chemical composition to the authentic oil. The development of an accurate and rapid analytical method using attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy is of essential importance for determination of authenticity of BCSO and quantification of oil adulterants. In this study, BCSO and grape seed oil (GSO) were mixed in various ratios to mimic the adulteration. A clustering group lasso method was developed by incorporating both the high correlation structure of spectral variables and the underlying group features into the model. Instead of assuming that groups are known a priori as does ordinary group lasso, the clustering group lasso infers groups of spectral features from the data and encourages spectral variables within a group to have a shared association with the response. The model using ATRFTIR spectroscopy proved to be a powerful tool to quantify BCSO adulteration with high accuracy and can accurately predict the quantity of adulterant at levels as low as 5%. With a substantial reduction in number of spectral features, the clustering group lasso model shows a simple regression coefficient profile with improved interpretability as compared to the ordinary group lasso model and other penalized models. The spectral regions automatically selected for quantification of BCSO adulteration can be helpful for the interpretation of the major chemical constituents of BCSO regarding its anti-cancer and anti-inflammatory effects from a chemometric perspective.	[Zhu, Ying; Zou, Lin; Tan, Tuck Lee] Nanyang Technol Univ, Natl Inst Educ, 1 Nanyang Walk, Singapore 637616, Singapore	Nanyang Technological University; National Institute of Education (NIE) Singapore	Zhu, Y (corresponding author), Nanyang Technol Univ, Natl Inst Educ, 1 Nanyang Walk, Singapore 637616, Singapore.	ying.zhu@nie.edu.sg	Lee, Augustine/AAE-6367-2020		National Institute of Education, Nanyang Technological University, Singapore [AcRF: RI 6/14 ZY]	National Institute of Education, Nanyang Technological University, Singapore(Nanyang Technological University)	The authors would like to thank the editor and the anonymous re-viewers for their valuable suggestions and comments that have helped us to improve the manuscript. This research is sponsored by Academic Research Funds (AcRF: RI 6/14 ZY) of National Institute of Education, Nanyang Technological University, Singapore.	Al-Ghamdi MS, 2001, J ETHNOPHARMACOL, V76, P45, DOI 10.1016/S0378-8741(01)00216-1; Al-Hader Abdelfattah, 1993, International Journal of Pharmacognosy, V31, P96; Ali BH, 2003, PHYTOTHER RES, V17, P299, DOI 10.1002/ptr.1309; Amin B, 2016, PLANTA MED, V82, P8, DOI 10.1055/s-0035-1557838; [Anonymous], 2006, J R STAT SOC B; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Bühlmann P, 2013, J STAT PLAN INFER, V143, P1835, DOI 10.1016/j.jspi.2013.05.019; Camacho J, 2021, CHEMOMETR INTELL LAB, V208, DOI 10.1016/j.chemolab.2020.104212; Chavent M, 2012, J STAT SOFTW, V50, P1; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Friedman JH, 2009, The Elements of Statistical Learning - Data Mining, Inference and Prediction, V2, P1, DOI DOI 10.1007/B94608; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Hastie T, 2001, GENOME BIOL, V2; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang J, 2012, STAT SCI, V27, P481, DOI 10.1214/12-STS392; Johnson R. A., 2002, APPL MULTIVARIATE ST; Khan M. Akram, 1999, Inflammopharmacology, V7, P15, DOI 10.1007/s10787-999-0023-y; Kiralan M, 2019, GRASAS ACEITES, V70, DOI 10.3989/gya.0570181; Lai YH, 2010, APPL SPECTROSC, V64, P649, DOI 10.1366/000370210791414362; Lê Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Louppe G., 2013, Adv. Neural Inf. Proces. Syst., V26; Lutterodt H, 2010, LWT-FOOD SCI TECHNOL, V43, P1409, DOI 10.1016/j.lwt.2010.04.009; Meinshausen N, 2010, J ROY STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Mohammed SJ, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/6515671; Moros J, 2010, TRAC-TREND ANAL CHEM, V29, P578, DOI 10.1016/j.trac.2009.12.012; NAES T, 1988, Journal of Chemometrics, V2, P155, DOI 10.1002/cem.1180020207; Ns T., 2017, A User-Friendly Guide to Multivariate Calibration and Classification, V2nd ed., DOI [10.1255/978-1-906715-25-0, DOI 10.1255/978-1-906715-25-0]; Nurrulhidayah AF, 2011, SPECTROSC-BIOMED APP, V25, P243, DOI 10.1155/2011/470986; Osborne B.G., 2006, ENCY ANAL CHEM, V1st ed., DOI [10.1002/9780470027318.a1018, DOI 10.1002/9780470027318.A1018]; Padhye Subhash, 2008, Cancer Ther, V6, P495; Pagola S, 2004, AAPS PHARMSCITECH, V5; Pavia D.L., 2001, Introduction to Spectroscopy: A Guide for Students of Organic Chemistry, V3rd; Pournelle G. H., 1953, Journal of Mammalogy, V34, P133, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Rodionova OY, 2016, CHEMOMETR INTELL LAB, V159, P89, DOI 10.1016/j.chemolab.2016.10.002; ROSSELL JB, 1983, J AM OIL CHEM SOC, V60, P333, DOI 10.1007/BF02543513; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shukla A. K., 2005, Journal of Oleo Science, V54, P317; Singh G, 2005, J SCI FOOD AGR, V85, P2297, DOI 10.1002/jsfa.2255; Stuart B., 1997, ANAL CHEM OPEN LEARN, V115; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vigneau E, 2003, COMMUN STAT-SIMUL C, V32, P1131, DOI 10.1081/SAC-120023882; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P83, DOI 10.1016/S0169-7439(01)00152-6; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Xie J, 2010, COMPUT BIOL SER, V15, P231, DOI 10.1007/978-1-84996-196-7_12; Zhu Y, 2017, CHEMOMETR INTELL LAB, V171, P55, DOI 10.1016/j.chemolab.2017.09.019; Zhu Y, 2016, SPECTROCHIM ACTA A, V159, P68, DOI 10.1016/j.saa.2016.01.018; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	49	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0169-7439	1873-3239		CHEMOMETR INTELL LAB	Chemometrics Intell. Lab. Syst.	JAN 15	2022	220								104471	10.1016/j.chemolab.2021.104471	http://dx.doi.org/10.1016/j.chemolab.2021.104471			11	Automation & Control Systems; Chemistry, Analytical; Computer Science, Artificial Intelligence; Instruments & Instrumentation; Mathematics, Interdisciplinary Applications; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Chemistry; Computer Science; Instruments & Instrumentation; Mathematics	1H9VU					2024-09-18	WOS:000796888500005
J	Zhu, Q; Liang, YC; Fan, ZW; Liu, YK; Zhou, CY; Zhang, H; He, L; Li, TS; Yang, JN; Zhou, YP; Wang, JX; Wang, L				Zhu, Qiang; Liang, Yuchao; Fan, Ziwen; Liu, Yukun; Zhou, Chunyao; Zhang, Hong; He, Lei; Li, Tianshi; Yang, Jianing; Zhou, Yanpeng; Wang, Jiaxiang; Wang, Lei			Development and validation of a novel survival prediction model for newly diagnosed lower-grade gliomas	NEUROSURGICAL FOCUS			English	Article						lower-grade gliomas; prediction model; prognosis; molecular subtype; individual management	TERM-FOLLOW-UP; PROMOTER METHYLATION; OLIGODENDROGLIOMA; TRIAL; CLASSIFICATION; GLIOBLASTOMA; RADIOTHERAPY; MUTATIONS; PROGNOSIS; PATHOLOGY	OBJECTIVE Diffuse gliomas are the most common primary gliomas with a poor prognosis. This study aimed to develop and validate prognostic models for predicting the survival probability in newly diagnosed lower-grade glioma (LGG) patients. METHODS Detailed data were obtained for newly diagnosed LGG from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) cohorts. Survival was assessed using Cox proportional hazards regression with adjustment for known prognostic factors. The model was established using the TCGA cohort, and independently validated using the CGGA cohort, to predict the 3-, 5-, and 10-year survival probabilities of patients. RESULTS Data from 293 patients with newly diagnosed LGG from the TCGA cohort were used to establish a prognostic model, and from 232 patients with primary LGG in the CGGA cohort to validate the model. Age, tumor grade, molecular subtype, tumor resection, and preoperative neurological deficits were included in the prediction model. The Cox regression model had a satisfactory corrected concordance index of 0.8508, 0.8510, and 0.8516 in the internal bootstrap validation at 3, 5, and 10 years, respectively. The calibration plots demonstrated high consistency of the predicted and observed outcomes. The CGGA cohort was used for external validation and showed satisfactory discrimination of 0.7776, 0.7682, and 0.7051 at 3, 5, and 10 years, respectively. The calibration plots demonstrated an acceptable calibration capability in the external validation. CONCLUSIONS This study established and validated a prognostic model to predict the survival probability of patients with newly diagnosed LGG. The model performed well in discrimination and calibration with ease of use, speed, accessibility, interpretability, and generalizability. An easily used nomogram based on the Cox model was established for clinical application. Moreover, a free, easy-to-use software interface based on the nomogram is provided online.	[Zhu, Qiang; Liang, Yuchao; Fan, Ziwen; Liu, Yukun; Zhou, Chunyao; Zhang, Hong; He, Lei; Li, Tianshi; Yang, Jianing; Zhou, Yanpeng; Wang, Jiaxiang; Wang, Lei] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University	Wang, L (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China.	wanglei_tiantan@163.com	zhu, qiang/AGD-1064-2022; Zhou, Chunyao/AAG-9787-2019; Wang, Jiaxiang/KHX-6982-2024; zhu, qiang/AGD-0934-2022	zhu, qiang/0000-0002-8253-1811	Beijing Municipal Natural Science Foundation [7202021]; Capital's Funds for Health Improvement and Research [2018-2-1072]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Capital's Funds for Health Improvement and Research	We would like to thank the CGGA for providing the clinical data of patients with newly diagnosed LGG. This study was supported by the research grants of the Beijing Municipal Natural Science Foundation (no. 7202021) and Capital's Funds for Health Improvement and Research (no. 2018-2-1072).	Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; Appay R, 2019, NEURO-ONCOLOGY, V21, P1, DOI 10.1093/neuonc/noz126.000; Bauman G, 1999, INT J RADIAT ONCOL, V45, P923, DOI 10.1016/S0360-3016(99)00284-9; Bauman G, 2009, INT J RADIAT ONCOL, V75, P1401, DOI 10.1016/j.ijrobp.2009.01.010; Baumert BG, 2008, ANN ONCOL, V19, P217, DOI 10.1093/annonc/mdn434; Bedogni G, 2009, J R STAT SOC A STAT, V172, P944, DOI 10.1111/j.1467-985X.2009.00614_16.x; Bell EH, 2018, JAMA ONCOL, V4, P1405, DOI 10.1001/jamaoncol.2018.1977; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cavaliere R, 2005, LANCET NEUROL, V4, P760, DOI 10.1016/S1474-4422(05)70222-2; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chang EF, 2008, J NEUROSURG, V109, P817, DOI 10.3171/JNS/2008/109/11/0817; Chen H, 2017, NEUROLOGY, V88, P1805, DOI 10.1212/WNL.0000000000003911; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.7326/M14-0698, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1038/bjc.2014.639, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1016/j.jclinepi.2014.11.010, 10.1016/j.eururo.2014.11.025]; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Gittleman H, 2020, NEURO-ONCOLOGY, V22, P665, DOI 10.1093/neuonc/noz191; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Gorlia T, 2013, NEURO-ONCOLOGY, V15, P1568, DOI 10.1093/neuonc/not117; Gorovets D, 2012, CLIN CANCER RES, V18, P2490, DOI 10.1158/1078-0432.CCR-11-2977; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Ostrom QT, 2020, NEURO-ONCOLOGY, V22, P1, DOI 10.1093/neuonc/noaa200; Pekmezci M, 2017, ACTA NEUROPATHOL, V133, P1001, DOI 10.1007/s00401-017-1690-1; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Schiff D, 2007, NEUROLOGY, V69, P1366, DOI 10.1212/01.wnl.0000277271.47601.a1; Schomas DA, 2009, NEURO-ONCOLOGY, V11, P437, DOI 10.1215/15228517-2008-102; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Touat M, 2020, NATURE, V580, P517, DOI 10.1038/s41586-020-2209-9; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wen PY, 2020, NEURO-ONCOLOGY, V22, P1073, DOI 10.1093/neuonc/noaa106; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	40	2	2	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2022	52	4							E13	10.3171/2022.1.FOCUS21596	http://dx.doi.org/10.3171/2022.1.FOCUS21596			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	0K9BG	35364578	gold			2024-09-18	WOS:000781081800001
J	Gewirtz, JI; Skidmore, A; Smyth, MD; Limbrick, DD; Goyal, M; Shimony, JS; McKinstry, RC; Groves, ML; Strahle, JM				Gewirtz, Jordan I.; Skidmore, Alex; Smyth, Matthew D.; Limbrick, David D., Jr.; Goyal, Manu; Shimony, Joshua S.; McKinstry, Robert C.; Groves, Mari L.; Strahle, Jennifer M.			Use of fast-sequence spine MRI in pediatric patients	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						MRI; fast sequence; spine; sedation	PROTOCOL; HYDROCEPHALUS; CANCER	OBJECTIVE The immediate and long-term risk of anesthesia in the pediatric population is controversial. Traditional spine MRI protocols require the patient to remain still during the examination, and in young children this frequently results in the need for sedation administration. The authors' goal was to develop an abbreviated spine MRI protocol to reduce sedation administration in young patients undergoing spine MRI. METHODS After IRB approval, the medical records of all pediatric patients who underwent a fast spine MRI protocol between 2017 and 2019 were reviewed. The protocol consisted of T2-weighted half-Fourier acquisition single-shot turbo spin echo, T1-weighted turbo spin echo, and T2-weighted STIR sequences acquired in the sagittal plane. The total acquisition time was 2 minutes with no single sequence acquisition longer than 60 seconds. Interpretability of the scans was assessed in accordance with the radiology report in conjunction with the neurosurgeon's clinical notes. RESULTS A total of 47 fast spine MRI sessions were performed in 45 patients. The median age at the time of the MRI was 2.4 years (25th-75th quartile, 1.1-4.3 years; range 0.16-18.58 years). The most common indication for imaging was to rule out or follow a known syrinx (n = 30), followed by the need to rule out or follow known spinal dysraphism (n = 22). There were no uninterpretable or unusable scans. Eight of 47 scans were noted to have moderate motion artifact limitations with respect to the quality of the scan. Seven patients underwent a subsequent MRI with a sedated standard spine protocol within 1 year from the fast scan, which confirmed the findings on the fast MRI protocol with no new findings identified. CONCLUSIONS The authors report the first pediatric series of a fast spine MRI protocol for use in young patients. The protocol does not require sedation and is able to identify and monitor syrinx, spinal dysraphism, and potentially other intraspinal anomalies.	[Gewirtz, Jordan I.; Skidmore, Alex; Smyth, Matthew D.; Limbrick, David D., Jr.; Strahle, Jennifer M.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Goyal, Manu; Shimony, Joshua S.; McKinstry, Robert C.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Groves, Mari L.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA	Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine	Groves, ML (corresponding author), Washington Univ, St Louis, MO 63110 USA.	strahlej@wustl.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH [U54 HD087011]; Doris Duke Foundation	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF))	Support was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH under award no. U54 HD087011 to the Intellectual and Developmental Disabilities Research Center at Washington (J.S.S.) and the Doris Duke Foundation (J. M.S.).	[Anonymous], F1000 RES, DOI [10.12688/f1000research.2-166.v1, DOI 10.12688/F1000RESEARCH.2-166.V1]; [Anonymous], 2016, DRUG SAF COMM FDA AD; Ashley WW, 2005, J NEUROSURG, V103, P124, DOI 10.3171/ped.2005.103.2.0124; Boyle TP, 2014, PEDIATRICS, V134, pE47, DOI 10.1542/peds.2013-3739; Koral K, 2012, AM J NEURORADIOL, V33, P1851, DOI 10.3174/ajnr.A3076; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Patel DM, 2014, J NEUROSURG-PEDIATR, V13, P440, DOI 10.3171/2014.1.PEDS13447; Rappaport BA, 2015, NEW ENGL J MED, V372, P796, DOI 10.1056/NEJMp1414786; Robertson WD, 1996, AM J ROENTGENOL, V166, P909, DOI 10.2214/ajr.166.4.8610572; Sayah A, 2016, AM J ROENTGENOL, V207, P614, DOI 10.2214/AJR.15.15764; Sugahara T, 1997, AM J ROENTGENOL, V169, P1401, DOI 10.2214/ajr.169.5.9353469; US Food and Drug Administration, 2017, FDA DRUG SAF COMM FD	12	12	12	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2020	26	6					676	681		10.3171/2020.5.PEDS20137	http://dx.doi.org/10.3171/2020.5.PEDS20137			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PB5ZG	32947256	Green Published, Bronze			2024-09-18	WOS:000596398300012
J	Qiao, L; Ding, X; He, SH; Zhang, F; Yu, WL; Zhang, LS; Chen, DB; Gao, X; Chu, PL; Yan, YJ; Huang, Q; Yang, XH; Yin, MC				Qiao, Liang; Ding, Xing; He, Shaohui; Zhang, Fan; Yu, Wenlong; Zhang, Luosheng; Chen, Dingbang; Gao, Xin; Chu, Peilin; Yan, Yinjie; Huang, Quan; Yang, Xinghai; Yin, Mengchen			Measurement properties of health-related quality of life measures for people living with metastatic disease of the spine: a systematic review	INTERNATIONAL JOURNAL OF SURGERY			English	Article						clinical measurement; COSMIN methodology; HRQOL; measurement property; spinal metastases	GROUP OUTCOMES QUESTIONNAIRE; CROSS-CULTURAL ADAPTATION; EORTC QLQ-BM22 MODULE; METHODOLOGICAL QUALITY; EUROPEAN ORGANIZATION; CRITICAL-APPRAISAL; CHINESE VERSION; BONE METASTASES; CANCER-QUALITY; VALIDATION	Purpose:Patients with spinal metastases (SM) suffer from a significant quality of life (QoL) deterioration. The measurement of QoL has garnered significant attention. In this study, the authors aimed to investigate the frequency of QoL measurement, systematically appraise the measurement properties of identified instruments, and facilitate the effective selection of an appropriate QoL instrument for patients with SM.Methods:This systematic review adhered to the newly revised Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement guidelines. The methodological quality of the studies was assessed using the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist. Measurement property results were assessed using the adapted criteria. Each measurement property was allocated a separate rating (excellent, good, fair, or poor). Modified Letter Turned CommaBest evidence synthesis' was performed using COSMIN outcomes and the quality of findings.Result:Two hundred and nine publications were included, and 18 instruments were identified. ECOG, EuroQol-5D, SF-36, SOSGOQ, and EORTC-QLQ-C30 were the top five instruments used for patients with SM in published literature. The measurement properties evaluated included internal consistency (four instruments), reliability (three instruments), validity (five instruments), validity (nine measures), floor and ceiling effects (four instruments), responsiveness (four instruments), and interpretability (three measures). Based on the limited evidence, the Brief Pain Inventory (BPI) had the best methodological quality.Conclusions:Owing to the limitations of BPI in assessment domains, we cannot fully support the use of BPI. For the lack of high-quality research, it is challenging to nominate a single appropriate measure. Additional studies are needed to explore the evidence before a confirmatory decision is made.	[Qiao, Liang; Ding, Xing; Zhang, Fan; Yu, Wenlong; Yan, Yinjie; Yin, Mengchen] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [He, Shaohui; Zhang, Luosheng; Chen, Dingbang; Gao, Xin; Huang, Quan; Yang, Xinghai; Yin, Mengchen] Naval Med Univ, Changzheng Hosp, Affiliated Hosp 2, Shanghai, Peoples R China; [Chu, Peilin] Maanshan Gen Hosp Ranger Duree Healthcare, Dept Orthopaed, Shanghai, Anhui, Peoples R China; [Yin, Mengchen] Longhua Hosp, Shanghai 200032, Peoples R China	Shanghai University of Traditional Chinese Medicine; Naval Medical University	Yin, MC (corresponding author), Longhua Hosp, Shanghai 200032, Peoples R China.	qiaoliang1229@126.com; dingxing2006@126.com; heshaohui1025@163.com; fan_zhang1993@163.com; yuwenlong015@163.com; 17301712997@163.com; cdingbang@163.com; 15026962975@163.com; ahchcpl@hotmail.com; alanchelsea1986@126.com; huangquan0625@163.com; cnspineyang@163.com; yinmengchen0513@126.com			Project of Shanghai Municipal Health Commission [20204Y0165, 20224Y0165]; National Natural Science Foundation of China [82205145]; Research project of Shanghai University of Traditional Chinese Medicine [602064D]; Shanghai "Rising Stars of Medical Talents"-Youth Development Program-Youth Medical Talents-Specialist Program SHWSRS [2023-062]; Project of Chinese Society of Traditional Chinese Medicine youth talent lifting [2023-QNRC2-A03]	Project of Shanghai Municipal Health Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research project of Shanghai University of Traditional Chinese Medicine; Shanghai "Rising Stars of Medical Talents"-Youth Development Program-Youth Medical Talents-Specialist Program SHWSRS; Project of Chinese Society of Traditional Chinese Medicine youth talent lifting	The study was supported by the Project of Shanghai Municipal Health Commission (20204Y0165, 20224Y0165); National Natural Science Foundation of China (82205145); Research project of Shanghai University of Traditional Chinese Medicine(602064D); Shanghai "Rising Stars of Medical Talents"-Youth Development Program-Youth Medical Talents-Specialist Program SHWSRS (2023-062); the Project of Chinese Society of Traditional Chinese Medicine youth talent lifting (2023-QNRC2-A03).	Barzilai O, 2018, NEUROSURGERY, V82, P757, DOI 10.1093/neuros/nyx567; Bollen L, 2018, EUR J CANCER, V104, P81, DOI 10.1016/j.ejca.2018.08.028; Brodano GB, 2023, GLOB SPINE J, V13, P2367, DOI 10.1177/21925682221083913; Choi D, 2013, WORLD NEUROSURG, V80, pE175, DOI 10.1016/j.wneu.2013.02.054; Chow E, 2012, CANCER-AM CANCER SOC, V118, P1457, DOI 10.1002/cncr.26410; Datzmann T, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08578-x; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Falicov A, 2006, SPINE, V31, P2849, DOI 10.1097/01.brs.0000245838.37817.40; Gal R, 2022, BMC MUSCULOSKEL DIS, V23, DOI 10.1186/s12891-022-05837-1; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Guirado VMP, 2013, J NEUROSURG-SPINE, V19, P721, DOI 10.3171/2013.8.SPINE12706; Janssen SJ, 2017, SPINE J, V17, P768, DOI 10.1016/j.spinee.2015.07.456; Kurisunkal V, 2020, INDIAN J ORTHOP, V54, P181, DOI 10.1007/s43465-019-00008-2; Luksanapruksa P, 2021, SPINE J, V21, P1920, DOI 10.1016/j.spinee.2021.05.010; Miki-Rosário N, 2016, ANN PALLIAT MED, V5, P190, DOI 10.21037/apm.2016.06.02; Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086]; Mokkink LB, 2018, QUAL LIFE RES, V27, P1171, DOI 10.1007/s11136-017-1765-4; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2009, QUAL LIFE RES, V18, P313, DOI 10.1007/s11136-009-9451-9; Page MJ, 2021, INT J SURG, V88, DOI 10.1016/j.ijsu.2021.105906; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Püsküllüoglu M, 2014, QUAL LIFE RES, V23, P527, DOI 10.1007/s11136-013-0486-6; Raman S, 2016, RADIOTHER ONCOL, V119, P208, DOI 10.1016/j.radonc.2016.04.035; Rothrock RJ, 2021, NEUROSURGERY, V88, P402, DOI 10.1093/neuros/nyaa380; Schoenfeld AJ, 2022, SPINE J, V22, P39, DOI 10.1016/j.spinee.2021.03.007; Schoenfeld AJ, 2016, SPINE J, V16, P482, DOI 10.1016/j.spinee.2015.09.043; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Street J, 2010, SPINE, V35, P1377, DOI 10.1097/BRS.0b013e3181db96a5; Street J, 2009, J NEUROSURG-SPINE, V11, P512, DOI 10.3171/2009.4.SPINE08599; Street J, 2009, SPINE, V34, pS128, DOI 10.1097/BRS.0b013e3181b778b2; Su CC, 2023, J AM ACAD ORTHOP SUR, V31, pE645, DOI 10.5435/JAAOS-D-23-00091; Suzuki A, 2023, J CLIN MED, V12, DOI 10.3390/jcm12103442; Terwee CB, 2018, QUAL LIFE RES, V27, P1159, DOI 10.1007/s11136-018-1829-0; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Versteeg AL, 2018, CANCER-AM CANCER SOC, V124, P1828, DOI 10.1002/cncr.31240; Yekaninejad MS, 2014, EXPERT REV PHARM OUT, V14, P147, DOI 10.1586/14737167.2014.864559; Yin MC, 2022, SPINE J, V22, P2024, DOI 10.1016/j.spinee.2022.08.013; Zeng Liang, 2011, World J Oncol, V2, P123, DOI 10.4021/wjon322w; Zeng L, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/601720; Zhai SH, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.1016258; Zhang L, 2016, SUPPORT CARE CANCER, V24, P1019, DOI 10.1007/s00520-015-2870-y	42	0	0	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	JAN	2024	110	1					419	430		10.1097/JS9.0000000000000837	http://dx.doi.org/10.1097/JS9.0000000000000837			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FG3K1	37851519	hybrid, Green Published			2024-09-18	WOS:001144567700016
J	Bernatz, S; Koch, V; Dos Santos, DP; Ackermann, J; Gruenewald, LD; Weitkamp, I; Yel, I; Martin, SS; Lenga, L; Scholtz, JE; Vogl, TJ; Mahmoudi, S				Bernatz, Simon; Koch, Vitali; Dos Santos, Daniel Pinto; Ackermann, Jorg; Gruenewald, Leon D. D.; Weitkamp, Inga; Yel, Ibrahim; Martin, Simon S. S.; Lenga, Lukas; Scholtz, Jan-Erik; Vogl, Thomas J. J.; Mahmoudi, Scherwin			Comparison of radiomics models and dual-energy material decomposition to decipher abdominal lymphoma in contrast-enhanced CT	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Radiomics; Artificial intelligence; Lymphoma; Oncology; DECT	IODINE QUANTIFICATION; CANCER; NODES; DIAGNOSIS; CRITERIA; IMAGES	PurposeThe radiologists' workload is increasing, and computational imaging techniques may have the potential to identify visually unequivocal lesions, so that the radiologist can focus on equivocal and critical cases. The purpose of this study was to assess radiomics versus dual-energy CT (DECT) material decomposition to objectively distinguish visually unequivocal abdominal lymphoma and benign lymph nodes.MethodsRetrospectively, 72 patients [m, 47; age, 63.5 (27-87) years] with nodal lymphoma (n = 27) or benign abdominal lymph nodes (n = 45) who had contrast-enhanced abdominal DECT between 06/2015 and 07/2019 were included. Three lymph nodes per patient were manually segmented to extract radiomics features and DECT material decomposition values. We used intra-class correlation analysis, Pearson correlation and LASSO to stratify a robust and non-redundant feature subset. Independent train and test data were applied on a pool of four machine learning models. Performance and permutation-based feature importance was assessed to increase the interpretability and allow for comparison of the models. Top performing models were compared by the DeLong test.ResultsAbout 38% (19/50) and 36% (8/22) of the train and test set patients had abdominal lymphoma. Clearer entity clusters were seen in t-SNE plots using a combination of DECT and radiomics features compared to DECT features only. Top model performances of AUC = 0.763 (CI = 0.435-0.923) were achieved for the DECT cohort and AUC = 1.000 (CI = 1.000-1.000) for the radiomics feature cohort to stratify visually unequivocal lymphomatous lymph nodes. The performance of the radiomics model was significantly (p = 0.011, DeLong) superior to the DECT model.ConclusionsRadiomics may have the potential to objectively stratify visually unequivocal nodal lymphoma versus benign lymph nodes. Radiomics seems superior to spectral DECT material decomposition in this use case. Therefore, artificial intelligence methodologies may not be restricted to centers with DECT equipment.	[Bernatz, Simon; Koch, Vitali; Dos Santos, Daniel Pinto; Gruenewald, Leon D. D.; Weitkamp, Inga; Yel, Ibrahim; Martin, Simon S. S.; Lenga, Lukas; Scholtz, Jan-Erik; Vogl, Thomas J. J.; Mahmoudi, Scherwin] Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Bernatz, Simon] Goethe Univ Frankfurt Main, Univ Hosp Frankfurt, Dr Senckenberg Inst Pathol, D-60590 Frankfurt, Germany; [Dos Santos, Daniel Pinto] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Diagnost & Intervent Radiol, Kerpener Str 62, D-50937 Cologne, Germany; [Ackermann, Jorg] Goethe Univ Frankfurt, Inst Comp Sci, Dept Mol Bioinformat, Robert Mayer Str 11-15, D-60325 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Cologne; Goethe University Frankfurt	Bernatz, S (corresponding author), Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.; Bernatz, S (corresponding author), Goethe Univ Frankfurt Main, Univ Hosp Frankfurt, Dr Senckenberg Inst Pathol, D-60590 Frankfurt, Germany.	simon.bernatz@kgu.de; vitali.koch@kgu.de; daniel.pintodossantos@kgu.de; j.ackermann@bioinformatik.uni-frankfurt.de; leondavid.gruenewald@kgu.de; ingaweitkamp@gmx.de; ibrahim.yel@kgu.de; simon.martin@kgu.de; lukas.lenga@kgu.de; jan-erik.scholtz@web.de; thomas.vogl@kgu.de; scherwin.mahmoudi@kgu.de	Pinto dos Santos, Daniel/I-4609-2019; Koch, Vitali/HIZ-8667-2022	Bernatz, Simon/0000-0002-7758-8100	Projekt DEAL	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. This study was not funded by external sources.	Bedrikovetski S, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08773-w; Bernatz S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93756-x; Bi WL, 2019, CA-CANCER J CLIN, V69, P127, DOI 10.3322/caac.21552; Bian Y, 2022, CANCER IMAGING, V22, DOI 10.1186/s40644-021-00443-1; Chandarana H, 2011, AM J ROENTGENOL, V196, pW693, DOI 10.2214/AJR.10.5541; Chauvie S, 2021, LYMPHOMA; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; De Cecco CN, 2012, AM J ROENTGENOL, V199, pS98, DOI 10.2214/AJR.12.9207; Dong C, 2022, EUR RADIOL, V32, P243, DOI 10.1007/s00330-021-08153-9; DORFMAN RE, 1991, RADIOLOGY, V180, P319, DOI 10.1148/radiology.180.2.2068292; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Enke JS, 2022, CANCERS, V14, DOI 10.3390/cancers14030713; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Feng QL, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07053-3; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Inoue Y, 2021, SEMIN NUCL MED; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Kaltenbach B, 2018, EUR J RADIOL, V105, P20, DOI 10.1016/j.ejrad.2018.05.019; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lennartz S, 2021, CLIN NUCL MED, V46, P303, DOI 10.1097/RLU.0000000000003496; Li XB, 2016, EUR J RADIOL, V85, P1219, DOI 10.1016/j.ejrad.2016.03.030; Liguori C, 2015, MED DEVICES-EVID RES, V8, P265, DOI 10.2147/MDER.S70630; Lisson CS, 2022, CANCERS, V14, DOI 10.3390/cancers14020393; Liu YY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019251; Markotic V, 2021, PSYCHIAT DANUB, V33, pS216; Martin SS, 2018, EUR J RADIOL, V105, P255, DOI 10.1016/j.ejrad.2018.06.017; MILLNER M R, 1979, Medical Physics (Woodbury), V6, P70, DOI 10.1118/1.594555; Ollila TA, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0555-8; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rizzo S, 2018, EUR RADIOL, V28, P760, DOI 10.1007/s00330-017-5015-5; Starmans MPA, 2021, REPRODUCIBLE RADIOMI; Sun X., 2014, CORRELAT RECEIV, V21, P1389; Tatsugami F, 2022, JPN J RADIOL, V40, P547, DOI 10.1007/s11604-021-01233-2; Vallat R., 2018, The Journal of Open Source Software, V3, P1026, DOI DOI 10.21105/JOSS.01026; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; WHO. World Health Organization, 2017, EARL CANC DIAGN SAV; Xie YM, 2021, EUR RADIOL, V31, P6030, DOI 10.1007/s00330-020-07624-9; Yang J, 2022, PHYS MED BIOL, V67, DOI 10.1088/1361-6560/ac515b	41	1	1	1	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	OCT	2023	18	10					1829	1839		10.1007/s11548-023-02854-w	http://dx.doi.org/10.1007/s11548-023-02854-w		MAR 2023	11	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	R3KY2	36877288	hybrid			2024-09-18	WOS:000944089900001
J	Viyanchi, A; Rasekh, HR; Ghatari, AR; SafiKhani, HR				Viyanchi, Amir; Rasekh, Hamid Reza; Ghatari, Ali Rajabzadeh; SafiKhani, Hamid Reza			Selecting the Acceptance Criteria of Medicines in the Reimbursement List of Ppublic Health Insurance of Iran, Using the "Borda" Method: a Pilot Study	IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Health Insurances; Decision Making; "Borda" Method; Medicine Reimbursement	DRUG COVERAGE DECISIONS; COST-EFFECTIVENESS; CANCER DRUGS; 4TH HURDLE; AUSTRALIA; NICE; BENEFITS; SCHEME; TECHNOLOGIES; SUBMISSIONS	Decision-making for medicines to be accepted in Iran's public health insurance reimbursement list is a complex process and involves factors, which should be considered in applying a coverage for medicine costs. These processes and factors are not wholly assessed, while assessment of these factors is an essential need for getting a transparent and evidence-based approach toward medicine reimbursement in Iran. This paper aims to show an evidence-based approach toward medicine selection criteria to inform the medical reimbursement decision makers in Iranian health insurance organizations. To explore an adaptable decision-making framework while incorporating a method called "Borda" in medicine reimbursement assessment, we used the help of an expert group including decision makers and clinical researchers who are also policy makers to appraise the five chief criteria that have three sub criteria (Precision, Interpretability, and Cost). Also software "Math-lab" 7, "SPSS" 17 and Excel 2007 were used in this study. "Borda" estimates the amount of perceived values from different criteria and creates a range from one to five while providing a comprehensive measurement of a large spectrum of criteria. Participants reported that the framework provided an efficient approach to systematic consideration in a pragmatic format consisting of many parts to guide decision-makings, including criteria and value (a model with the core of Borda) and evidences (medicine reimbursement based on criteria). The most important criterion for medicine acceptance in health insurance companies, in Iran, is the "life-threatening" factor and "evidence quality" is accounted as the fifth important factor. This pilot study showed the usefulness of incorporating Borda in medicine reimbursement decisions to support a transparent and systematic appraisal of health insurance companies' deeds. Further research is needed to advance Borda-based approaches that are effective on health insurance decision making.	[Viyanchi, Amir; Rasekh, Hamid Reza] Shahid Beheshti Univ Med Sci, Sch Pharm, Tehran, Iran; [Ghatari, Ali Rajabzadeh] Tarbiat Modares Univ, Tehran, Iran; [SafiKhani, Hamid Reza] Natl Res Network Policy Making Econ & Hlth Manage, Strateg Council, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tarbiat Modares University	Viyanchi, A (corresponding author), Shahid Beheshti Univ Med Sci, Sch Pharm, Tehran, Iran.	viyanchi@gmail.com	GHATARI, ALI/V-9653-2019					Anis AH, 2001, MED CARE, V39, P315, DOI 10.1097/00005650-200104000-00003; [Anonymous], 1996, J MULTI-CRITERIA DEC; [Anonymous], 2010, Euro Observor; Arenas-Guzman R, 2005, J EUR ACAD DERMATOL, V19, P34, DOI 10.1111/j.1468-3083.2005.01285.x; Birkett DJ, 2001, HEALTH AFFAIR, V20, P104, DOI 10.1377/hlthaff.20.3.104; BLACK D, 1976, PUBLIC CHOICE, V28, P1, DOI 10.1007/BF01718454; Borda JC., 1784, HIST ROYAL ACAD SCI, V25, P81; BRINSMEAD G, 2004, EVALUATING PHARM HLT; Chambers JD, 2015, HEALTH AFFAIR, V34, P253, DOI 10.1377/hlthaff.2014.1123; Chim L, 2010, PHARMACOECONOMICS, V28, P463, DOI 10.2165/11533000-000000000-00000; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Dakin HA, 2006, HEALTH POLICY, V77, P352, DOI 10.1016/j.healthpol.2005.08.008; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Dolan JG, 2010, PATIENT, V3, P229, DOI 10.2165/11539470-000000000-00000; Dormuth CR, 2008, CLIN THER, V30, P1038, DOI 10.1016/j.clinthera.2008.06.003; Dowie J, 2003, HLTH CARE PRIORITY S, P9; Garcia-Lapresta J.L, 2002, MULTIPLE OBJECTIVE G, P46; García-Lapresta JL, 2002, PUBLIC CHOICE, V112, P167, DOI 10.1023/A:1015609200117; Gardenfors Peter., 1973, Theory and Decision, V4, P1, DOI DOI 10.1007/BF00133396; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Harris AH, 2008, MED DECIS MAKING, V28, P713, DOI 10.1177/0272989X08315247; Hill SR, 2000, JAMA-J AM MED ASSOC, V283, P2116, DOI 10.1001/jama.283.16.2116; Hsu JC, 2015, DARU, V23, DOI 10.1186/s40199-014-0080-7; Hutton J, 2006, INT J TECHNOL ASSESS, V22, P10, DOI 10.1017/S0266462306050781; Jena A, 2009, ENDOGENOUS COST EFFE, P15032; Kaltenthaler E, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15220; Knowles J.C., 1997, 1 ABT ASS INC, P43; Kozyrskyj AL, 2001, CAN MED ASSOC J, V165, P897; Le Pen C, 2003, Eur J Health Econ, V4, P30, DOI 10.1007/s10198-002-0145-2; Lee YC, 2006, PHARMACOECONOMICS, V24, P891, DOI 10.2165/00019053-200624090-00006; Lundkvist J, 2006, HEALTH POLICY, V79, P337, DOI 10.1016/j.healthpol.2006.02.004; Marchant T, 2000, SOC CHOICE WELFARE, V17, P381, DOI 10.1007/s003550050169; Mason AR, 2009, EUR J CANCER, V45, P1188, DOI 10.1016/j.ejca.2008.11.040; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS42, DOI 10.1002/pds.1436; Neumann PJ, 2008, HEALTH AFFAIR, V27, P1620, DOI 10.1377/hlthaff.27.6.1620; Nikfar Shekoufeh, 2005, BMC Int Health Hum Rights, V5, P5, DOI 10.1186/1472-698X-5-5; OECD, 2005, HLTH TECHN DEC MAK, P71; Polinski JM, 2008, J POPUL THER CLIN PH, V15, pE286; Pronk Marja H, 2004, Eur J Health Econ, V5, P274, DOI 10.1007/s10198-003-0223-0; Rocchi A, 2008, VALUE HEALTH, V11, P771, DOI 10.1111/j.1524-4733.2007.00298.x; Rogowski WH, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-194; Rosenbaum S, 1999, NEW ENGL J MED, V232-299, P340; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schoffski O, 1996, PHARMACOECONOMICS, V10, P37, DOI 10.2165/00019053-199600102-00007; Segal L, 2009, HEALTH ECON, V19, P449; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; STEWARTBROWN S, 1995, BRIT MED J, V311, P1543, DOI 10.1136/bmj.311.7019.1543; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Titlow K, 2000, HEALTH AFFAIR, V19, P240, DOI 10.1377/hlthaff.19.2.240; Wong H, 1999, DESIGNING BENEFITS P	50	4	4	0	3	SHAHEED BEHESHTI UNIV, SCH PHARMACY	TEHRAN	NO 10 SHAMS ALLEY, VALI-E ASR ST, TEHRAN, 00000, IRAN	1735-0328	1726-6890		IRAN J PHARM RES	Iran. J. Pharm. Res.	FAL	2015	14	4					1305	1316						12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DT6VK	26664402				2024-09-18	WOS:000381622400039
J	Ren, H; Wang, QB; Xiao, ZG; Mo, RW; Guo, JC; Hide, GR; Tu, MT; Zeng, YN; Ling, C; Li, P				Ren, He; Wang, Qiubo; Xiao, Zhengguang; Mo, Runwei; Guo, Jiachen; Hide, Gareth Richard; Tu, Mengting; Zeng, Yanan; Ling, Chen; Li, Ping			Fusing Diverse Decision Rules in 3D-Radiomics for Assisting Diagnosis of Lung Adenocarcinoma	JOURNAL OF IMAGING INFORMATICS IN MEDICINE			English	Article; Early Access						Diverse decision rules; 3D radiomics; Lung adenocarcinoma; Assisted diagnosis	HEALTH-ORGANIZATION CLASSIFICATION; NASOPHARYNGEAL CARCINOMA; NOMOGRAM; FEATURES; SECTION; CANCER; TUMORS	This study aimed to develop an interpretable diagnostic model for subtyping of pulmonary adenocarcinoma, including minimally invasive adenocarcinoma (MIA), adenocarcinoma in situ (AIS), and invasive adenocarcinoma (IAC), by integrating 3D-radiomic features and clinical data. Data from multiple hospitals were collected, and 10 key features were selected from 1600 3D radiomic signatures and 11 radiological features. Diverse decision rules were extracted using ensemble learning methods (gradient boosting, random forest, and AdaBoost), fused, ranked, and selected via RuleFit and SHAP to construct a rule-based diagnostic model. The model's performance was evaluated using AUC, precision, accuracy, recall, and F1-score and compared with other models. The rule-based diagnostic model exhibited excellent performance in the training, testing, and validation cohorts, with AUC values of 0.9621, 0.9529, and 0.8953, respectively. This model outperformed counterparts relying solely on selected features and previous research models. Specifically, the AUC values for the previous research models in the three cohorts were 0.851, 0.893, and 0.836. It is noteworthy that individual models employing GBDT, random forest, and AdaBoost demonstrated AUC values of 0.9391, 0.8681, and 0.9449 in the training cohort, 0.9093, 0.8722, and 0.9363 in the testing cohort, and 0.8440, 0.8640, and 0.8750 in the validation cohort, respectively. These results highlight the superiority of the rule-based diagnostic model in the assessment of lung adenocarcinoma subtypes, while also providing insights into the performance of individual models. Integrating diverse decision rules enhanced the accuracy and interpretability of the diagnostic model for lung adenocarcinoma subtypes. This approach bridges the gap between complex predictive models and clinical utility, offering valuable support to healthcare professionals and patients.	[Ren, He; Wang, Qiubo] Shanghai Univ Med & Hlth Sci, Zhoupu Hosp, Resp Dept, Shanghai, Peoples R China; [Ren, He; Guo, Jiachen; Tu, Mengting; Zeng, Yanan; Ling, Chen; Li, Ping] Shanghai Univ Med & Hlth Sci, Coll Med Instrumentat, Shanghai, Peoples R China; [Ren, He; Guo, Jiachen; Tu, Mengting; Zeng, Yanan; Ling, Chen; Li, Ping] Shanghai Univ Med & Hlth Sci, Collaborat Innovat Canter, Shanghai, Peoples R China; [Xiao, Zhengguang] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Radiol, Sch Med, Shanghai, Peoples R China; [Mo, Runwei] East China Univ Sci & Technol, Sch Mech & Power Engn, Shanghai 200030, Peoples R China; [Hide, Gareth Richard] Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Med Sch, Johannesburg, South Africa	Shanghai University of Medicine & Health Sciences; Shanghai University of Medicine & Health Sciences; Shanghai University of Medicine & Health Sciences; Shanghai Jiao Tong University; East China University of Science & Technology; University of Witwatersrand	Ling, C; Li, P (corresponding author), Shanghai Univ Med & Hlth Sci, Coll Med Instrumentat, Shanghai, Peoples R China.; Ling, C; Li, P (corresponding author), Shanghai Univ Med & Hlth Sci, Collaborat Innovat Canter, Shanghai, Peoples R China.	Lingc@sumhs.edu.cn; Lip@sumhs.edu.cn	James, XI/JOJ-7581-2023		Science and Technology Commission of Shanghai Municipality [22S31904600]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by The Science and Technology Commission of Shanghai Municipality (grant no. 22S31904600).	Behera M, 2016, CLIN LUNG CANCER, V17, pE57, DOI 10.1016/j.cllc.2016.03.009; Casal-Mouriño A, 2019, CANCER LETT, V451, P142, DOI 10.1016/j.canlet.2019.02.047; Chen XM, 2020, CANCER IMAGING, V20, DOI 10.1186/s40644-020-00320-3; Das SK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90367-4; Drevet G, 2020, LUNG CANCER, V139, P55, DOI 10.1016/j.lungcan.2019.10.023; Feng JX, 2022, COMPUT MATH METHOD M, V2022, DOI 10.1155/2022/4153211; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gao W, 2022, JAMA INTERN MED, V182, P283, DOI 10.1001/jamainternmed.2021.7769; Hoy H, 2019, CRIT CARE NURS CLIN, V31, P303, DOI 10.1016/j.cnc.2019.05.002; Jiang BH, 2014, ACTA RADIOL, V55, P302, DOI 10.1177/0284185113495834; Kuhn E, 2018, PATHOLOGICA, V110, P5; Lam LHT, 2022, NMR BIOMED, V35, DOI 10.1002/nbm.4792; Li JP, 2018, INT J BIOL SCI, V14, P549, DOI 10.7150/ijbs.24374; Lin Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23326-1; Liu SL, 2016, J CLIN ONCOL, V34, P307, DOI 10.1200/JCO.2015.63.4907; Luo C, 2022, J INFLAMM RES, V15, P4803, DOI 10.2147/JIR.S366922; Lv WB, 2020, IEEE J BIOMED HEALTH, V24, P2268, DOI 10.1109/JBHI.2019.2956354; Mengoli MC, 2018, PATHOLOGICA, V110, P39; Ren H, 2023, QUANT IMAG MED SURG, V13, DOI 10.21037/qims-22-491; Ren H, 2020, QUANT IMAG MED SURG, V10, P233, DOI 10.21037/qims.2019.12.02; Ren Y, 2020, INT J COMPUT ASS RAD, V15, P287, DOI 10.1007/s11548-019-02097-8; Santhanam AP, 2021, MED PHYS, V48, P667, DOI 10.1002/mp.14252; She YL, 2018, EUR RADIOL, V28, P5121, DOI 10.1007/s00330-018-5509-9; Shi LL, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.618677; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Wan K, 2023, STAT MED, V42, P3413, DOI 10.1002/sim.9812; Wen ZX, 2020, J CANCER RES CLIN, V146, P1603, DOI 10.1007/s00432-020-03180-3; Wu FZ, 2020, EUR J CANCER PREV, V29, P445, DOI 10.1097/CEJ.0000000000000569; Wu FZ, 2016, CLIN LUNG CANCER, V17, pE45, DOI 10.1016/j.cllc.2016.03.004; Wu YJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79690-4; Yang CJ, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12051121; Zhang H, 2022, Zhonghua Wai Ke Za Zhi, V60, P580, DOI 10.3760/cma.j.cn112139-20211008-00474; Zhang J, 2022, QUANT IMAG MED SURG, V12, P1359, DOI 10.21037/qims-21-555	35	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2948-2925	2948-2933		J IMAGING INFORM MED	J. Imaging Inform. Med.	2024 APR 2	2024										10.1007/s10278-024-00967-5	http://dx.doi.org/10.1007/s10278-024-00967-5		APR 2024	14	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	MS9Y2	38565729	hybrid			2024-09-18	WOS:001195754200002
J	Valen, J; Balki, I; Mendez, M; Qu, WD; Levman, J; Bilbily, A; Tyrrell, PN				Valen, John; Balki, Indranil; Mendez, Mauro; Qu, Wendi; Levman, Jacob; Bilbily, Alexander; Tyrrell, Pascal N.			Quantifying uncertainty in machine learning classifiers for medical imaging	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Uncertainty; Medical imaging; Neural network; Confidence		Purpose Machine learning (ML) models in medical imaging (MI) can be of great value in computer aided diagnostic systems, but little attention is given to the confidence (alternatively, uncertainty) of such models, which may have significant clinical implications. This paper applied, validated, and explored a technique for assessing uncertainty in convolutional neural networks (CNNs) in the context of MI. Materials and methods We used two publicly accessible imaging datasets: a chest x-ray dataset (pneumonia vs. control) and a skin cancer imaging dataset (malignant vs. benign) to explore the proposed measure of uncertainty based on experiments with different class imbalance-sample sizes, and experiments with images close to the classification boundary. We also further verified our hypothesis by examining the relationship with other performance metrics and cross-checking CNN predictions and confidence scores with an expert radiologist (available in the Supplementary Information). Additionally, bounds were derived on the uncertainty metric, and recommendations for interpretability were made. Results With respect to training set class imbalance for the pneumonia MI dataset, the uncertainty metric was minimized when both classes were nearly equal in size (regardless of training set size) and was approximately 17% smaller than the maximum uncertainty resulting from greater imbalance. We found that less-obvious test images (those closer to the classification boundary) produced higher classification uncertainty, about 10-15 times greater than images further from the boundary. Relevant MI performance metrics like accuracy, sensitivity, and sensibility showed seemingly negative linear correlations, though none were statistically significant (p >= 0.05). The expert radiologist and CNN expressed agreement on a small sample of test images, though this finding is only preliminary. Conclusions This paper demonstrated the importance of uncertainty reporting alongside predictions in medical imaging. Results demonstrate considerable potential from automatically assessing classifier reliability on each prediction with the proposed uncertainty metric.	[Valen, John; Balki, Indranil; Mendez, Mauro; Qu, Wendi; Bilbily, Alexander; Tyrrell, Pascal N.] Univ Toronto, Dept Med Imaging, Toronto, ON M5T 1W7, Canada; [Levman, Jacob] St Francis Xavier Univ, Dept Comp Sci, Antigonish, NS, Canada; [Tyrrell, Pascal N.] Univ Toronto, Dept Stat Sci, Toronto, ON, Canada; [Tyrrell, Pascal N.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; Saint Francis Xavier University - Canada; University of Toronto; University of Toronto	Tyrrell, PN (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON M5T 1W7, Canada.; Tyrrell, PN (corresponding author), Univ Toronto, Dept Stat Sci, Toronto, ON, Canada.; Tyrrell, PN (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	pascal.tyrrell@utoronto.ca	Tyrrell, Pascal/GWC-6317-2022	Tyrrell, Pascal/0000-0003-2277-3824; Mendez, Mauro/0000-0002-5418-7005				Balki I, 2019, CAN ASSOC RADIOL J, V70, P344, DOI 10.1016/j.carj.2019.06.002; Gal Y, 2016, PR MACH LEARN RES, V48; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Kendall A, 2017, 31 ANN C NEURAL INFO, V30; Kermany Daniel, 2018, Mendeley Data, V3; Kwon Y, 2020, COMPUT STAT DATA AN, V142, DOI 10.1016/j.csda.2019.106816; Leibig C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17876-z; Michelmore R., 2018, Evaluating Uncertainty Quantification in End-to-End Autonomous Driving Control; Park SH, 2018, RADIOLOGY, V286, P800, DOI 10.1148/radiol.2017171920; Tang A, 2018, CAN ASSOC RADIOL J, V69, P120, DOI 10.1016/j.carj.2018.02.002	10	5	5	1	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	APR	2022	17	4					711	718		10.1007/s11548-022-02578-3	http://dx.doi.org/10.1007/s11548-022-02578-3		MAR 2022	8	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	0J7UZ	35278156				2024-09-18	WOS:000767916400002
J	Nwanosike, EM; Conway, BR; Merchant, HA; Hasan, SS				Nwanosike, Ezekwesiri Michael; Conway, Barbara R.; Merchant, Hamid A.; Hasan, Syed Shahzad			Potential applications and performance of machine learning techniques and algorithms in clinical practice: A systematic review	INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS			English	Review						Machine learning; Clinical studies; Electronic health records (EHRs); Clinical practice; Model deployment; AUROC; Prediction; COVID-19	PREDICTION; DISEASE; CLASSIFICATION; MORTALITY; RISK; COVID-19; MODEL	Purpose: The advent of clinically adapted machine learning algorithms can solve numerous problems ranging from disease diagnosis and prognosis to therapy recommendations. This systematic review examines the performance of machine learning (ML) algorithms and evaluates the progress made to date towards their implementation in clinical practice.Methods: Systematic searching of databases (PubMed, MEDLINE, Scopus, Google Scholar, Cochrane Library and WHO Covid-19 database) to identify original articles published between January 2011 and October 2021. Studies reporting ML techniques in clinical practice involving humans and ML algorithms with a performance metric were considered.Results: Of 873 unique articles identified, 36 studies were eligible for inclusion. The XGBoost (extreme gradient boosting) algorithm showed the highest potential for clinical applications (n = 7 studies); this was followed jointly by random forest algorithm, logistic regression, and the support vector machine, respectively (n = 5 studies). Prediction of outcomes (n = 33), in particular Inflammatory diseases (n = 7) received the most attention followed by cancer and neuropsychiatric disorders (n = 5 for each) and Covid-19 (n = 4). Thirty-three out of the thirty-six included studies passed more than 50% of the selected quality assessment criteria in the TRIPOD checklist. In contrast, none of the studies could achieve an ideal overall bias rating of 'low' based on the PROBAST checklist. In contrast, only three studies showed evidence of the deployment of ML algorithm(s) in clinical practice.Conclusions: ML is potentially a reliable tool for clinical decision support. Although advocated widely in clinical practice, work is still in progress to validate clinically adapted ML algorithms. Improving quality standards, transparency, and interpretability of ML models will further lower the barriers to acceptability.	[Nwanosike, Ezekwesiri Michael; Conway, Barbara R.; Merchant, Hamid A.; Hasan, Syed Shahzad] Univ Huddersfield, Sch Appl Sci, Dept Pharm, Huddersfield HD1 3DH, W Yorkshire, England; [Hasan, Syed Shahzad] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia	University of Huddersfield; University of Newcastle	Hasan, SS (corresponding author), Univ Huddersfield, Sch Appl Sci, Dept Pharm, Huddersfield HD1 3DH, W Yorkshire, England.	s.hasan@hud.ac.uk	MERCHANT, HAMID/Z-6014-2019; Hasan, Syed Shahzad/V-9082-2018; Conway, Barbara/AAY-7055-2021; MERCHANT, HAMID/I-4741-2017	Conway, Barbara/0000-0001-5570-3318; Nwanosike, PhD, Ezekwesiri/0000-0003-1831-6591; MERCHANT, HAMID/0000-0002-7668-5013; Hasan, Syed Shahzad/0000-0002-4058-2215				Alhazmi A, 2021, J ORAL PATHOL MED, V50, P444, DOI 10.1111/jop.13157; Anahtar MN, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01260-20; Assaf D, 2020, INTERN EMERG MED, V15, P1435, DOI 10.1007/s11739-020-02475-0; Banu A Bazila, 2018, Asian Pac J Cancer Prev, V19, P2917; Basile AO, 2019, TRENDS PHARMACOL SCI, V40, P624, DOI 10.1016/j.tips.2019.07.005; Behnoush B, 2021, HUM EXP TOXICOL, V40, P1225, DOI 10.1177/0960327121991910; Bergeron MF, 2020, J ALZHEIMERS DIS, V77, P1545, DOI 10.3233/JAD-191340; Bolourani S, 2021, J MED INTERNET RES, V23, DOI 10.2196/24246; Bora A, 2021, LANCET DIGIT HEALTH, V3, pE10, DOI 10.1016/S2589-7500(20)30250-8; Brinker TJ, 2019, EUR J CANCER, V119, P11, DOI 10.1016/j.ejca.2019.05.023; Char DS, 2020, AM J BIOETHICS, V20, P7, DOI 10.1080/15265161.2020.1819469; Collins GS, 2015, CIRCULATION, V131, P211, DOI 10.1161/CIRCULATIONAHA.114.014508; Corny J, 2020, J AM MED INFORM ASSN, V27, P1688, DOI 10.1093/jamia/ocaa154; Crutzen S, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3426; Damiati SA, 2020, AAPS PHARMSCITECH, V21, DOI 10.1208/s12249-020-01747-4; de Souza EM, 2021, J PSYCHIATR RES, V132, P1, DOI 10.1016/j.jpsychires.2020.09.025; Del Parigi A, 2019, PHARM MED, V33, P209, DOI 10.1007/s40290-019-00281-4; Delahanty RJ, 2019, ANN EMERG MED, V73, P334, DOI 10.1016/j.annemergmed.2018.11.036; Deshmukh F, 2020, AM J GASTROENTEROL, V115, P1657, DOI 10.14309/ajg.0000000000000632; Diao XL, 2021, JMIR MED INF, V9, DOI 10.2196/19739; Domínguez-Olmedo JL, 2021, J MED INTERNET RES, V23, DOI 10.2196/26211; Elfiky AA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0926; Fernandes FT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82885-y; Fujihara K, 2021, JMIR MED INF, V9, DOI 10.2196/22148; Gibson WJ, 2020, J THROMB THROMBOLYS, V49, P1, DOI 10.1007/s11239-019-01940-8; Goecks J, 2020, CELL, V181, P92, DOI 10.1016/j.cell.2020.03.022; Goulooze S, 2020, CLIN PHARMACOL THER, V107, P786, DOI 10.1002/cpt.1744; Guncar G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18564-8; Halasz G, 2021, J MED INTERNET RES, V23, DOI 10.2196/29058; Hong S, 2020, JMIR MED INF, V8, DOI 10.2196/15932; Hung M, 2019, GERODONTOLOGY, V36, P395, DOI 10.1111/ger.12432; Icten Z, 2020, VALUE HEALTH, V23, pS1; Islam MM, 2018, STUD HEALTH TECHNOL, V247, P166, DOI 10.3233/978-1-61499-852-5-166; Jagga Z, 2015, PERS MED, V12, P371, DOI [10.2217/pme.15.5, 10.2217/PME.15.5]; Jayatilake SMDAC, 2021, J HEALTHC ENG, V2021, DOI 10.1155/2021/6679512; Jimenez-Solem E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81844-x; Kautzky A, 2021, ACTA PSYCHIAT SCAND, V143, P36, DOI 10.1111/acps.13250; Kautzky A, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.16m11385; Kim HJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/24225; Kim YK, 2018, PROG NEURO-PSYCHOPH, V80, P71, DOI 10.1016/j.pnpbp.2017.06.024; Kivrak M, 2021, COMPUT METH PROG BIO, V201, DOI 10.1016/j.cmpb.2021.105951; Kouchaki S, 2019, BIOINFORMATICS, V35, P2276, DOI 10.1093/bioinformatics/bty949; Koutsouleris N, 2016, LANCET PSYCHIAT, V3, P935, DOI 10.1016/S2215-0366(16)30171-7; Kubota KJ, 2016, MOVEMENT DISORD, V31, P1314, DOI 10.1002/mds.26693; Kukar M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90265-9; Lee C, 2021, LANCET DIGIT HEALTH, V3, pE158, DOI 10.1016/S2589-7500(20)30314-9; Li CF, 2017, KIDNEY BLOOD PRESS R, V42, P1045, DOI 10.1159/000485592; Li JX, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250370; Lichtner G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92475-7; Lo Vercio L, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/abbff2; Luo G, 2015, HEALTH INF SCI SYST, V3, DOI 10.1186/s13755-015-0011-0; MacGregor RM, 2021, ANN BIOMED ENG, V49, P922, DOI 10.1007/s10439-020-02639-1; Magunia H, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03720-4; Mancini A, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03566-7; Marcos M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0240200; Navlakha S, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06038-2; Ngiam KY, 2019, LANCET ONCOL, V20, pE262, DOI 10.1016/S1470-2045(19)30149-4; Noseworthy PA, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.119.007988; Olsen CR, 2020, AM HEART J, V229, P1, DOI 10.1016/j.ahj.2020.07.009; Patel A., 2019, BLOOD, V134, P1, DOI [10.1002/central/CN-02048753/full, DOI 10.1002/CENTRAL/CN-02048753/FULL]; Patel D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83967-7; Radakovich N, 2020, LANCET HAEMATOL, V7, pE541, DOI 10.1016/S2352-3026(20)30121-6; Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259; Rashidi P, 2019, CURR OPIN ANESTHESIO, V32, P653, DOI 10.1097/ACO.0000000000000779; Ross MK, 2018, ANN AM THORAC SOC, V15, P49, DOI 10.1513/AnnalsATS.201702-101OC; Roth JA, 2018, INFECT CONT HOSP EP, V39, P1457, DOI 10.1017/ice.2018.265; Russak AJ, 2020, J CARDIOVASC PHARM T, V25, P379, DOI 10.1177/1074248420928651; Schöning V, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02720-w; Sendak M.P., 2020, EMJ Innovations; Shim JG, 2020, ARCH OSTEOPOROS, V15, DOI 10.1007/s11657-020-00802-8; Shouval R, 2021, BRIT J HAEMATOL, V192, P239, DOI 10.1111/bjh.16915; Shouval R, 2015, J CLIN ONCOL, V33, P3144, DOI 10.1200/JCO.2014.59.1339; Siontis KC, 2020, CIRC RES, V127, P155, DOI 10.1161/CIRCRESAHA.120.316401; Stachel A, 2021, BMJ HEALTH CARE INFO, V28, DOI 10.1136/bmjhci-2020-100235; Stark GF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226765; Turki T, 2019, COMPUT BIOL MED, V107, P302, DOI 10.1016/j.compbiomed.2018.12.017; Veeranki SPK, 2019, STUD HEALTH TECHNOL, V264, P1566, DOI 10.3233/SHTI190537; Veronese E, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/867924; Waljee AK, 2018, INFLAMM BOWEL DIS, V24, P45, DOI 10.1093/ibd/izx007; Wang SJ, 2019, STUD HEALTH TECHNOL, V264, P888, DOI 10.3233/SHTI190351; Wang WJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234722; Wernly B, 2021, INT J MED INFORM, V145, DOI 10.1016/j.ijmedinf.2020.104312; Wolff RF, 2019, ANN INTERN MED, V170, P51, DOI 10.7326/M18-1376; Wu YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17061828; Xiao J, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1860-0; Xu M, 2021, J MED INTERNET RES, V23, DOI 10.2196/25535; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Zhdanov A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.18377; Zhou YD, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.019628; Zimmerman A, 2020, REV CARDIOVASC MED, V21, P345, DOI 10.31083/j.rcm.2020.03.120	90	43	44	2	43	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1386-5056	1872-8243		INT J MED INFORM	Int. J. Med. Inform.	MAR	2022	159								104679	10.1016/j.ijmedinf.2021.104679	http://dx.doi.org/10.1016/j.ijmedinf.2021.104679		JAN 2022	11	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	0W1KM	34990939	Green Accepted			2024-09-18	WOS:000788794900002
J	Rio-Torto, I; Fernandes, K; Teixeira, LF				Rio-Torto, Isabel; Fernandes, Kelwin; Teixeira, Luis F.			Understanding the decisions of CNNs: An in-model approach	PATTERN RECOGNITION LETTERS			English	Article						Explainable AI; Explainability; Interpretability; Deep Llearning; Convolutional Nneural Nnetworks		With the outstanding predictive performance of Convolutional Neural Networks on different tasks and their widespread use in real-world scenarios, it is essential to understand and trust these black-box models. While most of the literature focuses on post-model methods, we propose a novel in-model joint architecture, composed by an explainer and a classifier. This architecture outputs not only a class label, but also a visual explanation of such decision, without the need for additional labelled data to train the explainer besides the image class. The model is trained end-to-end, with the classifier taking as input an image and the explainer's resulting explanation, thus allowing for the classifier to focus on the relevant areas of such explanation. Moreover, this approach can be employed with any classifier, provided that the necessary connections to the explainer are made. We also propose a three-phase training process and two alternative custom loss functions that regularise the produced explanations and encourage desired properties, such as sparsity and spatial contiguity. The architecture was validated in two datasets (a subset of ImageNet and a cervical cancer dataset) and the obtained results show that it is able to produce meaningful image- and class-dependent visual explanations, without direct supervision, aligned with intuitive visual features associated with the data. Quantitative assessment of explanation quality was conducted through iterative perturbation of the input image according to the explanation heatmaps. The impact on classification performance is studied in terms of average function value and AOPC (Area Over the MoRF (Most Relevant First) Curve). For further evaluation, we propose POMPOM (Percentage of Meaningful Pixels Outside the Mask) as another measurable criteria of explanation goodness. These analyses showed that the proposed method outperformed state-of-the-art post-model methods, such as LRP (Layer-wise Relevance Propagation). (C) 2020 Elsevier B.V. All rights reserved.	[Rio-Torto, Isabel; Teixeira, Luis F.] Univ Porto, Fac Engn, Rua Dr Roberto Frias S-N, P-4200465 Porto, Portugal; [Teixeira, Luis F.] Univ Porto, INESC TEC, Campus Fac Engn, P-4200465 Porto, Portugal; [Fernandes, Kelwin] NILG AI, P-4200479 Porto, Portugal	Universidade do Porto; INESC TEC; Universidade do Porto	Rio-Torto, I (corresponding author), Univ Porto, Fac Engn, Rua Dr Roberto Frias S-N, P-4200465 Porto, Portugal.	icrtto@gmail.com	Teixeira, Luis/E-1319-2011	Teixeira, Luis/0000-0002-4050-7880; Rio-Torto, Isabel/0000-0002-2302-8597				Adebayo J, 2018, ADV NEUR IN, V31; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Buslaev A, 2020, INFORMATION, V11, DOI 10.3390/info11020125; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Ferreira PM, 2018, IEEE ACCESS, V6, P53930, DOI 10.1109/ACCESS.2018.2870063; Geirhos R., 2019, P INT C LEARNING REP, P1; Gilpin LH, 2018, PR INT CONF DATA SC, P80, DOI 10.1109/DSAA.2018.00018; Gunning D., 2017, DEFENSE ADV RES PROJ, V2, P1; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; Kanehira A, 2019, PROC CVPR IEEE, P8595, DOI [10.1109/CVPR.2019.00879, 10.1109/CVPR.2019.00880]; Kauffman RP, 2013, MED PRIN PRACT, V22, P313, DOI 10.1159/000346137; Kim Been, 2016, ADV NEURAL INFORM PR, P2280; Montavon G, 2018, DIGIT SIGNAL PROCESS, V73, P1, DOI 10.1016/j.dsp.2017.10.011; Rio-Torto Isabel, 2019, Pattern Recognition and Image Analysis. 9th Iberian Conference, IbPRIA 2019. Proceedings. Lecture Notes in Computer Science (LNCS 11867), P3, DOI 10.1007/978-3-030-31332-6_1; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Samek W, 2017, IEEE T NEUR NET LEAR, V28, P2660, DOI 10.1109/TNNLS.2016.2599820; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Simonyan K., 2014, WORKSH TRACK P 2 INT; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Springenberg J., 2015, ICLR WORKSH TRACK; Sundararajan M, 2017, PR MACH LEARN RES, V70; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	23	15	15	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8655	1872-7344		PATTERN RECOGN LETT	Pattern Recognit. Lett.	MAY	2020	133						373	380		10.1016/j.patrec.2020.04.004	http://dx.doi.org/10.1016/j.patrec.2020.04.004			8	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	LT0WV					2024-09-18	WOS:000536798000028
J	Kang, TY; Ding, W; Zhang, LY; Ziemek, D; Zarringhalam, K				Kang, Tianyu; Ding, Wei; Zhang, Luoyan; Ziemek, Daniel; Zarringhalam, Kourosh			A biological network-based regularized artificial neural network model for robust phenotype prediction from gene expression data	BMC BIOINFORMATICS			English	Article						Artificial neural network; Gene regulatory networks; Prediction of response; Clinical trial; Group Lasso	CANCER; SELECTION; DISEASE; RARE; CLASSIFICATION; SCHIZOPHRENIA; DIAGNOSIS	Background: Stratification of patient subpopulations that respond favorably to treatment or experience and adverse reaction is an essential step toward development of new personalized therapies and diagnostics. It is currently feasible to generate omic-scale biological measurements for all patients in a study, providing an opportunity for machine learning models to identify molecular markers for disease diagnosis and progression. However, the high variability of genetic background in human populations hampers the reproducibility of omic-scale markers. In this paper, we develop a biological network-based regularized artificial neural network model for prediction of phenotype from transcriptomic measurements in clinical trials. To improve model sparsity and the overall reproducibility of the model, we incorporate regularization for simultaneous shrinkage of gene sets based on active upstream regulatory mechanisms into the model. Results: We benchmark our method against various regression, support vector machines and artificial neural network models and demonstrate the ability of our method in predicting the clinical outcomes using clinical trial data on acute rejection in kidney transplantation and response to Infliximab in ulcerative colitis. We show that integration of prior biological knowledge into the classification as developed in this paper, significantly improves the robustness and generalizability of predictions to independent datasets. We provide a Java code of our algorithm along with a parsed version of the STRING DB database. Conclusion: In summary, we present a method for prediction of clinical phenotypes using baseline genome-wide expression data that makes use of prior biological knowledge on gene-regulatory interactions in order to increase robustness and reproducibility of omic-scale markers. The integrated group-wise regularization methods increases the interpretability of biological signatures and gives stable performance estimates across independent test sets.	[Kang, Tianyu; Ding, Wei; Zhang, Luoyan] Univ Massachusetts Boston, Dept Comp Sci, 100 Morrissey Blvd, Boston, MA 02125 USA; [Ziemek, Daniel] Pfizer Worldwide Res & Dev, Inflammat & Immunol, Berlin, Germany; [Zarringhalam, Kourosh] Univ Massachusetts Boston, Dept Math, 100 Morrissey Blvd, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; Pfizer; University of Massachusetts System; University of Massachusetts Boston	Zarringhalam, K (corresponding author), Univ Massachusetts Boston, Dept Math, 100 Morrissey Blvd, Boston, MA 02125 USA.	kourosh.zarringhalam@umb.edu		Ding, Wei/0000-0002-3383-551X	National Science Foundation [1743010]; Div Of Information & Intelligent Systems; Direct For Computer & Info Scie & Enginr [1743010] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Information & Intelligent Systems; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The research of KZ and WD was supported by the National Science Foundation grant # 1743010.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2006, J R STAT SOC B; Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Binder H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-18; Boddu R, 2015, HUM MOL GENET, V24, P4078, DOI 10.1093/hmg/ddv147; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; CHO WCS, 2007, MOL CANCER, V6; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Díaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Fakhry CT, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1181-8; Flood DG, 2011, BIOCHEM PHARMACOL, V81, P1422, DOI 10.1016/j.bcp.2011.01.021; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Furukawa S, 2013, AM J TRANSPLANT, V13, P2035, DOI 10.1111/ajt.12328; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guest PC, 2013, GENOME MED, V5, DOI 10.1186/gm421; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Jack RH, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-71; Jacob L., 2009, P 26 ANN INT C MACH, P433; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu GJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-775; Liu ZH, 2012, CELL RES, V22, P1092, DOI 10.1038/cr.2012.42; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; McShane LM, 2013, CLIN TRIALS, V10, P653, DOI 10.1177/1740774513499458; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Oermann EK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21161; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778; Simon N, 2013, J COMPUT GRAPH STAT, V22, P231, DOI 10.1080/10618600.2012.681250; Sokolov A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004790; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tebani A, 2016, INT J MOL SCI, V17; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Weiner 3rd J, 2016, TECHNICAL REPORT; Zarringhalam K, 2014, BIOINFORMATICS, V30, P69, DOI 10.1093/bioinformatics/btu272; Zarringhalam K, 2013, BIOINFORMATICS, V29, P3167, DOI 10.1093/bioinformatics/btt557	48	24	29	0	18	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	DEC 19	2017	18								565	10.1186/s12859-017-1984-2	http://dx.doi.org/10.1186/s12859-017-1984-2			11	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	FR1SH	29258445	gold, Green Published			2024-09-18	WOS:000418847000001
J	Surkov, YI; Serebryakova, IA; Kuzinova, YK; Konopatskova, OM; Safronov, DV; Kapralov, SV; Genina, EA; Tuchin, VV				Surkov, Yuriy I.; Serebryakova, Isabella A.; Kuzinova, Yana K.; Konopatskova, Olga M.; Safronov, Dmitriy V.; Kapralov, Sergey V.; Genina, Elina A.; Tuchin, Valery V.			Multimodal Method for Differentiating Various Clinical Forms of Basal Cell Carcinoma and Benign Neoplasms In Vivo	DIAGNOSTICS			English	Article						basal cell carcinoma; benign neoplasm; diffuse reflectance spectroscopy; optical coherence tomography; high-frequency ultrasound; texture image analysis; multimodal diagnostic method; machine learning	OPTICAL COHERENCE TOMOGRAPHY; HIGH-FREQUENCY ULTRASOUND; DIAGNOSIS; FEATURES; IMAGES	Correct classification of skin lesions is a key step in skin cancer screening, which requires high accuracy and interpretability. This paper proposes a multimodal method for differentiating various clinical forms of basal cell carcinoma and benign neoplasms that includes machine learning. This study was conducted on 37 neoplasms, including benign neoplasms and five different clinical forms of basal cell carcinoma. The proposed multimodal screening method combines diffuse reflectance spectroscopy, optical coherence tomography and high-frequency ultrasound. Using diffuse reflectance spectroscopy, the coefficients of melanin pigmentation, erythema, hemoglobin content, and the slope coefficient of diffuse reflectance spectroscopy in the wavelength range 650-800 nm were determined. Statistical texture analysis of optical coherence tomography images was used to calculate first- and second-order statistical parameters. The analysis of ultrasound images assessed the shape of the tumor according to parameters such as area, perimeter, roundness and other characteristics. Based on the calculated parameters, a machine learning algorithm was developed to differentiate the various clinical forms of basal cell carcinoma. The proposed algorithm for classifying various forms of basal cell carcinoma and benign neoplasms provided a sensitivity of 70.6 +/- 17.3%, specificity of 95.9 +/- 2.5%, precision of 72.6 +/- 14.2%, F1 score of 71.5 +/- 15.6% and mean intersection over union of 57.6 +/- 20.1%. Moreover, for differentiating basal cell carcinoma and benign neoplasms without taking into account the clinical form, the method achieved a sensitivity of 89.1 +/- 8.0%, specificity of 95.1 +/- 0.7%, F1 score of 89.3 +/- 3.4% and mean intersection over union of 82.6 +/- 10.8%.	[Surkov, Yuriy I.; Serebryakova, Isabella A.; Genina, Elina A.; Tuchin, Valery V.] Saratov NG Chernyshevskii State Univ, Inst Phys, Saratov 410012, Russia; [Surkov, Yuriy I.; Serebryakova, Isabella A.; Genina, Elina A.; Tuchin, Valery V.] Tomsk State Univ, Lab Laser Mol Imaging & Machine Learning, Tomsk 634050, Russia; [Surkov, Yuriy I.; Konopatskova, Olga M.; Tuchin, Valery V.] Saratov NG Chernyshevskii State Univ, Lab Biomed Photoacoust, Saratov 410012, Russia; [Kuzinova, Yana K.; Konopatskova, Olga M.; Safronov, Dmitriy V.; Kapralov, Sergey V.] Saratov State Med Univ, Dept Fac Surg & Oncol, Saratov 410012, Russia; [Tuchin, Valery V.] Russian Acad Sci, Inst Precis Mech & Control, FRC Saratov Sci Ctr, Saratov 410028, Russia	Saratov State University; Tomsk State University; Saratov State University; Razumovsky Saratov State Medical University; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Institute of Precision Mechanics & Control of the Russian Academy of Sciences	Surkov, YI; Tuchin, VV (corresponding author), Saratov NG Chernyshevskii State Univ, Inst Phys, Saratov 410012, Russia.; Surkov, YI; Tuchin, VV (corresponding author), Tomsk State Univ, Lab Laser Mol Imaging & Machine Learning, Tomsk 634050, Russia.; Surkov, YI; Tuchin, VV (corresponding author), Saratov NG Chernyshevskii State Univ, Lab Biomed Photoacoust, Saratov 410012, Russia.; Tuchin, VV (corresponding author), Russian Acad Sci, Inst Precis Mech & Control, FRC Saratov Sci Ctr, Saratov 410028, Russia.	surkov9898@gmail.com; s.izabell2014@gmail.com; yan.prokhorova@gmail.com; o.konopatskova@mail.ru; dr.safronof@yandex.ru; sergejkapralov@yandex.ru; eagenina@yandex.ru; tuchinvv@mail.ru	Surkov, Yuriy/AAN-9628-2020; Serebryakova, Isabella/AAN-8377-2020; Genina, Elina/D-4358-2013; Tuchin, Valery/C-7865-2013	Genina, Elina/0000-0002-1223-1100; Serebryakova, Isabella/0000-0001-6285-9222; Tuchin, Valery/0000-0001-7479-2694	Ministry of Science and Higher Education of Russian Federation	Ministry of Science and Higher Education of Russian Federation	No Statement Available	Adabi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17398-8; Baltrusaitis T, 2019, IEEE T PATTERN ANAL, V41, P423, DOI 10.1109/TPAMI.2018.2798607; Barcaui ED, 2014, AN BRAS DERMATOL, V89, P828, DOI 10.1590/abd1806-4841.20143176; Bath-Hextall F, 2014, LANCET ONCOL, V15, P96, DOI 10.1016/S1470-2045(13)70530-8; Bevk M, 2002, COMP MED SY, P239, DOI 10.1109/CBMS.2002.1011383; Borisova E., 2014, Proc. SPIE, V9129, P251; Chahal HS, 2017, J AM ACAD DERMATOL, V76, P353, DOI 10.1016/j.jaad.2016.08.019; Chandra J, 2023, ENVIRON RES, V235, DOI 10.1016/j.envres.2023.116649; Chen CL, 2023, ENVIRON SCI POLLUT R, V30, P71001, DOI 10.1007/s11356-023-27420-4; Cugmas B, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.037003; Davies E.R., 2008, HDB TEXTURE ANAL, P1; de Vries E, 2023, BRIT J DERMATOL, V188, P693, DOI 10.1093/bjd/ljad065; Desai TD, 2007, DERMATOL SURG, V33, P1220, DOI 10.1111/j.1524-4725.2007.33257.x; Dolotov LE, 2003, PROC SPIE, V5067, P139, DOI 10.1117/12.518497; Garcia-Uribe A, 2012, CANCER RES, V72, P2738, DOI 10.1158/0008-5472.CAN-11-4027; Ghanadan A, 2014, INDIAN J DERMATOL, V59, P56, DOI 10.4103/0019-5154.123496; Halip IA, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12030735; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Haws AL, 2012, J AM ACAD DERMATOL, V66, P106, DOI 10.1016/j.jaad.2011.02.042; Hu W, 2022, BMC CANCER, V22, DOI 10.1186/s12885-022-09940-3; James AP, 2014, INFORM FUSION, V19, P4, DOI 10.1016/j.inffus.2013.12.002; Krakowski AC, 2022, J AM ACAD DERMATOL, V86, pS1, DOI 10.1016/j.jaad.2022.03.023; Kranz S, 2023, LASER SURG MED, V55, P257, DOI 10.1002/lsm.23638; Lashway SG, 2023, CANCER EPIDEMIOL, V85, DOI 10.1016/j.canep.2023.102379; Longo C, 2014, J AM ACAD DERMATOL, V71, P716, DOI 10.1016/j.jaad.2014.04.067; Lupu M, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13030422; Marvdashti T, 2016, BIOMED OPT EXPRESS, V7, P3721, DOI 10.1364/BOE.7.003721; Marzuka Alexander G., 2015, Yale Journal of Biology and Medicine, V88, P167; Mostaço-Guidolin LB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02190; Mostaço-Guidolin LB, 2011, PHYS MED BIOL, V56, P5319, DOI 10.1088/0031-9155/56/16/016; Peris K, 2023, EUR J CANCER, V192, DOI 10.1016/j.ejca.2023.113254; Peris K, 2019, EUR J CANCER, V118, P10, DOI 10.1016/j.ejca.2019.06.003; Raupov D S., 2016, Optics in Health Care and Biomedical Optics VII, V10024, P666; Sachdeva S, 2009, INDIAN J DERMATOL VE, V75, P93, DOI 10.4103/0378-6323.45238; Sawyer TW, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaefd2; Shalhout SZ, 2022, CLIN CANCER RES, V28, P2211, DOI 10.1158/1078-0432.CCR-21-2971; Silver F.H., 2019, J DERM RES THER, V5, P8, DOI [10.23937/2469-5750/1510067, DOI 10.23937/2469-5750/1510067]; Silver FH, 2023, CANCERS, V15, DOI 10.3390/cancers15010156; Sundararajan M., 2020, PMLR, P9269; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Ulrich M, 2015, BRIT J DERMATOL, V173, P428, DOI 10.1111/bjd.13853; Urban K, 2021, JAAD INT, V2, P98, DOI 10.1016/j.jdin.2020.10.013; Wang SQ, 2019, CHINESE MED J-PEKING, V132, P2021, DOI 10.1097/CM9.0000000000000369; Wang ST, 2022, IEEE T CYBERNETICS, V52, P12623, DOI 10.1109/TCYB.2021.3069920; wma, WMA declaration of Helsinki-Ethical principles for medical research involving human subjects; Yang DD, 2023, BRIT J DERMATOL, V188, P237, DOI 10.1093/bjd/ljac064; Yang Y, 2011, BIOMED OPT EXPRESS, V2, P2551, DOI 10.1364/BOE.2.002551; Yin JC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3589097; Yücel D, 2016, SKIN RES TECHNOL, V22, P497, DOI 10.1111/srt.12291; Zhang Y, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201900154; Zyuryukina OA, 2019, OPT SPECTROSC+, V127, P555, DOI 10.1134/S0030400X19090297	51	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	JAN	2024	14	2							202	10.3390/diagnostics14020202	http://dx.doi.org/10.3390/diagnostics14020202			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8E7	38248078	gold			2024-09-18	WOS:001148973900001
J	Bian, C; Wang, XB; Su, YC; Wang, YH; Wong, KC; Li, XT				Bian, Chuang; Wang, Xubin; Su, Yanchi; Wang, Yunhe; Wong, Ka-chun; Li, Xiangtao			scEFSC: Accurate single-cell RNA-seq data analysis via ensemble consensus clustering based on multiple feature selections	COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL			English	Article						scEFSC; scRNA-seq; Feature selection; Consensus clustering	CLASS-I; CANCER; TRANSCRIPTOMICS	With the development of next-generation sequencing technologies, single-cell RNA sequencing (scRNAseq) has become one indispensable tool to reveal the wide heterogeneity between cells. Clustering is a fundamental task in this analysis to disclose the transcriptomic profiles of single cells and is one of the key computational problems that has received widespread attention. Recently, many clustering algorithms have been developed for the scRNA-seq data. Nevertheless, the computational models often suffer from realistic restrictions such as numerical instability, high dimensionality and computational scalability. Moreover, the accumulating cell numbers and high dropout rates bring a huge computational challenge to the analysis. To address these limitations, we first provide a systematic and extensive performance evaluation of four feature selection methods and nine scRNA-seq clustering algorithms on fourteen real single-cell RNA-seq datasets. Based on this, we then propose an accurate single-cell data analysis via Ensemble Feature Selection based Clustering, called scEFSC. Indeed, the algorithm employs several unsupervised feature selections to remove genes that do not contribute significantly to the scRNA-seq data. After that, different single-cell RNA-seq clustering algorithms are proposed to cluster the data filtered by multiple unsupervised feature selections, and then the clustering results are combined using weighted-based meta-clustering. We applied scEFSC to the fourteen real single-cell RNAseq datasets and the experimental results demonstrated that our proposed scEFSC outperformed the other scRNA-seq clustering algorithms with several evaluation metrics. In addition, we established the biological interpretability of scEFSC by carrying out differential gene expression analysis, gene ontology enrichment and KEGG analysis. scEFSC is available at https://github.com/Conan-Bian/scEFSC. (c) 2022 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Bian, Chuang; Wang, Xubin; Su, Yanchi; Li, Xiangtao] Jilin Univ, Sch Artificial Intelligence, Changchun 130000, Jilin, Peoples R China; [Wang, Yunhe] Hebei Univ Technol, Sch Artificial Intelligence, Tianjin 300401, Peoples R China; [Wong, Ka-chun] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Peoples R China	Jilin University; Hebei University of Technology; City University of Hong Kong	Li, XT (corresponding author), Jilin Univ, Sch Artificial Intelligence, Changchun 130000, Jilin, Peoples R China.; Wang, YH (corresponding author), Hebei Univ Technol, Sch Artificial Intelligence, Tianjin 300401, Peoples R China.	conanbian486@gmail.com; wangxb19@mails.jlu.edu.cn; suyanchi@gmail.com; wangyh082@hebut.edu.cn; kc.w@cityu.edu.hk; lixt314@jlu.edu.cn	XIN, WANG/KGK-5385-2024; tong, li/KDO-7821-2024; Wong, Ka-Chun/L-7160-2019; Wang, Xubin/LDG-1201-2024	Wang, Xubin/0000-0001-6217-1305	National Natural Science Foundation of China [62076109, 32000464]; Fundamental Research Funds for the Central Universities; Research Grants Council of the Hong Kong Special Administrative Region [CityU] [11200218]; Health and Medical Research Fund, of the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region [07181426]; Hong Kong Institute for Data Science (HKIDS) at the City University of Hong Kong; City University of Hong Kong [CityU 11202219, CityU 11203520]; Shenzhen Research Institute, City University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Grants Council of the Hong Kong Special Administrative Region [CityU]; Health and Medical Research Fund, of the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; Hong Kong Institute for Data Science (HKIDS) at the City University of Hong Kong; City University of Hong Kong(City University of Hong Kong); Shenzhen Research Institute, City University of Hong Kong(City University of Hong Kong)	The work described in this paper was substantially supported by the National Natural Science Foundation of China under Grant No. 62076109, and also funded by "the Fundamental Research Funds for the Central Universities". The work described in this paper was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region [CityU 11200218], a grant from the Health and Medical Research Fund, of the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region [07181426], and the funding from the Hong Kong Institute for Data Science (HKIDS) at the City University of Hong Kong. The work described in this paper was partially supported by two grants from the City University of Hong Kong (CityU 11202219, CityU 11203520). This research was substantially sponsored by a research project (Grant No. 32000464) from the National Natural Science Foundation of China and was substantially supported by the Shenzhen Research Institute, City University of Hong Kong.	Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cai C., 2010, P 16 ACM SIGKDD INT, P333, DOI [10.1145/1835804.1835848, DOI 10.1145/1835804.1835848]; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Geddes TA, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3179-5; Grün D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guo MZ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004575; Hadjitodorov ST, 2006, INFORM FUSION, V7, P264, DOI 10.1016/j.inffus.2005.01.008; He X., 2006, P ADV NEURAL INFORM, P507; Hedlund E, 2018, MOL ASPECTS MED, V59, P36, DOI 10.1016/j.mam.2017.07.003; Huh R, 2020, NUCLEIC ACIDS RES, V48, P86, DOI 10.1093/nar/gkz959; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Li JD, 2018, ACM COMPUT SURV, V50, DOI 10.1145/3136625; Li XT, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab368; Li XT, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab090; Li XT, 2020, IEEE ACM T COMPUT BI, V17, P1773, DOI 10.1109/TCBB.2019.2906601; Li Xiangtao, 2020, IEEEACM T COMPUTATIO, V18, P2445; Lin PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1188-0; Marty R, 2018, CELL, V175, P416, DOI 10.1016/j.cell.2018.08.048; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Risso D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006378; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Segerstolpe Å, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Silipo R., 2014, 7 TECHNIQUES DIMENSI, P1; Slyper M., STUDY ICA BLOOD MONO; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tran D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21312-2; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; von Hertzen LC, 2011, CANCER METAST REV, V30, P211, DOI 10.1007/s10555-011-9284-1; Wan S, 2020, GENOME RES, V30, P205, DOI 10.1101/gr.254557.119; Wang YJ, 2016, DIABETES, V65, P3028, DOI 10.2337/db16-0405; Wang YH, 2022, IEEE T SYST MAN CY-S, V52, P5016, DOI 10.1109/TSMC.2021.3112049; Xin YR, 2016, CELL METAB, V24, P608, DOI 10.1016/j.cmet.2016.08.018; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang YC, 2019, BIOINFORMATICS, V35, P1269, DOI 10.1093/bioinformatics/bty793; Yu ZH, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab125; Zeestraten ECM, 2014, BRIT J CANCER, V110, P459, DOI 10.1038/bjc.2013.696; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhao Z., 2007, P 24 INT C MACHINE L, V227, P1151, DOI 10.1145/1273496.1273641; Zhu XS, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.604790; Zurauskiene J, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0984-y	48	10	10	4	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2001-0370			COMPUT STRUCT BIOTEC	Comp. Struct. Biotechnol. J..		2022	20						2181	2197		10.1016/j.csbj.2022.04.023	http://dx.doi.org/10.1016/j.csbj.2022.04.023			17	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	7N9UE	35615016	Green Published, gold			2024-09-18	WOS:000907679700001
J	Hu, LS; Wang, LJ; Hawkins-Daarud, A; Eschbacher, JM; Singleton, KW; Jackson, PR; Clark-Swanson, K; Sereduk, CP; Peng, S; Wang, PW; Wang, JW; Baxter, LC; Smith, KA; Mazza, GL; Stokes, AM; Bendok, BR; Zimmerman, RS; Krishna, C; Porter, AB; Mrugala, MM; Hoxworth, JM; Wu, T; Tran, NL; Swanson, KR; Li, J				Hu, Leland S.; Wang, Lujia; Hawkins-Daarud, Andrea; Eschbacher, Jennifer M.; Singleton, Kyle W.; Jackson, Pamela R.; Clark-Swanson, Kamala; Sereduk, Christopher P.; Peng, Sen; Wang, Panwen; Wang, Junwen; Baxter, Leslie C.; Smith, Kris A.; Mazza, Gina L.; Stokes, Ashley M.; Bendok, Bernard R.; Zimmerman, Richard S.; Krishna, Chandan; Porter, Alyx B.; Mrugala, Maciej M.; Hoxworth, Joseph M.; Wu, Teresa; Tran, Nhan L.; Swanson, Kristin R.; Li, Jing			Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma	SCIENTIFIC REPORTS			English	Article							CEREBRAL BLOOD-VOLUME; PERFUSION MRI; HETEROGENEITY; EXPRESSION; MULTIFORME; PREDICTION; DIFFUSION; FEATURES; INTERVAL; GENOME	Radiogenomics uses machine-learning (ML) to directly connect the morphologic and physiological appearance of tumors on clinical imaging with underlying genomic features. Despite extensive growth in the area of radiogenomics across many cancers, and its potential role in advancing clinical decision making, no published studies have directly addressed uncertainty in these model predictions. We developed a radiogenomics ML model to quantify uncertainty using transductive Gaussian Processes (GP) and a unique dataset of 95 image-localized biopsies with spatially matched MRI from 25 untreated Glioblastoma (GBM) patients. The model generated predictions for regional EGFR amplification status (a common and important target in GBM) to resolve the intratumoral genetic heterogeneity across each individual tumor-a key factor for future personalized therapeutic paradigms. The model used probability distributions for each sample prediction to quantify uncertainty, and used transductive learning to reduce the overall uncertainty. We compared predictive accuracy and uncertainty of the transductive learning GP model against a standard GP model using leave-one-patient-out cross validation. Additionally, we used a separate dataset containing 24 image-localized biopsies from 7 high-grade glioma patients to validate the model. Predictive uncertainty informed the likelihood of achieving an accurate sample prediction. When stratifying predictions based on uncertainty, we observed substantially higher performance in the group cohort (75% accuracy, n=95) and amongst sample predictions with the lowest uncertainty (83% accuracy, n=72) compared to predictions with higher uncertainty (48% accuracy, n=23), due largely to data interpolation (rather than extrapolation). On the separate validation set, our model achieved 78% accuracy amongst the sample predictions with lowest uncertainty. We present a novel approach to quantify radiogenomics uncertainty to enhance model performance and clinical interpretability. This should help integrate more reliable radiogenomics models for improved medical decision-making.	[Hu, Leland S.; Wang, Lujia; Hoxworth, Joseph M.; Wu, Teresa; Li, Jing] Mayo Clin Arizona, Dept Radiol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA; [Hu, Leland S.; Wang, Lujia; Wu, Teresa; Li, Jing] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, 699 S Mill Ave, Tempe, AZ 85281 USA; [Hu, Leland S.; Wang, Lujia; Hawkins-Daarud, Andrea; Singleton, Kyle W.; Jackson, Pamela R.; Clark-Swanson, Kamala; Swanson, Kristin R.; Li, Jing] Mayo Clin Arizona, Math NeuroOncol Lab, Precis Neurotherapeut Innovat Program, 5777 East Mayo Blvd,Support Serv Bldg Suite 2-700, Phoenix, AZ 85054 USA; [Eschbacher, Jennifer M.] St Josephs Hosp, Dept Pathol, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Baxter, Leslie C.] Mayo Clin Arizona, Dept Neuropsychol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA; [Smith, Kris A.] St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Mazza, Gina L.] Mayo Clin Arizona, Dept Quantitat Hlth Sci, Scottsdale, AZ 85259 USA; [Stokes, Ashley M.] St Josephs Hosp, Dept Imaging Res, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Sereduk, Christopher P.; Bendok, Bernard R.; Zimmerman, Richard S.; Krishna, Chandan; Tran, Nhan L.; Swanson, Kristin R.] Mayo Clin Arizona, Dept Neurosurg, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA; [Porter, Alyx B.; Mrugala, Maciej M.] Mayo Clin Arizona, Dept Neurooncol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA; [Sereduk, Christopher P.] Mayo Clin Arizona, Dept Canc Biol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA; [Peng, Sen] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ 85004 USA; [Wang, Panwen; Wang, Junwen] Mayo Clin Arizona, Dept Quantitat Hlth Sci, Ctr Individualized Med, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Mayo Clinic; Mayo Clinic Phoenix; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Mayo Clinic; Mayo Clinic Phoenix; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix	Hu, LS (corresponding author), Mayo Clin Arizona, Dept Radiol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.; Hu, LS (corresponding author), Arizona State Univ, Sch Comp Informat & Decis Syst Engn, 699 S Mill Ave, Tempe, AZ 85281 USA.; Hu, LS (corresponding author), Mayo Clin Arizona, Math NeuroOncol Lab, Precis Neurotherapeut Innovat Program, 5777 East Mayo Blvd,Support Serv Bldg Suite 2-700, Phoenix, AZ 85054 USA.	hu.leland@mayo.edu	Stokes, Ashley/AAE-5546-2022; Wang, Lujia/ACO-4039-2022; Swanson, Kristin/D-7599-2011; Wang, Junwen/D-3700-2011	Baxter, Leslie/0000-0002-3971-863X; Swanson, Kristin/0000-0002-2464-6119; Wang, Junwen/0000-0002-4432-4707; Wang, Lujia/0000-0002-0475-004X	Mayo Clinic Foundation; James S. McDonnell Foundation; Ivy Foundation; Arizona Biomedical Research Commission;  [NS082609];  [CA221938];  [CA220378];  [NSF-1149602]; National Cancer Institute [U01CA220378] Funding Source: NIH RePORTER	Mayo Clinic Foundation; James S. McDonnell Foundation; Ivy Foundation; Arizona Biomedical Research Commission; ; ; ; ; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NS082609, CA221938, CA220378, NSF-1149602, Mayo Clinic Foundation, James S. McDonnell Foundation, Ivy Foundation, Arizona Biomedical Research Commission.	Aghi M, 2005, CLIN CANCER RES, V11, P8600, DOI 10.1158/1078-0432.CCR-05-0713; [Anonymous], 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0036; [Anonymous], 2020, Radiology; Bai RY, 2011, TRENDS MOL MED, V17, P301, DOI 10.1016/j.molmed.2011.01.011; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Barajas RF, 2010, RADIOLOGY, V254, P564, DOI 10.1148/radiol.09090663; Beck D., 2016, EXPLORING PREDICTION; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Dreyer KJ, 2017, RADIOLOGY, V285, P713, DOI 10.1148/radiol.2017171183; Ene CI, 2011, CANCER CELL, V20, P695, DOI 10.1016/j.ccr.2011.11.018; Furgason JM, 2014, MUTAGENESIS, V29, P341, DOI 10.1093/mutage/geu026; Gupta A, 2015, CLIN NEURORADIOL, V25, P143, DOI 10.1007/s00062-014-0289-3; Gutman DA, 2013, RADIOLOGY, V267, P560, DOI 10.1148/radiol.13120118; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hosny A, 2018, NAT REV CANCER, V18, P500, DOI 10.1038/s41568-018-0016-5; Hu LS, 2015, AM J NEURORADIOL, V36, P2242, DOI 10.3174/ajnr.A4451; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Hu LS, 2017, NEURO-ONCOLOGY, V19, P128, DOI 10.1093/neuonc/now135; Hu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141506; Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112; Itakura H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7582; Jain R, 2014, RADIOLOGY, V272, P484, DOI 10.1148/radiol.14131691; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kutner M. H., 2005, APPL LINEAR STAT MOD; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Montgomery DC, 2012, GEOFFREYVINING G INT; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Peng S, 2017, NEURO-ONCOLOGY, V19, P833, DOI 10.1093/neuonc/now269; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Prakash VJ, 2014, SURVEY SEMISUPERVISE; Price SJ, 2006, AM J NEURORADIOL, V27, P1969; Quiñonero-Candela J, 2006, LECT NOTES ARTIF INT, V3944, P1; Ramakrishnan AG, 2002, NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS, P365, DOI 10.1109/NNSP.2002.1030048; Ryoo I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071704; Semmineh NB, 2015, MAGN RESON MED, V74, P772, DOI 10.1002/mrm.25435; Shrestha DL, 2006, NEURAL NETWORKS, V19, P225, DOI 10.1016/j.neunet.2006.01.012; Solomatine DP, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006839; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stadlbauer A, 2006, RADIOLOGY, V240, P803, DOI 10.1148/radiol.2403050937; Tykocinski ES, 2012, NEURO-ONCOLOGY, V14, P613, DOI 10.1093/neuonc/nos073; Wang SY, 2014, 2014 INTERNATIONAL CONFERENCE ON AUTOMATIC CONTROL THEORY AND APPLICATION, P1; Wineinger Nathan E., 2008, International Journal of Computational Biology and Drug Design, V1, P368, DOI 10.1504/IJCBDD.2008.022208; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954	52	13	15	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	FEB 16	2021	11	1							3932	10.1038/s41598-021-83141-z	http://dx.doi.org/10.1038/s41598-021-83141-z			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT6VP	33594116	Green Published, gold			2024-09-18	WOS:000626728100026
J	Wang, Y; Zhang, MH; Sang, L; Li, ZY; Wang, XM; Yang, ZY; Yu, ZJ; Wang, ZQ; Sang, L				Wang, Yan; Zhang, Minghui; Sang, Li; Li, Ziyi; Wang, Xuemei; Yang, Ziyi; Yu, Zijun; Wang, Zhongqing; Sang, Liang			Bibliometric and visualized analysis of reporting and data systems from 2000 to 2022: research situation, global trends, and hotspots	QUANTITATIVE IMAGING IN MEDICINE AND SURGERY			English	Article						Bibliometrics; visualized analysis; reporting and data system (RADS); Web of Science (WOS); VOSviewer	BREAST-CANCER; ULTRASOUND; ULTRASONOGRAPHY; CHALLENGES; MRI	Background: The reporting and data system (RADS) has been researched across the world since it was first developed. This study used bibliometrics to analyze the research trends and current status of this field over the past almost 23 years and explored possible future research hotspots. Methods: We searched the Web of Science (WOS) literature on RADSs from January 1, 2000, to November 1, 2022, and evaluated the findings visually with VOSviewer (1.6.18), CiteSpace (6.1.3), and the "bibliometrix" package in R version 4.2.1. Results: We included 6,239 publications from 88 countries and regions. The number of published has shown an overall growth trend, especially since 2016. The United States was the country with the highest number of publications and citations. The top 10 most productive institutions in RADS research were mainly from South Korea and the United States. Kim EK was the most published author, and Turkbey B had the most cited publication. European Radiology had the most publications on the subject, while Radiology was the most influential journal. Magnetic resonance imaging, carcinoma, ultrasound, RADS, mammography, breast neoplasms , and diagnosis were the most common keywords. Artificial intelligence (AI) appears to be an emerging hotspot in the research of RADS. Conclusions: This study provides an overview of the development status of research into RADSs over the past 23 years. Research into RADSs has included various systems of the body, with the most studied being the breast, prostate, liver, and thyroid. In terms of auxiliary diagnosis, there is an increasing amount of research into the application of AI in RADSs, which along with the interpretability of AI, will be a hotspot of research in the following years.	[Wang, Yan; Zhang, Minghui; Li, Ziyi; Wang, Xuemei; Yang, Ziyi; Yu, Zijun; Sang, Liang] China Med Univ, Affiliated Hosp 1, Dept Ultrasonog, 155 Nanjing North St, Shenyang 110000, Peoples R China; [Sang, Li] Shouguang Hosp Tradit Chinese Med, Dept Acupuncture & Massage, Shouguang, Peoples R China; [Wang, Zhongqing] China Med Univ, Affiliated Hosp 1, Dept Informat Ctr, 155 Nanjing North St, Shenyang 110000, Peoples R China	China Medical University; China Medical University	Sang, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Ultrasonog, 155 Nanjing North St, Shenyang 110000, Peoples R China.; Wang, ZQ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Informat Ctr, 155 Nanjing North St, Shenyang 110000, Peoples R China.	wangzhongqing@cmu.edu.cn; 13889167622@163.com	wang, xu/IAN-4886-2023; Zhang, Minghui/M-1873-2015; sang, liang/AAY-4073-2020; yang, ziyi/JGD-5349-2023		Liaoning Natural Science Foundation [2022-YGJC-52]	Liaoning Natural Science Foundation(Natural Science Foundation of Liaoning Province)	Funding: This study was supported by the Liaoning Natural Science Foundation (No. 2022-YGJC-52) .	Andreotti RF, 2020, RADIOLOGY, V294, P168, DOI 10.1148/radiol.2019191150; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Bi WL, 2019, CA-CANCER J CLIN, V69, P127, DOI 10.3322/caac.21552; Buda M, 2019, RADIOLOGY, V292, P695, DOI 10.1148/radiol.2019181343; Chernyak V, 2018, RADIOLOGY, V289, P816, DOI 10.1148/radiol.2018181494; Currie G, 2020, SEMIN NUCL MED, V51, P102, DOI 10.1053/j.semnuclmed.2020.08.002; Eghtedari M, 2021, AM J ROENTGENOL, V216, P860, DOI 10.2214/AJR.20.24894; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Gupta RT, 2020, J MAGN RESON IMAGING, V52, P33, DOI 10.1002/jmri.26896; Ha EJ, 2021, KOREAN J RADIOL, V22, P1569, DOI 10.3348/kjr.2021.0106; Ha EJ, 2017, THYROID, V27, P1463, DOI 10.1089/thy.2016.0654; Hoang JK, 2021, AM J ROENTGENOL, V216, P570, DOI 10.2214/AJR.20.24608; Hoeks CMA, 2011, RADIOLOGY, V261, P46, DOI 10.1148/radiol.11091822; Jiang YL, 2021, RADIOLOGY, V298, P38, DOI 10.1148/radiol.2020200292; Joe BN, 2014, RADIOLOGY, V273, pS23, DOI 10.1148/radiol.14141233; Jungmann F, 2023, EUR RADIOL, V33, P1844, DOI 10.1007/s00330-022-09165-9; Kapetas P, 2019, INVEST RADIOL, V54, P257, DOI 10.1097/RLI.0000000000000543; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Kim DH, 2023, AM J ROENTGENOL, V220, P791, DOI 10.2214/AJR.22.28556; Kim PH, 2020, THYROID, V30, P1159, DOI 10.1089/thy.2019.0812; Kim YY, 2019, EUR RADIOL, V29, P1124, DOI 10.1007/s00330-018-5641-6; Laino ME, 2022, EUR J RADIOL, V150, DOI 10.1016/j.ejrad.2022.110251; Lee SH, 2014, ULTRASONOGRAPHY, V33, P3, DOI 10.14366/usg.13012; Li W, 2019, EUR J RADIOL, V114, P111, DOI 10.1016/j.ejrad.2019.03.016; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Panebianco V, 2018, EUR UROL, V74, P294, DOI 10.1016/j.eururo.2018.04.029; Park AY, 2019, KOREAN J RADIOL, V20, P759, DOI 10.3348/kjr.2018.0515; Purysko AS, 2016, RADIOGRAPHICS, V36, P1354, DOI 10.1148/rg.2016150234; Quaia E, 2019, RADIOLOGY, V293, P4, DOI 10.1148/radiol.2019190005; Rago T, 2014, BEST PRACT RES CL EN, V28, P519, DOI 10.1016/j.beem.2014.02.003; REMINGTON PL, 1992, CA-CANCER J CLIN, V42, P367, DOI 10.3322/canjclin.42.6.367; Robbins HA, 2019, J THORAC ONCOL, V14, P1662, DOI 10.1016/j.jtho.2019.05.012; Rodriguez-Ruiz A, 2019, RADIOLOGY, V290, P305, DOI 10.1148/radiol.2018181371; Rouviere O, 2019, LANCET ONCOL, V20, P100, DOI 10.1016/S1470-2045(18)30569-2; Ruan JL, 2022, RADIOLOGY, V305, P149, DOI 10.1148/radiol.212319; Rud E, 2016, EUR UROL, V70, pE136, DOI 10.1016/j.eururo.2016.04.017; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Spak DA, 2017, DIAGN INTERV IMAG, V98, P179, DOI 10.1016/j.diii.2017.01.001; Suarez-Ibarrola R, 2022, EUR UROL FOCUS, V8, P409, DOI 10.1016/j.euf.2021.03.020; Terzi E, 2022, SEMIN LIVER DIS, V42, P104, DOI 10.1055/s-0041-1732356; Tessler FN, 2018, RADIOLOGY, V287, P1082, DOI 10.1148/radiol.2018184008; Tessler FN, 2017, J AM COLL RADIOL, V14, P587, DOI 10.1016/j.jacr.2017.01.046; Thomassin-Naggara I, 2014, DIAGN INTERV IMAG, V95, P759, DOI 10.1016/j.diii.2014.06.006; Thompson DF, 2015, PHARMACOTHERAPY, V35, P551, DOI 10.1002/phar.1586; Turkbey B, 2023, RADIOLOGY, V307, DOI 10.1148/radiol.223128; Turkbey B, 2019, EUR UROL, V76, P340, DOI 10.1016/j.eururo.2019.02.033; van der Pol CB, 2019, GASTROENTEROLOGY, V156, P976, DOI 10.1053/j.gastro.2018.11.020; van der Velden BHM, 2022, MED IMAGE ANAL, V79, DOI 10.1016/j.media.2022.102470; van der Zwaard S, 2020, J APPL PHYSIOL, V129, P967, DOI 10.1152/japplphysiol.00489.2020; Wildman-Tobriner B, 2022, AM J ROENTGENOL, V219, P547, DOI 10.2214/AJR.22.27430; Youk JH, 2017, ULTRASONOGRAPHY, V36, P300, DOI 10.14366/usg.17024	52	0	0	1	1	AME PUBLISHING COMPANY	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2223-4292	2223-4306		QUANT IMAG MED SURG	Quant. Imaging Med. Surg.	MAR	2024	14	3					2280	2295		10.21037/qims-23-1283	http://dx.doi.org/10.21037/qims-23-1283			16	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	RG3L9		gold, Green Published			2024-09-18	WOS:001226474100012
J	Liang, MY; Jiang, X; Cao, J; Zhang, SP; Liu, HS; Li, B; Wang, L; Zhang, CL; Jia, XJ				Liang, Meiyan; Jiang, Xing; Cao, Jie; Zhang, Shupeng; Liu, Haishun; Li, Bo; Wang, Lin; Zhang, Cunlin; Jia, Xiaojun			HSG-MGAF Net: Heterogeneous subgraph-guided multiscale graph attention fusion network for interpretable prediction of whole-slide image	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Heterogeneous subgraph; Multiscale; Whole slide image; Interpretability; Graph; Hypergraph	CANCER	Background and objective: Pathological whole slide image (WSI) prediction and region of interest (ROI) localization are important issues in computer-aided diagnosis and postoperative analysis in clinical applications. Existing computer-aided methods for predicting WSI are mainly based on multiple instance learning (MIL) and its variants. However, most of the methods are based on instance independence and identical distribution assumption and performed at a single scale, which not fully exploit the hierarchical multiscale heterogeneous information contained in WSI. Methods: Heterogeneous Subgraph-Guided Multiscale Graph Attention Fusion Network (HSG-MGAF Net) is proposed to build the topology of critical image patches at two scales for adaptive WSI prediction and lesion localization. The HSG-MGAF Net simulates the hierarchical heterogeneous information of WSI through graph and hypergraph at two scales, respectively. This framework not only fully exploits the low-order and potential high-order correlations of image patches at each scale, but also leverages the heterogeneous information of the two scales for adaptive WSI prediction. Results: We validate the superiority of the proposed method on the CAMELYON16 and the TCGA- NSCLC, and the results show that HSG-MGAF Net outperforms the state-of-the-art method on both datasets. The average ACC, AUC and F1 score of HSG-MGAF Net can reach 92.7 %/0.951/0.892 and 92.2 %/0.957/0.919, respectively. The obtained heatmaps can also localize the positive regions more accurately, which have great consistency with the pixel-level labels. Conclusions: The results demonstrate that HSG-MGAF Net outperforms existing weakly supervised learning methods by introducing critical heterogeneous information between the two scales. This approach paves the way for further research on light weighted heterogeneous graph-based WSI prediction and ROI localization.	[Liang, Meiyan; Jiang, Xing; Zhang, Shupeng; Jia, Xiaojun] Shanxi Univ, Sch Phys & Elect Engn, Taiyuan 030006, Peoples R China; [Cao, Jie] Beijing Inst Technol, Sch Opt & Photon, Beijing 100081, Peoples R China; [Liu, Haishun] Tsinghua Univ, Dept Automat, BNRIST, Beijing 100084, Peoples R China; [Li, Bo] Shanxi Rongjun Hosp, Dept Rehabil Treatment, Taiyuan 030000, Peoples R China; [Wang, Lin] Shanxi Med Univ, Shanxi Bethune Hosp,Hosp 3, Tongji Shanxi Hosp,Dept Pathol, Shanxi Acad Med Sci, Taiyuan 030032, Peoples R China; [Zhang, Cunlin] Capital Normal Univ, Dept Phys, Beijing 100048, Peoples R China	Shanxi University; Beijing Institute of Technology; Tsinghua University; Shanxi Medical University; Capital Normal University	Liang, MY (corresponding author), Shanxi Univ, Sch Phys & Elect Engn, Taiyuan 030006, Peoples R China.; Cao, J (corresponding author), Beijing Inst Technol, Sch Opt & Photon, Beijing 100081, Peoples R China.	meiyanliang@sxu.edu.cn; caojie@bit.edu.cn	Liang, Meiyan/HPH-6710-2023; Jia, Xiaojun/IUM-2172-2023		National Natural Science Foun- dation of China [11804209]; Shanxi Scholarship Council of China [2023-010]; Natural Science Foundation of Shanxi Province [202303021211014, 20210302123411, 202203021222015]; China Postdoctoral Science Foundation [2023M742577]	National Natural Science Foun- dation of China(National Natural Science Foundation of China (NSFC)); Shanxi Scholarship Council of China; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported in part by National Natural Science Foun- dation of China under Grant 11804209, Research Project Supported by Shanxi Scholarship Council of China No. 2023-010, Natural Science Foundation of Shanxi Province under Grant 202303021211014, 20210302123411 and 202203021222015, China Postdoctoral Science Foundation 2023M742577.	Abels E, 2019, J PATHOL, V249, P286, DOI 10.1002/path.5331; Bai S, 2021, PATTERN RECOGN, V110, DOI 10.1016/j.patcog.2020.107637; Bándi P, 2019, IEEE T MED IMAGING, V38, P550, DOI 10.1109/TMI.2018.2867350; Cai Hongmin, 2022, 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P922, DOI 10.1109/BIBM55620.2022.9995017; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Chen JA, 2021, LECT NOTES COMPUT SC, V12905, P752, DOI 10.1007/978-3-030-87240-3_72; Chen RJ, 2021, LECT NOTES COMPUT SC, V12908, P339, DOI 10.1007/978-3-030-87237-3_33; Das K, 2020, IEEE ACCESS, V8, P213502, DOI 10.1109/ACCESS.2020.3040106; De A, 2022, INT C PATT RECOG, P4420, DOI 10.1109/ICPR56361.2022.9956229; Dehaene O, 2020, Arxiv, DOI [arXiv:2012.03583, DOI 10.48550/ARXIV.2012.03583]; Deng SJ, 2020, FRONT MED-PRC, V14, P470, DOI 10.1007/s11684-020-0782-9; Duran-Lopez L, 2020, IEEE ACCESS, V8, P128613, DOI 10.1109/ACCESS.2020.3008868; Echle A, 2021, BRIT J CANCER, V124, P686, DOI 10.1038/s41416-020-01122-x; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hanna MG, 2020, ADV ANAT PATHOL, V27, P251, DOI 10.1097/PAP.0000000000000273; Hashimoto N, 2020, PROC CVPR IEEE, P3851, DOI 10.1109/CVPR42600.2020.00391; He L, 2012, COMPUT METH PROG BIO, V107, P538, DOI 10.1016/j.cmpb.2011.12.007; Hou WT, 2022, AAAI CONF ARTIF INTE, P933; Huang ZW, 2021, LECT NOTES COMPUT SC, V12908, P561, DOI 10.1007/978-3-030-87237-3_54; Ilse M, 2018, PR MACH LEARN RES, V80; Jaume G, 2021, PROC CVPR IEEE, P8102, DOI 10.1109/CVPR46437.2021.00801; Li B, 2021, PROC CVPR IEEE, P14313, DOI 10.1109/CVPR46437.2021.01409; Li RY, 2018, LECT NOTES COMPUT SC, V11071, P174, DOI 10.1007/978-3-030-00934-2_20; Li WJ, 2019, LECT NOTES COMPUT SC, V11764, P532, DOI 10.1007/978-3-030-32239-7_59; Liang MY, 2023, COMPUT METH PROG BIO, V229, DOI 10.1016/j.cmpb.2022.107268; Liu L, 2023, J RADIAT RES APPL SC, V16, DOI 10.1016/j.jrras.2023.100555; Liu P, 2023, COMPUT METH PROG BIO, V231, DOI 10.1016/j.cmpb.2023.107433; Lu MY, 2021, NAT BIOMED ENG, V5, P555, DOI 10.1038/s41551-020-00682-w; Lu WQ, 2020, IEEE COMPUT SOC CONF, P1049, DOI 10.1109/CVPRW50498.2020.00138; Maksoud S, 2020, PROC CVPR IEEE, P3861, DOI 10.1109/CVPR42600.2020.00392; Nair A, 2022, BMC BIOINFORMATICS, V23, DOI 10.1186/s12859-022-05063-5; Rong Y, 2020, Arxiv, DOI [arXiv:1907.10903, DOI 10.48550/ARXIV.1907.10903]; Shao ZC, 2021, ADV NEUR IN; Sheikh Taimoor Shakeel, 2022, 2022 IEEE 5th International Conference on Knowledge Innovation and Invention (ICKII ), P30, DOI 10.1109/ICKII55100.2022.9983555; Su ZY, 2023, Arxiv, DOI arXiv:2301.07700; Sureka M, 2020, IEEE INT C BIOINF BI, P331, DOI 10.1109/BIBE50027.2020.00060; Thandiackal K, 2022, LECT NOTES COMPUT SC, V13681, P699, DOI 10.1007/978-3-031-19803-8_41; Tizhoosh Hamid Reza, 2018, J Pathol Inform, V9, P38, DOI 10.4103/jpi.jpi_53_18; Tokunaga H, 2019, PROC CVPR IEEE, P12589, DOI 10.1109/CVPR.2019.01288; Vorndran J, 2023, NEURAL COMPUT APPL, V35, P12775, DOI 10.1007/s00521-023-08364-9; Wang X., 2022, P MEDICAL IMAGING DE; Wang X, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P2022, DOI 10.1145/3308558.3313562; Wang XL, 2019, INT CONF MEASURE, P1, DOI [10.1109/ICMIC48233.2019.9068567, 10.1109/TCYB.2019.2935141]; Xia X, 2021, AAAI CONF ARTIF INTE, V35, P4503; Xiang JX, 2023, COMPUT BIOL MED, V152, DOI 10.1016/j.compbiomed.2022.106340; Zhang HR, 2022, PROC CVPR IEEE, P18780, DOI 10.1109/CVPR52688.2022.01824; Zheng Yi, 2022, IEEE Trans Med Imaging, V41, P3003, DOI 10.1109/TMI.2022.3176598	47	0	0	6	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	APR	2024	247								108099	10.1016/j.cmpb.2024.108099	http://dx.doi.org/10.1016/j.cmpb.2024.108099		MAR 2024	13	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	OS3Q6	38442623				2024-09-18	WOS:001209230600001
J	Zhao, FJ; Dong, DD; Du, HY; Guo, YA; Su, X; Wang, ZW; Xie, XY; Wang, MJ; Zhang, HY; Cao, X; He, XW				Zhao, Fengjun; Dong, Didi; Du, Hongyan; Guo, Yinan; Su, Xue; Wang, Zhiwei; Xie, Xiaoyang; Wang, Mingjuan; Zhang, Haiyan; Cao, Xin; He, Xiaowei			Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Endometrial hyperplasia; Endometrial intraepithelial neoplasia; Computer-aided-diagnosis; Convolutional neural network; Histopathological image	LIQUID-BASED CYTOLOGY; NUCLEAR MORPHOMETRY; BETA-CATENIN; EXPRESSION; CLASSIFICATION; CARCINOMA; TEXTURE; CANCER; PTEN; DISCRIMINATION	Background and objective: Endometrial hyperplasia (EH), a uterine pathology characterized by an increased gland-to-stroma ratio compared to normal endometrium (NE), may precede the development of endometrial cancer (EC). Particularly, atypical EH also known as endometrial intraepithelial neoplasia (EIN), has been proven to be a precursor of EC. Thus, diagnosing different EH (EIN, hyperplasia without atypia (HwA) and NE) and screening EIN from non-EIN are crucial for the health of female reproductive system. Computer-aided-diagnosis (CAD) was used to diagnose endometrial histological images based on machine learning and deep learning. However, these studies perform single-scale image analysis and thus can only characterize partial endometrial features. Empirically, both global (cytological changes relative to background) and local features (gland-to-stromal ratio and lesion dimension) are helpful in identifying endometrial lesions. Methods: We proposed a global-to-local multi-scale convolutional neural network (G2LNet) to diagnose different EH and to screen EIN in endometrial histological images stained by hematoxylin and eosin (H&E). The G2LNet first used a supervised model in the global part to extract contextual features of endometrial lesions, and simultaneously deployed multi-instance learning in the local part to obtain textural features from multiple image patches. The contextual and textural features were used together to diagnose different endometrial lesions after fusion by a convolutional block attention module. In addition, we visualized the salient regions on both the global image and local images to investigate the interpretability of the model in endometrial diagnosis. Results: In the five-fold cross validation on 7812 H&E images from 467 endometrial specimens, G2LNet achieved an accuracy of 97.01% for EH diagnosis and an area-under-the-curve (AUC) of 0.9902 for EIN screening, significantly higher than state-of-the-arts. In external validation on 1631 H&E images from 135 specimens, G2LNet achieved an accuracy of 95.34% for EH diagnosis, which was comparable to that of a mid-level pathologist (95.71%). Specifically, G2LNet had advantages in diagnosing EIN, while humans performed better in identifying NE and HwA. Conclusions: The developed G2LNet that integrated both the global (contextual) and local (textural) features may help pathologists diagnose endometrial lesions in clinical practices, especially to improve the accuracy and efficiency of screening for precancerous lesions.(c) 2022 Elsevier B.V. All rights reserved.	[Zhao, Fengjun; Dong, Didi; Wang, Zhiwei; Xie, Xiaoyang; Cao, Xin; He, Xiaowei] Northwest Univ, Sch Informat Sci & Technol, Xian Key Lab Radi & Intelligent Percept, Xian 710069, Shaanxi, Peoples R China; [Du, Hongyan; Guo, Yinan; Su, Xue; Wang, Mingjuan; Zhang, Haiyan] Northwest Women & Childrens Hosp, Dept Pathol, Xian 710061, Shaanxi, Peoples R China	Northwest University Xi'an	He, XW (corresponding author), Northwest Univ, Sch Informat Sci & Technol, Xian Key Lab Radi & Intelligent Percept, Xian 710069, Shaanxi, Peoples R China.; Du, HY (corresponding author), Northwest Women & Childrens Hosp, Dept Pathol, Xian 710061, Shaanxi, Peoples R China.	hongyandudu@163.com; hexw@nwu.edu.cn	Zhang, Haiyan/HPG-4116-2023; Cao, Xin/L-7110-2019; Zhao, Fengjun/D-7085-2012; He, XW/JXN-0620-2024	Zhao, Fengjun/0000-0001-8658-8412	National Natural Sci-ence Foundation of China [61971350]; Shaanxi International Sci-ence and Technology Cooperation Program [2021KW-55]; Shaanxi Key RD Plan [2020SF-036]; China Postdoctoral Science Foun-dation [2019M653717]; Xi?an Science and Technology Plan [201805060ZD11CG44]	National Natural Sci-ence Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi International Sci-ence and Technology Cooperation Program; Shaanxi Key RD Plan; China Postdoctoral Science Foun-dation(China Postdoctoral Science Foundation); Xi?an Science and Technology Plan	This work was supported in part by the National Natural Sci-ence Foundation of China (61971350) , Shaanxi International Sci-ence and Technology Cooperation Program (2021KW-55) , Shaanxi Key R&D Plan (2020SF-036) , China Postdoctoral Science Foun-dation (2019M653717) , and Xi?an Science and Technology Plan (201805060ZD11CG44) .	Afshar P, 2019, IEEE SIGNAL PROC MAG, V36, P132, DOI 10.1109/MSP.2019.2900993; Araújo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Baak JPA, 2005, J CLIN PATHOL, V58, P1, DOI 10.1136/jcp.2004.021071; Berends MJW, 2001, INT J CANCER, V92, P398, DOI 10.1002/ijc.1206; Chandra V, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e8; Cinel L, 2002, PATHOL INT, V52, P384, DOI 10.1046/j.1440-1827.2002.01358.x; Downing MJ, 2020, INT J GYNECOL PATHOL, V39, P333, DOI 10.1097/PGP.0000000000000615; Edris F, 2007, J MINIM INVAS GYN, V14, P68, DOI 10.1016/j.jmig.2006.08.007; Emons G, 2015, GEBURTSH FRAUENHEILK, V75, P135, DOI 10.1055/s-0034-1396256; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ganesan R., 2014, STANDARDS DATASETS R; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gonthier C., 2017, INT J GYNECOL CANCER, V27, P93; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hecht JL, 2005, MODERN PATHOL, V18, P324, DOI 10.1038/modpathol.3800328; Horrée N, 2007, HUM PATHOL, V38, P1232, DOI 10.1016/j.humpath.2007.01.008; Hosny A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002711; Hou YQ, 2021, EUR RADIOL, V31, P24, DOI 10.1007/s00330-020-07110-2; Huang GL, 2017, IEEE ICC; Jarboe EA, 2010, SEMIN DIAGN PATHOL, V27, P215, DOI 10.1053/j.semdp.2010.09.007; Jha S, 2016, JAMA-J AM MED ASSOC, V316, P2353, DOI 10.1001/jama.2016.17438; Khan A, 2020, ARTIF INTELL REV, V53, P5455, DOI 10.1007/s10462-020-09825-6; Konrad J, 2018, ULTRASOUND Q, V34, P29, DOI 10.1097/RUQ.0000000000000322; Lax SF, 2019, PATHOLOGE, V40, P13, DOI 10.1007/s00292-019-0568-5; Lee H, 2012, MODERN PATHOL, V25, P1508, DOI 10.1038/modpathol.2012.111; Liu ZY, 2017, CLIN CANCER RES, V23, P7253, DOI 10.1158/1078-0432.CCR-17-1038; Makris GM, 2017, DIAGN CYTOPATHOL, V45, P202, DOI 10.1002/dc.23649; Mao TL, 2013, J GYNECOL ONCOL, V24, P376, DOI 10.3802/jgo.2013.24.4.376; Mutter GL, 2000, INT J GYNECOL PATHOL, V19, P301, DOI 10.1097/00004347-200010000-00002; Mutter GL, 2000, GYNECOL ONCOL, V76, P287, DOI 10.1006/gyno.1999.5580; Neofytou MS, 2015, IEEE J BIOMED HEALTH, V19, P1129, DOI 10.1109/JBHI.2014.2332760; Norimatsu Y, 2007, ANN DIAGN PATHOL, V11, P103, DOI 10.1016/j.anndiagpath.2006.06.009; Orbo A, 2003, INT J GYNECOL PATHOL, V22, P141, DOI 10.1097/01.PGP.0000055170.26935.F8; Owings RA, 2014, ARCH PATHOL LAB MED, V138, P484, DOI 10.5858/arpa.2012-0709-RA; Peiró G, 2001, INT J GYNECOL PATHOL, V20, P359, DOI 10.1097/00004347-200110000-00008; Pouliakis A, 2014, DIAGN CYTOPATHOL, V42, P582, DOI 10.1002/dc.23077; Raffone A, 2021, GYNECOL ONCOL, V162, P401, DOI 10.1016/j.ygyno.2021.05.029; Raffone A, 2019, ARCH GYNECOL OBSTET, V299, P1233, DOI 10.1007/s00404-019-05103-1; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Revel A, 2002, HUM REPROD, V17, P1947, DOI 10.1093/humrep/17.8.1947; Sanderson PA, 2017, HUM REPROD UPDATE, V23, P232, DOI 10.1093/humupd/dmw042; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Sun H, 2020, IEEE J BIOMED HEALTH, V24, P1664, DOI 10.1109/JBHI.2019.2944977; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Takahashi Y, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248526; Travaglino A, 2019, HISTOPATHOLOGY, V74, P676, DOI 10.1111/his.13776; Trimble CL, 2012, OBSTET GYNECOL, V120, P1160, DOI [http://10.1097/AOG.0b013e31826bb121, 10.1097/AOG.0b013e31826bb121]; Ueno Y, 2017, RADIOLOGY, V284, P748, DOI 10.1148/radiol.2017161950; Vlachokosta AA, 2013, MED BIOL ENG COMPUT, V51, P859, DOI 10.1007/s11517-013-1058-1; Vlachokosta AA, 2013, ANAL QUANT CYTOL, V35, P105; Werner HMJ, 2013, MODERN PATHOL, V26, P428, DOI 10.1038/modpathol.2012.174; Wise MR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.175; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Wu JY, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.1.014501; Xiong Y, 2010, EUR J GYNAECOL ONCOL, V31, P160; Zaino R., 2014, WHO Classification of Tumours of female reproductive Organs, V4th, P125; Zhang YZ, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-020-02660-x; Zhou LL, 2019, TRANSL ONCOL, V12, P292, DOI 10.1016/j.tranon.2018.10.012; Zygouris D, 2014, ANAL QUANT CYTOPATHO, V36, P189	60	10	10	3	25	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUN	2022	221								106906	10.1016/j.cmpb.2022.106906	http://dx.doi.org/10.1016/j.cmpb.2022.106906		JUN 2022	10	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	2M5WJ	35671602				2024-09-18	WOS:000817769500005
J	McCarrier, KP; Atkinson, TM; DeBusk, KPA; Liepa, AM; Scanlon, M; Coons, SJ				McCarrier, Kelly P.; Atkinson, Thomas M.; DeBusk, Kendra P. A.; Liepa, Astra M.; Scanlon, Michael; Coons, Stephen Joel		Patient-Reported Outcome Consortiu; Non-Small Cell Lung Canc Working G	Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument	CLINICAL THERAPEUTICS			English	Article						NSCLC; patient-reported outcome (PRO); content validity; qualitative research; scale development	REPEATED 24-HOUR RECALL; PRO INSTRUMENTS; 7-DAY; ONCOLOGY; THERAPY; SUPPORT; TRIALS	Purpose: The purpose of this article was to describe the process and results of the preliminary qualitative development of a new symptoms-based patient reported outcome (PRO) measure intended for assessing treatment benefit in clinical trials of advanced non small cell lung cancer (NSCLC). Methods: Individual qualitative interviews were conducted in adults with NSCLC (Stages I IV) in the United States. Experienced interviewers conducted concept-elicitation (CE) and cognitive interviews using semistructured interview guides. The CE interview guide was used for eliciting spontaneous reports of symptom experiences along with probing to further explore and confirm concepts. Interview transcripts were coded and analyzed by professional qualitative coders, and were summarized by like content using an iterative coding framework. Data from the CE interviews were considered alongside existing literature and clinical expert opinion during an item-generation process, leading to the development of a preliminary version of the NSCLC Symptom Assessment Questionnaire (SAQ). Three waves of cognitive interviews were conducted to evaluate concept relevance, item interpretability, and structure of the draft items and to facilitate further instrument refinement. Findings: Fifty-one subjects (mean [SD] age, 64.9 [11.2] years; 51.0% women) participated in the CE interviews. A total of 1897 expressions of NSCLC-related symptoms were identified and coded in interview transcripts, representing 42 distinct symptom concepts. A 9-item initial-draft instrument was developed for testing in 3 waves of cognitive interviews with additional subjects with NSCLC (n = 20), during which both paper and electronic versions of the instrument were evaluated and refined. Participant responses and feedback during cognitive interviews led to the removal of 2 items and substantial modifications to others. Implications: The NSCLC-SAQ is a 7-item PRO measure intended for use in advanced NSCLC clinical trials to support medical product labelling. The NSCLC-SAQ uses a 7-day recall period and verbal rating scales. It was developed in accordance with the US Food and Drug Administration's PRO Guidance and scientific best practices, and the resulting qualitative interview data provide evidence of content validity. The NSCLC-SAQ has been prepared in both paper and electronic administration formats and a tablet computer based version is currently undergoing quantitative testing to confirm its measurement properties and support US Food and Drug Administration qualification. (C) 2016 Elsevier HS Journals, Inc. All rights reserved.	[McCarrier, Kelly P.; Scanlon, Michael] Hlth Res Associates, 6505 216th St SW,Suite 105, Mountlake Terrace, WA 98043 USA; [Atkinson, Thomas M.] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, 1275 York Ave, New York, NY 10021 USA; [DeBusk, Kendra P. A.] Genentech Inc, Patient Ctr Outcomes Res, San Francisco, CA USA; [Liepa, Astra M.] Eli Lilly & Co, Global Patient Outcomes & Real World Evidence, Indianapolis, IN 46285 USA; [Coons, Stephen Joel] Crit Path Inst, Patient Reported Outcome Consortium, Tucson, AZ USA	Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; Eli Lilly	McCarrier, KP (corresponding author), Hlth Res Associates, 6505 216th St SW,Suite 105, Mountlake Terrace, WA 98043 USA.	mccarrier@hrainc.net	Atkinson, Thomas/JFA-6487-2023	McCarrier, Kelly/0000-0003-2301-0984	AbbVie; Boehringer Ingelheim; Bristol-Meyers Squibb; Eli Lilly and Company; Genentech; Merck Sharp Dohme Corp; Novartis Pharmaceuticals; FDA grant [1U18FD005320]; National Institutes of Health [P30 CA08748-49]	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Meyers Squibb(Bristol-Myers Squibb); Eli Lilly and Company(Eli Lilly); Genentech(Roche HoldingGenentech); Merck Sharp Dohme Corp(Merck & Company); Novartis Pharmaceuticals(Novartis); FDA grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the following members of the PRO Consortium: AbbVie, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly and Company, Genentech, Merck Sharp & Dohme Corp, and Novartis Pharmaceuticals. Critical Path Institute's PRO Consortium is supported by FDA grant 1U18FD005320. This project was also supported by National Institutes of Health grant P30 CA08748-49, which provided partial support for the Memorial Sloan Kettering Behavioral Research Methods Core Facility used in conducting this investigation. The research described in this article was planned, conducted, interpreted, and reported by participants in a multi-stakeholder, pre-competitive collaboration convened by the Critical Path Institute's Patient Reported Outcome Consortium, a non-profit public private partnership.	American Cancer Society, Cancer facts and figures; Atkinson TM, 2015, QUAL LIFE RES, V24, P51; Basch E, 2012, VALUE HEALTH, V15, P401, DOI 10.1016/j.jval.2012.03.1385; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Basse SJ, 2013, VALUE HEALTH, V16, pA2, DOI 10.1016/j.jval.2013.03.010; Bennett AV, 2012, VALUE HEALTH, V15, P466, DOI 10.1016/j.jval.2011.12.005; Bennett AV, 2010, J CYST FIBROS, V9, P419, DOI 10.1016/j.jcf.2010.08.008; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Brod M, 2009, QUAL LIFE RES, V18, P1263, DOI 10.1007/s11136-009-9540-9; CELLA DF, 1995, LUNG CANCER-J IASLC, V12, P199, DOI 10.1016/0169-5002(95)00450-F; Coons SJ, 2011, CLIN PHARMACOL THER, V90, P743, DOI 10.1038/clpt.2011.203; HOLLEN PJ, 1993, EUR J CANCER, V29A, pS51, DOI 10.1016/S0959-8049(05)80262-X; Ironmonger L, 2015, BRIT J CANCER, V112, P207, DOI 10.1038/bjc.2014.596; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; McCarrier KP, 2016, PATIENT, V9, P117, DOI 10.1007/s40271-015-0132-1; Mendoza TR, 2011, ONCOLOGIST, V16, P217, DOI 10.1634/theoncologist.2010-0193; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Muhr T., 2004, USERS MANUAL ATLAS T; *NAT CANC I, 2010, COMM TERM CRIT ADV E; Patrick DL, 2011, VALUE HEALTH, V14, P978, DOI 10.1016/j.jval.2011.06.013; Patrick DL, 2011, VALUE HEALTH, V14, P967, DOI 10.1016/j.jval.2011.06.014; Trotti A, 2007, J CLIN ONCOL, V25, P5121, DOI 10.1200/JCO.2007.12.4784; US Dept Health and Human Services, 2009, GUID IND PAT REP OUT; US Dept Health and Human Services, 2014, GUID IND FDA STAFF Q; Wood WA, 2015, J PAIN SYMPTOM MANAG, V49, P513, DOI 10.1016/j.jpainsymman.2014.06.011	25	24	25	0	5	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	0149-2918	1879-114X		CLIN THER	Clin. Ther.	APR	2016	38	4					794	810		10.1016/j.clinthera.2016.03.012	http://dx.doi.org/10.1016/j.clinthera.2016.03.012			17	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DL6FI	27041408	Bronze, Green Accepted			2024-09-18	WOS:000375734700013
J	Dal Bo, M; Polano, M; Ius, T; Di Cintio, F; Mondello, A; Manini, I; Pegolo, E; Cesselli, D; Di Loreto, C; Skrap, M; Toffoli, G				Dal Bo, Michele; Polano, Maurizio; Ius, Tamara; Di Cintio, Federica; Mondello, Alessia; Manini, Ivana; Pegolo, Enrico; Cesselli, Daniela; Di Loreto, Carla; Skrap, Miran; Toffoli, Giuseppe			Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						Glioma; Machine learning; Prognosis; Carmustine wafer; Tumor mutational burden	CENTRAL-NERVOUS-SYSTEM; ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA; CANCER; MUTATIONS; SURVIVAL; CLASSIFICATION; CHEMOTHERAPY; RADIOTHERAPY; CONCOMITANT	BackgroundGlioma grade 4 (GG4) tumors, including astrocytoma IDH-mutant grade 4 and the astrocytoma IDH wt are the most common and aggressive primary tumors of the central nervous system. Surgery followed by Stupp protocol still remains the first-line treatment in GG4 tumors. Although Stupp combination can prolong survival, prognosis of treated adult patients with GG4 still remains unfavorable. The introduction of innovative multi-parametric prognostic models may allow refinement of prognosis of these patients. Here, Machine Learning (ML) was applied to investigate the contribution in predicting overall survival (OS) of different available data (e.g. clinical data, radiological data, or panel-based sequencing data such as presence of somatic mutations and amplification) in a mono-institutional GG4 cohort.MethodsBy next-generation sequencing, using a panel of 523 genes, we performed analysis of copy number variations and of types and distribution of nonsynonymous mutations in 102 cases including 39 carmustine wafer (CW) treated cases. We also calculated tumor mutational burden (TMB). ML was applied using eXtreme Gradient Boosting for survival (XGBoost-Surv) to integrate clinical and radiological information with genomic data.ResultsBy ML modeling (concordance (c)- index = 0.682 for the best model), the role of predicting OS of radiological parameters including extent of resection, preoperative volume and residual volume was confirmed. An association between CW application and longer OS was also showed. Regarding gene mutations, a role in predicting OS was defined for mutations of BRAF and of other genes involved in the PI3K-AKT-mTOR signaling pathway. Moreover, an association between high TMB and shorter OS was suggested. Consistently, when a cutoff of 1.7 mutations/megabase was applied, cases with higher TMB showed significantly shorter OS than cases with lower TMB.ConclusionsThe contribution of tumor volumetric data, somatic gene mutations and TBM in predicting OS of GG4 patients was defined by ML modeling.	[Dal Bo, Michele; Polano, Maurizio; Di Cintio, Federica; Mondello, Alessia; Toffoli, Giuseppe] IRCCS, Expt & Clin Pharmacol Unit, Ctr Riferimento Oncol Aviano CRO, I-33081 Aviano, Italy; [Ius, Tamara; Skrap, Miran] Univ Hosp Udine, Head Neck & Neurosci Dept, Neurosurg Unit, I-33100 Udine, Italy; [Manini, Ivana; Pegolo, Enrico; Cesselli, Daniela; Di Loreto, Carla] Univ Hosp Udine, Inst Pathol, I-33100 Udine, Italy; [Manini, Ivana; Pegolo, Enrico; Cesselli, Daniela; Di Loreto, Carla] Univ Udine, Dept Med, I-33100 Udine, Italy	IRCCS Aviano (CRO); University of Udine; University Hospital of Udine; University of Udine; University Hospital of Udine; University of Udine	Polano, M (corresponding author), IRCCS, Expt & Clin Pharmacol Unit, Ctr Riferimento Oncol Aviano CRO, I-33081 Aviano, Italy.	mpolano@cro.it	skrap, miran/AAB-1708-2022; ius, tamara/F-1084-2018; Toffoli, Giuseppe/F-6642-2018; Mondello, Alessia/HPE-6793-2023; Di Cintio, Federica/AAX-6420-2020; Polano, Maurizio/AAB-9679-2020	Mondello, Alessia/0009-0003-7888-7393; Di Cintio, Federica/0000-0001-6011-6548; Polano, Maurizio/0000-0002-6101-1382; skrap, miran/0000-0002-6592-6416	Progetto di Ricerca Finalizzata Regione Friuli Venezia Giulia Anno [LR 13/2021]; Progetto Giovani Ricercatori [GR-2016-02364678]; Ministero della Salute, Rome, Italy	Progetto di Ricerca Finalizzata Regione Friuli Venezia Giulia Anno; Progetto Giovani Ricercatori; Ministero della Salute, Rome, Italy(Ministry of Health, Italy)	Progetto di Ricerca Finalizzata Regione Friuli Venezia Giulia Anno 2021 LR 13/2021, art. 8, c. 28-30 (M.S.); Progetto Giovani Ricercatori n. GR-2016-02364678, Ministero della Salute, Rome, Italy (T.I.).	Bergstra J., 2013, TPROC 30 INT C MACH, V28, P115; Bouche V, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.772052; BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brown TJ, 2016, JAMA ONCOL, V2, P1460, DOI 10.1001/jamaoncol.2016.1373; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Della Pepa GM, 2021, NEUROSURGERY, V89, P873, DOI 10.1093/neuros/nyab320; Di Cintio F, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.603647; Edlind MP, 2014, ASIAN J ANDROL, V16, P378, DOI 10.4103/1008-682X.122876; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Gynecologic oncology, 1991, CURR OPIN OBSTET GYN, V3, P134, DOI [10.1097/00001703-199102000-00017, DOI 10.1097/00001703-199102000-00017]; Han F, 2016, ONCOTARGETS THER, V9, P3485, DOI 10.2147/OTT.S99942; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hodges TR, 2017, NEURO-ONCOLOGY, V19, P1047, DOI 10.1093/neuonc/nox026; Iuchi T, 2022, NEURO-ONCOL ADV, V4, DOI 10.1093/noajnl/vdab189; Ius T, 2023, J NEURO-ONCOL, V162, P267, DOI 10.1007/s11060-023-04274-x; Ius T, 2020, CANCERS, V12, DOI 10.3390/cancers12020386; Ius T, 2022, J NEUROSURG SCI, V66, P173, DOI 10.23736/S0390-5616.20.04850-X; Ius T, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0489-2; Jansen T, 2020, STUD HEALTH TECHNOL, V270, P307, DOI 10.3233/SHTI200172; Karschnia P, 2023, NEURO-ONCOLOGY, V25, P940, DOI 10.1093/neuonc/noac193; Langhans J, 2017, ONCOGENESIS, V6, DOI 10.1038/s41389-017-0004-8; Louis DN, 2021, NEURO-ONCOLOGY, V23, P1231, DOI 10.1093/neuonc/noab106; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-21; McGrail DJ, 2021, ANN ONCOL, V32, P661, DOI 10.1016/j.annonc.2021.02.006; McNulty SN, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99278-w; Menna G, 2022, NEUROSURG FOCUS, V52, DOI 10.3171/2021.11.FOCUS21589; Merino DM, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000147; Moncada-Torres A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86327-7; Nam JY, 2017, J ONCOL PRACT, V13, P629, DOI 10.1200/JOP.2017.025536; Pallud J, 2015, NEURO-ONCOLOGY, V17, P1609, DOI 10.1093/neuonc/nov126; Pearson JRD, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.40; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Polano M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030576; Polano M, 2019, CANCERS, V11, DOI 10.3390/cancers11101562; Poon MTC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68011-4; Ricciardi L, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.884158; Spooner A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77220-w; Stiglic G, 2020, WIRES DATA MIN KNOWL, V10, DOI 10.1002/widm.1379; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Su LP, 2022, OPEN MED-WARSAW, V17, P1724, DOI 10.1515/med-2022-0585; Sundrani S, 2021, JCO CLIN CANCER INFO, V5, P364, DOI 10.1200/CCI.20.00172; Touat M, 2020, NATURE, V580, P517, DOI 10.1038/s41586-020-2209-9; Villani V, 2023, J TRANSL MED, V21, DOI 10.1186/s12967-023-04057-y; Wang JG, 2016, NAT GENET, V48, P768, DOI 10.1038/ng.3590; Wang LH, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6658-1; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wen PY, 2020, NEURO-ONCOLOGY, V22, P1073, DOI 10.1093/neuonc/noaa106; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Xu J, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000029668; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang P, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-021-04498-7; Zhang Y, 2018, CANCERS, V10, DOI 10.3390/cancers10090297; Zhao J, 2019, NAT MED, V25, P462, DOI 10.1038/s41591-019-0349-y	57	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	JUL 7	2023	21	1							450	10.1186/s12967-023-04308-y	http://dx.doi.org/10.1186/s12967-023-04308-y			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	L7HX9	37420248	gold, Green Published			2024-09-18	WOS:001024944200001
J	Ikechukwu, AV; Murali, S				Ikechukwu, Agughasi Victor; Murali, S.			CX-Net: an efficient ensemble semantic deep neural network for ROI identification from chest-x-ray images for COPD diagnosis	MACHINE LEARNING-SCIENCE AND TECHNOLOGY			English	Article						chest x-ray; COPD; CX-Net; ensemble learning; SHAP and Grad-CAM; VinDR-chest x-ray	COMPUTER-AIDED DIAGNOSIS; LUNG-CANCER; SEGMENTATION; SHAPE; RECOGNITION; EMPHYSEMA	Automatic identification of salient features in large medical datasets, particularly in chest x-ray (CXR) images, is a crucial research area. Accurately detecting critical findings such as emphysema, pneumothorax, and chronic bronchitis can aid radiologists in prioritizing time-sensitive cases and screening for abnormalities. However, traditional deep neural network approaches often require bounding box annotations, which can be time-consuming and challenging to obtain. This study proposes an explainable ensemble learning approach, CX-Net, for lung segmentation and diagnosing lung disorders using CXR images. We compare four state-of-the-art convolutional neural network models, including feature pyramid network, U-Net, LinkNet, and a customized U-Net model with ImageNet feature extraction, data augmentation, and dropout regularizations. All models are trained on the Montgomery and VinDR-CXR datasets with and without segmented ground-truth masks. To achieve model explainability, we integrate SHapley Additive exPlanations (SHAP) and gradient-weighted class activation mapping (Grad-CAM) techniques, which enable a better understanding of the decision-making process and provide visual explanations of critical regions within the CXR images. By employing ensembling, our outlier-resistant CX-Net achieves superior performance in lung segmentation, with Jaccard overlap similarity of 0.992, Dice coefficients of 0.994, precision of 0.993, recall of 0.980, and accuracy of 0.976. The proposed approach demonstrates strong generalization capabilities on the VinDr-CXR dataset and is the first study to use these datasets for semantic lung segmentation with semi-supervised localization. In conclusion, this paper presents an explainable ensemble learning approach for lung segmentation and diagnosing lung disorders using CXR images. Extensive experimental results show that our method efficiently and accurately extracts regions of interest in CXR images from publicly available datasets, indicating its potential for integration into clinical decision support systems. Furthermore, incorporating SHAP and Grad-CAM techniques further enhances the interpretability and trustworthiness of the AI-driven diagnostic system.	[Ikechukwu, Agughasi Victor; Murali, S.] Maharaja Inst Technol Mysore, Dept CSE, Mysore 571477, Karnataka, India		Ikechukwu, AV (corresponding author), Maharaja Inst Technol Mysore, Dept CSE, Mysore 571477, Karnataka, India.	victor.agughasi@gmail.com	Agughasi, Victor Ikechukwu/ABU-3111-2022	Agughasi, Victor Ikechukwu/0000-0002-1175-3089				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agusti B., 2019, CHRONIC OBSTRUCTIVE, V1, P1; Ahmad WSHMW, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0014-8; Antonelli Michela, 2021, ARXIV210605735; Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4; Ayan E, 2019, 2019 SCIENTIFIC MEETING ON ELECTRICAL-ELECTRONICS & BIOMEDICAL ENGINEERING AND COMPUTER SCIENCE (EBBT), DOI 10.1109/ebbt.2019.8741582; Babenko B, 2011, IEEE T PATTERN ANAL, V33, P1619, DOI 10.1109/TPAMI.2010.226; Bejnordi BE, 2016, IEEE T MED IMAGING, V35, P404, DOI 10.1109/TMI.2015.2476509; Bustos A, 2020, MED IMAGE ANAL, V66, DOI 10.1016/j.media.2020.101797; Calli E, 2021, MED IMAGE ANAL, V72, DOI 10.1016/j.media.2021.102125; Calli E, 2019, PROC SPIE, V10950, DOI 10.1117/12.2514290; Candemir S, 2014, IEEE T MED IMAGING, V33, P577, DOI 10.1109/TMI.2013.2290491; Chaddad A, 2021, J MED IMAGING, V8, DOI 10.1117/1.JMI.8.S1.014502; Chaurasia A, 2017, 2017 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING (VCIP); Chen Y., 2019, arXiv, DOI DOI 10.1109/ICCV.2019.00353; Cheng TYD, 2016, J THORAC ONCOL, V11, P1653, DOI 10.1016/j.jtho.2016.05.021; Chouhan N, 2021, COMPUT BIOL MED, V132, DOI 10.1016/j.compbiomed.2021.104318; Cohen JP, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9448; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Coppini G, 2013, MED ENG PHYS, V35, P63, DOI 10.1016/j.medengphy.2012.03.011; Gupta KD, 2023, NEURAL PROCESS LETT, V55, P205, DOI 10.1007/s11063-021-10555-1; Datta S., 2021, J AMBIENT INTELL HUM, V123, P1, DOI [10.1007/s12652-021-02824-5, DOI 10.1007/S12652-021-02824-5]; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Deserno TM, 2013, CURR MED IMAGING, V9, P79; Dewangan KK, 2022, MULTIMED TOOLS APPL, V81, P13935, DOI 10.1007/s11042-022-12385-2; Dudani S. A., 1976, IEEE Transactions on Systems, Man and Cybernetics, VSMC-6, P325, DOI 10.1109/TSMC.1976.5408784; Johnson AEW, 2019, Arxiv, DOI [arXiv:1901.07042, DOI 10.48550/ARXIV.1901.07042]; FIX E, 1989, INT STAT REV, V57, P238, DOI 10.2307/1403797; Geldermann I, 2013, J DIGIT IMAGING, V26, P698, DOI 10.1007/s10278-013-9590-y; Gómez O, 2020, NEURAL COMPUT APPL, V32, P15949, DOI 10.1007/s00521-019-04532-y; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Horry MJ, 2020, IEEE ACCESS, V8, P149808, DOI 10.1109/ACCESS.2020.3016780; Kassani SH, 2019, Arxiv, DOI arXiv:1909.11870; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Iakovidis DK, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104019; Ioffe S, 2015, Arxiv, DOI [arXiv:1502.03167, 10.48550/arXiv.1502.03167]; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jaszcz A, 2022, SCI PROGRAMMING-NETH, V2022, DOI 10.1155/2022/4494139; Johnson AEW, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0322-0; Kalinovsky A., 2016, 13 INT C PATT REC IN, P21; Khan MA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11122208; Kingma DP, 2014, ADV NEUR IN, V27; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Kwong T, 2022, Arxiv, DOI arXiv:2109.08853; Lehmann TM, 2005, J AM MED INFORM ASSN, V12, P497, DOI 10.1197/jamia.M1652; Li H., 2021, NEURAL COMPUT APPL, V33, P4619, DOI [10.1007/s00521-020-05536-7, DOI 10.1007/S00521-020-05536-7]; Lim JU, 2022, J THORAC DIS, V14, P553, DOI 10.21037/jtd-21-655; Liu WF, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-12743-y; Lundberg S M., 2021, NAT COMMUN, V12, P1, DOI [10.1038/s41467-020-20314-w, DOI 10.1038/S41467-020-20314-W]; Majkowska A, 2020, RADIOLOGY, V294, P421, DOI 10.1148/radiol.2019191293; Miniati M, 2011, EUR J RADIOL, V80, pE169, DOI 10.1016/j.ejrad.2010.08.021; Mique E.  Jr., 2020, IOP Conference Series: Materials Science and Engineering, V803, DOI 10.1088/1757-899X/803/1/012004; Moran I, 2023, IEEE ACCESS, V11, P40629, DOI 10.1109/ACCESS.2023.3269397; Munawar F, 2020, IEEE ACCESS, V8, P153535, DOI 10.1109/ACCESS.2020.3017915; Nair V., Rectified linear units improve restricted Boltzmann machines', P8; Narin A, 2021, PATTERN ANAL APPL, V24, P1207, DOI 10.1007/s10044-021-00984-y; Nguyen H, 2022, Arxiv, DOI arXiv:2012.15029; Niazi MKK, 2019, LANCET ONCOL, V20, pE253, DOI 10.1016/S1470-2045(19)30154-8; Novikov AA, 2018, IEEE T MED IMAGING, V37, P1865, DOI 10.1109/TMI.2018.2806086; Nur-A-Alam, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21041480; Oakden-Rayner L, 2020, ACAD RADIOL, V27, P106, DOI 10.1016/j.acra.2019.10.006; Pham Van Tien, 2023, The 3rd International Conference on Artificial Intelligence and Computer Vision (AICV2023). Lecture Notes on Data Engineering and Communications Technologies (164), P251, DOI 10.1007/978-3-031-27762-7_24; Ragab DA, 2019, PEERJ, V7, DOI 10.7717/peerj.6201; Rajpurkar P, 2017, Arxiv, DOI arXiv:1711.05225; Rehman NU, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11199023; Karim MR, 2020, Arxiv, DOI arXiv:2004.04582; Ronneberger O, 2015, Arxiv, DOI arXiv:1505.04597; Rozenberg E, 2019, Arxiv, DOI arXiv:1909.08842; Rozenberg E, 2021, IEEE ACCESS, V9, P67620, DOI 10.1109/ACCESS.2021.3075555; Sadre R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95561-y; Salehi M, 2021, BRIT J RADIOL, V94, DOI 10.1259/bjr.20201263; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Seghers D, 2007, IEEE T MED IMAGING, V26, P1115, DOI 10.1109/TMI.2007.896924; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Shao YQ, 2014, IEEE T MED IMAGING, V33, P1761, DOI 10.1109/TMI.2014.2305691; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Souza JC, 2019, COMPUT METH PROG BIO, V177, P285, DOI 10.1016/j.cmpb.2019.06.005; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Tahir AM, 2022, COGN COMPUT, V14, P1752, DOI 10.1007/s12559-021-09955-1; Torralba A, 2008, IEEE T PATTERN ANAL, V30, P1958, DOI 10.1109/TPAMI.2008.128; Tsiknakis N, 2020, EXP THER MED, V20, P727, DOI 10.3892/etm.2020.8797; van Ginneken B, 2000, MED PHYS, V27, P2445, DOI 10.1118/1.1312192; van Ginneken B, 2006, MED IMAGE ANAL, V10, P19, DOI 10.1016/j.media.2005.02.002; Victor Ikechukwu A., 2022, IRJMETS, V04, P3051; Victor Ikechukwu A., 2021, Glob. Transitions Proc., V2, P375, DOI [DOI 10.1016/J.GLTP.2021.08.027, 10.1016/J.GLTP.2021.08.027]; Victor Ikechukwu A., 2022, IJATEE, V9, DOI [10.19101/IJATEE.2021.875564, DOI 10.19101/IJATEE.2021.875564]; Wanchaitanawong J., 2021, J MED ASSOC THAILAND, V104, P79, DOI [DOI 10.35755/JMEDASSOCTHAI.2021.S04.00049, 10.35755/jmedassocthai.2021.S04.00049]; Wang HY, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101846; Wang XS, 2017, PROC CVPR IEEE, P3462, DOI 10.1109/CVPR.2017.369; Wang ZQ, 2019, IEEE ACCESS, V7, P105146, DOI 10.1109/ACCESS.2019.2892795; Wei MW, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/5894010; Xu T, 2012, COMPUT MED IMAG GRAP, V36, P452, DOI 10.1016/j.compmedimag.2012.04.005; Yu TL, 2005, PROC CVPR IEEE, P655	94	3	3	3	17	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND		2632-2153		MACH LEARN-SCI TECHN	Mach. Learn.-Sci. Technol.	JUN 1	2023	4	2							025021	10.1088/2632-2153/acd2a5	http://dx.doi.org/10.1088/2632-2153/acd2a5			29	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Science & Technology - Other Topics	G4YZ6		gold			2024-09-18	WOS:000989241800001
J	Zhang, JP; Zhong, F; He, KQ; Ji, MQ; Li, SL; Li, CY				Zhang, Junpeng; Zhong, Fan; He, Kaiqiao; Ji, Mengqi; Li, Shuli; Li, Chunying			Recent Advancements and Perspectives in the Diagnosis of Skin Diseases Using Machine Learning and Deep Learning: A Review	DIAGNOSTICS			English	Review						dermatology; vitiligo; deep learning; machine learning; image segmentation; classification	COMPUTER-AIDED DIAGNOSIS; IMAGE CLASSIFICATION; SEGMENTATION; LESIONS; DERMATOLOGISTS; ALGORITHMS; CHALLENGES; VITILIGO; NETWORKS; CANCER	Objective: Skin diseases constitute a widespread health concern, and the application of machine learning and deep learning algorithms has been instrumental in improving diagnostic accuracy and treatment effectiveness. This paper aims to provide a comprehensive review of the existing research on the utilization of machine learning and deep learning in the field of skin disease diagnosis, with a particular focus on recent widely used methods of deep learning. The present challenges and constraints were also analyzed and possible solutions were proposed. Methods: We collected comprehensive works from the literature, sourced from distinguished databases including IEEE, Springer, Web of Science, and PubMed, with a particular emphasis on the most recent 5-year advancements. From the extensive corpus of available research, twenty-nine articles relevant to the segmentation of dermatological images and forty-five articles about the classification of dermatological images were incorporated into this review. These articles were systematically categorized into two classes based on the computational algorithms utilized: traditional machine learning algorithms and deep learning algorithms. An in-depth comparative analysis was carried out, based on the employed methodologies and their corresponding outcomes. Conclusions: Present outcomes of research highlight the enhanced effectiveness of deep learning methods over traditional machine learning techniques in the field of dermatological diagnosis. Nevertheless, there remains significant scope for improvement, especially in improving the accuracy of algorithms. The challenges associated with the availability of diverse datasets, the generalizability of segmentation and classification models, and the interpretability of models also continue to be pressing issues. Moreover, the focus of future research should be appropriately shifted. A significant amount of existing research is primarily focused on melanoma, and consequently there is a need to broaden the field of pigmented dermatology research in the future. These insights not only emphasize the potential of deep learning in dermatological diagnosis but also highlight directions that should be focused on.	[Zhang, Junpeng; Zhong, Fan; Ji, Mengqi] Sichuan Univ, Coll Elect Engn, Chengdu 610017, Peoples R China; [He, Kaiqiao; Li, Shuli; Li, Chunying] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China	Sichuan University; Air Force Military Medical University	Li, SL; Li, CY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China.	junpeng.zhang@scu.edu.cn; zhongfan@stu.scu.edu.cn; hekqiao@163.com; mengqi12616@163.com; lishli@fmmu.edu.cn; lichying@fmmu.edu.cn	Zhang, Junpeng/C-5457-2012	Zhang, Junpeng/0000-0002-9478-8243	National Natural Science Foundation of China's Mathematics Tianyuan Foundation	National Natural Science Foundation of China's Mathematics Tianyuan Foundation(National Natural Science Foundation of China (NSFC))	No Statement Available	Abbas Q, 2021, VIS COMPUT IND BIOME, V4, DOI 10.1186/s42492-021-00091-z; Abdullah M.N., 2022, AIP Conference Proceedings, VVolume 2617; Abdullah SNHS, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/8603609; Adegun A, 2019, LECT NOTES COMPUT SC, V11663, P232, DOI 10.1007/978-3-030-27272-2_20; Ahmad B, 2022, INT J IMAG SYST TECH, V32, P218, DOI 10.1002/ima.22661; Ahmad B, 2020, IEEE ACCESS, V8, P39025, DOI 10.1109/ACCESS.2020.2975198; Al-masni MA, 2020, COMPUT METH PROG BIO, V190, DOI 10.1016/j.cmpb.2020.105351; Alam MN, 2016, IEEE ENG MED BIO, P1365, DOI 10.1109/EMBC.2016.7590961; Alican B., 2018, P MED IM COMP ASS IN; Anand V, 2023, EXPERT SYST APPL, V213, DOI 10.1016/j.eswa.2022.119230; Anthal J, 2017, 2017 INTERNATIONAL CONFERENCE ON CURRENT TRENDS IN COMPUTER, ELECTRICAL, ELECTRONICS AND COMMUNICATION (CTCEEC), P922, DOI 10.1109/CTCEEC.2017.8455029; Bajwa MN, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072488; Balaji VR, 2020, MEASUREMENT, V163, DOI 10.1016/j.measurement.2020.107922; Banditsingha P., 2022, P 2022 JOINT INT C D; Benyahia S, 2022, TISSUE CELL, V74, DOI 10.1016/j.tice.2021.101701; Bian ZX, 2019, IEEE INT C BIOINFORM, P931, DOI 10.1109/BIBM47256.2019.8983145; Bozorgtabar B, 2017, IBM J RES DEV, V61, DOI 10.1147/JRD.2017.2708283; Brinker TJ, 2019, EUR J CANCER, V113, P47, DOI 10.1016/j.ejca.2019.04.001; Burlando M, 2021, CASE REP DERMATOL, V13, P372, DOI 10.1159/000514198; Cai G, 2023, VISUAL COMPUT, V39, P2781, DOI 10.1007/s00371-022-02492-4; Cao Hu, 2023, Computer Vision - ECCV 2022 Workshops: Proceedings. Lecture Notes in Computer Science (13803), P205, DOI 10.1007/978-3-031-25066-8_9; Castelvecchi D, 2016, NATURE, V538, P21, DOI [10.1038/nature.2016.20491, 10.1038/538020a]; Celebi M. E., 2015, DERMOSCOPY IMAGE ANA, P97, DOI DOI 10.1201/B19107; Chi JN, 2022, COMPUT BIOL MED, V150, DOI 10.1016/j.compbiomed.2022.106112; Chica JF, 2019, J MED SIGNALS SENS, V9, P88, DOI 10.4103/jmss.JMSS_52_18; Codella Noel, 2015, Machine Learning in Medical Imaging. 6th International Workshop, MLMI 2015, held in conjunction with MICCAI 2015. Proceedings: LNCS 9352, P118, DOI 10.1007/978-3-319-24888-2_15; Codella NCF, 2017, IBM J RES DEV, V61, DOI 10.1147/JRD.2017.2708299; Codella NCF, 2018, I S BIOMED IMAGING, P168, DOI 10.1109/ISBI.2018.8363547; Combalia M, 2019, arXiv, DOI 10.48550/arXiv.1908.02288; Czajkowska J, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21175846; Thanh DNH, 2021, INT J COMPUT APPL T, V66, P89, DOI 10.1504/IJCAT.2021.119757; Dang T., 2021, Med. Image Anal, V67, P101831; Dash M, 2020, COMPUT BIOL CHEM, V86, DOI 10.1016/j.compbiolchem.2020.107247; Deng ZL, 2017, IEEE IMAGE PROC, P1732, DOI 10.1109/ICIP.2017.8296578; Du-Harpur X, 2020, BRIT J DERMATOL, V183, P423, DOI 10.1111/bjd.18880; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fan C, 2023, J DIGIT IMAGING, V36, P339, DOI 10.1007/s10278-022-00696-7; Filali Idir, 2019, Mendeley Data; Ghesu FC, 2019, IEEE T PATTERN ANAL, V41, P176, DOI 10.1109/TPAMI.2017.2782687; Giotis I, 2015, EXPERT SYST APPL, V42, P6578, DOI 10.1016/j.eswa.2015.04.034; Gladence LM., 2015, ARPN J Eng Appl Sci, V10, P5947; Goyal M, 2020, COMPUT BIOL MED, V127, DOI 10.1016/j.compbiomed.2020.104065; Guo LF, 2022, ANN TRANSL MED, V10, DOI 10.21037/atm-22-1738; Haenssle HA, 2018, ANN ONCOL, V29, P1836, DOI 10.1093/annonc/mdy166; Halimi A, 2017, EUR SIGNAL PR CONF, P241, DOI 10.23919/EUSIPCO.2017.8081205; Hameed N, 2018, COMPUT SCI ELECTR, P186, DOI 10.1109/CEEC.2018.8674183; Han SS, 2018, J INVEST DERMATOL, V138, P1529, DOI 10.1016/j.jid.2018.01.028; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hesamian MH, 2019, J DIGIT IMAGING, V32, P582, DOI 10.1007/s10278-019-00227-x; Hosny KM, 2022, J DIGIT IMAGING, V35, P258, DOI 10.1007/s10278-021-00552-0; Hosny KM, 2020, J DIGIT IMAGING, V33, P1325, DOI 10.1007/s10278-020-00371-9; Hosny KM, 2020, MULTIMED TOOLS APPL, V79, P24029, DOI 10.1007/s11042-020-09067-2; Iranpoor R, 2020, 2020 6TH IRANIAN CONFERENCE ON SIGNAL PROCESSING AND INTELLIGENT SYSTEMS (ICSPIS), DOI 10.1109/ICSPIS51611.2020.9349577; Jaiswal JK, 2017, 2017 2ND WORLD CONGRESS ON COMPUTING AND COMMUNICATION TECHNOLOGIES (WCCCT), P65, DOI 10.1109/WCCCT.2016.25; Jasil SPG, 2023, SOFT COMPUT, DOI 10.1007/s00500-023-08035-w; Ji L, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12102478; Jian Liu, 2019, Artificial Intelligence and Security. 5th International Conference, ICAIS 2019. Proceedings: Lecture Notes in Computer Science (LNCS 11633), P214, DOI 10.1007/978-3-030-24265-7_19; Jinxi Xu, 2017, ACM SIGIR Forum, V51, P168, DOI 10.1145/3130348.3130364; Jonsson A, 2019, KIDNEY DIS-BASEL, V5, P18, DOI 10.1159/000492670; Karthik R, 2022, BIOMED SIGNAL PROCES, V73, DOI 10.1016/j.bspc.2021.103406; Kassem MA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11081390; Kassem MA, 2020, IEEE ACCESS, V8, P114822, DOI 10.1109/ACCESS.2020.3003890; Khatibi T, 2021, SKIN RES TECHNOL, V27, P126, DOI 10.1111/srt.12920; Kivanc K., 2016, Photonic Therapeutics and Diagnostics XII, VVolume 9689; Li HF, 2021, NEUROCOMPUTING, V464, P364, DOI 10.1016/j.neucom.2021.08.096; Li YL, 2021, IEEE J BIOMED HEALTH, V25, P3082, DOI 10.1109/JBHI.2021.3055213; Li ZQ, 2015, PROC CVPR IEEE, P1356, DOI 10.1109/CVPR.2015.7298741; Liang JY, 2021, IEEE INT CONF COMP V, P1833, DOI 10.1109/ICCVW54120.2021.00210; Liu J, 2020, CMC-COMPUT MATER CON, V62, P1187, DOI 10.32604/cmc.2020.05883; Liu L, 2023, DERMATOLOGY THER, V13, P569, DOI 10.1007/s13555-022-00874-z; Liu LN, 2020, COMPUT MED IMAG GRAP, V84, DOI 10.1016/j.compmedimag.2020.101765; Liu Y, 2020, NAT MED, V26, P900, DOI 10.1038/s41591-020-0842-3; Long J., 2015, CVPR, P3431; Lopez AR, 2017, 2017 13TH IASTED INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING (BIOMED), P49, DOI 10.2316/P.2017.852-053; Low M, 2020, I S BIOMED IMAGING, P1992, DOI [10.1109/ISBI45749.2020.9098682, 10.1109/isbi45749.2020.9098682]; Luo W, 2020, J AMB INTEL HUM COMP, DOI 10.1007/s12652-020-02357-5; Luo WF, 2018, INT C PATT RECOG, P1438, DOI 10.1109/ICPR.2018.8545571; Lv QJ, 2020, IEEE J TRANSL ENG HE, V8, DOI 10.1109/JTEHM.2019.2952610; Marcus G., 2019, Rebooting AI: Building Artificial IntelligenceWe Can Trust; Maron RC, 2019, EUR J CANCER, V119, P57, DOI 10.1016/j.ejca.2019.06.013; Mohammed KK, 2020, BIOMED ENG-APP BAS C, V32, DOI 10.4015/S1016237220500362; Muhaba K A, 2022, Skin Health Dis, V2, pe81, DOI 10.1002/ski2.81; Muñoz-López C, 2021, J EUR ACAD DERMATOL, V35, P546, DOI 10.1111/jdv.16979; Murugan A, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1400-8; Naeem A, 2020, IEEE ACCESS, V8, P110575, DOI 10.1109/ACCESS.2020.3001507; Nasiri S, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3351-y; Nasr-Esfahani E, 2019, COMPUT MED IMAG GRAP, V78, DOI 10.1016/j.compmedimag.2019.101658; Nosseir A, 2019, PROCEEDINGS OF 2019 8TH INTERNATIONAL CONFERENCE ON SOFTWARE AND INFORMATION ENGINEERING (ICSIE 2019), P259, DOI 10.1145/3328833.3328862; Nurhudatiana A, 2015, COMM COM INF SC, V516, P323, DOI 10.1007/978-3-662-46742-8_30; Oliveira RB, 2018, NEURAL COMPUT APPL, V29, P613, DOI 10.1007/s00521-016-2482-6; Pacheco AGC, 2020, COMPUT BIOL MED, V116, DOI 10.1016/j.compbiomed.2019.103545; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n160, 10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Pal A, 2018, COMPUT METH PROG BIO, V159, P59, DOI 10.1016/j.cmpb.2018.01.027; Panayides AS, 2020, IEEE J BIOMED HEALTH, V24, P1837, DOI 10.1109/JBHI.2020.2991043; Parameshwar H., 2018, P 2018 INT C ADV COM; Patel S, 2021, CLIN DERMATOL, V39, P667, DOI 10.1016/j.clindermatol.2021.03.012; Pathan S, 2018, BIOMED SIGNAL PROCES, V39, P237, DOI 10.1016/j.bspc.2017.07.010; Peng LH, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.995323; Peng YJ, 2019, MULTIMED TOOLS APPL, V78, P10965, DOI 10.1007/s11042-018-6523-2; Pennisi A, 2015, PROC INT C TOOLS ART, P791, DOI 10.1109/ICTAI.2015.117; Popescu D, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22020496; Prinyakupt J, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0037-1; R D Seeja, 2019, Asian Pac J Cancer Prev, V20, P1555; Raghavendra PVSP, 2023, J DIGIT IMAGING, V36, P2227, DOI 10.1007/s10278-023-00862-5; Rahman MA, 2017, MIDWEST SYMP CIRCUIT, P1356, DOI 10.1109/MWSCAS.2017.8053183; Reddy DA, 2023, KNOWL INF SYST, V65, P4111, DOI 10.1007/s10115-023-01865-y; Rehman MZU, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22186915; Reis HC, 2022, MED BIOL ENG COMPUT, V60, P643, DOI 10.1007/s11517-021-02473-0; Ribani Ricardo, 2019, 2019 32nd SIBGRAPI Conference on Graphics, Patterns and Images Tutorials (SIBGRAPI-T). Proceedings, P47, DOI 10.1109/SIBGRAPI-T.2019.00010; Rodrigues M, 2017, J AM ACAD DERMATOL, V77, P1, DOI 10.1016/j.jaad.2016.10.048; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rotemberg V, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00815-z; Salahuddin Z, 2022, COMPUT BIOL MED, V140, DOI 10.1016/j.compbiomed.2021.105111; Saood A, 2021, BMC MED IMAGING, V21, DOI 10.1186/s12880-020-00529-5; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sengupta A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00095; Serte S, 2022, T EMERG TELECOMMUN T, V33, DOI 10.1002/ett.4080; Shahabi F, 2021, INT SYM HIGH CAPAC, P50, DOI 10.1109/HONET53078.2021.9615400; Shamshad F, 2023, MED IMAGE ANAL, V88, DOI 10.1016/j.media.2023.102802; Shetty B, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-22644-9; Silberg J., 2019, McKinsey Glob. Inst, V1; Silva Jesus, 2021, Image Processing and Capsule Networks. ICIPCN 2020. Advances in Intelligent Systems and Computing (AISC 1200), P20, DOI 10.1007/978-3-030-51859-2_3; Silverberg NB, 2015, CURR DERMATOL REP, V4, P36, DOI 10.1007/s13671-014-0098-6; Singh M, 2019, EXPERT REV CLIN IMMU, V15, P177, DOI 10.1080/1744666X.2019.1550358; Song Yan-Yan, 2015, Shanghai Arch Psychiatry, V27, P130, DOI 10.11919/j.issn.1002-0829.215044; Sreedhar B., 2020, 2020 Fourth International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC), P654, DOI 10.1109/I-SMAC49090.2020.9243501; Srinivasu PN, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21082852; Stofa Marzuraikah Mohd, 2022, Proceedings of the 6th International Conference on Electrical, Control and Computer Engineering: InECCE2021. Lecture Notes in Electrical Engineering (842), P1025, DOI 10.1007/978-981-16-8690-0_89; Suganya R, 2016, INT CONF RECENT; Sumithra R, 2015, PROCEDIA COMPUT SCI, V45, P76, DOI 10.1016/j.procs.2015.03.090; Tan TY, 2020, KNOWL-BASED SYST, V187, DOI 10.1016/j.knosys.2019.06.015; Tanaka M, 2021, INT J COMPUT ASS RAD, V16, P1875, DOI 10.1007/s11548-021-02440-y; Thamilselvan P., 2016, INDIAN J SCI TECHNOL, V9, P1, DOI [10.17485/ijst/2016/v9i43/104642, DOI 10.17485/ijst/2016/v9i43/104642]; Thanh Dang N. H., 2020, Frontiers in Intelligent Computing: Theory and Applications. Proceedings of the 7th International Conference on FICTA (2018). Advances in Intelligent Systems and Computing (AISC 1014), P171, DOI 10.1007/978-981-13-9920-6_18; Thanh DNH, 2019, 2019 6TH INTERNATIONAL CONFERENCE ON ELECTRICAL AND ELECTRONICS ENGINEERING (ICEEE 2019), P116, DOI 10.1109/ICEEE2019.2019.00030; Tschandl P, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.161; Tschandl P, 2020, NAT MED, V26, P1229, DOI 10.1038/s41591-020-0942-0; Tschandl P, 2019, LANCET ONCOL, V20, P938, DOI 10.1016/S1470-2045(19)30333-X; Tschandl P, 2019, COMPUT BIOL MED, V104, P111, DOI 10.1016/j.compbiomed.2018.11.010; Wang P, 2021, PATTERN RECOGN LETT, V141, P61, DOI 10.1016/j.patrec.2020.07.042; Wu WT, 2021, MILITARY MED RES, V8, DOI 10.1186/s40779-021-00338-z; Wu Z, 2019, IEEE ACCESS, V7, P66505, DOI 10.1109/ACCESS.2019.2918221; Yanagisawa Y, 2023, J DERMATOL SCI, V109, P30, DOI 10.1016/j.jdermsci.2023.01.005; Yao K, 2022, IEEE J BIOMED HEALTH, V26, P4976, DOI 10.1109/JBHI.2022.3162118; Yin XX, 2022, J HEALTHC ENG, V2022, DOI 10.1155/2022/4189781; Yoganathan SA, 2022, J MED PHYS, V47, P40, DOI 10.4103/jmp.jmp_87_21; Yuan YD, 2017, Arxiv, DOI arXiv:1703.05165; Yuan YD, 2019, IEEE J BIOMED HEALTH, V23, P519, DOI 10.1109/JBHI.2017.2787487; Yuan YD, 2017, IEEE T MED IMAGING, V36, P1876, DOI 10.1109/TMI.2017.2695227; Zeng GD, 2018, LECT NOTES COMPUT SC, V10882, P513, DOI 10.1007/978-3-319-93000-8_58; Zhang B, 2021, CHIN J MECH ENG-EN, V34, DOI 10.1186/s10033-021-00629-5; Zhao C, 2021, MED BIOL ENG COMPUT, V59, P1815, DOI 10.1007/s11517-021-02397-9; Zorgui Sana, 2020, Impact of Digital Technologies on Public Health in Developed and Developing Countries. 18th International Conference, ICOST 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12157), P89, DOI 10.1007/978-3-030-51517-1_8	153	3	3	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	DEC	2023	13	23							3506	10.3390/diagnostics13233506	http://dx.doi.org/10.3390/diagnostics13233506			30	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF2H0	38066747	Green Published, gold			2024-09-18	WOS:001116979400001
J	Marques, C; Frenoy, P; Fiolet, T; Crépet, A; Severi, G; Mancini, FR				Marques, Chloe; Frenoy, Pauline; Fiolet, Thibault; Crepet, Amelie; Severi, Gianluca; Mancini, Francesca Romana			Challenges of studying the dietary exposure to chemical mixtures: Example of the association with mortality risk in the E3N French prospective cohort	SCIENCE OF THE TOTAL ENVIRONMENT			English	Article						Chemical; Mixture; Diet; Sparse non-negative matrix under-approximation; Mortality; Cohort	TOTAL ANTIOXIDANT CAPACITY; MEASUREMENT ERROR; PESTICIDE MIXTURES; PREGNANT-WOMEN; IDENTIFICATION; POPULATION; CANCER; FRUITS	Food is contaminated by many chemicals which interact with each other, resulting in additive, synergistic or antago-nistic effects. It is thus necessary to study the health effects of dietary exposure to chemical mixtures rather than single contaminants.We aimed to investigate the association between dietary exposure to chemical mixtures and mortality risk in the E3N French prospective cohort.We included 72,585 women from the E3N cohort who completed a food frequency questionnaire in 1993. From 197 chemicals, and using sparse non-negative matrix under-approximation (SNMU), we identified six main chemical mix-tures to which these women were chronically exposed through the diet. We estimated the associations between dietary exposure to these mixtures and all-cause or cause-specific mortality using Cox proportional hazard models. During the follow-up (1993-2014), 6441 deaths occurred. We observed no association between dietary exposure to three mixtures and all-cause mortality, and a non-monotonic inverse association for the three other mixtures.These results could be explained by the fact that, despite the different dietary adjustment strategies tested, we did not fully succeed in excluding the residual confounding from the overall effect of the diet. We also questioned the number of chemicals to include in mixtures' studies, as a balance needs to be reached between including a large number of chemicals and the interpretability of the results. Integrating a priori knowledge, such as toxicological data, could lead to the identification of more parsimonious mixtures, thus to more interpretable results. Moreover, as the SNMU is a non-supervised method, which identifies the mixtures only on the basis of the correlations between the exposure variables, and not in relation to the outcome, it would be interesting to test supervised methods. Finally, further studies are needed to identify the most adequate approach to investigate the health effects of dietary exposure to chemical mixtures in observational studies.	[Marques, Chloe; Frenoy, Pauline; Fiolet, Thibault; Severi, Gianluca; Mancini, Francesca Romana] Paris Saclay Univ, Exposome & Hered team, UVSQ, Inserm,Gustave Roussy,Exposome & Hered team,CESP U, F-94805 Villejuif, France; [Crepet, Amelie] French Agcy Food Environm & Occupat Hlth & Safety, Risk Assessment Dept, Methodol & Survey Unit, F-94701 Maisons Alfort, France; [Severi, Gianluca] Univ Florence, Dept Stat Comp Sci Applicat G Parenti, Florence, Italy; [Mancini, Francesca Romana] Gustave Roussy, Ctr Res Epidemiol & Populat Hlth CESP, Inserm U1018, Exposome Hered Canc & Hlth Team, 114 Rue Edouard Vaillant, F-94805 Villejuif, France	UNICANCER; Gustave Roussy; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); University of Florence; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Mancini, FR (corresponding author), Gustave Roussy, Ctr Res Epidemiol & Populat Hlth CESP, Inserm U1018, Exposome Hered Canc & Hlth Team, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	francesca.mancini@gustaveroussy.fr	mancini, francesca romana/GRF-5129-2022; Fiolet, Thibault/JHT-7123-2023; Severi, Gianluca/H-3774-2018; Mancini, Francesca Romana/H-3778-2018	Marques, Chloe/0000-0003-3203-7310; Mancini, Francesca Romana/0000-0003-2297-3869	National Research Agency under the program "Investment in the future" [ANR-10-COHO-0006]; University Paris-Saclay Doctoral School of Public Health EDSP; Ministry of Higher Education, Research and Innovation [2103586016]	National Research Agency under the program "Investment in the future"; University Paris-Saclay Doctoral School of Public Health EDSP; Ministry of Higher Education, Research and Innovation	This work was realized with the data of the E3N cohort of the Inserm and supported by the Mutuelle Generale de l'Education Nationale (MGEN), the Gustave Roussy Institute, and the French League Against Cancer for the constitution and maintenance of the cohort. This work has benefited from State aid managed by the National Research Agency under the program "Investment in the future" bearing the reference ANR-10-COHO-0006 as well as subsidy from the Ministry of Higher Education, Research and Innovation for public service charges bearing the reference no 2103586016. This work was also supported by a doctoral & nbsp;<STRONG>Funding & nbsp;</STRONG>from the University Paris-Saclay Doctoral School of Public Health EDSP.	ANSES, 2013, Table de composition nutritionnelle des aliments Ciqual; ANSES, 2011, 2 FRENCH TOT DIET ST; ANSES, 2011, Second French Total Diet Study (FTDS2) Report 1. Inorganic contaminants, minerals, persistent organic pollutants, mycotoxins and phytoestrogens; Béchaux C, 2013, FOOD CHEM TOXICOL, V59, P191, DOI 10.1016/j.fct.2013.06.006; Cano-Sancho G, 2021, J EPIDEMIOL COMMUN H, V75, P108, DOI 10.1136/jech-2020-213789; Clavel-Chapelon F, 1997, EUR J CANCER PREV, V6, P473, DOI 10.1097/00008469-199710000-00007; Clavel-Chapelon F, 2015, INT J EPIDEMIOL, V44, P801, DOI 10.1093/ije/dyu184; Crépet A, 2013, ENVIRON RES, V126, P125, DOI 10.1016/j.envres.2013.03.008; Crepet A, 2019, INT J HYG ENVIR HEAL, V222, P291, DOI 10.1016/j.ijheh.2018.12.002; de Jong E., 2022, EFSA Support. Publ., V19, DOI [10.2903/sp. efsa.2022.en-7555, DOI 10.2903/SP.EFSA.2022.EN-7555]; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Edefonti V, 2008, INT J CANCER, V122, P609, DOI 10.1002/ijc.23064; Eskola M, 2020, CRIT REV FOOD SCI, V60, P1890, DOI 10.1080/10408398.2019.1612320; Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189; Gibson EA, 2019, CURR ENV HLTH REP, V6, P53, DOI 10.1007/s40572-019-00229-5; Gillis N, 2013, LINEAR ALGEBRA APPL, V438, P3991, DOI 10.1016/j.laa.2012.04.033; Gillis N, 2010, PATTERN RECOGN, V43, P1676, DOI 10.1016/j.patcog.2009.11.013; Goodson WH, 2015, CARCINOGENESIS, V36, pS254, DOI 10.1093/carcin/bgv039; Harrell FE, 2001, REGRESSION MODELING; Henn BC, 2014, CURR OPIN PEDIATR, V26, P223, DOI 10.1097/MOP.0000000000000067; Hernández AF, 2017, ARCH TOXICOL, V91, P3211, DOI 10.1007/s00204-017-2043-5; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Kopp B, 2018, ENVIRON MOL MUTAGEN, V59, P742, DOI 10.1002/em.22214; Laouali N, 2019, DIABETOLOGIA, V62, P2222, DOI 10.1007/s00125-019-04972-0; Lee DH, 2017, ENVIRON INT, V108, P170, DOI 10.1016/j.envint.2017.08.015; Lee WC, 2017, ENVIRON INT, V99, P321, DOI 10.1016/j.envint.2016.12.015; Mancini FR, 2021, ENVIRON INT, V152, DOI 10.1016/j.envint.2021.106467; Mancini FR, 2020, FOOD ADDIT CONTAM A, V37, P39, DOI 10.1080/19440049.2019.1678772; Mancini FR, 2018, DIABETOLOGIA, V61, P308, DOI 10.1007/s00125-017-4489-7; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067; Rebouillat P, 2022, ENVIRON HEALTH-GLOB, V21, DOI 10.1186/s12940-022-00862-y; Rebouillat P, 2021, INT J EPIDEMIOL, V50, P1184, DOI 10.1093/ije/dyab015; Rebouillat P, 2021, EUR J NUTR, V60, P1475, DOI 10.1007/s00394-020-02344-8; Sandoval-Insausti H, 2022, ENVIRON INT, V159, DOI 10.1016/j.envint.2021.107024; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Sirot V, 2009, FOOD ADDIT CONTAM A, V26, P623, DOI 10.1080/02652030802695506; Thiébaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012; Thomsen ST, 2022, CRIT REV FOOD SCI, V62, P7479, DOI 10.1080/10408398.2021.1915240; Thorpe MG, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0495-6; Traoré T, 2018, FOOD CHEM TOXICOL, V111, P310, DOI 10.1016/j.fct.2017.11.016; Traoré T, 2016, FOOD CHEM TOXICOL, V98, P179, DOI 10.1016/j.fct.2016.10.028; Valcke M, 2017, ENVIRON INT, V108, P63, DOI 10.1016/j.envint.2017.07.023; van Woudenbergh GJ, 2013, AM J CLIN NUTR, V98, P1533, DOI 10.3945/ajcn.112.056333; VanLiere MJ, 1997, INT J EPIDEMIOL, V26, pS128, DOI 10.1093/ije/26.suppl_1.S128; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S	47	1	1	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0048-9697	1879-1026		SCI TOTAL ENVIRON	Sci. Total Environ.	SEP 20	2023	892								164350	10.1016/j.scitotenv.2023.164350	http://dx.doi.org/10.1016/j.scitotenv.2023.164350		JUN 2023	11	Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology	L6ZE0	37236483	Green Submitted, Bronze			2024-09-18	WOS:001024714100001
J	Fu, X; Sahai, E; Wilkins, A				Fu, Xiao; Sahai, Erik; Wilkins, Anna			Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response	JOURNAL OF PATHOLOGY			English	Review; Early Access						advanced analytics; digital pathology; tumour microenvironment; artificial intelligence; biomarker	ARTIFICIAL-INTELLIGENCE; REPORTING GUIDELINE; IMMUNE CONTEXTURE; BREAST-CANCER; PROSTATE; GRADE; CLASSIFICATION; DEFINITION; CARCINOMA; DIAGNOSIS	In recent years, the application of advanced analytics, especially artificial intelligence (AI), to digital H & E images, and other histological image types, has begun to radically change how histological images are used in the clinic. Alongside the recognition that the tumour microenvironment (TME) has a profound impact on tumour phenotype, the technical development of highly multiplexed immunofluorescence platforms has enhanced the biological complexity that can be captured in the TME with high precision. AI has an increasingly powerful role in the recognition and quantitation of image features and the association of such features with clinically important outcomes, as occurs in distinct stages in conventional machine learning. Deep-learning algorithms are able to elucidate TME patterns inherent in the input data with minimum levels of human intelligence and, hence, have the potential to achieve clinically relevant predictions and discovery of important TME features. Furthermore, the diverse repertoire of deep-learning algorithms able to interrogate TME patterns extends beyond convolutional neural networks to include attention-based models, graph neural networks, and multimodal models. To date, AI models have largely been evaluated retrospectively, outside the well-established rigour of prospective clinical trials, in part because traditional clinical trial methodology may not always be suitable for the assessment of AI technology. However, to enable digital pathology-based advanced analytics to meaningfully impact clinical care, specific measures of 'added benefit' to the current standard of care and validation in a prospective setting are important. This will need to be accompanied by adequate measures of explainability and interpretability. Despite such challenges, the combination of expanding datasets, increased computational power, and the possibility of integration of pre-clinical experimental insights into model development means there is exciting potential for the future progress of these AI applications. & COPY; 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.	[Fu, Xiao; Sahai, Erik; Wilkins, Anna] Francis Crick Inst, Tumour Cell Biol Lab, London, England; [Fu, Xiao] Francis Crick Inst, Biomol Modelling Lab, London, England; [Wilkins, Anna] Inst Canc Res, Div Radiotherapy & Imaging, London, England; [Wilkins, Anna] Royal Marsden Hosp NHS Trust, London, England; [Fu, Xiao; Wilkins, Anna] Francis Crick Inst, Tumour Cell Biol Lab, 1 Midland Rd, London NW1 1AT, England	Francis Crick Institute; Francis Crick Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Francis Crick Institute	Fu, X; Wilkins, A (corresponding author), Francis Crick Inst, Tumour Cell Biol Lab, 1 Midland Rd, London NW1 1AT, England.	xiao.fu@crick.ac.uk; anna.wilkins@icr.ac.uk		Fu, Xiao/0000-0002-8611-891X; Wilkins, Anna/0000-0002-0425-584X	Prostate Cancer Research; European Research Council; AstraZeneca; imCORE; RMH/ICR Cancer Research UK RadNet Centre; Royal Marsden NHS Foundation Trust funding; Institute of Cancer Research; Crick	Prostate Cancer Research; European Research Council(European Research Council (ERC)); AstraZeneca(AstraZeneca); imCORE; RMH/ICR Cancer Research UK RadNet Centre; Royal Marsden NHS Foundation Trust funding; Institute of Cancer Research; Crick	& nbsp;XF acknowledges funding from Prostate Cancer Research and the European Research Council. AW acknowledges funding from AstraZeneca and imCORE, the RMH/ICR Cancer Research UK RadNet Centre, and Royal Marsden NHS Foundation Trust funding to the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research. ES acknowledges funding from the Crick and the European Research Council.	AbdulJabbar K, 2020, NAT MED, V26, P1054, DOI 10.1038/s41591-020-0900-x; Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; [Anonymous], NAT MED; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Bedin V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-260; Bera K, 2019, NAT REV CLIN ONCOL, V16, P703, DOI 10.1038/s41571-019-0252-y; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Brooks M, 2016, ONCOTARGET, V7, P82609, DOI 10.18632/oncotarget.12089; Bruni D, 2020, NAT REV CANCER, V20, P662, DOI 10.1038/s41568-020-0285-7; Bulten W, 2022, NAT MED, V28, P154, DOI 10.1038/s41591-021-01620-2; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chen PHC, 2019, NAT MED, V25, P1453, DOI 10.1038/s41591-019-0539-7; Chen RJ., 2022, CANCER CELL, V40:; Chen X, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/9258649; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Courtiol P, 2019, NAT MED, V25, P1519, DOI 10.1038/s41591-019-0583-3; Danenberg E, 2022, NAT GENET, V54, P660, DOI 10.1038/s41588-022-01041-y; Diao JA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21896-9; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; du Terrail JO, 2023, NAT MED, DOI 10.1038/s41591-022-02155-w; Echle A, 2021, BRIT J CANCER, V124, P686, DOI 10.1038/s41416-020-01122-x; Elmarakeby HA, 2021, NATURE, V598, P348, DOI 10.1038/s41586-021-03922-4; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Esteva A, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00613-w; Evans T, 2022, FUTURE GENER COMP SY, V133, P281, DOI 10.1016/j.future.2022.03.009; Failmezger H, 2020, CANCER RES, V80, P1199, DOI 10.1158/0008-5472.CAN-19-2268; Foersch S, 2023, NAT MED, V29, DOI 10.1038/s41591-022-02134-1; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fu Y, 2020, NAT CANCER, V1, P800, DOI 10.1038/s43018-020-0085-8; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gobbi H, 1999, CANCER-AM CANCER SOC, V85, P2170, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2170::AID-CNCR11>3.0.CO;2-X; Graham S, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101563; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbias A, 2017, Gulf J Oncolog, V1, P41; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; He B, 2020, NAT BIOMED ENG, V4, P827, DOI 10.1038/s41551-020-0578-x; He SS, 2022, NAT BIOTECHNOL, V40, DOI 10.1038/s41587-022-01483-z; Hirata E, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026781; Ho BCS, 2006, HISTOPATHOLOGY, V49, P603, DOI 10.1111/j.1365-2559.2006.02524.x; Hoch T, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abk1692; Hollon TC, 2020, NAT MED, V26, P52, DOI 10.1038/s41591-019-0715-9; Humphrey PA, 2016, EUR UROL, V70, P106, DOI 10.1016/j.eururo.2016.02.028; Ibrahim H, 2021, TRIALS, V22, DOI 10.1186/s13063-020-04951-6; Ing N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13196-4; Jackson HW, 2020, NATURE, V578, P615, DOI 10.1038/s41586-019-1876-x; Jairath NK, 2021, EUR UROL, V79, P374, DOI 10.1016/j.eururo.2020.11.021; Kalra S, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0238-2; Karimi E, 2023, NATURE, V614, P555, DOI 10.1038/s41586-022-05680-3; Kather JN, 2020, NAT CANCER, V1, P789, DOI 10.1038/s43018-020-0087-6; Kather JN, 2019, NAT MED, V25, P1054, DOI 10.1038/s41591-019-0462-y; Kather JN, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002730; Kather JN, 2018, ELIFE, V7, DOI 10.7554/eLife.36967; Keikhosravi A, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01151-5; Kendall TJ, 2021, LANCET ONCOL, V22, pE435, DOI 10.1016/S1470-2045(21)00344-2; Keren L, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5851; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kim J, 2022, NAT METHODS, V19, P1653, DOI 10.1038/s41592-022-01657-2; Komura D, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110424; Kuett L, 2022, NAT CANCER, V3, P122, DOI 10.1038/s43018-021-00301-w; Lee S, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03686-0; Li MM, 2022, NAT BIOMED ENG, V6, P1353, DOI 10.1038/s41551-022-00942-x; Lin JR, 2023, CELL, V186, P363, DOI 10.1016/j.cell.2022.12.028; Lipkova J, 2022, CANCER CELL, V40, P1095, DOI 10.1016/j.ccell.2022.09.012; Liu XX, 2020, LANCET DIGIT HEALTH, V2, pE537, DOI [10.1136/bmj.m3164, 10.1016/S2589-7500(20)30218-1, 10.1016/S2589-7500(20)30219-3]; Liu XX, 2020, NAT MED, V26, P1364, DOI 10.1038/s41591-020-1034-x; Lu MY, 2021, NATURE, V594, P106, DOI 10.1038/s41586-021-03512-4; Lu MY, 2021, NAT BIOMED ENG, V5, P555, DOI 10.1038/s41551-020-00682-w; Mahmood F, 2020, IEEE T MED IMAGING, V39, P3257, DOI 10.1109/TMI.2019.2927182; Mandrekar SJ, 2005, AM J PHARMACOGENOMIC, V5, P317, DOI 10.2165/00129785-200505050-00004; McConnell JC, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0664-2; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Metze K, 2013, EXPERT REV MOL DIAGN, V13, P719, DOI 10.1586/14737159.2013.828889; Mobadersany P, 2018, P NATL ACAD SCI USA, V115, pE2970, DOI 10.1073/pnas.1717139115; Moldoveanu D, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abi5072; Natrajan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001961; Ozyoruk KB, 2022, NAT BIOMED ENG, DOI 10.1038/s41551-022-00952-9; PAGE DL, 1995, AM J CLIN PATHOL, V103, P123; Pagès F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Penet MF, 2017, CLIN CANCER RES, V23, P2245, DOI 10.1158/1078-0432.CCR-16-1516; Phillips D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26974-6; Pulsawatdi AV, 2020, MOL ONCOL, V14, P2384, DOI 10.1002/1878-0261.12764; Raciti P, 2023, ARCH PATHOL LAB MED, V147, P1178, DOI 10.5858/arpa.2022-0066-OA; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Rivera SC, 2020, LANCET DIGIT HEALTH, V2, pE549, DOI [10.1136/bmj.m3210, 10.1016/S2589-7500(20)30219-3, 10.1038/s41591-020-1037-7]; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Sabo E, 2001, CLIN CANCER RES, V7, P533; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Sauerbrei W, 2018, JNCI-J NATL CANCER I, V110, P803, DOI 10.1093/jnci/djy088; Schaumberg Andrew RM., 2016, BIORXIV; Scholler N, 2022, NAT MED, V28, P1872, DOI 10.1038/s41591-022-01916-x; Schulz KF, 2010, TRIALS, V11, DOI [10.1186/1745-6215-11-32, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Schurch CM., 2020, CELL, V182:; Shmatko A, 2022, NAT CANCER, V3, P1026, DOI 10.1038/s43018-022-00436-4; Sirinukunwattana K, 2021, GUT, V70, P544, DOI 10.1136/gutjnl-2019-319866; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Sorin M, 2023, NATURE, V614, P548, DOI 10.1038/s41586-022-05672-3; Sounderajah V, 2020, NAT MED, V26, P807, DOI 10.1038/s41591-020-0941-1; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Spratt DE, 2022, J CLIN ONCOL, V40, DOI 10.1200/JCO.2022.40.6_suppl.223; Stolz BJ, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm2456; Strom P, 2020, LANCET ONCOL, V21, P222, DOI 10.1016/S1470-2045(19)30738-7; Taghavi M, 2021, ABDOM RADIOL, V46, P249, DOI 10.1007/s00261-020-02624-1; Taube JM, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-002197; van der Kwast TH, 2021, AM J SURG PATHOL, V45, P1118, DOI 10.1097/PAS.0000000000001728; Vasey B, 2023, CLIN RADIOL, V78, P130, DOI 10.1016/j.crad.2022.09.131; Vasey B, 2022, NAT MED, V28, P924, DOI 10.1038/s41591-022-01772-9; Vasey B, 2022, BMJ-BRIT MED J, V377, DOI [10.1136/bmj-2022-070904, 10.1038/s41591-022-01772-9]; Wang JW, 2020, I S BIOMED IMAGING, P239, DOI [10.1109/ISBI45749.2020.9098534, 10.1109/isbi45749.2020.9098534]; Wershof E, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000880; Wu ZQ, 2022, NAT BIOMED ENG, V6, P1435, DOI 10.1038/s41551-022-00951-w; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhang WR, 2022, NAT METHODS, V19, P759, DOI 10.1038/s41592-022-01498-z	122	5	5	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3417	1096-9896		J PATHOL	J. Pathol.	2023 AUG 8	2023										10.1002/path.6153	http://dx.doi.org/10.1002/path.6153		AUG 2023	14	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	O4UJ2	37551703	hybrid, Green Published			2024-09-18	WOS:001043777300001
J	Zhao, BL; Wang, Y; Hu, MH; Wu, Y; Liu, JN; Li, QL; Dai, M; Sun, WQ; Zhai, GT				Zhao, Bailiang; Wang, Yan; Hu, Menghan; Wu, Yue; Liu, Jiannan; Li, Qingli; Dai, Min; Sun, Wendell Q.; Zhai, Guangtao			Auxiliary Diagnosis of Papillary Thyroid Carcinoma Based on Spectral Phenotype	PHENOMICS			English	Article						Interpretable pathologic model; Pathological analysis; Intraoperative detection; Spectral phenotype	ALGORITHM; PREDICTION; ABSORPTION	Thyroid cancer, a common endocrine malignancy, is one of the leading death causes among endocrine tumors. The diagnosis of pathological section analysis suffers from diagnostic delay and cumbersome operating procedures. Therefore, we intend to construct the models based on spectral data that can be potentially used for rapid intraoperative papillary thyroid carcinoma (PTC) diagnosis and characterize PTC characteristics. To alleviate any concerns pathologists may have about using the model, we conducted an analysis of the used bands that can be interpreted pathologically. A spectra acquisition system was first built to acquire spectra of pathological section images from 91 patients. The obtained spectral dataset contains 217 spectra of normal thyroid tissue and 217 spectra of PTC tissue. Clinical data of the corresponding patients were collected for subsequent model interpretability analysis. The experiment has been approved by the Ethics Review Committee of the Wuhu Hospital of East China Normal University. The spectral preprocessing method was used to process the spectra, and the preprocessed signal respectively optimized by the first and secondary informative wavelengths selection was used to develop the PTC detection models. The PTC detection model using mean centering (MC) and multiple scattering correction (MSC) has optimal performance, and the reasons for the good performance were analyzed in combination with the spectral acquisition process and composition of the test slide. For model interpretable analysis, the near-ultraviolet band selected for modeling corresponds to the location of amino acid absorption peak, and this is consistent with the clinical phenomenon of significantly lower amino acid concentrations in PTC patients. Moreover, the absorption peak of hemoglobin selected for modeling is consistent with the low hemoglobin index in PTC patients. In addition, the correlation analysis was performed between the selected wavelengths and the clinical data, and the results show: the reflection intensity of selected wavelengths in normal cells has a moderate correlation with cell arrangement structure, nucleus size and free thyroxine (FT4), and has a strong correlation with triiodothyronine (T3); the reflection intensity of selected bands in PTC cells has a moderate correlation with free triiodothyronine (FT3).	[Zhao, Bailiang; Hu, Menghan; Li, Qingli] East China Normal Univ, Shanghai Key Lab Multidimens Informat Proc, Shanghai 200241, Peoples R China; [Zhao, Bailiang; Sun, Wendell Q.] Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai 200093, Peoples R China; [Wang, Yan; Dai, Min] Second Peoples Hosp Wuhu, Dept Pathol, Wuhu 241000, Anhui, Peoples R China; [Wu, Yue] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Ophthalmol Dept, Shanghai 610101, Peoples R China; [Liu, Jiannan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Oral Maxillofacial Head Neck Oncol, Shanghai 200011, Peoples R China; [Zhai, Guangtao] Shanghai Jiao Tong Univ, Inst Image Commun & Informat Proc, Shanghai 200240, Peoples R China	East China Normal University; University of Shanghai for Science & Technology; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, MH (corresponding author), East China Normal Univ, Shanghai Key Lab Multidimens Informat Proc, Shanghai 200241, Peoples R China.; Dai, M (corresponding author), Second Peoples Hosp Wuhu, Dept Pathol, Wuhu 241000, Anhui, Peoples R China.	mhhu@ce.ecnu.edu.cn; daimin0123@163.com	Li, Qingli/AAG-9646-2019; Zhao, Bailiang/HIR-1823-2022; Zhai, Guangtao/X-5949-2019; Hu, Menghan/AAK-7153-2021; Sun, Wendell Q./C-8125-2011	Hu, Menghan/0000-0002-8557-8930; Zhao, Bailiang/0000-0003-0659-6565; Dai, Min/0000-0001-5354-1239; Zhai, Guangtao/0000-0001-8165-9322; Sun, Wendell Q./0000-0002-7002-4652	Fundamental Research Funds for the Central Universities	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	No Statement Available	Abooshahab R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00385; Barberio Manuel, 2018, Current Directions in Biomedical Engineering, V4, P399, DOI 10.1515/cdbme-2018-0095; Chen C, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.201900099; Cheng Q, 2017, ONCOTARGET, V8, P16690, DOI 10.18632/oncotarget.15128; Chowdhury SR., 2020, Adv Mater Lett, V11, P1, DOI [10.5185/amlett.2020.031482, DOI 10.5185/AMLETT.2020.031482]; Cooper G, 2004, J ELECTRON SPECTROSC, V137, P795, DOI 10.1016/j.elspec.2004.02.102; Cui HZ, 2022, CHAOS SOLITON FRACT, V155, DOI 10.1016/j.chaos.2021.111736; de Santana FB, 2022, SPECTROCHIM ACTA A, V279, DOI 10.1016/j.saa.2022.121441; de Veld DCG, 2005, LASER SURG MED, V36, P356, DOI 10.1002/lsm.20122; Dervieux E, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.10.105001; Dicker DT, 2006, CANCER BIOL THER, V5, P1033, DOI 10.4161/cbt.5.8.3261; Durante C, 2013, J CLIN ENDOCR METAB, V98, P636, DOI 10.1210/jc.2012-3401; Fan W, 2012, FOOD ANAL METHOD, V5, P585, DOI 10.1007/s12161-011-9285-2; Fontenelle LC, 2016, HORM METAB RES, V48, P787, DOI 10.1055/s-0042-121421; Fu JS, 2022, INFRARED PHYS TECHN, V125, DOI 10.1016/j.infrared.2022.104231; Giacomelli MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159337; Harari A, 2016, J SURG RES, V201, P244, DOI 10.1016/j.jss.2015.10.037; Hu MH, 2016, INFRARED PHYS TECHN, V79, P198, DOI 10.1016/j.infrared.2016.10.009; Issa MM, 2015, SPECTROCHIM ACTA A, V142, P204, DOI 10.1016/j.saa.2015.01.064; Kamal AM, 2021, IEEE SENS J, V21, P17758, DOI 10.1109/JSEN.2021.3082850; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Lao CC, 2021, COMPUT ELECTRON AGR, V182, DOI 10.1016/j.compag.2021.106031; Luisa A., 2015, PROENVIRONMENT, V8, P590; Ma LF, 2022, IEEE T CIRC SYST VID, V32, P6113, DOI 10.1109/TCSVT.2022.3157828; Marín NM, 2005, GYNECOL ONCOL, V99, pS116, DOI 10.1016/j.ygyno.2005.07.054; Medeiros-Neto LP, 2019, VIB SPECTROSC, V101, P1, DOI 10.1016/j.vibspec.2018.12.008; Mehnati P, 2016, IRAN J RADIOL, V13, DOI 10.5812/iranjradiol.31581; Miia HURSKAINEN., 2019, 2019 INT C INF CONTR, P234, DOI [10.12783/dtetr/icicr2019/30575, DOI 10.12783/DTETR/ICICR2019/30575]; Mill J, 2022, PHENOMICS, V2, P1, DOI 10.1007/s43657-021-00036-9; Rinschen MM, 2019, NAT REV MOL CELL BIO, V20, P353, DOI 10.1038/s41580-019-0108-4; Roll W, 2019, J NUCL MED, V60, P1461, DOI 10.2967/jnumed.118.222174; Sbroscia M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70165-0; Shen CT, 2017, CLIN ENDOCRINOL, V87, P844, DOI 10.1111/cen.13437; Shurrab K, 2020, LASER MED SCI, V35, P701, DOI 10.1007/s10103-019-02894-2; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Silalahi DD, 2018, VIB SPECTROSC, V97, P55, DOI 10.1016/j.vibspec.2018.05.002; Sprague BL, 2011, CANCER CAUSE CONTROL, V22, P125, DOI 10.1007/s10552-010-9682-7; Stenman S, 2021, IEEE J BIOMED HEALTH, V25, P422, DOI 10.1109/JBHI.2020.2994970; Trajanovski S, 2021, IEEE T BIO-MED ENG, V68, P1330, DOI 10.1109/TBME.2020.3026683; Zhang GS, 2021, SPECTROCHIM ACTA A, V263, DOI 10.1016/j.saa.2021.120187; Zhao XH, 2022, IEEE ACCESS, V10, P27917, DOI 10.1109/ACCESS.2022.3156096	41	3	3	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2730-583X	2730-5848		PHENOMICS	Phenomics	OCT	2023	3	5					469	484		10.1007/s43657-023-00113-1	http://dx.doi.org/10.1007/s43657-023-00113-1			16	Genetics & Heredity	Emerging Sources Citation Index (ESCI)	Genetics & Heredity	CA0G8	37881321				2024-09-18	WOS:001122405200008
J	Bastien, P; Bertrand, F; Meyer, N; Maumy-Bertrand, M				Bastien, Philippe; Bertrand, Frederic; Meyer, Nicolas; Maumy-Bertrand, Myriam			Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data	BIOINFORMATICS			English	Article							PROPORTIONAL HAZARDS MODEL; PENALIZED COX REGRESSION; GENE-EXPRESSION; VARIABLE SELECTION; PREDICT SURVIVAL; ALGORITHM; LASSO; ADENOCARCINOMA; REGULARIZATION; REDUCTION	Motivation: A vast literature from the past decade is devoted to relating gene profiles and subject survival or time to cancer recurrence. Biomarker discovery from high-dimensional data, such as transcriptomic or single nucleotide polymorphism profiles, is a major challenge in the search for more precise diagnoses. The proportional hazard regression model suggested by Cox (1972), to study the relationship between the time to event and a set of covariates in the presence of censoring is the most commonly used model for the analysis of survival data. However, like multivariate regression, it supposes that more observations than variables, complete data, and not strongly correlated variables are available. In practice, when dealing with high-dimensional data, these constraints are crippling. Collinearity gives rise to issues of over-fitting and model misidentification. Variable selection can improve the estimation accuracy by effectively identifying the subset of relevant predictors and enhance the model interpretability with parsimonious representation. To deal with both collinearity and variable selection issues, many methods based on least absolute shrinkage and selection operator penalized Cox proportional hazards have been proposed since the reference paper of Tibshirani. Regularization could also be performed using dimension reduction as is the case with partial least squares (PLS) regression. We propose two original algorithms named sPLSDR and its non-linear kernel counterpart DKsPLSDR, by using sparse PLS regression (sPLS) based on deviance residuals. We compared their predicting performance with state-of-the-art algorithms on both simulated and real reference benchmark datasets. Results: sPLSDR and DKsPLSDR compare favorably with other methods in their computational time, prediction and selectivity, as indicated by results based on benchmark datasets. Moreover, in the framework of PLS regression, they feature other useful tools, including biplots representation, or the ability to deal with missing data. Therefore, we view them as a useful addition to the toolbox of estimation and prediction methods for the widely used Cox's model in the high-dimensional and low-sample size settings.	[Bastien, Philippe] LOreal Rech & Innovat, D-93601 Aulnay Sous Bois, France; [Bertrand, Frederic; Maumy-Bertrand, Myriam] Univ Strasbourg, Labex IRMIA, CNRS UMR 7501, IRMA, F-67084 Strasbourg, France; [Meyer, Nicolas] Univ Strasbourg, Labex IRMIA, Fac Med Strasbourg, INSERM EA3430,Lab Biostat, F-67084 Strasbourg, France	L'Oreal Group; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bastien, P (corresponding author), LOreal Rech & Innovat, D-93601 Aulnay Sous Bois, France.	pbastien@rd.loreal.com; fbertran@math.unistra.fr	Bertrand, Frédéric/ABA-2622-2020	Bastien, Philippe/0000-0002-5602-5827; Bertrand, Frederic/0000-0002-0837-8281; Myriam, Maumy-Bertrand/0000-0002-4615-1512	CNRS UMR [7501]; INSERM [EA3430]; University of Strasbourg; L'Oreal; Recherche et Innovation; Labex IRMIA	CNRS UMR(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Strasbourg; L'Oreal(L'Oreal Group); Recherche et Innovation; Labex IRMIA	CNRS UMR 7501, INSERM EA3430, University of Strasbourg, L'Oreal, Recherche et Innovation and Labex IRMIA.	AKRITAS MG, 1994, ANN STAT, V22, P1299, DOI 10.1214/aos/1176325630; ALIZADEH AA, 2000, NATURE, V11, P403; [Anonymous], 2003, ADV LEARN THEORY MET; [Anonymous], 2010, ARXIV; [Anonymous], 2009, STAT APPL GENET MOL, DOI DOI 10.2202/1544-6115.1438; [Anonymous], 2010, Borrowing Strength: Theory Powering Applications-A Festschrift for Lawrence D. Brown, DOI DOI 10.1214/10-IMSC0LL606; [Anonymous], 1994, Modelling Survival Data in Medical Research; Antoniadis A, 2010, SCAND J STAT, V37, P531, DOI 10.1111/j.1467-9469.2009.00685.x; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bastien P, 2005, COMPUT STAT DATA AN, V48, P17, DOI 10.1016/j.csda.2004.02.005; Bastien P., 2001, PLS RELATED METHODS; Bastien P, 2008, CHEMOMETR INTELL LAB, V91, P78, DOI 10.1016/j.chemolab.2007.09.009; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; COX DR, 1972, J R STAT SOC B, V34, P187; DEJONG S, 1994, J CHEMOMETR, V8, P169, DOI 10.1002/cem.1180080208; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fan JQ, 2002, ANN STAT, V30, P74; Fan X., 2002, SAS M CARLO STUDIES; Friedman J., 2004, WORKING PAPER; Fu WJJ, 1998, J COMPUT GRAPH STAT, V7, P397, DOI 10.2307/1390712; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; GARTHWAITE PH, 1994, J AM STAT ASSOC, V89, P122, DOI 10.2307/2291207; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gönen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Jolliffe IT, 2003, J COMPUT GRAPH STAT, V12, P531, DOI 10.1198/1061860032148; KAISER HF, 1962, PSYCHOMETRIKA, V27, P179, DOI 10.1007/BF02289635; Kim J, 2008, J COMPUT GRAPH STAT, V17, P994, DOI 10.1198/106186008X386210; Krämer N, 2007, COMPUTATION STAT, V22, P249, DOI 10.1007/s00180-007-0038-z; Lambert-Lacroix S., 2011, TECHNICAL REPORT; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Li HZ, 2004, BIOINFORMATICS, V20, P208, DOI 10.1093/bioinformatics/bth900; Li LX, 2006, BIOINFORMATICS, V22, P466, DOI 10.1093/bioinformatics/bti824; LINDGREN F, 1993, J CHEMOMETR, V7, P45, DOI 10.1002/cem.1180070104; Magidson J., 2010, 2010 JSM P AM STAT A, P2739; Marx BD, 1996, TECHNOMETRICS, V38, P374, DOI 10.2307/1271308; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Nguyen DV, 2002, BIOINFORMATICS, V18, P1625, DOI 10.1093/bioinformatics/18.12.1625; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; RANNAR S, 1994, J CHEMOMETR, V8, P111, DOI 10.1002/cem.1180080204; Romain B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-561; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosipal R, 2002, J MACH LEARN RES, V2, P97, DOI 10.1162/15324430260185556; Schmid M, 2011, BIOMETRICS, V67, P524, DOI 10.1111/j.1541-0420.2010.01459.x; Segal MR, 2006, BIOSTATISTICS, V7, P268, DOI 10.1093/biostatistics/kxj006; Simon N, 2013, J COMPUT GRAPH STAT, V22, P231, DOI 10.1080/10618600.2012.681250; Simon N, 2011, J STAT SOFTW, V39, P1; Sohn I, 2009, BIOINFORMATICS, V25, P1775, DOI 10.1093/bioinformatics/btp322; Tenenhaus A, 2007, COMPUT STAT DATA AN, V51, P4083, DOI 10.1016/j.csda.2007.01.004; Tenenhaus M., 1998, La regression PLS; Tenenhaus M., 1999, P 32 JOURN STAT SOC, P721; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; Wang S, 2009, BIOMETRIKA, V96, P307, DOI 10.1093/biomet/asp016; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wold H., 1966, Multivar. Anal, P391; WOLD S, 1983, LECT NOTES MATH, V973, P286; Xu RH, 1999, J NONPARAMETR STAT, V12, P83, DOI 10.1080/10485259908832799; Zhang HH, 2007, BIOMETRIKA, V94, P691, DOI 10.1093/biomet/asm037; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	68	30	32	1	25	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	FEB 1	2015	31	3					397	404		10.1093/bioinformatics/btu660	http://dx.doi.org/10.1093/bioinformatics/btu660			8	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CC0WG	25286920	Bronze			2024-09-18	WOS:000350058800014
J	Zou, J; Shen, YK; Wu, SN; Wei, H; Li, QJ; Xu, SH; Ling, Q; Kang, M; Liu, ZL; Huang, H; Chen, X; Wang, YX; Liao, XL; Tan, G; Shao, Y				Zou, Jie; Shen, Yan-Kun; Wu, Shi-Nan; Wei, Hong; Li, Qing-Jian; Xu, San Hua; Ling, Qian; Kang, Min; Liu, Zhao-Lin; Huang, Hui; Chen, Xu; Wang, Yi-Xin; Liao, Xu-Lin; Tan, Gang; Shao, Yi			Prediction Model of Ocular Metastases in Gastric Adenocarcinoma: Machine Learning-Based Development and Interpretation Study	TECHNOLOGY IN CANCER RESEARCH & TREATMENT			English	Article						ocular metastases in gastric adenocarcinoma; machine learning; gradient boosting machine; Shapley additive explanations; risk factor	CHOROIDAL METASTASIS; CANCER; CHEMOTHERAPY; MANAGEMENT; PROGNOSIS; TUMOR; CEA	Background: Although gastric adenocarcinoma (GA) related ocular metastasis (OM) is rare, its occurrence indicates a more severe disease. We aimed to utilize machine learning (ML) to analyze the risk factors of GA-related OM and predict its risks. Methods: This is a retrospective cohort study. The clinical data of 3532 GA patients were collected and randomly classified into training and validation sets in a ratio of 7:3. Those with or without OM were classified into OM and non-OM (NOM) groups. Univariate and multivariate logistic regression analyses and least absolute shrinkage and selection operator were conducted. We integrated the variables identified through feature importance ranking and further refined the selection process using forward sequential feature selection based on random forest (RF) algorithm before incorporating them into the ML model. We applied six ML algorithms to construct the predictive GA model. The area under the receiver operating characteristic (ROC) curve indicated the model's predictive ability. Also, we established a network risk calculator based on the best performance model. We used Shapley additive interpretation (SHAP) to identify risk factors and to confirm the interpretability of the black box model. We have de-identified all patient details. Results: The ML model, consisting of 13 variables, achieved an optimal predictive performance using the gradient boosting machine (GBM) model, with an impressive area under the curve (AUC) of 0.997 in the test set. Utilizing the SHAP method, we identified crucial factors for OM in GA patients, including LDL, CA724, CEA, AFP, CA125, Hb, CA153, and Ca2+. Additionally, we validated the model's reliability through an analysis of two patient cases and developed a functional online web prediction calculator based on the GBM model. Conclusion: We used the ML method to establish a risk prediction model for GA-related OM and showed that GBM performed best among the six ML models. The model may identify patients with GA-related OM to provide early and timely treatment.	[Zou, Jie; Shen, Yan-Kun; Wu, Shi-Nan; Wei, Hong; Xu, San Hua; Ling, Qian; Kang, Min; Huang, Hui; Shao, Yi] Nanchang Univ, Affiliated Hosp 1, Jiangxi Med Coll, Dept Ophthalmol,Jiangxi Branch,Natl Clin Res Ctr O, Nanchang, Jiangxi, Peoples R China; [Wu, Shi-Nan; Li, Qing-Jian] Xiamen Univ, Eye Inst, Sch Med, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China; [Liu, Zhao-Lin; Tan, Gang] Univ South China, Affiliated Hosp 1, Natl Clin Res Ctr Ocular Dis, Dept Ophthalmol,Hunan Branch, Hengyan, Hunan, Peoples R China; [Chen, Xu] Maastricht Univ, Dept Ophthalmol & Visual Sci, Maastricht, Limburg, Netherlands; [Wang, Yi-Xin] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, Wales; [Liao, Xu-Lin] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Shatin, Hong Kong, Peoples R China; [Shao, Yi] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Shao, Yi] Nanchang Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanchang 330006, Jiangxi, Peoples R China; [Tan, Gang] Univ South China, Affiliated Hosp 1, Dept Ophthalmol, Hengyan 421001, Hunan, Peoples R China	Nanchang University; Xiamen University; University of South China; Maastricht University; Cardiff University; Chinese University of Hong Kong; Fudan University; Nanchang University; University of South China	Shao, Y (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanchang 330006, Jiangxi, Peoples R China.; Tan, G (corresponding author), Univ South China, Affiliated Hosp 1, Dept Ophthalmol, Hengyan 421001, Hunan, Peoples R China.	tangang99@hotmail.com; freebee99@163.com	Wu, Shi-Nan/ADC-1885-2022; Kang, Min/GOK-0957-2022; Yixin, Wang/JRY-9837-2023; Liu, Junjie/KHV-6949-2024	WU, Shi-Nan/0000-0002-6992-9059	Major (Key) R&D Program of Jiangxi Province	Major (Key) R&D Program of Jiangxi Province	No Statement Available	Amemiya T, 2002, OPHTHALMIC EPIDEMIOL, V9, P35, DOI 10.1076/opep.9.1.35.1718; Bibault JE, 2021, GUT, V70, P884, DOI 10.1136/gutjnl-2020-321799; Bogunovic H, 2017, INVEST OPHTH VIS SCI, V58, pBIO141, DOI 10.1167/iovs.17-21789; Castano-Duque L, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.1039947; Celebi ARC, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0840-6; Chen M, 2018, NAT GENET, V50, P206, DOI 10.1038/s41588-017-0027-2; Chen Y, 2021, CANCER MANAG RES, V13, P5835, DOI 10.2147/CMAR.S311474; Duke-Elder S., 1966, SYST OPHTHALMOL, V10, P799; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Han J., 2015, PLoS One, V10; Handelman GS, 2018, J INTERN MED, V284, P603, DOI 10.1111/joim.12822; He RJ, 2017, ONCOTARGET, V8, P23817, DOI 10.18632/oncotarget.15909; Hoshi H, 2020, SURG CLIN N AM, V100, P523, DOI 10.1016/j.suc.2020.02.004; Hu PJ, 2019, CANCERS, V11, DOI 10.3390/cancers11050733; Ichikawa J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-313; Ieni A, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/234851; Isonishi S, 2009, INT J CLIN ONCOL, V14, P70, DOI 10.1007/s10147-008-0800-4; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Kalafi EY, 2019, FOLIA BIOL-PRAGUE, V65, P212; Kanavati F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99940-3; Kanda Tomohiro, 2005, Journal of Nippon Medical School, V72, P66, DOI 10.1272/jnms.72.66; Karim M, 2022, PEERJ COMPUT SCI, V8, DOI 10.7717/peerj-cs.1107; Kawai S, 2013, WORLD J GASTROENTERO, V19, P1485, DOI 10.3748/wjg.v19.i9.1485; Kim DH, 2015, WORLD J GASTROENTERO, V21, P1216, DOI 10.3748/wjg.v21.i4.1216; Konstantinidis L, 2017, ASIA-PAC J OPHTHALMO, V6, P208, DOI 10.22608/APO.201712; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Li Q, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1512; Liu C, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00282; Lordick F, 2016, NAT REV CLIN ONCOL, V13, P348, DOI 10.1038/nrclinonc.2016.15; Luo HY, 2019, LANCET ONCOL, V20, P1645, DOI 10.1016/S1470-2045(19)30637-0; Nienhüser H, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2017.12.08; Nurczyk K, 2023, ADV MED SCI-POLAND, V68, P138, DOI 10.1016/j.advms.2023.02.005; Perez BC, 2022, G3-GENES GENOM GENET, V12, DOI 10.1093/g3journal/jkac039; Qu ZH, 2021, ONCOTARGETS THER, V14, P4451, DOI 10.2147/OTT.S315532; Quer G, 2021, J AM COLL CARDIOL, V77, P300, DOI 10.1016/j.jacc.2020.11.030; Rodríguez-Pérez R, 2020, J COMPUT AID MOL DES, V34, P1013, DOI 10.1007/s10822-020-00314-0; Rodríguez-Pérez R, 2020, J MED CHEM, V63, P8761, DOI 10.1021/acs.jmedchem.9b01101; Sako A, 2004, CANCER LETT, V208, P43, DOI 10.1016/j.canlet.2003.11.010; Schmidt-Erfurth U, 2018, INVEST OPHTH VIS SCI, V59, P3199, DOI 10.1167/iovs.18-24106; Schnoeller TJ, 2017, ONCOTARGET, V8, P47110, DOI 10.18632/oncotarget.16943; Shao SL, 2021, J PERS MED, V11, DOI 10.3390/jpm11080748; Shields CL, 2015, CORNEA, V34, P42, DOI 10.1097/ICO.0000000000000285; Shung DL, 2020, GASTROENTEROLOGY, V158, P160, DOI 10.1053/j.gastro.2019.09.009; Sisik A, 2013, ASIAN PAC J CANCER P, V14, P4289, DOI 10.7314/APJCP.2013.14.7.4289; Subhash VV, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/308574; Sun ZP, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-397; Takeda T., 2022, Endoscopy, V54, pE469; Tkacz M, 2016, POSTEP HIG MED DOSW, V70, P1367, DOI 10.5604/17322693.1227643; Tsuruta Y., 2022, Ear Nose Throat J, V101; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1016/S0140-6736(07)61602-X, 10.1371/journal.pmed.0040297]; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Xu ZZ, 2024, IEEE T NEUR NET LEAR, V35, P3740, DOI [10.1109/TNNLS.2022.3197156, 10.1049/sil2.12104]; Yamamoto M, 2007, J CANCER RES CLIN, V133, P471, DOI 10.1007/s00432-006-0189-2; Yang AP, 2014, CLIN CHIM ACTA, V437, P183, DOI 10.1016/j.cca.2014.07.034; Yang CJ, 2014, CANCER CHEMOTH PHARM, V73, P199, DOI 10.1007/s00280-013-2341-4; Yardimci AH, 2020, DIAGN INTERV RADIOL, V26, P515, DOI 10.5152/dir.2020.19507; Yuan B, 2019, REV ESP ENFERM DIG, V111, P839, DOI 10.17235/reed.2019.6201/2019; Zheng HC, 2010, HISTOL HISTOPATHOL, V25, P445, DOI 10.14670/HH-25.445; Zhong LK, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.740267; Zhou X, 2016, TECHNOL CANCER RES T, V15, P697, DOI 10.1177/1533034615595792; Zhou ZM, 2021, TECHNOL HEALTH CARE, V29, pS287, DOI 10.3233/THC-218026	61	0	0	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1533-0346	1533-0338		TECHNOL CANCER RES T	Technol. Cancer Res. Treat.		2024	23								15330338231219352	10.1177/15330338231219352	http://dx.doi.org/10.1177/15330338231219352			15	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	FG6R4	38233736	Green Published, gold			2024-09-18	WOS:001144653200001
J	Tavolara, TE; Su, ZY; Gurcan, MN; Niazi, MKK				Tavolara, Thomas E.; Su, Ziyu; Gurcan, Metin N.; Niazi, M. Khalid Khan			One label is all you need: Interpretable AI-enhanced histopathology for oncology	SEMINARS IN CANCER BIOLOGY			English	Article						Artificial intelligence; Weakly supervised; Multiple instance learning; Histopathology; Verifiable AI; Interpretable AI; Explainable AI; Morphological markers; Tumor detection; Metastasis; Tumor subtyping; Tumor grading; Molecular markers; Gene expression; Molecular subtyping; Genetic markers; Mutational burden; Microsatellite instability; Chromosomal instability; Homologous recombination deficiency	WHOLE-SLIDE IMAGES; ARTIFICIAL-INTELLIGENCE; SURVIVAL PREDICTION; PROSTATE-CANCER; SEGMENTATION; PATHOLOGY	Artificial Intelligence (AI)-enhanced histopathology presents unprecedented opportunities to benefit oncology through interpretable methods that require only one overall label per hematoxylin and eosin (H&E) slide with no tissue-level annotations. We present a structured review of these methods organized by their degree of verifiability and by commonly recurring application areas in oncological characterization. First, we discuss morphological markers (tumor presence/absence, metastases, subtypes, grades) in which AI-identified regions of interest (ROIs) within whole slide images (WSIs) verifiably overlap with pathologist-identified ROIs. Second, we discuss molecular markers (gene expression, molecular subtyping) that are not verified via H&E but rather based on overlap with positive regions on adjacent tissue. Third, we discuss genetic markers (mutations, mutational burden, microsatellite instability, chromosomal instability) that current technologies cannot verify if AI methods spatially resolve specific genetic alterations. Fourth, we discuss the direct prediction of survival to which AIidentified histopathological features quantitatively correlate but are nonetheless not mechanistically verifiable. Finally, we discuss in detail several opportunities and challenges for these one-label-per-slide methods within oncology. Opportunities include reducing the cost of research and clinical care, reducing the workload of clinicians, personalized medicine, and unlocking the full potential of histopathology through new imaging-based biomarkers. Current challenges include explainability and interpretability, validation via adjacent tissue sections, reproducibility, data availability, computational needs, data requirements, domain adaptability, external validation, dataset imbalances, and finally commercialization and clinical potential. Ultimately, the relative ease and minimum upfront cost with which relevant data can be collected in addition to the plethora of available AI methods for outcome-driven analysis will surmount these current limitations and achieve the innumerable opportunities associated with AI-driven histopathology for the benefit of oncology.	[Tavolara, Thomas E.; Su, Ziyu; Gurcan, Metin N.; Niazi, M. Khalid Khan] Wake Forest Univ, Ctr Artificial Intelligence Res, Sch Med, Winston Salem, NC USA; [Niazi, M. Khalid Khan] 486 N Patterson Ave, Winston Salem, NC 27101 USA	Wake Forest University	Niazi, MKK (corresponding author), 486 N Patterson Ave, Winston Salem, NC 27101 USA.	mniazi@wakehealth.edu	Su, Ziyu/HHZ-6759-2022		National Institutes of Health [R01CA276301, R21EB029493, R21CA273665, R01DC020715]; Alliance Clinical Trials in Oncology [GR125886]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance Clinical Trials in Oncology	The research was partially funded by a National Institutes of Health R01CA276301 (PIs: Niazi, Wei) , Trailblazer award R21EB029493 (PIs: Niazi, Segal) , R21CA273665 (PI: Gurcan) , R01DC020715 (PIs: Gurcan and Moberly) , and Alliance Clinical Trials in Oncology GR125886 (PIs: Frankel and Niazi) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Alliance Clinical Trials in Oncology.	Abels E, 2019, J PATHOL, V249, P286, DOI 10.1002/path.5331; Alsaafin A, 2023, COMMUN BIOL, V6, DOI 10.1038/s42003-023-04583-x; Baxi V, 2022, MODERN PATHOL, V35, P23, DOI 10.1038/s41379-021-00919-2; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Bera K, 2019, NAT REV CLIN ONCOL, V16, P703, DOI 10.1038/s41571-019-0252-y; Berbís MA, 2023, EBIOMEDICINE, V88, DOI 10.1016/j.ebiom.2022.104427; Bilal M, 2021, LANCET DIGIT HEALTH, V3, pE763, DOI 10.1016/S2589-7500(21)00180-1; Brockmoeller S, 2022, J PATHOL, V256, P269, DOI 10.1002/path.5831; Bulten W, 2020, LANCET ONCOL, V21, P233, DOI 10.1016/S1470-2045(19)30739-9; Bychkov A., 2023, The Pathologist, P18; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Cao L, 2023, MED IMAGE ANAL, V88, DOI 10.1016/j.media.2023.102837; Chauhan C, 2021, AM J PATHOL, V191, P1673, DOI 10.1016/j.ajpath.2021.06.011; Chen RJ, 2023, NAT BIOMED ENG, V7, P719, DOI 10.1038/s41551-023-01056-8; Chen RJ, 2022, PROC CVPR IEEE, P16123, DOI 10.1109/CVPR52688.2022.01567; Chen RJ, 2022, CANCER CELL, V40, P865, DOI 10.1016/j.ccell.2022.07.004; Chen RJ, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P3995, DOI 10.1109/ICCV48922.2021.00398; Chen RJ, 2021, LECT NOTES COMPUT SC, V12908, P339, DOI 10.1007/978-3-030-87237-3_33; Chen RJ, 2022, IEEE T MED IMAGING, V41, P757, DOI [10.1109/TITS.2020.3030218, 10.1109/TMI.2020.3021387]; Chikontwe P., 2022, INT C MEDICAL IMAGE; Chuang WY, 2021, MODERN PATHOL, V34, P1901, DOI 10.1038/s41379-021-00838-2; Cifci D, 2022, J PATHOL, V257, P430, DOI 10.1002/path.5898; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Courtiol P, 2020, Arxiv, DOI arXiv:1802.02212; Courtiol P, 2019, NAT MED, V25, P1519, DOI 10.1038/s41591-019-0583-3; Dooper S, 2023, MED IMAGE ANAL, V88, DOI 10.1016/j.media.2023.102881; Dov D, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101814; du Terrail JO, 2023, NAT MED, DOI 10.1038/s41591-022-02155-w; Dundar M. M., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2732, DOI 10.1109/ICPR.2010.669; Dundar MM, 2011, IEEE T BIO-MED ENG, V58, P1977, DOI 10.1109/TBME.2011.2110648; Echle A, 2021, BRIT J CANCER, V124, P686, DOI 10.1038/s41416-020-01122-x; Fremond S, 2023, LANCET DIGIT HEALTH, V5, pe71, DOI 10.1016/S2589-7500(22)00210-2; Freyre CAC, 2021, TOXICOL PATHOL, V49, P798, DOI 10.1177/0192623320987202; Fu Y, 2020, NAT CANCER, V1, P800, DOI 10.1038/s43018-020-0085-8; Graham S, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101563; Hashimoto N, 2020, PROC CVPR IEEE, P3851, DOI 10.1109/CVPR42600.2020.00391; Hildebrand LA, 2021, CANCERS, V13, DOI 10.3390/cancers13030391; Hou L, 2016, PROC CVPR IEEE, P2424, DOI 10.1109/CVPR.2016.266; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Ilse M, 2018, PR MACH LEARN RES, V80; Jackson BR, 2021, ACAD PATHOL, V8, DOI 10.1177/2374289521990784; Javed S, 2022, Arxiv, DOI arXiv:2206.01794; Jiang YH, 2020, CANCER COMMUN, V40, P154, DOI 10.1002/cac2.12012; Kanavati F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66333-x; Kather JN, 2020, NAT CANCER, V1, P789, DOI 10.1038/s43018-020-0087-6; Kleppe A, 2021, NAT REV CANCER, V21, P199, DOI 10.1038/s41568-020-00327-9; Kumar N, 2017, IEEE T MED IMAGING, V36, P1550, DOI 10.1109/TMI.2017.2677499; Laleh NG, 2022, MED IMAGE ANAL, V79, DOI 10.1016/j.media.2022.102474; Lazard T., 2023, P IEEECVF C COMPUTER; Li B, 2021, PROC CVPR IEEE, P14313, DOI 10.1109/CVPR46437.2021.01409; Li C, 2018, MED IMAGE ANAL, V45, P121, DOI 10.1016/j.media.2017.12.002; Li HL, 2023, PROC CVPR IEEE, P7454, DOI 10.1109/CVPR52729.2023.00720; Li RY, 2018, LECT NOTES COMPUT SC, V11071, P174, DOI 10.1007/978-3-030-00934-2_20; Li ZX, 2023, ISCIENCE, V26, DOI 10.1016/j.isci.2022.105872; Liao HT, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.102; Lin TC, 2023, PROC CVPR IEEE, P19830, DOI 10.1109/CVPR52729.2023.01899; Liu KN, 2023, PROC CVPR IEEE, P3355, DOI 10.1109/CVPR52729.2023.00327; Lu MK, 2021, PR MACH LEARN RES, V156, P159; Lu MY, 2023, PROC CVPR IEEE, P19764, DOI 10.1109/CVPR52729.2023.01893; Lu MY, 2022, MED IMAGE ANAL, V76, DOI 10.1016/j.media.2021.102298; Lu MY, 2021, NATURE, V594, P106, DOI 10.1038/s41586-021-03512-4; Lu MY, 2021, NAT BIOMED ENG, V5, P555, DOI 10.1038/s41551-020-00682-w; Marini N., 2021, MICCAI WORKSH COMP P; Maron O, 1998, ADV NEUR IN, V10, P570; McKay F, 2022, J PATHOL CLIN RES, V8, P209, DOI 10.1002/cjp2.263; Naik N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19334-3; Neto PC, 2022, CANCERS, V14, DOI 10.3390/cancers14102489; Niazi MKK, 2019, LANCET ONCOL, V20, pE253, DOI 10.1016/S1470-2045(19)30154-8; Niazi MKK, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4735-5; Niehues JM, 2023, CELL REP MED, V4, DOI 10.1016/j.xcrm.2023.100980; Oliveira SP, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10144728; Oner MU, 2023, MED IMAGE ANAL, V87, DOI 10.1016/j.media.2023.102813; Pinckaers H, 2021, IEEE T MED IMAGING, V40, P1817, DOI 10.1109/TMI.2021.3066295; Qaiser T, 2018, HISTOPATHOLOGY, V72, P227, DOI 10.1111/his.13333; Qu H, 2021, NPJ PRECIS ONCOL, V5, DOI 10.1038/s41698-021-00225-9; Qu L., 2022, INT C MEDICAL IMAGE; Qu L., 2022, Advances in Neural Information Processing Systems, P15368; Renshaw AA, 2007, AM J CLIN PATHOL, V127, P144, DOI 10.1309/5KF89P63F4F6EUHB; Saillard C, 2020, HEPATOLOGY, V72, P2000, DOI 10.1002/hep.31207; Sajjad U, 2023, CANCERS, V15, DOI 10.3390/cancers15133428; Saldanha OL, 2023, NPJ PRECIS ONCOL, V7, DOI 10.1038/s41698-023-00365-0; Scheirer WJ, 2013, IEEE T PATTERN ANAL, V35, P1757, DOI 10.1109/TPAMI.2012.256; Schirris Y, 2022, MED IMAGE ANAL, V79, DOI 10.1016/j.media.2022.102464; Schmauch B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17678-4; Schrammen PL, 2022, J PATHOL, V256, P50, DOI 10.1002/path.5800; Shao W, 2021, IEEE T MED IMAGING, V40, P3739, DOI 10.1109/TMI.2021.3097319; Shao ZC, 2021, ADV NEUR IN; Sharma Y., 2021, Medical Imaging with Deep Learning; Shi B., 2022, INT WORKSHOP COMPUTA; Shmatko A, 2022, NAT CANCER, V3, P1026, DOI 10.1038/s43018-022-00436-4; Silva-Rodriguez J, 2021, IEEE J BIOMED HEALTH, V25, P3094, DOI 10.1109/JBHI.2021.3061457; Sirinukunwattana K, 2017, MED IMAGE ANAL, V35, P489, DOI 10.1016/j.media.2016.08.008; Sornapudi Sudhir, 2018, J Pathol Inform, V9, P5, DOI 10.4103/jpi.jpi_74_17; Su ZY, 2022, MED IMAGE ANAL, V79, DOI 10.1016/j.media.2022.102462; Sun CL, 2020, IEEE J BIOMED HEALTH, V24, P1643, DOI 10.1109/JBHI.2019.2949837; Swiderska-Chadaj Z, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101547; Tan LX, 2023, MED BIOL ENG COMPUT, V61, P1565, DOI 10.1007/s11517-023-02799-x; Tavolara T.E., 2021, Medical Imaging 2021: Digital Pathology; Tavolara T.E., 2022, Medical Imaging 2022: Digital and Computational Pathology; Tavolara TE, 2022, PROC SPIE, V12039, DOI 10.1117/12.2612892; Tavolara TE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55257-w; Tourniaire Paul, 2021, MICCAI WORKSH COMP P; Verma R, 2021, IEEE T MED IMAGING, V40, P3413, DOI 10.1109/TMI.2021.3085712; Wang XL, 2019, INT CONF MEASURE, P1, DOI [10.1109/ICMIC48233.2019.9068567, 10.1109/TCYB.2019.2935141]; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weitz P, 2021, IEEE INT CONF COMP V, P611, DOI 10.1109/ICCVW54120.2021.00074; Wibawa M.S., 2022, EUROPEAN C COMPUTER; Wu W, 2022, LECT NOTES COMPUT SC, V13574, P100, DOI 10.1007/978-3-031-17266-3_10; Wulczyn E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233678; Xiang HC, 2023, MED IMAGE ANAL, V89, DOI 10.1016/j.media.2023.102890; Xu HM, 2020, IEEE ACM T COMPUT BI, V17, P1871, DOI 10.1109/TCBB.2019.2941195; Xu ZR, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102394; Yang ZY, 2023, VIRCHOWS ARCH, V482, P525, DOI 10.1007/s00428-023-03502-z; Yao JW, 2020, MED IMAGE ANAL, V65, DOI 10.1016/j.media.2020.101789; Yu JG, 2023, IEEE T MED IMAGING, V42, P1809, DOI 10.1109/TMI.2023.3241204; Zhang DH, 2022, IEEE J TRANSL ENG HE, V10, DOI 10.1109/JTEHM.2022.3156851; Zhang HR, 2022, PROC CVPR IEEE, P18780, DOI 10.1109/CVPR52688.2022.01824; Zhao L, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/ac3b32; Zheng QY, 2023, CANCERS, V15, DOI 10.3390/cancers15123198; Zheng QY, 2023, CANCERS, V15, DOI 10.3390/cancers15113000; Zheng Y., 2023, IEEE Trans. Med. Imaging; Zhou CJ, 2021, COMPUT MED IMAG GRAP, V88, DOI 10.1016/j.compmedimag.2021.101861; Zhu XL, 2017, PROC CVPR IEEE, P6855, DOI 10.1109/CVPR.2017.725; Zhu ZH, 2023, IEEE T MED IMAGING, V42, P1337, DOI 10.1109/TMI.2022.3227066	124	5	5	9	13	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X	1096-3650		SEMIN CANCER BIOL	Semin. Cancer Biol.	DEC	2023	97						70	85		10.1016/j.semcancer.2023.09.006	http://dx.doi.org/10.1016/j.semcancer.2023.09.006		NOV 2023	16	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	CR5E5	37832751				2024-09-18	WOS:001126975300001
J	Henriques, L; Teixeira, DS				Henriques, Leonor; Teixeira, Diogo S.			Assessing Affective Valence and Activation in Stretching Activities with the Feeling Scale and the Felt Arousal Scale: A Systematic Review	PERCEPTUAL AND MOTOR SKILLS			English	Review						core affect; feeling; arousal; exercise; measurement	PHYSICAL-ACTIVITY; TAI-CHI; AFFECTIVE RESPONSES; HEALTH-BENEFITS; EXERCISE; INTENSITY; BEHAVIOR; MODEL; PERSPECTIVE; ADHERENCE	Affective responses have been considered key determinants for exercise adherence, but research on affective responses to stretching activities is scarce. Given the role of these responses in exercise adherence, our aim in this review was to explore (a) the utility and feasibility of core affect in stretching-related activities as measured by the Feeling Scale (FS) and/or the Felt Arousal Scale (FAS); (b) the timing of administering these scales; and (c) the scales' applicability and interpretability in this context. Inclusion criteria for studies in this review were experimental and non-experimental studies written in English that based affect assessment on the FS and/or FAS and that applied these scales to participants engaged in physical activity, individually or in groups. We also considered studies that focused on stretching activities that were either isolated or components of a class/activity and studies that used healthy participants of any age. Exclusion criteria were populations with mental health problems, cancer, diabetes, hypertension, cardiovascular disease, or diseases likely to alter pain perception or be associated with chronic pain, instrument validation studies, gray literature, and systematic reviews. We searched PubMed, SPORTDiscus and PsycINFO databases, and we added studies retrieved manually from reference sections while following PRISMA guidelines. We used the Effective Public Health Practice Project tool for judging methodological quality of research articles. Our final analyses were based on 12 empirical studies published between 2003 and 2021with a total of 718 participants. Both scales were found to be useful and feasible in the most usual places for exercise, but core affect results cannot be properly interpreted due to variability of study protocols and the absence of guidelines for adequate baseline assessment. Most studies recorded affect responses pre-session, during session, and post-session. We observed no standardized timing or frequency of assessment, and there was high heterogeneity among stretching protocols. Currently, research in core affect assessment of stretching-related activities lacks sufficient methodological quality to draw generalizable conclusions.	[Henriques, Leonor; Teixeira, Diogo S.] Lusofona Univ, Fac Phys Educ & Sport, Lisbon, Portugal; [Henriques, Leonor; Teixeira, Diogo S.] Res Ctr Sport Phys Educ & Exercise & Hlth CIDEFES, Lisbon, Portugal; [Henriques, Leonor] ULHT, Fac Educ Fis & Desporto, Campo Grande 376, P-1749024 Lisbon, Portugal	Lusofona University	Henriques, L (corresponding author), ULHT, Fac Educ Fis & Desporto, Campo Grande 376, P-1749024 Lisbon, Portugal.	leonor.henriques14@gmail.com	Teixeira, Diogo/J-5489-2019	Teixeira, Diogo/0000-0003-4587-5903				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andrade AJ, 2022, PSYCHOL SPORT EXERC, V62, DOI 10.1016/j.psychsport.2022.102223; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Barbosa Germanna Medeiros, 2018, Rev. Bras. Ciênc. Esporte, V40, P418, DOI 10.1016/j.rbce.2018.06.002; Beltrao NB, 2020, J SPORT REHABIL, V29, P904, DOI 10.1123/jsr.2018-0443; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brand R, 2018, GER J EXERC SPORT RE, V48, P48, DOI [10.1007/s12662-017-0477-9, 10.1007/s12662-017-0450-7]; Cavarretta DJ, 2019, FRONT SPORTS ACT LIV, V1, DOI 10.3389/fspor.2019.00005; Chao CHN, 2014, PERCEPT MOTOR SKILL, V118, P926, DOI 10.2466/10.06.PMS.118k27w5; Cheval B, 2021, EXERC SPORT SCI REV, V49, P168, DOI 10.1249/JES.0000000000000252; Cruz-Ferreira A, 2011, ARCH PHYS MED REHAB, V92, P2071, DOI 10.1016/j.apmr.2011.06.018; DiGiacomo M, 2010, J ALTERN COMPLEM MED, V16, P1245, DOI 10.1089/acm.2010.0510; Duda J.L., 1998, ADV SPORT EXERCISE P; Edwards MK, 2018, PHYSIOL BEHAV, V186, P16, DOI 10.1016/j.physbeh.2017.12.037; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Ekkekakis P., 2000, PSYCHOL SPORT EXERCI, V1, P71, DOI DOI 10.1016/S1469-0292(00)00010-8; Ekkekakis P, 2016, SPORT AND EXERCISE PSYCHOLOGY RESEARCH: FROM THEORY TO PRACTICE, P389, DOI 10.1016/B978-0-12-803634-1.00018-2; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Emanuel A, 2021, INT J SPORT PHYSIOL, V16, P135, DOI 10.1123/ijspp.2019-0733; Evmenenko A, 2022, INT J SPORT EXERC PS, V20, P168, DOI 10.1080/1612197X.2020.1854818; Fernández-Rodríguez R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111761; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Follador L, 2019, PERCEPT MOTOR SKILL, V126, P223, DOI 10.1177/0031512518823661; Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/S2214-109X(18)30357-7, 10.1016/s2214-109x(18)30357-7]; Haile L., 2015, Perceived exertion laboratory manual, P29, DOI [DOI 10.1007/978-1-4939-1917-8, 10.1007/978-1-4939-1917-8]; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Ladwig MA, 2017, ACSMS HEALTH FIT J, V21, P10, DOI 10.1249/FIT.0000000000000332; Lee J, 2021, PERCEPT MOTOR SKILL, V128, P2255, DOI 10.1177/00315125211022700; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Martin Dantas E. H., 2008, FIT PERFORM J, V7, P289, DOI [10.3900/fpj.7.5.289.e, DOI 10.3900/FPJ.7.5.289.E]; McAuley E, 2003, PREV MED, V37, P110, DOI 10.1016/S0091-7435(03)00089-6; McAuley E, 2003, ANN BEHAV MED, V25, P1, DOI 10.1207/S15324796ABM2501_01; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Melo RRV, 2021, MLTJ-MUSCLE LIGAMENT, V11, P536, DOI 10.32098/mltj.03.2021.19; Methley AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0579-0; Miyamoto GC, 2013, BRAZ J PHYS THER, V17, P517, DOI 10.1590/S1413-35552012005000127; Nikitara K, 2021, EUR J PUBLIC HEALTH, V31, P840, DOI 10.1093/eurpub/ckab067; Opplert J, 2018, SPORTS MED, V48, P299, DOI 10.1007/s40279-017-0797-9; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n160; Panao I, 2020, NUTR DIET, V77, P41, DOI 10.1111/1747-0080.12575; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rebar AL, 2016, HEALTH PSYCHOL REV, V10, P395, DOI 10.1080/17437199.2016.1183505; Reed J., 2014, J SPORT BEHAV, V37, P268; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Riebe D., 2018, ACSMS GUIDELINES EXE; Rodrigues F, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10020098; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Smith C, 2007, COMPLEMENT THER MED, V15, P77, DOI 10.1016/j.ctim.2006.05.001; Stevens CJ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.568331; Strobach T., 2020, Performance Enhancement Health, V8, P100162, DOI [DOI 10.1016/J.PEH.2020.100162, https://doi.org/10.1016/j.peh.2020.100162]; Sullivan M, 2019, J HEALTH PSYCHOL, V24, P1658, DOI 10.1177/1359105317694487; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Telles Shirley, 2012, Indian J Physiol Pharmacol, V56, P245; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Thomas J, 2020, J AFFECT DISORDERS, V265, P475, DOI 10.1016/j.jad.2020.01.070; Thompson WR, 2022, ACSMS HEALTH FIT J, V26, P11, DOI 10.1249/FIT.0000000000000732; Vandoni M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149997; Veldman SLC, 2021, INT J BEHAV NUTR PHY, V18, DOI 10.1186/s12966-020-01072-w; Wang Chenchen, 2010, BMC Complement Altern Med, V10, P23, DOI 10.1186/1472-6882-10-23; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Williams DM, 2008, J SPORT EXERCISE PSY, V30, P471, DOI 10.1123/jsep.30.5.471; Williams DM, 2014, EMOT REV, V6, P277, DOI 10.1177/1754073914523052; Yeh Gloria Y, 2008, Prev Cardiol, V11, P82; Yeh GY, 2009, J CARDIOPULM REHABIL, V29, P152, DOI 10.1097/HCR.0b013e3181a33379; Yoshihara K, 2014, BIOPSYCHOSOC MED, V8, DOI 10.1186/1751-0759-8-1; Zenko Z., 2021, Essentials of exercise and sport psychology: An open access textbook, P271, DOI DOI 10.51224/B1000; Zenko Z, 2016, J SPORT EXERCISE PSY, V38, P149, DOI 10.1123/jsep.2015-0286	70	3	3	1	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	2023	130	3					1099	1122		10.1177/00315125231160203	http://dx.doi.org/10.1177/00315125231160203		MAR 2023	24	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	I6YD9	36855919	hybrid, Green Published			2024-09-18	WOS:000941817600001
J	Alsharaiah, MA; Baniata, LH; Adwan, O; Abu-Shareha, AA; Abu Alhaf, M; Kharma, Q; Hussein, A; Abualghanam, O; Alassaf, N; Baniata, M				Alsharaiah, Mohammad A.; Baniata, Laith H.; Adwan, Omar; Abu-Shareha, Ahmad Adel; Abu Alhaf, Mosleh; Kharma, Qasem; Hussein, Abdelrahman; Abualghanam, Orieb; Alassaf, Nabeel; Baniata, Mohammad			Attention-based Long Short Term Memory Model for DNA Damage Prediction in Mammalian Cells	INTERNATIONAL JOURNAL OF ADVANCED COMPUTER SCIENCE AND APPLICATIONS			English	Article						Mammalian cell; deep learning techniques; attention; LSTM; classification; DNA damage	CLASSIFICATION; CYCLE; REPAIR; CANCER	The understanding of DNA damage intensity - concentration-level is critical for biological and biomedical research, such as cellular homeostasis, tumor suppression, immunity, and gametogenesis. Therefore, recognizing and quantifying DNA damage intensity levels is a substantial issue, which requires further robust and effective approaches. DNA damage has several intensity levels. These levels of DNA damage in malignant cells and in other unhealthy cells are significant in the assessment of lesion stages located in normal cells. There is a need to get more insight from the available biological data to predict, explore and classify DNA damage intensity levels. Herein, the development process relied on the available biological dataset related to DNA damage signaling pathways, which plays a crucial role in DNA damage in the mammalian cell system. The biological dataset that was used in the proposed model consists of 15000 records intensity - concentration-level for a set of five proteins which regulate DNA damage. This research paper proposes an innovative deep learning model, which consists of an attention-based long short term-memory (AT-LSTM) model for DNA damage multi class predictions. The proposed model splits the prediction procedure into dual stages. For the first stage, we adopt the related feature sequences which are inserted as input to the LSTM neural network. In the next stage, the attention feature is applied efficiently to adopt the related feature sequences which are inserted as input to the softmax layer for prediction in the following frame. Our developed framework not only solves the long-term dependence problem of prediction effectively, but also enhances the interpretability of the prediction methods that was established on the neural network. We conducted a novel proposed model on big and complex biological datasets to perform prediction and multi classification tasks. Indeed, the (AT-LSTM) model has the ability to predict and classify the DNA damage in several classes: No-Damage, Low-damage, Medium-damage, High-damage, and Excess -damage. The experimental results show that our framework for DNA damage intensity level can be considered as state of the art for the biological DNA damage prediction domain.	[Alsharaiah, Mohammad A.; Adwan, Omar; Abu-Shareha, Ahmad Adel; Abu Alhaf, Mosleh; Kharma, Qasem; Hussein, Abdelrahman; Abualghanam, Orieb] Al Ahliyya Amman Univ, Amman, Jordan; [Baniata, Laith H.] Gachon Univ, Seongnam, South Korea; [Alassaf, Nabeel] Univ Jordan, Amman, Jordan; [Baniata, Mohammad] Ubion, Seoul, South Korea	Al-Ahliyya Amman University; Gachon University; University of Jordan	Alsharaiah, MA (corresponding author), Al Ahliyya Amman Univ, Amman, Jordan.; Baniata, LH (corresponding author), Gachon Univ, Seongnam, South Korea.		Baniata, Laith/S-3656-2018; AbuAlganam, Oraib/HJP-7786-2023; Abualhaj, Mosleh/IQS-2781-2023; Abu-Shareha, Ahmad/S-8633-2016; Alassaf, Nabeel/C-8427-2015	Baniata, Laith/0000-0002-0029-0859; AbuAlganam, Oraib/0000-0002-2057-9457; Alassaf, Nabeel/0000-0001-9409-2353; Abualhaj, Mosleh/0000-0002-7465-8038; AbuAlganam, Oraib/0000-0002-2485-9237; Abu-Shareha, Ahmad/0000-0002-2374-3152				[Anonymous], 2001, CURRENT TOPICS COMPU; Atila Ü, 2020, COMPUT METH PROG BIO, V186, DOI 10.1016/j.cmpb.2019.105192; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chen XC, 2020, ANAL CHEM, V92, P14267, DOI 10.1021/acs.analchem.0c03741; Csikász-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; DUDOIT S, 2000, 576 U CAL DEP STAT; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; Fu JL, 2017, PROC CVPR IEEE, P4476, DOI 10.1109/CVPR.2017.476; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hamada H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004795; Hartuv E, 2000, GENOMICS, V66, P249, DOI 10.1006/geno.2000.6187; Iwamoto K, 2011, BIOSYSTEMS, V103, P384, DOI 10.1016/j.biosystems.2010.11.011; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim Y. Y., 2017, Intercultural communication. Core theories, issues and concepts, DOI [10.1002/9781118783665.ieicc0041, DOI 10.1002/9781118783665.IEICC0041]; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Li G, 1998, BRIT J DERMATOL, V139, P3; Li LP, 2001, BIOINFORMATICS, V17, P1131, DOI 10.1093/bioinformatics/17.12.1131; Ling H, 2010, BIOSYSTEMS, V101, P213, DOI 10.1016/j.biosystems.2010.07.005; Ma JZ, 2018, NAT METHODS, V15, P290, DOI [10.1038/NMETH.4627, 10.1038/nmeth.4627]; Maluf SW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/696104; Martín-Navarro A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1562-7; Nelson BC, 2020, MUTAGENESIS, V35, P1, DOI 10.1093/mutage/gez048; Novák M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Qu ZL, 2003, AM J PHYSIOL-CELL PH, V284, pC349, DOI 10.1152/ajpcell.00066.2002; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sommer C, 2017, MOL BIOL CELL, V28, P3428, DOI 10.1091/mbc.E17-05-0333; Tashima Y, 2008, J BIOSCI BIOENG, V106, P368, DOI 10.1263/jbb.106.368; Vadivazhagu D. M. a. S, 2020, PREDICTING DNA DAMAG; Vaswani A, 2023, Arxiv, DOI [arXiv:1706.03762, DOI 10.48550/ARXIV.1706.03762]; Won S.-B. C. a. H.-H, 2003, MACHINE LEARNING DNA; Yoni Schirris E. G. I. N. H. M. H. J. T., 2021, ELECT ENG SYSTEMS SC	34	1	1	0	7	SCIENCE & INFORMATION SAI ORGANIZATION LTD	WEST YORKSHIRE	19 BOLLING RD, BRADFORD, WEST YORKSHIRE, 00000, ENGLAND	2158-107X	2156-5570		INT J ADV COMPUT SC	Int. J. Adv. Comput. Sci. Appl.	SEP	2022	13	9					91	99						9	Computer Science, Theory & Methods	Emerging Sources Citation Index (ESCI)	Computer Science	5S9LO					2024-09-18	WOS:000875502200001
J	Mercieca-Bebber, R; Palmer, MJ; Brundage, M; Calvert, M; Stockler, MR; King, MT				Mercieca-Bebber, Rebecca; Palmer, Michael J.; Brundage, Michael; Calvert, Melanie; Stockler, Martin R.; King, Madeleine T.			Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review	BMJ OPEN			English	Review						patient-reported outcomes; health-related quality of life; missing data; quality assurance; systematic review; methodology	QUALITY-OF-LIFE; CANCER CLINICAL-TRIALS; RANDOMIZED CONTROLLED-TRIALS; METHODOLOGICAL ISSUES; PRACTICAL ISSUES; PREVENTION; ASSESSMENTS; COLLECTION; GUIDELINES; BREAST	Objectives Patient-reported outcomes (PROs) provide important information about the impact of treatment from the patients' perspective. However, missing PRO data may compromise the interpretability and value of the findings. We aimed to report: (1) a non-technical summary of problems caused by missing PRO data; and (2) a systematic review by collating strategies to: (A) minimise rates of missing PRO data, and (B) facilitate transparent interpretation and reporting of missing PRO data in clinical research. Our systematic review does not address statistical handling of missing PRO data. Data sources MEDLINE and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases (inception to 31 March 2015), and citing articles and reference lists from relevant sources. Eligibility criteria English articles providing recommendations for reducing missing PRO data rates, or strategies to facilitate transparent interpretation and reporting of missing PRO data were included. Methods 2 reviewers independently screened articles against eligibility criteria. Discrepancies were resolved with the research team. Recommendations were extracted and coded according to framework synthesis. Results 117 sources (55% discussion papers, 26% original research) met the eligibility criteria. Design and methodological strategies for reducing rates of missing PRO data included: incorporating PRO-specific information into the protocol; carefully designing PRO assessment schedules and defining termination rules; minimising patient burden; appointing a PRO coordinator; PRO-specific training for staff; ensuring PRO studies are adequately resourced; and continuous quality assurance. Strategies for transparent interpretation and reporting of missing PRO data include utilising auxiliary data to inform analysis; transparently reporting baseline PRO scores, rates and reasons for missing data; and methods for handling missing PRO data. Conclusions The instance of missing PRO data and its potential to bias clinical research can be minimised by implementing thoughtful design, rigorous methodology and transparent reporting strategies. All members of the research team have a responsibility in implementing such strategies.	[Mercieca-Bebber, Rebecca; Stockler, Martin R.; King, Madeleine T.] Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia; [Mercieca-Bebber, Rebecca; King, Madeleine T.] Univ Sydney, Sch Psychol, Psychooncol Cooperat Res Grp, Sydney, NSW, Australia; [Palmer, Michael J.; Brundage, Michael] Queens Univ, Canc Res Inst, Dept Canc Care & Epidemiol, Kingston, ON, Canada; [Calvert, Melanie] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Stockler, Martin R.] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia	University of Sydney; University of Sydney; Queens University - Canada; University of Birmingham; University of Sydney	Mercieca-Bebber, R (corresponding author), Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia.; Mercieca-Bebber, R (corresponding author), Univ Sydney, Sch Psychol, Psychooncol Cooperat Res Grp, Sydney, NSW, Australia.	Rebecca.Mercieca@sydney.edu.au	Calvert, Melanie/F-7055-2011; MerciecaBebber, Rebecca/KPB-5783-2024; Stockler, Martin/N-3859-2016	Mercieca-Bebber, Rebecca/0000-0003-3708-9099; Calvert, Melanie/0000-0002-1856-837X	Sydney Catalyst, courtesy of the Cancer Institute New South Wales; Australian Government through Cancer Australia	Sydney Catalyst, courtesy of the Cancer Institute New South Wales; Australian Government through Cancer Australia(Australian Government)	RM-B is supported by Sydney Catalyst, courtesy of the Cancer Institute New South Wales. MTK is supported by the Australian Government through Cancer Australia.	Aaronson N K, 1990, Oncology (Williston Park), V4, P59; [Anonymous], REFL PAP US IN PRESS; [Anonymous], ASSESSING QUALITY LI; [Anonymous], 2009, GUID IND PAT REP OUT; [Anonymous], 2002, GUIDELINES ASSESSING; [Anonymous], QUAL LIFE RES; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Bell ML, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-118; Bell ML, 2014, STAT METHODS MED RES, V23, P440, DOI 10.1177/0962280213476378; Bernhard J, 1998, STAT MED, V17, P517, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<517::AID-SIM799>3.0.CO;2-S; Bernhard J, 1998, STAT MED, V17, P587, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<587::AID-SIM806>3.3.CO;2-R; Bernhard J, 1998, STAT MED, V17, P633, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<633::AID-SIM810>3.0.CO;2-U; Bernhard J, 1998, STAT MED, V17, P511, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<511::AID-SIM798>3.3.CO;2-3; Brundage M, 2013, QUAL LIFE RES, V22, P1161, DOI 10.1007/s11136-012-0252-1; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Bylicki O, 2015, ANN ONCOL, V26, P231, DOI 10.1093/annonc/mdu489; Calvert M, 2015, LANCET, V385, P1073, DOI 10.1016/S0140-6736(15)60599-2; Calvert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110216; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Cantrell MA, 2007, J ADV NURS, V60, P544, DOI 10.1111/j.1365-2648.2007.04448.x; Cella D F, 1994, Qual Manag Health Care, V2, P28; CELLA DF, 1995, SUPPORT CARE CANCER, V3, P11, DOI 10.1007/BF00343916; Cherny NI, 2015, ANN ONCOL, V26, P1547, DOI 10.1093/annonc/mdv249; Curran D, 1998, STAT MED, V17, P739, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<739::AID-SIM818>3.0.CO;2-M; Curran D, 1998, STAT MED, V17, P697, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<697::AID-SIM815>3.0.CO;2-Y; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Edwards P, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000008.pub3, 10.1002/14651858.MR000008.pub4]; Efficace F, 2015, CANCER-AM CANCER SOC, V121, P3335, DOI 10.1002/cncr.29489; Fairclough DL, 2010, DESIGN AND ANALYSIS OF QUALITY OF LIFE STUDIES IN CLINICAL TRIALS, SECOND EDITION, P1, DOI 10.1201/9781420061185; Fairclough DL, 1998, STAT MED, V17, P667, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<667::AID-SIM813>3.3.CO;2-Y; Fairclough DL, 1998, STAT MED, V17, P781, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<781::AID-SIM821>3.0.CO;2-O; Fallowfield L, 1998, STAT MED, V17, P541; Fallowfield LJ, 2005, LUNG CANCER, V48, P365, DOI 10.1016/j.lungcan.2004.11.018; Fielding S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-57; Fielding S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-51; Friedlander M, 2016, ANN ONCOL, V27, P66, DOI 10.1093/annonc/mdw080; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Ganz PA, 1998, STAT MED, V17, P613, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<613::AID-SIM808>3.0.CO;2-9; Gheorghe A, 2015, PHARMACOECONOMICS, V33, P1195, DOI 10.1007/s40273-015-0298-3; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Hahn EA, 1998, STAT MED, V17, P547, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<547::AID-SIM802>3.0.CO;2-F; Hayden K A, 1993, Oncol Nurs Forum, V20, P1415; Hellard ME, 2001, J EPIDEMIOL COMMUN H, V55, P348, DOI 10.1136/jech.55.5.348; Jüni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; King MT, 2011, EXPERT REV PHARM OUT, V11, P171, DOI [10.1586/erp.11.9, 10.1586/ERP.11.9]; Kyte D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110229; Land SR, 2007, J CLIN ONCOL, V25, P5113, DOI 10.1200/JCO.2007.12.1749; Larkin ME, 2012, CLIN TRIALS, V9, P418, DOI 10.1177/1740774512449532; Little RJ, 2012, STAT MED, V31, P3433, DOI 10.1002/sim.5519; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mercieca-Bebber RL, 2016, EUR J CANCER, V56, P144, DOI 10.1016/j.ejca.2015.12.025; Moher D, 2000, J CLIN EPIDEMIOL, V53, P964, DOI 10.1016/S0895-4356(00)00188-8; Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086]; Osoba D, 2005, EUR J CANCER, V41, P280, DOI 10.1016/j.ejca.2004.10.017; Osoba D, 1996, J Natl Cancer Inst Monogr, P107; Osoba D, 2007, VALUE HEALTH, V10, pS138, DOI 10.1111/j.1524-4733.2007.00278.x; Palmer MJ, 2015, QUAL LIFE RES, V24, P138; Rouette J, 2015, QUAL LIFE RES, V24, P1317, DOI 10.1007/s11136-014-0871-9; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schandelmaier S, 2015, ANN ONCOL, V26, P1966, DOI 10.1093/annonc/mdv283; Scott Richard B, 2004, Clin Trials, V1, P31, DOI 10.1191/1740774504cn008xx; Staquet M, 1996, QUAL LIFE RES, V5, P496, DOI 10.1007/BF00540022; Tabachnik BG., 2012, Using Multivariate Statistics, V6th; Tang ST, 2002, CANCER INVEST, V20, P1086, DOI 10.1081/CNV-120005928; Taphoorn MJB, 2010, ONCOLOGIST, V15, P618, DOI 10.1634/theoncologist.2009-0291; Walker M, 2003, J NEURO-ONCOL, V63, P179, DOI 10.1023/A:1023900802254; Wilcox Sara, 2001, Controlled Clinical Trials, V22, P279, DOI 10.1016/S0197-2456(00)00130-6; Wisniewski SR, 2006, BIOL PSYCHIAT, V59, P997, DOI 10.1016/j.biopsych.2006.01.017; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006; Young T, 1999, PSYCHO-ONCOL, V8, P260, DOI 10.1002/(SICI)1099-1611(199905/06)8:3<260::AID-PON383>3.0.CO;2-Z	70	90	95	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	6							e010938	10.1136/bmjopen-2015-010938	http://dx.doi.org/10.1136/bmjopen-2015-010938			47	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR9ST	27311907	Green Published, gold			2024-09-18	WOS:000380237100076
J	Eng, JY; Moy, FM; Bulgiba, A; Rampal, S				Eng, Jui-Yee; Moy, Foong-Ming; Bulgiba, Awang; Rampal, Sanjay			Consistency and Generalizability of Dietary Patterns in a Multiethnic Working Population	JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS			English	Article						Dietary pattern; Consistency; Generalizability; Multiethnic	EXPLORATORY FACTOR-ANALYSIS; LIFE-STYLE FACTORS; CANCER RISK; NUTRITIONAL EPIDEMIOLOGY; METABOLIC SYNDROME; MEASUREMENT ERROR; ETHNIC-GROUPS; YOUNG-ADULTS; FOOD; HEALTH	Background Dietary pattern analysis is a complementary method to nutrient analysis in evaluating overall diet-disease hypotheses. Although studies have been conducted to derive dietary patterns among Malaysians, their consistency across subgroups has not been examined. Objective The study aimed to derive dietary patterns empirically and to examine the consistency and generalizability of patterns across sex, ethnicity, and urban status in a working population. Design This was a cross-sectional study using data from the Clustering of Lifestyle Risk Factors and Understanding its Association with Stress on Health and Well-Being among School Teachers in Malaysia study collected between August 2014 and November 2015. Dietary intake was assessed using a food frequency questionnaire, and dietary patterns were derived using factor analysis. Participants/setting Participants were teachers from selected public schools from three states in Peninsular Malaysia (n=4,618). Main outcome measures Dietary patterns derived using factor analysis. Statistical analyses performed Separate factor analysis was conducted by sex, ethnicity, and urban status to identify dietary patterns. Eigenvalue >2, scree plot, Velicer's minimum average partial analysis, and Horn's parallel analysis were used to determine the number of factors to retain. The interpretability of each dietary pattern was evaluated. The consistency and generalizability of dietary patterns across subgroups were assessed using the Tucker congruence coefficient. Results There was no subgroup-specific dietary pattern found. Thus, dietary patterns were derived using the pooled sample in the final model. Two dietary patterns (Western and Prudent) were derived. The Western dietary pattern explained 15.4% of total variance, characterized by high intakes of refined grains, animal-based foods, added fat, and sugar-sweetened beverages as well as fast food. The Prudent dietary pattern explained 11.1% of total variance and was loaded with pulses, legumes, vegetables, and fruits. Conclusions The derived Western and Prudent dietary patterns were consistent and generalizable across subgroups of sex, ethnicity, and urban status. Further research is needed to explore associations between these dietary patterns and chronic diseases.	[Eng, Jui-Yee; Moy, Foong-Ming; Bulgiba, Awang; Rampal, Sanjay] Univ Malaya, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Moy, FM (corresponding author), Univ Malaya, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur 50603, Malaysia.	moyfm@um.edu.my	Rampal, Sanjay/B-9691-2010; Bulgiba, Awang/B-8271-2010; Moy, Foong Ming/B-7899-2010	Bulgiba, Awang/0000-0002-5313-0445; ENG, JUI YEE/0000-0003-0131-5189; Moy, Foong Ming/0000-0002-0306-4419	Malaysia Ministry of Higher Education High Impact Research Grant [H-20001-00-E2000069]; University of Malaya [PG060-2013A]	Malaysia Ministry of Higher Education High Impact Research Grant; University of Malaya(Universiti Malaya)	This work was funded by a Malaysia Ministry of Higher Education High Impact Research Grant (no. H-20001-00-E2000069) and Postgraduate Research Grant from the University of Malaya (no. PG060-2013A).	Aekplakorn W, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/468759; [Anonymous], 2013, NUTR PRO VERSION 5 0; [Anonymous], FOOD NUTR RES; [Anonymous], 2008, REPORT WHO EXPERT CO; [Anonymous], 1997, Nutrient Composition of Malaysian Foods; [Anonymous], 2009, TELEFORM VERSION 10; [Anonymous], 2013, Stata Statistical Software: Release 13; [Anonymous], NAT HLTH MORB SURV 2; Asma A., 2014, EXPLORATION DIETARY; Ax E, 2016, BRIT J NUTR, V115, P95, DOI 10.1017/S0007114515004110; Batis C, 2014, BRIT J NUTR, V111, P1441, DOI 10.1017/S0007114513003917; Bertuccio P, 2013, ANN ONCOL, V24, P1450, DOI 10.1093/annonc/mdt108; Beydoun MA, 2008, EUR J CLIN NUTR, V62, P303, DOI 10.1038/sj.ejcn.1602700; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Borges Camila Aparecida, 2015, Rev. bras. epidemiol., V18, P837, DOI 10.1590/1980-5497201500040013; Brennan SF, 2010, AM J CLIN NUTR, V91, P1294, DOI 10.3945/ajcn.2009.28796; Chee S, 1997, MAL J NUTR, V3, P10; Costello AB, 2005, PRACT ASSES RES EVAL, V10, P9; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daniel CR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-12; Day NE, 2004, INT J EPIDEMIOL, V33, P1373, DOI 10.1093/ije/dyh138; Dekker LH, 2015, J NUTR, V145, P1884, DOI 10.3945/jn.114.207472; Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261; Fraser GE, 2009, EPIDEMIOLOGY, V20, P289, DOI 10.1097/EDE.0b013e31819642c4; Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189; Gaskin CJ, 2014, INT J NURS STUD, V51, P511, DOI 10.1016/j.ijnurstu.2013.10.005; Hasan AR, 2014, MALAY J U ERBCOANOIS, V51, P15; Hazizi AS, 2014, PERTANIKA J SCI TECH, V22, P401; Health Promotion Board, EN NUTR COMP; Helen-Ng LC, 2012, COMMUNITY DENT ORAL, V40, P560, DOI 10.1111/j.1600-0528.2012.00704.x; Higgs S, 2016, CURR OPIN BEHAV SCI, V9, P1, DOI 10.1016/j.cobeha.2015.10.005; Hodge A, 2016, PUBLIC HEALTH NUTR, V19, P191, DOI 10.1017/S1368980015003730; Hodge AM, 2007, AM J EPIDEMIOL, V165, P603, DOI 10.1093/aje/kwk061; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Institute for Public Health, 2015, National Health and Morbidity Survey 2015 - Report on Smoking Status Among Malaysian Adults; Ishak N, 2013, PROCD SOC BEHV, V105, P438, DOI 10.1016/j.sbspro.2013.11.046; Judd Suzanne E, 2014, Front Nutr, V1, P29, DOI 10.3389/fnut.2014.00029; Kang Y, 2016, EUR J NUTR, V55, P2321, DOI 10.1007/s00394-015-1127-3; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kjollesdal MKR, 2010, EUR J CLIN NUTR, V64, P1150, DOI 10.1038/ejcn.2010.116; Knudsen VK, 2014, EUR J CLIN NUTR, V68, P736, DOI 10.1038/ejcn.2014.38; Koster-Rasmussen R, 2014, PUBLIC HEALTH NUTR, P1; Lorenzo-Seva U., 2006, EUR J RES METHODS BE, V2, P15; Malik VS, 2012, DIABETES CARE, V35, P12, DOI 10.2337/dc11-0386; McEvoy CT, 2014, J ACAD NUTR DIET, V114, P1759, DOI 10.1016/j.jand.2014.05.001; Michels KB, 2009, EPIDEMIOLOGY, V20, P295, DOI 10.1097/EDE.0b013e3181931515; Minkov M., 2013, CROSS CULTURAL ANAL; Mirnalini K Jr, 2008, Malays J Nutr, V14, P1; Moy FM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-611; Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008; Naja F, 2011, PUBLIC HEALTH NUTR, V14, P1570, DOI 10.1017/S136898001100070X; Nanri A, 2013, EUR J CLIN NUTR, V67, P18, DOI 10.1038/ejcn.2012.171; Noor MI, 2002, MALAY J NUTR, V5, P4; Norimah A K Jr, 2008, Malays J Nutr, V14, P25; Ocké MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Rhee JJ, 2015, DIABETES CARE, V38, P596, DOI 10.2337/dc14-1986; Rodríguez-Monforte M, 2015, BRIT J NUTR, V114, P1341, DOI 10.1017/S0007114515003177; Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697; San-Cristobal R, 2015, NUTRIENTS, V7, P9523, DOI 10.3390/nu7115482; Sherzai A, 2012, NUTR REV, V70, P423, DOI 10.1111/j.1753-4887.2012.00490.x; Slattery ML, 2010, APPL PHYSIOL NUTR ME, V35, P207, DOI 10.1139/H10-006; Soon JM, 2014, INT J NUT FOOD SCI, V3, P11; Spronk I, 2014, BRIT J NUTR, V111, P1713, DOI 10.1017/S0007114514000087; Steinemann N, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1305193; Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010; van Dam RM, 2005, BRIT J NUTR, V93, P573, DOI 10.1079/BJN20051453; Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5; Whittle CR, 2012, BRIT J NUTR, V108, P1494, DOI 10.1017/S0007114511006787; Willett W., 1998, NUTR EPIDEMIOLOGY; Xu SH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040180; Yap RWK, 2011, J NUTRIGENET NUTRIGE, V4, P309, DOI 10.1159/000334358; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; Yusof AS, 2012, ASIAN PAC J CANCER P, V13, P4713, DOI 10.7314/APJCP.2012.13.9.4713	76	10	11	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-2672	2212-2680		J ACAD NUTR DIET	J. Acad. Nutr. Diet.	JUL	2018	118	7					1249	+		10.1016/j.jand.2018.01.014	http://dx.doi.org/10.1016/j.jand.2018.01.014			17	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	GK8OY	29615325				2024-09-18	WOS:000436487300011
J	Yan, S; Kwan, YH; Tan, CS; Thumboo, J; Low, LL				Yan, Shi; Kwan, Yu Heng; Tan, Chuen Seng; Thumboo, Julian; Low, Lian Leng			A systematic review of the clinical application of data-driven population segmentation analysis	BMC MEDICAL RESEARCH METHODOLOGY			English	Review						Systematic review; Population segmentation; Data analytics; Population health; Public health; Health policy; Health services research	LATENT CLASS ANALYSIS; POSTTRAUMATIC-STRESS-DISORDER; ELDERLY CARDIAC PATIENTS; CLUSTER-ANALYSIS; DIETARY PATTERNS; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; EATING PATTERNS; OLDER-ADULTS; CANCER-RISK	BackgroundData-driven population segmentation analysis utilizes data analytics to divide a heterogeneous population into parsimonious and relatively homogenous groups with similar healthcare characteristics. It is a promising patient-centric analysis that enables effective integrated healthcare interventions specific for each segment. Although widely applied, there is no systematic review on the clinical application of data-driven population segmentation analysis.MethodsWe carried out a systematic literature search using PubMed, Embase and Web of Science following PRISMA criteria. We included English peer-reviewed articles that applied data-driven population segmentation analysis on empirical health data. We summarized the clinical settings in which segmentation analysis was applied, compared and contrasted strengths, limitations, and practical considerations of different segmentation methods, and assessed the segmentation outcome of all included studies. The studies were assessed by two independent reviewers.ResultsWe retrieved 14,514 articles and included 216 articles. Data-driven population segmentation analysis was widely used in different clinical contexts. 163 studies examined the general population while 53 focused on specific population with certain diseases or conditions, including psychological, oncological, respiratory, cardiovascular, and gastrointestinal conditions. Variables used for segmentation in the studies are heterogeneous. Most studies (n=170) utilized secondary data in community settings (n=185). The most common segmentation method was latent class/profile/transition/growth analysis (n=96) followed by K-means cluster analysis (n=60) and hierarchical analysis (n=50), each having its advantages, disadvantages, and practical considerations. We also identified key criteria to evaluate a segmentation framework: internal validity, external validity, identifiability/interpretability, substantiality, stability, actionability/accessibility, and parsimony.ConclusionsData-driven population segmentation has been widely applied and holds great potential in managing population health. The evaluations of segmentation outcome require the interplay of data analytics and subject matter expertise. The optimal framework for segmentation requires further research.	[Yan, Shi] Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore; [Kwan, Yu Heng] Duke NUS Med Sch, Program Hlth Serv & Syst Res, 8 Coll Rd, Singapore 169857, Singapore; [Tan, Chuen Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr 2, Singapore 117549, Singapore; [Thumboo, Julian] Singapore Gen Hosp, Rheumatol & Immunol, 16 Coll Rd,Block 6,Level 9, Singapore 169854, Singapore; [Low, Lian Leng] Singapore Gen Hosp, Family Med & Continuing Care, Outram Rd,Bowyer Block,Block A,Level 2, Singapore 169608, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital	Low, LL (corresponding author), Singapore Gen Hosp, Family Med & Continuing Care, Outram Rd,Bowyer Block,Block A,Level 2, Singapore 169608, Singapore.	low.lian.leng@singhealth.com.sg	Kwan, Yu/I-4099-2019; Tan, Chuen/K-1078-2013; Low, Lian Leng/M-2853-2016	Low, Lian Leng/0000-0003-4228-2862				Adams MA, 2015, AM J PREV MED, V49, P878, DOI 10.1016/j.amepre.2015.05.024; Adams MA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-34; Adams MA, 2012, AM J HEALTH BEHAV, V36, P757, DOI 10.5993/AJHB.36.6.4; Adams MA, 2011, PREV MED, V52, P326, DOI 10.1016/j.ypmed.2011.02.020; [Anonymous], 2013, CHOOSE HLTH DELAWARE; Bailey RL, 2006, J AM DIET ASSOC, V106, P1194, DOI 10.1016/j.jada.2006.05.012; Bamia C, 2005, BRIT J NUTR, V94, P100, DOI 10.1079/BJN20051456; Beard JR, 2016, GERONTOLOGIST, V56, pS163, DOI 10.1093/geront/gnw037; Berlin KS, 2014, J PEDIATR PSYCHOL, V39, P174, DOI 10.1093/jpepsy/jst084; Bittmann RM, 2007, EXPERT SYST, V24, P171, DOI 10.1111/j.1468-0394.2007.00428.x; Boone-Heinonen J, 2008, ANN BEHAV MED, V36, P217, DOI 10.1007/s12160-008-9074-3; Boudier A, 2013, AM J RESP CRIT CARE, V188, P550, DOI 10.1164/rccm.201301-0156OC; Buskirk T.D., 2018, Survey Practice, V11, P1, DOI [DOI 10.29115/SP-2018-0003, 10.29115/sp-2018-0003]; Calinski T., 1974, Commun. Stat. Theory Methods, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chawla S, K MEANS UNIFIED APPR; Chong JL, 2017, ANN ACAD MED SINGAP, V46, P287; Collins LM, 2010, SCI YORK, V122-23; Conry MC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-692; Croezen S, 2009, J NUTR HEALTH AGING, V13, P776, DOI 10.1007/s12603-009-0213-8; Duda RO, 1973, LEONARDO, V97-99; Engeset D, 2005, EUR J CLIN NUTR, V59, P675, DOI 10.1038/sj.ejcn.1602129; Erlich Z, 2003, J COMPUT INFORM SYST, V43, P100; Eshghi A., 2011, Journal of Data Science, V9, P271, DOI [DOI 10.6339/JDS.20110409(2).0009, 10.6339/jds.2011.09(2).929, DOI 10.6339/JDS.201104_09(2).0009]; EVERITT B, 1980, QUAL QUANT, V14, P75, DOI 10.1007/BF00154794; Finch H., 2005, Journal of Data Science, V3, P85, DOI DOI 10.6339/JDS.2005.03(1).192; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Freeman K, 2012, INT J PEDIATR OTORHI, V76, P122, DOI 10.1016/j.ijporl.2011.10.019; Fukuoka Y, 2007, QUAL LIFE RES, V16, P1655, DOI 10.1007/s11136-007-9272-7; Gelbard R, 2007, DATA KNOWL ENG, V63, P155, DOI 10.1016/j.datak.2007.01.002; Gjelsvik A, 2014, AM J HEALTH BEHAV, V38, P492, DOI 10.5993/AJHB.38.4.2; Griffin B, 2014, ANN BEHAV MED, V48, P205, DOI 10.1007/s12160-014-9589-8; Guthrie E, 2003, GUT, V52, P1616, DOI 10.1136/gut.52.11.1616; Hair J., 2010, Multivariate data analysis: A global perspective; Harrington JM, 2014, PUBLIC HEALTH NUTR, V17, P2674, DOI 10.1017/S1368980014000111; Hearty AP, 2009, BRIT J NUTR, V101, P598, DOI 10.1017/S0007114508014128; Héroux M, 2012, PREV SCI, V13, P183, DOI 10.1007/s11121-011-0255-0; Hickendorff M, 2017, LEARN INDIVID DIFFER, V4-15; Hofstetter H, 2014, PREV MED, V67, P141, DOI 10.1016/j.ypmed.2014.07.007; Horn SR, 2016, J PSYCHIATR RES, V83, P151, DOI 10.1016/j.jpsychires.2016.08.018; Huang A., 2008, P NZ COMPUTER SCI RE, V2008, P49; HUIJBREGTS PPCW, 1995, INT J EPIDEMIOL, V24, P313, DOI 10.1093/ije/24.2.313; Iannotti RJ, 2013, J ADOLESCENT HEALTH, V53, P280, DOI 10.1016/j.jadohealth.2013.03.007; Jadczakova V., 2013, ACTA UNIV SIL MEND B, V61, P1215, DOI DOI 10.11118/actaun201361041215; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kang J, 2014, PREV MED, V64, P121, DOI 10.1016/j.ypmed.2014.03.023; Keel PK, 2004, ARCH GEN PSYCHIAT, V61, P192, DOI 10.1001/archpsyc.61.2.192; Kodner Dennis L, 2002, Int J Integr Care, V2, pe12; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Laska MN, 2009, PREV SCI, V10, P376, DOI 10.1007/s11121-009-0140-2; Leclerc BS, 2009, CAN J PUBLIC HEALTH, V100, P263, DOI 10.1007/BF03403944; Lindgren TG, 2008, NURS RES, V57, P14, DOI 10.1097/01.NNR.0000280654.50642.1a; Lo Siou G, 2011, AM J EPIDEMIOL, V173, P956, DOI 10.1093/aje/kwq458; Love BC, 2002, PSYCHON B REV, V9, P829, DOI 10.3758/BF03196342; Low LL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195243; Lynn J, 2007, MILBANK Q, V85, P185, DOI 10.1111/j.1468-0009.2007.00483.x; Magidson J., 2002, Can J Market Res, V20, P36; Miller KA, 2015, PREV MED, V81, P303, DOI 10.1016/j.ypmed.2015.09.027; Milligan G.W., 1996, CLUSTERING VALIDATIO; Mira-Solves Jose J, 2014, Aten Primaria, V46 Suppl 3, P16, DOI 10.1016/S0212-6567(14)70061-7; Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P285, DOI 10.1007/978-3-642-12541-6_10; Nelson MC, 2005, AM J PREV MED, V28, P259, DOI 10.1016/j.amepre.2004.12.006; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Newby PK, 2004, AM J CLIN NUTR, V80, P759; Norman GJ, 2003, PREV MED, V37, P635, DOI 10.1016/j.ypmed.2003.09.011; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Penrod JD, 2007, J AM GERIATR SOC, V55, P407, DOI 10.1111/j.1532-5415.2007.01078.x; Peretti-Watel P, 2006, DRUG ALCOHOL DEPEN, V82, pS71, DOI 10.1016/S0376-8716(06)80012-8; Pietrzak RH, 2014, J AFFECT DISORDERS, V162, P102, DOI 10.1016/j.jad.2014.03.024; Pryer JA, 2001, PUBLIC HEALTH NUTR, V4, P787, DOI 10.1079/PHN200098; Pryer JA, 2001, J EPIDEMIOL COMMUN H, V55, P29, DOI 10.1136/jech.55.1.29; Reedy J, 2010, AM J EPIDEMIOL, V171, P479, DOI 10.1093/aje/kwp393; Sedrakyan A, 2006, AM HEART J, V151, P720, DOI 10.1016/j.ahj.2005.05.010; Simons-Morton BG, 2013, ACCIDENT ANAL PREV, V51, P27, DOI 10.1016/j.aap.2012.10.011; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Stine NW, 2013, JAMA-J AM MED ASSOC, V309, P449, DOI 10.1001/jama.2012.154302; Terry P, 2001, AM J EPIDEMIOL, V154, P1143, DOI 10.1093/aje/154.12.1143; Tucker KL, 2002, AM J CLIN NUTR, V76, P245, DOI 10.1093/ajcn/76.1.245; van der Laan MRE, 2014, SOC SCI MED, V113, P68, DOI 10.1016/j.socscimed.2014.05.012; Verger P, 2009, EUR J PUBLIC HEALTH, V19, P618, DOI 10.1093/eurpub/ckp057; Vuik SI, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0115-z; Vuik SI, 2016, HEALTH AFFAIR, V35, P769, DOI 10.1377/hlthaff.2015.1311; Walsh D, 2006, SUPPORT CARE CANCER, V14, P831, DOI 10.1007/s00520-005-0899-z; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408; Wedel Michel, 2012, Market Segmentation: Conceptual and Methodological Foundations, V2nd; Wirfält E, 2009, EUR J CLIN NUTR, V63, P707, DOI 10.1038/ejcn.2008.40; Wolf EJ, 2012, ARCH GEN PSYCHIAT, V69, P698, DOI 10.1001/archgenpsychiatry.2011.1574; Yim O, 2015, QUANT METH PSYCHOL, V11, P8, DOI 10.20982/tqmp.11.1.p008; Zhou Yi Yvonne, 2014, Perm J, V18, P18, DOI 10.7812/TPP/14-005; 2010, DAT MIN KNOWL DISC, P1	90	51	53	0	15	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	NOV 3	2018	18								121	10.1186/s12874-018-0584-9	http://dx.doi.org/10.1186/s12874-018-0584-9			12	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GZ3HE	30390641	Green Published, gold			2024-09-18	WOS:000449276900001
J	Lu, LQ; Townsend, KA; Daigle, BJ 				Lu, Liangqun; Townsend, Kevin A.; Daigle, Bernie J., Jr.			GEOlimma: differential expression analysis and feature selection using pre-existing microarray data	BMC BIOINFORMATICS			English	Article						GEOlimma; Differential expression; DE prior probabilities; Feature selection; Supervised classification	GENE-EXPRESSION; INTEGRATION; DISCOVERY; PACKAGE; GENOME; RISK; TOOL	Background Differential expression and feature selection analyses are essential steps for the development of accurate diagnostic/prognostic classifiers of complicated human diseases using transcriptomics data. These steps are particularly challenging due to the curse of dimensionality and the presence of technical and biological noise. A promising strategy for overcoming these challenges is the incorporation of pre-existing transcriptomics data in the identification of differentially expressed (DE) genes. This approach has the potential to improve the quality of selected genes, increase classification performance, and enhance biological interpretability. While a number of methods have been developed that use pre-existing data for differential expression analysis, existing methods do not leverage the identities of experimental conditions to create a robust metric for identifying DE genes. Results In this study, we propose a novel differential expression and feature selection method-GEOlimma-which combines pre-existing microarray data from the Gene Expression Omnibus (GEO) with the widely-applied Limma method for differential expression analysis. We first quantify differential gene expression across 2481 pairwise comparisons from 602 curated GEO Datasets, and we convert differential expression frequencies to DE prior probabilities. Genes with high DE prior probabilities show enrichment in cell growth and death, signal transduction, and cancer-related biological pathways, while genes with low prior probabilities were enriched in sensory system pathways. We then applied GEOlimma to four differential expression comparisons within two human disease datasets and performed differential expression, feature selection, and supervised classification analyses. Our results suggest that use of GEOlimma provides greater experimental power to detect DE genes compared to Limma, due to its increased effective sample size. Furthermore, in a supervised classification analysis using GEOlimma as a feature selection method, we observed similar or better classification performance than Limma given small, noisy subsets of an asthma dataset. Conclusions Our results demonstrate that GEOlimma is a more effective method for differential gene expression and feature selection analyses compared to the standard Limma method. Due to its focus on gene-level differential expression, GEOlimma also has the potential to be applied to other high-throughput biological datasets.	[Lu, Liangqun; Daigle, Bernie J., Jr.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Lu, Liangqun; Townsend, Kevin A.; Daigle, Bernie J., Jr.] Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA	University of Memphis; University of Memphis	Daigle, BJ  (corresponding author), Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA.		Daigle, Bernie/AAO-5462-2021; Lu, Liangqun/AAW-8759-2021		Army Research Laboratory [W911NF-17-1-0069]	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	Research was sponsored by the Army Research Laboratory and was accomplished under Grant Number W911NF-17-1-0069. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein. The funding body played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Abusamra H, 2013, PROCEDIA COMPUT SCI, V23, P5, DOI 10.1016/j.procs.2013.10.003; Alkhateeb A, 2019, CANCER INFORM, V18, DOI 10.1177/1176935119835522; Ang JC, 2016, IEEE ACM T COMPUT BI, V13, P971, DOI 10.1109/TCBB.2015.2478454; [Anonymous], 2009, ELEMENTS STAT LEARNI; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolón-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Boluki S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1893-4; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Crow M, 2019, P NATL ACAD SCI USA, V116, P6491, DOI 10.1073/pnas.1802973116; Daigle BJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000718; Daigle BJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-214; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engreitz JM, 2010, J BIOMED INFORM, V43, P932, DOI 10.1016/j.jbi.2010.07.001; Giles CB, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1888-1; Gliddon HD, 2018, IMMUNOLOGY, V153, P171, DOI 10.1111/imm.12841; Govindarajan R, 2012, J PHARM BIOALLIED SC, V4, pS310, DOI 10.4103/0975-7406.100283; Han J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28299-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrington CA, 2000, CURR OPIN MICROBIOL, V3, P285, DOI 10.1016/S1369-5274(00)00091-6; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hou YN, 2018, ADV SCI, V5, DOI 10.1002/advs.201800640; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim RD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r70; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; McNeish D, 2016, STRUCT EQU MODELING, V23, P750, DOI 10.1080/10705511.2016.1186549; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morrison JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-233; Nazarov PV, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3819-y; Pandurangan AK, 2018, WORLD J GASTRO ONCOL, V10, P244, DOI 10.4251/wjgo.v10.i9.244; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2004, Stat Appl Genet Mol Biol, V3, DOI DOI 10.2202/1544-6115.1027; Stoughton RB, 2005, ANNU REV BIOCHEM, V74, P53, DOI 10.1146/annurev.biochem.74.082803.133212; Van den Berge K, 2019, ANNU REV BIOMED DA S, V2, P139, DOI 10.1146/annurev-biodatasci-072018-021255; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei CM, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-87; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	53	7	7	0	50	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	FEB 3	2021	22	1							44	10.1186/s12859-020-03932-5	http://dx.doi.org/10.1186/s12859-020-03932-5			20	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	QB8YK	33535967	Green Published, gold, Green Submitted			2024-09-18	WOS:000614422600001
J	Teng, XY; Han, K; Jin, W; Ma, LR; Wei, LR; Min, DL; Chen, LB; Du, YZ				Teng, Xiaoyan; Han, Kun; Jin, Wei; Ma, Liru; Wei, Lirong; Min, Daliu; Chen, Libo; Du, Yuzhen			Development and validation of an early diagnosis model for bone metastasis in non-small cell lung cancer based on serological characteristics of the bone metastasis mechanism	ECLINICALMEDICINE			English	Article						Bone metastasis; Early diagnosis; Machine learning; Model interpretability; Risk assessment	METABOLIC MARKERS	Background Bone metastasis signi fi cantly impact the prognosis of non-small cell lung cancer (NSCLC) patients, reducing their quality of life and shortening their survival. Currently, there are no effective tools for the diagnosis and risk assessment of early bone metastasis in NSCLC patients. This study employed machine learning to analyze serum indicators that are closely associated with bone metastasis, aiming to construct a model for the timely detection and prognostic evaluation of bone metastasis in NSCLC patients. Methods The derivation cohort consisted of 664 individuals with stage IV NSCLC, diagnosed between 2015 and 2018. The variables considered in this study included age, sex, and 18 speci fi c serum indicators that have been linked to the occurrence of bone metastasis in NSCLC. Variable selection used multivariate logistic regression analysis and Lasso regression analysis. Six machine learning methods were utilized to develop a bone metastasis diagnostic model, assessed with Area Under the Curve (AUC), Decision Curve Analysis (DCA), sensitivity, speci fi city, and validation cohorts. External validation used 113 NSCLC patients from the Medical Alliance (2019 - 2020). Furthermore, a prospective validation study was conducted on a cohort of 316 patients (2019 - 2020) who were devoid of bone metastasis, and followed-up for at least two years to assess the predictive capabilities of this model. The model ' s prognostic value was evaluated using Kaplan - Meier survival curves. Findings Through variable selection, 11 serum indictors were identi fi ed as independent predictive factors for NSCLC bone metastasis. Six machine learning models were developed using age, sex, and these serum indicators. A random forest (RF) model demonstrated strong performance during the training and internal validation cohorts, achieving an AUC of 0.98 (95% CI 0.95 - 0.99) for internal validation. External validation further con fi rmed the RF model ' s effectiveness, yielding an AUC of 0.97 (95% CI 0.94 - 0.99). The calibration curves demonstrated a high level of concordance between the anticipated risk and the observed risk of the RF model. Prospective validation revealed that the RF model could predict the occurrence of bone metastasis approximately 10.27 +/- 3.58 months in advance, according to the results of the SPECT. An online computing platform (https://bonemetastasis.shinyapps.io/shiny_cls_ 1model/) for this RF model is publicly available and free-to-use by doctors and patients. Interpretation This study innovatively employs age, gender, and 11 serological markers closely related to the mechanism of bone metastasis to construct an RF model, providing a reliable tool for the early screening and prognostic assessment of bone metastasis in NSCLC patients. However, as an exploratory study, the fi ndings require further validation through large-scale, multicenter prospective studies.	[Teng, Xiaoyan; Jin, Wei; Ma, Liru; Wei, Lirong; Du, Yuzhen] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Lab Med, Shanghai 200233, Peoples R China; [Han, Kun; Min, Daliu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Oncol, Shanghai 200233, Peoples R China; [Chen, Libo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Dept Nucl Med, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Du, YZ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Lab Med, Shanghai 200233, Peoples R China.; Chen, LB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Dept Nucl Med, Shanghai 200233, Peoples R China.	lbchen@sjtu.edu.cn; yzdu@sjtu.edu.cn	Han, Kun/KII-3425-2024		National Natural Science Foundation of China [81974315]; Shanghai Municipal Science and Technology Commission Medical Innovation Research Project [20Y11903300]; Shanghai Municipal Health Commission Health Industry Clinical Research Youth Program [20204Y034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission Medical Innovation Research Project; Shanghai Municipal Health Commission Health Industry Clinical Research Youth Program	Funding This work is supported by the National Natural Science Foundation of China (NO.81974315) ; Shanghai Municipal Science and Technology Commission Medical Innovation Research Project (NO.20Y11903300) ; Shanghai Municipal Health Commission Health Industry Clinical Research Youth Program (NO.20204Y034) .	Adams SJ, 2023, LANCET, V401, P390, DOI 10.1016/S0140-6736(22)01694-4; Chen QY, 2022, EJSO-EUR J SURG ONC, V48, P2149, DOI 10.1016/j.ejso.2022.06.019; Chung JH, 2005, YONSEI MED J, V46, P388, DOI 10.3349/ymj.2005.46.3.388; Clézardin P, 2021, PHYSIOL REV, V101, P797, DOI 10.1152/physrev.00012.2019; Coleman RE, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00216-3; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Fornetti J, 2018, J BONE MINER RES, V33, P2099, DOI 10.1002/jbmr.3618; Goecks J, 2020, CELL, V181, P92, DOI 10.1016/j.cell.2020.03.022; Guan X, 2021, ANN MED, V53, P257, DOI 10.1080/07853890.2020.1868564; Hong S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234927; Jung JM, 2021, J KOREAN MED SCI, V36, DOI 10.3346/jkms.2021.36.e52; Li R, 2021, INT J GEN MED, V14, P7639, DOI 10.2147/IJGM.S335296; Liu WC, 2021, CANCER MANAG RES, V13, P8723, DOI 10.2147/CMAR.S330591; Muscarella AM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143764; Ogunleye A, 2020, IEEE ACM T COMPUT BI, V17, P2131, DOI 10.1109/TCBB.2019.2911071; Peterson LM, 2018, J NUCL MED, V59, P1823, DOI 10.2967/jnumed.118.211102; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Shilo S, 2020, NAT MED, V26, P29, DOI 10.1038/s41591-019-0727-5; Tang CH, 2013, CLIN CHIM ACTA, V426, P102, DOI 10.1016/j.cca.2013.09.011; Teng XY, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07046-2; Truslow JG, 2022, CIRC-CARDIOVASC QUAL, V15, P377, DOI 10.1161/CIRCOUTCOMES.121.008007; Wang H, 2018, CANCER CELL, V34, P823, DOI 10.1016/j.ccell.2018.10.002; Wang MN, 2020, BONE RES, V8, DOI 10.1038/s41413-020-00105-1; Wood DE, 2018, J NATL COMPR CANC NE, V16, P412, DOI 10.6004/jnccn.2018.0020; Wood SL, 2012, CANCER TREAT REV, V38, P284, DOI 10.1016/j.ctrv.2011.06.011; Wu Bingqun, 2019, Zhongguo Fei Ai Za Zhi, V22, P105, DOI 10.3779/j.issn.1009-3419.2019.02.05; [许尧 Xu Yao], 2019, [中华骨科杂志, Chinese Journal of Orthopedics], V39, P329; Youth Specialists Committee of Lung Cancer Beijing Medical Award Foundaton Chinese Lung Cancer Union, 2019, Zhongguo Fei Ai Za Zhi, V22, P187, DOI 10.3779/j.issn.1009-3419.2019.04.01; Zhang C, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5445-3; Zhu ZL, 2021, WORLD J SURG ONCOL, V19, DOI 10.1186/s12957-021-02141-5	30	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2589-5370		ECLINICALMEDICINE	EClinicalMedicine	JUN	2024	72								102617	10.1016/j.eclinm.2024.102617	http://dx.doi.org/10.1016/j.eclinm.2024.102617			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SR3A2	38707910	Green Published, gold			2024-09-18	WOS:001236126400001
J	Jaworek-Korjakowska, J; Brodzicki, A; Cassidy, B; Kendrick, C; Yap, MH				Jaworek-Korjakowska, Joanna; Brodzicki, Andrzej; Cassidy, Bill; Kendrick, Connah; Yap, Moi Hoon			Interpretability of a Deep Learning Based Approach for the Classification of Skin Lesions into Main Anatomic Body Sites	CANCERS			English	Article						deep learning; transfer learning; malignant melanoma; skin cancer; convolutional neural networks; dermoscopy images	ABCD RULE; DERMATOSCOPY; DIAGNOSIS	Simple Summary The detection of skin moles driven by current deep learning based approaches yields impressive results in the classification of malignant melanoma. It has been observed that the specific criteria for in situ and early invasive melanoma highly depend on the anatomic site of the body. To address this problem, we propose a deep learning architecture based framework to classify skin lesions into the three most important anatomic sites, including the face, trunk and extremities, and acral lesions. In this study, we take advantage of pretrained networks,we perform in depth analysis on database, architecture, and result regarding the effectiveness of the proposed framework. Experiments confirm the ability of the developed algorithms to classify skin lesions into the most important anatomical sites with 91.45% overall accuracy for the EfficientNetB0 architecture, which is a state-of-the-art result in this domain. Over the past few decades, different clinical diagnostic algorithms have been proposed to diagnose malignant melanoma in its early stages. Furthermore, the detection of skin moles driven by current deep learning based approaches yields impressive results in the classification of malignant melanoma. However, in all these approaches, the researchers do not take into account the origin of the skin lesion. It has been observed that the specific criteria for in situ and early invasive melanoma highly depend on the anatomic site of the body. To address this problem, we propose a deep learning architecture based framework to classify skin lesions into the three most important anatomic sites, including the face, trunk and extremities, and acral lesions. In this study, we take advantage of pretrained networks, including VGG19, ResNet50, Xception, DenseNet121, and EfficientNetB0, to calculate the features with an adjusted and densely connected classifier. Furthermore, we perform in depth analysis on database, architecture, and result regarding the effectiveness of the proposed framework. Experiments confirm the ability of the developed algorithms to classify skin lesions into the most important anatomical sites with 91.45% overall accuracy for the EfficientNetB0 architecture, which is a state-of-the-art result in this domain.	[Jaworek-Korjakowska, Joanna; Brodzicki, Andrzej] AGH Univ Sci & Technol, Dept Automat Control & Robot, PL-30059 Krakow, Poland; [Cassidy, Bill; Kendrick, Connah; Yap, Moi Hoon] Manchester Metropolitan Univ, Dept Comp & Math, John Dalton Bldg,Chester St, Manchester M1 5GD, Lancs, England	AGH University of Krakow; Manchester Metropolitan University	Jaworek-Korjakowska, J; Brodzicki, A (corresponding author), AGH Univ Sci & Technol, Dept Automat Control & Robot, PL-30059 Krakow, Poland.	jaworek@agh.edu.pl; brodzicki@agh.edu.pl; B.Cassidy@mmu.ac.uk; Connah.Kendrick@mmu.ac.uk; M.Yap@mmu.ac.uk	Jaworek-Korjakowska, Joanna/W-3601-2017	Jaworek-Korjakowska, Joanna/0000-0003-0146-8652; kendrick, connah/0000-0002-3623-6598; Brodzicki, Andrzej/0000-0001-7713-526X; Yap, Moi Hoon/0000-0001-7681-4287	EPSRC [EP/N02700/1]; FAST Healthcare NetworksPlus; program "Excellence initiative-research university"	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FAST Healthcare NetworksPlus; program "Excellence initiative-research university"	We gratefully acknowledge the funding support of EPSRC (EP/N02700/1) and FAST Healthcare NetworksPlus. Research project partly supported by program "Excellence initiative-research university" for the AGH University of Science and Technology	[Anonymous], 2000, Interactive atlas of dermoscopy; Argenziano G, 1998, ARCH DERMATOL, V134, P1563, DOI 10.1001/archderm.134.12.1563; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Calinski T., 1974, Commun. Stat. Theory Methods, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chollet Francois, 2015, Keras; Codella NCF, 2018, I S BIOMED IMAGING, P168, DOI 10.1109/ISBI.2018.8363547; Combalia M., 2019, BCN20000: Dermoscopic Lesions in the Wild; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; GmbH F.S. FotoFinder Moleanalyzer Pro & AI;, 2013, FOTOFINDER MOLEANALY; González-Cruz C, 2020, ACTAS DERMO-SIFILOGR, V111, P313, DOI 10.1016/j.ad.2019.09.002; Han SS, 2020, JAMA DERMATOL, V156, P29, DOI 10.1001/jamadermatol.2019.3807; He K, 2016, IDENTITY MAPPINGS DE, P770, DOI [10.1007/978-3-319-46493-0_38, DOI 10.1007/978-3-319-46493-0_38, DOI 10.1109/CVPR.2016.90]; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; King DB, 2015, ACS SYM SER, V1214, P1; McInnes L, 2020, Arxiv, DOI [arXiv:1802.03426, 10.21105/joss.00861, DOI 10.48550/ARXIV.1802.03426]; NACHBAR F, 1994, J AM ACAD DERMATOL, V30, P551, DOI 10.1016/S0190-9622(94)70061-3; Ngo H. T., 2020, ARXIV200905977; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI [10.1007/s11263-019-01228-7, 10.1109/ICCV.2017.74]; Simonyan K, 2015, Arxiv, DOI arXiv:1409.1556; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tan MX, 2019, PR MACH LEARN RES, V97; Tschandl P, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.161; Tschandl P, 2020, NAT MED, V26, P1229, DOI 10.1038/s41591-020-0942-0; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Winkler JK, 2020, EUR J CANCER, V127, P21, DOI 10.1016/j.ejca.2019.11.020; Yu C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193321	29	11	11	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	DEC	2021	13	23							6048	10.3390/cancers13236048	http://dx.doi.org/10.3390/cancers13236048			14	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	XW5DJ	34885158	Green Published, gold			2024-09-18	WOS:000735639400001
J	Ou, Y; Ye, SQ; Ding, L; Zhou, KQ; Zain, AM				Ou, Yun; Ye, Shao-Qiang; Ding, Lei; Zhou, Kai-Qing; Zain, Azlan Mohd			Hybrid Knowledge Extraction Framework Using Modified Adaptive Genetic Algorithm and BPNN	IEEE ACCESS			English	Article						Artificial neural networks; Knowledge engineering; Genetic algorithms; Feature extraction; Classification algorithms; Clustering algorithms; Expert systems; Adaptive genetic algorithm; back propagation neural network; attribute reduction; classification prediction; knowledge extraction	RULES	Fault diagnosis based on the expert system (ES) is still a research topic of manufacturing in Industry 4.0 because of the stronger interpretability. As the core component of the ES, fault diagnosis accuracy is positively correlated to the precision of the knowledge base. But it is difficult for users to understand the knowledge obtained from the original dataset utilizing the existing knowledge extraction method. Therefore, it is of great significance to extract easy-to-understand and exact rules from the NN framework. This paper proposes a hybrid extraction framework to perform the rule extraction for overcoming this drawback. First, an improved adaptive genetic algorithm (GA) using a logistic function, namely LAGA, is proposed to solve the traditional GA's insufficient prediction performance issue. Compared with the other three mainstream adaptive GAs, the experiment results of optimizing six selected test functions by these GA variants show that the LAGA algorithm's convergence accuracy and speed have been greatly improved, especially for high latitude functions. On this basis, a rule extraction method based on the symbol rule and NN, namely the LAGA-BP framework, is discussed in this manuscript to classify the real-valued attributes. This framework obtains hidden knowledge (knowledge refinement process) by NN and further transforms the acquired hidden knowledge into more easy-to-understand rule knowledge (rule extraction process). The execution of the LAGA-BP framework could be separated into two phases. The first phase is to optimize a back propagation NN (BPNN) using the LAGA and refine prediction classification knowledge over the optimized BPNN. In the second phase, an attribute reduction algorithm using multi-layered NN (SD algorithm) based on two different superposed networks is used in this framework to reduce data-set attributes and then uses the K-means clustering algorithm to extract the if-then rule from the simplified attributes. The Wisconsin breast cancer dataset is used as a case study to reveal the correctness and robustness of the proposed LAGA-BP method. Consulting relevant medical personnel and referencing relevant data shows that the rules extracted using this method help verify the diagnosis results, thus verifying the proposed framework's feasibility and practicality.	[Ou, Yun; Ye, Shao-Qiang; Ding, Lei; Zhou, Kai-Qing] Jishou Univ, Coll Informat Sci & Engn, Jishou 416000, Hunan, Peoples R China; [Zain, Azlan Mohd] Univ Teknol Malaysia, Big Data Ctr, Skudai 80310, Johor, Malaysia	Jishou University; Universiti Teknologi Malaysia	Ou, Y (corresponding author), Jishou Univ, Coll Informat Sci & Engn, Jishou 416000, Hunan, Peoples R China.	yun_ou@jsu.edu.cn	Ye, Qiang/IAR-4370-2023; Zhou, Kai-Qing/AAK-5243-2020; Mohd Zain, Azlan/K-6829-2012	Mohd Zain, Azlan/0000-0003-2004-3289	Research Foundation of Education Bureau of Hunan Province, China [21C0383]; National Natural Science Foundation of China [62066016, 61966014]; Natural Science Foundation of Hunan Province, China [2020JJ5458]	Research Foundation of Education Bureau of Hunan Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province)	This work was supported in part by the Research Foundation of Education Bureau of Hunan Province, China, under Grant 21C0383; in part by the National Natural Science Foundation of China, under Grant 62066016 and Grant 61966014; and in part by the Natural Science Foundation of Hunan Province, China, under Grant 2020JJ5458.	[Anonymous], Breast Cancer Wisconsin (Original) Data Set; Benitez JM, 1997, IEEE T NEURAL NETWOR, V8, P1156, DOI 10.1109/72.623216; Chan Veronica K H, 2020, [Petroleum, 油气], V6, P329; Chen C., 2011, RES APPL IMPROVED AD; Ding X. L., 2008, RES KNOWLEDGE ACQUIS; GALLANT SI, 1988, COMMUN ACM, V31, P152, DOI 10.1145/42372.42377; Hruschka ER, 2000, IEEE IJCNN, P407, DOI 10.1109/IJCNN.2000.861342; Kou L, 2020, IET POWER ELECTRON, V13, P1236, DOI 10.1049/iet-pel.2019.0835; Liu Z. K., 1999, COMPUT APPL RES, V16, P7; Martin T. H., 2018, NEURAL NETWORK DESIG, V2nd; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mohamed MH, 2011, NEUROCOMPUTING, V74, P3180, DOI 10.1016/j.neucom.2011.04.009; Policicchio VL, 2012, ARTIF INTELL, V191, P61, DOI 10.1016/j.artint.2012.07.003; Ren Zi-wu, 2006, Journal of System Simulation, V18, P41; Ramos AR, 2019, J INTELL MANUF, V30, P429, DOI 10.1007/s10845-016-1256-4; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sánchez M, 2020, COMPUT IND, V121, DOI 10.1016/j.compind.2020.103247; SESTITO S, 1993, INT J INTELL SYST, V8, P779, DOI 10.1002/int.4550080704; Setiono R, 2000, IEEE T NEURAL NETWOR, V11, P512, DOI 10.1109/72.839020; Singh H. R., 2020, Int. J. Fuzzy Syst. Appl., V9, P59; Singh N, 2019, EXPERT SYST APPL, V130, P188, DOI 10.1016/j.eswa.2019.04.029; Siyan W., 2009, COLL MATH PHYS; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Su BT, 2021, J INTELL MANUF, V32, P957, DOI 10.1007/s10845-020-01597-8; Surjanovic S., 2021, VIRTUAL LIB SIMULATI; Vidyarthi VK, 2020, J HYDROL, V585, DOI 10.1016/j.jhydrol.2020.124804; Wang G, 2021, J INTELL MANUF, V32, P1, DOI 10.1007/s10845-020-01554-5; Wang ST, 2020, APPL SOFT COMPUT, V86, DOI 10.1016/j.asoc.2019.105941; Wen L, 2018, IEEE T IND ELECTRON, V65, P5990, DOI 10.1109/TIE.2017.2774777; Wu B., 2000, EXPERT SYSTEM, V2nd; Xu Y, 2017, IEEE ACCESS, V5, P17368, DOI 10.1109/ACCESS.2017.2731945; Yanzhao Z., 2014, IMPROVEMENT APPL RES; Yuping Z., 2009, RES APPL ADAPTIVE GE; Zhang Y. Q., 2010, RES KNOWLEDGE ACQUIS; Zhang Zhong-ming, 2010, Journal of Jilin University (Information Science Edition), V28, P506; Zhou KQ, 2019, J INTELL MANUF, V30, P1831, DOI 10.1007/s10845-017-1355-x; Zhou Q, 2019, J INTELL MANUF, V30, P1693, DOI 10.1007/s10845-017-1351-1; Zhu YA, 2020, ARTIF INTELL MED, V103, DOI 10.1016/j.artmed.2020.101811	38	5	5	3	15	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2022	10						72037	72050		10.1109/ACCESS.2022.3188689	http://dx.doi.org/10.1109/ACCESS.2022.3188689			14	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	3Q7LP		gold			2024-09-18	WOS:000838408200001
J	Sun, HS; Jiao, J; Ren, YY; Guo, Y; Wang, YY				Sun, Hongshuang; Jiao, Jing; Ren, Yunyun; Guo, Yi; Wang, Yuanyuan			Multimodal fusion model for classifying placenta ultrasound imaging in pregnancies with hypertension disorders	PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH			English	Article						Placenta; Multimodal fusion; Hypertensive disorder of pregnancy; Deep convolutional neural networks; Ultrasound	ARTIFICIAL-INTELLIGENCE; PATHOPHYSIOLOGY; CLASSIFICATION; PREECLAMPSIA; PATHOLOGY; RISK; SURVIVAL; CANCER; IMAGES	Background: A multimodal fusion model was proposed to assist the traditional visual diagnosis in evaluating the placental features of hypertension disorders of pregnancy (HDP).Objective: The aim of this study was to analyse and compare the placental features between normal and HDP pregnancies and propose a multimodal fusion deep learning model for differentiating and characterizing the placental features from HDP to normal pregnancy.Methods: This observational prospective study included 654 pregnant women, including 75 with HDPs. Grayscale ultrasound images (GSIs) and Microflow images (MFIs) of the placentas were collected from all patients during routine obstetric examinations. On the basis of intelligent extraction and features fusion, after quantities of training and optimization, the classification model named GMNet (the intelligent network based on GSIs and MFIs) was introduced for differentiating the placental features of normal and HDP pregnancies. The distributions of placental features extracted by the deep convolutional neural networks (DCNNs) were visualized by Uniform Manifold Approximation and Projection for Dimension Reduction (UMAP). Metrics including sensitivity, speci-ficity, accuracy, and the area under the curve (AUC) were used to score the model. Finally, placental tissue samples were randomly selected for microscopic analyses to prove the interpretability and effectiveness of the GMNet model.Results: Compared with the Normal group in ultrasonic images, the light spots were rougher and the parts with focal cystic or hypoechogenic lesions were increased in the HDP groups. The overall diagnostic performance of the GMNet model depending on the region of interest (ROI) was excellent (AUC: 97%), with a sensitivity of 90.0%, a specificity of 93.5%, and an accuracy of 93.1%. The fusion features of GSIs and MFIs in the placenta showed a higher discriminative power than single-mode features (fusion features vs GSI features vs MFI features, 97.0% vs 91.2% vs 94.8%). Furthermore, according to the microscopic analysis, unevenly distributed villi, increased syncyte nodules and aggregated intervillous cellulose deposition were particularly frequent in the HDP cases.Conclusions: The GMNet model could sensitively identify abnormal changes in the placental microstructure in pregnancies with HDP.	[Sun, Hongshuang; Ren, Yunyun] Fudan Univ, Obstet & Gynecol Hosp, 128 Shenyang Rd, Shanghai 200090, Peoples R China; [Jiao, Jing; Guo, Yi; Wang, Yuanyuan] Fudan Univ, Dept Elect Engn, 220 Handan Rd, Shanghai 200433, Peoples R China; [Jiao, Jing; Guo, Yi; Wang, Yuanyuan] Key Lab Med Imaging Comp & Comp Assisted Intervent, Shanghai, Peoples R China	Fudan University; Fudan University	Ren, YY (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, 128 Shenyang Rd, Shanghai 200090, Peoples R China.; Guo, Y; Wang, YY (corresponding author), Fudan Univ, Dept Elect Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	yyren_fckyy@163.com; guoyi@fudan.edu.cn; yywang@fudan.edu.cn	Wang, Yuan/AGY-5735-2022		Research Project of Shanghai Municipal Health Commission [202240083]; hospital foundation of Obstetrics and Gynecology Hospital Affiliated to Fudan University [20019]	Research Project of Shanghai Municipal Health Commission; hospital foundation of Obstetrics and Gynecology Hospital Affiliated to Fudan University	This work was supported by the Research Project of Shanghai Municipal Health Commission (Grants 202240083) and the hospital foundation of Obstetrics and Gynecology Hospital Affiliated to Fudan University (Grant Number 20019) . We thank all collaborators who contributed to our research papers. The authors are grateful to all study participants.	Abinader R, 2019, OBSTET GYN CLIN N AM, V46, P367, DOI 10.1016/j.ogc.2019.01.011; Akkus Z, 2019, J AM COLL RADIOL, V16, P1318, DOI 10.1016/j.jacr.2019.06.004; Ardakani AA, 2019, EUR RADIOL, V29, P4258, DOI 10.1007/s00330-018-5908-y; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; BROSENS I, 1972, J OBSTET GYN BR COMM, V79, P794; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Burgos-Artizzu XP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38576-w; Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577; Cain MA, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.047; Chen CY, 2011, ARCH GYNECOL OBSTET, V284, P13, DOI 10.1007/s00404-010-1555-5; Chi JN, 2017, J DIGIT IMAGING, V30, P477, DOI 10.1007/s10278-017-9997-y; Cusimano MC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.001; Daskalakis G, 2008, ACTA OBSTET GYN SCAN, V87, P403, DOI 10.1080/00016340801908783; DEWOLF F, 1975, AM J OBSTET GYNECOL, V123, P164, DOI 10.1016/0002-9378(75)90522-0; DIGNAM WJ, 1967, AM J OBSTET GYNECOL, V98, P587, DOI 10.1016/0002-9378(67)90169-X; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gudmundsson S, 2009, SEMIN PERINATOL, V33, P270, DOI 10.1053/j.semperi.2009.04.005; Gupta K, 2022, J MATERN-FETAL NEO M, V35, P5587, DOI 10.1080/14767058.2021.1887847; Hafez S, 2017, PROG MOL BIOL TRANSL, V145, P1, DOI 10.1016/bs.pmbts.2016.12.001; Jarmuzek P, 2015, NEUROENDOCRINOL LETT, V36, P101; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Lei BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12818; Li Wanjun, 2016, Chinese Journal of Biomedical Engineering, V35, P411, DOI 10.3969/j.issn.0258-8021.2016.04.004; Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276; Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056; Roberts DJ, 2008, ARCH PATHOL LAB MED, V132, P641, DOI 10.1043/1543-2165(2008)132[641:PPASG]2.0.CO;2; Sebire NJ, 2008, J CLIN PATHOL, V61, P1276, DOI 10.1136/jcp.2008.055251; Stuart JJ, 2018, J AM COLL CARDIOL, V72, P1252, DOI 10.1016/j.jacc.2018.05.077; Sun C, 2020, PLACENTA, V96, P10, DOI 10.1016/j.placenta.2020.05.003; Tan MX, 2021, PR MACH LEARN RES, V139, P7102; Thompson MO, 2002, PLACENTA, V23, P685, DOI 10.1053/plac.2002.0837; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; VERMEULEN RCW, 1985, AM J OBSTET GYNECOL, V153, P806, DOI 10.1016/0002-9378(85)90356-4; Yampaca T, 2020, MED ULTRASON, V22, P51, DOI 10.11152/mu-2270; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	36	3	3	1	7	ELSEVIER SCI LTD	London	125 London Wall, London, ENGLAND	2210-7789			PREGNANCY HYPERTENS	Pregnancy Hypertens.	MAR	2023	31						46	53		10.1016/j.preghy.2022.12.003	http://dx.doi.org/10.1016/j.preghy.2022.12.003		DEC 2022	8	Obstetrics & Gynecology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Cardiovascular System & Cardiology	G5UZ9	36577178				2024-09-18	WOS:000989819100001
J	Yang, L; Zhang, ZG; Gao, HY; Wu, YC; Wei, HP; Kong, JJ; Wang, R; Cheng, J; Tian, JH				Yang, Lin; Zhang, Zhigang; Gao, Huiya; Wu, Yuchen; Wei, Huaping; Kong, Jiajia; Wang, Rui; Cheng, Jie; Tian, Jinhui			Cultural Adaptation and Validation of Questionnaires for Evaluation of Health-Related Quality of Life with Dysphagia in Different Countries: A Systematic Review	DYSPHAGIA			English	Review; Early Access						Deglutition; Dysphagia; Questionnaire; Quality of life; Cultural adaptation; Validation; Quality evaluation	EATING ASSESSMENT TOOL-10; QOL OUTCOMES TOOL; OROPHARYNGEAL DYSPHAGIA; NECK-CANCER; PSYCHOMETRIC PROPERTIES; SPANISH VERSION; INVENTORY MDADI; ARABIC VERSION; DUTCH VERSION; RELIABILITY	Dysphagia can have devastating and long-lasting effects on the patient's health-related quality of life (HRQoL). In recent years, a number of questionnaires for the evaluation of the HRQoL of patients with dysphagia have been developed and have been adapted for use in different countries and cultures. However, problems may arise in the process of cultural adaptation and validation, which can affect the quality of the questionnaires and their measurements. This study was conducted to systematically summarize the cultural adaptation and validation of questionnaires for the evaluation of dysphagia-related HRQoL in different countries, assessing the varieties, measurement properties, and qualities of these questionnaires, with the aim of identifying the status of their adaptation and validation and ways in which they might be improved. Four databases were searched, and relevant articles were screened, with data from eligible reports extracted and reviewed. The methodological quality of the included articles was evaluated using the QualSyst critical appraisal tool. The HRQoL questionnaires for patients with dysphagia were assessed using the quality criteria for the measurement properties of health status questionnaires proposed by Terwee et al. and Timmerman et al. 29 studies published between 2008 and 2020 were included. The questionnaires described in these 29 studies were translated into 19 languages and culturally adapted to 21 countries. The adapted questionnaires were based on the Swallowing quality of life questionnaire (SWAL-QOL) by Mchorney et al., the Dysphagia Handicap Index (DHI) by Silbergleit et al., the M.D. Anderson Dysphagia Inventory (MDADI) by Chen et al., and the Eating Assessment Tool-10 (EAT-10) by Belafsky et al. It was found that the questionnaires were reliable and valid instruments for the assessment of dysphagia-related HRQoL, but the quality criteria for cultural adaptation and validation were not strictly followed, especially in the categories of criterion validity, agreement, responsiveness, and interpretability. In conclusion, although the questionnaires were found to be both reliable and valid, the quality criteria should be considered and strictly followed in the cultural adaptation and validation process in the future.	[Yang, Lin; Zhang, Zhigang; Gao, Huiya; Wu, Yuchen; Wei, Huaping; Kong, Jiajia; Wang, Rui; Cheng, Jie] Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China; [Yang, Lin; Zhang, Zhigang; Gao, Huiya; Kong, Jiajia; Wang, Rui; Cheng, Jie] Lanzhou Univ, Sch Nursing, Lanzhou, Peoples R China; [Tian, Jinhui] Lanzhou Univ, Evidence Based Med Ctr, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Zhang, ZG (corresponding author), Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China.; Zhang, ZG (corresponding author), Lanzhou Univ, Sch Nursing, Lanzhou, Peoples R China.	zzg3444@163.com	wang, rui/JAC-6240-2023	li, jia xi/0000-0002-8197-8590				Abu-Ghanem S, 2016, FOLIA PHONIATR LOGO, V68, P261, DOI 10.1159/000484557; Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Alagiakrishnan K, 2013, ARCH GERONTOL GERIAT, V56, P1, DOI 10.1016/j.archger.2012.04.011; [Anonymous], 2016, Clinical management in adults and children; [Anonymous], 2002, Cengage learning; [Anonymous], 2004, Standard quality assessment criteria for evaluating primary research papers from a variety of fields. (HTA Initiative #13), DOI DOI 10.7939/R37M04F16; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919, DOI 10.1177/000348940811701210; Bogaardt HCA, 2009, DYSPHAGIA, V24, P66, DOI 10.1007/s00455-008-9174-z; Bours GJ, 2009, J ADV NURS, V65, P477, DOI 10.1111/j.1365-2648.2008.04915.x; Burgos R, 2012, NUTR HOSP, V27, P2048, DOI 10.3305/nh.2012.27.6.6100; Calman KC., 1987, QUALITY LIFE CANC PA, P1987; Carlsson S, 2012, DYSPHAGIA, V27, P361, DOI 10.1007/s00455-011-9375-8; Chen AY, 2001, ARCH OTOLARYNGOL, V127, P870; Cordier R, 2017, DYSPHAGIA, V32, P250, DOI 10.1007/s00455-016-9754-2; Cordier R, 2018, DYSPHAGIA, V33, P441, DOI 10.1007/s00455-017-9873-4; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Demir N, 2016, DYSPHAGIA, V31, P644, DOI 10.1007/s00455-016-9723-9; Dwivedi RC, 2012, EUR ARCH OTO-RHINO-L, V269, P1233, DOI 10.1007/s00405-011-1756-y; Farahat M, 2015, FOLIA PHONIATR LOGO, V67, P231, DOI 10.1159/000442199; Farahat M, 2014, DYSPHAGIA, V29, P459, DOI 10.1007/s00455-014-9528-7; Giraldo-Cadavid LF, 2016, DYSPHAGIA, V31, P398, DOI 10.1007/s00455-016-9690-1; Finizia C, 2012, DYSPHAGIA, V27, P325, DOI 10.1007/s00455-011-9369-6; Georgopoulos VC, 2018, DYSPHAGIA, V33, P91, DOI 10.1007/s00455-017-9837-8; Ginocchio D, 2016, DYSPHAGIA, V31, P626, DOI 10.1007/s00455-016-9720-z; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Hajdú SF, 2017, DYSPHAGIA, V32, P472, DOI 10.1007/s00455-017-9785-3; Hambleton RK., 1993, EDUC MEAS-ISSUES PRA, V12, P38, DOI [10.1111/j.1745-3992.1993.tb00543.x, DOI 10.1111/J.1745-3992.1993.TB00543.X]; HUNT SM, 1991, HEALTH POLICY, V19, P33, DOI 10.1016/0168-8510(91)90072-6; Jones E, 2018, DYSPHAGIA, V33, P141, DOI 10.1007/s00455-017-9844-9; Khaldoun E, 2009, GASTROEN CLIN BIOL, V33, P167, DOI 10.1016/j.gcb.2008.12.012; Kraus EM, 2018, DYSPHAGIA, V33, P431, DOI 10.1007/s00455-017-9872-5; Kwon CH, 2013, ANN REHABIL MED-ARM, V37, P479, DOI 10.5535/arm.2013.37.4.479; Lai XX, 2021, DYSPHAGIA, V36, P670, DOI 10.1007/s00455-020-10181-4; Lam PM, 2011, DYSPHAGIA, V26, P117, DOI 10.1007/s00455-010-9272-6; Lee CC, 2009, J TRANSCULT NURS, V20, P77, DOI 10.1177/1043659608325852; Logemann JA, 1998, FOLIA PHONIATR LOGO, V50, P311, DOI 10.1159/000021473; Malagelada JR, 2015, J CLIN GASTROENTEROL, V49, P370, DOI 10.1097/MCG.0000000000000307; Martino R, 2010, DYSPHAGIA, V25, P26, DOI 10.1007/s00455-009-9225-0; Matsuda Y, 2018, DYSPHAGIA, V33, P123, DOI 10.1007/s00455-017-9842-y; McHorney CA, 2000, DYSPHAGIA, V15, P115, DOI 10.1007/s004550010012; McHorney CA, 2000, DYSPHAGIA, V15, P122, DOI 10.1007/s004550010013; Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086]; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Montes-Jovellar L, 2019, HEAD NECK-J SCI SPEC, V41, P122, DOI 10.1002/hed.25478; Nogueira DS, 2015, DYSPHAGIA, V30, P511, DOI 10.1007/s00455-015-9630-5; Oda C, 2017, PATIENT PREFER ADHER, V11, P193, DOI 10.2147/PPA.S126052; Peters M, 2006, HEADACHE, V46, P82, DOI 10.1111/j.1526-4610.2006.00298.x; Prosiegel M, 2004, Int MS J, V11, P22; Rivelsrud MC, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1248-0; Rogers SN, 2016, BRIT J ORAL MAX SURG, V54, pE45, DOI 10.1016/j.bjoms.2016.02.012; Samuels EE, 2021, FOLIA PHONIATR LOGO, V73, P42, DOI 10.1159/000504222; Sartorius N., 1994, QUALITY LIFE ASSESSM, V1, P3; Schindler A, 2013, ANN OTO RHINOL LARYN, V122, P717, DOI 10.1177/000348941312201109; Shapira-Galitz Y, 2019, DYSPHAGIA, V34, P63, DOI 10.1007/s00455-018-9914-7; Silbergleit AK, 2012, DYSPHAGIA, V27, P46, DOI 10.1007/s00455-011-9336-2; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Spertus JA, 2008, CIRCULATION, V118, P2103, DOI 10.1161/CIRCULATIONAHA.107.747568; Speyer R, 2013, OTOLARYNG CLIN N AM, V46, P989, DOI 10.1016/j.otc.2013.08.004; Speyer R, 2011, DYSPHAGIA, V26, P407, DOI 10.1007/s00455-011-9327-3; Takizawa C, 2016, DYSPHAGIA, V31, P434, DOI 10.1007/s00455-016-9695-9; Tarameshlu M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007254; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; THIER SO, 1992, MED CARE, V30, pMS15, DOI 10.1097/00005650-199205001-00002; Timmerman AA, 2014, DYSPHAGIA, V29, P183, DOI 10.1007/s00455-013-9511-8; Vanderwegen J, 2013, DYSPHAGIA, V28, P11, DOI 10.1007/s00455-012-9408-y; Guedes RLV, 2013, DYSPHAGIA, V28, P24, DOI 10.1007/s00455-012-9409-x; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Yee K, 2020, ASIA-PAC J CLIN ONCO, V16, P372, DOI 10.1111/ajco.13384	70	4	4	0	21	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	2021 JUN 28	2021										10.1007/s00455-021-10330-3	http://dx.doi.org/10.1007/s00455-021-10330-3		JUN 2021	12	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	TB0AL	34181064				2024-09-18	WOS:000667605800001
J	Huang, P; Xiao, HL; He, P; Li, CT; Guo, XD; Tian, SK; Feng, P; Chen, H; Sun, YC; Mercaldo, F; Santone, A; Qin, J				Huang, Pan; Xiao, Hualiang; He, Peng; Li, Chentao; Guo, Xiaodong; Tian, Sukun; Feng, Peng; Chen, Hu; Sun, Yuchun; Mercaldo, Francesco; Santone, Antonella; Qin, Jing			LA-ViT: A Network With Transformers Constrained by Learned-Parameter-Free Attention for Interpretable Grading in a New Laryngeal Histopathology Image Dataset	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Semantics; Transformers; Pathology; Convolutional neural networks; Bioinformatics; Tumors; Target recognition; Laryngeal cancer; pathological grading; histopathological images; image semantics; interpretable; transformer		Grading laryngeal squamous cell carcinoma (LSCC) based on histopathological images is a clinically significant yet challenging task. However, more low-effect background semantic information appeared in the feature maps, feature channels, and class activation maps, which caused a serious impact on the accuracy and interpretability of LSCC grading. While the traditional transformer block makes extensive use of parameter attention, the model overlearns the low-effect background semantic information, resulting in ineffectively reducing the proportion of background semantics. Therefore, we propose an end-to-end network with transformers constrained by learned-parameter-free attention (LA-ViT), which improve the ability to learn high-effect target semantic information and reduce the proportion of background semantics. Firstly, according to generalized linear model and probabilistic, we demonstrate that learned-parameter-free attention (LA) has a stronger ability to learn highly effective target semantic information than parameter attention. Secondly, the first-type LA transformer block of LA-ViT utilizes the feature map position subspace to realize the query. Then, it uses the feature channel subspace to realize the key, and adopts the average convergence to obtain a value. And those construct the LA mechanism. Thus, it reduces the proportion of background semantics in the feature maps and feature channels. Thirdly, the second-type LA transformer block of LA-ViT uses the model probability matrix information and decision level weight information to realize key and query, respectively. And those realize the LA mechanism. So, it reduces the proportion of background semantics in class activation maps. Finally, we build a new complex semantic LSCC pathology image dataset to address the problem, which is less research on LSCC grading models because of lacking clinically meaningful datasets. After extensive experiments, the whole metrics of LA-ViT outperform those of other state-of-the-art methods, and the visualization maps match better with the regions of interest in the pathologists' decision-making. Moreover, the experimental results conducted on a public LSCC pathology image dataset show that LA-ViT has superior generalization performance to that of other state-of-the-art methods.	[Huang, Pan; He, Peng; Guo, Xiaodong; Feng, Peng] Chongqing Univ, Coll Optoelect Engn, Chongqing 400044, Peoples R China; [Xiao, Hualiang] Army Med Univ, Daping Hosp, Dept Pathol, Chongqing 400037, Peoples R China; [Li, Chentao] Chongqing Univ, Coll Math & Stat, Chongqing 400044, Peoples R China; [Tian, Sukun; Chen, Hu; Sun, Yuchun] Peking Univ Sch & Hosp Stomatol, Fac Prosthodont, Ctr Digital Dent, Beijing 100081, Peoples R China; [Tian, Sukun; Chen, Hu; Sun, Yuchun] Natl Engn Res Ctr Oral Biomat & Digital Med Devic, Coll Optoelect Engn, Beijing 100081, Peoples R China; [Mercaldo, Francesco; Santone, Antonella] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, I-86100 Campobasso, Italy; [Qin, Jing] Hong Kong Polytech Univ, Sch Nursing, Hong Kong 999077, Peoples R China	Chongqing University; Army Medical University; Chongqing University; University of Molise; Hong Kong Polytechnic University	He, P; Feng, P (corresponding author), Chongqing Univ, Coll Optoelect Engn, Chongqing 400044, Peoples R China.; Tian, SK (corresponding author), Peking Univ Sch & Hosp Stomatol, Fac Prosthodont, Ctr Digital Dent, Beijing 100081, Peoples R China.	panhuang@cqu.edu.cn; dpbl_xhl@163.com; coe-fp@cqu.edu.cn; 20201984@cqu.edu.cn; gxd@cqu.edu.cn; sukhum169@bjmu.edu.cn; penghe@cqu.edu.cn; ccen@bjmu.edu.cn; kqsyc@bjmu.edu.cn; harry.qin@polyu.edu.hk	Tian, Su/B-8286-2019; Huang, Pan/AAC-5550-2021	huang, pan/0000-0001-8158-2628; Tian, Sukun/0000-0001-8289-5968; FENG, PENG/0000-0002-7420-2161; Guo, Xiaodong/0000-0003-0673-5262	Graduate Scientific Research and Innovation Foundation of Chongqing	Graduate Scientific Research and Innovation Foundation of Chongqing	No Statement Available	Borba M, 2010, ORL-J OTO-RHIN-LARYN, V72, P319, DOI 10.1159/000319904; Chattopadhay A, 2018, IEEE WINT CONF APPL, P839, DOI 10.1109/WACV.2018.00097; Chu XX, 2021, ADV NEUR IN; Ding XH, 2021, PROC CVPR IEEE, P13728, DOI 10.1109/CVPR46437.2021.01352; Dosovitskiy A., 2021, P INT C LEARN REPR, DOI DOI 10.48550/ARXIV.2010.11929; Du J, 2023, IEEE T EM TOP COMP I, V7, P845, DOI 10.1109/TETCI.2022.3199733; Fu BK, 2022, COMPUT METH PROG BIO, V221, DOI 10.1016/j.cmpb.2022.106924; Fu R., 2020, BRIT MACH VIS C BMVC, DOI [10.48550/arXiv.2008.02312, DOI 10.48550/ARXIV.2008.02312]; Guo ZY, 2023, AAAI CONF ARTIF INTE, P746; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hoda SA, 2021, AM J CLIN PATHOL, V155, P148, DOI [10.1093/AJCP/AQAA162, 10.1093/ajcp/aqaa162]; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/TPAMI.2019.2913372, 10.1109/CVPR.2018.00745]; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Jiang PT, 2021, IEEE T IMAGE PROCESS, V30, P5875, DOI 10.1109/TIP.2021.3089943; Li KC, 2023, IEEE T PATTERN ANAL, V45, P12581, DOI 10.1109/TPAMI.2023.3282631; Li NN, 2024, IEEE T NEUR NET LEAR, V35, P12772, DOI 10.1109/TNNLS.2023.3264730; Li WL, 2022, IEEE SIGNAL PROC LET, V29, P1559, DOI 10.1109/LSP.2022.3186273; Li YH, 2022, PROC CVPR IEEE, P4794, DOI 10.1109/CVPR52688.2022.00476; Liu Z, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P9992, DOI 10.1109/ICCV48922.2021.00986; Liu Z, 2022, PROC CVPR IEEE, P11966, DOI 10.1109/CVPR52688.2022.01167; Marur S, 2016, MAYO CLIN PROC, V91, P386, DOI 10.1016/j.mayocp.2015.12.017; Omeiza Daniel, 2019, arXiv, DOI DOI 10.48550/ARXIV.1908.01224; Peng ZL, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P357, DOI 10.1109/ICCV48922.2021.00042; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shen YQ, 2022, IEEE T MED IMAGING, V41, P3835, DOI 10.1109/TMI.2022.3198526; Tan MX, 2019, PR MACH LEARN RES, V97; Thiagarajan P, 2022, IEEE T MED IMAGING, V41, P815, DOI 10.1109/TMI.2021.3123300; Tolstikhin I, 2021, ADV NEUR IN, V34; Wang HJ, 2020, Cambria Sinophone Wo, P111, DOI 10.1109/CVPRW50498.2020.00020; Wang XY, 2022, MED IMAGE ANAL, V81, DOI 10.1016/j.media.2022.102559; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Yang CL, 2022, PROC CVPR IEEE, P11988, DOI 10.1109/CVPR52688.2022.01169; Yang LX, 2021, PR MACH LEARN RES, V139; Yu WH, 2022, PROC CVPR IEEE, P10809, DOI 10.1109/CVPR52688.2022.01055; Yuan L, 2021, 2021 IEEE/CVF INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV 2021), P538, DOI 10.1109/ICCV48922.2021.00060; Zheng YS, 2023, IEEE T MED IMAGING, V42, P2726, DOI 10.1109/TMI.2023.3264781; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zidan U, 2023, EXPERT SYST APPL, V216, DOI 10.1016/j.eswa.2022.119452	38	3	3	18	20	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194	2168-2208		IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	JUN	2024	28	6					3557	3570		10.1109/JBHI.2024.3373438	http://dx.doi.org/10.1109/JBHI.2024.3373438			14	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	TP0K1	38442048				2024-09-18	WOS:001242344200025
J	Patwari, M; Gutjahr, R; Raupach, R; Maier, A				Patwari, Mayank; Gutjahr, Ralf; Raupach, Rainer; Maier, Andreas			Limited parameter denoising for low-dose X-ray computed tomography using deep reinforcement learning	MEDICAL PHYSICS			English	Article						computed tomography; image reconstruction; reinforcement learning	CT; NETWORK; RECONSTRUCTION; REDUCTION	Background The use of deep learning has successfully solved several problems in the field of medical imaging. Deep learning has been applied to the CT denoising problem successfully. However, the use of deep learning requires large amounts of data to train deep convolutional networks (CNNs). Moreover, due to the large parameter count, such deep CNNs may cause unexpected results. Purpose In this study, we introduce a novel CT denoising framework, which has interpretable behavior and provides useful results with limited data. Methods We employ bilateral filtering in both the projection and volume domains to remove noise. To account for nonstationary noise, we tune the sigma parameters of the volume for every projection view and every volume pixel. The tuning is carried out by two deep CNNs. Due to the impracticality of labeling, the two-deep CNNs are trained via a Deep-Q reinforcement learning task. The reward for the task is generated by using a custom reward function represented by a neural network. Our experiments were carried out on abdominal scans for the Mayo Clinic the cancer imaging archive (TCIA) dataset and the American association of physicists in medicine (AAPM) Low Dose CT Grand Challenge. Results Our denoising framework has excellent denoising performance increasing the peak signal to noise ratio (PSNR) from 28.53 to 28.93 and increasing the structural similarity index (SSIM) from 0.8952 to 0.9204. We outperform several state-of-the-art deep CNNs, which have several orders of magnitude higher number of parameters (p-value [PSNR] = 0.000, p-value [SSIM] = 0.000). Our method does not introduce any blurring, which is introduced by mean squared error (MSE) loss-based methods, or any deep learning artifacts, which are introduced by wasserstein generative adversarial network (WGAN)-based models. Our ablation studies show that parameter tuning and using our reward network results in the best possible results. Conclusions We present a novel CT denoising framework, which focuses on interpretability to deliver good denoising performance, especially with limited data. Our method outperforms state-of-the-art deep neural networks. Future work will be focused on accelerating our method and generalizing it to different geometries and body parts.	[Patwari, Mayank; Maier, Andreas] Friedrich Alexander Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91058 Erlangen, Germany; [Patwari, Mayank; Gutjahr, Ralf; Raupach, Rainer] Siemens Healthineers AG, CT Concepts, Forchheim, Germany	University of Erlangen Nuremberg	Patwari, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91058 Erlangen, Germany.	mayank.patwari@fau.de	Maier, Andreas/AAV-6505-2021	Patwari, Mayank/0000-0001-5197-5260	Siemens Healthineers (Siemens Healthineers AG)	Siemens Healthineers (Siemens Healthineers AG)	Siemens Healthineers (Siemens Healthineers AG)	Angel E., 2012, AIDR 3D ITERATIVE RE; [Anonymous], 1937, Bull Int Acad Pol Sic Let Cl Sci Math Nat; [Anonymous], 2016, Medical Physics; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; Bellemare MG, 2017, PR MACH LEARN RES, V70; BELLMAN R, 1966, SCIENCE, V153, P34, DOI 10.1126/science.153.3731.34; Borsdorf A., 2008, 2008 IEEE Nuclear Science Symposium Conference Record, P5335, DOI DOI 10.1109/NSSMIC.2008.4774438.; Chen GH, 2006, IEEE IMAGE PROC, P2929, DOI 10.1109/ICIP.2006.313132; Chen H, 2017, IEEE T MED IMAGING, V36, P2524, DOI 10.1109/TMI.2017.2715284; Chen H, 2017, BIOMED OPT EXPRESS, V8, P679, DOI 10.1364/BOE.8.000679; Clevert D.-A., 2016, 4 INT C LEARN REPR I; Fan FL, 2020, IEEE T MED IMAGING, V39, P2035, DOI 10.1109/TMI.2019.2963248; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Geyer LL, 2015, RADIOLOGY, V276, P338, DOI 10.1148/radiol.2015132766; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; He J, 2019, IEEE T MED IMAGING, V38, P371, DOI 10.1109/TMI.2018.2865202; Hessel M, 2018, AAAI CONF ARTIF INTE, P3215; Kachelriess M, 2020, PHYS MEDICA, V71, P176, DOI 10.1016/j.ejmp.2020.02.017; Kalra MK, 2005, EMERG RADIOL, V11, P267, DOI 10.1007/s10140-004-0395-7; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; KIJEWSKI MF, 1987, PHYS MED BIOL, V32, P565, DOI 10.1088/0031-9155/32/5/003; Kingma D. P., 2017, arXiv; Lee CS, 2020, EUR RADIOL, V30, P1825, DOI 10.1007/s00330-019-06625-7; Li K, 2014, MED PHYS, V41, DOI 10.1118/1.4867863; Li M, 2020, IEEE T MED IMAGING, V39, P2289, DOI 10.1109/TMI.2020.2968472; Li YS, 2019, IEEE T MED IMAGING, V38, P2469, DOI 10.1109/TMI.2019.2910760; Liu J, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab18db; Liu P, 2018, LECT NOTES COMPUT SC, V11070, P12, DOI 10.1007/978-3-030-00928-1_2; Lorch B, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P59, DOI 10.1007/978-3-662-46224-9_12; Lu YY, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P137, DOI 10.1007/978-3-662-46224-9_25; Maier A, 2016, SER MED PHYS BIOMED, P113; Maier A, 2011, MED PHYS, V38, P5896, DOI 10.1118/1.3633901; Maier AK, 2019, NAT MACH INTELL, V1, P373, DOI 10.1038/s42256-019-0077-5; Manduca A, 2009, MED PHYS, V36, P4911, DOI 10.1118/1.3232004; Manhart M., 2014, P 3 CT M, V1, P91; McCollough C., Low Dose CT Image and Projection Data (LDCT-and-Projection-Data); Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Monga Manoj, 2007, Int. braz j urol., V33, P855, DOI 10.1590/S1677-55382007000600023; Oppelt A., 2005, Imaging Systems for Medical Diagnostics, V2nd edn, pp 996, DOI DOI 10.1145/2505515.2507827; Paszke A., 2019, NEURIPS, V32, P8024, DOI DOI 10.48550/ARXIV.1912.01703; Patwari Mayank, 2020, Medical Image Computing and Computer Assisted Intervention - MICCAI 2020. 23rd International Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12262), P506, DOI 10.1007/978-3-030-59713-9_49; Patwari M., 2020, 6 INT C IMAGE FORMAT, P174; Patwari M., 2020, EUROPEAN C RADIOLOGY; Patwari M, 2019, LECT NOTES COMPUT SC, V11905, P113, DOI 10.1007/978-3-030-33843-5_11; Ramirez-Giraldo JC., 2015, ADMIRE ADV MODELED I; Remedios D, 2020, EUR RADIOL, V30, P1837, DOI 10.1007/s00330-019-06624-8; Shan HM, 2019, NAT MACH INTELL, V1, P269, DOI 10.1038/s42256-019-0057-9; Shan HM, 2018, IEEE T MED IMAGING, V37, P1522, DOI 10.1109/TMI.2018.2832217; Shen CY, 2018, IEEE T MED IMAGING, V37, P1430, DOI 10.1109/TMI.2018.2823679; Syben C., 2017, P 5 INT C IM FORM XR, P386; van Aarle W, 2016, OPT EXPRESS, V24, P25129, DOI 10.1364/OE.24.025129; van Aarle W, 2015, ULTRAMICROSCOPY, V157, P35, DOI 10.1016/j.ultramic.2015.05.002; van Hasselt H, 2016, AAAI CONF ARTIF INTE, P2094; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang ZY, 2016, PR MACH LEARN RES, V48; Wolterink Jelmer M., 2017, Simulation and Synthesis in Medical Imaging. Second International Workshop, SASHIMI 2017. Held in Conjunction with MICCAI 2017. Proceedings: LNCS 10557, P14, DOI 10.1007/978-3-319-68127-6_2; Wu DF, 2017, IEEE T MED IMAGING, V36, P2479, DOI 10.1109/TMI.2017.2753138; Yang QS, 2018, IEEE T MED IMAGING, V37, P1348, DOI 10.1109/TMI.2018.2827462; Yin XR, 2019, IEEE T MED IMAGING, V38, P2903, DOI 10.1109/TMI.2019.2917258; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5; Yu LF, 2010, MED PHYS, V37, P234, DOI 10.1118/1.3264614; Zhang H., 2020, IEEE T MED IMAGING	62	8	8	1	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	JUL	2022	49	7					4540	4553		10.1002/mp.15643	http://dx.doi.org/10.1002/mp.15643		APR 2022	14	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	3E5WL	35362172	Green Published, Green Submitted			2024-09-18	WOS:000784234700001
J	Zhang, R; Hong, MP; Cai, HJ; Liang, YT; Chen, XJ; Liu, ZW; Wu, ML; Zhou, CR; Bao, CZ; Wang, HF; Yang, SM; Hu, QG				Zhang, Rong; Hong, Minping; Cai, Hongjie; Liang, Yanting; Chen, Xinjie; Liu, Ziwei; Wu, Meilian; Zhou, Cuiru; Bao, Chenzhengren; Wang, Huafeng; Yang, Shaomin; Hu, Qiugen			Predicting the pathological invasiveness in patients with a solitary pulmonary nodule via Shapley additive explanations interpretation of a tree-based machine learning radiomics model: a multicenter study	QUANTITATIVE IMAGING IN MEDICINE AND SURGERY			English	Article						Pulmonary nodules; invasiveness; radiomics; extreme gradient boosting (XGBoost); Shapley additive explanations (SHAP)	LUNG; CANCER	Background: Radiomics models could help assess the benign and malignant invasiveness and prognosis of pulmonary nodules. However, the lack of interpretability limits application of these models. We thus aimed to construct and validate an interpretable and generalized computed tomography (CT) radiomics model to evaluate the pathological invasiveness in patients with a solitary pulmonary nodule in order to improve the management of these patients.Methods: We retrospectively enrolled 248 patients with CT-diagnosed solitary pulmonary nodules. Radiomic features were extracted from nodular region and perinodular regions of 3 and 5 mm. After coarse to-fine feature selection, the radiomics score (radscore) was calculated using the least absolute shrinkage and selection operator logistic method. Univariate and multivariate logistic regression analyses were performed to determine the invasiveness-related clinicoradiological factors. The clinical-radiomics model was then constructed using the logistic and extreme gradient boosting (XGBoost) algorithms. The Shapley additive explanations (SHAP) method was then used to explain the contributions of the features. After removing batch effects with the ComBat algorithm, we assessed the generalization of the explainable clinical-radiomics model in two independent external validation cohorts (n=147 and n=149).Results: The clinical-radiomic XGBoost model integrating the radscore, CT value, nodule length, and crescent sign demonstrated better predictive performance than did the clinical-radiomics logistic model in assessing pulmonary nodule invasiveness, with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.889 [95% confidence interval (CI), 0.848-0.927] in the training cohort. The SHAP algorithm illustrates the contribution of each feature in the final model. The specific model decision process was visualized using a tree-based decision heatmap. Satisfactory generalization performance was shown with AUCs of 0.889 (95% CI, 0.823-0.942) and 0.915 (95% CI, 0.851-0.963) in the two external validation cohorts.Conclusions: An interpretable and generalized clinical-radiomics model for predicting pulmonary nodule invasibility was constructed to help clinicians determine the invasiveness of pulmonary nodules and devise assessment strategies in an easily understandable manner.	[Zhang, Rong; Chen, Xinjie; Liu, Ziwei; Wu, Meilian; Zhou, Cuiru; Wang, Huafeng; Hu, Qiugen] Southern Med Univ, Shunde Hosp, Peoples Hosp Shunde 1, Dept Radiol, 1 Jiazi Rd, Foshan 528308, Peoples R China; [Hong, Minping] Zhejiang Chinese Med Univ, Jiaxing TCM Hosp, Dept Radiol, Jiaxing, Peoples R China; [Cai, Hongjie] Zhejiang Chinese Med Univ, Sch Clin Med 1, Hangzhou, Peoples R China; [Liang, Yanting] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Peoples R China; [Bao, Chenzhengren] Southern Med Univ, Affiliated Chencun Hosp, Dept Orthopaed, Dept Radiol,Affiliated Chencun Hosp,Shunde Hosp,Pe, Foshan, Peoples R China; [Yang, Shaomin] Lecong Hosp Shunde, Dept Radiol, 45 Lecong Ave, Foshan 528315, Peoples R China	Southern Medical University - China; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; Southern Medical University - China	Wang, HF; Hu, QG (corresponding author), Southern Med Univ, Shunde Hosp, Peoples Hosp Shunde 1, Dept Radiol, 1 Jiazi Rd, Foshan 528308, Peoples R China.; Yang, SM (corresponding author), Lecong Hosp Shunde, Dept Radiol, 45 Lecong Ave, Foshan 528315, Peoples R China.	52881316@qq.com; ysmsin@aliyun.com; hu6009@163.com	Liu, Ziwei/AAG-6939-2021		Guangdong Medical Science and Technology Research Fund [A2021483]; Research Launch Project of Shunde Hospital of Southern Medical University [SRSP2021021]; Medical Health Science and Technology Project Zhejiang Provincial Health Commission [2023ky338]; Science and Technology Planning Project of Foshan [2220001005383]	Guangdong Medical Science and Technology Research Fund; Research Launch Project of Shunde Hospital of Southern Medical University; Medical Health Science and Technology Project Zhejiang Provincial Health Commission; Science and Technology Planning Project of Foshan	Funding: The study was supported by the grants of the Guangdong Medical Science and Technology Research Fund (No. A2021483) , the Research Launch Project of Shunde Hospital of Southern Medical University (No. SRSP2021021) , the Medical Health Science and Technology Project Zhejiang Provincial Health Commission (No. 2023ky338) , and the Science and Technology Planning Project of Foshan (No. 2220001005383) .	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Altorki NK, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110639; Beig N, 2019, RADIOLOGY, V290, P783, DOI 10.1148/radiol.2018180910; Bertsimas D, 2022, JAMA SURG, V157, DOI 10.1001/jamasurg.2022.1819; Borczuk AC, 2022, MODERN PATHOL, V35, P28, DOI 10.1038/s41379-021-00934-3; Chen NX, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.833283; Cheng JH, 2022, IEEE J BIOMED HEALTH, V26, P673, DOI 10.1109/JBHI.2021.3095476; Chu ZG, 2020, AM J ROENTGENOL, V215, P351, DOI 10.2214/AJR.19.22381; Cohen JG, 2018, DIAGN INTERV IMAG, V99, P291, DOI 10.1016/j.diii.2017.12.013; Fan L, 2019, EUR RADIOL, V29, P889, DOI 10.1007/s00330-018-5530-z; Huang LY, 2022, EUR RADIOL, V32, P1983, DOI 10.1007/s00330-021-08268-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]; Kameda K, 2018, J THORAC ONCOL, V13, P1919, DOI 10.1016/j.jtho.2018.08.2022; Lee SM, 2013, RADIOLOGY, V268, P265, DOI 10.1148/radiol.13120949; Li R, 2020, JCO CLIN CANCER INFO, V4, P637, DOI 10.1200/CCI.20.00002; Liu H, 2021, QUANT IMAG MED SURG, V11, P2756, DOI 10.21037/qims-20-734; Lu Shuyu, 2021, AMIA Annu Symp Proc, V2021, P813; Lundberg SM, 2020, NAT MACH INTELL, V2, P56, DOI 10.1038/s42256-019-0138-9; Ma MW, 2022, EUR RADIOL, V32, P1652, DOI 10.1007/s00330-021-08271-4; Nicholson AG, 2022, J THORAC ONCOL, V17, P362, DOI 10.1016/j.jtho.2021.11.003; Nishino M, 2019, RADIOLOGY, V290, P793, DOI 10.1148/radiol.2018182619; Ren H, 2021, QUANT IMAG MED SURG, V11, P4042, DOI 10.21037/qims-20-1378; Tang X, 2022, J CANCER RES CLIN, V148, P2247, DOI 10.1007/s00432-022-04015-z; Thai AA, 2021, LANCET, V398, P535, DOI 10.1016/S0140-6736(21)00312-3; Tseng PY, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03179-9; Wang TT, 2022, RADIOLOGY, V302, P425, DOI 10.1148/radiol.2021210109; Wang YX, 2022, EUR RADIOL, V32, P8737, DOI 10.1007/s00330-022-08887-0; Wu LY, 2021, EUR RADIOL, V31, P9030, DOI 10.1007/s00330-021-07948-0; Yu ZY, 2022, BMC MED IMAGING, V22, DOI 10.1186/s12880-022-00862-x; Zhang Y, 2022, J THORAC CARDIOV SUR, V163, P456, DOI 10.1016/j.jtcvs.2020.11.151; Zhu MH, 2022, RESP RES, V23, DOI 10.1186/s12931-022-02016-7; Zou Y, 2022, COMPUT METH PROG BIO, V225, DOI 10.1016/j.cmpb.2022.107038	32	2	2	8	14	AME PUBLISHING COMPANY	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2223-4292	2223-4306		QUANT IMAG MED SURG	Quant. Imaging Med. Surg.	DEC 1	2023	13	12					7828	+		10.21037/qims-23-615	http://dx.doi.org/10.21037/qims-23-615		OCT 2023	15	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GN3W7	38106261	Green Published, gold			2024-09-18	WOS:001081891000001
J	Cui, SN; Tseng, HH; Pakela, J; Ten Haken, RK; El Naqa, I				Cui, Sunan; Tseng, Huan-Hsin; Pakela, Julia; Ten Haken, Randall K.; El Naqa, Issam			Introduction to machine and deep learning for medical physicists	MEDICAL PHYSICS			English	Article						deep learning; machine learning; medical physics	RADIATION-THERAPY; LOGISTIC-REGRESSION; NEURAL-NETWORKS; BIG DATA; CANCER; PREDICTION; RADIOTHERAPY; CLASSIFICATION; ARCHITECTURES; ONCOLOGY	Recent years have witnessed tremendous growth in the application of machine learning (ML) and deep learning (DL) techniques in medical physics. Embracing the current big data era, medical physicists equipped with these state-of-the-art tools should be able to solve pressing problems in modern radiation oncology. Here, a review of the basic aspects involved in ML/DL model building, including data processing, model training, and validation for medical physics applications is presented and discussed. Machine learning can be categorized based on the underlying task into supervised learning, unsupervised learning, or reinforcement learning; each of these categories has its own input/output dataset characteristics and aims to solve different classes of problems in medical physics ranging from automation of processes to predictive analytics. It is recognized that data size requirements may vary depending on the specific medical physics application and the nature of the algorithms applied. Data processing, which is a crucial step for model stability and precision, should be performed before training the model. Deep learning as a subset of ML is able to learn multilevel representations from raw input data, eliminating the necessity for hand crafted features in classical ML. It can be thought of as an extension of the classical linear models but with multilayer (deep) structures and nonlinear activation functions. The logic of going "deeper" is related to learning complex data structures and its realization has been aided by recent advancements in parallel computing architectures and the development of more robust optimization methods for efficient training of these algorithms. Model validation is an essential part of ML/DL model building. Without it, the model being developed cannot be easily trusted to generalize to unseen data. Whenever applying ML/DL, one should keep in mind, according to Amara's law, that humans may tend to overestimate the ability of a technology in the short term and underestimate its capability in the long term. To establish ML/DL role into standard clinical workflow, models considering balance between accuracy and interpretability should be developed. Machine learning/DL algorithms have potential in numerous radiation oncology applications, including automatizing mundane procedures, improving efficiency and safety of auto-contouring, treatment planning, quality assurance, motion management, and outcome predictions. Medical physicists have been at the frontiers of technology translation into medicine and they ought to be prepared to embrace the inevitable role of ML/DL in the practice of radiation oncology and lead its clinical implementation.	[Cui, Sunan; Tseng, Huan-Hsin; Pakela, Julia; Ten Haken, Randall K.; El Naqa, Issam] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48103 USA; [Cui, Sunan; Pakela, Julia] Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cui, SN (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48103 USA.; Cui, SN (corresponding author), Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA.	sunan@umich.edu	cui, sunan/AAA-3286-2020; Naqa, Issam/T-3066-2019					Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abouelmehdi K, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-017-0110-7; ACKLEY DH, 1985, COGNITIVE SCI, V9, P147; [Anonymous], 2015, NATURE, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; [Anonymous], 2005, ARTIFICIAL NEURAL NE; [Anonymous], 1998, REINFORCEMENT LEARNI; [Anonymous], 2017, P INT C LEARN REPR; Avanzo M, 2017, PHYS MEDICA, V38, P122, DOI 10.1016/j.ejmp.2017.05.071; Bahdanau D, 2016, Arxiv, DOI arXiv:1409.0473; Baldi Pierre., 2012, P ICML WORKSH UNS TR, P37; Bi WL, 2019, CA-CANCER J CLIN, V69, P127, DOI 10.3322/caac.21552; Bibault JE, 2016, CANCER LETT, V382, P110, DOI 10.1016/j.canlet.2016.05.033; Bishop CM, 2006, PATTERN RECOGNITION, V1, DOI [DOI 10.1117/1, DOI 10.1117/1.2819119]; Boldrini L, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00977; Brahma PP, 2016, IEEE T NEUR NET LEAR, V27, P1997, DOI 10.1109/TNNLS.2015.2496947; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen Xi, 2016, ADV NEURAL INFORM PR, V29; Cho K., 2014, P 2014 C EMP METH NA, P1724, DOI DOI 10.3115/V1/D14-1179; Chuanqi Tan, 2018, Artificial Neural Networks and Machine Learning - ICANN 2018. 27th International Conference on Artificial Neural Networks. Proceedings: Lecture Notes in Computer Science (LNCS 11141), P270, DOI 10.1007/978-3-030-01424-7_27; Clevert AD, 2015, ARXIV151107289; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.7326/M14-0698, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1038/bjc.2014.639, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1016/j.jclinepi.2014.11.010, 10.1016/j.eururo.2014.11.025]; Conforti F, 2018, LANCET ONCOL, V19, P737, DOI 10.1016/S1470-2045(18)30261-4; Cui SN, 2019, MED PHYS, V46, P2497, DOI 10.1002/mp.13497; Cui S, 2019, IEEE T RADIAT PLASMA, V3, P242, DOI 10.1109/TRPMS.2018.2884134; Dalmis MU, 2017, MED PHYS, V44, P533, DOI 10.1002/mp.12079; Deist TM, 2018, MED PHYS, V45, P3449, DOI 10.1002/mp.12967; Dietterich T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Efron B., 1993, INTRO BOOTSTRAP MONO; El Naqa I, 2019, MED PHYS, V46, P1914, DOI 10.1002/mp.13433; El Naqa I, 2017, PHYS MED BIOL, V62, pR179, DOI 10.1088/1361-6560/aa7c55; Naqa I, 2016, METHODS, V111, P32, DOI 10.1016/j.ymeth.2016.08.010; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Emami H, 2018, MED PHYS, V45, P3627, DOI 10.1002/mp.13047; Emre Celebi M, 2016, UNSUPERVISED LEARNIN, V1st; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Feng M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00110; Ghorbani A, 2019, ARXIV190402868STATML; Glorot X., 2011, 14 INT C ARTIF INTEL, P315; Goller C, 1996, IEEE IJCNN, P347, DOI 10.1109/ICNN.1996.548916; Good D, 2013, INT J RADIAT ONCOL, V87, P176, DOI 10.1016/j.ijrobp.2013.03.015; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672; Guyon I., 2003, J MACH LEARN RES, V3, P1157; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hau K, 2019, TECHNICAL REPORT; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He Kaiming, 2015, ARXIV07061234; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI [10.1162/neco.1997.9.8.17, DOI 10.1162/NECO.1997.9.8.1735, 10.1162/neco.1997.9.8.1735]; Hochreiter S., 1991, Untersuchungen zu dynamischen neuronalen netzen, V91; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Ibragimov B, 2018, MED PHYS, V45, P4763, DOI 10.1002/mp.13122; Jain LC, 1999, INT SER COMPUTAT INT, P1; Jordan M. I., 1997, ADV PSYCHOL, V121, P471, DOI [DOI 10.1016/S0166-4115(97)80111-2, 10.1016/s0166-4115(97)80111-2]; Kang J, 2015, INT J RADIAT ONCOL, V93, P1127, DOI 10.1016/j.ijrobp.2015.07.2286; Kelvin X, 2015, ABS150203044 CORR; Kingma D. P., 2013, CORR; Kingma DP, 2014, ADV NEUR IN, V27; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Levine AB, 2019, TRENDS CANCER, V5, P157, DOI 10.1016/j.trecan.2019.02.002; LINIAL N, 1991, INFORM COMPUT, V90, P33, DOI 10.1016/0890-5401(91)90058-A; Luong M.-T., 2015, ARXIV; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Mattonen SA, 2016, INT J RADIAT ONCOL, V94, P1121, DOI 10.1016/j.ijrobp.2015.12.369; McNutt TR, 2018, MED PHYS, V45, pE863, DOI 10.1002/mp.12817; Men K, 2019, INT J RADIAT ONCOL, V105, P440, DOI 10.1016/j.ijrobp.2019.06.009; Meyer P, 2018, COMPUT BIOL MED, V98, P126, DOI 10.1016/j.compbiomed.2018.05.018; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Mirza M., 2014, ARXIV; Mohri M., 2012, FDN MACHINE LEARNING; Nair G., 2010, ICML, P807, DOI 10.1123/jab.2016-0355; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ng A. Y., 2004, Proceedings of the Twenty-First International Conference on Machine Learning, ICML'04, page, DOI DOI 10.1145/1015330.1015435; Ng AY, 2002, ADV NEUR IN, V14, P841; Nikolov S., 2018, ARXIV180904430; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Perlich C, 2004, J MACH LEARN RES, V4, P211, DOI 10.1162/153244304322972694; Puterman ML, 1994, MARKOV DECISION PROC; Putora PM, 2015, MACHINE LEARNING RAD, P57; Radford A., 2016, P 4 INT C LEARN REPR, P1; Ratcliffe S, 2016, ROY AMARA; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rubin Donald B., 1988, P SURV RES METH SECT, V79, P84; Ruder S., 2016, ARXIV; Sahiner B, 2019, MED PHYS, V46, pe1, DOI 10.1002/mp.13264; Schuler T, 2019, ADV RADIAT ONCOL, V4, P191, DOI 10.1016/j.adro.2018.09.013; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Shiraishi S, 2016, MED PHYS, V43, P378, DOI 10.1118/1.4938583; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Springenberg J. T., 2016, ADV NEURAL INFORM PR, P4134; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sutton RS, 2000, ADV NEUR IN, V12, P1057; Tannenbaum C, 2019, NATURE, V575, P137, DOI 10.1038/s41586-019-1657-6; Thompson RF, 2018, RADIOTHER ONCOL, V129, P421, DOI 10.1016/j.radonc.2018.05.030; Tseng HH, 2020, ONCOLOGY-BASEL, V98, P344, DOI 10.1159/000493575; Tseng HH, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00266; Tseng HH, 2017, MED PHYS, V44, P6690, DOI 10.1002/mp.12625; Valdes G, 2017, RADIOTHER ONCOL, V125, P392, DOI 10.1016/j.radonc.2017.10.014; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vaswani A, 2017, ADV NEUR IN, V30; Vidal R, 2017, ABS171204741 CORR; Walach J, DATA ANAL OMIC SCI M, P165; Wang J, 2018, ENVIRON TECHNOL, V39, P3055, DOI 10.1080/09593330.2017.1371797; Wolterink JM, 2017, ABS170801155 CORR; Zhen X, 2017, PHYS MED BIOL, V62, P8246, DOI 10.1088/1361-6560/aa8d09; Zhu JY, 2017, IEEE I CONF COMP VIS, P2242, DOI 10.1109/ICCV.2017.244	109	64	68	1	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	JUN	2020	47	5					E127	E147		10.1002/mp.14140	http://dx.doi.org/10.1002/mp.14140			21	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	PB0JZ	32418339	Green Accepted, Green Published			2024-09-18	WOS:000596015500003
J	Pota, M; Scalco, E; Sanguineti, G; Farneti, A; Cattaneo, GM; Rizzo, G; Esposito, M				Pota, Marco; Scalco, Elisa; Sanguineti, Giuseppe; Farneti, Alessia; Cattaneo, Giovanni Mauro; Rizzo, Giovanna; Esposito, Massimo			Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification	ARTIFICIAL INTELLIGENCE IN MEDICINE			English	Article; Proceedings Paper	15th Conference on Artificial Intelligence in Medicine (AIME)	JUN 17-20, 2015	Univ Pavia, Pavia, ITALY		Univ Pavia	Classification; Fuzzy logic; Rule-based systems; Radiomics; Parotid gland; Xerostomia	NECK-CANCER; SUBMANDIBULAR-GLANDS; HEAD; VOLUME; IMRT; DEFORMATION; IRRADIATION; THERAPY	Motivation: Patients under radiotherapy for head-and-neck cancer often suffer of long-term xerostomia, and/or consistent shrinkage of parotid glands. In order to avoid these drawbacks, adaptive therapy can be planned for patients at risk, if the prediction is obtained timely, before or during the early phase of treatment. Artificial intelligence can address the problem, by learning from examples and building classification models. In particular, fuzzy logic has shown its suitability for medical applications, in order to manage uncertain data, and to build transparent rule-based classifiers. In previous works, clinical, dosimetric and image-based features were considered separately, to find different possible predictors of parotid shrinkage. On the other hand, a few works reported possible image-based predictors of xerostomia, while the combination of different types of features has been little addressed. Objective: This paper proposes the application of a novel machine learning approach, based on both statistics and fuzzy logic, aimed at the classification of patients at risk of i) parotid gland shrinkage and ii) 12-months xerostomia. Both problems are addressed with the aim of individuating predictors and models to classify respective outcomes. Methods: Knowledge is extracted from a real dataset of radiotherapy patients, by means of a recently developed method named Likelihood-Fuzzy Analysis, based on the representation of statistical information by fuzzy rule-based models. This method enables to manage heterogeneous variables and missing data, and to obtain interpretable fuzzy models presenting good generalization power (thus high performance), and to measure classification confidence. Numerous features are extracted to characterize patients, coming from different sources, i.e. clinical features, dosimetric parameters, and radiomics-based measures obtained by texture analysis of Computed Tomography images. A learning approach based on the composition of simple models in a more complicated one allows to consider the features separately, in order to identify predictors and models to use when only some data source is available, and obtaining more accurate results when more information can be combined. Results: Regarding parotid shrinkage, a number of good predictors is detected, some already known and confirmed here, and some others found here, in particular among radiomics-based features. A number of models are also designed, some using single features and others involving models composition to improve classification accuracy. In particular, the best model to be used at the initial treatment stage, and another one applicable at the half treatment stage are identified. Regarding 12-months toxicity, some possible predictors are detected, in particular among radiomics-based features. Moreover, the relation between final parotid shrinkage rate and 12-months xerostomia is evaluated. The method is compared to the naive Bayes classifier, which reveals similar results in terms of classification accuracy and best predictors. The interpretable fuzzy rule-based models are explicitly presented, and the dependence between predictors and outcome is explained, thus furnishing in some cases helpful insights about the considered problems. Conclusion: Thanks to the performance and interpretability of the fuzzy classification method employed, predictors of both parotid shrinkage and xerostomia are detected, and their influence on each outcome is revealed. Moreover, models for predicting parotid shrinkage at initial and half radiotherapy stages are found. (C) 2017 Elsevier B.V. All rights reserved.	[Pota, Marco; Esposito, Massimo] Natl Res Council Italy, Inst High Performance Comp & Networking ICAR, Via P Castellino 111, I-80131 Naples, Italy; [Scalco, Elisa; Rizzo, Giovanna] Natl Res Council Italy, Inst Mol Bioimaging & Physiol IBFM, Via Flli Cervi 93, I-20090 Segrate, MI, Italy; [Sanguineti, Giuseppe; Farneti, Alessia] Ist Nazl Tumori Regina Elena, Radiotherapy, Rome, Italy; [Cattaneo, Giovanni Mauro] Ist Sci San Raffaele, Med Phys Dept, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Calcolo e Reti ad Alte Prestazioni (ICAR-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pota, M (corresponding author), Natl Res Council Italy, Inst High Performance Comp & Networking ICAR, Via P Castellino 111, I-80131 Naples, Italy.	marco.pota@na.icar.cnr.it	Scalco, Elisa/J-3619-2018; Pota, Marco/AAX-9053-2020; Esposito, Massimo/AAX-3348-2020	Scalco, Elisa/0000-0003-2721-5792; RIZZO, GIOVANNA/0000-0002-6341-1304; ESPOSITO, MASSIMO/0000-0002-7196-7994				[Anonymous], 2009, ACM SIGKDD Explor Newsl, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; [Anonymous], INT J RAD ONCOL BIOL; [Anonymous], ADV DECISION SCI FUT; [Anonymous], P PMAMCM 2014 SANT I; [Anonymous], LECT NOTES COMPUT SC; [Anonymous], RADIOLOGY; [Anonymous], ORAL RADIOL; Barker JL, 2004, INT J RADIAT ONCOL, V59, P960, DOI 10.1016/j.ijrobp.2003.12.024; Belli ML, 2014, STRAHLENTHER ONKOL, P1; Bhide SA, 2010, INT J RADIAT ONCOL, V76, P1360, DOI 10.1016/j.ijrobp.2009.04.005; Broggi S, 2015, TECHNOL CANCER RES T, V14, P683, DOI 10.7785/tcrt.2012.500440; Broggi S, 2010, RADIOTHER ONCOL, V94, P206, DOI 10.1016/j.radonc.2009.12.014; Eisbruch A, 2001, INT J RADIAT ONCOL, V50, P695, DOI 10.1016/S0360-3016(01)01512-7; Faggiano E, 2011, PHYS MED BIOL, V56, P775, DOI 10.1088/0031-9155/56/3/015; Fiorentino A, 2012, BRIT J RADIOL, V85, P1415, DOI 10.1259/bjr/30678306; Fiorino C, 2012, RADIOTHER ONCOL, V104, P224, DOI 10.1016/j.radonc.2012.06.003; Fiorino C, 2011, PHYS MED BIOL, V56, P3301, DOI 10.1088/0031-9155/56/11/008; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Jiang LX, 2005, LECT NOTES COMPUT SC, V3453, P688, DOI 10.1007/11408079_63; Osorio EMV, 2008, INT J RADIAT ONCOL, V70, P875, DOI 10.1016/j.ijrobp.2007.10.063; Pota M, 2015, LECT NOTES ARTIF INT, V9105, P257, DOI 10.1007/978-3-319-19551-3_34; Pota M, 2015, BIOSYST ENG, V138, P77, DOI 10.1016/j.biosystemseng.2015.06.007; Pota M, 2014, STUD HEALTH TECHNOL, V207, P360, DOI 10.3233/978-1-61499-474-9-360; Sanguineti G, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0331-x; Scalco E, 2013, RADIOTHER ONCOL, V109, P384, DOI 10.1016/j.radonc.2013.09.019; Teshima K, 2012, J RADIAT RES, V53, P492, DOI 10.1269/jrr.11115; Teshima K, 2010, JPN J CLIN ONCOL, V40, P42, DOI 10.1093/jjco/hyp113; Tomitaka E, 2011, JPN J CLIN ONCOL, V41, P503, DOI 10.1093/jjco/hyq236; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	29	49	55	2	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0933-3657	1873-2860		ARTIF INTELL MED	Artif. Intell. Med.	SEP	2017	81				SI		41	53		10.1016/j.artmed.2017.03.004	http://dx.doi.org/10.1016/j.artmed.2017.03.004			13	Computer Science, Artificial Intelligence; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Computer Science; Engineering; Medical Informatics	FK6JB	28325604				2024-09-18	WOS:000413608900005
J	Albers, EAC; Fraterman, I; Walraven, I; Wilthagen, E; Schagen, SB; van der Ploeg, IM; Wouters, MWJM; van de Poll-franse, LV; de Ligt, KM				Albers, Elaine A. C.; Fraterman, Itske; Walraven, Iris; Wilthagen, Erica; Schagen, Sanne B.; van der Ploeg, Iris M.; Wouters, Michel W. J. M.; van de Poll-franse, Lonneke V.; de Ligt, Kelly M.			Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy	JOURNAL OF PATIENT-REPORTED OUTCOMES			English	Review						Patient reported outcome measures; Data visualization; Shared decision-making; Systematic review	OF-LIFE INFORMATION; CANCER-PATIENTS; CARE; PRO; FEASIBILITY; DESIGN	Purpose The use of Patient-Reported Outcome Measures (PROMs) for individual patient management within clinical practice is becoming increasingly important. New evidence about graphic visualization formats for PROMs scores has become available. This systematic literature review evaluated evidence for graphic visualization formats of PROMs data in clinical practice for patients and clinicians, for both individual and group level PROMs data. Methods Studies published between 2000 and 2020 were extracted from CINAHL, PubMed, PsychInfo, and Medline. Studies included patients >= 18 years old in daily clinical practice. Papers not available in English, without full-text access, or that did not specifically describe visualization of PROMs data were excluded. Outcomes were: visualization preferences; interpretation accuracy; guidance for clinical interpretation. Results Twenty-five out of 789 papers were included for final analysis. Most frequently studied formats were: bar charts, line graphs, and pie charts. Patients preferred bar charts and line graphs as these were easy and quick for retrieving information about their PROMs scores over time. Clinicians' interpretation accuracy and preferences were similar among graphic visualization formats. Scores were most often compared with patients' own previous scores; to further guide clinical interpretation, scores were compared to norm population scores. Different 'add-ons' improved interpretability for patients and clinicians, e.g. using colors, descriptions of measurement scale directionality, descriptive labels, and brief definitions. Conclusion There was no predominant graphical visualization format approach in terms of preferences or interpretation accuracy for both patients and clinicians. Detailed clarification of graph content is essential. Plain English summary Patient-Reported Outcome Measures (PROMs) capture patients' self-reported health through the use of questionnaires. PROMs measure health related quality of life, daily functioning, and symptom experience, which are becoming increasingly important to incorporate in clinical practice for individual patient management. To present PROMs within clinical practice, raw or summarized PROMs scores can be visualized in graphical formats. To be useful during clinical encounters, both patients and clinicians ought to interpret such formats correctly. New evidence about graphic visualization formats for PROMs scores has become available. Therefore, we systematically reviewed the literature to evaluate evidence for graphic visualization formats of PROMs data in clinical practice. In 25 included papers, most studies used graphical formats like bar charts, line graphs, and pie charts for presenting PROMs scores. There was no predominant graphical visualization format approach in terms of preferences or interpretation accuracy for both patients and clinicians. Patients preferred bar charts and line graphs as these were easy and quick for retrieving information about their PROMs scores over time. Clinicians' interpretation accuracy and preferences were similar among graphic visualization formats. The graphical interpretation of PROMs data for patients and clinicians can be improved by using colors, descriptions of measurement scale directionality, descriptive labels, and brief definitions.	[Albers, Elaine A. C.; Fraterman, Itske; Walraven, Iris; Schagen, Sanne B.; van de Poll-franse, Lonneke V.; de Ligt, Kelly M.] Netherlands Canc Inst, Dept Psychosocial Res, Div Psychosocial Res & Epidmiol, Amsterdam, Netherlands; [Walraven, Iris] Radboudumc, Dept Hlth Evidence, Nijmegen, Netherlands; [Wilthagen, Erica] Netherlands Canc Inst, Lib & Sci Informat Dept, Amsterdam, Netherlands; [Schagen, Sanne B.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [van der Ploeg, Iris M.; Wouters, Michel W. J. M.] Antoni van Leeuwenhoek, Dept Surg Oncol, Amsterdam, Netherlands; [Wouters, Michel W. J. M.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [van de Poll-franse, Lonneke V.] Netherlands Comprehens Canc Org, Dept Res & Dev, Utrecht, Netherlands; [van de Poll-franse, Lonneke V.] Tilburg Univ, Ctr Res Psychol, Dept Med & Clin Psychol, Somat Disorders, Tilburg, Netherlands	Netherlands Cancer Institute; Radboud University Nijmegen; Netherlands Cancer Institute; University of Amsterdam; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Tilburg University	de Ligt, KM (corresponding author), Netherlands Canc Inst, Dept Psychosocial Res, Div Psychosocial Res & Epidmiol, Amsterdam, Netherlands.	K.d.ligt@nki.nl	van de Poll, Lonneke/AAA-9509-2021; Wouters, Michel/B-5882-2019	van de Poll-Franse, Lonneke V/0000-0003-0413-6872; Wouters, Michel/0000-0001-6173-0662; Wilthagen, Erica/0000-0002-5677-1934; Albers, Elaine/0000-0002-4083-016X; van der Ploeg, Iris/0000-0003-2805-2104; Fraterman, Itske/0000-0001-7974-8422				Bantug ET, 2016, PATIENT EDUC COUNS, V99, P483, DOI 10.1016/j.pec.2015.10.027; Basch Ethan, 2018, Am Soc Clin Oncol Educ Book, V38, P122, DOI 10.1200/EDBK_200383; Berry DL, 2011, J CLIN ONCOL, V29, P1029, DOI 10.1200/JCO.2010.30.3909; Bramer WM, 2016, J MED LIBR ASSOC, V104, P240, DOI 10.3163/1536-5050.104.3.014; Brundage M, 2005, J CLIN ONCOL, V23, P6949, DOI 10.1200/JCO.2005.12.514; Brundage M, 2003, QUAL LIFE RES, V12, P395, DOI 10.1023/A:1023404731041; Brundage M, 2018, QUAL LIFE RES, V27, P75, DOI 10.1007/s11136-017-1710-6; Brundage M, 2011, QUAL LIFE RES, V20, P979, DOI 10.1007/s11136-011-9848-0; Brundage MD, 2015, QUAL LIFE RES, V24, P2457, DOI 10.1007/s11136-015-0974-y; Chen J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-211; Clouston SAP, 2017, AGE AGEING, V46, P493, DOI 10.1093/ageing/afw229; Damman OC, 2019, HEALTH EXPECT, V22, P939, DOI 10.1111/hex.12899; Fischer KI, 2020, J PATIENT-REP OUTCOM, V4, DOI 10.1186/s41687-020-0173-7; Geerards D, 2019, J MED INTERNET RES, V21, DOI 10.2196/12212; Grossman LV, 2018, APPL CLIN INFORM, V9, P565, DOI 10.1055/s-0038-1667041; Hancock SL, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038190; Hartzler Andrea L, 2015, EGEMS (Wash DC), V3, P1133, DOI 10.13063/2327-9214.1133; Hartzler AL, 2016, J AM MED INFORM ASSN, V23, P38, DOI 10.1093/jamia/ocv101; Hildon Z, 2012, PATIENT EDUC COUNS, V88, P298, DOI 10.1016/j.pec.2012.02.006; Izard J, 2014, SURGERY, V155, P789, DOI 10.1016/j.surg.2013.12.007; Jagsi R, 2013, J ONCOL PRACT, V9, pE290, DOI 10.1200/JOP.2012.000823; Kuijpers W, 2016, QUAL LIFE RES, V25, P595, DOI 10.1007/s11136-015-1107-3; Liu LH, 2020, HEALTH EXPECT, V23, P846, DOI 10.1111/hex.13057; Loth FL, 2016, PATIENT EDUC COUNS, V99, P2012, DOI 10.1016/j.pec.2016.08.004; McNair AGK, 2010, J CLIN ONCOL, V28, P738, DOI 10.1200/JCO.2009.23.9111; Nadelson S, 2014, WORLDV EVID-BASED NU, V11, P344, DOI 10.1111/wvn.12059; Oerlemans S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7079; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Ragouzeos D, 2019, PATIENT EDUC COUNS, V102, P503, DOI 10.1016/j.pec.2018.10.016; Santana MJ, 2009, PATIENT, V2, P159, DOI 10.2165/11313620-000000000-00000; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Smith KC, 2016, SUPPORT CARE CANCER, V24, P4149, DOI 10.1007/s00520-016-3240-0; Snyder C, 2019, MED CARE, V57, pS1, DOI 10.1097/MLR.0000000000001089; Snyder C, 2019, QUAL LIFE RES, V28, P345, DOI 10.1007/s11136-018-2020-3; Snyder CF, 2017, CANCER-AM CANCER SOC, V123, P1848, DOI 10.1002/cncr.30530; Snyder CF, 2011, J CLIN ONCOL, V29, P1216, DOI 10.1200/JCO.2010.33.2080; Snyder CF, 2009, LANCET, V374, P369, DOI 10.1016/S0140-6736(09)61400-8; Tolbert E, 2019, QUAL LIFE RES, V28, P609, DOI 10.1007/s11136-018-2065-3; Tolbert E, 2018, MED DECIS MAKING, V38, P994, DOI 10.1177/0272989X18791177; van Overveld LFJ, 2017, HEALTH EXPECT, V20, P1275, DOI 10.1111/hex.12567; Williams MV, 2002, FAM MED, V34, P383; Yang LY, 2018, SUPPORT CARE CANCER, V26, P41, DOI 10.1007/s00520-017-3865-7	42	14	14	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2509-8020		J PATIENT-REP OUTCOM	J. Patient-Rep. Outcomes	MAR 3	2022	6	1							18	10.1186/s41687-022-00424-3	http://dx.doi.org/10.1186/s41687-022-00424-3			41	Health Care Sciences & Services; Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	ZM0PJ	35239055	gold, Green Published			2024-09-18	WOS:000764068500001
J	Bhattacharya, A; Li, Y; Love, M				Bhattacharya, Arjun; Li, Yun; Love, Michael, I			MOSTWAS: Multi-Omic Strategies for Transcriptome-Wide Association Studies	PLOS GENETICS			English	Article							BREAST-CANCER; SUSCEPTIBILITY LOCI; EQTL ANALYSIS; TRANS-EQTLS; EXPRESSION; GENES; SCHIZOPHRENIA; MECHANISMS; IMPUTATION; FRAMEWORK	Author summary Transcriptome-wide association studies (TWAS) are a powerful strategy to study gene-trait associations by integrating genome-wide association studies (GWAS) with gene expression datasets. TWAS increases study power and interpretability by mapping genetic variants to genes. However, traditional TWAS consider only variants that are close to a gene and thus ignores important variants far away from the gene that may be involved in complex regulatory mechanisms. Here, we present MOSTWAS (Multi-Omic Strategies for TWAS), a suite of tools that extends the TWAS framework to include these distal variants. MOSTWAS leverages multi-omic data of regulatory biomarkers (transcription factors, microRNAs, epigenetics) and borrows from techniques in mediation analysis to prioritize distal variants that are around these regulatory biomarkers. Using simulations and real public data from brain tissue and breast tumors, we show that MOSTWAS improves upon traditional TWAS in both predictive performance and power to detect gene-trait associations. MOSTWAS also aids in identifying possible mechanisms for gene regulation using a novel added-last test that assesses the added information gained from the distal variants beyond the local association. In conclusion, our method aids in detecting important risk genes for traits and disorders and the possible complex interactions underlying genetic regulation within a tissue. Traditional predictive models for transcriptome-wide association studies (TWAS) consider only single nucleotide polymorphisms (SNPs) local to genes of interest and perform parameter shrinkage with a regularization process. These approaches ignore the effect of distal-SNPs or other molecular effects underlying the SNP-gene association. Here, we outline multi-omics strategies for transcriptome imputation from germline genetics to allow more powerful testing of gene-trait associations by prioritizing distal-SNPs to the gene of interest. In one extension, we identify mediating biomarkers (CpG sites, microRNAs, and transcription factors) highly associated with gene expression and train predictive models for these mediators using their local SNPs. Imputed values for mediators are then incorporated into the final predictive model of gene expression, along with local SNPs. In the second extension, we assess distal-eQTLs (SNPs associated with genes not in a local window around it) for their mediation effect through mediating biomarkers local to these distal-eSNPs. Distal-eSNPs with large indirect mediation effects are then included in the transcriptomic prediction model with the local SNPs around the gene of interest. Using simulations and real data from ROS/MAP brain tissue and TCGA breast tumors, we show considerable gains of percent variance explained (1-2% additive increase) of gene expression and TWAS power to detect gene-trait associations. This integrative approach to transcriptome-wide imputation and association studies aids in identifying the complex interactions underlying genetic regulation within a tissue and important risk genes for various traits and disorders.	[Bhattacharya, Arjun] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Li, Yun; Love, Michael, I] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Li, Yun; Love, Michael, I] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA	University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Love, M (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA.; Love, M (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.		Bhattacharya, Arjun/AAN-2986-2021	Love, Michael/0000-0001-8401-0545; Bhattacharya, Arjun/0000-0003-1196-4385; Li, Yun/0000-0002-9275-4189	National Institute of Environmental Health Sciences [P30-ES010126]; National Heart, Lung, and Blood Institute [R01-HL129132, R01-HL146500]; National Institute of General Medical Sciences [R01-GM105785]; National Institute of Child Health and Human Development [U54-HD079124]; National Cancer Institute [P01-CA142538]; National Institute of Mental Health [R01-MH118349]; French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm; Institut Pasteur de Lille; Universite de Lille 2; Lille University Hospital; Medical Research Council [503480]; Alzheimer's Research UK [503176]; Wellcome Trust [082604/2/07/Z]; German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) [01GI0102, 01GI0711, 01GI0420]; NIH/NIA [R01 AG033193, U01AG032984, U24 AG021886, U01 AG016976]; NIA [AG081220]; AGES [N01-AG-12100]; NHLBI [R01 HL105756]; Icelandic Heart Association; Erasmus Medical Center and Erasmus University; Alzheimer's Association [ADGC-10-196728]; National Institute on Aging [AG034504, AG041232]; Cancer Research UK [C1287/A16563, C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565]; European Union [634935, 633784]; European Community [223175 [HEALTHF2-2009-223175]]; National Institutes of Health [CA128978]; Post-Cancer GWAS initiative [1U19CA148537, 1U19 CA148065-01, 1U19 CA148112]; Department of Defense [W81XWH-10-1-0341]; Canadian Institutes of Health Research CIHR [PSR-SIIRI-701];  [U01MH103339];  [U01MH103365];  [U01MH103392];  [U01MH103340];  [U01MH103346];  [R01MH105472];  [R01MH094714];  [R01MH105898];  [R21MH102791];  [R21MH105881];  [R21MH103877];  [P50MH106934]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur de Lille; Universite de Lille 2; Lille University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Wellcome Trust(Wellcome Trust); German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND)(Federal Ministry of Education & Research (BMBF)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGES; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Icelandic Heart Association; Erasmus Medical Center and Erasmus University; Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Research UK(Cancer Research UK); European Union(European Union (EU)); European Community; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-Cancer GWAS initiative; Department of Defense(United States Department of Defense); Canadian Institutes of Health Research CIHR(Canadian Institutes of Health Research (CIHR)); ; ; ; ; ; ; ; ; ; ; ; 	A.B. is supported by the National Institute of Environmental Health Sciences (P30-ES010126, https://www.niehs.nih.gov/), Y.L. is partially supported by the National Heart, Lung, and Blood Institute (R01-HL129132, https://www.nhlbi.nih.gov/), the National Institute of General Medical Sciences (R01-GM105785, https://www.nigms.nih.gov/), the National Heart, Lung, and Blood Institute (R01-HL146500, https://www.nhlbi.nih.gov/), and the National Institute of Child Health and Human Development (U54-HD079124, https://www.nichd.nih.gov/). M.I.L.is supported by the National Cancer Institute (P01-CA142538, https://www.cancer.gov/), the National Institute of Environmental Health Sciences (P30-ES010126, https://www.niehs.nih.gov/), and the National Institute of Mental Health (R01-MH118349, https://www.nimh.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Melissa Troester, Colin Begg, Terry Furey, Michael Gandal, Sasha Gusev, Karen Mohlke, Brandon Pierce, Bogdan Pasaniuc, Hudson Santos, Jason Stein, and Cindy Wen for engaging conversation and guidance during the research process. We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients, and their families. The iSelect chips were funded by the French National Foundation on Alzheimer's disease and related disorders. EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Institut Pasteur de Lille, Universite de Lille 2 and the Lille University Hospital. GERAD was supported by the Medical Research Council (Grant no 503480), Alzheimer's Research UK (Grant no 503176), the Wellcome Trust (Grant no 082604/2/07/Z) and German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) grant no 01GI0102, 01GI0711, 01GI0420. CHARGE was partly supported by the NIH/NIA grant R01 AG033193 and the NIA AG081220 and AGES contract N01-AG-12100, the NHLBI grant R01 HL105756, the Icelandic Heart Association, and the Erasmus Medical Center and Erasmus University. ADGC was supported by the NIH/NIA grants: U01AG032984, U24 AG021886, U01 AG016976, and the Alzheimer's Association grant ADGC-10-196728. We also thank the Psychiatric Genomics Consortium for their publicly available GWAS summary statistics (https://www.med.unc.edu/pgc/) and the Pickrell Lab at the New York Genome Center for their GWAS browser and GWAX summary statistics (http://gwasbrowser.nygenome.org/downloads/gwas-browser/). We thank the PsychENCODE project for sharing their eQTL dataset for external validation of models. Data were generated as part of the PsychENCODE Consortium supported by: U01MH103339, U01MH103365, U01MH103392, U01MH103340, U01MH103346, R01MH105472, R01MH094714, R01MH105898, R21MH102791, R21MH105881, R21MH103877, and P50MH106934 awarded to: Schahram Akbarian (Icahn School of Medicine at Mount Sinai), Gregory Crawford (Duke), Stella Dracheva (Icahn School of Medicine at Mount Sinai), Peggy Farnham (USC), Mark Gerstein (Yale), Daniel Geschwind (UCLA), Thomas M. Hyde (LIBD), Andrew Jaffe (LIBD), James A. Knowles (USC), Chunyu Liu (UIC), Dalila Pinto (Icahn School of Medicine at Mount Sinai), Nenad Sestan (Yale), Pamela Sklar (Icahn School of Medicine at Mount Sinai), Matthew State (UCSF), Patrick Sullivan (UNC), Flora Vaccarino (Yale), Sherman Weissman (Yale), Kevin White (UChicago) and Peter Zandi (JHU). We thank the members of the ROSMAP project for providing their publicly available data. The ROSMAP project was supported by funding from the National Institute on Aging (AG034504 and AG041232). Funding for BCAC and iCOGS came from: Cancer Research UK [grant numbers C1287/A16563, C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565], the European Union's Horizon 2020 Research and Innovation Programme (grant numbers 634935 and 633784 for BRIDGES and B-CAST respectively), the European Community's Seventh Framework Programme under grant agreement n degrees 223175 [HEALTHF2-2009-223175] (COGS), the National Institutes of Health [CA128978] and Post-Cancer GWAS initiative [1U19CA148537, 1U19 CA148065-01 (DRIVE) and 1U19 CA148112-the GAME-ON initiative], the Department of Defense [W81XWH-10-1-0341], and the Canadian Institutes of Health Research CIHR) for the CIHR Team in Familial Risks of Breast Cancer [grant PSR-SIIRI-701]. All studies and funders as listed in Michailidou K et al (2013 and 2015) and in Guo Q et al (2015) are acknowledged for their contributions.	Ahmad DAJ, 2016, BREAST CANCER RES TR, V159, P457, DOI 10.1007/s10549-016-3967-9; Bao FF, 2017, CELL CYCLE, V16, P2073, DOI 10.1080/15384101.2017.1361064; Bengtsson H., 2019, future: Unified parallel and distributed processing in R for everyone Version 1.14.0; Bennett D A., 2013, Current Alzheimer Research, V9, P646, DOI 10.2174/156720512801322663; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Bhattacharya A., 2020, MOSTWAS MODELS TWAS, DOI [10.5281/ZENODO.4314067, DOI 10.5281/ZENODO.4314067]; Bhattacharya A, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1942-6; Bischl B., 2015, J STAT SOFTW, V64, P1; Blauwendraat C, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0320-1; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Brynedal B, 2017, AM J HUM GENET, V100, P581, DOI 10.1016/j.ajhg.2017.02.004; Chang F, 2018, CANCER SCI, V109, P3428, DOI 10.1111/cas.13786; Chen L, 2018, MOL THER-METH CLIN D, V10, P57, DOI 10.1016/j.omtm.2018.06.007; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; De Jager PL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.142; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Ding B, 2020, bioRxiv, DOI [10.1101/2020.07.19.211151, 10.1101/2020.07.19.211151, DOI 10.1101/2020.07.19.211151]; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Guo Q, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv081; Guo XY, 2018, AM J HUM GENET, V102, P890, DOI 10.1016/j.ajhg.2018.03.016; Gusev A, 2018, NAT GENET, V50, P538, DOI 10.1038/s41588-018-0092-1; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; He YP, 2017, P NATL ACAD SCI USA, V114, pE1633, DOI 10.1073/pnas.1618353114; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Idaghdour Y., 2019, SINGLE CELL EQTLGEN; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Khan S, 2018, ONCOTARGET, V9, P4249, DOI 10.18632/oncotarget.22747; Ko JY, 2017, MOL CELLS, V40, P169, DOI 10.14348/molcells.2017.0033; Köster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambertz I, 2015, CLIN CANCER RES, V21, P3327, DOI 10.1158/1078-0432.CCR-14-2024; Lee Gunhee, 2017, Genomics & Informatics, V15, P156; Lin GN, 2015, NEURON, V85, P742, DOI 10.1016/j.neuron.2015.01.010; Liu JZ, 2017, NAT GENET, V49, P325, DOI 10.1038/ng.3766; Liu XY, 2019, CELL, V177, P1022, DOI 10.1016/j.cell.2019.04.014; Mackinnon David P, 2004, Multivariate Behav Res, V39, P99; Mamoor S., 2020, OSF PREPRINTS, DOI [10.31219/OSF.IO/R6UYD, DOI 10.31219/OSF.IO/R6UYD]; Mancuso N, 2019, NAT GENET, V51, P675, DOI 10.1038/s41588-019-0367-1; Matsubara M, 2016, ONCOTARGET, V7, P31602, DOI 10.18632/oncotarget.9395; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nagpal S, 2019, AM J HUM GENET, V105, P258, DOI 10.1016/j.ajhg.2019.05.018; Ni Y, 2017, HUM MOL GENET, V26, P243, DOI 10.1093/hmg/ddw382; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pierce BL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03209-9; Pierce BL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004818; Pinu FR, 2019, METABOLITES, V9, DOI 10.3390/metabo9040076; Piro RM, 2011, EUR J HUM GENET, V19, P1173, DOI 10.1038/ejhg.2011.96; Preacher KJ, 2012, COMMUN METHODS MEAS, V6, P77, DOI 10.1080/19312458.2012.679848; Privé F, 2018, BIOINFORMATICS, V34, P2781, DOI 10.1093/bioinformatics/bty185; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radisky ES, 2015, FRONT BIOSCI-LANDMRK, V20, P1144, DOI 10.2741/4364; Raj T, 2018, NAT GENET, V50, P1584, DOI 10.1038/s41588-018-0238-1; Reitz C, 2014, FUTUR NEUROL, V9, P119, DOI 10.2217/FNL.14.1; Saha Ashis, 2018, F1000Res, V7, P1860, DOI 10.12688/f1000research.17145.1; Sey NYA., 2020, NAT NEUROSCI, V1, P11, DOI [10.1038/s41593-019-0563-4, DOI 10.1038/S41593-019-0563-4]; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shan NY, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2651-6; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Sinnott-Armstrong N., 2020, BIORXIV, DOI [10.1101/2020.04.20.051631, DOI 10.1101/2020.04.20.051631]; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI DOI 10.2307/270723; Teng XC, 2019, CNS NEUROSCI THER, V25, P887, DOI 10.1111/cns.13156; Thomson LMF., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Van Der Wijst MGP, 2020, ELIFE, V9, DOI 10.7554/eLife.52155; Viana J, 2017, HUM MOL GENET, V26, P210, DOI 10.1093/hmg/ddw373; Waldmann Patrik, 2013, Frontiers in Genetics, V4, P270, DOI 10.3389/fgene.2013.00270; Wang DF, 2018, SCIENCE, V362, DOI 10.1126/science.aat8464; Wason JMS, 2012, AM J HUM GENET, V90, P760, DOI 10.1016/j.ajhg.2012.03.007; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3; Yang F., 2019, PREPRINT NOT PEER RE, P803106, DOI [10.1101/803106, DOI 10.1101/803106]; Yang F, 2017, GENOME RES, V27, P1859, DOI 10.1101/gr.216754.116; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yao J, 2018, J CELL BIOCHEM, V119, P680, DOI 10.1002/jcb.26231; Yao ZX, 2020, CANCER RES, V80, DOI 10.1158/1538-7445.AM2020-162; Yuan XZ., 2017, J ALZHEIMERS DIS, P303, DOI [10.3233/JAD-170061, DOI 10.3233/JAD-170061]; Zeng Y., 2017, The bigLASSO Package: A Memory-and Computation-Efficient Solver for LASSO Model Fitting with Big Data in R; Zhang F., 2020, P 2019 INT C IND, V244; Zhang W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11874-7; Zhou J, 2018, NAT GENET, V50, P1171, DOI 10.1038/s41588-018-0160-6; Zhou JX, 2016, ONCOTARGET, V7, P7415, DOI 10.18632/oncotarget.7294	89	38	41	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	MAR	2021	17	3							e1009398	10.1371/journal.pgen.1009398	http://dx.doi.org/10.1371/journal.pgen.1009398			30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU3PX	33684137	Green Published, gold, Green Submitted			2024-09-18	WOS:000627195900002
J	Karabacak, M; Schupper, AJ; Carr, MT; Bhimani, AD; Steinberger, J; Margetis, K				Karabacak, Mert; Schupper, Alexander J.; Carr, Matthew T.; Bhimani, Abhiraj D.; Steinberger, Jeremy; Margetis, Konstantinos			Development and internal validation of machine learning models for personalized survival predictions in spinal cord glioma patients	SPINE JOURNAL			English	Article						Artificial intelligence; Machine learning; Online calculator; Personalized medicine; Prognostic modeling; Pre- cision oncology; Spinal glioma; Survival prediction	PROGNOSTIC-FACTORS; MANAGEMENT; DIAGNOSIS; AREA	BACKGROUND CONTEXT: Numerous factors have been associated with the survival outcomes in patients with spinal cord gliomas (SCG). Recognizing these specific determinants is crucial, yet it is also vital to establish a reliable and precise prognostic model for estimating individual survival outcomes. OBJECTIVE: The objectives of this study are twofold: first, to create an array of interpretable machine learning (ML) models developed for predicting survival outcomes among SCG patients; and second, to integrate these models into an easily navigable online calculator to showcase their prospective clinical applicability. STUDY DESIGN: This was a retrospective, population-based cohort study aiming to predict the outcomes of interest, which were binary categorical variables, in SCG patients with ML models. PATIENT SAMPLE: The National Cancer Database (NCDB) was utilized to identify adults aged 18 years or older who were diagnosed with histologically confirmed SCGs between 2010 and 2019. OUTCOME MEASURES: The outcomes of interest were survival outcomes at three specific time points postdiagnosis: 1, 3, and 5 years. These outcomes were formed by combining the "Vital Status" and "Last Contact or Death (Months from Diagnosis)" variables. Model performance was evaluated visually and numerically. The visual evaluation utilized receiver operating characteristic (ROC) curves, precision-recall curves (PRCs), and calibration curves. The numerical evaluation involved metrics such as sensitivity, specificity, accuracy, area under the PRC (AUPRC), area under the ROC curve (AUROC), and Brier Score. METHODS: We employed five ML algorithms - TabPFN, CatBoost, XGBoost, LightGBM, and Random Forest - along with the Optuna library for hyperparameter optimization. The models that yielded the highest AUROC values were chosen for integration into the online calculator. To enhance the explicability of our models, we utilized SHapley Additive exPlanations (SHAP) for assessing the relative significance of predictor variables and incorporated partial dependence plots (PDPs) to delineate the influence of singular variables on the predictions made by the top performing models. RESULTS: For the 1-year survival analysis, 4,913 patients [5.6% with 1-year mortality]; for the 3year survival analysis, 4,027 patients (11.5% with 3-year mortality]; and for the 5-year survival analysis, 2,854 patients (20.4% with 5-year mortality) were included. The top models achieved AUROCs of 0.938 for 1-year mortality (TabPFN), 0.907 for 3-year mortality (LightGBM), and 0.902 for 5-year mortality (Random Forest). Global SHAP analyses across survival outcomes at different time points identified histology, tumor grade, age, surgery, radiotherapy, and tumor size as the most significant predictor variables for the top -performing models. CONCLUSIONS: This study demonstrates ML techniques can develop highly accurate prognostic models for SCG patients with excellent discriminatory ability. The interactive online calculator provides a tool for assessment by physicians (https://huggingface.co/spaces/MSHS-NeurosurgeryResearch/NCDB-SCG). Local interpretability informs prediction influences for a given individual. External validation across diverse datasets could further substantiate potential utility and generalizability. This robust, interpretable methodology aligns with the goals of precision medicine, establishing a foundation for continued research leveraging ML's predictive power to enhance patient counseling. (c) 2024 Elsevier Inc. All rights reserved.	[Karabacak, Mert; Schupper, Alexander J.; Carr, Matthew T.; Bhimani, Abhiraj D.; Steinberger, Jeremy; Margetis, Konstantinos] Mount Sinai Hlth Syst, Dept Neurosurg, 1468 Madison Ave, New York, NY 10029 USA		Margetis, K (corresponding author), Mount Sinai Hlth Syst, Dept Neurosurg, 1468 Madison Ave, New York, NY 10029 USA.	Konstantinos.Margetis@mountsinai.org	Karabacak, Mert/HMW-1735-2023	Margetis, Konstantinos/0000-0002-3715-8093; Karabacak, Mert/0000-0002-9263-9893				Adams H, 2012, SPINE, V37, pE727, DOI 10.1097/BRS.0b013e31824584c0; Akiba T, 2019, Arxiv, DOI [arXiv:1907.10902, DOI 10.48550/ARXIV.1907.10902]; Balachandran VP, 2015, LANCET ONCOL, V16, pE173, DOI 10.1016/S1470-2045(14)71116-7; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Callegaro D, 2017, CANCER-AM CANCER SOC, V123, P2802, DOI 10.1002/cncr.30721; Campello C, 2021, REV NEUROL-FRANCE, V177, P515, DOI 10.1016/j.neurol.2021.02.384; Chalif EJ, 2023, SPINE J, V23, P1015, DOI 10.1016/j.spinee.2023.02.010; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.7326/M14-0698, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1038/bjc.2014.639, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1016/j.jclinepi.2014.11.010, 10.1016/j.eururo.2014.11.025]; Cruz JA, 2006, CANCER INFORM, V2, P59; Diaz-Aguilar D, 2019, J CLIN NEUROSCI, V61, P14, DOI 10.1016/j.jocn.2018.11.025; Fröhlich H, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1122-7; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 2015, SPRINGER SER STAT, P399, DOI 10.1007/978-3-319-19425-7_17; Helal A, 2022, OPER NEUROSURG, V22, P106, DOI 10.1227/ONS.0000000000000084; Hersh AM, 2022, J NEURO-ONCOL, V158, P117, DOI 10.1007/s11060-022-04017-4; Hollmann N, 2023, Arxiv, DOI [arXiv:2207.01848, DOI 10.48550/ARXIV.2207.01848]; Karabacak M, 2023, CANCERS, V15, DOI 10.3390/cancers15030812; Ke GL, 2017, ADV NEUR IN, V30; Kotecha R, 2019, NEURO-ONCOLOGY, V21, P707, DOI 10.1093/neuonc/noz014; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kuo CC, 2024, J NEUROSURG-PEDIATR, V33, DOI 10.3171/2023.8.PEDS2352; Liu H, 2023, TURK NEUROSURG, V33, P626, DOI 10.5137/1019-5149.JTN.41103-22.1; Lundberg SM, 2017, ADV NEUR IN, V30; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Milano MT, 2010, J NEURO-ONCOL, V98, P83, DOI 10.1007/s11060-009-0054-7; Musolf AM, 2022, HUM GENET, V141, P1515, DOI 10.1007/s00439-021-02402-z; Niculescu-Mizil A., 2005, P 22 INT C MACH LEAR, P625, DOI [10.1145/1102351.1102430, DOI 10.1145/1102351.1102430]; Ostrom QT, 2022, NEURO-ONCOLOGY, V24, pv1, DOI 10.1093/neuonc/noac202; Platt JC, 2000, ADV NEUR IN, P61; Prokhorenkova L, 2019, Arxiv, DOI [arXiv:1706.09516, DOI 10.48550/ARXIV.1706.09516]; Ryu SM, 2019, WORLD NEUROSURG, V124, pE331, DOI 10.1016/j.wneu.2018.12.091; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Wang CW, 2020, WORLD NEUROSURG, V143, pE149, DOI 10.1016/j.wneu.2020.07.049; Xiao R, 2016, CLIN NEUROL NEUROSUR, V144, P82, DOI 10.1016/j.clineuro.2016.03.009; Yuan CH, 2020, J NEUROSURG-SPINE, V35, P651, DOI 10.3171/2021.1.SPINE202017	39	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN	2024	24	6					1065	1076		10.1016/j.spinee.2024.02.002	http://dx.doi.org/10.1016/j.spinee.2024.02.002		MAY 2024	12	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	TP2Z8	38365005				2024-09-18	WOS:001242411900001
J	Sheikhalishahi, S; Miotto, R; Dudley, JT; Lavelli, A; Rinaldi, F; Osmani, V				Sheikhalishahi, Seyedmostafa; Miotto, Riccardo; Dudley, Joel T.; Lavelli, Alberto; Rinaldi, Fabio; Osmani, Venet			Natural Language Processing of Clinical Notes on Chronic Diseases: Systematic Review	JMIR MEDICAL INFORMATICS			English	Review						electronic health records; clinical notes; chronic diseases; natural language processing; machine learning; deep learning; heart disease; stroke; cancer; diabetes; lung disease	ELECTRONIC MEDICAL-RECORDS; CORONARY-ARTERY-DISEASE; HEALTH RECORDS; INFORMATION EXTRACTION; RISK-FACTORS; HEART-DISEASE; AUTOMATIC IDENTIFICATION; NEGATION DETECTION; EJECTION FRACTION; RADIOLOGY REPORTS	Background: Novel approaches that complement and go beyond evidence-based medicine are required in the domain of chronic diseases, given the growing incidence of such conditions on the worldwide population. A promising avenue is the secondary use of electronic health records (EHRs), where patient data are analyzed to conduct clinical and translational research. Methods based on machine learning to process EHRs are resulting in improved understanding of patient clinical trajectories and chronic disease risk prediction, creating a unique opportunity to derive previously unknown clinical insights. However, a wealth of clinical histories remains locked behind clinical narratives in free-form text. Consequently, unlocking the full potential of EHR data is contingent on the development of natural language processing (NLP) methods to automatically transform clinical text into structured clinical data that can guide clinical decisions and potentially delay or prevent disease onset. Objective: The goal of the research was to provide a comprehensive overview of the development and uptake of NLP methods applied to free-text clinical notes related to chronic diseases, including the investigation of challenges faced by NLP methodologies in understanding clinical narratives. Methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed and searches were conducted in 5 databases using "clinical notes," " natural language processing," and " chronic disease" and their variations as keywords to maximize coverage of the articles. Results: Of the 2652 articles considered, 106 met the inclusion criteria. Review of the included papers resulted in identification of 43 chronic diseases, which were then further classified into 10 disease categories using the International Classification of Diseases, 10th Revision. The majority of studies focused on diseases of the circulatory system (n=38) while endocrine and metabolic diseases were fewest (n=14). This was due to the structure of clinical records related to metabolic diseases, which typically contain much more structured data, compared with medical records for diseases of the circulatory system, which focus more on unstructured data and consequently have seen a stronger focus of NLP. The review has shown that there is a significant increase in the use of machine learning methods compared to rule-based approaches; however, deep learning methods remain emergent (n=3). Consequently, the majority of works focus on classification of disease phenotype with only a handful of papers addressing extraction of comorbidities from the free text or integration of clinical notes with structured data. There is a notable use of relatively simple methods, such as shallow classifiers (or combination with rule-based methods), due to the interpretability of predictions, which still represents a significant issue for more complex methods. Finally, scarcity of publicly available data may also have contributed to insufficient development of more advanced methods, such as extraction of word embeddings from clinical notes. Conclusions: Efforts are still required to improve (1) progression of clinical NLP methods from extraction toward understanding; (2) recognition of relations among entities rather than entities in isolation; (3) temporal extraction to understand past, current, and future clinical events; (4) exploitation of alternative sources of clinical knowledge; and (5) availability of large-scale, de-identified clinical corpora.	[Sheikhalishahi, Seyedmostafa; Osmani, Venet] Fdn Bruno Kessler Res Inst, eHlth Res Grp, Trento, Italy; [Sheikhalishahi, Seyedmostafa] Univ Trento, Dept Informat Engn & Comp Sci, Trento, Italy; [Miotto, Riccardo; Dudley, Joel T.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Inst Next Generat Healthcare, New York, NY 10029 USA; [Lavelli, Alberto] Fdn Bruno Kessler Res Inst, NLP Res Grp, Trento, Italy; [Rinaldi, Fabio] Univ Zurich, Inst Computat Linguist, Zurich, Switzerland	Fondazione Bruno Kessler; University of Trento; Icahn School of Medicine at Mount Sinai; Fondazione Bruno Kessler; University of Zurich	Osmani, V (corresponding author), Fdn Bruno Kessler Res Inst, EHlth Res Grp, Via Sommarive 18, I-38123 Povo, Trento, Italy.	vosmani@fbk.eu	Rinaldi, Fabio/AAZ-8560-2021	Osmani, Venet/0000-0001-7306-2972; Miotto, Riccardo/0000-0002-7815-6000; Dudley, Joel/0000-0002-7036-6492; Rinaldi, Fabio/0000-0001-5718-5462; Lavelli, Alberto/0000-0002-7175-6804; Sheikhalishahi, Seyedmostafa/0000-0002-0121-0160	European Union [769765]; H2020 Societal Challenges Programme [769765] Funding Source: H2020 Societal Challenges Programme	European Union(European Union (EU)); H2020 Societal Challenges Programme(Horizon 2020European Union (EU)H2020 Societal Challenges Programme)	This work was partially supported by the European Union's Horizon 2020 research and innovation program under grant agreement #769765.	Abbe A, 2016, INT J METH PSYCH RES, V25, P86, DOI 10.1002/mpr.1481; Abhyankar S, 2014, J AM MED INFORM ASSN, V21, P801, DOI 10.1136/amiajnl-2013-001915; Afzal M, 2017, TELEMED E-HEALTH, V23, P404, DOI 10.1089/tmj.2016.0157; Afzal N, 2018, INT J MED INFORM, V111, P83, DOI 10.1016/j.ijmedinf.2017.12.024; Afzal N, 2017, J VASC SURG, V65, P1753, DOI 10.1016/j.jvs.2016.11.031; Al-Haddad MA, 2010, HPB, V12, P688, DOI 10.1111/j.1477-2574.2010.00235.x; Alnazzawi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162287; American Heart Association, TYP HEART FAIL; Ananda-Rajah MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107797; [Anonymous], 2014, WHO: Global Status Report on Noncommunicable Disease. [pdf]; Ashish N, 2014, HEALTH INFORM J, V20, P288, DOI 10.1177/1460458213494032; Backenroth D, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0575-5; Baechle Christopher, 2017, Journal of Big Data, V4, DOI 10.1186/s40537-017-0067-6; BARNETT GO, 1987, JAMA-J AM MED ASSOC, V258, P67, DOI 10.1001/jama.258.1.67; Boytcheva S, 2015, CYBERN INF TECHNOL, V15, P58, DOI 10.1515/cait-2015-0055; Bozkurt S, 2015, J AM MED INFORM ASSN, V22, pE81, DOI 10.1136/amiajnl-2014-003009; Buchan K, 2017, J BIOMED INFORM, V72, P23, DOI 10.1016/j.jbi.2017.06.019; Byrd RJ, 2014, INT J MED INFORM, V83, P983, DOI 10.1016/j.ijmedinf.2012.12.005; Carrell DS, 2014, AM J EPIDEMIOL, V179, P749, DOI 10.1093/aje/kwt441; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Castro SM, 2017, J BIOMED INFORM, V69, P177, DOI 10.1016/j.jbi.2017.04.011; Chang EK, 2016, J CLIN GASTROENTEROL, V50, P889, DOI 10.1097/MCG.0000000000000583; Chang NW, 2015, J BIOMED INFORM, V58, pS150, DOI 10.1016/j.jbi.2015.09.013; Chapman BE, 2011, J BIOMED INFORM, V44, P728, DOI 10.1016/j.jbi.2011.03.011; Chase HS, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0418-4; Chen QC, 2015, J BIOMED INFORM, V58, pS158, DOI 10.1016/j.jbi.2015.09.002; Chen Wei, 2016, J Pathol Inform, V7, P46; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Chiticariu Laura, 2013, EMNLP; Cronin RM, 2017, INT J MED INFORM, V105, P110, DOI 10.1016/j.ijmedinf.2017.06.004; Denny JC, 2012, MED DECIS MAKING, V32, P188, DOI 10.1177/0272989X11400418; Denny JC, 2010, J AM MED INFORM ASSN, V17, P383, DOI 10.1136/jamia.2010.004804; Figueroa RL, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0548-8; Flynn RWV, 2010, PHARMACOEPIDEM DR S, V19, P843, DOI 10.1002/pds.1981; Ford E, 2016, J AM MED INFORM ASSN, V23, P1007, DOI 10.1093/jamia/ocv180; Garcelon N, 2017, J AM MED INFORM ASSN, V24, P607, DOI 10.1093/jamia/ocw144; Garvin JH, 2012, J AM MED INFORM ASSN, V19, P859, DOI 10.1136/amiajnl-2011-000535; Garvin JH, 2018, JMIR MED INF, V6, DOI 10.2196/medinform.9150; Gaskin GL, 2016, EUR J OPHTHALMOL, V26, P328, DOI 10.5301/ejo.5000706; Geraci J, 2017, EVID-BASED MENT HEAL, V20, P83, DOI 10.1136/eb-2017-102688; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Goldstein BA, 2017, J AM MED INFORM ASSN, V24, P198, DOI 10.1093/jamia/ocw042; Heintzelman NH, 2013, J AM MED INFORM ASSN, V20, P898, DOI 10.1136/amiajnl-2012-001076; Jensen K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46226; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jonnagaddala J, 2014, TECHNOLOGIES APPL AR, P219, DOI DOI 10.1007/978-3-319-13987-6_21; Jonnagaddala J, 2015, J BIOMED INFORM, V58, pS203, DOI 10.1016/j.jbi.2015.08.003; Jonnagaddala J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/636371; Jouhet V, 2012, METHOD INFORM MED, V51, P242, DOI 10.3414/ME11-01-0005; Karystianis G, 2015, J BIOMED INFORM, V58, pS183, DOI 10.1016/j.jbi.2015.06.013; Kasthurirathne SN, 2017, J BIOMED INFORM, V69, P160, DOI 10.1016/j.jbi.2017.04.008; Kim Y, 2017, J BIOMED INFORM, V67, P42, DOI 10.1016/j.jbi.2017.01.017; Kreimeyer K, 2017, J BIOMED INFORM, V73, P14, DOI 10.1016/j.jbi.2017.07.012; Kruse Clemens Scott, 2016, JMIR Med Inform, V4, pe19, DOI 10.2196/medinform.5525; Kullo IJ, 2010, J AM MED INFORM ASSN, V17, P568, DOI 10.1136/jamia.2010.004366; Leeper NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063499; Liao KP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136651; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]; Lin FPY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07111-0; Luo Y, 2014, J AM MED INFORM ASSN, V21, P824, DOI 10.1136/amiajnl-2013-002443; Miller T, 2017, J BIOMED INFORM, V69, P251, DOI 10.1016/j.jbi.2017.04.015; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Mishra NK, 2012, CLIN MED RES, V10, P106, DOI 10.3121/cmr.2012.1047; Mykowiecka A, 2009, J BIOMED INFORM, V42, P923, DOI 10.1016/j.jbi.2009.07.007; Napolitano G, 2016, ARTIF INTELL MED, V70, P77, DOI 10.1016/j.artmed.2016.06.001; Nath C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153749; Ni YZ, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0149-3; Nunes AP, 2016, DIABETES RES CLIN PR, V121, P192, DOI 10.1016/j.diabres.2016.09.012; Osborne JD, 2016, J AM MED INFORM ASSN, V23, P1077, DOI 10.1093/jamia/ocw006; Ou Y, 2014, HIKM 14 P 7 AUSTR WO; Ou Y, 2015, ARTIF INTELL MED, V64, P41, DOI 10.1016/j.artmed.2015.03.001; Pakhomov SVS, 2008, J AM MED INFORM ASSN, V15, P198, DOI 10.1197/jamia.M2585; Pakhomov Sergeui, 2008, AMIA Annu Symp Proc, P545; Pakhomov S, 2007, AM J MANAG CARE, V13, P281; Pakhomov Serguei Vs, 2010, Inform Prim Care, V18, P125; Patterson OV, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0580-8; Ping XO, 2013, TELEMED E-HEALTH, V19, P704, DOI 10.1089/tmj.2012.0241; Pivovarov R, 2012, J BIOMED INFORM, V45, P471, DOI 10.1016/j.jbi.2012.01.002; Pons E, 2016, RADIOLOGY, V279, P329, DOI 10.1148/radiol.16142770; Popejoy LL, 2015, J AM MED INFORM ASSN, V22, pE93, DOI 10.1136/amiajnl-2014-002702; Roberts K, 2015, J BIOMED INFORM, V58, pS111, DOI 10.1016/j.jbi.2015.06.010; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; Ross EG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154952; SANCHISGOMAR F, 2016, ANN TRANSL MED, V4, DOI [DOI 10.21037/ATM.2016.06.33, 10.21037/atm.2016.06.33]; Shi XB, 2016, IEEE ACCESS, V4, P7074, DOI 10.1109/ACCESS.2016.2614541; Shivade C, 2014, J AM MED INFORM ASSN, V21, P221, DOI 10.1136/amiajnl-2013-001935; Small AM, 2017, J BIOMED INFORM, V72, P77, DOI 10.1016/j.jbi.2017.06.016; Smith DH, 2008, QUAL LIFE RES, V17, P1277, DOI 10.1007/s11136-008-9399-1; Soguero-Ruiz C, 2016, IEEE J BIOMED HEALTH, V20, DOI 10.1109/JBHI.2014.2361688; Spasic I, 2014, INT J MED INFORM, V83, P605, DOI 10.1016/j.ijmedinf.2014.06.009; Teixeira PL, 2017, J AM MED INFORM ASSN, V24, P162, DOI 10.1093/jamia/ocw071; Thomas AA, 2014, WORLD J UROL, V32, P99, DOI 10.1007/s00345-013-1040-4; Tian Z, 2017, MED CARE, V55, pE73, DOI 10.1097/MLR.0000000000000346; Topaz M, 2017, WESTERN J NURS RES, V39, P147, DOI 10.1177/0193945916668493; Torii M, 2015, J BIOMED INFORM, V58, pS164, DOI 10.1016/j.jbi.2015.08.011; Turner CA, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0518-1; Viani N, 2018, INT J MED INFORM, V111, P140, DOI 10.1016/j.ijmedinf.2017.12.013; Vijayakrishnan R, 2014, J CARD FAIL, V20, P459, DOI 10.1016/j.cardfail.2014.03.008; Walsh JA, 2017, ARTHRIT CARE RES, V69, P1414, DOI 10.1002/acr.23140; Wang H, 2014, J BIOMED INFORM, V48, P130, DOI 10.1016/j.jbi.2013.12.017; Wang SV, 2017, J AM MED INFORM ASSN, V24, P339, DOI 10.1093/jamia/ocw082; Wang YS, 2018, J BIOMED INFORM, V77, P34, DOI 10.1016/j.jbi.2017.11.011; Wang Y, 2015, INT J MED INFORM, V84, P1039, DOI 10.1016/j.ijmedinf.2015.06.007; Ware H, 2009, J AM MED INFORM ASSN, V16, P585, DOI 10.1197/jamia.M3091; Warner JL, 2016, J ONCOL PRACT, V12, P157, DOI 10.1200/JOP.2015.004622; Watson AJ, 2011, PSYCHOSOMATICS, V52, P319, DOI 10.1016/j.psym.2011.02.007; Wei WQ, 2016, J AM MED INFORM ASSN, V23, pE20, DOI 10.1093/jamia/ocv130; Wei Wei-Qi, 2010, AMIA Annu Symp Proc, V2010, P857; Wright A, 2013, J AM MED INFORM ASSN, V20, P887, DOI 10.1136/amiajnl-2012-001576; Yang H, 2015, J BIOMED INFORM, V58, pS171, DOI 10.1016/j.jbi.2015.09.006; Yang H, 2009, J AM MED INFORM ASSN, V16, P596, DOI 10.1197/jamia.M3096; Ye CY, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9268; Yim WW, 2017, J ASSOC INF SCI TECH, V68, P2662, DOI 10.1002/asi.23937; Yim WW, 2016, J BIOMED INFORM, V64, P179, DOI 10.1016/j.jbi.2016.10.005; Zheng CY, 2015, CLIN THER, V37, P2048, DOI 10.1016/j.clinthera.2015.07.002; Zheng L, 2016, JMIR MED INF, V4, P38, DOI 10.2196/medinform.6328; Zhou L, 2014, APPL CLIN INFORM, V5, P349, DOI 10.4338/ACI-2013-10-RA-0080; Zopf JJ, 2012, J DIGIT IMAGING, V25, P43, DOI 10.1007/s10278-011-9425-7	119	226	239	4	111	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY East, Unit 1100, TORONTO, ON M5A 0P6, CANADA		2291-9694		JMIR MED INF	JMIR Med. Inf.	APR-JUN	2019	7	2					15	32	e12239	10.2196/12239	http://dx.doi.org/10.2196/12239			18	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Informatics	IG4MN	31066697	Green Published, gold, Green Submitted	Y	N	2024-09-18	WOS:000473777800002
J	Mokhtari, A; Casale, R; Salahuddin, Z; Paquier, Z; Guiot, T; Woodruff, HC; Lambin, P; Van Laethem, JL; Hendlisz, A; Bali, MA				Mokhtari, Ayoub; Casale, Roberto; Salahuddin, Zohaib; Paquier, Zelda; Guiot, Thomas; Woodruff, Henry C.; Lambin, Philippe; Van Laethem, Jean-Luc; Hendlisz, Alain; Bali, Maria Antonietta			Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study	DIAGNOSTICS			English	Article						radiomics; computed tomography (CT); pancreas; pancreatic ductal carcinomas; survival analyses	PROGNOSTIC-FACTORS; CANCER; BODY; SMOKING; TAIL; SEGMENTATION; ASSOCIATION; FEATURES	Highlights What are the main findings? This multicenter retrospective study, encompassing two hospital sites for training and leveraging data from forty-seven different hospitals for testing, aimed to develop machine learning models utilising both clinical and radiomics features (individually and in combination) extracted from pre-treatment CT scans. The objective was to predict PFS and OS in patients with PDAC. Among the various models developed, the model based on the combination of clinical and CT-derived tumour radiomics features demonstrated superior performance for OS with a C-index of 0.72 in the testing dataset. Conversely, the model based solely on clinical features excelled in predicting PFS, achieving a C-index of 0.70 in the testing dataset. What is the implication of the main finding? The analysis further highlighted the high relevance of clinical features both for OS and PFS outcomes in patients with PDAC.Highlights What are the main findings? This multicenter retrospective study, encompassing two hospital sites for training and leveraging data from forty-seven different hospitals for testing, aimed to develop machine learning models utilising both clinical and radiomics features (individually and in combination) extracted from pre-treatment CT scans. The objective was to predict PFS and OS in patients with PDAC. Among the various models developed, the model based on the combination of clinical and CT-derived tumour radiomics features demonstrated superior performance for OS with a C-index of 0.72 in the testing dataset. Conversely, the model based solely on clinical features excelled in predicting PFS, achieving a C-index of 0.70 in the testing dataset. What is the implication of the main finding? The analysis further highlighted the high relevance of clinical features both for OS and PFS outcomes in patients with PDAC.Abstract Purpose. This multicenter retrospective study aims to identify reliable clinical and radiomic features to build machine learning models that predict progression-free survival (PFS) and overall survival (OS) in pancreatic ductal adenocarcinoma (PDAC) patients. Methods. Between 2010 and 2020 pre-treatment contrast-enhanced CT scans of 287 pathology-confirmed PDAC patients from two sites of the Hopital Universitaire de Bruxelles (HUB) and from 47 hospitals within the HUB network were retrospectively analysed. Demographic, clinical, and survival data were also collected. Gross tumour volume (GTV) and non-tumoral pancreas (RPV) were semi-manually segmented and radiomics features were extracted. Patients from two HUB sites comprised the training dataset, while those from the remaining 47 hospitals of the HUB network constituted the testing dataset. A three-step method was used for feature selection. Based on the GradientBoostingSurvivalAnalysis classifier, different machine learning models were trained and tested to predict OS and PFS. Model performances were assessed using the C-index and Kaplan-Meier curves. SHAP analysis was applied to allow for post hoc interpretability. Results. A total of 107 radiomics features were extracted from each of the GTV and RPV. Fourteen subgroups of features were selected: clinical, GTV, RPV, clinical & GTV, clinical & GTV & RPV, GTV-volume and RPV-volume both for OS and PFS. Subsequently, 14 Gradient Boosting Survival Analysis models were trained and tested. In the testing dataset, the clinical & GTV model demonstrated the highest performance for OS (C-index: 0.72) among all other models, while for PFS, the clinical model exhibited a superior performance (C-index: 0. 70). Conclusions. An integrated approach, combining clinical and radiomics features, excels in predicting OS, whereas clinical features demonstrate strong performance in PFS prediction.	[Mokhtari, Ayoub; Casale, Roberto; Bali, Maria Antonietta] Univ Libre Bruxelles, Hop Univ Bruxelles, Inst Jules Bordet, Radiol Dept, B-1070 Brussels, Belgium; [Salahuddin, Zohaib; Woodruff, Henry C.; Lambin, Philippe] Maastricht Univ, GROW Res Inst Oncol & Reprod, Dept Precis Med, NL-6220MD Maastricht, Netherlands; [Paquier, Zelda; Guiot, Thomas] Univ Libre Bruxelles, Hop Univ Bruxelles, Inst Jules Bordet, Med Phys Dept, B-1070 Brussels, Belgium; [Woodruff, Henry C.; Lambin, Philippe] Maastricht Univ, Med Ctr, GROW Sch Oncol & Reprod, Dept Radiol & Nucl Med, NL-6229HX Maastricht, Netherlands; [Van Laethem, Jean-Luc; Hendlisz, Alain] Univ Libre Bruxelles, Hop Univ Bruxelles, Dept Gastroenterol & Digest Oncol, B-1070 Brussels, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Maastricht University; Institut Jules Bordet; Universite Libre de Bruxelles; Maastricht University; Universite Libre de Bruxelles	Mokhtari, A; Bali, MA (corresponding author), Univ Libre Bruxelles, Hop Univ Bruxelles, Inst Jules Bordet, Radiol Dept, B-1070 Brussels, Belgium.	ayoub.mokhtari@ulb.be; mbali@hubruxelles.be	Woodruff, Henry/AAS-5573-2021; Salahuddin, Zohaib/AFK-4778-2022	Paquier, Zelda/0000-0002-1041-0009; Woodruff, Henry/0000-0001-7911-5123; Lambin, Philippe/0000-0001-7961-0191; hendlisz, alain/0000-0003-2122-1948	Les amis de Bordet [degrees 952172, degrees 952103, degrees 101034347, DIGITAL-2022-CLOUD-AI-02, degrees 101100633]; European Union	Les amis de Bordet; European Union(European Union (EU))	Authors extend their sincere gratitude to Marco Brunetti for his precious and significant contributions to the field of artificial intelligence and computer science research. Authors acknowledge financial support for the Maastricht contribution from the European Union's Horizon research and innovation programme under grant agreement: CHAIMELEON n degrees 952172, EuCanImage n degrees 952103, IMI-OPTIMA n degrees 101034347, EUCAIM (DIGITAL-2022-CLOUD-AI-02) n degrees 101100633.	Abunahel BM, 2021, EUR RADIOL, V31, P3447, DOI 10.1007/s00330-020-07376-6; Ahmed TM, 2023, DIAGN INTERV IMAG, V104, P435, DOI 10.1016/j.diii.2023.03.002; Artinyan A, 2008, HPB, V10, P371, DOI 10.1080/13651820802291233; Attiyeh MA, 2019, ABDOM RADIOL, V44, P3148, DOI 10.1007/s00261-019-02112-1; Attiyeh MA, 2018, ANN SURG ONCOL, V25, P1034, DOI 10.1245/s10434-017-6323-3; Baek ET, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04103-w; Barat M, 2021, JPN J RADIOL, V39, P514, DOI 10.1007/s11604-021-01098-5; Bartoli M, 2020, JPN J RADIOL, V38, P1111, DOI 10.1007/s11604-020-01057-6; Bian Y, 2019, PANCREAS, V48, P1195, DOI 10.1097/MPA.0000000000001404; Bodalal Z, 2019, ABDOM RADIOL, V44, P1960, DOI 10.1007/s00261-019-02028-w; Brennan MF, 1996, ANN SURG, V223, P506, DOI 10.1097/00000658-199605000-00006; Cheng SH, 2019, EUR J RADIOL, V113, P188, DOI 10.1016/j.ejrad.2019.02.009; Dreyer SB, 2018, BRIT J SURG, V105, pE183, DOI 10.1002/bjs.10772; Gapstur SM, 2011, ARCH INTERN MED, V171, P444, DOI 10.1001/archinternmed.2010.536; Healy GM, 2022, EUR RADIOL, V32, P2492, DOI 10.1007/s00330-021-08314-w; Hruban RH, 2019, J PATHOL, V248, P131, DOI 10.1002/path.5260; Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z; Kaissis G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218642; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Larue RTHM, 2017, ACTA ONCOL, V56, P1544, DOI 10.1080/0284186X.2017.1351624; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; Lee SJ, 2020, PANCREATOLOGY, V20, P1486, DOI 10.1016/j.pan.2020.08.015; Li K, 2019, AM J TRANSL RES, V11, P4491; Litjens G, 2023, DIAGNOSTICS, V13, DOI 10.3390/diagnostics13203198; Lorensen WE, 1987, ACM SIGGRAPH Computer Graphics, V21, P163, DOI [DOI 10.1145/37402.37422, /10.1145/37402.37422]; Nakamura K, 2011, JPN J CLIN ONCOL, V41, P225, DOI 10.1093/jjco/hyq185; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Orlhac F, 2022, J NUCL MED, V63, P172, DOI 10.2967/jnumed.121.262464; Orlhac F, 2019, RADIOLOGY, V291, P52, DOI 10.1148/radiol.2019182023; Park S, 2021, AM J ROENTGENOL, V217, P1104, DOI 10.2214/AJR.20.23490; Park YW, 2022, EUR RADIOL, V32, P4500, DOI 10.1007/s00330-022-08575-z; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pelucchi C, 2014, PANCREAS, V43, P47, DOI 10.1097/MPA.0b013e3182a7c74b; Pölsterl S, 2020, J MACH LEARN RES, V21; Puleo F, 2018, GASTROENTEROLOGY, V155, P1999, DOI 10.1053/j.gastro.2018.08.033; Qiu WL, 2019, CANCER MANAG RES, V11, P9253, DOI 10.2147/CMAR.S218414; Racu ML, 2022, CANCER RES, V82, P86; Salahuddin Z, 2023, CANCERS, V15, DOI 10.3390/cancers15071932; Sandrasegaran K, 2019, EUR RADIOL, V29, P1067, DOI 10.1007/s00330-018-5662-1; Sanduleanu S, 2018, RADIOTHER ONCOL, V127, P349, DOI 10.1016/j.radonc.2018.03.033; Schlitter AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41064; Shen HS, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00618; Shin J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242571; Siegel RL, 2023, CA-CANCER J CLIN, V73, P17, DOI 10.3322/caac.21763; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Tempero MA, 2021, J NATL COMPR CANC NE, V19, P439, DOI 10.6004/jnccn.2021.0017; Tikhonova VS, 2023, EUR RADIOL, V33, P1152, DOI 10.1007/s00330-022-09046-1; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Wang YX, 2022, EUR RADIOL, V32, P8737, DOI 10.1007/s00330-022-08887-0; Watanabe I, 2004, PANCREAS, V28, P160, DOI 10.1097/00006676-200403000-00007; Wong JY, 2020, INT J RADIAT ONCOL, V108, pE769; Yang QX, 2022, JCO PRECIS ONCOL, V6, DOI 10.1200/PO.21.00362; Yu GP, 1997, CANCER DETECT PREV, V21, P497; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08794-1; Zhu XY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009204; Zins M, 2018, RADIOLOGY, V287, P374, DOI 10.1148/radiol.2018171670	59	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	APR	2024	14	7							712	10.3390/diagnostics14070712	http://dx.doi.org/10.3390/diagnostics14070712			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN5J5	38611625	Green Published, gold			2024-09-18	WOS:001201140000001
